FN Clarivate Analytics Web of Science
VR 1.0
PT B
AU Tourlomousis, F
   Babakhanov, A
   Ding, HZ
   Chang, RC
AF Tourlomousis, Filippos
   Babakhanov, Azizbek
   Ding, Houzhu
   Chang, Robert C.
GP ASME
TI A NOVEL MELT ELECTROSPINNING SYSTEM FOR STUDYING CELL SUBSTRATE
   INTERACTIONS
SO PROCEEDINGS OF THE ASME 10TH INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE, 2015, VOL 2
LA English
DT Proceedings Paper
CT 10th ASME International Manufacturing Science and Engineering Conference
   (MSEC2015)
CY JUN 08-12, 2015
CL Charlotte, NC
SP ASME, Mfg Engn Div
ID PHENOMENOLOGICAL OBSERVATIONS; SCAFFOLDS; CUES
AB Controlling cell behavior has generated immense attention in the fields of tissue engineering and regenerative medicine. Particular emphasis has been given to the creation of 3D biomimetic cellular microenvironments that replicate the complex nature of the extracellular matrix (ECM). A key factor that has not been rigorously deconstructed using scalable, layered manufacturing approaches is the structural dimension or scale aspect of in vitro culture models. Melt electrospinning represents a bio-additive manufacturing process that has been relatively under-reported. Although complex in nature, the melt electrospinning process can furnish a 3D cell delivery format with physiologically relevant 3D structural cues. In the present work, poly-epsilon-caprolactone (PCL) has been chosen as the biomaterial substrate. Rheological studies that guide the design phase of the reported system have been performed for the entire PCL melt processing range, implicating the governing effect of the experimental melt temperature on the scale and the topography in the final processed material. Notable challenges that arise from the nature of the process with respect to the electrospun fiber stability and resolution have been overcome through the design of a novel heating element configuration. In this paper, a reliable biofabrication process with tunable processing of the fiber diameter and alignment is reported. Fundamental parametric studies utilizing the Major processing parameters demonstrate the potential for the system to precisely fabricate 3D PCL scaffolds with microstructural features.
C1 [Tourlomousis, Filippos; Babakhanov, Azizbek; Ding, Houzhu; Chang, Robert C.] Stevens Inst Technol, Dept Mech Engn, Hoboken, NJ 07030 USA.
RP Tourlomousis, F (reprint author), Stevens Inst Technol, Dept Mech Engn, Hoboken, NJ 07030 USA.
CR Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bird R. B., 1987, DYNAMICS POLYM LIQUI
   Brown T., 2011, ADV MAT
   Brown TD, 2014, MAT SCI ENG C-MATER, V45, P698, DOI 10.1016/j.msec.2014.07.034
   Brown TD, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0013-7
   Brown TD, 2011, ADV MATER, V23, P5651, DOI 10.1002/adma.201103482
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   Dalton P., MELT ELECTROSPINNING
   Dalton PD, 2007, POLYMER, V48, P6823, DOI 10.1016/j.polymer.2007.09.037
   Dalton PD, 2013, BIOMATER SCI-UK, V1, P171, DOI 10.1039/c2bm00039c
   Dalton PD, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034109
   Detta N, 2010, POLYM INT, V59, P1558, DOI 10.1002/pi.2954
   Farooque TM, 2014, BIOMATERIALS, V35, P2558, DOI 10.1016/j.biomaterials.2013.12.092
   Farrugia BL, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025001
   Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062
   Hogue M. E., 2011, BIOPOLYMERS, V97, P83
   Hutmacher DW, 2011, CHEM-ASIAN J, V6, P44, DOI 10.1002/asia.201000436
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Ladoux B, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/11/116601
   Luo CJ, 2012, CHEM SOC REV, V41, P4708, DOI 10.1039/c2cs35083a
   Muerza-Cascante M. L., 2014, TISSUE ENG PART B-RE, P1
   Park JU, 2007, NAT MATER, V6, P782, DOI 10.1038/nmat1974
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Zhang ZG, 2014, J BIOMED MATER RES B, V102, P12, DOI 10.1002/jbm.b.32947
   Zhou HJ, 2006, POLYMER, V47, P7497, DOI 10.1016/j.polymer.2006.08.042
   Zhrnayev E, 2008, J NON-NEWTON FLUID, V153, P95, DOI 10.1016/j.jnnfm.2007.11.011
NR 29
TC 0
Z9 0
U1 1
U2 7
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5683-3
PY 2015
AR V002T03A006
PG 11
WC Engineering, Manufacturing; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BD9RJ
UT WOS:000365147200019
DA 2018-10-20
ER

PT J
AU Wu, SY
   An, SSA
   Hulme, J
AF Wu, Si-Ying
   An, Seong Soo A.
   Hulme, John
TI Current applications of graphene oxide in nanomedicine
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Review
DE imaging; green; cancer; therapy; diagnostics; antibacterial;
   cytotoxicity; contrast agent; biofunctionalization
ID PEGYLATED NANOGRAPHENE OXIDE; BONE MORPHOGENETIC PROTEIN-2;
   CHEMO-PHOTOTHERMAL THERAPY; ENHANCED RAMAN-SCATTERING; DRUG-DELIVERY;
   FUNCTIONALIZED GRAPHENE; BIOMEDICAL APPLICATIONS; IN-VIVO;
   NANO-GRAPHENE; TARGETED DELIVERY
AB Graphene has attracted the attention of the entire scientific community due to its unique mechanical and electrochemical, electronic, biomaterial, and chemical properties. The water-soluble derivative of graphene, graphene oxide, is highly prized and continues to be intensely investigated by scientists around the world. This review seeks to provide an overview of the currents applications of graphene oxide in nanomedicine, focusing on delivery systems, tissue engineering, cancer therapies, imaging, and cytotoxicity, together with a short discussion on the difficulties and the trends for future research regarding this amazing material.
C1 [Wu, Si-Ying; An, Seong Soo A.; Hulme, John] Gachon Univ, Gachon Med Res Inst, Dept Bionanotechnol, Sungnamsi, South Korea.
RP An, SSA (reprint author), Gachon Univ, Gachon Med Res Inst, Dept Bionanotechnol, San 65, Songnam 461701, South Korea.
EM seongaan@gachon.ac.kr; flp15@gachon.ac.kr
FU National Research Foundation Korea [2012014335]
FX This research was supported by the National Research Foundation Korea
   project number 2012014335.
CR Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114
   Ahluwalia A., 2013, BIONANOMATERIALS, V14, P195, DOI [10.1515/bnm-2013-0011, DOI 10.1515/BNM-2013-0011]
   Ali-Boucetta H, 2013, ADV HEALTHC MATER, V2, P433, DOI 10.1002/adhm.201200248
   Ananta JS, 2010, NAT NANOTECHNOL, V5, P815, DOI [10.1038/nnano.2010.203, 10.1038/NNANO.2010.203]
   Bai H, 2014, J PHYS CHEM C, V118, P10519, DOI 10.1021/jp503413s
   Bai H, 2010, CHEM COMMUN, V46, P2376, DOI 10.1039/c000051e
   Balcioglu M, 2015, ACS BIOMATER SCI ENG, V1, P27, DOI 10.1021/ab500029h
   Bao HQ, 2011, SMALL, V7, P1569, DOI 10.1002/smll.201100191
   Bressan E, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0296-9
   Bussy C, 2013, ACCOUNTS CHEM RES, V46, P692, DOI 10.1021/ar300199e
   Campbell S, 2015, ACS MACRO LETT, V4, P312, DOI 10.1021/acsmacrolett.5b00057
   Carpio IEM, 2012, NANOSCALE, V4, P4746, DOI 10.1039/c2nr30774j
   Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016
   Chaudhuri B, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015009
   Chen BA, 2011, J MATER CHEM, V21, P7736, DOI 10.1039/c1jm10341e
   Chen DQ, 2015, J CONTROL RELEASE, V210, P230, DOI 10.1016/j.jconrel.2015.04.021
   Chen HQ, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/16/165101
   Chen H, 2013, J THER ULTRASOUND, V1, DOI 10.1186/2050-5736-1-10
   Chen Y, 2015, CHEM SOC REV, V44, P2681, DOI 10.1039/c4cs00300d
   Chowdhury SM, 2015, J NANOMED NANOTECHNO, V11, P109
   Cianfrocca M, 2010, CANCER-AM CANCER SOC, V116, P3969, DOI 10.1002/cncr.25362
   Dallavalle M, 2015, ACS APPL MATER INTER, V7, P4406, DOI 10.1021/am508938u
   Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006
   Deepachitra R, 2015, MATER MANUF PROCESS, V30, P804, DOI 10.1080/10426914.2014.994758
   Depan D, 2011, MAT SCI ENG C-MATER, V31, P1305, DOI 10.1016/j.msec.2011.04.010
   Dinauer N, 2005, BIOMATERIALS, V26, P5898, DOI 10.1016/j.biomaterials.2005.02.038
   Ding ZJ, 2014, ACS APPL MATER INTER, V6, P19797, DOI 10.1021/am505084s
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Dubey P, 2015, ADV COLLOID INTERFAC, V221, P4, DOI 10.1016/j.cis.2015.02.007
   El-Aneed A, 2004, J CONTROL RELEASE, V94, P1, DOI 10.1016/j.jconrel.2003.09.013
   Ethirajan M, 2011, CHEM SOC REV, V40, P340, DOI 10.1039/b915149b
   Fan HL, 2010, BIOMACROMOLECULES, V11, P2345, DOI 10.1021/bm100470q
   Feng LZ, 2011, NANOMEDICINE-UK, V6, P317, DOI 10.2217/NNM.10.158
   Feng LZ, 2011, NANOSCALE, V3, P1252, DOI 10.1039/c0nr00680g
   Feng LY, 2013, ADV MATER, V25, P168, DOI 10.1002/adma.201203229
   Gao L, 2014, BIOSENS BIOELECTRON, V60, P22, DOI 10.1016/j.bios.2014.03.039
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Ge SG, 2014, SENSOR ACTUAT B-CHEM, V192, P317, DOI 10.1016/j.snb.2013.10.127
   Georgantzopoulou A., 2015, EFFECTS SILVER NANOP
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Gollavelli G, 2012, BIOMATERIALS, V33, P2532, DOI 10.1016/j.biomaterials.2011.12.010
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Gu YJ, 2015, BIOSENS BIOELECTRON, V66, P24, DOI 10.1016/j.bios.2014.10.070
   Gurunathan S, 2013, INT J NANOMED, V8, P2719, DOI 10.2147/IJN.S45174
   Gurunathan S, 2013, J IND ENG CHEM, V19, P1280, DOI 10.1016/j.jiec.2012.12.029
   Gurunathan S, 2013, INT J NANOMED, V8, P1015, DOI 10.2147/IJN.S42047
   Gurunathan S, 2012, INT J NANOMED, V7, P5901, DOI 10.2147/IJN.S37397
   Hinzmann M, 2014, INT J NANOMED, V9, P2409, DOI 10.2147/IJN.S62497
   Hong H, 2012, BIOMATERIALS, V33, P4147, DOI 10.1016/j.biomaterials.2012.02.031
   Hong SW, 2014, BIOMED RES INT, DOI 10.1155/2014/212149
   Hou WC, 2015, ENVIRON SCI TECHNOL, V49, P3435, DOI 10.1021/es5047155
   Hu WB, 2010, ACS NANO, V4, P4317, DOI 10.1021/nn101097v
   Huang J, 2012, SMALL, V8, P2577, DOI 10.1002/smll.201102743
   Huang J, 2010, NANOSCALE, V2, P2733, DOI 10.1039/c0nr00473a
   Huang N, 2015, ANAL CHIM ACTA, V853, P249, DOI 10.1016/j.aca.2014.10.016
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Huschka R, 2011, J AM CHEM SOC, V133, P12247, DOI 10.1021/ja204578e
   Jaque D, 2014, NANOSCALE, V6, P9494, DOI 10.1039/c4nr00708e
   Johannsen M, 2005, INT J HYPERTHER, V21, P637, DOI 10.1080/02656730500158360
   Josefsen LB, 2012, THERANOSTICS, V2, P916, DOI 10.7150/thno.4571
   Justin R, 2014, MAT SCI ENG C-MATER, V34, P50, DOI 10.1016/j.msec.2013.10.010
   Kakran M, 2011, CURR MED CHEM, V18, P4503, DOI 10.2174/092986711797287548
   Kanakia S, 2013, INT J NANOMED, V8, P2821, DOI 10.2147/IJN.S47062
   Karakoti A, 2010, CHEM SOC REV, V39, P4422, DOI 10.1039/b919677n
   Kim H, 2014, SMALL, V10, P117, DOI 10.1002/smll.201202636
   Kim H, 2013, ACS NANO, V7, P6735, DOI 10.1021/nn403096s
   Kim MG, 2015, BIOMATERIALS, V48, P129, DOI 10.1016/j.biomaterials.2015.01.009
   Kim SJ, 2015, ACS NANO, V9, P2677, DOI 10.1021/nn5064634
   Kim TH, 2015, ACS NANO, V9, P3780, DOI 10.1021/nn5066028
   Kim TH, 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/193401, DOI 10.1155/2014/193401]
   Kurantowicz N, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0749-y
   La WG, 2014, INT J NANOMED, V9, P107, DOI 10.2147/IJN.S50742
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Li JL, 2014, J BIOMED MATER RES A, V102, P2181, DOI 10.1002/jbm.a.34871
   Li KY, 2014, ACS APPL MATER INTER, V6, P5900, DOI 10.1021/am5008134
   Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v
   Lim DK, 2013, NANO LETT, V13, P4075, DOI 10.1021/nl4014315
   Lim HN, 2011, INT J NANOMED, V6, P1817, DOI 10.2147/IJN.S23392
   Liu HW, 2012, J MATER CHEM, V22, P17311, DOI 10.1039/c2jm32772d
   Liu JQ, 2013, ACTA BIOMATER, V9, P9243, DOI 10.1016/j.actbio.2013.08.016
   Liu KP, 2011, J MATER CHEM, V21, P12034, DOI 10.1039/c1jm10749f
   Liu QH, 2012, NANOSCALE, V4, P7084, DOI 10.1039/c2nr32525j
   Liu SB, 2011, ACS NANO, V5, P6971, DOI 10.1021/nn202451x
   Liu XH, 2014, ACS APPL MATER INTER, V6, P8173, DOI 10.1021/am500812h
   Liu YY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03469
   Liu ZM, 2013, PHYS CHEM CHEM PHYS, V15, P2961, DOI 10.1039/c2cp43715e
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Liu Z, 2011, MATER TODAY, V14, P316, DOI 10.1016/S1369-7021(11)70161-4
   Lu YJ, 2012, INT J NANOMED, V7, P1737, DOI 10.2147/IJN.S29376
   Ma J, 2012, J APPL POLYM SCI, V123, P2933, DOI 10.1002/app.34901
   Madeira C, 2015, TRENDS BIOTECHNOL, V33, P35, DOI 10.1016/j.tibtech.2014.11.003
   Mangadlao JD, 2015, CHEM COMMUN, V51, P2886, DOI 10.1039/c4cc07836e
   Mao L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03126
   Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368
   Matsusaki M, 2012, ADV MATER, V24, P454, DOI 10.1002/adma.201103698
   Mendes RG, 2013, J MATER CHEM B, V1, P401, DOI 10.1039/c2tb00085g
   Mogharabi M, 2014, J PHARM SCI, V22, DOI [10.1186/2008-2231-22-23, DOI 10.1186/2008-2231-22-23]
   Mu QX, 2012, ACS APPL MATER INTER, V4, P2259, DOI 10.1021/am300253c
   Mudavath SL, 2014, DRUG DES DEV THER, V8, P1235, DOI 10.2147/DDDT.S63994
   Nanda SS, 2015, INT J NANOMED, V10, P549, DOI 10.2147/IJN.S75768
   Nasongkla N., 2004, ANGEW CHEM, V116, P6483
   Nezakati T, 2014, ARCH TOXICOL, V88, P1987, DOI 10.1007/s00204-014-1361-0
   Nilsson EE, 2015, TRANSL RES, V165, P12, DOI 10.1016/j.trsl.2014.02.003
   Nishiguchi A, 2011, ADV MATER, V23, P3506, DOI 10.1002/adma.201101787
   Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233
   Pan YZ, 2012, EXPERT OPIN DRUG DEL, V9, P1365, DOI 10.1517/17425247.2012.729575
   Parveen S, 2012, NANOMED-NANOTECHNOL, V8, P147, DOI 10.1016/j.nano.2011.05.016
   Peng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6716
   Nguyen P, 2012, J PHYS CHEM LETT, V3, P1024, DOI 10.1021/jz300033g
   Prajapati VK, 2012, J INFECT DIS, V205, P333, DOI 10.1093/infdis/jir735
   Qi W, 2014, J MATER CHEM B, V2, P325, DOI 10.1039/c3tb21387k
   Qin XC, 2013, J PHOTOCH PHOTOBIO B, V120, P156, DOI 10.1016/j.jphotobiol.2012.12.005
   Rana VK, 2011, MACROMOL MATER ENG, V296, P131, DOI 10.1002/mame.201000307
   Rao CNR, 2009, ANGEW CHEM INT EDIT, V48, P7752, DOI 10.1002/anie.200901678
   Ren HL, 2010, ACS NANO, V4, P7169, DOI 10.1021/nn101696r
   Ren TB, 2012, POLYM CHEM-UK, V3, P2561, DOI 10.1039/c2py20343j
   Robinson JT, 2011, J AM CHEM SOC, V133, P6825, DOI 10.1021/ja2010175
   Rong PF, 2014, THERANOSTICS, V4, P229, DOI 10.7150/thno.8070
   Ryu S, 2013, TISSUE ENG REGEN MED, V10, P39, DOI 10.1007/s13770-013-0384-6
   Sasidharan A, 2012, SMALL, V8, P1251, DOI 10.1002/smll.201102393
   Seabra AB, 2014, CHEM RES TOXICOL, V27, P159, DOI 10.1021/tx400385x
   Servant A, 2014, BIOORG MED CHEM LETT, V24, P1638, DOI 10.1016/j.bmcl.2014.01.051
   Servant A, 2014, ADV HEALTHC MATER, V3, P1334, DOI 10.1002/adhm.201400016
   Shen H, 2012, THERANOSTICS, V2, P283, DOI 10.7150/thno.3642
   Shi SX, 2014, BIOCONJUGATE CHEM, V25, P1609, DOI 10.1021/bc500332c
   Shi SX, 2013, BIOMATERIALS, V34, P3002, DOI 10.1016/j.biomaterials.2013.01.047
   Shi XZ, 2013, BIOMATERIALS, V34, P4786, DOI 10.1016/j.biomaterials.2013.03.023
   Shin SR, 2014, ADV FUNCT MATER, V24, P6136, DOI 10.1002/adfm.201401300
   Smolkova B, 2015, FOOD CHEM TOXICOL, V77, P64, DOI 10.1016/j.fct.2014.12.015
   Soenen SJ, 2015, CHEM REV, V115, P2109, DOI 10.1021/cr400714j
   Sreejith S, 2012, J AM CHEM SOC, V134, P17346, DOI 10.1021/ja305352d
   Sreeprasad TS, 2011, ACS APPL MATER INTER, V3, P2643, DOI 10.1021/am200447p
   Srivastava S, 2012, SMALL, V8, P1099, DOI 10.1002/smll.201101863
   Srivatsan A, 2011, MOL PHARMACEUT, V8, P1186, DOI 10.1021/mp200018y
   Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8
   Tang LAL, 2012, SMALL, V8, P423, DOI 10.1002/smll.201101690
   Termaat MF, 2005, J BONE JOINT SURG AM, V87A, P1367, DOI 10.2106/JBJS.D.02585
   Tian B, 2011, ACS NANO, V5, P7000, DOI 10.1021/nn201560b
   Tripathi SK, 2013, CARBON, V51, P224, DOI 10.1016/j.carbon.2012.08.047
   Wan CY, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055010
   Wang H, 2014, INT J NANOMED, V9, P1433, DOI 10.2147/IJN.S58783
   Wang HS, 2011, THERMOCHIM ACTA, V526, P229, DOI 10.1016/j.tca.2011.10.006
   Wang L, 2014, RSC ADV, V4, P40312, DOI 10.1039/c4ra04529g
   Wang Y, 2011, TRENDS BIOTECHNOL, V29, P205, DOI 10.1016/j.tibtech.2011.01.008
   Wang YH, 2013, BIOMATERIALS, V34, P7715, DOI 10.1016/j.biomaterials.2013.06.045
   WEITMAN SD, 1992, CANCER RES, V52, P3396
   Wen HY, 2012, SMALL, V8, P760, DOI 10.1002/smll.201101613
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
   Wojtoniszak M, 2012, COLLOID SURFACE B, V89, P79, DOI 10.1016/j.colsurfb.2011.08.026
   Xiong HL, 2014, J PHOTOCH PHOTOBIO B, V138, P191, DOI 10.1016/j.jphotobiol.2014.05.023
   Yang K, 2015, EXPERT OPIN DRUG DEL, V12, P601, DOI 10.1517/17425247.2015.978760
   Yang K, 2012, BIOMATERIALS, V33, P2206, DOI 10.1016/j.biomaterials.2011.11.064
   Yang K, 2011, ACS NANO, V5, P516, DOI 10.1021/nn1024303
   Yang K, 2010, NANO LETT, V10, P3318, DOI 10.1021/nl100996u
   Yang XY, 2008, J PHYS CHEM C, V112, P17554, DOI 10.1021/jp806751k
   Yao Y., 2013, J MOL GENET MED, V7, P86, DOI [10.4172/1747-0862.1000086., DOI 10.4172/1747-0862.1000086]
   Yao Y, 2015, SENSOR ACTUAT B-CHEM, V211, P52, DOI 10.1016/j.snb.2014.12.134
   Yin PT, 2015, CHEM REV, V115, P2483, DOI 10.1021/cr500537t
   Yue H, 2012, BIOMATERIALS, V33, P4013, DOI 10.1016/j.biomaterials.2012.02.021
   Zhan SH, 2015, ACS APPL MATER INTER, V7, P4290, DOI 10.1021/am508682s
   Zhang B, 2012, BIOSENS BIOELECTRON, V31, P105, DOI 10.1016/j.bios.2011.09.046
   Zhang H, 2015, BIOMATERIALS, V42, P66, DOI 10.1016/j.biomaterials.2014.11.055
   Zhang HC, 2013, J MATER CHEM B, V1, P2542, DOI 10.1039/c3tb20405g
   Zhang JB, 2011, IND ENG CHEM RES, V50, P13885, DOI 10.1021/ie202132m
   Zhang LM, 2013, J MATER CHEM B, V1, P749, DOI 10.1039/c2tb00096b
   Zhang LM, 2011, SMALL, V7, P460, DOI 10.1002/smll.201001522
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
   Zhang YB, 2010, ACS NANO, V4, P3181, DOI 10.1021/nn1007176
   Zhao XB, 2015, BIOCONJUGATE CHEM, V26, P128, DOI 10.1021/bc5005137
   Zheng X, 2009, J MED CHEM, V52, P4306, DOI 10.1021/jm9001617
   Zhi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060034
   Zhou HJ, 2014, POLYM CHEM-UK, V5, P3563, DOI 10.1039/c4py00136b
   Zhou KF, 2010, NEW J CHEM, V34, P2950, DOI 10.1039/c0nj00283f
   Zhu L, 2007, NANO LETT, V7, P3592, DOI 10.1021/nl071303v
   Zwicke G.L., 2012, NANO REV, V3
NR 176
TC 42
Z9 42
U1 1
U2 104
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2015
VL 10
SI SI
BP 9
EP 24
DI 10.2147/IJN.S88285
PG 16
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA CW6QL
UT WOS:000365122300003
PM 26345988
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Deiana, M
   Mettra, B
   Matczyszyn, K
   Piela, K
   Pitrat, D
   Olesiak-Banska, J
   Monnereau, C
   Andraud, C
   Samoc, M
AF Deiana, Marco
   Mettra, Bastien
   Matczyszyn, Katarzyna
   Piela, Katarzyna
   Pitrat, Delphine
   Olesiak-Banska, Joanna
   Monnereau, Cyrille
   Andraud, Chantal
   Samoc, Marek
TI Interactions of a biocompatible water-soluble anthracenyl polymer
   derivative with double-stranded DNA
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID CALF THYMUS DNA; MINOR-GROOVE; 2-PHOTON ABSORPTION; ETHIDIUM-BROMIDE;
   ANTICANCER DRUG; SMALL MOLECULES; B-DNA; DOUBLE HELIX; BINDING;
   FLUORESCENCE
AB We have studied the interaction of a polymeric water soluble anthracenyl derivative (Ant-PHEA) with salmon testes DNA. The results from UV-Vis, fluorescence, Fourier transform infrared (FT-IR) and circular dichroism spectroscopies indicate that the groove binding process regulates the interaction between Ant-PHEA and DNA. The binding constants, calculated by absorption spectroscopy at 298, 304 and 310 K, were equal to 3.2 x 10(5) M-1, 4.7 x 10(5) M-1, and 6.6 x 10(5) M-1 respectively, proving a relatively high affinity of Ant-PHEA for salmon testes DNA. Results of Hoechst 33258 displacement assays strongly support the groove binding mode of Ant-PHEA to DNA. The association stoichiometry of the Ant-PHEA:DNA adduct was found to be 1 for every 5 base pairs. FT-IR spectra, recorded at different Ant-PHEA/DNA molar ratios, indicate the involvement of the phosphate groups and adenine and thymine DNA bases in the association process. Thermodynamic results suggest that hydrophobic forces regulate the binding of Ant-PHEA with DNA without excluding some extent of involvement of van der Waals forces and hydrogen bonding arising due to surface binding between the hydrophilic polymeric arms of the ligand and the functional groups positioned on the edge of the groove. The resulting composite biomaterial could constitute a valuable candidate for future biological and/or photonic applications.
C1 [Deiana, Marco; Matczyszyn, Katarzyna; Olesiak-Banska, Joanna; Samoc, Marek] Wroclaw Univ Technol, Fac Chem, Adv Mat Engn & Modelling Grp, PL-50370 Wroclaw, Poland.
   [Mettra, Bastien; Pitrat, Delphine; Monnereau, Cyrille; Andraud, Chantal] Univ Lyon 1, Ecole Normale Super Lyon, CNRS UMR 5182, Chim Lab, F-69365 Lyon, France.
   [Piela, Katarzyna] Wroclaw Univ Technol, Fac Chem, Dept Phys & Quantum Chem, PL-50370 Wroclaw, Poland.
RP Matczyszyn, K (reprint author), Wroclaw Univ Technol, Fac Chem, Adv Mat Engn & Modelling Grp, Wyb Wyspianskiego 27, PL-50370 Wroclaw, Poland.
EM katarzyna.matczyszyn@pwr.edu.pl
OI Olesiak-Banska, Joanna/0000-0002-7226-0077; Monnereau,
   Cyrille/0000-0002-8928-2416; Matczyszyn, Katarzyna/0000-0001-8578-8340;
   Samoc, Marek/0000-0002-5404-2455
FU NCN OPUS project [DEC-2013/09/B/ST5/03417]
FX The financial support from NCN OPUS project DEC-2013/09/B/ST5/03417 and
   a statutory activity subsidy from the Polish Ministry of Science and
   Higher Education for the Faculty of Chemistry of WUT are acknowledged.
CR ALEXEEV DG, 1987, NATURE, V325, P821, DOI 10.1038/325821a0
   BAGULEY BC, 1991, ANTI-CANCER DRUG DES, V6, P1
   Bailly C, 1998, BIOCONJUGATE CHEM, V9, P513, DOI 10.1021/bc980008m
   Banerjee D, 2007, J PHYS CHEM B, V111, P10833, DOI 10.1021/jp074697n
   BENESI HA, 1949, J AM CHEM SOC, V71, P2703, DOI 10.1021/ja01176a030
   Bhadra K, 2011, BBA-GEN SUBJECTS, V1810, P485, DOI 10.1016/j.bbagen.2011.01.011
   Bi SY, 2008, SPECTROCHIM ACTA A, V69, P123, DOI 10.1016/j.saa.2007.03.017
   Ciardelli F, 2013, POLYM INT, V62, P22, DOI 10.1002/pi.4395
   Deiana M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129817
   Demeunynck M, 2002, DNA RNA BINDERS SMAL, DOI [10.1002/, DOI 10.1002/]
   DERVAN PB, 1986, SCIENCE, V232, P464, DOI 10.1126/science.2421408
   Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0
   Dewey T. G., 1991, BIOPHYSICAL BIOCH AS, DOI 10.1007/978-1-4757-9513-4
   Dey S, 2010, POLYHEDRON, V29, P1583, DOI 10.1016/j.poly.2010.01.022
   DICKERSON RE, 1981, J MOL BIOL, V149, P761, DOI 10.1016/0022-2836(81)90357-0
   Dorraji P. S., 2012, J BRAZIL CHEM SOC, V24, P939
   Dragan AI, 2012, J FLUORESC, V22, P1189, DOI 10.1007/s10895-012-1059-8
   Ellestad G. A., 2012, NATURAL PROD BIOMOL, V2, P635
   Ellestad G. A., 2012, COMPREHENSIVE CHIROP, V2
   FREDERICK CA, 1990, BIOCHEMISTRY-US, V29, P2538, DOI 10.1021/bi00462a016
   Froehlich E, 2011, J PHYS CHEM B, V115, P9873, DOI 10.1021/jp205079u
   Froehlich E, 2011, BIOMACROMOLECULES, V12, P511, DOI 10.1021/bm1013102
   Garbett NC, 2007, NAT PROTOC, V2, P3166, DOI 10.1038/nprot.2007.475
   Gonzalez M. V., 1996, J INORG BIOCHEM, V63, P57
   Grote JG, 2004, J PHYS CHEM B, V108, P8584, DOI 10.1021/jp038056d
   Guan Y, 2006, ANAL CHIM ACTA, V570, P21, DOI 10.1016/j.aca.2006.03.106
   Guo YJ, 2007, SPECTROCHIM ACTA A, V68, P231, DOI 10.1016/j.saa.2006.11.019
   Hackl EV, 1997, J MOL STRUCT, V408, P229, DOI 10.1016/S0022-2860(96)09534-8
   He GS, 2008, CHEM REV, V108, P1245, DOI 10.1021/cr050054x
   Heckman EM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2378400
   Huang Y, 2009, ORG BIOMOL CHEM, V7, P2278, DOI 10.1039/b823416g
   Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749
   Ihmels H, 2005, TOP CURR CHEM, V258, P161, DOI 10.1007/b135804
   Jalali F, 2017, ARAB J CHEM, V10, pS3947, DOI 10.1016/j.arabjc.2014.06.001
   James M.B., 1991, BIOCHEMISTRY-US, V30, P8918
   Jaumot J, 2012, CURR PHARM DESIGN, V18, P1900, DOI 10.2174/138161212799958486
   Kalanur SS, 2009, J ELECTROANAL CHEM, V636, P93, DOI 10.1016/j.jelechem.2009.09.018
   Kumar CV, 2000, TETRAHEDRON, V56, P7027, DOI 10.1016/S0040-4020(00)00526-3
   Kumar KA, 2009, APPL ORGANOMET CHEM, V23, P409, DOI 10.1002/aoc.1534
   Kumar S, 2012, J BIOSCIENCES, V37, P553, DOI 10.1007/s12038-012-9212-8
   Kwon YW, 2012, POLYM J, V44, P1191, DOI 10.1038/pj.2012.165
   Lakowicz J. R., 1999, PRINCIPLES FLUORESCE
   Laughton CA, 1996, BIOCHEMISTRY-US, V35, P5655, DOI 10.1021/bi952162r
   LAVERY R, 1981, NUCLEIC ACIDS RES, V9, P3765, DOI 10.1093/nar/9.15.3765
   Li XL, 2012, BIOMACROMOLECULES, V13, P873, DOI 10.1021/bm2017959
   Liu J, 2002, J INORG BIOCHEM, V91, P269, DOI 10.1016/S0162-0134(02)00441-5
   Liu YJ, 2008, SPECTROCHIM ACTA A, V70, P171, DOI 10.1016/j.saa.2007.07.029
   Mansouri M, 2013, MOLECULES, V18, P789, DOI 10.3390/molecules18010789
   MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8
   Massin J, 2013, OPT MATER, V35, P1810, DOI 10.1016/j.optmat.2013.04.021
   Massin J, 2013, CHEM SCI, V4, P2833, DOI 10.1039/c3sc22325f
   Matczyszyn K, 2012, J NANOPHOTONICS, V6, DOI 10.1117/1.JNP.6.064505
   MEYERALMES FJ, 1993, BIOCHEMISTRY-US, V32, P4246, DOI 10.1021/bi00067a012
   Mojzisova H, 2009, BIOPHYS J, V97, P2348, DOI 10.1016/j.bpj.2009.07.053
   Monnereau C, 2012, NEW J CHEM, V36, P2328, DOI 10.1039/c2nj40407a
   MORJANI H, 1993, CANCER RES, V53, P4784
   Nafisi S, 2005, DNA CELL BIOL, V24, P634, DOI 10.1089/dna.2005.24.634
   Nafisi S, 2007, J MOL STRUCT, V827, P35, DOI 10.1016/j.molstruc.2006.05.004
   Nakamoto N., 2008, METHOD BIOCHEM ANAL, V51, P1
   Navarro JRG, 2013, BIOMATERIALS, V34, P8344, DOI 10.1016/j.biomaterials.2013.07.032
   Neault JF, 1998, J PHYS CHEM B, V102, P1610, DOI 10.1021/jp972082s
   Neault JF, 1996, J BIOL CHEM, V271, P8140, DOI 10.1074/jbc.271.14.8140
   Neidle S, 2001, NAT PROD REP, V18, P291, DOI 10.1039/a705982e
   NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0
   Olesiak-Banska J, 2013, J PHYS CHEM B, V117, P12013, DOI 10.1021/jp407144k
   Olesiak-Banska J, 2012, CHEM PHYS, V404, P33, DOI 10.1016/j.chemphys.2012.02.001
   Olesiak-Banska J, 2011, BIOPOLYMERS, V95, P365, DOI 10.1002/bip.21583
   Ortiz M, 2011, J PHOTOCH PHOTOBIO A, V218, P26, DOI 10.1016/j.jphotochem.2010.11.020
   Paul A, 2012, CURR SCI INDIA, V102, P212
   Pawlicki M, 2009, ANGEW CHEM INT EDIT, V48, P3244, DOI 10.1002/anie.200805257
   PJURA PE, 1987, J MOL BIOL, V197, P257, DOI 10.1016/0022-2836(87)90123-9
   Pratviel G, 1998, ADV INORG CHEM, V45, P251, DOI 10.1016/S0898-8838(08)60027-6
   Qiao CY, 2008, SPECTROCHIM ACTA A, V70, P136, DOI 10.1016/j.saa.2007.07.038
   Rafique B, 2013, BIOSENS BIOELECTRON, V44, P21, DOI 10.1016/j.bios.2012.12.028
   Raman N, 2012, MONATSH CHEM, V143, P1487, DOI 10.1007/s00706-012-0718-4
   ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017
   Sarkar R, 2007, BIOMACROMOLECULES, V8, P3332, DOI 10.1021/bm700690p
   Sarwar T, 2015, MOL BIOSYST, V11, P522, DOI 10.1039/c4mb00636d
   Senthil K., 2009, INT J BIOTECHNOLOGY, V5, P251
   Shahabadi N, 2014, MOL BIOSYST, V10, P338, DOI 10.1039/c3mb70340a
   Shahabadi N, 2010, TRANSIT METAL CHEM, V35, P699, DOI 10.1007/s11243-010-9382-x
   Shakir M, 2009, SPECTROCHIM ACTA A, V71, P1851, DOI 10.1016/j.saa.2008.07.002
   Shi Y, 2011, BIOMACROMOLECULES, V12, P797, DOI 10.1021/bm101414w
   Sirajuddin M, 2013, J PHOTOCH PHOTOBIO B, V124, P1, DOI 10.1016/j.jphotobiol.2013.03.013
   Slobodyansky E., 1998, BIOPOLYMERS, V27, P1107
   Srour H, 2015, MACROMOL RAPID COMM, V36, P55, DOI 10.1002/marc.201400478
   Sun HX, 2011, BIOCHIMIE, V93, P1351, DOI 10.1016/j.biochi.2011.06.007
   Tan WB, 2006, PHOTOCHEM PHOTOBIOL, V82, P20, DOI 10.1562/2005-05-24-RA-539
   WALKER GT, 1985, BIOCHEMISTRY-US, V24, P7471, DOI 10.1021/bi00346a066
   Zhao N, 2010, SPECTROCHIM ACTA A, V75, P1435, DOI 10.1016/j.saa.2010.01.013
NR 90
TC 12
Z9 12
U1 1
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2015
VL 17
IS 45
BP 30318
EP 30327
DI 10.1039/c5cp05381a
PG 10
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA CW2ZP
UT WOS:000364862000012
PM 26506886
DA 2018-10-20
ER

PT J
AU Plonska-Brzezinska, ME
   Bobrowska, DM
   Sharma, A
   Rodziewicz, P
   Tomczyk, M
   Czyrko, J
   Brzezinski, K
AF Plonska-Brzezinska, M. E.
   Bobrowska, D. M.
   Sharma, A.
   Rodziewicz, P.
   Tomczyk, M.
   Czyrko, J.
   Brzezinski, K.
TI Triple helical collagen-like peptide interactions with selected
   polyphenolic compounds
SO RSC ADVANCES
LA English
DT Article
ID SURFACE-PLASMON RESONANCE; SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE
   MICROSCOPY; ALUMINUM-CHLORIDE PRETREATMENT; IMAGING ELLIPSOMETRY; TEA
   POLYPHENOLS; CROSS-LINKING; HYDROPHOBIC INTERACTIONS;
   MOLECULAR-STRUCTURE; MASS-SPECTROMETRY
AB Because collagen is the most abundant component of connective tissue, it is an excellent biomaterial in numerous medical applications. However, the utility of collagen is limited by its low mechanical strength in aqueous solutions and its susceptibility to proteolytic degradation in vivo. To improve the physical properties of collagen and to enhance its chemical resistance, it is necessary to stabilize its structure through chemical or physical modifications. In this study, we analyzed the interactions of a model molecule, a synthetic triple helical collagen-like peptide, with polyphenols such as curcumin, rutin, quercetin, naringin, and hypericin. Interactions between the peptide and polyphenolic compounds were analyzed using various techniques. The layer-by-layer assembly processes of a gold surface using the peptide and polyphenols was performed via surface plasmon resonance (SPR), atomic force microscopy (AFM), and ellipsometry. SPR screening of polyphenols was conducted in real time to select compounds that bind to the collagen-like peptide and could thus be applied to the stabilization of collagen. Selected polyphenols, especially naringin and hypericin, demonstrated notable binding to the peptide. To determine the nature of these interactions, experiments were supplemented with crystallographic studies and molecular docking of plant metabolites and collagen-like peptides.
C1 [Plonska-Brzezinska, M. E.; Bobrowska, D. M.; Rodziewicz, P.; Czyrko, J.; Brzezinski, K.] Univ Bialystok, Fac Chem & Biol, Inst Chem, PL-15399 Bialystok, Poland.
   [Sharma, A.] Ecole Polytech, CNRS, Lab Chim Mol, F-91128 Palaiseau, France.
   [Tomczyk, M.] Med Univ Bialystok, Fac Pharm, Dept Pharmacognosy, PL-15230 Bialystok, Poland.
RP Plonska-Brzezinska, ME (reprint author), Univ Bialystok, Fac Chem & Biol, Inst Chem, Hurtowa 1, PL-15399 Bialystok, Poland.
EM mplonska@uwb.edu.pl; k.brzezinski@uwb.edu.pl
RI Tomczyk, Michal/G-2161-2016
OI Tomczyk, Michal/0000-0002-4063-1048; Brzezinski,
   Krzysztof/0000-0001-9339-7745
FU National Science Centre, Poland [2011/01/B/ST5/06051,
   2012/05/E/ST5/03800]; European Funds for Regional Development as part of
   the Operational Programme Development of Eastern Poland
   [POPW.01.03.00-20-034/09]; European Community's Seventh Framework
   Programme (FP7) under BioStruct-X [283570]
FX We gratefully acknowledge the financial support of the National Science
   Centre, Poland (grants #2011/01/B/ST5/06051 and 2012/05/E/ST5/03800) to
   M.E.P.-B. AFM and FTIR were funded by the European Funds for Regional
   Development as part of the Operational Programme Development of Eastern
   Poland 2007-2013 (project: POPW.01.03.00-20-034/09). We thank HZB for
   the allocation of synchrotron radiation beamtime. Crystallographic study
   leading to these results has received funding from the European
   Community's Seventh Framework Programme (FP7/2007-2013) under
   BioStruct-X (grant agreement: 283570).
CR Aicart-Ramos C, 2012, BIOCHEMISTRY-US, V51, P7403, DOI 10.1021/bi300848x
   Allison DP, 2002, CURR OPIN BIOTECH, V13, P47, DOI 10.1016/S0958-1669(02)00283-5
   AVNIR D, 1994, CHEM MATER, V6, P1605, DOI 10.1021/cm00046a008
   BABU PS, 1995, MOL CELL BIOCHEM, V152, P13
   Bae YM, 2004, ANAL CHEM, V76, P1799, DOI 10.1021/ac034748m
   Bailey M, 2001, AM J PATHOL, V159, P1981, DOI 10.1016/S0002-9440(10)63048-9
   Bakhtiar R, 2013, J CHEM EDUC, V90, P203, DOI 10.1021/ed200549g
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Bella J, 2006, J MOL BIOL, V362, P298, DOI 10.1016/j.jmb.2006.07.014
   Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980
   Borch J, 2004, ANAL CHEM, V76, P5243, DOI 10.1021/ac049335f
   Hernandez JCR, 2007, BIOPHYS J, V93, P202, DOI 10.1529/biophysj.106.102491
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Choi S, 2010, JALA-J LAB AUTOM, V15, P172, DOI 10.1016/j.jala.2009.09.002
   D'Armiento J, 2003, J CLIN INVEST, V112, P1308, DOI 10.1172/JCI200320226
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Damodaran G, 2009, J BIOMED MATER RES A, V89A, P1001, DOI 10.1002/jbm.a.32045
   Davila J, 2013, LANGMUIR, V29, P7488, DOI 10.1021/la3045779
   Ellis DL, 1996, BIOMATERIALS, V17, P291, DOI 10.1016/0142-9612(96)85567-0
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Erdmann RS, 2011, ANGEW CHEM INT EDIT, V50, P6835, DOI 10.1002/anie.201008118
   Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028
   FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2
   Garcia-Marin A, 2014, ANAL CHEM, V86, P4969, DOI 10.1021/ac5005212
   Georgiadis R, 2000, J AM CHEM SOC, V122, P3166, DOI 10.1021/ja9930824
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   HOFMANN H, 1978, J MOL BIOL, V125, P137, DOI 10.1016/0022-2836(78)90342-X
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Isenburg JC, 2006, BIOMATERIALS, V27, P3645, DOI 10.1016/j.biomaterials.2006.02.016
   Isenburg JC, 2005, BIOMATERIALS, V26, P1237, DOI 10.1016/j.biomaterials.2004.04.034
   Jarman-Smith ML, 2004, J MATER SCI-MATER M, V15, P925, DOI 10.1023/B:JMSM.0000036281.47596.cc
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kpegba K, 2007, ANAL CHEM, V79, P5479, DOI 10.1021/ac062276g
   Kramer RZ, 1998, J MOL BIOL, V280, P623, DOI 10.1006/jmbi.1998.1881
   Kumar VA, 2014, BIOMACROMOLECULES, V15, P1484, DOI 10.1021/bm500091e
   Kuroda Y, 1999, MUTAT RES-REV MUTAT, V436, P69, DOI 10.1016/S1383-5742(98)00019-2
   Li YJ, 2008, ANAL CHEM, V80, P891, DOI 10.1021/ac701873v
   LONG CG, 1992, J MOL BIOL, V225, P1, DOI 10.1016/0022-2836(92)91020-P
   LONG CG, 1993, BIOCHEMISTRY-US, V32, P11688, DOI 10.1021/bi00094a027
   Luther JM, 2011, NAT MATER, V10, P361, DOI [10.1038/nmat3004, 10.1038/NMAT3004]
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   Madhan B, 2002, BIOMATERIALS, V23, P2841, DOI 10.1016/S0142-9612(01)00410-0
   Mandal A., 2010, BIOL ENG, V2, P63
   MARCHAND R, 1993, BRAIN RES BULL, V30, P415, DOI 10.1016/0361-9230(93)90273-E
   MLCZOCH J, 1975, RESPIRATION, V32, P424
   Munoz MG, 2000, LANGMUIR, V16, P1083, DOI 10.1021/la990142a
   Newton L, 2013, J MATER CHEM C, V1, P376, DOI 10.1039/c2tc00146b
   Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498
   PELI E, 1990, J OPT SOC AM A, V7, P2032, DOI 10.1364/JOSAA.7.002032
   Quinones M, 2013, PHARMACOL RES, V68, P125, DOI 10.1016/j.phrs.2012.10.018
   Rathi Badal, 2013, Sci Pharm, V81, P567, DOI 10.3797/scipharm.1301-16
   Saravanan S, 2014, IND CROP PROD, V54, P272, DOI 10.1016/j.indcrop.2014.01.038
   Shalev M, 2011, MATERIALS, V4, P469, DOI 10.3390/ma4030469
   Sigal GB, 1996, ANAL CHEM, V68, P490, DOI 10.1021/ac9504023
   SPEER DP, 1975, J SURG RES, V19, P169, DOI 10.1016/0022-4804(75)90077-3
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Swamy Radhakrishnan Narayana, 2011, BMC Res Notes, V4, P399, DOI 10.1186/1756-0500-4-399
   Taatjes DJ, 2013, J CELL PHYSIOL, V228, P1949, DOI 10.1002/jcp.24363
   Tang HR, 2003, BIOPOLYMERS, V70, P403, DOI 10.1002/bip.10499
   Tang HR, 2003, J AGR FOOD CHEM, V51, P6652, DOI 10.1021/jf034380u
   Tiong WHC, 2008, LANGMUIR, V24, P11752, DOI 10.1021/la801913c
   Tomczyk M, 2006, BIOCHEM SYST ECOL, V34, P770, DOI 10.1016/j.bse.2006.06.002
   Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231
   Venkatesan N, 2000, BRIT J PHARMACOL, V129, P231, DOI 10.1038/sj.bjp.0703067
   Vita J. A., 2005, AM J CLIN NUTR, V81, p292S
   VONDERMARK K, 1981, INT REV CONNECT TISS, V9, P265
   Vutukuru S, 2006, LANGMUIR, V22, P10152, DOI 10.1021/la062093p
   Vyavahare N, 1999, AM J PATHOL, V155, P973, DOI 10.1016/S0002-9440(10)65197-8
   Wang W, 2013, ANAL CHEM, V85, P4446, DOI 10.1021/ac303783j
   Ward J, 2010, BIOMACROMOLECULES, V11, P3093, DOI 10.1021/bm100898p
   Wark AW, 2005, ANAL CHEM, V77, P3904, DOI 10.1021/ac050402v
   WASSER SK, 1991, J REPROD FERTIL, V92, P415
   Yamada H, 2007, CARDIOVASC RES, V73, P439, DOI 10.1016/j.cardiores.2006.11.008
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yanase Y, 2010, BIOSENS BIOELECTRON, V26, P674, DOI 10.1016/j.bios.2010.06.065
   Yang CS, 2009, ARCH TOXICOL, V83, P11, DOI 10.1007/s00204-008-0372-0
   Zeugois DI, 2010, J BIOMED MATER RES A, V92A, P1310, DOI 10.1002/jbm.a.32383
NR 79
TC 3
Z9 4
U1 0
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 116
BP 95443
EP 95453
DI 10.1039/c5ra15469c
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA CW3QR
UT WOS:000364907300006
DA 2018-10-20
ER

PT J
AU Poorvisha, R
   Suriyaraj, SP
   Thavamani, P
   Naidu, R
   Megharaj, M
   Bhattacharyya, A
   Selvakumar, R
AF Poorvisha, R.
   Suriyaraj, S. P.
   Thavamani, P.
   Naidu, Ravi
   Megharaj, Mallavarapu
   Bhattacharyya, Amitava
   Selvakumar, R.
TI Synthesis and characterisation of 3-dimensional hydroxyapatite
   nanostructures using a thermoplastic polyurethane nanofiber sacrificial
   template
SO RSC ADVANCES
LA English
DT Article
ID CALCIUM PHOSPHATES; AQUEOUS-SOLUTIONS; IN-VIVO; NANOPARTICLES; CERAMICS;
   SURFACE; SIZE; BIOMATERIAL; COMPOSITE; MEMBRANE
AB In this study, we report a facile synthesis of shape controlled three dimensional hydroxyapatite nanostructures (HAp) using a sacrificial thermoplastic polyurethane (TPU) nanofiber template. The TPU nanofibers synthesised using an electrospinning process were used as a template during the HAp synthesis through a precipitation process. Various HAp morphologies including distinctly placed cylindrically porous HAp architecture, coral reef like, tightly packed fibrous sheet like and nanofiber like were synthesised using the TPU nanofiber template. All the synthesised HAp were characterized using appropriate techniques like Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), field emission scanning electron microscopy (FESEM) attached with selected area electron diffraction (SAED), energy dispersive X-ray spectroscopy (EDS) and X-ray photoelectron spectroscopy (XPS). The morphology, pore arrangement and the particle size of the HAp varied significantly with varying dimensions of the template and the template available per unit area of HAp. Hence, we have achieved four different 3D HAp morphologies using a single type of TPU nanofiber template. The TPU templated HAp nanostructures were more biodegradable than the control HAp.
C1 [Poorvisha, R.; Suriyaraj, S. P.; Selvakumar, R.] PSG Inst Adv Studies, Nanobiotechnol Lab, Coimbatore 641004, Tamil Nadu, India.
   [Thavamani, P.; Naidu, Ravi; Megharaj, Mallavarapu; Selvakumar, R.] Univ Newcastle, GCER, Callaghan, NSW 2308, Australia.
   [Bhattacharyya, Amitava] PSG Inst Adv Studies, Adv Text & Polymer Res Lab, Coimbatore 641004, Tamil Nadu, India.
RP Selvakumar, R (reprint author), PSG Inst Adv Studies, Nanobiotechnol Lab, Coimbatore 641004, Tamil Nadu, India.
EM rsk@psgias.ac.in
RI Bhattacharyya, Amitava/O-3382-2017; Mallavarapu, Megharaj/D-3408-2011
OI Bhattacharyya, Amitava/0000-0001-6644-4294; Mallavarapu,
   Megharaj/0000-0002-6230-518X
FU Water Technology Initiatives (WTI), Department of Science and
   Technology, Government of India [DST/TM/WTI/2K13/137]
FX The authors are thankful to Water Technology Initiatives (WTI),
   Department of Science and Technology, Government of India for funding
   this study (Sanction no: DST/TM/WTI/2K13/137). Support and help rendered
   by PSG Management and PSG Institute of Advanced Studies is acknowledged.
   COE medical textiles, South India textile research association (SITRA)
   is acknowledged for helping us through FE-SEM imaging. The authors are
   thankful to Bayer Material Science for providing polymers.
CR Bailliez S, 2004, CHEM ENG J, V98, P141, DOI 10.1016/j.cej.2003.07.001
   Bajsic Emi Govorcin, 2014, Journal of Polymers, DOI 10.1155/2014/289283
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Cyster LA, 2005, BIOMATERIALS, V26, P697, DOI 10.1016/j.biomaterials.2004.03.017
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Erzsebet S. B., 2009, CHEM PAP, V63, P568
   Eslami H, 2010, MATER SCI-POLAND, V28, P5
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Gao S, 2009, J FLUORINE CHEM, V130, P550, DOI 10.1016/j.jfluchem.2009.03.007
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Ji LJ, 2011, CHEM COMMUN, V47, P9048, DOI 10.1039/c1cc11819f
   Junior J. H. S. A., 2013, MAT RES, V16, P860
   Lee JH, 2012, J MATER CHEM, V22, P11556, DOI 10.1039/c2jm31224g
   Li Z., 2007, J MATER SCI-MATER M, V16, P213
   Liang C, 2011, NANOTECHNOLOGY, V22
   Lu HB, 2000, ANAL CHEM, V72, P2886, DOI 10.1021/ac990812h
   Mahabole MP, 2005, B MATER SCI, V28, P535, DOI 10.1007/BF02706339
   Maries G. R. E., 2005, ANALELE U DIN ORADEA, V2, P125
   Mi HY, 2014, J BIOMED MATER RES B, V102, P1434, DOI 10.1002/jbm.b.33122
   Neumann M., 2006, EUR J TRAUMA, V2, P125
   Nguyen N., 2012, J MICRONANOMECHATRON, P1
   Paul W, 1999, J MATER SCI-MATER M, V10, P383, DOI 10.1023/A:1008918412198
   Pedicini A., 2003, J POLYM, V44, P6857
   Petrovic Z., 1991, J PROG POLYM SCI, V16, P695
   Raikar G. N., 1997, SURF SCI SPECTRA, V4, P9
   Rigo ECS, 2004, MAT SCI ENG C-BIO S, V24, P647, DOI 10.1016/j.msec.2004.08.044
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   SAGGIOWOYANSKY J, 1992, AM CERAM SOC BULL, V71, P1674
   Salimi E., 2012, ISRN CERAM, V2012
   Schachschal S, 2007, COLLOID POLYM SCI, V285, P1175, DOI 10.1007/s00396-007-1685-x
   Sheikh FA, 2012, EXPRESS POLYM LETT, V6, P41, DOI 10.3144/expresspolymlett.2012.5
   Singh A, 2012, B MATER SCI, V35, P1031, DOI 10.1007/s12034-012-0384-5
   Suriyaraj SP, 2015, RSC ADV, V5, P68420, DOI 10.1039/c5ra09469k
   Suriyaraj SP, 2015, RSC ADV, V5, P26905, DOI 10.1039/c5ra02523k
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Temenoff J. S., 2008, BIOMATERIAL DEGRADAT, P178
   Tjandra W, 2006, NANOTECHNOLOGY, V17, P5988, DOI 10.1088/0957-4484/17/24/014
   Wen T, 2014, DALTON T, V43, P7464, DOI 10.1039/c3dt53591f
   Xia ZG, 2009, MATER RES BULL, V44, P1626, DOI 10.1016/j.materresbull.2009.04.014
   Yao C, 2013, POLYM COMPOSITE, V34, P1163, DOI 10.1002/pc.22525
   Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301
   Zhang Y, 2011, CHEM COMMUN, V47, P4126, DOI 10.1039/c1cc10489f
   Zhang YJ, 2003, CHEM PHYS LETT, V376, P493, DOI 10.1016/S0009-2614(03)01038-8
NR 43
TC 2
Z9 2
U1 4
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 118
BP 97773
EP 97780
DI 10.1039/c5ra18593a
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CW8AF
UT WOS:000365220100083
DA 2018-10-20
ER

PT J
AU Sugimoto, H
   Imakita, K
   Fujii, M
AF Sugimoto, H.
   Imakita, K.
   Fujii, M.
TI Growth of novel boron-rich nanocrystals from oxygen-deficient
   borophosphosilicate glasses for boron neutron capture therapy
SO RSC ADVANCES
LA English
DT Article
ID SILICON NANOCRYSTALS; NANOPARTICLES; BNCT; SIZE; PHOTOLUMINESCENCE;
   LUMINESCENCE; PHOSPHORUS; SPECTRA; ALLOYS; RANGE
AB We develop a new type of boron (B)-rich nanocrystals (NCs) for applications in Boron Neutron Capture Therapy (BNCT). Phase separation of oxygen (O) deficient borophosphosilicate glasses (BPSG) by annealing in inert ambient gas results in the growth of different types of B-rich NCs. When the silicon (Si) concentration is much higher than the others, B and phosphorus (P) co-doped Si-NCs are grown. In the opposite case, cubic boron phosphide (BP) NCs are grown. In between two extremes, we demonstrate the growth of a new type of cubic NCs consisting of B, Si and P with an average B concentration up to 36 at%. The B-rich NCs are dispersible in water and exhibit photoluminescence in the biological window. These properties in combination with the capability of the bio-functionalization via the surface Si-hydrogen (H) and Si-O bonds suggest that the B-rich NCs can be a multifunctional biomaterial used for imaging, diagnosis and BNCT.
C1 [Sugimoto, H.; Imakita, K.; Fujii, M.] Kobe Univ, Grad Sch Engn, Dept Elect & Elect Engn, Nada Ku, Kobe, Hyogo 6578501, Japan.
RP Fujii, M (reprint author), Kobe Univ, Grad Sch Engn, Dept Elect & Elect Engn, Nada Ku, Kobe, Hyogo 6578501, Japan.
EM fujii@eedept.Kobe-u.ac.jp
RI Kobe Univ, Engineering/D-2028-2017; Fujii, Minoru/G-3777-2011; Sugimoto,
   Hiroshi/G-3034-2013
OI Fujii, Minoru/0000-0003-4869-7399; 
FU JSPS Bilateral Joint Research Projects (Japan-Czech Republic); 
   [26-3120]
FX HS acknowledges Grant-in-Aid for JSPS Fellows (# 26-3120). This work is
   supported by 2014 JSPS Bilateral Joint Research Projects (Japan-Czech
   Republic).
CR Achilli C, 2014, NANOMED-NANOTECHNOL, V10, P589, DOI 10.1016/j.nano.2013.10.003
   Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162
   Barth R. F., 1999, NEUROSURGERY, V44, P146
   Barth R. F., 2009, APPL RADIAT ISOTOPES, V67, P67
   Barth RF, 2003, J NEURO-ONCOL, V62, P1
   Barth RF, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-146
   Chen GJ, 2014, MOL PHARMACEUT, V11, P3291, DOI 10.1021/mp400641u
   Dasog M, 2014, ACS NANO, V8, P9636, DOI 10.1021/nn504109a
   Grandi S, 2012, J SOL-GEL SCI TECHN, V64, P358, DOI 10.1007/s10971-012-2865-9
   Hannah DC, 2012, NANO LETT, V12, P4200, DOI 10.1021/nl301787g
   Hessel C. M., 2011, CHEM MATER, V24, P393
   Hyam RS, 2008, COLLOID SURFACE A, V315, P61, DOI 10.1016/j.colsurfa.2007.07.010
   Irvine DJ, 2011, NAT MATER, V10, P342, DOI 10.1038/nmat3014
   Kabalka GW, 1997, J NUCL MED, V38, P1762
   Lee JE, 2010, J AM CHEM SOC, V132, P552, DOI 10.1021/ja905793q
   Lu ZH, 1997, APPL PHYS LETT, V71, P2764, DOI 10.1063/1.120438
   LUCOVSKY G, 1979, PHYS REV B, V19, P2064, DOI 10.1103/PhysRevB.19.2064
   Maruyama K, 2004, J CONTROL RELEASE, V98, P195, DOI 10.1016/j.jconrel.2004.04.018
   Montalti M, 2015, CHEM SOC REV, V44, P4853, DOI 10.1039/c4cs00486h
   Mortensen MW, 2006, APPL RADIAT ISOTOPES, V64, P315, DOI 10.1016/j.apradiso.2005.08.003
   PEARSON GL, 1949, PHYS REV, V75, P865, DOI 10.1103/PhysRev.75.865
   Shubina ES, 2002, J ORGANOMET CHEM, V657, P155, DOI 10.1016/S0022-328X(02)01380-3
   Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326
   Soloway AH, 1998, CHEM REV, V98, P1515, DOI 10.1021/cr941195u
   Soraru GD, 1999, CHEM MATER, V11, P910, DOI 10.1021/cm980353l
   Soraru GD, 2000, J SOL-GEL SCI TECHN, V18, P11, DOI 10.1023/A:1008733511697
   Sugimoto H, 2015, RSC ADV, V5, P8427, DOI 10.1039/c4ra13530j
   Sugimoto H, 2014, NANOSCALE, V6, P122, DOI 10.1039/c3nr03863g
   Sugimoto H, 2013, J PHYS CHEM C, V117, P11850, DOI 10.1021/jp4027767
   Sugimoto H, 2012, J PHYS CHEM C, V116, P17969, DOI 10.1021/jp305832x
   TAGUE TJ, 1994, J AM CHEM SOC, V116, P4970, DOI 10.1021/ja00090a048
   Tsutsui K, 2008, J APPL PHYS, V104, DOI 10.1063/1.3014033
NR 32
TC 5
Z9 5
U1 0
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 119
BP 98248
EP 98253
DI 10.1039/c5ra18500a
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA CX0QZ
UT WOS:000365403000044
DA 2018-10-20
ER

PT J
AU Mitra, T
   Manna, PJ
   Raja, STK
   Gnanamani, A
   Kundu, PP
AF Mitra, Tapas
   Manna, Piyali Jana
   Raja, S. T. K.
   Gnanamani, A.
   Kundu, P. P.
TI Curcumin loaded nano graphene oxide reinforced fish scale collagen - a
   3D scaffold biomaterial for wound healing applications
SO RSC ADVANCES
LA English
DT Article
ID GRAPHITE OXIDE; STEM-CELLS; SKIN; FILMS; DELIVERY; SHEETS; BONE;
   DIFFERENTIATION; ADSORPTION; REDUCTION
AB In recent years, graphene oxide (GO) has been functionalized to make GO a potential useful material in the biomedical field. GO is a one-atom thick planar sheet of sp(2)-bonded carbon atoms with functional groups containing oxygen attached to both the sides and surface area of the flake. Functionalized GO has attracted significant research interest based on its potential application in different fields including biomedicine. In the present work we prepare highly stabilized nano graphene oxide (NGO) in aqueous media. NGO is functionalized with type I collagen (2 : 1, NGO : collagen) to make a 3D scaffold as a novel platform for better tissue engineering research. The functionalization of NGO is achieved by a grafting process, an innovative method to modify the properties of NGO. The size of the prepared NGO is measured by dynamic light scattering, and the collagen functionalized NGO (CFNGO) is characterized by X-ray diffraction, attenuated total reflectance (ATR)-FTIR, ultraviolet visible (UV-vis), atomic force microscopy (AFM) and Raman spectroscopy. The surface property of the CFNGO is characterized by employing transmission electron microscopy (TEM) and scanning electron microscopy (SEM). The mechanical stability of the CFNGO is three times greater than that of native collagen. An in vitro cell line study reveals no toxicity of CFNGO against NIH 3T3 fibroblast cell line. The antimicrobial study of curcumin loaded CFNGO shows Gram +ve and Gram -ve organism growth is reduced by a considerable amount, and in vivo wound healing studies showed faster wound healing efficiency of curcumin loaded CFNGO scaffold than that of collagen alone. These findings suggest that curcumin loaded CFNGO could serve as a better platform for wound healing applications.
C1 [Mitra, Tapas; Manna, Piyali Jana; Kundu, P. P.] Univ Calcutta, Univ Coll Sci & Technol, Dept Polymer Sci & Technol, Kolkata 700009, W Bengal, India.
   [Raja, S. T. K.; Gnanamani, A.] CSIR, Div Microbiol, Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
RP Kundu, PP (reprint author), Univ Calcutta, Univ Coll Sci & Technol, Dept Polymer Sci & Technol, 92 APC Rd, Kolkata 700009, W Bengal, India.
EM ppk923@yahoo.com
RI Selvaraj, ThirupathiKumaraRaja/P-1646-2014
OI Selvaraj, ThirupathiKumaraRaja/0000-0002-0502-1172; Mitra,
   Tapas/0000-0003-0813-7389
FU UGC, New Delhi
FX One of he authors Dr Tapas Mitra acknowledges UGC, New Delhi, for
   financial assistance provided in the form of Dr D. S. Kothari
   Post-Doctoral Fellowship. All authors thank Dr Achintya Singha,
   Department of Physics, Bose Institute, 93/1, Acharya Prafulla Chandra
   Road, Kolkata 700009, India, for his assistance with Raman spectroscopy.
   Authors also acknowledge Mr Sourav Chakraborty, Calcutta University -
   DBT Interdisciplinary Program in Life Science (DBT-IPLS), 35 Ballygunge
   Circular Road Kolkata-700019, for AFM analysis. Authors also acknowledge
   Miss Urmila Goswami, CRNN, University of Calcutta, JD-2, Salt Lake City,
   Kolkata 700098, West Bengal, India for her help with the TEM images of
   the samples.
CR Aggarwal BB, 2003, ANTICANCER RES, V23, P363
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Bama P., 2010, INT J PHARM PHARM SC, V2, P133
   Bao HQ, 2011, SMALL, V7, P1569, DOI 10.1002/smll.201100191
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bilgen G, 1999, TURK J VET ANIM SCI, V23, P483
   Bisht Savita, 2009, Curr Drug Discov Technol, V6, P192
   Cha CY, 2013, ACS NANO, V7, P2891, DOI 10.1021/nn401196a
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Chng ELK, 2013, CHEM-EUR J, V19, P8227, DOI 10.1002/chem.201300824
   Cuong TV, 2010, MATER LETT, V64, P399, DOI 10.1016/j.matlet.2009.11.029
   Desimone MF, 2010, J MATER CHEM, V20, P666, DOI 10.1039/b921572g
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Gopinath D, 2004, BIOMATERIALS, V25, P1911, DOI 10.1016/S0142-9612(03)00625-2
   Han SY, 2005, DYES PIGMENTS, V64, P157, DOI 10.1016/j.dyepig.2004.05.008
   Hong J, 2012, ACS NANO, V6, P81, DOI 10.1021/nn202607r
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Jonglareonrak A, 2005, FOOD CHEM, V93, P475, DOI 10.1016/j.foodchem.2004.10.026
   Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y
   La WG, 2013, SMALL, V9, DOI 10.1002/smll.201300571
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
   Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v
   Liu L, 2012, TALANTA, V93, P350, DOI 10.1016/j.talanta.2012.02.051
   Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907
   Malesu V. K., 2011, INT J APPL BIOL PHAR, V3, P402
   Manna PJ, 2015, INT J BIOL MACROMOL, V75, P437, DOI 10.1016/j.ijbiomac.2015.01.047
   Mitra T, 2014, J CHEM SCI, V126, P127, DOI 10.1007/s12039-013-0543-2
   Nagai T, 2004, INT J FOOD SCI TECH, V39, P239, DOI 10.1111/j.1365-2621.2004.00777.x
   Nagai T, 2002, FOOD CHEM, V78, P173, DOI 10.1016/S0308-8146(01)00396-X
   Nagai T, 2000, FOOD CHEM, V68, P277, DOI 10.1016/S0308-8146(99)00188-0
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Nguyen V. C., 2013, INT J POLYM SCI, V2013
   Ogawa M, 2003, J AGR FOOD CHEM, V51, P8088, DOI 10.1021/jf034350r
   Panchatcharam M, 2006, MOL CELL BIOCHEM, V290, P87, DOI 10.1007/s11010-006-9170-2
   Paredes JI, 2008, LANGMUIR, V24, P10560, DOI 10.1021/la801744a
   Park SY, 2008, FOOD CHEM TOXICOL, V46, P2881, DOI 10.1016/j.fct.2008.05.030
   Park S, 2008, CHEM MATER, V20, P6592, DOI 10.1021/cm801932u
   Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]
   Pati F, 2010, BIORESOURCE TECHNOL, V101, P3737, DOI 10.1016/j.biortech.2009.12.133
   Schniepp HC, 2006, J PHYS CHEM B, V110, P8535, DOI 10.1021/jp060936f
   Shi XT, 2012, ADV FUNCT MATER, V22, P751, DOI 10.1002/adfm.201102305
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Strasser EM, 2005, BIOCHEM PHARMACOL, V70, P552, DOI 10.1016/j.bcp.2005.05.030
   Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8
   Swatschek D, 2002, EUR J PHARM BIOPHARM, V53, P107, DOI 10.1016/S0939-6411(01)00192-8
   Tang ML, 2013, BIOMATERIALS, V34, P6402, DOI 10.1016/j.biomaterials.2013.05.024
   Vajragupta O, 2005, BIOORG MED CHEM LETT, V15, P3364, DOI 10.1016/j.bmcl.2005.05.032
   Wakeland S, 2010, CARBON, V48, P3463, DOI 10.1016/j.carbon.2010.05.043
   Wang JC, 2011, POLYM INT, V60, P816, DOI 10.1002/pi.3025
   Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6
   Xia ZM, 2013, ACTA BIOMATER, V9, P7308, DOI 10.1016/j.actbio.2013.03.038
   Yang D, 2009, CARBON, V47, P145, DOI 10.1016/j.carbon.2008.09.045
   Yang K, 2011, ACS NANO, V5, P516, DOI 10.1021/nn1024303
   Yunoki S, 2003, J BIOSCI BIOENG, V96, P575, DOI 10.1016/S1389-1723(04)70152-8
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
   Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068
NR 58
TC 12
Z9 12
U1 1
U2 49
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 119
BP 98653
EP 98665
DI 10.1039/c5ra15726a
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA CX0QZ
UT WOS:000365403000093
DA 2018-10-20
ER

PT J
AU Wang, XC
   Shi, MC
   Zhai, D
   Wu, CT
AF Wang, Xiaocheng
   Shi, Mengchao
   Zhai, Dong
   Wu, Chengtie
TI Preparation, physicochemical properties and in vitro bioactivity of
   hierarchically porous bioactive glass scaffolds
SO RSC ADVANCES
LA English
DT Article
ID GENE-EXPRESSION; IMMOBILIZATION; BIOMATERIALS; REGENERATION; EFFICIENCY;
   STIFFNESS; STRENGTH; BEHAVIOR; LIPASE; SBA-15
AB Exploring bioactive scaffolds with the desired architecture and high osteogenic capacity has been a challenging issue for biomaterials and bone tissue engineering. Herein, a hierarchically porous bioactive glass scaffold (noted as YMBG) has been prepared by using P123, yeast cells and polyurethane sponges as templates. This synthesis strategy created high porosity scaffolds with interconnected macropores (300-500 mm), well-ordered mesopores (similar to 5 nm) and mid-level pores (20 nm to 2 mm). The utilization of yeast cells as a midpore biotemplate in the scaffolds significantly promoted the crystallization and improved their mechanical strengths. In addition, the prepared scaffolds could support attachment and proliferation of BMSCs, and more importantly, significantly improved the expression of bone-related genes (Runx2, OCN, Col I and BMP2). The results suggest that the novel bioactive glass scaffolds with widely-distributed porous structures, which can be employed as an effective carrier for a variety of therapeutic molecules and tissue cells, are expected to be a promising biomaterial for bone regeneration and tissue engineering.
C1 [Wang, Xiaocheng; Shi, Mengchao; Zhai, Dong; Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Wu, CT (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM chengtiewu@mail.sic.ac.cn
FU Recruitment Program of Global Young Talent, China; National High
   Technology Research and Development Program of China (863 Program)
   [SS2015AA020302]; Program of Shanghai Outstanding Academic Leaders
   [15XD1503900]
FX Funding for this study was provided by the Recruitment Program of Global
   Young Talent, China (Dr Wu), the National High Technology Research and
   Development Program of China (863 Program, SS2015AA020302) and Program
   of Shanghai Outstanding Academic Leaders (15XD1503900).
CR Alcaide M, 2010, ACTA BIOMATER, V6, P892, DOI 10.1016/j.actbio.2009.09.008
   Arcos D, 2009, J MATER SCI-MATER M, V20, P447, DOI 10.1007/s10856-008-3616-x
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Chatzistavrou X, 2004, PHYS STATUS SOLIDI A, V201, P944, DOI 10.1002/pssa.200306776
   Cui JJ, 2009, COLLOID SURFACE B, V74, P274, DOI 10.1016/j.colsurfb.2009.07.030
   Deng Y, 2015, INT J NANOMED, V10, P1425, DOI 10.2147/IJN.S75557
   Douglas T, 2007, BIOMACROMOLECULES, V8, P1085, DOI 10.1021/bm0609644
   Fan J, 2003, ANGEW CHEM INT EDIT, V42, P3146, DOI 10.1002/anie.200351027
   Gao SL, 2010, BIORESOURCE TECHNOL, V101, P3830, DOI 10.1016/j.biortech.2010.01.023
   Gibson M. F. A. L. J., 1999, CELLULAR SOLIDS STRU, P429
   He W, 2014, ADV FUNCT MATER, V24, P2206, DOI 10.1002/adfm.201303278
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Her GJ, 2013, ACTA BIOMATER, V9, P5170, DOI 10.1016/j.actbio.2012.10.012
   Hong YL, 2010, ADV MATER, V22, P754, DOI 10.1002/adma.200901656
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Huang MJ, 2012, J MATER CHEM, V22, P626, DOI 10.1039/c1jm13905c
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kang Y, 2007, IND ENG CHEM RES, V46, P4474, DOI 10.1021/ie061440n
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Kobayashi M, 1998, J BIOMED MATER RES, V42, P223, DOI 10.1002/(SICI)1097-4636(199811)42:2<223::AID-JBM7>3.0.CO;2-R
   Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000
   Li X, 2008, J MATER CHEM, V18, P4103, DOI 10.1039/b805114c
   Li X, 2007, CHEM MATER, V19, P4322, DOI 10.1021/cm0708564
   Li Z, 2013, BIOMATERIALS, V34, P7616, DOI 10.1016/j.biomaterials.2013.06.059
   Luo C, 2012, J MATER CHEM, V22, P15654, DOI 10.1039/c2jm32007j
   Selvakumar R, 2014, RSC ADV, V4, P52156, DOI 10.1039/c4ra07903e
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu CT, 2012, INTERFACE FOCUS, V2, P292, DOI 10.1098/rsfs.2011.0121
   Wu CT, 2011, ACTA BIOMATER, V7, P2644, DOI 10.1016/j.actbio.2011.03.009
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Wu Y, 2014, ADV FUNCT MATER, V24, P4473, DOI 10.1002/adfm.201304304
   Xia W, 2008, MICROPOR MESOPOR MAT, V108, P345, DOI 10.1016/j.micromeso.2007.04.013
   Xu MC, 2013, BIOMATER SCI-UK, V1, P933, DOI 10.1039/c3bm60028a
   Yan XX, 2005, J NON-CRYST SOLIDS, V351, P3209, DOI 10.1016/j.jnoncrysol.2005.08.024
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Yun HS, 2007, CHEM COMMUN, P2139, DOI 10.1039/b702103h
   Zhang B, 2015, COLLOID SURFACE B, V131, P129, DOI 10.1016/j.colsurfb.2015.04.060
   Zhang XD, 2013, COLLOID SURFACE B, V103, P114, DOI 10.1016/j.colsurfb.2012.10.002
   Zhu YF, 2008, MICROPOR MESOPOR MAT, V112, P494, DOI 10.1016/j.micromeso.2007.10.029
   Zhu YF, 2011, MICROPOR MESOPOR MAT, V143, P311, DOI 10.1016/j.micromeso.2011.03.007
NR 41
TC 0
Z9 0
U1 2
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 120
BP 98796
EP 98804
DI 10.1039/c5ra19125d
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CW9OL
UT WOS:000365328000009
DA 2018-10-20
ER

PT J
AU Hu, ZM
   Li, C
   Nie, RM
   Li, YQ
   Tang, JX
   Deng, XY
AF Hu, Zhimei
   Li, Chi
   Nie, Riming
   Li, Yan-Qing
   Tang, Jian-Xin
   Deng, Xianyu
TI Biomaterial functionalized graphene oxides with tunable work function
   for high sensitive organic photodetectors
SO RSC ADVANCES
LA English
DT Article
ID HIGH-DETECTIVITY; TRANSPARENT; FILMS; IMMOBILIZATION; COMPOSITES;
   ELECTRODES; MOLECULES; CATALYSIS
AB Graphene acts as an ideal material for transparent conductive electrodes in optoelectronic devices attributed to its excellent electrical conductivity, optical transparency, and mechanical properties. Graphene oxide (GO) in the form of a colloidal suspension is considered to be more commonly useful because of its low cost and high volume production. However, controlling the work function of graphene and GO as transparent electrodes in optoelectronic devices is still a challenging task, since it is important to match the energy level of the active materials. In this study, GO sheets functionalized with amino acids were fabricated via a mild and environmentally friendly approach. The work functions of the novel amino acid functionalized graphenes and their compounds with poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) were tuned over a wide range, which matched well with the energy of various semiconductors. Organic photodetectors with the functionalized GO exhibited the highest normalized detectivity of 5.7 x 10(12) jones at -0.1 V. The results indicated that the synthesized solution-processable GO exhibits promising potential as transparent electrodes for various photoelectric devices.
C1 [Hu, Zhimei; Nie, Riming; Deng, Xianyu] Harbin Inst Technol, Res Ctr Adv Funct Mat & Devices, Shenzhen Key Lab Adv Mat, Shenzhen Grad Sch,Sch Mat Sci & Engn, Shenzhen 518055, Peoples R China.
   [Li, Chi; Li, Yan-Qing; Tang, Jian-Xin] Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Jiangsu Key Lab Carbon Based Funct Mat & Devices, Suzhou 215123, Peoples R China.
RP Deng, XY (reprint author), Harbin Inst Technol, Res Ctr Adv Funct Mat & Devices, Shenzhen Key Lab Adv Mat, Shenzhen Grad Sch,Sch Mat Sci & Engn, Shenzhen 518055, Peoples R China.
EM jxtang@suda.edu.cn; xydeng@hitsz.edu.cn
RI Tang, Jianxin/A-1452-2013; Li, Yanqing/C-7262-2013
OI Deng, Xianyu/0000-0003-0653-6765
FU Shenzhen Research Foundation Project [JCYJ20140417161,
   KQCX20140521144147315]
FX This work is supported by the Shenzhen Research Foundation Project
   (Grants JCYJ20140417161, and KQCX20140521144147315).
CR Bao HQ, 2011, SMALL, V7, P1569, DOI 10.1002/smll.201100191
   Deng XY, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400215
   Depan D, 2014, BIOMATER SCI-UK, V2, P264, DOI 10.1039/c3bm60192g
   Devi R, 2014, J CHEM SCI, V126, P75, DOI 10.1007/s12039-013-0536-1
   Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83
   Eda G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2937846
   Gong X, 2009, SCIENCE, V325, P1665, DOI 10.1126/science.1176706
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Kapitanova OO, 2012, J KOREAN PHYS SOC, V60, P1789, DOI 10.3938/jkps.60.1789
   Li AY, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4870096
   Li QZ, 2013, IND ENG CHEM RES, V52, P6343, DOI 10.1021/ie400558u
   Liu YF, 2015, ORG ELECTRON, V26, P81, DOI 10.1016/j.orgel.2015.06.031
   Lu F, 2012, ACS APPL MATER INTER, V4, P3278, DOI 10.1021/am300634n
   Lu Q., 2010, SCI CHINA TECHNOL SC, V9, P2311
   Nie RM, 2014, ACS APPL MATER INTER, V6, P7032, DOI 10.1021/am501977w
   Nie RM, 2014, J MATER CHEM A, V2, P6734, DOI 10.1039/c4ta00152d
   Si Y, 2008, NANO LETT, V8, P1679, DOI 10.1021/nl080604h
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Su Q, 2009, ADV MATER, V21, P3191, DOI 10.1002/adma.200803808
   Sun ST, 2010, J MATER CHEM, V20, P5605, DOI 10.1039/c0jm01269f
   Wan L, 2015, J MATER SCI, V50, P2148, DOI 10.1007/s10853-014-8777-z
   Wang X, 2008, NANO LETT, V8, P323, DOI 10.1021/nl072838r
   Wang Y, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3204698
   Wu JB, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2924771
   Wu JB, 2010, ACS NANO, V4, P43, DOI 10.1021/nn900728d
   Xu T., 2011, ENERG ENVIRON SCI, V8, P2700
   Xu YF, 2010, CARBON, V48, P3308, DOI 10.1016/j.carbon.2010.05.017
   Yan H, 2009, POLYM J, V41, P1028, DOI 10.1295/polymj.PJ2009143
   Yin ZY, 2010, ACS NANO, V4, P5263, DOI 10.1021/nn1015874
   Yoo D, 2014, NANO RES, V7, P717, DOI 10.1007/s12274-014-0433-z
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
   Zhang WF, 2013, NANOSCALE, V5, P6030, DOI 10.1039/c3nr01323e
   Zhang Y., 2010, ACS NANO, V4, P2865
   Zhu JH, 2011, CARBON, V49, P1900, DOI 10.1016/j.carbon.2011.01.014
NR 34
TC 9
Z9 9
U1 5
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 120
BP 99431
EP 99438
DI 10.1039/c5ra19476h
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CW9OL
UT WOS:000365328000083
DA 2018-10-20
ER

PT J
AU Bhaskar, TBV
   Ma, N
   Lendlein, A
   Roch, T
AF Bhaskar, Thanga Bhuvanesh Vijaya
   Ma, Nan
   Lendlein, Andreas
   Roch, Toralf
TI The interaction of human macrophage subsets with silicone as a
   biomaterial
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Biomaterials; silicone; macrophage subsets; cytokines/chemokines
ID POLY(N-BUTYL ACRYLATE) NETWORKS; BREAST IMPLANTS; ANTIINFLAMMATORY
   CYTOKINES; INNATE IMMUNITY; ACTIVATION; POLARIZATION; CELLS;
   POLYDIMETHYLSILOXANE; ATTACHMENT; ELASTOMERS
AB Silicones are widely used as biomaterials for medical devices such as extracorporeal equipments. However, there is often conflicting evidence about their supposed cell-and histocompatibility. Macrophages could mediate silicone-induced adverse responses such as foreign body reaction and fibrous encapsulation. The polarization behaviour of macrophages could determine the clinical outcome after implantation of biomaterials. Induction of classically activated macrophages (CAM) may induce and support uncontrolled inflammatory responses and undesired material degradation. In contrast, polarization into alternatively activated macrophages (AAM) is assumed to support healing processes and implant integration.
   This study compared the interaction of non-polarized macrophages (M0), CAM, and AAM with commercially available tissue culture polystyrene (TCP) and a medical grade silicone-based biomaterial, regarding the secretion of inflammatory mediators such as cytokines and chemokines. Firstly, by using the Limulus amoebocyte lysate (LAL) test the silicone films were shown to be free of soluble endotoxins, which is the prerequisite to investigate their interaction with primary immune cells. Primary human monocyte-derived macrophages (M0) were polarized into CAM and AAM by addition of suitable differentiation factors. These macrophage subsets were incubated on the materials for 24 hours and their viability and cytokine secretion was assessed. In comparison to TCP, cell adhesion was lower on silicone after 24 hours for all three macrophage subsets. However, compared to TCP, silicone induced higher levels of certain inflammatory and chemotactic cytokines in M0, CAM, and AAM macrophage subsets.
   Conclusively, it was shown that silicone has the ability to induce a pro-inflammatory state to different magnitudes dependent on the macrophage subsets. This priming of the macrophage phenotype by silicone could explain the incidence of severe foreign body complications observed in vivo.
C1 [Bhaskar, Thanga Bhuvanesh Vijaya; Ma, Nan; Lendlein, Andreas; Roch, Toralf] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Bhaskar, Thanga Bhuvanesh Vijaya; Ma, Nan; Lendlein, Andreas; Roch, Toralf] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
   [Bhaskar, Thanga Bhuvanesh Vijaya; Lendlein, Andreas] Univ Potsdam, Inst Chem, Potsdam, Germany.
   [Ma, Nan; Lendlein, Andreas] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany.
   [Bhaskar, Thanga Bhuvanesh Vijaya; Ma, Nan; Lendlein, Andreas; Roch, Toralf] Helmholtz Virtual Inst Multifunct Biomat Med, Teltow, Germany.
   [Bhaskar, Thanga Bhuvanesh Vijaya; Ma, Nan; Lendlein, Andreas; Roch, Toralf] Helmholtz Virtual Inst Multifunct Biomat Med, Berlin, Germany.
RP Roch, T (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM toralf.roch@hzg.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Roch, Toralf/0000-0003-2948-8700
FU Helmholtz Virtual Institute, Multifunctional Biomaterials for Medicine
   [VH-VI-423]; Helmholtz-Association, Impuls- und Vernetzungsfond [SO-036]
FX The authors acknowledge Ruth Hesse and Anja Muller-Heyn for their
   technical assistance. This work was funded by the Helmholtz Virtual
   Institute, Multifunctional Biomaterials for Medicine (grant no.
   VH-VI-423) and partially supported by the Helmholtz-Association, Impuls-
   und Vernetzungsfond (grant no. SO-036).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   [Anonymous], 2012, GUIDANCE IND PYROGEN
   Backovic A, 2007, J IMMUNOL METHODS, V328, P118, DOI 10.1016/j.jim.2007.08.016
   Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406
   BERG B, 1981, REFERENCE VALUES LAB, P55
   BONFIELD TL, 1991, J BIOMED MATER RES, V25, P165, DOI 10.1002/jbm.820250204
   Braune S, 2011, CLIN HEMORHEOL MICRO, V49, P375, DOI 10.3233/CH-2011-1487
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Franca DCC, 2011, J CRANIOFAC SURG, V22, P837, DOI 10.1097/SCS.0b013e31820f367b
   Classen Andrea, 2009, V531, P29, DOI 10.1007/978-1-59745-396-7_3
   Colas A., 2013, BIOMATERIAL SCI, P82
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772
   Duffield S., 2003, CLIN SCI, V104, P27
   Franca Diurianne Caroline Campos, 2013, Acta Inform Med, V21, P93, DOI 10.5455/aim.2013.21.93-97
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   GARRIDO L, 1993, MAGNET RESON MED, V29, P839, DOI 10.1002/mrm.1910290620
   Grutz G, 2005, J LEUKOCYTE BIOL, V77, P3, DOI 10.1189/jlb.0904484
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   Iribarren Pablo, 2002, BMC Immunol, V3, P6, DOI 10.1186/1471-2172-3-6
   Isailovic N, 2015, J AUTOIMMUN, V60, P1, DOI 10.1016/j.jaut.2015.04.006
   Ishida Y, 2006, J IMMUNOL, V176, P5598, DOI 10.4049/jimmunol.176.9.5598
   Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010
   Jung DH, 2007, PLAST RECONSTR SURG, V120, P1997, DOI 10.1097/01.prs.0000287323.71630.e6
   Koster M, 2013, CLIN HEMORHEOL MICRO, V54, P325, DOI 10.3233/CH-131737
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Lampert FM, 2012, GEBURTSH FRAUENHEILK, V72, P243, DOI 10.1055/s-0031-1298323
   Legrand AP, 2005, J MATER SCI-MATER M, V16, P477, DOI 10.1007/s10856-005-6989-0
   Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   McFarland CD, 2000, J BIOMED MATER RES, V49, P200, DOI 10.1002/(SICI)1097-4636(200002)49:2<200::AID-JBM7>3.3.CO;2-C
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Naim JO, 1998, COLLOID SURFACE B, V11, P79, DOI 10.1016/S0927-7765(98)00023-X
   Naim JO, 2000, CLIN DIAGN LAB IMMUN, V7, P366, DOI 10.1128/CDLI.7.3.366-370.2000
   Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162
   OWEN MJ, 1981, CHEMTECH, V11, P288
   Prantl L, 2014, CLIN HEMORHEOL MICRO, V58, P521, DOI 10.3233/CH-141812
   Roch T, 2014, CLIN HEMORHEOL MICRO, V58, P147, DOI 10.3233/CH-141885
   Roch T, 2011, MACROMOL SYMP, V309-310, P182, DOI 10.1002/masy.201100048
   Rohrich RJ, 1999, PLAST RECONSTR SURG, V104, P1786, DOI 10.1097/00006534-199911000-00026
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   van Diest PJ, 1998, J CLIN PATHOL, V51, P493, DOI 10.1136/jcp.51.7.493
   Vazquez G, 2007, AESTHET PLAST SURG, V31, P330, DOI 10.1007/s00266-006-0207-4
   Wick G, 2013, ANNU REV IMMUNOL, V31, P107, DOI 10.1146/annurev-immunol-032712-095937
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wolfram D, 2012, PLAST RECONSTR SURG, V129, P327
NR 51
TC 5
Z9 5
U1 0
U2 9
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2015
VL 61
IS 2
BP 119
EP 133
DI 10.3233/CH-151991
PG 15
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CV9GP
UT WOS:000364596000002
PM 26444613
DA 2018-10-20
ER

PT J
AU Braune, S
   Zhou, S
   Groth, B
   Jung, F
AF Braune, S.
   Zhou, S.
   Groth, B.
   Jung, F.
TI Quantification of adherent platelets on polymer-based biomaterials.
   Comparison of colorimetric and microscopic assessment
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Platelet; biomaterial; thrombogenicity; lactate dehydrogenase; acid
   phosphatase; colorimetric assay; microscopy
ID IN-VITRO; BLOOD-PLATELETS; ADHESION; SURFACE; HEMOCOMPATIBILITY;
   COAGULATION; ADSORPTION; THROMBOSIS; STANDARDS; ARTERIES
AB BACKGROUND: Platelet adhesion to artificial surfaces is one of the most important indicators for the thrombogenicity of implant materials. Currently, a variety of enzyme activity-based colorimetric assays or microscopy-based techniques are commonly in use to assess this characteristic. Studies about how data of colorimetric assays correlate with the image-based quantification of adherent platelets are scarce. To address this question, the present study compared two colorimetric assays (lactate dehydrogenase (LDH) and acid phosphatase (ACP)) with an image-based quantification of the density of platelets adhering on polymer-based biomaterial surfaces.
   MATERIALS AND METHODS: Tri-sodium citrated whole blood was collected from apparently healthy subjects and platelet rich plasma (PRP) was prepared according to a standardized protocol. An in vitro static thrombogenicity test was applied to study platelet adhesion from PRP adjusted to 50,000 platelets per mu L on three different polymers: medical grade polytetrafluoroethylene (PTFE), silicone and polyethylene terephthalate (PET). For the direct image-based approach, surface adherent platelets were fixed, fluorescently labelled and microscopically visualized. The image-based determination of platelet densities provided reference values for the comparison with data of the colorimetric assays. Correlation between standard platelet concentrations and ACP/LDH absorbance measurements were analysed to estimate accuracy and association of both parameters. ACP and LDH release from resting and ADP-stimulated platelets was studied to estimate how platelet activation influences colorimetric assay results.
   RESULTS: The density of adherent platelets ranged from 15,693 +/- 2,487 platelets.mm(-2) (PTFE) to 423 +/- 99 platelets.mm(-2) (silicone) and 4,621 +/- 1,427 platelets.mm(-2) (PET) and differed significantly between the three polymers (ANOVA: p < 0.05). Correlation coefficients between microscopic and colorimetric determination of platelet densities ranged between r = 0.93 (LDH, p < 0.001) and r = 0.94 (ACP, p < 0.001). ACP absorbance measurements of platelet standards with different concentrations corresponded well to an ideal linear regression, while LDH data either deceeded or exceeded the expected values. The LDH release during ADP-induced platelet activation was significantly higher compared to the release of ACP.
   CONCLUSION: For an adjusted platelet concentration of 50,000 platelets.mu L-1, both colorimetric assays (ACP and LDH) allowed a similar accurate quantification of the mean platelet density compared to the microscopic evaluation. Better linearity of the assay standards, less variability of the results and a lower influence of platelet activation on the measurements mark the ACP assay as more suitable for the assessment of material surface adherent platelets compared to the LDH assay, particularly, if near physiological platelet concentrations are applied.
C1 [Braune, S.; Zhou, S.; Groth, B.; Jung, F.] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14531 Teltow, Germany.
   [Braune, S.; Zhou, S.; Groth, B.; Jung, F.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14531 Teltow, Germany.
   [Zhou, S.] Tianjin Univ, Helmholtz Zentrum Geesthacht, Joint Lab Biomat & Regenerat Med, Teltow, Germany.
RP Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14531 Teltow, Germany.
EM friedrich.jung@hzg.de
RI Braune, Steffen/D-2315-2015; Jung, Friedrich/L-1301-2013; Lendlein,
   Andreas/K-9553-2013
OI Jung, Friedrich/0000-0001-8098-7180; Lendlein,
   Andreas/0000-0003-4126-4670
FU Helmholtz-Association; Impuls- und Vernetzungsfond [SO-036]; German
   Federal Ministry of Education and Research (BMBF) [0315496]
FX This work was financially supported by the Helmholtz-Association,
   Impuls- und Vernetzungsfond (grant no. SO-036) and the German Federal
   Ministry of Education and Research (BMBF, grant no. 0315496).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   BAK IJ, 1969, Z ZELLFORSCH MIK ANA, V96, P641, DOI 10.1007/BF00973339
   BELLAVITE P, 1994, ANAL BIOCHEM, V216, P444, DOI 10.1006/abio.1994.1066
   BERG B, 1981, REFERENCE VALUES LAB, P55
   Bertino AM, 2003, TRANSFUSION, V43, P857, DOI 10.1046/j.1537-2995.2003.t01-4-00431.x
   Braune S, 2012, CLIN HEMORHEOL MICRO, V52, P349, DOI 10.3233/CH-2012-1610
   Braune S, 2011, CLIN HEMORHEOL MICRO, V49, P375, DOI 10.3233/CH-2011-1487
   Braune S, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-33
   Cattaneo M, 2013, J THROMB HAEMOST, V11, P1183, DOI 10.1111/jth.12231
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   CONDREA E, 1987, CLIN CHIM ACTA, V169, P309, DOI 10.1016/0009-8981(87)90330-5
   Eriksson Andreas C., 2005, Journal of Pharmacological and Toxicological Methods, V52, P356, DOI 10.1016/j.vascn.2005.06.002
   Erlandsen SL, 2001, J HISTOCHEM CYTOCHEM, V49, P809, DOI 10.1177/002215540104900702
   Favaloro EJ, 2010, CLIN CHEM LAB MED, V48, P579, DOI 10.1515/CCLM.2010.121
   Favaloro EJ, 2008, SEMIN THROMB HEMOST, V34, P709, DOI 10.1055/s-0029-1145254
   Frank RD, 2000, J BIOMED MATER RES, V52, P374, DOI 10.1002/1097-4636(200011)52:2<374::AID-JBM18>3.3.CO;2-Q
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Harrison P, 2005, BLOOD REV, V19, P111, DOI 10.1016/j.blre.2004.05.002
   Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Lima-Oliveira G., 2014, J MED BIOCHEM, P1
   Lippi G, 2012, SEMIN THROMB HEMOST, V38, P565, DOI 10.1055/s-0032-1315961
   Liu T, 2014, J BIOMED MATER RES A, V102, P3754, DOI 10.1002/jbm.a.35025
   Lutter C, 2015, CLIN HEMORHEOL MICRO, V59, P219, DOI 10.3233/CH-141839
   Mackie I, 2013, INT J LAB HEMATOL, V35, P1, DOI 10.1111/ijlh.12004
   Massa TM, 2007, J BIOMED MATER RES A, V81A, P178, DOI 10.1002/jbm.a.30936
   Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528
   Neffe AT, 2013, MACROMOL BIOSCI, V13, P1720, DOI 10.1002/mabi.201300309
   Okroj W, 2009, ACTA BIOENG BIOMECH, V11, P45
   Papp J, 2014, CLIN HEMORHEOL MICRO, V56, P1, DOI 10.3233/CH-2012-1636
   Papp J, 2013, CLIN HEMORHEOL MICRO, V53, P81, DOI 10.3233/CH-2012-1578
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Paternotte E, 2013, CLIN HEMORHEOL MICRO, V54, P223, DOI 10.3233/CH-131728
   Pierce BF, 2012, MACROMOL BIOSCI, V12, P312, DOI 10.1002/mabi.201100237
   Polasek J, 2004, PLATELETS, V15, P403, DOI 10.1080/09537100410001721315
   Reinhart WH, 2013, CLIN HEMORHEOL MICRO, V53, P71, DOI 10.3233/CH-2012-1577
   Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227
   Seyfert UT, 2002, BIOMOL ENG, V19, P91, DOI 10.1016/S1389-0344(02)00015-1
   SHATTIL SJ, 1994, CURR OPIN CELL BIOL, V6, P695, DOI 10.1016/0955-0674(94)90096-5
   Sheriff J, 2010, ANN BIOMED ENG, V38, P1442, DOI 10.1007/s10439-010-9936-2
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Ullm S, 2014, BIOMATERIALS, V35, P9755, DOI 10.1016/j.biomaterials.2014.08.023
   Vanickova M, 2006, PLATELETS, V17, P470, DOI 10.1080/09537100600758875
NR 45
TC 5
Z9 5
U1 1
U2 13
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2015
VL 61
IS 2
BP 225
EP 236
DI 10.3233/CH-151995
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CV9GP
UT WOS:000364596000012
PM 26410874
DA 2018-10-20
ER

PT J
AU Giovagnoli, S
   Luca, G
   Blasi, P
   Mancuso, F
   Schoubben, A
   Arato, I
   Calvitti, M
   Falabella, G
   Basta, G
   Bodo, M
   Calafiore, R
   Ricci, M
AF Giovagnoli, Stefano
   Luca, Giovanni
   Blasi, Paolo
   Mancuso, Francesca
   Schoubben, Aurelie
   Arato, Iva
   Calvitti, Mario
   Falabella, Giulia
   Basta, Giuseppe
   Bodo, Maria
   Calafiore, Riccardo
   Ricci, Maurizio
TI Alginates in Pharmaceutics and Biomedicine: Is the Future so Bright?
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Alginate; microencapsulation; alginate drug delivery systems; cell
   microencapsulation; clinical studies; cell transplantation
ID IN-VITRO CHARACTERIZATION; PANCREATIC-CELL CLUSTERS; TYPE-1
   DIABETIC-PATIENT; DRUG-DELIVERY SYSTEMS; ORAL INSULIN DELIVERY; PORCINE
   SERTOLI-CELLS; HUMAN-FACTOR-IX; POLYELECTROLYTE COMPLEXES; SODIUM
   ALGINATE; MATRIX TABLETS
AB Alginate represents one of the most appealing biopolymers for pharmaceutical and biomedical applications. Alginate as a biomaterial for clinical use has been established, although not free from issues. Here we provide a critical review on some of the main recent advances in alginate research in drug delivery and its prominent role in cell microencapsulation for the treatment of diseases, such as type 1 diabetes mellitus. A brief description of the basic properties of the polymer will be provided as well. Based on our experience and contributions, as well as wide research in the field, the correlation between physicochemical and biological properties of alginate systems and clinical outcomes will be investigated and discussed to address the actual future clinical impact of alginate-based delivery strategies.
C1 [Giovagnoli, Stefano; Schoubben, Aurelie; Ricci, Maurizio] Univ Perugia, Dept Pharmaceut Sci, I-06123 Perugia, Italy.
   [Luca, Giovanni; Mancuso, Francesca; Arato, Iva; Calvitti, Mario; Falabella, Giulia; Bodo, Maria] Univ Perugia, Dept Expt Med, I-06123 Perugia, Italy.
   [Blasi, Paolo] Univ Camerino, Sch Pharm, I-62032 Camerino, Italy.
   [Basta, Giuseppe; Calafiore, Riccardo] Univ Perugia, Dept Med, I-06123 Perugia, Italy.
RP Giovagnoli, S (reprint author), Univ Perugia, Dept Pharmaceut Sci, Via Liceo 1, I-06123 Perugia, Italy.
EM stefano.giovagnoli@unipg.it
RI Giovagnoli, Stefano/N-1064-2018
OI Giovagnoli, Stefano/0000-0001-5043-7233; Blasi,
   Paolo/0000-0002-8543-4275
FU Altucell Inc., Dix Hills, New York, NY
FX This work has been supported by a grant from Mr. Gary Harlem (Altucell
   Inc. 3 Astor Court, Dix Hills, New York, NY).
CR Abdelbary GA, 2008, EUR J PHARM BIOPHARM, V69, P1019, DOI 10.1016/j.ejpb.2008.01.011
   AEBISCHER P, 1994, EXP NEUROL, V126, P151, DOI 10.1006/exnr.1994.1053
   Agulhon P, 2014, CARBOHYD POLYM, V112, P525, DOI 10.1016/j.carbpol.2014.05.097
   Agulhon P, 2012, BIOMACROMOLECULES, V13, P1899, DOI 10.1021/bm300420z
   Almond A, 2005, CARBOHYD RES, V340, P907, DOI 10.1016/j.carres.2005.01.014
   ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227
   [Anonymous], 2003, F231503 ASTM INT
   [Anonymous], 2011, F231511 ASTM INT
   [Anonymous], 2010, F231510 ASTM INT
   [Anonymous], 2006, F2064002006E1 ASTM I
   Aquino RP, 2012, CARBOHYD POLYM, V89, P740, DOI 10.1016/j.carbpol.2012.04.003
   Araujo V, 2013, J PHARM SCI-US, V102, P2748, DOI 10.1002/jps.23656
   ASTM International, 2000, F2064 ASTM INT
   Auriemma G, 2013, CARBOHYD POLYM, V92, P367, DOI 10.1016/j.carbpol.2012.09.056
   Basta G, 2010, Process for the ultrapurification of alginates, Patent No. [US2010/0298262A1, 20100298262]
   Basta G, 2011, DIABETES CARE, V34, P2406, DOI 10.2337/dc11-0731
   Becheran-Maron L, 2004, INT J BIOL MACROMOL, V34, P127, DOI 10.1016/j.ijbiomac.2004.03.010
   Bhandari B, 2009, Australian Patent, Patent No. [WO2009062254, 2009062254]
   Bidarra SJ, 2014, ACTA BIOMATER, V10, P1646, DOI 10.1016/j.actbio.2013.12.006
   Bistoni G, 2012, BIOMATERIALS, V33, P5333, DOI 10.1016/j.biomaterials.2012.04.020
   Bjornmalm M, 2014, J CONTROL RELEASE, V190, P139, DOI 10.1016/j.jconrel.2014.04.030
   Breger JC, 2015, J BIOMED MATER RES B, V103, P1120, DOI 10.1002/jbm.b.33282
   Buthe A, 2004, J MICROENCAPSUL, V21, P865, DOI 10.1080/02652040400015478
   Calafiore R, 2006, DIABETES CARE, V29, P137, DOI 10.2337/diacare.29.01.06.dc05-1270
   Calafiore R, 2004, BIOTECHNOL APPL BIOC, V39, P159, DOI 10.1042/BA20030151
   Calafiore R, 2014, ADV DRUG DELIVER REV, V67-68, P84, DOI 10.1016/j.addr.2013.09.020
   Calafiore Riccardo, 2007, V140, P197
   Calija B, 2013, COLLOID SURFACE B, V110, P395, DOI 10.1016/j.colsurfb.2013.05.016
   Cascone S, 2012, DRUG DEV IND PHARM, V38, P1486, DOI 10.3109/03639045.2011.653814
   Cefalu WT, 2013, DIABETES CARE, V36, P1, DOI 10.2337/dc12-2182
   Cesaro A, 2012, EUR BIOPHYS J BIOPHY, V41, P379, DOI 10.1007/s00249-011-0753-9
   Chan AW, 2009, BIOMACROMOLECULES, V10, P609, DOI 10.1021/bm801316z
   Chan LW, 2007, DRUG DEV IND PHARM, V33, P667, DOI 10.1080/03639040600943814
   CHANG PL, 1993, HUM GENE THER, V4, P433, DOI 10.1089/hum.1993.4.4-433
   Chiu CT, 2013, ALIMENT PHARM THER, V38, P1054, DOI 10.1111/apt.12482
   Choi HG, 2000, J CONTROL RELEASE, V68, P397, DOI 10.1016/S0168-3659(00)00276-5
   CID E, 1986, BIOPHARM DRUG DISPOS, V7, P559, DOI 10.1002/bdd.2510070605
   Cocchietto M, 2013, J FUNCT BIOMATER, V4, P312, DOI 10.3390/jfb4040312
   Dang TD, 2013, COLLOID SURFACE B, V102, P766, DOI 10.1016/j.colsurfb.2012.09.016
   de Oliveira EF, 2014, COLLOID SURFACE B, V113, P146, DOI 10.1016/j.colsurfb.2013.08.038
   de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010
   de Vos P, 2012, BIOMATERIALS, V33, P5552, DOI 10.1016/j.biomaterials.2012.04.039
   Deat-Laine E, 2012, INT J PHARMACEUT, V439, P136, DOI 10.1016/j.ijpharm.2012.10.003
   Del Gaudio P, 2005, INT J PHARM, V302, P1, DOI 10.1016/j.ijpharm.2005.05.041
   Del Gaudio P, 2014, EUR J PHARM BIOPHARM, V87, P541, DOI 10.1016/j.ejpb.2014.02.010
   Dentini M, 2007, CARBOHYD POLYM, V67, P465, DOI 10.1016/j.carbpol.2006.06.020
   Donati I, 2005, BIOMACROMOLECULES, V6, P1031, DOI 10.1021/bm049306e
   Dorati R, 2013, J MICROENCAPSUL, V30, P559, DOI 10.3109/02652048.2013.764938
   Douglas KL, 2005, J BIOMAT SCI-POLYM E, V16, P43, DOI 10.1163/1568562052843339
   Draget KI, 2003, BIOMACROMOLECULES, V4, P1661, DOI 10.1021/bm034105g
   DRAGET KI, 2002, BIOPOLYMERS, V6, P215
   Draget KI, 2011, FOOD HYDROCOLLOID, V25, P251, DOI 10.1016/j.foodhyd.2009.10.007
   Du J, 2014, AAPS PHARMSCITECH, V15, P1535, DOI 10.1208/s12249-014-0176-x
   Duarte ARC, 2014, LANGMUIR, V30, P12391, DOI 10.1021/la502822v
   Dumitriu RP, 2009, CELL CHEM TECHNOL, V43, P251
   Dumitriu S., 2002, POLYM BIOMATERIALS
   Dusseault J, 2006, J BIOMED MATER RES A, V76A, P243, DOI 10.1002/jbm.a.30541
   Ebara M., 2014, NIMS MONOGRAPHS, P9
   Elliott RB, 2011, 23 WORLD C IPITA PRA
   Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x
   Elmowafy E, 2014, INT J NANOMED, V9, P4449, DOI 10.2147/IJN.S66876
   Emerich DF, 2014, ADV DRUG DELIVER REV, V67-68, P131, DOI 10.1016/j.addr.2013.07.008
   Engl W, 2008, CURR OPIN COLLOID IN, V13, P206, DOI 10.1016/j.cocis.2007.09.003
   ERTESVAG H, 1995, MOL MICROBIOL, V16, P719, DOI 10.1111/j.1365-2958.1995.tb02433.x
   Espevik T., 2009, BIOARTIFICIAL PANCRE, P279
   Fallarino F, 2009, J EXP MED, V206, P2511, DOI 10.1084/jem.20090134
   Fang YP, 2007, J PHYS CHEM B, V111, P2456, DOI 10.1021/jp0689870
   Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200
   FRANKLIN MJ, 1994, J BACTERIOL, V176, P1821, DOI 10.1128/jb.176.7.1821-1830.1994
   Fu S, 2011, AAPS PHARMSCITECH, V12, P453, DOI 10.1208/s12249-011-9587-0
   Gannon PM, CMBO PERSPECTIVE BIO
   Gattas-Asfura KM, 2014, J MATER CHEM B, V2, P8208, DOI 10.1039/c4tb01241k
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Giovagnoli S, 2005, J CONTROL RELEASE, V107, P65, DOI 10.1016/j.jconrel.2005.05.021
   Giovagnoli S, 2010, PHARM RES-DORD, V27, P285, DOI 10.1007/s11095-009-0017-x
   Goh CH, 2012, CARBOHYD POLYM, V88, P1, DOI 10.1016/j.carbpol.2011.11.012
   Gryshkov O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107911
   Hadi MA, 2015, PAK J PHARM SCI, V28, P185
   Hansson SF, 2013, J PATHOL, V229, P719, DOI 10.1002/path.4166
   Hariyadi DM, 2010, J DRUG TARGET, V18, P831, DOI 10.3109/1061186X.2010.525651
   Hassan N, 2010, PHARM DEV TECHNOL, V15, P124, DOI 10.3109/10837450903055494
   HASSAN RM, 1992, COLLOID POLYM SCI, V270, P1237, DOI 10.1007/BF01095065
   Hassan RM, 2013, J LIFE MED, V1, P41
   Hasse C, 1997, LANCET, V350, P1296, DOI 10.1016/S0140-6736(05)62473-7
   HAUG A, 1965, ACTA CHEM SCAND, V19, P341, DOI 10.3891/acta.chem.scand.19-0341
   HAUG A, 1967, ACTA CHEM SCAND, V21, P768, DOI 10.3891/acta.chem.scand.21-0768
   HAUG A, 1966, ACTA CHEM SCAND, V20, P183, DOI 10.3891/acta.chem.scand.20-0183
   HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691
   HODSDON AC, 1995, J CONTROL RELEASE, V33, P143, DOI 10.1016/0168-3659(94)00076-7
   Hortelano G, 1996, BLOOD, V87, P5095
   Hosseini SM, 2014, CARBOHYD POLYM, V103, P573, DOI 10.1016/j.carbpol.2013.12.078
   Hosseini SM, 2013, INT J BIOL MACROMOL, V62, P582, DOI 10.1016/j.ijbiomac.2013.09.054
   Huanbutta K, 2013, CARBOHYD POLYM, V97, P26, DOI 10.1016/j.carbpol.2013.04.073
   Huang KS, 2014, ELECTROPHORESIS, V35, P330, DOI 10.1002/elps.201300194
   Ige O. O., 2012, ISRN MAT SCI, V2012
   Ikinci G, 2004, INT J PHARM, V277, P173, DOI 10.1016/j.ijpharm.2003.10.040
   Itoh K, 2010, DRUG DEV IND PHARM, V36, P449, DOI 10.3109/03639040903244480
   Iwanaga S, 2013, COLLOID SURFACE B, V109, P301, DOI 10.1016/j.colsurfb.2013.04.007
   Jacobs-Tulleneers-Thevissen D, 2013, DIABETOLOGIA, V56, P1605, DOI 10.1007/s00125-013-2906-0
   Jayant RD, 2011, INT J PHARMACEUT, V403, P268, DOI 10.1016/j.ijpharm.2010.10.035
   Jelvehgari M, 2014, JUNDISHAPUR J NAT PH, V9, P39
   Jitraruch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113609
   Kanjickal DG, 2004, CRIT REV THER DRUG, V21, P345
   Kashima K, 2011, DESALIN WATER TREAT, V34, P257, DOI 10.5004/dwt.2011.2892
   Khotimchenko YS, 2001, RUSS J MAR BIOL, V27, pS53, DOI DOI 10.1023/A:1013851022276
   Kim T, 2012, J MINIM INVAS GYN, V19, P731, DOI 10.1016/j.jmig.2012.08.003
   King A. H., 1983, FOOD HYDROCOLLOIDS, V2, P115
   Ko JA, 2012, BIOTECHNOL LETT, V34, P515, DOI 10.1007/s10529-011-0791-5
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Korbutt GS, 2000, DIABETOLOGIA, V43, P474, DOI 10.1007/s001250051331
   Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649
   Lacerda L, 2014, MAT SCI ENG C-MATER, V39, P161, DOI 10.1016/j.msec.2014.01.054
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Li DH, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/981321
   Li L, 2014, INT J PHARMACEUT, V476, P253, DOI 10.1016/j.ijpharm.2014.09.057
   Li XY, 2009, J MICROENCAPSUL, V26, P315, DOI 10.1080/02652040802328685
   Li XX, 2009, POLYM DEGRAD STABIL, V94, P1, DOI 10.1016/j.polymdegradstab.2008.10.017
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lin YH, 2005, BIOMATERIALS, V26, P2105, DOI 10.1016/j.biomaterials.2004.06.011
   Lin YS, 2013, ELECTROPHORESIS, V34, P425, DOI 10.1002/elps.201200282
   LIU HW, 1993, HUM GENE THER, V4, P291, DOI 10.1089/hum.1993.4.3-291
   Liu L, 2013, J COLLOID INTERF SCI, V404, P85, DOI 10.1016/j.jcis.2013.04.044
   Liu XD, 2002, J MICROENCAPSUL, V19, P775, DOI 10.1080/0265204021000022743
   Liu XD, 2003, J APPL POLYM SCI, V87, P848, DOI 10.1002/app.11537
   Lotfipour F, 2012, ADV PHARM BULL, V2, P71, DOI 10.5681/apb.2012.010
   Luca G, 2005, CELL TRANSPLANT, V14, P249, DOI 10.3727/000000005783983034
   Luca G, 2003, BIOMATERIALS, V24, P3101, DOI 10.1016/S0142-9612(03)00118-2
   Luca G, 2013, J CONTROL RELEASE, V165, P75, DOI 10.1016/j.jconrel.2012.08.028
   Lucinda-Silva RM, 2003, J MICROENCAPSUL, V20, P145, DOI 10.1080/02652040210162621
   Luo YC, 2014, INT J BIOL MACROMOL, V64, P353, DOI 10.1016/j.ijbiomac.2013.12.017
   Maderuelo C, 2011, J CONTROL RELEASE, V154, P2, DOI 10.1016/j.jconrel.2011.04.002
   Mansourpour M., 2015, AAPS PHARMSCITECH
   Martins S, 2007, CARBOHYD POLYM, V69, P725, DOI 10.1016/j.carbpol.2007.02.012
   Matricardi P, 2008, EXPERT OPIN DRUG DEL, V5, P417, DOI [10.1517/17425247.5.4.417, 10.1517/17425247.5.4.417 ]
   Maurstad G, 2003, J PHYS CHEM B, V107, P8172, DOI 10.1021/jp0271965
   MELIA CD, 1991, CRIT REV THER DRUG, V8, P395
   MICHAELS AS, 1961, J PHYS CHEM-US, V65, P1765, DOI 10.1021/j100827a020
   Mithun U, 2014, INT J CHEM TECH RES, V6, P3579
   Mladenovska K, 2007, INT J PHARM, V345, P59, DOI 10.1016/j.ijpharm.2007.05.059
   Mobus K, 2009, EUR J PHARM BIOPHARM, V72, P42
   Mobus K., 2012, EUR J PHARM SCI, V45, P358
   Moe Storker T., 1995, V67, P245
   Mobus K, 2012, EUR J PHARM BIOPHARM, V81, P121, DOI 10.1016/j.ejpb.2012.01.018
   MONSHIPOURI M, 1995, J MICROENCAPSUL, V12, P255, DOI 10.3109/02652049509010294
   Montanucci P, 2014, BIOMED RES INT
   Morch YA, 2006, BIOMACROMOLECULES, V7, P1471, DOI 10.1021/bm060010d
   Moroni A, 2011, DRUG DEV IND PHARM, V37, P216, DOI 10.3109/03639045.2010.504726
   Moyer HR, 2010, ANN PLAS SURG, V65, P497, DOI 10.1097/SAP.0b013e3181d37713
   Muniswamy P, 2012, J BIOMED PHARM RES, V1, P101
   Omer A, 2003, DIABETES, V52, P69, DOI 10.2337/diabetes.52.1.69
   Orive G, 2014, ADV DRUG DELIVER REV, V67-68, P3, DOI 10.1016/j.addr.2013.07.009
   OTTERLEI M, 1991, J IMMUNOTHER, V10, P286, DOI 10.1097/00002371-199108000-00007
   Ouwerx C, 1998, POLYM GELS NETW, V6, P393, DOI 10.1016/S0966-7822(98)00035-5
   Paques JP, 2014, ADV COLLOID INTERFAC, V209, P163, DOI 10.1016/j.cis.2014.03.009
   Paredes Juarez Genaro Alberto, 2014, Front Bioeng Biotechnol, V2, P26, DOI 10.3389/fbioe.2014.00026
   Patel VM, 2007, AAPS PHARMSCITECH, V8
   Pawar SN, 2012, BIOMATERIALS, V33, P3279, DOI 10.1016/j.biomaterials.2012.01.007
   PHILIPP B, 1989, PROG POLYM SCI, V14, P91, DOI 10.1016/0079-6700(89)90018-X
   Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014
   Poojari R, 2013, EXPERT OPIN DRUG DEL, V10, P1061, DOI 10.1517/17425247.2013.796361
   Prakash A, 1999, DRUGS, V57, P383, DOI 10.2165/00003495-199957030-00013
   Prokop A, 1997, ANN NY ACAD SCI, V831, P223
   Qi M., 2014, ADV MED, V2014, P1
   Reis CP, 2006, J MICROENCAPSUL, V23, P245, DOI 10.1080/02652040500286086
   Reis CP, 2007, BIOTECHNOL BIOENG, V96, P977, DOI 10.1002/bit.21164
   RENDLEMAN JA, 1978, FOOD CHEM, V3, P127, DOI 10.1016/0308-8146(78)90031-6
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   Ricci M, 2005, J CONTROL RELEASE, V107, P395, DOI 10.1016/j.jconrel.2005.06.023
   RINAUDO M, 1993, INT J BIOL MACROMOL, V15, P281, DOI 10.1016/0141-8130(93)90027-J
   Rokstad AMA, 2014, ADV DRUG DELIVER REV, V67-68, P111, DOI 10.1016/j.addr.2013.07.010
   Rondeau E, 2008, LANGMUIR, V24, P6937, DOI 10.1021/la703339u
   Roy DS, 2002, EUR J PHARM SCI, V16, P193
   Roy Harekrishna, 2014, Int J Appl Basic Med Res, V4, pS31, DOI 10.4103/2229-516X.140728
   Rraju K.N, 2011, INT J PHARM PHARM SC, V3, P239
   Saether HV, 2008, CARBOHYD POLYM, V74, P813, DOI 10.1016/j.carbpol.2008.04.048
   Sagiri SS, 2014, AAPS PHARMSCITECH, V15, P1197, DOI 10.1208/s12249-014-0147-2
   Sankar R, 2013, DRUG DES DEV THER, V7, P1455, DOI 10.2147/DDDT.S52890
   Santos E, 2013, J CONTROL RELEASE, V170, P1, DOI 10.1016/j.jconrel.2013.04.015
   Sarmento B, 2007, PHARM RES, V24, P2198, DOI 10.1007/s11095-007-9367-4
   Schatz C, 2004, BIOMACROMOLECULES, V5, P1882, DOI 10.1021/bm049786
   Schoubben A, 2010, CHEM ENG J, V160, P363, DOI 10.1016/j.cej.2010.02.062
   Schoubben A, 2009, EUR J PHARM SCI, V36, P226, DOI 10.1016/j.ejps.2008.09.008
   Scocca Sarah, 2007, Current Drug Delivery, V4, P103, DOI 10.2174/156720107780362311
   SELAWRY HP, 1993, CELL TRANSPLANT, V2, P123, DOI 10.1177/096368979300200206
   Siepmann J, 2012, J CONTROL RELEASE, V161, P351, DOI 10.1016/j.jconrel.2011.10.006
   Simsek-Ege FA, 2003, J APPL POLYM SCI, V88, P346, DOI 10.1002/app.11989
   Skaugrud O, 1999, BIOTECHNOL GENET ENG, V16, P23, DOI 10.1080/02648725.1999.10647970
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   Sosnik Alejandro, 2014, ISRN Pharm, V2014, P926157, DOI 10.1155/2014/926157
   Spasojevic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109837
   Sriamornsak P, 2007, EUR J PHARM BIOPHARM, V66, P435, DOI 10.1016/j.ejpb.2006.12.003
   Stewart MB, 2014, CARBOHYD POLYM, V112, P486, DOI 10.1016/j.carbpol.2014.06.001
   Stewart MB, 2014, CARBOHYD POLYM, V102, P246, DOI 10.1016/j.carbpol.2013.11.034
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   Strugala V, 2012, ISRN OBSTET GYNECOL, V2012
   Su R, 2011, INT J BIOL MACROMOL, V49, P979, DOI 10.1016/j.ijbiomac.2011.08.018
   Suarez-Pinzon W, 2000, DIABETES, V49, P1810, DOI 10.2337/diabetes.49.11.1810
   Suksamran T, 2009, J MICROENCAPSUL, V26, P563, DOI 10.3109/02652040802500622
   Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285
   Swain Suryakanta, 2012, Recent Pat Drug Deliv Formul, V6, P259
   Syed IA, 2014, INT J PHARM INVESTIG, V4, P38, DOI 10.4103/2230-973X.127739
   Tapia C, 2004, EUR J PHARM BIOPHARM, V57, P65, DOI 10.1016/S0939-641(03)00153-X
   Tenenbaum DJ, POLYM AND PEOPLE
   Tharavanij T, 2008, TRANSPLANTATION, V86, P1161, DOI 10.1097/TP.0b013e31818a7f45
   Thompson RC, 2009, PHILOS T R SOC B, V364, P2153, DOI 10.1098/rstb.2009.0053
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   Tiwari SB, 2011, DRUG POLYM MATRICES, P131
   Trouche E, 2010, CELL TRANSPLANT, V19, P1623, DOI 10.3727/096368910X514297
   Tuch BE, 2009, DIABETES CARE, V32, P1887, DOI 10.2337/dc09-0744
   U. S. Department of Health and Human Services FDA, 2009, GUID IND CONS ALL PA
   U.S. Pharmacopeia/National Formulary, 2011, 85 BACT END TEST
   Valla S, 1996, CARBOHYDR EUR, V14, P14
   VELINGS NM, 1995, POLYM GELS NETW, V3, P311, DOI 10.1016/0966-7822(94)00043-7
   Vold IMN, 2006, BIOMACROMOLECULES, V7, P2136, DOI 10.1021/bm060099n
   von Schmeling HHKB, 2011, COLLOID POLYM SCI, V289, P1407, DOI 10.1007/s00396-011-2464-2
   Wen JP, 2007, J GENE MED, V9, P1002, DOI 10.1002/jgm.1098
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Wittaya-areekul S, 2006, INT J PHARM, V312, P113, DOI 10.1016/j.ijpharm.2006.01.003
   Woitiski CB, 2009, ACTA BIOMATER, V5, P2475, DOI 10.1016/j.actbio.2009.03.007
   WONG H, 1986, INT J ARTIF ORGANS, V9, P335
   Zhang H, 2006, J AM CHEM SOC, V128, P12205, DOI 10.1021/ja0635682
   Zhang TT, 2010, J PHARM SCI-US, V99, P4678, DOI 10.1002/jps.22163
   Zhang YL, 2011, EUR J PHARM BIOPHARM, V77, P11, DOI 10.1016/j.ejpb.2010.09.016
   Zhao XH, 2010, J APPL PHYS, V107, DOI 10.1063/1.3343265
NR 224
TC 7
Z9 7
U1 5
U2 40
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 33
BP 4917
EP 4935
DI 10.2174/1381612821666150820105639
PG 19
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CV8FO
UT WOS:000364516500010
PM 26290204
DA 2018-10-20
ER

PT J
AU Rodoplu, D
   Boyaci, IH
   Bozkurt, AG
   Eksi, H
   Zengin, A
   Tamer, U
   Aydogan, N
   Ozcan, S
   Tugcu-Demiroz, F
AF Rodoplu, Didem
   Boyaci, Ismail H.
   Bozkurt, Akif G.
   Eksi, Haslet
   Zengin, Adem
   Tamer, Ugur
   Aydogan, Nihal
   Ozcan, Sadan
   Tugcu-Demiroz, Fatmanur
TI Quantitative Characterization of Magnetic Mobility of Nanoparticle in
   Solution-Based Condition
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Magnetophoretic mobility; Saturation magnetism; Initial Mobility;
   Superparamagnetic iron oxide nanoparticles
ID IRON-OXIDE NANOPARTICLES; SURFACE-PLASMON RESONANCE; ESCHERICHIA-COLI
   O157-H7; DOT-LABELED ANTIBODIES; MAGNETOPHORETIC MOBILITY; BIOLOGICAL
   APPLICATIONS; IMMUNOMAGNETIC SEPARATION; SALMONELLA-ENTERITIDIS;
   LISTERIA-MONOCYTOGENES; NANOSTRUCTURED FILMS
AB Magnetic nanoparticles are considered as the ideal substrate to selectively isolate target molecules or organisms from sample solutions in a wide variety of applications including bioassays, bioimaging and environmental chemistry. The broad array of these applications in fields requires the accurate magnetic characterization of nanoparticles for a variety of solution based-conditions. Because the freshly synthesized magnetic nanoparticles demonstrated a perfect magnetization value in solid form, they exhibited a different magnetic behavior in solution. Here, we present simple quantitative method for the measurement of magnetic mobility of nanoparticles in solution-based condition. Magnetic mobility of the nanoparticles was quantified with initial mobility of the particles using UV-vis absorbance spectroscopy in water, ethanol and MES buffer. We demonstrated the efficacy of this method through a systematic characterization of four different core-shell structures magnetic nanoparticles over three different surface modifications. The solid nanoparticles were characterized using transmission electron microscopy (TEM), X-ray diffraction (XRD) and saturation magnetization (Ms). The surfaces of the nanoparticles were functionalized with 11-mercaptoundecanoic acid and bovine serum albumin BSA was selected as biomaterial. The effect of the surface modification and solution media on the stability of the nanoparticles was monitored by zeta potentials and hydrodynamic diameters of the nanoparticles. Results obtained from the mobility experiments indicate that the initial mobility was altered with solution media, surface functionalization, size and shape of the magnetic nanoparticle. The proposed method easily determines the interactions between the magnetic nanoparticles and their surrounding biological media, the magnetophoretic responsiveness of nanoparticles and the initial mobilities of the nanoparticles.
C1 [Rodoplu, Didem; Boyaci, Ismail H.] Hacettepe Univ, Inst Sci, Nanotechnol & Nanomed Div, TR-06800 Ankara, Turkey.
   [Boyaci, Ismail H.; Bozkurt, Akif G.; Eksi, Haslet] Hacettepe Univ, Dept Food Engn, Fac Engn, TR-06800 Ankara, Turkey.
   [Zengin, Adem] Yuzuncu Yil Univ, Dept Chem Engn, Fac Engn & Architecture, TR-65080 Van, Turkey.
   [Tamer, Ugur] Gazi Univ, Dept Analyt Chem, Fac Pharm, TR-06330 Ankara, Turkey.
   [Aydogan, Nihal] Hacettepe Univ, Dept Chem Engn, Fac Engn, TR-06800 Ankara, Turkey.
   [Ozcan, Sadan] Hacettepe Univ, Dept Engn Phys, Fac Engn, TR-06800 Ankara, Turkey.
   [Tugcu-Demiroz, Fatmanur] Gazi Univ, Dept Pharmaceut Technol, Fac Pharm, TR-06330 Ankara, Turkey.
RP Boyaci, IH (reprint author), Hacettepe Univ, Dept Food Engn, TR-06800 Ankara, Turkey.
EM ihb@hacettepe.edu.tr; utamer@gazi.edu.tr
RI Bayram, Cem/D-7403-2013
OI Bayram, Cem/0000-0001-8717-4668
CR Agarwal R, 2008, SMALL, V4, P1872, DOI 10.1002/smll.200800556
   Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927
   Amagliani G, 2006, J APPL MICROBIOL, V100, P375, DOI 10.1111/j.1365-2672.2005.02761.x
   Andreu JS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021402
   Arai T, 2007, J OPT A-PURE APPL OP, V9, P699, DOI 10.1088/1464-4258/9/7/022
   Arai T, 2006, MATER RES SOC SYMP P, V915, P41
   Aravamudhan S, 2008, SENSOR ACTUAT B-CHEM, V132, P623, DOI 10.1016/j.snb.2008.01.046
   Arbos P, 2002, INT J PHARM, V242, P129, DOI 10.1016/S0378-5173(02)00182-5
   Arias JL, 2001, J CONTROL RELEASE, V77, P309, DOI 10.1016/S0168-3659(01)00519-3
   Asthana R, 2006, MATERIALS PROCESSING AND MANUFACTURING SCIENCE, pXVIII, DOI 10.1016/B978-075067716-5/50001-7
   Augustin MA, 2009, ADV FOOD NUTR RES, V58, P183, DOI 10.1016/S1043-4526(09)58005-9
   Bagwe RP, 2003, J DISPER SCI TECHNOL, V24, P453, DOI 10.1081/DIS-120021801
   Bakumov V, 2007, J EUR CERAM SOC, V27, P3287, DOI 10.1016/j.jeurceramsoc.2007.01.004
   Bally M, 2009, NANOMEDICINE-UK, V4, P447, DOI [10.2217/nnm.09.16, 10.2217/NNM.09.16]
   Baniukevic J, 2013, BIOSENS BIOELECTRON, V43, P281, DOI 10.1016/j.bios.2012.12.014
   Bao N, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2937088
   Benelmekki M, 2011, J MAGN MAGN MATER, V323, P1945, DOI 10.1016/j.jmmm.2011.02.027
   Benelmekki M, 2011, J NANOPART RES, V13, P3199, DOI 10.1007/s11051-010-0218-6
   Beyaz S., 2009, J OPTOELECTRON ADV S, V1, P447
   Boyaci IH, 2005, ANAL BIOANAL CHEM, V382, P1234, DOI 10.1007/s00216-005-3263-8
   Chalmers JJ, 1999, J MAGN MAGN MATER, V194, P231, DOI 10.1016/S0304-8853(98)00557-5
   Cheng YX, 2009, TALANTA, V77, P1332, DOI 10.1016/j.talanta.2008.09.014
   Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050
   Chu HY, 2008, APPL SPECTROSC, V62, P922, DOI 10.1366/000370208785284330
   Crespo P, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/48/484006
   Crystallization Reserach Tools, 2014, CRYST RES TOOLS, V18, P51
   Davar F, 2009, J ALLOY COMPD, V476, P797, DOI 10.1016/j.jallcom.2008.09.121
   DAVIS RS, 1993, MEAS SCI TECHNOL, V4, P141, DOI 10.1088/0957-0233/4/2/001
   De Las Cuevas G, 2008, J PHYS CHEM C, V112, P945, DOI 10.1021/jp0755286
   Digigow RG, 2014, J MAGN MAGN MATER, V362, P72, DOI 10.1016/j.jmmm.2014.03.026
   Ding HL, 2012, CHEM MATER, V24, P4572, DOI 10.1021/cm302828d
   Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   Dudak FC, 2008, J RAPID METH AUT MIC, V16, P122, DOI 10.1111/j.1745-4581.2008.00120.x
   Dudak Fahriye Ceyda, 2011, Front Biosci (Elite Ed), V3, P1109
   Dudak FC, 2009, J RAPID METH AUT MIC, V17, P315, DOI 10.1111/j.1745-4581.2009.00155.x
   El-Boubbou K, 2007, J AM CHEM SOC, V129, P13392, DOI 10.1021/ja076086e
   Faraudo J, 2010, COLLOID POLYM SCI, V288, P207, DOI 10.1007/s00396-009-2107-z
   Farimani MHR, 2013, PHYSICA E, V53, P207, DOI 10.1016/j.physe.2013.04.032
   Friedman G, 2005, CURR OPIN COLLOID IN, V10, P158, DOI 10.1016/j.cocis.2005.08.002
   Gao JH, 2006, ADV MATER, V18, P3145, DOI 10.1002/adma.200601058
   GERBER R, 1983, IEEE T MAGN, V19, P2115, DOI 10.1109/TMAG.1983.1062795
   GILL SJ, 1960, REV SCI INSTRUM, V31, P1299, DOI 10.1063/1.1716878
   Gu HW, 2006, CHEM COMMUN, P941, DOI 10.1039/b514130c
   Gu HW, 2003, CHEM COMMUN, P1966, DOI 10.1039/b305421g
   Gubin SP, 2005, RUSS CHEM REV, V74, P489, DOI DOI 10.1070/RC2005V074N06ABEH000897
   Hafeli UO, 2005, J MAGN MAGN MATER, V293, P224, DOI 10.1016/j.jmmm.2005.02.001
   Hatch DM, 2008, CHEMBIOCHEM, V9, P2433, DOI 10.1002/cbic.200800188
   Hecht E, 2001, OPTICS, P680
   Hofmann-Amtenbrink M, 2009, NANOSTRUCTURED MAT B, P119
   Jin T, 2009, J FOOD SCI, V74, pM46, DOI 10.1111/j.1750-3841.2008.01013.x
   Jing Y, 2008, FASEB J, V22, P4239, DOI 10.1096/fj.07-105544
   Jun YW, 2008, ACCOUNTS CHEM RES, V41, P179, DOI 10.1021/ar700121f
   Jung JS, 2007, J MAGN MAGN MATER, V310, P2361, DOI 10.1016/j.jmmm.2006.11.180
   Kang WS, 2008, FABRICATION NANOPART
   Kim D, 2009, J AM CHEM SOC, V131, P454, DOI 10.1021/ja8086906
   Kolhatkar AG, 2013, INT J MOL SCI, V14, P15977, DOI 10.3390/ijms140815977
   Larumbe S, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/26/266007
   Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e
   Lee KB, 2004, ANGEW CHEM INT EDIT, V43, P3048, DOI 10.1002/anie.200454088
   Lim J, 2011, ACS NANO, V5, P217, DOI 10.1021/nn102383s
   Lin J, 2001, J SOLID STATE CHEM, V159, P26, DOI 10.1006/jssc.2001.9117
   Lin YS, 2005, ANAL CHEM, V77, P1753, DOI 10.1021/ac048990k
   Liu JC, 2009, ANALYST, V134, P2087, DOI 10.1039/b908069d
   Liu WT, 2006, J BIOSCI BIOENG, V102, P1, DOI 10.1263/jbb.102.1
   Liu YC, 2002, J MICROBIOL METH, V51, P369, DOI 10.1016/S0167-7012(02)00107-0
   Mayer DP, 2012, PRZ ELEKTROTECHNICZN, P229
   McCloskey KE, 2000, CYTOMETRY, V40, P307, DOI 10.1002/1097-0320(20000801)40:4<307::AID-CYTO6>3.0.CO;2-H
   Moghal J, 2012, ACS APPL MATER INTER, V4, P854, DOI 10.1021/am201494m
   Murphy D, 2004, HELV CHIM ACTA, V87, P2727, DOI 10.1002/hlca.200490245
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Nishida K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001269
   Olbrich C, 2004, J CONTROL RELEASE, V96, P425, DOI 10.1016/j.jconrel.2004.02.024
   Pal S, 2009, J APPL PHYS, V105, DOI 10.1063/1.3059607
   Pamme N, 2004, ANAL CHEM, V76, P7250, DOI 10.1021/ac049183c
   Parak WJ, 2003, NANOTECHNOLOGY, V14, pR15, DOI 10.1088/0957-4484/14/7/201
   Pei ZC, 2010, ANAL BIOCHEM, V398, P161, DOI 10.1016/j.ab.2009.11.038
   Polyanskiy M, 2013, REFRACTIVE INDEX DAT
   Ranjbakhsh E, 2012, CHEM ENG J, V179, P272, DOI 10.1016/j.cej.2011.10.097
   Ravindranath SP, 2009, ANAL CHEM, V81, P2840, DOI 10.1021/ac802158y
   Ray TR, 2015, LANGMUIR, V31, P3577, DOI 10.1021/la504511j
   Rong H., 2007, NANOTECHNOLOGY, V18
   Rotariu O, 2002, J MAGN MAGN MATER, V252, P390, DOI 10.1016/S0304-8853(02)00707-2
   Sajja VSK, 2011, BIOTECHNOL BIOENG, V108, P2107, DOI 10.1002/bit.23157
   Salado J, 2011, CHEM MATER, V23, P2879, DOI 10.1021/cm200253k
   Salazar-Alvarez G, 2008, J AM CHEM SOC, V130, P13234, DOI 10.1021/ja0768744
   Simsek T, 2014, J MAGN MAGN MATER, V351, P47, DOI 10.1016/j.jmmm.2013.09.051
   Smolensky ED, 2013, J MATER CHEM B, V1, P2818, DOI 10.1039/c3tb00369h
   Su XL, 2004, ANAL CHEM, V76, P4806, DOI 10.1021/ac049442+
   Sulatha Dwarakanath, 2006, Journal of Clinical Ligand Assay, V29, P136
   Suttiponparnit K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9772-1
   Tamer U, 2010, J NANOPART RES, V12, P1187, DOI 10.1007/s11051-009-9749-0
   Temur E, 2010, ANAL BIOANAL CHEM, V397, P1595, DOI 10.1007/s00216-010-3676-x
   Thapa D, 2004, MATER LETT, V58, P2692, DOI 10.1016/j.matlet.2004.03.045
   Varshney M, 2005, J FOOD PROTECT, V68, P1804, DOI 10.4315/0362-028X-68.9.1804
   Varshney M, 2007, BIOSENS BIOELECTRON, V22, P2408, DOI 10.1016/j.bios.2006.08.030
   Wang J, 2005, PERSP BIOANAL, V1, P369, DOI 10.1016/S1871-0069(05)01011-6
   Ware MW, 2003, J MICROBIOL METH, V55, P575, DOI 10.1016/j.mimet.2003.06.001
   Watarai H, 2004, ANAL BIOANAL CHEM, V378, P1693, DOI 10.1007/s00216-003-2354-7
   Wei Y., 2012, PROCEDIA ENG, V27, P632, DOI DOI 10.1016/J.PROENG.2011.12.498
   West JL, 2000, CURR OPIN BIOTECH, V11, P215, DOI 10.1016/S0958-1669(00)00082-3
   West JL, 2003, ANNU REV BIOMED ENG, V5, P285, DOI 10.1146/annurev.bioeng.5.011303.120723
   Yang H, 2008, MICROFLUID NANOFLUID, V5, P571, DOI 10.1007/s10404-008-0302-8
   Yang LJ, 2006, ANALYST, V131, P394, DOI 10.1039/b510888h
   Yavuz CT, 2009, CHEM ENG SCI, V64, P2510, DOI 10.1016/j.ces.2008.11.018
   Yu FQ, 2010, BIOMATERIALS, V31, P5842, DOI 10.1016/j.biomaterials.2010.03.072
   Yu LSL, 2002, J MICROBIOL METH, V49, P63, DOI 10.1016/S0167-7012(01)00352-9
NR 108
TC 4
Z9 4
U1 2
U2 17
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 37
BP 5389
EP 5400
DI 10.2174/1381612821666150917092327
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CV8GC
UT WOS:000364518200008
PM 26377661
DA 2018-10-20
ER

PT J
AU Cui, HX
   Guo, J
   Han, Z
   Guo, YX
   Guo, ML
AF Cui, H. X.
   Guo, J.
   Han, Z.
   Guo, Y. X.
   Guo, M. L.
TI Biocompatibility of differently proportioned HA/PLGA/BMP-2 composite
   biomaterials in rabbits
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE HA/PLGA/BMP-2 composite material; Histocompatibility; Bone tissue
   engineering
ID BONE REGENERATION; MECHANICAL-PROPERTIES; IN-VITRO; BMP-2; SCAFFOLDS;
   COMPATIBILITY; MICROSPHERES; DELIVERY; VIVO
AB The aim of this study was to assess the histocompatibility of hydroxyapatite (HA)/poly(lactic-co-glycolic acid) (PLGA)/bone morphogenetic protein-2 (BMP-2) composite materials in rabbits. Thirty healthy New Zealand white rabbits were randomly divided into 3 groups (N = 10). HA/PLGA/BMP-2 composite materials with the HA/PLGA proportions of 1: 1, 1: 2, and 1: 3 were implanted in the animals, which were subsequently sacrificed on the 30th and 60th days post-implantation to allow for differences in routine blood and biochemical indices to be assessed between the animal groups. The degree of biomaterial degradation was also assessed in the three groups. Thirty and 60 days after the implantation of titanium plates and composite materials, no rabbits succumbed to inflammatory reactions, adverse reactions, abnormal blood routine and biochemical indices, or unstable liver functions. The presence of newborn tissues was identified within the 60 days post-implantation. No significant differences were observed between the three groups (P < 0.05). The wide clinical application of HA/PLGA/BMP-2 composite biomaterial, which is highly compatible with rabbits with no apparent effects on the animals, is highly feasible.
C1 [Cui, H. X.; Guo, J.; Han, Z.; Guo, Y. X.; Guo, M. L.] Luoyang Orthoped Hosp Henan Prov, Luoyang, Henan Province, Peoples R China.
RP Guo, ML (reprint author), Luoyang Orthoped Hosp Henan Prov, Luoyang, Henan Province, Peoples R China.
EM guomalongloth@126.com
CR Bhattarai SR, 2008, J BIOMED MATER RES A, V86A, P289, DOI 10.1002/jbm.a.31490
   Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648
   Hannink G, 2013, J MATER SCI-MATER M, V24, P325, DOI 10.1007/s10856-012-4802-4
   Ji Y, 2010, ANN BIOMED ENG, V38, P632, DOI 10.1007/s10439-009-9888-6
   Jose MV, 2009, ACTA BIOMATER, V5, P305, DOI 10.1016/j.actbio.2008.07.019
   Kharaziha M, 2010, J MECH BEHAV BIOMED, V3, P530, DOI 10.1016/j.jmbbm.2010.06.003
   Kleinschmidt K, 2013, BIOMATERIALS, V34, P5926, DOI 10.1016/j.biomaterials.2013.04.029
   Kobayashi S, 2009, J MATER SCI-MATER M, V20, P379, DOI 10.1007/s10856-008-3583-2
   Lee JW, 2011, BIOMATERIALS, V32, P744, DOI 10.1016/j.biomaterials.2010.09.035
   Lin YT, 2012, J MATER SCI-MATER M, V23, P2453, DOI 10.1007/s10856-012-4723-2
   Lin ZY, 2010, J CONTROL RELEASE, V144, P190, DOI 10.1016/j.jconrel.2010.02.016
   Nguyen DT, 2013, J BIOMAT SCI-POLYM E, V24, P1071, DOI 10.1080/09205063.2012.735099
   Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020
   Sagar N, 2012, J BIOMED MATER RES B, V100B, P624, DOI 10.1002/jbm.b.31983
   Schopper C, 2008, J BIOMED MATER RES A, V85A, P954, DOI 10.1002/jbm.a.31525
   Testori T, 2012, INT J PERIODONT REST, V32, P295
   Thorey F, 2011, J APPL BIOMATER BIOM, V9, P26, DOI 10.5301/JABB.2011.7731
   Wu ZM, 2010, J PHARM PHARMACOL, V62, P873, DOI [10.1211/jpp.62.05.0008, 10.1211/jpp.62.07.0008]
   Xia Y, 2012, J BIOMED MATER RES A, V100A, P1044, DOI 10.1002/jbm.a.33232
   Zheng Z, 2010, BIOMATERIALS, V31, P9293, DOI 10.1016/j.biomaterials.2010.08.041
NR 20
TC 3
Z9 4
U1 1
U2 12
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2015
VL 14
IS 4
BP 13511
EP 13518
DI 10.4238/2015.October.28.12
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CV9BJ
UT WOS:000364582000048
PM 26535665
OA Bronze
DA 2018-10-20
ER

PT S
AU Michaels, SC
   Moses, KC
   Bachmann, RJ
   Hamilton, R
   Pena-Francesch, A
   Lanba, A
   Demirel, MC
   Quinn, RD
AF Michaels, Simone C.
   Moses, Kenneth C.
   Bachmann, Richard J.
   Hamilton, Reginald
   Pena-Francesch, Abdon
   Lanba, Asheesh
   Demirel, Melik C.
   Quinn, Roger D.
BE Wilson, SP
   Verschure, PFMJ
   Mura, A
   Prescott, TJ
TI Biomimicry of the Manduca Sexta Forewing Using SRT Protein Complex for
   FWMAV Development
SO BIOMIMETIC AND BIOHYBRID SYSTEMS, LIVING MACHINES 2015
SE Lecture Notes in Artificial Intelligence
LA English
DT Proceedings Paper
CT 4th International Conference on Biomimetic and Biohybrid Systems (Living
   Machines)
CY JUL 28-31, 2015
CL Barcelona, SPAIN
SP Convergence Sci Network Biomimet & Neurotechnol, Univ Sheffield, Univ Pompeu Fabra Barcelona, Inst Catalana Recerca Estudis Avancats
DE Protein; Wing; FWMAV; Biomaterial; Manduca sexta; Hawkmoth; Biomimicry
ID FLIGHT
AB A new thermoplastic protein complex, Squid Ring Teeth (SRT), has been adapted for use in the artificial reconstruction of a Manduca sexta wing. The SRT protein complex exhibits consistent material properties over a wide range of temperatures (25 degrees C to 196 degrees C) and retains it mechanical integrity across a large frequency spectrum (0.1 Hz to 150 Hz). Insect-inspired wings comprised of SRT can therefore be reliable and robust, which are essential characteristics for flapping wing MAVs (FWMAV). The preliminary results in this paper suggest that a thorough analysis of an SRT-based wing be conducted using load cell, optical digitization, and PIV techniques. With these results, we believe it will be possible to accurately mimic the M. sexta wing in order to pave the way for next generation FWMAV development.
C1 [Michaels, Simone C.; Moses, Kenneth C.; Bachmann, Richard J.; Quinn, Roger D.] Case Western Reserve Univ, Biol Inspired Robot Lab, Cleveland, OH 44106 USA.
   [Hamilton, Reginald; Pena-Francesch, Abdon; Lanba, Asheesh; Demirel, Melik C.] Penn State Univ, State Coll, PA USA.
RP Michaels, SC (reprint author), Case Western Reserve Univ, Biol Inspired Robot Lab, Cleveland, OH 44106 USA.
EM scm61@case.edu; kcm7@case.edu; rjb3@case.edu; MDemirel@engr.psu.edu;
   rdq@case.edu
RI Demirel, Melik/E-3775-2016
OI Demirel, Melik/0000-0003-0466-7649; Pena-Francesch,
   Abdon/0000-0002-7779-1651
CR Ansari SA, 2006, PROG AEROSP SCI, V42, P129, DOI 10.1016/j.paerosci.2006.07.001
   Chirarattananon P, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/2/025004
   Combes SA, 2010, ENCY AEROSPACE ENG, P1
   DeLeon N.E., 2011, MANUFACTURING EVALUA
   ENNOS AR, 1989, J EXP BIOL, V142, P87
   O'Hara RP, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/4/046011
   OHara R.P., 2011, MAT PROPERTY STRUCTU
   Pena Francesch A., 2014, ADV FUNCTIONAL MAT, V24, P6227
   Pena Francesch A., 2014, ADV FUNCTIONAL MAT, V24, P7401
NR 9
TC 1
Z9 1
U1 1
U2 2
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0302-9743
BN 978-3-319-22979-9; 978-3-319-22978-2
J9 LECT NOTES ARTIF INT
PY 2015
VL 9222
BP 86
EP 91
DI 10.1007/978-3-319-22979-9_8
PG 6
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Theory & Methods; Robotics
SC Computer Science; Robotics
GA BD8QF
UT WOS:000364183200008
DA 2018-10-20
ER

PT J
AU Wang, L
   Xu, C
   Zhu, YJ
   Yu, Y
   Sun, N
   Zhang, XQ
   Feng, K
   Qin, JH
AF Wang, Li
   Xu, Cong
   Zhu, Yujuan
   Yu, Yue
   Sun, Ning
   Zhang, Xiaoqing
   Feng, Ke
   Qin, Jianhua
TI Human induced pluripotent stem cell-derived beating cardiac tissues on
   paper
SO LAB ON A CHIP
LA English
DT Article
ID CARDIOMYOCYTE DIFFERENTIATION; CULTURE; NEURONS
AB There is a growing interest in using paper as a biomaterial scaffold for cell-based applications. In this study, we made the first attempt to fabricate a paper-based array for the culture, proliferation, and direct differentiation of human induced pluripotent stem cells (hiPSCs) into functional beating cardiac tissues and create "a beating heart on paper." This array was simply constructed by binding a cured multi-well polydimethylsiloxane (PDMS) mold with common, commercially available paper substrates. Three types of paper material (print paper, chromatography paper and nitrocellulose membrane) were tested for adhesion, proliferation and differentiation of human-derived iPSCs. We found that hiPSCs grew well on these paper substrates, presenting a three-dimensional (3D)-like morphology with a pluripotent property. The direct differentiation of human iPSCs into functional cardiac tissues on paper was also achieved using our modified differentiation approach. The cardiac tissue retained its functional activities on the coated print paper and chromatography paper with a beating frequency of 40-70 beats per min for up to three months. Interestingly, human iPSCs could be differentiated into retinal pigment epithelium on nitrocellulose membrane under the conditions of cardiac-specific induction, indicating the potential roles of material properties and mechanical cues that are involved in regulating stem cell differentiation. Taken together, these results suggest that different grades of paper could offer great opportunities as bioactive, low-cost, and 3D in vitro platforms for stem cell-based high-throughput drug testing at the tissue/organ level and for tissue engineering applications.
C1 [Wang, Li; Xu, Cong; Zhu, Yujuan; Yu, Yue; Zhang, Xiaoqing; Feng, Ke; Qin, Jianhua] Chinese Acad Sci, Dalian Inst Chem Phys, Dept Biotechnol, Dalian, Peoples R China.
   [Sun, Ning] Fudan Univ, Coll Basic Med Sci, Dept Physiol & Pathophysiol, Shanghai 200032, Peoples R China.
RP Qin, JH (reprint author), Chinese Acad Sci, Dalian Inst Chem Phys, Dept Biotechnol, Dalian, Peoples R China.
EM jhqin@dicp.ac.cn
OI Sun, Ning/0000-0002-7861-3646; Yu, Yue/0000-0003-0633-9577; xu,
   cong/0000-0001-8714-1890
FU International Science & Technology Cooperation Program of China
   [2015DFA00740]; Key Laboratory of Separation Science for Analytical
   Chemistry (Dalian Institute of Chemical Physics, Chinese Academy of
   Sciences); National Nature Science Foundation of China [81273483,
   81201689]; Special Fund for Agro-scientific Research in the Public
   Interest [201303045]
FX This research was supported by the International Science & Technology
   Cooperation Program of China (2015DFA00740), Key Laboratory of
   Separation Science for Analytical Chemistry (Dalian Institute of
   Chemical Physics, Chinese Academy of Sciences), National Nature Science
   Foundation of China (No. 81273483, 81201689), and Special Fund for
   Agro-scientific Research in the Public Interest (No. 201303045).
CR Bilousova G., 2011, STEM CELLS, V20, P233
   Brandl C, 2014, NEUROMOL MED, V16, P551, DOI 10.1007/s12017-014-8308-8
   Cimetta E, 2013, LAB CHIP, V13, P355, DOI 10.1039/c2lc40836h
   Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498
   Csobonyeiova M, 2015, CELL TISSUE BANK, V16, P171, DOI 10.1007/s10561-014-9462-9
   Derda R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018940
   Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106
   Giri S, 2015, DRUG DISCOV TODAY, V20, P37, DOI 10.1016/j.drudis.2014.10.011
   Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127
   Ikonen L, 2013, BIOMED RES INT, DOI 10.1155/2013/285678
   Kawada J, 2012, LAB CHIP, V12, P4508, DOI 10.1039/c2lc40268h
   Khademhosseini A, 2007, BIOMED MICRODEVICES, V9, P149, DOI 10.1007/s10544-006-9013-7
   Kitagawa Y, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035011
   Lee J, 2013, BIOMATERIALS, V34, P8140, DOI 10.1016/j.biomaterials.2013.07.074
   Lian X., 2012, P NATL ACAD SCI USA, V27, P1848
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109
   Mosadegh B, 2015, BIOMATERIALS, V52, P262, DOI 10.1016/j.biomaterials.2015.02.012
   Mosadegh B, 2014, ADV HEALTHC MATER, V3, P1036, DOI 10.1002/adhm.201300575
   Myers FB, 2013, INTEGR BIOL-UK, V5, P1495, DOI 10.1039/c2ib20191g
   Park HJ, 2014, BIOMATERIALS, V35, P9811, DOI 10.1016/j.biomaterials.2014.09.002
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Sapp MC, 2015, ACTA BIOMATER, V13, P199, DOI 10.1016/j.actbio.2014.11.039
   Stout DA, 2012, INT J NANOMED, V7, P5653, DOI 10.2147/IJN.S34574
   Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
NR 26
TC 17
Z9 17
U1 7
U2 49
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
EI 1473-0189
J9 LAB CHIP
JI Lab Chip
PY 2015
VL 15
IS 22
BP 4283
EP 4290
DI 10.1039/c5lc00919g
PG 8
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA CV2FL
UT WOS:000364072300005
PM 26430714
DA 2018-10-20
ER

PT J
AU Newman, P
   Lu, Z
   Roohani-Esfahani, SI
   Church, TL
   Biro, M
   Davies, B
   King, A
   Mackenzie, K
   Minett, AI
   Zreiqat, H
AF Newman, P.
   Lu, Z.
   Roohani-Esfahani, S. I.
   Church, T. L.
   Biro, M.
   Davies, B.
   King, A.
   Mackenzie, K.
   Minett, A. I.
   Zreiqat, H.
TI Porous and strong three-dimensional carbon nanotube coated ceramic
   scaffolds for tissue engineering
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; CHEMICAL-VAPOR-DEPOSITION; BONE-FORMATION;
   CELLULAR BEHAVIOR; PROLIFERATION; GROWTH; DIFFERENTIATION;
   BIOCOMPATIBILITY; REGENERATION; COMPOSITES
AB Biomaterials research is investigating increasingly complex materials capable of mirroring the highly organized biochemical and architectural environments of the body. Accordingly, tissue scaffolds with nanoscale properties that mirror the fibrous proteins present in tissue are being developed. Such materials can benefit from the inherent dimensional similarities and nanocomposite nature of the cellular environment, altering nanoscale dimensional and biochemical properties to mimic the regulatory characteristics of natural cellular environments. One nanomaterial which demonstrates potential across a diverse range of biomaterial applications is carbon nanotubes (CNTs). Building on previous reports, a method to coat CNTs throughout 3D porous structures is developed. Through modifications to typical chemical vapour deposition (CVD), a high-quality uniform coating of carbon nanotubes (CNTs) is demonstrated over beta-tricalcium phosphate/hydroxyapatite (or TCP/HA), which is in clinical use; and the high-mechanical-strength multicomponent ceramic Ca2ZnSi2O7-ZnAl2O4, (or Sr-HT-Gah). The resulting materials address deficiencies of previously reported CNT biomaterials by simultaneously presenting properties of high porosity, biocompatibility and a mechanical stability. Together, this unique combination of properties makes these scaffolds versatile materials for tissue engineering in load bearing applications.
C1 [Newman, P.; Lu, Z.; Roohani-Esfahani, S. I.; Davies, B.; Zreiqat, H.] Univ Sydney, Sch Aeronaut Mech & Mechatron Engn, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.
   [Newman, P.; Church, T. L.; Davies, B.; King, A.; Mackenzie, K.; Minett, A. I.] Univ Sydney, Sch Chem & Biomol Engn, Lab Sustainable Technol, Sydney, NSW 2006, Australia.
   [Church, T. L.] Stockholm Univ, Dept Mat & Environm Chem, S-10691 Stockholm, Sweden.
   [Biro, M.] Centenary Inst Canc Med & Cell Biol, Sydney, NSW 2042, Australia.
   [Biro, M.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
RP Newman, P (reprint author), Univ Sydney, Sch Aeronaut Mech & Mechatron Engn, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.
EM p.newman@sydney.edu.au; hala.zreiqat@sydney.edu.au
OI Roohani, Iman/0000-0001-6618-8577; Lu, ZuFu/0000-0003-4843-4441; King,
   Alice/0000-0002-1637-757X
FU Australian National Health and Medical Research Council; Rebecca Copper
   Foundation; Australian Research Council
FX The authors gratefully acknowledge the financial support of the
   Commonwealth Government for providing an Australian Postgraduate Award
   Scholarship to P.N. The Australian National Health and Medical Research
   Council, the Rebecca Copper Foundation and the Australian Research
   Council are also acknowledged for financial support. The authors
   acknowledge the facilities of the Australian Microscopy and
   Microanalysis Research Facility at the Australian Centre for Microscopy
   and Microanalysis, The University of Sydney, and the scientific and
   technical assistance with SEM, TEM and CT analysis that was provided by
   Mr Victor Lo and Dr Matthew Foley.
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Ali-Boucetta H, 2011, METHODS MOL BIOL, V726, P299, DOI 10.1007/978-1-61779-052-2_19
   Baik KY, 2011, SMALL, V7, P741, DOI 10.1002/smll.201001930
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bhattacharya M, 2011, J BIOMED MATER RES A, V96A, P75, DOI 10.1002/jbm.a.32958
   Boccaccini AR, 2007, ADV FUNCT MATER, V17, P2815, DOI 10.1002/adfm.200600887
   BOTHWELL TH, 1995, NUTR REV, V53, P237
   Breuer O, 2004, POLYM COMPOSITE, V25, P630, DOI 10.1002/pc.20058
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Casey A, 2007, CARBON, V45, P1425, DOI 10.1016/j.carbon.2007.03.033
   Chahine NO, 2014, TISSUE ENG PT A, V20, P2305, DOI [10.1089/ten.tea.2013.0328, 10.1089/ten.TEA.2013.0328]
   Chen WQ, 2014, NANO TODAY, V9, P759, DOI 10.1016/j.nantod.2014.12.002
   Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006
   Ducati C, 2002, J APPL PHYS, V92, P3299, DOI 10.1063/1.1499746
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Endo M, 2008, TOP APPL PHYS, V111, P13, DOI 10.1007/978-3-540-72865-8_2
   Fan L, 2012, NANO LETT, V12, P3668, DOI 10.1021/nl301428w
   Firme CP, 2010, NANOMED-NANOTECHNOL, V6, P245, DOI 10.1016/j.nano.2009.07.003
   Goh KL, 2005, BBA-GEN SUBJECTS, V1722, P183, DOI 10.1016/j.bbagen.2004.12.004
   Habelitz S, 2002, J STRUCT BIOL, V138, P227, DOI 10.1016/S1047-8477(02)00029-1
   Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962
   Hirata E, 2011, CARBON, V49, P3284, DOI 10.1016/j.carbon.2011.04.002
   Hirata E, 2009, J BIOMED MATER RES B, V90B, P629, DOI 10.1002/jbm.b.31327
   Holy J, 2011, IET NANOBIOTECHNOL, V5, P41, DOI 10.1049/iet-nbt.2010.0014
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Huang FM, 1998, J APPL PHYS, V84, P4022, DOI 10.1063/1.368585
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jan E, 2007, NANO LETT, V7, P1123, DOI 10.1021/nl0620132
   Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5
   Kaiser JP, 2009, NANOMEDICINE-UK, V4, P57, DOI 10.2217/17435889.4.1.57
   Kalbacova M, 2007, CARBON, V45, P2266, DOI 10.1016/j.carbon.2007.06.025
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kirschner CM, 2013, SMALL, V9, P578, DOI 10.1002/smll.201201841
   Kostarelos K, 2009, NAT NANOTECHNOL, V4, P627, DOI 10.1038/nnano.2009.241
   Lakhkar NJ, 2013, ADV DRUG DELIVER REV, V65, P405, DOI 10.1016/j.addr.2012.05.015
   Lewitus DY, 2011, ADV FUNCT MATER, V21, P2624, DOI 10.1002/adfm.201002429
   Li C, 2008, COMPOS SCI TECHNOL, V68, P1227, DOI 10.1016/j.compscitech.2008.01.006
   Liu Z, 2009, NAT PROTOC, V4, P1372, DOI 10.1038/nprot.2009.146
   Lobo AO, 2010, CARBON, V48, P245, DOI 10.1016/j.carbon.2009.09.012
   Lu CG, 2006, J PHYS CHEM B, V110, P20254, DOI 10.1021/jp0632283
   Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   MacKenzie KJ, 2013, CARBON, V59, P344, DOI 10.1016/j.carbon.2013.03.029
   MacKenzie KJ, 2010, IND ENG CHEM RES, V49, P5323, DOI 10.1021/ie9019787
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   Mei F, 2007, BIOMACROMOLECULES, V8, P3729, DOI 10.1021/bm7006295
   Miralles P, 2012, ENVIRON SCI TECHNOL, V46, P9224, DOI 10.1021/es202995d
   Mooney E, 2008, NANO LETT, V8, P2137, DOI 10.1021/nl073300o
   Mwenifumbo S, 2007, J MATER CHEM, V17, P1894, DOI 10.1039/b617708e
   Namgung S, 2011, ACS NANO, V5, P7383, DOI 10.1021/nn2023057
   Namgung S, 2011, SMALL, V7, P56, DOI 10.1002/smll.201001513
   Nayak TR, 2010, ACS NANO, V4, P7717, DOI 10.1021/nn102738c
   Newman P, 2013, NANOMED-NANOTECHNOL, V9, P1139, DOI 10.1016/j.nano.2013.06.001
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   Ogihara N, 2012, NANOMEDICINE-UK, V7, P981, DOI [10.2217/NNM.12.1, 10.2217/nnm.12.1]
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Park SY, 2007, ADV MATER, V19, P2530, DOI 10.1002/adma.200600875
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   Porter AE, 2007, NAT NANOTECHNOL, V2, P713, DOI 10.1038/nnano.2007.347
   Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001
   Quigley AF, 2012, ADV HEALTHC MATER, V1, P801, DOI 10.1002/adhm.201200102
   Roduner E, 2006, CHEM SOC REV, V35, P583, DOI 10.1039/b502142c
   Roohani-Esfahani SI, 2013, ACTA BIOMATER, V9, P7014, DOI 10.1016/j.actbio.2013.02.039
   Roohani-Esfahani SI, 2013, MATER LETT, V107, P378, DOI 10.1016/j.matlet.2013.06.046
   Ryman-Rasmussen JP, 2009, NAT NANOTECHNOL, V4, P747, DOI [10.1038/NNANO.2009.305, 10.1038/nnano.2009.305]
   Saito N, 2014, CHEM REV, V114, P6040, DOI 10.1021/cr400341h
   Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68
   Shimizu M, 2012, ADV MATER, V24, P2176, DOI 10.1002/adma.201103832
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   Soenen SJ, 2012, METHOD ENZYMOL, V509, P195, DOI 10.1016/B978-0-12-391858-1.00011-3
   Tay CY, 2010, CARBON, V48, P1095, DOI 10.1016/j.carbon.2009.11.031
   Touri R, 2013, BIOMED RES INT, DOI 10.1155/2013/465086
   Usui Y, 2008, SMALL, V4, P240, DOI 10.1002/smll.200700670
   Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c
   Yang XS, 2011, J PHYS CHEM C, V115, P14093, DOI 10.1021/jp203469y
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
   Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311
NR 81
TC 3
Z9 5
U1 1
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 42
BP 8337
EP 8347
DI 10.1039/c5tb01052g
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA CU9MG
UT WOS:000363868000010
DA 2018-10-20
ER

PT J
AU Tang, JY
   Bao, LH
   Li, X
   Chen, L
   Hong, FF
AF Tang, Jingyu
   Bao, Luhan
   Li, Xue
   Chen, Lin
   Hong, Feng F.
TI Potential of PVA-doped bacterial nano-cellulose tubular composites for
   artificial blood vessels
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID POLYVINYL-ALCOHOL HYDROGEL; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES; VASCULAR GRAFTS; POLY(VINYL ALCOHOL);
   NANOCOMPOSITE; PROSTHESIS; RELEASE; SYSTEM; BYPASS
AB Bacterial nano-cellulose (BNC) hydrogel has been suggested as a promising biomaterial for artificial blood vessels. However, some properties of BNC do not achieve all of the requirements of a native blood vessel - compliance, for instance. In order to improve the properties of BNC tubes, poly(vinyl alcohol) (PVA) was introduced in the BNC tubes to make composites. Two types of pristine BNC tubes with different inner structures were produced in two bioreactors. A PVA tube and PVA-BNC tubular composites were made for comparison by using a thermally-induced phase separation method. The morphology, water permeability, cytotoxicity, and mechanical properties, including the axial stretch strength, suture retention, burst pressure, and compliance of all the tubes, were evaluated and compared. The results indicated that PVA impregnated into BNC tubes and then significantly improved the properties of BNC, especially the mechanical properties and water permeability. The BNC tube itself played a great role in the performances of the composites as the skeleton base material. The PVA-BNC composite tubes could constitute new biomaterial candidates for vascular grafts.
C1 [Tang, Jingyu; Bao, Luhan; Li, Xue; Chen, Lin; Hong, Feng F.] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Grp Microbiol Engn & Ind Biotechnol, Shanghai 201620, Peoples R China.
   [Hong, Feng F.] Donghua Univ, Minist Educ, Key Lab High Performance Fibers & Prod, Shanghai 201620, Peoples R China.
RP Hong, FF (reprint author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, Grp Microbiol Engn & Ind Biotechnol, North Ren Min Rd 2999, Shanghai 201620, Peoples R China.
EM fhong@dhu.edu.cn
RI Hong, Feng/D-3878-2017
OI Hong, Feng/0000-0001-5120-3519
FU Program for New Century Excellent Talents in University [NCET-12-0828];
   National Natural Science Foundation of China [51373031]; Science and
   Technology Commission of Shanghai Municipality [12nm0500600]; 111
   Project [B07024]; Fundamental Research Funds for Central Universities
   [2232014A3-04]
FX Sponsoring funds: financial support provided by Program for New Century
   Excellent Talents in University (NCET-12-0828), by the National Natural
   Science Foundation of China (No. 51373031), the Science and Technology
   Commission of Shanghai Municipality (12nm0500600), the 111 Project
   B07024, and the Fundamental Research Funds for the Central Universities
   (2232014A3-04) is gratefully acknowledged.
CR [Anonymous], 2010, [No title captured], Patent No. 101921700
   [Anonymous], 2010, [No title captured], Patent No. 20101270524
   [Anonymous], 2010, [No title captured], Patent No. 20102511755
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Bodin A., 2008, MODERN MULTIDISCIPLI, P619
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Fink H, 2011, J BIOMED MATER RES A, V97A, P52, DOI 10.1002/jbm.a.33031
   Gatenholm P, 2010, MRS BULL, V35, P208, DOI 10.1557/mrs2010.653
   Gea S, 2010, MATER LETT, V64, P901, DOI 10.1016/j.matlet.2010.01.042
   Gelin K, 2007, POLYMER, V48, P7623, DOI 10.1016/j.polymer.2007.10.039
   Hong F., 2010, China Patent, Patent No. [CN201809341, 201809341]
   Hong F, 2015, BIOMED RES INT, DOI 10.1155/2015/560365
   Indriyatia R., 2012, PRO CHEM, V4, P73
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Kong XY, 2012, J BIOMED MATER RES A, V100A, P1938, DOI 10.1002/jbm.a.34136
   Konig G, 2009, BIOMATERIALS, V30, P1542, DOI 10.1016/j.biomaterials.2008.11.011
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Leitao AF, 2013, COLLOID SURFACE B, V111, P493, DOI 10.1016/j.colsurfb.2013.06.031
   Leitao AF, 2013, MATERIALS, V6, P1956, DOI 10.3390/ma6051956
   Lozinsky VI, 1998, ENZYME MICROB TECH, V23, P227, DOI 10.1016/S0141-0229(98)00036-2
   MARTZ H, 1987, J BIOMED MATER RES, V21, P399, DOI 10.1002/jbm.820210311
   McClure MJ, 2012, J MECH BEHAV BIOMED, V10, P48, DOI 10.1016/j.jmbbm.2012.02.026
   Million LE, 2008, J BIOMED MATER RES B, V86B, P444, DOI 10.1002/jbm.b.31040
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P305, DOI 10.1002/jbm.b.30543
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Millon LE, 2009, J BIOMED MATER RES B, V90B, P922, DOI 10.1002/jbm.b.31364
   Mori Y, 1997, J MATER SCI, V32, P491, DOI 10.1023/A:1018586307534
   Pavaloiu RD, 2014, INT J BIOL MACROMOL, V68, P117, DOI 10.1016/j.ijbiomac.2014.04.040
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Prichard HL, 2011, J CARDIOVASC TRANSL, V4, P674, DOI 10.1007/s12265-011-9306-y
   Putra A, 2008, POLYMER, V49, P1885, DOI 10.1016/j.polymer.2008.02.022
   Qiu KY, 2012, J MATER SCI, V47, P6066, DOI 10.1007/s10853-012-6517-9
   Quint C, 2012, J VASC SURG, V55, P790, DOI 10.1016/j.jvs.2011.07.098
   Rouabhia M, 2014, ACS APPL MATER INTER, V6, P1439, DOI 10.1021/am4027983
   Sayers RD, 1998, BRIT J SURG, V85, P934
   Scherner M, 2014, J SURG RES, V189, P340, DOI 10.1016/j.jss.2014.02.011
   Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   Seifu DG, 2013, NAT REV CARDIOL, V10, P410, DOI 10.1038/nrcardio.2013.77
   Sonoda H, 2002, J BIOMED MATER RES, V60, P191, DOI 10.1002/jbm.10055
   Stoica-Guzun A, 2013, RADIAT PHYS CHEM, V84, P200, DOI 10.1016/j.radphyschem.2012.06.017
   Stroescu M, 2013, J FOOD ENG, V114, P153, DOI 10.1016/j.jfoodeng.2012.08.023
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Valenta J., 1993, BIOMECHANICS, P142
   van Det RJ, 2009, EUR J VASC ENDOVASC, V37, P457, DOI 10.1016/j.ejvs.2008.11.041
   Wan WK, 2002, J BIOMED MATER RES, V63, P854, DOI 10.1002/jbm.10333
   Wang JH, 2010, MAT SCI ENG C-MATER, V30, P214, DOI 10.1016/j.msec.2009.10.006
   Wang SD, 2009, J APPL POLYM SCI, V113, P2675, DOI 10.1002/app.30346
   Wang WZ, 2015, J BIOMED MATER RES A, V103, P1784, DOI 10.1002/jbm.a.35315
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Yaguchi T, 2002, J ARTIF ORGANS, V5, P117
   Zidi M, 2003, COMPUT BIOL MED, V33, P65, DOI 10.1016/S0010-4825(02)00059-8
NR 52
TC 18
Z9 20
U1 10
U2 88
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 43
BP 8537
EP 8547
DI 10.1039/c5tb01144b
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA CV2RC
UT WOS:000364103100013
DA 2018-10-20
ER

PT J
AU Kim, YJ
   Takahashi, Y
   Kato, N
   Matsunaga, YT
AF Kim, Young-Jin
   Takahashi, Yuta
   Kato, Norihiro
   Matsunaga, Yukiko T.
TI Fabrication of biomimetic bundled gel fibres using dynamic microfluidic
   gelation of phase-separated polymer solutions
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID NANOFIBROUS SCAFFOLDS; AQUEOUS-SOLUTIONS; HYDROGELS; SUPERCAPACITORS;
   GLYCOL); TISSUES; STORAGE
AB Here, we discuss the fabrication of biomimetic bundle-structured gel fibres using a microfluidic device and the rapid cross-linking of a phase-separated polymer blend solution. The products are potential candidates for cell culture scaffolds that mimic artificial tissues. Two naturally derived, biocompatible polysaccharide polymers are the raw materials for the bundled gel fibres, which are approximately 200-400 mu m in diameter and consist of 10(2)-10(3) aligned continuous microfibres of 1-3 mu m in diameter. They create a composite fibrous material with enhanced toughness and tensile strength because of the unique three-dimensional, cross-linked hierarchic structure. Because the main component of the gel fibre is temperature responsive, the mechanical properties improve at higher temperatures, yet are reversible without collapsing in response to temperature changes. Cell cultures form a cylinder-like shape along the fibre orientation. These unique features would be advantageous for tissue scaffolds as well as other biomaterial applications such as tissue engineering, actuators, drug carriers, and biosensors with the remotely controllable "on-off'' properties.
C1 [Kim, Young-Jin; Takahashi, Yuta; Matsunaga, Yukiko T.] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan.
   [Kim, Young-Jin] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028472, Japan.
   [Takahashi, Yuta; Kato, Norihiro] Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 3218585, Japan.
   [Matsunaga, Yukiko T.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan.
RP Matsunaga, YT (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.
EM mat@iis.u-tokyo.ac.jp
OI Matsunaga, Yukiko/0000-0002-0483-9423
FU PRESTO, Japan Science and Technology (JST), Japan; JSPS [25706010]
FX This work was partly supported by PRESTO, Japan Science and Technology
   (JST), Japan. This work was also supported by a JSPS Grant-in-Aid for
   Young Scientists (A) (No. 25706010 to Y.T.M.).
CR Ali U, 2012, J TEXT I, V103, P80, DOI 10.1080/00405000.2011.552254
   Barber J, 2011, TISSUE ENG PART A, V19, P1265
   Boustany K., 1976, J ELASTOPLAST, V8, P160, DOI DOI 10.1177/009524437600800202
   Caner C, 1998, J FOOD SCI, V63, P1049, DOI 10.1111/j.1365-2621.1998.tb15852.x
   Chae SK, 2013, ADV MATER, V25, P3071, DOI 10.1002/adma.201300837
   Chang CY, 2011, CARBOHYD POLYM, V84, P40, DOI 10.1016/j.carbpol.2010.12.023
   Chung BG, 2012, LAB CHIP, V12, P45, DOI 10.1039/c1lc20859d
   Du HB, 2010, J PHYS CHEM B, V114, P16594, DOI 10.1021/jp105652c
   Fang M, 2012, ACS NANO, V6, P9503, DOI 10.1021/nn302483x
   Fu YP, 2012, ADV MATER, V24, P5713, DOI 10.1002/adma.201202930
   Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Gonzalez-Rodriguez D, 2012, SCIENCE, V338, P910, DOI 10.1126/science.1226418
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   HASHIMOTO T, 1995, PHYS REV LETT, V74, P126, DOI 10.1103/PhysRevLett.74.126
   Hey MJ, 2005, POLYMER, V46, P2567, DOI 10.1016/j.polymer.2005.02.019
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Holzwarth JM, 2011, J MATER CHEM, V21, P10243, DOI 10.1039/c1jm10522a
   Kang E, 2012, ADV MATER, V24, P4271, DOI 10.1002/adma.201201232
   Kim Y.- J., 2012, ANGEW CHEM INT EDIT, V124, P10689
   Kim YJ, 2013, ADV FUNCT MATER, V23, P5753, DOI 10.1002/adfm.201300746
   Kim YJ, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064203
   Kiriya D, 2012, ANGEW CHEM INT EDIT, V51, P7942, DOI 10.1002/anie.201202078
   Koster S, 2007, LANGMUIR, V23, P357, DOI 10.1021/la062473a
   LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239
   Lee WY, 2011, TISSUE ENG PART C-ME, V17, P651, DOI 10.1089/ten.tec.2010.0621
   Liedl T, 2010, NAT NANOTECHNOL, V5, P520, DOI [10.1038/NNANO.2010.107, 10.1038/nnano.2010.107]
   Liu F, 2014, J AM CHEM SOC, V136, P6846, DOI 10.1021/ja502410e
   Matsunaga YT, 2011, ADV MATER, V23, pH90, DOI 10.1002/adma.201004375
   Onoe H, 2013, NAT MATER, V12, P584, DOI [10.1038/NMAT3606, 10.1038/nmat3606]
   Sadeghi R, 2009, FLUID PHASE EQUILIBR, V280, P68, DOI 10.1016/j.fluid.2009.03.005
   Schafmeister CE, 1997, NAT STRUCT BIOL, V4, P1039, DOI 10.1038/nsb1297-1039
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Tanaka H, 2000, J PHYS-CONDENS MAT, V12, pR207, DOI 10.1088/0953-8984/12/15/201
   Teo WE, 2005, NANOTECHNOLOGY, V16, P1878, DOI 10.1088/0957-4484/16/9/077
   Tsougeni K, 2010, LAB CHIP, V10, P462, DOI 10.1039/b916566e
   vandeWitte P, 1996, J MEMBRANE SCI, V117, P1, DOI 10.1016/0376-7388(96)00088-9
   Xu JH, 2006, LAB CHIP, V6, P131, DOI 10.1039/b509939k
   Yue ZL, 2010, BIOMATERIALS, V31, P8141, DOI 10.1016/j.biomaterials.2010.07.059
   Zhai SC, 2012, J MATER SCI, V47, P949, DOI 10.1007/s10853-011-5874-0
   Zhang DH, 2014, ACS NANO, V8, P4571, DOI 10.1021/nn5001386
NR 41
TC 6
Z9 6
U1 4
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 41
BP 8154
EP 8161
DI 10.1039/c5tb01395j
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CT9QY
UT WOS:000363152900012
DA 2018-10-20
ER

PT J
AU Turdean-Ionescu, C
   Stevensson, B
   Grins, J
   Izquierdo-Barba, I
   Garcia, A
   Arcos, D
   Vallet-Regi, M
   Eden, M
AF Turdean-Ionescu, Claudia
   Stevensson, Baltzar
   Grins, Jekabs
   Izquierdo-Barba, Isabel
   Garcia, Ana
   Arcos, Daniel
   Vallet-Regi, Maria
   Eden, Mattias
TI Composition-dependent in vitro apatite formation at mesoporous bioactive
   glass-surfaces quantified by solid-state NMR and powder XRD
SO RSC ADVANCES
LA English
DT Article
ID SIMULATED BODY-FLUID; PHOSPHOSILICATE GLASSES; SILICATE-GLASSES; GEL
   GLASSES; REACTIVITY; P-31; MINERALIZATION; DISSOLUTION; SPECTROSCOPY;
   SCAFFOLDS
AB Silicate-based bioactive glasses exhibit bone-bonding properties due to the formation of a hydroxycarbonate apatite (HCA) layer at the glass surface on its contact with living tissues. This bone-healing process is triggered by ionic exchange between the glass and the surrounding fluids and thereby depends on the glass composition. In this work, the HCA formation from three mesoporous bioactive glasses (MBGs) of different compositions immersed in a simulated body fluid (SBF) was monitored for variable time intervals between 15 minutes to 30 days. By utilizing two independent assessment techniques, solid-state P-31 NMR spectroscopy and powder X-ray diffraction (PXRD), we report the first quantitative assessment of the HCA growth (i.e., "in vitro bioactivity") from a bioactive glass: both techniques allow for monitoring the crystallization of the amorphous calcium phosphate (ACP) precursor into HCA, i.e., a profile of the relative ACP/HCA fractions of the biomimetic phosphate layer formed at each MBG surface and SBF-exposure period. The amount of HCA present in each solid specimen after the SBF treatment, as well as the composition of the remaining cation-depleted MBG phase, was determined from PXRD data in conjunction with measured concentrations of Ca, Si, and P in the solution. In contrast with previous findings from in vitro bioactivity assessments of the same MBG compositions, the HCA formation is herein observed to increase concurrently with the Ca and P contents of the MBG; these apparently different composition-bioactivity observations stem from a significantly lower MBG-loading in the SBF solution utilized herein. The results are discussed in relation to the general task of performing bioactivity testing in SBF, where we highlight the importance of adapting the concentration of the biomaterial to its composition to avoid perturbing the HCA crystallization and thereby altering the outcome of the test.
C1 [Turdean-Ionescu, Claudia; Stevensson, Baltzar; Grins, Jekabs; Eden, Mattias] Stockholm Univ, Arrhenius Lab, Dept Mat & Environm Chem, SE-10691 Stockholm, Sweden.
   [Izquierdo-Barba, Isabel; Garcia, Ana; Arcos, Daniel; Vallet-Regi, Maria] Univ Complutense Madrid, Inst Invest Sanitaria Hosp 12 Octubre I 12, Fac Farm, Dept Quim Inorgan & Bioinorgan, Madrid 28040, Spain.
   [Izquierdo-Barba, Isabel; Garcia, Ana; Arcos, Daniel; Vallet-Regi, Maria] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain.
RP Eden, M (reprint author), Stockholm Univ, Arrhenius Lab, Dept Mat & Environm Chem, SE-10691 Stockholm, Sweden.
EM mattias.eden@mmk.su.se
RI IZQUIERDO-BARBA, ISABEL/M-9921-2014; Vallet-Regi, Maria/M-3378-2014;
   Garcia Fontecha, Ana/B-1301-2015
OI IZQUIERDO-BARBA, ISABEL/0000-0002-4139-4646; Vallet-Regi,
   Maria/0000-0002-6104-4889; Garcia Fontecha, Ana/0000-0002-8792-872X
FU Swedish Research Council [VR-NT 2010-4943, 2014-4667]; Ministerio de
   Ciencia e Innovacion [MAT2012-35556]; Ministerio de Economia y
   Competitividad [MAT2013-43299-R]; Agening Network of Excellence
   [CSO2010-11384-E]; Carl Trygger Foundation; Swedish Research Council;
   Knut and Alice Wallenberg Foundation; Faculty of Natural Sciences at
   Stockholm University
FX This work was supported by the Swedish Research Council (projects VR-NT
   2010-4943; 2014-4667), the Faculty of Natural Sciences at Stockholm
   University, Ministerio de Ciencia e Innovacion (project MAT2012-35556),
   Ministerio de Economia y Competitividad (project MAT2013-43299-R) and
   Agening Network of Excellence (CSO2010-11384-E). C. T.-I. was supported
   by a postdoctoral grant from the Carl Trygger Foundation. We gratefully
   acknowledge NMR equipment Grants from the Swedish Research Council, and
   the Knut and Alice Wallenberg Foundation. We thank Renny Mathew for
   experimental help.
CR [Anonymous], 23317 ISO
   Arcos D, 2003, J BIOMED MATER RES A, V65A, P344, DOI 10.1002/jbm.a.10503
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.3.CO;2-I
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Cerruti M, 2005, BIOMATERIALS, V26, P1665, DOI 10.1016/j.biomaterials.2004.07.009
   Dietrich E, 2009, ADV ENG MATER, V11, pB98, DOI 10.1002/adem.200800400
   Eden M, 2011, J NON-CRYST SOLIDS, V357, P1595, DOI 10.1016/j.jnoncrysol.2010.11.098
   Garcia A, 2009, CHEM MATER, V21, P5474, DOI 10.1021/cm9022776
   Gregg S. J, 1982, ADSORPTION SURFACE A
   Gunawidjaja PN, 2012, J MATER CHEM, V22, P7214, DOI 10.1039/c2jm15066b
   Gunawidjaja PN, 2012, PHILOS T R SOC A, V370, P1376, DOI 10.1098/rsta.2011.0257
   Gunawidjaja PN, 2010, J PHYS CHEM C, V114, P19345, DOI 10.1021/jp105408c
   Hayakawa S, 1999, J AM CERAM SOC, V82, P2155
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Izquierdo-Barba I, 2000, J BIOMED MATER RES, V51, P191, DOI 10.1002/(SICI)1097-4636(200008)51:2<191::AID-JBM7>3.0.CO;2-T
   Izquierdo-Barba I, 2008, CHEM MATER, V20, P3191, DOI DOI 10.1021/CM800172X
   Jones JR, 2001, J BIOMED MATER RES, V58, P720, DOI 10.1002/jbm.10053
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lebecq I, 2007, J BIOMED MATER RES A, V83A, P156, DOI 10.1002/jbm.a.31228
   Leonova E, 2008, J PHYS CHEM C, V112, P5552, DOI 10.1021/jp7107973
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Li X, 2007, CHEM MATER, V19, P4322, DOI 10.1021/cm0708564
   Lin KSK, 2005, CHEM MATER, V17, P4493, DOI 10.1021/cm0505654c
   Lopez-Noriega A, 2006, CHEM MATER, V18, P3137, DOI 10.1021/cm060488o
   Macon ALB, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5403-9
   Mathew R, 2013, CHEM MATER, V25, P1877, DOI 10.1021/cm400487a
   Mathew R, 2011, J PHYS CHEM C, V115, P20572, DOI 10.1021/jp206237n
   O'Donnell MD, 2009, J MATER SCI-MATER M, V20, P1611, DOI 10.1007/s10856-009-3732-2
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Pecharsky V. K., 2009, FUNDAMENTALS POWDER
   RODRIGUEZCARVAJ.J, 1998, NEWSLETTER, V20, P35
   Rohanova D., 2015, J NONCRYST SOLIDS, DOI [10.1016/j.jnoncrysol.2015.03.016, DOI 10.1016/J.JN0NCRYS0L.2015.03.016]
   Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207
   Skipper LJ, 2005, PHYS CHEM GLASSES, V46, P372
   Souza MT, 2013, J NON-CRYST SOLIDS, V382, P57, DOI 10.1016/j.jnoncrysol.2013.10.001
   Stevensson B, 2014, J PHYS CHEM B, V118, P8863, DOI 10.1021/jp504601c
   Vallet-Regi M, 2003, EUR J INORG CHEM, P1029
   Wilson A. J. C., 1995, INT TABLES CRYSTALLO
   Yan HW, 2001, CHEM MATER, V13, P1374, DOI 10.1021/cm000895e
   Yan XX, 2010, MICROPOR MESOPOR MAT, V132, P282, DOI 10.1016/j.micromeso.2010.03.009
   Yan XX, 2006, BIOMATERIALS, V27, P3396, DOI 10.1016/j.biomaterials.2006.01.043
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Yun HS, 2008, SOLID STATE SCI, V10, P1083, DOI 10.1016/j.solidstatesciences.2007.11.037
   Yun HS, 2007, CHEM COMMUN, P2139, DOI 10.1039/b702103h
   Zhang D, 2008, MATER CHEM PHYS, V111, P497, DOI 10.1016/j.matchemphys.2008.04.055
   Zhang K, 2003, J BIOMED MATER RES A, V66A, P860, DOI 10.1002/jbm.a.10093
   Zhu YF, 2008, MICROPOR MESOPOR MAT, V112, P494, DOI 10.1016/j.micromeso.2007.10.029
NR 49
TC 13
Z9 13
U1 3
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 105
BP 86061
EP 86071
DI 10.1039/c5ra13410b
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA CU0BD
UT WOS:000363179500011
OA Bronze
DA 2018-10-20
ER

PT J
AU Balaji, A
   Vellayappan, MV
   John, AA
   Subramanian, AP
   Jaganathan, SK
   SelvaKumar, M
   Faudzi, AAB
   Supriyanto, E
   Yusof, M
AF Balaji, Arunpandian
   Vellayappan, Muthu Vignesh
   John, Agnes Aruna
   Subramanian, Aruna Priyadarshini
   Jaganathan, Saravana Kumar
   SelvaKumar, M.
   Faudzi, Ahmad Athif bin Mohd
   Supriyanto, Eko
   Yusof, Mustafa
TI Biomaterials based nano-applications of Aloe vera and its perspective: a
   review
SO RSC ADVANCES
LA English
DT Review
ID TISSUE ENGINEERING APPLICATIONS; BIOMEDICAL APPLICATIONS; DRUG-DELIVERY;
   REGENERATIVE MEDICINE; NANOFIBROUS SCAFFOLDS; DERMAL WOUNDS; LEAF GEL;
   PEG-PLA; NANOPARTICLES; EXTRACT
AB Aloe vera is noted for its meritable medicinal as well as commercial usages. From the past until now, it has been used as a promising remedy for several ailments. Recently, the concept of nanotechnology has astonishingly changed its outlook for biomedical applications. Nanotechnology has revolutionized several fields with its admirable capabilities and ground-breaking innovations. In the field of medicine, nanostructured materials have introduced a great range of flexibility by refashioning traditional practices and also by exploring new effective approaches. Accordingly, the usage of Aloe vera in the form of hydrogels, nanoparticles, nanocomposites, nanofibers and bio-inspired sponges has extended its well established application spectrum in the fields of wound healing, tissue engineering and drug delivery. In addition, the growing interest in consuming and synthesizing materials based on green or eco-friendly methods also highly encourages the use of numerous plant-based natural products including Aloe vera. Hence, an effort has been made to discuss the works related to recent advancements made in the use of Aloe vera, especially in the form of biomaterial-based nanostructures. This will encourage scientists to explore the unplumbed abilities of Aloe vera. Moreover, it will also help the industry players to recognise its immense potential and bring significant Aloe products to the market.
C1 [Balaji, Arunpandian; Vellayappan, Muthu Vignesh; John, Agnes Aruna; Subramanian, Aruna Priyadarshini; Jaganathan, Saravana Kumar; Supriyanto, Eko; Yusof, Mustafa] Univ Teknol Malaysia, IJN UTM Cardiovasc Engn Ctr, Fac Biosci & Med Engn, Johor Baharu 81310, Malaysia.
   [SelvaKumar, M.] Indian Inst Technol, Rubber Technol Ctr, Kharagpur 721302, W Bengal, India.
   [Faudzi, Ahmad Athif bin Mohd] Univ Teknol Malaysia, Fac Elect Engn, Dept Control & Mechatron Engn, Johor Baharu 81310, Malaysia.
RP Jaganathan, SK (reprint author), Univ Teknol Malaysia, IJN UTM Cardiovasc Engn Ctr, Fac Biosci & Med Engn, Johor Baharu 81310, Malaysia.
EM jaganathaniitkgp@gmail.com
RI Jaganathan, Saravana Kumar/N-2385-2017
OI Balaji, Arunpandian/0000-0002-6745-9188
FU Ministry of Higher Education Malaysia [R.J130000.7809.4F444,
   Q.J130000.2509.10H13]
FX This work was supported partly by the Ministry of Higher Education
   Malaysia with the Grant Vot numbers: R.J130000.7809.4F444 and
   Q.J130000.2509.10H13.
CR Ahmad M. R., 2014, P INT C TEXT ENG FAS, DOI [10.1007/978-981-287-011-7_2, DOI 10.1007/978-981-287-011-7_2]
   Ahmed F, 2004, J CONTROL RELEASE, V96, P37, DOI 10.1016/j.jconrel.2003.12.021
   Almeida JF, 2011, INT J BIOL MACROMOL, V49, P948, DOI 10.1016/j.ijbiomac.2011.08.010
   Amar S, 2008, INDIAN J DERMATOL, V53, P163
   Antherton P., 1998, NURS STAND, V12, P49
   Ayeshamariam A, 2014, J OPTOELECTRON BIOME, V6, P85
   Balaji A, 2015, INT J NANOMED, V10, P5909, DOI 10.2147/IJN.S84307
   Bhaarathy V, 2014, MAT SCI ENG C-MATER, V44, P268, DOI 10.1016/j.msec.2014.08.018
   Boudreau MD, 2006, J ENVIRON SCI HEAL C, V24, P103, DOI 10.1080/10590500600614303
   BRADLEY PR, 1992, BRIT HERBAL COMPENDI
   Castleman M., 1991, THE HEALING HERBS, P42
   Chandran SP, 2006, BIOTECHNOL PROGR, V22, P577, DOI 10.1021/bp0501423
   Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569
   Chauhan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032049
   Chithra P, 1998, J ETHNOPHARMACOL, V59, P179, DOI 10.1016/S0378-8741(97)00112-8
   Chithra P, 1998, J ETHNOPHARMACOL, V59, P195, DOI 10.1016/S0378-8741(97)00124-4
   Coats B. C., 1979, SILENT HEALER A MODE
   Collins CE, 1935, AM J ROENTGENOL RADI, V33, P396
   Dagne E, 2000, CURR ORG CHEM, V4, P1055, DOI 10.2174/1385272003375932
   Das N, 2004, NATURAL PRODUCT RADI, V3, P85
   Davis R. H., 1997, SCI APPROACH
   DAVIS RH, 1994, J AM PODIAT MED ASSN, V84, P77, DOI 10.7547/87507315-84-2-77
   DAVIS RH, 1989, J AM PODIAT MED ASSN, V79, P559, DOI 10.7547/87507315-79-11-559
   Eshun K, 2004, CRIT REV FOOD SCI, V44, P91, DOI 10.1080/10408690490424694
   Esmaeili A, 2015, SYNTH REACT INORG M, V45, P40, DOI 10.1080/15533174.2013.818027
   Fenig E, 2004, ONCOL REP, V11, P213
   Fisher MB, 2013, TISSUE ENG PART B-RE, V19, P1, DOI [10.1089/ten.teb.2012.0723, 10.1089/ten.TEB.2012.0723]
   Furukawa F., 1991, ANTIMICROB AGENTS CH, V35, P2463
   Gabriela G. P., 2014, BIOMED RES INT, V2014, P9
   Gaur A., 2008, ASIAN J PHARM, P80
   GRINDLAY D, 1986, J ETHNOPHARMACOL, V16, P117, DOI 10.1016/0378-8741(86)90085-1
   Gupta RB, 2006, NANOPARTICLE TECHNOL, P1
   Hamman JH, 2008, MOLECULES, V13, P1599, DOI 10.3390/molecules13081599
   Harrison RH, 2014, TISSUE ENG PART B-RE, V20, P1, DOI 10.1089/ten.TEB.2013.0668
   Hayes Steven M., 1999, General Dentistry, V47, P268
   Heggers J P, 1996, J Altern Complement Med, V2, P271, DOI 10.1089/acm.1996.2.271
   Hilt JZ, 2004, ADV DRUG DELIVER REV, V56, P1533, DOI 10.1016/j.addr.2004.07.002
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Ibrahim U., 2010, J BIOL CHEM, V38, P19
   Ibrahim U, 2013, CURR NANOSCI, V9, P489
   Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025
   Inpanya P, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035008
   Jettanacheawchankit S, 2009, J PHARMACOL SCI, V109, P525, DOI 10.1254/jphs.08204FP
   Jitin P. M., 2014, AM J PHYTOMED CLIN T, V2, P61
   Jittapiromsak N, 2010, TISSUE ENG PT A, V16, P1997, DOI [10.1089/ten.tea.2009.0593, 10.1089/ten.TEA.2009.0593]
   Josias H., 2008, MOLECULES, V13, P1599, DOI DOI 10.3390/M0LECULES13081599
   KAEHLER T, 1994, CLIN CHEM, V40, P1797
   Karuppuswamy P, 2014, APPL SURF SCI, V322, P162, DOI 10.1016/j.apsusc.2014.10.074
   Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Lissoni P, 1998, NAT IMMUN, V16, P27, DOI 10.1159/000069427
   Lya P., 2014, BMC P, V8, pP61
   Mandeville FB, 1939, RADIOLOGY, V32, P598
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Mary SA, 2015, J TEXT I, V106, P886, DOI 10.1080/00405000.2014.951247
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Moon S. K., 2011, POLYM REV, V5, P23
   Mora-Huertas CE, 2010, INT J PHARMACEUT, V385, P113, DOI 10.1016/j.ijpharm.2009.10.018
   Myung H. C., 2003, SEMIN INTEGR MED, V1, P53
   Nadagouda MN, 2008, GREEN CHEM, V10, P859, DOI 10.1039/b804703k
   Ni Y, 2004, INT IMMUNOPHARMACOL, V4, P1745, DOI 10.1016/j.intimp.2004.07.006
   Nithya K., 2013, INT C ADV NAN EM ENG
   Pal K, 2009, DES MONOMERS POLYM, V12, P197, DOI 10.1163/156855509X436030
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Pankaj K. S., 2013, PHARM PHARM, V4, P599
   Panneerselvam J., 2013, ACS APPL MATER INTER, V5, P7291
   Parish LC, 1991, INT J DERMATOL, V30, P679
   Park YI, 2006, NEW PERSPECTIVES ALO
   Pecere T, 2000, CANCER RES, V60, P2800
   Pim-on R., 2008, POLYMER, V49, P4723
   Prabaharan M, 2009, MACROMOL BIOSCI, V9, P515, DOI 10.1002/mabi.200800269
   Prabjone R, 2006, CLIN HEMORHEOL MICRO, V35, P359
   Ratner B. D., 2004, BIOMATERIALS SCI INT, P1
   Reynolds T, 1999, J ETHNOPHARMACOL, V68, P3, DOI 10.1016/S0378-8741(99)00085-9
   Rigogliuso S, 2012, CHEM ENGINEER TRANS, V27, P415, DOI 10.3303/CET1227070
   Roco MC, 2003, CURR OPIN BIOTECH, V14, P337, DOI 10.1016/S0958-1669(03)00068-5
   Ruben P., 2011, INT J POLYM ANAL CH, V16, P449
   Ruben P., 2013, INT J BIOL MACROMOL, V52, P221
   Saccu D, 2001, J AGR FOOD CHEM, V49, P4526, DOI 10.1021/jf010179c
   Saji Viswanathan S., 2010, International Journal of Nano and Biomaterials, V3, P119, DOI 10.1504/IJNBM.2010.037801
   Sani B., 2013, ODONTOLOGY, V102, P310
   Sarah I. H., 2014, J AL NAHRAIN U, V17, P165
   Saritha V, 2010, INT J PHARM BIOL ARC, V1, P376
   Savio M. G., 2013, ELECTRON J BIOTECHN, V16, P3458
   SHELTON RM, 1991, INT J DERMATOL, V30, P679, DOI 10.1111/j.1365-4362.1991.tb02607.x
   Shreya M, 2015, APPL NANOSCI, V106, P886
   Shuna C., 2014, J APPL POLYM SCI, V131, P40592
   Silva SS, 2014, CARBOHYD POLYM, V112, P264, DOI 10.1016/j.carbpol.2014.05.042
   Silva SS, 2013, CARBOHYD POLYM, V98, P581, DOI 10.1016/j.carbpol.2013.06.022
   Silva SS, 2013, ACTA BIOMATER, V9, P6790, DOI 10.1016/j.actbio.2013.02.027
   Singh B, 2012, POLYM-PLAST TECHNOL, V51, P1303, DOI 10.1080/03602559.2012.698684
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Sridhar R, 2014, J BIOMAT SCI-POLYM E, V25, P985, DOI 10.1080/09205063.2014.917039
   Suganya S, 2014, INT J BIOL MACROMOL, V68, P135, DOI 10.1016/j.ijbiomac.2014.04.031
   Suganya S, 2014, IRAN POLYM J, V23, P237, DOI 10.1007/s13726-013-0219-2
   Suganyaa S., 2014, J BIOMATER APPL, V29, P46
   Thomas J. B., 2005, NANOTECHNOLOGY BIOMA, P605
   Thomson R.H., 1971, NATURALLY OCCURRING
   Townsend J., 1998, ALOE VERA UK REFEREN
   TYLER VE, 1993, HONEST HERBAL SENSIB
   Versari D, 2007, CURR PHARM DESIGN, V13, P1811, DOI 10.2174/138161207780831239
   Vogler BK, 1999, BRIT J GEN PRACT, V49, P823
   Weiss RB, 2003, J CLIN ONCOL, V21, P1825, DOI 10.1200/JCO.2003.09.006
   *WHO, 1999, WHO MON SEL MED PLAN, V1
   Xiao RZ, 2010, INT J NANOMED, V5, P1057, DOI [10.2147/IJN.S14912, 10.2147/ijn.S14912]
   Xie JP, 2007, ACS NANO, V1, P429, DOI 10.1021/nn7000883
   Yagi A, 2003, PLANTA MED, V69, P269, DOI 10.1055/s-2003-38481
   Yildirimer L, 2012, TRENDS BIOTECHNOL, V30, P638, DOI 10.1016/j.tibtech.2012.08.004
   Young C. N., 2004, J APPL POLYM SCI, V91, P1612
   Zhang Y, 2010, NANO BIOMED ENG, V2, P252
   Zhang YZ, 2007, INT J NANOMED, V2, P623
   Zoli W, 2005, BREAST CANCER RES, V7, pR681, DOI 10.1186/bcr1274
NR 112
TC 7
Z9 7
U1 1
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 105
BP 86199
EP 86213
DI 10.1039/c5ra13282g
PG 15
WC Chemistry, Multidisciplinary
SC Chemistry
GA CU0BD
UT WOS:000363179500026
DA 2018-10-20
ER

PT J
AU Bernardeschi, D
   Nguyen, Y
   Russo, FY
   Mosnier, I
   Ferrary, E
   Sterkers, O
AF Bernardeschi, Daniele
   Nguyen, Yann
   Russo, Francesca Yoshie
   Mosnier, Isabelle
   Ferrary, Evelyne
   Sterkers, Olivier
TI Cutaneous and Labyrinthine Tolerance of Bioactive Glass S53P4 in Mastoid
   and Epitympanic Obliteration Surgery: Prospective Clinical Study
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID CHRONIC OTITIS-MEDIA; BONE-GRAFT SUBSTITUTES; CANAL WALL; IN-VITRO;
   AUTOGENOUS BONE; CHRONIC OSTEOMYELITIS; CAVITY OBLITERATION;
   GENE-TRANSFER; GRANULES; REHABILITATION
AB Objective. To evaluate the cutaneous and the inner ear tolerance of bioactive glass S53P4 when used in the mastoid and epitympanic obliteration for chronic otitis surgery. Material and Methods. Forty-one cases have been included in this prospective study. Cutaneous tolerance was clinically evaluated 1 week, 1 month, and 3 months after surgery with a physical examination of the retroauricular and external auditory canal (EAC) skin and the presence of otalgia; the inner ear tolerance was assessed by bone-conduction hearing threshold 1 day after surgery and by the presence of vertigo or imbalance. Results. All surgeries but 1 were uneventful: all patients maintained the preoperative bone-conduction hearing threshold except for one case in which the round window membrane was opened during the dissection of the cholesteatoma in the hypotympanum and this led to a dead ear. No dizziness or vertigo was reported. Three months after surgery, healing was achieved in all cases with a healthy painless skin. No cases of revision surgery for removal of the granules occurred in this study. Conclusion. The bioactive glass S53P4 is a well-tolerated biomaterial for primary or revision chronic otitis surgery, as shown by the local skin reaction which lasted less than 3 months and by the absence of labyrinthine complications.
C1 [Bernardeschi, Daniele; Nguyen, Yann; Russo, Francesca Yoshie; Mosnier, Isabelle; Ferrary, Evelyne; Sterkers, Olivier] Grp Hosp Pitie Salpetriere, AP HP, Serv Otorhinolaryngol, Dept Otol Implants Auditifs & Chirurg Base Crane, F-75013 Paris, France.
   [Bernardeschi, Daniele; Nguyen, Yann; Russo, Francesca Yoshie; Mosnier, Isabelle; Ferrary, Evelyne; Sterkers, Olivier] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France.
   [Bernardeschi, Daniele; Nguyen, Yann; Russo, Francesca Yoshie; Mosnier, Isabelle; Ferrary, Evelyne; Sterkers, Olivier] INSERM, UMR S Rehabil Chirurg Miniinvas & Robotisee Audit, F-75018 Paris, France.
RP Bernardeschi, D (reprint author), Grp Hosp Pitie Salpetriere, AP HP, Serv Otorhinolaryngol, Dept Otol Implants Auditifs & Chirurg Base Crane, F-75013 Paris, France.
EM daniele.bernardeschi@psl.aphp.fr
OI Russo, Francesca Yoshie/0000-0001-5244-2423
CR ANDERSSON OH, 1992, J MATER SCI-MATER M, V3, P145, DOI 10.1007/BF00705283
   Bernardeschi D, 2015, OTOL NEUROTOL, V36, P604, DOI 10.1097/MAO.0000000000000702
   Bernardeschi D, 2014, EUR ARCH OTO-RHINO-L, V271, P59, DOI 10.1007/s00405-013-2393-4
   Bosetti M, 2005, BIOMATERIALS, V26, P3873, DOI 10.1016/j.biomaterials.2004.09.059
   Chelikh L, 2003, ACTA OTO-LARYNGOL, V123, P199, DOI 10.1080/00016480310001042
   Cho SW, 2012, CLIN EXP OTORHINOLAR, V5, P23, DOI 10.3342/ceo.2012.5.1.23
   Coraca-Huber DC, 2014, J ORTHOP RES, V32, P175, DOI 10.1002/jor.22463
   Couloigner V, 2002, NEPHROLOGIE, V23, P245
   Couloigner V, 2006, PFLUG ARCH EUR J PHY, V453, P11, DOI 10.1007/s00424-006-0103-4
   D'Arc MB, 2004, ANN OTO RHINOL LARYN, V113, P711, DOI 10.1177/000348940411300907
   D'Arc MB, 2003, J MATER SCI-MATER M, V14, P229, DOI 10.1023/A:1022828606312
   DACULSI G, 1992, ANN OTO RHINOL LARYN, V101, P669, DOI 10.1177/000348949210100808
   DECHER H, 1985, LARYNG RHINOL OTOL V, V64, P423, DOI 10.1055/s-2007-1008172
   Deveze A, 2010, OTOL NEUROTOL, V31, P220, DOI 10.1097/MAO.0b013e3181c9960d
   Dornhoffer JL, 1999, OTOLARYNG HEAD NECK, V120, P361, DOI 10.1016/S0194-5998(99)70276-7
   Drago L, 2014, FUTURE MICROBIOL, V9, P593, DOI 10.2217/fmb.14.20
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   HENCH L, 1993, INTRO BIOCERAMICS
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   IRVING RM, 1994, CLIN OTOLARYNGOL, V19, P158, DOI 10.1111/j.1365-2273.1994.tb01202.x
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5
   Lindfors NC, 2009, J BIOMED MATER RES B, V90B, P131, DOI 10.1002/jbm.b.31263
   McAndrew J, 2013, IRISH J MED SCI, V182, P509, DOI 10.1007/s11845-012-0895-5
   MONTANDON P, 1995, ORL J OTO-RHINO-LARY, V57, P198, DOI 10.1159/000276739
   Munukka E, 2008, J MATER SCI-MATER M, V19, P27, DOI 10.1007/s10856-007-3143-1
   PALVA T, 1973, ACTA OTO-LARYNGOL, V75, P289, DOI 10.3109/00016487309139718
   Peltola M, 1998, HEAD NECK-J SCI SPEC, V20, P315, DOI 10.1002/(SICI)1097-0347(199807)20:4<315::AID-HED6>3.0.CO;2-1
   Peltola M, 2006, HEAD NECK-J SCI SPEC, V28, P834, DOI 10.1002/hed.20436
   Pernaa K, 2011, J Long Term Eff Med Implants, V21, P139
   Rantakokko J, 2012, SCAND J SURG, V101, P66, DOI 10.1177/145749691210100113
   Romano CL, 2014, BONE JOINT J, V96B, P845, DOI 10.1302/0301-620X.96B6.33014
   Sarin J, 2012, ANN OTO RHINOL LARYN, V121, P563, DOI 10.1177/000348941212100901
   Shea M C Jr, 1972, Otolaryngol Clin North Am, V5, P161
   Silvola JT, 2012, OTOLARYNG HEAD NECK, V147, P119, DOI 10.1177/0194599812438168
   Stoor P, 2010, ANN OTO RHINOL LARYN, V119, P377, DOI 10.1177/000348941011900603
   Turunen T, 2004, CLIN ORAL IMPLAN RES, V15, P135, DOI 10.1111/j.1600-0501.2004.00989.x
   Valimaki VV, 2006, SCAND J SURG, V95, P95
   Valimaki VV, 2005, J BIOMED MATER RES A, V75A, P501, DOI 10.1002/jbm.a.30236
   Valimaki VV, 2005, TISSUE ENG, V11, P387, DOI 10.1089/ten.2005.11.387
   Virolainen P, 1997, J BIOMED MATER RES, V35, P9, DOI 10.1002/(SICI)1097-4636(199704)35:1<9::AID-JBM2>3.3.CO;2-H
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
NR 43
TC 5
Z9 5
U1 2
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 242319
DI 10.1155/2015/242319
PG 6
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CT9DS
UT WOS:000363117200001
PM 26504792
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Romagnoli, C
   Zonefrati, R
   Galli, G
   Puppi, D
   Pirosa, A
   Chiellini, F
   Martelli, FS
   Tanini, A
   Brandi, ML
AF Romagnoli, Cecilia
   Zonefrati, Roberto
   Galli, Gianna
   Puppi, Dario
   Pirosa, Alessandro
   Chiellini, Federica
   Martelli, Francesco Saverio
   Tanini, Annalisa
   Brandi, Maria Luisa
TI In Vitro Behavior of Human Adipose Tissue-Derived Stem Cells on
   Poly(epsilon-caprolactone) Film for Bone Tissue Engineering Applications
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID MARROW STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; REGENERATIVE MEDICINE;
   PERIODONTAL-LIGAMENT; SURFACE MODIFICATION; SCAFFOLDS; POLYCAPROLACTONE;
   ADHESION; REPAIR; PROLIFERATION
AB Bone tissue engineering is an emerging field, representing one of the most exciting challenges for scientists and clinicians. The possibility of combining mesenchymal stem cells and scaffolds to create engineered tissues has brought attention to a large variety of biomaterials in combination with osteoprogenitor cells able to promote and regenerate bone tissue. Human adipose tissue is officially recognized as an easily accessible source of mesenchymal stem cells (AMSCs), a significant factor for use in tissue regenerative medicine. In this study, we analyze the behavior of a clonal finite cell line derived from human adipose tissue seeded on poly(epsilon-caprolactone) (PCL) film, prepared by solvent casting. PCL polymer is chosen for its good biocompatibility, biodegradability, and mechanical properties. We observe that AMSCs are able to adhere to the biomaterial and remain viable for the entire experimental period. Moreover, we show that the proliferation process and osteogenic activity of AMSCs are maintained on the biofilm, demonstrating that the selected biomaterial ensures cell colonization and the development of an extracellular mineralized matrix. The results of this study highlight that AMSCs and PCL film can be used as a suitable model to support regeneration of new bone for future tissue engineering strategies.
C1 [Romagnoli, Cecilia; Zonefrati, Roberto; Galli, Gianna; Tanini, Annalisa; Brandi, Maria Luisa] Univ Florence, Dept Surg & Translat Med, I-50139 Florence, Italy.
   [Puppi, Dario; Pirosa, Alessandro; Chiellini, Federica] Univ Pisa, UdR INSTMPisa, Dept Chem & Ind Chem, BIOLab Res Grp, I-56124 Pisa, Italy.
   [Martelli, Francesco Saverio] Microdent Inst, I-50123 Florence, Italy.
RP Brandi, ML (reprint author), Univ Florence, Dept Surg & Translat Med, I-50139 Florence, Italy.
EM marialuisa.brandi@unifi.it
RI Chiellini, Federica/F-3233-2010; Pirosa, Alessandro/B-9179-2018; Puppi,
   Dario/I-4008-2012
OI Chiellini, Federica/0000-0003-4680-9975; Pirosa,
   Alessandro/0000-0002-3795-3193; Puppi, Dario/0000-0002-9251-4388
FU Tuscan Region (Italy)
FX This study was founded and supported by the Tuscan Region (Italy) as
   part of the program POR CReO FESR 2007-2013, "Le ali alle tue idee."
CR Asatrian G, 2015, STEM CELLS CLONING, V8, P39, DOI 10.2147/SCCAA.S48423
   Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709
   Boquest AC, 2006, METH MOL B, V325, P35
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Choong C, 2012, J BIOMED MATER RES A, V100A, P353, DOI 10.1002/jbm.a.33278
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   Gastaldi G, 2010, J BIOMED MATER RES A, V94A, P790, DOI 10.1002/jbm.a.32721
   Ghorbani FM, 2015, CARBOHYD POLYM, V118, P133, DOI 10.1016/j.carbpol.2014.10.071
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Hidalgo-Bastida LA, 2010, TISSUE ENG PART B-RE, V16, P405, DOI [10.1089/ten.teb.2009.0714, 10.1089/ten.TEB.2009.0714]
   Hu JZ, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-246
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kim SE, 2014, CARBOHYD POLYM, V99, P700, DOI 10.1016/j.carbpol.2013.08.053
   Kishimoto S, 2012, BIORESEARCH OPEN ACC, V1, P314, DOI 10.1089/biores.2012.0251
   Lee KH, 2003, POLYMER, V44, P1287, DOI 10.1016/S0032-3861(02)00820-0
   Li XM, 2011, J BIOMED MATER RES B, V97B, P10, DOI 10.1002/jbm.b.31773
   Lu ZF, 2015, NANOMED-NANOTECHNOL, V11, P219, DOI 10.1016/j.nano.2014.09.008
   Lu ZF, 2011, TISSUE ENG PT A, V17, P1651, DOI 10.1089/ten.tea.2010.0567
   Lu ZF, 2012, NANOMED-NANOTECHNOL, V8, P507, DOI 10.1016/j.nano.2011.07.012
   Marino G, 2012, J BIOMED MATER RES A, V100A, P543, DOI 10.1002/jbm.a.33296
   Marolt D, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt10
   Marrazzo C, 2008, POLYM ENG SCI, V48, P336, DOI 10.1002/pen.20937
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Nardone V, 2012, INT J BIOMATER, V2012
   Oyane A, 2005, J BIOMED MATER RES A, V75A, P138, DOI 10.1002/jbm.a.30397
   Panetta NJ, 2010, CURR STEM CELL RES T, V5, P122
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Puppi D., 2011, BIODEGRADABLE POLYM, P545
   Puppi D, 2012, BIOMED MICRODEVICES, V14, P1115, DOI 10.1007/s10544-012-9677-0
   Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Song L, 2005, STEM CELLS DEV, V14, P712, DOI 10.1089/scd.2005.14.712
   Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132
   Sudo K, 2007, STEM CELLS, V25, P1610, DOI 10.1634/stemcells.2006-0504
   Sun JJ, 2007, J MATER SCI-MATER M, V18, P1017, DOI 10.1007/s10856-007-0155-9
   Tognarini I, 2008, BIOMATERIALS, V29, P809, DOI 10.1016/j.biomaterials.2007.10.043
   Velasco MA, 2015, BIOMED RES INT, V2015, P21, DOI DOI 10.1155/2015/729076
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Zhang HN, 2009, J BIOMAT SCI-POLYM E, V20, P1975, DOI 10.1163/156856208X396074
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
   Zhang Y, 2010, BIOMATERIALS, V31, P3231, DOI 10.1016/j.biomaterials.2010.01.029
   Zhou CJ, 2013, ACS APPL MATER INTER, V5, P3847, DOI 10.1021/am4005072
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 49
TC 1
Z9 1
U1 1
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 323571
DI 10.1155/2015/323571
PG 12
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CT9GH
UT WOS:000363124400001
PM 26558266
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wahl, EA
   Fierro, FA
   Peavy, TR
   Hopfner, U
   Dye, JF
   Machens, HG
   Egana, JT
   Schenck, TL
AF Wahl, Elizabeth A.
   Fierro, Fernando A.
   Peavy, Thomas R.
   Hopfner, Ursula
   Dye, Julian F.
   Machens, Hans-Guenther
   Egana, Jose T.
   Schenck, Thilo L.
TI In Vitro Evaluation of Scaffolds for the Delivery of Mesenchymal Stem
   Cells to Wounds
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; STROMAL CELLS; REGENERATIVE MEDICINE; DERMAL
   REGENERATION; PARACRINE FACTORS; TISSUE; MIGRATION; EXPRESSION;
   DIFFERENTIATION; COLLAGEN
AB Mesenchymal stemcells (MSCs) have been shown to improve tissue regeneration in several preclinical and clinical trials. These cells have been used in combination with three-dimensional scaffolds as a promising approach in the field of regenerative medicine. We compare the behavior of human adipose-derived MSCs (AdMSCs) on four different biomaterials that are awaiting or have already received FDA approval to determine a suitable regenerative scaffold for delivering these cells to dermal wounds and increasing healing potential. AdMSCs were isolated, characterized, and seeded onto scaffolds based on chitosan, fibrin, bovine collagen, and decellularized porcine dermis. In vitro results demonstrated that the scaffolds strongly influence key parameters, such as seeding efficiency, cellular distribution, attachment, survival, metabolic activity, and paracrine release. Chick chorioallantoic membrane assays revealed that the scaffold composition similarly influences the angiogenic potential of AdMSCs in vivo. The wound healing potential of scaffolds increases by means of a synergistic relationship between AdMSCs and biomaterial resulting in the release of proangiogenic and cytokine factors, which is currently lacking when a scaffold alone is utilized. Furthermore, the methods used herein can be utilized to test other scaffold materials to increase their wound healing potential with AdMSCs.
C1 [Wahl, Elizabeth A.; Hopfner, Ursula; Machens, Hans-Guenther; Egana, Jose T.; Schenck, Thilo L.] Tech Univ Munich, Univ Hosp Klinikum Rechts Isar, Dept Plast Surg & Hand Surg, D-81675 Munich, Germany.
   [Fierro, Fernando A.] Univ Calif Davis, Inst Regenerat Cures, Sacramento, CA 95817 USA.
   [Peavy, Thomas R.] Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA.
   [Dye, Julian F.] Royal Inst Great Britain, UCL, Inst Biomed Engn, London W1S 4BS, England.
   [Egana, Jose T.] Univ Chile, Fac Sci, FONDAP Ctr Genome Regulat, Santiago 7800024, Chile.
RP Egana, JT (reprint author), Tech Univ Munich, Univ Hosp Klinikum Rechts Isar, Dept Plast Surg & Hand Surg, D-81675 Munich, Germany.
EM tomasega@gmail.com
FU CIRM-BMBF Early Translational II Award; FONDAP Center for Genome
   regulation [15090007]
FX This project was supported by a grant from the CIRM-BMBF Early
   Translational II Award to Jose T. Egana and Fernando A. Fierro and the
   FONDAP Center for Genome regulation (no. 15090007) to Jose T. Egana. The
   authors acknowledge the efforts by Ravneet S. Kang from the Department
   of Biological Sciences, California State University, Sacramento, in
   analyzing confocal images for seeding efficiencies of the matrices.
CR Akpinar G, 2014, STEM CELLS INT, V2014
   Amos PJ, 2008, ANN PLAS SURG, V60, P437, DOI 10.1097/SAP.0b013e318095a771
   Anthony DF, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-10
   Asare Y, 2013, THROMB HAEMOSTASIS, V109, P391, DOI 10.1160/TH12-11-0831
   Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890
   Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539
   Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74
   Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A
   Baron F, 2012, BIOL BLOOD MARROW TR, V18, P822, DOI 10.1016/j.bbmt.2011.09.003
   Bieback K, 2012, J MOL MED, V90, P773, DOI 10.1007/s00109-012-0915-y
   Bishop CJ, 2014, ANN BIOMED ENG, V42, P1557, DOI 10.1007/s10439-013-0932-1
   Blaber SP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-172
   Branch MJ, 2012, INVEST OPHTH VIS SCI, V53, P5109, DOI 10.1167/iovs.11-8673
   Brem H, 2010, AM J SURG, V200, P473, DOI 10.1016/j.amjsurg.2009.12.021
   Broughton 2nd G., 2006, PLASTIC RECONSTRUCTI, V117, p1e
   Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904
   Chen GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098565
   Chen HT, 2012, J CELL MOL MED, V16, DOI 10.1111/j.1582-4934.2011.01335.x
   Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
   Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736
   Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]
   Danner S, 2012, J INVEST DERMATOL, V132, P1707, DOI 10.1038/jid.2012.31
   Dash SN, 2014, REJUV RES, V17, P40, DOI 10.1089/rej.2013.1467
   Dohle D. S., 2009, J VISUALIZED EXPT
   DUNCAN MR, 1991, J INVEST DERMATOL, V97, P686, DOI 10.1111/1523-1747.ep12483971
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Garcia-Gareta E, 2013, BIORESEARCH OPEN ACC, V2, P412, DOI 10.1089/biores.2013.0043
   Glasberg SB, 2012, PLAST RECONSTR SURG, V129, P1223, DOI 10.1097/PRS.0b013e31824ec429
   Gould Lisa, 2015, Wound Repair Regen, V23, P1, DOI 10.1111/wrr.12245
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Harris LJ, 2010, J SURG RES, V163, pE105, DOI 10.1016/j.jss.2010.04.025
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hou CL, 2013, BIOMATERIALS, V34, P112, DOI 10.1016/j.biomaterials.2012.09.022
   Hou Y, 2014, CELL BIOL INT, V38, P1050, DOI 10.1002/cbin.10294
   Jackson WM, 2012, STEM CELL TRANSL MED, V1, P44, DOI 10.5966/sctm.2011-0024
   Kang S. K., 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/342968
   Kim EJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.2
   King Jonathan, 2013, J Med Case Rep, V7, P258, DOI 10.1186/1752-1947-7-258
   Lin CS, 2012, STEM CELLS DEV, V21, P2770, DOI 10.1089/scd.2012.0176
   Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807
   Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158
   Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI [10.1021/bp.128, 10.1002/btpr.128]
   Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200
   Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018
   McClelland RE, 2000, J BIOMECH ENG-T ASME, V122, P268, DOI 10.1115/1.429657
   Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932
   Mirastschijski U, 2013, PLAST RECONSTR SURG, V132, P861, DOI 10.1097/PRS.0b013e31829fe461
   Mirsaidi A, 2012, J TISSUE ENG REGEN M, V6, P378, DOI 10.1002/term.440
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Monteiro G. A., 2013, J TISSUE ENG, V4, P1
   Newman Robert E., 2009, Inflammation & Allergy Drug Targets, V8, P110
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pozner JN, 2013, AESTHET SURG J, V33, P681, DOI 10.1177/1090820X13491279
   Providence KM, 2008, ARCH DERMATOL RES, V300, P303, DOI 10.1007/s00403-008-0845-2
   Qi JF, 1997, BLOOD, V90, P3595
   Reagan MR, 2011, STEM CELLS, V29, P920, DOI 10.1002/stem.645
   Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Shin L, 2013, STEM CELL TRANSL MED, V2, P33, DOI 10.5966/sctm.2012-0041
   Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230
   Steigman Shaun A, 2007, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01e02s1
   Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132
   Thomson T., 2000, DESIGN APPL HYDROPHI
   Tjwa M, 2003, CELL TISSUE RES, V314, P5, DOI 10.1007/s00441-003-0776-3
   Egana JT, 2009, TISSUE ENG PT A, V15, P1191, DOI 10.1089/ten.tea.2008.0097
   Tully-Dartez S, 2010, TISSUE ENG PART C-ME, V16, P339, DOI [10.1089/ten.tec.2009.0132, 10.1089/ten.TEC.2009.0132]
   Volkmer E, 2012, J MATER SCI-MATER M, V23, P2793, DOI 10.1007/s10856-012-4725-0
   Xie MW, 2013, J INVEST DERMATOL, V133, P553, DOI 10.1038/jid.2012.326
   Xing YJ, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-6
   Yasuda H, 2010, J NEUROSURG, V112, P336, DOI 10.3171/2009.2.JNS08495
   Yew TL, 2011, CELL TRANSPLANT, V20, P693, DOI 10.3727/096368910X550198
   Zippel Nina, 2010, Recent Pat Biotechnol, V4, P1, DOI 10.2174/187220810790069497
   Zomorodian E., 2012, STEM CELLS INT, V2012
NR 74
TC 5
Z9 5
U1 0
U2 7
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 108571
DI 10.1155/2015/108571
PG 14
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CT9AW
UT WOS:000363109100001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Satish, A
   Korrapati, PS
AF Satish, Aishwarya
   Korrapati, Purna Sai
TI Fabrication of a triiodothyronine incorporated nanofibrous biomaterial:
   its implications on wound healing
SO RSC ADVANCES
LA English
DT Article
ID POLYCAPROLACTONE NANOFIBERS; PROLIFERATION; DELIVERY; SKIN; MIGRATION;
   INSULIN; GROWTH; MICE
AB With rising incidents of non-healing chronic wounds, functional restoration of the organs after a major wound insult is an essential requisite. The delivery of endogenous molecules through nanomaterials for supporting healing of such wounds has gained impetus in the past decade. Triiodothyronine (T-3) is a hormone that exerts its activity at various target organs and is reported to play a critical role in repair and regeneration of tissues after injury. The encapsulation of T-3 in nanofibers and its sustained release to enable wound healing has been attempted for the first time in this work. The physico-chemical characterization confirmed the encapsulation and uniform distribution of the hormone in the nanofiber. Functional characterization of the composite nanofibers revealed the significant positive influence of the T-3-entrapped nanofibers on the proliferation and migration of skin cells. Consistent with the in vitro results, application of the composite nanofibers on full thickness excisional wounds in rat model (in vivo) confirmed the potential of the hormone in accelerating the rate of wound closure. Thus this work reveals the effect of prolonged sustained delivery of T-3 from nanofibers which might promote the healing of chronic wounds.
C1 [Satish, Aishwarya; Korrapati, Purna Sai] CSIR Cent Leather Res Inst, Biomat Dept, Madras 600020, Tamil Nadu, India.
RP Korrapati, PS (reprint author), CSIR Cent Leather Res Inst, Biomat Dept, Madras 600020, Tamil Nadu, India.
EM purnasaik.clri@gmail.com
FU DST-INSPIRE programme, New Delhi [IF130876]
FX The authors are grateful to the Director, CSIR - CLRI for his constant
   support. The first author would like to acknowledge the DST-INSPIRE
   programme, New Delhi for the research fellowship (IF130876).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Antonini Dario, 2013, Front Endocrinol (Lausanne), V4, P104, DOI 10.3389/fendo.2013.00104
   Azarbayjani AF, 2010, J PHARM PHARM SCI, V13, P400
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   BRAJKOVICH IE, 1983, METABOLISM, V32, P745, DOI 10.1016/0026-0495(83)90101-4
   Bui HT, 2014, MACROMOL RES, V22, P1288, DOI 10.1007/s13233-014-2179-6
   da Silva MA, 2009, TISSUE ENG PT A, V15, P377, DOI 10.1089/ten.tea.2007.0327
   Fuquan D., 1999, SCI CHINA CHEM, V42, P663
   Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610
   Hulbert AJ, 2000, BIOL REV, V75, P519, DOI 10.1017/S146479310000556X
   Karuppuswamy P, 2015, MATER LETT, V141, P180, DOI 10.1016/j.matlet.2014.11.044
   Kassem R, 2012, CLIN EXP DERMATOL, V37, P850, DOI 10.1111/j.1365-2230.2012.04456.x
   Kenawy ER, 2009, MATER CHEM PHYS, V113, P296, DOI 10.1016/j.matchemphys.2008.07.081
   Krishnaswamy VR, 2014, SCI REP-UK, V4, DOI 10.1038/srep07385
   Lin Y, 2011, BRIT J PHARMACOL, V162, P597, DOI 10.1111/j.1476-5381.2010.01056.x
   Liu Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-1
   Madhaiyan K, 2013, INT J PHARMACEUT, V444, P70, DOI 10.1016/j.ijpharm.2013.01.040
   Mdzinarishvili A, 2013, DRUG DELIV TRANSL RE, V3, P309, DOI 10.1007/s13346-012-0117-8
   MEHREGAN AH, 1974, J CUTAN PATHOL, V1, P113, DOI 10.1111/j.1600-0560.1974.tb00201.x
   Merrell JG, 2009, CLIN EXP PHARMACOL P, V36, P1149, DOI 10.1111/j.1440-1681.2009.05216.x
   Montero G. A., 2005, INT SOC ADVANCEMENT
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mourouzis I., 2013, J THYROID RES, V2013, P1
   Paneva D, 2008, EUR POLYM J, V44, P566, DOI 10.1016/j.eurpolymj.2008.01.010
   Safer J. D., 2008, THYROID DISORDERS CU, V14, P181
   Safer J. D., 2013, J THYROID RES, V2013, P1
   Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192
   Safer JD, 2003, THYROID, V13, P159, DOI 10.1089/105072503321319468
   Safer JD, 2001, THYROID, V11, P717, DOI 10.1089/10507250152484547
   Shoba E, 2014, RSC ADV, V4, P60209, DOI 10.1039/c4ra10239h
   Tarameshloo Mahsa, 2012, Anat Cell Biol, V45, P170, DOI 10.5115/acb.2012.45.3.170
   Zhang G.-Y., 2013, THESIS U LUBECK
NR 33
TC 11
Z9 11
U1 1
U2 4
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 102
BP 83773
EP 83780
DI 10.1039/c5ra14142g
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CT4CB
UT WOS:000362752400028
DA 2018-10-20
ER

PT J
AU Wang, J
   Qiu, WT
   Wang, N
   Li, L
AF Wang, Jia
   Qiu, Wenting
   Wang, Ning
   Li, Li
TI Influence of hydroxyapatite on thermoplastic foaming performance of
   water-plasticized poly(vinyl alcohol)
SO RSC ADVANCES
LA English
DT Article
ID MECHANICAL-PROPERTIES; INTERMOLECULAR INTERACTIONS; BILAYERED SCAFFOLD;
   POLY(ACRYLIC ACID); BIOMATERIAL; BLENDS; FTIR; CARTILAGE; SURFACE;
   STATES
AB Poly(vinyl alcohol) (PVA)/hydroxyapatite (HA) composite foams suitable for bone tissue restoration were prepared through thermoplastic molding foaming using water as both a plasticizer and physical blowing agent. The effects of HA content on the foaming properties of the composites including the water states, water evaporation behaviors, interactions among the components as well as the cell structure and mechanical properties of the composite foams were studied. The results showed that HA nano-particles could form different hydrogen bonding or coordination interactions with water and PVA, thus making the bounded water in the system increase to a larger extent and the phase transition temperature of free water shift from 0.24 degrees C to -1.26 degrees C, consequently changing the relative content of different water. In this way, more nonfreezing water was formed, which was beneficial to the controllable foaming of water. HA particles could also act as a heterogeneous nucleating agent, thus effectively increasing the number of heterogeneous nucleating points in the system. With an increase in the HA content, foams with a more dense and uniform cell structure were obtained, and the mean size of the cell decreased from 760 mu m (HA 0 wt%) to 270 mu m (HA 20 wt%). The addition of HA improved the compression yield strength and compression modulus of the composite foams.
C1 [Wang, Jia; Qiu, Wenting; Wang, Ning; Li, Li] Sichuan Univ, Polymer Res Inst, State Key Lab Polymer Mat Engn, Chengdu 610065, Peoples R China.
RP Li, L (reprint author), Sichuan Univ, Polymer Res Inst, State Key Lab Polymer Mat Engn, Chengdu 610065, Peoples R China.
EM powerlily@scu.edu.cn
FU International Science & Technology Cooperation Program of China
   [2013DFG52300]; National Natural Science Foundation of China [51121001]
FX The authors greatly acknowledge the financial support of the
   International Science & Technology Cooperation Program of China
   (2013DFG52300) and the National Natural Science Foundation of China
   (51121001).
CR Aronin CEP, 2009, J BIOMED MATER RES A, V89A, P632, DOI 10.1002/jbm.a.32015
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chen N, 2007, PLAST RUBBER COMPOS, V36, P283, DOI 10.1179/174328907X237575
   [陈晓 Chen Xiao], 2013, [高分子通报, Polymer Bulletin], P26
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   Daniliuc L, 1996, POLYMER, V37, P5219, DOI 10.1016/0032-3861(96)00328-X
   DANILIUC L, 1992, EUR POLYM J, V28, P1365, DOI 10.1016/0014-3057(92)90277-9
   Eaves D., 2004, HDB POLYM FOAMS
   Georgiou G, 2007, J BIOMED MATER RES B, V80B, P322, DOI 10.1002/jbm.b.30600
   Gonzalez JS, 2014, J MECH BEHAV BIOMED, V34, P47, DOI 10.1016/j.jmbbm.2014.01.019
   Guo YW, 2014, ARTIF ORGANS, V38, P580, DOI 10.1111/aor.12257
   Ibrahim NS, 2013, MATER LETT, V113, P25, DOI 10.1016/j.matlet.2013.09.026
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002
   Li L, 2005, J APPL POLYM SCI, V98, P774, DOI 10.1002/app.22158
   Li WB, 2005, POLYMER, V46, P12026, DOI 10.1016/j.polymer.2005.09.016
   Li Y M, 2011, SYST SCI HICSS 2011, P1
   Mansur HS, 2004, POLYMER, V45, P7193, DOI 10.1016/j.polymer.2004.08.036
   Miyata S, 2004, MAT SCI ENG C-BIO S, V24, P425, DOI 10.1016/j.msec.2003.11.007
   Pan YS, 2013, MECH TIME-DEPEND MAT, V17, P195, DOI 10.1007/s11043-012-9186-9
   Pan YS, 2010, J WUHAN UNIV TECHNOL, V25, P474, DOI 10.1007/s11595-010-0026-y
   Ping ZH, 2001, POLYMER, V42, P8461, DOI 10.1016/S0032-3861(01)00358-5
   Qu D, 2011, J BIOMED MATER RES B, V96B, P9, DOI 10.1002/jbm.b.31697
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Maiolo AS, 2012, MAT SCI ENG C-MATER, V32, P1490, DOI 10.1016/j.msec.2012.04.030
   Tanigami T, 1999, EUR POLYM J, V35, P1165, DOI 10.1016/S0014-3057(98)00087-1
   Wang Q, 2011, ACTA POLYM SIN, P932, DOI 10.3724/SP.J.1105.2011.11135
   Wang R, 2003, POLYM INT, V52, P1820, DOI 10.1002/pi.1385
   Wang R., 2001, POLYM MAT SCI ENG, P111
   Wang X, 2012, CHEM J CHINESE U, V33, P813, DOI 10.3969/j.issn.0251-0790.2012.04.029
   White LJ, 2012, ACTA BIOMATER, V8, P61, DOI 10.1016/j.actbio.2011.07.032
   Xiong X. H., 2007, CHINA PLAST IND, P10
   Zhao N, 2014, IND ENG CHEM RES, V53, P11962, DOI 10.1021/ie502018v
NR 33
TC 9
Z9 10
U1 6
U2 28
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 103
BP 84578
EP 84586
DI 10.1039/c5ra11993f
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CT5LF
UT WOS:000362851000030
DA 2018-10-20
ER

PT S
AU Cetiner, BN
   Erkmen, ZE
AF Cetiner, B. N.
   Erkmen, Z. E.
BE Oral, AY
   Bahsi, ZB
   Ozer, M
   Sezer, M
   Akoz, ME
TI Production and Characterization of Alumina-Titania Biocomposite
SO 4TH INTERNATIONAL CONGRESS IN ADVANCES IN APPLIED PHYSICS AND MATERIALS
   SCIENCE (APMAS 2014)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 4th International Congress in Advances in Applied Physics and Materials
   Science (APMAS)
CY APR 24-27, 2014
CL Fethiye, TURKEY
DE Tialite; Seydisehir Alumina; bioceramic composites and structural
   properties
ID SOL-GEL SYNTHESIS; CERAMICS; COMPOSITES
AB Alumina is a biomaterial of choice for more than 20 years due to its high hardness accompanied by low friction, wear and inertness to in vivo environment. It has been reported that titanium oxidized to the rutile phase is bioactive. This is a property discovered for certain ceramics such as Bioglass and sintered hydroxylapatite (HA). But the combination of alumina and titania forming tialite (Aluminium titanate-50 mol % Al2O3 and 50 mol % TiO2) is a new challenge. In this work we made firstly the beneficiation of the Seydisehir alumina by leaching it in the acidic solution "the Aqua Regia" followed by preparation of batches containing 2,5 wt %, 3,5 wt % and 4,5 wt % of MgO as the sintering aid, 1 wt % of SiO2 and the balance; the alumina and titania powder mixture (1:1 mole). After sintering these batches at 1600 degrees C for about 12 h, their mechanical properties (the compression and hardness testings) and phase ratios (the XRD analysis) were analyzed and compared with the control group containing the laboratory scale alumina instead of the Seydisehir alumina. Following the characterization (the SEM and the EDS analysis) of the substrate material, the comparison of two different materials was carried out.
C1 [Cetiner, B. N.; Erkmen, Z. E.] Univ Marmara, Fac Engn, Dept Met & Mat Engn, TR-34722 Istanbul, Turkey.
RP Cetiner, BN (reprint author), Univ Marmara, Fac Engn, Dept Met & Mat Engn, Goztepe Campus, TR-34722 Istanbul, Turkey.
EM nilgun.cetiner@marmara.edu.tr; cerkmen@marmara.edu.tr
CR Ananthakumar S, 2006, ACTA MATER, V54, P2965, DOI 10.1016/j.actamat.2006.02.032
   Beherei HH, 2009, CERAM INT, V35, P1991, DOI 10.1016/j.ceramint.2008.10.014
   Bueno S, 2008, J EUR CERAM SOC, V28, P1961, DOI 10.1016/j.jeurceramsoc.2008.01.017
   Celik E., COMMUNICATION
   Chen CH, 2007, J EUR CERAM SOC, V27, P13, DOI 10.1016/j.jeurceramsoc.2006.04.182
   Forsgren J, 2007, ACTA BIOMATER, V3, P980, DOI 10.1016/j.actbio.2007.03.006
   Jayasankar M, 2008, J SOLID STATE CHEM, V181, P2748, DOI 10.1016/j.jssc.2008.06.057
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Lee SW, 2003, WEAR, V255, P1040, DOI 10.1016/S0043-1648(03)00099-1
   Low IM, 2008, MATER CHEM PHYS, V111, P9, DOI 10.1016/j.matchemphys.2008.03.017
   Naghizadeh R, 2009, MATER SCI ENG B-ADV, V157, P20, DOI 10.1016/j.mseb.2008.12.002
   Otterstein E, 2008, THERMOCHIM ACTA, V468, P10, DOI 10.1016/j.tca.2007.11.023
   Park JB, 2013, BIOMATERIALS: PRINCIPLES AND PRACTICES
   Park SY, 2003, CERAM INT, V29, P707, DOI 10.1016/S0272-8842(02)00221-3
   Shi CG, 1998, MATER RES BULL, V33, P817, DOI 10.1016/S0025-5408(98)00061-0
   Sobhani M, 2008, J MATER PROCESS TECH, V206, P282, DOI 10.1016/j.jmatprotec.2007.12.023
   Verne E, 2002, BIOMATERIALS, V23, P3395, DOI 10.1016/S0142-9612(02)00040-6
NR 17
TC 0
Z9 0
U1 0
U2 4
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1295-8
J9 AIP CONF PROC
PY 2015
VL 1653
AR 020028
DI 10.1063/1.4914219
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BD6KC
UT WOS:000362294100028
OA Bronze
DA 2018-10-20
ER

PT S
AU Oboh, I
   Aluyor, E
   Audu, T
AF Oboh, I.
   Aluyor, E.
   Audu, T.
BE Oral, AY
   Bahsi, ZB
   Ozer, M
   Sezer, M
   Akoz, ME
TI Kinetic Modelling for Zinc (II) Ions Biosorption Onto Luffa Cylindrica
SO 4TH INTERNATIONAL CONGRESS IN ADVANCES IN APPLIED PHYSICS AND MATERIALS
   SCIENCE (APMAS 2014)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 4th International Congress in Advances in Applied Physics and Materials
   Science (APMAS)
CY APR 24-27, 2014
CL Fethiye, TURKEY
DE Coefficient of non-determination; biomaterial; Luffa cylindrica;
   non-linear regression; Kinetic models
ID AQUEOUS-SOLUTION; WASTE-WATER; REMOVAL; ADSORPTION; CU(II);
   10-AMINE-4-AZADECYLSILICA; EQUILIBRIUM; ADSORBENT; CAPACITY; FE(III)
AB The biosorption of Zinc (II) ions onto a biomaterial - Luffa cylindrica has been studied. This biomaterial was characterized by elemental analysis, surface area, pore size distribution, scanning electron microscopy, and the biomaterial before and after sorption, was characterized by Fourier Transform Infra Red (FTIR) spectrometer. The kinetic nonlinear models fitted were Pseudo-first order, Pseudo-second order and Intra-particle diffusion. A comparison of non-linear regression method in selecting the kinetic model was made. Four error functions, namely coefficient of determination (R-2), hybrid fractional error function (HYBRID), average relative error (ARE), and sum of the errors squared (ERRSQ), were used to predict the parameters of the kinetic models. The strength of this study is that a biomaterial with wide distribution particularly in the tropical world and which occurs as waste material could be put into effective utilization as a biosorbent to address a crucial environmental problem.
C1 [Oboh, I.] Univ Uyo, Dept Chem & Petr Engn, Uyo, Nigeria.
   [Aluyor, E.; Audu, T.] Univ Uyo, Dept Chem Engn, Benin, Nigeria.
RP Oboh, I (reprint author), Univ Uyo, Dept Chem & Petr Engn, Uyo, Nigeria.
EM innocentoboh@uniuyo.edu.ng
CR Abdelwahab O, 2013, CHEM ENG RES DES, V91, P165, DOI 10.1016/j.cherd.2012.07.005
   Arenas LT, 2004, MATER LETT, V58, P895, DOI 10.1016/j.matlet.2003.07.031
   Bal K. J., 2004, NARC LIBIRD IPGRI
   Basil JL, 2006, J HAZARD MATER, V133, P143
   Goyal P, 2008, INT J ENVIRON SCI TE, V5, P27, DOI 10.1007/BF03325994
   Hamoudi S, 2003, MICROPOR MESOPOR MAT, V59, P195, DOI 10.1016/S1387-1811(03)00311-1
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Jacques RA, 2007, SEPAR SCI TECHNOL, V42, P591, DOI 10.1080/01496390601069952
   Kuyucak N., 1990, BIOSORPTION HEAVY ME, P173
   Largegren S., 1898, KUNGLIGA SUENSK VETE, V241, P1
   Lima EC, 2007, J HAZARD MATER, V140, P211, DOI 10.1016/j.jhazmat.2006.06.073
   MARSHALL WE, 1995, J ENVIRON SCI HEAL A, V30, P241, DOI 10.1080/10934529509376198
   Mazali IO, 2005, AN ACAD BRAS CIENC, V77, P25, DOI 10.1590/S0001-37652005000100003
   Mishra V., 2014, APPL WATER SCI, V44, P218
   Passos CG, 2008, COLLOID SURFACE A, V316, P297, DOI 10.1016/j.colsurfa.2007.09.025
   Passos CG, 2006, J COLLOID INTERF SCI, V302, P396, DOI 10.1016/j.jcis.2006.06.052
   Pavia D.L., 1996, INTRO SPECTROSCOPY
   Rodrigues MS, 2012, J HAZARD MATER, V217, P246, DOI 10.1016/j.jhazmat.2012.03.022
   Sahmoune MN, 2009, INT J ENVIRON RES, V3, P229
   Vaghetti JCP, 2003, J ANAL ATOM SPECTROM, V18, P376, DOI 10.1039/b209133j
   Vimala R, 2011, DESALINATION, V275, P291, DOI 10.1016/j.desal.2011.03.014
   Volesky B., 2003, SORPTION BIOSORPTION, P316
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
NR 23
TC 0
Z9 0
U1 0
U2 2
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1295-8
J9 AIP CONF PROC
PY 2015
VL 1653
AR 020079
DI 10.1063/1.4914270
PG 8
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BD6KC
UT WOS:000362294100079
OA Bronze
DA 2018-10-20
ER

PT J
AU Siebert, JR
   Eade, A
   Osterhout, DJ
AF Siebert, Justin R.
   Eade, AmberM.
   Osterhout, Donna J.
TI Biomaterial Approaches to Enhancing Neurorestoration after Spinal Cord
   Injury: Strategies for Overcoming Inherent Biological Obstacles
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID CHONDROITIN SULFATE PROTEOGLYCANS; CENTRAL-NERVOUS-SYSTEM; OLFACTORY
   ENSHEATHING CELLS; LEUKEMIA INHIBITORY FACTOR; LONG-TERM SURVIVAL;
   OLIGODENDROCYTE PROGENITOR CELLS; CUPRIZONE-INDUCED DEMYELINATION;
   CELLULAR INFLAMMATORY RESPONSE; MYELIN-ASSOCIATED GLYCOPROTEIN; PROMOTES
   FUNCTIONAL RECOVERY
AB While advances in technology and medicine have improved both longevity and quality of life in patients living with a spinal cord injury, restoration of full motor function is not often achieved. This is due to the failure of repair and regeneration of neuronal connections in the spinal cord after injury. In this review, the complicated nature of spinal cord injury is described, noting the numerous cellular and molecular events that occur in the central nervous system following a traumatic lesion. In short, postinjury tissue changes create a complex and dynamic environment that is highly inhibitory to the process of neural regeneration. Strategies for repair are outlined with a particular focus on the important role of biomaterials in designing a therapeutic treatment that can overcome this inhibitory environment. The importance of considering the inherent biological response of the central nervous system to both injury and subsequent therapeutic interventions is highlighted as a key consideration for all attempts at improving functional recovery.
C1 [Siebert, Justin R.; Eade, AmberM.] Seton Hill, Lake Erie Coll Osteopath Med, Greensburg, PA 15601 USA.
   [Osterhout, Donna J.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA.
RP Osterhout, DJ (reprint author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA.
EM osterhod@upstate.edu
CR Adamo AM, 2006, EXP NEUROL, V198, P519, DOI 10.1016/j.expneurol.2005.12.027
   Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812
   Akiyama Y, 2002, GLIA, V39, P229, DOI 10.1002/glia.10102
   Akiyama Y, 2002, J NEUROSCI, V22, P6623
   Akiyama Y, 2004, NEURON GLIA BIOL, V1, P47, DOI 10.1017/s1740925x04000079
   Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008
   Andrews MR, 2007, J NEUROTRAUM, V24, P1773, DOI 10.1089/neu.2007.0353
   Andrews MR, 2004, EXP NEUROL, V190, P311, DOI 10.1016/j.expneurol.2004.08.011
   Apara A, 2014, NEURAL REGEN RES, V9, P1418, DOI 10.4103/1673-5374.139454
   Armstrong RC, 2002, J NEUROSCI, V22, P8574
   Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002
   Assuncao-Silva RC, 2015, STEM CELLS INT, DOI 10.1155/2015/948040
   Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004
   BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499
   Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123
   Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006
   Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014
   Baumann N, 2001, PHYSIOL REV, V81, P871
   Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X
   Beller JA, 2014, NEURAL REGEN RES, V9, P343, DOI 10.4103/1673-5374.128235
   BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0
   Blakemore W. F., 1973, NAT NEUROSCI, V4, P1116
   Blesch A, 1999, J NEUROSCI, V19, P3556
   Blesch A, 2004, MOL CELL NEUROSCI, V27, P190, DOI 10.1016/j.mcn.2004.06.007
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964
   Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015
   BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P805, DOI 10.1111/j.1460-9568.1995.tb00683.x
   Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705
   Bugiani M, 2013, BRAIN, V136, P209, DOI 10.1093/brain/aws320
   BUNGE RP, 1993, ADV NEUROL, V59, P75
   Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004
   Cadavid D., 2014, NEUROLOGY SP3, V82, P154
   Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001
   Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226
   Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8
   Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000
   Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje
   Chockalingam K, 2007, PROTEIN ENG DES SEL, V20, P155, DOI 10.1093/protein/gzm008
   CHUNG KS, 1983, J COMP NEUROL, V217, P47, DOI 10.1002/cne.902170105
   Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001
   Cox A. A., 2015, J NEUROTRAUMA
   Crespo D, 2007, EXP NEUROL, V206, P159, DOI 10.1016/j.expneurol.2007.05.001
   Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73
   Dahlin LB, 2004, J AM SOC SURG HAND, V4, P143, DOI DOI 10.1016/J.JASSH.2004.06.006
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Dasari VR, 2007, J NEUROTRAUM, V24, P391, DOI 10.1089/neu.2006.0142
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   Deal DN, 2012, J AM ACAD ORTHOP SUR, V20, P63, DOI 10.5435/JAAOS-20-02-063
   DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007
   Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070
   Dow KE, 1998, CELL MOL LIFE SCI, V54, P567, DOI 10.1007/s000180050185
   Dowling P, 1999, NEUROLOGY, V53, P1676, DOI 10.1212/WNL.53.8.1676
   Elatorai I. M., 2003, SPINAL CORD MED PRIN, P3
   Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004
   Fawcett James W, 2008, J Biol, V7, P25, DOI 10.1186/jbiol89
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999
   Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195
   FILBIN MT, 1995, CURR OPIN NEUROBIOL, V5, P588, DOI 10.1016/0959-4388(95)80063-8
   Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011
   Fisher J. D., 2015, CLIN IMMUNOLOGY
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296
   FOKSEANG J, 1995, DEV BIOL, V171, P1, DOI 10.1006/dbio.1995.1255
   Fouad K, 2004, EUR J NEUROSCI, V20, P2479, DOI 10.1111/j.1460-9568.2004.03716.x
   Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072
   Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3
   Franklin RJM, 2002, BRAIN RES BULL, V57, P827, DOI 10.1016/S0361-9230(01)00765-1
   Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436
   Freund P, 2007, J COMP NEUROL, V502, P644, DOI 10.1002/cne.21321
   FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669
   Friedman W, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P546
   Fujita Y, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00338
   Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006
   Geddis MS, 2003, J NEUROBIOL, V54, P555, DOI 10.1002/neu.10183
   Giehl KM, 1997, EUR J NEUROSCI, V9, P2479, DOI 10.1111/j.1460-9568.1997.tb01665.x
   Giehl KM, 1998, J NEUROSCI, V18, P7351
   Goetz L. L., 2014, MEDSCAPE
   Goldberg JL, 2003, GENE DEV, V17, P941, DOI 10.1101/gad.1062303
   Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5
   Gregg C, 2005, DEVELOPMENT, V132, P565, DOI 10.1242/dev.01592
   Grill R, 1997, J NEUROSCI, V17, P5560
   Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628
   Gu Haigang, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P11
   Haggerty AE, 2013, NEUROSCI BULL, V29, P445, DOI 10.1007/s12264-013-1362-7
   Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733
   Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818
   Hammond ENL, 1999, NEUROREPORT, V10, P2671, DOI 10.1097/00001756-199908200-00043
   Harlow DE, 2014, EXP NEUROL, V251, P39, DOI 10.1016/j.expneurol.2013.10.017
   Henke-Fahle S, 2001, MOL CELL NEUROSCI, V18, P541, DOI 10.1006/mcne.2001.1034
   Hiebert GW, 2002, J NEUROSCI RES, V69, P160, DOI 10.1002/jnr.10275
   Houweling DA, 1998, EXP NEUROL, V153, P49, DOI 10.1006/exnr.1998.6867
   HUGHES JT, 1988, PARAPLEGIA, V26, P71, DOI 10.1038/sc.1988.15
   Iwashita Y, 2000, EXP NEUROL, V164, P292, DOI 10.1006/exnr.2000.7440
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Jin Y, 2011, J NEUROSCI METH, V199, P208, DOI 10.1016/j.jneumeth.2011.05.007
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Jones LL, 2001, MICROSC RES TECHNIQ, V54, P317, DOI 10.1002/jemt.1144
   Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6
   Kamber D, 2009, EXP NEUROL, V219, P112, DOI 10.1016/j.expneurol.2009.05.004
   Kandel E. R., 1991, PRINCIPLES NEUROSCIE
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kim David H, 2003, Spine J, V3, P510, DOI 10.1016/S1529-9430(03)00117-7
   KLEIN R, 1990, DEVELOPMENT, V109, P845
   Kobayashi NR, 1997, J NEUROSCI, V17, P9583
   Krenz NR, 2000, J NEUROCHEM, V74, P730, DOI 10.1046/j.1471-4159.2000.740730.x
   Kubo Takekazu, 2008, Ther Clin Risk Manag, V4, P605
   Kwon BK, 2004, EXP NEUROL, V189, P45, DOI 10.1016/j.expneurol.2004.05.034
   Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899
   Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014
   Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7
   Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974
   Lau LW, 2012, ANN NEUROL, V72, P419, DOI 10.1002/ana.23599
   Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009
   Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X
   Li GL, 1999, ACTA NEUROPATHOL, V98, P473, DOI 10.1007/s004010051112
   Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003
   Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627
   LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6
   Lingor P, 2007, J NEUROCHEM, V103, P181, DOI 10.1111/j.1471-4159.2007.04756.x
   Liu Y, 1999, J NEUROSCI, V19, P4370
   Liu Y, 2002, EXP NEUROL, V178, P150, DOI 10.1006/exnr.2002.7977
   Logan A, 2006, BRAIN, V129, P490, DOI 10.1093/brain/awh706
   Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692
   Lu P, 2001, J COMP NEUROL, V436, P456, DOI 10.1002/cne.1080
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Matsushima GK, 2001, BRAIN PATHOL, V11, P107
   Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L
   McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006
   McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x
   McTigue DM, 2006, J NEUROPATH EXP NEUR, V65, P406, DOI 10.1097/01.jnen.0000218447.32320.52
   McTigue DM, 1998, J NEUROSCI, V18, P5354
   Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460
   Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664
   Mi S, 2013, CNS DRUGS, V27, P493, DOI 10.1007/s40263-013-0068-8
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001
   Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0
   Moon LDF, 2001, NAT NEUROSCI, V4, P465
   Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737
   Munzel EJ, 2013, DRUGS, V73, P2017, DOI 10.1007/s40265-013-0146-8
   Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165
   Nazari-Robati M, 2013, BBA-PROTEINS PROTEOM, V1834, P479, DOI 10.1016/j.bbapap.2012.11.002
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575
   Oberoi HS, 2013, ADV DRUG DELIVER REV, V65, P1667, DOI 10.1016/j.addr.2013.09.014
   Osterhout D. J., NANOSPHERE DEL UNPUB
   Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281
   Pabari A, 2014, PLAST RECONSTR SURG, V133, P1420, DOI 10.1097/PRS.0000000000000226
   Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566
   Pendleton JC, 2013, EXP NEUROL, V247, P113, DOI 10.1016/j.expneurol.2013.04.003
   Pepinsky RB, 2014, J PHARMACOL EXP THER, V350, P110, DOI 10.1124/jpet.113.211771
   Perale G, 2011, ACS CHEM NEUROSCI, V2, P336, DOI 10.1021/cn200030w
   Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6
   PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Pilakka-Kanthikeel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062241
   Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S
   Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015
   Radtke C, 2003, FASEB J, V17, P335, DOI 10.1096/fj.03-0214fje
   Ramer MS, 2002, MOL CELL NEUROSCI, V19, P239, DOI 10.1006/mcne.2001.1067
   Raposo C, 2014, GLIA, V62, P1895, DOI 10.1002/glia.22676
   REMAHL S, 1990, J NEUROCYTOL, V19, P883, DOI 10.1007/BF01186817
   Reynolds AJ, 2000, BRAIN RES REV, V33, P169, DOI 10.1016/S0165-0173(00)00028-X
   RICHARDSON PM, 1984, J NEUROCYTOL, V13, P165, DOI 10.1007/BF01148324
   Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591
   Romero MI, 2001, J NEUROSCI, V21, P8408
   Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3
   Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958
   Sakiyama-Elbert S., 2012, HDB CLIN NEUROLOGY S, P109
   Saxena T, 2015, ACS NANO, V9, P1492, DOI 10.1021/nn505980z
   SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0
   Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004
   Sengottuvel Vetrivel, 2011, Commun Integr Biol, V4, P391, DOI 10.4161/cib.4.4.15552
   Sengottuvel V, 2011, J NEUROSCI, V31, P2688, DOI 10.1523/JNEUROSCI.4885-10.2011
   Setzu A, 2004, GLIA, V45, P307, DOI 10.1002/glia.10321
   Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134
   Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310
   Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.3.CO;2-#
   Siebert J. R., 2014, BIOMED RES INT, V2014
   Siebert J. R., STRATEGIES IN PRESS
   Siebert JR, 2011, J NEUROCHEM, V119, P176, DOI 10.1111/j.1471-4159.2011.07370.x
   Siebert JR, 2011, EXP NEUROL, V231, P19, DOI 10.1016/j.expneurol.2011.05.002
   Siebert JR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-69
   Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Steencken ACC, 2010, NEUROSCIENCE, V170, P971, DOI 10.1016/j.neuroscience.2010.06.064
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   Stidworthy MF, 2003, BRAIN PATHOL, V13, P329
   STOLL G, 1989, J NEUROSCI, V9, P2327
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594
   Surey S, 2014, NEUROSCIENCE, V275, P62, DOI 10.1016/j.neuroscience.2014.06.003
   Tan AM, 2005, J ANAT, V207, P717, DOI 10.1111/j.1469-7580.2005.00452.x
   Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tester NJ, 2008, EXP NEUROL, V209, P483, DOI 10.1016/j.expneurol.2007.07.019
   Tester NJ, 2007, J NEUROSCI RES, V85, P1110, DOI 10.1002/jnr.21199
   Tobias CA, 2001, J NEUROTRAUM, V18, P287, DOI 10.1089/08977150151070937
   Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138
   Tom VJ, 2009, J NEUROTRAUM, V26, P2323, DOI 10.1089/neu.2009.1047
   Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0
   Tsai SY, 2011, STROKE, V42, P186, DOI 10.1161/STROKEAHA.110.590083
   Twiss JL, 2006, BRAIN PATHOL, V16, P320, DOI 10.1111/j.1750-3639.2006.00039.x
   Tyor WR, 2002, J NEUROL SCI, V200, P33, DOI 10.1016/S0022-510X(02)00113-2
   Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354
   Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087
   VAZQUEZ ME, 1991, NEUROREPORT, V2, P593, DOI 10.1097/00001756-199110000-00010
   Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007
   Walthers CM, 2015, BIOMARK INSIGHTS, V10, P11, DOI [10.4137/BMIMI.S20063, 10.4137/BMI.S20063]
   Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867
   Wang MD, 2011, TISSUE ENG PART B-RE, V17, P177, DOI 10.1089/ten.teb.2010.0648
   Wang T, 2012, BRAIN RES BULL, V87, P499, DOI 10.1016/j.brainresbull.2012.02.011
   Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1
   Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473
   Woodhoo A, 2007, BRAIN, V130, P2175, DOI 10.1093/brain/awm125
   Wu B, 2009, J NEUROTRAUM, V26, P1847, DOI 10.1089/neu.2008.0551
   Xie F, 2008, EXP NEUROL, V209, P302, DOI 10.1016/j.expneurol.2007.07.005
   Xie YM, 2006, J BIOL CHEM, V281, P16482, DOI 10.1074/jbc.M603131200
   Xu GY, 2004, EXP NEUROL, V187, P329, DOI 10.1016/j.expneurol.2004.01.029
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   YAWO H, 1985, J NEUROSCI, V5, P1626
   Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3
   Yick LW, 2000, NEUROREPORT, V11, P1063, DOI 10.1097/00001756-200004070-00032
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   Young W, 2002, PROG BRAIN RES, V137, P231
   Zhang YJ, 2015, EXP NEUROL, V266, P68, DOI 10.1016/j.expneurol.2015.02.006
   Zhao RR, 2011, J NEUROSCI METH, V201, P228, DOI 10.1016/j.jneumeth.2011.08.003
   Zhou LJ, 2003, J NEUROSCI RES, V74, P221, DOI 10.1002/jnr.10718
   Zhou XF, 2007, J NEUROSCI RES, V85, P1601, DOI 10.1002/jnr.21220
   Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013
   Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951
   Zuo J, 2002, EXP NEUROL, V176, P221, DOI 10.1006/exnr.2002.7922
NR 245
TC 8
Z9 9
U1 0
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 752572
DI 10.1155/2015/752572
PG 20
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CT4AC
UT WOS:000362747100001
PM 26491685
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Neacsu, P
   Mazare, A
   Schmuki, P
   Cimpean, A
AF Neacsu, Patricia
   Mazare, Anca
   Schmuki, Patrik
   Cimpean, Anisoara
TI Attenuation of the macrophage inflammatory activity by TiO2 nanotubes
   via inhibition of MAPK and NF-kappa B pathways
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE titania nanotubes; macrophage; mitogen-activated protein kinases;
   NF-kappa B; inflammatory mediators
ID NITRIC-OXIDE SYNTHASE; ACTIVATED PROTEIN-KINASE; RAW 264.7 CELLS;
   PROINFLAMMATORY CYTOKINE PRODUCTION; SIGNAL-REGULATED KINASE;
   GENE-EXPRESSION; IN-VITRO; RAW-264.7 MACROPHAGES; MURINE MACROPHAGES;
   SURFACE-TOPOGRAPHY
AB Biomaterial implantation in a living tissue triggers the activation of macrophages in inflammatory events, promoting the transcription of pro-inflammatory mediator genes. The initiation of macrophage inflammatory processes is mainly regulated by signaling proteins of mitogen-activated protein kinase (MAPK) and by nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) pathways. We have previously shown that titania nanotubes modified Ti surfaces (Ti/TiO2) mitigate the immune response, compared with flat Ti surfaces; however, little is known regarding the underlying mechanism. Therefore, the aim of this study is to investigate the mechanism(s) by which this nanotopography attenuates the inflammatory activity of macrophages. Thus, we analyzed the effects of TiO2 nanotubes on the activation of MAPK and NF-kappa B signaling pathways in standard and lipopolysaccharide-evoked conditions. Results showed that the Ti/TiO2 significantly reduce the expression levels of the phosphorylated forms of p38, ERK1/2, c-Jun NH2-terminal kinase (JNK), IKK beta, and IkB-alpha. Furthermore, a significant reduction in the p65 nuclear accumulation on the nanotubular surface was remarked. Following, by using specific MAPK inhibitors, we observed that lipopolysaccharide-induced production of monocyte chemotactic protein-1 and nitric oxide was significantly inhibited on the Ti/TiO2 surface via p38 and ERK1/2, but not via JNK. However, the selective inhibitor for JNK signaling pathway (SP600125) was effective in reducing tumor necrosis factor alpha release as well as monocyte chemotactic protein-1 and nitric oxide production. Altogether, these data suggest that titania nanotubes can attenuate the macrophage inflammatory response via suppression of MAPK and NF-kappa B pathways providing a potential mechanism for their anti-inflammatory activity.
C1 [Neacsu, Patricia; Cimpean, Anisoara] Univ Bucharest, Dept Biochem & Mol Biol, Bucharest 050095, Romania.
   [Mazare, Anca; Schmuki, Patrik] Univ Erlangen Nurnberg, Dept Mat Sci, D-91054 Erlangen, Germany.
RP Cimpean, A (reprint author), Univ Bucharest, Dept Biochem & Mol Biol, 91-95 Splaiul Independentei, Bucharest 050095, Romania.
EM anisoara.cimpean@bio.unibuc.ro
OI Mazare, Anca/0000-0002-4836-946X
FU Romanian Ministry of National Education, CNCS-UEFISCDI [PNII-ID-PCE
   188/2011]
FX This work was supported by the Romanian Ministry of National Education,
   CNCS-UEFISCDI through project PNII-ID-PCE 188/2011.
CR Abarikwu SO, 2014, BBA-GEN SUBJECTS, V1840, P2373, DOI 10.1016/j.bbagen.2014.03.006
   Achoui M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015105
   Ainslie KM, 2009, J BIOMED MATER RES A, V91A, P647, DOI 10.1002/jbm.a.32262
   Ajizian SJ, 1999, J INFECT DIS, V179, P939, DOI 10.1086/314659
   Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Bergqvist S, 2008, PROTEIN SCI, V17, P2051, DOI 10.1110/ps.037481.108
   Bhat NR, 1998, J NEUROSCI, V18, P1633
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Budai MM, 2013, MOL IMMUNOL, V56, P471, DOI 10.1016/j.molimm.2013.05.005
   Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858
   Chamberlain ML, 2011, J BIOMATER NANOBIOTE, V2, P293
   Chan ED, 1998, BIOCHEM BIOPH RES CO, V253, P790, DOI 10.1006/bbrc.1998.9857
   Chan ED, 2001, AM J PHYSIOL-CELL PH, V280, pC441
   Chen BC, 2001, BRIT J PHARMACOL, V134, P1055, DOI 10.1038/sj.bjp.0704334
   Chen BC, 1999, IMMUNOLOGY, V97, P124
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Choi HJ, 2008, EUR J PHARMACOL, V601, P171, DOI 10.1016/j.ejphar.2008.09.032
   Dai XH, 2015, J NANOMATER, DOI 10.1155/2015/712810
   Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5
   Feng GJ, 1999, J IMMUNOL, V163, P6403
   Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1
   Ghrebi S, 2013, J BIOMED MATER RES A, V101, P2118, DOI 10.1002/jbm.a.34509
   Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2
   Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144
   Ion R, 2015, ACTA BIOMATER, V24, P370, DOI 10.1016/j.actbio.2015.06.016
   Jang KJ, 2013, INT J MOL MED, V31, P1357, DOI 10.3892/ijmm.2013.1330
   Jang SI, 2006, EUR J PHARMACOL, V542, P1, DOI 10.1016/j.ejphar.2006.04.044
   Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017
   Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621
   Kim DH, 2013, FOOD CHEM TOXICOL, V58, P273, DOI 10.1016/j.fct.2013.04.051
   Kim KN, 2013, FOOD CHEM TOXICOL, V57, P126, DOI 10.1016/j.fct.2013.03.017
   Kim SH, 2004, PHARMACOL RES, V49, P433, DOI 10.1016/j.phrs.2003.11.004
   Kim YH, 2004, EUR J PHARMACOL, V494, P1, DOI 10.1016/j.ejphar.2004.04.040
   Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651
   Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152
   Lee KH, 2012, INT J MOL SCI, V13, P2985, DOI 10.3390/ijms13032985
   Lee K, 2014, CHEM REV, V114, P9385, DOI 10.1021/cr500061m
   Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910
   Neacsu P, 2014, INT J BIOCHEM CELL B, V55, P187, DOI 10.1016/j.biocel.2014.09.006
   Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049
   RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420
   Rajapakse N, 2008, IMMUNOLOGY, V123, P348, DOI 10.1111/j.1365-2567.2007.02683.x
   Rajyalakshmi A, 2011, INT J NANOMED, V6, P1765, DOI 10.2147/IJN.S22763
   Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X
   Smith BS, 2013, BIOMATER SCI-UK, V1, P322, DOI 10.1039/c2bm00079b
   Soromou LW, 2012, MOLECULES, V17, P3574, DOI 10.3390/molecules17033574
   Sung MJ, 2009, INT IMMUNOPHARMACOL, V9, P319, DOI 10.1016/j.intimp.2008.12.005
   Tsao LT, 2005, BIOCHEM PHARMACOL, V70, P618, DOI 10.1016/j.bcp.2005.05.032
   Uto T, 2005, BIOCHEM PHARMACOL, V70, P1211, DOI 10.1016/j.bcp.2005.07.011
   Wang N, 2011, BIOMATERIALS, V32, P6900, DOI 10.1016/j.biomaterials.2011.06.023
   Waterfield JD, 2010, J BIOMED MATER RES A, V95A, P837, DOI 10.1002/jbm.a.32857
   WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955
   Xagorari A, 2002, BRIT J PHARMACOL, V136, P1058, DOI 10.1038/sj.bjp.0704803
   Xagorari A, 2001, J PHARMACOL EXP THER, V296, P181
   Yang Y, 2014, MEDIAT INFLAMM, V2014, P352
   Yoon WJ, 2012, ARCH PHARM RES, V35, P1421, DOI 10.1007/s12272-012-0812-5
   Yuan F, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-84
   Zhou HY, 2008, EUR J PHARMACOL, V586, P340, DOI 10.1016/j.ejphar.2008.02.044
NR 60
TC 11
Z9 11
U1 1
U2 17
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2015
VL 10
BP 6455
EP 6467
DI 10.2147/IJN.S92019
PG 13
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA CT3AN
UT WOS:000362678300002
PM 26491301
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Cecen, B
   Kozaci, D
   Yuksel, M
   Erdemli, D
   Bagriyanik, A
   Havitcioglu, H
AF Cecen, Berivan
   Kozaci, Didem
   Yuksel, Mithat
   Erdemli, Diler
   Bagriyanik, Alper
   Havitcioglu, Hasan
TI Biocompatibility of MG-63 cells on collagen, poly-L-lactic acid,
   hydroxyapatite scaffolds with different parameters
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Collagen; Hydroxyapatite; MG-63; Poly-L-lactic acid; Scaffold
ID COMPOSITE SCAFFOLDS; CHITIN FIBERS; IN-VITRO
AB Purpose: In this study, osteoblast-like MG-63 cells were cultured on 3 different scaffold types composed of (a) collagen + poly-L-lactic acid (PLLA), (b) collagen + hydroxyapatite (HA; 30 degrees C) or (c) collagen + hydroxyapatite (HA; 37 degrees C) and produced with different porosities.
   Methods: Biomechanical properties of the scaffolds were characterized by tensile strength measurements. Properties of the cell-seeded scaffolds were evaluated with scanning electron microscopy (SEM). Cell adhesion and proliferation capacities were evaluated. Alkaline phosphatase (ALP) levels in media were measured. Transmission electron microscopy (TEM) and histological analyses were used to assess morphological characteristics.
   Results: Our results showed that collagen-based PLLA and HA scaffolds have good cell biocompatibility. MTT test showed that the scaffolds exhibited no cytotoxicity. According to the force and displacement data, collagen + HA at 37 degrees C showed the highest mechanical strength and displacement.
   Conclusion: The results suggest that collagen-based PLLA and HA scaffolds might improve osteoblastic growth in vitro and have biomaterial integration potential in possible therapeutic approaches for future clinical studies.
C1 [Cecen, Berivan; Erdemli, Diler; Havitcioglu, Hasan] Dokuz Eylul Univ, Inst Hlth Sci, Dept Biomech, TR-35340 Izmir, Turkey.
   [Kozaci, Didem] Adnan Menderes Univ, Fac Med, Dept Med Biochem, Aydin, Turkey.
   [Yuksel, Mithat] Ege Univ, Fac Engn, Dept Chem Engn, Izmir, Turkey.
   [Bagriyanik, Alper] Dokuz Eylul Univ, Fac Med, Dept Histol, TR-35340 Izmir, Turkey.
   [Havitcioglu, Hasan] Dokuz Eylul Univ, Fac Med, Dept Orthopaed & Traumatol, TR-35340 Izmir, Turkey.
RP Cecen, B (reprint author), Dokuz Eylul Univ, Biyomekan Anabilim Dali, TR-35340 Izmir, Turkey.
EM berivan.erik@deu.edu.tr
OI Bagriyanik, Husnu Alper/0000-0003-4064-7637
CR Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Li XM, 2006, MAT SCI ENG C-BIO S, V26, P716, DOI 10.1016/j.msec.2005.06.062
   Li XM, 2006, J BIOMED MATER RES B, V77B, P219, DOI 10.1002/jbm.b.30425
   Liuyun Jiang, 2009, J Biomed Sci, V16, P65, DOI 10.1186/1423-0127-16-65
   Panzavolta S, 2012, J MATER SCI-MATER M, V23, P1363, DOI 10.1007/s10856-012-4618-2
   Paul W, 2007, J MATER SCI-MATER M, V18, P699, DOI 10.1007/s10856-006-0005-1
   Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   WEI J, 2004, EUR POLYM J, V40, P509, DOI DOI 10.1016/J.EURP0LYMJ.2003.10.028
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 15
TC 6
Z9 6
U1 1
U2 17
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2015
VL 13
IS 1
BP 10
EP 16
DI 10.5301/jabfm.5000182
PG 7
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA CS8WM
UT WOS:000362370500002
PM 24744232
DA 2018-10-20
ER

PT J
AU Bryan, N
   Ashwin, H
   Smart, NJ
   Wohlert, S
   Bayon, Y
   Hunt, JA
AF Bryan, Nicholas
   Ashwin, Helen
   Smart, Neil J.
   Wohlert, Stephen
   Bayon, Yves
   Hunt, John A.
TI Characterisation and comparison of the host response of 6 tissue-based
   surgical implants in a subcutaneous in vivo rat model
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Animal model; Biomaterial; Hernia; Inflammation; In vivo
ID VENTRAL HERNIA REPAIR; BIOLOGIC PROSTHESES; CROSS-LINKING; COLLAGEN;
   CELLS; DECELLULARIZATION; BIOMATERIALS; INFLAMMATION; LYMPHOCYTES;
   MACROPHAGES
AB Background: Hernia repair often involves fascial augmentation using biologic prostheses. Small processing changes during preparation modulate host tissue response, which influence material efficacy and longevity. In this pilot study, a rat model was used to determine the specific influence of tissue origin, decellularisation treatment and 1,6-hexamethylene diisocyanate (HMDI) cross-linking.
   Methods: Materials (1 cm(2)) were implanted subcutaneously into 6-week-old Wistar rats (4 materials per animal, n=6/material per time point) for 2, 5, 7, 14 and 28 days. Histologic processing was carried out after resin infiltration, observing classical histopathology and pathologic indexing. Materials comprised 6 tissue-based grafts covering both experimental and commercial porcine decellularised dermal and small intestinal submucosal materials.
   Results: Subcutaneous delivery of biologics demonstrated material-specific inflammatory/host responses. Controlled variations of the Permacol (TM) manufacturing process showed sodium dodecyl sulfate (SDS) was the most proinflammatory decellularisation reagent, and HMDI cross-linking had no effect on host response. All materials remained recoverable after 28 days, although Surgisis (TM) had partially resorbed.
   Conclusion: Differences in host responses exist between biologic implants for hernia repair in this rat model. It is postulated that these modifications are induced during processing and may have an effect on the clinical outcome of hernia repair.
C1 [Bryan, Nicholas; Hunt, John A.] Univ Liverpool, Inst Ageing & Chron Dis, Clin Engn UKCTE, Liverpool L69 3GA, Merseyside, England.
   [Ashwin, Helen; Wohlert, Stephen; Bayon, Yves] Covidien Sofradim Prod, Trevoux, France.
   [Smart, Neil J.] Royal Devon & Exeter Hosp, Exeter Hlth Sci Res Unit, Exeter EX2 5DW, Devon, England.
RP Bryan, N (reprint author), Univ Liverpool, Inst Ageing & Chron Dis, Clin Engn UKCTE, Duncan Bldg,Daulby St, Liverpool L69 3GA, Merseyside, England.
EM n.bryan@liv.ac.uk
OI Ashwin, Helen/0000-0003-1029-0032; Hunt, John/0000-0002-5168-4778
FU Covidien
FX The authors would like to thank Covidien for funding this research.
CR Bellows CF, 2006, EXPERT REV MED DEVIC, V3, P657, DOI 10.1586/17434440.3.5.657
   Bras LED, 2012, HERNIA, V16, P77, DOI 10.1007/s10029-011-0859-0
   Bras LED, 2010, J BIOMED MATER RES B, V95B, P239, DOI 10.1002/jbm.b.31704
   Bryan D, 2005, CYTOKINE, V31, P429, DOI 10.1016/j.cyto.2005.06.015
   Bryan N, 2009, BIOMATERIALS, V30, P180, DOI 10.1016/j.biomaterials.2008.09.003
   Butler CE, 2010, J AM COLL SURGEONS, V211, P368, DOI 10.1016/j.jamcollsurg.2010.04.024
   Butterfield TA, 2006, J ATHL TRAINING, V41, P457
   Catena F, 2007, SURG ENDOSC, V21, P690, DOI 10.1007/s00464-006-9110-y
   Deeken CR, 2011, J AM COLL SURGEONS, V212, P880, DOI 10.1016/j.jamcollsurg.2011.01.006
   Dubay DA, 2003, SURG CLIN N AM, V83, P463, DOI 10.1016/S0039-6109(02)00196-2
   EFRON JE, 1990, J SURG RES, V48, P460, DOI 10.1016/0022-4804(90)90013-R
   FOSTER SJ, 1986, BIOCHEM PHARMACOL, V35, P1709, DOI 10.1016/0006-2952(86)90328-X
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gaertner WB, 2007, J GASTROINTEST SURG, V11, P1275, DOI 10.1007/s11605-007-0242-8
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goldberg SR, 2010, SURG CLIN N AM, V90, P1133, DOI 10.1016/j.suc.2010.08.003
   Haney AF, 2000, FERTIL STERIL, V73, P988, DOI 10.1016/S0015-0282(00)00490-8
   Hiles M, 2009, SURG INNOV, V16, P26, DOI 10.1177/1553350609331397
   Hsu PW, 2009, J PLAST RECONSTR AES, V62, P1484, DOI 10.1016/j.bjps.2008.04.060
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   KIKLY K, 2001, DENDRITIC CELLS, P539
   Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012
   MARTIN CW, 1990, BRIT J PLAST SURG, V43, P655, DOI 10.1016/0007-1226(90)90185-3
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Miserez M, 2010, BRIT J SURG, V97, P1598, DOI 10.1002/bjs.7282
   Mulier KE, 2011, HERNIA, V15, P315, DOI 10.1007/s10029-010-0777-6
   Nienhuijs S W, 2008, Int J Surg, V6, P351, DOI 10.1016/j.ijsu.2008.02.005
   Oliveira HC, 2010, IMMUNOBIOLOGY, V215, P215, DOI 10.1016/j.imbio.2009.03.009
   Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4
   Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008
   REISER K, 1992, FASEB J, V6, P2439
   Sandor M, 2008, TISSUE ENG PT A, V14, P2021, DOI 10.1089/ten.tea.2007.0317
   Smart NJ, 2012, SURG-J R COLL SURG E, V10, P159, DOI 10.1016/j.surge.2012.02.006
   Smart NJ, 2011, SURG INNOV, P221
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Tsirogianni AK, 2006, INJURY, V37, pS5, DOI 10.1016/j.injury.2006.02.035
   van't Riet M, 2007, Hernia, V11, P409
   VATER CA, 1979, BIOCHEM J, V181, P639, DOI 10.1042/bj1810639
   Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067
NR 43
TC 2
Z9 2
U1 0
U2 4
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2015
VL 13
IS 1
BP 35
EP 42
DI 10.5301/jabfm.5000172
PG 8
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA CS8WM
UT WOS:000362370500005
PM 24700265
DA 2018-10-20
ER

PT J
AU Loh, XJ
   Karim, AA
   Owh, C
AF Loh, Xian Jun
   Karim, Anis Abdul
   Owh, Cally
TI Poly(glycerol sebacate) biomaterial: synthesis and biomedical
   applications
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Review
ID TAILORED MECHANICAL-PROPERTIES; BIODEGRADABLE ELASTOMERS; NANOFIBROUS
   SCAFFOLDS; TISSUE; REGENERATION; BIOCOMPATIBILITY; CULTURE; ACID;
   COMPOSITES; COPOLYMERS
AB The recently developed poly(glycerol sebacate) (PGS) has been gaining attraction as a biomaterial for tissue engineering applications. Reported in 2002, a simple polycondensation method was developed to synthesize PGS for soft tissue engineering applications. It has since become a highly sought after biomaterial due to its soft, robust and flexible characteristics and it is relatively low cost compared to other biodegradable elastomers currently available in the market. We summarise in this review, the various synthetic approaches of PGS and highlight selected applications in nerve guidance, soft tissue regeneration, vascular and myocardial tissue regeneration, blood vessel reconstruction, drug delivery, and the replacement of photoreceptor cells. A critical assessment of the material is provided as a scope for future improvement. The future outlook of this material is also provided at the end of this review.
C1 [Loh, Xian Jun; Karim, Anis Abdul; Owh, Cally] ASTAR, IMRE, Singapore 117602, Singapore.
   [Loh, Xian Jun] Natl Univ Singapore, Dept Mat Sci & Engn, Singapore 117576, Singapore.
   [Loh, Xian Jun] Singapore Eye Res Inst, Singapore 168751, Singapore.
RP Loh, XJ (reprint author), ASTAR, IMRE, 3 Res Link, Singapore 117602, Singapore.
EM lohxj@imre.a-star.edu.sg
OI Loh, Xian Jun/0000-0001-8118-6502
CR Allen RA, 2014, BIOMATERIALS, V35, P165, DOI 10.1016/j.biomaterials.2013.09.081
   Appel EA, 2012, CHEM SOC REV, V41, P6195, DOI 10.1039/c2cs35264h
   Aydin HM, 2013, BIOMATER SCI-UK, V1, P503, DOI 10.1039/c3bm00157a
   Bodakhe S, 2013, NANOMEDICINE-UK, V8, P1777, DOI 10.2217/nnm.12.192
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2011, J MECH BEHAV BIOMED, V4, P1805, DOI 10.1016/j.jmbbm.2011.05.038
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Chen QZ, 2011, SOFT MATTER, V7, P6484, DOI 10.1039/c1sm05350g
   Dong WF, 2013, POLYMERS-BASEL, V5, P1339, DOI 10.3390/polym5041339
   Dou QQ, 2014, ADV HEALTHC MATER, V3, P977, DOI 10.1002/adhm.201300627
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FDA: U.S. Food and Drug Administration, SEL COMM GRAS SUBST
   Frydrych M, 2013, J MATER CHEM B, V1, P6650, DOI 10.1039/c3tb20842g
   Gaharwar AK, 2015, BIOMATER SCI-UK, V3, P46, DOI 10.1039/c4bm00222a
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Gerecht S, 2007, BIOMATERIALS, V28, P4826, DOI 10.1016/j.biomaterials.2007.07.039
   Guillemette MD, 2010, MACROMOL BIOSCI, V10, P1330, DOI 10.1002/mabi.201000165
   Guo XL, 2014, J BIOMED MATER RES A, V102, P3903, DOI 10.1002/jbm.a.35066
   Ifkovits JL, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034104
   Jeffries EM, 2015, ACTA BIOMATER, V18, P30, DOI 10.1016/j.actbio.2015.02.005
   Kai D, 2014, ACS SUSTAIN CHEM ENG, V2, P106, DOI 10.1021/sc400340p
   Karim AA, 2015, SOFT MATTER, V11, P5425, DOI 10.1039/c5sm00665a
   Kemppainen JM, 2010, J BIOMED MATER RES A, V94A, P9, DOI 10.1002/jbm.a.32653
   Kharaziha M, 2013, BIOMATERIALS, V34, P6355, DOI 10.1016/j.biomaterials.2013.04.045
   Labet M, 2009, CHEM SOC REV, V38, P3484, DOI 10.1039/b820162p
   Lang N., 2014, SCI TRANSL MED, V6
   Li XD, 2015, BIOMACROMOLECULES, V16, P1525, DOI 10.1021/acs.biomac.5b00018
   Li ZB, 2015, CHEM SOC REV, V44, P2865, DOI 10.1039/c5cs00089k
   Liang SL, 2010, BIOMATERIALS, V31, P8516, DOI 10.1016/j.biomaterials.2010.07.105
   Liang SL, 2012, POLYM INT, V61, P17, DOI 10.1002/pi.3165
   Liu QY, 2009, POLYM DEGRAD STABIL, V94, P1427, DOI 10.1016/j.polymdegradstab.2009.05.023
   Loh XJ, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39924
   Loh XJ, 2011, J MATER CHEM, V21, P2246, DOI 10.1039/c0jm03051a
   Loh XJ, 2009, MACROMOL BIOSCI, V9, P1069, DOI 10.1002/mabi.200900081
   Loh XJ, 2009, SOFT MATTER, V5, P2937, DOI 10.1039/b904171k
   Loh XJ, 2009, MACROMOLECULES, V42, P194, DOI 10.1021/ma8019865
   Low ZW, 2015, RSC ADV, V5, P57678, DOI 10.1039/c5ra09926a
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Nguyen VPN, 2011, SOFT MATTER, V7, P2150, DOI 10.1039/c0sm00764a
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Park H, 2011, BIOMATERIALS, V32, P1856, DOI 10.1016/j.biomaterials.2010.11.032
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Pomerantseva I, 2009, J BIOMED MATER RES A, V91A, P1038, DOI 10.1002/jbm.a.32327
   Pritchard CD, 2010, BIOMATERIALS, V31, P2153, DOI 10.1016/j.biomaterials.2009.11.074
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Rai R, 2013, MAT SCI ENG C-MATER, V33, P3677, DOI 10.1016/j.msec.2013.04.058
   Ravichandran R, 2011, TISSUE ENG PT A, V17, P1363, DOI [10.1089/ten.tea.2010.0441, 10.1089/ten.TEA.2010.0441]
   Ravichandran R, 2013, INT J CARDIOL, V167, P1461, DOI 10.1016/j.ijcard.2012.04.045
   Redenti S, 2009, BIOMATERIALS, V30, P3405, DOI 10.1016/j.biomaterials.2009.02.046
   Roether JA, 2014, MATER SCI TECH-LOND, V30, P574, DOI 10.1179/1743284713Y.0000000499
   Salehi S, 2014, KLIN MONATSBL AUGENH, V231, P626, DOI 10.1055/s-0034-1368533
   Salehi S, 2014, RSC ADV, V4, P16951, DOI 10.1039/c4ra01237b
   Salehi S, 2014, MACROMOL MATER ENG, V299, P455, DOI 10.1002/mame.201300187
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Toh WS, 2014, MAT SCI ENG C-MATER, V45, P690, DOI 10.1016/j.msec.2014.04.026
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wu Y, 2012, J APPL POLYM SCI, V123, P1612, DOI 10.1002/app.34556
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
   Ye EY, 2014, MATER TODAY, V17, P194, DOI 10.1016/j.mattod.2014.04.004
   Ye HY, 2015, RSC ADV, V5, P48720, DOI 10.1039/c5ra08222f
   Zhao X, 2015, J MATER CHEM B, V3, P3222, DOI 10.1039/c4tb01693a
   Zhou L, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42196
NR 67
TC 35
Z9 34
U1 4
U2 63
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 39
BP 7641
EP 7652
DI 10.1039/c5tb01048a
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CS8PP
UT WOS:000362350600001
DA 2018-10-20
ER

PT J
AU Khaing, ZZ
   Seidlits, SK
AF Khaing, Zin Z.
   Seidlits, Stephanie K.
TI Hyaluronic acid and neural stem cells: implications for biomaterial
   design
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Review
ID SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; OLIGODENDROCYTE PROGENITOR
   CELLS; MOLECULAR-WEIGHT HYALURONAN; EXTRACELLULAR-MATRIX PROTEOGLYCANS;
   CHONDROITIN SULFATE PROTEOGLYCAN; RESTRICTED PRECURSOR CELLS; NOGO-66
   RECEPTOR ANTIBODY; MEDIATED MOTILITY RHAMM; TRAUMATIC BRAIN-INJURY
AB While in the past hyaluronic acid (HA) was considered a passive component with a primarily structural role in tissues, research over the past few decades has revealed its diverse and complex biological functions, resulting in a major ideological shift. HA is abundant during normal central nervous system (CNS) development and, although down-regulated, remains ubiquitous in adult extracellular matrix (ECM). Significant changes in HA content are associated with pathological conditions, including stroke, traumatic injury and multiple sclerosis, and these changes likely disrupt repair by endogenous neural stem cells (NSCs). In this review, we describe recent findings in HA biology relevant to NSCs-focusing on the potential of HA-NSC interactions to mediate CNS regeneration. Currently, HA biomaterials are being developed to counteract matrix changes associated with CNS injury and disease, thereby promoting NSC survival and directing differentiation. In parallel, HA-based biomaterials engineered to mimic the native CNS microenvironment are being used to investigate the relationship between NSCs and their HA-rich surroundings within a controlled experimental space. As our understanding of HA-NSC interactions improves, so will the therapeutic potential of HA-based biomaterials. Efforts to better understand the relationship between HA bioactivities and biomaterial design parameters are already underway. Although significant progress has been made improving techniques for controlled fabrication of HA-based hydrogels with precisely defined features, there is still much work to be done. Ideally, future designs will incorporate multiple types of microenvironmental cues - orthogonally tuned in time and space - to direct differentiation of NSCs into various specialized lineages within a single biomaterial platform.
C1 [Khaing, Zin Z.] Univ Washington, Inst Stem Cell & Regenerat Med, Dept Neurol Surg, Seattle, WA 98195 USA.
   [Seidlits, Stephanie K.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Brain Res Inst, Dept Bioengn, Los Angeles, CA 90024 USA.
RP Khaing, ZZ (reprint author), Univ Washington, Inst Stem Cell & Regenerat Med, Dept Neurol Surg, Seattle, WA 98195 USA.
EM zink@uw.edu
CR Abaskharoun M, 2010, BRAIN RES, V1327, P6, DOI 10.1016/j.brainres.2010.02.048
   Addington CP, 2014, BIOMATERIALS, V35, P3263, DOI 10.1016/j.biomaterials.2013.12.102
   Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139
   Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038
   Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005
   Arulmoli J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08499
   Aurand ER, 2014, STEM CELL RES, V12, P11, DOI 10.1016/j.scr.2013.09.013
   Aurand ER, 2012, J FUNCT BIOMATER, V3, P839, DOI 10.3390/jfb3040839
   Austin JW, 2012, J NEUROCHEM, V122, P344, DOI 10.1111/j.1471-4159.2012.07789.x
   Austin JW, 2012, BIOMATERIALS, V33, P4555, DOI 10.1016/j.biomaterials.2012.03.022
   Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611
   Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279
   Back SA, 2011, ANN NEUROL, V70, P465, DOI 10.1002/ana.22484
   Baier C, 2007, MATRIX BIOL, V26, P348, DOI 10.1016/j.matbio.2007.02.002
   Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   Bambakidis NC, 2003, J NEUROSURG, V99, P70, DOI 10.3171/spi.2003.99.1.0070
   Bambakidis NC, 2009, J NEUROSURG-SPINE, V10, P171, DOI 10.3171/2008.10.SPI08231
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201
   Barbucci R, 2000, J BIOMAT SCI-POLYM E, V11, P383, DOI 10.1163/156856200743779
   Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014
   Bergstrom T, 2014, BBA-GEN SUBJECTS, V1840, P2526, DOI 10.1016/j.bbagen.2014.01.021
   BIGNAMI A, 1992, BRAIN RES, V579, P173, DOI 10.1016/0006-8993(92)90759-3
   BIGNAMI A, 1992, INT J DEV NEUROSCI, V10, P45, DOI 10.1016/0736-5748(92)90006-L
   BIGNAMI A, 1992, INT J DEV NEUROSCI, V10, P291, DOI 10.1016/0736-5748(92)90018-U
   BIGNAMI A, 1992, EXP NEUROL, V117, P90, DOI 10.1016/0014-4886(92)90115-7
   Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x
   Boregowda Rajeev K, 2006, J Carcinog, V5, P2, DOI 10.1186/1477-3163-5-2
   Bouvier-Labit C, 2002, J NEURO-ONCOL, V60, P127, DOI 10.1023/A:1020630732625
   Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358
   Bruckner G, 2003, J CHEM NEUROANAT, V26, P37, DOI 10.1016/S0891-0618(03)00036-X
   Bruckner G, 2008, NEUROSCIENCE, V151, P489, DOI 10.1016/j.neuroscience.2007.10.033
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Cam C, 2014, ACTA BIOMATER, V10, P205, DOI 10.1016/j.actbio.2013.10.002
   CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0
   Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exner.2002.7981
   Cargill R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.006
   Carletti B, 2011, CURR NEUROPHARMACOL, V9, P313, DOI 10.2174/157015911795596603
   Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822
   Carulli D, 2007, J COMP NEUROL, V501, P83, DOI 10.1002/cne.21231
   Cassiani-Ingoni R, 2007, J NEUROPATH EXP NEUR, V66, P637, DOI 10.1097/nen.0b013e318093f3ef
   Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3
   CELIO MR, 1994, BRAIN RES REV, V19, P128, DOI 10.1016/0165-0173(94)90006-X
   Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Chopra A, 2014, BIOMATERIALS, V35, P71, DOI 10.1016/j.biomaterials.2013.09.066
   Cizkova D, 2009, CELL MOL NEUROBIOL, V29, P999, DOI 10.1007/s10571-009-9387-1
   Colognato H, 2011, DEV NEUROBIOL, V71, P924, DOI 10.1002/dneu.20966
   Csoka T., 1996, INVAS METAST, V17, P297
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200
   DeForest CA, 2012, ANGEW CHEM, V124, P1852, DOI DOI 10.1002/ANGE.201106463
   DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y
   Delpech B, 2002, ANTICANCER RES, V22, P2423
   DELPECH B, 1993, EUR J CANCER, V29A, P1012, DOI 10.1016/S0959-8049(05)80214-X
   Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019
   Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898
   Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036
   Dzwonek J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00175
   Edelman DB, 2005, EXP NEUROL, V192, P1, DOI 10.1016/j.expneurol.2004.10
   Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927
   Eng D, 2010, ACTA BIOMATER, V6, P2407, DOI 10.1016/j.actbio.2009.12.049
   Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Florczyk SJ, 2013, BIOMATERIALS, V34, P10143, DOI 10.1016/j.biomaterials.2013.09.034
   Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Frenkel JS, 2014, INT WOUND J, V11, P159, DOI 10.1111/j.1742-481X.2012.01057.x
   Frischknecht R, 2012, ADV EXP MED BIOL, V970, P153, DOI 10.1007/978-3-7091-0932-8_7
   Fujiwara T, 2008, GENES CELLS, V13, P759, DOI 10.1111/j.1365-2443.2008.01203.x
   FUXE K, 1994, NEUROSCI LETT, V169, P25, DOI 10.1016/0304-3940(94)90348-4
   Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x
   Gao F, 2008, CLIN INVEST MED, V31, pE106, DOI 10.25011/cim.v31i3.3467
   Giamanco KA, 2010, NEUROSCIENCE, V170, P1314, DOI 10.1016/j.neuroscience.2010.08.032
   Gilg AG, 2008, CLIN CANCER RES, V14, P1804, DOI 10.1158/1078-0432.CCR-07-1228
   Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8
   Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263
   Griffin DR, 2015, NAT MATER, V14, P737, DOI [10.1038/nmat4294, 10.1038/NMAT4294]
   Griffin DR, 2013, BIOMACROMOLECULES, V14, P1199, DOI 10.1021/bm400169d
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hachet E, 2012, BIOMACROMOLECULES, V13, P1818, DOI 10.1021/bm300324m
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Han LH, 2013, BIOMATERIALS, V34, P4251, DOI 10.1016/j.biomaterials.2013.02.051
   Happel MFK, 2014, P NATL ACAD SCI USA, V111, P2800, DOI 10.1073/pnas.1310272111
   He H, 2013, J BIOL CHEM, V288, P25792, DOI 10.1074/jbc.M113.479584
   Heris HK, 2012, MACROMOL BIOSCI, V12, P202, DOI 10.1002/mabi.201100335
   Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005
   Hoffmann JC, 2010, SOFT MATTER, V6, P5056, DOI 10.1039/c0sm00140f
   Horn EM, 2007, J NEUROSURG-SPINE, V6, P133, DOI 10.3171/spi.2007.6.2.133
   Horowitz MP, 2011, ANTIOXID REDOX SIGN, V15, P855, DOI 10.1089/ars.2010.3629
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Hugnot JP, 2011, FRONT BIOSCI-LANDMRK, V16, P1044, DOI 10.2741/3734
   Ishii K, 2001, J NEUROSCI RES, V65, P500, DOI 10.1002/jnr.1180
   Jackson J. A., 2004, STEM CELL THERAPY AU, P11
   Jager C, 2013, NEUROSCIENCE, V238, P168, DOI 10.1016/j.neuroscience.2013.02.014
   Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315
   Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337
   Johnson P, 2000, BIOCHEM PHARMACOL, V59, P455, DOI 10.1016/S0006-2952(99)00266-X
   Kasko AM, 2010, FUTURE MED CHEM, V2, P1669, DOI 10.4155/FMC.10.253
   Ke Y, 2006, STEM CELLS, V24, P1011, DOI 10.1634/stemcells.2005-0249
   Keung AJ, 2011, STEM CELLS, V29, P1886, DOI 10.1002/stem.746
   Khaing ZZ, 2014, MATER TODAY, V17, P332, DOI 10.1016/j.mattod.2014.05.011
   Khaing ZZ, 2012, NEUROSCI LETT, V519, P103, DOI 10.1016/j.neulet.2012.02.027
   Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033
   Khetan S, 2011, SOFT MATTER, V7, P830, DOI 10.1039/c0sm00852d
   Kim J, 2008, BIOPOLYMERS, V89, P1144, DOI 10.1002/bip.21066
   KOOCHEKPOUR S, 1995, INT J CANCER, V63, P450, DOI 10.1002/ijc.2910630325
   Koppe G, 1997, HISTOCHEM J, V29, P11, DOI 10.1023/A:1026408716522
   Kouvidi K, 2011, J BIOL CHEM, V286, P38509, DOI 10.1074/jbc.M111.275875
   Kurkowska-Jastrzebska I, 1999, EXP NEUROL, V156, P50, DOI 10.1006/exnr.1998.6993
   Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974
   Kwok JCF, 2010, J NEUROCHEM, V114, P1447, DOI 10.1111/j.1471-4159.2010.06878.x
   Lam J, 2014, ADV FUNCT MATER, V24, P7053, DOI 10.1002/adfm.201401483
   Lavik E, 2011, THERAPEUTIC ANGIOGENESIS FOR VASCULAR DISEASES, P145, DOI 10.1007/978-90-481-9495-7_7
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Lei YG, 2011, J CONTROL RELEASE, V153, P255, DOI 10.1016/j.jconrel.2011.01.028
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Lewis ND, 2014, J NEUROIMMUNOL, V277, P26, DOI 10.1016/j.jneuroim.2014.09.014
   Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048824
   Li XW, 2014, J NEUROTRAUM, V31, P1431, DOI 10.1089/neu.2013.3215
   Li XW, 2013, FASEB J, V27, P1127, DOI 10.1096/fj.12-211151
   Liang JR, 2007, J IMMUNOL, V178, P2469, DOI 10.4049/jimmunol.178.4.2469
   Liang Y, 2013, BIOMATERIALS, V34, P5521, DOI 10.1016/j.biomaterials.2013.03.095
   Lim TC, 2013, FASEB J, V27, P1023, DOI 10.1096/fj.12-221515
   Lin CM, 2009, SURG NEUROL, V72, P50, DOI 10.1016/j.wneu.2009.09.004
   Lindwall C, 2013, BRAIN RES, V1503, P62, DOI 10.1016/j.brainres.2013.01.045
   Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018
   Liu Y, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-135
   Loulier K, 2006, J NEUROCHEM, V98, P530, DOI 10.1111/j.1471-4159.2006.03896.x
   Lowry N, 2012, BIOMATERIALS, V33, P2892, DOI 10.1016/j.biomaterials.2011.12.048
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   Mabry KM, 2015, BIOMATERIALS, V49, P47, DOI 10.1016/j.biomaterials.2015.01.047
   MARGOLIS RU, 1975, BIOCHEMISTRY-US, V14, P85, DOI 10.1021/bi00672a014
   Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389
   Matsumoto T, 2012, NEUROSCI LETT, V520, P115, DOI 10.1016/j.neulet.2012.05.048
   McKinnon DD, 2014, ADV MATER, V26, P865, DOI 10.1002/adma.201303680
   McPherson CA, 2014, NEUROTOX RES, V25, P45, DOI 10.1007/s12640-013-9422-3
   McRae PA, 2012, NEUROCHEM INT, V61, P963, DOI 10.1016/j.neuint.2012.08.007
   Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182
   MERZAK A, 1994, CANCER RES, V54, P3988
   Meszar Z, 2008, BRAIN RES BULL, V75, P414, DOI 10.1016/j.brainresbull.2007.10.052
   Miron VE, 2011, BBA-MOL BASIS DIS, V1812, P184, DOI 10.1016/j.bbadis.2010.09.010
   Moon C, 2004, NEUROSCI LETT, V367, P133, DOI 10.1016/j.neulet.2004.05.101
   Moon C, 2006, J VET MED SCI, V68, P761, DOI 10.1292/jvms.68.761
   Moon LDF, 2003, J NEUROSCI RES, V71, P23, DOI 10.1002/jnr.10449
   Moshayedi Pouria, 2013, Biomatter, V3, DOI 10.4161/biom.23863
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   Naruse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053109
   Nguyen HX, 2014, J COMP NEUROL, V522, P2767, DOI 10.1002/cne.23604
   Nielsen HM, 2012, CURR ALZHEIMER RES, V9, P257
   Nimmo CM, 2011, BIOMACROMOLECULES, V12, P824, DOI 10.1021/bm101446k
   NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469
   Novak T, 2015, ACTA BIOMATER, V11, P274, DOI 10.1016/j.actbio.2014.09.031
   Okun E, 2010, J NEUROCHEM, V114, P462, DOI 10.1111/j.1471-4159.2010.06778.x
   Olofsson B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090921
   Owen SC, 2013, LANGMUIR, V29, P7393, DOI 10.1021/la305000w
   Oz Buge, 2000, Pathology and Oncolgy Research, V6, P118
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   Pan LJ, 2009, J NEUROSCI RES, V87, P3207, DOI 10.1002/jnr.22142
   Park JB, 2008, CELL ADHES MIGR, V2, P202, DOI 10.4161/cam.2.3.6320
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Perosa SR, 2002, BRAIN RES BULL, V58, P509, DOI 10.1016/S0361-9230(02)00822-5
   Piao JH, 2013, GLIA, V61, P361, DOI 10.1002/glia.22438
   Piaton G, 2010, J NEUROCHEM, V114, P1243, DOI 10.1111/j.1471-4159.2010.06831.x
   Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012
   Preston M, 2013, ANN NEUROL, V73, P266, DOI 10.1002/ana.23788
   Preston Marnie, 2011, Front Biosci (Schol Ed), V3, P1165
   Purcell BP, 2012, BIOMATERIALS, V33, P7849, DOI 10.1016/j.biomaterials.2012.07.005
   Radotra B, 1997, ANTICANCER RES, V17, P945
   RADOTRA B, 1994, NEUROPATH APPL NEURO, V20, P399, DOI 10.1111/j.1365-2990.1994.tb00986.x
   Ramanan VV, 2010, J MATER CHEM, V20, P8920, DOI 10.1039/c0jm00734j
   Rampon C, 2008, STEM CELLS, V26, P1673, DOI 10.1634/stemcells.2008-0122
   Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x
   Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016
   Roberts JJ, 2014, BIOMACROMOLECULES, V15, P1132, DOI 10.1021/bm401524h
   Rosines E, 2007, BIOMATERIALS, V28, P4806, DOI 10.1016/j.biomaterials.2007.07.034
   Ruff CA, 2012, EXP NEUROL, V235, P78, DOI 10.1016/j.expneurol.2011.02.010
   Ruffini F, 2004, AM J PATHOL, V164, P1519, DOI 10.1016/S0002-9440(10)63709-1
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Ruppert SM, 2014, IMMUNOL RES, V58, P186, DOI 10.1007/s12026-014-8495-2
   Schizas N, 2014, J BIOMATER APPL, V28, P825, DOI 10.1177/0885328213483636
   Scott JE, 2002, BIOMACROMOLECULES, V3, P547, DOI 10.1021/bm010170j
   Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Seidlits SK, 2013, EXPERT OPIN DRUG DEL, V10, P499, DOI 10.1517/17425247.2013.764864
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   Seidlits SK, 2009, ADV FUNCT MATER, V19, P3543, DOI 10.1002/adfm.200901115
   Senkov O, 2014, PROG BRAIN RES, V214, P53, DOI 10.1016/B978-0-444-63486-3.00003-7
   Setzu A, 2006, GLIA, V54, P297, DOI 10.1002/glia.20371
   Shepard JA, 2012, BIOMATERIALS, V33, P7412, DOI 10.1016/j.biomaterials.2012.06.081
   Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/i.tins.2007.11.001
   Shin T, 2005, BRAIN RES, V1041, P95, DOI 10.1016/j.brainres.2005.02.019
   Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128
   Slevin M, 1998, LAB INVEST, V78, P987
   Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261
   Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107
   Sontag CJ, 2014, STEM CELL REP, V2, P620, DOI 10.1016/j.stemcr.2014.03.005
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Stowers RS, 2015, P NATL ACAD SCI USA, V112, P1953, DOI 10.1073/pnas.1421897112
   Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215
   Suttkus A, 2016, MOL NEUROBIOL, V53, P73, DOI 10.1007/s12035-014-8990-4
   Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200
   Talbott JF, 2005, EXP NEUROL, V192, P11, DOI 10.1016/j.expneurol.2004.05.038
   Tang SQ, 2007, J BIOMED MATER RES A, V82A, P323, DOI 10.1002/jbm.a.30974
   Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310414
   Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013
   Thomas AM, 2013, BIOMATERIALS, V34, P2213, DOI 10.1016/j.biomaterials.2012.12.002
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025
   Tibbitt MW, 2013, MACROMOLECULES, V46, P2785, DOI 10.1021/ma302522x
   Tokatlian T, 2015, ADV HEALTHC MATER, V4, P1084, DOI 10.1002/adhm.201400783
   Tokatlian T, 2014, BIOMATERIALS, V35, P825, DOI 10.1016/j.biomaterials.2013.10.014
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002
   Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   Valenzuela JC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0606
   Vedunova M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00149
   Vulic K, 2012, J AM CHEM SOC, V134, P882, DOI 10.1021/ja210638x
   Wakao N, 2011, NEUROSCI LETT, V488, P299, DOI 10.1016/j.neulet.2010.11.051
   Wallace M, 2014, CHEM-EUR J, V20, P16484, DOI 10.1002/chem.201405500
   Wang AM, 2014, J BIOL CHEM, V289, P9418, DOI 10.1074/jbc.M113.541441
   Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y
   Wang J, 2012, NEUROSCIENCE, V210, P467, DOI 10.1016/j.neuroscience.2012.03.016
   Wang X., 2012, INTERFACE FOCUS
   Wang Y, 2011, PHARM RES-DORDR, V28, P1406, DOI 10.1007/s11095-011-0452-3
   Ward JA, 2003, AM J PATHOL, V162, P1403, DOI 10.1016/S0002-9440(10)64273-3
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]
   Xu KM, 2015, ACTA BIOMATER, V24, P159, DOI 10.1016/j.actbio.2015.06.026
   Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209
   Yang Y, 2011, DEV BIOL, V350, P127, DOI 10.1016/j.ydbio.2010.11.028
   Yao SL, 2013, PROG NAT SCI-MATER, V23, P103, DOI 10.1016/j.pnsc.2013.02.009
   YASUHARA O, 1994, BRAIN RES, V635, P269, DOI 10.1016/0006-8993(94)91448-6
   Zawko SA, 2010, ACTA BIOMATER, V6, P2415, DOI 10.1016/j.actbio.2010.02.021
   Zhang T, 2007, J BIOACT COMPAT POL, V22, P19, DOI 10.1177/0883911506074025
   Zhao C, 2009, J NEUROSCI RES, V87, P3447, DOI 10.1002/jnr.22231
   Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958
   ZHONG SP, 1994, BIOMATERIALS, V15, P359, DOI 10.1016/0142-9612(94)90248-8
   Zhu H, 2006, STEM CELLS, V24, P928, DOI 10.1634/stemcells.2005-0186
   Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9
NR 248
TC 6
Z9 6
U1 3
U2 44
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 40
BP 7850
EP 7866
DI 10.1039/c5tb00974j
PG 17
WC Materials Science, Biomaterials
SC Materials Science
GA CT2VO
UT WOS:000362663000004
DA 2018-10-20
ER

PT J
AU Fan, CJ
   Wang, DA
AF Fan, Changjiang
   Wang, Dong-An
TI Potential use of alginate beads as a chondrocyte delivery vehicle and
   stepwise dissolving porogen in a hydrogel scaffold for cartilage tissue
   engineering
SO RSC ADVANCES
LA English
DT Article
ID DEGRADABLE PEG HYDROGELS; ARTICULAR-CARTILAGE; HYALURONIC-ACID;
   STEM-CELLS; IN-VITRO; SYSTEM; ENCAPSULATION; BIOMATERIAL; CULTURE
AB The submicron- or nano-sized pores and uncontrollable degradation of conventional hydrogels have severely constrained cell growth and neo-tissue formation. In this study, alginate beads are explored as both delivery vehicles of chondrocytes and stimuli-responsive porogens within hydrogel scaffolds for cartilage tissue engineering. A typical chondroitin sulfate (CS)-alginate beads composite gel (CS-ABG) is fabricated by photo-encapsulating alginate beads into the CS gel, and subsequently batch-wise dissolution and leaching out of the alginate beads is achieved by twice exposing CS-ABG to chelating agents. The combining and gradual removal of alginate beads effectively modulate the gel's physical properties (e.g. swelling ratio, crosslink density) as well as create macro-scale cavities within CS-ABG. The efficacy of CS-ABG as a scaffold for cartilage tissue engineering is compared with a conventional photocrosslinked CS gel (CS-G). The CS-ABG constructs are developed by co-encapsulating chondrocytes and cell-laden alginate beads within the CS gel body and undergo EDTA treatment on day 7 and 14 of culture, respectively, for stepwise removal of the alginate beads. The chondrocytes cultured in CS-ABG constructs exhibit higher cell viability and proliferation, enhanced cartilage-specific gene expressions as well as ECM production compared with those in CS-G constructs. This study demonstrates the potential of alginate beads as cell delivery vehicles and gradually dissolving porogens within gel scaffolds for cartilage tissue engineering.
C1 [Fan, Changjiang; Wang, Dong-An] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore 637457, Singapore.
   [Fan, Changjiang] Qingdao Univ, Inst Translat Med, Coll Med, Qingdao 266071, Peoples R China.
RP Wang, DA (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, 70 Nanyang Dr, Singapore 637457, Singapore.
EM DAWang@ntu.edu.sg
RI Wang, Dong-an/G-6195-2010
FU NSFC, China [51328301]; AcRF Tier 2, Ministry of Education, Singapore
   [ARC 1/13]
FX The work is financially supported by AcRF Tier 2 ARC 1/13, Ministry of
   Education, Singapore, and NSFC (51328301), China.
CR Atzet S, 2008, BIOMACROMOLECULES, V9, P3370, DOI 10.1021/bm800686h
   Bryant SJ, 2004, MACROMOLECULES, V37, P6726, DOI 10.1021/ma0499324
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fan CJ, 2015, EUR POLYM J, V72, P651, DOI 10.1016/j.eurpolymj.2015.02.038
   Fan CJ, 2015, MACROMOL BIOSCI, V15, P535, DOI 10.1002/mabi.201400453
   Fan CJ, 2013, J MATER CHEM B, V1, P4251, DOI 10.1039/c3tb20600a
   Gong YH, 2010, TISSUE ENG PT A, V16, P3611, DOI [10.1089/ten.tea.2010.0219, 10.1089/ten.TEA.2010.0219]
   Han LH, 2013, BIOMATERIALS, V34, P4251, DOI 10.1016/j.biomaterials.2013.02.051
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003
   Hwang YS, 2009, BIOMATERIALS, V30, P499, DOI 10.1016/j.biomaterials.2008.07.028
   Jin R, 2010, BIOMATERIALS, V31, P3103, DOI 10.1016/j.biomaterials.2010.01.013
   Khalil M, 2001, J HEPATOL, V34, P68, DOI 10.1016/S0168-8278(00)00080-5
   Kim J, 2014, MACROMOL RAPID COMM, V35, P1578, DOI 10.1002/marc.201400278
   Lau TT, 2013, BIOMATERIALS, V34, P6659, DOI 10.1016/j.biomaterials.2013.05.034
   Lee DA, 2003, ACTA ORTHOP SCAND, V74, P6, DOI 10.1080/00016470310013581
   Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050
   Leong W, 2013, ACTA BIOMATER, V9, P6459, DOI 10.1016/j.actbio.2012.10.047
   Loening AM, 2000, ARCH BIOCHEM BIOPHYS, V381, P205, DOI 10.1006/abbi.2000.1988
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   Metters A, 2005, BIOMACROMOLECULES, V6, P290, DOI 10.1021/bm049607o
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006
   Ochi M, 2004, ARTIF ORGANS, V28, P28, DOI 10.1111/j.1525-1594.2004.07317.x
   Oliveira JT, 2010, J BIOMED MATER RES A, V93A, P852, DOI 10.1002/jbm.a.32574
   Rayment P, 2009, FOOD HYDROCOLLOID, V23, P816, DOI 10.1016/j.foodhyd.2008.04.011
   Rocher V, 2008, WATER RES, V42, P1290, DOI 10.1016/j.watres.2007.09.024
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006
   Skaalure SC, 2014, ACTA BIOMATER, V10, P3409, DOI 10.1016/j.actbio.2014.04.013
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Strehin I, 2010, BIOMATERIALS, V31, P2788, DOI 10.1016/j.biomaterials.2009.12.033
   Su K, 2012, ADV FUNCT MATER, V22, P972, DOI 10.1002/adfm.201102884
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Wang CC, 2011, BIOMATERIALS, V32, P7118, DOI 10.1016/j.biomaterials.2011.06.018
   Wang DA, 2003, BIOMATERIALS, V24, P3969, DOI 10.1016/S0142-9612(03)00280-1
   Zhang C, 2011, ACTA BIOMATER, V7, P3362, DOI 10.1016/j.actbio.2011.05.024
   Zhang C, 2009, SOFT MATTER, V5, P3831, DOI 10.1039/b912102a
   Zhu HG, 2005, BIOMACROMOLECULES, V6, P2221, DOI 10.1021/bm0501656
NR 43
TC 2
Z9 2
U1 7
U2 34
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 98
BP 80688
EP 80697
DI 10.1039/c5ra15376j
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA CS9KK
UT WOS:000362409800078
DA 2018-10-20
ER

PT J
AU Silveira, CP
   Apolinario, LM
   Favaro, WJ
   Paula, AJ
   Duran, N
AF Silveira, C. P.
   Apolinario, L. M.
   Favaro, W. J.
   Paula, A. J.
   Duran, N.
TI Hybrid biomaterial based on porous silica nanoparticles and Pluronic
   F-127 for sustained release of sildenafil: in vivo study on prostate
   cancer
SO RSC ADVANCES
LA English
DT Article
ID DRUG-DELIVERY; PROTEIN CORONA; SIZE; EFFICACY; SYSTEM; BIOCOMPATIBILITY;
   BIODISTRIBUTION; CLASSIFICATION; STABILIZATION; NANOCARRIERS
AB We describe here a drug depot hydrogel system comprising sildenafil (SIL; commercially available as Viagra (R)) incorporated in mesoporous silica nanoparticles (MSNs; around 60 nm of diameter) and conjugated with a thermosensitive poloxamer (Pluronic F-127 or PF127; possessing a liquid-gel transition over a determined temperature). The conjugation of these components results in an anticancer biomaterial with optimized physico-chemical properties: (i) MSNs are colloidally stabilized mainly through repulsive depletion forces manifested in PF127 concentrations above 5 wt%; (ii) the gelation temperature of the systems is set to about 20 degrees C (attained with 18 wt% of PF127) in order to result in prompt gelation when they are intraperitoneally administered (in rats) as liquids; (iii) and the hydrogel is able to induce a prolonged release of MSNs + SIL. After testing these new formulations against chemically induced prostate cancer in rats, the histopathological analyses of the prostate showed that the hybrid systems were able to largely reduce the prostate tumor level, and also highlighted the role of the MSNs in this process, since the improvement of the tumor condition was proportional to the nanoparticles concentration.
C1 [Silveira, C. P.; Duran, N.] Univ Estadual Campinas UNICAMP, Inst Chem, Campinas, SP, Brazil.
   [Apolinario, L. M.; Favaro, W. J.] Univ Estadual Campinas UNICAMP, Dept Struct Funct Biol, Campinas, SP, Brazil.
   [Favaro, W. J.; Duran, N.] Farmabrasilis R&D Div, Campinas, SP, Brazil.
   [Paula, A. J.] Univ Fed Ceara, Dept Fis, Solid Biol Interface Grp SolBIN, Fortaleza, Ceara, Brazil.
   [Favaro, W. J.; Duran, N.] Univ Estadual Campinas UNICAMP, Inst Chem, NanoBioss, Campinas, SP, Brazil.
RP Paula, AJ (reprint author), Univ Fed Ceara, Dept Fis, Solid Biol Interface Grp SolBIN, Fortaleza, Ceara, Brazil.
EM amaurijp@gmail.com; duran@iqm.unicamp.br
RI UFC, DF/E-1564-2017; Paula, Amauri/D-9254-2011; Universidade Federal do
   Ceara, Physics Department/J-4630-2016
OI Paula, Amauri/0000-0002-3113-2597; Universidade Federal do Ceara,
   Physics Department/0000-0002-9247-6780; Apolinario, Leticia
   Montanholi/0000-0003-1627-4973; Duran, Nelson/0000-0001-8372-5143;
   Favaro, Wagner/0000-0001-5830-8938
FU FAPESP; CNPq; INOMAT (MCTI/CNPq); FUNCAP; NanoBioss (MCTI); Brazilian
   Network of Nanotoxicology (MCTI/CNPq)
FX Support from FAPESP, CNPq, INOMAT (MCTI/CNPq), FUNCAP, NanoBioss (MCTI)
   and the Brazilian Network of Nanotoxicology (MCTI/CNPq) are
   acknowledged.
CR ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Boorjian SA, 2008, J UROLOGY, V179, P1354, DOI 10.1016/j.juro.2007.11.061
   Cauda V, 2009, J AM CHEM SOC, V131, P11361, DOI 10.1021/ja809346n
   Chen F, 2014, MOL PHARMACEUT, V11, P4007, DOI 10.1021/mp500306k
   Chen F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05080
   Crocker JC, 1999, PHYS REV LETT, V82, P4352, DOI 10.1103/PhysRevLett.82.4352
   Das A, 2010, P NATL ACAD SCI USA, V107, P18202, DOI 10.1073/pnas.1006965107
   Djavan B, 2001, J UROLOGY, V166, P1679, DOI 10.1016/S0022-5347(05)65652-2
   Dumortier G, 2006, PHARM RES, V23, P2709, DOI 10.1007/s11095-006-9104-4
   Favaro W. J., 2014, Br. Pat., Patent No. [10 2014 023118 8, 1020140231188]
   Fu CH, 2013, BIOMATERIALS, V34, P2565, DOI 10.1016/j.biomaterials.2012.12.043
   Heilmann S, 2013, INT J PHARMACEUT, V444, P96, DOI 10.1016/j.ijpharm.2013.01.027
   Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007
   Ibrahim EA, 2012, ACTA PHARMACEUT, V62, P59, DOI 10.2478/v10007-012-0009-y
   Kecht J, 2008, CHEM MATER, V20, P7207, DOI 10.1021/cm801484r
   Li SH, 2013, LANGMUIR, V29, P5742, DOI 10.1021/la401056t
   Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t
   Lu J., 2010, NANOMEDICINE, V8, P212
   Lu J, 2007, SMALL, V3, P1341, DOI 10.1002/smll.200700005
   Lu J, 2010, SMALL, V6, P1794, DOI 10.1002/smll.201000538
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   Maeda H, 2002, BIOMEDICAL ASPECTS OF DRUG TARGETING, P211
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   Mai WX, 2013, INTEGR BIOL-UK, V5, P19, DOI 10.1039/c2ib20137b
   Meng H, 2011, ACS NANO, V5, P4131, DOI 10.1021/nn200809t
   Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6
   MIYAZAKI S, 1986, CHEM PHARM BULL, V34, P1801
   Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]
   Monopoli MP, 2011, NAT NANOTECHNOL, V6, P11, DOI 10.1038/nnano.2011.267
   MORIKAWA K, 1987, CANCER RES, V47, P37
   Nakanishi K, 2005, HANDBOOK OF SOL-GEL SCIENCE AND TECHNOLOGY: PROCESSING CHARACTERIZATION AND APPLICATIONS, VOL. II: CHARACTERIZATION AND PROPERTIES OF SOL-GEL MATERIALS AND PRODUCTS, P191
   Padilla M, 2000, J AM DENT ASSOC, V131, P184, DOI 10.14219/jada.archive.2000.0146
   Padovani GC, 2015, J PHYS CHEM C, V119, P18741, DOI 10.1021/acs.occ.5b04274
   Paula AJ, 2014, ACS APPL MATER INTER, V6, P3437, DOI 10.1021/am405594q
   Paula AJ, 2013, ACS APPL MATER INTER, V5, P8387, DOI 10.1021/am4014693
   Paula AJ, 2012, J BRAZIL CHEM SOC, V23, P1807, DOI 10.1590/S0103-50532012005000048
   Paula AJ, 2012, CHEM COMMUN, V48, P591, DOI 10.1039/c1cc16535f
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Pragatheeswaran AM, 2013, LANGMUIR, V29, P9694, DOI 10.1021/la401639g
   Sarfati M, 2003, BLOOD, V101, P265, DOI 10.1182/blood-2002-01-0075
   Serafini P, 2006, J EXP MED, V203, P2691, DOI 10.1084/jem.20061104
   Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946
   Shi Z, 2011, CANCER RES, V71, P3735, DOI 10.1158/0008-5472.CAN-11-0375
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   Tang L, 2013, MOL PHARMACEUT, V10, P883, DOI 10.1021/mp300684a
   Tao ZM, 2010, ACS NANO, V4, P789, DOI 10.1021/nn9015345
   Xie M, 2014, INT J PHARMACEUT, V474, P223, DOI 10.1016/j.ijpharm.2014.08.027
   Yuan L, 2011, J PHYS CHEM C, V115, P9926, DOI 10.1021/jp201053d
   Zhang Q, 2014, ADV FUNCT MATER, V24, P2450, DOI 10.1002/adfm.201302988
   Zhang X, 2012, J AM CHEM SOC, V134, P9910, DOI 10.1021/ja303787e
NR 51
TC 3
Z9 3
U1 3
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 99
BP 81348
EP 81355
DI 10.1039/c5ra15006j
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CS9UB
UT WOS:000362436800055
DA 2018-10-20
ER

PT J
AU Ma, T
   Ge, XY
   Jia, SN
   Jiang, X
   Zhang, Y
   Lin, Y
AF Ma, Ting
   Ge, Xi-Yuan
   Jia, Sheng-Nan
   Jiang, Xi
   Zhang, Yu
   Lin, Ye
TI The influence of titanium surfaces treated by alkalis on macrophage and
   osteoblast-like cell adhesion and gene expression in vitro
SO RSC ADVANCES
LA English
DT Article
ID BONE-FORMATION; BIOMATERIAL SURFACES; IMPLANT SURFACES; DENTAL IMPLANTS;
   WEAR PARTICLES; TNF-ALPHA; DIFFERENTIATION; OSSEOINTEGRATION;
   HYDROPHILICITY; MICROROUGHNESS
AB Achieving fast and long-term osseointegration is one of the major goals in dental implant design. Physic-chemical surface modification is a key to osseointegration improvement. Two types of alkaline modifications, 1 M sodium bicarbonate and 0.05 M sodium hydroxide, were applied on the sand-blasting and acid etching (SLA) titanium surface. After the alkaline treatments, superhydrophilic SLA surfaces were produced. The mRNA expression level of IL-1 beta of Raw264.7 cells cultured on the sodium bicarbonate treated SLA surface was inhibited compared with SLA and sodium hydroxide treated surfaces, while MMP-9 expression on the sodium hydroxide treated SLA surface was increased with comparison to SLA and sodium bicarbonate treated surfaces. Cell adhesion of osteoblast-like MG63 cells on surfaces with alkaline treatments were moderately more pronounced than that on the SLA surface. With comparison to SLA surface, the proliferation of MG63 cells was decreased, while the alkaline phosphatase (ALP) activity was enhanced on the sodium bicarbonate treated SLA surface after 3 days. An increased mRNA expression level of integrin alpha(v) of MG63 cells were observed on the alkali treated surfaces compared with the SLA surface. Integrin beta 1, osteocalcin (OCN) and bone morphogenetic protein-2 (BMP-2) were enhanced on the sodium bicarbonate treated SLA surface when compared to the SLA surface. The results imply that the inflammation-related gene expression of macrophage cells is changed on sodium hydroxide and sodium bicarbonate treated SLA surfaces; the early adhesion of osteoblast-like cells is enhanced by both alkaline treatments, while the osteogenic differentiation is improved on sodium bicarbonate treated surface.
C1 [Ma, Ting; Jia, Sheng-Nan; Jiang, Xi; Zhang, Yu; Lin, Ye] Peking Univ, Sch Stomatol, Dept Oral Implantol, Beijing 100081, Peoples R China.
   [Ge, Xi-Yuan] Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing 100081, Peoples R China.
RP Zhang, Y (reprint author), Peking Univ, Sch Stomatol, Dept Oral Implantol, Beijing 100081, Peoples R China.
EM zhang76yu@163.com; yorcklin@263.net
OI Jia, Shengnan/0000-0002-5673-7744
FU National Basic Research Program of China (973 Program) [2012CB933900]
FX This study was supported by a Grant from the National Basic Research
   Program of China (973 Program-2012CB933900) and the authors gratefully
   thank for the Central Laboratory of Peking University School of
   Stomatology. Titanium substrates were generously provided by Wego (Wego
   Jericom Biomaterials Co., Weihai, China). Technical assistance of
   engineer Jishu Yin (Wego Jericom Biomaterials Co., Weihai, China) is
   gratefully acknowledged.
CR Al Mustafa M, 2015, CLIN ORAL IMPLAN RES, V26, P15, DOI 10.1111/clr.12294
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Borras T, 2009, EXP EYE RES, V88, P738, DOI 10.1016/j.exer.2008.11.027
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Calvo-Guirado JL, 2010, CLIN ORAL IMPLAN RES, V21, P308, DOI 10.1111/j.1600-0501.2009.01841.x
   Chiapasco M, 2004, INT J ORAL MAX IMPL, V19, P76
   Chug A, 2013, J ORAL MAX SURG MED, V25, P1, DOI 10.1016/j.ajoms.2012.01.008
   Cochran DL, 1999, J PERIODONTOL, V70, P139, DOI 10.1902/jop.1999.70.2.139
   Colnot C, 2007, J DENT RES, V86, P862, DOI 10.1177/154405910708600911
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   De Jong PT, 2011, ACTA HISTOCHEM, V113, P556, DOI 10.1016/j.acthis.2010.06.001
   Feller L., 2015, BIOMED RES INT, V2015, P1
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Gardner AB, 2013, BIOMED RES INT, DOI 10.1155/2013/732182
   Gittens RA, 2014, ACTA BIOMATER, V10, P3363, DOI 10.1016/j.actbio.2014.03.037
   Gittens RA, 2014, ACTA BIOMATER, V10, P2907, DOI 10.1016/j.actbio.2014.03.032
   Goodman SB, 2007, BIOMATERIALS, V28, P5044, DOI 10.1016/j.biomaterials.2007.06.035
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   Gu Y, 2010, FEMS IMMUNOL MED MIC, V58, P218, DOI 10.1111/j.1574-695X.2009.00625.x
   Hamlet S., COMMUNICATION
   Hamlet S, 2011, ACTA BIOMATER, V7, P2345, DOI 10.1016/j.actbio.2011.01.032
   Huynh-Ba G, 2008, CLIN ORAL IMPLAN RES, V19, P1154, DOI 10.1111/j.1600-0501.2008.01596.x
   Jiang ZL, 2013, DIS MARKERS, V34, P295, DOI 10.3233/DMA-130974
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Klein MO, 2013, CLIN IMPLANT DENT R, V15, P166, DOI 10.1111/j.1708-8208.2011.00339.x
   Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI [10.1089/ten.teb.2009.0687, 10.1089/ten.TEB.2009.0687]
   Lee JS, 2014, J PERIODONTAL IMPLAN, V44, P242, DOI 10.5051/jpis.2014.44.5.242
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004
   Milleret V, 2011, EUR CELLS MATER, V21, P430, DOI 10.22203/eCM.v021a32
   Moussa FM, 2014, J CELL BIOCHEM, V115, P1243, DOI 10.1002/jcb.24760
   Omar O, 2010, J MATER SCI-MATER M, V21, P969, DOI 10.1007/s10856-009-3915-x
   Osta B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00048
   Ram V. S., 2015, J CLIN DIAGN RES, V9
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   SMITH DE, 1989, J PROSTHET DENT, V62, P567, DOI 10.1016/0022-3913(89)90081-4
   Song WL, 2013, SOFT MATTER, V9, P2985, DOI 10.1039/c3sm27739a
   Song WL, 2009, ADV MATER, V21, P1830, DOI 10.1002/adma.200803680
   Stadlinger B, 2012, BRIT J ORAL MAX SURG, V50, P74, DOI 10.1016/j.bjoms.2010.11.013
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Tugulu S, 2010, J MATER SCI-MATER M, V21, P2751, DOI 10.1007/s10856-010-4138-x
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wall I, 2009, BONE, V45, P17, DOI 10.1016/j.bone.2009.03.662
   Wang XK, 2015, J BIOMED MATER RES A, V103, P1907, DOI 10.1002/jbm.a.35323
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 49
TC 2
Z9 2
U1 2
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 99
BP 81378
EP 81387
DI 10.1039/c5ra10701f
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA CS9UB
UT WOS:000362436800059
DA 2018-10-20
ER

PT J
AU Duan, HB
   Ma, YJ
   Liu, X
   Hao, LJ
   Zhao, NR
AF Duan, Haibo
   Ma, Yijuan
   Liu, Xiao
   Hao, Lijing
   Zhao, Naru
TI Hierarchically nanostructured hydroxyapatite microspheres as drug
   delivery carriers and their effects on cell viability
SO RSC ADVANCES
LA English
DT Article
ID MESOPOROUS BIOACTIVE GLASSES; IN-VITRO RELEASE; HYDROTHERMAL SYNTHESIS;
   GROWTH-PROCESS; GENTAMICIN; CARBONATE; BONE; FABRICATION; PHOSPHATE;
   PROPERTY
AB Hydroxyapatite microspheres (HAMSs) were fabricated via hydrothermal synthesis using propionamide (PA) as a pH-adjusting agent and trisodium citrate (TSC) as a regulating agent. Scanning electron microscopy (SEM) images indicated that the microspheres possessed well-defined 3D nanostructures constructed by nanoplates as building blocks. In vitro cell tests demonstrated that the HAMSs with or without heat treatment were able to promote the proliferation of mouse bone mesenchymal stem cells (mBMSCs). Gentamicin sulphate (GS), an anti-inflammatory, was successfully loaded in the HAMS particles at a distinctively high loading efficiency of approximately 87%. The resultant HAMS-GS delivery systems displayed a sustained release property, and the release of GS from the HAMS-B-GS500 system could significantly inhibit S. epidermidis growth. Moreover, the biocompatibility tests indicated that the HAMS-B-GS500 system exhibited excellent biocompatibility and had no toxic effects on the mBMSCs. These outstanding characteristics may make HAMSs a good candidate as an injectable and drug-loading biomaterial for in vivo tissue regeneration and drug control release.
C1 [Duan, Haibo; Ma, Yijuan; Liu, Xiao; Hao, Lijing; Zhao, Naru] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
   [Duan, Haibo; Ma, Yijuan; Liu, Xiao; Hao, Lijing; Zhao, Naru] Nation Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China.
RP Zhao, NR (reprint author), S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
EM nrzhao@scut.edu.cn
FU National Basic Research Programme of China [2012CB619100]; National
   Natural Science Foundation of China [51232002]; Science and Technology
   Programme of Guangdong Province [2012A061100002]; Fundamental Research
   Funds for the Central Universities [2015ZZ009]
FX The authors sincerely thank Professor Xuetao Shi, South China University
   of Technology, Guangzhou, China, for his kind help on the preparation of
   this manuscript. This work was financially supported by the National
   Basic Research Programme of China (Grant No. 2012CB619100), the National
   Natural Science Foundation of China (Grant No. 51232002), the Science
   and Technology Programme of Guangdong Province (Grant No.
   2012A061100002) and the Fundamental Research Funds for the Central
   Universities (Grant No. 2015ZZ009).
CR ANABEL LM, 1998, ADV MATER, V10, P49
   Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5
   Aviv M, 2007, J BIOMED MATER RES A, V83A, P10, DOI 10.1002/jbm.a.31184
   Cai YR, 2008, J MATER CHEM, V18, P3775, DOI 10.1039/b805407j
   Chen JD, 2015, COLLOID SURFACE B, V127, P47, DOI 10.1016/j.colsurfb.2014.12.055
   Cho JS, 2008, J ALLOY COMPD, V464, P282, DOI 10.1016/j.jallcom.2007.09.092
   Culpepper BK, 2013, BIOMATERIALS, V34, P2455, DOI 10.1016/j.biomaterials.2012.12.026
   Dallari D, 2012, BIOMATERIALS, V33, P72, DOI 10.1016/j.biomaterials.2011.09.029
   Eimar H, 2012, ACTA BIOMATER, V8, P3400, DOI 10.1016/j.actbio.2012.06.002
   Fleet ME, 2003, J SOLID STATE CHEM, V174, P412, DOI 10.1016/S0022-4596(03)00281-0
   Govindan R, 2014, J MATER CHEM B, V2, P5468, DOI 10.1039/c4tb00549j
   GRANT RL, 1992, TOXICOLOGY, V76, P153, DOI 10.1016/0300-483X(92)90162-8
   Guo YJ, 2013, MAT SCI ENG C-MATER, V33, P3166, DOI 10.1016/j.msec.2013.03.040
   Guo YP, 2014, J MATER CHEM B, V2, P2899, DOI 10.1039/c3tb21829e
   Guo YP, 2012, MICROPOR MESOPOR MAT, V155, P245, DOI 10.1016/j.micromeso.2012.01.037
   Guo YP, 2011, CHEM COMMUN, V47, P12215, DOI [10.1039/c1c15190h, 10.1039/c1cc15190h]
   Hao LJ, 2014, MATER LETT, V131, P252, DOI 10.1016/j.matlet.2014.05.193
   Hao LJ, 2014, POWDER TECHNOL, V253, P172, DOI 10.1016/j.powtec.2013.11.020
   Hong MH, 2011, J MATER SCI-MATER M, V22, P349, DOI 10.1007/s10856-010-4197-z
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Iafisco M, 2014, MAT SCI ENG C-MATER, V35, P212, DOI 10.1016/j.msec.2013.11.009
   Kniep R, 1996, ANGEW CHEM INT EDIT, V35, P2624, DOI 10.1002/anie.199626241
   Lacy MK, 1998, CLIN INFECT DIS, V27, P23, DOI 10.1086/514620
   Liu Y, 2012, BIOMATERIALS, V33, P8745, DOI 10.1016/j.biomaterials.2012.08.010
   Long T, 2013, RSC ADV, V3, P24169, DOI 10.1039/c3ra44497j
   Ma YJ, 2014, J INORG MATER, V29, P284, DOI 10.3724/SP.J.1077.2014.13271
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Mizushima Y, 2006, J CONTROL RELEASE, V110, P260, DOI 10.1016/j.jconrel.2005.09.051
   OGINO T, 1987, GEOCHIM COSMOCHIM AC, V51, P2757, DOI 10.1016/0016-7037(87)90155-4
   Oyane A, 2012, ACTA BIOMATER, V8, P2034, DOI 10.1016/j.actbio.2012.02.003
   Qi C, 2013, CHEM-EUR J, V19, P5332, DOI 10.1002/chem.201203886
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   Ristic BZ, 2014, BIOMATERIALS, V35, P4428, DOI 10.1016/j.biomaterials.2014.02.014
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Sivakumar M, 2002, CARBOHYD POLYM, V49, P281, DOI 10.1016/S0144-8617(01)00331-9
   Sousa A, 2008, ACTA BIOMATER, V4, P671, DOI 10.1016/j.actbio.2007.11.003
   Sun RX, 2009, MAT SCI ENG C-BIO S, V29, P1088, DOI 10.1016/j.msec.2008.08.010
   Takai C, 2009, CHEM COMMUN, V37, P5533
   Virto MR, 2007, BIOMATERIALS, V28, P877, DOI 10.1016/j.biomaterials.2006.09.045
   Virto MR, 2003, BIOMATERIALS, V24, P79, DOI 10.1016/S0142-9612(02)00254-5
   Wu J, 2010, ADV MATER, V22, P749, DOI 10.1002/adma.200903020
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
   Wu YJ, 2010, CRYST GROWTH DES, V10, P4240, DOI 10.1021/cg100859m
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Xia W, 2008, EUR J PHARM BIOPHARM, V69, P546, DOI 10.1016/j.ejpb.2007.11.018
   Yang H, 2013, RSC ADV, V3, P23184, DOI 10.1039/c3ra44839h
   Yang H, 2013, MATER CHEM PHYS, V141, P488, DOI 10.1016/j.matchemphys.2013.05.048
   Yang H, 2013, CRYSTENGCOMM, V15, P5760, DOI 10.1039/c3ce40710a
   Yang LX, 2012, CERAM INT, V38, P495, DOI 10.1016/j.ceramint.2011.07.033
   Yang PP, 2009, BIOMATERIALS, V30, P4786, DOI [10.1016/j.biomaterials.2009.05.038, 10.1016/j.biomatetials.2009.05.038]
   Yu M, 2014, CERAM INT, V40, P12617, DOI 10.1016/j.ceramint.2014.04.100
   Zhang HB, 2009, J PHYS CHEM SOLIDS, V70, P243, DOI 10.1016/j.jpcs.2008.10.011
   Zhang WD, 2014, APPL SURF SCI, V322, P71, DOI 10.1016/j.apsusc.2014.10.064
   Zhao LZ, 2008, MICROPOR MESOPOR MAT, V109, P210, DOI 10.1016/j.micromeso.2007.04.041
NR 54
TC 11
Z9 11
U1 4
U2 36
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 101
BP 83522
EP 83529
DI 10.1039/c5ra11956a
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CS9UQ
UT WOS:000362438300099
DA 2018-10-20
ER

PT J
AU Gentile, P
   Ghione, C
   Tonda-Turo, C
   Kalaskar, DM
AF Gentile, P.
   Ghione, C.
   Tonda-Turo, C.
   Kalaskar, D. M.
TI Peptide functionalisation of nanocomposite polymer for bone tissue
   engineering using plasma surface polymerisation
SO RSC ADVANCES
LA English
DT Article
ID ACRYLIC-ACID; ORTHOPEDIC IMPLANTS; FIBROBLAST-GROWTH; ADHESION; CELLS;
   BIOMATERIALS; COATINGS; COLLAGEN; IMMOBILIZATION; MINERALIZATION
AB In this work, we explored the modification of a new nanocomposite polymer called POSS-PCU for its functionalisation with bone inducing peptides using a plasma surface polymerisation method for bone tissue engineering applications. KRSR and FHRRIKA peptides, which are heparin binding domains, have been shown before to induce cell adhesion and bone mineralisation. In this work a plasma surface polymerisation process was developed to graft biomimetic peptides on polymeric biomaterial. Plasma polymerisation and peptide coupling was confirmed using various techniques such as toluidine blue O assay, IR-spectroscopy and X-ray photon spectroscopy (XPS). Surface chemical analysis confirmed that 10 W power and 20 min of plasma treatment was optimum in order to obtain the highest grafting density of carboxyl groups, which were later used to attach bone biomimetic peptides via carbodiimide chemistry. IR-spectroscopy and XPS confirmed functionalisation with carboxyl and peptide grafting. Finally, preliminarily in vitro study with bone marrow mesenchymal stem cells was performed in order to assess the efficacy of peptide functionalised surfaces to promote differentiation into osteogenic lineage. Cell tests showed increased cell adhesion and osteoblastic differentiation on KRSR and FHRRIKA peptide modified samples. This study has implications for the design and development of a new generation of orthopedic implants using the plasma modification technique.
C1 [Gentile, P.] Newcastle Univ, Sch Mech & Syst Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Ghione, C.; Tonda-Turo, C.] Politecn Torino, Dept Mech & Aerosp Engn, I-10129 Turin, Italy.
   [Kalaskar, D. M.] UCL, Ctr Nanotechnol & Tissue Engn, UCL Div Surg & Intervent Sci, London NW3 2PF, England.
RP Gentile, P (reprint author), Newcastle Univ, Sch Mech & Syst Engn, Stephenson Bldg,Claremont Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM piergiorgio.gentile@ncl.ac.uk; d.kalaskar@ucl.ac.uk
OI Gentile, Piergiorgio/0000-0002-3036-6594
FU Marie Curie programme [FP7-PEOPLE-2011-IEF-302315-NBC-ReGen4]; UK EPSRC
   Centre for Innovative Manufacturing of Medical Devices (MeDe Innovation,
   EPSRC) [EP/K029592/1]; Engineering and Physical Sciences Research
   Council [EP/K029592/1]
FX The authors acknowledge the Marie Curie programme
   (FP7-PEOPLE-2011-IEF-302315-NBC-ReGen4 Grant) and the UK EPSRC Centre
   for Innovative Manufacturing of Medical Devices (MeDe Innovation, EPSRC
   grant EP/K029592/1) for financial support. Finally, thanks are also due
   to Prof Steven Armes and Dr Lee Fielding for access to ATR-FTIR. X-ray
   photoelectron spectra were obtained at the National EPSRC XPS User's
   Service (NEXUS) at Newcastle University, a UK EPSRC Mid-Range Facility.
CR Choi HS, 2004, SURF COAT TECH, V182, P55, DOI 10.1016/S0257-8972(02)00880-6
   Ciardelli G, 2010, J BIOMED MATER RES A, V92A, P137, DOI 10.1002/jbm.a.32344
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   Dupont KM, 2012, CELL TISSUE RES, V347, P575, DOI 10.1007/s00441-011-1197-3
   Elahi MF, 2014, MATERIALS, V7, P2956, DOI 10.3390/ma7042956
   Fortunati E, 2013, BIOMACROMOLECULES, V14, P626, DOI 10.1021/bm301524e
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Hancock S., 2005, JOURNAL
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   Hasenbein ME, 2002, BIOMATERIALS, V23, P3937, DOI 10.1016/S0142-9612(02)00129-1
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   LIEBERMAN MA, 2005, PRINC PLASM DISCH, P1
   Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005
   Mathews S, 2011, BIOCHEM BIOPH RES CO, V414, P270, DOI 10.1016/j.bbrc.2011.09.071
   Olbrich M, 2007, J BIOMAT SCI-POLYM E, V18, P453, DOI 10.1163/156856207780425059
   Punshon G, 2005, BIOMATERIALS, V26, P6271, DOI 10.1016/j.biomaterials.2005.03.034
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Santocildes-Romero ME, 2015, J TISSUE ENG REGEN M, V9, P619, DOI 10.1002/term.2003
   Schuler M, 2009, J BIOMED MATER RES B, V91B, P517, DOI 10.1002/jbm.b.31425
   Shen H, 2008, BIOMATERIALS, V29, P2388, DOI 10.1016/j.biomaterials.2008.02.008
   Solouk A, 2011, IRAN POLYM J, V20, P91
   Talreja Prakash S, 2013, J Indian Soc Periodontol, V17, P131, DOI 10.4103/0972-124X.107490
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tan Aaron, 2013, Critical Reviews in Biomedical Engineering, V41, P495
   Tan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077112
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Wu J, 2009, POLYM REV, V49, P25, DOI 10.1080/15583720802656237
   Zaldivar RJ, 2010, J COMPOS MATER, V44, P1435, DOI 10.1177/0021998309355846
   Zhang BGX, 2014, INT J MOL SCI, V15, P11878, DOI 10.3390/ijms150711878
   Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x
NR 33
TC 13
Z9 13
U1 2
U2 39
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 97
BP 80039
EP 80047
DI 10.1039/c5ra15579g
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CS1OC
UT WOS:000361834900093
DA 2018-10-20
ER

PT S
AU Ekdahl, KN
   Teramura, Y
   Asif, S
   Jonsson, N
   Magnusson, PU
   Nilsson, B
AF Ekdahl, Kristina N.
   Teramura, Yuji
   Asif, Sana
   Jonsson, Nina
   Magnusson, Peetra U.
   Nilsson, Bo
BE Lambris, JD
   Ekdahl, KN
   Ricklin, D
   Nilsson, B
TI Thromboinflammation in Therapeutic Medicine
SO IMMUNE RESPONSES TO BIOSURFACES: MECHANISMS AND THERAPEUTIC
   INTERVENTIONS
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 1st International Conference on Immune Response to Biosurfaces
CY SEP 27-OCT 02, 2014
CL Chania, GREECE
DE Coagulation; Complement; Extracorporeal treatment; Platelets;
   Therapeutic medicine; Thromboinflammation
ID CLINICAL ISLET TRANSPLANTATION; MEDIATED INFLAMMATORY REACTION;
   LEUKOCYTE INTEGRIN MAC-1; GLYCOPROTEIN IB-ALPHA; COMPLEMENT ACTIVATION;
   CONTACT ACTIVATION; WHOLE-BLOOD; VASCULAR INJURY; INHIBITS COMPLEMENT;
   BIOMATERIAL SURFACE
AB Thromboinflammation is primarily triggered by the humoral innate immune system, which mainly consists of the cascade systems of the blood, i.e., the complement, contact/coagulation and fibrinolytic systems. Activation of these systems subsequently induces activation of endothelial cells, leukocytes and platelets, finally resulting in thrombotic and inflammatory reactions. Such reactions are triggered by a number of medical procedures, e.g., treatment with biomaterials or drug delivery devices as well as in transplantation with cells, cell clusters or whole vascularized organs. Here, we (1) describe basic mechanisms for thromboinflammation; (2) review thromboinflammatory reactions in therapeutic medicine; and (3) discuss emerging strategies to dampen thromboinflammation.
C1 [Ekdahl, Kristina N.; Nilsson, Bo] Uppsala Univ, Immunol Genet & Pathol, Uppsala, Sweden.
   [Teramura, Yuji] Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Asif, Sana; Jonsson, Nina; Magnusson, Peetra U.] Uppsala Univ, Dept Immunol Genet & Pathol IGP, Rudbeck Lab C5 3, S-75185 Uppsala, Sweden.
   [Jonsson, Nina] Linnaeus Univ, Linnaeus Ctr Biomat Chem, S-39182 Kalmar, Sweden.
RP Ekdahl, KN (reprint author), Uppsala Univ, Immunol Genet & Pathol, Uppsala, Sweden.
EM Kristina.Nilsson_Ekdahl@igp.uu.se
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
FU Swedish Research Council (VR) [2013-65X-05647-34-4]; European Community
   [602699]; Carl Tryggers Foundation; Swedish Foundation for International
   Cooperation in Research and Higher Education (STINT); Bilateral Joint
   Research Projects (Japan-Sweden) of the Japan Society for the Promotion
   of Science (JSPS); AFA Insurance; Linnaeus University
FX We thank Dr. Deborah McClellan for excellent editorial assistance. This
   work was supported by grant 2013-65X-05647-34-4 from the Swedish
   Research Council (VR), the European Community's Seventh Framework
   Programme under the grant agreement no. 602699 (DIREKT), the Carl
   Tryggers Foundation, the Swedish Foundation for International
   Cooperation in Research and Higher Education (STINT), the Bilateral
   Joint Research Projects (Japan-Sweden) of the Japan Society for the
   Promotion of Science (JSPS), and from the AFA Insurance. AFA is a
   nonprofit insurance company that is jointly owned by the Swedish Labor
   Organization and the Swedish Employers Organization, and faculty grants
   from the Linnaeus University.
CR Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Back J, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4399
   Back J, 2010, BIOCHEM BIOPH RES CO, V391, P11, DOI 10.1016/j.bbrc.2009.10.123
   Back J, 2009, BIOMATERIALS, V30, P6573, DOI 10.1016/j.biomaterials.2009.07.052
   Buergler JM, 2005, J THROMB THROMBOLYS, V19, P115, DOI 10.1007/s11239-005-1381-y
   Cai M, 2011, J MOL CELL CARDIOL, V51, P927, DOI 10.1016/j.yjmcc.2011.09.003
   Cavalli A, 2010, MINERVA UROL NEFROL, V62, P1
   Chavakis T, 2003, J BIOL CHEM, V278, P45375, DOI 10.1074/jbc.M304344200
   Chien HW, 2012, BIOMATERIALS, V33, P5706, DOI 10.1016/j.biomaterials.2012.04.031
   Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218
   Crikis S, 2010, AM J TRANSPLANT, V10, P2586, DOI 10.1111/j.1600-6143.2010.03257.x
   Croix DA, 1996, J EXP MED, V183, P1857, DOI 10.1084/jem.183.4.1857
   Dwyer KM, 2004, J CLIN INVEST, V113, P1440, DOI 10.1172/JCI200419560
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066
   Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891
   Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507
   Engberg AE, 2015, BIOMATERIALS, V36, P55, DOI 10.1016/j.biomaterials.2014.09.011
   Engberg AE, 2011, J BIOMED MATER RES A, V97A, P74, DOI 10.1002/jbm.a.33030
   Engberg AE, 2009, BIOMATERIALS, V30, P2653, DOI 10.1016/j.biomaterials.2009.01.001
   Goto M, 2008, XENOTRANSPLANTATION, V15, P225, DOI 10.1111/j.1399-3089.2008.00482.x
   Gustafson EK, 2011, TRANSPLANTATION, V91, P632, DOI 10.1097/TP.0b013e31820ae459
   Hajishengallis G, 2013, TRENDS IMMUNOL, V34, P1, DOI 10.1016/j.it.2012.08.003
   Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x
   Hamad OA, 2010, PLOS ONE, V5, P12889
   Hamad OA, 2012, ADV EXP MED BIOL, V946, P185, DOI 10.1007/978-1-4614-0106-3_11
   Hamad OA, 2010, J IMMUNOL, V184, P2686, DOI 10.4049/jimmunol.0902810
   Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810
   Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667
   Jin RC, 2005, MICROCIRCULATION, V12, P247, DOI 10.1080/10739680590925493
   Johansson H, 2005, DIABETES, V54, P1755, DOI 10.2337/diabetes.54.6.1755
   Kolafova H., 2014, MEDIAT INFLAMM, V2014, DOI DOI 10.1155/2014/694312
   Kourtzelis I, 2010, BLOOD, V116, P631, DOI 10.1182/blood-2010-01-264051
   Langer HF, 2012, CIRC RES, V110, P1202, DOI 10.1161/CIRCRESAHA.111.256370
   Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x
   Lappegard KT, 2008, J BIOMED MATER RES A, V87A, P129, DOI 10.1002/jbm.a.31750
   Leijon J, 2013, TISSUE ENG PT A, V19, P1336, DOI [10.1089/ten.tea.2011.0712, 10.1089/ten.TEA.2011.0712]
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4
   Moll G, 2012, STEM CELLS, V30, P1565, DOI 10.1002/stem.1111
   Moll G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021703
   Nilsson B, 1998, BLOOD, V92, P1661
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson B, 2014, MOL IMMUNOL, V61, P185, DOI 10.1016/j.molimm.2014.06.009
   Nilsson B, 2011, CURR OPIN ORGAN TRAN, V16, P620, DOI 10.1097/MOT.0b013e32834c2393
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Nilsson PH, 2010, BIOMATERIALS, V31, P4484, DOI 10.1016/j.biomaterials.2010.02.036
   Nilsson PH, 2012, BIOMATERIALS, V34, P985
   Qu HC, 2011, MOL IMMUNOL, V48, P481, DOI 10.1016/j.molimm.2010.10.004
   Reutershan J, 2007, J IMMUNOL, V179, P1254, DOI 10.4049/jimmunol.179.2.1254
   RICHTER AW, 1984, INT ARCH ALLER A IMM, V74, P36, DOI 10.1159/000233512
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Roberts V, 2013, PURINERG SIGNAL, V9, P135, DOI 10.1007/s11302-012-9342-3
   Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267
   Simon DI, 2012, CIRC J, V76, P1811, DOI 10.1253/circj.CJ-12-0801
   Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193
   Singh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055852
   Teramura Y, 2013, BIOMATERIALS, V34, P2683, DOI 10.1016/j.biomaterials.2013.01.015
   Teramura Y, 2011, TRANSPLANTATION, V91, P271, DOI 10.1097/TP.0b013e3182034fa4
   Teramura Y, 2010, BIOCONJUGATE CHEM, V21, P792, DOI 10.1021/bc900494x
   Teramura Y, 2009, TRANSPLANTATION, V88, P624, DOI 10.1097/TP.0b013e3181b230ac
   van der Windt DJ, 2007, XENOTRANSPLANTATION, V14, P288, DOI 10.1111/j.1399-3089.2007.00419.x
   van Golen RF, 2012, FREE RADICAL BIO MED, V52, P1382, DOI 10.1016/j.freeradbiomed.2012.01.013
   Vazquez MA, 2009, CURR OPIN NEPHROL HY, V18, P116, DOI 10.1097/MNH.0b013e328325d635
   Wang YM, 2005, CIRCULATION, V112, P2993, DOI 10.1161/CIRCULATIONHA.105.571315
   Watkins NJ, 1997, IMMUNOPHARMACOLOGY, V38, P111, DOI 10.1016/S0162-3109(97)00068-4
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
   Yang Guang, 2010, J Cardiovasc Dis Res, V1, P59, DOI 10.4103/0975-3583.64432
   Yang W, 2012, BIOMATERIALS, V33, P7945, DOI 10.1016/j.biomaterials.2012.07.035
NR 70
TC 9
Z9 9
U1 1
U2 5
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
BN 978-3-319-18603-0; 978-3-319-18602-3
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2015
VL 865
BP 3
EP 17
DI 10.1007/978-3-319-18603-0_1
PG 15
WC Biology; Immunology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Immunology; Research &
   Experimental Medicine
GA BD5WF
UT WOS:000361838300002
PM 26306440
DA 2018-10-20
ER

PT S
AU Moore, LB
   Kyriakides, TR
AF Moore, Laura Beth
   Kyriakides, Themis R.
BE Lambris, JD
   Ekdahl, KN
   Ricklin, D
   Nilsson, B
TI Molecular Characterization of Macrophage-Biomaterial Interactions
SO IMMUNE RESPONSES TO BIOSURFACES: MECHANISMS AND THERAPEUTIC
   INTERVENTIONS
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 1st International Conference on Immune Response to Biosurfaces
CY SEP 27-OCT 02, 2014
CL Chania, GREECE
DE Biomaterials; Foreign body response; Foreign body giant cells;
   Inflammation; Inflammasome; Macrophage
ID FOREIGN-BODY RESPONSE; GIANT-CELL FORMATION; KAPPA-B ACTIVATION;
   IN-VIVO; OSTEOCLAST DIFFERENTIATION; MATRICELLULAR PROTEINS;
   RHEUMATOID-ARTHRITIS; E-CADHERIN; DC-STAMP; FUSION
AB Implantation of biomaterials in vascularized tissues elicits the sequential engagement of molecular and cellular elements that constitute the foreign body response. Initial events include the non-specific adsorption of proteins to the biomaterial surface that render it adhesive for cells such as neutrophils and macrophages. The latter undergo unique activation and in some cases undergo cell-cell fusion to form foreign body giant cells that contribute to implant damage and fibrotic encapsulation. In this review, we discuss the molecular events that contribute to macrophage activation and fusion with a focus on the role of the inflammasome, signaling pathways such as JAK/STAT and NF-kappa B, and the putative involvement of micro RNAs in the regulation of these processes.
C1 [Moore, Laura Beth] Yale Univ, Dept Genet, New Haven, CT USA.
   [Moore, Laura Beth; Kyriakides, Themis R.] Yale Univ, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA.
   [Kyriakides, Themis R.] Yale Univ, Biomed Engn, New Haven, CT USA.
   [Kyriakides, Themis R.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06519 USA.
RP Kyriakides, TR (reprint author), Yale Univ, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA.
EM themis.kyriakides@yale.edu
FU NIGMS NIH HHS [T32 GM007223, R01 GM072194]
CR Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Anglicheau D, 2010, TRANSPLANTATION, V90, P105, DOI 10.1097/TP.0b013e3181e913c2
   Barker TH, 2005, AM J PATHOL, V166, P923, DOI 10.1016/S0002-9440(10)62312-7
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002
   Bueter CL, 2014, J IMMUNOL, V192, P5943, DOI 10.4049/jimmunol.1301695
   Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x
   Cekaite Lina, 2010, Front Biosci (Elite Ed), V2, P818
   Chang DT, 2009, J BIOMED MATER RES A, V89A, P490, DOI 10.1002/jbm.a.31981
   Chen SY, 2014, RHEUMATOL INT, V34, P285, DOI 10.1007/s00296-013-2720-5
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Cheng HS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00422
   Chuang-Tsai S, 2003, AM J PATHOL, V163, P445, DOI 10.1016/S0002-9440(10)63674-7
   Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236
   Dormoy-Raclet V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3388
   Dou C, 2014, BBA-GENE REGUL MECH, V1839, P1084, DOI 10.1016/j.bbagrm.2014.08.002
   Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024
   Fet N, 2014, LANGENBECK ARCH SURG, V399, P579, DOI 10.1007/s00423-014-1192-8
   Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613
   Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012
   Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020
   Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012
   Helming L, 2007, EUR J IMMUNOL, V37, P33, DOI 10.1002/eji.200636788
   Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005
   Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665
   Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200
   Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257
   Jay SM, 2007, AM J PATHOL, V171, P632, DOI 10.2353/ajpath.2007.061213
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Klueh U, 2005, BIOMATERIALS, V26, P1155, DOI 10.1016/j.biomaterials.2004.04.017
   Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399
   Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v
   Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452
   Lemaire Irma, 2012, Front Biosci (Elite Ed), V4, P41
   Li YT, 2012, ARTHRITIS RHEUM-US, V64, P3240, DOI 10.1002/art.34550
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   Maitra R, 2009, MOL IMMUNOL, V47, P175, DOI 10.1016/j.molimm.2009.09.023
   Malik AF, 2011, P NATL ACAD SCI USA, V108, P20095, DOI 10.1073/pnas.1105152108
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7
   Miyamoto H, 2012, J BIOL CHEM, V287, P32479, DOI 10.1074/jbc.M112.358226
   Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575
   Montagner S, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-14
   Mooney JE, 2014, IMMUNOL CELL BIOL, V92, P518, DOI 10.1038/icb.2014.19
   Moore LB, 2015, ACTA BIOMATER, V11, P37, DOI 10.1016/j.actbio.2014.09.022
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   Morris AH, 2014, MATRIX BIOL, V37, P183, DOI 10.1016/j.matbio.2014.03.002
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Nothnick WB, 2008, SEMIN REPROD MED, V26, P494, DOI 10.1055/s-0028-1096129
   Park KM, 2014, DEVELOPMENT, V141, P2760, DOI 10.1242/dev.102194
   Pellegrino L, 2013, NUCLEIC ACIDS RES, V41, P5400, DOI 10.1093/nar/gkt245
   Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004
   Puolakkainen P, 2003, AM J PATHOL, V162, P627, DOI 10.1016/S0002-9440(10)63856-4
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Rhee I, 2013, MOL CELL BIOL, V33, P2458, DOI 10.1128/MCB.00197-13
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Shibuya H, 2013, MOD RHEUMATOL, V23, P674, DOI 10.1007/s10165-012-0710-1
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Sissons JR, 2012, J IMMUNOL, V189, P23, DOI 10.4049/jimmunol.1102477
   Skokos EA, 2011, AM J PATHOL, V178, P2311, DOI 10.1016/j.ajpath.2011.01.045
   St Pierre CA, 2010, J ORTHOP RES, V28, P1418, DOI 10.1002/jor.21149
   Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759
   Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270
   Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335
   Sugatani T, 2011, BLOOD, V117, P3648, DOI 10.1182/blood-2010-10-311415
   Suska F, 2005, BIOMATERIALS, V26, P519, DOI 10.1016/j.biomaterials.2004.02.066
   Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0
   Tang LP, 2002, J BIOMED MATER RES, V62, P471, DOI 10.1002/jbm.10271
   Tsai AT, 2005, BIOMATERIALS, V26, P5835, DOI 10.1016/j.biomaterials.2005.03.003
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wolf MT, 2014, TISSUE ENG PART C-ME, V21, P148
   Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409
   Yagi M, 2006, J BONE MINER METAB, V24, P355, DOI 10.1007/s00774-006-0697-9
   Yang J, 2014, J BIOMED MATER RES A, V102, P2017, DOI 10.1002/jbm.a.35152
   Yu MJ, 2011, J IMMUNOL, V187, P1797, DOI 10.4049/jimmunol.1002628
   Zaveri TD, 2014, BIOMATERIALS, V35, P3504, DOI 10.1016/j.biomaterials.2014.01.007
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 90
TC 13
Z9 13
U1 2
U2 11
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
BN 978-3-319-18603-0; 978-3-319-18602-3
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2015
VL 865
BP 109
EP 122
DI 10.1007/978-3-319-18603-0_7
PG 14
WC Biology; Immunology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Immunology; Research &
   Experimental Medicine
GA BD5WF
UT WOS:000361838300008
PM 26306446
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Li, XG
   Tao, L
   Cao, C
   Shi, HS
   Li, L
   Chen, L
   Li, SR
AF Li, Xiaoge
   Tao, Ling
   Cao, Chuan
   Shi, Haishan
   Li, Le
   Chen, Liang
   Li, Shirong
TI A new surgical method for penile girth enhancement
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Penis; penile girth enhancement; model; biomaterial; ultrasound
ID AUGMENTATION; SILICONE; FAT
AB Objective: We developed a new surgical model of penile girth enhancement in dog, with minimal damage, fewer complications, and high success rate, to enable the experimental investigation of penile implants. Methods: We obtained materials for penile girth enhancement by processing the pericardium and blood vessel wall collected from pigs. Incisions were made at the penile bulb for the implantation of the materials, and facilitate observation and data collection, based on the anatomical features of dog's penis. We measured the girth of the flaccid penis before and after the operation, and erectile function at 1-month postoperation. In addition to evaluation of recovery from the incision and local pathological changes, ultrasonic examination was performed to monitor the long-term changes associated with implantation. Results: The mean girth of the flaccid penis significantly increased from 7.37 +/- 0.40 cm before the operation, to 8.70 +/- 0.56 cm postoperation. Dogs resumed normal mating at 1 month after the operation, without any significant change in the mating time. Ultrasonic examination clearly illustrated the implants, and helped in the measurement of the distance between the materials and the baculum. Conclusion: Chinese Rural dog is a promising animal model for penile girth enhancement surgery. The findings demonstrated that surgical implantation into penile bulb was associated with less damage, faster postoperative recovery, and higher success. For the first time, ultrasonic examination provided objective data on the surgical outcomes of penile girth enhancement.
C1 [Li, Xiaoge; Tao, Ling; Cao, Chuan; Shi, Haishan; Li, Le; Chen, Liang; Li, Shirong] Third Mil Med Univ, Southwest Hosp, Dept Plast & Reconstruct Surg, Chongqing, Peoples R China.
RP Li, SR (reprint author), Third Mil Med Univ, Southwest Hosp, Dept Plast & Reconstruct Surg, Chongqing, Peoples R China.
EM zhengxing@vip.163.com
CR Bjurlin Marc A, 2010, J Clin Aesthet Dermatol, V3, P41
   CHRIST JE, 1982, PLAST RECONSTR SURG, V69, P337, DOI 10.1097/00006534-198202000-00028
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P219, DOI 10.1097/00006534-199102000-00001
   Foxton G, 2011, AUSTRALAS J DERMATOL, V52, pE12, DOI 10.1111/j.1440-0960.2010.00665.x
   Il Kwak T, 2011, J SEX MED, V8, P3407, DOI 10.1111/j.1743-6109.2010.01748.x
   Karakan T, 2012, CASE REP UROL, V2012
   Lee SW, 2007, YONSEI MED J, V48, P723, DOI 10.3349/ymj.2007.48.4.723
   Manny T, 2011, J SEX MED, V8, P3505, DOI 10.1111/j.1743-6109.2010.01980.x
   Perovic SV, 2006, EUR UROL, V49, P139, DOI 10.1016/j.eururo.2005.08.016
   Shamsodini A, 2012, J SEX MED, V9, P3279, DOI 10.1111/j.1743-6109.2011.02563.x
   Silberstein J, 2008, J SEX MED, V5, P2231, DOI 10.1111/j.1743-6109.2008.00911.x
   Spyriounis PK, 2012, J PLAST RECONSTR AES, V65, pE15, DOI 10.1016/j.bjps.2011.07.025
   Yang B, 2009, J PLAST RECONSTR AES, V62, P357, DOI 10.1016/j.bjps.2008.11.033
   Yang Zhe, 2012, Zhonghua Zheng Xing Wai Ke Za Zhi, V28, P172
NR 14
TC 0
Z9 0
U1 0
U2 2
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2015
VL 8
IS 7
BP 10753
EP 10759
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CR7UR
UT WOS:000361557500055
PM 26379868
DA 2018-10-20
ER

PT J
AU Plenderleith, RA
   Pateman, CJ
   Rodenburg, C
   Haycock, JW
   Claeyssens, F
   Sammond, C
   Rimmer, S
AF Plenderleith, Richard A.
   Pateman, Christopher J.
   Rodenburg, Cornelia
   Haycock, John W.
   Claeyssens, Frederik
   Sammond, Chris
   Rimmer, Stephen
TI Arginine-glycine-aspartic acid functional branched semi-interpenetrating
   hydrogels
SO SOFT MATTER
LA English
DT Article
ID METHACRYLATE-BLOCK-(2,3 PROPANDIOL-1-METHACRYLATE-STAT-ETHANDIOL
   DIMETHACRYLATE)); INTERPENETRATING NETWORK HYDROGELS; MESENCHYMAL
   STEM-CELLS; MATRIX STIFFNESS; RGD PEPTIDES; REGENERATIVE MEDICINE;
   DERMAL FIBROBLASTS; FTIR SPECTROSCOPY; BLOCK CONETWORKS; DRUG-DELIVERY
AB For the first time a series of functional hydrogels based on semi-interpenetrating networks with both branched and crosslinked polymer components have been prepared and we show the successful use of these materials as substrates for cell culture. The materials consist of highly branched poly(N-isopropyl acrylamide)s with peptide functionalised end groups in a continuous phase of crosslinked poly(vinyl pyrrolidone). Functionalisation of the end groups of the branched polymer component with the GRGDS peptide produces a hydrogel that supports cell adhesion and proliferation. The materials provide a new synthetic functional biomaterial that has many of the features of extracellular matrix, and as such can be used to support tissue regeneration and cell culture. This class of high water content hydrogel material has important advantages over other functional hydrogels in its synthesis and does not require post-processing modifications nor are functional-monomers, which change the polymerisation process, required. Thus, the systems are amenable to large scale and bespoke manufacturing using conventional moulding or additive manufacturing techniques. Processing using additive manufacturing is exemplified by producing tubes using microstereolithography.
C1 [Plenderleith, Richard A.; Rimmer, Stephen] Univ Sheffield, Dept Chem, Polymer & Biomat Chem Labs, Sheffield S3 7HF, S Yorkshire, England.
   [Pateman, Christopher J.; Haycock, John W.; Claeyssens, Frederik] Univ Sheffield, Kroto Res Inst, Dept Mat & Engn, Sheffield S3 7HQ, S Yorkshire, England.
   [Rodenburg, Cornelia] Univ Sheffield, Dept Mat Sci & Engn, Sheffield S1 3JD, S Yorkshire, England.
   [Sammond, Chris] Sheffield Hallam Univ, Mat & Engn Res Inst, Sheffield South S1 1WN, Yorks, England.
RP Rimmer, S (reprint author), Univ Sheffield, Dept Chem, Polymer & Biomat Chem Labs, Sheffield S3 7HF, S Yorkshire, England.
EM s.rimmer@bradford.ac.uk
RI Rodenburg, Cornelia/O-4363-2017
OI Rodenburg, Cornelia/0000-0002-9590-375X; Haycock,
   John/0000-0002-3950-3583; Sammon, Chris/0000-0003-1714-1726
FU EPSRC; Biotechnology and Biological Sciences Research Council
   [BB/E012981/1, BB/D524983/1]; Engineering and Physical Sciences Research
   Council [1520640]
FX The authors acknowledge funding from EPSRC for a studentship for Richard
   Penderleith.
CR Billiet T, 2012, BIOMATERIALS, V33, P6020, DOI 10.1016/j.biomaterials.2012.04.050
   Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/NMAT4009, 10.1038/nmat4009]
   Chien HW, 2014, BIOTECHNOL J, V9, P1613, DOI 10.1002/biot.201300433
   Collett J, 2007, J R SOC INTERFACE, V4, P117, DOI 10.1098/rsif.2006.0158
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dragan ES, 2014, CHEM ENG J, V243, P572, DOI 10.1016/j.cej.2014.01.065
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Grundfest-Broniatowski SF, 2009, ASAIO J, V55, P400, DOI 10.1097/MAT.0b013e3181a8deba
   Guan Y, 2011, SOFT MATTER, V7, P6375, DOI 10.1039/c0sm01541e
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Hansen TD, 2014, BIOMATER SCI-UK, V2, P745, DOI [10.1039/C3BM60278H, 10.1039/c3bm60278h]
   Hopkins S, 2009, SOFT MATTER, V5, P4928, DOI 10.1039/b909656f
   Hopp I, 2013, BIOMATERIALS, V34, P5070, DOI 10.1016/j.biomaterials.2013.03.075
   Ingavle GC, 2014, BIOMATERIALS, V35, P3558, DOI 10.1016/j.biomaterials.2014.01.002
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kilian KA, 2012, ANGEW CHEM INT EDIT, V51, P4891, DOI 10.1002/anie.201108746
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kostanski LK, 2009, J BIOMAT SCI-POLYM E, V20, P271, DOI 10.1163/156856208X3999107
   Kumar V, 2014, ORG ELECTRON, V15, P2059, DOI 10.1016/j.orgel.2014.06.001
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Li X, 2014, BIOMATERIALS, V35, P5679, DOI 10.1016/j.biomaterials.2014.03.067
   Maeda Y, 2001, MACROMOLECULES, V34, P1391, DOI 10.1021/ma001306t
   Malik S, 2004, J PHYS CHEM B, V108, P597, DOI 10.1021/jp036590f
   Martinez E, 2009, NANOMEDICINE-UK, V4, P65, DOI 10.2217/17435889.4.1.65
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McHugh KJ, 2013, J BIOMED MATER RES B, V101, P1571, DOI 10.1002/jbm.b.32968
   MORITA Y, 1992, RADIAT PHYS CHEM, V39, P473
   Owaki T, 2014, BIOTECHNOL J, V9, P904, DOI 10.1002/biot.201300432
   Ozbolat IT, 2013, IEEE T BIO-MED ENG, V60, P691, DOI 10.1109/TBME.2013.2243912
   Perlin L, 2008, SOFT MATTER, V4, P2331, DOI 10.1039/b801646a
   Postek MT, 2008, SCANNING, V30, P457, DOI 10.1002/sca.20129
   Ralston DR, 1999, BRIT J DERMATOL, V140, P605
   Maia FR, 2014, MACROMOL BIOSCI, V14, P759, DOI 10.1002/mabi.201300567
   Rimmer S, 2005, BIOMATERIALS, V26, P2219, DOI 10.1016/j.biomaterials.2004.07.013
   Rimmer S, 2007, SOFT MATTER, V3, P971, DOI 10.1039/b705188c
   Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934
   Rzaev ZMO, 2007, PROG POLYM SCI, V32, P534, DOI 10.1016/j.progpolymsci.2007.01.006
   Sammon C, 2006, POLYMER, V47, P6123, DOI 10.1016/j.polymer.2006.06.013
   Saunders BR, 2009, ADV COLLOID INTERFAC, V147-48, P251, DOI 10.1016/j.cis.2008.08.008
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Seelbach RJ, 2014, ACTA BIOMATER, V10, P4340, DOI 10.1016/j.actbio.2014.06.028
   Shivashanka M., 2012, INT J PHRAM PHRAM SC, V4, P1
   Smith LE, 2006, BIOMATERIALS, V27, P2806, DOI 10.1016/j.biomaterials.2005.12.018
   Su YL, 2003, MOL SIMULAT, V29, P803, DOI 10.1080/0892702031000121888
   Su YL, 2002, MACROMOLECULES, V35, P6426, DOI 10.1021/ma0105284
   Sun Y, 2007, BIOMATERIALS, V28, P661, DOI 10.1016/j.biomaterials.2006.09.024
   Tong XM, 2014, BIOMATERIALS, V35, P1807, DOI 10.1016/j.biomaterials.2013.11.064
   Wang LS, 2006, ADV FUNCT MATER, V16, P1171, DOI 10.1002/adfm.200500408
   Yamato M, 2007, PROG POLYM SCI, V32, P1123, DOI 10.1016/j.progpolymsci.2007.06.002
   Ye K, 2015, NANO LETT, V15, P4720, DOI 10.1021/acs.nanolett.5b01619
   Yu CH, 2013, CELL REP, V5, P1456, DOI 10.1016/j.celrep.2013.10.040
   Yu Q, 2014, ADV FUNCT MATER, V24, P3751, DOI 10.1002/adfm.201304274
   Zhang R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2341
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 56
TC 2
Z9 2
U1 1
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2015
VL 11
IS 38
BP 7567
EP 7578
DI 10.1039/c5sm00695c
PG 12
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA CS1NQ
UT WOS:000361833500014
PM 26280624
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Soto-Rios, PC
   Nakano, K
   Leon-Romero, M
   Aikawa, Y
   Arai, S
   Nishimura, O
AF Soto-Rios, Paula Cecilia
   Nakano, Kazunori
   Leon-Romero, Marco
   Aikawa, Yoshio
   Arai, Shigeyuki
   Nishimura, Osamu
TI Differences in the removal mechanisms of Undaria pinnatifida and
   Phragmites australis as biomaterials for lead removal
SO WATER SCIENCE AND TECHNOLOGY
LA English
DT Article
DE biomaterials; heavy metals; permeable reactive barriers
ID PERMEABLE REACTIVE BARRIERS; HEAVY-METAL; GROUNDWATER REMEDIATION;
   BIOSORPTION; ADSORPTION; BROWN; ALGAE
AB This study offers the opportunity to utilize Undaria pinnatifida and Phragmites australis to remove lead from water in permeable reactive barrier (PRB) technology. Its efficacy was tested using batch experiments and PRB column systems. From the batch experiment results, a higher adsorption capacity was observed for Undaria pinnatifida. Nevertheless, Phragmites australis in the column system efficiently removed lead and the breakthrough occurred at the same time for both biomaterials. To dissipate this difference, a sequential extraction for metal speciation analysis was used for both columns. The results have shown that each biomaterial has a dominant mechanism. Phragmites australis removed lead by physical adsorption, whereas Undaria pinnatifida showed a higher tendency to bind lead due to organic matter, primary and secondary minerals.
C1 [Soto-Rios, Paula Cecilia; Leon-Romero, Marco; Aikawa, Yoshio; Nishimura, Osamu] Tohoku Univ, Ecol Engn Lab, Grad Sch Engn, Tohoku 9808579, Japan.
   [Nakano, Kazunori] Nihon Univ, Ecol Engn Lab, Fac Engn, Nihon 9638642, Japan.
   [Arai, Shigeyuki] Mitsubishi Mat Corp, Environm Technol Res Ctr, Kurihara, Miyagi 9895402, Japan.
RP Soto-Rios, PC (reprint author), Tohoku Univ, Ecol Engn Lab, Grad Sch Engn, Tohoku 9808579, Japan.
EM cecisoto@eco.civil.tohoku.ac.jp
CR Babel S, 2004, CHEMOSPHERE, V54, P951, DOI 10.1016/j.chemosphere.2003.10.001
   Cardwell AJ, 2002, CHEMOSPHERE, V48, P653, DOI 10.1016/S0045-6535(02)00164-9
   Choong J., 2002, WATER RES, V36, P1814
   Dabrowski A, 2001, ADV COLLOID INTERFAC, V93, P135, DOI 10.1016/S0001-8686(00)00082-8
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   Duruibe JO, 2007, INT J PHYS SCI, V2, P112
   Fu W, 2011, J ENVIRON MANAGE, V92, P407
   Gavaskar AR, 1999, J HAZARD MATER, V68, P41, DOI 10.1016/S0304-3894(99)00031-X
   Hashim MA, 2004, CHEM ENG J, V97, P249, DOI 10.1016/S1385-8947(03)00216-X
   KIM YH, 1995, BIOTECHNOL LETT, V17, P345, DOI 10.1007/BF01190651
   Kurniawan TA, 2006, SCI TOTAL ENVIRON, V366, P409, DOI 10.1016/j.scitotenv.2005.10.001
   Obiri-Nyarko F, 2014, CHEMOSPHERE, V111, P243, DOI 10.1016/j.chemosphere.2014.03.112
   Park D, 2010, BIOTECHNOL BIOPROC E, V15, P86, DOI 10.1007/s12257-009-0199-4
   PEREBAR, 2002, EVK1CT199900035 PERE
   Rocca C. della, 2007, Desalination, V210, P194, DOI 10.1016/j.desal.2006.05.044
   Roehl KE, 2005, LONG TERM PERFORMANC
   Romera E, 2007, BIORESOURCE TECHNOL, V98, P3344, DOI 10.1016/j.biotech.2006.09.026
   Schiewer S., 2000, REMEDIATION, P139
   SCOTT CD, 1992, BIOTECHNOL BIOENG, V39, P1064, DOI 10.1002/bit.260391011
   Soto Rios P. C., 2014, WATER SCI TECHNOL, V70, P307
   Southichak B, 2009, WATER SCI TECHNOL, V59, P339, DOI 10.2166/wst.2009.867
   Southichak B., 2002, THESIS TOHOKU U SEND
   TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017
   Thiruverikatachari R, 2008, J IND ENG CHEM, V14, P145, DOI 10.1016/j.jiec.2007.10.001
   VOLESKY B, 1994, FEMS MICROBIOL REV, V14, P291, DOI 10.1111/j.1574-6976.1994.tb00102.x
   Volesky B., 1990, BIOSORPTION HEAVY ME, P3
   Walter J., 1974, PURE APPL CHEM J, P375, DOI [10.1016/B978-0-408-70636-0.50006-5, DOI 10.1016/B978-0-408-70636-0.50006-5]
   Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002
   Yong H. K., 1995, BIOTECHNOL LETT, V17, P345
NR 29
TC 1
Z9 2
U1 0
U2 16
PU IWA PUBLISHING
PI LONDON
PA ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H0QS, ENGLAND
SN 0273-1223
EI 1996-9732
J9 WATER SCI TECHNOL
JI Water Sci. Technol.
PY 2015
VL 72
IS 7
BP 1226
EP 1233
DI 10.2166/wst.2015.334
PG 8
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA CS1PL
UT WOS:000361839200022
PM 26398039
DA 2018-10-20
ER

PT J
AU McCanna, DJ
   Barthod-Malat, AV
   Gorbet, MB
AF McCanna, David Joseph
   Barthod-Malat, Aurore V.
   Gorbet, Maud B.
TI In vitro methods of assessing ocular biocompatibility using
   THP-1-derived macrophages
SO CUTANEOUS AND OCULAR TOXICOLOGY
LA English
DT Article
DE AlamarBlue; annexin V; benzalkonium chloride; biocompatibility; CD54;
   confocal microscopy; macrophage
ID STANDARD REFERENCE MATERIALS; RUBBER LATEX MATERIALS; INTRAOCULAR
   LENSES; BENZALKONIUM CHLORIDE; CELL-DEATH; CAPSULAR BIOCOMPATIBILITY;
   SIGNAL-TRANSDUCTION; CYTOTOXICITY TESTS; ALAMAR BLUE; SURFACE
AB Macrophages play an important role in the elimination of infections, the removal of debris and in tissue repair after infection and trauma. In vitro models that assess ocular biomaterials for toxicity typically focus on the effects of these materials on epithelial or fibroblast cells. This investigation evaluated known ocular toxins deposited on model materials for their effects on the viability and activation of macrophages. THP-1-derived macrophages were cultured onto silicone films (used as a base biomaterial) deposited with chemical toxins (benzalkonium chloride (BAK), zinc diethyldithiocarbamate (ZDEC) and lipopolysaccharide (LPS)). Utilizing three fluorescent dyes calcein, ethidium homodimer-1 (EthD-1) and annexin V, the viability of macrophages attached to the biomaterial was determined using confocal microscopy. Propidium iodide (PI) staining and alamarBlue (R) (resazurin) reduction were used to assess cell death and metabolic activity. CD14, CD16, CD33, CD45, and CD54 expression of adherent macrophages, were also evaluated to detect LPS activation of macrophages using flow cytometry. The sensitivity of this test battery was demonstrated as significant toxicity from treated surfaces with ZDEC (0.001-0.01%), and BAK (0.001%-0.1%) was detected. Also, macrophage activation could be detected by measuring CD54 expression after exposure to adsorbed LPS. These in vitro methods will be helpful in determining the toxicity potential of new ocular biomaterials.
C1 [McCanna, David Joseph; Gorbet, Maud B.] Univ Waterloo, Ctr Contact Lens Res, Sch Optometry & Vis Sci, Waterloo, ON N2L 3G1, Canada.
   [Barthod-Malat, Aurore V.; Gorbet, Maud B.] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada.
RP McCanna, DJ (reprint author), Univ Waterloo, Ctr Contact Lens Res, Sch Optometry & Vis Sci, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
EM djmccann@uwaterloo.ca
FU 20:20 NSERC Opthalmic Materials Network
FX Authors do not have any financial/conflicting interests to disclose.
   This project was funded by 20:20 NSERC Opthalmic Materials Network.
CR Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P1141, DOI 10.1016/S0886-3350(02)01425-6
   Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218
   Ammar DA, 2011, BRIT J OPHTHALMOL, V95, P1466, DOI 10.1136/bjophthalmol-2011-300012
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ANDREESEN R, 1990, J LEUKOCYTE BIOL, V47, P490
   Anwar Z, 2013, CURR OPIN OPHTHALMOL, V24, P136, DOI 10.1097/ICU.0b013e32835c8aba
   AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244
   AUWERX J, 1992, LEUKEMIA RES, V16, P317, DOI 10.1016/0145-2126(92)90070-N
   Baudouin Christophe, 2012, Trans Am Ophthalmol Soc, V110, P40
   Beasley AM, 1996, J INVEST SURG, V9, P399, DOI 10.3109/08941939609025857
   Buchen SY, 2012, OPHTHALMOLOGY, V119, pE4, DOI 10.1016/j.ophtha.2012.04.006
   Crocker PR, 2012, ANN NY ACAD SCI, V1253, P102, DOI 10.1111/j.1749-6632.2011.06449.x
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   Devitt A, 2003, CELL DEATH DIFFER, V10, P371, DOI 10.1038/sj.cdd.4401168
   DEVOS AF, 1995, EXP EYE RES, V60, P199, DOI 10.1016/S0014-4835(95)80011-5
   DURANDCAVAGNA G, 1989, FUND APPL TOXICOL, V13, P500, DOI 10.1016/0272-0590(89)90286-8
   Eckhardt A, 2009, BIOMATERIALS, V30, P1665, DOI 10.1016/j.biomaterials.2008.09.024
   Goto Y, 2003, ARCH OPHTHALMOL-CHIC, V121, P835, DOI 10.1001/archopht.121.6.835
   Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012
   Hao XJ, 2012, BIOMATERIALS, V33, P5659, DOI 10.1016/j.biomaterials.2012.04.052
   Hexig B, 2008, J ARTIF ORGANS, V11, P204, DOI 10.1007/s10047-008-0429-0
   Hopkins HA, 1995, AM J PHYSIOL-LUNG C, V269, pL849
   Hoyer JD, 2008, AM J CLIN PATHOL, V129, P316, DOI 10.1309/E36008Y2H08Q1AYY
   Huang XD, 2010, J CATARACT REFR SURG, V36, P290, DOI 10.1016/j.jcrs.2009.09.027
   Hyde GK, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025001
   IKARASHI Y, 1992, J BIOMED MATER RES, V26, P339, DOI 10.1002/jbm.820260306
   Imayasu Masaki, 1994, CLAO Journal, V20, P183
   Iribarren Pablo, 2002, BMC Immunol, V3, P6, DOI 10.1186/1471-2172-3-6
   Irwin EF, 2008, J BIOMAT SCI-POLYM E, V19, P1363, DOI 10.1163/156856208786052407
   Ishikawa N, 2011, J CATARACT REFR SURG, V37, P1333, DOI 10.1016/j.jcrs.2011.04.001
   Jager MJ, 2011, PROG RETIN EYE RES, V30, P129, DOI 10.1016/j.preteyeres.2010.11.004
   Jha P, 2007, INVEST OPHTH VIS SCI, V48, P5091, DOI 10.1167/iovs.07-0651
   Lee HS, 2013, J BIOMED MATER RES A, V101, P203, DOI 10.1002/jbm.a.34309
   Lucas AD, 2001, IN VITRO MOL TOXICOL, V14, P169
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Matylevitch NP, 1998, AM J PATHOL, V153, P567, DOI 10.1016/S0002-9440(10)65599-X
   Melino M, 2012, WORLD J GASTROENTERO, V18, P1732, DOI 10.3748/wjg.v18.i15.1732
   Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661
   Michee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072459
   Miyake K, 2001, ARCH OPHTHALMOL-CHIC, V119, P387, DOI 10.1001/archopht.119.3.387
   Munoz LE, 2007, J LEUKOCYTE BIOL, V81, P6, DOI 10.1189/jlb.0306166
   NAKAMURA A, 1990, BIOMATERIALS, V11, P92
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x
   Park H, 1996, PHARMACEUT RES, V13, P1770, DOI 10.1023/A:1016012520276
   Park JC, 2002, YONSEI MED J, V43, P518, DOI 10.3349/ymj.2002.43.4.518
   Perez VL, 2013, J AUTOIMMUN, V45, P7, DOI 10.1016/j.jaut.2013.06.011
   Pick N., 2004, BIOL PROCED ONLINE, V6, P220, DOI DOI 10.1251/BP092
   Roesel M, 2008, GRAEF ARCH CLIN EXP, V246, P1609, DOI 10.1007/s00417-008-0886-4
   ROTHLEIN R, 1986, J IMMUNOL, V137, P1270
   Saika S, 1998, GRAEF ARCH CLIN EXP, V236, P758, DOI 10.1007/s004170050155
   Sakaguchi H, 2007, ARCH DERMATOL RES, V298, P427, DOI 10.1007/s00403-006-0714-9
   Song L, 2010, J PHYS CHEM B, V114, P7172, DOI 10.1021/jp100876c
   Stevens AM, 2012, ACTA OPHTHALMOL, V90, pe221, DOI 10.1111/j.1755-3768.2011.02338.x
   Thomas L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070691
   TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208
   Tsuchiya T, 1994, J Biomater Appl, V9, P138
   TSUCHIYA T, 1993, J BIOMED MATER RES, V27, P885, DOI 10.1002/jbm.820270707
   TSUCHIYA T, 1993, J APPL BIOMATER, V4, P153, DOI 10.1002/jab.770040206
   Tsuchiya Toshie, 1994, Clinical Materials, V16, P1, DOI 10.1016/0267-6605(94)90085-X
   Uusitalo M, 1997, GRAEF ARCH CLIN EXP, V235, P506, DOI 10.1007/BF00947008
   Vermonden T, 2008, BIOMACROMOLECULES, V9, P919, DOI 10.1021/bm7013075
   Wang ZQ, 2001, IMMUNOLOGY, V102, P331, DOI 10.1046/j.1365-2567.2001.01171.x
   Wiegand C, 2008, GMS HYG INFECT CONTR, V3
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Youn HY, 2004, TOXICOL IN VITRO, V18, P841, DOI 10.1016/j.tiv.2004.04.007
   Zhao H, 2010, CYTOM PART A, V77A, P399, DOI 10.1002/cyto.a.20867
NR 69
TC 1
Z9 1
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1556-9527
EI 1556-9535
J9 CUTAN OCUL TOXICOL
JI Cutan. Ocul. Toxicol.
PY 2015
VL 34
IS 2
BP 89
EP 100
DI 10.3109/15569527.2014.908205
PG 12
WC Ophthalmology; Toxicology
SC Ophthalmology; Toxicology
GA CR4SM
UT WOS:000361328600001
PM 24738714
DA 2018-10-20
ER

PT J
AU Feng, SB
   Nie, L
   Zou, P
   Suo, JP
AF Feng, Shuibin
   Nie, Lei
   Zou, Peng
   Suo, Jinping
TI Drug-loaded PLGA-mPEG microparticles as treatment for atopic
   dermatitis-like skin lesions in BALB/c mice model
SO JOURNAL OF MICROENCAPSULATION
LA English
DT Article
DE Biomaterial; controlled release; dermatitis; microspheres
ID IN-VIVO EVALUATION; ALLERGIC RHINITIS; BIODEGRADABLE MICROPARTICLES;
   CHITOSAN NANOPARTICLES; POLYMER DEGRADATION; VITRO RELEASE; NC/NGA MICE;
   NASAL SPRAY; MOUSE MODEL; DELIVERY
AB This study evaluated the feasibility of mizolastine-loaded microparticles as therapy for atopic dermatitis. Microparticles have been researched for decades as a controlled-release drug delivery system, but seldom been used as treatment for skin disease. In this research, we induced dermatitis in BALB/c mice model by repeated topical application of dinitrofluorobenzene and compared the mizolastine microparticles injection and daily mizolastine injection treatment. The results showed that the mizolastine microparticles treatments significantly inhibited ear thickness and dermatitis index in dermatitis model compared with the dermatitis mice without treatment, showing a similar curative effect compared with daily mizolastine injection treatment, and the improvement continued for several days. Inflammatory cells infiltration into the ears and the plasma level of immunoglobulin E were also suppressed by mizolastine microparticles according to the histopathology analysis. In conclusion, the results suggested that drug-loaded microparticles could be a proper candidate for the treatment of skin diseases.
C1 [Feng, Shuibin; Nie, Lei; Zou, Peng; Suo, Jinping] Huazhong Univ Sci & Technol, Coll Mat Sci & Engn, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
RP Suo, JP (reprint author), 1034 Luoyu Rd, Wuhan, Peoples R China.
EM jinpingsuo@hust.edu.cn
OI nie, lei/0000-0002-6175-5883
CR Al-Qadi S, 2012, J CONTROL RELEASE, V157, P383, DOI 10.1016/j.jconrel.2011.08.008
   Avgoustakis K, 2002, J CONTROL RELEASE, V79, P123, DOI 10.1016/S0168-3659(01)00530-2
   Bachert C, 2001, ALLERGY, V56, P653, DOI 10.1034/j.1398-9995.2001.00756.x
   Bachert C, 2011, J ASTHMA, V48, P965, DOI 10.3109/02770903.2011.616616
   Barzegar C, 2002, REV FR ALLERGOL, V42, P410, DOI 10.1016/S0335-7457(02)00169-7
   Belloni B, 2007, J ALLERGY CLIN IMMUN, V120, P1223, DOI 10.1016/j.jaci.2007.08.060
   Bjorses K, 2011, ACTA BIOMATER, V7, P2558, DOI 10.1016/j.actbio.2011.03.003
   Boguniewicz M, 2006, J ALLERGY CLIN IMMUN, V117, pS475, DOI 10.1016/j.jaci.2005.10.018
   Boguniewicz Mark, 2003, Journal of Allergy and Clinical Immunology, V112, pS140, DOI 10.1016/j.jaci.2003.09.031
   Dibildox J, 2001, J ALLERGY CLIN IMMUN, V108, pS54, DOI 10.1067/mai.2001.115567
   Fujii Y, 2009, SKIN PHARMACOL PHYS, V22, P240, DOI 10.1159/000235551
   Fujimoto M, 2009, EUR J PHARMACOL, V602, P432, DOI 10.1016/j.ejphar.2008.11.040
   Hazekawa M, 2012, J MICROENCAPSUL, V29, P211, DOI 10.3109/02652048.2011.622054
   Hochhaus G, 2008, CLIN THER, V30, P1, DOI 10.1016/j.clinthera.2008.01.005
   Inagaki N, 2006, EUR J PHARMACOL, V546, P189, DOI 10.1016/j.ejphar.2006.07.019
   Jay SM, 2009, J CONTROL RELEASE, V134, P26, DOI 10.1016/j.jconrel.2008.10.019
   Jhunjhunwala S, 2012, J CONTROL RELEASE, V159, P78, DOI 10.1016/j.jconrel.2012.01.013
   Kang JS, 2008, INT IMMUNOPHARMACOL, V8, P1475, DOI 10.1016/j.intimp.2008.06.004
   Karal-Yilmaz O, 2011, J MICROENCAPSUL, V28, P46, DOI 10.3109/02652048.2010.523795
   Kim CH, 2012, SCAND J IMMUNOL, V75, P471, DOI 10.1111/j.1365-3083.2011.02659.x
   Koo J, 1998, CLIN THER, V20, P283, DOI 10.1016/S0149-2918(98)80091-X
   Lecaroz C, 2006, J MICROENCAPSUL, V23, P782, DOI 10.1080/02652040600946886
   Lee JS, 2012, J CONTROL RELEASE, V158, P312, DOI 10.1016/j.jconrel.2011.10.025
   Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060
   Leynadier F, 1996, ANN ALLERG ASTHMA IM, V76, P163, DOI 10.1016/S1081-1206(10)63417-5
   Li J, 2008, J APPL POLYM SCI, V109, P475, DOI 10.1002/app.28122
   Li J, 2008, J APPL POLYM SCI, V108, P2458, DOI 10.1002/app.27823
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Matsuoka H, 2003, ALLERGY, V58, P139, DOI 10.1034/j.1398-9995.2003.23790.x
   Na JH, 2012, J CONTROL RELEASE, V163, P2, DOI 10.1016/j.jconrel.2012.07.028
   Nagai H, 1997, J PHARMACOL EXP THER, V283, P321
   Park J, 2009, NANOMED-NANOTECHNOL, V5, P410, DOI 10.1016/j.nano.2009.02.002
   Patel B, 2012, J CONTROL RELEASE, V162, P310, DOI 10.1016/j.jconrel.2012.07.003
   de la Ossa DHP, 2012, J CONTROL RELEASE, V161, P927, DOI 10.1016/j.jconrel.2012.05.003
   Pople PV, 2012, INT J PHARMACEUT, V434, P70, DOI 10.1016/j.ijpharm.2012.04.051
   Reis CP, 2014, DRUG DEV IND PHARM, V40, P409, DOI 10.3109/03639045.2013.767826
   Rosado C, 2013, PHARM DEV TECHNOL, V18, P710, DOI 10.3109/10837450.2012.712537
   Rosca ID, 2004, J CONTROL RELEASE, V99, P271, DOI 10.1016/j.jconrel.2004.07.007
   Samukawa K, 2012, J PHARMACOL SCI, V118, P391, DOI 10.1254/jphs.11182FP
   Terakawa M, 2008, EUR J PHARMACOL, V601, P186, DOI 10.1016/j.ejphar.2008.10.040
   Yang XZ, 2011, J CONTROL RELEASE, V156, P203, DOI 10.1016/j.jconrel.2011.07.035
   Yang YY, 2001, BIOMATERIALS, V22, P231, DOI 10.1016/S0142-9612(00)00178-2
   Yeh MK, 2004, J MICROENCAPSUL, V21, P91, DOI 10.1080/02652040310001619794
   Yuan XY, 2011, EUR J PHARMACOL, V658, P263, DOI 10.1016/j.ejphar.2011.02.013
   Zou P, 2012, POLYMER, V53, P1245, DOI 10.1016/j.polymer.2012.01.044
NR 45
TC 1
Z9 2
U1 0
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0265-2048
EI 1464-5246
J9 J MICROENCAPSUL
JI J. Microencapsul.
PY 2015
VL 32
IS 2
BP 201
EP 209
DI 10.3109/02652048.2014.995727
PG 9
WC Chemistry, Applied; Engineering, Chemical; Pharmacology & Pharmacy
SC Chemistry; Engineering; Pharmacology & Pharmacy
GA CR4UM
UT WOS:000361335100012
PM 25539424
DA 2018-10-20
ER

PT J
AU Ge, HL
   Kong, Y
   Pan, Y
   Deng, LH
   Shou, D
   Lu, QY
AF Ge, Hanli
   Kong, Yong
   Pan, Yan
   Deng, Linhong
   Shou, Dan
   Lu, Qingyun
TI Polydopamine Core Half-Polyamidoamine Dendrimers Based Drug-Delivery
   Platform and Characterization by Electrochemical Impedance Spectroscopy
SO JOURNAL OF THE ELECTROCHEMICAL SOCIETY
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYER; SOLUBILITY ENHANCEMENT; SURFACE-CHEMISTRY;
   PAMAM DENDRIMERS; ASCORBIC-ACID; DOPAMINE; NANOPARTICLES;
   FUNCTIONALIZATION; IMMOBILIZATION; MEMBRANE
AB Dopamine was self-polymerized onto the surface of a glassy carbon electrode (GCE), and the obtained polydopamine (PDOA) functioned as a scaffold for the grafting of half-polyamidoamine (H-PAMAM) dendrimers, which is a new class of polymeric biomaterial as drug carriers. Aspirin was chosen as the model drug and loaded into the H-PAMAM dendrimers via ion pairing, hydrogen bonding and hydrophobic interaction. The synthesis of H-PAMAM dendrimers grafted PDOA was characterized by electrochemical impedance spectroscopy (EIS), attenuated total reflection infrared spectroscopy (ATR-TR), atomic force microscopy (AFM), transmission electron microscopy (TEM), UV-visible spectroscopy and water contact measurement. The process of aspirin loading and delivery was also monitored by EIS. The results demonstrate that PDOA films can be used as an excellent platform for grafting of H-PAMAM dendrimers, which is an ideal carrier for drug loading and delivery. (C) 2015 The Electrochemical Society. All rights reserved.
C1 [Ge, Hanli; Kong, Yong; Pan, Yan; Deng, Linhong] Changzhou Univ, Jiangsu Key Lab Adv Catalyt Mat & Technol, Changzhou 213164, Peoples R China.
   [Shou, Dan] Zhejiang Acad Tradit Chinese Med, Dept Med, Hangzhou 310007, Zhejiang, Peoples R China.
   [Lu, Qingyun] Changzhou Univ, Hua Lookeng Honors Coll, Changzhou 213164, Peoples R China.
RP Ge, HL (reprint author), Changzhou Univ, Jiangsu Key Lab Adv Catalyt Mat & Technol, Changzhou 213164, Peoples R China.
EM yzkongyong@126.com; shoudanok@163.com
CR Amoozgar Z, 2014, BIOMACROMOLECULES, V15, P4187, DOI 10.1021/bm5011933
   Arteta MY, 2014, J PHYS CHEM B, V118, P12892, DOI 10.1021/jp506510s
   Bagherzadeh M, 2014, ELECTROCHIM ACTA, V115, P573, DOI 10.1016/j.electacta.2013.11.012
   Barreto WJ, 1999, SPECTROCHIM ACTA A, V55, P65
   Cao CY, 2014, J POWER SOURCES, V248, P224, DOI 10.1016/j.jpowsour.2013.09.027
   Chegeni BK, 2014, COLLOID POLYM SCI, V292, P3337, DOI 10.1007/s00396-014-3398-2
   Chen W, 2000, MACROMOLECULES, V33, P9169, DOI 10.1021/ma000791p
   Cui JW, 2012, BIOMACROMOLECULES, V13, P2225, DOI 10.1021/bm300835r
   Devarakonda B, 2004, INT J PHARM, V284, P133, DOI 10.1016/j.ijpharm.2004.07.006
   Duncan R, 2005, ADV DRUG DELIVER REV, V57, P2215, DOI 10.1016/j.addr.2005.09.019
   Fei B, 2008, CARBON, V46, P1795, DOI 10.1016/j.carbon.2008.06.049
   Feng JJ, 2012, NEW J CHEM, V36, P148, DOI 10.1039/c1nj20850k
   Gupta U, 2006, BIOMACROMOLECULES, V7, P649, DOI 10.1021/bm050802s
   He H, 2005, J COLLOID INTERF SCI, V289, P446, DOI 10.1016/j.jcis.2005.03.085
   He YK, 2014, J MATER CHEM A, V2, P9548, DOI 10.1039/c3ta15301k
   Jo S, 2013, MACROMOL BIOSCI, V13, P1389, DOI 10.1002/mabi.201300203
   Kolhe P, 2006, BIOMATERIALS, V27, P660, DOI 10.1016/j.biomaterials.2005.06.007
   Kong Y, 2014, ANAL CHIM ACTA, V809, P54, DOI 10.1016/j.aca.2013.12.003
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Leng ZH, 2013, CARBOHYD POLYM, V98, P1173, DOI 10.1016/j.carbpol.2013.07.021
   Li XJ, 2014, BIOMATERIALS, V35, P6576, DOI 10.1016/j.biomaterials.2014.04.043
   Li YL, 2006, THIN SOLID FILMS, V497, P270, DOI 10.1016/j.tsf.2005.10.048
   Liao YA, 2010, MATER CHEM PHYS, V121, P534, DOI 10.1016/j.matchemphys.2010.02.019
   Liao Y, 2009, APPL SURF SCI, V255, P8207, DOI 10.1016/j.apsusc.2009.05.038
   Lin Q, 2013, J NANOPART RES, V15, P1
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   Mondin G, 2013, J COLLOID INTERF SCI, V411, P187, DOI 10.1016/j.jcis.2013.08.028
   Pop-Georgievski O, 2013, THIN SOLID FILMS, V543, P180, DOI 10.1016/j.tsf.2012.11.128
   Shervedani RK, 2008, ELECTROCHIM ACTA, V53, P6293, DOI 10.1016/j.electacta.2008.04.051
   Shervedani RK, 2008, ELECTROANAL, V20, P550, DOI 10.1002/elan.200704096
   Shervedani RK, 2007, ANAL CHIM ACTA, V587, P254, DOI 10.1016/j.aca.2007.01.053
   Shervedani RK, 2010, ELECTROANAL, V22, P969, DOI 10.1002/elan.200900327
   Shervedani RK, 2009, J ELECTROANAL CHEM, V633, P259, DOI 10.1016/j.jelechem.2009.05.012
   Shervedani RK, 2009, SENSOR ACTUAT B-CHEM, V139, P657, DOI 10.1016/j.snb.2009.03.060
   Shervedani RK, 2006, SENSOR ACTUAT B-CHEM, V115, P614, DOI 10.1016/j.snb.2005.10.027
   Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087
   Wang JT, 2009, J POWER SOURCES, V192, P336, DOI 10.1016/j.jpowsour.2009.03.014
   Wang L, 2013, COMMUN COMPUT PHYS, V13, P13, DOI 10.4208/cicp.300611.120911s
   Zhao DM, 2009, COLLOID SURFACE B, V74, P317, DOI 10.1016/j.colsurfb.2009.07.044
   Zhou ZY, 2013, INT J PHARMACEUT, V452, P173, DOI 10.1016/j.ijpharm.2013.04.075
NR 40
TC 7
Z9 7
U1 1
U2 18
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA
SN 0013-4651
EI 1945-7111
J9 J ELECTROCHEM SOC
JI J. Electrochem. Soc.
PY 2015
VL 162
IS 10
BP G87
EP G93
DI 10.1149/2.0221510jes
PG 7
WC Electrochemistry; Materials Science, Coatings & Films
SC Electrochemistry; Materials Science
GA CR7BB
UT WOS:000361501800101
DA 2018-10-20
ER

PT J
AU Jia, XJ
   Chen, MW
   Wan, JB
   Su, HX
   He, CW
AF Jia, Xuejing
   Chen, Meiwan
   Wan, Jian-Bo
   Su, Huanxing
   He, Chengwei
TI Review on the extraction, characterization and application of soybean
   polysaccharide
SO RSC ADVANCES
LA English
DT Review
ID STEPWISE ENZYMATIC DEGRADATION; CELL-WALL POLYSACCHARIDES; BY-PRODUCT
   OKARA; SOLUBLE POLYSACCHARIDES; EMULSIFYING PROPERTIES; ACIDIC
   CONDITIONS; BEET PECTIN; PHYSICOCHEMICAL STABILITY; MOLECULAR
   CONSTRUCTION; RHEOLOGICAL PROPERTIES
AB Soybean polysaccharide (SPS) is a class of soluble polysaccharide derived from soybean cotyledon, soybean meal or okara, and has broadly been used in the food industry. In recent decades, due to its attractive physicochemical properties, SPS has been developed into various emulsifiers or stabilizers for beverages. Additionally, studies have emerged to reveal its potential in biomaterial and biological applications. In this review, we critically appraise the latest literature on the extraction and the structural features of SPS, and provide a perspective on the biological applications of SPS. We focus on the current strategies for the extraction of this unique polysaccharide, specific structural features, and functional utilization of SPS. Notably, SPS-based food additives have been demonstrated to add value in biological applications due to their anticancer and immunoregulatory effects, encouraging us to use SPS directly in the area of biomedicine. Lastly, we suggest some potential directions for the development of SPS for extensive utilization in biomedicine.
C1 [Jia, Xuejing; Chen, Meiwan; Wan, Jian-Bo; Su, Huanxing; He, Chengwei] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa 999078, Peoples R China.
RP He, CW (reprint author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, N22-7038 Ave Univ, Taipa 999078, Peoples R China.
EM chengweihe@umac.mo
OI Wan, Jian-Bo/0000-0002-6750-2617
FU Macao Science and Technology Development Fund [074/2013/A]; Research
   Fund of the University of Macau [MYRG107(Y1-L3)-ICMS13-HCW,
   MYRG2015-00081-ICMS-QRCM]
FX This study was supported by the Macao Science and Technology Development
   Fund (074/2013/A) and the Research Fund of the University of Macau
   (MYRG107(Y1-L3)-ICMS13-HCW, MYRG2015-00081-ICMS-QRCM).
CR Aspinall G. O., 1967, J CHEM SOC C, P1065
   ASPINALL GO, 1971, CAN J CHEMISTRY, V49, P1019, DOI 10.1139/v71-169
   Chen H., 2011, FOOD SCI TECHNOL, V36, P211
   [陈红 CHEN Hong], 2011, [食品科学, Food Science], V32, P139
   [陈红 CHEN Hong], 2011, [吉林农业大学学报, Journal of Jilin Agricultural University], V33, P581
   Chen WP, 2010, J FOOD SCI, V75, pC478, DOI 10.1111/j.1750-3841.2010.01688.x
   [陈姿含 Chen Zihan], 2012, [食品与发酵工业, Food and Fermentation Industries], V38, P194
   [丁冬梅 Ding Dongmei], 2014, [中草药, Chinese Traditional and Herbal Drugs], V45, P46
   Fang X, 2003, BIOSCI BIOTECH BIOCH, V67, P1864, DOI 10.1271/bbb.67.1864
   Funami T, 2008, FOOD HYDROCOLLOID, V22, P1528, DOI 10.1016/j.foodhyd.2007.10.008
   Furuta H, 2003, BIOSCI BIOTECH BIOCH, V67, P677, DOI 10.1271/bbb.67.677
   Furuta H, 1998, BIOSCI BIOTECH BIOCH, V62, P2300, DOI 10.1271/bbb.62.2300
   Furuta H, 1999, FOOD HYDROCOLLOID, V13, P267, DOI 10.1016/S0268-005X(99)00009-0
   HIGASHIRA K, 1988, NAGOYA KEIZAI DAIGAK, V22, P9
   Hisashi K., 1997, JPN J CROP SCI, V66, P62
   Hou ZQ, 2010, J AGR FOOD CHEM, V58, P8604, DOI 10.1021/jf1015686
   Huisman MMH, 1999, CARBOHYD POLYM, V38, P299, DOI 10.1016/S0144-8617(98)00127-1
   Huisman MMH, 1998, CARBOHYD POLYM, V37, P87, DOI 10.1016/S0144-8617(97)00111-2
   Inada N., 2014, BIOSCI BIOTECH BIOCH, V79, P97
   KAWAMURA S, 1961, AGR BIOL CHEM TOKYO, V25, P527, DOI 10.1080/00021369.1961.10857841
   Khare SK, 1995, BIORESOURCE TECHNOL, V54, P323, DOI 10.1016/0960-8524(95)00155-7
   KIOSSEOGLOU V, 1988, LEBENSM WISS TECHNOL, V21, P33
   Lai Fu-rao, 2010, Journal of South China University of Technology, V38, P50, DOI 10.3969/j.issn.1000-565X.2010.04.010
   Li J, 2009, BIOSCI BIOTECH BIOCH, V73, P2568, DOI 10.1271/bbb.70799
   Li SH, 2014, J TAIWAN INST CHEM E, V45, P6, DOI 10.1016/j.jtice.2013.05.019
   Li Y., 2006, BEVERAGE FAST FROZEN, V12, P33
   Liao HF, 2005, LIFE SCI, V77, P400, DOI 10.1016/j.lfs.2004.10.080
   Liu J, 2015, J AGR FOOD CHEM, V63, P225, DOI 10.1021/jf505172m
   Liu J, 2015, INT J BIOL MACROMOL, V72, P1182, DOI 10.1016/j.ijbiomac.2014.08.058
   [娄冠群 Lou Guanqun], 2010, [中国油脂, China Oils and Fats], V35, P61
   Mateos-Aparicio I, 2010, CARBOHYD POLYM, V82, P245, DOI 10.1016/j.carbpol.2010.04.020
   Meng Y. C., 2009, FOOD RES DEV, V30, P83
   MORITA M, 1965, AGR BIOL CHEM TOKYO, V29, P564
   Nakamura A, 2006, INT DAIRY J, V16, P361, DOI 10.1016/j.idairyj.2005.01.014
   Nakamura A, 2004, FOOD HYDROCOLLOID, V18, P795, DOI 10.1016/j.foodhyd.2003.12.005
   Nakamura A, 2003, FOOD HYDROCOLLOID, V17, P333, DOI 10.1016/S0268-005X(02)00095-4
   Nakamura A, 2002, BIOSCI BIOTECH BIOCH, V66, P1155, DOI 10.1271/bbb.66.1155
   Nakamura A, 2002, BIOSCI BIOTECH BIOCH, V66, P1301, DOI 10.1271/bbb.66.1301
   Nakamura A, 2001, BIOSCI BIOTECH BIOCH, V65, P2249, DOI 10.1271/bbb.65.2249
   Nakamura A, 2007, J AGR FOOD CHEM, V55, P502, DOI 10.1021/jf062634g
   Nakamura A, 2006, FOOD HYDROCOLLOID, V20, P1029, DOI 10.1016/j.foodhyd.2005.12.002
   Nakamura A, 2012, FOOD HYDROCOLLOID, V29, P75, DOI 10.1016/j.foodhyd.2012.01.018
   Nakauma M, 2008, FOOD HYDROCOLLOID, V22, P1254, DOI 10.1016/j.foodhyd.2007.09.004
   Nobuhara T, 2014, FOOD HYDROCOLLOID, V34, P39, DOI 10.1016/j.foodhyd.2013.01.022
   Ntazinda A, 2014, DAIRY SCI TECHNOL, V94, P283, DOI 10.1007/s13594-014-0162-9
   Ray M, 2013, FOOD RES INT, V52, P298, DOI 10.1016/j.foodres.2013.03.008
   Redondo-Cuenca A, 2008, FOOD CHEM, V108, P1099, DOI 10.1016/j.foodchem.2007.11.061
   Salarbashi D, 2014, FOOD CHEM, V146, P614, DOI 10.1016/j.foodchem.2013.09.014
   Salarbashi D, 2013, CARBOHYD POLYM, V98, P1127, DOI 10.1016/j.carbpol.2013.07.031
   Shi XQ, 2015, LWT-FOOD SCI TECHNOL, V62, P89, DOI 10.1016/j.lwt.2015.01.024
   SHOREY RL, 1985, J AM DIET ASSOC, V85, P1461
   Song H., 2011, CHINA FOOD ADDIT, P89
   Surel O, 2005, J SCI FOOD AGR, V85, P1343, DOI 10.1002/jsfa.2097
   Tajik S, 2013, CARBOHYD POLYM, V97, P817, DOI 10.1016/j.carbpol.2013.05.037
   Tian H. J., 2014, FOOD RES DEV, V35, P66
   [田龙 TIAN Long], 2008, [中国油脂, China Oils and Fats], V33, P64
   TODD JJ, 1993, PLANT PHYSIOL, V102, P663, DOI 10.1104/pp.102.2.663
   [涂宗财 TU Zongcai], 2011, [食品工业科技, Science & Technology of Food Industry], V32, P118
   Wang Q, 2005, CARBOHYD RES, V340, P2637, DOI 10.1016/j.carres.2005.08.012
   [王思远 Wang Siyuan], 2013, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V28, P33
   Wu JE, 2014, FOOD HYDROCOLLOID, V39, P144, DOI 10.1016/j.foodhyd.2013.12.029
   Wu MH, 2011, IMMUNOL INVEST, V40, P39, DOI 10.3109/08820139.2010.513021
   [熊杰 XIONG Jie], 2009, [大豆科学, Soybean Science], V28, P1119
   Xiong X. H., 2014, FOOD BIOPROD PROCESS, V94, P1
   [熊小辉 Xiong Xiaohui], 2013, [中国油脂, China Oils and Fats], V38, P64
   Yamaguchi F, 1996, CARBOHYD POLYM, V30, P265, DOI 10.1016/S0144-8617(96)00046-X
   Yao L, 2011, INT J MOL SCI, V12, P8096, DOI 10.3390/ijms12118096
   Yao XQ, 2012, CARBOHYD POLYM, V90, P392, DOI 10.1016/j.carbpol.2012.05.056
   [易阳 Yi Yang], 2013, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V28, P50
   Yin Y., 2009, SCI TECHNOL FOOD IND, V30, P83
   [张树和 ZHANG Shuhe], 2008, [中国微生态学杂志, Chinese Journal of Microecology], V20, P135
   Zhang X. J., 2012, DRUG EVAL RES, V35, P420
   [张秀娟 Zhang Xiujuan], 2014, [食品工业科技, Science & Technology of Food Industry], V35, P359
   [张秀娟 Zhang Xiujuan], 2013, [中国微生态学杂志, Chinese Journal of Microecology], V25, P521
   [张秀娟 Zhang Xiujuan], 2012, [食品工业科技, Science & Technology of Food Industry], V33, P389
   Zhao JJ, 2014, FOOD RES INT, V66, P216, DOI 10.1016/j.foodres.2014.09.019
   Zhao JJ, 2015, FOOD HYDROCOLLOID, V44, P443, DOI 10.1016/j.foodhyd.2014.10.025
   Zhao X., 2013, FOOD FERMENT IND, V39, P44
   许晨, 2002, [中国海洋药物, Chinese Journal of Marine Drugs], V21, P26
NR 79
TC 6
Z9 6
U1 13
U2 65
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 90
BP 73525
EP 73534
DI 10.1039/c5ra12421b
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA CQ8LY
UT WOS:000360860500024
DA 2018-10-20
ER

PT J
AU Chen, SS
   Lu, XM
   Zhu, DD
   Lu, QH
AF Chen, Shuangshuang
   Lu, Xuemin
   Zhu, Dandan
   Lu, Qinghua
TI Targeted grafting of thermoresponsive polymers from a penetrative
   honeycomb structure for cell sheet engineering
SO SOFT MATTER
LA English
DT Article
ID PROTEIN ADSORPTION; HIERARCHICAL STRUCTURES; BREATH FIGURES; SURFACE;
   ADHESION; BRUSHES; FILMS; ROUGHNESS; CHEMISTRY; BIOMATERIALS
AB Responsive membranes have been used to construct smart biomaterial interfaces. We report a novel approach to fabricate honeycomb films with a pattern of thermoresponsive polymer, namely poly( N-isopropylacrylamide). The approach was based on a combination of the breath figure method and reversible addition-fragmentation chain transfer. The hybrid film had morphological and chemical patterns resulting in varied wettability and morphology at various stages, as well as high thermo-responsiveness. Enhanced cell adhesion was observed at an incubation temperature of 37 degrees C, which is above its lower critical solution temperature (LCST). Furthermore, cells could be harvested at temperatures below the LCST without trypsin treatment. The non-invasive characteristics give this membrane potential as a substrate for cell sheet engineering.
C1 [Chen, Shuangshuang; Lu, Xuemin; Zhu, Dandan; Lu, Qinghua] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Sch Chem & Chem Engn, Shanghai 200240, Peoples R China.
RP Lu, XM (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Sch Chem & Chem Engn, Shanghai 200240, Peoples R China.
EM xueminlu@sjtu.edu.cn; qhlu@sjtu.edu.cn
RI shuangshuang, chen/R-4029-2017
OI shuangshuang, chen/0000-0002-8478-5030
FU Chinese National Programs for Fundamental Research and Development (973
   Project) [2012CB933803]; National Science Foundation of China [21374060,
   51173103]; Excellent Academic Leaders of Shanghai [11XD1403000]
FX This work was supported by the Major Program of Chinese National
   Programs for Fundamental Research and Development (973 Project:
   2012CB933803), the National Science Foundation of China (21374060,
   51173103), and the Excellent Academic Leaders of Shanghai (11XD1403000).
CR Ahuja R.T., 2009, SENSOR ACTUAT B-CHEM, V136, P275
   Arisaka Y, 2013, BIOMATERIALS, V34, P4214, DOI 10.1016/j.biomaterials.2013.02.056
   Baharloo B, 2005, J BIOMED MATER RES A, V74A, P12, DOI 10.1002/jbm.a.30321
   Bai H, 2013, ANGEW CHEM INT EDIT, V52, P12240, DOI 10.1002/anie.201303594
   Baussard JF, 2004, POLYMER, V45, P3615, DOI 10.1016/j.polymer.2004.03.081
   Bhushan B, 2009, PHILOS T R SOC A, V367, P1631, DOI 10.1098/rsta.2009.0014
   Bryksin AV, 2014, ACTA BIOMATER, V10, P1761, DOI 10.1016/j.actbio.2014.01.019
   Chen DQ, 2011, INT J NANOMED, V6, P2053, DOI 10.2147/IJN.S24344
   Chen SS, 2015, CHEM COMMUN, V51, P5698, DOI 10.1039/c4cc10379c
   Chen SS, 2015, BIOMATER SCI-UK, V3, P85, DOI 10.1039/c4bm00233d
   Chu E, 2015, ACS APPL MATER INTER, V7, P12505, DOI 10.1021/am5080248
   Cooperstein MA, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4894530
   Cui JX, 2013, MACROMOL RAPID COMM, V34, P310, DOI 10.1002/marc.201200634
   de Leon AS, 2013, POLYM CHEM-UK, V4, P4024, DOI 10.1039/c3py00394a
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Ercole F, 2010, POLYM CHEM-UK, V1, P37, DOI 10.1039/b9py00300b
   Escale P, 2012, EUR POLYM J, V48, P1001, DOI 10.1016/j.eurpolymj.2012.03.001
   Fang N, 2005, COLLOID SURFACE B, V42, P245, DOI 10.1016/j.colsurfb.2004.11.002
   George J, 2008, J BIOMED MATER RES A, V87A, P1103, DOI 10.1002/jbm.a.32277
   Heng LP, 2013, LANGMUIR, V29, P9491, DOI 10.1021/la401991n
   Hernandez-Guerrero M, 2008, J MATER CHEM, V18, P4718, DOI 10.1039/b807495j
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Isenberg BC, 2008, BIOMATERIALS, V29, P2565, DOI 10.1016/j.biomaterials.2008.02.023
   Jones JR, 2006, MATER TODAY, V9, P34, DOI 10.1016/S1369-7021(06)71741-2
   Kohen A., 1999, CHEM BIOL, V6, P191
   Kroning A, 2015, ACS APPL MATER INTER, V7, P12430, DOI 10.1021/am5075997
   Li LH, 2011, COLLOID SURFACE B, V85, P12, DOI 10.1016/j.colsurfb.2010.09.028
   Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031
   Mrksich M, 2002, CURR OPIN CHEM BIOL, V6, P794, DOI 10.1016/S1367-5931(02)00362-9
   Nagase K, 2011, MACROMOL BIOSCI, V11, P400, DOI 10.1002/mabi.201000312
   Natalia B, 2015, J BIOMED MATER RES A, V103, P145, DOI 10.1002/jbm.a.35163
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Okano T, 1996, P SOC PHOTO-OPT INS, V2779, P34, DOI 10.1117/12.237120
   Psarra E, 2015, ACS APPL MATER INTER, V7, P12516, DOI 10.1021/am508161q
   Ranella A, 2010, ACTA BIOMATER, V6, P2711, DOI 10.1016/j.actbio.2010.01.016
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Romeis D, 2015, ACS APPL MATER INTER, V7, P12496, DOI 10.1021/am507959k
   Shimauchi H., 2013, JPN DENT SCI REV, V49, P118
   Talab SS, 2014, BJU INT, V114, P937, DOI 10.1111/bju.12685
   Wan LS, 2012, J AM CHEM SOC, V134, P95, DOI 10.1021/ja2092745
   Wan PB, 2012, PROG CHEM, V24, P1
   Yamazaki H, 2014, J BIOSCI BIOENG, V118, P455, DOI 10.1016/j.jbiosc.2014.03.006
   Yin RX, 2010, COLLOID SURFACE B, V76, P483, DOI 10.1016/j.colsurfb.2009.12.008
   Zhang Y, 2007, ADV MATER, V19, P913, DOI 10.1002/adma.200601169
   Zhao C, 2013, BIOMATERIALS, V34, P4714, DOI 10.1016/j.biomaterials.2013.03.028
NR 45
TC 6
Z9 6
U1 3
U2 44
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2015
VL 11
IS 37
BP 7420
EP 7427
DI 10.1039/c5sm01769f
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA CR7SC
UT WOS:000361550000023
PM 26268946
DA 2018-10-20
ER

PT J
AU Yu, ML
   Yu, MF
   Zhu, LQ
   Wang, TT
   Zhou, Y
   Wang, HM
AF Yu, Meng-Liu
   Yu, Meng-Fei
   Zhu, Li-Qin
   Wang, Tian-Tian
   Zhou, Yi
   Wang, Hui-Ming
TI The Effects of TiO2 Nanodot Films with RGD Immobilization on
   Light-Induced Cell Sheet Technology
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; ARG-GLY-ASP; GENE-EXPRESSION; PEPTIDE; ADHESION;
   TITANIUM; GROWTH; DIFFERENTIATION; ATTACHMENT; DETACHMENT
AB Cell sheet technology is a new strategy in tissue engineering which could be possible to implant into the body without a scaffold. In order to get an integrated cell sheet, a light-induced method via UV365 is used for cell sheet detachment from culture dishes. In this study, we investigated the possibility of cell detachment and growth efficiency on TiO2 nanodot films with RGD immobilization on light-induced cell sheet technology. Mouse calvaria-derived, preosteoblastic (MC3T3-E1) cells were cultured on TiO2 nanodot films with (TR) or without (TN) RGD immobilization. After cells were cultured with or without 5.5mW/cm(2) UV365 illumination, cell morphology, cell viability, osteogenesis related RNA and protein expression, and cell detachment ability were compared, respectively. Light-induced cell detachment was possible when cells were cultured on TR samples. Also, cells cultured on TR samples showed better cell viability, alongside higher protein and RNA expression than on TN samples. This study provides a new biomaterial for light-induced cell/cell sheet harvesting.
C1 [Yu, Meng-Liu; Yu, Meng-Fei; Zhou, Yi; Wang, Hui-Ming] Zhejiang Univ, Coll Med, Affiliated Hosp Stomatol, Hangzhou 310006, Zhejiang, Peoples R China.
   [Zhu, Li-Qin; Wang, Hui-Ming] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310006, Zhejiang, Peoples R China.
   [Wang, Tian-Tian] Zhejiang Univ, State Key Lab Silicon Mat, Dept Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China.
RP Wang, HM (reprint author), Zhejiang Univ, Coll Med, Affiliated Hosp Stomatol, Hangzhou 310006, Zhejiang, Peoples R China.
EM hmwang1960@hotmail.com
FU National Natural Science Foundation of China [81171003, 81371120];
   Medical Technology and Education of Zhejiang Province of China
   [wkj-zj-11]
FX This work is financially supported by National Natural Science
   Foundation of China (81171003 and 81371120) and Medical Technology and
   Education of Zhejiang Province of China (wkj-zj-11).
CR Andiappan M., 2013, PROG BIOMATER, V2, P1
   BHALERAO J, 1995, TISSUE CELL, V27, P369, DOI 10.1016/S0040-8166(95)80058-1
   Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a
   Cao FY, 2015, ACS APPL MATER INTER, V7, P6698, DOI 10.1021/acsami.5b00064
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Csucs G, 2003, BIOMATERIALS, V24, P1713, DOI 10.1016/S0142-9612(02)00568-9
   deLaat A, 1997, CARCINOGENESIS, V18, P1013, DOI 10.1093/carcin/18.5.1013
   Fukumori K, 2009, ACTA BIOMATER, V5, P470, DOI 10.1016/j.actbio.2008.06.018
   Guillaume-Gentil O, 2011, BIOMATERIALS, V32, P4376, DOI 10.1016/j.biomaterials.2011.02.058
   Han YL, 2013, COLLOID SURFACE B, V111, P479, DOI 10.1016/j.colsurfb.2013.06.042
   Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402
   Hazrin-Chong NH, 2012, J MICROBIOL METH, V90, P96, DOI 10.1016/j.mimet.2012.04.014
   Hong Y, 2013, BIOMATERIALS, V34, P11, DOI 10.1016/j.biomaterials.2012.09.043
   Huang HL, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-36
   Huang YC, 2013, SPINE J, V13, P352, DOI 10.1016/j.spinee.2012.12.005
   Inaba R, 2009, BIOMATERIALS, V30, P3573, DOI 10.1016/j.biomaterials.2009.03.045
   Ito A, 2005, BIOMATERIALS, V26, P6185, DOI 10.1016/j.biomaterials.2005.03.039
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KM, 2013, ACTA BIOMATER, V9, P5600, DOI 10.1016/j.actbio.2012.10.036
   Little MW, 2007, J PHYS CHEM C, V111, P1412, DOI 10.1021/jp063154v
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marie PJ, 2014, CALCIFIED TISSUE INT, V94, P46, DOI 10.1007/s00223-013-9733-7
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   MCAUSLAN BR, 1987, J BIOMED MATER RES, V21, P921, DOI 10.1002/jbm.820210708
   Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4
   Oya K, 2009, BIOMATERIALS, V30, P1281, DOI 10.1016/j.biomaterials.2008.11.030
   Papadopoulou EL, 2009, J PHYS CHEM C, V113, P2891, DOI 10.1021/jp8085057
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   QUAITE FE, 1994, PLANT MOL BIOL, V24, P475, DOI 10.1007/BF00024115
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Schliephake H, 2008, J MATER CHEM, V18, P2404, DOI 10.1039/015355b
   Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   STEIN GS, 1990, FASEB J, V4, P3111
   Tang ZL, 2010, BIOMATERIALS, V31, P7435, DOI 10.1016/j.biomaterials.2010.06.040
   Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806
   Von Recum HA, 1999, EXP EYE RES, V69, P97, DOI 10.1006/exer.1999.0682
   Wang F, 2013, INT J MOL SCI, V14, P13447, DOI 10.3390/ijms140713447
   Wu YS, 2015, INT J ONCOL, V46, P2586, DOI 10.3892/ijo.2015.2976
   Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2
   Zhu K, 2007, NANO LETT, V7, P69, DOI 10.1021/nl062000o
NR 43
TC 1
Z9 1
U1 1
U2 11
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 582359
DI 10.1155/2015/582359
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CR3CN
UT WOS:000361208200001
PM 26417596
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lu, DS
   Zheng, ZZ
   Guo, SZ
   Wang, C
   Kaplan, DL
   Wang, XQ
AF Lu, Disi
   Zheng, Zhaozhu
   Guo, Shaozhe
   Wang, Cheng
   Kaplan, David L.
   Wang, Xiaoqin
TI Binding Quantum Dots to Silk Biomaterials for Optical Sensing
SO JOURNAL OF SENSORS
LA English
DT Article
ID COMPOSITES; GLUCOSE; NANOCRYSTALS; PROTEINS; SENSORS; CHARGE; SIZE; FILM
AB Quantum dots (QDs), have great potential for fabricating optical sensing devices and imaging biomaterial degradation in vivo. In the present study, 2-mercaptoethylamine- (MEA-) and mercaptopropionic acid-(MPA-) capped CdTe-QDs were physically incorporated in silk films that contained a high content (>30%) of crystalline beta-sheet structure. The beta-sheets were induced by the addition of glycerol, water annealing, glycerol/annealing, or treatment with methanol. Incorporation of QDs did not influence the formation of beta-sheets. When the films were extracted with water, most QDs remained associated with the silk, based on the retention of photoluminescence in the silk films and negligible photoluminescence in the extracts. Compared to the solution state, photoluminescence intensity significantly decreased for MEA-QDs but not for MPA-QDs in the silk films, while the emission maximum blue shifted (approximate to 4 nm) slightly for both. Further film digestion using protease XIV, alpha-chymotrypsin, and the combination of the two proteases suggested that QDs may be bound to the silk beta-sheet regions but not the amorphous regions. QDs photoluminescence in silk films was quenched when the concentration of hydrogen peroxide (H2O2) was above 0.2-0.3 mM, indicating the QDs-incorporated silk films can be used to report oxidation potential in solution.
C1 [Lu, Disi; Wang, Cheng] Heilongjiang Univ, Coll Chem Engn & Mat Chem, Harbin 150086, Peoples R China.
   [Zheng, Zhaozhu; Guo, Shaozhe; Wang, Xiaoqin] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Wang, XQ (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM xiaoqin.wang@tufts.edu
FU Natural Science Foundation of China Grant [51273138]; Start-Up Fund of
   Soochow University [14317432]; Natural Science Foundation of Suzhou City
   Jiangsu Province China [SYN201403]; Postdoctoral Science Foundation of
   Jiangsu Province China
FX This work was supported by Natural Science Foundation of China Grant
   (Project no. 51273138), Start-Up Fund of Soochow University (Project no.
   14317432), Natural Science Foundation of Suzhou City Jiangsu Province
   China (Grant no. SYN201403), and Postdoctoral Science Foundation of
   Jiangsu Province China.
CR Bakker E, 2004, ANAL CHEM, V76, P3285, DOI 10.1021/ac049580z
   Brown J., 2015, ACTA BIOMATER, V11, P212
   Broza YY, 2013, NANOMEDICINE-UK, V8, P785, DOI [10.2217/NNM.13.64, 10.2217/nnm.13.64]
   Cho S, 2013, CHEM MATER, V25, P1071, DOI 10.1021/cm3040505
   Chong Y, 2014, BIOMATERIALS, V35, P5041, DOI 10.1016/j.biomaterials.2014.03.021
   Dong ZM, 2013, J PROTEOME RES, V12, P5213, DOI 10.1021/pr4005772
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Gaponik N, 2002, J PHYS CHEM B, V106, P7177, DOI 10.1021/jp025541k
   Gill R, 2008, ANGEW CHEM INT EDIT, V47, P1676, DOI 10.1002/anie.200704794
   Hardy JG, 2013, MACROMOL BIOSCI, V13, P1431, DOI 10.1002/mabi.201300233
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Ismaili H, 2011, CHEM MATER, V23, P1519, DOI 10.1021/cm103284g
   Kaniyankandy S, 2010, PHYS CHEM CHEM PHYS, V12, P4210, DOI 10.1039/b921130f
   Kuang H, 2011, TRAC-TREND ANAL CHEM, V30, P1620, DOI 10.1016/j.trac.2011.04.022
   Li YP, 2013, LUMINESCENCE, V28, P667, DOI 10.1002/bio.2413
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   Luccardini C, 2006, LANGMUIR, V22, P2304, DOI 10.1021/la052704y
   Ludwigs S, 2003, NAT MATER, V2, P744, DOI 10.1038/nmat997
   Ma Q, 2011, ANALYST, V136, P4883, DOI 10.1039/c1an15741h
   Murphy CJ, 2002, ANAL CHEM, V74, p520A, DOI 10.1021/ac022124v
   Osaki F, 2004, J AM CHEM SOC, V126, P6520, DOI 10.1021/ja048792a
   Pellegrino T, 2004, NANO LETT, V4, P703, DOI 10.1021/nl035172j
   Pritchard EM, 2012, BIOPOLYMERS, V97, P479, DOI 10.1002/bip.22026
   Reece TJ, 2003, APPL PHYS LETT, V82, P142, DOI 10.1063/1.1533844
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Saran AD, 2011, COLLOID SURFACE A, V384, P393, DOI 10.1016/j.colsurfa.2011.04.022
   Stolarek R, 2010, CLIN CHIM ACTA, V411, P1849, DOI 10.1016/j.cca.2010.08.031
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109
   Venugopal BR, 2006, J PHYS CHEM B, V110, P772, DOI 10.1021/jp054774j
   Yao HB, 2012, ACS NANO, V6, P8250, DOI 10.1021/nn3029315
   Zimnitsky D, 2007, LANGMUIR, V23, P4509, DOI 10.1021/la0636917
NR 32
TC 3
Z9 3
U1 2
U2 26
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 1687-725X
EI 1687-7268
J9 J SENSORS
JI J. Sens.
PY 2015
AR 819373
DI 10.1155/2015/819373
PG 10
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA CR3GG
UT WOS:000361218700001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Sund, JB
   Wolter, SD
   Parker, CB
   Natishan, PM
   Glass, JT
AF Sund, James B.
   Wolter, Scott D.
   Parker, Charles B.
   Natishan, Paul M.
   Glass, Jeffrey T.
TI Diamond for Biosensing: Electrochemical Detection of NOx Species with
   Thiol-Amine Functionalized Diamond
SO JOURNAL OF THE ELECTROCHEMICAL SOCIETY
LA English
DT Article
ID NITRIC-OXIDE MICROSENSOR; MODIFIED CARBON-FIBER; ELECTROCATALYTIC
   OXIDATION; ELECTRODE; FILMS; POLYMER; SENSORS; BRAIN
AB Diamond has long been of interest as a biomaterial due to its expected biocompatibility and chemical stability. Progress in surface functionalization of diamond and diamond electrochemistry has extended this interest to use as a biosensor platform. The sensitivity and selectivity of the diamond surface can be enhanced by covalently attaching carbon-based biochemicals. In this communication, an amine-thiol molecule was attached to a boron-doped diamond (BDD) surface to produce an enhanced ability to detect NO species. In the case of hydrogen terminated BDD, it was found that NO (aqueous) oxidation was insufficiently distinct to electrochemically detect NO. However, the amine-thiol functionalized BDD surface provided a distinct oxidation peak from 65 nanomolar to 236 nanomolar concentrations. Multiple cyclic voltammagrams with amine-thiol functionalized BDD electrode in (HPLC-quality) purified water indicated that the covalently attached surface molecules resisted decomposition during both anodic and cathodic polarization. (C) The Author(s) 2015. Published by ECS. All rights reserved.
C1 [Sund, James B.; Parker, Charles B.; Glass, Jeffrey T.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA.
   [Wolter, Scott D.] Elon Univ, Dept Phys, Elon, NC 27244 USA.
   [Natishan, Paul M.] Naval Res Lab, Washington, DC 20375 USA.
RP Sund, JB (reprint author), Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA.
EM cbparker@duke.edu
FU NASA [NNL05AA14A]
FX A significant amount of this work was funded in part by Dr. Seun Kahng,
   NASA grant No. NNL05AA14A; Boron doped diamond samples were provided by
   Taka Tachibana, Kobe Steel, Ltd., Electronics Research Laboratory. 1-5-5
   Takatsukadai, Nishi-ku, Kobe 651-2271 Japan. We also thank Corey P.
   Causey and his doctoral advisor Professor Eric J. Toone in the
   Departments of Chemistry and Biochemistry, Duke University, Durham, NC
   USA for their direct involvement in extending the amine surface tether
   to a terminal Thiol. We are grateful to Dr. Michael Garcia, Nicki
   Thompson, and Prof. Joseph Bonaventura for help in developing the NO
   calibration protocol. Finally, we thank Edmond F. Bowden of North
   Carolina State University for use of the electrochemical cell.
CR Allen BW, 2000, NITRIC OXIDE-BIOL CH, V4, P75, DOI 10.1006/niox.2000.0273
   Beckman Joseph S., 1995, Methods (Orlando), V7, P35, DOI 10.1006/meth.1995.1005
   BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030
   Casero E, 2003, TALANTA, V61, P61, DOI 10.1016/S0039-9140(03)00360-6
   Casero E, 2003, ANAL BIOANAL CHEM, V375, P294, DOI 10.1007/s00216-002-1650-y
   Ciszewski A, 1996, ELECTROANAL, V8, P293, DOI 10.1002/elan.1140080316
   Davies IR, 2008, METHOD ENZYMOL, V436, P63, DOI 10.1016/S0076-6879(08)36005-4
   Derjaguin D. L. H., 1973, CARBON, V11, P299
   Fabre B, 1997, J ELECTROANAL CHEM, V426, P75, DOI 10.1016/S0022-0728(96)04985-6
   Fan CH, 2000, ANAL CHIM ACTA, V423, P95, DOI 10.1016/S0003-2670(00)01093-X
   Fan CH, 2002, ANAL SCI, V18, P129, DOI 10.2116/analsci.18.129
   Feelisch M, 1996, METHODS NITRIC OXIDE
   Ferreira NR, 2005, ANAL CHIM ACTA, V535, P1, DOI 10.1016/j.aca.2004.12.017
   Friedemann MN, 1996, ANAL CHEM, V68, P2621, DOI 10.1021/ac960093w
   GE Analytical Instruments, 2009, SEIVERS NITRIC OXIDE
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Haruyama T, 1998, BIOSENS BIOELECTRON, V13, P763, DOI 10.1016/S0956-5663(98)00040-2
   He XC, 2000, ANALYST, V125, P793, DOI 10.1039/a909837b
   ICHIMORI K, 1994, REV SCI INSTRUM, V65, P2714, DOI 10.1063/1.1144674
   Ji YB, 1999, ARCH BIOCHEM BIOPHYS, V362, P67, DOI 10.1006/abbi.1998.1013
   Kato D, 2005, SENSOR ACTUAT B-CHEM, V108, P384, DOI 10.1016/j.snb.2004.12.095
   Katrlik J, 2002, BIOELECTROCHEMISTRY, V56, P73, DOI 10.1016/S1567-5394(02)00024-5
   Kitajima A, 2001, ELECTROCHEMISTRY, V69, P16
   Kitamura Y, 2000, ANAL CHEM, V72, P2957, DOI 10.1021/ac000165q
   LANTOINE F, 1995, J ELECTROANAL CHEM, V392, P85, DOI 10.1016/0022-0728(95)04042-M
   Lee Y, 2004, ANAL CHEM, V76, P536, DOI 10.1021/ac035064h
   Mizutani F, 2001, SENSOR ACTUAT B-CHEM, V76, P489, DOI 10.1016/S0925-4005(01)00596-2
   Park JK, 1998, BIOSENS BIOELECTRON, V13, P1187, DOI 10.1016/S0956-5663(98)00078-5
   Pontie M, 1999, ELECTROANAL, V11, P845, DOI 10.1002/(SICI)1521-4109(199908)11:12<845::AID-ELAN845>3.3.CO;2-4
   Shin JH, 2005, ANAL CHEM, V77, P3494, DOI 10.1021/ac048153i
   Smith SR, 1998, INORG CHIM ACTA, V273, P316, DOI 10.1016/S0020-1693(97)06062-3
   Steffen K., 2004, ELECTROANAL, V16, P253
   Strother T, 2002, LANGMUIR, V18, P968, DOI 10.1021/la0112561
   Sund JB, 2014, APPL SURF SCI, V301, P293, DOI 10.1016/j.apsusc.2014.02.067
   Wallace John L., 1995, Methods (Orlando), V7, P55, DOI 10.1006/meth.1995.1008
   WENNMALM A, 1990, ANAL BIOCHEM, V187, P359, DOI 10.1016/0003-2697(90)90470-T
   Williams D. L. H., 2004, NITROSATION REACTION
   Xian YZ, 1999, ANAL CHIM ACTA, V381, P191, DOI 10.1016/S0003-2670(98)00765-X
NR 38
TC 2
Z9 2
U1 4
U2 23
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA
SN 0013-4651
EI 1945-7111
J9 J ELECTROCHEM SOC
JI J. Electrochem. Soc.
PY 2015
VL 162
IS 8
BP B225
EP B229
DI 10.1149/2.0691508jes
PG 5
WC Electrochemistry; Materials Science, Coatings & Films
SC Electrochemistry; Materials Science
GA CR2WS
UT WOS:000361192200038
OA Other Gold
DA 2018-10-20
ER

PT J
AU Miki, M
   Morita, M
AF Miki, Masahito
   Morita, Masafumi
TI Evaluation of the Biocompatibility of a Ti-Ta-Sn Alloy Using Cell
   Cultures
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium alloy; cell adhesion rate; cell proliferation rate;
   cytotoxicity analysis; metallic biomaterial
AB The purpose of this study was to determine the suitability of a newly developed Ti-Ta-Sn alloy for use as a metallic biomaterial. The in vitro cell toxicity was determined by testing the corroding metal solutions using cell culture. Besides the cell adhesion rate, cell proliferation and colony formation were tested on the metal plates. Results of the cytotoxicity tests for higher concentrations of the corroding metal solutions (32 ppm and 64 ppm) revealed that the toxicity for U937 macrophages was lowest for the Ti-Ta-Sn alloy, followed by SUS316L and Co-Cr-Mo, with Ni-Ti being the most toxic. The Ti-Ta-Sn solution showed no cytotoxicity, even at a concentration of 64 ppm. The Co-Cr-Mo and Ni-Ti solutions showed high cytotoxicity for L929 cells. The cytotoxicity that was measured from the lactate dehydrogenase (LDH) release was highest for the Co-Cr-Mo alloy, followed by Ni-Ti, SUS316L, and Ti-Ta-Sn that showed the lowest value. Besides, the success rate of cell adhesion was highest for the Ti-Ta-Sn alloy after culturing for 6, 12, and 24 h. The cell proliferation tests showed that the cell proliferation speed and the relative cell proliferation rate after 3 days were both highest on Ti-Ta-Sn plates. Colony formation was highest on the Ti-Ta-Sn plates, and it was lowest on Co-Cr-Mo and SUS316L plates. These results demonstrated the suitability of the Ti-Ta-Sn alloy for use as a metallic biomaterial at the cellular level.
C1 [Miki, Masahito] Saitama Univ, Res & Dev Bur, Tech Support Ctr, Saitama 3388570, Japan.
   [Morita, Masafumi] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan.
RP Miki, M (reprint author), Saitama Univ, Res & Dev Bur, Tech Support Ctr, Saitama 3388570, Japan.
EM miki@mech.saitama-u.ac.jp
FU Japan Science and Technology Agency Revitalization Promotion Program
   (A-STEP) [241FS0064]
FX Part of this study was conducted under the auspices of the Japan Science
   and Technology Agency Revitalization Promotion Program (A-STEP), seeds
   validation type (241FS0064).
CR Hanawa T., 2007, METALS BIOMATERIALS, P85
   Ishihara K., 2010, FOUNDAMETALS BIOMATE, P30
   Ishikawa Y., 2014, MAT SCI TECHN JAPAN, V51, P217
   Kawanishi S, 2001, FREE RADICAL BIO MED, V31, P108, DOI 10.1016/S0891-5849(01)00558-5
   Kobayashi E., 2002, MAT JAPAN, V41, P553
   Miki M., 2014, MAT SCI TECHN JAPAN, V51, P117
   Oshida Y, 1991, ZAIRYO TO KANKYO, V40, P834
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA, P80
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
NR 9
TC 1
Z9 1
U1 0
U2 4
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PY 2015
VL 56
IS 7
BP 1087
EP 1091
DI 10.2320/matertrans.M2015062
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CR2JZ
UT WOS:000361156900038
OA Bronze
DA 2018-10-20
ER

PT J
AU Kowalski, SJ
   Szadzinska, J
   Pawlowski, A
AF Kowalski, S. J.
   Szadzinska, J.
   Pawlowski, A.
TI Ultrasonic-Assisted Osmotic Dehydration of Carrot Followed by Convective
   Drying with Continuous and Intermittent Heating
SO DRYING TECHNOLOGY
LA English
DT Article
DE Carrot; Intermittent drying; Osmotic pretreatment; Quality; Ultrasound
ID POWER ULTRASOUND; PRODUCT QUALITY; BETA-CAROTENE; COLOR CHANGES;
   KINETICS; PRETREATMENT; SLICES; VEGETABLES; PINEAPPLE; FRUITS
AB The aim of the studies was to analyze the effect of ultrasound action on osmotic pretreatment and then on drying kinetics in continuous and intermittent drying conditions, and on the final product quality. This article presents the results of intermittent-convective drying of carrot preceded by ultrasonic assisted osmotic dehydration in fructose aqueous solutions. The theoretical drying kinetics developed from the numerical solution of mathematical model is validated using the experimental data. It has been shown that combination of ultrasonic assisted osmosis with intermittent-convective drying accelerates the drying process and improves the quality of dried biomaterial. A good adherence of the numerically determined kinetic curves confirms the usefulness of the presented model and its possible application to construction of controlled and optimized drying processes.
C1 [Kowalski, S. J.; Szadzinska, J.; Pawlowski, A.] Poznan Univ Tech, Inst Technol & Chem Engn, Dept Proc Engn, PL-60965 Poznan, Poland.
RP Kowalski, SJ (reprint author), Poznan Univ Tech, Inst Technol & Chem Engn, Dept Proc Engn, Berdychowo 4, PL-60965 Poznan, Poland.
EM Stefan.J.Kowalski@put.poznan.pl
RI Pawlowski, Andrzej/P-3989-2015; Szadzinska, Justyna/R-5862-2016
FU National Science Center Poland [2012/05/B/ST8/01773]
FX This work was carried out as a part of the research project No
   2012/05/B/ST8/01773 sponsored by the National Science Center Poland.
CR Adams M., 1999, BASIC FOOD SAFETY HL, P29
   Burri BJ, 1997, NUTR RES, V17, P547, DOI 10.1016/S0271-5317(97)00011-0
   Chua KJ, 2003, BIORESOURCE TECHNOL, V90, P285, DOI 10.1016/S0960-8524(03)00133-0
   Chua KJ, 2001, DRY TECHNOL, V19, P1949, DOI 10.1081/DRT-100107282
   Fernandes FAN, 2009, J FOOD ENG, V90, P186, DOI 10.1016/j.jfoodeng.2008.06.021
   Frias J, 2010, J AGR FOOD CHEM, V58, P10539, DOI 10.1021/jf102797y
   Gajewska I., 1974, PHYS CHEM HDB
   Jayaraman KS, 2006, HDB IND DRYING, P606
   Kek SP, 2013, FOOD BIOPROD PROCESS, V91, P495, DOI 10.1016/j.fbp.2013.05.003
   Koca N, 2007, J FOOD ENG, V78, P449, DOI 10.1016/j.jfoodeng.2005.10.014
   Kowalski SJ, 2014, DRY TECHNOL, V32, P1310, DOI 10.1080/07373937.2014.915555
   Kowalski SJ, 2013, DRY TECHNOL, V31, P1849, DOI 10.1080/07373937.2013.833518
   Kowalski SJ, 2010, DRY TECHNOL, V28, P1023, DOI 10.1080/07373937.2010.497095
   Kowalski SJ, 2013, J FOOD ENG, V118, P393, DOI 10.1016/j.jfoodeng.2013.04.028
   Krokida MK, 2000, DRY TECHNOL, V18, P1251, DOI 10.1080/07373930008917775
   Kudra T, 2004, DRY TECHNOL, V22, P917, DOI [10.1081/DRT-120038572, 10.1081/drt-120038572]
   Lewicki PP, 2006, HDB IND DRYING, P665
   Pan YK, 1999, DRY TECHNOL, V17, P2323, DOI 10.1080/07373939908917686
   Pan YK, 2003, DRY TECHNOL, V21, P1101, DOI 10.1081/DRT-120021877
   Sabarez HT, 2012, DRY TECHNOL, V30, P989, DOI 10.1080/07373937.2012.677083
   Sagar VR, 2010, J FOOD SCI TECH MYS, V47, P15, DOI 10.1007/s13197-010-0010-8
   Saltmarch M., 1982, Diabetes, V31, P29
   Sikorski Z.E., 2007, FOOD CHEM FOOD INGRE
   Tan M, 2001, DRY TECHNOL, V19, P2193, DOI 10.1081/DRT-100107494
   Zheng J, 2014, INT J FOOD SCI TECH, V49, P531, DOI 10.1111/ijfs.12334
NR 25
TC 13
Z9 14
U1 1
U2 19
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0737-3937
EI 1532-2300
J9 DRY TECHNOL
JI Dry. Technol.
PY 2015
VL 33
IS 13
SI SI
BP 1570
EP 1580
DI 10.1080/07373937.2015.1012265
PN 1
PG 11
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA CQ5RS
UT WOS:000360663900007
DA 2018-10-20
ER

PT J
AU Lim, JI
   Kim, SH
AF Lim, Jin Ik
   Kim, Soo Hyun
TI Blood-compatible Bio-inspired Surface of
   Poly(L-lactide-co-epsilon-caprolactone) Films Prepared Using Poor
   Co-solvent Casting
SO POLYMER-KOREA
LA English
DT Article
DE antithrombotic material; lotus-leaf-like structure; co-solvent system;
   blood vessel; surface modification
ID ENDOTHELIAL GROWTH-FACTOR; SUPERHYDROPHOBIC SURFACES; LOTUS-LEAF;
   MICROSPHERES; FABRICATION; BEHAVIOR; RELEASE; ACID)
AB Simple poor-cosolvent casting was used to surface treat biodegradable elastic poly(L-lactide-co-epsilon-caprolactone) (PLCL; 50:50) copolymer films that presented lotus-leaf-like structures. We evaluated whether the lotus-leaflike-structured PLCL (L-PLCL) films could be used as a biomaterial for artificial vascular grafts. The surface morphology, hydrophobicity, and antithrombotic efficiency of the films were examined while immersed in platelet-rich plasma (PRP) using scanning electron microscopy (SEM) and a contact angle meter. The recovery and crystallinity of the films were measured using a tensile-strength testing machine and an X-ray diffractometer, respectively. The solvent containing acetic acid, as a poor co-solvent, and methylene chloride mixed in a 1:2 ratio produced an optimal PLCL film with a water contact angle of approximately 124 degrees. Furthermore, the surface of the L-PLCL films immersed in PRP showed a lower rate of platelet adhesion (<10%) than that of the surface of an untreated PLCL film immersed in PRP.
C1 [Lim, Jin Ik] Dancook Univ, Coll Engn, Lab Biointetfaces Tissue Engn, Dept Chem Engn,Inst Tissue Regenerat Engn,Coll En, Yongin 448701, Gyeonggi Do, South Korea.
   [Kim, Soo Hyun] Korea Inst Sci & Technol, Biomat Res Ctr, Div Life & Hlth Sci, Seoul 136791, South Korea.
   [Kim, Soo Hyun] Korea Univ, KU KIST Grad Sch Converging Sci & Technol, Seoul 136701, South Korea.
RP Kim, SH (reprint author), Korea Inst Sci & Technol, Biomat Res Ctr, Div Life & Hlth Sci, Seoul 136791, South Korea.
EM soohkim@kist.re.kr
OI Kim, Soo Hyun/0000-0002-8391-3686
FU National Research Foundation of Korea Grant - Korean Government (MEST)
   [NRF-2010-C1AAA001-2010-0028939]; Fundamental Research Program of KIST
FX This work was supported by the National Research Foundation of Korea
   Grant funded by the Korean Government (MEST)
   NRF-2010-C1AAA001-2010-0028939 and the Fundamental Research Program of
   KIST.
CR AGRAWAL CM, 1992, BIOMATERIALS, V13, P176, DOI 10.1016/0142-9612(92)90068-Y
   Brash J.L., 1995, PROTEINS INTERFACE 2, V5, P1
   Chen G., 2001, MAT SCI ENG C, V17, P36
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   COURTNEY JM, 1994, BRIT MED BULL, V50, P966, DOI 10.1093/oxfordjournals.bmb.a072937
   Crick CR, 2010, CHEM-EUR J, V16, P3568, DOI 10.1002/chem.200903335
   Ensikat HJ, 2011, BEILSTEIN J NANOTECH, V2, P152, DOI 10.3762/bjnano.2.19
   FORBES CD, 1995, SCOT MED J, V40, P99, DOI 10.1177/003693309504000401
   Gao L., 2009, LANGMUIR, V25, P1410
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057
   Kim HI, 2011, BIOMATERIALS, V32, P2241, DOI 10.1016/j.biomaterials.2010.11.067
   Kim SI, 2014, COLLOID SURFACE B, V114, P28, DOI 10.1016/j.colsurfb.2013.09.038
   Kim Y. H., 1996, POLYM MAT ENCY, P825
   Lim JI, 2013, POLYM-KOREA, V37, P411, DOI 10.7317/pk.2013.37.4.411
   Ma ML, 2006, CURR OPIN COLLOID IN, V11, P193, DOI 10.1016/j.cocis.2006.06.002
   Olsson P, 2000, J BIOMAT SCI-POLYM E, V11, P1261, DOI 10.1163/156856200744192
   Schwarzer HC, 2005, CHEM ENG SCI, V60, P11, DOI 10.1016/j.ces.2004.06.050
   Shen H, 2007, BIOMATERIALS, V28, P4219, DOI 10.1016/j.biomaterials.2007.06.004
   Shen H, 2010, ACTA BIOMATER, V6, P455, DOI 10.1016/j.actbio.2009.07.016
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Song WL, 2009, ADV MATER, V21, P1830, DOI 10.1002/adma.200803680
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Wu H, 2012, REACT FUNCT POLYM, V72, P427, DOI 10.1016/j.reactfunctpolym.2012.04.007
   Yan YY, 2011, ADV COLLOID INTERFAC, V169, P80, DOI 10.1016/j.cis.2011.08.005
   Yianni YP, 1992, STRUCTURAL DYNAMIC P, P187
   Zhou M, 2008, J NANO RES-SW, V2, P129, DOI 10.4028/www.scientific.net/JNanoR.2.129
   Zolnik BS, 2008, J CONTROL RELEASE, V127, P137, DOI 10.1016/j.jconrel.2008.01.004
NR 28
TC 0
Z9 0
U1 0
U2 25
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 0379-153X
J9 POLYM-KOREA
JI Polym.-Korea
PD JAN
PY 2015
VL 39
IS 1
BP 40
EP 45
DI 10.7317/pk.2015.39.1.40
PG 6
WC Polymer Science
SC Polymer Science
GA CQ3QF
UT WOS:000360516900006
DA 2018-10-20
ER

PT J
AU Priya, BA
   Senthilguru, K
   Agarwal, T
   Narayana, SNGH
   Giri, S
   Pramanik, K
   Pal, K
   Banerjee, I
AF Priya, B. Anu
   Senthilguru, K.
   Agarwal, T.
   Narayana, S. N. Gautham Hari
   Giri, S.
   Pramanik, K.
   Pal, K.
   Banerjee, I.
TI Nickel doped nanohydroxyapatite: vascular endothelial growth factor
   inducing biomaterial for bone tissue engineering
SO RSC ADVANCES
LA English
DT Article
ID BIOACTIVE GLASS SCAFFOLDS; OSTEOBLAST-LIKE CELLS; IN-VITRO;
   HYDROXYAPATITE NANOPARTICLES; FACTOR-1-ALPHA EXPRESSION; HYPOXIA;
   ANGIOGENESIS; BEHAVIOR; PROTEIN; COBALT
AB Biomaterial induced activation of vascular endothelial growth factor (VEGF) pathway for angiogenesis is now gaining recognition as an effective option for tissue engineering. In this context, bivalent nickel (Ni2+) ion doped nano-hydroxyapatites (nHAp) were synthesized by wet chemical method, characterized and evaluated for their osteoconductive and proangiogenic properties. Electron microscopy (FESEM and TEM) along with ICP-OES analysis ensured formation of Ni2+ doped nanoparticles (average ferret diameter 15-17 nm). The 'apatite identity' of the nanoparticles was confirmed by XRD and FT-IR. Analysis revealed that Ni2+ doping caused no significant distortion in the crystal structure but decreased the crystallinity of nHAp considerably. Similarly, no major variation in the surface area (BET analysis), the zeta potential and the protein adsorption was observed among the samples. Biological characterization showed that Ni2+ doping influenced the cell viability, proliferation and differentiation of bone cells (MG-63) in a concentration dependent way. ELISA and RT-PCR study revealed that Ni2+ doped nHAp induced cellular VEGF expression many fold in comparison to control. Profiling of hypoxia inducible factor 1 alpha (HIF-1 alpha) expression by immuno-cytochemistry and RT-PCR implied its involvement in cellular VEGF production. In conclusion, Ni2+ doped nHAp may serve as proangiogenic-osteogenic biomaterial for bone tissue engineering.
C1 [Priya, B. Anu; Senthilguru, K.; Agarwal, T.; Narayana, S. N. Gautham Hari; Pramanik, K.; Pal, K.; Banerjee, I.] Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela 769008, Odisha, India.
   [Giri, S.] Natl Inst Technol, Dept Chem, Rourkela 769008, Odisha, India.
RP Banerjee, I (reprint author), Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela 769008, Odisha, India.
EM banerjeei@nitrkl.ac.in
RI Pramanik, Krishna/M-3729-2018
OI Pramanik, Krishna/0000-0002-5676-7740; Banerjee,
   Indranil/0000-0003-3634-8765; Pal, Kunal/0000-0002-4618-8809; Giri,
   Supratim/0000-0002-1658-1968; Agarwal, Tarun/0000-0002-3300-7781
FU DBT, Govt of India (RGYI scheme project) [BT/PR6230/GBD/27/391/2012,
   BT/PR6227/GBD/27/390/2012]
FX 1. PSG Institute of Advanced Studies for HR-TEM analysis. 2. SAIF, IIT
   Madras for ICP-OES analysis. 3. DBT, Govt of India (RGYI scheme project
   no. BT/PR6230/GBD/27/391/2012). 4. DBT, Govt of India (RGYI scheme
   project no. BT/PR6227/GBD/27/390/2012). 5. Prof. T. K. Maiti for
   providing the molecular biology laboratory facility. 6. Centre of
   Excellence, orthopaedic Tissue engineering and Rehabilitation
   (TEQIP-II).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Armstrong D, 1998, OPHTHALMOLOGICA, V212, P410, DOI 10.1159/000027378
   Baiguera S, 2013, ANGIOGENESIS, V16, P1, DOI 10.1007/s10456-012-9307-8
   Bose S, 2013, TRENDS BIOTECHNOL, V31, P594, DOI 10.1016/j.tibtech.2013.06.005
   CARROLL M, 1995, P NATL ACAD SCI USA, V92, P2869, DOI 10.1073/pnas.92.7.2869
   Chachami G, 2004, AM J RESP CELL MOL, V31, P544, DOI 10.1165/rcmb.2003-0426OC
   Chen LA, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/10/105708
   Cheng K, 2005, BIOMATERIALS, V26, P6288, DOI 10.1016/j.biomaterials.2005.03.041
   Chun YS, 2002, J KOREAN MED SCI, V17, P581, DOI 10.3346/jkms.2002.17.5.581
   CIVJAN S, 1975, J DENT RES, V54, P89, DOI 10.1177/00220345750540014301
   Das KK, 2008, INDIAN J MED RES, V128, P412
   Feng WK, 2009, MOL PHARMACOL, V75, P174, DOI 10.1124/mol.108.051516
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Fields RC, 2003, TISSUE ENG, V9, P1281, DOI 10.1089/10763270360728198
   Fini M, 2003, BIOMATERIALS, V24, P4929, DOI 10.1016/S0142-9612(03)00416-2
   Frohlich M, 2008, CURR STEM CELL RES T, V3, P254, DOI 10.2174/157488808786733962
   Gergely G, 2010, CENT EUR J CHEM, V8, P375, DOI 10.2478/s11532-010-0004-4
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Guerra-Lopez J, 2000, J SOLID STATE CHEM, V151, P163, DOI 10.1006/jssc.1999.8615
   Guerra-Lopez J, 2001, J RAMAN SPECTROSC, V32, P255, DOI 10.1002/jrs.689
   Han YC, 2009, J NANOPART RES, V11, P1235, DOI 10.1007/s11051-008-9507-8
   Hasan A, 2014, BIOMATERIALS, V35, P7308, DOI 10.1016/j.biomaterials.2014.04.091
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   Hwang JT, 2004, CARCINOGENESIS, V25, P2497, DOI 10.1093/carcin/bgh253
   Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673
   Kaczmarek M, 2007, FREE RADICAL BIO MED, V42, P1246, DOI 10.1016/j.freeradbiomed.2007.01.026
   Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029
   Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730
   Kulanthaivel S, 2015, CERAM INT, V41, P11323, DOI 10.1016/j.ceramint.2015.05.090
   Lee SH, 2012, J BIOL CHEM, V287, P14760, DOI 10.1074/jbc.M112.340232
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Li Y, 2010, MAT SCI ENG C-MATER, V30, P1137, DOI 10.1016/j.msec.2010.06.011
   Lukman H., 2010, KEY ENG MATER, V447, P770
   Mabilleau G, 2010, ACTA BIOMATER, V6, P1555, DOI 10.1016/j.actbio.2009.10.035
   Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417
   Monmaturapoj N, 2008, J MET MAT MINER, V18, P15
   Mravic M., 2014, BIOMED RES INT, V2014, P1
   Neelakandeswari N, 2012, TETRAHEDRON LETT, V53, P2980, DOI 10.1016/j.tetlet.2012.03.086
   Nemec A. A., 2008, FASEB J, V22, P764
   Panseri S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-32
   Pautke C, 2004, ANTICANCER RES, V24, P3743
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Perez AL, 2003, INT ENDOD J, V36, P564, DOI 10.1046/j.1365-2591.2003.00691.x
   Puvvada N, 2010, NANOSCALE, V2, P2631, DOI 10.1039/c0nr00611d
   Rajendran A, 2014, CERAM INT, V40, P10831, DOI 10.1016/j.ceramint.2014.03.075
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Saeri MR, 2003, MATER LETT, V57, P4064, DOI 10.1016/S0167-577X(03)00266-0
   Salarian M, 2009, MATER SCI-POLAND, V27, P961
   Sallam S.M., 2012, BIOPHYS CHEM, V3, P278
   Salnikow K, 1999, CARCINOGENESIS, V20, P1819, DOI 10.1093/carcin/20.9.1819
   Sanosh KP, 2009, B MATER SCI, V32, P465, DOI 10.1007/s12034-009-0069-x
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
   Shyong YJ, 2015, J MATER CHEM B, V3, P2331, DOI 10.1039/c4tb01639d
   Tank K. P., 2013, J NANOPART RES, V15, P1
   Tay SL, 2013, INTERMETALLICS, V33, P8, DOI 10.1016/j.intermet.2012.09.016
   Vandamme K., 2010, TISSUE ENG PART C-ME, V17, P311
   Wadekar MP, 2006, J PHARMACEUT BIOMED, V41, P1473, DOI 10.1016/j.jpba.2006.03.032
   Wakamura M, 1998, COLLOID SURFACE A, V142, P107, DOI 10.1016/S0927-7757(98)00486-5
   Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JC131581
   Wang YF, 2008, J WUHAN UNIV TECHNOL, V23, P395, DOI 10.1007/s11595-007-3395-0
   WASSELL DTH, 1995, BIOMATERIALS, V16, P697, DOI 10.1016/0142-9612(95)99697-K
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Williams RL, 2013, J MATER CHEM B, V1, P4370, DOI 10.1039/c3tb20775g
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Yan-Zhong Z., 2011, NANOSCALE RES LETT, V6, P1
   Zerbo I. R., 2005, BIOMATERIALS, V26, P1445
   Zhuang Z, 2013, ACTA BIOMATER, V9, P6732, DOI 10.1016/j.actbio.2013.02.001
NR 72
TC 4
Z9 4
U1 5
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 89
BP 72515
EP 72528
DI 10.1039/c5ra09560c
PG 14
WC Chemistry, Multidisciplinary
SC Chemistry
GA CQ4CO
UT WOS:000360552000012
DA 2018-10-20
ER

PT J
AU Xu, JK
   Zhu, WY
   Jiang, LJ
   Xu, J
   Zhang, YC
   Cui, YZ
AF Xu, Jinku
   Zhu, Weiyue
   Jiang, Lijuan
   Xu, Jing
   Zhang, Yongchun
   Cui, Yuezhi
TI Carbazole-grafted silicone hydrogel with a high refractive index for
   intraocular lens
SO RSC ADVANCES
LA English
DT Article
ID POLYSILOXANES; ADHESION
AB The refractive index (RI) is an important parameter for intraocular lens biomaterials. In this paper, a novel carbazole-grafted methacrylic polysiloxane macromonomer (MA-CZ-PDMS) with a high RI value was synthesized and its structure was confirmed by proton nuclear magnetic resonance (H-1 NMR). The polysiloxane macromonomer can copolymerize with monomers of 3-methacryloxypropyl tris(trimethylsiloxy) silane (TRIS) and N, N-dimethylacrylamide (DMA) to prepare transparent high RI silicone hydrogel. Increasing MA-CZ-PDMS macromonomer content in the silicone hydrogels improved its water content, RI value, and mechanical properties, however decreased slightly glass transition temperature (T-g) and transmittance of blue light. The carbazole-grafted silicone hydrogel possessed good cytocompatibility and in vivo biocompatibility in rabbit eyes. The results demonstrate that the carbazole-grafted silicone hydrogel has a potential application as high RI ocular refractive correction biomaterial.
C1 [Xu, Jinku; Zhu, Weiyue; Xu, Jing; Zhang, Yongchun; Cui, Yuezhi] Qilu Univ Technol, Sch Chem & Pharmaceut Engn, Shandong Prov Key Lab Fine Chem, Jinan 250353, Peoples R China.
   [Xu, Jinku] Jiangxi Agr Univ, Sch Biosci & Bioengn, Key Lab Bioresources Protect & Utilizat Nanchang, Nanchang 330045, Peoples R China.
   [Jiang, Lijuan] Shandong Success Pharmaceut Technol Co Ltd, Jinan 250353, Peoples R China.
RP Xu, JK (reprint author), Qilu Univ Technol, Sch Chem & Pharmaceut Engn, Shandong Prov Key Lab Fine Chem, Jinan 250353, Peoples R China.
EM xujk@qlu.edu.cn
FU National Nature Science Foundation of China [51163007, 21276149]; Nature
   Science Foundation of Jiangxi Province [20114BAB206025]; Nature Science
   Foundation of Shandong Province [ZR2013BQ014]; Science and Technology
   Development Program of Shandong Province [2014GSF118009]; Nature Science
   Foundation of Jiangxi Agricultural University [09003332]; Program for
   Scientific Research Innovation Team in Colleges and Universities of
   Shandong Province
FX The projects were supported by National Nature Science Foundation of
   China (No. 51163007 and 21276149); Nature Science Foundation of Jiangxi
   Province (No. 20114BAB206025), Nature Science Foundation of Shandong
   Province (No. ZR2013BQ014), Science and Technology Development Program
   of Shandong Province (No. 2014GSF118009), Nature Science Foundation of
   Jiangxi Agricultural University (No. 09003332), and Program for
   Scientific Research Innovation Team in Colleges and Universities of
   Shandong Province.
CR Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Beiko G, 2007, CURR OPIN OPHTHALMOL, V18, P74, DOI 10.1097/ICU.0b013e328011fbab
   Belfield KD, 1998, MACROMOLECULES, V31, P2918, DOI 10.1021/ma970910+
   Foster A., 2000, COMMUNITY EYE HLTH, V13, P17
   Glasser A, 2006, CURR OPIN OPHTHALMOL, V17, P12, DOI 10.1097/01.icu.0000193069.32369.e1
   Hao XJ, 2012, BIOMATERIALS, V33, P5659, DOI 10.1016/j.biomaterials.2012.04.052
   Hao XJ, 2010, BIOMATERIALS, V31, P8153, DOI 10.1016/j.biomaterials.2010.07.065
   Hua YJ, 2001, MACROMOLECULES, V34, P2488, DOI 10.1021/ma0018502
   Hume EBH, 2004, INVEST OPHTH VIS SCI, V45, P3161, DOI 10.1167/iovs.03-1242
   Koopmans SA, 2006, INVEST OPHTH VIS SCI, V47, P2976, DOI 10.1167/iovs.05-1346
   Koopmans SA, 2003, INVEST OPHTH VIS SCI, V44, P250, DOI 10.1167/iovs.02-0256
   LAI YC, 1995, J APPL POLYM SCI, V56, P317, DOI 10.1002/app.1995.070560303
   Lan XK, 2010, EUR POLYM J, V46, P1545, DOI 10.1016/j.eurpolymj.2010.04.011
   Liu YY, 2005, BIOMATERIALS, V26, P6367, DOI 10.1016/j.biomaterials.2005.04.011
   Menapace R, 2007, GRAEF ARCH CLIN EXP, V245, P473, DOI 10.1007/s00417-006-0391-6
   NISHI H, 1981, B CHEM SOC JPN, V54, P1897, DOI 10.1246/bcsj.54.1897
   Nishi O, 1998, J CATARACT REFR SURG, V24, P975, DOI 10.1016/S0886-3350(98)80054-0
   Nishi O, 2008, J CATARACT REFR SURG, V34, P302, DOI 10.1016/j.jcrs.2007.09.042
   PEPPAS NA, 1990, J MEMBRANE SCI, V48, P281, DOI 10.1016/0376-7388(90)85009-A
   Senchyna M, 2004, CURR EYE RES, V28, P25, DOI 10.1076/ceyr.28.1.25.23496
   Sparrow JM, 2007, BRIT J OPHTHALMOL, V91, P852, DOI 10.1136/bjo.2006.111211
   Tanito M, 2010, J CATARACT REFR SURG, V36, P299, DOI 10.1016/j.jcrs.2009.08.036
   Tranoudis Ioannis, 2004, Cont Lens Anterior Eye, V27, P193, DOI 10.1016/j.clae.2004.08.003
   Wang T, 2012, IND ENG CHEM RES, V51, P15832, DOI 10.1021/ie302638g
   Zhang Shangtong, 2005, Cont Lens Anterior Eye, V28, P113, DOI 10.1016/j.clae.2005.06.003
NR 25
TC 5
Z9 5
U1 2
U2 21
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 89
BP 72736
EP 72744
DI 10.1039/c5ra10614a
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CQ4CO
UT WOS:000360552000035
DA 2018-10-20
ER

PT J
AU Oak, JJ
   Bang, JI
   Bae, KC
   Kim, YH
   Lee, YC
   Chun, HH
   Park, YH
AF Oak, J-J.
   Bang, J. I.
   Bae, K-C
   Kim, Y. H.
   Lee, Y-C.
   Chun, H. H.
   Park, Y. H.
TI CHARACTERIZATION OF THE GRADED MICROSTRUCTURE IN POWDER SINTERED POROUS
   TITANIUM
SO ARCHIVES OF METALLURGY AND MATERIALS
LA English
DT Article
DE titanium; powder metallurgy; porous structure; sintering; biomaterial
ID MECHANICAL-PROPERTIES; BIOMATERIALS; BEHAVIOR; ALLOYS
AB The proposed sintering process produce porosity and functional graded microstructure in the sinterd titanium powders. Titanium powders with different micro sizes were sintered at the proposed temperature region at 1200 and 1300 degrees C for 2h. The apatite-forming on the graded microstructure is observed by immersion test in Hanks balanced salt soluion at 37 degrees C. Sintering condition of titanium powders is estimated by thermogravitmetry-differential thermal analysis (TG-DTA). The synthersied surface structures and apatite-forming ability were characterized by a field emission scanning electron microscopy (FE-SEM) observation and energy dispersive X-ray spectroscopy (EDS) analysis. As results, these graded microstructure of sintered porous titanium powders reveals apatite-forming ability as osseointegration by calcification in Hanks balanced salt soluion(HBSS) at 37 degrees C.
C1 [Oak, J-J.] Pusan Natl Univ, GCRC SOP, Busan, South Korea.
   [Bang, J. I.; Bae, K-C; Kim, Y. H.; Park, Y. H.] Pusan Natl Univ, Dept Mat Sci & Engn, Busan, South Korea.
   [Lee, Y-C.] Korea Inst Ind Technol, Busan, South Korea.
   [Chun, H. H.] Pusan Natl Univ, Dept Naval Architechture & Ocean Engn, Busan, South Korea.
RP Park, YH (reprint author), Pusan Natl Univ, Dept Mat Sci & Engn, Busan, South Korea.
EM yhpark@pusan.ac.kr
FU National Research Foundation of Korea (NRF) grant - Korea government
   (MEST) through GCRC-SOP [2011-0030658]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MEST) through GCRC-SOP
   (2011-0030658).
CR Akahori T, 2013, J JPN I MET, V77, P543, DOI 10.2320/jinstmet.J2013052
   German RM, 2013, MATERIALS, V6, P3641, DOI 10.3390/ma6083641
   Guden M, 2005, MATER CHARACT, V54, P399, DOI 10.1016/j.matchar.2005.01.006
   Gwak J.-N., 2013, J KOREAN POWDER META, V20, P467
   Jones JR, 2006, PHILOS T ROY SOC A, V364, P263, DOI 10.1098/rsta.2005.1689
   Kim H.M., 2000, BIOCERAMICS, V192-1, P227
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Miura Hideshi, 2013, [JOURAL OF KOREAN POWER METALLURGY INSTIT, 한국분말야금학회지], V20, P323
   Niinomi M, 2007, BIOMED MATER, V2, pS167, DOI 10.1088/1748-6041/2/3/S15
   Oak JJ, 2007, MAT SCI ENG A-STRUCT, V449, P220, DOI 10.1016/j.msea.2006.02.307
   Oak JJ, 2007, J MATER RES, V22, P1346, DOI 10.1557/JMR.2007.0154
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Paital SR, 2007, BIOMED MATER, V2, P274, DOI 10.1088/1748-6041/2/4/011
   Ramesh K.T., 2002, SCIENCE, V33, P927
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Wang H, 2013, J NON-CRYST SOLIDS, V379, P155, DOI 10.1016/j.jnoncrysol.2013.08.001
   Yavari SA, 2014, J MECH BEHAV BIOMED, V36, P109, DOI 10.1016/j.jmbbm.2014.04.010
NR 17
TC 0
Z9 0
U1 0
U2 5
PU POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST METALL & MATER SCI PAS
PI WARSZAWA
PA PL, 00-901 WARSZAWA, POLAND
SN 1733-3490
EI 2300-1909
J9 ARCH METALL MATER
JI Arch. Metall. Mater.
PY 2015
VL 60
IS 2
BP 1265
EP 1269
DI 10.1515/amm-2015-0111
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA CP5WE
UT WOS:000359955000127
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Gao, JL
   Chu, JK
   Shang, HX
   Guan, L
AF Gao, Jiali
   Chu, Jinkui
   Shang, Haixin
   Guan, Le
TI Vibration attenuation performance of long-eared owl plumage
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE biomaterial; material properties; multi-scale structure
ID AERODYNAMIC NOISE; TRAILING-EDGE; SILENT FLIGHT
AB A comparative study of vibration attenuation behaviour of primary remex with lateral branches from the long-eared owl (a silent flying bird), golden eagle and pigeon (two noisy flying birds) was conducted in order to investigate the damping ability of owl's primary remex. Amplitude variation of the measurement points on the rachis with vane structures was measured by a laser displacement sensor, and vibration process of the observation point on the barb with lateral barbules was recorded by a high-speed camera. Amplitude-time analysis results indicate that loss factors of long-eared owl's complete primary feathers and barbs are higher than those of the golden eagle and pigeon feathers. Thus, vibration amplitudes of the long-eared owl feathers and their barbs decay much faster, showing a superior vibration-damping characteristic. Consequently, mechanical noise caused by the relative motion of the owl primary feather structures during flight may be effectively suppressed. Vibration reduction principle of the long-eared owl primary feather was briefly discussed based on the damping-by-branching mechanism at last.
C1 [Gao, Jiali; Chu, Jinkui; Shang, Haixin; Guan, Le] Dalian Univ Technol, Minist Educ, Key Lab Precis & Nontradit Machining, Dalian, Peoples R China.
RP Chu, JK (reprint author), Dalian Univ Technol, Minist Educ, Key Lab Precis & Nontradit Machining, Dalian, Peoples R China.
EM chujk@dlut.edu.cn
RI Guan, Le/C-6634-2009
FU National Basic Research Program of China [2011CB302101, 2011CB302105]
FX The authors would like to thank Dalian Forest Zoo for providing the
   feather samples of long-eared owl, golden eagle and pigeon. Financial
   support for this research was provided by the National Basic Research
   Program of China (grants: 2011CB302101 and 2011CB302105).
CR Bachmann T, 2012, J ANAT, V221, P1, DOI 10.1111/j.1469-7580.2012.01504.x
   Bachmann T, 2012, INTEGR COMP BIOL, V52, pE9
   Bachmann T, 2011, J ANAT, V219, P192, DOI 10.1111/j.1469-7580.2011.01384.x
   Borelli G. A., 1680, DE MOTU ANIMALIUM, P182
   Chen K, 2012, J BIONIC ENG, V9, P192, DOI 10.1016/S1672-6529(11)60109-1
   Gao J., 2014, SHOCK VIB, V2014
   Geyer T, 2010, EXP FLUIDS, V48, P291, DOI 10.1007/s00348-009-0739-x
   Graham R.R., 1934, J ROYAL AERONAUTICAL, V286, P837
   GRUSCHKA HD, 1971, NATURE, V233, P409, DOI 10.1038/233409a0
   Hansson KM, 2002, BIOSENS BIOELECTRON, V17, P747, DOI 10.1016/S0956-5663(02)00048-9
   Herr M, 3470 AIAA, P3470
   HOWE MS, 1991, J ACOUST SOC AM, V90, P482, DOI 10.1121/1.401273
   Jaworski JW, 2013, J FLUID MECH, V723, P456, DOI 10.1017/jfm.2013.139
   Klan S, 2009, EXP FLUIDS, V46, P975, DOI 10.1007/s00348-008-0600-7
   Kroeger R. A., 1972, 96117 DTIC, P96
   Lilley GM, 2001, J SOUND VIB, V239, P849, DOI 10.1006/jsvi.2000.3219
   Lilley GM, 1998, AIAA PAPER, V4, P1
   Mascha E, 1903, Z WISSENSCHAFTLICHE, V77, P606
   Punyamurtula VK, 2007, ADV ENG MATER, V9, P209, DOI 10.1002/adem.200600177
   Rao MD, 2003, J SOUND VIB, V262, P457, DOI 10.1016/S0022-460X(03)00106-8
   Sharma JN, 2014, ACTA MECH, V225, P1581, DOI 10.1007/s00707-013-1010-3
   Sick H, 1937, J ORNITHOL, V85, P206, DOI DOI 10.1007/BF01905702
   Sun S., 2008, NOISE VIBRAT CONT, V3, P119
   Theckes B, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046010
   Videler JJ, 2005, AVIAN FLIGHT
   Viswanathan KK, 2011, ACTA MECH, V221, P309, DOI 10.1007/s00707-011-0505-z
NR 26
TC 1
Z9 1
U1 2
U2 15
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2015
VL 4
IS 3
BP 187
EP 198
DI 10.1680/bbn.15.00003
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP9HP
UT WOS:000360205000004
DA 2018-10-20
ER

PT S
AU Gasymov, OK
   Aydemirova, A
   Alekperov, O
   Aslanov, RB
   Khalilova, K
   Gasimov, N
   Mamedov, N
   Mamedova, I
   Babayev, S
   Gasanov, N
AF Gasymov, Oktay K.
   Aydemirova, Arzu
   Alekperov, Oktay
   Aslanov, Rasim B.
   Khalilova, Khuraman
   Gasimov, Nagi
   Mamedov, Nazim
   Mamedova, Irada
   Babayev, Sardar
   Gasanov, Namig
BE Tsuboi, N
   Wakita, K
   Yamada, A
   Shirakata, S
   Wada, T
   Niki, S
   Imaizumi, M
   Hara, K
   Uchitomi, N
TI IR ellipsometry of silk fibroin films on Al nanoislands
SO PHYSICA STATUS SOLIDI C: CURRENT TOPICS IN SOLID STATE PHYSICS, VOL 12,
   NO 6
SE Physica Status Solidi C-Current Topics in Solid State Physics
LA English
DT Proceedings Paper
CT 19th International Conference on Ternary and Multinary Compounds (ICTMC)
CY SEP 01-05, 2014
CL Niigata, JAPAN
SP Japan Soc Appl Physics, Murata Sci Fdn, Niigata Prefecture, Nakaya Corporat, NAMICS Corporat, Tokyo Instruments Inc, Bunkoukeiki Co Ltd, Fdn Promot Mat Sci & Technol Japan, Int Servo Data Corporat, Osaka Asahi Metal Mfg Co Ltd, TOYO Corporat, ULVAC TECHNO Ltd, Japan Soc Appl Physics, Japanese Profess Grp Multinary Compounds & Solar Cells
DE surface enhanced ellipsometry; protein films; plasmon; metallic
   nanoislands
ID BIOMATERIAL
AB Infrared spectroscopic ellipsometry (IRSE) is a powerful tool for the characterization of various types of organic and inorganic films. In application to protein films, IRSE can be utilized to detect structural changes, orientation of specific group, etc. Because of sensitivity, enhanced IRSE will be very useful to study protein thin films. Here we show that fibroin films on Al mirror display surface-enhanced infrared spectroscopic ellipsometry (SEIRSE). AFM data indicate that nanoislands on the Al mirror are responsible for the plasmon-enhanced mechanism. SEIRSE for fibroin films shows non-uniform enhancement across the spectrum. Possible mechanisms of such enhancement are provided. Evidently, as proposed previously, at least two mechanisms, the electromagnetic (EM) and chemical, are expected to contribute to the enhancement.
C1 [Gasymov, Oktay K.; Aydemirova, Arzu; Alekperov, Oktay; Aslanov, Rasim B.; Khalilova, Khuraman; Gasimov, Nagi; Mamedov, Nazim; Mamedova, Irada; Babayev, Sardar] Azerbaijan Natl Acad Sci, Inst Phys, Baku 1143, Azerbaijan.
   [Gasanov, Namig] Minist Agr, Inst Silk Farming, Genje 2012, Azerbaijan.
RP Gasymov, OK (reprint author), Azerbaijan Natl Acad Sci, Inst Phys, 131 H Javid, Baku 1143, Azerbaijan.
EM oktay.qasimov@physics.science.az; ozalekperov@physics.science.az
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bradford DC, 2005, J PHYS CHEM B, V109, P20914, DOI 10.1021/jp052764c
   Guan L, 2013, CELLS TISSUES ORGANS, V198, P190, DOI 10.1159/000355944
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hinrichs K, 2005, APPL SPECTROSC, V59, p272A, DOI 10.1366/000370205774783106
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Monti P., 1998, J RAMAN SPECTROSC, V29
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
NR 9
TC 1
Z9 1
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
SN 1862-6351
J9 PHYS STATUS SOLIDI C
PY 2015
VL 12
IS 6
BP 628
EP 630
DI 10.1002/pssc.201500005
PG 3
WC Physics, Condensed Matter
SC Physics
GA BD3UN
UT WOS:000360198000033
DA 2018-10-20
ER

PT J
AU Carvalho, I
   Polcar, T
   Henriques, M
   Carvalho, S
AF Carvalho, Isabel
   Polcar, Tomas
   Henriques, Mariana
   Carvalho, Sandra
TI MATERIALS INCOMPATIBILITY AS A MAJOR CAUSE OF HIP PROSTHESES REJECTION
SO REVIEWS ON ADVANCED MATERIALS SCIENCE
LA English
DT Article
ID DIAMOND-LIKE CARBON; METAL-ON-METAL; EPIDERMIDIS BIOFILM FORMATION;
   PULSED-LASER DEPOSITION; TOTAL JOINT REPLACEMENT; SILVER ION RELEASE;
   SI-C-ON; STAPHYLOCOCCUS-EPIDERMIDIS; BIOMEDICAL APPLICATIONS;
   SYNOVIAL-FLUID
AB The development of new multifunctional coatings to apply on medical biomaterials continues to be required, since materials commonly used in hip prostheses still presenting failures. Multifunctionality is the result of a synergy, on the nanoscale level, of good corrosion, mechanical and tribological properties. Additionally, a biomaterial must always be biocompatible. Besides these properties, the major challenge would be to get a material that also has antimicrobial activity. In this context, the development of advanced materials with the ability to present these properties is being regarded as a strategy to prevent the colonization of implant and biofilm formation by bacteria. So, in this review, the attention is focused on the description of the fundamental points of the natural synovial joint, since, its mechanical and tribological characteristics are the main causes that lead to the necessity of its replacement by an implant. Moreover, a contextualization was also performed on the hip replacement surgery and the biomaterials used, with a focus on their mechanical and tribological properties. Finally, it is explained the need of surface modification and the potential of TiCN coatings doped with silver.
C1 [Carvalho, Isabel; Polcar, Tomas] Czech Tech Univ, Fac Elect Engn, Dept Control Engn, Tech 2, CR-16635 Prague 6, Czech Republic.
   [Polcar, Tomas] Univ Southampton, Engn Mat, Southampton SO17 1BJ, Hants, England.
   [Henriques, Mariana] Univ Minho, Ctr Biol Engn, CEB, LIBRO, P-4700057 Braga, Portugal.
   [Carvalho, Sandra] Univ Minho, GRF CFUM, P-4800058 Guimaraes, Portugal.
   [Carvalho, Sandra] Univ Coimbra, SEG CEMUC Mech Engn Dept, P-3030788 Coimbra, Portugal.
RP Carvalho, I (reprint author), Czech Tech Univ, Fac Elect Engn, Dept Control Engn, Tech 2, CR-16635 Prague 6, Czech Republic.
EM isascarvalho@hotmail.com
RI Henriques, Mariana/A-2117-2013; Carvalho, Sandra/F-3530-2013; Polcar,
   Tomas/G-5742-2013
OI Henriques, Mariana/0000-0003-0317-4877; Carvalho,
   Sandra/0000-0002-3643-4973; Polcar, Tomas/0000-0002-0863-6287; Carvalho,
   Isabel/0000-0002-7569-2019
FU FEDER funds through the program COMPETE - Programa Operacional Factores
   de Competitividade; national funds through FCT - Fundacao para a Ciencia
   e a Tecnologia [PEST-C/FIS/UI607/2011, PEST-C/EME/UI0285/2011,
   PTDC/CTM/102853/2008]; FCT - Fundacao para a Ciencia e a Tecnologia
   [SFRH / BD / 67022 / 2009]; FCT [UID/BIO/04469/2013,
   RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462)]; project "BioInd -
   Biotechnology and Bioengineering for improved Industrial and Agro-Food
   processes" - Programa Operacional Regional do Norte (ON.2 - O Novo
   Norte), QREN, FEDER [NORTE-07-0124-FEDER-000028]
FX This research is sponsored by FEDER funds through the program COMPETE -
   Programa Operacional Factores de Competitividade - and by national funds
   through FCT - Fundacao para a Ciencia e a Tecnologia - in the framework
   of the Strategic Projects PEST-C/FIS/UI607/2011, PEST-C/EME/UI0285/2011,
   PTDC/CTM/102853/2008, and FCT - Fundacao para a Ciencia e a Tecnologia
   through the grant SFRH / BD / 67022 / 2009.; The authors thank the FCT
   Strategic Project of UID/BIO/04469/2013 unit, the project
   RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462) and the project
   "BioInd - Biotechnology and Bioengineering for improved Industrial and
   Agro-Food processes", REF. NORTE-07-0124-FEDER-000028 Co-funded by the
   Programa Operacional Regional do Norte (ON.2 - O Novo Norte), QREN,
   FEDER.
CR Allcock BW, 2003, SURF COAT TECH, V163, P62, DOI 10.1016/S0257-8972(02)00586-8
   Amstutz HC, 1996, CLIN ORTHOP RELAT R, pS11
   An YH, 1996, J HOSP INFECT, V33, P93, DOI 10.1016/S0195-6701(96)90094-8
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anderson AE, 2010, J BIOMECH, V43, P1351, DOI 10.1016/j.jbiomech.2010.01.010
   [Anonymous], 2013, NJR 10 ANN REP
   Archibald LK, 1997, INFECT DIS CLIN N AM, V11, P245, DOI 10.1016/S0891-5520(05)70354-8
   Ateshian GA, 2009, J BIOMECH, V42, P1163, DOI 10.1016/j.jbiomech.2009.04.040
   Babonneau D, 1998, SURF SCI, V409, P358, DOI 10.1016/S0039-6028(98)00280-5
   Bahl R, 1999, APPL PHYS A-MATER, V69, pS643, DOI 10.1007/s003390051495
   Bellantone M, 2002, ANTIMICROB AGENTS CH, V46, P1940, DOI 10.1128/AAC.46.6.1940-1945.2002
   Betts AJ, 2005, MATER DESIGN, V26, P217, DOI 10.1016/j.matdes.2004.02.006
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155
   Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P570, DOI 10.2106/JBJS.D.02121
   Bull SJ, 2003, SURF COAT TECH, V163, P499, DOI 10.1016/S0257-8972(02)00650-3
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Carvalho I, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/3/035009
   Cereatti A, 2010, J BONE JOINT SURG BR, V92B, P311, DOI 10.1302/0301-620X.92B2.22625
   Chekan NM, 2009, DIAM RELAT MATER, V18, P1006, DOI 10.1016/j.diamond.2009.02.024
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Corbett KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013520
   Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000
   DAVIDSON JA, 1993, CLIN ORTHOP RELAT R, P361
   De Scheerder I, 2000, J INVASIVE CARDIOL, V12, P389
   Delaunay C, 2010, ORTHOP TRAUMATOL-SUR, V96, P894, DOI 10.1016/j.otsr.2010.05.008
   Donaruma L. G., 1987, J POLYM SCI POL LETT, V26, P414
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Doorn PF, 1998, J BIOMED MATER RES, V42, P103, DOI 10.1002/(SICI)1097-4636(199810)42:1<103::AID-JBM13>3.0.CO;2-M
   Ehab Kheir DS, 2009, ORTHOPAEDICS TRAUMA, V23, P450
   Endrino JL, 2008, SURF COAT TECH, V202, P3675, DOI 10.1016/j.surfcoat.2008.01.011
   Endrino JL, 2002, SURF COAT TECH, V157, P95, DOI 10.1016/S0257-8972(02)00138-X
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   Fang TH, 2004, APPL SURF SCI, V228, P365, DOI 10.1016/j.apsusc.2004.01.053
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Feng WR, 2007, APPL SURF SCI, V253, P4923, DOI 10.1016/j.apsusc.2006.10.069
   Firkins PJ, 2001, J BIOMECH, V34, P1291, DOI 10.1016/S0021-9290(01)00096-3
   Fitzpatrick F, 2002, J HOSP INFECT, V52, P212, DOI 10.1053/jhin.2002.1309
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Genda E, 2001, J BIOMECH, V34, P895, DOI 10.1016/S0021-9290(01)00041-0
   Gispert MP, 2008, J BIOMED MATER RES B, V84B, P98, DOI 10.1002/jbm.b.30849
   Gispert MP, 2007, WEAR, V263, P1060, DOI 10.1016/j.wear.2006.11.036
   Gispert MP, 2006, WEAR, V260, P149, DOI 10.1016/j.wear.2004.12.040
   GRILL A, 1993, WEAR, V168, P143, DOI 10.1016/0043-1648(93)90210-D
   Guimaraes F, 2008, SURF COAT TECH, V202, P2403, DOI 10.1016/j.surfcoat.2007.08.056
   Hall RM, 1997, BIOMATERIALS, V18, P1017, DOI 10.1016/S0142-9612(97)00034-3
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Harman MK, 1997, J ARTHROPLASTY, V12, P938, DOI 10.1016/S0883-5403(97)90164-9
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hlidek P, 2008, THIN SOLID FILMS, V516, P4581, DOI 10.1016/j.tsf.2007.05.085
   Hsieh JH, 2008, SURF COAT TECH, V202, P5586, DOI 10.1016/j.surfcoat.2008.06.107
   Huang HL, 2010, SURF COAT TECH, V205, P1636, DOI 10.1016/j.surfcoat.2010.07.096
   Munoz AI, 2011, J MATER SCI-MATER M, V22, P437, DOI 10.1007/s10856-010-4224-0
   Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P2046, DOI 10.1007/s11999-010-1251-6
   Jaiswal S, 2012, COLLOID SURFACE B, V94, P170, DOI 10.1016/j.colsurfb.2012.01.035
   Jamuna-Thevi K, 2011, VACUUM, V86, P235, DOI 10.1016/j.vacuum.2011.06.011
   Jassim SS, 2012, SEMIN ARTHROPLASTY, V23, P197
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Kelly PJ, 2010, SURF COAT TECH, V205, P1606, DOI 10.1016/j.surfcoat.2010.07.029
   Kelly PJ, 2009, SURF COAT TECH, V204, P1137, DOI 10.1016/j.surfcoat.2009.05.012
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   KNOX P, 1988, Q J EXP PHYSIOL CMS, V73, P33, DOI 10.1113/expphysiol.1988.sp003121
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   KURRAT HJ, 1978, J ANAT, V126, P145
   Lackner JM, 2004, SURF COAT TECH, V188, P519, DOI 10.1016/j.surfcoat.2004.07.009
   Lan WC, 2013, CERAM INT, V39, P4099, DOI 10.1016/j.ceramint.2012.10.264
   Lee SH, 2013, THIN SOLID FILMS, V529, P374, DOI 10.1016/j.tsf.2012.09.027
   Liu CL, 2005, MATER LETT, V59, P3813, DOI 10.1016/j.matlet.2005.06.058
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lo KH, 2009, MAT SCI ENG R, V65, P39, DOI 10.1016/j.mser.2009.03.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Love CA, 2013, TRIBOL INT, V63, P141, DOI 10.1016/j.triboint.2012.09.006
   Mack D, 1999, J HOSP INFECT, V43, pS113, DOI 10.1016/S0195-6701(99)90074-9
   Martinez-Martinez D, 2005, THIN SOLID FILMS, V472, P64, DOI 10.1016/j.tsf.2004.06.140
   Mattei L, 2011, TRIBOL INT, V44, P532, DOI 10.1016/j.triboint.2010.06.010
   McKellop H, 1996, CLIN ORTHOP RELAT R, pS128
   Mellon SJ, 2013, MATURITAS, V75, P221, DOI 10.1016/j.maturitas.2013.04.011
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017
   Morrison ML, 2006, DIAM RELAT MATER, V15, P138, DOI 10.1016/j.diamond.2005.08.031
   Moura M., 2013, METHODS, V18, P19
   Mulligan CP, 2005, SURF COAT TECH, V200, P1495, DOI 10.1016/j.surfcoat.2005.08.063
   Myant C, 2014, J MECH BEHAV BIOMED, V34, P338, DOI 10.1016/j.jmbbm.2013.12.016
   Nevelos JE, 1999, BIOMATERIALS, V20, P1833, DOI 10.1016/S0142-9612(99)00081-2
   Nishii T, 2004, OSTEOARTHR CARTILAGE, V12, P650, DOI 10.1016/j.joca.2004.04.009
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Oliveira C, 2008, SURF COAT TECH, V203, P490, DOI 10.1016/j.surfcoat.2008.06.121
   Ollivere B, 2012, J BONE JOINT SURG BR, V94B, P10, DOI 10.1302/0301-620X.94B1.28047
   Park J., 2007, BIOMATERIALS
   Pawaskar SS, 2011, MED ENG PHYS, V33, P96, DOI 10.1016/j.medengphy.2010.09.009
   Piscanec S, 2004, ACTA MATER, V52, P1237, DOI 10.1016/j.actamat.2003.11.020
   Pishbin F, 2013, ACTA BIOMATER, V9, P7469, DOI 10.1016/j.actbio.2013.03.006
   Pivec R, 2012, LANCET, V380, P1768, DOI 10.1016/S0140-6736(12)60607-2
   Pramanik S, 2005, TRENDS BIOMATER ARTI, V19, P15
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Ratner B.D., 1996, BIOMATER SCI
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   Ribeiro Marta, 2012, Biomatter, V2, P176, DOI 10.4161/biom.22905
   Roba M, 2009, BIOMATERIALS, V30, P2072, DOI 10.1016/j.biomaterials.2008.12.062
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Saikko V, 1997, WEAR, V207, P86, DOI 10.1016/S0043-1648(96)07482-0
   Sanchez-Lopez JC, 2012, SURF COAT TECH, V206, P2192, DOI 10.1016/j.surfcoat.2011.09.059
   Sant SB, 2007, ACTA BIOMATER, V3, P341, DOI 10.1016/j.actbio.2006.10.008
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   Schmidt TA, 2007, OSTEOARTHR CARTILAGE, V15, P35, DOI 10.1016/j.joca.2006.06.005
   Schrand AM, 2010, WIRES NANOMED NANOBI, V2, P544, DOI 10.1002/wnan.103
   Serro AP, 2009, SURF COAT TECH, V203, P3701, DOI 10.1016/j.surfcoat.2009.06.010
   Sharkey PF, 2002, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000036002.13841.32
   Silva E, 2010, SURF COAT TECH, V205, P2134, DOI 10.1016/j.surfcoat.2010.08.126
   Slonaker M, 2004, MATER DESIGN, V25, P395, DOI 10.1016/j.matdes.2003.11.011
   Stobie N, 2009, COLLOID SURFACE B, V72, P62, DOI 10.1016/j.colsurfb.2009.03.014
   Suh J, 1995, OPERATIVE TECH SPORT, V3, P78
   SUH JK, 1995, J BIOMECH, V28, P357, DOI 10.1016/0021-9290(94)00103-B
   Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1
   Takadoum J, 1997, SURF COAT TECH, V88, P232, DOI 10.1016/S0257-8972(96)02905-2
   TANDON PN, 1990, APPL MATH MODEL, V14, P312, DOI 10.1016/0307-904X(90)90083-H
   Tipper JL, 2001, WEAR, V250, P120, DOI 10.1016/S0043-1648(01)00653-6
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   Tseng CC, 2009, THIN SOLID FILMS, V517, P4970, DOI 10.1016/j.tsf.2009.03.136
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Wang FC, 2008, PHYS MED BIOL, V53, P1277, DOI 10.1088/0031-9155/53/5/008
   Wang XQ, 2009, J ORTHOP RES, V27, P1487, DOI 10.1002/jor.20917
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   WILLIAMS DF, 1987, MATER SCI TECH-LOND, V3, P797, DOI 10.1179/mst.1987.3.10.797
   Wong M, 2003, BONE, V33, P1, DOI 10.1016/S8756-3282(03)00083-8
   Yao SH, 2006, SURF COAT TECH, V201, P2520, DOI 10.1016/j.surfcoat.2006.04.066
   Yen SK, 2001, BIOMATERIALS, V22, P125, DOI 10.1016/S0142-9612(00)00133-2
   Yoshida H, 2006, J BIOMECH, V39, P1996, DOI 10.1016/j.jbiomech.2005.06.026
   Zhang GJ, 2009, APPL SURF SCI, V255, P8788, DOI 10.1016/j.apsusc.2009.06.090
   Zhao J, 2009, J MATER SCI-MATER M, V20, P101, DOI 10.1007/s10856-008-3491-5
NR 134
TC 0
Z9 0
U1 1
U2 17
PU INST PROBLEMS MECHANICAL ENGINEERING-RUSSIAN ACAD SCIENCES
PI ST PTERSBURG
PA BOLSHOJ 61, VAS OSTROV, ST PTERSBURG, 199178, RUSSIA
SN 1606-5131
J9 REV ADV MATER SCI
JI Rev. Adv. Mater. Sci.
PY 2015
VL 42
IS 1
BP 36
EP 49
PG 14
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CP8AC
UT WOS:000360110800005
DA 2018-10-20
ER

PT J
AU Aunkor, MTH
   Mahbubul, IM
   Saidur, R
   Metselaar, HSC
AF Aunkor, M. T. H.
   Mahbubul, I. M.
   Saidur, R.
   Metselaar, H. S. C.
TI Deoxygenation of graphene oxide using household baking soda as a
   reducing agent: a green approach
SO RSC ADVANCES
LA English
DT Article
ID EXFOLIATED GRAPHITE OXIDE; LITHIUM ION BATTERIES; CHEMICAL-REDUCTION;
   ROOM-TEMPERATURE; FUNCTIONALIZED GRAPHENE; PHOTOVOLTAIC DEVICES;
   SOLVOTHERMAL METHOD; PRODUCE GRAPHENE; AG NANOPARTICLES; FACILE
   SYNTHESIS
AB A one-step, novel, easy, fast, facile, economic, and environmental friendly route to reduce graphene oxide (GO) is studied and explained in this study. The household baking soda (sodium bicarbonate/NaHCO3) was applied here as a reducing agent. In aqueous solution, NaHCO3 hydrolyses into hydroxide ion and leads to deoxygenate GO sheets. The confirmation of oxygen reduction was checked with UV-visible spectroscopy, X-ray diffraction, Fourier transform infrared spectrometry and Raman spectroscopy. Thermal behavior of graphene was analyzed by thermogravimetry analysis and differential scanning calorimetry. Again, atomic force microscopy, scanning electron microscopy, field emission scanning electron microscopy and transmission electron microscopy were used for morphological study. Energy dispersive X-ray spectrometer was applied to analyze the elemental composition. The results of the above experiments demonstrate that the house-hold baking soda is able to produce functional graphene, which can be a suitable replacement of hydrazine, sodium borohydrate or other toxic reducing agents. This method is high yielding and safe to use in biomaterial applications.
C1 [Aunkor, M. T. H.; Mahbubul, I. M.; Metselaar, H. S. C.] Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur 50603, Malaysia.
   [Saidur, R.] King Fahd Univ Petr & Minerals KFUPM, Ctr Res Excellence Renewable Energy CoRE RE, Dhahran 31261, Saudi Arabia.
RP Mahbubul, IM (reprint author), Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur 50603, Malaysia.
EM immahbubul@gmail.com; h.metselaar@um.edu.my
RI Islam, Mohammed Mahbubul/A-6303-2013; Engineering, Faculty/I-7935-2015;
   Metselaar, Hendrik/B-5324-2010
OI Islam, Mohammed Mahbubul/0000-0002-2101-3471; Engineering,
   Faculty/0000-0002-4848-7052; Metselaar, Hendrik/0000-0003-1047-654X
FU University of Malaya under the High Impact Research MoE from the
   Ministry of Education Malaysia [UM.C/625/1/HIR/MoE/ENG/40
   (D000040-16001)]
FX "The authors would like to thank the University of Malaya for financial
   support under the High Impact Research MoE Grant:
   UM.C/625/1/HIR/MoE/ENG/40 (D000040-16001) from the Ministry of Education
   Malaysia".
CR Acik M, 2010, NAT MATER, V9, P840, DOI [10.1038/nmat2858, 10.1038/NMAT2858]
   Ahmed MS, 2013, CARBON, V61, P164, DOI 10.1016/j.carbon.2013.04.080
   Akhavan O, 2012, CARBON, V50, P1853, DOI 10.1016/j.carbon.2011.12.035
   Amarnath CA, 2011, CARBON, V49, P3497, DOI 10.1016/j.carbon.2011.04.048
   Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872
   Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925
   Bo Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep04684
   Bosch-Navarro C, 2012, NANOSCALE, V4, P3977, DOI 10.1039/c2nr30605k
   Bose S, 2012, J MATER CHEM, V22, P9696, DOI 10.1039/c2jm00011c
   Cai WW, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3220807
   Cambaz ZG, 2008, CARBON, V46, P841, DOI 10.1016/j.carbon.2008.02.013
   Cheianov VV, 2007, SCIENCE, V315, P1252, DOI 10.1126/science.1138020
   Chen DZ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/32/325601
   De Silva KSB, 2012, J MATER CHEM, V22, P13941, DOI 10.1039/c2jm30323j
   Dickinson JW, 2013, SENSORS-BASEL, V13, P3635, DOI 10.3390/s130303635
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Du FP, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/47/475704
   Fan XB, 2008, ADV MATER, V20, P4490, DOI 10.1002/adma.200801306
   Fan ZJ, 2011, ACS NANO, V5, P191, DOI 10.1021/nn102339t
   Fan ZJ, 2010, CARBON, V48, P1686, DOI 10.1016/j.carbon.2009.12.063
   Fernandez-Merino MJ, 2010, J PHYS CHEM C, V114, P6426, DOI 10.1021/jp100603h
   Gao J, 2010, CHEM MATER, V22, P2213, DOI 10.1021/cm902635j
   Guo CX, 2011, ADV ENERGY MATER, V1, P736, DOI 10.1002/aenm.201100223
   Guo CX, 2010, ANGEW CHEM INT EDIT, V49, P3014, DOI 10.1002/anie.200906291
   Gurunathan S, 2013, COLLOID SURFACE B, V111, P376, DOI 10.1016/j.colsurfb.2013.06.018
   Heo Y, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1196-7
   Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215
   Janowska I, 2009, APPL CATAL A-GEN, V371, P22, DOI 10.1016/j.apcata.2009.09.013
   Jayasena B, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-95
   Jeong HK, 2008, J AM CHEM SOC, V130, P1362, DOI 10.1021/ja076473o
   Ji ZY, 2012, NEW J CHEM, V36, P1774, DOI 10.1039/c2nj40133a
   Jin M, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/27/275402
   Jin YH, 2013, APPL SURF SCI, V268, P541, DOI 10.1016/j.apsusc.2013.01.004
   Katsnelson MI, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195426
   Khanra P, 2012, CHEM ENG J, V183, P526, DOI 10.1016/j.cej.2011.12.075
   Kim HJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05176
   Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y
   Kuila T, 2012, CARBON, V50, P914, DOI 10.1016/j.carbon.2011.09.053
   Lei YD, 2011, GREEN CHEM, V13, P1655, DOI 10.1039/c1gc15081b
   Li CB, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0875-8
   Li J, 2013, J MATER CHEM A, V1, P1481, DOI 10.1039/c2ta00638c
   Li YG, 2011, J AM CHEM SOC, V133, P7296, DOI 10.1021/ja201269b
   Liu CG, 2010, NANO LETT, V10, P4863, DOI 10.1021/nl102661q
   Liu S, 2011, CARBON, V49, P3158, DOI 10.1016/j.carbon.2011.03.036
   Liu ZF, 2008, ADV MATER, V20, P3924, DOI 10.1002/adma.200800366
   Lotya M, 2009, J AM CHEM SOC, V131, P3611, DOI 10.1021/ja807449u
   Malesevic A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/30/305604
   McAllister MJ, 2007, CHEM MATER, V19, P4396, DOI 10.1021/cm0630800
   Mehrali M, 2014, ACS APPL MATER INTER, V6, P3947, DOI 10.1021/am500845x
   Mei XG, 2011, CARBON, V49, P5389, DOI 10.1016/j.carbon.2011.08.019
   Metin O, 2013, NANO RES, V6, P10, DOI 10.1007/s12274-012-0276-4
   Meyer JC, 2007, NATURE, V446, P60, DOI 10.1038/nature05545
   Naeimi H, 2015, NEW J CHEM, V39, P2697, DOI 10.1039/c4nj02340d
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]
   Peng HD, 2012, J PHYS CHEM C, V116, P16294, DOI 10.1021/jp3043889
   Qian Y, 2011, MATER LETT, V65, P56, DOI 10.1016/j.matlet.2010.09.042
   Ren PG, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/5/055705
   Shao YY, 2010, ELECTROANAL, V22, P1027, DOI 10.1002/elan.200900571
   Shin HJ, 2009, ADV FUNCT MATER, V19, P1987, DOI 10.1002/adfm.200900167
   Song P, 2012, RSC ADV, V2, P1168, DOI 10.1039/c1ra00934f
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Sun GL, 2008, MATER LETT, V62, P703, DOI 10.1016/j.matlet.2007.06.035
   Thakur S, 2012, CARBON, V50, P5331, DOI 10.1016/j.carbon.2012.07.023
   Tran D. N., 2014, CARBON
   Khai TV, 2013, CHEM ENG J, V232, P346, DOI 10.1016/j.cej.2013.07.123
   Tung VC, 2009, NAT NANOTECHNOL, V4, P25, DOI [10.1038/nnano.2008.329, 10.1038/NNANO.2008.329]
   Ulbricht H, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.075404
   Pham VH, 2012, J MATER CHEM, V22, P10530, DOI 10.1039/c2jm30562c
   Wang DW, 2012, CARBON, V50, P3333, DOI 10.1016/j.carbon.2011.12.054
   Wang GM, 2011, NANO RES, V4, P563, DOI 10.1007/s12274-011-0112-2
   Wang GX, 2008, J PHYS CHEM C, V112, P8192, DOI 10.1021/jp710931h
   Wang GX, 2009, CARBON, V47, P2049, DOI 10.1016/j.carbon.2009.03.053
   Wang GX, 2009, CARBON, V47, P1359, DOI 10.1016/j.carbon.2009.01.027
   Wang GX, 2009, CARBON, V47, P68, DOI 10.1016/j.carbon.2008.09.002
   Wang Y, 2011, ACS APPL MATER INTER, V3, P1127, DOI 10.1021/am1012613
   Williams JR, 2007, SCIENCE, V317, P638, DOI 10.1126/science.1144657
   XianaGuo C., 2011, ENERG ENVIRON SCI, V4, P4504
   Xu LQ, 2010, MACROMOLECULES, V43, P8336, DOI 10.1021/ma101526k
   Yan J, 2010, CARBON, V48, P3825, DOI 10.1016/j.carbon.2010.06.047
   Yang HB, 2011, J PHYS CHEM C, V115, P12209, DOI 10.1021/jp201178a
   Yang S, 2012, RSC ADV, V2, P8827, DOI 10.1039/c2ra20746j
   Yoo E, 2008, NANO LETT, V8, P2277, DOI 10.1021/nl800957b
   Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a
   Zhang YW, 2012, RSC ADV, V2, P538, DOI 10.1039/c1ra00641j
   Zhao JG, 2012, CARBON, V50, P4939, DOI 10.1016/j.carbon.2012.06.024
   Zhu CZ, 2010, ACS NANO, V4, P2429, DOI 10.1021/nn1002387
   Zhu JX, 2011, NANOSCALE, V3, P1084, DOI 10.1039/c0nr00744g
   Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068
   Zhuo QQ, 2013, CARBON, V52, P559, DOI 10.1016/j.carbon.2012.10.014
   Zickler GA, 2006, CARBON, V44, P3239, DOI 10.1016/j.carbon.2006.06.029
NR 91
TC 10
Z9 10
U1 0
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 86
BP 70461
EP 70472
DI 10.1039/c5ra10520j
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA CQ2BN
UT WOS:000360404400071
DA 2018-10-20
ER

PT J
AU Zhan, YX
   Niu, XR
AF Zhan, Yuexing
   Niu, Xinrui
TI Tuning methods and mechanical modelling of hydrogels
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE biomaterial; material properties; modelling
ID DOUBLE-NETWORK HYDROGELS; POLY(ETHYLENE GLYCOL) HYDROGELS; BIOMEDICAL
   APPLICATIONS; LARGE-DEFORMATION; DRUG-DELIVERY; POLYACRYLAMIDE
   HYDROGELS; NANOCOMPOSITE HYDROGELS; VISCOELASTIC PROPERTIES; SPHERICAL
   INDENTATION; COMPOSITE-MATERIALS
AB Hydrogels are cross-linked polymeric networks filled with high water content. They are used as tissue/cell culture scaffolds, biomedical devices and healthcare products. As the performance of hydrogels is significantly affected by their mechanical properties, it is required to tune hydrogels into desired mechanical systems. To provide guidance to the tuning process, it is important to evaluate and model the mechanical properties of hydrogels. However, due to the structural complexity of hydrogels, both tuning and modelling face challenges and uncertainties. This article briefly reviews the tuning methods and summarises key mechanical models that address linear elastic, hyperelastic, viscoelastic, poroelastic and hybrid mechanical behaviours of hydrogels.
C1 [Zhan, Yuexing; Niu, Xinrui] City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon, Hong Kong, Peoples R China.
   [Zhan, Yuexing; Niu, Xinrui] City Univ Hong Kong, CASM, Kowloon, Hong Kong, Peoples R China.
RP Zhan, YX (reprint author), City Univ Hong Kong, Dept Mech & Biomed Engn, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM yxzhan4-c@my.cityu.edu.hk
OI NIU, Xinrui/0000-0001-9965-4423
FU City University of Hong Kong [7200274, 2011SRG067, 9610217]
FX The authors acknowledge the financial support from the City University
   of Hong Kong for Start-up Grant for New Faculty 7200274, Strategic
   Research Grant 2011SRG067 and Equipment Fund 9610217.
CR Andrade A.L., 2012, J NANOMATER, V2012, P15
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   Billiet T, 2012, BIOMATERIALS, V33, P6020, DOI 10.1016/j.biomaterials.2012.04.050
   Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886
   Cai SQ, 2010, J APPL PHYS, V108, DOI 10.1063/1.3517146
   Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534
   Chan BK, 2012, MACROMOL BIOSCI, V12, P1490, DOI 10.1002/mabi.201200234
   Chan EP, 2012, SOFT MATTER, V8, P1492, DOI 10.1039/c1sm06514a
   Choi YJ, 2006, J NANOSCI NANOTECHNO, V6, P633, DOI 10.1166/jnn.2006.132
   Chyasnavichyus M, 2014, LANGMUIR, V30, P10566, DOI 10.1021/la404925h
   Cordell JM, 2009, J MECH BEHAV BIOMED, V2, P560, DOI 10.1016/j.jmbbm.2009.01.009
   Counto U. J., 1964, MAGAZINE CONCRETE RE, V16, P129
   Crichton ML, 2011, BIOMATERIALS, V32, P4670, DOI 10.1016/j.biomaterials.2011.03.012
   Cui J, 2012, MACROMOLECULES, V45, P6104, DOI 10.1021/ma300593g
   Cui J, 2012, BIOMACROMOLECULES, V13, P584, DOI 10.1021/bm300015s
   Delaney JT, 2010, SOFT MATTER, V6, P866, DOI 10.1039/b922888h
   DERJAGUIN BV, 1975, J COLLOID INTERF SCI, V53, P314, DOI 10.1016/0021-9797(75)90018-1
   Di Giacomo R, 2013, IEEE T NANOTECHNOL, V12, P1026, DOI 10.1109/TNANO.2013.2285438
   Djonlagic J, 2004, J POLYM SCI POL PHYS, V42, P3987, DOI 10.1002/polb.20247
   Douce J, 2004, THIN SOLID FILMS, V466, P114, DOI 10.1016/j.tsf.2004.03.024
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Einstein A, 1905, ANN PHYS-BERLIN, V17, P549
   Einstein A., 1956, INVESTIGATIONS THEOR
   El-Mohdy H.L.A., 2013, J POLYM RES, V20, P1
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003
   Faghihi S, 2014, MAT SCI ENG C-MATER, V38, P299, DOI 10.1016/j.msec.2014.02.015
   Friedrich K., 2005, POLYM COMPOSITES NAN
   Fu SY, 2002, COMPOS PART B-ENG, V33, P291, DOI 10.1016/S1359-8368(02)00013-6
   FUNG YCB, 1967, AM J PHYSIOL, V213, P1532
   Gaharwar AK, 2013, MAT SCI ENG C-MATER, V33, P1800, DOI 10.1016/j.msec.2012.12.099
   Gaharwar AK, 2011, ACTA BIOMATER, V7, P4139, DOI 10.1016/j.actbio.2011.07.023
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gong JP, 2010, SOFT MATTER, V6, P2583, DOI 10.1039/b924290b
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   GUTH E, 1945, J APPL PHYS, V16, P20, DOI 10.1063/1.1707495
   Guvendiren M, 2013, CURR OPIN BIOTECH, V24, P841, DOI 10.1016/j.copbio.2013.03.009
   Haque MA, 2012, POLYMER, V53, P1805, DOI 10.1016/j.polymer.2012.03.013
   Henderson KJ, 2010, MACROMOLECULES, V43, P6193, DOI 10.1021/ma100963m
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hong W, 2008, J MECH PHYS SOLIDS, V56, P1779, DOI 10.1016/j.jmps.2007.11.010
   Hu YH, 2012, ACTA MECH SOLIDA SIN, V25, P441, DOI 10.1016/S0894-9166(12)60039-1
   Hu YH, 2011, J APPL PHYS, V110, DOI 10.1063/1.3647758
   Hu YH, 2011, J MATER RES, V26, P785, DOI 10.1557/jmr.2010.35
   Hu YH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3370354
   Huang GY, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/012001
   Huang WC, 2014, ACTA BIOMATER, V10, P3546, DOI 10.1016/j.actbio.2014.04.025
   Huang WC, 2012, SOFT MATTER, V8, P10868, DOI 10.1039/c2sm26361k
   HYON SH, 1994, J BIOMAT SCI-POLYM E, V5, P397, DOI 10.1163/156856294X00103
   Ji XL, 2002, POLYM ENG SCI, V42, P983, DOI 10.1002/pen.11007
   Johnson JA, 2010, PROG POLYM SCI, V35, P332, DOI 10.1016/j.progpolymsci.2009.12.002
   JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141
   Kalcioglu ZI, 2012, SOFT MATTER, V8, P3393, DOI 10.1039/c2sm06825g
   Karimi A, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40257
   Karimi A, 2014, TISSUE CELL, V46, P97, DOI 10.1016/j.tice.2013.12.004
   Kim B, 2013, J APPL POLYM SCI, V130, P3574, DOI 10.1002/app.39544
   KINLOCH AJ, 1985, J MATER SCI, V20, P4169, DOI 10.1007/BF00552413
   Kirschner CM, 2013, ACTA MATER, V61, P931, DOI 10.1016/j.actamat.2012.10.037
   Kurokawa T, 2010, ACTA BIOMATER, V6, P1353, DOI 10.1016/j.actbio.2009.10.046
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Levesque SG, 2005, BIOMATERIALS, V26, P7436, DOI 10.1016/j.biomaterials.2005.05.054
   LEWIS TB, 1970, J APPL POLYM SCI, V14, P1449, DOI 10.1002/app.1970.070140604
   Lin DC, 2007, J BIOMECH ENG-T ASME, V129, P430, DOI 10.1115/1.2720924
   Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9
   Lin WC, 2011, SOFT MATTER, V7, P6578, DOI 10.1039/c1sm05420a
   Lin WC, 2010, MACROMOLECULES, V43, P2554, DOI 10.1021/ma901937r
   Liu JQ, 2014, EUR POLYM J, V50, P9, DOI 10.1016/j.eurpolymj.2013.10.015
   Liu TY, 2006, LANGMUIR, V22, P9740, DOI 10.1021/la061471n
   Lu GD, 2007, POLYM INT, V56, P1016, DOI [10.1002/pi.2235, 10.1002/pi]
   Lucas SR, 2008, ACTA BIOMATER, V4, P117, DOI 10.1016/j.actbio.2007.08.003
   Lucas SR, 2009, BIOMECH MODEL MECHAN, V8, P487, DOI 10.1007/s10237-009-0152-7
   Mandal SK, 2013, CHEM-EUR J, V19, P12486, DOI 10.1002/chem.201300302
   Mattice JM, 2006, J MATER RES, V21, P2003, DOI 10.1557/JMR.2006.0243
   MAXWELL D, 1984, J MATER SCI LETT, V3, P9, DOI 10.1007/BF00720061
   Mishra S, 2005, J POLYM SCI POL PHYS, V43, P107, DOI 10.1002/polb.20296
   Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836
   MOONEY M, 1951, J COLL SCI IMP U TOK, V6, P162, DOI 10.1016/0095-8522(51)90036-0
   Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574
   NIELSEN LE, 1979, J POLYM SCI POL PHYS, V17, P1897, DOI 10.1002/pol.1979.180171106
   NIELSEN LE, 1970, J APPL PHYS, V41, P4626, DOI 10.1063/1.1658506
   OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026
   Omidian H, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P1, DOI 10.1007/978-1-4419-5919-5_1
   Ou YC, 1998, J POLYM SCI POL PHYS, V36, P789
   Oyen ML, 2006, PHILOS MAG, V86, P5625, DOI 10.1080/14786430600740666
   Oyen ML, 2014, INT MATER REV, V59, P44, DOI 10.1179/1743280413Y.0000000022
   Parlato M, 2014, MACROMOL BIOSCI, V14, P687, DOI 10.1002/mabi.201300418
   Pasqui D, 2011, MATER LETT, V65, P392, DOI 10.1016/j.matlet.2010.10.053
   Peak CW, 2013, COLLOID POLYM SCI, V291, P2031, DOI 10.1007/s00396-013-3021-y
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   RADFORD KC, 1971, J MATER SCI, V6, P1286, DOI 10.1007/BF00552042
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   RIVLIN RS, 1948, PHILOS TR R SOC S-A, V241, P379, DOI 10.1098/rsta.1948.0024
   Roberts JJ, 2011, J BIOMED MATER RES B, V99B, P158, DOI 10.1002/jbm.b.31883
   Sakai M, 2002, PHILOS MAG A, V82, P1841, DOI 10.1080/01418610210134738
   Sannino A, 2009, MATERIALS, V2, P353, DOI 10.3390/ma2020353
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   Sasson A, 2012, J MECH BEHAV BIOMED, V8, P143, DOI 10.1016/j.jmbbm.2011.12.008
   Schapery R. A., 1997, Mechanics of Time-Dependent Materials, V1, P209, DOI 10.1023/A:1009767812821
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shapiro JM, 2014, ACTA MECH SINICA-PRC, V30, P7, DOI 10.1007/s10409-014-0025-x
   Shin SR, 2012, ACS NANO, V6, P362, DOI 10.1021/nn203711s
   Sneddon I. N., 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507
   Strange DGT, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4789368
   Sudheesh Kumar PT, 2012, ACS APPL MATER INTER, V4, P2618, DOI DOI 10.1021/AM300292V
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   TABOR D, 1948, PROC R SOC LON SER-A, V192, P247, DOI 10.1098/rspa.1948.0008
   Tabor D., 1951, HARDNESS METALS
   Tighe BJ, 2013, EYE CONTACT LENS, V39, P4, DOI 10.1097/ICL.0b013e318275452b
   Tokuyama H, 2007, LANGMUIR, V23, P11246, DOI 10.1021/la701492u
   Tuncaboylu DC, 2011, MACROMOLECULES, V44, P4997, DOI 10.1021/ma200579v
   Verbeek CJR, 2003, MATER LETT, V57, P1919, DOI 10.1016/S0167-577X(02)01105-9
   Wang QM, 2014, ACTA MECH SINICA-PRC, V30, P20, DOI 10.1007/s10409-014-0015-z
   Wang Q, 2012, SOFT MATTER, V8, P6048, DOI 10.1039/c2sm07233e
   Wang X, 2012, P ROY SOC A-MATH PHY, V468, P3824, DOI 10.1098/rspa.2012.0385
   WEI Qingbo, 2014, J POLYM RES, V21, P1
   Weng LH, 2008, BIOMATERIALS, V29, P2153, DOI 10.1016/j.biomaterials.2008.01.012
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wu CJ, 2013, MACROMOL BIOSCI, V13, P59, DOI 10.1002/mabi.201200362
   Wu CJ, 2011, MACROMOLECULES, V44, P8215, DOI 10.1021/ma200562k
   Xu YX, 2013, ACS NANO, V7, P4042, DOI 10.1021/nn4000836
   YEOH OH, 1993, RUBBER CHEM TECHNOL, V66, P754, DOI 10.5254/1.3538343
   Yun J, 2011, MATER SCI ENG B-ADV, V176, P276, DOI 10.1016/j.mseb.2010.11.011
   Zhang MG, 2014, BIOMECH MODEL MECHAN, V13, P1, DOI 10.1007/s10237-013-0481-4
   Zhao XH, 2012, J MECH PHYS SOLIDS, V60, P319, DOI 10.1016/j.jmps.2011.10.005
NR 133
TC 2
Z9 2
U1 1
U2 21
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2015
VL 4
IS 2
BP 140
EP 154
DI 10.1680/bbn.14.00029
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP8OT
UT WOS:000360154200005
DA 2018-10-20
ER

PT J
AU Utku, FS
   Yuca, E
   Seckin, E
   Goller, G
   Karatas, AY
   Urgen, M
   Tamerler, C
AF Utku, Feride Sermin
   Yuca, Esra
   Seckin, Eren
   Goller, Gultekin
   Karatas, Ayten Yazgan
   Urgen, Mustafa
   Tamerler, Candan
TI Protein-mediated hydroxyapatite composite layer formation on nanotubular
   titania
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE biocompatible; biointerface; biomaterial
ID CALCIUM-PHOSPHATE COATINGS; IN-VITRO; ELECTROCHEMICAL DEPOSITION;
   SURFACE MODIFICATION; MATERIALS SCIENCE; DENTAL IMPLANTS; OXIDE
   NANOTUBES; SUBSTRATE; PEPTIDES; CELL
AB Realising controllable interactions at the bio-nanomaterial interfaces are vital in developing next-generation engineered implant materials. Titanium-based implants are key materials in biomedical engineering due to excellent bulk mechanical properties and biocompatibilities. Advanced bio-interfaces resolving nanostructured modulated surfaces that allow manipulation with the biological molecules is one of the keys to enhance favourable interactions with the surrounding biological species. Here, we developed a protein-mediated hydroxyapatite composite layer on nanotubular titania surface. Green fluorescence protein, engineered to contain hydroxyapatite binding peptides (GFPuv-HABP), was co-deposited with the hydroxyapatite precursors onto the titania nanotubes that are formed by anodisation. Ordered titanium dioxide nanotubular surfaces were coated with hydroxyapatite at physiological pH and temperature using simulated body fluid and pulsed electrochemical cathodisation. The hydroxyapatite deposit interdigitated into the nanotubes, producing a metal oxide-mineral composite. The engineered GFPuv-HABP protein was then self-assembled on the hydroxyapatite, forming a bio-modulated interface. Additionally, the engineered proteins were co-deposited with the precursor ions of hydroxyapatite mineral on the nanotubular titania plate. Bio-mediated assembly resulted in formation of a hybrid composite as an integrated interface on the nanotubular surface. Biomolecular assisted fabrication of hybrid composite interface on metal oxide substrate offers wide range of opportunities to design novel interfaces.
C1 [Utku, Feride Sermin] Yeditepe Univ, Dept Biomed Engn, Istanbul, Turkey.
   [Yuca, Esra; Tamerler, Candan] Univ Kansas, Bioengn Res Ctr, Lawrence, KS 66045 USA.
   [Yuca, Esra] Yildiz Tech Univ, Dept Mol Biol & Genet, Istanbul, Turkey.
   [Seckin, Eren; Goller, Gultekin; Urgen, Mustafa] Istanbul Tech Univ, Dept Met Engn, TR-80626 Istanbul, Turkey.
   [Karatas, Ayten Yazgan] Istanbul Tech Univ, Dept Mol Biol & Genet, TR-80626 Istanbul, Turkey.
   [Tamerler, Candan] Univ Kansas, Dept Mech Engn, Lawrence, KS 66045 USA.
RP Tamerler, C (reprint author), Univ Kansas, Bioengn Res Ctr, Lawrence, KS 66045 USA.
EM ctamerler@ku.edu
RI Urgen, Mustafa/D-5422-2014
OI Urgen, Mustafa/0000-0003-3549-0049; UTKU, FERIDE
   SERMIN/0000-0002-5143-3602; Tamerler, Candan/0000-0002-1960-2218
FU TUBITAK BIDEB [2218, 2219]; TR-SPO; University of Kansas NFRF funds
FX This study has been supported by TUBITAK BIDEB 2218 and 2219
   Post-Doctoral Research Project, TR-SPO and University of Kansas NFRF
   funds. We thank Huseyin Sezer, Talat Apak, Berk Alkan, SevginTurkeli and
   Mizrap Canibeyaz for the characterisation of CHA coatings.
CR ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531
   Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255
   ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   Alves C, 2005, SURF COAT TECH, V194, P196, DOI 10.1016/j.surfcoat.2004.10.009
   Angelescu N, 2011, METAL INT, V16, P125
   Ban S, 1998, J BIOMED MATER RES, V42, P387, DOI 10.1002/(SICI)1097-4636(19981205)42:3<387::AID-JBM6>3.3.CO;2-Q
   BAN SJ, 1995, BIOMATERIALS, V16, P977, DOI 10.1016/0142-9612(95)94904-Y
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Bavykin DV, 2006, ADV MATER, V18, P2807, DOI 10.1002/adma.200502696
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Boyan BD, 2001, ANN REV MATER RES, V31, P357, DOI 10.1146/annurev.matsci.31.1.357
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   CHEHROUDI B, 1992, CELL MATER, V2, P89
   COOK SD, 1991, CLIN ORTHOP RELAT R, P280
   Deporter D, 2009, INT J PERIODONT REST, V29, P625
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Evans JS, 2008, MRS BULL, V33, P514, DOI 10.1557/mrs2008.103
   Faghihi S, 2007, ADV MATER, V19, P1069, DOI 10.1002/adma.200602276
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Frenkel SR, 2002, J BIOMED MATER RES, V63, P706, DOI 10.1002/jbm.10408
   Fukumoto S, 1999, MAT SCI ENG A-STRUCT, V263, P205, DOI 10.1016/S0921-5093(98)01166-6
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gungormus M, 2008, BIOMACROMOLECULES, V9, P966, DOI 10.1021/bm701037x
   Gungormus M, 2012, INT J ORAL SCI, V4, P69, DOI 10.1038/ijos.2012.40
   Hnilova M, 2012, J COLLOID INTERF SCI, V365, P97, DOI 10.1016/j.jcis.2011.09.006
   Ho WF, 2009, SURF COAT TECH, V203, P3142, DOI 10.1016/j.surfcoat.2009.03.042
   HULBERT SF, 1973, J BIOMED MATER RES, V7, P1, DOI 10.1002/jbm.820070303
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Jiang PL, 2013, ELECTROCHIM ACTA, V107, P16, DOI 10.1016/j.electacta.2013.05.120
   Kannan S, 2008, J AM CERAM SOC, V91, P1, DOI 10.1111/j.1551-2916.2007.02117.x
   Kar A, 2006, SURF COAT TECH, V201, P3723, DOI 10.1016/j.surfcoat.2006.09.008
   Khatayevich D, 2010, ACTA BIOMATER, V6, P4634, DOI 10.1016/j.actbio.2010.06.004
   Kokubo T, 2004, J MATER SCI-MATER M, V15, P99, DOI 10.1023/B:JMSM.0000011809.36275.0c
   Kunze J, 2008, ELECTROCHIM ACTA, V53, P6995, DOI 10.1016/j.electacta.2008.01.027
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Leeuwenburgh SCG, 2006, BIOMATERIALS, V27, P3368, DOI 10.1016/j.biomaterials.2006.01.052
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198
   Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865
   Narayanan R, 2007, SCRIPTA MATER, V56, P229, DOI 10.1016/j.scriptamat.2006.10.004
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Redepenning J, 1996, J BIOMED MATER RES, V30, P287
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Rossler S, 2003, J BIOMED MATER RES A, V64A, P655, DOI 10.1002/jbm.a.10330
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Seker UOS, 2009, BIOMACROMOLECULES, V10, P250, DOI 10.1021/bm8009895
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P67, DOI 10.1023/A:1008838813120
   Slosarczyk A, 2005, J MOL STRUCT, V744, P657, DOI 10.1016/j.molstruc.2004.11.078
   Stojanovic D, 2007, J EUR CERAM SOC, V27, P1595, DOI 10.1016/j.jeurceramsoc.2006.04.111
   Tamerler C, 2006, LANGMUIR, V22, P7712, DOI 10.1021/la0606897
   Tamerler C, 2009, ACS NANO, V3, P1606, DOI 10.1021/nn900720g
   Tomsia AP, 2011, INT J ORAL MAX IMPL, V26, P25
   Utku FS, 2014, CERAM INT, V40, P15479, DOI 10.1016/j.ceramint.2014.07.004
   Utku FS, 2008, J STRUCT BIOL, V162, P361, DOI 10.1016/j.jsb.2008.01.004
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Wang H, 2009, APPL SURF SCI, V255, P4074, DOI 10.1016/j.apsusc.2008.10.111
   Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]
   Woesz A, 2006, J MATER RES, V21, P2068, DOI 10.1557/JMR.2006.0251
   Yazici H, 2013, ACTA BIOMATER, V9, P5341, DOI 10.1016/j.actbio.2012.11.004
   Yen SK, 2003, MATER CHEM PHYS, V77, P70, DOI 10.1016/S0254-0584(01)00562-4
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yuca E, 2011, BIOTECHNOL BIOENG, V108, P1021, DOI 10.1002/bit.23041
   Yucesoy DT, 2015, JOM-US, V67, P754, DOI 10.1007/s11837-015-1350-7
   Zhang QY, 2009, J BIOMED MATER RES A, V88A, P481, DOI 10.1002/jbm.a.31820
   Zhou Y, 2015, NANOMED-NANOTECHNOL, V11, P431, DOI 10.1016/j.nano.2014.10.003
NR 72
TC 3
Z9 3
U1 1
U2 30
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2015
VL 4
IS 2
BP 155
EP 165
DI 10.1680/bbn.15.00001
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP8OT
UT WOS:000360154200006
DA 2018-10-20
ER

PT J
AU Yao, HB
   Fan, MH
   Wang, YJ
   Luo, GS
   Fei, WY
AF Yao, Hongbao
   Fan, Maohong
   Wang, Yujun
   Luo, Guangsheng
   Fei, Weiyang
TI Magnetic titanium dioxide based nanomaterials: synthesis,
   characteristics, and photocatalytic application in pollutant degradation
SO JOURNAL OF MATERIALS CHEMISTRY A
LA English
DT Review
ID FERRITE COMPOSITE NANOPARTICLES; VISIBLE-LIGHT; NICKEL FERRITE; TIO2
   PHOTOCATALYST; ACTIVATED CARBON; BIOMATERIAL SYSTEM; ENVIRONMENTAL
   APPLICATIONS; SEPARATED PHOTOCATALYST; SHELL NANOCOMPOSITES; ORGANIC
   POLLUTANTS
AB Magnetic titanium dioxide based nanocomposites have been gaining increasingly high attention in sustainable environmental protection fields; these materials can integrate the advantages of magnetic recovery and the superior photocatalysis performance of titanium dioxide. However, direct contact between crystalline photoactive titanium dioxide and magnetic iron oxide gives rise to lower photoreactivity than pure titanium dioxide for the pollutant degradation. To overcome the challenge, a number of researches have been done and significant process has been made in this area in recent years. This review primarily focuses on the properties of magnetic particles, structural models, preparation methods and techniques to improve photocatalytic performance of magnetic titanium dioxide based photocatalysts, and aims to provide a systematic overview of the current knowledge of these subjects. Notably, the recently discovered technique coupling graphene into magnetic iron oxide-titanium dioxide system is discussed, which opens a promising future for preparation of magnetic semiconductors with excellent properties. Current challenges and prospects are also proposed at the end of this article. In particular, the examination of corresponding deactivation or regeneration mechanisms should be investigated further, from the point of view of practical applications.
C1 [Yao, Hongbao; Fan, Maohong] Univ Wyoming, Dept Chem & Petr Engn, Laramie, WY 82071 USA.
   [Yao, Hongbao; Wang, Yujun; Luo, Guangsheng; Fei, Weiyang] Tsinghua Univ, Dept Chem Engn, State Key Lab Chem Engn, Beijing 100084, Peoples R China.
   [Fan, Maohong] Univ Wyoming, Sch Energy Resources, Laramie, WY 82071 USA.
   [Fan, Maohong] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.
RP Fan, MH (reprint author), Univ Wyoming, Dept Chem & Petr Engn, Laramie, WY 82071 USA.
EM mfan@uwyo.edu; wangyujun@mail.tsinghua.edu.cn
RI Fan, Maohong/H-3624-2015
OI Fan, Maohong/0000-0003-1334-7292
FU Department of Energy; State of Wyoming
FX The authors gratefully acknowledge the great support from the Department
   of Energy and State of Wyoming.
CR Abd Aziz A, 2014, CHEM ENG J, V235, P264, DOI 10.1016/j.cej.2013.09.043
   Alvarez PM, 2010, APPL CATAL B-ENVIRON, V100, P338, DOI 10.1016/j.apcatb.2010.08.010
   Ao YH, 2009, J PHYS CHEM SOLIDS, V70, P1042, DOI 10.1016/j.jpcs.2009.05.019
   Ao YH, 2008, J HAZARD MATER, V160, P295, DOI 10.1016/j.jhazmat.2008.02.114
   Arabatzis IM, 2002, J PHOTOCH PHOTOBIO A, V149, P237, DOI 10.1016/S1010-6030(01)00645-1
   Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051
   Aziz AA, 2013, J EXP NANOSCI, V8, P295, DOI 10.1080/17458080.2012.675087
   Belessi V, 2009, APPL CATAL B-ENVIRON, V87, P181, DOI 10.1016/j.apcatb.2008.09.012
   Belova V, 2011, ULTRASON SONOCHEM, V18, P310, DOI 10.1016/j.ultsonch.2010.06.012
   Beydoun D, 2002, J MOL CATAL A-CHEM, V180, P193, DOI 10.1016/S1381-1169(01)00429-0
   Beydoun D, 2002, MAT SCI ENG B-SOLID, V94, P71, DOI 10.1016/S0921-5107(02)00085-5
   Beydoun D, 2001, CHEM ENG TECHNOL, V24, P745, DOI 10.1002/1521-4125(200107)24:7<745::AID-CEAT745>3.0.CO;2-D
   Beydoun D, 2000, J PHYS CHEM B, V104, P4387, DOI 10.1021/jp992088c
   Chen F, 1999, CATAL LETT, V58, P245, DOI 10.1023/A:1019071126825
   Chen F, 2001, CHEMOSPHERE, V44, P1159, DOI 10.1016/S0045-6535(00)00277-0
   Chen JY, 2010, J MATER SCI, V45, P6018, DOI 10.1007/s10853-010-4685-z
   Chen XB, 2005, ADV FUNCT MATER, V15, P41, DOI 10.1002/adfm.200400184
   Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535
   Chen YH, 2009, J HAZARD MATER, V172, P20, DOI 10.1016/j.jhazmat.2009.06.122
   Chen YH, 2009, IND ENG CHEM RES, V48, P7616, DOI 10.1021/ie900509t
   Chen YH, 2009, J HAZARD MATER, V163, P973, DOI 10.1016/j.jhazmat.2008.07.097
   CHOI WY, 1994, J PHYS CHEM-US, V98, P13669, DOI 10.1021/j100102a038
   Chung YS, 2004, MATER CHEM PHYS, V86, P375, DOI 10.1016/j.matchemphys.2004.03.027
   Cornell R.M., 2006, IRON OXIDES STRUCTUR
   Costa AL, 2012, J COLLOID INTERF SCI, V388, P31, DOI 10.1016/j.jcis.2012.07.077
   Cushing SK, 2012, J AM CHEM SOC, V134, P15033, DOI 10.1021/ja305603t
   Dabrowski A, 2005, CHEMOSPHERE, V58, P1049, DOI 10.1016/j.chemosphere.2004.09.067
   Fu WY, 2006, COLLOID SURFACE A, V289, P47, DOI 10.1016/j.colsurfa.2006.04.013
   Fu WY, 2006, MATER LETT, V60, P2723, DOI 10.1016/j.matlet.2006.01.078
   Fu WY, 2005, MATER LETT, V59, P3530, DOI 10.1016/j.matlet.2005.06.071
   Fu YP, 2010, J MATER RES, V25, P134, DOI 10.1557/JMR.2010.0015
   Fu YS, 2012, IND ENG CHEM RES, V51, P725, DOI 10.1021/ie2026212
   Fu YS, 2012, AICHE J, V58, P3298, DOI 10.1002/aic.13716
   Gao Y, 2003, MATER CHEM PHYS, V80, P348, DOI 10.1016/S0254-0584(02)00515-1
   Gawande MB, 2013, CHEM SOC REV, V42, P3371, DOI 10.1039/c3cs35480f
   Ghavami M, 2014, MAT SCI SEMICON PROC, V26, P69, DOI 10.1016/j.mssp.2014.04.007
   Gondal MA, 2012, J ENVIRON SCI HEAL A, V47, P570, DOI 10.1080/10934529.2012.650566
   Gopal M, 1997, J MATER SCI, V32, P6001, DOI 10.1023/A:1018671212890
   Gul IH, 2008, J MAGN MAGN MATER, V320, P270, DOI 10.1016/j.jmmm.2007.05.032
   Gupta VK, 2009, J ENVIRON MANAGE, V90, P2313, DOI 10.1016/j.jenvman.2008.11.017
   HAGUE DC, 1994, J AM CERAM SOC, V77, P1957, DOI 10.1111/j.1151-2916.1994.tb07078.x
   Hankare PP, 2011, APPL CATAL B-ENVIRON, V107, P333, DOI 10.1016/j.apcatb.2011.07.033
   Harra J, 2013, POWDER TECHNOL, V243, P46, DOI 10.1016/j.powtec.2013.03.027
   He YM, 2015, APPL CATAL B-ENVIRON, V168, P1, DOI 10.1016/j.apcatb.2014.12.017
   He YM, 2015, ENVIRON SCI TECHNOL, V49, P649, DOI 10.1021/es5046309
   He ZQ, 2012, SEP PURIF TECHNOL, V96, P50, DOI 10.1016/j.seppur.2012.05.005
   Hou WB, 2013, ADV FUNCT MATER, V23, P1612, DOI 10.1002/adfm.201202148
   Huang HC, 2006, THIN SOLID FILMS, V515, P1033, DOI 10.1016/j.tsf.2006.07.071
   Hussain ST, 2011, INT J ENVIRON SCI TE, V8, P351, DOI 10.1007/BF03326222
   Jiang Y, 2014, ACS APPL MATER INTER, V6, P11766, DOI 10.1021/am5025275
   Kostedt WL, 2010, ENVIRON PROG SUSTAIN, V29, P10, DOI 10.1002/ep.10364
   Kwon S, 2008, CRIT REV ENV SCI TEC, V38, P197, DOI 10.1080/10643380701628933
   Lee SW, 2006, MATER CHEM PHYS, V96, P483, DOI 10.1016/j.matchemphys.2005.07.039
   Lee SW, 2004, CHEM MATER, V16, P1160, DOI 10.1021/cm0351902
   Li HX, 2007, ENVIRON SCI TECHNOL, V41, P4410, DOI 10.1021/es062680x
   Li W, 2011, J AM CHEM SOC, V133, P15830, DOI 10.1021/ja2055287
   Li XY, 2012, J MATER SCI, V47, P465, DOI 10.1007/s10853-011-5821-0
   Li Y, 2011, PARTICUOLOGY, V9, P475, DOI 10.1016/j.partic.2011.04.005
   Liang YT, 2011, NANO LETT, V11, P2865, DOI 10.1021/nl2012906
   Liang YL, 2014, RSC ADV, V4, P56883, DOI 10.1039/c4ra08258c
   Lin Y, 2012, EUR J INORG CHEM, P4439, DOI 10.1002/ejic.201200454
   Linley S, 2014, ACS APPL MATER INTER, V6, P4658, DOI 10.1021/am4039272
   Liu SQ, 2012, ENVIRON CHEM LETT, V10, P209, DOI 10.1007/s10311-011-0348-9
   Ljubas D, 2014, SEP PURIF TECHNOL, V136, P274, DOI 10.1016/j.seppur.2014.09.018
   Luo JY, 2011, ACS NANO, V5, P8943, DOI 10.1021/nn203115u
   Luo L, 2009, J HAZARD MATER, V161, P175, DOI 10.1016/j.jhazmat.2008.03.105
   Luo ML, 2009, APPL CATAL B-ENVIRON, V87, P1, DOI 10.1016/j.apcatb.2008.09.002
   Ma Y, 2001, CHEMOSPHERE, V44, P1087, DOI 10.1016/S0045-6535(00)00360-X
   Mathew DS, 2007, CHEM ENG J, V129, P51, DOI 10.1016/j.cej.2006.11.001
   Matos J, 1998, APPL CATAL B-ENVIRON, V18, P281, DOI 10.1016/S0926-3373(98)00051-4
   Nakaruk A, 2012, J SOL-GEL SCI TECHN, V61, P175, DOI 10.1007/s10971-011-2607-4
   Nakata K, 2012, J PHOTOCH PHOTOBIO C, V13, P169, DOI 10.1016/j.jphotochemrev.2012.06.001
   Nam HD, 1998, JPN J APPL PHYS 1, V37, P4603, DOI 10.1143/JJAP.37.4603
   Narayani H, 2013, CATAL LETT, V143, P807, DOI 10.1007/s10562-013-1024-4
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Pang HA, 2011, CATAL COMMUN, V12, P611, DOI 10.1016/j.catcom.2010.12.015
   Pelaez M, 2012, APPL CATAL B-ENVIRON, V125, P331, DOI 10.1016/j.apcatb.2012.05.036
   Pongsorrarith V, 2012, MATER LETT, V67, P1, DOI 10.1016/j.matlet.2011.09.018
   Primo A, 2011, PHYS CHEM CHEM PHYS, V13, P886, DOI 10.1039/c0cp00917b
   Rafatullah M, 2010, J HAZARD MATER, V177, P70, DOI 10.1016/j.jhazmat.2009.12.047
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Reyes-Garcia EA, 2007, J PHYS CHEM C, V111, P17146, DOI 10.1021/jp070941z
   Reyes-Garcia EA, 2009, SOLID STATE NUCL MAG, V35, P74, DOI 10.1016/j.ssnmr.2009.02.004
   Shan AY, 2010, APPL CATAL A-GEN, V389, P1, DOI 10.1016/j.apcata.2010.08.053
   Shchukin DG, 2002, PHOTOCH PHOTOBIO SCI, V1, P742, DOI 10.1039/b207477j
   Shen JH, 2012, J MATER CHEM, V22, P13341, DOI 10.1039/c2jm31998e
   Shi ZL, 2011, J TAIWAN INST CHEM E, V42, P652, DOI 10.1016/j.jtice.2010.10.001
   Shi ZL, 2012, RUSS J PHYS CHEM A+, V86, P1326, DOI 10.1134/S0036024412060337
   Shi ZL, 2011, PHOTOCHEM PHOTOBIOL, V87, P626, DOI 10.1111/j.1751-1097.2011.00893.x
   Su JW, 2014, NANOSCALE, V6, P5181, DOI 10.1039/c4nr00534a
   Sun JW, 2013, RSC ADV, V3, P22490, DOI 10.1039/c3ra43416h
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Tang HQ, 2012, SEP PURIF TECHNOL, V95, P165, DOI 10.1016/j.seppur.2012.05.004
   Tang SCN, 2013, WATER RES, V47, P2613, DOI 10.1016/j.watres.2013.02.039
   Tang YH, 2013, J HAZARD MATER, V252, P115, DOI 10.1016/j.jhazmat.2013.02.053
   Tawkaew S, 2008, MATER CHEM PHYS, V108, P147, DOI 10.1016/j.matchemphys.2007.09.026
   TERABE K, 1994, J MATER SCI, V29, P1617, DOI 10.1007/BF00368935
   Tojo S, 2008, J PHYS CHEM C, V112, P14948, DOI 10.1021/jp804985f
   Tong H, 2012, ADV MATER, V24, P229, DOI 10.1002/adma.201102752
   Tryba B, 2003, APPL CATAL B-ENVIRON, V41, P427, DOI 10.1016/S0926-3373(02)00173-X
   Vereb G, 2012, APPL CATAL A-GEN, V417, P26, DOI 10.1016/j.apcata.2011.12.018
   Wang CX, 2009, J PHYS CHEM C, V113, P4008, DOI 10.1021/jp809835a
   Wang Y, 2014, RSC ADV, V4, P44442, DOI 10.1039/c4ra07457b
   Wang ZH, 2012, INT J PHOTOENERGY, DOI 10.1155/2012/202519
   Watson S, 2005, J NANOPART RES, V7, P691, DOI 10.1007/s11051-005-7520-8
   Watson S, 2002, J PHOTOCH PHOTOBIO A, V148, P303, DOI 10.1016/S1010-6030(02)00057-6
   Wu W., 2014, NANOSCALE, V7, P38
   Xiang QJ, 2010, APPL CATAL B-ENVIRON, V96, P557, DOI 10.1016/j.apcatb.2010.03.020
   Xu H, 2008, J SOLID STATE CHEM, V181, P2516, DOI 10.1016/j.jssc.2008.06.019
   Xu MW, 2005, MATER LETT, V59, P2194, DOI 10.1016/j.matlet.2005.02.065
   Xu SH, 2007, SCI TECHNOL ADV MAT, V8, P40, DOI 10.1016/j.stam.2006.09.009
   Xu SH, 2007, APPL CATAL B-ENVIRON, V71, P177, DOI 10.1016/j.apcatb.2006.09.004
   Xu SH, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/9/095606
   Xuan SH, 2009, J PHYS CHEM C, V113, P553, DOI 10.1021/jp8073859
   Yamazaki S, 2001, WATER RES, V35, P1022, DOI 10.1016/S0043-1354(00)00347-X
   Yao SH, 2012, ENVIRON TECHNOL, V33, P983, DOI 10.1080/09593330.2011.604857
   Yao SH, 2010, PHOTOCHEM PHOTOBIOL, V86, P1215, DOI 10.1111/j.1751-1097.2010.00813.x
   Ye MM, 2010, CHEM-EUR J, V16, P6243, DOI 10.1002/chem.200903516
   Zhang N, 2012, NANOSCALE, V4, P5792, DOI 10.1039/c2nr31480k
   Zhang N, 2012, NANOSCALE, V4, P2227, DOI 10.1039/c2nr00009a
   Zhang YH, 2011, ACS NANO, V5, P7426, DOI 10.1021/nn202519j
   Zhang ZY, 2014, NANOSCALE, V6, P5217, DOI 10.1039/c3nr06562f
   Zhao D, 2008, ENVIRON SCI TECHNOL, V42, P308, DOI 10.1021/es071770e
   Zheng ZK, 2011, J MATER CHEM, V21, P9079, DOI 10.1039/c1jm10983a
   Zi ZF, 2008, J MAGN MAGN MATER, V320, P2746, DOI 10.1016/j.jmmm.2008.06.009
NR 127
TC 24
Z9 25
U1 14
U2 186
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-7488
EI 2050-7496
J9 J MATER CHEM A
JI J. Mater. Chem. A
PY 2015
VL 3
IS 34
BP 17511
EP 17524
DI 10.1039/c5ta03215f
PG 14
WC Chemistry, Physical; Energy & Fuels; Materials Science,
   Multidisciplinary
SC Chemistry; Energy & Fuels; Materials Science
GA CP7EL
UT WOS:000360049900002
DA 2018-10-20
ER

PT S
AU Sun, G
   Fang, Y
AF Sun, Gang
   Fang, Yan
BE Wu, Y
   Deng, W
TI Micro-morphological Models for Hydrophobicity on the Surface of Moth
   Wing
SO PROCEEDINGS OF THE AASRI INTERNATIONAL CONFERENCE ON INDUSTRIAL
   ELECTRONICS AND APPLICATIONS (IEA 2015)
SE AER-Advances in Engineering Research
LA English
DT Proceedings Paper
CT AASRI International Conference on Industrial Electronics and
   Applications (IEA)
CY JUN 27-28, 2015
CL London, ENGLAND
SP Amer Appl Sci Res Inst, Huazhong Normal Univ
DE micro-morphology; contact angle; hydrophobicity model; biomaterial; moth
ID MECHANISM
AB The micro-morphology, wettability and chemical composition of the moth wing surfaces were investigated by a scanning electron microscope (SEM), a contact angle (CA) meter and a Fourier transform infrared spectrometer (FT-IR). The micro-morphological models for hydrophobicity on the wing surface were established on the basis of the Cassie-Baxter equation. The wetting mechanism was discussed from the perspective of biological coupling. The moth wing surfaces are composed of naturally hydrophobic material and display micro/nano hierarchical structures, including primary structure (micrometric scales), secondary structure (submicro longitudinal ridges and lateral bridges) and tertiary structure (nano stripes). The wing surfaces exhibit high hydrophobicity (CA 150 similar to 158 degrees) and low adhesion (sliding angle 1 similar to 3 degrees). The cooperative effect of material element and structural element contributes to the special wettability of the wing surface. In micro-dimension, the smaller the width and the bigger the spacing of the scale, the stronger the hydrophobicity of the wing surfaces. In nano-dimension, the smaller the height and the smaller the width and the bigger the spacing of the longitudinal ridge, the stronger the hydrophobicity of the wing surfaces. The micro/nano structural model provides CA predictions in good accord with the data measured. The result may bring inspiration for biomimetic design and preparation of smart interfacial materials and novel self-cleaning coatings.
C1 [Sun, Gang; Fang, Yan] Changchun Normal Univ, Sch Life Sci, Changchun 130032, Peoples R China.
RP Fang, Y (reprint author), Changchun Normal Univ, Sch Life Sci, Changchun 130032, Peoples R China.
EM sungang@nenu.edu.cn; fangyan124@aliyun.com
CR Fang Y, 2007, CHINESE SCI BULL, V52, P711, DOI 10.1007/s11434-007-0120-5
   Gleiche M, 2000, NATURE, V403, P173, DOI 10.1038/35003149
   Higgins AM, 2000, NATURE, V404, P476, DOI 10.1038/35006597
   Liu H, 2006, SOFT MATTER, V2, P811, DOI 10.1039/b606654b
   Sun TL, 2005, ACCOUNTS CHEM RES, V38, P644, DOI 10.1021/ar040224c
   Wang XJ, 2009, CHINESE SCI BULL, V54, P569, DOI 10.1007/s11434-009-0071-0
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ATLANTIS PRESS
PI PARIS
PA 29 AVENUE LAVMIERE, PARIS, 75019, FRANCE
SN 2352-5401
BN 978-94-62520-65-3
J9 AER ADV ENG RES
PY 2015
VL 2
BP 707
EP 711
PG 5
WC Engineering, Multidisciplinary; Engineering, Mechanical; Materials
   Science, Multidisciplinary
SC Engineering; Materials Science
GA BD3KW
UT WOS:000359815600175
DA 2018-10-20
ER

PT J
AU Xu, F
   Bao, MM
   Rui, LF
   Liu, JJ
   Li, JL
   Dou, YJ
   Yang, K
   Yuan, B
   Ma, YQ
AF Xu, Fan
   Bao, Meimei
   Rui, Longfei
   Liu, Jiaojiao
   Li, Jingliang
   Dou, Yujiang
   Yang, Kai
   Yuan, Bing
   Ma, Yuqiang
TI Self-assembly of monolayered lipid membranes for surface-coating of a
   nanoconfined Bombyx mori silk fibroin film
SO RSC ADVANCES
LA English
DT Article
ID DRUG-DELIVERY; BIOMATERIAL; SCAFFOLDS; BILAYERS; BEHAVIOR; METHANOL
AB Regenerated Bombyx mori (B. mori) silk fibroin is a type of widely used biomaterial. The beta-sheet structure of it after methanol treatment provides water-insolubility and mechanical stability while on the other side leads to a hydrophobic surface which is less preferred by biological systems. In this work we prepare a novel type of nanoconfined silk fibroin film with a thickness below 100 nm. The film has a flat while hydrophobic surface because of its beta-sheet structure due to the z-direction confinement during formation. Different types of lipid monolayers, DOPC, DPPC and MO, are assembled on the silk film surface. The lipid coating, especially the DPPC membrane, provides a much smoother and more hydrophilic surface due to the gel phase tails of the lipids, in comparison with the DOPC and MO ones which are in a liquid phase and have a much stronger interfacial association between silk film surface and lipid tails. Such a lipid coating preserves the biocompatibility and cellular affinity of the silk film which promises potential applications as surface coatings for materials for biological use.
C1 [Xu, Fan; Ma, Yuqiang] Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210093, Jiangsu, Peoples R China.
   [Xu, Fan; Ma, Yuqiang] Nanjing Univ, Dept Phys, Nanjing 210093, Jiangsu, Peoples R China.
   [Bao, Meimei; Rui, Longfei; Liu, Jiaojiao; Yang, Kai; Yuan, Bing; Ma, Yuqiang] Soochow Univ, Ctr Soft Condensed Matter Phys & Interdisciplinar, Suzhou 215006, Peoples R China.
   [Bao, Meimei; Rui, Longfei; Liu, Jiaojiao; Yang, Kai; Yuan, Bing; Ma, Yuqiang] Soochow Univ, Coll Phys Optoelect & Energy, Suzhou 215006, Peoples R China.
   [Dou, Yujiang] Soochow Univ, Sch Elect & Informat Engn, Suzhou 215006, Peoples R China.
   [Li, Jingliang] Deakin Univ, Inst Frontier Mat, Waurn Ponds, Vic 3216, Australia.
RP Xu, F (reprint author), Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210093, Jiangsu, Peoples R China.
EM xfjjhd@126.com; yuanbing@suda.edu.cn; myqiang@nju.edu.cn
RI li, jingliang/E-5075-2010
OI li, jingliang/0000-0003-0709-2246
FU National Science Foundation of China [91027040, 31061160496, 21374074,
   21422404]; National Basic Research Program of China [2012CB821500];
   Natural Science Foundation of Jiangsu Province of China [BK2012177,
   BK20131194]
FX This work was financially supported by the National Science Foundation
   of China (No. 91027040, 31061160496, 21374074, and 21422404), and the
   National Basic Research Program of China (No. 2012CB821500). B.Y. and
   K.Y. thank the support of the Natural Science Foundation of Jiangsu
   Province of China (No. BK2012177 and BK20131194). The authors also thank
   the Small Angle X-ray Scattering Station (BL16B) and X-ray Diffraction
   Station (BL14B) at Shanghai Synchrotron Radiation Facility (SSRF) for
   sample characterizations.
CR Ahmed S, 2011, SOFT MATTER, V7, P1936, DOI 10.1039/c0sm01045f
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI 10.1089/tea.2007.0224
   Dou YJ, 2014, APPL SURF SCI, V296, P95, DOI 10.1016/j.apsusc.2014.01.050
   FRASER RDB, 1973, CONFORMATION FIBROUS, P95
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   Goksu EI, 2009, BBA-BIOMEMBRANES, V1788, P254, DOI 10.1016/j.bbamem.2008.08.021
   Howland MC, 2005, J AM CHEM SOC, V127, P6752, DOI 10.1021/ja043439q
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kawahara Y, 2006, MACROMOL MATER ENG, V291, P458, DOI 10.1002/mame.200500350
   KELLER D, 2005, PHYS REV LETT, V94, P1
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kweon HY, 1999, J APPL POLYM SCI, V73, P2887, DOI 10.1002/(SICI)1097-4628(19990929)73:14<2887::AID-APP12>3.0.CO;2-I
   Kweon HY, 2000, POLYMER, V41, P7361, DOI 10.1016/S0032-3861(00)00100-2
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee D.W., 2014, P NATL ACAD SCI USA, V111, P768
   Li MZ, 2003, POLYM ADVAN TECHNOL, V14, P694, DOI 10.1002/pat.409
   Liu JJ, 2013, LANGMUIR, V29, P8039, DOI 10.1021/la4015652
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Plaza GR, 2008, J APPL POLYM SCI, V109, P1793, DOI 10.1002/app.28288
   Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rui LF, 2015, BBA-BIOMEMBRANES, V1848, P1203, DOI 10.1016/j.bbamem.2015.02.018
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shi YF, 2014, MACROMOLECULES, V47, P7987, DOI 10.1021/ma501864g
   Shreve AP, 2008, LANGMUIR, V24, P13250, DOI 10.1021/la802909c
   Sublimi Saponetti Matilde, 2014, PLoS One, V9, pe115780, DOI 10.1371/journal.pone.0115780
   Sugihara K, 2010, ACS NANO, V4, P5047, DOI 10.1021/nn100773q
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Tero R, 2012, MATERIALS, V5, P2658, DOI 10.3390/ma5122658
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Zhang H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-117
NR 33
TC 0
Z9 0
U1 3
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 81
BP 65684
EP 65689
DI 10.1039/c5ra09683a
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA CO6BU
UT WOS:000359243000005
DA 2018-10-20
ER

PT J
AU Kobielarz, M
   Chwilkowska, A
   Turek, A
   Maksymowicz, K
   Marciniak, M
AF Kobielarz, Magdalena
   Chwilkowska, Agnieszka
   Turek, Artur
   Maksymowicz, Krzysztof
   Marciniak, Monika
TI Influence of selective digestion of elastin and collagen on mechanical
   properties of human aortas
SO ACTA OF BIOENGINEERING AND BIOMECHANICS
LA English
DT Article
DE collagen; elastin; selective digestion; mechanical properties; human
   aorta
ID ARTERIAL STIFFNESS; UNIAXIAL TENSION; ABDOMINAL AORTAS; TISSUE; WALL;
   PURIFICATION; BIOMATERIAL; SCAFFOLDS; DISEASE; STRESS
AB Purpose: There are two families of fibres taking part in the process of mechanical loads transfer, i.e. elastin and collagen fibres. Their number, spatial arrangement and specific properties determine the capacity of a blood vessels to resist mechanical loads resulting from the impact of blood on vessel walls. The purpose of the present paper is to define the load-bearing capacities of elastin and collagen scaffolds equivalent to natural fibre arrangements of human aorta and produced by selective digestion. Methods: Samples of thoracic human aortas were digested by using phosphate buffer of trypsin at pH 8.0 for 22 hours in order to degrade elastin and by autoclaving followed by incubation in 90% formic acid for 22 hours. The efficacy of digestion was assessed immunohistochemically. Mechanical properties of pre-stretched native and digested samples were determined by uniaxial tensile test. Results: Samples subjected to autoclaving have been successfully deprived of both types of collagen and elastin has been intact. Treatment with trypsin caused a removal of elastin and the presence of type I and IV collagen was demonstrated. Digestion of aortic samples either by formic acid or trypsin has resulted significantly decreasing mechanical properties in comparison with native samples. Conclusions: Collagen and elastin scaffold-like stuctures have been effectively produced by selective digestion of thoracic human aorta and their contribution to the load-bearing process was evaluated. Isolated collagen network are more durable and stiffer and less deformable than elastin network, hence are responsible for load-bearing process at higher strain since the range of working of elastin is at lower strain values.
C1 [Kobielarz, Magdalena] Wroclaw Univ Technol, Dept Biomed Engn Mechatron & Theory Mech, PL-50371 Wroclaw, Poland.
   [Kobielarz, Magdalena] Reg Specialist Hosp Wroclaw, Ctr Res & Dev, Wroclaw, Poland.
   [Chwilkowska, Agnieszka] Med Univ, Dept Med Biochem, Wroclaw, Poland.
   [Turek, Artur] Med Univ Silesia, Sch Pharm, Div Lab Med Sosnowiec, Katowice, Poland.
   [Turek, Artur] Chair & Dept Biopharm, Sosnowiec, Poland.
   [Turek, Artur] Polish Acad Sci, Ctr Polymer & Carbon Mat, Zabrze, Poland.
   [Maksymowicz, Krzysztof] Wroclaw Med Univ, Dept Forens Med, Fac Med, Wroclaw, Poland.
   [Marciniak, Monika] Wroclaw Univ Technol, Dept Plast Forming & Metrol, PL-50370 Wroclaw, Poland.
RP Kobielarz, M (reprint author), Wroclaw Univ Technol, Dept Biomed Engn Mechatron & Theory Mech, Ul Lukasiewicza 7-9, PL-50371 Wroclaw, Poland.
EM magdalena.kobielarz@pwr.edu.pl
FU European Regional Development Fund, within Innovative Economy
   Operational Program
FX This publication is part of the project "Wrovasc - Integrated
   Cardiovascular Centre", co-financed by the European Regional Development
   Fund, within Innovative Economy Operational Program, 2007-2013.
CR ARMENTANO RL, 1991, AM J PHYSIOL, V260, pH1870
   Assoul N, 2008, J BIOMECH, V41, P2227, DOI 10.1016/j.jbiomech.2008.04.017
   Carmo M, 2002, EUR J VASC ENDOVASC, V23, P543, DOI 10.1054/ejvs.2002.1620
   Chow MJ, 2011, J SURG RES, V171, P434, DOI 10.1016/j.jss.2010.04.007
   Claridge MW, 2009, ATHEROSCLEROSIS, V205, P477, DOI 10.1016/j.atherosclerosis.2008.12.030
   Cwalina B, 2005, INT J ARTIF ORGANS, V28, P648
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5
   Faury G, 2001, PATHOL BIOL, V49, P310, DOI 10.1016/S0369-8114(01)00147-X
   Gasior-Glogowska M., 2010, ACTA BIOENG BIOMECH, V12, P53
   Gundiah N, 2007, J BIOMECH, V40, P586, DOI 10.1016/j.jbiomech.2006.02.004
   Hanuza J, 2010, J RAMAN SPECTROSC, V41, P1163, DOI 10.1002/jrs.2554
   Holzapfel GA, 2006, J THEOR BIOL, V238, P290, DOI 10.1016/j.jtbi.2005.05.006
   KATSUDA S, 1992, ARTERIOSCLER THROMB, V12, P494, DOI 10.1161/01.ATV.12.4.494
   Kobielarz M, 2013, J THEOR APP MECH-POL, V51, P949
   Kot M, 2011, T FAMENA, V35, P49
   LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   Maksymowicz K, 2011, ADV CLIN EXP MED, V20, P221
   Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235
   Mecham RP, 2008, METHODS, V45, P32, DOI 10.1016/j.ymeth.2008.01.007
   Pezowicz C, 2010, J THEOR APP MECH-POL, V48, P917
   ROACH MR, 1957, CAN J BIOCH PHYSL, V35, P181
   Sakuragi S, 2010, INT J CARDIOL, V138, P112, DOI 10.1016/j.ijcard.2009.04.027
   Schriefl AJ, 2015, ACTA BIOMATER, V17, P125, DOI 10.1016/j.actbio.2015.01.003
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   Sokolis DP, 2006, J BIOMECH, V39, P1651, DOI 10.1016/j.jbiomech.2005.05.003
   Turek A, 2013, NUKLEONIKA, V58, P511
   WALKERCAPRIOGLIO HM, 1992, CELL TISSUE RES, V269, P141, DOI 10.1007/BF00384734
   Watton PN, 2009, J BIOMECH, V42, P1320, DOI 10.1016/j.jbiomech.2009.03.012
   Zou Y, 2009, ANN BIOMED ENG, V37, P1572, DOI 10.1007/s10439-009-9724-z
NR 31
TC 1
Z9 1
U1 1
U2 13
PU WROCLAW UNIV TECHNOLOGY
PI WROCLAW
PA WROCLAW UNIV TECHNOLOGY, MECHANICAL DEPT, WYBRZEZE WYSPIANSKIEGO 27,
   WROCLAW, 50-370, POLAND
SN 1509-409X
J9 ACTA BIOENG BIOMECH
JI Acta Bioeng. Biomech.
PY 2015
VL 17
IS 2
BP 55
EP 62
DI 10.5277/ABB-00184-2014-02
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA CP2TR
UT WOS:000359730600006
PM 26415712
DA 2018-10-20
ER

PT J
AU Wu, JT
   Sun, TP
   Huang, CW
   Su, CT
   Wu, CY
   Yeh, SY
   Yang, DK
   Chen, LC
   Ding, ST
   Chen, HY
AF Wu, Jyun-Ting
   Sun, Ting-Pi
   Huang, Chao-Wei
   Su, Chiao-Tzu
   Wu, Chih-Yu
   Yeh, Shu-Yun
   Yang, Deng-Kai
   Chen, Lin-Chi
   Ding, Shih-Torng
   Chen, Hsien-Yeh
TI Tunable coverage of immobilized biomolecules for biofunctional interface
   design
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID COATINGS; ADHESION; POLYMERS
AB The controlled coverage of immobilized biomolecules is introduced, illustrating a concept for designing biomaterial surfaces such that the extent of manipulation employed to elicit biological responses is controlled according to density changes in the underlying chemical motifs and the density of immobilized biomolecules.
C1 [Wu, Jyun-Ting; Sun, Ting-Pi; Su, Chiao-Tzu; Wu, Chih-Yu; Yeh, Shu-Yun; Chen, Hsien-Yeh] Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
   [Huang, Chao-Wei; Ding, Shih-Torng] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10617, Taiwan.
   [Su, Chiao-Tzu] Aeon Biotherapeut Corp, Taipei 11494, Taiwan.
   [Yang, Deng-Kai; Chen, Lin-Chi] Natl Taiwan Univ, Dept Bioind Mechatron Engn, Taipei 10617, Taiwan.
RP Wu, JT (reprint author), Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
EM hsychen@ntu.edu.tw
OI Yang, Deng-Kai/0000-0001-5161-8052; Chen, Lin-Chi/0000-0001-5947-2019;
   Ding, Shih-Torng/0000-0002-9866-1776
FU Ministry of Science and Technology of Taiwan [101-2628-E-002-034-MY3,
   102-2911-I-002-507]; National Taiwan University [102R7745, 103R7745]
FX H.-Y. Chen gratefully acknowledges support from the Ministry of Science
   and Technology of Taiwan (101-2628-E-002-034-MY3 and 102-2911-I-002-507)
   and the National Taiwan University (102R7745 and 103R7745).
CR Alves D, 2014, BIOFOULING, V30, P483, DOI 10.1080/08927014.2014.889120
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen HY, 2013, CHEM COMMUN, V49, P4531, DOI 10.1039/c3cc41491d
   Elkasabi YM, 2011, BIOMATERIALS, V32, P1809, DOI 10.1016/j.biomaterials.2010.10.046
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Kerwin SM, 2010, J AM CHEM SOC, V132, P2466, DOI 10.1021/ja1005306
   Lee D, 2009, SENSOR ACTUAT B-CHEM, V135, P444, DOI 10.1016/j.snb.2008.10.026
   Luo Y, 2004, BIOMACROMOLECULES, V5, P2315, DOI 10.1021/bm0495811
   Rusu GB, 2014, BIOSENS BIOELECTRON, V53, P154, DOI 10.1016/j.bios.2013.09.035
   Su CT, 2014, COLLOID SURFACE B, V116, P727, DOI 10.1016/j.colsurfb.2013.11.044
   Sun TL, 2011, CHEM SOC REV, V40, P2909, DOI 10.1039/c0cs00124d
   Tsai MY, 2014, ADV FUNCT MATER, V24, P2281, DOI 10.1002/adfm.201303050
   Yang R, 2012, LANGMUIR, V28, P12266, DOI 10.1021/la302059s
   Yoshioka K, 1997, J AM CERAM SOC, V80, P2667
   Zhao XB, 2011, LANGMUIR, V27, P7654, DOI 10.1021/la201245q
NR 16
TC 12
Z9 12
U1 4
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 9
BP 1266
EP 1269
DI 10.1039/c5bm00127g
PG 4
WC Materials Science, Biomaterials
SC Materials Science
GA CO8XE
UT WOS:000359454700002
PM 26261855
DA 2018-10-20
ER

PT J
AU Ruso, JM
   Sartuqui, J
   Messina, PV
AF Ruso, Juan M.
   Sartuqui, Javier
   Messina, Paula V.
TI Multiscale Inorganic Hierarchically Materials: Towards an Improved
   Orthopaedic Regenerative Medicine
SO CURRENT TOPICS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Bio-glass; Bioactive scaffolds; Bone; Hydroxyapatite; Templates; Tissue
   engineering
ID BIOACTIVE GLASS SCAFFOLDS; NANOCRYSTALLINE HYDROXYAPATITE PASTE;
   DRUG-DELIVERY-SYSTEMS; FULLERENE-LIKE STRUCTURES; BONE TISSUE
   REGENERATION; MECHANICAL-PROPERTIES; PROTEIN ADSORPTION; OSTEOBLAST
   ADHESION; APATITE FORMATION; LAMELLAR BONE
AB Bone is a biologically and structurally sophisticated multifunctional tissue. It dynamically responds to biochemical, mechanical and electrical clues by remodelling itself and accordingly the maximum strength and toughness are along the lines of the greatest applied stress. The challenge is to develop an orthopaedic biomaterial that imitates the micro- and nano-structural elements and compositions of bone to locally match the properties of the host tissue resulting in a biologically fixed implant. Looking for the ideal implant, the convergence of life and materials sciences occurs. Researchers in many different fields apply their expertise to improve implantable devices and regenerative medicine. Materials of all kinds, but especially hierarchical nano-materials, are being exploited. The application of nano-materials with hierarchical design to calcified tissue reconstructive medicine involve intricate systems including scaffolds with multifaceted shapes that provides temporary mechanical function; materials with nano-topography modifications that guarantee their integration to tissues and that possesses functionalized surfaces to transport biologic factors to stimulate tissue growth in a controlled, safe, and rapid manner. Furthermore materials that should degrade on a timeline coordinated to the time that takes the tissues regrow, are prepared. These implantable devices are multifunctional and for its construction they involve the use of precise strategically techniques together with specific material manufacturing processes that can be integrated to achieve in the design, the required multifunctionality. For such reasons, even though the idea of displacement from synthetic implants and tissue grafts to regenerative-medicine-based tissue reconstruction has been guaranteed for well over a decade, the reality has yet to emerge. In this paper, we examine the recent approaches to create enhanced bioactive materials. Their design and manufacturing procedures as well as the experiments to integrate them into engineer hierarchical inorganic materials for their practical application in calcified tissue reparation are evaluated.
C1 [Ruso, Juan M.] Univ Santiago de Compostela, Dept Appl Phys, Soft Matter & Mol Biophys Grp, Santiago De Compostela 15782, Spain.
   [Sartuqui, Javier; Messina, Paula V.] Univ Nacl Sur, Dept Chem, RA-8000 Bahia Blanca, Buenos Aires, Argentina.
   [Sartuqui, Javier; Messina, Paula V.] INQUISUR CONICET, Buenos Aires, DF, Argentina.
RP Messina, PV (reprint author), Univ Nacl Sur, Dept Chem, RA-8000 Bahia Blanca, Buenos Aires, Argentina.
EM pmessina@uns.edu.ar
OI Ruso, Juan/0000-0001-5909-6754
FU CONICET
FX The authors acknowledge Universidad Nacional del Sur (PGI 24/Q064),
   Concejo Nacional de Investigaciones Cientificas y Tecnicas de la
   Republica Argentina (CONICET, PIP - 11220130100100CO) and Fundacion
   Ramon Areces. JS have doctoral fellowships of CONICET. PVM is an
   independent researcher of CONICET.
CR Ackerman L.V., 1976, MONOGRAPHS PATHOLOGY
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Aparicio C, 2007, J BIOMED MATER RES A, V82A, P521, DOI 10.1002/jbm.a.31164
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Arts JJC, 2006, BIOMATERIALS, V27, P1110, DOI 10.1016/j.biomaterials.2005.07.024
   Autumn K, 2000, NATURE, V405, P681
   Avnir D, 2006, J MATER CHEM, V16, P1013, DOI [10.1039/b512706h, 10.1039/5512706h]
   Avnir D., 1998, CHEM ORGANOSILICON C, P2317
   Avnir D., 1996, BIOCH ASPECTS SOL GE
   Barthelat F, 2007, PHILOS T R SOC A, V365, P2907, DOI 10.1098/rsta.2007.0006
   Bass JD, 2007, CHEM MATER, V19, P4349, DOI 10.1021/cm071305g
   Behrens P., 2009, HDB BIOMINERALIZATIO
   Bhushan B, 2009, PHILOS T R SOC A, V367, P1445, DOI 10.1098/rsta.2009.0011
   Bobbio A., 1970, B HIST DENT, V20, P1
   Brambilla G, 2009, ADV OPT PHOTONICS, V1, P107, DOI 10.1364/AOP.1.000107
   Brinker C.J., 1990, SOL GEL SCI PHYS CHE, P1
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Cai YR, 2008, J MATER CHEM, V18, P3775, DOI 10.1039/b805407j
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Chen B, 2008, P R SOC A, V464, P1639, DOI 10.1098/rspa.2007.0350
   Chen B, 2012, LANGMUIR, V28, P2937, DOI 10.1021/la204154h
   Chen IH, 2011, J MECH BEHAV BIOMED, V4, P713, DOI 10.1016/j.jmbbm.2010.12.013
   Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003
   Chen PY, 2008, ACTA BIOMATER, V4, P587, DOI 10.1016/j.actbio.2007.12.010
   Chen Q, 2013, J MECH BEHAV BIOMED, V19, P3, DOI 10.1016/j.jmbbm.2012.10.012
   Chen XB, 2009, ACTA BIOMATER, V5, P2290, DOI 10.1016/j.actbio.2009.02.027
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Choi SY, 2012, J MATER CHEM, V22, P25288, DOI 10.1039/c2jm33354f
   Choi Y., 2007, J MATER SCI, V17, P3780
   CHOPRA NG, 1995, SCIENCE, V269, P966, DOI 10.1126/science.269.5226.966
   Chu CL, 2013, SURF COAT TECH, V232, P68, DOI 10.1016/j.surfcoat.2013.04.054
   Chung WJ, 2011, NATURE, V478, P364, DOI 10.1038/nature10513
   Clyne T. W., 1996, INTRO COMPOSITE MAT
   Colilla M, 2008, EXPERT OPIN THER PAT, V18, P639, DOI 10.1517/13543770802106746
   Colilla M, 2008, INT J NANOMED, V3, P403
   Collins M.W., 2004, OPTIMIZATION MECH NA
   Coradin T, 2006, CURR MED CHEM, V13, P99, DOI 10.2174/092986706775197999
   Cowin S., 2001, BONE MECH HDB
   Currey JD, 2010, J MECH BEHAV BIOMED, V3, P357, DOI 10.1016/j.jmbbm.2010.03.002
   Currey J.D., 2002, BONES STRUCTURE MECH
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   D'Elia N.L., 2013, BIOCH BIOPHYS ACTA G, V1830, P5014
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Dan N, 2000, TRENDS BIOTECHNOL, V18, P370, DOI 10.1016/S0167-7799(00)01482-7
   Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036
   Deliormanli AM, 2012, J EUR CERAM SOC, V32, P3637, DOI 10.1016/j.jeurceramsoc.2012.05.005
   Diaz A, 2006, ACTA BIOMATER, V2, P173, DOI 10.1016/j.actbio.2005.12.006
   Doiphode ND, 2011, J MATER SCI-MATER M, V22, P515, DOI 10.1007/s10856-011-4236-4
   Dolatshahi-Pirouz A, 2008, COLLOID SURFACE B, V66, P53, DOI 10.1016/j.colsurfb.2008.05.010
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Dreesman H., 1892, BEITR KLIN CHIR, V9, P804
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Engel E, 2008, TRENDS BIOTECHNOL, V26, P39, DOI 10.1016/j.tibtech.2007.10.005
   FELDMAN Y, 1995, SCIENCE, V267, P222, DOI 10.1126/science.267.5195.222
   Fernandez-Leyes M, 2012, J MATER SCI, V47, P2837, DOI 10.1007/s10853-011-6113-4
   Ferrer ML, 2006, CHEM MATER, V18, P554, DOI 10.1021/cm052087z
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Fratzl P, 2007, J R SOC INTERFACE, V4, P637, DOI 10.1098/rsif.2007.0218
   Fu Q, 2011, MAT SCI ENG C-MATER, V31, P1245, DOI 10.1016/j.msec.2011.04.022
   Fu Q, 2011, ACTA BIOMATER, V7, P3547, DOI 10.1016/j.actbio.2011.06.030
   Fu QA, 2011, ADV FUNCT MATER, V21, P1058, DOI 10.1002/adfm.201002030
   Fu QS, 2011, BIOMATERIALS, V32, P7333, DOI 10.1016/j.biomaterials.2011.06.051
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Gao HJ, 2005, J APPL MECH-T ASME, V72, P732, DOI 10.1115/1.1988348
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   Gravina N., 2014, J MATER CHEM B, V2, P834
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Gutierrez MC, 2008, CHEM MATER, V20, P634, DOI 10.1021/cm702028z
   Hacohen YR, 1998, NATURE, V395, P336, DOI 10.1038/26380
   Han M, 2003, LANGMUIR, V19, P9868, DOI 10.1021/la030132g
   Hassan N, 2012, SOFT MATTER, V8, P9553, DOI 10.1039/c2sm26263k
   Hassan N, 2012, SOFT MATTER, V8, P6582, DOI 10.1039/c2sm25489a
   Hassan N, 2011, LANGMUIR, V27, P8905, DOI 10.1021/la201555f
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hodge A. J., 1963, ASPECTS PROTEIN STRU, P289
   Huang TS, 2011, MAT SCI ENG C-MATER, V31, P1482, DOI 10.1016/j.msec.2011.06.004
   Huber FX, 2008, J MATER SCI-MATER M, V19, P33, DOI 10.1007/s10856-007-3039-0
   Huber FX, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-50
   Huber FX, 2006, ARCH ORTHOP TRAUM SU, V126, P533, DOI 10.1007/s00402-006-0170-1
   Hulander M, 2011, INT J NANOMED, V6, P2653, DOI 10.2147/IJN.S24578
   Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450
   IMAE T, 1986, J PHYS CHEM-US, V90, P5216, DOI 10.1021/j100412a065
   Innocenzi P, 2011, CHEM MATER, V23, P2501, DOI 10.1021/cm200050r
   ISRAELACHVILI JN, 1985, INTERMOLECULAR SURFA
   Jiang PL, 2013, ELECTROCHIM ACTA, V107, P16, DOI 10.1016/j.electacta.2013.05.120
   Johnson F. E., 2006, BIONIC HUMAN HLTH PR
   Jones JR, 2010, P I MECH ENG H, V224, P1373, DOI 10.1243/09544119JEIM836
   Jones JR, 2006, PHILOS T ROY SOC A, V364, P263, DOI 10.1098/rsta.2005.1689
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1
   Katz A, 2006, TRIBOL LETT, V21, P135, DOI 10.1007/s11249-006-9029-4
   Keshmiri M, 2003, J NON-CRYST SOLIDS, V324, P289, DOI 10.1016/S0022-3093(03)00363-6
   Koegler P, 2012, ADV DRUG DELIVER REV, V64, P1820, DOI 10.1016/j.addr.2012.06.001
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Lipowsky Reinhard, 2006, Biophysical Reviews and Letters, V1, P223, DOI 10.1142/S1793048006000100
   Lord MS, 2006, BIOMATERIALS, V27, P4856, DOI 10.1016/j.biomaterials.2006.05.037
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Ma ZJ, 2013, APPL SURF SCI, V284, P738, DOI 10.1016/j.apsusc.2013.08.003
   Manzano M., 2009, EXPERT OPIN DRUG DEL, V6, P1
   Manzano M, 2012, PROG SOLID STATE CH, V40, P17, DOI 10.1016/j.progsolidstchem.2012.05.001
   MARGULIS L, 1993, NATURE, V365, P113, DOI 10.1038/365113b0
   Mattheck C, 1998, DESIGN NATURE LEARNI
   McConnell GA, 1996, PHYS REV E, V54, P5447, DOI 10.1103/PhysRevE.54.5447
   Messina PV, 2013, RSC ADV, V3, P24256, DOI 10.1039/c3ra42204f
   Messina PV, 2013, COLLOID POLYM SCI, V291, P835, DOI 10.1007/s00396-012-2798-4
   Meyers MA, 2008, J MECH BEHAV BIOMED, V1, P76, DOI 10.1016/j.jmbbm.2007.03.001
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Midha S., 2013, ACTA BIOMATER
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Nieto A, 2009, ACTA BIOMATER, V5, P3478, DOI 10.1016/j.actbio.2009.05.033
   Niklas KJ, 2006, AM J BOT, V93, P1369, DOI 10.3732/ajb.93.10.1369
   NIKLAS KJ, 1992, PLANT BIOMECHANICS E
   Nishiguchi S, 2001, J BIOMED MATER RES, V54, P198, DOI 10.1002/1097-4636(200102)54:2<198::AID-JBM6>3.0.CO;2-7
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Orlando G, 2010, TRANSPL P, V42, P1011, DOI 10.1016/j.transproceed.2010.03.066
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Paul W, 2006, AM J BIOCH BIOTECHNO, V2, P41, DOI DOI 10.3844/AJBBSP.2006.41.48
   Pompe W, 2013, BIO-NANOMATERIALS: DESIGNING MATERIALS INSPIRED BY NATURE, P1, DOI 10.1002/9783527655267
   Puckett S, 2008, INT J NANOMED, V3, P229
   Rahmany MB, 2013, ACTA BIOMATER, V9, P5431, DOI 10.1016/j.actbio.2012.11.019
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Redlich M, 2008, J MATER RES, V23, P2909, DOI 10.1557/JMR.2008.0350
   Ren TZ, 2006, LANGMUIR, V22, P3886, DOI 10.1021/la0533011
   Reznikov N, 2014, BONE, V59, P93, DOI 10.1016/j.bone.2013.10.023
   Rhee H, 2009, MAT SCI ENG C-MATER, V29, P2333, DOI 10.1016/j.msec.2009.06.002
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   RIEGER W, 2001, WORLD TRIBOLOGY FORU
   Rock M, 1933, German Patent, Patent No. [583589, DRP 583.589]
   Ruso JM, 2013, DALTON T, V42, P7991, DOI 10.1039/c3dt32936d
   Ruso JM, 2013, LANGMUIR, V29, P2350, DOI 10.1021/la305080x
   Sachot N, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0684
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Samorodnitzky-Naveh GR, 2009, NANOMEDICINE-UK, V4, P943, DOI [10.2217/nnm.09.68, 10.2217/NNM.09.68]
   Sanchez C., 2001, BIOMIMETISME MAT
   Sanchez C, 2008, CHEM MATER, V20, P682, DOI 10.1021/cm702100t
   Schubert D, 2006, BIOCHEM BIOPH RES CO, V342, P86, DOI 10.1016/j.bbrc.2006.01.129
   Schwarz F, 2006, J CLIN PERIODONTOL, V33, P491, DOI 10.1111/j.1600-051X.2006.00936.x
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Shirtliff VJ, 2003, J MATER SCI, V38, P4697, DOI 10.1023/A:1027414700111
   Shruti S, 2013, ACTA BIOMATER, V9, P4836, DOI 10.1016/j.actbio.2012.09.024
   Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126
   Silva-Bermudez P, 2013, SURF COAT TECH, V233, P147, DOI 10.1016/j.surfcoat.2013.04.028
   Smeets Ralf, 2008, Schweiz Monatsschr Zahnmed, V118, P203
   Stephanopoulos N., 2008, CHEM REV, V108, P4935
   Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046
   Stupp SI, 2010, NANO LETT, V10, P4783, DOI 10.1021/nl103567y
   Sun RX, 2013, MATER RES BULL, V48, P1143, DOI 10.1016/j.materresbull.2012.12.013
   Tahir MN, 2010, PHYS STATUS SOLIDI B, V247, P2338, DOI 10.1002/pssb.201046076
   Tan AW, 2012, CERAM INT, V38, P4421, DOI 10.1016/j.ceramint.2012.03.002
   TENNE R, 1992, NATURE, V360, P444, DOI 10.1038/360444a0
   Tenne R, 2009, ANNU REV MATER RES, V39, P387, DOI 10.1146/annurev-matsci-082908-145429
   Termine John D., 1996, P24
   Thian ES, 2008, J BIOMED MATER RES A, V85A, P188, DOI 10.1002/jbm.a.31564
   Tirrell D. A., 1994, HIERARCHICAL STRUCTU
   Torquato S., 2002, RANDOM HETEROGENEOUS
   Vagaska B, 2010, PHYSIOL RES, V59, P309
   Vallet-Regi M, 2008, J BIOMED NANOTECHNOL, V4, P1, DOI 10.1166/jbn.2008.002
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   van den Dolder J, 2003, BIOMATERIALS, V24, P1745, DOI 10.1016/S0142-9612(02)00537-9
   Vanzillotta PS, 2006, DENT MATER, V22, P275, DOI 10.1016/j.dental.2005.03.012
   Vincent J. F. V., 1990, STRUCTURAL BIOMATERI
   Vincent JFV, 2006, J R SOC INTERFACE, V3, P471, DOI 10.1098/rsif.2006.0127
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   WAINWRIGHT SA, 1982, MECH DESIGN ORGANISM
   Wang GC, 2012, J MATER CHEM, V22, P19081, DOI 10.1039/c2jm34367c
   Wang HS, 2012, MATER LETT, V76, P237, DOI 10.1016/j.matlet.2012.02.099
   Wang XX, 2002, BIOMATERIALS, V23, P1353, DOI 10.1016/S0142-9612(01)00254-X
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2006, ADV BIOCHEM ENG BIOT, V103, P275
   Wei J, 2010, BIOMATERIALS, V31, P1260, DOI 10.1016/j.biomaterials.2009.11.005
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
   Weiner S, 1997, BONE, V20, P509, DOI 10.1016/S8756-3282(97)00053-7
   Wen CE, 2002, J MATER RES, V17, P2633, DOI 10.1557/JMR.2002.0382
   WHITE SW, 1977, NATURE, V266, P421, DOI 10.1038/266421a0
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Wu CT, 2011, ACTA BIOMATER, V7, P3563, DOI 10.1016/j.actbio.2011.06.028
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu SL, 2008, NANO LETT, V8, P3803, DOI 10.1021/nl802145n
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yang DY, 2013, BIOMATERIALS, V34, P5747, DOI 10.1016/j.biomaterials.2013.04.028
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   Yao HB, 2011, CHEM SOC REV, V40, P3764, DOI 10.1039/c0cs00121j
   Zarzycki J., 1997, J SOL-GEL SCI TECHN, V8, P1
   Zhang L., 2009, SCI TECHNOL ADV MAT, V10
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang WJ, 2013, BIOMATERIALS, V34, P3184, DOI 10.1016/j.biomaterials.2013.01.008
   Zhao LZ, 2013, NANOBIOMATERIALS IN CLINICAL DENTISTRY, P337
   Zhao LZ, 2012, BIOMATERIALS, V33, P2629, DOI 10.1016/j.biomaterials.2011.12.024
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
NR 205
TC 1
Z9 1
U1 0
U2 29
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1568-0266
EI 1873-5294
J9 CURR TOP MED CHEM
JI Curr. Top. Med. Chem.
PY 2015
VL 15
IS 22
BP 2290
EP 2305
DI 10.2174/1568026615666150605115610
PG 16
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA CO7ZT
UT WOS:000359384400005
PM 26043736
DA 2018-10-20
ER

PT J
AU Liang, KN
   Xiao, SM
   Shi, WY
   Li, JS
   Yang, X
   Gao, Y
   Gou, YP
   Hao, LY
   He, LB
   Cheng, L
   Xu, X
   Zhouab, XD
   Li, JY
AF Liang, Kunneng
   Xiao, Shimeng
   Shi, Wenyuan
   Li, Jianshu
   Yang, Xiao
   Gao, Yuan
   Gou, Yaping
   Hao, Liying
   He, Libang
   Cheng, Lei
   Xu, Xin
   Zhouab, Xuedong
   Li, Jiyao
TI 8DSS-promoted remineralization of demineralized dentin in vitro
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID TERMINATED PAMAM DENDRIMER; BIOMIMETIC MINERALIZATION; CPP-ACP; ENAMEL;
   COLLAGEN; BIOMINERALIZATION; INHIBITION; NUCLEATION; PROTEINS;
   PHOSPHOPHORYN
AB Dentin phosphoprotein (DPP) plays an extremely important role in the biomineralization of human tooth. The repetitive nucleotide sequence of aspartate-serine-serine (DSS) is the fundamental unit within DPP, and peptides containing 8 repeats of DSS (8DSS) have been shown to possess the ability to induce remineralization of the demineralized enamel. In this work, we coated the 8DSS peptide on the completely demineralized dentin to evaluate the effect of 8DSS peptide coating on dentin remineralization. Human dentin samples were demineralized with 37% phosphoric acid for 2 min, and then the 8DSS peptide (1 mg mL(-1)) was coated and the binding strength of the 8DSS peptide to demineralized dentin was examined using attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR). Then the coated dentin samples were immersed in artificial saliva for 3 weeks. After that, the remineralized dentin samples were characterized by scanning electron microscopy (SEM), energy dispersive spectroscopy (EDS), X-ray diffraction (XRD) analysis and ATR-FTIR. The mechanical properties of the remineralized surfaces were determined by nano-indentation and atomic force microscopy (AFM). The results showed that the 8DSS peptide had good binding strength to demineralized dentin and could induce nanocrystals precipitation both on the surfaces and within the dentinal tubules. The mechanical properties of the 8DSS-coated samples were significantly improved. In contrast, there were hardly any newly generated minerals deposited on the samples without 8DSS peptide coating. In conclusion, the 8DSS peptide may be a promising biomaterial for restoring the demineralized human dentin.
C1 [Liang, Kunneng; Xiao, Shimeng; Gao, Yuan; Gou, Yaping; Hao, Liying; He, Libang; Cheng, Lei; Xu, Xin; Zhouab, Xuedong; Li, Jiyao] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
   [Liang, Kunneng; Gao, Yuan; Gou, Yaping; He, Libang; Cheng, Lei; Xu, Xin; Zhouab, Xuedong; Li, Jiyao] Sichuan Univ, West China Hosp Stomatol, Dept Operat Dent & Endodont, Chengdu 610041, Sichuan Provinc, Peoples R China.
   [Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA.
   [Li, Jianshu; Yang, Xiao] Sichuan Univ, Coll Polymer Sci & Engn, Dept Biomed Polymers & Artificial Organs, Chengdu 610065, Peoples R China.
RP Li, JY (reprint author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
EM jiyaoliscu@163.com
OI Yang, Xiao/0000-0002-0036-1872; Li, Jianshu/0000-0002-1522-7326
FU National Natural Science Foundation of China [81170958, 51073102,
   81400508]; Specialized Research Fund for the Doctoral Program of Higher
   Education of China [20100181110056, 20130181120125]; Sichuan Province
   Science and Technology support program [2011SZ0130]
FX Financial support from National Natural Science Foundation of China
   (Grant No. 81170958, 51073102 and 81400508, L. He), Specialized Research
   Fund for the Doctoral Program of Higher Education of China (Grant No.
   20100181110056 and 20130181120125, L. He) and Sichuan Province Science
   and Technology support program (Grant No. 2011SZ0130) is gratefully
   acknowledged. The authors thank the New Century Excellent Talents
   University Support Program and Professor Wenyuan Shi, School of
   Dentistry, University of California, Los Angeles for guiding us to
   synthesize 8DSS peptides. The authors also thank Chengdu Sennuowei
   Biotechnology Co., Ltd for providing us the equipment for the
   experiment.
CR Boanini E, 2006, EUR J INORG CHEM, P4821, DOI 10.1002/ejic.200600423
   Cao Y, 2014, CLIN ORAL INVEST, V18, P873, DOI 10.1007/s00784-013-1035-y
   Cao Y, 2014, ACS APPL MATER INTER, V6, P410, DOI 10.1021/am4044823
   Cao Y, 2013, J DENT, V41, P818, DOI 10.1016/j.jdent.2013.06.008
   Colfen H, 2010, NAT MATER, V9, P960, DOI 10.1038/nmat2911
   Deng M, 2013, INT J ORAL SCI, V5, P103, DOI 10.1038/ijos.2013.31
   Duijsters PPE, 1982, CARIES RES, V16, P201, DOI [10.1159/000260599, DOI 10.1159/000260599]
   Featherstone J D B, 2009, Adv Dent Res, V21, P4, DOI 10.1177/0895937409335590
   George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869
   George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729
   Guo B, 2012, INT J ORAL SCI, V4, P152, DOI 10.1038/ijos.2012.45
   Hao JJ, 2004, BONE, V34, P921, DOI 10.1016/j.bone.2004.01.020
   He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945
   Hsu CC, 2011, J DENT RES, V90, P88, DOI 10.1177/0022034510381904
   Hsu CC, 2011, J MECH BEHAV BIOMED, V4, P1982, DOI 10.1016/j.jmbbm.2011.06.017
   LEE SL, 1980, INT J PEPT PROT RES, V16, P231
   Li JH, 2013, BIOMATERIALS, V34, P6738, DOI 10.1016/j.biomaterials.2013.05.046
   Liang KN, 2015, MACROMOL MATER ENG, V300, P107, DOI 10.1002/mame.201400207
   Liang KN, 2014, RSC ADV, V4, P43496, DOI 10.1039/c4ra07100j
   Liu Y, 2011, ADV MATER, V23, P975, DOI 10.1002/adma.201003882
   LUSSI A, 1988, ARCH ORAL BIOL, V33, P685, DOI 10.1016/0003-9969(88)90124-0
   Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Rahiotis C, 2007, J DENT, V35, P695, DOI 10.1016/j.jdent.2007.05.008
   Ruan Q, 2015, J MATER CHEM B, V3, P3112, DOI 10.1039/c5tb00163c
   Sun J, 2014, J MATER CHEM B, V2, P4544, DOI 10.1039/c4tb00451e
   Toroian D, 2007, J BIOL CHEM, V282, P22437, DOI 10.1074/jbc.M700591200
   Veis A, 1998, EUR J ORAL SCI, V106, P234, DOI 10.1111/j.1600-0722.1998.tb02181.x
   Vollenweider M, 2007, ACTA BIOMATER, V3, P936, DOI 10.1016/j.actbio.2007.04.003
   Wang Q, 2011, SOFT MATTER, V7, P9673, DOI 10.1039/c1sm05018d
   Xu HHK, 2011, DENT MATER, V27, P762, DOI 10.1016/j.dental.2011.03.016
   Yang Y, 2014, J DENT RES, V93, P520, DOI 10.1177/0022034514522815
   Yarbrough DK, 2010, CALCIFIED TISSUE INT, V86, P58, DOI 10.1007/s00223-009-9312-0
   Zhang H, 2015, COLLOID SURFACE B, V128, P304, DOI 10.1016/j.colsurfb.2015.01.058
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
   Zhou YZ, 2012, ACS APPL MATER INTER, V4, P6900, DOI 10.1021/am302041b
NR 36
TC 14
Z9 14
U1 4
U2 40
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 33
BP 6763
EP 6772
DI 10.1039/c5tb00764j
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CO8ZD
UT WOS:000359460100006
DA 2018-10-20
ER

PT J
AU Horiuchi, N
   Endo, J
   Wada, N
   Nozaki, K
   Nakamura, M
   Nagai, A
   Katayama, K
   Yamashita, K
AF Horiuchi, N.
   Endo, J.
   Wada, N.
   Nozaki, K.
   Nakamura, M.
   Nagai, A.
   Katayama, K.
   Yamashita, K.
TI Dielectric properties of fluorine substituted hydroxyapatite: the effect
   of the substitution on configuration of hydroxide ion chains
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID SINTERED HYDROXYFLUORAPATITES; MONOCLINIC HYDROXYAPATITE;
   MECHANICAL-PROPERTIES; SHARK TEETH; REORIENTABILITY; CONDUCTIVITY;
   SPECTROSCOPY; FLUORAPATITE; DISSOLUTION; TRANSITION
AB Hydroxyapatite (HAp) [Ca-5(PO4)(3)OH] is an extremely popular biomaterial. Moreover, HAp durability is well-known to be enhanced by fluoridation. We prepared fluoridated HAp (F-HAp; Ca-5(PO4)(3)(OH)(1-x)F-x) ceramics by substituting F- ions for OH- ions of HAp. F-substitution dependence of dielectric properties in F-HAp was measured to detect the configuration change of OH- ion chains. Dielectric relaxation of two kinds was observed. Each kind had a different relaxation time. Faster relaxation, which is associated with the reorientation motion of OH- ions, was only observed at the low F-substitution range (0 <= x <= 0.35). The relaxation strength decreased as the F-substitution increased. It became zero at x = 0.35, suggesting that F-substitution induces hydrogen bonds. One F- ion substituted for an OH- ion forms two hydrogen bonds with the two neighboring OH- ions and inhibits the motion of OH- ions, which results in some kind of ordered configuration in F-HAp. The configuration might be an origin that enhances the durability of the F-HAp.
C1 [Horiuchi, N.; Wada, N.; Nozaki, K.; Nakamura, M.; Nagai, A.; Yamashita, K.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Inorgan Mat, Chiyoda Ku, Tokyo 1010062, Japan.
   [Endo, J.; Katayama, K.] Tokai Univ, Dept Appl Chem, Hiratsuka, Kanagawa 2591292, Japan.
RP Horiuchi, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Inorgan Mat, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM nhori.bcr@tmd.ac.jp
RI Nakamura, Miho/T-3166-2017
FU JSPS KAKENHI Grant [23300178]; Kazuchika Okura Memorial Foundation
FX This work was partially supported by JSPS KAKENHI Grant No. 23300178.
   One of the authors (N.H.) appreciates a grant from the Kazuchika Okura
   Memorial Foundation (2012).
CR ARENDS J, 1968, PHYS LETT A, VA 27, P720, DOI 10.1016/0375-9601(68)91025-6
   BAUMER A, 1985, B MINERAL, V108, P145
   Chen CL, 2014, ANGEW CHEM INT EDIT, V53, P1543, DOI 10.1002/anie.201307689
   Chen YM, 2005, BIOMATERIALS, V26, P1205, DOI 10.1016/j.biomaterials.2004.04.027
   Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906
   Dorozhkin SV, 1997, J CRYST GROWTH, V182, P133, DOI 10.1016/S0022-0248(97)00331-X
   Dorozhkin SV, 1997, J COLLOID INTERF SCI, V191, P489, DOI 10.1006/jcis.1997.4942
   ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Enax J, 2012, J STRUCT BIOL, V178, P290, DOI 10.1016/j.jsb.2012.03.012
   FREUND F, 1977, J CHEM SOC DALTON, P1136, DOI 10.1039/dt9770001136
   Gittings JP, 2009, ACTA BIOMATER, V5, P743, DOI 10.1016/j.actbio.2008.08.012
   Gross KA, 2004, BIOMATERIALS, V25, P1375, DOI 10.1016/S0142-9612(03)00565-9
   Gross KA, 2004, BIOMATERIALS, V25, P1385, DOI 10.1016/S0142-9612(03)00636-7
   Heling I, 1981, J Oral Implantol, V9, P548
   HITMI N, 1988, J PHYS CHEM SOLIDS, V49, P541, DOI 10.1016/0022-3697(88)90065-0
   HITMI N, 1986, J PHYS CHEM SOLIDS, V47, P533, DOI 10.1016/0022-3697(86)90155-1
   Hochrein O, 2005, CHEM MATER, V17, P1978, DOI 10.1021/cm0401903
   Horiuchi N, 2013, J APPL PHYS, V113, DOI 10.1063/1.4799130
   Horiuchi N, 2013, J CERAM SOC JPN, V121, P770, DOI 10.2109/jcersj2.121.770
   Ikoma T, 1999, J MATER SCI LETT, V18, P1225, DOI 10.1023/A:1006610521173
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   MORENO EC, 1974, NATURE, V247, P64, DOI 10.1038/247064a0
   Orlovskii VP, 1996, INORG MATER+, V32, P654
   Rodriguez-Lorenzo LM, 2003, J PHYS CHEM B, V107, P8316, DOI [10.1021/jp027556o, 10.1021/jp0275560o]
   Shellis R P, 1994, Int Dent J, V44, P263
   Suzuki S, 2004, CERAM INT, V30, P625, DOI 10.1016/j.ceramint.2003.07.006
   TAKAHASHI T, 1978, ELECTROCHIM ACTA, V23, P369, DOI 10.1016/0013-4686(78)80076-0
   Tofail SAM, 2005, FERROELECTRICS, V319, P117, DOI 10.1080/00150190590965523
   Uskokovic V, 2015, RSC ADV, V5, P36614, DOI 10.1039/c4ra17180b
   Van Rees H. B., 1973, MAT RES B, V8, P1307
   YAMASHITA K, 1995, J AM CERAM SOC, V78, P1191, DOI 10.1111/j.1151-2916.1995.tb08468.x
   YAMASHITA K, 1990, SOLID STATE IONICS, V40-1, P918, DOI 10.1016/0167-2738(90)90153-I
   Yashima M, 2014, J PHYS CHEM C, V118, P5180, DOI 10.1021/jp412771f
   Yashima M, 2011, J PHYS CHEM C, V115, P25077, DOI 10.1021/jp208746y
NR 35
TC 4
Z9 4
U1 1
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 33
BP 6790
EP 6797
DI 10.1039/c5tb00944h
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CO8ZD
UT WOS:000359460100009
DA 2018-10-20
ER

PT J
AU Castro, NJ
   O'Brien, J
   Zhang, LG
AF Castro, Nathan J.
   O'Brien, Joseph
   Zhang, Lijie Grace
TI Integrating biologically inspired nanomaterials and table-top
   stereolithography for 3D printed biomimetic osteochondral scaffolds
SO NANOSCALE
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; ARTICULAR-CARTILAGE; NANOCRYSTALLINE
   HYDROXYAPATITE; ACID HYDROGELS; BONE; REGENERATION; BIOMATERIAL;
   OSTEOBLAST; CELLS; POLYCAPROLACTONE
AB The osteochondral interface of an arthritic joint is notoriously difficult to regenerate due to its extremely poor regenerative capacity and complex stratified architecture. Native osteochondral tissue extracellular matrix is composed of numerous nanoscale organic and inorganic constituents. Although various tissue engineering strategies exist in addressing osteochondral defects, limitations persist with regards to tissue scaffolding which exhibit biomimetic cues at the nano to micro scale. In an effort to address this, the current work focused on 3D printing biomimetic nanocomposite scaffolds for improved osteochondral tissue regeneration. For this purpose, two biologically-inspired nanomaterials have been synthesized consisting of (1) osteoconductive nanocrystalline hydroxyapatite (nHA) (primary inorganic component of bone) and (2) core-shell poly(lactic-co-glycolic) acid (PLGA) nanospheres encapsulated with chondrogenic transforming growth-factor beta 1 (TGF-beta 1) for sustained delivery. Then, a novel table-top stereolithography 3D printer and the nano-ink (i.e., nHA + nanosphere + hydrogel) were employed to fabricate a porous and highly interconnected osteochondral scaffold with hierarchical nano-to-micro structure and spatiotemporal bioactive factor gradients. Our results showed that human bone marrow-derived mesenchymal stem cell adhesion, proliferation, and osteochondral differentiation were greatly improved in the biomimetic graded 3D printed osteochondral construct in vitro. The current work served to illustrate the efficacy of the nano-ink and current 3D printing technology for efficient fabrication of a novel nanocomposite hydrogel scaffold. In addition, tissue-specific growth factors illustrated a synergistic effect leading to increased cell adhesion and directed stem cell differentiation.
C1 [Castro, Nathan J.; Zhang, Lijie Grace] George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA.
   [O'Brien, Joseph] George Washington Univ, Dept Orthoped Surg, Washington, DC 20052 USA.
   [O'Brien, Joseph] George Washington Univ, Dept Neurol Surg, Washington, DC 20052 USA.
   [Zhang, Lijie Grace] George Washington Univ, Dept Biomed Engn, Washington, DC 20052 USA.
   [Zhang, Lijie Grace] George Washington Univ, Dept Med, Washington, DC 20052 USA.
RP Zhang, LG (reprint author), George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA.
EM lgzhang@gwu.edu
OI Castro, Nathan/0000-0002-2526-3849
FU NIH [DP2EB020549]; GW Institute for Biomedical Engineering
FX The authors would like to thank NIH Director's New Innovator Award
   (DP2EB020549) and GW Institute for Biomedical Engineering for financial
   support.
CR Baji A, 2006, MATER MANUF PROCESS, V21, P211, DOI 10.1081/AMP-200068681
   Bian WG, 2012, RAPID PROTOTYPING J, V18, P68, DOI 10.1108/13552541211193511
   Castro N. J., 2015, CELL MOL BIOENG, P1
   Castro NJ, 2014, AICHE J, V60, P432, DOI 10.1002/aic.14296
   Chim H, 2012, CELL TISSUE RES, V350, P89, DOI 10.1007/s00441-012-1449-x
   Dawson JI, 2008, BIOMATERIALS, V29, P3105, DOI 10.1016/j.biomaterials.2008.03.040
   Ergun A, 2012, TISSUE ENG PT A, V18, P2426, DOI [10.1089/ten.tea.2011.0625, 10.1089/ten.TEA.2011.0625]
   Ergun A, 2011, J BIOMED MATER RES A, V99A, P354, DOI 10.1002/jbm.a.33190
   Erisken C, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/16/165302
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   Ertan A. B., 2011, J TISSUE ENG REGEN M, V7, P149
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Holmes B, 2015, TISSUE ENG PT A, V21, P403, DOI [10.1089/ten.tea.2014.0138, 10.1089/ten.TEA.2014.0138]
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Hwang YK, 2008, LANGMUIR, V24, P2446, DOI 10.1021/la703546f
   Ichinose S, 2005, CLIN EXP PHARMACOL P, V32, P561, DOI 10.1111/j.1440-1681.2005.04231.x
   Im O, 2012, INT J NANOMED, V7, P2087, DOI 10.2147/IJN.S29743
   Iwatsubo T, 2006, BIOMACROMOLECULES, V7, P95, DOI 10.1021/bm0504476
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kim M, 2012, J MECH BEHAV BIOMED, V11, P92, DOI 10.1016/j.jmbbm.2012.03.006
   Li J., 2011, INT J SMART NANO MAT, V3, P2
   Lin-Gibson S, 2007, BIOMACROMOLECULES, V8, P1511, DOI 10.1021/bm061139q
   Madhumathi K, 2009, INT J BIOL MACROMOL, V45, P12, DOI 10.1016/j.ijbiomac.2009.03.011
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Marchesi DG, 2000, EUR SPINE J, V9, P372, DOI 10.1007/s005860000203
   Matsumura K, 2010, J BIOMED MATER RES A, V92A, P1225, DOI 10.1002/jbm.a.32448
   Moreau David, 2014, Biomatter, V4, pe28764, DOI 10.4161/biom.28764
   Murphy SV, 2013, J BIOMED MATER RES A, V101, P272, DOI 10.1002/jbm.a.34326
   O'Brien CM, 2015, TISSUE ENG PART B-RE, V21, P103, DOI [10.1089/ten.TEB.2014.0168, 10.1089/ten.teb.2014.0168]
   Ozkan S, 2010, J BIOMED MATER RES A, V92A, P1007, DOI 10.1002/jbm.a.32425
   Ozkan S, 2009, BIOMATERIALS, V30, P4336, DOI 10.1016/j.biomaterials.2009.04.050
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Sibilla P, 2006, J DENT RES, V85, P354, DOI 10.1177/154405910608500414
   Smith IO, 2009, WIRES NANOMED NANOBI, V1, P226, DOI 10.1002/wnan.026
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   Sugino A, 2008, J MATER SCI-MATER M, V19, P2269, DOI 10.1007/s10856-007-3327-8
   Sun LL, 2012, TISSUE ENG PT A, V18, P1741, DOI [10.1089/ten.tea.2011.0456, 10.1089/ten.TEA.2011.0456]
   Tang GW, 2012, J BIOMAT SCI-POLYM E, V23, P2241, DOI 10.1163/156856211X614185
   Tarafder S, 2010, LANGMUIR, V26, P16625, DOI 10.1021/la101851f
   Tezcan B, 2010, J MOL HISTOL, V41, P247, DOI 10.1007/s10735-010-9284-4
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
   Wang M, 2012, J NANOSCI NANOTECHNO, V12, P7692, DOI 10.1166/jnn.2012.6624
   Weigel T, 2006, EXPERT REV MED DEVIC, V3, P835, DOI 10.1586/17434440.3.6.835
   Wu LC, 2011, BIOMATERIALS, V32, P5341, DOI 10.1016/j.biomaterials.2011.04.014
   Zhang L, 2009, ADV BIOMATERIALS FUN, P205
   Zhang LJ, 2008, INT J NANOMED, V3, P323
   Zhang Lijie, 2009, Critical Reviews in Biomedical Engineering, V37, P1
   Zhang LJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/17/175101
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhou XZ, 2008, INT J ARTIF ORGANS, V31, P480
   Zustiak SP, 2010, BIOMACROMOLECULES, V11, P1348, DOI 10.1021/bm100137q
NR 53
TC 44
Z9 44
U1 11
U2 159
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PY 2015
VL 7
IS 33
BP 14010
EP 14022
DI 10.1039/c5nr03425f
PG 13
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CP0DV
UT WOS:000359546900025
PM 26234364
OA Green Accepted
DA 2018-10-20
ER

PT S
AU Lang, XY
   Lyubovitsky, J
AF Lang, Xuye
   Lyubovitsky, Julia
BE Amelink, A
   Vitkin, IA
TI Second harmonic generation (SHG) and two-photon fluorescence (TPF)
   contrast imaging in biomaterial analysis
SO NOVEL BIOPHOTONICS TECHNIQUES AND APPLICATIONS III
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Novel Biophotonics Techniques and Applications III
CY JUN 24-25, 2015
CL Munich, GERMANY
SP SPIE, Opt Soc
DE Second Harmonic Generation (SHG) microscopy; two-photon fluorescence
   (TPF) microscopy; collagen imaging; polarization; cross-linking;
   genipin; biomaterial; hydrogel
ID COLLAGEN
AB Collagen hydrogels are natural biomaterials that comprise 3D networks of high water content and have viscoelastic properties and biocompatibility similar to native tissues. Consequently, these materials play an important role in tissue engineering and regenerative medicine for quite some time. Second harmonic generation (SHG) and two-photon fluorescence (TPF) contrasts transpire as valuable label-free spectroscopic probes for analysis of these biomaterials and this presentation will report the structural, mechanical and physicochemical parameters leading to the observed optical SHG and TPF effects in synthesized 3D collagen hydrogels. We will present results regarding understanding the dependency of collagen fiber formation on ion types, new results regarding strengthening of these biomaterials with a nontoxic chemical cross-linker genipin and polarization selection of collagen fibers' orientations.
C1 [Lang, Xuye; Lyubovitsky, Julia] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
   [Lyubovitsky, Julia] Univ Calif Riverside, Dept Bioengn, Mat Sci & Engn 239, Riverside, CA 92521 USA.
RP Lyubovitsky, J (reprint author), Univ Calif Riverside, Dept Biochem, A110 Bourns Hall, Riverside, CA 92521 USA.
EM julial@ucr.edu
CR Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009
   Gusachenko I, 2012, BIOPHYS J, V102, P2220, DOI 10.1016/j.bpj.2012.03.068
   Hwang Y., 2011, ACS APPL MATER INTER, V4, P261
   Hwang YJ, 2011, ANAL METHODS-UK, V3, P529, DOI 10.1039/c0ay00381f
   Lang XY, 2015, ANAL METHODS-UK, V7, P1680, DOI 10.1039/c4ay02242d
   Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7
   Xu P, 2004, P SOC PHOTO-OPT INS, V5323, P343, DOI 10.1117/12.528740
NR 7
TC 0
Z9 0
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-1-62841-705-0
J9 PROC SPIE
PY 2015
VL 9540
AR 95400Y
DI 10.1117/12.2197636
PG 6
WC Engineering, Biomedical; Optics; Radiology, Nuclear Medicine & Medical
   Imaging
SC Engineering; Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BD3FP
UT WOS:000359602700024
DA 2018-10-20
ER

PT S
AU Ma, YH
   Shang, WB
   Fan, XY
   Gao, ZH
   Wang, HB
   Luy, XM
AF Ma, Yunhai
   Shang, Wenbo
   Fan, Xueying
   Gao, Zhihui
   Wang, Hubiao
   Luy, Xueman
BE Carl, J
TI Microstructure and Performance of Mg-substituted alpha-TCP Porous
   Ceramics
SO PROCEEDINGS OF THE 2015 ASIA-PACIFIC ENERGY EQUIPMENT ENGINEERING
   RESEARCH CONFERENCE (AP3ER 2015)
SE AER-Advances in Engineering Research
LA English
DT Proceedings Paper
CT Asia-Pacific Energy Equipment Engineering Research Conference (AP3ER)
CY JUN 13-14, 2015
CL Zhuhai, PEOPLES R CHINA
DE beta-TCP; Mg-substituted; porosity; Microstructure; Immersion
ID TRICALCIUM PHOSPHATE; BIOCERAMICS; MAGNESIUM
AB beta-tricalcium phosphate(beta-TCP) is an important biomaterial with good biocompatibility. The study was concentrated on the microstructure and performance of Mg-substituted beta-TCP porous ceramics. The 6mol.% Mg-doped powders were fabricated by the method of gel-sol combustion with raw materials of Ca(NO3)2, PBTC and Mg(NO3)2. Mg-substituted beta-TCP porous ceramics were obtained by molded-pressing with the foaming agent and the binder before calcined at 1000 degrees C. The mechanical properties, microstructure, immersion performance had been evaluated by means of mechanical testing machine, X-ray diffraction, scanning electron microscopy with EDS and immersion test. The compressive test showed that the compressive strength of Mg-doped porous ceramics increased 10.5% from 5.92MPa to 6.54MPa compared with the pure porous scaffolds. The SEM Images demonstrated that the porosity of ceramic was about 65%, the size of interconnect holes were ranging from 50 to 200 mu m. Immersion test indicated that the Mg-substituted improved the performance of degradation apparently.
C1 [Ma, Yunhai; Shang, Wenbo; Fan, Xueying; Gao, Zhihui; Wang, Hubiao; Luy, Xueman] Jilin Univ, Coll Biol & Agr Engn, Changchun, Peoples R China.
   [Ma, Yunhai; Shang, Wenbo; Fan, Xueying; Gao, Zhihui; Wang, Hubiao; Luy, Xueman] Jilin Univ, Minist Educ, Key Lab Bion Engn, Changchun 130021, Peoples R China.
   [Luy, Xueman] Jilin Univ, China Japan Union Hosp, Changchun 130033, Peoples R China.
RP Luy, XM (reprint author), Jilin Univ, Coll Biol & Agr Engn, Nanling Campus, Changchun, Peoples R China.
EM myh@jlu.edu.cn; shangwenbo123@163.com; 390916495@qq.com;
   570814141@qq.com; 616598148@qq.com; lv_xueman@sina.com
CR Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Engin NO, 1999, J EUR CERAM SOC, V19, P2569
   HENCH L, 1993, INTRO BIOCERAMICS
   Ilaria C., 2011, CERAM INT, V37, P127
   Itatani K, 2002, J MATER SCI-MATER M, V13, P707, DOI 10.1023/A:1015754229181
   Lin FH, 2001, BIOMATERIALS, V22, P2981, DOI 10.1016/S0142-9612(01)00044-8
   Lin KL, 2006, J INORG MATER, V21, P1429
   Okuma T, 2001, NUTRITION, V17, P679, DOI 10.1016/S0899-9007(01)00551-2
   Rude RK, 2004, J NUTR BIOCHEM, V15, P710, DOI 10.1016/j.jnutbio.2004.08.001
   Toriyama M., 1987, J CERAM SOC JPN YOGY, V95, P822
   Wang X, 2013, MAT SCI ENG C-MATER, V33, P618, DOI 10.1016/j.msec.2012.10.006
   YONEZAKI H, 1998, J MATER SCI-MATER M, V9, P381
   Yoshida K, 2005, J AM CERAM SOC, V88, P2315, DOI 10.1111/j.1551-2916.2005.00399.x
   [张士华 Zhang Shihua], 2005, [南京理工大学学报. 自然科学版, Journal of nanjing university of science and technology], V29, P231
NR 14
TC 0
Z9 0
U1 0
U2 3
PU ATLANTIS PRESS
PI PARIS
PA 29 AVENUE LAVMIERE, PARIS, 75019, FRANCE
SN 2352-5401
BN 978-94-62520-63-9
J9 AER ADV ENG RES
PY 2015
VL 9
BP 156
EP 161
PG 6
WC Engineering, Multidisciplinary; Engineering, Mechanical; Materials
   Science, Multidisciplinary
SC Engineering; Materials Science
GA BD3KU
UT WOS:000359813100038
DA 2018-10-20
ER

PT S
AU Lu, G
   Yu, HP
   Wang, YZ
   Luo, YY
   Zeng, ZQ
AF Lu, Guang
   Yu, Heping
   Wang, Yongzhou
   Luo, Yongyue
   Zeng, Zongqiang
BE Carl, J
TI Preparation and Mechanical Properties of Prevulcanized Natural Rubber
   Latex/Chitosan/Poly (3-hydroxybutyrate) Blends
SO PROCEEDINGS OF THE 2015 ASIA-PACIFIC ENERGY EQUIPMENT ENGINEERING
   RESEARCH CONFERENCE (AP3ER 2015)
SE AER-Advances in Engineering Research
LA English
DT Proceedings Paper
CT Asia-Pacific Energy Equipment Engineering Research Conference (AP3ER)
CY JUN 13-14, 2015
CL Zhuhai, PEOPLES R CHINA
DE natural rubber latex; chitosan; poly(3-hydroxybutyrate); blend;
   mechanical properties
ID BEHAVIOR; LATEX
AB In order to obtain natural rubber (NR) latex-based biomaterial, the NR latex concentrate was prepared into prevulcanized natural rubber latex (SNRL) and then blended with a water dispersion of chitosan (CS) and poly(3-hydroxybutyrate) (PHB) together, with the total amount of CS and PHB is of 1, 3, 5, 10 parts per hundred rubber (phr), and CS and PHB is of a ratio of 1:1; the SNRL was also blended with a water dispersion of CS or PHB only in the same amount for properties comparison. The mechanical properties including the tensile strength, elongation at break, 300% modulus, tear strength and hardness of the 24h water-leached SNRL/CS/PHB, SNRL/CS or SNRL/PHB films were tested. The results indicated that, the tensile strength first increased with increase in CS/PHB, CS or PHB content up to 1.0 phr then decreased, the elongation at break decreased, the 300% modulus, tear strength and Shore A hardness increased, with increase in CS/PHB, CS or PHB content, whereas most of the tensile strength and elasticity of the films can be retained when the content of CS/PHB, CS or PHB was less than 5.0 phr.
C1 [Lu, Guang; Yu, Heping; Wang, Yongzhou; Luo, Yongyue; Zeng, Zongqiang] Chinese Acad Trop Agr Sci, Agr Prod Proc Res Inst, Zhanjiang, Peoples R China.
RP Lu, G (reprint author), Chinese Acad Trop Agr Sci, Agr Prod Proc Res Inst, Zhanjiang, Peoples R China.
EM lug_sc8@163.com; yheping@yahoo.com; wyz011120@163.com;
   lyy6226@hotmail.com; zengzongqiang08@163.com
CR Johns J, 2009, INT J POLYM ANAL CH, V14, P508, DOI 10.1080/10236660903072797
   Johns J, 2009, J MATER SCI, V44, P4087, DOI 10.1007/s10853-009-3589-2
   Klamklang S., 2002, SCI ASIA, V28, P135
   Lu G., 2012, China Patent, Patent No. [ZL 201010225247.5, 2010102252475]
   Lu G, 2012, ADV MATER RES-SWITZ, V396-398, P400, DOI 10.4028/www.scientific.net/AMR.396-398.400
   Meng X., 2009, FUNCTIONAL MAT, V40, P436
   [孟晓荣 MENG Xiaorong], 2007, [功能高分子学报, Journal of Functional Polymer], V19/20, P364
   Rao V, 2008, J THERM ANAL CALORIM, V92, P801, DOI 10.1007/s10973-007-8854-5
   Rao V, 2008, J APPL POLYM SCI, V107, P2217, DOI 10.1002/app.27265
   Zhang LN, 2006, MODIFIED MAT NATURAL
NR 10
TC 0
Z9 0
U1 0
U2 1
PU ATLANTIS PRESS
PI PARIS
PA 29 AVENUE LAVMIERE, PARIS, 75019, FRANCE
SN 2352-5401
BN 978-94-62520-63-9
J9 AER ADV ENG RES
PY 2015
VL 9
BP 269
EP 272
PG 4
WC Engineering, Multidisciplinary; Engineering, Mechanical; Materials
   Science, Multidisciplinary
SC Engineering; Materials Science
GA BD3KU
UT WOS:000359813100063
DA 2018-10-20
ER

PT S
AU Triwahyuni, E
   Muryanto
   Sudiyani, Y
   Abimanyu, H
AF Triwahyuni, Eka
   Muryanto
   Sudiyani, Yanni
   Abimanyu, Haznan
BE Bakar, RBA
   Froome, C
TI The effect of substrate loading on simultaneous saccharification and
   fermentation process for bioethanol production from oil palm empty fruit
   bunches
SO 2ND INTERNATIONAL CONFERENCE ON SUSTAINABLE ENERGY ENGINEERING AND
   APPLICATION (ICSEEA) 2014 SUSTAINABLE ENERGY FOR GREEN MOBILITY
SE Energy Procedia
LA English
DT Proceedings Paper
CT 2nd International Conference on Sustainable Energy Engineering and
   Application (ICSEEA)
CY OCT 14-16, 2014
CL Indonesian Inst Sci, Res Ctr Elect Power & Mechatron, Bandung, INDONESIA
HO Indonesian Inst Sci, Res Ctr Elect Power & Mechatron
DE simultaneous saccharification and fermentation (SSF); substrate loading;
   high-concentration ethanol; high-concentration substrate
ID DIFFERENT PROCESS CONFIGURATIONS; LIGNOCELLULOSIC MATERIALS;
   ENZYMATIC-HYDROLYSIS; ETHANOL-PRODUCTION; PRETREATMENT; STRAW; BIOMASS;
   ALKALI
AB Increasing energy demand and concern about increased greenhouse gas emissions make lignocellulosic biomass increasingly to be recognized as having great potential for biofuel and biomaterial production based on the biorefinery concept. Oil Palm Empty Fruit Bunches (EFBs) is one of the major solid wastes in the palm oil industries as a source of lignocellulosic biomass. Cellulose is the highest component of EFBs that can be converted to ethanol. The aim of this research was to investigate the different strategies for high substrate loading on SSF process of bioethanol production from EFBs. Increasing substrate loading is one of the most important challenges to make bioethanol production more economical. This research used two methods to increase the substrate concentration loading on Simultaneous Saccharification and Fermentation (SSF) i.e: direct variation of substrate concentration loading and substrate loading gradually to obtain a high-concentration substrate. A range of substrate loading was from 15% to 25% (g.mL(-1)). The SSF process was carried out at 32 degrees C, pH 4.8, and 150 rpm for 72 hours. The result shows that the highest concentration of ethanol can be produced by a high concentration of substrate loading gradually. The highest ethanol concentration was 83.40 g.L-1 (80.21% ethanol yield) by using 25% (g.mL(-1)) substrate loading gradually, 18 FPU/g substrate enzyme Cellic (R) Ctec2 and 20% Cellic (R) Htec2 (based on volume of Cellic (R) Ctec2), and 1% (g.mL(-1)) yeast Saccharomyces cereviceae in SSF process. Whereas, 20% (g.mL(-1)) concentration substrate loading by directly or gradually produce almost same ethanol concentration. (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Triwahyuni, Eka; Muryanto; Sudiyani, Yanni; Abimanyu, Haznan] Indonesian Inst Sci, Res Ctr Chem, Tangerang Selatan 15314, Indonesia.
RP Triwahyuni, E (reprint author), Indonesian Inst Sci, Res Ctr Chem, Tangerang Selatan 15314, Indonesia.
EM ekatriwahyuni@gmail.com
OI Abimanyu, Haznan/0000-0003-1532-2232; , muryanto/0000-0002-9478-6037
CR Adney B., 2008, NRELTP51042628
   Alfani F, 2000, J IND MICROBIOL BIOT, V25, P184, DOI 10.1038/sj.jim.7000054
   Andric P, 2010, BIOTECHNOL ADV, V28, P308, DOI 10.1016/j.biotechadv.2010.01.003
   Badger P.C., 2002, TRENDS NEW CROPS NEW
   Lopez-Linares JC, 2014, FUEL, V122, P112, DOI 10.1016/j.fuel.2014.01.024
   Carolina CM., 2011, PROCESS SAF ENVIRON, V90, P189
   Chen HZ, 2007, APPL BIOCHEM MICRO+, V43, P57, DOI 10.1134/S0003683807010103
   Collins K., 2007, EN INF ADM EIA EN OU
   CONVERSE AO, 1990, APPL BIOCHEM BIOTECH, V24-5, P67, DOI 10.1007/BF02920234
   Coyle WT, 2010, REPORT EC RES SERVIC
   Duangwang Sairudee, 2013, Advanced Materials Research, V622-623, P117, DOI 10.4028/www.scientific.net/AMR.622-623.117
   Han M, 2014, BIOPROCESS BIOSYST E
   Han M, 2013, PROCESS BIOCHEM, V48, P488, DOI 10.1016/j.procbio.2013.01.007
   Hodge DB, 2008, BIORESOURCE TECHNOL, V99, P8940, DOI 10.1016/j.biortech.2008.05.015
   Jorgensen H, 2007, BIOTECHNOL BIOENG, V96, P862, DOI 10.1002/bit.21115
   Kang KE, 2013, FUEL, V109, P520, DOI 10.1016/j.fuel.2013.03.026
   Koppram R., 2013, TRENDS BIOTECHNOL
   Madson P. W., 2009, ALCOHOL TXB, P292
   Manzanares P, 2011, J CHEM TECHNOL BIOT, V86, P881, DOI 10.1002/jctb.2604
   Minister of Agriculture, 2012, AGR STAT 2012
   Modenbach AA, 2013, BIOMASS BIOENERG, V56, P526, DOI 10.1016/j.biombioe.2013.05.031
   National Renewable Energy Laboratory, STAND BIOM AN PROC
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   Sheil D, 2009, IMPACTS OPPORTUNITIE
   Sluiter B., 2011, NRELTP51042618
   Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7
   TARKOW H, 1969, ADV CHEM SER, P197
   Triwahyuni E., 2013, P INT C BIOT 2012, P129
   Wang W, 2011, APPL BIOCHEM BIOTECH, V164, P1139, DOI 10.1007/s12010-011-9200-8
   Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P2026, DOI 10.1016/j.biortech.2005.01.018
   Yano S., 2009, J JPN I ENERGY, V88, P923
   Zhang YHP, 2009, ENERG ENVIRON SCI, V2, P272, DOI 10.1039/b818694d
NR 32
TC 14
Z9 14
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2015
VL 68
BP 138
EP 146
DI 10.1016/j.egypro.2015.03.242
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BD2EH
UT WOS:000358692000017
OA Other Gold
DA 2018-10-20
ER

PT J
AU Nguyen, KV
   Minteer, SD
AF Khiem Van Nguyen
   Minteer, Shelley D.
TI Investigating DNA hydrogels as a new biomaterial for enzyme
   immobilization in biobatteries
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID GLUCOSE-OXIDASE; BIOFUEL CELLS; OXIDATION; DEVICES
AB We report the usage of DNA hydrogels for enzyme entrapment in an enzymatic biobattery. With the recent advancements in DNA nanotechnology, the incorporation of DNA materials to bioelectrocatalytic electrodes holds great promise to improve the performance of bioelectrocatalysis-based devices.
C1 [Minteer, Shelley D.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.
   Univ Utah, Dept Mat Sci & Engn, Salt Lake City, UT 84112 USA.
RP Minteer, SD (reprint author), Univ Utah, Dept Chem, 315 S 1400 E Room 2020, Salt Lake City, UT 84112 USA.
EM minteer@chem.utah.edu
OI Minteer, Shelley/0000-0002-5788-2249
FU Air Force Office of Scientific Research
FX The authors would like to acknowledge the Air Force Office of Scientific
   Research for funding.
CR Bardea A, 1997, J AM CHEM SOC, V119, P9114, DOI 10.1021/ja971192+
   Bhatnagar D, 2011, PHYS CHEM CHEM PHYS, V13, P86, DOI 10.1039/c0cp01362e
   Calabrese-Barton S., 2004, CHEM REV, V104, P4867
   Cooney MJ, 2008, ENERG ENVIRON SCI, V1, P320, DOI 10.1039/b809009b
   GREGG BA, 1990, ANAL CHEM, V62, P258, DOI 10.1021/ac00202a007
   Heller A, 2006, CURR OPIN CHEM BIOL, V10, P664, DOI 10.1016/j.cbpa.2006.09.018
   Kim YH, 2013, ANGEW CHEM INT EDIT, V52, P1437, DOI 10.1002/anie.201207423
   Leech D, 2012, ELECTROCHIM ACTA, V84, P223, DOI 10.1016/j.electacta.2012.02.087
   Lilienthal S, 2015, ACS APPL MATER INTER, V7, P8923, DOI 10.1021/acsami.5b02156
   Liu DS, 2011, NPG ASIA MATER, V3, P109, DOI 10.1038/asiamat.2011.147
   Merchant SA, 2009, LANGMUIR, V25, P7736, DOI 10.1021/la9004938
   Meredith MT, 2012, ANNU REV ANAL CHEM, V5, P157, DOI 10.1146/annurev-anchem-062011-143049
   Moore CM, 2004, BIOMACROMOLECULES, V5, P1241, DOI 10.1021/bm0345256
   Neto SA, 2015, J POWER SOURCES, V285, P493, DOI 10.1016/j.jpowsour.2015.03.121
   Park N, 2009, NAT MATER, V8, P432, DOI [10.1038/NMAT2419, 10.1038/nmat2419]
   Um SH, 2006, NAT MATER, V5, P797, DOI 10.1038/nmat1741
   Wheeldon IR, 2008, P NATL ACAD SCI USA, V105, P15275, DOI 10.1073/pnas.0805249105
   Xing YZ, 2011, ADV MATER, V23, P1117, DOI 10.1002/adma.201003343
   Yang DY, 2014, ACCOUNTS CHEM RES, V47, P1902, DOI 10.1021/ar5001082
   Zhu Z., 2009, ANGEW CHEM INT EDIT, V49, P1052
NR 20
TC 9
Z9 9
U1 5
U2 34
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2015
VL 51
IS 66
BP 13071
EP 13073
DI 10.1039/c5cc04810a
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA CO4SO
UT WOS:000359151100002
PM 26165384
DA 2018-10-20
ER

PT J
AU Ouyang, ZZ
   Bai, S
AF Ouyang, Zhenzhong
   Bai, Shan
TI Preparation and In-Vitro Biocompatibility of Gelatin/SA/HYA Composite
   Scaffold for Tissue Engineering
SO POLYMERS & POLYMER COMPOSITES
LA English
DT Article
DE Gelatin; Hyaluronic acid; Sodium alginate; Composite hydrogel;
   Biocompatibility; in-vitro
ID CHEMICAL CROSS-LINKING; HYALURONIC-ACID; GELATIN/CHITOSAN MICROSPHERES;
   BIOLOGICAL-PROPERTIES; FABRICATION; BIOMATERIAL; SPONGE; SIZE
AB Novel gelatin/sodium alginate (SA) porous scaffolds containing hyaluronic acid (HYA) were fabricated via freeze-drying technique and their in-vitro biocompatibility was investigated. It was demonstrated that the gelatin/SA/HYA composite scaffolds had highly homogeneous and interconnected pores with average pore size ranging from 50 to 400 mu m. The extracts of gelatin/SA/HYA with various contents of 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC) showed no toxicity due to easy removal of excess EDC. Fibroblastic cells attached to the culture plate and showed normal morphology when cultured in the extract of gelatin/SA/HYA hydrogel. The introduction of HYA into the gelatin/SA matrix facilitated the adhesion of fibroblasts in the gelatin/SA/HYA scaffolds. The haemolytic test indicated that the gelatin/SA/HYA composite hydrogel showed no haemolysis. Therefore, the gelatin/SA/HYA composite scaffolds would be suitable for cell adhesion and growth and could offer new and important options for tissue engineering applications.
C1 [Ouyang, Zhenzhong; Bai, Shan] Changsha Environm Protect Coll, Changsha, Hunan, Peoples R China.
RP Ouyang, ZZ (reprint author), Changsha Environm Protect Coll, Changsha, Hunan, Peoples R China.
EM zhenzhongouyang@163.com
CR [Anonymous], 1992, 109934 ISO
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Choi SM, 2013, INT J POLYM MATER PO, V62, P384, DOI 10.1080/00914037.2012.710862
   Jha AK, 2011, BIOMATERIALS, V32, P2466, DOI 10.1016/j.biomaterials.2010.12.024
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kuo C. K., 2007, J BIOMED MATER RES A, V90, P899
   Li JX, 2006, BIOMACROMOLECULES, V7, P2243, DOI 10.1021/bm0603342
   Liu HF, 2004, J BIOMAT SCI-POLYM E, V15, P25, DOI 10.1163/156856204322752219
   Liu Y, 2013, POLYM-PLAST TECHNOL, V52, P1154, DOI 10.1080/03602559.2013.798818
   Mao J. S., 2003, BIOMATERIALS, V24, P1621
   Peng ZY, 2012, J MACROMOL SCI B, V51, P12, DOI 10.1080/00222348.2011.562807
   Peng ZY, 2012, POLYM-PLAST TECHNOL, V51, P739, DOI 10.1080/03602559.2012.663037
   Peng ZY, 2012, POLYM-PLAST TECHNOL, V51, P381, DOI 10.1080/03602559.2011.639830
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Price RD, 2005, AM J CLIN DERMATOL, V6, P393, DOI 10.2165/00128071-200506060-00006
   Rosellini E, 2008, J BIOMED MATER RES A, V91, P447
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Srivastava S, 2012, INT J POLYM MATER, V61, P679, DOI 10.1080/00914037.2011.610070
   Sun L. P., 2009, BIOMED MATER, V4, P1
   Tang SQ, 2007, J BIOMED MATER RES A, V82A, P323, DOI 10.1002/jbm.a.30974
   Wu L, 2013, J MACROMOL SCI A, V50, P1121, DOI 10.1080/10601325.2013.829360
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yamane S, 2007, J BIOMED MATER RES A, V81A, P586, DOI 10.1002/jbm.a.31095
   Zhou ZH, 2013, MATER RES INNOV, V17, P420, DOI 10.1179/1433075X13Y.0000000084
   Zhou ZH, 2013, INT J POLYM MATER PO, V62, P81, DOI 10.1080/00914037.2012.664213
   Zhou ZH, 2013, POLYM-PLAST TECHNOL, V52, P45, DOI 10.1080/03602559.2012.718400
   Zhou ZH, 2012, POLYM POLYM COMPOS, V20, P791, DOI 10.1177/096739111202000904
NR 27
TC 1
Z9 1
U1 1
U2 13
PU ISMITHERS
PI SHROPSHIRE
PA SHAWBURY, SHREWSBURY, SHROPSHIRE, SY4 4NR, ENGLAND
SN 0967-3911
J9 POLYM POLYM COMPOS
JI Polym. Polym. Compos.
PY 2015
VL 23
IS 7
BP 503
EP 508
DI 10.1177/096739111502300709
PG 6
WC Materials Science, Characterization & Testing; Materials Science,
   Composites; Polymer Science
SC Materials Science; Polymer Science
GA CO1AM
UT WOS:000358885300009
DA 2018-10-20
ER

PT J
AU Christo, SN
   Diener, KR
   Bachhuka, A
   Vasilev, K
   Hayball, JD
AF Christo, Susan N.
   Diener, Kerrilyn R.
   Bachhuka, Akash
   Vasilev, Krasimir
   Hayball, John D.
TI Innate Immunity and Biomaterials at the Nexus: Friends or Foes
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID TOLL-LIKE RECEPTORS; SELF-ASSEMBLED MONOLAYERS; FOREIGN-BODY RESPONSE;
   GIANT-CELL FORMATION; GROUP BOX 1; NLRP3 INFLAMMASOME ACTIVATION;
   MOBILITY GROUP BOX-1; NF-KAPPA-B; POLY(ETHYLENE GLYCOL)-BASED HYDROGELS;
   TITANIUM SURFACE-TOPOGRAPHY
AB Biomaterial implants are an established part of medical practice, encompassing a broad range of devices that widely differ in function and structural composition. However, one common property amongst biomaterials is the induction of the foreign body response: an acute sterile inflammatory reaction which overlaps with tissue vascularisation and remodelling and ultimately fibrotic encapsulation of the biomaterial to prevent further interaction with host tissue. Severity and clinical manifestation of the biomaterial-induced foreign body response are different for each biomaterial, with cases of incompatibility often associated with loss of function. However, unravelling the mechanisms that progress to the formation of the fibrotic capsule highlights the tightly intertwined nature of immunological responses to a seemingly noncanonical "antigen." In this review, we detail the pathways associated with the foreign body response and describe possible mechanisms of immune involvement that can be targeted. We also discuss methods of modulating the immune response by altering the physiochemical surface properties of the biomaterial prior to implantation. Developments in these areas are reliant on reproducible and effective animal models and may allow a "combined" immunomodulatory approach of adapting surface properties of biomaterials, as well as treating key immune pathways to ultimately reduce the negative consequences of biomaterial implantation.
C1 [Christo, Susan N.; Diener, Kerrilyn R.; Hayball, John D.] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst & Hanson Inst, Expt Therapeut Lab, Adelaide, SA 5000, Australia.
   [Diener, Kerrilyn R.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robarts Res Inst, Adelaide, SA 5005, Australia.
   [Bachhuka, Akash; Vasilev, Krasimir] Univ S Australia, Mawson Inst, Adelaide, SA 5095, Australia.
   [Hayball, John D.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia.
RP Hayball, JD (reprint author), Univ S Australia, Sch Pharm & Med Sci, Sansom Inst & Hanson Inst, Expt Therapeut Lab, Adelaide, SA 5000, Australia.
EM john.hayball@unisa.edu.au
RI Hayball, John/F-4137-2013
OI Hayball, John/0000-0002-3089-4506
CR Abe A, 2014, PATHOL INT, V64, P267, DOI 10.1111/pin.12167
   Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Agrawal P, 2014, INT J LOW EXTR WOUND, V13, P180, DOI 10.1177/1534734614544523
   Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Akita K, 1997, J BIOL CHEM, V272, P26595, DOI 10.1074/jbc.272.42.26595
   Al-Okla S, 1999, CELL MICROBIOL, V1, P157, DOI 10.1046/j.1462-5822.1999.00016.x
   ALTIERI DC, 1986, J CLIN INVEST, V78, P968, DOI 10.1172/JCI112687
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121
   Artel A, 2011, TISSUE ENG PT A, V17, P2133, DOI [10.1089/ten.tea.2010.0571, 10.1089/ten.TEA.2010.0571]
   AYER LM, 1994, J RHEUMATOL, V21, P2071
   Babiak I, 2014, INT WOUND J, V11, P476, DOI 10.1111/j.1742-481X.2012.01112.x
   Bai B, 2013, BIOMED RES INT, DOI 10.1155/2013/361906
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   Baker DW, 2011, BIOMACROMOLECULES, V12, P997, DOI 10.1021/bm1013487
   Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023
   Bar-On E, 2009, J CHILD ORTHOP, V3, P137, DOI 10.1007/s11832-009-0165-x
   Barbe F., 2014, CYTOKINE GROWTH F R, V25, P681
   Barbosa JN, 2006, J BIOMED MATER RES A, V76A, P737, DOI 10.1002/jbm.a.30602
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Barbosa JN, 2003, J BIOMED MATER RES A, V65A, P429, DOI 10.1002/jbm.a.10488
   Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613
   Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363
   Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837
   Behera AK, 2006, J IMMUNOL, V177, P657, DOI 10.4049/jimmunol.177.1.657
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   Betancourt T, 2006, INT J NANOMED, V1, P483, DOI 10.2147/nano.2006.1.4.483
   Bhagwat SS, 2009, PURINERG SIGNAL, V5, P107, DOI 10.1007/s11302-008-9117-z
   Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164
   Bianchi ME, 1998, AM J HUM GENET, V63, P1573, DOI 10.1086/302170
   BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Boccafoschi F, 2014, J TISSUE ENG REGEN M, V8, P253, DOI 10.1002/term.1526
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960
   BURD PR, 1995, J EXP MED, V181, P1373, DOI 10.1084/jem.181.4.1373
   Burton L, 2013, J ORTHOP RES, V31, P73, DOI 10.1002/jor.22190
   Cachinho S. C. P., 2012, INT J BIOMATERIALS, V2012
   Caicedo MS, 2013, J ORTHOP RES, V31, P1633, DOI 10.1002/jor.22411
   Campana L, 2009, J LEUKOCYTE BIOL, V86, P609, DOI 10.1189/jlb.0908576
   Carver W, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/101979
   Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105
   Castro PR, 2012, MICROVASC RES, V84, P9, DOI 10.1016/j.mvr.2012.04.003
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Chang DT, 2009, J BIOMED MATER RES A, V89A, P490, DOI 10.1002/jbm.a.31981
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chitanuwat A, 2013, J ORAL SCI, V55, P45, DOI 10.2334/josnusd.55.45
   Chiumiento A, 2007, BIOMACROMOLECULES, V8, P523, DOI 10.1021/bm060664m
   Chrcanovic BR, 2014, J ORAL REHABIL, V41, P443, DOI 10.1111/joor.12157
   Chrcanovic BR, 2014, J DENT, V42, P1509, DOI 10.1016/j.jdent.2014.09.013
   CHRISTENSON L, 1991, J BIOMED MATER RES, V25, P1119, DOI 10.1002/jbm.820250906
   Chuang SK, 2002, J DENT RES, V81, P572, DOI 10.1177/154405910208100814
   Cobelli N, 2011, NAT REV RHEUMATOL, V7, P600, DOI 10.1038/nrrheum.2011.128
   Collie AMB, 2011, J BIOMED MATER RES A, V96A, P162, DOI 10.1002/jbm.a.32963
   Communi D, 2000, CELL SIGNAL, V12, P351, DOI 10.1016/S0898-6568(00)00083-8
   Crane DD, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00438
   Curtsinger JM, 1999, J IMMUNOL, V162, P3256
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   DAYTON ET, 1988, P NATL ACAD SCI USA, V85, P569, DOI 10.1073/pnas.85.2.569
   de Fougerolles AR, 2002, IMMUNOL REV, V186, P208, DOI 10.1034/j.1600-065X.2002.18617.x
   de Zoete MR, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016287
   DEUEL TF, 1981, P NATL ACAD SCI-BIOL, V78, P4584, DOI 10.1073/pnas.78.7.4584
   Diacovo TG, 1996, BLOOD, V88, P146
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Diener KR, 2013, IMMUNOL CELL BIOL, V91, P443, DOI 10.1038/icb.2013.25
   Dolatshahi-Pirouz A, 2010, ACS NANO, V4, P2874, DOI 10.1021/nn9017872
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506
   Ebina Masahito, 2011, Pulm Med, V2011, P916486, DOI 10.1155/2011/916486
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345
   Entezari M, 2012, MOL MED, V18, P477, DOI 10.2119/molmed.2012.00024
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710
   Fink J, 2008, CLIN HEMORHEOL MICRO, V39, P205, DOI 10.3233/CH-2008-1090
   Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741
   Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200
   Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gamboa JR, 2013, COLLOID SURFACE B, V104, P318, DOI 10.1016/j.colsurfb.2012.11.035
   Gao Q., 2015, J LEUKOCYTE BIOL
   Garg K, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/031001
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Ge WS, 2011, WORLD J GASTROENTERO, V17, P4090, DOI 10.3748/wjg.v17.i36.4090
   Ghasemzadeh M, 2013, BLOOD, V121, P4555, DOI 10.1182/blood-2012-09-459636
   Gifford R, 2005, J BIOMED MATER RES A, V75A, P755, DOI 10.1002/jbm.a.30359
   Gilchrist CL, 2014, BIOMATERIALS, V35, P10015, DOI 10.1016/j.biomaterials.2014.08.047
   Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   GOODMAN S, 1994, ACTA ORTHOP SCAND, V65, P157, DOI 10.3109/17453679408995425
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gowen BB, 2000, MATRIX BIOL, V19, P61, DOI 10.1016/S0945-053X(99)00052-9
   Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313
   Grainger DW, 2013, NAT BIOTECHNOL, V31, P507, DOI 10.1038/nbt.2600
   GRIERSON JP, 1995, J BIOL CHEM, V270, P4451, DOI 10.1074/jbc.270.9.4451
   Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P729
   Guo TL, 2014, MOLECULES, V19, P149, DOI 10.3390/molecules19010149
   Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC
   Hamilton RF, 2008, FREE RADICAL BIO MED, V44, P1246, DOI 10.1016/j.freeradbiomed.2007.12.027
   Han SH, 2014, CLIN ENDOSC, V47, P415, DOI 10.5946/ce.2014.47.5.415
   Harvey AG, 2013, EXPERT REV MED DEVIC, V10, P257, DOI [10.1586/ERD.12.82, 10.1586/erd.12.82]
   Hassan H, 2011, THESCIENTIFICWORLDJO, V11, P2418, DOI 10.1100/2011/429192
   Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939
   Hirata I, 2003, J BIOMED MATER RES A, V66A, P669, DOI 10.1002/jbm.a.10067
   Hodgkinson CR, 2008, THROMB HAEMOSTASIS, V100, P301, DOI 10.1160/TH08-03-0179
   Holand W, 2008, EXPERT REV MED DEVIC, V5, P729, DOI 10.1586/17434440.5.6.729
   Hoesli CA, 2014, BIOMATERIALS, V35, P879, DOI 10.1016/j.biomaterials.2013.09.076
   HOFFMAN AS, 1974, J BIOMED MATER RES, V8, P77, DOI 10.1002/jbm.820080309
   Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631
   Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725
   Hou C., 2014, CELLULAR MOL IMMUNOL
   Hovgaard MB, 2008, J PHYS CHEM B, V112, P8241, DOI 10.1021/jp801103n
   Hulander M, 2013, COLLOID SURFACE B, V110, P261, DOI 10.1016/j.colsurfb.2013.04.010
   Hulander M, 2011, INT J NANOMED, V6, P2653, DOI 10.2147/IJN.S24578
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110
   Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861
   Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095
   Ireland LD, 2014, CONTRACEPTION, V90, P253, DOI 10.1016/j.contraception.2014.05.010
   Itala A, 2003, J BIOMED MATER RES B, V65B, P163, DOI 10.1002/jbm.b.10529
   Jacobs SR, 2012, J LEUKOCYTE BIOL, V92, P469, DOI 10.1189/jlb.0312132
   Jahed Z, 2014, BIOMATERIALS, V35, P9363, DOI 10.1016/j.biomaterials.2014.07.022
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jensen SS, 2005, INT J ORAL MAX IMPL, V20, P703
   Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033
   Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   Kam KR, 2014, TISSUE ENG PT A, V20, P130, DOI [10.1089/ten.tea.2012.0772, 10.1089/ten.TEA.2012.0772]
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Kanbe N, 1999, CLIN EXP ALLERGY, V29, P105
   Kanbe N, 1999, INT ARCH ALLERGY IMM, V119, P138, DOI 10.1159/000024189
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558
   Kelsh Rhiannon M, 2013, Trends Cancer Res, V9, P1
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Khan MM, 2012, STROKE, V43, P1376, DOI 10.1161/STROKEAHA.111.635516
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim J, 2003, J AM CHEM SOC, V125, P3150, DOI 10.1021/ja028987n
   Kim MH, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-13
   Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399
   Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547
   Kopnin PB, 2004, ONCOGENE, V23, P8834, DOI 10.1038/sj.onc.1208108
   Kosyfaki P, 2014, ACTA BIOMATER, V10, P4861, DOI 10.1016/j.actbio.2014.07.028
   Kovarova M, 2012, J IMMUNOL, V189, P2006, DOI 10.4049/jimmunol.1201065
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kukkonen MK, 2014, OCCUP ENVIRON MED, V71, P48, DOI 10.1136/oemed-2013-101555
   Kulka A, 2006, MOL IMMUNOL, V43, P1579, DOI 10.1016/j.molimm.2005.09.019
   Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Labrousse AM, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00051
   Lachke MW, 2014, ACTA BIOMATER, V10, P4661, DOI 10.1016/j.actbio.2014.07.004
   Lahdeoja T, 2010, J ORTHOP RES, V28, P184, DOI 10.1002/jor.20979
   Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007
   Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Le Nga N, 2011, J Diabetes Sci Technol, V5, P605
   Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Lee SA, 2014, YONSEI MED J, V55, P1165, DOI 10.3349/ymj.2014.55.5.1165
   Lefrancais E, 2012, EUR CYTOKINE NETW, V23, P120, DOI 10.1684/ecn.2012.0320
   Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109
   Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9
   LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485
   Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011
   Li LC, 2014, J CELL MOL MED, V18, P2331, DOI 10.1111/jcmm.12419
   Liu L, 1997, CLIN EXP IMMUNOL, V109, P204, DOI 10.1046/j.1365-2249.1997.4311329.x
   Liu LY, 2014, BIOCHEM BIOPH RES CO, V450, P851, DOI 10.1016/j.bbrc.2014.06.074
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]
   Lopacinska JM, 2012, NANOSCALE, V4, P3739, DOI 10.1039/c2nr11455k
   Lopetuso LR, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-18
   Lorenzoni G, 2014, J EVAL CLIN PRACT, V20, P570, DOI 10.1111/jep.12132
   Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133
   Lukens JR, 2014, P NATL ACAD SCI USA, V111, P1066, DOI 10.1073/pnas.1318688111
   Lunov O, 2011, ACS NANO, V5, P9648, DOI 10.1021/nn203596e
   Luzina IG, 2013, AM J RESP CELL MOL, V49, P999, DOI 10.1165/rcmb.2013-0093OC
   Lynn AD, 2011, ACTA BIOMATER, V7, P123, DOI 10.1016/j.actbio.2010.07.033
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Ma QL, 2014, BIOMATERIALS, V35, P9853, DOI 10.1016/j.biomaterials.2014.08.025
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Maitra R, 2009, MOL IMMUNOL, V47, P175, DOI 10.1016/j.molimm.2009.09.023
   Maitra R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002438
   Malik AF, 2011, P NATL ACAD SCI USA, V108, P20095, DOI 10.1073/pnas.1105152108
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Marcolongo M, 1998, J BIOMED MATER RES, V39, P161, DOI 10.1002/(SICI)1097-4636(199801)39:1<161::AID-JBM18>3.0.CO;2-I
   Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Marvie P, 2010, J CELL MOL MED, V14, P1726, DOI 10.1111/j.1582-4934.2009.00801.x
   Matena J, 2015, INT J MOL SCI, V16, P7478, DOI 10.3390/ijms16047478
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   Maugeri N, 2014, ANTIOXID REDOX SIGN, V20, P1060, DOI 10.1089/ars.2013.5298
   Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018
   McIvor ME, 1998, PACE, V21, P1847, DOI 10.1111/j.1540-8159.1998.tb00002.x
   McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McNamara LE, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414536177
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   Mesure L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012949
   Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x
   Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342
   MILNER P, 1992, J VASC RES, V29, P420, DOI 10.1159/000158960
   Mohiuddin M, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-394
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Morris AH, 2014, MATRIX BIOL, V37, P183, DOI 10.1016/j.matbio.2014.03.002
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Muller D., 2011, STEM CELLS INT, V2011
   Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016
   Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109
   Mustafa K, 2003, CLIN ORAL IMPLAN RES, V14, P50, DOI 10.1034/j.1600-0501.2003.140107.x
   Nair A, 2008, LANGMUIR, V24, P2015, DOI 10.1021/la7025973
   Nakayama T, 2004, J CLIN INVEST, V114, P1317, DOI 10.1172/JCI200422089
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661
   Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nimeri G, 2003, J BIOMED MATER RES A, V67A, P439, DOI 10.1002/jbm.a.10081
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P573, DOI 10.1163/156856294X00527
   Nonckreman CJ, 2010, COLLOID SURFACE B, V77, P139, DOI 10.1016/j.colsurfb.2010.01.014
   Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200
   Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363
   Oosting M, 2014, P NATL ACAD SCI USA, V111, pE4478, DOI 10.1073/pnas.1410293111
   Oppenheim JJ, 2007, ADV EXP MED BIOL, V601, P185
   Oviedo-Socarras T, 2014, MICROVASC RES, V93, P23, DOI 10.1016/j.mvr.2014.02.011
   PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0
   Palod PA, 2014, APPL BIOCHEM BIOTECH, V174, P1059, DOI 10.1007/s12010-014-0988-x
   Papenburg BJ, 2010, SOFT MATTER, V6, P4377, DOI 10.1039/b927207k
   Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005
   Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200
   Park TH, 2012, AESTHET PLAST SURG, V36, P421, DOI 10.1007/s00266-011-9803-z
   Pazyar N, 2012, CURR CLIN PHARMACOL, V7, P271, DOI 10.2174/157488412803305821
   PERALTA O, 1995, J STEROID BIOCHEM, V53, P223, DOI 10.1016/0960-0760(95)00051-Z
   Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195
   Piccinini AM, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/672395
   Pietrella D, 2013, EUR J IMMUNOL, V43, P679, DOI 10.1002/eji.201242691
   Pitsch RJ, 1997, J VASC SURG, V26, P70, DOI 10.1016/S0741-5214(97)70149-6
   Provoost S, 2011, J IMMUNOL, V187, P3331, DOI 10.4049/jimmunol.1004062
   Py BF, 2014, CELL REP, V6, P1122, DOI 10.1016/j.celrep.2014.02.015
   Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045
   Rahmany MB, 2013, ACTA BIOMATER, V9, P5431, DOI 10.1016/j.actbio.2012.11.019
   Rankin AL, 2010, J IMMUNOL, V184, P1526, DOI 10.4049/jimmunol.0903306
   Ranzato E, 2010, CELL BIOCHEM BIOPHYS, V57, P9, DOI 10.1007/s12013-010-9077-0
   Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ratner BD, 2011, J CARDIOVASC TRANSL, V4, P523, DOI 10.1007/s12265-011-9287-x
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Reisetter AC, 2011, J BIOL CHEM, V286, P21844, DOI 10.1074/jbc.M111.238519
   Rezzani R, 2004, ARCH HISTOL CYTOL, V67, P211, DOI 10.1679/aohc.67.211
   Ribatti D, 2012, BBA-MOL BASIS DIS, V1822, P2, DOI 10.1016/j.bbadis.2010.11.010
   Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153
   ROCHE WR, 1985, INT J CANCER, V36, P721, DOI 10.1002/ijc.2910360617
   Rodriguez A, 2008, J BIOMED MATER RES A, V85A, P556, DOI 10.1002/jbm.a.31562
   Rodriguez A, 2010, J BIOMED MATER RES A, V92A, P214, DOI 10.1002/jbm.a.32362
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Rogers TH, 2010, BIOMATERIALS, V31, P594, DOI 10.1016/j.biomaterials.2009.09.077
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Rouhiainen A, 2004, BLOOD, V104, P1174, DOI 10.1182/blood-2003-10-3536
   Rowe SM, 2008, AM J RESP CRIT CARE, V178, P822, DOI 10.1164/rccm.200712-1894OC
   Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004
   Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858
   Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Secott TE, 2004, INFECT IMMUN, V72, P3724, DOI 10.1128/IAI.72.7.3724-3732.2004
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Shen EC, 2006, CLIN ORAL IMPLAN RES, V17, P572, DOI 10.1111/j.1600-0501.2005.01241.X
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Sivaraman B, 2009, LANGMUIR, V25, P3050, DOI 10.1021/la8036814
   Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887
   Smith Kevin Christopher, 2008, Dermatol Online J, V14, P3
   Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706
   Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060
   Soskolne WA, 2002, CLIN ORAL IMPLAN RES, V13, P86, DOI 10.1034/j.1600-0501.2002.130111.x
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Stehlik C, 2007, J IMMUNOL, V179, P7993, DOI 10.4049/jimmunol.179.12.7993
   Suehiro K, 2000, J BIOCHEM-TOKYO, V128, P705, DOI 10.1093/oxfordjournals.jbchem.a022804
   Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053
   Szott LM, 2011, CURR OPIN CHEM BIOL, V15, P677, DOI 10.1016/j.cbpa.2011.04.021
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Tamaki Y, 2009, J RHEUMATOL, V36, P598, DOI 10.3899/jrheum.080390
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Tang LP, 1998, J BIOMAT SCI-POLYM E, V9, P1257
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Teunissen AM, 2014, EUR J CONTRACEP REPR, V19, P15, DOI 10.3109/13625187.2013.862231
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thompson JK, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-24
   TREZZINI C, 1988, BIOCHEM BIOPH RES CO, V156, P477, DOI 10.1016/S0006-291X(88)80866-0
   Tsuchiya K, 2014, EUR J IMMUNOL, V44, P3696, DOI 10.1002/eji.201444673
   Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244
   Valladares RD, 2014, J BIOMED MATER RES A, V102, P3004, DOI 10.1002/jbm.a.34972
   Vanni S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5916
   Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600
   Vieira EP, 2009, LANGMUIR, V25, P9879, DOI 10.1021/la9009948
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102
   VROMAN L, 1980, BLOOD, V55, P156
   Wahamaa H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3450
   Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248
   Wegiel B, 2014, J CLIN INVEST, V124, P4926, DOI 10.1172/JCI72853
   Wettero J, 2000, J BIOMED MATER RES, V51, P742, DOI 10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D
   Wiegering Verena, 2014, BMC Hematol, V14, P18, DOI 10.1186/2052-1839-14-18
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Winter M, 2011, NANOTOXICOLOGY, V5, P326, DOI 10.3109/17435390.2010.506957
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Yang D, 2013, EUR J IMMUNOL, V43, P1412, DOI 10.1002/eji.201243138
   Yang EJ, 2012, BIOMATERIALS, V33, P6858, DOI 10.1016/j.biomaterials.2012.06.016
   Yang J, 2014, J BIOMED MATER RES A, V102, P2017, DOI 10.1002/jbm.a.35152
   Yaseen M, 2010, BIOMATERIALS, V31, P3781, DOI 10.1016/j.biomaterials.2010.01.107
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   YOKOYAMA M, 1986, J BIOMED MATER RES, V20, P867, DOI 10.1002/jbm.820200702
   Zafiropoulos GG, 2014, J ORAL IMPLANTOL, V40, P271, DOI 10.1563/AAID-JOI-D-11-00048
   ZANETTI A, 1994, BLOOD, V84, P1116
   Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zhang Q, 2012, J SURG RES, V176, P343, DOI 10.1016/j.jss.2011.06.069
   Zhang WJ, 2013, J CLIN IMMUNOL, V33, P925, DOI 10.1007/s10875-013-9881-6
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831
NR 345
TC 15
Z9 16
U1 3
U2 31
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 342304
DI 10.1155/2015/342304
PG 23
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CN5VE
UT WOS:000358498700001
PM 26247017
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ren, B
   Zhai, ZB
   Guo, K
   Liu, YP
   Hou, WH
   Zhu, QS
   Zhu, JY
AF Ren, Bo
   Zhai, Zhenbo
   Guo, Kai
   Liu, Yanpu
   Hou, Weihuan
   Zhu, Qingsheng
   Zhu, Jinyu
TI The application of porous tantalum cylinder to the repair of comminuted
   bone defects: a study of rabbit firearm injuries
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Firearm injury; tibial defect; porous tantalum
ID SCAFFOLDS; INGROWTH; IMPLANT; MODEL; GRAFT; MANAGEMENT; INFECTION;
   SURGERY
AB The aim of this study is to investigate the effect of porous tantalum material in repair tibial defects caused by firearm injuries in a rabbit model. A multifunctional biological impact machine was used to establish a rabbit tibial defect model of firearm injury. Porous tantalum rods were processed into a hollow cylinder. Kirschner wires were used for intramedullary fixation. We compared the differences of the bone ingrowth of the porous tantalum material by gross observations, X-rays and histological evaluations. The radiographic observations revealed that fibrous tissue covered the material surface after 4 weeks, and periosteal reactions and new bone callus extending materials appeared after 8 weeks. After 16 weeks, the calluses of the firearm injury group were completely wrapped around a porous tantalum material. The group with the highest Lane-Sandhu X-rays cores was the firearm injury and tantalum implant group, and the blank control group exhibited the lowest scores. The histological evaluations revealed that the presence of new bone around the biomaterial had grown into the porous tantalum. By the 16th week, the areas of bone tissue of the firearm injury group was significant higher than that of non-firearm injury group (P<0.05). The comminuted fractures treated with tantalum cylinders exhibited greater bone ingrowth in the firearm injury group. In conditions of firearm injuries, the porous tantalum biomaterial exhibited bone ingrowth that was beneficial to the treatment of bone defects.
C1 [Ren, Bo; Guo, Kai; Zhu, Qingsheng; Zhu, Jinyu] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Shaanxi, Peoples R China.
   [Ren, Bo] Xian Honghui Hosp, Dept Orthopaed, Xian, Shaanxi, Peoples R China.
   [Zhai, Zhenbo] Shanxi Prov Canc Hosp, Dept Gynecol Oncol, Xian, Shaanxi, Peoples R China.
   [Liu, Yanpu] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Shaanxi, Peoples R China.
   [Hou, Weihuan] Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Shaanxi, Peoples R China.
RP Zhu, JY (reprint author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, 127 Changle Western Rd, Xian 710032, Shaanxi, Peoples R China.
EM zhuqsh@fmmu.edu.cn; zhujinyu@fmmu.edu.cn
CR Adams JE, 2005, J HAND SURG-AM, V30A, P1128, DOI 10.1016/j.jhsa.2005.08.008
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bullens PHJ, 2010, INJURY, V41, P1284, DOI 10.1016/j.injury.2010.07.247
   Bullens PHJ, 2010, J BIOMED MATER RES B, V92B, P24, DOI 10.1002/jbm.b.31485
   Bullens PHJ, 2009, CLIN ORTHOP RELAT R, V467, P783, DOI 10.1007/s11999-008-0686-5
   Chou TGR, 2010, J BIOMED MATER RES A, V92A, P942, DOI 10.1002/jbm.a.32413
   Frank M, 2013, ACTA CHIR ORTHOP TR, V80, P197
   Frigg A, 2010, CLIN ORTHOP RELAT R, V468, P209, DOI 10.1007/s11999-009-0948-x
   Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.001
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Li BC, 2009, J TRAUMA, V66, P450, DOI 10.1097/TA.0b013e3181848cd6
   [刘彦普 Liu Yanpu], 2003, [实用口腔医学杂志, Journal of Practical Stomatology], V19, P269
   LIU YQ, 1988, J TRAUMA, V28, pS95, DOI 10.1097/00005373-198801001-00021
   Maiden N, 2009, FORENSIC SCI MED PAT, V5, P204, DOI 10.1007/s12024-009-9096-6
   Mattila VM, 2006, J TRAUMA, V61, P1222, DOI 10.1097/01.ta.0000197179.50226.1d
   Mrosek EH, 2010, J ORTHOP RES, V28, P141, DOI 10.1002/jor.20983
   Patil N, 2009, J BIOMED MATER RES B, V89B, P242, DOI 10.1002/jbm.b.31198
   Poultsides LA, 2008, J ORTHOP RES, V26, P1355, DOI 10.1002/jor.20608
   Ramrattan NN, 2005, TISSUE ENG, V11, P1212, DOI 10.1089/ten.2005.11.1212
   Tian L, 2009, J TRAUMATIC SURG, V11, P438
   Tosti R, 2013, ORTHOP CLIN N AM, V44, P529, DOI 10.1016/j.ocl.2013.06.006
   van der Stok J, 2013, TISSUE ENG PT A, V19, P2605, DOI [10.1089/ten.tea.2013.0181, 10.1089/ten.TEA.2013.0181]
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   Yavari SA, 2013, MAT SCI ENG C-MATER, V33, P4849, DOI 10.1016/j.msec.2013.08.006
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 27
TC 2
Z9 4
U1 0
U2 6
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2015
VL 8
IS 4
BP 5055
EP 5064
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CN4CV
UT WOS:000358377700030
PM 26131078
DA 2018-10-20
ER

PT J
AU Zhang, L
   Qian, JS
   Fan, YJ
   Feng, W
   Tao, Z
   Yang, HY
AF Zhang, Lei
   Qian, Jiasheng
   Fan, Yujiao
   Feng, Wei
   Tao, Zhen
   Yang, Haiyang
TI A facile CO2 switchable nanocomposite with reversible transition from
   sol to self-healable hydrogel
SO RSC ADVANCES
LA English
DT Article
ID SURFACTANTS; CHEMISTRY; LAPONITE; CLAY
AB In this paper, we report a CO2/N-2-switchable sol to gel transition system based on a triblock copolymer of dimethylaminoethyl methacrylate (DMAEMA) and ethylene oxide (EO), with a measured composition DMAEMA(6)-EO109-DMAEMA(6), in aqueous nanoclay dispersions. LAPONITE (R) is exfoliated and stabilized by Pluronic F127. The aqueous mixture exhibits a strong response to CO2, changing from a low viscous sol to a self-healable gel. In the presence of CO2, the PDMAEMA blocks are protonated and the positive charged triblock copolymer bridge the negative charged nanoclays, formation of a physical network. As a consequence, a sol to gel transition is observed at the macro level. Upon removal of CO2 through bubbling with N-2, a corresponding gel to sol transition occurs due to the deconstruction of the physical network, which is a result of the departure of the deprotonated PDMAEMA blocks from the nanoclays. This sol to gel transition is fully reversible. Furthermore, the formed gel possesses excellent self-healing ability, meaning that this hydrogel is capable of autonomous healing upon damage. Thus, we believe the fundamentals of the present CO2-responsive smart hydrogel may hold promise for a wide range of areas, such as intelligent delivery systems and smart biomaterial fields, or a potential CO2 plugging agent for enhanced oil recovery (EOR) performed by CO2 flooding.
C1 [Zhang, Lei; Fan, Yujiao; Feng, Wei; Tao, Zhen; Yang, Haiyang] Univ Sci & Technol China, Dept Polymer Sci & Engn, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.
   [Zhang, Lei; Qian, Jiasheng] Anhui Univ, Dept Chem & Chem Engn, Hefei 230000, Peoples R China.
RP Yang, HY (reprint author), Univ Sci & Technol China, Dept Polymer Sci & Engn, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.
EM yhy@ustc.edu.cn
RI Feng, Wei/L-8814-2014
OI Feng, Wei/0000-0001-8715-0113; TAO, ZHEN/0000-0002-6298-2877
FU National Natural Science Foundation of China [51273189]; National
   Science and Technology Major Project of the Ministry of Science and
   Technology of China [2011ZX05010-003]; Petro China Innovation Foundation
   [2012D-5006-0202]; China Postdoctoral Science Foundation [2013M531513]
FX This work was supported by the National Natural Science Foundation of
   China (Grant no. 51273189), the National Science and Technology Major
   Project of the Ministry of Science and Technology of China
   (2011ZX05010-003), Petro China Innovation Foundation (2012D-5006-0202),
   and China Postdoctoral Science Foundation funded project (no.
   2013M531513).
CR Bonino CA, 2011, SOFT MATTER, V7, P11510, DOI 10.1039/c1sm06109g
   Dawson JI, 2013, ADV MATER, V25, P4069, DOI 10.1002/adma.201301034
   Han D, 2011, ACS MACRO LETT, V1, P57
   Hao X, 2013, J MATER CHEM A, V1, P6920, DOI 10.1039/c3ta10285h
   Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9
   Herrera NN, 2004, LANGMUIR, V20, P1564, DOI 10.1021/la0349267
   Hu ZQ, 2013, RSC ADV, V3, P12021, DOI 10.1039/c3ra42425a
   Jessop PG, 2005, NATURE, V436, P1102, DOI 10.1038/4361102a
   Jessop PG, 2012, ENERG ENVIRON SCI, V5, P7240, DOI 10.1039/c2ee02912j
   Jessop PG, 2010, GREEN CHEM, V12, P809, DOI 10.1039/b926885e
   Lamont RE, 1998, J AM CHEM SOC, V120, P7602, DOI 10.1021/ja9742895
   Lin SJ, 2013, MACROMOL RAPID COMM, V34, P1118, DOI 10.1002/marc.201300288
   Liu MJ, 2015, NATURE, V517, P68, DOI 10.1038/nature14060
   Liu YX, 2006, SCIENCE, V313, P958, DOI 10.1126/science.1128142
   Nagai D, 2011, CHEM COMMUN, V47, P8856, DOI 10.1039/c1cc12084k
   Nelson A, 2005, LANGMUIR, V21, P9176, DOI 10.1021/la050680p
   Ning JY, 2013, MACROMOLECULES, V46, P5317, DOI 10.1021/ma4009059
   Qian Y, 2014, GREEN CHEM, V16, P4963, DOI 10.1039/c4gc01242a
   Rudkevich DM, 2004, ANGEW CHEM INT EDIT, V43, P558, DOI 10.1002/anie.200300606
   Sun YL, 2010, COLLOID POLYM SCI, V288, P997, DOI 10.1007/s00396-010-2225-7
   van Olphen H., 1977, INTRO CLAY COLLOID C
   Wu YT, 2009, J MATER CHEM, V19, P7340, DOI 10.1039/b909125d
   Yan B, 2013, SOFT MATTER, V9, P2011, DOI 10.1039/c2sm27469h
   Yan Q., 2011, ANGEW CHEM, V123, P5025, DOI DOI 10.1002/ANGE.201100708
NR 24
TC 5
Z9 5
U1 7
U2 83
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 76
BP 62229
EP 62234
DI 10.1039/c5ra10597h
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA CN3UO
UT WOS:000358353100088
DA 2018-10-20
ER

PT J
AU Leiviska, T
   Keranen, A
   Vainionpaa, N
   Al Amir, J
   Hormi, O
   Tanskanen, J
AF Leiviska, T.
   Keranen, A.
   Vainionpaa, N.
   Al Amir, J.
   Hormi, O.
   Tanskanen, J.
TI Vanadium(V) removal from aqueous solution and real wastewater using
   quaternized pine sawdust
SO WATER SCIENCE AND TECHNOLOGY
LA English
DT Article
DE biomaterial; chemical modification; strong anion exchanger; vanadate
ID METAL SPECIATION; RECOVERY; CHITOSAN; SORPTION; IONS
AB Cross-linked and quaternized pine sawdust was tested for vanadium removal from a synthetic aqueous solution as well as from real industrial wastewater which had a considerable amount of vanadium and other ions such as sulphate, ammonium and nickel. The maximum vanadium sorption capacity of the modified pine sawdust was found to be 130 mg/g in synthetic solution and 103 mg/g in real wastewater. Modified pine sawdust worked well over a wide range of pH. Column studies with real wastewater proved that vanadium was efficiently desorbed from the material with 2 M NaOH and that the material could be reused.
C1 [Leiviska, T.; Keranen, A.; Vainionpaa, N.; Al Amir, J.; Tanskanen, J.] Univ Oulu, Chem Proc Engn, FIN-90014 Oulu, Finland.
   [Hormi, O.] Univ Oulu, Dept Chem, FIN-90014 Oulu, Finland.
RP Leiviska, T (reprint author), Univ Oulu, Chem Proc Engn, POB 4300, FIN-90014 Oulu, Finland.
EM tiina.leiviska@oulu.fi
FU Maj and Tor Nessling Foundation; Maa- ja vesitekniikan tuki ry
FX This work was financially supported by the Maj and Tor Nessling
   Foundation and Maa- ja vesitekniikan tuki ry.
CR [Anonymous], 1980, 3047 SFS
   [Anonymous], 2009, 103041 SFSEN
   [Anonymous], 1990, 5047 SFS
   [Anonymous], 1997, 13395 SFSEN ISO
   [Anonymous], 2005, 11732 SFSEN ISO
   ATSDR-Agency for Toxic Substances and Disease Registry, 2012, TOX PROF VAN
   Dowex, 2014, ION EXCH RES WAT CON
   Guzman J, 2002, LANGMUIR, V18, P1567, DOI 10.1021/la010802n
   Keranen A., 2015, DESALIN WATER TREAT, V53, P2645
   Keranen A, 2013, CHEM ENG SCI, V98, P59, DOI 10.1016/j.ces.2013.05.007
   Lazaridis NK, 2003, SEPAR SCI TECHNOL, V38, P2201, DOI 10.1081/SS-120021620
   Min XB, 2009, T NONFERR METAL SOC, V19, P1360, DOI 10.1016/S1003-6326(08)60450-1
   Naeem A, 2007, WATER RES, V41, P1596, DOI 10.1016/j.watres.2007.01.002
   Namasivayam C, 2006, ADSORPTION, V12, P103, DOI 10.1007/s10450-006-0373-3
   Navarro R, 2003, MACROMOL BIOSCI, V3, P552, DOI 10.1002/mabi.200300013
   Ro CU, 1999, ANAL CHEM, V71, P1521, DOI 10.1021/ac981070f
   Roccaro P., 2008, QUAL WAT RES EXP PER
   Wang WY, 2010, CHEM ENG J, V157, P161, DOI 10.1016/j.cej.2009.11.024
   Xu X, 2013, CARBOHYD POLYM, V98, P132, DOI 10.1016/j.carbpol.2013.05.058
   Xu X, 2010, CARBOHYD POLYM, V82, P1212, DOI 10.1016/j.carbpol.2010.06.053
   Yeom BY, 2009, J HAZARD MATER, V166, P415, DOI 10.1016/j.jhazmat.2008.11.032
NR 21
TC 6
Z9 7
U1 1
U2 8
PU IWA PUBLISHING
PI LONDON
PA ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H0QS, ENGLAND
SN 0273-1223
EI 1996-9732
J9 WATER SCI TECHNOL
JI Water Sci. Technol.
PY 2015
VL 72
IS 3
BP 437
EP 442
DI 10.2166/wst.2015.227
PG 6
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA CN7GX
UT WOS:000358603500013
PM 26204076
DA 2018-10-20
ER

PT S
AU Kien, PT
   Kanji, T
   Ishikawa, K
AF Pham Trung Kien
   Kanji, Tsuru
   Ishikawa, Kunio
BE VanToi, V
   Phuong, THL
TI Development and Characterization of Porous Calcium Phosphate Cement
   Using alpha-Tricalcium Phosphate Bead
SO 5TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING IN VIETNAM
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 5th International Conference on the Development of Biomedical
   Engineering in Vietnam
CY JUN 16-18, 2014
CL Ho Chi Minh City, VIETNAM
SP Vietnam Natl Univ, Int Univ Vietnam Natl Univ, Arizona State Univ, ViKOmed, Trung Son Sci Equipment, SAIGON SCIENTISTS, USN Global, Off Naval Res, Sci & Technol, Natl Instruments, U S ARMY RDECOM, Univ Alberta, ITS Vietnam, SAIGON ISG, SPIE
DE alpha-TCP; brushite; apatite; porous cement; setting reaction
AB Interconnected set porous-calcium phosphate cement (set porous-CPC), which has fully interconnected pores could be an ideal bone substitute. In this study, set porous-CPC consisting of alpha-tricalcium phosphate (alpha-TCP) beads and acidic calcium phosphate solution was developed and its basic setting reaction was studied. When alpha-TCP beads were exposed to the acidic calcium phosphate solution, brushite (CaHPO4 center dot 2H(2)O) was formed on the surface of the alpha-TCP beads. The formed brushite crystals interlocked with each other, resulting in a setting reaction of alpha-TCP microspheres within 10 min at 37 degrees C. As a result of this setting reaction, a fully-interconnected calcium phosphate macroporous structure was obtained. The set porous-CPC were immersed into simulated body fluid (SBF) at 37oC for different immersion time, The result clearly showed that brushite surface layer transformed to apatite layer after 3 days immersion into SBF solution by dissolution-precipitation reaction. Since apatite layer show excellent tissue response, the set porous-CPC would be a promising biomaterial used as artificial bone substitutes, and as the scaffold for tissue engineering.
C1 [Pham Trung Kien] Ho Chi Minh Univ Technol, Dept Ceram Mat, Ho Chi Minh City, Vietnam.
   [Kanji, Tsuru; Ishikawa, Kunio] Kyushu Univ, Dept Biomat, Fukuoka 812, Japan.
RP Kien, PT (reprint author), Ho Chi Minh Univ Technol, Dept Ceram Mat, Ho Chi Minh City, Vietnam.
CR Brown WE, 1986, J AM CERAM SOC, P352
   Burguera EF, 2006, J BIOMED MATER RES B, V77B, P126, DOI 10.1002/jbm.b.30403
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kunio I, 2012, KEY ENG MATER, V493-494, P832
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P634, DOI 10.1016/0142-9612(89)90120-8
   Monma H., 1976, J CERAM SOC JPN, V84, P209
   Pham TK, 2010, J AUSTR CERAMIC SOC, V46, P63
   Real RP, 2002, BIOMATERIALS, V23, P3673
NR 9
TC 0
Z9 0
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-319-11776-8; 978-3-319-11775-1
J9 IFMBE PROC
PY 2015
VL 46
BP 507
EP 510
DI 10.1007/978-3-319-11776-8_125
PG 4
WC Engineering, Biomedical
SC Engineering
GA BD0WM
UT WOS:000357778100125
DA 2018-10-20
ER

PT J
AU Lozano-Perez, AA
   Gil, AL
   Perez, SA
   Cutillas, N
   Meyer, H
   Pedreno, M
   Aznar-Cervantes, SD
   Janiak, C
   Cenis, JL
   Ruiz, J
AF Abel Lozano-Perez, A.
   Gil, Ana L.
   Perez, Sergio A.
   Cutillas, Natalia
   Meyer, Hajo
   Pedreno, Monica
   Aznar-Cervantes, Salvador D.
   Janiak, Christoph
   Cenis, Jose Luis
   Ruiz, Jose
TI Antitumor properties of platinum(IV) prodrug-loaded silk fibroin
   nanoparticles
SO DALTON TRANSACTIONS
LA English
DT Article
ID PLGA-PEG NANOPARTICLES; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; TARGETED
   DELIVERY; ANTICANCER DRUGS; CANCER-THERAPY; PT(IV) PRODRUG;
   SERUM-ALBUMIN; CISPLATIN; RESISTANCE
AB Platinum(IV) complexes take advantage of the exclusive conditions that occur within the tumor to carry out their cytotoxic activity. On the other hand, silk fibroin has natural properties which make it very interesting as a biomaterial: high biocompatibility, biodegradability, low immunogenicity, high cellular penetration capacity and high reactive surface. Herein we report the preparation of silk fibroin nanoparticles (SFNs) loaded with the hydrophobic Pt(IV) complex cis,cis,trans-[Pt(NH3)(2)Cl-2(O2CC6H5)(2)] (PtBz). Only a small fraction of the loaded PtBz is released (less than 10% after 48 h). PtBz-SFNs trigger strong cytotoxic effects against human ovarian carcinoma A2780 cells and their cisplatin-resistant variant A2780cisR cells. Interestingly, PtBz-SFNs are very cytotoxic (nanomolar IC50 values) toward the triple negative breast tumor cell line MDA-MB-231, and also toward SK-BR-3 and MCF-7, while maintaining an excellent selectivity index.
C1 [Abel Lozano-Perez, A.; Aznar-Cervantes, Salvador D.; Cenis, Jose Luis] Inst Murciano Invest & Desarrollo Agr & Alimentar, E-30150 Murcia, Spain.
   [Gil, Ana L.; Perez, Sergio A.; Cutillas, Natalia; Pedreno, Monica; Ruiz, Jose] Univ Murcia, Dept Quim Inorgan, E-30071 Murcia, Spain.
   [Gil, Ana L.; Perez, Sergio A.; Cutillas, Natalia; Pedreno, Monica; Ruiz, Jose] IMIB Arrixaca, E-30071 Murcia, Spain.
   [Meyer, Hajo; Janiak, Christoph] Univ Dusseldorf, Inst Anorgan Chem & Strukturchem, D-40204 Dusseldorf, Germany.
RP Ruiz, J (reprint author), Univ Murcia, Dept Quim Inorgan, E-30071 Murcia, Spain.
EM jrui@um.es
RI Ruiz, Jose/B-8271-2008; Lozano Perez, Antonio Abel/B-4373-2013;
   Cutillas, Natalia/L-6501-2014; Janiak, Christoph/A-6021-2013
OI Ruiz, Jose/0000-0002-0834-337X; Lozano Perez, Antonio
   Abel/0000-0002-5749-3737; Cutillas, Natalia/0000-0002-1158-9303; Janiak,
   Christoph/0000-0002-6288-9605; AZNAR CERVANTES,
   SALVADOR/0000-0001-9809-7215
FU Spanish Ministerio de Economia y Competitividad; FEDER/ERDF
   [SAF2011-26611]; Fundacion Seneca-CARM [15354/PI/10]; FEDER/ERDF of the
   Region of Murcia
FX This work was supported by the Spanish Ministerio de Economia y
   Competitividad and FEDER/ERDF (Project SAF2011-26611) and by Fundacion
   Seneca-CARM (Project 15354/PI/10). COST CM1105 for providing
   opportunities of discussion and Dr Ignacio Lopez for AAS assistance are
   also acknowledged. Dr A. Abel Lozano-Perez's research contract was
   partially supported (80%) by the FEDER/ERDF of the Region of Murcia
   2007-2013.
CR Ang WH, 2005, J AM CHEM SOC, V127, P1382, DOI 10.1021/ja0432618
   BRANDON RJ, 1984, J MED CHEM, V27, P861, DOI 10.1021/jm00373a009
   Cabral H, 2011, ACCOUNTS CHEM RES, V44, P999, DOI 10.1021/ar200094a
   Chen MJ, 2012, J BIOMED MATER RES A, V100A, P203, DOI 10.1002/jbm.a.33265
   Chen T. R., 1975, TCA MANUAL, V1, P229
   Della Rocca J, 2011, ACCOUNTS CHEM RES, V44, P957, DOI 10.1021/ar200028a
   Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105
   Dhar S, 2011, P NATL ACAD SCI USA, V108, P1850, DOI 10.1073/pnas.1011379108
   Dhar S, 2009, P NATL ACAD SCI USA, V106, P22199, DOI 10.1073/pnas.0912276106
   Fuertes MA, 2003, CHEM REV, V103, P645, DOI 10.1021/cr020010d
   Graf N, 2012, ADV DRUG DELIVER REV, V64, P993, DOI 10.1016/j.addr.2012.01.007
   Graf N, 2012, ACS NANO, V6, P4530, DOI 10.1021/nn301148e
   Gu Y, 2014, BIOMATERIALS, V35, P2253, DOI 10.1016/j.biomaterials.2013.11.087
   Hall MD, 2007, J MED CHEM, V50, P3403, DOI 10.1021/jm070280u
   Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139
   Kamaly N, 2012, CHEM SOC REV, V41, P2971, DOI 10.1039/c2cs15344k
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167
   Kelland LR, 2000, DRUGS, V59, P1, DOI 10.2165/00003495-200059004-00001
   Kolishetti N, 2010, P NATL ACAD SCI USA, V107, P17939, DOI 10.1073/pnas.1011368107
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Li J, 2012, CHEM SCI, V3, P2083, DOI 10.1039/c2sc01086k
   Lu Q, 2011, ACTA BIOMATER, V7, P2782, DOI 10.1016/j.actbio.2011.03.001
   Maldonado CR, 2013, COORDIN CHEM REV, V257, P2668, DOI 10.1016/j.ccr.2013.04.014
   Mathur AB, 2010, NANOMEDICINE-UK, V5, P807, DOI 10.2217/NNM.10.51
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Min YZ, 2014, ANGEW CHEM INT EDIT, V53, P1012, DOI 10.1002/anie.201308834
   Min YZ, 2012, ANGEW CHEM INT EDIT, V51, P6742, DOI 10.1002/anie.201201562
   Moreno D, 2010, EUR J PHARM BIOPHARM, V74, P265, DOI 10.1016/j.ejpb.2009.10.005
   Oberoi HS, 2013, ADV DRUG DELIVER REV, V65, P1667, DOI 10.1016/j.addr.2013.09.014
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Ozgur A, 2012, INT J PHARMACEUT, V422, P472, DOI 10.1016/j.ijpharm.2011.11.013
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Prabhakar U., 2013, CANCER RES, V73, P2417
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Qu J, 2014, MAT SCI ENG C-MATER, V44, P166, DOI 10.1016/j.msec.2014.08.034
   Seib FP, 2013, ADV HEALTHC MATER, V2, P1606, DOI 10.1002/adhm.201300034
   Shi PJ, 2013, BIOMATERIALS, V34, P5947, DOI 10.1016/j.biomaterials.2013.04.046
   SIAMWIZA MN, 1975, BIOCHEMISTRY-US, V14, P4870, DOI 10.1021/bi00693a014
   Subia B, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/3/035103
   Subia B, 2014, INTEGR BIOL-UK, V6, P203, DOI 10.1039/c3ib40184g
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011
   Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691
   Zhang W, 2013, BIOMATERIALS, V34, P6046, DOI 10.1016/j.biomaterials.2013.04.055
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
   Zheng YR, 2014, J AM CHEM SOC, V136, P8790, DOI 10.1021/ja5038269
NR 48
TC 10
Z9 10
U1 11
U2 42
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-9226
EI 1477-9234
J9 DALTON T
JI Dalton Trans.
PY 2015
VL 44
IS 30
BP 13513
EP 13521
DI 10.1039/c5dt00378d
PG 9
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA CN1VM
UT WOS:000358208400016
PM 25799077
DA 2018-10-20
ER

PT J
AU Wen, XX
   Zheng, YD
   Wu, J
   Wang, LN
   Yuan, ZY
   Peng, J
   Meng, HY
AF Wen, Xiaoxiao
   Zheng, Yudong
   Wu, Jian
   Wang, Lu-Ning
   Yuan, Zhenya
   Peng, Jiang
   Meng, Haoye
TI Immobilization of collagen peptide on dialdehyde bacterial cellulose
   nanofibers via covalent bonds for tissue engineering and regeneration
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE bacterial cellulose; dialdehyde cellulose; collagen peptide; composite
   materials; cytoactivity
ID DRUG-DELIVERY-SYSTEMS; CROSS-LINKING; IN-VITRO; DISSOLUTION PROFILES;
   AMINO-ACID; PART 1; SCAFFOLDS; POLYSACCHARIDES; ADSORPTION; STABILITY
AB Bacterial cellulose (BC) is an alternative nanostructured biomaterial to be utilized for a wide range of biomedical applications. Because of its low bioactivity, which restricted its practical application, collagen and collagen hydrolysate were usually composited into BC. It is necessary to develop a new method to generate covalent bonds between collagen and cellulose to improve the immobilization of collagen on BC. This study describes a facile dialdehyde BC/collagen peptide nanocomposite. BC was oxidized into dialdehyde bacterial cellulose (DBC) by regioselective oxidation, and then composited with collagen peptide (Col-p) via covalent bonds to form Schiff's base type compounds, which was demonstrated by the results of microstructures, contact angle, Col-p content, and peptide-binding ratio. The peptide-binding ratio was further affected by the degree of oxidation, pH value, and zeta potential. In vitro desorption measurement of Col-p suggested a controlled release mechanism of the nanocomposite. Cell tests indicated that the prepared DBC/Col-p composite was bioactive and suitable for cell adhesion and attachment. This work demonstrates that the DBC/Col-p composite is a promising material for tissue engineering and regeneration.
C1 [Wen, Xiaoxiao; Zheng, Yudong; Wang, Lu-Ning; Yuan, Zhenya] Univ Sci & Technol Beijing, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
   [Wu, Jian] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Suzhou, Peoples R China.
   [Peng, Jiang; Meng, Haoye] Chinese Peoples Liberat Army Gen Hosp, Inst Orthoped, Beijing, Peoples R China.
RP Zheng, YD (reprint author), Univ Sci & Technol Beijing, Sch Mat Sci & Engn, 30 Xueyuan Rd, Beijing 100083, Peoples R China.
EM zhengyudong@mater.ustb.edu.cn
FU National Natural Science Foundation of China [51473019, 51273021];
   National Science and Technology Support Project of China [2011BAK15B04];
   National Basic Research Program of China [2014CB542201]
FX This study is financially supported by the National Natural Science
   Foundation of China Project (Grant number 51473019 and Grant number
   51273021), the National Science and Technology Support Project of China
   (Grant number 2011BAK15B04), and the National Basic Research Program of
   China (Grant number 2014CB542201).
CR Acevedo-Jake AM, 2015, BIOMACROMOLECULES, V16, P145, DOI 10.1021/bm501281a
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   BOWES JH, 1968, BIOCHIM BIOPHYS ACTA, V168, P341, DOI 10.1016/0005-2795(68)90156-6
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Cai ZJ, 2011, J APPL POLYM SCI, V120, P2938, DOI 10.1002/app.33318
   CASSEL JM, 1949, J RES NAT BUR STAND, V42, P557, DOI 10.6028/jres.042.047
   Changez M, 2003, BIOMATERIALS, V24, P527, DOI 10.1016/S0142-9612(02)00364-2
   Cordova A, 2002, J AM CHEM SOC, V124, P1866, DOI 10.1021/ja017833p
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   d'Ayala GG, 2008, MOLECULES, V13, P2069, DOI 10.3390/molecules13092069
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Dugan JM, 2013, NANOMEDICINE-UK, V8, P287, DOI [10.2217/NNM.12.211, 10.2217/nnm.12.211]
   EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441
   Fathima NN, 2004, INT J BIOL MACROMOL, V34, P241, DOI 10.1016/j.ijbiomac.2004.05.004
   Fernandes R, 2006, BIOCHEM MOL BIOL EDU, V34, P294, DOI 10.1002/bmb.2006.494034042636
   Fuchs D, 2006, IND ENG CHEM RES, V45, P6578, DOI 10.1021/ie0602097
   Honary S, 2013, TROP J PHARM RES, V12, P255, DOI 10.4314/tjpr.v12i2.19
   JACKSON DS, 1957, BIOCHIM BIOPHYS ACTA, V26, P638, DOI 10.1016/0006-3002(57)90112-9
   Jung Y, 2012, J TISSUE ENG REGEN M, V6, P227
   Kanth SV, 2009, PROCESS BIOCHEM, V44, P869, DOI 10.1016/j.procbio.2009.04.008
   Kim UJ, 2000, BIOMACROMOLECULES, V1, P488, DOI 10.1021/bm0000337
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Larraneta E, 2014, J PHARM SCI-US, V103, P197, DOI 10.1002/jps.23774
   Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025
   Liu Y, 2011, J BIOMED MATER RES A, V99A, P485, DOI 10.1002/jbm.a.33209
   Luan JB, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/6/065006
   Luo HL, 2008, MATER CHEM PHYS, V110, P193, DOI 10.1016/j.matchemphys.2008.01.040
   Martinez H, 2012, J BIOMED MATER RES A, V100A, P948, DOI 10.1002/jbm.a.34035
   Mitsumori S, 2006, J AM CHEM SOC, V128, P1040, DOI 10.1021/ja056984f
   OLIVER RF, 1980, BRIT J EXP PATHOL, V61, P544
   Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029
   Paul DR, 2011, INT J PHARMACEUT, V418, P13, DOI 10.1016/j.ijpharm.2010.10.037
   Pretsch E., 2009, STRUCTURE DETERMINAT
   Rezwan K, 2004, LANGMUIR, V20, P10055, DOI 10.1021/la048459k
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Salgin S, 2012, INT J ELECTROCHEM SC, V7, P12404
   Saska S, 2012, J MATER CHEM, V22, P22102, DOI 10.1039/c2jm33762b
   Shebani AN, 2008, THERMOCHIM ACTA, V471, P43, DOI 10.1016/j.tca.2008.02.020
   Siepmann J, 2011, INT J PHARMACEUT, V418, P6, DOI 10.1016/j.ijpharm.2011.03.051
   SINGH M, 1982, BIOMATERIALS, V3, P16, DOI 10.1016/0142-9612(82)90055-2
   SUH J, 1994, BIOORG CHEM, V22, P318, DOI 10.1006/bioo.1994.1025
   Tan X, 2012, EXPERT OPIN DRUG DEL, V9, P1263, DOI 10.1517/17425247.2012.711756
   Wu J, 2014, RSC ADV, V4, P3998, DOI 10.1039/c3ra45407j
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yu SM, 2011, SOFT MATTER, V7, P7927, DOI 10.1039/c1sm05329a
NR 46
TC 10
Z9 12
U1 4
U2 56
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2015
VL 10
BP 4623
EP 4637
DI 10.2147/IJN.S84452
PG 15
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA CN2XC
UT WOS:000358284900001
PM 26229466
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wang, HY
   Jia, HR
   Lu, XL
   Chen, B
   Zhou, GX
   He, NY
   Chen, Z
   Wu, FG
AF Wang, Hong-Yin
   Jia, Hao-Ran
   Lu, Xiaolin
   Chen, Bo
   Zhou, Gaoxin
   He, Nongyue
   Chen, Zhan
   Wu, Fu-Gen
TI Imaging plasma membranes without cellular internalization: multisite
   membrane anchoring reagents based on glycol chitosan derivatives
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID IN-VIVO; POLYMERIC NANOPARTICLES; DNA HYBRIDIZATION; FLUORESCENT-PROBE;
   SERUM-ALBUMIN; LIVING CELLS; SURFACE; OLIGONUCLEOTIDES; ASSEMBLIES;
   ADHESION
AB Plasma membrane imaging has received substantial attention due to its capability for dynamically tracing significant biological processes including cell trafficking, vesicle transportation, apoptosis, etc. However, cellular internalization of staining molecules poses challenges to the development of fluorescent dyes to specifically label plasma membranes rather than intracellular organelles. In this work, glycol chitosan, a multifunctional biomaterial derived from natural polymers, was used for the first time to image the plasma membranes based on a strategy of multisite membrane anchoring. A glycol chitosan derivative, glycol chitosan-cholesterol-FITC (Chito-Chol-FITC), was synthesized by using glycol chitosan as the backbone, and PEG-cholesterols and FITC molecules as side chains. The cholesterol groups and FITC molecules serve as hydrophobic anchoring units and fluorescent units, respectively. Benefitting from the strategy, this molecular probe could rapidly stain the cell membrane within 5 min as well as effectively restrain the cellular uptake process-it could tolerate an incubation time of 6 h without substantial cellular internalization. Its imaging performance far exceeds that of the current commercial plasma membrane imaging reagents based on small molecules (such as DiD and FM families), which will be easily internalized by the cells within 10-15 min. The present work shows the biomacromolecular assembly of the glycol chitosan derivative on the cell surface, which may shed new light on the interactions of biomaterials with biological systems. Besides, the multisite membrane anchoring strategy developed herein also provides a novel platform for future cell surface engineering studies.
C1 [Wang, Hong-Yin; Jia, Hao-Ran; Lu, Xiaolin; Chen, Bo; Zhou, Gaoxin; He, Nongyue; Wu, Fu-Gen] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Chen, Zhan] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
RP Wu, FG (reprint author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
EM wufg@seu.edu.cn
RI Wu, Fu-Gen/B-1444-2009; Chen, Zhan/G-8312-2016; Wang,
   Hong-Yin/C-1423-2014
OI Wu, Fu-Gen/0000-0003-1773-2868; Chen, Zhan/0000-0001-8687-8348; 
FU National Key Basic Research Program of China (973 Program)
   [2010CB933903]; National Natural Science Foundation of China [21303017];
   Fundamental Research Funds for the Central Universities [2242014K10010];
   Scientific Research Foundation of Graduate School of Southeast
   University [YBJJ1412]; Graduate Students' Scientific Research Innovation
   Project of Jiangsu Province Ordinary University [CXZZ13 0122];
   University of Michigan
FX This work was supported by grants from the National Key Basic Research
   Program of China (973 Program) (No. 2010CB933903), the National Natural
   Science Foundation of China (21303017), the Fundamental Research Funds
   for the Central Universities (2242014K10010), the Scientific Research
   Foundation of Graduate School of Southeast University (YBJJ1412), and
   Graduate Students' Scientific Research Innovation Project of Jiangsu
   Province Ordinary University (No. CXZZ13 0122). ZC thanks the University
   of Michigan for supporting his sabbatical.
CR Altman MO, 2013, SCI REP-UK, V3, DOI [10.1038/srep03343, 10.1038/srep03343(2013)]
   Benkoski JJ, 2005, J PHYS CHEM B, V109, P9773, DOI 10.1021/jp044947p
   Borisenko G. G., 2008, NUCLEIC ACIDS RES, V37, pe28
   Bunge A, 2007, LANGMUIR, V23, P4455, DOI 10.1021/la063188u
   Chanana M, 2005, NANO LETT, V5, P2605, DOI 10.1021/nl0521219
   Chandra RA, 2006, ANGEW CHEM INT EDIT, V45, P896, DOI 10.1002/ANIE.200502421
   Chen MM, 2011, CARBOHYD POLYM, V84, P1244, DOI 10.1016/j.carbpol.2011.01.012
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Fakhrullin RF, 2012, CHEM SOC REV, V41, P4189, DOI 10.1039/c2cs15264a
   Gartner ZJ, 2009, P NATL ACAD SCI USA, V106, P4606, DOI 10.1073/pnas.0900717106
   Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108
   Germain M, 2006, BIOSENS BIOELECTRON, V21, P1566, DOI 10.1016/j.bios.2005.07.011
   Heek T, 2013, BIOCONJUGATE CHEM, V24, P153, DOI 10.1021/bc3005655
   Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050
   Hsiao SC, 2009, LANGMUIR, V25, P6985, DOI 10.1021/la900150n
   Inui O, 2010, ACS APPL MATER INTER, V2, P1514, DOI 10.1021/am100134v
   Jakobsen U, 2008, J AM CHEM SOC, V130, P10462, DOI 10.1021/ja8030054
   Jeong JH, 2013, J AM CHEM SOC, V135, P8770, DOI 10.1021/ja400636d
   Kamitani R, 2009, CHEMBIOCHEM, V10, P230, DOI 10.1002/cbic.200800621
   Kawamura R, 2013, LANGMUIR, V29, P6429, DOI 10.1021/la4012229
   Ke GL, 2014, ACS APPL MATER INTER, V6, P15329, DOI 10.1021/am503818n
   Kitamura N, 2013, BIOORGAN MED CHEM, V21, P7175, DOI 10.1016/j.bmc.2013.08.063
   Koo CK, 2009, INORG CHEM, V48, P7501, DOI 10.1021/ic9007679
   Kreder R, 2015, RSC ADV, V5, P22899, DOI 10.1039/c4ra16225k
   Krol S, 2006, NANO LETT, V6, P1933, DOI 10.1021/nl061049r
   Li M, 2014, CHEM-ASIAN J, V9, P3121, DOI 10.1002/asia.201402711
   Li N, 2008, BRAIN RES, V1215, P11, DOI 10.1016/j.brainres.2007.09.095
   Li XM, 2012, COLLOID SURFACE B, V92, P136, DOI 10.1016/j.colsurfb.2011.11.030
   Liu HP, 2011, ANGEW CHEM INT EDIT, V50, P7052, DOI 10.1002/anie.201101266
   Liu HP, 2010, CHEM-EUR J, V16, P3791, DOI 10.1002/chem.200901546
   Liu JS, 2012, CELL REP, V2, P1461, DOI 10.1016/j.celrep.2012.08.037
   Liu JS, 2012, TRENDS CELL BIOL, V22, P683, DOI 10.1016/j.tcb.2012.09.004
   Ma XC, 2014, J AM CHEM SOC, V136, P17734, DOI 10.1021/ja511656q
   Matsuda M, 2014, BIOCONJUGATE CHEM, V25, P2134, DOI 10.1021/bc500465j
   Mercier R, 2013, CELL, V152, P997, DOI 10.1016/j.cell.2013.01.043
   Luan NM, 2013, BIOMATERIALS, V34, P5019, DOI 10.1016/j.biomaterials.2013.03.041
   Palte MJ, 2012, J AM CHEM SOC, V134, P6218, DOI 10.1021/ja2106477
   Parveen S, 2008, J DRUG TARGET, V16, P108, DOI [10.1080/10611860701794353, 10.1080/10611860701794353 ]
   Patwa A, 2011, CHEM SOC REV, V40, P5844, DOI 10.1039/c1cs15038c
   Pereira P, 2013, MACROMOL BIOSCI, V13, P1369, DOI 10.1002/mabi.201300123
   Pfeiffer I, 2004, J AM CHEM SOC, V126, P10224, DOI 10.1021/ja048514b
   Qiu LP, 2014, J AM CHEM SOC, V136, P13090, DOI 10.1021/ja5047389
   Rabuka D, 2008, J AM CHEM SOC, V130, P5947, DOI 10.1021/ja710644g
   RAGNARSON B, 1992, HISTOCHEMISTRY, V97, P329, DOI 10.1007/BF00270034
   Ralston KS, 2014, NATURE, V508, P526, DOI 10.1038/nature13242
   Sakurai K, 2013, BIOMATERIALS, V34, P361, DOI 10.1016/j.biomaterials.2012.09.080
   Selden NS, 2012, J AM CHEM SOC, V134, P765, DOI 10.1021/ja2080949
   Shi GX, 2014, ADV HEALTHC MATER, V3, P142, DOI 10.1002/adhm.201300084
   Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109
   Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682
   Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053
   Teramura Y, 2010, SOFT MATTER, V6, P1081, DOI 10.1039/b913621e
   Tomita U, 2013, BIOTECHNOL BIOENG, V110, P2785, DOI 10.1002/bit.24933
   Veerabadran NG, 2007, MACROMOL BIOSCI, V7, P877, DOI 10.1002/mabi.200700061
   Wang B, 2014, ADV MATER, V26, P2371, DOI 10.1002/adma.201304593
   Wang B, 2013, POLYM CHEM-UK, V4, P5212, DOI 10.1039/c3py00097d
   Wang YS, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/14/145101
   Weber RJ, 2014, BIOMACROMOLECULES, V15, P4621, DOI 10.1021/bm501467h
   Wong Tin W, 2009, Recent Pat Drug Deliv Formul, V3, P8
   Xiong XL, 2013, ANGEW CHEM INT EDIT, V52, P1472, DOI 10.1002/anie.201207063
   Yhee JY, 2014, J CONTROL RELEASE, V193, P202, DOI 10.1016/j.jconrel.2014.05.009
   Yu JM, 2008, EUR POLYM J, V44, P555, DOI 10.1016/j.eurpolymj.2008.01.013
   Yu JM, 2009, J PHARM PHARMACOL, V61, P713, DOI [10.1211/jpp/61.06.0003, 10.1211/jpp.61.06.0003]
   Zhang CQ, 2014, ACS APPL MATER INTER, V6, P8971, DOI 10.1021/am5025897
   Zhang WD, 2013, BIOMATERIALS, V34, P6495, DOI 10.1016/j.biomaterials.2013.04.030
   Zhang XD, 2012, BIOMATERIALS, V33, P6408, DOI 10.1016/j.biomaterials.2012.05.047
   Zhang XF, 2014, ACS APPL MATER INTER, V6, P12372, DOI 10.1021/am503849c
   Zhang ZD, 2014, MOL CELL BIOCHEM, V385, P79, DOI 10.1007/s11010-013-1816-2
   Zhu CL, 2011, CHEM COMMUN, V47, P5524, DOI 10.1039/c0cc05158f
NR 69
TC 15
Z9 15
U1 4
U2 52
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 30
BP 6165
EP 6173
DI 10.1039/c5tb00930h
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CN3UC
UT WOS:000358351400004
DA 2018-10-20
ER

PT J
AU Kai, D
   Jiang, S
   Low, ZW
   Loh, XJ
AF Kai, Dan
   Jiang, Shan
   Low, Zhi Wei
   Loh, Xian Jun
TI Engineering highly stretchable lignin-based electrospun nanofibers for
   potential biomedical applications
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID THERMAL-PROPERTIES; MECHANICAL-PROPERTIES; PHYSICAL-PROPERTIES;
   POLYPROPYLENE COMPOSITES; POLYMER COMPOSITES; GRAFT-COPOLYMERS;
   STEM-CELLS; POLYETHYLENE; DELIVERY; POLY(DMAEMA-CO-PPGMA)
AB Lignin, one of the most abundant biopolymers on Earth, has been recognized as a renewable alternative to traditional petroleum-based plastics. The integration of lignin with synthetic and engineering plastics is an important approach to develop sustainable polymers. However, it is challenging to blend lignin with other polymers due to its brittle nature and poor dispersion in many composites. In order to improve the miscibility and compatibility of lignin with other plastics, a series of poly(methyl methacrylate) (PMMA) grafted lignin copolymers were prepared from atom transfer radical polymerization. The chain length of PMMA oligomers and glass transition temperature of the lignin copolymers was controlled by varying the lignin: methyl methacrylate ratio. The lignin mass fractions in the copolymers varied from 5.6% to 46.1%. These lignin-PMMA copolymers were further blended with poly(e-caprolactone) (PCL) and engineered into nanofibrous composites by electrospinning. Tensile test and dynamical mechanical analysis showed that the incorporation of lignin-PMMA copolymers significantly improved the tensile strength, Young's modulus, and storage modulus of the resulting nanofibrous composites. The length of the PMMA chain played a crucial role in the miscibility of lignin in PCL, and therefore enhanced the stiffness and ultimate elongation of the resulting nanofibers. Cell culture studies suggested that these PCL/lignin-PMMA nanofibers were biocompatible and promoted the proliferation, attachment and interactions of human dermal fibroblasts. With reinforced mechanical properties and good biocompatibility, these green and stretchable electrospun nanofibers are potentially useful as biomaterial substrates for biomedical applications.
C1 [Kai, Dan; Jiang, Shan; Loh, Xian Jun] ASTAR, IMRE, Singapore 117602, Singapore.
   [Low, Zhi Wei; Loh, Xian Jun] Natl Univ Singapore, Dept Mat Sci & Engn, Singapore 117576, Singapore.
   [Loh, Xian Jun] Singapore Eye Res Inst, Singapore 168751, Singapore.
RP Kai, D (reprint author), ASTAR, IMRE, 3 Res Link, Singapore 117602, Singapore.
EM kaid@imre.a-star.edu.sg; lohxj@imre.a-star.edu.sg
OI Loh, Xian Jun/0000-0001-8118-6502
FU Institute of Materials Research and Engineering (IMRE); A*STAR (Agency
   for Science, Technology and Research), Singapore; Science and
   Engineering Research Council (SERC) Personal Care Program
FX This work was supported by the Institute of Materials Research and
   Engineering (IMRE), A*STAR (Agency for Science, Technology and
   Research), Singapore, and funded by the Science and Engineering Research
   Council (SERC) Personal Care Program.
CR Ago M, 2012, BIOMACROMOLECULES, V13, P918, DOI 10.1021/bm201828g
   Alexy P, 2000, POLYMER, V41, P4901, DOI 10.1016/S0032-3861(99)00714-4
   Ashammakhi N, 2007, J NANOSCI NANOTECHNO, V7, P862, DOI 10.1166/jnn.2007.485
   Aussawasathien D, 2005, SYNTHETIC MET, V154, P37, DOI 10.1016/j.synthmet.2005.07.018
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Chen F, 2011, POLYM COMPOSITE, V32, P1019, DOI 10.1002/pc.21087
   Chen XY, 2015, CHEM COMMUN, V51, P487, DOI 10.1039/c4cc08681c
   Chung YL, 2013, ACS SUSTAIN CHEM ENG, V1, P1231, DOI 10.1021/sc4000835
   Cui CZ, 2013, BIORESOURCES, V8, P864
   Gregorova A, 2005, WOOD RES-SLOVAKIA, V50, P41
   Hilburg SL, 2014, POLYMER, V55, P995, DOI 10.1016/j.polymer.2013.12.070
   HUANG YF, 1992, J APPL POLYM SCI, V45, P71, DOI 10.1002/app.1992.070450108
   Jankovic A, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5333-y
   Kai D., 2012, NANOTECHNOLOGY, V23, P10
   Kai D, 2014, ACTA BIOMATER, V10, P2727, DOI 10.1016/j.actbio.2014.02.030
   Kai D, 2013, BIOTECHNOL J, V8, P59, DOI 10.1002/biot.201200249
   Kai D, 2011, J BIOMED MATER RES A, V99A, P376, DOI 10.1002/jbm.a.33200
   Kai D, 2011, J BIOMED MATER RES B, V98B, P379, DOI 10.1002/jbm.b.31862
   Kanani AG, 2011, J NANOMATER, DOI 10.1155/2011/724153
   Kim YS, 2010, BIOMACROMOLECULES, V11, P981, DOI 10.1021/bm901455p
   Kriegel C, 2008, CRIT REV FOOD SCI, V48, P775, DOI 10.1080/10408390802241325
   Laurichesse S, 2014, PROG POLYM SCI, V39, P1266, DOI 10.1016/j.progpolymsci.2013.11.004
   Li ZB, 2015, CHEM SOC REV, V44, P2865, DOI 10.1039/c5cs00089k
   Lin ZF, 2013, BIOMACROMOLECULES, V14, P2206, DOI 10.1021/bm4003442
   Loh XJ, 2015, CHEM COMMUN, V51, P10815, DOI 10.1039/c5cc03686k
   Loh XJ, 2013, MAT SCI ENG C-MATER, V33, P4545, DOI 10.1016/j.msec.2013.07.011
   Loh XJ, 2013, J APPL POLYM SCI, V127, P992, DOI 10.1002/app.37530
   Loh XJ, 2009, MACROMOL BIOSCI, V9, P1069, DOI 10.1002/mabi.200900081
   Loh XJ, 2009, SOFT MATTER, V5, P2937, DOI 10.1039/b904171k
   Lora JH, 2002, J POLYM ENVIRON, V10, P39, DOI 10.1023/A:1021070006895
   Mai C, 1999, APPL MICROBIOL BIOT, V51, P527, DOI 10.1007/s002530051428
   Mai C, 2000, ENZYME MICROB TECH, V27, P167, DOI 10.1016/S0141-0229(00)00214-3
   MEISTER JJ, 1992, MACROMOLECULES, V25, P611, DOI 10.1021/ma00028a020
   Mohanty S, 2006, COMPOS SCI TECHNOL, V66, P538, DOI 10.1016/j.compscitech.2005.06.014
   Ouyang WZ, 2012, J POLYM ENVIRON, V20, P1, DOI 10.1007/s10924-011-0359-4
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Poursorkhabi V., 2015, J APPL POLYM SCI, V132, P9
   Pucciariello R, 2004, POLYMER, V45, P4159, DOI 10.1016/j.polymer.2004.03.098
   Qin XH, 2012, J THERM ANAL CALORIM, V107, P1007, DOI 10.1007/s10973-011-1640-4
   Sailaja RRN, 2010, MATER DESIGN, V31, P4369, DOI 10.1016/j.matdes.2010.03.046
   Sailaja RRN, 2005, POLYM INT, V54, P1589, DOI 10.1002/pi.1864
   Saito T, 2013, RSC ADV, V3, P21832, DOI 10.1039/c3ra44794d
   Saito T, 2012, GREEN CHEM, V14, P3295, DOI 10.1039/c2gc35933b
   Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481
   Tajvidi M, 2006, J APPL POLYM SCI, V101, P4341, DOI 10.1002/app.24289
   Thakur VK, 2014, ACS SUSTAIN CHEM ENG, V2, P1072, DOI 10.1021/sc500087z
   Tortora M, 2014, BIOMACROMOLECULES, V15, P1634, DOI 10.1021/bm500015j
   Ugartondo V, 2008, BIORESOURCE TECHNOL, V99, P6683, DOI 10.1016/j.biortech.2007.11.038
   Van der Schueren L, 2011, EUR POLYM J, V47, P1256, DOI 10.1016/j.eurpolymj.2011.02.025
   Viswanathan P, 2015, BIOMACROMOLECULES, V16, P66, DOI 10.1021/bm500671j
   Wang JF, 2011, J POLYM SCI POL CHEM, V49, P3728, DOI 10.1002/pola.24809
   Wang SX, 2013, ACS APPL MATER INTER, V5, P12275, DOI 10.1021/am4043867
   Xu X, 2014, MACROMOL RES, V22, P1084, DOI 10.1007/s13233-014-2161-3
   Ye HY, 2015, RSC ADV, V5, P48720, DOI 10.1039/c5ra08222f
NR 54
TC 60
Z9 60
U1 6
U2 58
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 30
BP 6194
EP 6204
DI 10.1039/c5tb00765h
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA CN3UC
UT WOS:000358351400007
DA 2018-10-20
ER

PT J
AU Gorka, AP
   Nani, RR
   Schnermann, MJ
AF Gorka, Alexander P.
   Nani, Roger R.
   Schnermann, Martin J.
TI Cyanine polyene reactivity: scope and biomedical applications
SO ORGANIC & BIOMOLECULAR CHEMISTRY
LA English
DT Review
ID INFRARED FLUORESCENT-PROBES; BIOMATERIAL-ASSOCIATED INFLAMMATION; DYE
   LABELING REAGENTS; IN-VIVO; LIVING CELLS; HYDROGEN-SULFIDE; ORGANIC
   FLUOROPHORES; PHOTOACTIVATABLE FLUOROPHORES; IMPROVED PHOTOSTABILITY;
   NIR FLUORESCENCE
AB Cyanines are indispensable fluorophores that form the chemical basis of many fluorescence-based applications. A feature that distinguishes cyanines from other common fluorophores is an exposed polyene linker that is both crucial to absorption and emission and subject to covalent reactions that dramatically alter these optical properties. Over the past decade, reactions involving the cyanine polyene have been used as foundational elements for a range of biomedical techniques. These include the optical sensing of biological analytes, super-resolution imaging, and near-IR light-initiated uncaging. This review surveys the chemical reactivity of the cyanine polyene and the biomedical methods enabled by these reactions. The overarching goal is to highlight the multifaceted nature of cyanine chemistry and biology, as well as to point out the key role of reactivity-based insights in this promising area.
C1 [Gorka, Alexander P.; Nani, Roger R.; Schnermann, Martin J.] NCI, Biol Chem Lab, Ctr Canc Res, Frederick, MD 21702 USA.
RP Schnermann, MJ (reprint author), NCI, Biol Chem Lab, Ctr Canc Res, Frederick, MD 21702 USA.
EM martin.schnermann@nih.gov
OI Schnermann, Martin/0000-0002-0503-0116
FU Intramural Research Program of the National Institutes of Health; Center
   for Cancer Research; National Cancer Institute, National Institutes of
   Health
FX We thank Rolf Swenson (NIH, NHLBI) and members of the Chemical Biology
   Laboratory for helpful suggestions. This work was supported by the
   Intramural Research Program of the National Institutes of Health, Center
   for Cancer Research, and the National Cancer Institute, National
   Institutes of Health.
CR Alford R, 2009, MOL IMAGING, V8, P341, DOI 10.2310/7290.2009.00031
   Altman RB, 2012, NAT METHODS, V9, P626, DOI 10.1038/nmeth0612-626b
   Bak DW, 2015, MOL BIOSYST, V11, P678, DOI 10.1039/c4mb00571f
   Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101
   Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598
   Berbasova T, 2013, J AM CHEM SOC, V135, P16111, DOI 10.1021/ja404900k
   Brieke C, 2012, ANGEW CHEM INT EDIT, V51, P8446, DOI 10.1002/anie.201202134
   Busch D. R., 2010, MOL IMAGING PRINCIPL, P214
   BYERS GW, 1976, PHOTOCHEM PHOTOBIOL, V23, P37, DOI 10.1111/j.1751-1097.1976.tb06768.x
   Chen GW, 2012, CHEM COMMUN, V48, P2949, DOI 10.1039/c2cc17617c
   Chen P, 1998, DYES PIGMENTS, V37, P213, DOI 10.1016/S0143-7208(97)00059-4
   Chen XQ, 2011, CHEM SOC REV, V40, P4783, DOI 10.1039/c1cs15037e
   Chen Y, 2013, INT J BIOL MACROMOL, V52, P52, DOI 10.1016/j.ijbiomac.2012.09.005
   Chozinski TJ, 2014, FEBS LETT, V588, P3603, DOI 10.1016/j.febslet.2014.06.043
   Crivat G, 2012, TRENDS BIOTECHNOL, V30, P8, DOI 10.1016/j.tibtech.2011.08.002
   Davies SS, 2014, CHEM PHYS LIPIDS, V181, P1, DOI 10.1016/j.chemphyslip.2014.03.002
   Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]
   Dempsey GT, 2009, J AM CHEM SOC, V131, P18192, DOI 10.1021/ja904588g
   Deniz E, 2012, J PHYS CHEM C, V116, P6058, DOI 10.1021/jp211796p
   Dore TM, 2011, NEUROMETHODS, V55, P57, DOI 10.1007/978-1-61779-031-7_4
   Engel E, 2008, INVEST OPHTH VIS SCI, V49, P1777, DOI 10.1167/iovs.07-0911
   ERNST LA, 1989, CYTOMETRY, V10, P3, DOI 10.1002/cyto.990100103
   FABIAN J, 1992, CHEM REV, V92, P1197, DOI 10.1021/cr00014a003
   Fan JL, 2013, CHEM SOC REV, V42, P29, DOI 10.1039/c2cs35273g
   Farina M, 2011, LIFE SCI, V89, P555, DOI 10.1016/j.lfs.2011.05.019
   Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007
   Gerdes MJ, 2013, P NATL ACAD SCI USA, V110, P11982, DOI 10.1073/pnas.1300136110
   Goodson P, 2012, AM J PHYSIOL-LUNG C, V302, pL410, DOI 10.1152/ajplung.00260.2011
   Gorka AP, 2014, J AM CHEM SOC, V136, P14153, DOI 10.1021/ja5065203
   Grimm JB, 2013, PROG MOL BIOL TRANSL, V113, P1, DOI 10.1016/B978-0-12-386932-6.00001-6
   Guo ZQ, 2014, CHEM SOC REV, V43, P16, DOI 10.1039/c3cs60271k
   Guo ZQ, 2012, CHEM SCI, V3, P2760, DOI 10.1039/c2sc20540h
   Guo Z, 2010, CHEM-EUR J, V16, P14424, DOI 10.1002/chem.201001769
   Han JY, 2010, CHEM REV, V110, P2709, DOI 10.1021/cr900249z
   Heilemann M, 2005, J AM CHEM SOC, V127, P3801, DOI 10.1021/ja044686x
   Henary M, 2008, TOP HETEROCYCL CHEM, V14, P221, DOI 10.1007/7081_2008_111
   Hilderbrand SA, 2008, BIOCONJUGATE CHEM, V19, P1635, DOI 10.1021/bc800188p
   Hossion AML, 2013, ACS MED CHEM LETT, V4, P124, DOI 10.1021/ml3003617
   Hu C, 2013, ORG LETT, V15, P4022, DOI 10.1021/ol401838p
   Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014
   Jiang MY, 2008, J AM CHEM SOC, V130, P4236, DOI 10.1021/ja800140g
   Jing CR, 2011, ACCOUNTS CHEM RES, V44, P784, DOI 10.1021/ar200099f
   Kanofsky JR, 2000, PHOTOCHEM PHOTOBIOL, V71, P361, DOI 10.1562/0031-8655(2000)071<0361:SAERFQ>2.0.CO;2
   Karton-Lifshin N, 2013, ORG BIOMOL CHEM, V11, P2903, DOI 10.1039/c3ob27385g
   Karton-Lifshin N, 2012, J AM CHEM SOC, V134, P20412, DOI 10.1021/ja308124q
   Karton-Lifshin N, 2011, J AM CHEM SOC, V133, P10960, DOI 10.1021/ja203145v
   Kim HN, 2012, CHEM SOC REV, V41, P3210, DOI 10.1039/c1cs15245a
   Kim JY, 2011, J CONTROL RELEASE, V156, P398, DOI 10.1016/j.jconrel.2011.07.017
   Kim YM, 2007, BIOORG MED CHEM LETT, V17, P5054, DOI 10.1016/j.bmcl.2007.07.026
   Kisin-Finfer E, 2014, BIOORG MED CHEM LETT, V24, P2453, DOI 10.1016/j.bmcl.2014.04.022
   Kundu K, 2010, ANGEW CHEM INT EDIT, V49, P6134, DOI 10.1002/anie.201002228
   Kundu K, 2009, ANGEW CHEM INT EDIT, V48, P299, DOI 10.1002/anie.200804851
   Lee H, 2013, PHOTOCHEM PHOTOBIOL, V89, P326, DOI 10.1111/php.12009
   Lee H, 2011, BIOCONJUGATE CHEM, V22, P777, DOI 10.1021/bc100584d
   Lee YJ, 2001, J CELL SCI, V114, P677
   LENHARD JR, 1993, J PHYS CHEM-US, V97, P8269, DOI 10.1021/j100133a025
   LEPAJA S, 1983, Z NATURFORSCH A, V38, P56
   Levitus M, 2011, Q REV BIOPHYS, V44, P123, DOI 10.1017/S0033583510000247
   Li P, 2008, ANALYST, V133, P1409, DOI 10.1039/b802836b
   Li YH, 2015, J AM CHEM SOC, V137, P6407, DOI 10.1021/jacs.5b04097
   Lim SY, 2014, J AM CHEM SOC, V136, P7018, DOI 10.1021/ja500962u
   Lin VS, 2015, CHEM SOC REV, V44, P4596, DOI 10.1039/c4cs00298a
   Lippert AR, 2014, J INORG BIOCHEM, V133, P136, DOI 10.1016/j.jinorgbio.2013.10.010
   Lou ZR, 2013, ANALYST, V138, P6291, DOI 10.1039/c3an00198a
   Luo SL, 2011, BIOMATERIALS, V32, P7127, DOI 10.1016/j.biomaterials.2011.06.024
   Magalotti S, 2013, MOL IMAGING BIOL, V15, P423, DOI 10.1007/s11307-013-0614-2
   Maity D, 2013, ORG BIOMOL CHEM, V11, P2098, DOI 10.1039/c2ob27138a
   Marshall Milton V, 2010, Open Surg Oncol J, V2, P12
   Marshall MV, 2010, MOL IMAGING BIOL, V12, P583, DOI 10.1007/s11307-010-0317-x
   Mishra A, 2000, CHEM REV, V100, P1973, DOI 10.1021/cr990402t
   Montserrat M., 2013, BIOCHIM BIOPHYS ACTA, V1830, P3317
   Moysan E, 2013, MOL PHARMACEUT, V10, P430, DOI 10.1021/mp300370t
   MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001
   Mustroph H, 2006, ANGEW CHEM INT EDIT, V45, P2016, DOI 10.1002/anie.200502820
   Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335
   Myochin T, 2011, J AM CHEM SOC, V133, P3401, DOI 10.1021/ja1063058
   Nani RR, 2015, ORG LETT, V17, P302, DOI 10.1021/ol503398f
   Nguyen QT, 2013, NAT REV CANCER, V13, P653, DOI 10.1038/nrc3566
   Oushiki D, 2010, J AM CHEM SOC, V132, P2795, DOI 10.1021/ja910090v
   Panigrahi M, 2012, TETRAHEDRON, V68, P781, DOI 10.1016/j.tet.2011.10.069
   Pansare VJ, 2012, CHEM MATER, V24, P812, DOI 10.1021/cm2028367
   Patonay G, 2005, APPL SPECTROSC, V59, P682, DOI 10.1366/0003702053945976
   Pu KY, 2013, ANGEW CHEM INT EDIT, V52, P10325, DOI 10.1002/anie.201303420
   Que EL, 2008, CHEM REV, V108, P1517, DOI 10.1021/cr078203u
   Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028
   Redy-Keisar O, 2014, NAT PROTOC, V9, P27, DOI 10.1038/nprot.2013.166
   Renikuntla BR, 2004, ORG LETT, V6, P909, DOI 10.1021/ol036081w
   Rotaru A, 2007, ANGEW CHEM INT EDIT, V46, P6180, DOI 10.1002/anie.200700641
   Ruebner A, 1999, P NATL ACAD SCI USA, V96, P14692, DOI 10.1073/pnas.96.26.14692
   Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929
   Samanta A, 2010, CHEM COMMUN, V46, P7406, DOI 10.1039/c0cc02366c
   Sasaki E, 2005, J AM CHEM SOC, V127, P3684, DOI 10.1021/ja042967z
   Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018
   Selvam S, 2011, BIOMATERIALS, V32, P7785, DOI 10.1016/j.biomaterials.2011.07.020
   Sengupta P, 2014, CHEM REV, V114, P3189, DOI 10.1021/cr400614m
   Sengupta P, 2012, DEV CELL, V23, P1092, DOI 10.1016/j.devcel.2012.09.022
   Shell TA, 2014, ANGEW CHEM INT EDIT, V53, P875, DOI 10.1002/anie.201308816
   Shi YM, 2013, ANALYST, V138, P1952, DOI 10.1039/c3an36807f
   Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109
   Shiraishi Y, 2014, CHEM COMMUN, V50, P11583, DOI 10.1039/c4cc05412a
   Shuhendler AJ, 2014, NAT BIOTECHNOL, V32, P373, DOI 10.1038/nbt.2838
   Singha S, 2015, CHEM SOC REV, V44, P4367, DOI 10.1039/c4cs00328d
   Singha S, 2015, ANAL CHEM, V87, P1188, DOI 10.1021/ac503806w
   Stennett EMS, 2014, CHEM SOC REV, V43, P1057, DOI 10.1039/c3cs60211g
   STREKOWSKI L, 1992, J ORG CHEM, V57, P4578, DOI 10.1021/jo00043a009
   Strekowski L, 2004, J HETEROCYCLIC CHEM, V41, P227, DOI 10.1002/jhet.5570410213
   Strekowski L, 1996, J HETEROCYCLIC CHEM, V33, P1685, DOI 10.1002/jhet.5570330622
   Suri S, 2015, J BIOMED MATER RES A, V103, P76, DOI 10.1002/jbm.a.35162
   Swanson PA, 2011, P NATL ACAD SCI USA, V108, P8803, DOI 10.1073/pnas.1010042108
   Tang B, 2007, CHEM COMMUN, P3726, DOI 10.1039/b707173f
   Tarazi L, 1998, TALANTA, V46, P1413, DOI 10.1016/S0039-9140(98)00012-5
   Tian JW, 2011, CHEM-EUR J, V17, P6626, DOI 10.1002/chem.201100148
   Toutchkine A, 2003, J AM CHEM SOC, V125, P4132, DOI 10.1021/ja0290882
   Toutchkine A, 2007, ORG LETT, V9, P2775, DOI 10.1021/ol070780h
   Uno SN, 2014, NAT CHEM, V6, P681, DOI [10.1038/NCHEM.2002, 10.1038/nchem.2002]
   van de Linde S, 2014, CHEM SOC REV, V43, P1076, DOI 10.1039/c3cs60195a
   van der Velde JHM, 2014, J PHYS CHEM LETT, V5, P3792, DOI 10.1021/jz501874f
   van der Velde JHM, 2013, CHEMPHYSCHEM, V14, P4084, DOI 10.1002/cphc.201300785
   Vaughan JC, 2013, J AM CHEM SOC, V135, P1197, DOI 10.1021/ja3105279
   Vaughan JC, 2012, NAT METHODS, V9, P1181, DOI [10.1038/NMETH.2214, 10.1038/nmeth.2214]
   Viger ML, 2014, ACS NANO, V8, P4815, DOI 10.1021/nn500702g
   Wang BS, 2013, CHEM COMMUN, V49, P5790, DOI 10.1039/c3cc42313a
   Wang WJ, 2012, SCIENCE, V338, P1340, DOI 10.1126/science.1226135
   Wang X, 2013, CHEM SCI, V4, P2551, DOI 10.1039/c3sc50369k
   Warther D, 2010, BIOORGAN MED CHEM, V18, P7753, DOI 10.1016/j.bmc.2010.04.084
   Widengren J, 2007, J PHYS CHEM A, V111, P429, DOI 10.1021/jp0646325
   WILLIAMS CHG, 1856, T R SOC EDINBURGH, V21, P377
   Wu XJ, 2014, BIOORG MED CHEM LETT, V24, P314, DOI 10.1016/j.bmcl.2013.11.016
   Wu XM, 2015, CHEM SOC REV, V44, P4179, DOI 10.1039/c4cs00152d
   Yang YM, 2012, ANGEW CHEM INT EDIT, V51, P3125, DOI 10.1002/anie.201107919
   Yang ZH, 2012, ORG BIOMOL CHEM, V10, P5073, DOI 10.1039/c2ob25516b
   Yang Z, 2013, J AM CHEM SOC, V135, P11657, DOI 10.1021/ja405372k
   Yapici I, 2015, J AM CHEM SOC, V137, P1073, DOI 10.1021/ja506376j
   Ye YP, 2003, J AM CHEM SOC, V125, P7766, DOI 10.1021/ja034186o
   Yin J, 2015, CHEM SOC REV, V44, P4619, DOI 10.1039/c4cs00275j
   You Y, 2014, CHEM SCI, V5, P4123, DOI 10.1039/c4sc01637h
   Yuan L, 2013, CHEM SOC REV, V42, P622, DOI 10.1039/c2cs35313j
   Yuan L, 2010, CHEM COMMUN, V46, P7930, DOI 10.1039/c0cc02390f
   Zheng QS, 2014, PHOTOCHEM PHOTOBIOL, V90, P448, DOI 10.1111/php.12204
   Zheng QS, 2014, CHEM SOC REV, V43, P1044, DOI 10.1039/c3cs60237k
   Zhu DJ, 2013, ORG BIOMOL CHEM, V11, P4577, DOI 10.1039/c3ob40932e
NR 141
TC 35
Z9 35
U1 5
U2 71
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-0520
EI 1477-0539
J9 ORG BIOMOL CHEM
JI Org. Biomol. Chem.
PY 2015
VL 13
IS 28
BP 7584
EP 7598
DI 10.1039/c5ob00788g
PG 15
WC Chemistry, Organic
SC Chemistry
GA CN2IC
UT WOS:000358243200001
PM 26052876
DA 2018-10-20
ER

PT J
AU Rosengren-Holmberg, JP
   Andersson, J
   Smith, JR
   Alexander, C
   Alexander, MR
   Tovar, G
   Ekdahl, KN
   Nicholls, IA
AF Rosengren-Holmberg, Jenny P.
   Andersson, Jonas
   Smith, James R.
   Alexander, Cameron
   Alexander, Morgan R.
   Tovar, Guenter
   Ekdahl, Kristina N.
   Nicholls, Ian A.
TI Heparin molecularly imprinted surfaces for the attenuation of complement
   activation in blood
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID IN-VITRO MODEL; CARDIOPULMONARY BYPASS; BIOMATERIAL; COAGULATION;
   BINDING; PROTEOGLYCANS; INFLAMMATION; RECOGNITION; INHIBITION;
   STRATEGIES
AB Heparin-imprinted synthetic polymer surfaces with the ability to attenuate activation of both the complement and the coagulation system in whole blood were successfully produced. Imprinting was achieved using a template coated with heparin, a highly sulfated glycosaminoglycan known for its anticoagulant properties. The N,N'-diacryloylpiperazine-methacrylic acid copolymers were characterized using goniometry, AFM and XPS. The influence of the molecular imprinting process on morphology and template rebinding was demonstrated by radioligand binding assays. Surface hemocompatibility was evaluated using human whole blood without anticoagulants followed by measurement of complement activation markers C3a and sC5b-9 and platelet consumption as a surrogate coagulation activation marker. The observed low thrombogenicity of this copolymer combined with the attenuation of complement activation induced by the molecular imprint offer potential for the development of self-regulating surfaces with important potential clinical applications. We propose a mechanism for the observed phenomena based upon the recruitment of endogenous sulfated glycosaminoglycans with heparin-like activities.
C1 [Rosengren-Holmberg, Jenny P.; Ekdahl, Kristina N.; Nicholls, Ian A.] Linnaeus Univ, Dept Chem & Biomed Sci, Ctr Biomat Chem, SE-39182 Kalmar, Sweden.
   [Rosengren-Holmberg, Jenny P.] Swedish Natl Forens Ctr, Drugs Unit, SE-58194 Linkoping, Sweden.
   [Andersson, Jonas; Ekdahl, Kristina N.] Univ Uppsala Hosp, Clin Immunol Sect, Rudbeck Lab C5, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden.
   [Smith, James R.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
   [Alexander, Cameron; Alexander, Morgan R.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
   [Tovar, Guenter] Univ Stuttgart, Inst Interfacial Engn, D-70569 Stuttgart, Germany.
   [Tovar, Guenter] Fraunhofer Inst Interfacial Engn & Biotechnol, D-70569 Stuttgart, Germany.
   [Nicholls, Ian A.] Uppsala Univ, Biomed Ctr, Dept Chem, SE-75123 Uppsala, Sweden.
RP Rosengren-Holmberg, JP (reprint author), Linnaeus Univ, Dept Chem & Biomed Sci, Ctr Biomat Chem, SE-39182 Kalmar, Sweden.
EM ian.nicholls@lnu.se
RI Nilsson Ekdahl, Kristina/B-5301-2012; Alexander, Morgan/C-2506-2009;
   Smith, James/D-2350-2011; Alexander, Cameron/N-7729-2014; Smith,
   James/F-1108-2014
OI Alexander, Morgan/0000-0001-5182-493X; Smith, James/0000-0001-8805-3788;
   Alexander, Cameron/0000-0001-8337-1875; Smith,
   James/0000-0001-8805-3788; Rosengren Holmberg, Jenny/0000-0003-2417-9175
FU Swedish Research Council (VR); Carl Tryggers Foundation; Linnaeus
   University; European Community's Seventh Framework Programme [602699];
   Engineering and Physical Sciences Research Council [EP/H005625/1]
FX This work was supported by grants from the Swedish Research Council
   (VR), Carl Tryggers Foundation, Linnaeus University and the European
   Community's Seventh Framework Programme in the projects Biodesign and
   DIREKT (no 602699). The authors thank Professors Bo Nilsson and Rolf
   Larsson (both Uppsala University, Sweden), Dr Michael J. Whitcombe
   (University of Leicester, UK) and Dr Jesper G. Wiklander (Linnaeus
   University) for helpful discussions and Ms. Kerstin Sandholm for
   technical assistance.
CR Alexander C, 2006, J MOL RECOGNIT, V19, P106, DOI 10.1002/jmr.760
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   Baydemir G., 2014, ARTIF CELL NANOMED B, P1
   BJORK I, 1982, MOL CELL BIOCHEM, V48, P161, DOI 10.1007/BF00421226
   Cunliffe D, 2003, LANGMUIR, V19, P2888, DOI 10.1021/la026358l
   D'Souza SM, 1999, NATURE, V398, P312, DOI 10.1038/18636
   Drelich J, 1996, J COLLOID INTERF SCI, V179, P37, DOI 10.1006/jcis.1996.0186
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hoshino Y, 2008, J AM CHEM SOC, V130, P15242, DOI 10.1021/ja8062875
   Karlsson BCG, 2009, J AM CHEM SOC, V131, P13297, DOI 10.1021/ja902087t
   KODAMA K, 1987, THROMB HAEMOSTASIS, V58, P1064
   Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230
   Lappegard KT, 2004, ANN THORAC SURG, V78, P38, DOI 10.1016/j.athorascur.2004.02.005
   Larsson R., 2004, ENCY BIOMATER BIOMED, V2, P753
   Li LF, 2013, ANAL BIOCHEM, V434, P242, DOI 10.1016/j.ab.2012.12.007
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x
   MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849
   Nicholls IA, 2001, BIOSEPARATION, V10, P301, DOI 10.1023/A:1021541631063
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Piletsky SA, 1999, MACROMOLECULES, V32, P633, DOI 10.1021/ma9812736
   Reber D, 2008, HEART SURG FORUM, V11, pE276, DOI 10.1532/HSF98.20081024
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Sellergren B., 2001, TECHNIQUES INSTRUMEN
   Shi HQ, 1999, NATURE, V398, P593
   Svenson J, 2001, ANAL CHIM ACTA, V435, P19, DOI 10.1016/S0003-2670(00)01396-9
   Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev
   van Der Giessen W. J., 1999, CURR INTERV CARDIOL, V1, P234
   VLATAKIS G, 1993, NATURE, V361, P645, DOI 10.1038/361645a0
   Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676
   Yoshimi Y, 2013, ANALYST, V138, P5121, DOI 10.1039/c3an00909b
NR 39
TC 8
Z9 8
U1 0
U2 35
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 8
BP 1208
EP 1217
DI 10.1039/c5bm00047e
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CM8GR
UT WOS:000357937400004
PM 26222036
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Bishop, CJ
   Abubaker-Sharif, B
   Guiriba, T
   Tzeng, SY
   Green, JJ
AF Bishop, C. J.
   Abubaker-Sharif, B.
   Guiriba, T.
   Tzeng, S. Y.
   Green, J. J.
TI Gene delivery polymer structure-function relationships elucidated via
   principal component analysis
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID DNA; NANOPARTICLES; CANCER; SIRNA
AB Principal component analysis was applied to a biomaterial library of poly(beta-amino ester)s, useful for non-viral gene delivery, to elucidate chemical parameters that drive biological function. Correlative relationships and principal components were analyzed between 24 physico-chemical polymer properties and 3 cell-based functional variables in human glioblastoma cells (transfection, uptake, and viability).
C1 [Bishop, C. J.; Abubaker-Sharif, B.; Tzeng, S. Y.; Green, J. J.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr, Baltimore, MD 21205 USA.
   [Guiriba, T.; Green, J. J.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21205 USA.
   [Green, J. J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.
   [Green, J. J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.
RP Green, JJ (reprint author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr, 400 North Broadway, Baltimore, MD 21205 USA.
EM green@jhu.edu
OI Abubaker-Sharif, Bedri/0000-0001-5003-7934
FU NIH [1R01EB016721]; NSF Research Fellowship [DGE-0707427]
FX We would like to acknowledge our funding sources: the NIH (1R01EB016721)
   and the NSF Research Fellowship awarded to CJB (DGE-0707427).
CR Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Bishop CJ, 2015, ACTA BIOMATER, V11, P393, DOI 10.1016/j.actbio.2014.09.020
   Bishop CJ, 2013, J AM CHEM SOC, V135, P6951, DOI 10.1021/ja4002376
   Bishop CJ, 2010, J HEART LUNG TRANSPL, V29, P27, DOI 10.1016/j.healun.2009.08.027
   Kamat CD, 2013, MOL CANCER THER, V12, P405, DOI 10.1158/1535-7163.MCT-12-0956
   Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667
   Sunshine JC, 2011, BIOMACROMOLECULES, V12, P3592, DOI 10.1021/bm200807s
   Tzeng SY, 2013, ADV HEALTHC MATER, V2, P468, DOI 10.1002/adhm.201200257
   Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763
NR 9
TC 11
Z9 11
U1 0
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2015
VL 51
IS 60
BP 12134
EP 12137
DI 10.1039/c5cc04417k
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA CM8LC
UT WOS:000357951400048
PM 26126593
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Cui, LL
   Chen, Y
   Zhang, H
   Zhong, J
   Sun, Y
   Shi, NQ
   Li, CL
   Kong, W
AF Zhang, Yong
   Cui, Lili
   Chen, Yan
   Zhang, Heng
   Zhong, Jian
   Sun, Yanan
   Shi, Nianqiu
   Li, Chunlei
   Kong, Wei
TI Zein-Based Nanofibres for Drug Delivery: Classes and Current
   Applications
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Biocompatibility; biomedical application; biopolymer; immunogenicity;
   zein
ID COAXIAL ELECTROSPINNING PROCESS; FIBROUS MEMBRANES; RELEASE PROFILES;
   CROSS-LINKING; ACETIC-ACID; FIBERS; COMPOSITE; FABRICATION; DEGRADATION;
   TEMPERATURE
AB Plant proteins have been drawing increasing attention owing to their safety, abundance and relatively low cost in comparison with animal proteins. The development of plant protein-based delivery vehicles may lead to the provision of novel pharmaceutical products to patients. Zein is a class of alcohol-soluble prolamine proteins present in maize endosperm that was approved as a generally recognised as safe excipient in 1985 by the US FDA for use in pharmaceutical film coatings. Over the past few decades, numerous studies have been carried out to illustrate zein's potential for novel applications in the biomedical field. This paper reviews the present status of zein-based nanofibres, with emphasis on their fabrication and biomedical applications, particularly for drug delivery. Their benefits and limitations are also discussed to provide further insight into zein's potential as a promising biomaterial.
C1 [Zhang, Yong; Chen, Yan; Sun, Yanan; Kong, Wei] Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China.
   [Zhang, Yong; Chen, Yan; Shi, Nianqiu; Kong, Wei] Jilin Univ, Sch Life Sci, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130012, Peoples R China.
   [Zhang, Yong; Li, Chunlei] China Shijiazhuang Pharmaceut Grp Co Ltd, State Key Lab New Pharmaceut Preparat & Excipient, Shijiazhuang 050051, Peoples R China.
   [Cui, Lili] Kings Coll London, Inst Pharmaceut Sci, Pharmaceut Biophys Grp, London SE1 9NH, England.
   [Zhang, Heng] Jilin Univ, Coll Mat Sci & Engn, Changchun 130025, Peoples R China.
   [Zhong, Jian] Natl Engn Res Ctr Nanotechnol, Shanghai 200241, Peoples R China.
   [Shi, Nianqiu] Jilin Med Coll, Sch Pharm, Dept Pharmaceut, Fengman 132013, Jilin, Peoples R China.
RP Zhang, Y (reprint author), Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Qianjin St 2699, Changchun 130012, Peoples R China.
EM zhangyongking1@gmail.com; weikong@jlu.edu.cn
RI Zhong, Jian/B-3743-2015; zhang, yong/H-2552-2013
OI Zhong, Jian/0000-0002-2475-3221; zhang, yong/0000-0001-6577-5235
FU China Postdoctoral Science Foundation [20110491321]; Hebei Provincial
   Natural Science Foundation of China-Shijiazhuang Pharmaceutical Group
   (CSPC) Foundation [C2011319001]; Fundamental Research Funds for the
   Central Universities [101832013]; Jilin Province Science and Technology
   Development Plan [20140309007YY]
FX This work was supported by the China Postdoctoral Science Foundation
   (Grant No 20110491321), Hebei Provincial Natural Science Foundation of
   China-Shijiazhuang Pharmaceutical Group (CSPC) Foundation (Grant No.
   C2011319001), Fundamental Research Funds for the Central Universities
   (Grant No. 101832013) and Jilin Province Science and Technology
   Development Plan (Grant No 20140309007YY).
CR [Anonymous], 1985, FED REGISTER, V50, P8997
   [Anonymous], 1939, Oil Paint Drug Rep, V137, P32, Patent No. [1, 316, 854, 1316854]
   [Anonymous], 1944, OIL PAINT DRUG REP, V54, P670
   Anton F., 1934, U.S. Patent, Patent No. [1,975,504, 1975504]
   Asher GN, 2013, ALTERN THER HEALTH M, V19, P20
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Brahatheeswaran D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045001
   Chakraborty S, 2009, ADV DRUG DELIVER REV, V61, P1043, DOI 10.1016/j.addr.2009.07.013
   Dhandayuthapani B., 2012, INT J BIOMATER, V2012
   Dhandayuthapani B, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025008
   ESEN A, 1987, J CEREAL SCI, V5, P117, DOI 10.1016/S0733-5210(87)80015-2
   Gorham J., 1821, Q J SCI LIT ART, V11, P206
   Huang WD, 2013, AAPS PHARMSCITECH, V14, P675, DOI 10.1208/s12249-013-9953-1
   Hurtado-Lopez P, 2006, J PHARM PHARMACOL, V58, P769, DOI 10.1211/jpp.58.6.0007
   Jiang HL, 2007, MACROMOL BIOSCI, V7, P517, DOI 10.1002/mabi.200600277
   Jiang QR, 2011, J BIOMAT SCI-POLYM E, V22, P1393, DOI 10.1163/092050610X508437
   Jiang QR, 2010, ACTA BIOMATER, V6, P4042, DOI 10.1016/j.actbio.2010.04.024
   Jiang YN, 2012, INT J PHARMACEUT, V438, P232, DOI 10.1016/j.ijpharm.2012.08.053
   John W.L., 2002, CEREAL CHEM, V79, P1
   Karthikeyan K, 2012, INT J PHARMACEUT, V438, P117, DOI 10.1016/j.ijpharm.2012.07.075
   Krishnan HB, 2011, J AGR FOOD CHEM, V59, P1223, DOI 10.1021/jf103613s
   Krishnan HB, 2010, J AGR FOOD CHEM, V58, P7323, DOI 10.1021/jf100927u
   Li JJ, 2013, J BIOMAT SCI-POLYM E, V24, P1923, DOI 10.1080/09205063.2013.808960
   Lin JT, 2012, ACS APPL MATER INTER, V4, P1050, DOI 10.1021/am201669z
   Lin LK, 2013, J TISSUE ENG REGEN M, V7, P994, DOI 10.1002/term.1493
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   Mellan I, 1961, BEHAV PLASTICISERS
   Miyoshi T, 2005, POLYM INT, V54, P1187, DOI 10.1002/pi.1829
   Neo YP, 2013, FOOD CHEM, V136, P1013, DOI 10.1016/j.foodchem.2012.09.010
   Nie W, 2012, MATER RES INNOV, V16, P14, DOI 10.1179/1433075X11Y.0000000013
   Nour A, 2013, DRUG DELIV TRANSL RE, V3, P542
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Rishi S, 2001, IND CROP PROD, V13, P171
   Selling GW, 2008, MACROMOL CHEM PHYSIC, V209, P1003, DOI 10.1002/macp.200700606
   Selling GW, 2007, MACROMOL CHEM PHYS, V208, P1002, DOI 10.1002/macp.200700056
   Song TY, 2010, CHINESE J POLYM SCI, V28, P171, DOI 10.1007/s10118-010-8239-2
   Sun G, 2013, NANOMED-NANOTECHNOL, V9, P829, DOI 10.1016/j.nano.2012.12.003
   THOMPSON GA, 1989, BIOESSAYS, V10, P108, DOI 10.1002/bies.950100404
   Torres-Giner S, 2008, FOOD HYDROCOLLOID, V22, P601, DOI 10.1016/j.foodhyd.2007.02.005
   Torres-Giner S, 2009, CARBOHYD POLYM, V77, P261, DOI 10.1016/j.carbpol.2008.12.035
   Unnithan AR, 2014, CARBOHYD POLYM, V102, P884, DOI 10.1016/j.carbpol.2013.10.070
   Wang YX, 2014, ACS APPL MATER INTER, V6, P1709, DOI 10.1021/am404624z
   Wang YX, 2012, J MATER CHEM, V22, P21592, DOI 10.1039/c2jm34611g
   Wang YX, 2012, MACROMOL MATER ENG, V297, P902, DOI 10.1002/mame.201100410
   WILSON CM, 1991, PLANT PHYSIOL, V95, P777, DOI 10.1104/pp.95.3.777
   Wongsasulak S, 2014, J FOOD ENG, V120, P110, DOI 10.1016/j.jfoodeng.2013.07.028
   Wongsasulak S, 2013, J FOOD SCI, V78, pN926, DOI 10.1111/1750-3841.12126
   Wongsasulak S, 2010, J APPL POLYM SCI, V118, P910, DOI 10.1002/app.32433
   Xu WJ, 2008, POLYM INT, V57, P1110, DOI 10.1002/pi.2450
   Yang JM, 2013, COLLOID SURFACE B, V102, P737, DOI 10.1016/j.colsurfb.2012.09.039
   Yao C, 2007, J BIOMAT SCI-POLYM E, V18, P731, DOI 10.1163/156856207781034070
   Yao C, 2007, J APPL POLYM SCI, V103, P380, DOI 10.1002/app.24619
   Yu DG, 2013, J MEMBRANE SCI, V428, P150, DOI 10.1016/j.memsci.2012.09.062
   Zamani M, 2013, INT J NANOMED, V8, P2997, DOI 10.2147/IJN.S43575
   1944, CHEM IND, V54, P670
NR 55
TC 9
Z9 9
U1 4
U2 34
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 22
BP 3199
EP 3207
DI 10.2174/1381612821666150531170448
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CM8GS
UT WOS:000357937500015
PM 26027566
DA 2018-10-20
ER

PT J
AU Nagaoka, H
AF Nagaoka, Hiroyuki
TI An HASApf-redoxin complex causing asymmetric catalytic oxidation via the
   regenerative formation of a reactive oxygen species
SO DALTON TRANSACTIONS
LA English
DT Article
ID IRON(III) PORPHYRIN COMPLEXES; OPTICALLY-ACTIVE ALCOHOLS; HEME-BINDING
   PROTEIN; ALPHA-HYDROXYLATION; HYDROGEN-PEROXIDE; BIO-CATALYSTS; PEA
   PROTEIN; RESOLUTION; CYTOCHROME-P450; BIOCATALYSIS
AB A PP (pea)-HASApf-redoxin complex eluted from encapsulated PP gel with aeration displays asymmetric oxidation activity over 200 times greater than that of a similar protein expressed by E. coli cells. The intermediate spin, identified in the ESR spectrum, appears at g = 4.3 and g = 2.0, suggesting that an iron electron-transfer system for the asymmetric oxidation of secondary alcohols may be successfully created by the PP-HASApf-redoxin complex (39 kDa). FTIR experiments provided values nu(s)(SO2) approximate to 950-1050 cm(-1) and nu(as)(SO2) approximate to 1100-1200 cm(-1) for metal-bound sulfinate S-O and Fe-O vibrations. The sulfur and iron detected by physicochemical inspection (IC/ICP-AES) may facilitate the electron transport of a sulfateiron complex (e.g., rubredoxin (6 kDa) or ferredoxin (9 kDa)) to the HASApf (21 kDa). The observations are consistently acceptable; i.e., the oxygen-driven PP-HASApf-redoxin complex functions regenerate via the successive asymmetric catalytic event - Fe(II) + O-2 -> Fe(III)-O-O- -> Fe(IV) = O (oxidizing rac-1 or rac-2) -> Fe(II) + H2O. Therefore, the use of a raw biomaterial as a PP-HASApf-redoxin complex-catalytic system for asymmetric oxidation is an important novelty, despite the apparent difficulties in working with pure dehydrogenase enzymatic/redox-cofactor systems for biotransformation.
C1 Sanyo Shokuhin Co Ltd R&D, Maebashi, Gunma 3710811, Japan.
RP Nagaoka, H (reprint author), Sanyo Shokuhin Co Ltd R&D, 555-4 Asakura, Maebashi, Gunma 3710811, Japan.
EM hnagaoka@sanyofoods.co.jp
FU Sanyo Shokuhin Co., Ltd
FX The author would like to thank Associate Prof. Osami Shoji from Nagoya
   University and Prof. Shinichi Ozaki from Yamaguchi University for
   providing the HASApf sample. Thanks to General Manager Koh Ueda from
   Wako Pure Chemical Industries Ltd, for placing SanCat-R on the market
   (PEG precipitate 2: Code No. 351-34213 (5 g)). This study was fully
   funded by Sanyo Shokuhin Co., Ltd.
CR Adam W, 1998, J AM CHEM SOC, V120, P11044, DOI 10.1021/ja981252r
   Auld DS, 2008, CELL MOL LIFE SCI, V65, P3961, DOI 10.1007/s00018-008-8593-1
   Egami H, 2007, J AM CHEM SOC, V129, P8940, DOI 10.1021/ja071916+
   Garcia-Rubio I, 2007, BIOPHYS J, V92, P1361, DOI 10.1529/biophysj.106.098277
   Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1
   Giles NM, 2003, BIOCHEM BIOPH RES CO, V300, P1, DOI 10.1016/S0006-291X(02)02770-5
   Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583
   Hirakawa H, 2010, CHEMBIOCHEM, V11, P1517, DOI 10.1002/cbic.201000226
   Ikeue T, 2001, ANGEW CHEM INT EDIT, V40, P2617, DOI 10.1002/1521-3773(20010716)40:14<2617::AID-ANIE2617>3.0.CO;2-B
   Izadi-Pruneyre N, 1999, EUR J BIOCHEM, V261, P562, DOI 10.1046/j.1432-1327.1999.00305.x
   Jepkorir G, 2010, J AM CHEM SOC, V132, P9857, DOI 10.1021/ja103498z
   Johansson AL, 2013, BIOCHEMISTRY-US, V52, P827, DOI 10.1021/bi301597a
   Kamezawa M., 1996, LIEBIGS ANN, V1996, P167
   Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106
   Lam MK, 2010, BIOTECHNOL ADV, V28, P500, DOI 10.1016/j.biotechadv.2010.03.002
   Landwehr M, 2006, J AM CHEM SOC, V128, P6058, DOI 10.1021/ja061261x
   Liou YF, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S4
   McDonald AR, 2010, J AM CHEM SOC, V132, P17118, DOI 10.1021/ja1045428
   Nagaoka H., 2003, Current Topics in Nutraceutical Research, V1, P281
   Nagaoka H, 2005, BIOTECHNOL PROGR, V21, P405, DOI 10.1021/bp0496777
   Nagaoka H, 1999, BIOSCI BIOTECH BIOCH, V63, P1991, DOI 10.1271/bbb.63.1991
   Nagaoka H, 2000, BIOSCI BIOTECH BIOCH, V64, P781, DOI 10.1271/bbb.64.781
   Nagaoka H, 2004, BIOTECHNOL PROGR, V20, P128, DOI 10.1021/bp0342046
   Nagaoka H, 2003, BIOTECHNOL PROGR, V19, P1149, DOI 10.1021/bp034059w
   Nagaoka H, 2001, BIOSCI BIOTECH BIOCH, V65, P634, DOI 10.1271/bbb.65.634
   Nagaoka H., 2014, RSC ADV, V4, P16333, DOI [10.1039/C3RA45936E, DOI 10.1039/C3RA45936E]
   Nagaoka H, 2014, ACS CATAL, V4, P553, DOI 10.1021/cs400768x
   Nagaoka H, 2012, BIOTECHNOL PROGR, V28, P953, DOI 10.1002/btpr.1580
   Ohgo Y, 2006, CHEM COMMUN, P1935, DOI 10.1039/b601412g
   Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264
   Ortiz de Montellano P.R., 2004, CYTOCHROME P450 STRU
   Ozaki S, 2014, J INORG BIOCHEM, V138, P31, DOI 10.1016/j.jinorgbio.2014.04.013
   Ozaki S, 2011, CHEM LETT, V40, P362, DOI 10.1246/cl.2011.362
   Paulsen I. T., 2005, NAT BIOTECHNOL, V23, P873
   Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039
   SAKAI M, 1995, SOIL SCI PLANT NUTR, V41, P605, DOI 10.1080/00380768.1995.10419622
   SANO S, 1986, P NATL ACAD SCI USA, V83, P531, DOI 10.1073/pnas.83.3.531
   Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237
   Shoji O, 2007, ANGEW CHEM INT EDIT, V46, P3656, DOI 10.1002/anie.200700068
   Sobolov B. S., 1996, J ORG CHEM, V61, P2125, DOI 10.1021/jo951408v
   Thakur VV, 2005, INDIAN J CHEM B, V44, P557
   Yosca TH, 2013, SCIENCE, V342, P825, DOI 10.1126/science.1244373
   Zhao ZY, 2013, RSC ADV, V3, P22008, DOI 10.1039/c3ra43382j
NR 43
TC 2
Z9 2
U1 0
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-9226
EI 1477-9234
J9 DALTON T
JI Dalton Trans.
PY 2015
VL 44
IS 29
BP 13384
EP 13393
DI 10.1039/c5dt01768h
PG 10
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA CM9IO
UT WOS:000358022300050
PM 26135291
DA 2018-10-20
ER

PT J
AU Qiu, JH
   Dong, SH
   Wang, HB
   Cheng, X
   Du, ZL
AF Qiu, Jinghong
   Dong, Shihua
   Wang, Haibo
   Cheng, Xu
   Du, Zongliang
TI Adsorption performance of low-cost gelatin-montmorillonite nanocomposite
   for Cr(III) ions
SO RSC ADVANCES
LA English
DT Article
ID TRIVALENT CHROMIUM REMOVAL; AQUEOUS-SOLUTION; ACTIVATED CARBON;
   WASTE-WATER; CR(VI) IONS; SORPTION; BINDING; BIOMASS; CLAY; CR
AB A gelatin-montmorillonite (G-MMT) nanocomposite was prepared by Na-montmorillonite (Na-MMT) and a biomaterial gelatin through an intercalation method. Samples were studied by XRD and FTIR and the results indicated that gelatin has been successfully intercalated into the interlayers of MMT. The effect of G-MMT nanocomposite adsorbed Cr(III) from aqueous solution was investigated in terms of the initial concentration of Cr(III), adsorption temperature and solution pH. The maximum adsorption capacity was 52.91 mg g(-1) for an initial Cr(III) concentration of 300 mg L-1, temperature of 343 K and pH value of 5.5. Furthermore, kinetic and isotherm models were used for the description of the adsorption process. The results demonstrated that the adsorption process was fitted to a pseudo-second-order kinetic model and the equilibrium data gave good fits with both Freundlich and Langmuir equations. The thermodynamic study revealed the endothermic and non-spontaneous nature of the adsorption process, and the increased randomness at the solid-solution interface.
C1 [Qiu, Jinghong; Dong, Shihua; Wang, Haibo; Cheng, Xu; Du, Zongliang] Sichuan Univ, Coll Light Ind Text & Food Sci Engn, Text Inst, Chengdu 610065, Peoples R China.
RP Cheng, X (reprint author), Sichuan Univ, Coll Light Ind Text & Food Sci Engn, Text Inst, Chengdu 610065, Peoples R China.
EM scuchx@163.com; dzl407@163.com
FU National Natural Science Foundation of China [51073101]; support plan of
   Science and Technology Department of Sichuan Province, China
   [2010GZ0177]
FX This work was funded by the National Natural Science Foundation of China
   (no. 51073101) and support plan of Science and Technology Department of
   Sichuan Province, China (no. 2010GZ0177).
CR Almeida MAF, 1997, WASTE MANAGE, V17, P201
   APHA (American Public Health Association), 1998, STANDARD METHODS EXA
   Aravindhan R, 2012, CLEAN TECHNOL ENVIR, V14, P727, DOI 10.1007/s10098-011-0440-7
   Bakhti A, 2001, EUR J SOIL SCI, V52, P683, DOI 10.1046/j.1365-2389.2001.00413.x
   Bhattacharyya KG, 2008, ADV COLLOID INTERFAC, V140, P114, DOI 10.1016/j.cis.2007.12.008
   Chen JH, 2013, J HAZARD MATER, V248, P285, DOI 10.1016/j.jhazmat.2013.01.042
   Chen J, 2013, J MATER SCI, V48, P7708, DOI 10.1007/s10853-013-7591-3
   Das DD, 2000, J COLLOID INTERF SCI, V232, P235, DOI 10.1006/jcis.2000.7141
   Donmez G, 2002, PROCESS BIOCHEM, V38, P751, DOI 10.1016/S0032-9592(02)00204-2
   Esfandian H, 2012, J VINYL ADDIT TECHN, V18, P250, DOI 10.1002/vnl.20310
   Fonseca-Correa R, 2013, J ANAL APPL PYROL, V101, P132, DOI 10.1016/j.jaap.2013.01.019
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Gode F, 2003, J HAZARD MATER, V100, P231, DOI 10.1016/S0304-3894(03)00110-9
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Ho YS, 1999, WATER RES, V33, P578, DOI 10.1016/S0043-1354(98)00207-3
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P183, DOI 10.1205/095758298529326
   Khezami L, 2005, J HAZARD MATER, V123, P223, DOI 10.1016/j.jhazmat.2005.04.012
   Konczyk J, 2010, DESALINATION, V263, P211, DOI 10.1016/j.desal.2010.06.061
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   LEYVARAMOS R, 1995, J CHEM TECHNOL BIOT, V62, P64, DOI 10.1002/jctb.280620110
   Li JH, 2012, J HAZARD MATER, V221, P56, DOI 10.1016/j.jhazmat.2012.04.004
   Li Q, 2007, J HAZARD MATER, V141, P163, DOI 10.1016/j.jhazmat.2006.06.109
   Li W, 2012, CHEM ENG J, V193, P88, DOI 10.1016/j.cej.2012.03.084
   Lodeiro P, 2008, ENVIRON CHEM, V5, P355, DOI 10.1071/EN08035
   Mohan D, 2006, J HAZARD MATER, V135, P280, DOI 10.1016/j.jhazmat.2005.11.075
   Oliveira DQL, 2008, J HAZARD MATER, V151, P280, DOI 10.1016/j.jhazmat.2007.11.001
   Park SJ, 2001, J COLLOID INTERF SCI, V243, P316, DOI 10.1006/jcis.2001.7910
   Romero-Gonzalez J, 2006, BIORESOURCE TECHNOL, V97, P178, DOI 10.1016/j.biortech.2005.01.037
   Sarin V, 2006, BIORESOURCE TECHNOL, V97, P15, DOI 10.1016/j.biortech.2005.02.010
   Tahir SS, 2007, SEP PURIF TECHNOL, V53, P312, DOI 10.1016/j.seppur.2006.08.008
   Tkaczyk C, 2010, J BIOMED MATER RES A, V94A, P214, DOI 10.1002/jbm.a.32700
   Vinichenko IG, 2005, RUSS J INORG CHEM+, V50, P187
   Webber W.J., 1963, J SANIT ENG DIV AM S, V89, P31
   Wu Y, 2008, BIORESOURCE TECHNOL, V99, P7709, DOI 10.1016/j.biortech.2008.01.069
   Yang ZH, 2013, J CENT SOUTH UNIV, V20, P1319, DOI 10.1007/s11771-013-1618-4
   Zhou Q, 2013, ADSORPTION, V19, P709, DOI 10.1007/s10450-013-9496-5
   Zhu J, 2011, CHEMOSPHERE, V84, P484, DOI 10.1016/j.chemosphere.2011.03.020
NR 38
TC 7
Z9 8
U1 6
U2 43
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 72
BP 58284
EP 58291
DI 10.1039/c5ra08781c
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CM6KW
UT WOS:000357798400021
DA 2018-10-20
ER

PT J
AU Peng, HS
   Chiu, DT
AF Peng, Hong-Shang
   Chiu, Daniel T.
TI Soft fluorescent nanomaterials for biological and biomedical imaging
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID SEMICONDUCTING POLYMER DOTS; AGGREGATION-INDUCED EMISSION; IN-VIVO;
   DRUG-DELIVERY; ORGANIC NANOPARTICLES; SILICA NANOPARTICLES; CLICK
   CHEMISTRY; CELLULAR UPTAKE; CONJUGATED POLYMERS; OXYGEN NANOSENSORS
AB Soft fluorescent nanomaterials have attracted recent attention as imaging agents for biological applications, because they provide the advantages of good biocompatibility, high brightness, and easy biofunctionalization. Here, we provide a survey of recent developments in fluorescent soft nano-sized biological imaging agents. Various soft fluorescent nanoparticles (NPs) (including dye-doped polymer NPs, semiconducting polymer NPs, small-molecule organic NPs, nanogels, micelles, vesicles, and biomaterial-based NPs) are summarized from the perspectives of preparation methods, structure, optical properties, and surface functionalization. Based on both optical and functional properties of the nano-sized imaging agents, their applications are then reviewed in terms of in vitro imaging, in vivo imaging, and cellular-process imaging, by means of specific or nonspecific targeting.
C1 [Peng, Hong-Shang; Chiu, Daniel T.] Univ Washington, Dept Chem, Seattle, WA 98195 USA.
   [Peng, Hong-Shang] Beijing Jiaotong Univ, Key Lab Luminescence & Opt Informat, Minist Educ, Inst Optoelect Technol, Beijing 100044, Peoples R China.
RP Chiu, DT (reprint author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.
EM chiu@chem.washington.edu
FU National Institutes of Health [R21CA186798, R01CA175215]
FX We are grateful to the National Institutes of Health (R21CA186798 and
   R01CA175215) for support of this work.
CR Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
   Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m
   Amici J, 2012, J MATER SCI, V47, P412, DOI 10.1007/s10853-011-5814-z
   An FF, 2013, J MATER CHEM B, V1, P3144, DOI 10.1039/c3tb20271b
   Averick SE, 2011, POLYM CHEM-UK, V2, P1476, DOI 10.1039/c1py00050k
   Behnke T, 2013, BIOMATERIALS, V34, P160, DOI 10.1016/j.biomaterials.2012.09.028
   Behnke T, 2012, DYES PIGMENTS, V94, P247, DOI 10.1016/j.dyepig.2012.01.021
   BENYA R, 1989, CATHETER CARDIO DIAG, V17, P231, DOI 10.1002/ccd.1810170410
   BIRKS JB, 1970, PHOTOPHYSICS AROMATI
   Brunstein M, 2013, OPT EXPRESS, V21, P26162, DOI 10.1364/OE.21.026162
   Buckle T, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/35/355101
   Bunschoten A, 2012, BIOMATERIALS, V33, P867, DOI 10.1016/j.biomaterials.2011.10.005
   Chan YH, 2012, ANAL CHEM, V84, P9431, DOI 10.1021/ac302245t
   Chan YH, 2011, ANAL CHEM, V83, P1448, DOI 10.1021/ac103140x
   Chen CY, 2011, CHEM COMMUN, V47, P994, DOI 10.1039/c0cc04450d
   Chen JI, 2013, MACROMOL BIOSCI, V13, P623, DOI 10.1002/mabi.201200396
   Chen Y, 2013, CHEM COMMUN, V49, P297, DOI 10.1039/c2cc37386f
   Cho EC, 2010, TRENDS MOL MED, V16, P561, DOI 10.1016/j.molmed.2010.09.004
   Cova L, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/24/245603
   Cu Y, 2009, NAT MATER, V8, P11, DOI 10.1038/nmat2347
   Davis CM, 2011, J PHYS CHEM C, V115, P19065, DOI 10.1021/jp206438p
   Demay-Drouhard P, 2013, CHEM-EUR J, V19, P8388, DOI 10.1002/chem.201300903
   Ding D, 2013, ADV MATER, V25, P6083, DOI 10.1002/adma.201301938
   Ding D, 2013, SMALL, V9, P3093, DOI 10.1002/smll.201300171
   Dmitriev RI, 2012, ANAL CHEM, V84, P2930, DOI 10.1021/ac3000144
   Feng LH, 2013, CHEM SOC REV, V42, P6620, DOI 10.1039/c3cs60036j
   Feng XL, 2012, ADV MATER, V24, P637, DOI 10.1002/adma.201102026
   Feng XL, 2010, ACS APPL MATER INTER, V2, P2429, DOI 10.1021/am100435k
   Fercher A, 2011, ACS NANO, V5, P5499, DOI 10.1021/nn200807g
   Fernando LP, 2010, BIOMACROMOLECULES, V11, P2675, DOI 10.1021/bm1007103
   Ferrari R, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/4/045102
   Fischer I, 2013, CHEM-EUR J, V19, P16646, DOI 10.1002/chem.201302647
   Fryd MM, 2012, ANNU REV PHYS CHEM, V63, P493, DOI 10.1146/annurev-physchem-032210-103436
   Fu GD, 2012, MACROMOL RAPID COMM, V33, P1523, DOI 10.1002/marc.201200337
   GARNETT MC, 2006, J OCCUP MED, V56, P307, DOI DOI 10.1093/OCCMED/KQL052
   Gluz E, 2013, J POLYM SCI POL CHEM, V51, P4282, DOI 10.1002/pola.26858
   Goncalves M, 2014, BIOMACROMOLECULES, V15, P492, DOI 10.1021/bm401400r
   Gong J, 2013, PROG CHEM, V25, P1928
   Goutayer M, 2010, EUR J PHARM BIOPHARM, V75, P137, DOI 10.1016/j.ejpb.2010.02.007
   Hayashi K, 2010, CHEM MATER, V22, P3768, DOI 10.1021/cm100810g
   He XX, 2012, ANAL CHEM, V84, P9056, DOI 10.1021/ac301461s
   Heintzmann R, 2009, NAT PHOTONICS, V3, P362, DOI 10.1038/nphoton.2009.102
   Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395
   Hemmer E, 2013, NANOSCALE, V5, P11339, DOI 10.1039/c3nr02286b
   Hoffmann K, 2013, ACS NANO, V7, P6674, DOI 10.1021/nn4029458
   Hong GS, 2012, NAT MED, V18, P1841, DOI 10.1038/nm.2995
   Hong YN, 2011, CHEM SOC REV, V40, P5361, DOI 10.1039/c1cs15113d
   Howes P, 2010, J AM CHEM SOC, V132, P3989, DOI 10.1021/ja1002179
   Howes P, 2009, CHEM COMMUN, P2490, DOI 10.1039/b903405f
   Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014
   Huang JG, 2011, NANO TODAY, V6, P478, DOI 10.1016/j.nantod.2011.08.002
   Jahn A, 2010, ACS NANO, V4, P2077, DOI 10.1021/nn901676x
   Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139
   Jin YH, 2011, ACS NANO, V5, P1468, DOI 10.1021/nn103304m
   Karnik R, 2008, NANO LETT, V8, P2906, DOI 10.1021/nl801736q
   Kietzke T, 2003, NAT MATER, V2, P408, DOI 10.1038/nmat889
   Kievit FM, 2011, ADV MATER, V23, pH217, DOI 10.1002/adma.201102313
   Kilin VN, 2014, BIOMATERIALS, V35, P4950, DOI 10.1016/j.biomaterials.2014.02.053
   Kim S, 2010, CHEM COMMUN, V46, P1617, DOI 10.1039/b923309a
   Kim Y, 2013, ACS NANO, V7, P9975, DOI 10.1021/nn4039063
   Kim YT, 2012, NANO LETT, V12, P3587, DOI 10.1021/nl301253v
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   Kolishetti N, 2010, P NATL ACAD SCI USA, V107, P17939, DOI 10.1073/pnas.1011368107
   Kondrashina AV, 2012, ADV FUNCT MATER, V22, P4931, DOI 10.1002/adfm.201201387
   Kurokawa N, 2004, CHEMPHYSCHEM, V5, P1609, DOI 10.1002/cphc.200400117
   Landfester K, 2002, ADV MATER, V14, P651, DOI 10.1002/1521-4095(20020503)14:9<651::AID-ADMA651>3.0.CO;2-V
   Laux EM, 2012, ANAL METHODS-UK, V4, P1759, DOI 10.1039/c2ay05822g
   Lee KJ, 2010, CHEM COMMUN, V46, P5229, DOI 10.1039/c002533j
   Lee YD, 2012, ACS NANO, V6, P6759, DOI 10.1021/nn3014905
   Lee YEK, 2010, ANAL CHEM, V82, P8446, DOI 10.1021/ac1015358
   Li JL, 2013, BIOMATERIALS, V34, P9519, DOI 10.1016/j.biomaterials.2013.08.066
   Li JT, 2013, LANGMUIR, V29, P11547, DOI 10.1021/la401990d
   Li K, 2014, CHEM SOC REV, V43, P6570, DOI 10.1039/c4cs00014e
   Li K, 2011, ADV FUNCT MATER, V21, P287, DOI 10.1002/adfm.201001435
   Li ZH, 2012, NANOSCALE, V4, P7097, DOI 10.1039/c2nr32047a
   Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847
   Liu Q, 2013, NANO LETT, V13, P2436, DOI 10.1021/nl400368v
   Louie AY, 2010, CHEM REV, V110, P3146, DOI 10.1021/cr9003538
   Ma CP, 2014, MACROMOL BIOSCI, V14, P235, DOI 10.1002/mabi.201300259
   Mackiewicz N, 2014, CHEM MATER, V26, P1834, DOI 10.1021/cm403822w
   Madsen J, 2013, J AM CHEM SOC, V135, P14863, DOI 10.1021/ja407380t
   Mahmoudi M, 2011, CHEM REV, V111, P253, DOI 10.1021/cr1001832
   Mahtab F, 2011, SMALL, V7, P1448, DOI 10.1002/smll.201002195
   Maldonado CR, 2013, COORDIN CHEM REV, V257, P2668, DOI 10.1016/j.ccr.2013.04.014
   Miki K, 2010, BIOMATERIALS, V31, P934, DOI 10.1016/j.biomaterials.2009.10.005
   Miyata K, 2011, REACT FUNCT POLYM, V71, P227, DOI 10.1016/j.reactfunctpolym.2010.10.009
   Montalti M, 2014, CHEM COMMUN, V50, P5326, DOI 10.1039/c3cc48464e
   Nalwa H. S., 2009, SOFT NANOMATERIALS
   Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714
   Ong BS, 2005, ADV MATER, V17, P1141, DOI 10.1002/adma.200401660
   Ozcan I, 2011, J PHARM SCI-US, V100, P4877, DOI 10.1002/jps.22678
   Pansare VJ, 2012, CHEM MATER, V24, P812, DOI 10.1021/cm2028367
   Papkovsky DB, 2013, CHEM SOC REV, V42, P8700, DOI 10.1039/c3cs60131e
   Park HS, 2012, MACROMOL RAPID COMM, V33, P1549, DOI 10.1002/marc.201200246
   Pecher J, 2010, CHEM REV, V110, P6260, DOI 10.1021/cr100132y
   Pecher J, 2010, BIOMACROMOLECULES, V11, P2776, DOI 10.1021/bm100854a
   Peng HS, 2010, ANGEW CHEM INT EDIT, V49, P4246, DOI 10.1002/anie.200906926
   Peng HS, 2010, ADV MATER, V22, P716, DOI 10.1002/adma.200901614
   Petkau K, 2011, J AM CHEM SOC, V133, P17063, DOI 10.1021/ja2075345
   Qiao J, 2012, J MATER CHEM, V22, P11543, DOI 10.1039/c2jm31093g
   Qin W, 2012, ADV FUNCT MATER, V22, P771, DOI 10.1002/adfm.201102191
   Reul R, 2012, POLYM CHEM-UK, V3, P694, DOI 10.1039/c2py00520d
   Rong Y, 2013, ACS NANO, V7, P376, DOI 10.1021/nn304376z
   Roy M, 2012, SMALL, V8, P1780, DOI 10.1002/smll.201102105
   Schadlich A, 2011, ACS NANO, V5, P8710, DOI 10.1021/nn2026353
   Sharma J, 2011, CHEM COMMUN, V47, P2294, DOI 10.1039/c0cc03711g
   So MK, 2006, NAT BIOTECHNOL, V24, P339, DOI 10.1038/nbt1188
   Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034
   Sun GR, 2010, NANOSCALE, V2, P548, DOI 10.1039/b9nr00304e
   Sun W, 2013, ANGEW CHEM INT EDIT, V52, P11294, DOI 10.1002/anie.201304822
   Swierczewska M, 2011, MOL IMAGING, V10, P3, DOI 10.2310/7290.2011.00001
   Szymanski C, 2005, J PHYS CHEM B, V109, P8543, DOI 10.1021/jp051062k
   Tang L, 2013, NANO TODAY, V8, P290, DOI 10.1016/j.nantod.2013.04.007
   Tantra R, 2011, NANOTOXICOLOGY, V5, P381, DOI 10.3109/17435390.2010.512987
   Tao ZM, 2013, ANGEW CHEM INT EDIT, V52, P13002, DOI 10.1002/anie.201307346
   Thielbeer F, 2011, BIOMACROMOLECULES, V12, P4386, DOI 10.1021/bm201394k
   Tosi G, 2011, J NEURAL TRANSM, V118, P145, DOI 10.1007/s00702-010-0497-1
   Tuncel D, 2010, NANOSCALE, V2, P484, DOI 10.1039/b9nr00374f
   Vollrath A, 2013, J MATER CHEM B, V1, P1994, DOI 10.1039/c3tb20089b
   Wang F, 2005, J AM CHEM SOC, V127, P10350, DOI 10.1021/ja0521730
   Wang G, 2011, CHEM MATER, V23, P4428, DOI 10.1021/cm201377u
   Wang M, 2010, PHARMACOL RES, V62, P90, DOI 10.1016/j.phrs.2010.03.005
   Wang SY, 2012, ACS NANO, V6, P6843, DOI 10.1021/nn301633m
   Wang XH, 2014, ANGEW CHEM INT EDIT, V53, P12471, DOI 10.1002/anie.201405048
   Wang XH, 2013, J MATER CHEM B, V1, P5143, DOI 10.1039/c3tb20884b
   Wang XH, 2012, J MATER CHEM, V22, P16066, DOI 10.1039/c2jm32122j
   Wang XD, 2013, SENSOR ACTUAT B-CHEM, V188, P257, DOI 10.1016/j.snb.2013.06.087
   Wang XD, 2012, J AM CHEM SOC, V134, P17011, DOI 10.1021/ja308830e
   Wang XD, 2011, CHEM SCI, V2, P901, DOI 10.1039/c0sc00610f
   Wang Y, 2012, BIOMACROMOLECULES, V13, P2585, DOI 10.1021/bm3008346
   Wang Z, 2013, BIOMATERIALS, V34, P6194, DOI 10.1016/j.biomaterials.2013.05.004
   Warnement MR, 2007, CURR NANOSCI, V3, P273, DOI 10.2174/157341307782418595
   Welsher K, 2011, P NATL ACAD SCI USA, V108, P8943, DOI 10.1073/pnas.1014501108
   Wu CF, 2006, LANGMUIR, V22, P2956, DOI 10.1021/la060188l
   Wu CF, 2011, ANGEW CHEM INT EDIT, V50, P3430, DOI 10.1002/anie.201007461
   Wu CF, 2013, ANGEW CHEM INT EDIT, V52, P3086, DOI 10.1002/anie.201205133
   Wu CF, 2010, ANGEW CHEM INT EDIT, V49, P9436, DOI 10.1002/anie.201004260
   Wu CF, 2010, J AM CHEM SOC, V132, P15410, DOI 10.1021/ja107196s
   Wu C, 2008, ACS NANO, V2, P2415, DOI 10.1021/nn800590n
   Wu CF, 2009, ANGEW CHEM INT EDIT, V48, P2741, DOI 10.1002/anie.200805894
   Wu CC, 2013, ACS NANO, V7, P5724, DOI 10.1021/nn402517v
   Wu PJ, 2014, ANAL CHEM, V86, P4831, DOI 10.1021/ac404237q
   Wu XM, 2013, CHEM SCI, V4, P1221, DOI 10.1039/c2sc22035k
   Ye DJ, 2014, NAT CHEM, V6, P519, DOI [10.1038/NCHEM.1920, 10.1038/nchem.1920]
   Ye FM, 2012, CHEM COMMUN, V48, P1778, DOI 10.1039/c2cc16486h
   Ye FM, 2011, J AM CHEM SOC, V133, P8146, DOI 10.1021/ja202945g
   Yoo L, 2012, BIOMATERIALS, V33, P6194, DOI 10.1016/j.biomaterials.2012.05.028
   Yu JB, 2012, ADV MATER, V24, P3498, DOI 10.1002/adma.201201245
   Yu JH, 2008, PHOTOCHEM PHOTOBIOL, V84, P1435, DOI 10.1111/j.1751-1097.2008.00434.x
   Zhang LZ, 2012, MACROMOL BIOSCI, V12, P83, DOI 10.1002/mabi.201100197
   Zhang XY, 2014, COLLOID SURFACE B, V113, P435, DOI 10.1016/j.colsurfb.2013.09.031
   Zhang XY, 2012, NANOSCALE, V4, P5581, DOI 10.1039/c2nr31281f
   Zhang XJ, 2012, ACS NANO, V6, P5429, DOI 10.1021/nn301308w
   Zhang Y, 2014, POLYM CHEM-UK, V5, P3824, DOI 10.1039/c4py00075g
   Zhang Y, 2013, CHEM COMMUN, V49, P8256, DOI 10.1039/c3cc44048f
   Zhou SY, 2013, POLYM CHEM-UK, V4, P4103, DOI 10.1039/c3py00522d
   Zhu LL, 2013, J AM CHEM SOC, V135, P5175, DOI 10.1021/ja400456h
   Zupke O, 2010, BIOMATERIALS, V31, P7086, DOI 10.1016/j.biomaterials.2010.05.073
NR 158
TC 128
Z9 130
U1 23
U2 309
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
EI 1460-4744
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PY 2015
VL 44
IS 14
BP 4699
EP 4722
DI 10.1039/c4cs00294f
PG 24
WC Chemistry, Multidisciplinary
SC Chemistry
GA CM4YA
UT WOS:000357691200011
PM 25531691
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Zorzi, GK
   Parraga, JE
   Seijo, B
   Sanchez, A
AF Zorzi, Giovanni K.
   Parraga, Jenny E.
   Seijo, Begona
   Sanchez, Alejandro
TI On the Biomaterials for Nanostructured Ocular Therapeutics
SO CURRENT ORGANIC CHEMISTRY
LA English
DT Article
DE Eye; nanotechnology; nanoparticles; drug delivery; biomaterial
ID SOLID LIPID NANOPARTICLES; OPHTHALMIC DRUG-DELIVERY; CHONDROITIN SULFATE
   PROTEOGLYCANS; DIFFERENT AMINE COMPOUNDS; PIGMENT EPITHELIAL-CELLS;
   POORLY ABSORBABLE DRUGS; LOADED GELATIN NANOPARTICLES; ENDOTOXIN-INDUCED
   UVEITIS; POLYMER MOLECULAR-WEIGHT; NONVIRAL GENE-TRANSFER
AB Due to its unique anatomy, drug delivery to eye structures has always been problematic. Many efforts have been addressed to enhance ocular bioavailability by lowering non-specific interactions between drug and tissue, increasing drug stability or increasing the residence time in the case of topical drugs. In this context, nanotechnology has been a very helpful tool for developing suitable drug delivery systems. More specifically, different kinds of strategies in this field have been proposed to overcome the problems related to ocular administration. However, the success of a nanoparticulated system relies on the correct choice of the material which it is made of. Based on these statements, the present article offers a review of the most important biomaterials employed in nanostructured systems for ocular drug delivery, especially those designated to delivery to the ocular surface and their impact on the final activity of such systems.
C1 [Zorzi, Giovanni K.] Univ Fed Rio Grande do Sul, Grad Program Pharmaceut Sci, Fac Pharm, BR-90610000 Porto Alegre, RS, Brazil.
   [Parraga, Jenny E.; Seijo, Begona; Sanchez, Alejandro] Univ Santiago de Compostela, Dept Pharm & Pharmaceut Technol, Fac Pharm, Santiago De Compostela 15782, Spain.
   [Seijo, Begona; Sanchez, Alejandro] Univ Clin Hosp Santiago de Compostela IDIS, Hlth Res Inst, Mol Image Grp, Santiago De Compostela 15706, Spain.
RP Sanchez, A (reprint author), Univ Santiago de Compostela, Dept Pharm & Pharmaceut Technol, Fac Pharm, Campus Sur, Santiago De Compostela 15782, Spain.
EM Alejandro.sanchez@usc.es
FU Ministry of Economy and Competitiveness of Spain [MAT2013-47501-C2-2-R];
   Xunta de Galicia (Competitive Reference Groups, FEDER Funds) [2014/043];
   CNPq/CAPES [BJT 028/2012]
FX Posthumous acknowledgement to Begona Seijo, an excellent scientist and
   professor, who was co-author of this work. This work was supported by
   grants of the Ministry of Economy and Competitiveness of Spain
   (MAT2013-47501-C2-2-R), Xunta de Galicia (Competitive Reference Groups,
   FEDER Funds, Ref. 2014/043) and CNPq/CAPES (BJT 028/2012).
CR Abdelbary G, 2011, PHARM DEV TECHNOL, V16, P44, DOI 10.3109/10837450903479988
   Adibkia K, 2007, J DRUG TARGET, V15, P407, DOI 10.1080/10611860701453125
   Almeida H, 2014, J PHARM PHARM SCI, V17, P278, DOI 10.18433/J3DP43
   Alonso MJ, 2003, J PHARM PHARMACOL, V55, P1451, DOI 10.1211/0022357022476
   ALONSO MJ, 1991, INT J PHARM, V68, P69, DOI 10.1016/0378-5173(91)90128-B
   Alonso-Sande M, 2006, MACROMOLECULES, V39, P4152, DOI 10.1021/ma060230j
   Alonso-Sande M, 2009, EUR J PHARM BIOPHARM, V72, P453, DOI 10.1016/j.ejpb.2008.02.005
   Ammar HO, 2009, AAPS PHARMSCITECH, V10, P808, DOI 10.1208/s12249-009-9268-4
   Aoyama T, 2002, J CONTROL RELEASE, V80, P345, DOI 10.1016/S0168-3659(02)00029-9
   Aragona P, 2004, CHEMISTRY AND BIOLOGY OF HYALURONAN, P529
   Aranaz I, 2009, CURR CHEM BIOL, V3, P203, DOI DOI 10.2174/187231309788166415
   Arima H, 1997, J PHARM SCI, V86, P438, DOI 10.1021/js9603865
   Asane GS, 2008, DRUG DEV IND PHARM, V34, P1246, DOI 10.1080/03639040802026012 
   ASARI A, 1992, ARCH HISTOL CYTOL, V55, P503, DOI 10.1679/aohc.55.503
   Attama AA, 2008, INT J PHARM, V355, P307, DOI 10.1016/j.ijpharm.2007.12.007
   Aukunuru JV, 2003, J PHARM PHARMACOL, V55, P1199, DOI 10.1211/0022357021701
   Barbault-Foucher S, 2002, J CONTROL RELEASE, V83, P365, DOI 10.1016/S0168-3659(02)00207-9
   Barbu E, 2006, J MATER CHEM, V16, P3439, DOI 10.1039/b605640g
   Basaran E., 2009, J MICROENCAPSUL, V27, P37
   Bejjani RA, 2005, CHIMIA, V59, P344, DOI 10.2533/000942905777676281
   Bhadra D, 2003, INT J PHARM, V257, P111, DOI 10.1016/S0378-5173(03)00132-7
   Bochot A, 2002, INVEST OPHTH VIS SCI, V43, P253
   Bochot A, 2000, PROG RETIN EYE RES, V19, P131, DOI 10.1016/S1350-9462(99)00014-2
   Borderie V, 2005, EMC OPHTALMOL, V2, P103
   Bourges JL, 2003, INVEST OPHTH VIS SCI, V44, P3562, DOI 10.1167/iovs.02-1068
   BOYLE D, 1991, INVEST OPHTH VIS SCI, V32, P1464
   Bucolo C, 2004, J PHARM PHARMACOL, V56, P841, DOI 10.1211/0022357023835
   Cai X, 2008, VISION RES, V48, P319, DOI 10.1016/j.visres.2007.07.012
   Calvo P, 1997, COLLOID POLYM SCI, V275, P46, DOI 10.1007/s003960050050
   Calvo P, 1996, J PHARM PHARMACOL, V48, P1147, DOI 10.1111/j.2042-7158.1996.tb03911.x
   Calvo P, 1997, INT J PHARM, V153, P41, DOI 10.1016/S0378-5173(97)00083-5
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   Calvo P, 1996, PHARMACEUT RES, V13, P311, DOI 10.1023/A:1016015803611
   Camelo S, 2007, MOL VIS, V13, P2263
   Carvalho ELS, 2009, METHOD ENZYMOL, V465, P289, DOI 10.1016/S0076-6879(09)65015-1
   Cavalli R, 2002, INT J PHARM, V238, P241, DOI 10.1016/S0378-5173(02)00080-7
   Chaplot SP, 2014, J PHARM PHARMACOL, V66, P542, DOI 10.1111/jphp.12104
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Cho YW, 2000, BIOMACROMOLECULES, V1, P609, DOI 10.1021/bm000036j
   Choi MJ, 2005, SKIN PHARMACOL PHYSI, V18, P209, DOI 10.1159/000086666
   Contreras-Ruiz L, 2013, GENE THER, V20, P467, DOI 10.1038/gt.2012.56
   Csaba N, 2009, ADV DRUG DELIVER REV, V61, P140, DOI 10.1016/j.addr.2008.09.005
   Cuna M, 2006, J NANOSCI NANOTECHNO, V6, P2887, DOI 10.1166/jnn.2006.435
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   de Campos AM, 2004, PHARM RES, V21, P803, DOI 10.1023/B:PHAM.0000026432.75781.cb
   De Campos AM, 2003, EUR J PHARM SCI, V20, P73, DOI 10.1016/S0928-0987(03)00178-7
   De Campos AM, 2001, INT J PHARM, V224, P159, DOI 10.1016/S0378-5173(01)00760-8
   de la Fuente M, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075105
   de la Fuente M, 2008, GENE THER, V15, P668, DOI 10.1038/gt.2008.16
   de la Fuente M, 2008, MACROMOL BIOSCI, V8, P441, DOI 10.1002/mabi.200700190
   de la Fuente M, 2008, INVEST OPHTH VIS SCI, V49, P2016, DOI 10.1167/iovs.07-1077
   de la Fuente M, 2010, ADV DRUG DELIVER REV, V62, P100, DOI 10.1016/j.addr.2009.11.026
   del Pozo-Rodriguez A, 2008, INT J PHARM, V360, P177, DOI 10.1016/j.ijpharm.2008.04.023
   del Pozo-Rodriguez A, 2007, INT J PHARM, V339, P261, DOI 10.1016/j.ijpharm.2007.02.015
   del Pozo-Rodriguez A, 2009, EUR J PHARM BIOPHARM, V71, P181, DOI 10.1016/j.ejpb.2008.09.015
   Diebold Y, 2007, BIOMATERIALS, V28, P1553, DOI 10.1016/j.biomaterials.2006.11.028
   DIEPOLD R, 1987, ARCH PHARM, V320, P909
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Dodane V, 1999, INT J PHARM, V182, P21, DOI 10.1016/S0378-5173(99)00030-7
   Dufes C, 2005, ADV DRUG DELIVER REV, V57, P2177, DOI 10.1016/j.addr.2005.09.017
   Durairaj C, 2010, INVEST OPHTH VIS SCI, V51, P5804, DOI 10.1167/iovs.10-5388
   El-Gazayerly ON, 1997, INT J PHARM, V158, P121, DOI 10.1016/S0378-5173(97)00186-5
   Elzoghby AO, 2013, J CONTROL RELEASE, V172, P1075, DOI 10.1016/j.jconrel.2013.09.019
   Fagerholm P, 1996, PROG RETIN EYE RES, V15, P281, DOI 10.1016/1350-9462(96)00004-3
   Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5
   Fattal E, 2006, ADV DRUG DELIVER REV, V58, P1203, DOI 10.1016/j.addr.2006.07.020
   Fenske DB, 2008, TOXICOL PATHOL, V36, P21, DOI 10.1177/0192623307310960
   Fialho Sílvia Ligório, 2007, Arq. Bras. Oftalmol., V70, P173, DOI 10.1590/S0004-27492007000100034
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Fukunaka Y, 2002, J CONTROL RELEASE, V80, P333, DOI 10.1016/S0168-3659(02)00026-3
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Gaudana R., 2008, PHARM RES, V26, P1197
   Giannavola C, 2003, PHARMACEUT RES, V20, P584, DOI 10.1023/A:1023290514575
   Goes RM, 2005, CURR EYE RES, V30, P405, DOI 10.1080/02713680590934148
   Graf A, 2009, EXPERT OPIN DRUG DEL, V6, P371, DOI [10.1517/17425240902870413, 10.1517/17425240902870413 ]
   Hao J, 2010, BRAIN RES BULL, V81, P256, DOI 10.1016/j.brainresbull.2009.06.011
   Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200
   Hathout RM, 2007, AAPS PHARMSCITECH, V8
   Heredero-Bermejo I, 2015, PARASITOL RES, V114, P473, DOI 10.1007/s00436-014-4205-1
   Holden CA, 2012, NANOMED-NANOTECHNOL, V8, P776, DOI 10.1016/j.nano.2011.08.018
   Hori K, 2007, J CONTROL RELEASE, V118, P169, DOI 10.1016/j.jconrel.2006.12.011
   Hosseinkhani H., 2002, J DRUG TARGET, V10, P197
   Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.cornel.2005.05.004
   Iezzi R, 2012, BIOMATERIALS, V33, P979, DOI 10.1016/j.biomaterials.2011.10.010
   Janes KA, 2003, J APPL POLYM SCI, V88, P2769, DOI 10.1002/app.12016
   Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X
   JARVINEN K, 1995, ADV DRUG DELIVER REV, V16, P3, DOI 10.1016/0169-409X(95)00010-5
   Jiang X, 2006, J GENE MED, V8, P477, DOI 10.1002/jgm.868
   Juberias JR, 1998, CURR EYE RES, V17, P39, DOI 10.1076/ceyr.17.1.39.5251
   JUBERIAS JR, 1995, INVEST OPHTH VIS SCI, V36, pS1009
   Kalam MA, 2009, J PHARM PHARMACOL, V61, pA75
   Kambhampati SP, 2015, EUR J PHARM BIOPHARM, V95, P239, DOI 10.1016/j.ejpb.2015.02.013
   Kaur A, 2008, ACTA PHARMACEUT, V58, P61, DOI 10.2478/v10007-007-0045-1
   Kaur IP, 2004, INT J PHARM, V269, P1, DOI 10.1016/j.ijpharm.2003.09.016
   Kaur IP, 2002, DRUG DEV IND PHARM, V28, P473
   Kawakami S, 2004, INT J PHARM, V278, P255, DOI 10.1016/j.ijpharm.2004.03.013
   Kawashima H, 1999, INT IMMUNOL, V11, P393, DOI 10.1093/intimm/11.3.393
   Kawashima H, 2000, TRENDS GLYCOSCI GLYC, V12, P283, DOI 10.4052/tigg.12.283
   Kinoshita S, 2001, PROG RETIN EYE RES, V20, P639, DOI 10.1016/S1350-9462(01)00007-6
   Kirker KR, 2004, J BURN CARE REHABIL, V25, P276, DOI 10.1097/01.BCR.0000124790.69026.3D
   Klang S, 2000, PHARM DEV TECHNOL, V5, P521, DOI 10.1081/PDT-100102035
   Klang SH, 1999, J CONTROL RELEASE, V57, P19, DOI 10.1016/S0168-3659(98)00107-2
   Kofuji K, 2005, EUR POLYM J, V41, P2784, DOI 10.1016/j.eurpolymj.2005.04.041
   Kompella UB, 2003, INVEST OPHTH VIS SCI, V44, P1192, DOI 10.1167/iovs.02-0791
   Zorzi GK, 2011, MOL PHARMACEUT, V8, P1783, DOI 10.1021/mp200155t
   Zorzi GK, 2011, MACROMOL BIOSCI, V11, P905, DOI 10.1002/mabi.201100005
   KOZLOV PV, 1983, POLYMER, V24, P651, DOI 10.1016/0032-3861(83)90001-0
   Kushibiki T, 2006, J CONTROL RELEASE, V112, P249, DOI 10.1016/j.jconrel.2006.02.003
   Kushibiki T, 2006, J CONTROL RELEASE, V110, P610, DOI 10.1016/j.jconrel.2005.11.007
   Kushibiki T, 2005, J CONTROL RELEASE, V105, P318, DOI 10.1016/j.jconrel.2005.02.030
   Kushibiki T, 2006, J BIOMAT SCI-POLYM E, V17, P645, DOI 10.1163/156856206777346278
   Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200
   Lajavardi L, 2007, INVEST OPHTH VIS SCI, V48, P3230, DOI 10.1167/iovs.06-1305
   Laroui H, 2007, BIOMACROMOLECULES, V8, P3879, DOI 10.1021/bm700836y
   Laude A, 2010, PROG RETIN EYE RES, V29, P466, DOI 10.1016/j.preteyeres.2010.04.003
   Law SL, 2000, J CONTROL RELEASE, V63, P135, DOI 10.1016/S0168-3659(99)00192-3
   Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5
   Lee D, 2007, PHARM RES, V24, P157, DOI 10.1007/s11095-006-9136-9
   Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6
   Lerner LE, 1998, EXP EYE RES, V67, P481, DOI 10.1006/exer.1998.0567
   Li N, 2009, INT J PHARMACEUT, V379, P131, DOI 10.1016/j.ijpharm.2009.06.020
   Li V H, 1986, J Microencapsul, V3, P213, DOI 10.3109/02652048609031575
   Li X, 2008, INT J PHARMACEUT, V363, P177, DOI 10.1016/j.ijpharm.2008.07.017
   Lopez AI, 2009, MOL BIOSYST, V5, P1148, DOI 10.1039/b904746h
   LOPEZ MI, 1995, INVEST OPHTH VIS SCI, V36, pS539
   Lopez-Cebral R, 2011, MED CHEM, V7, P145, DOI 1573-4064/11 $58.00+.00
   LOSA C, 1991, J PHARM PHARMACOL, V43, P548, DOI 10.1111/j.2042-7158.1991.tb03534.x
   LOSA C, 1992, J OCUL PHARMACOL, V8, P191, DOI 10.1089/jop.1992.8.191
   LOSA C, 1993, PHARMACEUT RES, V10, P80, DOI 10.1023/A:1018977130559
   Ludwig A, 2005, ADV DRUG DELIVER REV, V57, P1595, DOI 10.1016/j.addr.2005.07.005
   Mainardes RM, 2005, CURR DRUG TARGETS, V6, P363, DOI 10.2174/1389450053765914
   Mannermaa E, 2005, CURR EYE RES, V30, P345, DOI 10.1080/02713680590934058
   Marano RJ, 2004, EXP EYE RES, V79, P525, DOI 10.1016/j.exer.2004.06.023
   MARCHALHEUSSLER L, 1991, J FR OPHTALMOL, V14, P371
   MARCHALHEUSSLER L, 1993, PHARMACEUT RES, V10, P386, DOI 10.1023/A:1018936205485
   Maruyama-Tabata H, 2000, GENE THER, V7, P53, DOI 10.1038/sj.gt.3301044
   Mastorakos P, 2015, NANOSCALE, V7, P3845, DOI 10.1039/c4nr04284k
   Masuda I, 1996, INVEST OPHTH VIS SCI, V37, P1914
   Matsuo T, 1996, BIOCHEM BIOPH RES CO, V219, P947, DOI 10.1006/bbrc.1996.0326
   MEISNER D, 1995, ADV DRUG DELIVER REV, V16, P75, DOI 10.1016/0169-409X(95)00016-Z
   Muchow M, 2008, DRUG DEV IND PHARM, V34, P1394, DOI [10.1080/03639040802130061, 10.1080/03639040802130061 ]
   Nagarwal RC, 2009, J CONTROL RELEASE, V136, P2, DOI 10.1016/j.jconrel.2008.12.018
   Naik R, 2009, DRUG DISCOV TODAY, V14, P306, DOI 10.1016/j.drudis.2008.09.012
   Naveh N, 2000, GRAEF ARCH CLIN EXP, V238, P334, DOI 10.1007/s004170050361
   Olczyk P, 2008, POSTEP HIG MED DOSW, V62, P651
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Ooya T, 2003, J CONTROL RELEASE, V93, P121, DOI 10.1016/j.jconrel.2003.07.001
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   Paolicelli P, 2009, EXPERT OPIN DRUG DEL, V6, P239, DOI 10.1517/17425240902762818
   Pardeike J, 2009, INT J PHARMACEUT, V366, P170, DOI 10.1016/j.ijpharm.2008.10.003
   Park K, 2007, J CONTROL RELEASE, V122, P305, DOI 10.1016/j.jconrel.2007.04.009
   Parraga J. E., 2009, HUM GENE THER, V20, P1417
   Parraga JE, 2014, INT J PHARMACEUT, V477, P12, DOI 10.1016/j.ijpharm.2014.09.049
   Peeters L, 2007, BIOCHEM SOC T, V35, P47, DOI 10.1042/BST0350047
   Peeters L, 2005, INVEST OPHTH VIS SCI, V46, P3553, DOI 10.1167/iovs.05-0165
   Pignatello R, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070127
   Pignatello R, 2002, J PHARM SCI, V91, P2636, DOI 10.1002/jps.10227
   Pignatello R, 2002, BIOMATERIALS, V23, P3247, DOI 10.1016/S0142-9612(02)00080-7
   Pitkanen LH, 2001, INVEST OPHTH VIS SCI, V42, pS344
   Prego Cecilia, 2005, Expert Opin Drug Deliv, V2, P843, DOI 10.1517/17425247.2.5.843
   Prow TW, 2008, NANOMED-NANOTECHNOL, V4, P340, DOI 10.1016/j.nano.2008.06.003
   Qaddoumi MG, 2004, PHARM RES, V21, P641, DOI 10.1023/B:PHAM.0000022411.47059.76
   Rabinovich-Guilatt L, 2004, J DRUG TARGET, V12, P623, DOI 10.1080/10611860400015910
   Ranney DF, 2000, BIOCHEM PHARMACOL, V59, P105, DOI 10.1016/S0006-2952(99)00316-0
   Ravina M, 2010, MINI-REV MED CHEM, V10, P73, DOI 10.2174/138955710791112569
   Rowe R. C., 2003, HDB PHARM EXCIPIENTS, P462
   Rowe R. C., 2003, HDB PHARM EXCIPIENTS, P19
   Sahoo SK, 2008, DRUG DISCOV TODAY, V13, P144, DOI 10.1016/j.drudis.2007.10.021
   Sakai T, 2006, EXP EYE RES, V82, P657, DOI 10.1016/j.exer.2005.09.003
   Sanchez A., 2011, U.S. Patent, Patent No. 20110256059
   Sandri G, 2006, EUR J PHARM BIOPHARM, V62, P59, DOI 10.1016/j.ejpb.2005.07.002
   Sarker Dipak K., 2005, Current Drug Delivery, V2, P297, DOI 10.2174/156720105774370267
   Schipper NGM, 1999, EUR J PHARM SCI, V8, P335, DOI 10.1016/S0928-0987(99)00032-9
   Schipper NGM, 1996, PHARMACEUT RES, V13, P1686, DOI 10.1023/A:1016444808000
   Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740
   SCOTT JE, 1995, J ANAT, V187, P259
   Seki T, 2006, J PHARM SCI-US, V95, P1393, DOI 10.1002/jps.20616
   Seki T, 2007, INT J PHARM, V338, P213, DOI 10.1016/j.ijpharm.2007.02.004
   Shen J, 2009, J CONTROL RELEASE, V137, P217, DOI 10.1016/j.jconrel.2009.04.021
   Shen Y., 2007, AAPS J, V9, P371
   SHEPHERD VL, 1991, INVEST OPHTH VIS SCI, V32, P1779
   Sintzel MB, 1996, EUR J PHARM BIOPHARM, V42, P358
   Sogias IA, 2008, BIOMACROMOLECULES, V9, P1837, DOI 10.1021/bm800276d
   Souto EB, 2007, J BIOMED NANOTECHNOL, V3, P317, DOI 10.1166/jbn.2007.049
   Souto E. B., 2008, International Journal of Cosmetic Science, V30, P157, DOI 10.1111/j.1468-2494.2008.00433.x
   Spataro G, 2010, EUR J MED CHEM, V45, P326, DOI 10.1016/j.ejmech.2009.10.017
   Stanley R. G., 2008, SMALL ANIMAL CLIN PH, P557
   Sutter M, 2007, J CONTROL RELEASE, V119, P301, DOI 10.1016/j.jconrel.2007.03.003
   Sznitowska M, 1999, INT J PHARM, V184, P115, DOI 10.1016/S0378-5173(99)00106-4
   Sznitowska M, 2000, INT J PHARM, V202, P161, DOI 10.1016/S0378-5173(00)00443-9
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Tamilvanan S, 2004, PROG LIPID RES, V43, P489, DOI 10.1016/j.plipres.2004.09.001
   Tamilvanan S, 2004, EUR J PHARM BIOPHARM, V58, P357, DOI 10.1016/j.ejpb.2004.03.033
   Thakor D, 2007, MOL THER, V15, P2124, DOI 10.1038/sj.mt.6300256
   Theocharis DA, 2008, CONNECT TISSUE RES, V49, P124, DOI 10.1080/03008200802148496
   Thyagarajapuram N, 2007, J PHARM SCI-US, V96, P3363, DOI 10.1002/jps.21022
   Toropainen E, 2007, J GENE MED, V9, P208, DOI 10.1002/jgm.1011
   TREMBLAY C, 1985, INVEST OPHTH VIS SCI, V26, P711
   Vandamme TF, 2005, J CONTROL RELEASE, V102, P23, DOI 10.1016/j.jconrel.2004.09.015
   Vandervoort J, 2004, EUR J PHARM BIOPHARM, V57, P251, DOI 10.1016/s0939-6411(03)00187-5
   Vandervoort J, 1999, J Pharm Belg, V54, P85
   Vauthier C, 2003, ADV DRUG DELIVER REV, V55, P519, DOI 10.1016/S0169-409X(03)00041-3
   Vega E, 2006, J PHARM SCI-US, V95, P2393, DOI 10.1002/jps.20685
   Vega E, 2008, J PHARM SCI-US, V97, P5306, DOI 10.1002/jps.21383
   Wang WY, 2011, J PHARMACEUT BIOMED, V56, P825, DOI 10.1016/j.jpba.2011.07.017
   Weigel JA, 2003, GLYCOBIOLOGY, V13, P860
   Weigel JA, 2003, J BIOL CHEM, V278, P42802, DOI 10.1074/jbc.M307201200
   Weigel JA, 2002, BIOCHEM BIOPH RES CO, V294, P918, DOI 10.1016/S0006-291X(02)00558-2
   Wong K, 2006, BIOCONJUGATE CHEM, V17, P152, DOI 10.1021/bc0501597
   Yandrapu SK, 2013, NANOMED-NANOTECHNOL, V9, P514, DOI 10.1016/j.nano.2012.10.005
   Yang SC, 2004, PHARM RES, V21, P261, DOI 10.1023/B:PHAM.0000016238.44452.f1
   Yavuz B, 2013, SCI WORLD J, DOI 10.1155/2013/732340
   Yenice I, 2008, EXP EYE RES, V87, P162, DOI 10.1016/j.exer.2008.04.002
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4
   Zhang YQ, 2007, BIOTECHNOL APPL BIOC, V46, P197, DOI 10.1042/BA2060163
   Zhao DD, 1997, ACTA MED OKAYAMA, V51, P149
   Zillies Jan, 2005, J Pharm Pharm Sci, V7, P17
   Zillies JC, 2008, EUR J PHARM BIOPHARM, V70, P514, DOI 10.1016/j.ejpb.2008.04.026
   ZIMMER A, 1994, PHARMACEUT RES, V11, P1435, DOI 10.1023/A:1018995923348
   Zurowska-Pryczkowska K, 1999, EUR J PHARM BIOPHARM, V47, P255, DOI 10.1016/S0939-6411(98)00098-8
NR 221
TC 3
Z9 3
U1 3
U2 6
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1385-2728
EI 1875-5348
J9 CURR ORG CHEM
JI Curr. Org. Chem.
PY 2015
VL 19
IS 15
BP 1443
EP 1459
PG 17
WC Chemistry, Organic
SC Chemistry
GA CM3TL
UT WOS:000357607200001
DA 2018-10-20
ER

PT J
AU Kim, HY
   Miyazaki, S
AF Kim, Hee Young
   Miyazaki, Shuichi
TI Martensitic Transformation and Superelastic Properties of Ti-Nb Base
   Alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory effect; superelasticity; martensitic transformation;
   titanium alloy; biomaterial; alloy design; microstructure control;
   crystal structure
ID SHAPE-MEMORY BEHAVIOR; ELASTIC-DEFORMATION-BEHAVIOR;
   MECHANICAL-PROPERTIES; TITANIUM-ALLOY; BIOMEDICAL ALLOYS;
   THERMOMECHANICAL TREATMENT; CYCLIC DEFORMATION; SURFACE MODIFICATION;
   ALPHA''-MARTENSITE; HEAT-TREATMENT
AB Ti-Nb base alloys have been proposed as prospective candidates for Ni-free biomedical superelastic alloys due to their excellent mechanical properties with good biocompatibility, and many kinds of Ti-Nb base alloys exhibiting shape memory effect or superelasticity have been developed up to now. However, typical Ti-Nb base superelastic alloys show a small recovery strain which is less than one third of the recovery strain of practical Ti-Ni superelastic alloys. Over the last decade there have been extensive efforts to improve the properties of Ti-Nb base superelastic alloys through microstructure control and alloying. Low temperature annealing and aging are very effective to increase the critical stress for slip due to fine subgrain structure and precipitation hardening. The addition of interstitial alloying elements such as O and N raises the critical stress for slip and improves superelastic properties. In this paper, the roles of alloying elements on the martensitic transformation temperature, crystal structure, microstructure and deformation behavior in the Ti-Nb base alloys are reviewed and the alloy design strategy for biomedical superelastic alloys is proposed.
C1 [Kim, Hee Young; Miyazaki, Shuichi] Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
RP Kim, HY (reprint author), Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
EM heeykim@ims.tsukuba.ac.jp; miyazaki@ims.tsukuba.ac.jp
RI Kim, Hee Young/F-6065-2011; Miyazaki, Shuichi/A-3113-2012
OI Kim, Hee Young/0000-0003-1981-6678; Miyazaki,
   Shuichi/0000-0003-3849-4176
FU JSPS KAKENHI [26249104]; MEXT KAKENHI [25102704]
FX This work was partially supported by JSPS KAKENHI Grant Number 26249104
   and MEXT KAKENHI Grant Number 25102704.
CR Adharapurapu RR, 2007, EXP MECH, V47, P365, DOI 10.1007/s11340-006-9004-x
   Ahmed T, 1996, J MATER SCI, V31, P4267, DOI 10.1007/BF00356449
   Al-Zain Y, 2011, ACTA MATER, V59, P1464, DOI 10.1016/j.actamat.2010.11.008
   Al-Zain Y, 2010, ACTA MATER, V58, P4212, DOI 10.1016/j.actamat.2010.04.013
   Al-Zain Y, 2012, ACTA MATER, V60, P2437, DOI 10.1016/j.actamat.2011.12.033
   Baker C., 1971, Metal Science Journal, V5, P92
   BAKER C, 1969, PHILOS MAG, V19, P1223, DOI 10.1080/14786436908228647
   Barrabes M, 2007, J MATER SCI-MATER M, V18, P2123, DOI 10.1007/s10856-007-3012-y
   Biesiekierski A, 2012, ACTA BIOMATER, V8, P1661, DOI 10.1016/j.actbio.2012.01.018
   BOWLES JS, 1954, ACTA METALL MATER, V2, P129, DOI 10.1016/0001-6160(54)90102-9
   Buenconsejo PJS, 2009, ACTA MATER, V57, P2509, DOI 10.1016/j.actamat.2009.02.007
   Buenconsejo PJS, 2009, ACTA MATER, V57, P1068, DOI 10.1016/j.actamat.2008.10.041
   BYWATER KA, 1972, PHILOS MAG, V25, P1249, DOI 10.1080/14786437208223852
   Chai Y. W., 2008, ACTA MAT, P3088
   Chai Y. W., 2009, ACTA MAT, P4054
   Cheng Y, 2006, J MATER SCI, V41, P4961, DOI 10.1007/s10853-006-0096-6
   Chrzanowski W, 2008, J MATER SCI-MATER M, V19, P1553, DOI 10.1007/s10856-008-3374-9
   Chu CL, 2009, ACTA BIOMATER, V5, P2238, DOI 10.1016/j.actbio.2009.01.046
   Collings E. W., 1994, MAT PROPERTIES HDB T
   Cui Y, 2010, MAT SCI ENG A-STRUCT, V527, P652, DOI 10.1016/j.msea.2009.08.063
   Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   Elahinia MH, 2012, PROG MATER SCI, V57, P911, DOI 10.1016/j.pmatsci.2011.11.001
   Es-Souni M, 2005, ANAL BIOANAL CHEM, V381, P557, DOI 10.1007/s00216-004-2888-3
   Espinar E, 2011, J MATER SCI-MATER M, V22, P1119, DOI 10.1007/s10856-011-4292-9
   Farooq MU, 2014, MATER LETT, V121, P58, DOI 10.1016/j.matlet.2014.01.148
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Haider W, 2009, J MATER ENG PERFORM, V18, P760, DOI 10.1007/s11665-009-9435-5
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   Horiuchi Y, 2007, MATER TRANS, V48, P407, DOI 10.2320/matertrans.48.407
   Horiuchi Y, 2007, MATER TRANS, V48, P414, DOI 10.2320/matertrans.48.414
   Horiuchi Y, 2006, MATER TRANS, V47, P1209, DOI 10.2320/matertrans.47.1209
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   Hosoda H., 2006, MATER SCI FORUM, V638-642, P2046
   Ijaz MF, 2014, SCRIPTA MATER, V72-73, P29, DOI 10.1016/j.scriptamat.2013.10.007
   Inamura T, 2007, PHILOS MAG, V87, P3325, DOI 10.1080/14786430601003874
   Inamura T, 2005, MAT SCI ENG C-BIO S, V25, P426, DOI 10.1016/j.msec.2005.01.025
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   Inamura T, 2013, PHILOS MAG, V93, P618, DOI 10.1080/14786435.2012.725955
   Inamura T., 2010, PHILOS MAG, P3475
   Jepson K.S., 1970, SCI TECHNOLOGY APPL, P677
   Kent D, 2010, MAT SCI ENG A-STRUCT, V527, P2246, DOI 10.1016/j.msea.2009.11.059
   Kim H., 2014, MAT JAPAN, V53, P11
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V438, P839, DOI 10.1016/j.msea.2006.02.136
   Kim HY, 2007, MATER TRANS, V48, P400, DOI 10.2320/matertrans.48.400
   Kim HY, 2013, ACTA MATER, V61, P4874, DOI 10.1016/j.actamat.2013.04.060
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V417, P120, DOI 10.1016/j.msea.2005.10.065
   Kim HY, 2006, ACTA MATER, V54, P423, DOI 10.1016/j.actamat.2005.09.014
   Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Kim JI, 2006, MATER TRANS, V47, P505, DOI 10.2320/matertrans.47.505
   Kim JI, 2005, MAT SCI ENG A-STRUCT, V403, P334, DOI 10.1016/j.msea.2005.05.050
   Kim JI, 2005, MATER TRANS, V46, P852, DOI 10.2320/matertrans.46.852
   Kujala S, 2004, BIOMATERIALS, V25, P353, DOI 10.1016/S0142-9612(03)00488-5
   Li Q, 2012, MAT SCI ENG A-STRUCT, V536, P197, DOI 10.1016/j.msea.2011.12.103
   Li QA, 2010, AUSTRALAS PHYS ENG S, V33, P129, DOI 10.1007/s13246-010-0022-8
   Ma LW, 2013, INTERMETALLICS, V32, P44, DOI 10.1016/j.intermet.2012.07.024
   MACKENZIE JK, 1954, ACTA METALL MATER, V2, P138, DOI 10.1016/0001-6160(54)90103-0
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   Michiardi A, 2006, J BIOMED MATER RES B, V77B, P249, DOI 10.1002/jbm.b.30441
   Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054
   MIYAZAKI S, 1986, METALL TRANS A, V17, P115, DOI 10.1007/BF02644447
   MIYAZAKI S, 1989, ISIJ INT, V29, P353, DOI 10.2355/isijinternational.29.353
   MIYAZAKI S, 1986, METALL TRANS A, V17, P53, DOI 10.1007/BF02644442
   Miyazaki S, 2007, MATER SCI FORUM, V561-565, P5, DOI 10.4028/www.scientific.net/MSF.561-565.5
   MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135
   Moneim MS, 2002, CLIN ORTHOP RELAT R, P251
   MORNIROLI JP, 1973, MEM ETUD SCI REV MET, V70, P831
   Nii Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214104
   Niinomi M, 2008, MAT SCI ENG C-BIO S, V28, P406, DOI 10.1016/j.msec.2007.04.028
   Nozoe F, 2007, MATER TRANS, V48, P3007, DOI 10.2320/matertrans.MER2007182
   Obbard EG, 2011, ACTA MATER, V59, P112, DOI 10.1016/j.actamat.2010.09.015
   Otsuka K., 1998, SHAPE MEMORY MAT
   Pavon LL, 2015, SCRIPTA MATER, V95, P46, DOI 10.1016/j.scriptamat.2014.09.029
   Ping DH, 2005, SCRIPTA MATER, V52, P1287, DOI 10.1016/j.scriptamat.2005.02.029
   Pond RC, 2003, INT MATER REV, V48, P225, DOI 10.1179/095066003225010245
   Ramarolahy A, 2012, J MECH BEHAV BIOMED, V9, P83, DOI 10.1016/j.jmbbm.2012.01.017
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P363, DOI 10.1016/j.msec.2004.12.014
   Sasano H., 1985, P 5 INT C TIT, P1667
   Singh R, 2007, J MATER SCI-MATER M, V18, P725, DOI 10.1007/s10856-006-0016-y
   Sun F, 2011, J MECH BEHAV BIOMED, V4, P1864, DOI 10.1016/j.jmbbm.2011.06.003
   Sun F, 2011, MAT SCI ENG A-STRUCT, V528, P7811, DOI 10.1016/j.msea.2011.06.052
   Tada H, 2012, MATER TRANS, V53, P1981, DOI 10.2320/matertrans.M2012184
   Tahara M, 2009, ACTA MATER, V57, P2461, DOI 10.1016/j.actamat.2009.01.037
   Tahara M, 2014, ACTA MATER, V80, P317, DOI 10.1016/j.actamat.2014.07.012
   Tahara M, 2013, J ALLOY COMPD, V577, pS404, DOI 10.1016/j.jallcom.2011.12.113
   Tahara M, 2011, ACTA MATER, V59, P6208, DOI 10.1016/j.actamat.2011.06.015
   Tahara M, 2010, MAT SCI ENG A-STRUCT, V527, P6844, DOI 10.1016/j.msea.2010.07.052
   Tahara M, 2009, MATER TRANS, V50, P2726, DOI 10.2320/matertrans.MA200907
   Tahara M, 2009, FUNCT MATER LETT, V2, P79, DOI 10.1142/S1793604709000600
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   WECHSLER MS, 1953, T AM I MIN MET ENG, V197, P1503
   Williams J. C., 1973, P 2 INT C TIT, P1433
   Yamauchi K, 2011, SHAPE MEMORY AND SUPERELASTIC ALLOYS: TECHNOLOGIES AND APPLICATIONS, P1, DOI 10.1533/9780857092625
   Yang Y, 2014, J ALLOY COMPD, V591, P85, DOI 10.1016/j.jallcom.2013.12.207
   Yoneyama T, 2008, WOODHEAD PUBL MATER, P1
   Zhang DC, 2013, J MECH BEHAV BIOMED, V20, P29, DOI 10.1016/j.jmbbm.2013.01.015
   Zhang JY, 2013, MAT SCI ENG A-STRUCT, V563, P78, DOI 10.1016/j.msea.2012.11.045
   Zhou T, 2004, SCRIPTA MATER, V50, P343, DOI 10.1016/j.scriptamat.2003.10.012
   Zhu YF, 2012, J MECH BEHAV BIOMED, V12, P151, DOI 10.1016/j.jmbbm.2012.02.010
NR 102
TC 20
Z9 20
U1 2
U2 68
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PY 2015
VL 56
IS 5
BP 625
EP 634
DI 10.2320/matertrans.M2014454
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CM4YB
UT WOS:000357691400002
OA Bronze
DA 2018-10-20
ER

PT J
AU Roch, T
   Ma, N
   Kratz, K
   Lendlein, A
AF Roch, Toralf
   Ma, Nan
   Kratz, Karl
   Lendlein, Andreas
TI Cell-based detection of microbial biomaterial contaminations
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Biomaterials; polymers; endotoxins; microbial contaminations;
   immuno-compatibility
ID PATTERN-RECOGNITION RECEPTORS; ENDOTHELIAL-CELLS; INNATE IMMUNITY;
   IN-VIVO; ENDOTOXIN; TOLL; ADHESION; BACTERIAL; LIPOPOLYSACCHARIDE;
   REGULATORS
AB A major challenge in biomaterial synthesis and functionalization is the prevention of microbial contaminations such as endotoxins (lipopolysaccharides (LPS)). In addition to LPS, which are exclusively expressed by Gram negative bacteria, also other microbial products derived from fungi or Gram positive bacteria can be found as contaminations in research laboratories. Typically, the Limulus amebocyte lysate (LAL)-test is used to determine the endotoxin levels of medical devices. However, this test fails to detect material-bound LPS and other microbial contaminations and, as demonstrated in this study, detects LPS from various bacterial species with different sensitivities.
   In this work, a cell-based assay using genetically engineered RAW macrophages, which detect not only soluble but also material-bound microbial contaminations is introduced.
   The sensitivity of this cell-line towards different LPS species and different heat-inactivated microbes was investigated. As proof of principle a soft hydrophobic poly(n-butyl acrylate) network (cPnBA), which may due to adhesive properties strongly bind microbes, was deliberately contaminated with heat-inactivated bacteria. While the LAL-test failed to detect the microbial contamination, the cell-based assay clearly detected material-bound microbial contaminations. Our data demonstrate that a cell-based detection system should routinely be used as supplement to the LAL-test to determine microbial contaminations of biomaterials.
C1 [Roch, Toralf; Ma, Nan; Kratz, Karl; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Roch, Toralf; Ma, Nan; Kratz, Karl; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-14513 Teltow, Germany.
   [Roch, Toralf; Ma, Nan; Kratz, Karl; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Biomat Med, Teltow, Germany.
   [Roch, Toralf; Ma, Nan; Kratz, Karl; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Biomat Med, Berlin, Germany.
   [Ma, Nan; Lendlein, Andreas] Free Univ Berlin, Inst Chem & Biochem, Dept Biol, Chem & Pharm, Berlin, Germany.
   [Lendlein, Andreas] Univ Potsdam, Inst Chem, Potsdam, Germany.
RP Roch, T (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM toralf.roch@hzg.de
RI Ma, Nan/L-1282-2013; Kratz, Karl/K-7115-2013; Lendlein,
   Andreas/K-9553-2013
OI Ma, Nan/0000-0003-4006-1003; Kratz, Karl/0000-0002-9229-4266; Lendlein,
   Andreas/0000-0003-4126-4670; Roch, Toralf/0000-0003-2948-8700
FU German Federal Ministry of Education and Research (BMBF) [276 0315696A]
FX The authors thank German Federal Ministry of Education and Research
   (BMBF project number 276 0315696A 'Poly4Bio BB') for financial support
   as well as Anja Muller-Heyn, Angelika Ritschel, and Ruth Hesse for their
   technical assistance.
CR [Anonymous], 1987, GUID VAL LIM AM LYS, P1
   Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202
   Bar-Shavit Z, 2008, AUTOIMMUNITY, V41, P195, DOI 10.1080/08916930701694469
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Brandenburg K, 1996, J ENDOTOXIN RES, V3, P173, DOI 10.1177/096805199600300302
   Braune S., 2013, BIOINTERPHASES, V8, P30, DOI DOI 10.1186/1559-4106-8-33
   COOPER JF, 1990, J PARENT SCI TECHN, V44, P13
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P126, DOI 10.1002/pat.1816
   English K, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015560
   Furlani D, 2012, J CELL MOL MED, V16, P1094, DOI 10.1111/j.1582-4934.2011.01381.x
   GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   Hirayama C, 2002, J CHROMATOGR B, V781, P419, DOI 10.1016/S1570-0232(02)00430-0
   Hwang Jeong-Min, 2012, BMC Res Notes, V5, P78, DOI 10.1186/1756-0500-5-78
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Lendlein A, 2011, EXPERT REV MED DEVIC, V8, P533, DOI [10.1586/erd.11.39, 10.1586/ERD.11.39]
   Lendlein A, 2011, INT J ARTIF ORGANS, V34, P71, DOI 10.5301/IJAO.2011.6422
   Lewis JS, 2014, MRS BULL, V39, P25, DOI 10.1557/mrs.2013.310
   Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5
   Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156
   Neffe AT, 2013, MACROMOL BIOSCI, V13, P1720, DOI 10.1002/mabi.201300309
   Peter S.L., 2007, DRUGS PHARM SCI, V167, P361
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0
   RIETSCHEL ET, 1994, FASEB J, V8, P217
   Roch T, 2012, CLIN HEMORHEOL MICRO, V50, P131, DOI 10.3233/CH-2010-1449
   Roch T, 2012, CLIN HEMORHEOL MICRO, V52, P375, DOI 10.3233/CH-2012-1612
   Roch T, 2011, MACROMOL SYMP, V309-310, P182, DOI 10.1002/masy.201100048
   ROSLANSKY PF, 1991, J CLIN MICROBIOL, V29, P2477
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979
   SWEADNER KJ, 1977, APPL ENVIRON MICROB, V34, P382
   Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tanford C., 1980, HYDROPHOBIC EFFECT F, P233
   Tuladhar E, 2012, APPL ENVIRON MICROB, V78, P7769, DOI 10.1128/AEM.02144-12
   Vijayakumar R., 2012, EUROPEAN J PARENTERA, V17, P4
   Williams K.L., 2007, DRUGS PHARM SCI, V167, P27
   Williams K.L., 2007, DRUGS PHARM SCI, V167, P191
   Wischke C, 2012, J CONTROL RELEASE, V164, P299, DOI 10.1016/j.jconrel.2012.06.034
   Yoshikawa HY, 2012, J PHYS CHEM B, V116, P8024, DOI 10.1021/jp212385p
NR 43
TC 2
Z9 2
U1 0
U2 5
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2015
VL 60
IS 1
BP 51
EP 63
DI 10.3233/CH-151939
PG 13
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CM3SX
UT WOS:000357605600006
PM 25818158
DA 2018-10-20
ER

PT J
AU van der Stok, J
   Koolen, MKE
   de Maat, MPM
   Yavari, SA
   Alblas, J
   Patka, P
   Verhaar, JAN
   van Lieshout, EMM
   Zadpoor, AA
   Weinans, H
   Jahr, H
AF van der Stok, J.
   Koolen, M. K. E.
   de Maat, M. P. M.
   Yavari, S. Amin
   Alblas, J.
   Patka, P.
   Verhaar, J. A. N.
   van Lieshout, E. M. M.
   Zadpoor, A. A.
   Weinans, H.
   Jahr, H.
TI FULL REGENERATION OF SEGMENTAL BONE DEFECTS USING POROUS TITANIUM
   IMPLANTS LOADED WITH BMP-2 CONTAINING FIBRIN GELS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE BMP; bone graft; bone regeneration; fibrin; metal surface treatment;
   scaffold; titanium
ID HEPARIN-CONJUGATED FIBRIN; COLLOIDAL GELATIN GELS; MORPHOGENETIC
   PROTEIN-2; IN-VIVO; ORTHOPEDIC APPLICATIONS; MECHANICAL-PROPERTIES;
   TI-6AL-4V STRUCTURES; CONTROLLED DELIVERY; SUSTAINED DELIVERY;
   GROWTH-FACTORS
AB Regeneration of load-bearing segmental bone defects is a major challenge in trauma and orthopaedic surgery. The ideal bone graft substitute is a biomaterial that provides immediate mechanical stability, while stimulating bone regeneration to completely bridge defects over a short period. Therefore, selective laser melted porous titanium, designed and fine-tuned to tolerate full load-bearing, was filled with a physiologically concentrated fibrin gel loaded with bone morphogenetic protein-2 (BMP-2). This biomaterial was used to graft critical-sized segmental femoral bone defects in rats. As a control, porous titanium implants were either left empty or filled with a fibrin gels without BMP-2. We evaluated bone regeneration, bone quality and mechanical strength of grafted femora using in vivo and ex vivo mu CT scanning, histology, and torsion testing. This biomaterial completely regenerated and bridged the critical-sized bone defects within eight weeks. After twelve weeks, femora were anatomically re-shaped and revealed open medullary cavities. More importantly, new bone was formed throughout the entire porous titanium implants and grafted femora regained more than their innate mechanical stability: torsional strength exceeded twice their original strength. In conclusion, combining porous titanium implants with a physiologically concentrated fibrin gels loaded with BMP-2 improved bone regeneration in load-bearing segmental defects. This material combination now awaits its evaluation in larger animal models to show its suitability for grafting load-bearing defects in trauma and orthopaedic surgery.
C1 [van der Stok, J.; Koolen, M. K. E.; Verhaar, J. A. N.] Erasmus Univ, Med Ctr Rotterdam, Dept Orthopaed, Orthopaed Res Lab, Rotterdam, Netherlands.
   [Koolen, M. K. E.; Alblas, J.; Weinans, H.] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.
   [de Maat, M. P. M.] Erasmus Univ, Med Ctr Rotterdam, Dept Haematol, Rotterdam, Netherlands.
   [Yavari, S. Amin; Zadpoor, A. A.; Weinans, H.] Delft Univ Technol, Dept Biomed Engn, Delft, Netherlands.
   [Patka, P.] Erasmus Univ, Med Ctr Rotterdam, Dept Orthopaed, Dept Emergency Med, Rotterdam, Netherlands.
   [van Lieshout, E. M. M.] Erasmus Univ, Med Ctr Rotterdam, Dept Surg, Trauma Res Unit, Rotterdam, Netherlands.
   [Weinans, H.] Univ Med Ctr Utrecht, Dept Rheumatol, Utrecht, Netherlands.
   [Jahr, H.] Univ Hosp RWTH Aachen, Dept Orthopaed Surg, Aachen, Germany.
RP van der Stok, J (reprint author), Room Ee1614,Box 2040, NL-3000 CA Rotterdam, Netherlands.
EM j.vanderstok@erasmusmc.nl
RI Zadpoor, Amir A/A-8510-2008; Amin Yavari, Saber/G-9486-2013; Jahr,
   Holger/M-3099-2015; Amin Yavari, Saber/E-5360-2017
OI Amin Yavari, Saber/0000-0003-1677-5751; Jahr,
   Holger/0000-0001-7308-5584; Amin Yavari, Saber/0000-0003-1677-5751;
   Verhaar, Jan/0000-0003-3016-9600; Zadpoor, Amir
   Abbas/0000-0003-3234-2112
FU Dutch Ministry of Economic Affair; Dutch government [FES0908];
   START-Program of the Faculty of Medicine, RWTH Aachen; Osteosynthesis &
   Trauma Care foundation [2011-HWJV]; Project BONE-IP of the research
   program of the BioMedical Materials institute [P2.04]
FX This research forms part of the Project P2.04 BONE-IP of the research
   program of the BioMedical Materials institute, co-funded by the Dutch
   Ministry of Economic Affair and was supported by a grant from the Dutch
   government to The Netherlands Institute for Regenerative Medicine (NIRM,
   grant No. FES0908). This research project was further supported by the
   START-Program of the Faculty of Medicine, RWTH Aachen. Osteosynthesis &
   Trauma Care foundation is acknowledged for financial support
   (2011-HWJV).
CR Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790
   An YH, 1999, ANIMAL MODELS ORTHOP
   Angle SR, 2012, J MUSCULOSKEL NEURON, V12, P28
   Bandyopadhyay A, 2010, ACTA BIOMATER, V6, P1640, DOI 10.1016/j.actbio.2009.11.011
   Bandyopadhyay A, 2009, J MATER SCI-MATER M, V20, P29, DOI 10.1007/s10856-008-3478-2
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513
   Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029
   de Wild M, 2013, TISSUE ENG PT A, V19, P2645, DOI [10.1089/ten.tea.2012.0753, 10.1089/ten.TEA.2012.0753]
   Diefenderfer DL, 2003, J BONE JOINT SURG AM, V85A, P19, DOI 10.2106/00004623-200300003-00005
   EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   GIANNOUDIS PV, 2011, INJURY S2, V42, pS1
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013
   Hollander DA, 2006, BIOMATERIALS, V27, P955, DOI 10.1016/j.biomaterials.2005.07.041
   HOLM B, 1985, THROMB RES, V37, P165, DOI 10.1016/0049-3848(85)90043-X
   Hrabe NW, 2011, J BIOMED MATER RES B, V99B, P313, DOI 10.1002/jbm.b.31901
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Kaijzel EL, 2006, J THROMB HAEMOST, V4, P1975, DOI 10.1111/j.1538-7836.2006.02081.x
   Kaipel M, 2012, J ORTHOP RES, V30, P1563, DOI 10.1002/jor.22132
   Khan SN, 2004, EXPERT OPIN BIOL TH, V4, P741
   Kim SS, 2008, J BIOMED MATER RES A, V87A, P245, DOI 10.1002/jbm.a.31782
   KIRKERHEAD CA, 1995, VET SURG, V24, P408, DOI 10.1111/j.1532-950X.1995.tb01352.x
   Koo KH, 2012, ARTIF ORGANS, V36, P629, DOI 10.1111/j.1525-1594.2012.01444.x
   Koo KH, 2013, ARTIF ORGANS, V37, P487, DOI 10.1111/j.1525-1594.2012.01578.x
   La WG, 2012, ARTIF ORGANS, V36, P642, DOI 10.1111/j.1525-1594.2011.01420.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Milleret V, 2011, EUR CELLS MATER, V21, P430, DOI 10.22203/eCM.v021a32
   Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219
   Murakami N, 2002, J BIOMED MATER RES, V62, P169, DOI 10.1002/jbm.10236
   Murr LE, 2011, J MECH BEHAV BIOMED, V4, P1396, DOI 10.1016/j.jmbbm.2011.05.010
   Murr LE, 2010, PHILOS T R SOC A, V368, P1999, DOI 10.1098/rsta.2010.0010
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Nurnberger S, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P237, DOI 10.1007/978-3-7091-0286-2_16
   Onishi T, 1998, BONE, V22, P605, DOI 10.1016/S8756-3282(98)00056-8
   Pape HC, 2010, J ORTHOP TRAUMA, V24, pS36, DOI 10.1097/BOT.0b013e3181cec4a1
   Peterbauer-Scherb A, 2012, J TISSUE ENG REGEN M, V6, P434, DOI 10.1002/term.446
   Ponader S, 2010, J BIOMED MATER RES A, V92A, P56, DOI 10.1002/jbm.a.32337
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Ryan G, 2009, J BIOMED MATER RES B, V90B, P894, DOI 10.1002/jbm.b.31361
   Schmoekel H, 2004, J ORTHOPAED RES, V22, P376, DOI 10.1016/S0736-0266(03)00188-8
   Schmokel HG, 2004, VET SURG, V33, P112, DOI [10.1111/j.1532-950x.2004.04018.x, 10.1111/j.1532-950X.2004.04018.x]
   Schutzenberger S, 2012, ARCH ORTHOP TRAUM SU, V132, P1363, DOI 10.1007/s00402-012-1551-2
   Seebach E, 2014, ACTA BIOMATER, V10, P4730, DOI 10.1016/j.actbio.2014.07.017
   Senta H, 2009, CYTOKINE GROWTH F R, V20, P213, DOI 10.1016/j.cytogfr.2009.05.006
   Stamp R, 2009, J MATER SCI-MATER M, V20, P1839, DOI 10.1007/s10856-009-3763-8
   Stefan U, 2010, BONE, V47, P1048, DOI 10.1016/j.bone.2010.08.012
   Termaat MF, 2005, J BONE JOINT SURG AM, V87A, P1367, DOI 10.2106/JBJS.D.02585
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   van der Stok J, 2013, TISSUE ENG PT A, V19, P2605, DOI [10.1089/ten.tea.2013.0181, 10.1089/ten.TEA.2013.0181]
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   Wang HN, 2013, J CONTROL RELEASE, V166, P172, DOI 10.1016/j.jconrel.2012.12.015
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Woo EJ, 2013, CLIN ORTHOP RELAT R, V471, P1707, DOI 10.1007/s11999-012-2684-x
   Yang HS, 2010, TISSUE ENG PT A, V16, P1225, DOI [10.1089/ten.tea.2009.0390, 10.1089/ten.TEA.2009.0390]
   Yang HS, 2012, EXP MOL MED, V44, P350, DOI 10.3858/emm.2012.44.5.039
   Yavari SA, 2014, J MECH BEHAV BIOMED, V36, P109, DOI 10.1016/j.jmbbm.2014.04.010
   Yavari SA, 2013, MAT SCI ENG C-MATER, V33, P4849, DOI 10.1016/j.msec.2013.08.006
   Yavari SA, 2014, BIOMATERIALS, V35, P6172, DOI 10.1016/j.biomaterials.2014.04.054
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
NR 69
TC 20
Z9 20
U1 1
U2 16
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2015
VL 29
BP 141
EP 154
DI 10.22203/eCM.v029a11
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA CL6TY
UT WOS:000357101500007
PM 25738583
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Kunz, F
   Rebl, H
   Quade, A
   Matschegewski, C
   Finke, B
   Nebe, JB
AF Kunz, F.
   Rebl, H.
   Quade, A.
   Matschegewski, C.
   Finke, B.
   Nebe, J. B.
TI OSTEOBLASTS WITH IMPAIRED SPREADING CAPACITY BENEFIT FROM THE POSITIVE
   CHARGES OF PLASMA POLYMERISED ALLYLAMINE
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Osteoblast function; actin cytoskeleton; vinculin; spreading;
   cytochalasin D; titanium; surface modification; plasma polymerised
   allylamine; surface charge
ID TITANIUM SURFACES; FOCAL ADHESION; CELL-ADHESION; IN-VITRO; SUBCHONDRAL
   BONE; ACTIN; OSTEOARTHRITIS; OSTEOPOROSIS; MG-63; ORGANIZATION
AB Bone diseases such as osteoporosis, osteoarthritis and rheumatoid arthritis, impinge on the performance of orthopaedic implants by impairing bone regeneration. For this reason, the development of effective surface modifications supporting the ingrowth of implants in morbid bone tissue is essential. Our study is designed to elucidate if cells with restricted cell-function limiting adhesion processes benefit from plasma polymer deposition on titanium. We used the actin filament disrupting agent cytochalasin D (CD) as an experimental model for cells with impaired actin cytoskeleton. Indeed, the cell's capacity to adhere and spread was drastically reduced due to shortened actin filaments and vinculin contacts that were smaller. The coating of titanium with a positively charged nanolayer of plasma polymerised allylamine (PPAAm) abrogated these disadvantages in cell adhesion and the CD-treated osteoblasts were able to spread significantly. Interestingly, PPAAm increased spreading by causing enhanced vinculin number and contact length, but without significantly reorganising actin filaments. PPAAm with the monomer allylamine was deposited in a microwave-excited low-pressure plasma-processing reactor. Cell physiology was monitored by flow cytometry and confocal laser scanning microscopy, and the length and number of actin filaments was quantified by mathematical image processing. We showed that biomaterial surface modification with PPAAm could be beneficial even for osteoblasts with impaired cytoskeleton components. These insights into in vitro conditions may be used for the evaluation of future strategies to design implants for morbid bone tissue.
C1 [Kunz, F.; Rebl, H.; Matschegewski, C.; Nebe, J. B.] Univ Med Ctr Rostock, Dept Cell Biol, D-18057 Rostock, Germany.
   [Kunz, F.] Univ Rostock, Fac Interdisciplinary Res, D-18055 Rostock, Germany.
   [Quade, A.; Finke, B.] Leibniz Inst Plasma Sci & Technol eV INP, Greifswald, Germany.
   [Matschegewski, C.] Univ Rostock, Fac Agr & Environm Sci, D-18055 Rostock, Germany.
RP Nebe, JB (reprint author), Univ Med Ctr Rostock, Dept Cell Biol, Schillingallee 69, D-18057 Rostock, Germany.
EM barbara.nebe@med.uni-rostock.de
OI Finke, Birgit/0000-0002-5941-0376
FU European Union; State Ministry of Economic Affairs, Employment and
   Tourism of Mecklenburg-Vorpommern in Germany [EFRE:
   V220-630-08-TFMV-F-009, ESV: V220-630-08-TFMV-S-009]; DFG Research
   Training Group welisa [GRK 1505/1]; project Campus Plasma-Med (BMBF)
   [13N9779, 13N11188/INP, 13N9775, 13N11183/Cell Biol.]
FX The author FK is grateful to the European Union and to the State
   Ministry of Economic Affairs, Employment and Tourism of
   Mecklenburg-Vorpommern in Germany for financial support within the joint
   project Tissue Regeneration (GEREMA) (EFRE: V220-630-08-TFMV-F-009, ESV:
   V220-630-08-TFMV-S-009). We acknowledge the financial support of CM and
   FK by the DFG Research Training Group welisa (GRK 1505/1). BF and HR
   were financially supported by the project Campus Plasma-Med (BMBF,
   13N9779 and 13N11188/INP, 13N9775 and 13N11183/Cell Biol.). We
   acknowledge the excellent technical help of Janine Wetzel (BMBF,
   13N11183) and the valuable scientific input of Dr. Ulrike Bulnheim. We
   wish to confirm that there are no known conflicts of interest associated
   with this publication and there has been no significant financial
   support for this work that could have influenced its outcome.
CR Abbas A, 2009, COLLOID SURFACE B, V73, P315, DOI 10.1016/j.colsurfb.2009.06.007
   Beil FT, 2008, EUR J TRAUMA EMERG S, V34, P527, DOI 10.1007/s00068-008-8201-y
   Birkholz H, 2011, PROC SPIE, V8000, DOI 10.1117/12.895269
   Birkholz H, 2011, J COMPUT APPL MATH, V235, P2502, DOI 10.1016/j.cam.2010.11.003
   Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245
   Bray D, 1992, CELL MOVEMENTS, P75
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   CLOVER J, 1992, J CELL SCI, V103, P267
   Corrado A, 2005, CLIN RHEUMATOL, V24, P527, DOI 10.1007/s10067-005-1100-2
   Czekanska EM, 2012, EUR CELLS MATER, V24, P1
   DEQUEKER J, 1993, ARTHRITIS RHEUM, V36, P1702, DOI 10.1002/art.1780361209
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   El Miedany YM, 2000, JOINT BONE SPINE, V67, P521, DOI 10.1016/S1297-319X(00)00218-9
   Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451
   Finke B, 2011, SURF COAT TECH, V205, pS520, DOI 10.1016/j.surfcoat.2010.12.044
   Finke B, 2011, P INT PLASM CHEM SOC
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Finke B, 2014, LANGMUIR, V30, P13914, DOI 10.1021/la5019778
   Gabler C, 2014, INT J MOL SCI, V15, P2454, DOI 10.3390/ijms15022454
   Gonzalez R.C, 2008, DIGITAL IMAGE PROCES
   Hagiwara A, 2011, CYTOSKELETON, V68, P512, DOI 10.1002/cm.20528
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Hilal G, 1998, ARTHRITIS RHEUM, V41, P891, DOI 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X
   Hoene A, 2010, ACTA BIOMATER, V6, P676, DOI 10.1016/j.actbio.2009.09.003
   Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036
   Intranuovo F, 2011, ACTA BIOMATER, V7, P3336, DOI 10.1016/j.actbio.2011.05.020
   Kartsogiannis V, 2004, MOL CELL ENDOCRINOL, V228, P79, DOI 10.1016/j.mce.2003.06.002
   Klein-Nulend J, 2003, ADV SPACE RES, V32, P1551, DOI 10.1016/S0273-1177(03)00488-5
   LAJEUNESSE D, 1990, J BONE MINER RES, V5, P915
   Lajeunesse D, 2003, CURR OPIN RHEUMATOL, V15, P628, DOI 10.1097/00002281-200309000-00018
   Lanniel M, 2011, THIN SOLID FILMS, V519, P2003, DOI 10.1016/j.tsf.2010.10.054
   Lee JW, 2002, ANAL BIOANAL CHEM, V373, P526, DOI 10.1007/s00216-002-1339-2
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Matschegewski C, 2012, MATERIALS, V5, P1176, DOI 10.3390/ma5071176
   Matschegewski C, 2010, BIOMATERIALS, V31, P5729, DOI 10.1016/j.biomaterials.2010.03.073
   May JA, 1998, PLATELETS, V9, P227, DOI 10.1080/09537109876744
   Myers KA, 2007, BIOCHEM BIOPH RES CO, V364, P214, DOI 10.1016/j.bbrc.2007.09.109
   Nabavi N, 2011, BONE, V49, P965, DOI 10.1016/j.bone.2011.07.036
   Nebe B, 2013, HYG MED, V38, P192
   Nebe B, 2007, BIOMOL ENG, V24, P447, DOI 10.1016/j.bioeng.2007.07.004
   Nebe JB, 2012, MATER SCI FORUM, V706-709, P566, DOI 10.4028/www.scientific.net/MSF.706-709.566
   Nebe JGB, 2007, MACROMOL BIOSCI, V7, P567, DOI 10.1002/mabi.200600293
   Nebe JGB, 2008, METALLIC BIOMATERIAL, P179
   Neve A, 2011, CELL TISSUE RES, V343, P289, DOI 10.1007/s00441-010-1086-1
   Nileback E, 2014, ANALYST, V139, P5350, DOI 10.1039/c4an01393j
   Parreno J, 2008, MOL CELL BIOCHEM, V317, P21, DOI 10.1007/s11010-008-9801-x
   Perrini S, 2008, ENDOCRINOLOGY, V149, P1302, DOI 10.1210/en.2007-1349
   Raisz L G, 2000, Clin Cornerstone, V2, P1, DOI 10.1016/S1098-3597(00)90001-2
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rebl H, 2012, ACTA BIOMATER, V8, P3840, DOI 10.1016/j.actbio.2012.06.015
   Rebl H, 2010, INT J ARTIF ORGANS, V33, P738
   Ruoslahti E, 1996, EXP CELL RES, V227, P1, DOI 10.1006/excr.1996.0243
   Schnabelrauch M, 2014, INT J POLYM SCI, DOI 10.1155/2014/439784
   Schroder K, 2010, J ADHES SCI TECHNOL, V24, P1191, DOI 10.1163/016942409X12619870771501
   Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306
   Takai E, 2005, ANN BIOMED ENG, V33, P963, DOI 10.1007/s10439-005-3555-3
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107
   Walsh NC, 2009, J BONE MINER RES, V24, P1572, DOI [10.1359/JBMR.090320, 10.1359/jbmr.090320]
   Wittmann T, 2001, J CELL SCI, V114, P3795
   Wyrwa R, 2011, ADV ENG MATER, V13, pB165, DOI 10.1002/adem.201080116
   Yang J, 2010, BIOMATERIALS, V31, P8827, DOI 10.1016/j.biomaterials.2010.08.028
   Yang ZL, 2012, BIOMATERIALS, V33, P7959, DOI 10.1016/j.biomaterials.2012.07.050
   Yang ZL, 2011, MACROMOL BIOSCI, V11, P797, DOI 10.1002/mabi.201000474
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 65
TC 3
Z9 3
U1 1
U2 6
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2015
VL 29
BP 177
EP 189
DI 10.22203/eCM.v029a13
PG 13
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA CL6TY
UT WOS:000357101500009
PM 25738585
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Yue, C
   Zhao, B
   Ren, Y
   Kuijer, R
   van der Mei, HC
   Busscher, HJ
   Rochford, ETJ
AF Yue, C.
   Zhao, B.
   Ren, Y.
   Kuijer, R.
   van der Mei, H. C.
   Busscher, H. J.
   Rochford, E. T. J.
TI THE IMPLANT INFECTION PARADOX: WHY DO SOME SUCCEED WHEN OTHERS FAIL?
   OPINION AND DISCUSSION PAPER
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Implant infection; immune responses; host pathogens; infection risk;
   biofilms
ID PROSTHETIC JOINT INFECTION; TOTAL HIP-ARTHROPLASTY; CREVICULAR FLUID;
   ORAL MUCOSAL; COMPLICATION RATES; LANGERHANS CELLS; CUTANEOUS WOUNDS;
   DENDRITIC CELLS; REGISTER; SKIN
AB Biomaterial-implants are frequently used to restore function and form of human anatomy. However, the presence of implanted biomaterials dramatically elevates infection risk. Paradoxically, dental-implants placed in a bacteria-laden milieu experience moderate failure-rates, due to infection (0.0-1.1 %), similar to the ones of joint-arthroplasties placed in a near-sterile environment (0.1-1.3 %). Transcutaneous bone-fixation pins breach the immune-barrier of the epidermis, exposing underlying sterile-tissue to an unsterile external environment. In contrast to dental-implants, also placed in a highly unsterile environment, these pins give rise to relatively high infection-associated failure-rates of up to 23.0 %. Herein, we attempt to identify causes as to why dental-implants so often succeed, where others fail. The major part of all implants considered are metal-made, with similar surface-finishes. Material choice was therefore discarded as underlying the paradox. Antimicrobial activity of saliva has also been suggested as a cause for the success of dental-implants, but was discarded because saliva is the implant-site-fluid from which viable bacteria adhere. Crevicular fluid was discarded as it is largely analogous to serum. Instead, we attribute the relative success of dental-implants to (1) ability of oral tissues to heal rapidly in the continuous presence of commensal bacteria and opportunistic pathogens, and (2) tolerance of the oral immune-system. Inability of local tissue to adhere, spread and grow in presence of bacteria and an intolerant immune-system are identified as the likely main causes explaining the susceptibility of other implants to infection-associated failure. In conclusion, it is the authors' belief that new anti-infection strategies for a wide range of biomaterial-implants may be derived from the relative success of dental-implants.
C1 [Yue, C.; Kuijer, R.; van der Mei, H. C.; Busscher, H. J.; Rochford, E. T. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Zhao, B.; Ren, Y.] Univ Groningen, Univ Med Ctr Groningen, Dept Orthodont, NL-9700 RB Groningen, Netherlands.
RP Rochford, ETJ (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM e.rochford@umcg.nl
RI Kuijer, Roel/A-6690-2015
OI Kuijer, Roel/0000-0002-7637-4944
FU China Scholarship Council; W. J. Kolff institute
FX CY would like to thank the China Scholarship Council and W. J. Kolff
   institute for financial support.
CR Aboltins C, 2014, INTERN MED J, V44, P834, DOI 10.1111/imj.12510
   Al-Ahmad A, 2013, ARCH ORAL BIOL, V58, P1139, DOI 10.1016/j.archoralbio.2013.04.011
   Antalainen AK, 2013, INT J ORAL MAX IMPL, V28, P1612, DOI 10.11607/jomi.3277
   Benito N, 2014, J ORTHOP RES, V32, P633, DOI 10.1002/jor.22581
   Berezow AB, 2011, PERIODONTOL 2000, V55, P36, DOI 10.1111/j.1600-0757.2010.00350.x
   Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Chai WL, 2012, J R SOC INTERFACE, V9, P3528, DOI 10.1098/rsif.2012.0507
   Chehroudi B, 2002, BIOMATERIALS, V23, P229, DOI 10.1016/S0142-9612(01)00100-4
   Dale H, 2012, ACTA ORTHOP, V83, P449, DOI 10.3109/17453674.2012.733918
   De Bruyn H, 2013, CLIN IMPLANT DENT R, V15, P73, DOI 10.1111/j.1708-8208.2011.00359.x
   Derks J, 2015, J DENT RES, V94, p44S, DOI 10.1177/0022034514563077
   Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Engels-Deutsch M, 2011, ARCH ORAL BIOL, V56, P22, DOI 10.1016/j.archoralbio.2010.08.010
   Gorr SU, 2011, J CLIN PERIODONTOL, V38, P126, DOI 10.1111/j.1600-051X.2010.01664.x
   Hailer NP, 2015, ACTA ORTHOP, V86, P1, DOI 10.3109/17453674.2014.1002183
   Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x
   Iorio R, 2012, J ARTHROPLASTY, V27, P726, DOI 10.1016/j.arth.2011.09.013
   Isolauri E, 2001, AM J CLIN NUTR, V73, p444S, DOI 10.1093/ajcn/73.2.444s
   Ito H, 1998, ARCH ORAL BIOL, V43, P741, DOI 10.1016/S0003-9969(98)00066-1
   Jakubovics NS, 2008, FEMS MICROBIOL ECOL, V66, P637, DOI 10.1111/j.1574-6941.2008.00585.x
   Kraemer P, 2010, J SPINAL DISORD TECH, V23, pE59, DOI 10.1097/BSD.0b013e3181d1e14c
   Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868
   Le DH, 2014, CLIN ORTHOP RELAT R, V472, P2197, DOI 10.1007/s11999-014-3540-y
   Lee JJ, 2000, J ORAL MAXIL SURG, V58, P1372, DOI 10.1053/joms.2000.18269
   Lindgren JV, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-384
   Lukac J, 2003, J ORAL PATHOL MED, V32, P271, DOI 10.1034/j.1600-0714.2003.00127.x
   Mak K, 2009, J DERMATOL SCI, V56, P168, DOI 10.1016/j.jdermsci.2009.09.005
   Makela KT, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7592
   McKeown STW, 2007, J DENT RES, V86, P457, DOI 10.1177/154405910708600513
   Mombelli A, 2011, J CLIN PERIODONTOL, V38, P203, DOI 10.1111/j.1600-051X.2010.01666.x
   Mowat AM, 2005, VACCINE, V23, P1797, DOI 10.1016/j.vaccine.2004.11.008
   Ohara-Nemoto Y, 2008, J MED MICROBIOL, V57, P95, DOI 10.1099/jmm.0.47561-0
   Ostman PO, 2012, CLIN IMPLANT DENT R, V14, P852, DOI 10.1111/j.1708-8208.2012.00453.x
   Patterson MM, 2005, ORTHOP NURS, V24, P349
   Pedersen AB, 2010, ACTA ORTHOP, V81, P542, DOI 10.3109/17453674.2010.519908
   Peel TN, 2012, ANTIMICROB AGENTS CH, V56, P2386, DOI 10.1128/AAC.06246-11
   Petti S, 2001, ARCH ORAL BIOL, V46, P705, DOI 10.1016/S0003-9969(01)00033-4
   Pisano E, 2005, EUR J ORAL SCI, V113, P462, DOI 10.1111/j.1600-0722.2005.00246.x
   Pjetursson BE, 2007, CLIN ORAL IMPLAN RES, V18, P73, DOI 10.1111/j.1600-0501.2007.01467.x
   Prabhakara R, 2011, INFECT IMMUN, V79, P5010, DOI 10.1128/IAI.05571-11
   Santagati M, 2012, FEMS IMMUNOL MED MIC, V65, P23, DOI 10.1111/j.1574-695X.2012.00928.x
   Schalamon J, 2007, J PEDIATR SURG, V42, P1584, DOI 10.1016/j.jpedsurg.2007.04.022
   Schrama JC, 2010, ARTHRIT CARE RES, V62, P473, DOI 10.1002/acr.20036
   Schrementi ME, 2008, WOUND REPAIR REGEN, V16, P80, DOI 10.1111/j.1524-475X.2007.00320.x
   SCIUBBA JJ, 1978, J ORAL PATHOL MED, V7, P214, DOI 10.1111/j.1600-0714.1978.tb01596.x
   Shaik M, 2014, J MAXILLOFAC ORAL SU, V13, P47, DOI 10.1007/s12663-012-0443-x
   SHILLITOE EJ, 1972, ARCH ORAL BIOL, V17, P241, DOI 10.1016/0003-9969(72)90206-3
   SKAPSKI H, 1976, J PERIODONTAL RES, V11, P19, DOI 10.1111/j.1600-0765.1976.tb00046.x
   Stach Renee M, 2003, Implant Dent, V12, P87
   Stoodley P, 2011, FEMS IMMUNOL MED MIC, V62, P66, DOI 10.1111/j.1574-695X.2011.00793.x
   Stumbles PA, 2003, APMIS, V111, P741, DOI 10.1034/j.1600-0463.2003.11107806.x
   Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810
   VANLOON LAJ, 1989, J ORAL PATHOL MED, V18, P197
   Veiga-Malta I, 2004, CELL MICROBIOL, V6, P79, DOI 10.1046/j.1462-5822.2003.00344.x
   Villar CC, 2012, ORAL WOUND HEALING C, P287
   Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006
   Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009
   Williamson E, 2002, J IMMUNOL, V169, P3606, DOI 10.4049/jimmunol.169.7.3606
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zelles T, 1995, J DENT RES, V74, P1826, DOI 10.1177/00220345950740120301
NR 62
TC 10
Z9 10
U1 0
U2 10
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2015
VL 29
BP 303
EP 313
DI 10.22203/eCM.v029a23
PG 11
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA CL6TY
UT WOS:000357101500019
PM 26044130
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Baniasadi, H
   Ramazani, SAA
   Mashayekhan, S
   Farani, MR
   Ghaderinezhad, F
   Dabaghi, M
AF Baniasadi, Hossein
   Ramazani, Ahmad S. A.
   Mashayekhan, Shohreh
   Farani, Marzieh Ramezani
   Ghaderinezhad, Fariba
   Dabaghi, Mohammadhossein
TI Design, Fabrication, and Characterization of Novel Porous Conductive
   Scaffolds for Nerve Tissue Engineering
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS
LA English
DT Article
DE Biocompatibility; biodegradation; conductivity; polypyrrole; porous
   scaffold
ID IN-VITRO; CHITOSAN; POLYPYRROLE; GELATIN; REGENERATION; COMPOSITES;
   NANOFIBERS
AB Highly conductive polypyrrole/graphene (PYG) nanocomposite was synthesized with chemical oxidation process via emulsion polymerization and used for the preparation of novel porous conductive gelatin/chitosan-based scaffolds. The effect of PYG loading on various properties of scaffolds was investigated. The obtained results indicated that by introducing PYG into the polymeric matrix, the porosity and swelling capacity decreased while electrical conductivity and Young's modulus demonstrated increasing trend. The in vitro biodegradation test revealed that pure gelatin/chitosan matrix lost 80% of its weight after six weeks in the presence of lysozyme whilst the biodegradation rate was significantly lower for the conductive scaffolds. Furthermore, Schwann cell attachment and proliferation were evaluated by MTT assay and SEM image and the results revealed significant cell biocompatibility of the conductive scaffold with low amount of PYG. The results confirmed the potential of gelatin/chitosan/PYG compounding as a suitable biomaterial for using in nerve tissue engineering applications in which electrical stimulation plays a vital role.
C1 [Baniasadi, Hossein; Ramazani, Ahmad S. A.; Mashayekhan, Shohreh; Ghaderinezhad, Fariba; Dabaghi, Mohammadhossein] Sharif Univ Technol, Dept Chem & Petr Engn, POB 11365-8639, Tehran, Iran.
   [Farani, Marzieh Ramezani] Sharif Univ Technol, Kish Isl, Iran.
RP Ramazani, SAA (reprint author), Sharif Univ Technol, Dept Chem & Petr Engn, POB 11365-8639, Tehran, Iran.
EM ramazani@sharif.edu
OI Dabaghi, Mohammadhossein/0000-0002-8860-3775; Ramazani S.A.,
   Ahmad/0000-0002-0095-6104
CR Ai J, 2014, ARCH NEUROSCI, V1, DOI 10.5812/archneurosci.9144
   Alizadeh M, 2013, MAT SCI ENG C-MATER, V33, P3958, DOI 10.1016/j.msec.2013.05.039
   Amoabediny G., 2011, BIOMATERIALS SCI ENG
   Baniasadi H, 2015, INT J BIOL MACROMOL, V74, P360, DOI 10.1016/j.ijbiomac.2014.12.014
   Baniasadi H, 2014, SYNTHETIC MET, V196, P199, DOI 10.1016/j.synthmet.2014.08.007
   Bini TB, 2005, J MATER SCI-MATER M, V16, P367, DOI 10.1007/s10856-005-0637-6
   Brahatheeswaran D., 2011, INT J POLYM SCI
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Cong Y., 2013, NANOMATER
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Dalton P., 2008, TISSUE ENG
   Dhandayuthapani B., 2011, INT J POLYM SCI, V2011
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Guan S, 2013, J BIOMAT SCI-POLYM E, V24, P999, DOI 10.1080/09205063.2012.731374
   Hajiabbas M, 2015, ARTIF CELL NANOMED B, V43, P124, DOI 10.3109/21691401.2013.852101
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Lee JY, 2009, J R SOC INTERFACE, V6, P801, DOI 10.1098/rsif.2008.0403
   Lee JW, 2014, B KOREAN CHEM SOC, V35, P293, DOI 10.5012/bkcs.2014.35.1.293
   Lu XL, 2010, COMPOS PART A-APPL S, V41, P1516, DOI 10.1016/j.compositesa.2010.06.014
   Lum L. Y., 2003, TOPICS TISSUE ENG
   Peng ZY, 2011, POLYM-PLAST TECHNOL, V50, P1160, DOI 10.1080/03602559.2011.574670
   Qian YF, 2011, J BIOMAT SCI-POLYM E, V22, P1099, DOI 10.1163/092050610X499447
   Sadrolhosseini AR, 2013, INT J POLYM MATER PO, V62, P284, DOI 10.1080/00914037.2012.664209
   Sajesh KM, 2013, INT J BIOL MACROMOL, V62, P465, DOI 10.1016/j.ijbiomac.2013.09.028
   Su N, 2012, EXPRESS POLYM LETT, V6, P697, DOI 10.3144/expresspolymlett.2012.75
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Wan Y, 2004, MACROMOL BIOSCI, V4, P882, DOI 10.1002/mabi.200400044
   Wan Y, 2004, POLYMER, V45, P71, DOI 10.1016/j.polymer.2003.10.075
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Yan F, 2000, J APPL POLYM SCI, V77, P135, DOI 10.1002/(SICI)1097-4628(20000705)77:1<135::AID-APP18>3.0.CO;2-B
   Yan J, 2010, CARBON, V48, P487, DOI 10.1016/j.carbon.2009.09.066
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang K, 2010, CHEM MATER, V22, P1392, DOI 10.1021/cm902876u
NR 36
TC 8
Z9 8
U1 1
U2 30
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0091-4037
EI 1563-535X
J9 INT J POLYM MATER PO
JI Int. J. Polym. Mater. Polym. Biomat.
PY 2015
VL 64
IS 18
BP 969
EP 977
DI 10.1080/00914037.2015.1038817
PG 9
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA CL9KX
UT WOS:000357298300004
DA 2018-10-20
ER

PT J
AU Andrade, GF
   Carvalho, JL
   Armando, SC
   Goes, AM
   Sousa, EMB
AF Andrade, Gracielle F.
   Carvalho, Juliana L.
   Armando, S. C. Junior
   Goes, Alfredo M.
   Sousa, Edesia M. B.
TI Osteogenic differentiation of adipose-derived stem cells in mesoporous
   SBA-16 and SBA-16 hydroxyapatite scaffolds
SO RSC ADVANCES
LA English
DT Article
ID BIOACTIVE GLASS DISSOLUTION; TISSUE REGENERATION; IONIC PRODUCTS;
   DRUG-DELIVERY; SILICA; PROLIFERATION; BIOCERAMICS; GROWTH;
   CYTOCOMPATIBILITY; COPOLYMER
AB Adipose-derived stem cells (ASCs) are currently a point of focus for bone tissue engineering applications. In this study, a biomaterial (HA-SBA-16) has been developed based on the growth of calcium phosphate (HA) particles within an organized silica structure (SBA-16) to evaluate their application in the osteogenic differentiation process. Indeed, pure SBA-16 was used to compare the effect of structural characteristics on the biological application. The samples were characterized by N-2 Adsorption, transmission electron microscopy (TEM), energy-dispersive X-ray spectroscopy (EDS) and thermal analysis. In vitro assays were performed to evaluate the viability, cytotoxicity and biological behavior of the ASCs on SBA-16 and HA/SBA-16 nanocomposites to verify their potential as bioactive materials for applications in bone-tissue engineering. The differentiation capacity of the ASCs seeded in SBA-16 and HA/SBA-16 was confirmed by the induction of the increase in AP production/activity of the ASCs, the expression of osteogenic gene markers (type I collagen mRNA, osteopontin and osteocalcin), and functionally, by Von Kossa staining. The results showed that those compositions have beneficial effects in stem cells, maintaining cell viability and allowing/promoting osteogenic differentiation.
C1 [Andrade, Gracielle F.; Sousa, Edesia M. B.] Ctr Desenvolvimento Tecnol Nucl CDTN CNEN, SENAN, BR-30270901 Belo Horizonte, MG, Brazil.
   [Andrade, Gracielle F.; Armando, S. C. Junior] Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil.
   [Carvalho, Juliana L.; Goes, Alfredo M.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
RP Sousa, EMB (reprint author), Ctr Desenvolvimento Tecnol Nucl CDTN CNEN, SENAN, Av Presidente Antonio Carlos 6627,Campus UFMG, BR-30270901 Belo Horizonte, MG, Brazil.
EM sousaem@cdtn.br
RI Carvalho, Juliana/F-4498-2015; Cunha, Armando/G-1157-2012
OI Carvalho, Juliana/0000-0002-1423-0523; Cunha,
   Armando/0000-0002-1161-8936
FU CAPES; CNPq; FAPEMIG
FX This work was supported by funding from CAPES, CNPq, and FAPEMIG.
   Experiments and analyses involving electron microscopy were performed in
   the Microscopy Center of the Federal University of Minas Gerais, Belo
   Horizonte, Brazil (http://www.microscopia.ufmg.br).
CR Andrade GF, 2014, J MATER SCI-MATER M, V25, P2527, DOI 10.1007/s10856-014-5273-6
   Andrade GF, 2013, MICROPOR MESOPOR MAT, V168, P102, DOI 10.1016/j.micromeso.2012.09.034
   Arcos D, 2013, ACTA MATER, V61, P890, DOI 10.1016/j.actamat.2012.10.039
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Carvalho J.V.S., 2013, ANTARCT SCI, V56, P1
   Carvalho PH, 2013, ARQ BRAS CARDIOL, V100, P82, DOI 10.1590/S0066-782X2012005000114
   Cheng XL, 2012, CHEMPHYSCHEM, V13, P2392, DOI 10.1002/cphc.201200115
   Martins TMD, 2014, STEM CELL REV REP, V10, P697, DOI 10.1007/s12015-014-9529-9
   de Paula A. C. C., 2012, TISSUE ENG PART A, V19, P277
   Diaz A, 2006, ACTA BIOMATER, V2, P173, DOI 10.1016/j.actbio.2005.12.006
   Dominici K. L.-C. M., 2006, CYTOTHERAPY, V8, P315
   Fisichella H. D.-L.-P. Matthieu, 2009, TOXICOL IN VITRO, V23, P697
   Gobin O. C., 2006, THESIS U LAVAL
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hu YC, 2012, MICROPOR MESOPOR MAT, V147, P94, DOI 10.1016/j.micromeso.2011.06.001
   Kimata Y, 2003, MOL BIOL CELL, V14, P2559, DOI 10.1091/mbc.E02-11-0708
   Laaksonen H. S.-P. Timo, 2007, CHEM RES TOXICOL, V20, P1913
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Shi XT, 2008, J MATER SCI-MATER M, V19, P2933, DOI 10.1007/s10856-008-3424-3
   Sousa A, 2008, ACTA BIOMATER, V4, P671, DOI 10.1016/j.actbio.2007.11.003
   St John Thomas A, 2003, Am J Orthop (Belle Mead NJ), V32, P18
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 31
TC 1
Z9 1
U1 0
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 67
BP 54551
EP 54562
DI 10.1039/c5ra07330h
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA CL3QN
UT WOS:000356865500072
DA 2018-10-20
ER

PT J
AU Alexander, D
   Biller, R
   Rieger, M
   Ardjomandi, N
   Reinert, S
AF Alexander, Dorothea
   Biller, Regina
   Rieger, Melanie
   Ardjomandi, Nina
   Reinert, Siegmar
TI Phenotypic Characterization of a Human Immortalized Cranial Periosteal
   Cell Line
SO CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Cranial periosteal cells; SV40 immortalization; CD146 expression; TERT
   expression; Mineralization
ID MESENCHYMAL STEM-CELLS; LONG-TERM CULTURE; REPLICATIVE SENESCENCE;
   TELOMERASE ACTIVITY; STROMAL CELLS; IN-VITRO; CANCER; HALLMARKS
AB Background/Aims: Human cell material for basic research work is limited due to restricted patient numbers and occurring cell senescence during prolonged in vitro cell cultivation. In the present study, we established for the first time a human immortalized cranial periosteal cell line and characterized its phenotype in detail in comparison to that of parental cells. Methods: For this purpose, human primary cranial periosteal cells were stably transduced with the large T antigen cDNA from polyomavirus SV40 (TAg cells). Results: The functional activity of the large T antigen was demonstrated by human telomerase gene expression. Whereas TAg cells maintained long-term cell proliferation, immortalization did not compromise their osteogenic differentiation potential. In contrast, TAg cells showed an earlier and stronger mineralization compared to parental cells. Among the analysed stem cell surface markers, CD146 and MSCA-1 (mesenchymal stem cell antigen-1) were shown to be elevated in Tag cells. Gene expression analyses revealed in general higher constitutive m-RNA levels of key factors of osteogenesis than in parental cells. Conclusion: We conclude that the herein generated cell line represents a suitable cell source for basic science research studying bone biology, the osteogenesis process or biomaterial tests for bone regeneration purposes. Copyright (C) 2015 S. Karger AG, Basel
C1 [Alexander, Dorothea; Biller, Regina; Rieger, Melanie; Ardjomandi, Nina; Reinert, Siegmar] Univ Tubingen Hosp, Dept Oral & Maxillofacial Surg, D-72076 Tubingen, Germany.
RP Alexander, D (reprint author), Univ Tubingen Hosp, Dept Oral & Maxillofacial Surg, Osianderstr 2-8, D-72076 Tubingen, Germany.
EM dorothea.alexander@med.uni-tuebingen.de
CR Alexander D, 2010, CELL PHYSIOL BIOCHEM, V26, P1073, DOI 10.1159/000323985
   Allt G, 2001, CELLS TISSUES ORGANS, V169, P1, DOI 10.1159/000047855
   Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y
   Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x
   Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   Dazzi F, 2012, IMMUNOLOGY, V137, P206, DOI 10.1111/j.1365-2567.2012.03621.x
   Greider CW, 1996, SCI AM, V274, P92, DOI 10.1038/scientificamerican0296-92
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Lee WYW, 2013, CYTOTHERAPY, V15, P1484, DOI 10.1016/j.jcyt.2013.06.010
   Li NF, 2007, CELL PROLIFERAT, V40, P780, DOI 10.1111/j.1365-2184.2007.00462.x
   Low KC, 2013, TRENDS BIOCHEM SCI, V38, P426, DOI 10.1016/j.tibs.2013.07.001
   Nakamura-Ota M, 2014, CELL TISSUE BANK, V15, P373, DOI 10.1007/s10561-013-9394-9
   Razzouk S, 2012, J PERIODONTOL, V83, P547, DOI 10.1902/jop.2011.110384
   Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2
   Sobiesiak M, 2010, STEM CELLS DEV, V19, P669, DOI 10.1089/scd.2009.0290
   Thalmeier K, 2001, ACTA HAEMATOL-BASEL, V105, P159, DOI 10.1159/000046559
   Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213
   Wagner W, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt145
   Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b
   Wu LA, 2011, CELL TISSUE RES, V343, P545, DOI 10.1007/s00441-010-1120-3
   Zeng XM, 2007, STEM CELL REV, V3, P270, DOI 10.1007/s12015-007-9005-x
NR 25
TC 2
Z9 2
U1 0
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-8987
EI 1421-9778
J9 CELL PHYSIOL BIOCHEM
JI Cell. Physiol. Biochem.
PY 2015
VL 35
IS 6
BP 2244
EP 2254
DI 10.1159/000374029
PG 11
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA CL3FA
UT WOS:000356834600015
PM 25895553
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Swartjes, JJTM
   Sharma, PK
   van Kooten, TG
   van der Mei, HC
   Mahmoudi, M
   Busscher, HJ
   Rochford, ETJ
AF Swartjes, J. J. T. M.
   Sharma, P. K.
   van Kooten, T. G.
   van der Mei, H. C.
   Mahmoudi, M.
   Busscher, H. J.
   Rochford, E. T. J.
TI Current Developments in Antimicrobial Surface Coatings for Biomedical
   Applications
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Article
DE Antibacterial; antibiotics; antimicrobial peptides; bacterial adhesion;
   nanoparticles; quaternary ammonium compounds; surface coating
ID IMPLANT-ASSOCIATED INFECTIONS; HOST-DEFENSE PEPTIDES; ANTIBACTERIAL
   PROPERTIES; BACTERIAL ADHESION; MULTILAYER FILMS; SUPERHYDROPHOBIC
   SURFACES; RESISTANT STAPHYLOCOCCUS; NONSPECIFIC INTERACTIONS;
   IMMOBILIZING LYSOZYME; QUATERNIZED CHITOSAN
AB Bacterial adhesion and subsequent biofilm formation on material surfaces represent a serious problem in society from both an economical and health perspective. Surface coating approaches to prevent bacterial adhesion and biofilm formation are of increased importance due to the increasing prevalence of antibiotic resistant bacterial strains. Effective antimicrobial surface coatings can be based on an anti-adhesive principle that prevents bacteria to adhere, or on bactericidal strategies, killing organisms either before or after contact is made with the surface. Many strategies, however, implement a multifunctional approach that incorporates both of these mechanisms. For anti-adhesive strategies, the use of polymer chains, or hydrogels is preferred, although recently a new class of super-hydrophobic surfaces has been described which demonstrate improved anti-adhesive activity. In addition, bacterial killing can be achieved using antimicrobial peptides, antibiotics, chitosan or enzymes directly bound, tethered through spacer-molecules or encased in biodegradable matrices, nanoparticles and quaternary ammonium compounds. Notwithstanding the ubiquitous nature of the problem of microbial colonization of material surfaces, this review focuses on the recent developments in antimicrobial surface coatings with respect to biomaterial implants and devices. In this biomedical arena, to rank the different coating strategies in order of increasing efficacy is impossible, since this depends on the clinical application aimed for and whether expectations are short- or long term. Considering that the era of antibiotics to control infectious biofilms will eventually come to an end, the future for biofilm control on biomaterial implants and devices is likely with surface-associated modifications that are non-antibiotic related.
C1 [Swartjes, J. J. T. M.; Sharma, P. K.; van Kooten, T. G.; van der Mei, H. C.; Busscher, H. J.; Rochford, E. T. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
   [Mahmoudi, M.] Univ Tehran Med Sci, Fac Pharm, Dept Nanotechnol, Tehran, Iran.
   [Mahmoudi, M.] Univ Tehran Med Sci, Fac Pharm, Nanotechnol Res Ctr, Tehran, Iran.
RP van Kooten, TG (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, FB40,Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM T.G.van.Kooten@med.umcg.nl
RI Mahmoudi, Morteza/L-5332-2017
OI Mahmoudi, Morteza/0000-0002-2575-9684
FU UMCG, Groningen, The Netherlands
FX This study was funded by the UMCG, Groningen, The Netherlands. H.J.
   Busscher is also director of a consulting company, SASA BV (GN
   Schutterlaan 4, 9797 PC Thesinge, The Netherlands). Opinions and
   assertions contained herein are those of the authors and are not
   construed as necessarily representing views of the funding organization
   or their respective employers.
CR Akhavan O, 2010, SURF COAT TECH, V205, P219, DOI 10.1016/j.surfcoat.2010.06.036
   Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009
   Almodovar J, 2013, BIOTECHNOL BIOENG, V110, P609, DOI 10.1002/bit.24710
   Asri LATW, 2014, ADV FUNCT MATER, V24, P346, DOI 10.1002/adfm.201301686
   Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Bahar AA, 2013, PHARMACEUTICALS, V6, P1543, DOI 10.3390/ph6121543
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Belcarz A, 2013, INT J PHARMACEUT, V454, P285, DOI 10.1016/j.ijpharm.2013.06.076
   Bhattacharyya MS, 2010, J PHYS CHEM C, V114, P19928, DOI 10.1021/jp1078218
   Botequim D, 2012, LANGMUIR, V28, P7646, DOI 10.1021/la300948n
   Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494
   Buffet-Bataillon S, 2012, INT J ANTIMICROB AG, V39, P381, DOI 10.1016/j.ijantimicag.2012.01.011
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Charnley M, 2011, REACT FUNCT POLYM, V71, P329, DOI 10.1016/j.reactfunctpolym.2010.10.013
   Chen CP, 2012, ADV FUNCT MATER, V22, P780, DOI 10.1002/adfm.201102333
   Coad BR, 2013, SURF COAT TECH, V233, P169, DOI 10.1016/j.surfcoat.2013.05.019
   Daghighi S, 2013, BIOMATERIALS, V34, P8013, DOI 10.1016/j.biomaterials.2013.07.044
   Darouiche RO, 2003, CLIN INFECT DIS, V36, P1284, DOI 10.1086/374842
   Di Luca M, 2014, PATHOG DIS, V70, P257, DOI 10.1111/2049-632X.12151
   Ding FY, 2013, CARBOHYD POLYM, V98, P1547, DOI 10.1016/j.carbpol.2013.07.042
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Dutta P, 2011, ORG BIOMOL CHEM, V9, P5123, DOI 10.1039/c0ob00798f
   Epstein AK, 2012, P NATL ACAD SCI USA, V109, P13182, DOI 10.1073/pnas.1201973109
   Etayash H, 2014, ACS APPL MATER INTER, V6, P1131, DOI 10.1021/am404729c
   Faure E, 2012, ADV FUNCT MATER, V22, P5271, DOI 10.1002/adfm.201201106
   Fernandez L, 2011, DRUG RESIST UPDATE, V14, P1, DOI 10.1016/j.drup.2011.01.001
   Forsgren J, 2011, BIOTECHNOL LETT, V33, P1265, DOI 10.1007/s10529-011-0542-7
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180
   Garcia-Fernandez L, 2013, ADV MATER, V25, P529, DOI 10.1002/adma.201203362
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Guillaume O, 2012, J CONTROL RELEASE, V162, P492, DOI 10.1016/j.jconrel.2012.08.003
   Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015
   Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026
   HOLMBERG K, 1993, J ADHES SCI TECHNOL, V7, P503, DOI 10.1163/156856193X00826
   Holmberg KV, 2013, ACTA BIOMATER, V9, P8224, DOI 10.1016/j.actbio.2013.06.017
   Hu CM, 2013, ADV HEALTHC MATER, V2, P1314, DOI 10.1002/adhm.201300021
   Huang WJ, 2013, INT J BIOL MACROMOL, V53, P26, DOI 10.1016/j.ijbiomac.2012.10.024
   Huda S, 2010, ACS APPL MATER INTER, V2, P1206, DOI 10.1021/am100045v
   Humblot V, 2009, BIOMATERIALS, V30, P3503, DOI 10.1016/j.biomaterials.2009.03.025
   Hussain R, 2006, INT J PEPT RES THER, V12, P269, DOI 10.1007/s10989-006-9033-4
   Iarikov DD, 2014, BIOMACROMOLECULES, V15, P169, DOI 10.1021/bm401440h
   Jia BQ, 2012, ACS APPL MATER INTER, V4, P2897, DOI 10.1021/am3007609
   Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013
   Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004
   Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Kim JA, 2013, ACS NANO, V7, P7483, DOI 10.1021/nn403126e
   Kluin OS, 2009, BIOMATERIALS, V30, P4738, DOI 10.1016/j.biomaterials.2009.05.012
   Kong ZQ, 2013, COLLOID SURFACE B, V111, P536, DOI 10.1016/j.colsurfb.2013.07.006
   Konradi R, 2012, MACROMOL RAPID COMM, V33, P1663, DOI 10.1002/marc.201200422
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0
   Kumar A, 2008, NAT MATER, V7, P236, DOI 10.1038/nmat2099
   Laverty G, 2012, J BIOMED MATER RES A, V100A, P1803, DOI 10.1002/jbm.a.34132
   Lee HS, 2012, J MATER CHEM, V22, P19605, DOI 10.1039/c2jm34316a
   Lee HS, 2011, LANGMUIR, V27, P12458, DOI 10.1021/la202616u
   Lequeux I, 2014, EUR POLYM J, V51, P182, DOI 10.1016/j.eurpolymj.2013.11.012
   Li JS, 2013, ACS APPL MATER INTER, V5, P6704, DOI 10.1021/am401532z
   Liu Y, 2012, BIOMATERIALS, V33, P8745, DOI 10.1016/j.biomaterials.2012.08.010
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   Ma ML, 2006, CURR OPIN COLLOID IN, V11, P193, DOI 10.1016/j.cocis.2006.06.002
   Madhusudana Rao K., 2013, J BIOMED MATER RES A, P1
   Meyer B, 2003, INT BIODETER BIODEGR, V51, P249, DOI 10.1016/S0964-8305(03)00047-7
   MILNER ST, 1988, MACROMOLECULES, V21, P2610, DOI 10.1021/ma00186a051
   Mirshafiee V, 2013, CHEM COMMUN, V49, P2557, DOI 10.1039/c3cc37307j
   Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   Muszanska AK, 2011, BIOMATERIALS, V32, P6333, DOI 10.1016/j.biomaterials.2011.05.016
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   Noble ML, 2014, BIOMATER SCI-UK, V2, P893, DOI 10.1039/c3bm60203f
   Okshevsky M, 2013, CRIT REV MICROBIOL, V4, P1
   Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002
   Onaizi SA, 2011, BIOTECHNOL ADV, V29, P67, DOI 10.1016/j.biotechadv.2010.08.012
   Palermo EF, 2009, BIOMACROMOLECULES, V10, P1416, DOI 10.1021/bm900044x
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Pavlukhina S, 2010, BIOMACROMOLECULES, V11, P3448, DOI 10.1021/bm100975w
   Pavlukhina SV, 2012, ACS APPL MATER INTER, V4, P4708, DOI 10.1021/am3010847
   Peng ZX, 2011, ANTIMICROB AGENTS CH, V55, P860, DOI 10.1128/AAC.01005-10
   Peyre J, 2012, J PHYS CHEM B, V116, P13839, DOI 10.1021/jp305597y
   Pinto MS, 2011, COLLOID SURFACE A, V377, P182, DOI 10.1016/j.colsurfa.2010.12.038
   Pop-Georgievski O, 2011, BIOMACROMOLECULES, V12, P3232, DOI 10.1021/bm2007086
   Privett BJ, 2011, LANGMUIR, V27, P9597, DOI 10.1021/la201801e
   Rai A, 2010, J MATER CHEM, V20, P6789, DOI 10.1039/c0jm00817f
   Rapsch K, 2014, BIOCONJUGATE CHEM, V25, P308, DOI 10.1021/bc4004469
   Schaer TP, 2012, BIOMATERIALS, V33, P1245, DOI 10.1016/j.biomaterials.2011.10.038
   Shalev T, 2012, J MATER CHEM, V22, P2026, DOI 10.1039/c1jm13994k
   Shukla A, 2012, J CONTROL RELEASE, V157, P64, DOI 10.1016/j.jconrel.2011.09.062
   Siedenbiedel F, 2013, MACROMOL BIOSCI, V13, P1447, DOI 10.1002/mabi.201300219
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   Song L, 2011, MATER LETT, V65, P974, DOI 10.1016/j.matlet.2010.12.051
   Spellberg B, 2013, NEW ENGL J MED, V368, P299, DOI 10.1056/NEJMp1215093
   Stevens KNJ, 2011, BIOMATERIALS, V32, P1264, DOI 10.1016/j.biomaterials.2010.10.042
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Strobel C, 2011, J CONTROL RELEASE, V156, P37, DOI 10.1016/j.jconrel.2011.07.006
   Sui Y, 2012, J MEMBRANE SCI, V394, P107, DOI 10.1016/j.memsci.2011.12.038
   Swanson TE, 2011, J BIOMED MATER RES A, V97A, P167, DOI 10.1002/jbm.a.33043
   Swartjes JJTM, 2013, ADV FUNCT MATER, V23, P2843, DOI 10.1002/adfm.201202927
   Takigami I, 2010, ARCH ORTHOP TRAUM SU, V130, P1221, DOI 10.1007/s00402-009-0991-9
   Tan HL, 2013, INT J MOL SCI, V14, P1854, DOI 10.3390/ijms14011854
   Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084
   Tavares LS, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00412
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Tiller JC, 2011, ADV POLYM SCI, V240, P193, DOI 10.1007/12_2010_101
   Tischer M, 2012, CHEMMEDCHEM, V7, P22, DOI 10.1002/cmdc.201100404
   VANLOOSDRECHT MCM, 1990, AQUAT SCI, V52, P103, DOI 10.1007/BF00878244
   Wang BL, 2013, ACS APPL MATER INTER, V5, P4136, DOI 10.1021/am4000547
   Wang Y, 2012, SURF COAT TECH, V210, P71, DOI 10.1016/j.surfcoat.2012.08.066
   Wang Y, 2011, ADV FUNCT MATER, V21, P3916, DOI 10.1002/adfm.201100659
   Wong LS, 2009, CHEM REV, V109, P4025, DOI 10.1021/cr8004668
   Wong SY, 2010, J AM CHEM SOC, V132, P17840, DOI 10.1021/ja106288c
   Wong SY, 2010, BIOMATERIALS, V31, P4079, DOI 10.1016/j.biomaterials.2010.01.119
   Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447
   Yala JF, 2011, APPL MICROBIOL BIOT, V89, P623, DOI 10.1007/s00253-010-2930-7
   Yang WJ, 2011, LANGMUIR, V27, P7065, DOI 10.1021/la200620s
   Yuan SJ, 2011, LANGMUIR, V27, P2761, DOI 10.1021/la104442f
   Zhao C, 2013, LANGMUIR, V29, P1517, DOI 10.1021/la304511s
   Zhao Y, 2010, MAR DRUGS, V8, P24, DOI 10.3390/md8010024
   Zhou B, 2014, COLLOID SURFACE B, V116, P432, DOI 10.1016/j.colsurfb.2014.01.016
   Zhou CC, 2011, BIOMATERIALS, V32, P2704, DOI 10.1016/j.biomaterials.2010.12.040
NR 127
TC 32
Z9 33
U1 6
U2 152
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PY 2015
VL 22
IS 18
BP 2116
EP 2129
DI 10.2174/0929867321666140916121355
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA CL5ZL
UT WOS:000357044400002
PM 25245508
DA 2018-10-20
ER

PT J
AU Azari, P
   Luan, NS
   Gan, SN
   Yahya, R
   Wong, CS
   Chua, KH
   Pingguan-Murphy, B
AF Azari, Pedram
   Luan, Ng Sook
   Gan, Seng Neon
   Yahya, Rosiyah
   Wong, Chiow San
   Chua, Kien Hui
   Pingguan-Murphy, Belinda
TI Electrospun Biopolyesters as Drug Screening Platforms for Corneal
   Keratocytes
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS
LA English
DT Article
DE Biopolyesters; corneal keratocytes; electrospinning; polycaprolactone;
   polyhydroxybutyrate; polyhydroxybutyrate-co-hydroxyvalerate
ID EXTRACELLULAR-MATRIX; SCAFFOLDS; CELLS; MATS; DIFFERENTIATION;
   REGENERATION; DEGRADATION; LUMICAN; CULTURE; SYSTEM
AB In vitro drug screening techniques provide rapid and easy to analyze data, while saving a lot of animals from being sacrificed. An important part of any in vitro drug screening platform is a biomaterial which promotes cell growth and proliferation. The potential of electrospun scaffolds made of polyhydroxybutyrate (PHB), poly (3-hydroxybutyric acid-co-3-hydroxyvaleric acid) (PHBV), and polycaprolactone (PCL) were studied to serve as drug screening platform for corneal keratocyte tissues. The results showed that the proliferation rate was slightly higher for PCL and PHBV on day 7. Gene expression results showed that PCL was the best in maintaining keratocyte genes.
   [GRAPHICS]
   .
C1 [Azari, Pedram; Gan, Seng Neon; Yahya, Rosiyah] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur 50603, Malaysia.
   [Luan, Ng Sook; Chua, Kien Hui] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia.
   [Pingguan-Murphy, Belinda] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
   [Wong, Chiow San] Univ Malaya, Fac Sci, Dept Phys, Plasma Technol Res Ctr, Kuala Lumpur 50603, Malaysia.
RP Pingguan-Murphy, B (reprint author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
EM bpingguan@gmail.com
RI Pingguan-Murphy, Belinda/B-8332-2010; yahya, rosiyah/B-9604-2010;
   Engineering, Faculty/I-7935-2015; Wong, C.S./C-1047-2010; CHUA, KEK
   HENG/B-5261-2010; Azari, Pedram/Q-7407-2016
OI Pingguan-Murphy, Belinda/0000-0001-5567-1141; Engineering,
   Faculty/0000-0002-4848-7052; Wong, C.S./0000-0002-7186-2578; Azari,
   Pedram/0000-0002-1918-4247
FU University of Malaya [PV-107-2012A]; Ministry of Education Malaysia
   [UM.C/HIR/MOHE/ENG/44]
FX This study was supported by High Impact Research Grant
   (UM.C/HIR/MOHE/ENG/44) from the Ministry of Education Malaysia and
   Postgraduate Research Grant (PPP) (PV-107-2012A), University of Malaya.
CR Abadi FJH, 2014, INT J POLYM MATER PO, V63, P57, DOI 10.1080/00914037.2013.769248
   Abidin FZ, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-94
   Aghdam RM, 2014, INT J POLYM MATER PO, V63, P229, DOI 10.1080/00914037.2013.800983
   Chen Y, 2013, PROG RETIN EYE RES, V33, P28, DOI 10.1016/j.preteyeres.2012.10.001
   Cui WG, 2008, POLYM DEGRAD STABIL, V93, P731, DOI 10.1016/j.polymdegradstab.2007.12.002
   Cui WG, 2007, J APPL POLYM SCI, V103, P3105, DOI 10.1002/app.25464
   Cui WG, 2006, BIOMACROMOLECULES, V7, P1623, DOI 10.1021/bm060057z
   Ghafar NA, 2007, TISSUE ENG REGEN MED, V4, P557
   Ghasemi-Mobarakeh L, 2014, INT J POLYM MATER PO, V63, P240, DOI 10.1080/00914037.2013.830247
   Guan DH, 2008, APPL SURF SCI, V255, P324, DOI 10.1016/j.apsusc.2008.06.093
   Gunatillake PA, 2003, EUR CELLS MATER, V20, P1
   Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43
   JESTER JV, 1995, INVEST OPHTH VIS SCI, V36, P809
   Jester JV, 2003, EXP EYE RES, V77, P581, DOI 10.1016/S0014-4835(03)00188-X
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   Michelacci YM, 2003, BRAZ J MED BIOL RES, V36, P1037, DOI 10.1590/S0100-879X2003000800009
   Nikitovic D, 2008, IUBMB LIFE, V60, P818, DOI 10.1002/iub.131
   Piersma AH, 2004, TOXICOL LETT, V149, P147, DOI 10.1016/j.toxlet.2003.12.029
   Ritchey ER, 2011, MOL VIS, V17, P2440
   Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607
   Shenoy SL, 2005, POLYMER, V46, P3372, DOI 10.1016/j.polymer.2005.03.011
   Sombatmankhong K, 2007, POLYMER, V48, P1419, DOI 10.1016/j.polymer.2007.01.014
   Tehrani AH, 2010, J MATER SCI-MATER M, V21, P2989, DOI 10.1007/s10856-010-4149-7
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Wang LK, 2007, INT SER DEV HEAT TRA, P27
   West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010
   Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214
   Wilson S. E., 1998, EYE CONTACT LENS, V24, P181
   Wilson SE, 2003, AM J OPHTHALMOL, V136, P530, DOI 10.1016/S0002-9394(02)00085-0
NR 29
TC 3
Z9 3
U1 0
U2 17
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0091-4037
EI 1563-535X
J9 INT J POLYM MATER PO
JI Int. J. Polym. Mater. Polym. Biomat.
PY 2015
VL 64
IS 15
BP 785
EP 791
DI 10.1080/00914037.2015.1030648
PG 7
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA CL3TW
UT WOS:000356874500003
DA 2018-10-20
ER

PT J
AU Li, JJ
   Kim, K
   Roohani-Esfahani, SI
   Guo, J
   Kaplan, DL
   Zreiqat, H
AF Li, Jiao Jiao
   Kim, Kyungsook
   Roohani-Esfahani, Seyed-Iman
   Guo, Jin
   Kaplan, David L.
   Zreiqat, Hala
TI A biphasic scaffold based on silk and bioactive ceramic with stratified
   properties for osteochondral tissue regeneration
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE REPAIR; CALCIUM-PHOSPHATE
   CERAMICS; BMP-INDUCED OSTEOGENESIS; IN-VITRO; ENGINEERING SCAFFOLDS;
   SUBCHONDRAL BONE; BIOMATERIAL SCAFFOLDS; MECHANICAL-PROPERTIES;
   COMPOSITE SCAFFOLDS
AB Significant clinical challenges encountered in the effective long-term treatment of osteochondral defects have inspired advancements in scaffold-based tissue engineering techniques to aid repair and regeneration. This study reports the development of a biphasic scaffold produced via a rational combination of silk fibroin and bioactive ceramic with stratified properties to satisfy the complex and diverse regenerative requirements of osteochondral tissue. Structural examination showed that the biphasic scaffold contained two phases with different pore morphologies to match the cartilage and bone segments of osteochondral tissue, which were joined at a continuous interface. Mechanical assessment showed that the two phases of the biphasic scaffold imitated the load-bearing behaviour of native osteochondral tissue and matched its compressive properties. In vitro testing showed that different compositions in the two phases of the biphasic scaffold could direct the preferential differentiation of human mesenchymal stem cells towards the chondrogenic or osteogenic lineage. By featuring simple and reproducible fabrication and a well-integrated interface, the biphasic scaffold strategy established in this study circumvented the common problems experienced with integrated scaffold designs and could provide an effective approach for the regeneration of osteochondral tissue.
C1 [Li, Jiao Jiao; Roohani-Esfahani, Seyed-Iman; Zreiqat, Hala] Univ Sydney, Sch AMME, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.
   [Kim, Kyungsook; Guo, Jin; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Zreiqat, H (reprint author), Univ Sydney, Sch AMME, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.
EM hala.zreiqat@sydney.edu.au
OI Li, Jiao Jiao/0000-0002-3584-6765; Roohani, Iman/0000-0001-6618-8577
FU Australian National Health and Medical Research Council; U.S. National
   Institutes of Health [P41 EB002520, R01 DE106525]; Rebecca Cooper
   Foundation; Australian Postgraduate Award; Vice-Chancellor's Research
   Scholarship
FX The authors gratefully acknowledge the financial support of the
   Australian National Health and Medical Research Council, the U.S.
   National Institutes of Health (P41 EB002520, R01 DE106525), the Rebecca
   Cooper Foundation, the Australian Postgraduate Award and the
   Vice-Chancellor's Research Scholarship.
CR Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x
   Alford JW, 2005, AM J SPORT MED, V33, P295, DOI 10.1177/0363546504273510
   Alhadlaq A, 2004, ANN BIOMED ENG, V32, P911, DOI 10.1023/B:ABME.0000032454.53116.ee
   Barber FA, 2011, ARTHROSCOPY, V27, P60, DOI 10.1016/j.arthro.2010.06.023
   Bernstein A, 2013, ACTA BIOMATER, V9, P7490, DOI 10.1016/j.actbio.2013.03.021
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   Castro NJ, 2012, ANN BIOMED ENG, V40, P1628, DOI 10.1007/s10439-012-0605-5
   Chang CH, 2006, BIOMATERIALS, V27, P1876, DOI 10.1016/j.biomaterials.2005.10.014
   Chen GP, 2006, MAT SCI ENG C-BIO S, V26, P118, DOI 10.1016/j.msec.2005.07.024
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   Cui WD, 2011, J BIOSCI BIOENG, V111, P493, DOI 10.1016/j.jbiosc.2010.11.023
   Da H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054838
   de Vries-van Melle M. L., 2013, TISSUE ENG PART A, V20, P23
   Delcogliano M, 2014, KNEE SURG SPORT TR A, V22, P1260, DOI 10.1007/s00167-013-2717-3
   Deng TZ, 2014, J TISSUE ENG REGEN M, V8, P546, DOI 10.1002/term.1556
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Dormer NH, 2012, J BIOMED MATER RES A, V100A, P162, DOI 10.1002/jbm.a.33225
   Duan PG, 2014, J BIOMED MATER RES A, V102, P180, DOI 10.1002/jbm.a.34683
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Erisken C., 2010, TISSUE ENG PART A, V17, P1239
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Galperin A, 2013, ADV HEALTHC MATER, V2, P872, DOI 10.1002/adhm.201200345
   Giannoni P., 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1651., DOI 10.1002/TERM.1651, 10.1002/term.1651]
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Guilak F, 2014, J BIOMECH, V47, P1933, DOI 10.1016/j.jbiomech.2014.04.019
   Guo XM, 2004, TISSUE ENG, V10, P1818, DOI 10.1089/ten.2004.10.1818
   Guo XM, 2004, TISSUE ENG, V10, P1830, DOI 10.1089/ten.2004.10.1830
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Harris JD, 2011, OSTEOARTHR CARTILAGE, V19, P779, DOI 10.1016/j.joca.2011.02.010
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Jakob RP, 2002, CLIN ORTHOP RELAT R, P170
   Jeon JE, 2014, ANAT REC, V297, P26, DOI 10.1002/ar.22795
   Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442
   Jiang J, 2010, ANN BIOMED ENG, V38, P2183, DOI 10.1007/s10439-010-0038-y
   Jin QM, 2000, J BIOMED MATER RES, V52, P841, DOI 10.1002/1097-4636(20001215)52:4<841::AID-JBM31>3.0.CO;2-3
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Jung MR, 2012, J CONTROL RELEASE, V162, P485, DOI 10.1016/j.jconrel.2012.07.040
   Kandel RA, 2006, BIOMATERIALS, V27, P4120, DOI 10.1016/j.biomaterials.2006.03.005
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawakami M, 2011, BIO-MED MATER ENG, V21, P53, DOI 10.3233/BME-2011-0656
   Keeney M, 2009, TISSUE ENG PART B-RE, V15, P55, DOI 10.1089/ten.teb.2008.0388
   Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Laasanen MS, 2003, BIORHEOLOGY, V40, P133
   Lam J, 2014, ACTA BIOMATER, V10, P1112, DOI 10.1016/j.actbio.2013.11.020
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   Li JJ, 2014, J MATER CHEM B, V2, P7272, DOI 10.1039/c4tb01073f
   Li JJ, 2013, BIOMACROMOLECULES, V14, P2179, DOI 10.1021/bm400303w
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Lien SM, 2009, MAT SCI ENG C-BIO S, V29, P315, DOI 10.1016/j.msec.2008.07.017
   Magne D, 2005, TRENDS MOL MED, V11, P519, DOI 10.1016/j.molmed.2005.09.002
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   Manferdini C, 2016, J TISSUE ENG REGEN M, V10, P374, DOI 10.1002/term.1723
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Marquass B, 2010, J ORTHOP RES, V28, P1586, DOI 10.1002/jor.21173
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Mayr HO, 2013, ACTA BIOMATER, V9, P4845, DOI 10.1016/j.actbio.2012.07.040
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Miot S, 2012, EUR CELLS MATER, V23, P222, DOI 10.22203/eCM.v023a17
   Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414
   Mohan N, 2011, TISSUE ENG PT A, V17, P2845, DOI 10.1089/ten.tea.2011.0135
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nooeaid P, 2012, J CELL MOL MED, V16, P2247, DOI 10.1111/j.1582-4934.2012.01571.x
   O'Shea TM, 2008, TISSUE ENG PART B-RE, V14, P447, DOI 10.1089/ten.teb.2008.0327
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Pei M, 2009, OSTEOARTHR CARTILAGE, V17, P714, DOI 10.1016/j.joca.2008.11.017
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   POOLE AR, 2001, CLIN ORTHOP S, V391, P26
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Re'em T, 2012, ACTA BIOMATER, V8, P3283, DOI 10.1016/j.actbio.2012.05.014
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Roohani-Esfahani SI, 2013, ACTA BIOMATER, V9, P7014, DOI 10.1016/j.actbio.2013.02.039
   Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   Sheehy EJ, 2013, ACTA BIOMATER, V9, P5484, DOI 10.1016/j.actbio.2012.11.008
   Shimomura K, 2014, TISSUE ENG PT A, V20, P2291, DOI 10.1089/ten.tea.2013.0414
   Sundelacruz S, 2009, SEMIN CELL DEV BIOL, V20, P646, DOI 10.1016/j.semcdb.2009.03.017
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Wang W, 2010, BIOMATERIALS, V31, P8964, DOI 10.1016/j.biomaterials.2010.08.018
   Wang XH, 2004, BIOMATERIALS, V25, P3681, DOI 10.1016/j.biomaterials.2003.10.102
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Zhang SF, 2013, ACTA BIOMATER, V9, P7236, DOI 10.1016/j.actbio.2013.04.003
NR 103
TC 14
Z9 15
U1 5
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 26
BP 5361
EP 5376
DI 10.1039/c5tb00353a
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA CL4YO
UT WOS:000356964700026
PM 26167284
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Shen, CH
   Han, YM
   Wang, BL
   Tang, JM
   Chen, H
   Lin, QK
AF Shen, Chenghui
   Han, Yuemei
   Wang, Bailiang
   Tang, Junmei
   Chen, Hao
   Lin, Quankui
TI Ocular biocompatibility evaluation of POSS nanomaterials for biomedical
   material applications
SO RSC ADVANCES
LA English
DT Article
ID POLYHEDRAL OLIGOMERIC SILSESQUIOXANE; SILVER NANOPARTICLES; OXIDATIVE
   STRESS; CYTOTOXICITY; SILICA; CELLS; CYTOCOMPATIBILITY; BIOMATERIALS;
   APOPTOSIS; PATHWAYS
AB The tremendous advancement of polyhedral oligomeric silsesquioxanes (POSSs) has been focused on the field of biomaterial applications including tissue engineering, drug delivery, biomedical devices and biosensors. More recently, POSSs have been used in components of ophthalmic biomedical devices, such as contact lenses and intraocular lenses due to their chemical inertness and transparency. A systematic biocompatibility evaluation of POSS nanomaterials is thus essential. Herein, the ocular biocompatibility and cytotoxicity of POSS nanomaterials were investigated both in vitro and in vivo. Three types of commercial POSS nanomaterials with different functional groups were utilized in this research, including aminoethylaminopropylisobutyl-POSS (NH2-POSS), mercaptopropylisobutyl-POSS (SH-POSS) and octahydroxypropyldimethylsilyl-POSS (HO-POSS). The cellular metabolic activity, membrane integrality, cell apoptosis and oxidative damage were tested on human lens epithelial cells (HLECs) under different concentrations of POSS nanomaterial exposure. The ocular irritation on rabbit eyes was measured as well. The results show that the studied POSS nanomaterials do not exhibit any significant toxicity to cell growth and proliferation in most cases, except for the NH2-POSS, which decreases the cellular viability at high concentration. All of the POSS nanomaterials slightly induced oxidative stress as a result of an increase in reactive oxygen species (ROS), however they did not generate cell apoptosis. The animal experiment results also show that no acute ocular irritation can be detected after POSS nanomaterial administration. These results indicate the good ocular biocompatibility of the POSS nanomaterials in most cases, which have great potential in ocular biomedical applications.
C1 [Shen, Chenghui; Han, Yuemei; Wang, Bailiang; Tang, Junmei; Chen, Hao; Lin, Quankui] Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China.
   [Shen, Chenghui] Wenzhou Inst Biomat & Engn, Wenzhou 325000, Peoples R China.
RP Chen, H (reprint author), Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China.
EM Chenhao823@mail.eye.ac.cn; lqk97531@126.com
FU National Natural Science Foundation of China [51203120, 81271703,
   51403158]; Science & Technology Program of Wenzhou [Y20140177]; Medical
   & Health Technology Program of Zhejiang Province [2013KYA133,
   2014KYA149]
FX Financial support from the National Natural Science Foundation of China
   (51203120, 81271703, 51403158), Science & Technology Program of Wenzhou
   (Y20140177) and Medical & Health Technology Program of Zhejiang Province
   (2013KYA133, 2014KYA149) are greatly acknowledged.
CR Ahmed M, 2014, BIOMATERIALS, V35, P9033, DOI 10.1016/j.biomaterials.2014.07.008
   Andon FT, 2013, ACCOUNTS CHEM RES, V46, P733, DOI 10.1021/ar300020b
   Aranda A, 2013, TOXICOL IN VITRO, V27, P954, DOI 10.1016/j.tiv.2013.01.016
   Bhattacharjee S, 2013, NANOSCALE, V5, P4870, DOI 10.1039/c3nr34266b
   Bohmert L, 2012, ARCH TOXICOL, V86, P1107, DOI 10.1007/s00204-012-0840-4
   Bonafini Jr J. A., 2003, U.S. Pat, Patent No. 6586548
   Chen HM, 2015, CHEM RES TOXICOL, V28, P339, DOI 10.1021/tx500487w
   Chowdhury SM, 2013, BIOMATERIALS, V34, P283, DOI 10.1016/j.biomaterials.2012.09.057
   Chrusciel J. J., 2014, PROG POLYM SCI, V41, P67
   Cordes DB, 2010, CHEM REV, V110, P2081, DOI 10.1021/cr900201r
   Ghanbari H, 2011, MACROMOL RAPID COMM, V32, P1032, DOI 10.1002/marc.201100126
   Han XL, 2011, TOXICOLOGY, V287, P99, DOI 10.1016/j.tox.2011.06.011
   Huang YS, 2010, MOL VIS, V16, P341
   Jung Y, 2014, ACS APPL MATER INTER, V6, P6054, DOI 10.1021/am405099r
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kuo SW, 2011, PROG POLYM SCI, V36, P1649, DOI 10.1016/j.progpolymsci.2011.05.002
   Lee YH, 2014, BIOMATERIALS, V35, P4706, DOI 10.1016/j.biomaterials.2014.02.021
   Lin QK, 2015, J MATER CHEM B, V3, P3695, DOI 10.1039/c5tb00111k
   Lin QK, 2010, BIOMATERIALS, V31, P4017, DOI 10.1016/j.biomaterials.2010.01.092
   Marano F, 2011, ARCH TOXICOL, V85, P733, DOI 10.1007/s00204-010-0546-4
   McCusker C, 2005, CHEM COMMUN, P996, DOI 10.1039/b416266h
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Nowak JS, 2014, TOXICOL LETT, V224, P84, DOI 10.1016/j.toxlet.2013.10.003
   Oh WK, 2010, ACS NANO, V4, P5301, DOI 10.1021/nn100561e
   Phillips SH, 2004, CURR OPIN SOLID ST M, V8, P21, DOI 10.1016/j.cossms.2004.03.002
   Pierscionek BK, 2012, NANOMED-NANOTECHNOL, V8, P383, DOI 10.1016/j.nano.2011.06.016
   SCOTT DW, 1946, J AM CHEM SOC, V68, P356, DOI 10.1021/ja01207a003
   Tanaka K, 2013, POLYM J, V45, P247, DOI 10.1038/pj.2012.154
   Tanaka K, 2012, J MATER CHEM, V22, P1733, DOI 10.1039/c1jm14231c
   Tay CY, 2014, ACS APPL MATER INTER, V6, P6248, DOI 10.1021/am501266a
   Teng CP, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2014.102
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Wang BL, 2014, RSC ADV, V4, P52959, DOI 10.1039/c4ra08060b
   Wang BL, 2014, J COLLOID INTERF SCI, V431, P1, DOI 10.1016/j.jcis.2014.05.056
   Wu J, 2009, POLYM REV, V49, P25, DOI 10.1080/15583720802656237
   Wu J, 2011, ACS NANO, V5, P4476, DOI 10.1021/nn103530b
   Wu MH, 2010, ANAL CHEM, V82, P5447, DOI 10.1021/ac1003147
   Yan L, 2012, CHEM RES TOXICOL, V25, P1265, DOI 10.1021/tx300129f
   Zhang WA, 2013, PROG POLYM SCI, V38, P1121, DOI 10.1016/j.progpolymsci.2013.03.002
NR 39
TC 10
Z9 10
U1 6
U2 35
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 66
BP 53782
EP 53788
DI 10.1039/c5ra08668j
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA CL2UP
UT WOS:000356801300075
DA 2018-10-20
ER

PT J
AU Kandhasamy, S
   Ramanathan, G
   Kamalraja, J
   Balaji, R
   Mathivanan, N
   Sivagnanam, UT
   Perumal, PT
AF Kandhasamy, Subramani
   Ramanathan, Giriprasath
   Kamalraja, Jayabal
   Balaji, Ravichandran
   Mathivanan, Narayanasamy
   Sivagnanam, Uma Tiruchirapalli
   Perumal, Paramasivan Thirumalai
TI Synthesis, characterization and biological evaluation of chromen and
   pyrano chromen-5-one derivatives impregnated into a novel collagen based
   scaffold for tissue engineering applications
SO RSC ADVANCES
LA English
DT Article
ID POLY 3-HYDROXYBUTYRIC ACID; DRUG-DELIVERY; CROSS-LINKING; COUMARIN
   DERIVATIVES; REGENERATION; SKIN; FABRICATION; NANOFIBERS; COMPOSITE;
   POTENT
AB In this article, we describe the synthesis and biological evaluation of a novel 2-(methylamino)-3-nitro-4-(4-oxo- 4H-chromen-3-yl) pyrano[3,2-c]chromen-5(4H)-one (CCN). It is also determined that CCN impregnated into the collagen scaffold has the potential to mimic the function of the extracellular matrix as a biomaterial in the field of tissue engineering. The series of pyrano[3,2-c] chromen-5(4H)-one derivatives (4a-4j), was analyzed by H-1 NMR, C-13 NMR, mass spectra and FTIR analysis. Compound 4c was confirmed by single crystal XRD studies. All the compounds were screened for antimicrobial activity against Gram positive, Gram negative bacteria and yeast. Among all the compounds, compound (4a=CCN) showed activity against Gram positive and Gram negative bacteria, when compared to the synthesized compounds. Further, compound CCN was evaluated for cytotoxicity against MCF-7, Hep-2 and Vero cancer cell lines with IC50 values of 5.4 mu g ml(-1), 5.3 mu g ml(-1) and 68.4 mu g ml(-1) respectively. In addition, the results of flow cytometry and docking (PDBID: 1A27 with the ligand) studies supported the activity of the synthesized compound (4a). FTIR and NMR analysis of the CCN impregnated collagen scaffold were done to reveal the existence of the CCN molecule in the scaffold. The inherent property of the collagen scaffold was not significantly affected by the structure of the CCN molecule. The thermal and mechanical properties of the collagen scaffold impregnated with CCN molecules gives stability as well as supports the swelling. However, the COL-CCN scaffold showed an enhanced cell attachment and proliferation of NIH 3T3 fibroblast cells. Based on the results, the novel CCN molecule impregnated within a collagen scaffold has potential application as a biomaterial in tissue engineering.
C1 [Kandhasamy, Subramani; Kamalraja, Jayabal; Perumal, Paramasivan Thirumalai] CSIR, Cent Leather Res Inst, Div Organ Chem, Madras 600020, Tamil Nadu, India.
   [Ramanathan, Giriprasath; Sivagnanam, Uma Tiruchirapalli] CSIR, Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
   [Balaji, Ravichandran; Mathivanan, Narayanasamy] Univ Madras, Ctr Adv Studies Bot, Biocontrol & Microbial Metabolites Lab, Madras 600025, Tamil Nadu, India.
RP Perumal, PT (reprint author), CSIR, Cent Leather Res Inst, Div Organ Chem, Madras 600020, Tamil Nadu, India.
EM suma67@gmail.com; ptperumal@gmail.com
RI Tirichurapalli Sivagnanam, uma/E-1325-2017; Ramanathan,
   Giriprasath/E-2019-2017
OI Tirichurapalli Sivagnanam, uma/0000-0002-1401-2569; Ramanathan,
   Giriprasath/0000-0002-2541-6577; , Kandhasamy/0000-0001-9821-7694;
   Perumal, P T/0000-0003-2057-6368
FU TATA-CSIR-OSDD; CSIR, New Delhi, India
FX We thank TATA-CSIR-OSDD and CSIR, New Delhi, India for the financial
   support in the form of Senior Research Fellowship. The authors
   acknowledge the CSIR-CLRI for providing infrastructure to carry out this
   work.
CR Agarwal P., 2011, INT J BIOMED RES, V2, P181
   Al-Rifai AA, 2012, MED CHEM RES, V21, P468, DOI 10.1007/s00044-011-9553-0
   Archana D, 2013, INT J BIOL MACROMOL, V57, P193, DOI 10.1016/j.ijbiomac.2013.03.002
   Azagarsamy MA, 2014, ACS MACRO LETT, V3, P515, DOI 10.1021/mz500230p
   Bhardwaj N., 2013, INTEGR BIOL, V7, P142
   Boccafoschi F, 2005, BIOMATERIALS, V26, P7410, DOI 10.1016/j.biomaterials.2005.05.052
   Chicatun F, 2013, TISSUE ENG PT A, V19, P2553, DOI [10.1089/ten.TEA.2013.0114, 10.1089/ten.tea.2013.0114]
   Chicatun F, 2011, BIOMACROMOLECULES, V12, P2946, DOI 10.1021/bm200528z
   Davidenko N, 2010, ACTA BIOMATER, V6, P3957, DOI 10.1016/j.actbio.2010.05.005
   Duraipandy N, 2015, J MATER CHEM B, V3, P1415, DOI 10.1039/c4tb01791a
   Falini G, 2004, J MATER CHEM, V14, P2297, DOI 10.1039/b401393j
   Fazeli MR, 2007, FOOD CONTROL, V18, P646, DOI 10.1016/j.foodcont.2006.03.002
   Funke M, 2013, J MED CHEM, V56, P5182, DOI 10.1021/jm400587g
   Gaspar A, 2014, CHEM REV, V114, P4960, DOI 10.1021/cr400265z
   GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184
   Horn MM, 2009, CARBOHYD POLYM, V77, P239, DOI 10.1016/j.carbpol.2008.12.039
   Hwang YJ, 2011, ACS APPL MATER INTER, V3, P2579, DOI 10.1021/am200416h
   Jithendra P, 2013, ACS APPL MATER INTER, V5, P7291, DOI 10.1021/am401637c
   Kanungo I, 2015, PHYS CHEM CHEM PHYS, V17, P2778, DOI 10.1039/c4cp04363d
   Kharadi GJ, 2012, J THERM ANAL CALORIM, V107, P651, DOI 10.1007/s10973-011-1671-x
   Kim Y, 2013, J MATER CHEM B, V1, P3185, DOI 10.1039/c3tb20485e
   Kontogiorgis CA, 2005, J MED CHEM, V48, P6400, DOI 10.1021/jm0580149
   Kulkarni MV, 2006, CURR MED CHEM, V13, P2795, DOI 10.2174/092986706778521968
   Kumar B. Dillip, 2013, J MATER CHEM, V1, P3972
   Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060
   Lee HJ, 2012, CHEM MATER, V24, P881, DOI 10.1021/cm200733s
   Lee S, 2014, ACS APPL MATER INTER, V6, P1082, DOI 10.1021/am404627r
   Lin JT, 2012, ACS APPL MATER INTER, V4, P1050, DOI 10.1021/am201669z
   Luo DM, 2011, MATER LETT, V65, P2395, DOI 10.1016/j.matlet.2011.05.011
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Maddipatla MVSN, 2013, MACROMOLECULES, V46, P5133, DOI 10.1021/ma400584y
   Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t
   Melliou E, 2005, J NAT PROD, V68, P78, DOI 10.1021/np0497447
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Muthukumar T, 2013, COLLOID SURFACE B, V102, P694, DOI 10.1016/j.colsurfb.2012.09.041
   Nagai T, 2000, FOOD CHEM, V68, P277, DOI 10.1016/S0308-8146(99)00188-0
   Nagiah N, 2014, INT J POLYM MATER PO, V63, P583, DOI 10.1080/00914037.2013.854230
   Nagiah N, 2013, ADV POLYM TECH, V32, DOI 10.1002/adv.21370
   Nagiah N, 2013, POLYM BULL, V70, P2337, DOI 10.1007/s00289-013-0956-6
   National Committee for Clinical Laboratory Standards, 2000, M7A5 NCCLS, V20, P2
   Nihal K., 2007, PHOTOCHEM PHOTOBIOL, V83, P1237
   Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k
   Novelo B. M., 2014, J MATER CHEM B, V2, P2874
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Perumal S, 2014, EUR J PHARM SCI, V52, P26, DOI 10.1016/j.ejps.2013.10.006
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   Pochet L, 2000, BIOORGAN MED CHEM, V8, P1489, DOI 10.1016/S0968-0896(00)00071-7
   Ramanathan G, 2014, J BIOMATER TISS ENG, V4, P203, DOI 10.1166/jbt.2014.1157
   Rameshw J. A., 2009, J MATER SCI-MATER M, V20, P3
   Rappa G, 2000, ONCOL RES, V12, P113
   Reddy BVS, 2010, BIOORG MED CHEM LETT, V20, P7507, DOI 10.1016/j.bmcl.2010.10.003
   Rifai A., 2012, MED CHEM RES, V21, P468
   Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h
   Satieshkumar R., 2014, ACS APPL MATER INTER, V6, P15015
   Shi YA, 2011, BIOORG MED CHEM LETT, V21, P956, DOI 10.1016/j.bmcl.2010.12.059
   Singaravelu S, 2015, MATER LETT, V152, P90, DOI 10.1016/j.matlet.2015.03.088
   Sionkowska A, 2013, INT J BIOL MACROMOL, V52, P250, DOI 10.1016/j.ijbiomac.2012.10.002
   Sionkowska A, 2014, J MOL LIQ, V199, P318, DOI 10.1016/j.molliq.2014.09.028
   Sridhar R, 2015, CHEM SOC REV, V44, P790, DOI 10.1039/c4cs00226a
   Thaisrivongs S, 1996, J MED CHEM, V39, P2400, DOI 10.1021/jm950888f
   Trenor SR, 2004, CHEM REV, V104, P3059, DOI 10.1021/cr030037c
   Tronci G, 2013, J MATER CHEM B, V1, P5478, DOI 10.1039/c3tb20218f
   Tronci G, 2013, J MATER CHEM B, V1, P3705, DOI 10.1039/c3tb20720j
   Tsai RY, 2015, CARBOHYD POLYM, V115, P525, DOI 10.1016/j.carbpol.2014.08.108
   Wang LM, 2010, BIOMATERIALS, V31, P3976, DOI 10.1016/j.biomaterials.2010.01.131
   Yamamoto N, 2012, BIOCONJUGATE CHEM, V23, P1110, DOI 10.1021/bc200561n
   Yang EB, 1999, BIOCHEM BIOPH RES CO, V260, P682, DOI 10.1006/bbrc.1999.0958
   Zhang L, 2011, CARBOHYD POLYM, V84, P118, DOI 10.1016/j.carbpol.2010.11.009
NR 69
TC 11
Z9 11
U1 0
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 68
BP 55075
EP 55087
DI 10.1039/c5ra07133j
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA CL6BH
UT WOS:000357051100033
DA 2018-10-20
ER

PT J
AU Chen, J
   Yu, J
   He, Q
   Zhao, X
   Sang, HX
   Lei, W
   Wu, ZX
   Chen, JY
AF Chen, Jun
   Yu, Jin
   He, Qiang
   Zhao, Xiong
   Sang, Hongxun
   Lei, Wei
   Wu, Zixiang
   Chen, Jingyuan
TI A novel injectable porous surface modified bioactive bone cement for
   vertebroplasty: an in vivo biomechanical and osteogenic study in a
   rabbit osteoporosis model
SO AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH
LA English
DT Article
DE Osteoporosis; vertebroplasty; bone cement; bioglass
ID COMPRESSION FRACTURES; CANCELLOUS BONE; TRABECULAR BONE; STRENGTH;
   OVARIECTOMY; PREVALENCE; SHEEP; PMMA
AB Purpose: The aim of this study is to determine the feasibility and effectiveness of a novel injectable Porous Surface Modified Bioactive Bone Cement (PSMBBC) for vertebroplasty of aiding osteoporotic vertebrae in an osteoporosis model. Methods: 72 osteoporosis rabbits were randomly divided into three groups: the Polymethyl Methacrylate (PMMA) group, the PSMBBC group and the control group. PMMA and PSMBBC were administrated to osteoporotic vertebrae in vertebroplasty, respectively. The animals were sacrificed at 1w, 4w, 12w after the procedure. Micro-CT analysis, biomechanical tests and histological analysis were performed at each time point. Results: From 4 to 12 weeks after the implantation of bone cements, the bone volume fraction (BV/TV) of the PSMBBC group increased from 28.27 +/- 1.69% to 38.43 +/- 1.34%. However, the BV/TV of the PMMA group showed no significant difference after the implantation. At 4 weeks, direct contact between the bone and the bone cement was observed in the PSMBBC group. At 12 weeks, it was discovered that new intact bone trabecular was formed in PSMBBC group. Furthermore, the maximum compressive strength values of the PSMBBC group were significantly higher than those of the control group at each time point after implantation. Conclusions: In summary, this study was the first investigation to evaluate the potential application of PSMBBC for vertebroplasty. Results demonstrated its beneficial effects on the trabecular ingrowth of new bone and bone mineral density increase. With further validation, PSMBBC can become a valuable biomaterial for aiding osteoporotic vertebrae and usable bone cement applied in vertebroplasty.
C1 [Chen, Jun; Chen, Jingyuan] Fourth Mil Med Univ, Xijing Hosp, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian 710032, Shaanxi, Peoples R China.
   [Chen, Jun; Chen, Jingyuan] Fourth Mil Med Univ, Xijing Hosp, Sch Publ Hlth, Minist Educ,Key Lab Hazard Assessment & Control S, Xian 710032, Shaanxi, Peoples R China.
   [Chen, Jun; He, Qiang; Zhao, Xiong; Sang, Hongxun; Lei, Wei; Wu, Zixiang] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Shaanxi, Peoples R China.
   [Yu, Jin] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Med, Xian 710032, Shaanxi, Peoples R China.
RP Lei, W (reprint author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.
EM lei-wei@fmmu.edu.cn; wuzixiang@fmmu.edu.cn; jy_chen@fmmu.edu.cn
FU Research Fund for the National Natural Science Foundation of China
   (NSFC) [31170913]; NSFC [81000141]
FX This study work was supported by the Research Fund for the National
   Natural Science Foundation of China (NSFC No. 31170913). Jin Yu is
   supported by NSFC founding No. 81000141.
CR Aho A. J., 2004, Cell and Tissue Banking, V5, P213, DOI 10.1007/s10561-004-0214-0
   Barralet JE, 2002, J BIOMED MATER RES, V63, P1, DOI 10.1002/jbm.1074
   Boger A, 2008, J BIOMAT SCI-POLYM E, V19, P1125, DOI 10.1163/156856208785540154
   Castaneda S, 2006, SKELETAL RADIOL, V35, P34, DOI 10.1007/s00256-005-0022-z
   Cauley JA, 2007, JAMA-J AM MED ASSOC, V298, P2761, DOI 10.1001/jama.298.23.2761
   Chen Lih-Hui, 2011, Chang Gung Med J, V34, P352
   Covey MK, 2008, J NURS MEAS, V16, P155, DOI 10.1891/1061-3749.16.3.155
   Cunin G, 2000, SPINE, V25, P1070, DOI 10.1097/00007632-200005010-00006
   Denaro L, 2009, ORTHOP CLIN N AM, V40, P465, DOI 10.1016/j.ocl.2009.05.004
   Denaro V, 2009, CLIN CASES MINER BON, V6, P125
   Deramond H, 1998, RADIOL CLIN N AM, V36, P533, DOI 10.1016/S0033-8389(05)70042-7
   GRARDEL B, 1994, OSTEOPOROSIS INT, V4, P204, DOI 10.1007/BF01623240
   Hautamaki M, 2010, J MATER SCI-MATER M, V21, P1685, DOI 10.1007/s10856-010-4018-4
   He Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042525
   Ikeda S, 2001, BONE, V28, P625, DOI 10.1016/S8756-3282(01)00462-8
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4
   Lau EMC, 1996, J BONE MINER RES, V11, P1364
   Peters KR, 2002, NEUROSURGERY, V51, pS96, DOI 10.1227/01.NEU.0000031000.61275.4C
   Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5
   Schorlemmer S, 2005, BONE, V37, P491, DOI 10.1016/j.bone.2005.05.002
   Tan HL, 2012, ACTA BIOMATER, V8, P2166, DOI 10.1016/j.actbio.2012.03.013
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wu SS, 2003, J WOMEN HEALTH GEN-B, V12, P17, DOI 10.1089/154099903321154103
   Wu ZX, 2008, MED ENG PHYS, V30, P1112, DOI 10.1016/j.medengphy.2008.01.007
   Yang HL, 2011, ARTIF CELL BLOOD SUB, V39, P87, DOI 10.3109/10731199.2010.503319
NR 25
TC 2
Z9 2
U1 2
U2 10
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1943-8141
J9 AM J TRANSL RES
JI Am. J. Transl. Res.
PY 2015
VL 7
IS 3
BP 548
EP 557
PG 10
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA CK8LU
UT WOS:000356490400012
PM 26045894
DA 2018-10-20
ER

PT J
AU Perea-Gil, I
   Uriarte, JJ
   Prat-Vidal, C
   Galvez-Monton, C
   Roura, S
   Llucia-Valldeperas, A
   Soler-Botija, C
   Farre, R
   Navajas, D
   Bayes-Genis, A
AF Perea-Gil, Isaac
   Uriarte, Juan J.
   Prat-Vidal, Cristina
   Galvez-Monton, Carolina
   Roura, Santiago
   Llucia-Valldeperas, Aida
   Soler-Botija, Carolina
   Farre, Ramon
   Navajas, Daniel
   Bayes-Genis, Antoni
TI In vitro comparative study of two decellularization protocols in search
   of an optimal myocardial scaffold for recellularization
SO AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH
LA English
DT Article
DE Myocardial infarction; acellular myocardial scaffold; extracellular
   matrix; decellularization protocols; recellularization; adipose
   tissue-derived progenitor cells
ID MESENCHYMAL STEM-CELLS; CARDIAC EXTRACELLULAR-MATRIX; MARROW
   MONONUCLEAR-CELLS; HUMAN ADIPOSE-TISSUE; PROGENITOR CELLS;
   MICROMECHANICAL PROPERTIES; HEART; INFARCTION; REGENERATION;
   DIFFERENTIATION
AB Introduction. Selection of a biomaterial-based scaffold that mimics native myocardial extracellular matrix (ECM) architecture can facilitate functional cell attachment and differentiation. Although decellularized myocardial ECM accomplishes these premises, decellularization processes may variably distort or degrade ECM structure. Materials and methods. Two decellularization protocols (DP) were tested on porcine heart samples (epicardium, mid myocardium and endocardium). One protocol, DP1, was detergent-based (SDS and Triton X-100), followed by DNase I treatment. The other protocol, DP2, was focused in trypsin and acid with Triton X-100 treatments. Decellularized myocardial scaffolds were reseeded by embedding them in RAD16-I peptidic hydrogel with adipose tissue-derived progenitor cells (ATDPCs). Results. Both protocols yielded acellular myocardial scaffolds (similar to 82% and similar to 94% DNA reduction for DP1 and DP2, respectively). Ultramicroscopic assessment of scaffolds was similar for both protocols and showed filamentous ECM with preserved fiber disposition and structure. DP1 resulted in more biodegradable scaffolds (P = 0.04). Atomic force microscopy revealed no substantial ECM stiffness changes post-decellularization compared to native tissue. The Young's modulus did not differ between heart layers (P = 0.69) or decellularization protocols (P = 0.15). After one week, recellularized DP1 scaffolds contained higher cell density (236 +/- 106 and 98 +/- 56 cells/mm(2) for recellularized DP1 and DP2 scaffolds, respectively; P = 0.04). ATDPCs in both DP1 and DP2 scaffolds expressed the endothelial marker isolectin B4, but only in the DP1 scaffold ATDPCs expressed the cardiac markers GATA4, connexin43 and cardiac troponin T. Conclusions. In our hands, DP1 produced myocardial scaffolds with higher cell repopulation and promotes ATDPCs expression of endothelial and cardiomyogenic markers.
C1 [Perea-Gil, Isaac; Prat-Vidal, Cristina; Galvez-Monton, Carolina; Roura, Santiago; Llucia-Valldeperas, Aida; Soler-Botija, Carolina; Bayes-Genis, Antoni] Hosp Badalona Germans Trias & Pujol, Serv Cardiol, Hlth Sci Res Inst Germans Trias & Pujol IGTP, ICREC Heart Failure & Cardiac Regenerat Res Lab, Barcelona 08916, Spain.
   [Uriarte, Juan J.; Farre, Ramon; Navajas, Daniel] Univ Barcelona, Fac Med, Biophys & Bioengn Unit, Barcelona 7, Spain.
   [Uriarte, Juan J.; Farre, Ramon; Navajas, Daniel] CIBER Enfermedades Resp, Madrid, Spain.
   [Farre, Ramon] Inst Invest Biomed August Pi I Sunyer, Barcelona, Spain.
   [Navajas, Daniel] Inst Bioengn Catalonia, Barcelona, Spain.
   [Bayes-Genis, Antoni] Autonomous Univ Barcelona, Dept Med, Barcelona, Spain.
RP Bayes-Genis, A (reprint author), Hosp Badalona Germans Trias & Pujol, Serv Cardiol, Hlth Sci Res Inst Germans Trias & Pujol IGTP, ICREC Res Lab, Crta Canyet S-N, Barcelona 08916, Spain.
EM abayesgenis@gmail.com
RI Navajas, Daniel/E-4233-2010; Farre, Ramon/L-2664-2017
OI Navajas, Daniel/0000-0001-7150-9363; Farre, Ramon/0000-0002-9084-7824
FU Instituto de Salud Carlos III: Redes Tematicas de Investigacion
   Cooperativa en Salud [Red de Investigacion Cardiovascular (RIC)
   [RD12/0042/0047]; Ministerio de Ciencia e Innovacion
   [SAF-2011-30067-C02-01/02, SAF2011-22576, FIS-P11/00089,
   FIS-PI14/01682]; Fundacio Privada Daniel Bravo Andreu; La Marato de TV3
   [12/2232]; Societat Catalana de Cardiologia; Sociedad Espanola de
   Cardiologia; Instituto de Salud Carlos III: Redes Tematicas de
   Investigacion Cooperativa en Salud (Red de Investigacion en Terapia
   Celular-TerCel) [RD12/0019/0029];  [IF09/3667]
FX The authors want to thank the members of the Jesus Uson Minimally
   Invasive Surgery Centre (Caceres, Spain) for providing mediastinal
   adipose tissue samples from pigs that underwent cardiothoracic surgery.
   This work was supported in part by the Instituto de Salud Carlos III:
   Redes Tematicas de Investigacion Cooperativa en Salud [Red de
   Investigacion Cardiovascular (RIC; RD12/0042/0047) and Red de
   Investigacion en Terapia Celular-TerCel (RD12/0019/0029)] and by
   Infrastructure Grant (IF09/3667). The study also received funding from
   the Ministerio de Ciencia e Innovacion (SAF-2011-30067-C02-01/02 to ABG,
   SAF2011-22576 to RF, FIS-P11/00089 to DN and FIS-PI14/01682); from the
   Fundacio Privada Daniel Bravo Andreu; from La Marato de TV3 (12/2232 to
   SR); and from the Societat Catalana de Cardiologia and the Sociedad
   Espanola de Cardiologia.
CR Akhyari P, 2011, TISSUE ENG PART C-ME, V17, P915, DOI [10.1089/ten.tec.2011.0210, 10.1089/ten.TEC.2011.0210]
   Aleksandrova A, 2012, DEV BIOL, V363, P348, DOI 10.1016/j.ydbio.2011.12.036
   Andreu I, 2014, ACTA BIOMATER, V10, P3235, DOI 10.1016/j.actbio.2014.03.034
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Bayes-Genis A, 2010, J MOL CELL CARDIOL, V49, P771, DOI 10.1016/j.yjmcc.2010.08.010
   Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005
   Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Bissell M J, 1987, Prog Clin Biol Res, V249, P251
   Butt H J, 1995, NANOTECHNOLOGY, V1, P1, DOI DOI 10.1088/0957-4484/6/1/001
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Cui XJ, 2010, TOHOKU J EXP MED, V222, P281, DOI 10.1620/tjem.222.281
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Galvez-Monton C, 2013, REV ESP CARDIOL, V66, P391, DOI 10.1016/j.rec.2012.11.012
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Hersch N, 2013, BIOL OPEN, V2, P351, DOI 10.1242/bio.20133830
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017
   Kawamoto A, 2001, CIRCULATION, V103, P634
   Kim BS, 2012, CELL TISSUE RES, V348, P559, DOI 10.1007/s00441-012-1391-y
   Kumar BM, 2007, MOL CELLS, V24, P343
   Liang CH, 2004, BIOMATERIALS, V25, P3541
   Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810
   Lu P., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005058
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   Lu TY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3307
   Luque T, 2013, ACTA BIOMATER, V9, P6852, DOI 10.1016/j.actbio.2013.02.044
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Martinez-Estrada OM, 2005, CARDIOVASC RES, V65, P328, DOI 10.1016/j.cardiores.2004.11.015
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Miyagi Y, 2010, BIOMATERIALS, V31, P7684, DOI 10.1016/j.biomaterials.2010.06.048
   Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014
   Novakovic GV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014076
   Ock SA, 2010, TISSUE ENG PART C-ME, V16, P1481, DOI [10.1089/ten.tec.2010.0149, 10.1089/ten.TEC.2010.0149]
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Prat-Vidal C, 2014, INT J CARDIOL, V174, P654, DOI 10.1016/j.ijcard.2014.04.181
   Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914
   Rigol M, 2014, EUR J CLIN INVEST, V44, P83, DOI 10.1111/eci.12195
   Rigol M, 2010, J CARD FAIL, V16, P357, DOI 10.1016/j.cardfail.2009.12.006
   Robinson KA, 2005, CIRCULATION, V112, pI135
   Sarig U, 2012, TISSUE ENG PT A, V18, P2125, DOI [10.1089/ten.tea.2011.0586, 10.1089/ten.TEA.2011.0586]
   Sarig U, 2011, EXPERT OPIN BIOL TH, V11, P1055, DOI 10.1517/14712598.2011.578574
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Siepe M, 2006, J THORAC CARDIOV SUR, V132, P124, DOI 10.1016/j.jtcvs.2006.01.052
   Soler-Botija C, 2014, AM J TRANSL RES, V6, P291
   Soler-Botija C, 2012, ANN NY ACAD SCI, V1254, P57, DOI 10.1111/j.1749-6632.2012.06519.x
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Song JJ, 2014, TRENDS MOL MED, V17, P424
   Templin C, 2012, CIRCULATION, V126, P430, DOI 10.1161/CIRCULATIONAHA.111.087684
   Trinh LA, 2004, DEV CELL, V6, P371
   Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701
   Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]
   Wang B, 2010, J BIOMED MATER RES A, V94A, P1100, DOI 10.1002/jbm.a.32781
   Witzenburg C, 2012, J BIOMECH, V45, P842, DOI 10.1016/j.jbiomech.2011.11.025
   Xu YY, 2014, ACTA BIOMATER, V10, P3449, DOI 10.1016/j.actbio.2014.04.018
   Zhang J, 2013, CIRC RES, V111, P1125
   Zhang SN, 2011, J CELL MOL MED, V15, P2245, DOI 10.1111/j.1582-4934.2010.01217.x
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
   Zhou C, 2014, SCI REP, V4, P3733
NR 63
TC 17
Z9 17
U1 7
U2 28
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1943-8141
J9 AM J TRANSL RES
JI Am. J. Transl. Res.
PY 2015
VL 7
IS 3
BP 558
EP +
PG 18
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA CK8LU
UT WOS:000356490400013
PM 26045895
DA 2018-10-20
ER

PT J
AU Pielesz, A
   Machnicka, A
   Gawlowski, A
   Fabia, J
   Sarna, E
   Binias, W
AF Pielesz, Anna
   Machnicka, Alicja
   Gawlowski, Andrzej
   Fabia, Janusz
   Sarna, Ewa
   Binias, Wlodzimierz
TI Inhibitors of thermally induced burn incidents - characterization by
   microbiological procedure, electrophoresis, SEM, DSC and IR spectroscopy
SO ANALYST
LA English
DT Article
ID BOVINE SERUM-ALBUMIN; RAMAN-SPECTROSCOPY; FTIR SPECTROSCOPY;
   STRUCTURAL-CHANGES; GLYCATED ALBUMIN; COLLAGEN; AGGREGATION; SKIN;
   PROTEINS; FUCOIDAN
AB Differential scanning calorimetry (DSC) and thermogravimetric (TGA) investigations, acetate electrophoresis (CAE), Fourier-transform infrared spectrometry (FTIR), scanning electron microscopy (SEM) analysis and microbiological procedures were all carried out after heating the samples to a temperature sufficient for simulating a burn incident. In particular, the purpose of the present study was to analyze the effect of antioxidants, such as fucoidan from brown seaweed and flame-retardant cyclic organophosphates and phosphonates, on an organic chicken skin that gets changed by a burn incident. DSC was considered to be a useful tool in assessing in vitro temperature-mediated cross-linking; an innovative analytical conclusion was obtained from the experimentation described in the paper. FTIR tests revealed that heating a dry organic chicken skin to the boiling point leads to the disappearance of a wide band in the 1650-1550 cm(-1) area or the conversion of a band, which may be attributed to the intermolecular beta-sheet aggregates. Fucoidan from brown seaweed and flame-retardant cyclic organophosphates and phosphonates probably bind with the collagen that is changed by the burn (in addition to the influence of antioxidant solutions on samples of a blank or not boiled organic chicken skin) incident forming a polymer film with the collagen of the chicken skin surface (SEM analysis), decreasing the aggregation process and native collagen recovery. Good bacteriostatic properties were determined for fucoidan samples from brown seaweed and flame-retardant cyclic organophosphates and phosphonates against the pathogenic bacteria Escherichia coli and Staphylococcus aureus. Thus, it was observed that the fucoidan incorporated into collagen films can be used as a therapeutically active biomaterial that speeds up the wound-healing process.
C1 [Pielesz, Anna; Machnicka, Alicja; Gawlowski, Andrzej; Fabia, Janusz; Sarna, Ewa; Binias, Wlodzimierz] Univ Bielsko Biala, Fac Mat Civil & Environm Engn, Bielsko Biala, Poland.
RP Pielesz, A (reprint author), Univ Bielsko Biala, Fac Mat Civil & Environm Engn, Bielsko Biala, Poland.
EM apielesz@ath.bielsko.pl
RI Machnicka, Alicja/T-4332-2017
OI Machnicka, Alicja/0000-0003-0277-5160; Binias,
   Wlodzimierz/0000-0002-7260-7739
CR Alimova A, 2009, J PHOTOCH PHOTOBIO B, V96, P178, DOI 10.1016/j.jphotobiol.2009.06.004
   BAILEY AJ, 1995, BIOCHEM J, V305, P385, DOI 10.1042/bj3050385
   Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   Binder RJ, 2004, TISSUE ANTIGENS, V64, P442, DOI 10.1111/j.1399-0039.2004.00299.x
   Chen HI, 2010, INT J BIOL MACROMOL, V46, P535, DOI 10.1016/j.ijbiomac.2010.03.001
   Cohen MP, 2003, ARCH BIOCHEM BIOPHYS, V419, P25, DOI 10.1016/j.abb.2003.08.012
   Crane NJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.010902
   Crane NJ, 2010, WOUND REPAIR REGEN, V18, P409, DOI 10.1111/j.1524-475X.2010.00597.x
   Dong AC, 2000, J BIOL CHEM, V275, P27689
   Evers LH, 2010, EXP DERMATOL, V19, P777, DOI 10.1111/j.1600-0625.2010.01105.x
   Farhan KM, 2011, CLIN CHIM ACTA, V412, P386, DOI 10.1016/j.cca.2010.11.016
   Finot PA, 2005, ANN NY ACAD SCI, V1043, P1, DOI 10.1196/annals.1333.001
   GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0
   Honda C, 2000, CHEM PHARM BULL, V48, P464
   Horrocks AR, 2008, ADVANCES IN FIRE RETARDANT MATERIALS, P1, DOI 10.1533/9781845694701
   JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140
   Janowska G., 2007, PALNOSC POLIMEROW MA
   Meli M, 2003, J PROTEIN CHEM, V22, P521, DOI 10.1023/B:JOPC.0000005501.48719.84
   Mendelsohn R, 2006, BBA-BIOMEMBRANES, V1758, P923, DOI 10.1016/j.bbamem.2006.04.009
   Mentink CJAL, 2002, CLIN CHIM ACTA, V321, P69, DOI 10.1016/S0009-8981(02)00097-9
   Militello V, 2003, BIOPHYS CHEM, V105, P133, DOI 10.1016/S0301-4622(03)00153-4
   Paul RG, 1998, BIOCHEM J, V330, P1241, DOI 10.1042/bj3301241
   Pielesz A, 2011, CARBOHYD RES, V346, P1937, DOI 10.1016/j.carres.2011.05.016
   Pielesz A, 2014, ELECTROPHORESIS, V35, P2237, DOI 10.1002/elps.201400178
   Pielesz A, 2014, SPECTROCHIM ACTA A, V118, P287, DOI 10.1016/j.saa.2013.08.056
   Pouliot R, 1999, BBA-MOL CELL BIOL L, V1439, P341, DOI 10.1016/S1388-1981(99)00086-4
   Rondeau P, 2007, ARCH BIOCHEM BIOPHYS, V460, P141, DOI 10.1016/j.abb.2007.01.014
   Rondeau P, 2011, BIOCHIMIE, V93, P645, DOI 10.1016/j.biochi.2010.12.003
   Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167
   Semenza GL, 2000, J APPL PHYSIOL, V88, P1474
   Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2
   VARGHESE MC, 1986, ARCH DERMATOL, V122, P52, DOI 10.1001/archderm.122.1.52
   Votteler M, 2012, J BIOPHOTONICS, V5, P47, DOI 10.1002/jbio.201100068
   Wiens R, 2007, ANAL BIOANAL CHEM, V387, P1679, DOI 10.1007/s00216-006-1095-9
NR 34
TC 2
Z9 2
U1 2
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
EI 1364-5528
J9 ANALYST
JI Analyst
PY 2015
VL 140
IS 13
BP 4599
EP 4607
DI 10.1039/c5an00329f
PG 9
WC Chemistry, Analytical
SC Chemistry
GA CK4DO
UT WOS:000356171400033
PM 26029873
DA 2018-10-20
ER

PT J
AU Paul, NE
   Losel, R
   Hemmrich, K
   Goy, D
   Pallua, N
   Klee, D
AF Paul, N. E.
   Loesel, R.
   Hemmrich, K.
   Goy, D.
   Pallua, N.
   Klee, D.
TI L-arginine and arginine ethyl ester enhance proliferation of endothelial
   cells and preadipocytes - How an arginine ethyl ester-releasing
   biomaterial could support endothelial cell growth in tissue engineering
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Arginine; arginine ethyl ester; endothelial cells; preadipocytes;
   angiogenesis
ID HUMAN ADIPOSE-TISSUE; NITRIC-OXIDE; IN-VIVO; STROMAL CELLS;
   ANGIOGENESIS; DIFFERENTIATION; SECRETION; PRECURSOR; INSULIN; LEPTIN
AB Adipose tissue engineering is a promising solution for the reconstruction of soft tissue defects. An insufficient neovascularisation within the scaffolds that leads to necrosis and tissue loss is still a major shortcoming of current tissue engineering attempts. Biomaterials, which release angiogenic factors such as L-arginine, could overcome this challenge by supporting the neovascularisation of the constructs. L-arginine is insoluble in organic solvents and thus cannot be incorporated into commonly used polymers in contrast to its ethyl ester. Here, we compared the effects of arginine and its ethyl ester on endothelial cells and preadipocytes, and generated an arginine ethyl ester-releasing, angiogenic polymer. We cultivated adipose tissue-derived endothelial cells and preadipocytes in arginine-free medium supplemented with L-arginine or L-arginine ethyl ester and assayed the proliferation rate and the degree of adipogenic differentiation, respectively. Additionally, we prepared arginine ethyl ester-releasing poly(D, L-lactide) foils, and investigated their impact on endothelial cell proliferation. We could demonstrate that arginine ethyl ester like arginine significantly increased the proliferation of endothelial cells and preadipocytes without inhibiting an induced adipogenic conversion of the preadipocytes. Further, we could show that the arginine ethyl ester-releasing polymer significantly increased endothelial cell growth. The present data are helpful guidance for generating angiogenic biomaterials that promote endothelial cell growth, and thereby could support neovascularisation within tissue engineering approaches.
C1 [Paul, N. E.; Hemmrich, K.; Goy, D.; Pallua, N.] Rhein Westfal TH Aachen, Univ Hosp, Burn Ctr, Dept Plast Surg & Hand Surg, D-52074 Aachen, Germany.
   [Loesel, R.; Klee, D.] Rhein Westfal TH Aachen, Dept Text & Macromol Chem, D-52074 Aachen, Germany.
RP Paul, NE (reprint author), Rhein Westfal TH Aachen, Univ Hosp, Burn Ctr, Dept Plast Surg & Hand Surg, Pauwelsstr 30, D-52074 Aachen, Germany.
EM npaul@ukaachen.de
FU Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich
   Transregio 37]
FX This work was supported by a grant from the Deutsche
   Forschungsgemeinschaft (DFG), Sonderforschungsbereich Transregio 37.
CR Chin K, 1997, ONCOGENE, V15, P437, DOI 10.1038/sj.onc.1201201
   Cooke JP, 2003, ATHEROSCLEROSIS SUPP, V4, P53, DOI 10.1016/S1567-5688(03)00034-5
   Dulak J, 2000, ARTERIOSCL THROM VAS, V20, P659, DOI 10.1161/01.ATV.20.3.659
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P219, DOI 10.1097/00006534-199102000-00001
   FASEHUN OA, 1990, J PHARMACOL EXP THER, V255, P1348
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   FOLKMAN J, 1982, ANN NY ACAD SCI, V401, P212, DOI 10.1111/j.1749-6632.1982.tb25720.x
   Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA
   Hemmrich K, 2006, EXPERT REV MED DEVIC, V3, P635, DOI 10.1586/17434440.3.5.635
   Holmang A, 1996, DIABETOLOGIA, V39, P206, DOI 10.1007/BF00403964
   Hoss M, 2013, J TISSUE ENG REGEN M, V7, P312, DOI 10.1002/term.526
   Hutley LJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1037
   Jozkowicz A, 1999, ACTA BIOCHIM POL, V46, P703
   KERN PA, 1989, DIABETES, V38, P710, DOI 10.2337/diabetes.38.6.710
   Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d
   Neels JG, 2004, FASEB J, V18, P983, DOI 10.1096/fj.03-1101fje
   PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799
   Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683
   SILVERMAN KJ, 1988, BIOCHEM BIOPH RES CO, V153, P347, DOI 10.1016/S0006-291X(88)81229-4
   SPRINGHORN JP, 1995, IN VITRO CELL DEV-AN, V31, P473
   Stoppato M, 2013, BIOMATERIALS, V34, P4573, DOI 10.1016/j.biomaterials.2013.02.009
   VARZANEH FE, 1994, METABOLISM, V43, P906, DOI 10.1016/0026-0495(94)90275-5
   von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013
   Ziche M, 1997, J CLIN INVEST, V99, P2625, DOI 10.1172/JCI119451
   ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557
   ZICHE M, 1993, BIOCHEM BIOPH RES CO, V192, P1198, DOI 10.1006/bbrc.1993.1543
NR 28
TC 0
Z9 0
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2015
VL 25
IS 3
BP 289
EP 297
DI 10.3233/BME-151275
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK9CP
UT WOS:000356538400007
PM 26407115
DA 2018-10-20
ER

PT J
AU Yamamoto, K
   Yoshizawa, Y
   Yanagiguchi, K
   Ikeda, T
   Yamada, S
   Hayashi, Y
AF Yamamoto, Kohei
   Yoshizawa, Yuu
   Yanagiguchi, Kajiro
   Ikeda, Takeshi
   Yamada, Shizuka
   Hayashi, Yoshihiko
TI The Characterization of Fish (Tilapia) Collagen Sponge as a Biomaterial
SO INTERNATIONAL JOURNAL OF POLYMER SCIENCE
LA English
DT Article
ID I COLLAGEN; SCAFFOLDS; CHITOSAN; MATRICES
AB For scaffold manufacturing, the utility of bioactive natural organic materials derived from marine products is useful and indispensable as an alternative to bovine collagen. The weakest feature of fish collagen for scaffold application is its low degeneration temperature (T-d), indicating poor stability of fish collagen in mammals in vivo. We have focused on the tropical fish tilapia as a candidate for generating a clinical scaffold. The aim of this study was to confirm the T-d of tilapia type I atelocollagen (TAC) for biomedical application. Furthermore, the physical and structural properties were investigated and evaluated as a scaffold on a sponge form. Different concentrations {0.5%, 1.0%, and 2.0% (v/v)} of TAC solution were analyzed. Differential scanning calorimetry showed that the T-d of TAC was 35-36 degrees C. The scanning electron microscopy results indicated that the pore size (90-160 mu m) of TAC sponges is acceptable for cell proliferation. The tensile strength of porous sponges was in the range of 0.01-0.07 MPa. These findings indicate that the TAC sponge prepared from tilapia is one of candidates as a scaffold. The 1.0% (v/v) concentration of TAC solution is especially recommended to be advantageous for preparing and handling the solution and for sponge formation.
C1 [Yamamoto, Kohei; Yoshizawa, Yuu; Yanagiguchi, Kajiro; Ikeda, Takeshi; Yamada, Shizuka; Hayashi, Yoshihiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cariol, Nagasaki 8528588, Japan.
RP Hayashi, Y (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cariol, Nagasaki 8528588, Japan.
EM hayashi@nagasaki-u.ac.jp
FU Funds for Integrated Promotion of Social System Reform and Research and
   Development; Ministry of Education, Science, Sports and Culture of Japan
FX This work was supported by Funds for Integrated Promotion of Social
   System Reform and Research and Development, Contract Grant Sponsor:
   Ministry of Education, Science, Sports and Culture of Japan.
CR Chen VJ, 2004, BIOMATERIALS, V25, P2065, DOI 10.1016/j.biomaterials.2003.08.058
   Dawlee S, 2005, BIOMACROMOLECULES, V6, P2040, DOI 10.1021/bm050013a
   Dillow A., 2002, BIOMIMETIC MAT DESIG
   Hayashi Y., 2014, SEAFOOD PROCESSING B, P455
   Hayashi Y, 2012, ADV FOOD NUTR RES, V65, P107, DOI 10.1016/B978-0-12-416003-3.00006-8
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Ikoma T, 2003, INT J BIOL MACROMOL, V32, P199, DOI 10.1016/S0141-8130(03)00054-0
   KIMURA S, 1988, J FOOD SCI, V53, P1315, DOI 10.1111/j.1365-2621.1988.tb09266.x
   Lefler A, 2009, J BIOMAT SCI-POLYM E, V20, P1335, DOI 10.1163/092050609X12457417534295
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MATSUI R, 1991, COMP BIOCHEM PHYS B, V99, P171, DOI 10.1016/0305-0491(91)90025-9
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Winter AD, 2000, MOL CELL BIOL, V20, P4084, DOI 10.1128/MCB.20.11.4084-4093.2000
   Wu JL, 2011, CARBOHYD POLYM, V86, P1048, DOI 10.1016/j.carbpol.2011.05.060
   Yamada S, 2014, BIOMED RES INT, DOI 10.1155/2014/302932
   Yamamoto K, 2014, BIOMED RES INT, DOI 10.1155/2014/630757
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 18
TC 1
Z9 1
U1 0
U2 12
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-9422
EI 1687-9430
J9 INT J POLYM SCI
JI Int. J. Polym. Sci.
PY 2015
AR 957385
DI 10.1155/2015/957385
PG 5
WC Polymer Science
SC Polymer Science
GA CL2OB
UT WOS:000356782800001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zhang, WF
   Yu, JX
   Chang, HX
AF Zhang, Wenfeng
   Yu, Jingxue
   Chang, Haixin
TI Two dimensional nanosheets as conductive, flexible elements in
   biomaterials
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID TISSUE-ENGINEERED PERIOSTEUM; MESENCHYMAL STEM-CELLS; GRAPHENE OXIDE;
   COMPOSITE SCAFFOLDS; SUBRETINAL SPACE; DIFFERENTIATION; FILMS;
   STRATEGIES; DELIVERY; BEHAVIOR
AB Since the discovery of graphene in 2004, two-dimensional (2D) nanostructures have been attracting tremendous interest for a variety of applications, including bio-inspired applications, due to their fascinating electronic, mechanical and optical properties. Especially, graphene and other 2D or quasi-2D nanostructures show excellent conductivity and flexibility. Herein, we highlight the recent impressive progress concerning the use of two representative types of 2D and quasi-2D nanostructures, graphenebased nanosheets and ultrathin polymeric nanosheets, as conductive or/and flexible elements to engineer three dimensional (3D) tissues. The results feature the unique potential of these 2D and quasi-2D nanostructures in the biomaterial tissue engineering research field.
C1 [Zhang, Wenfeng; Yu, Jingxue; Chang, Haixin] Huazhong Univ Sci & Technol, Sch Mat Sci & Engn, Ctr Joining & Elect Packaging, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
RP Chang, HX (reprint author), Huazhong Univ Sci & Technol, Sch Mat Sci & Engn, Ctr Joining & Elect Packaging, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
EM hxchang@hust.edu.cn
RI zhang, wenfeng/C-5730-2011; Chang, Haixin/A-1753-2012
OI zhang, wenfeng/0000-0001-9487-9375; 
FU National Basic Research Program of China [2015CB258400]; Natural Science
   Foundation of China [51402118]; HUST [0118110089, 0124110361]
FX This study is supported by the National Basic Research Program of China
   (No. 2015CB258400), the Natural Science Foundation of China (No.
   51402118) and the HUST (No. 0118110089 and 0124110361).
CR Ahadian S, 2014, RSC ADV, V4, P9534, DOI 10.1039/c3ra46218h
   Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056
   Binder S, 2007, PROG RETIN EYE RES, V26, P516, DOI 10.1016/j.preteyeres.2007.02.002
   Chang HX, 2013, ENERG ENVIRON SCI, V6, P3483, DOI 10.1039/c3ee42518e
   Chang HX, 2013, ADV FUNCT MATER, V23, P1984, DOI 10.1002/adfm.201202460
   Chang HX, 2010, ANAL CHEM, V82, P2341, DOI 10.1021/ac9025384
   Chen D, 2012, CHEM REV, V112, P6027, DOI 10.1021/cr300115g
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Fan W, 2008, BONE, V42, P81, DOI 10.1016/j.bone.2007.08.048
   Foolen J, 2008, J ORTHOP RES, V26, P1263, DOI 10.1002/jor.20586
   Forrest JA, 2001, ADV COLLOID INTERFAC, V94, P167, DOI 10.1016/S0001-8686(01)00060-4
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Fujie T, 2014, ADV MATER, V26, P1699, DOI 10.1002/adma.201304183
   Fujie T, 2013, NANO LETT, V13, P3185, DOI 10.1021/nl401237s
   Fujie T, 2011, LANGMUIR, V27, P13173, DOI 10.1021/la203140a
   Fujie Y. O. T., 2011, FUNCTIONAL POLYM FIL, P907
   Ge Y, 2012, J MATER CHEM, V22, P17619, DOI 10.1039/c2jm33173j
   Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877
   Guillame-Gentil O, 2010, ADV MATER, V22, P5443, DOI 10.1002/adma.201001747
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hoffman MD, 2013, BIOMATERIALS, V34, P8887, DOI 10.1016/j.biomaterials.2013.08.005
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Hynes SR, 2010, GRAEF ARCH CLIN EXP, V248, P763, DOI 10.1007/s00417-009-1263-7
   Ku SH, 2013, BIOMATERIALS, V34, P2017, DOI 10.1016/j.biomaterials.2012.11.052
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Liu KP, 2011, J MATER CHEM, V21, P12034, DOI 10.1039/c1jm10749f
   Matsusaki M, 2007, ANGEW CHEM INT EDIT, V46, P4689, DOI 10.1002/anie.20070108
   Matsusaki M, 2012, ADV MATER, V24, P454, DOI 10.1002/adma.201103698
   Nishiguchi A, 2011, ADV MATER, V23, P3506, DOI 10.1002/adma.201101787
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Rao CNR, 2009, ANGEW CHEM INT EDIT, V48, P7752, DOI 10.1002/anie.200901678
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sanchez VC, 2011, CHEM RES TOXICOL, V25, P15, DOI DOI 10.1021/TX200339H
   Schonmeyr B, 2009, TISSUE ENG PT A, V15, P1833, DOI 10.1089/ten.tea.2008.0446
   Shan CS, 2009, LANGMUIR, V25, P12030, DOI 10.1021/la903265p
   Shi XT, 2014, ADV MATER, V26, P3290, DOI 10.1002/adma.201305804
   Shi XT, 2012, ADV FUNCT MATER, V22, P751, DOI 10.1002/adfm.201102305
   Shin SR, 2014, ADV FUNCT MATER, V24, P6136, DOI 10.1002/adfm.201401300
   Shin SR, 2013, ADV MATER, V25, P6385, DOI 10.1002/adma.201301082
   Stanzel BV, 2012, INVEST OPHTH VIS SCI, V53, P490, DOI 10.1167/iovs.11-8260
   Sun ZH, 2014, ACS NANO, V8, P4133, DOI 10.1021/nn500508c
   Taccola S, 2011, LANGMUIR, V27, P5589, DOI 10.1021/la2004134
   Tang LH, 2011, ACS NANO, V5, P3817, DOI 10.1021/nn200147n
   Tao S, 2007, LAB CHIP, V7, P695, DOI 10.1039/b618583e
   Thumann G, 2009, BIOMATERIALS, V30, P287, DOI 10.1016/j.biomaterials.2008.09.039
   Wang Y, 2013, J MATER CHEM B, V1, P3521, DOI 10.1039/c3tb20524j
   Zhou YF, 2007, BIOMATERIALS, V28, P814, DOI 10.1016/j.biomaterials.2006.09.032
   Zorlutuna P, 2012, ADV MATER, V24, P1782, DOI 10.1002/adma.201104631
NR 51
TC 4
Z9 4
U1 1
U2 36
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 25
BP 4959
EP 4964
DI 10.1039/c5tb00087d
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA CK6YS
UT WOS:000356375800004
DA 2018-10-20
ER

PT J
AU Purcel, G
   Surdu, A
   Stoleriu, S
AF Purcel, Gabriela
   Surdu, Adrian
   Stoleriu, Stefania
TI INFLUENCE OF SPARK PLASMA SINTERING CONDITIONS ON Si3N4 CERAMICS USED
   FOR BONE IMPLANTS
SO REVISTA ROMANA DE MATERIALE-ROMANIAN JOURNAL OF MATERIALS
LA English
DT Article
DE Si3N4; spark plasma sintering; biocompatibility
ID STRUCTURAL ORTHOPEDIC IMPLANTS; SILICON-NITRIDE; MECHANICAL-PROPERTIES;
   ALPHA-SI3N4 CERAMICS; COMPOSITES; ADDITIVES
AB Silicon nitride attracts the attention of many researchers for its use in orthopedic and dental applications, but is not yet established as a biomaterial, the research is ongoing. Present paper deals with the obtaining of Si3N4 ceramics unconventional heat treatment (spark plasma sintering.
   The sintering process was pursued through the variation of four Influencing parameters: sintering temperature, the heating rate, the pressure applied during sintering and soaking time. The obtained ceramics were characterized using X-ray diffraction for the phases determination and scanning electron microscopy for microstructure characterization. Also, were determined ceramic and mechanical properties.
   By testing the biocompatibility of these ceramics in contact with the physiological environment by following the evolution of pH and ionic conductivity on immersion of ceramics in SBF is found that pH values and ionic conductivity samples varies widely In the first days but after stabilizes around SBF values.
   Regarding the antibacterial effect, the tests indicate a triple value of biofilm inhibition area for the Si3N4 samples, as comparing with pure titanium, measured under the same condition. Also, was evaluated the MG-63 cell proliferation (by lactate dehydrogenase method - LDH) and morphology.
C1 [Purcel, Gabriela; Surdu, Adrian; Stoleriu, Stefania] Univ Politehn Bucuresti, Bucharest 011061, Romania.
RP Stoleriu, S (reprint author), Univ Politehn Bucuresti, 1,Sect 1, Bucharest 011061, Romania.
EM stefania.stoleriu@upb.ro
OI STOLERIU, Stefania/0000-0003-3553-2034; Surdu,
   Vasile-Adrian/0000-0002-4207-5380
FU Sectoral Operational Programme Human Resources Development; European
   Social Fund; Romanian Government [POSDRU/156/1.2/G/135764]
FX This research was financially supported by Sectoral Operational
   Programme Human Resources Development, financed from the European Social
   Fund and by the Romanian Government under the contract number
   POSDRU/156/1.2/G/135764 "Improvement and implementation of universitary
   master programs in the field of Applied Chemistry and Materials Science
   - ChimMaster".
CR Albu F, 2012, REV ROM MATER, V42, P164
   Bal BS, 2012, ACTA BIOMATER, V8, P2889, DOI 10.1016/j.actbio.2012.04.031
   Ceja-Cardenas L, 2010, J ALLOY COMPD, V501, P345, DOI 10.1016/j.jallcom.2010.04.102
   Chen F, 2008, MATER CHEM PHYS, V107, P67, DOI 10.1016/j.matchemphys.2007.06.042
   Geibel MA, 2005, EUR J MED RES, V10, P333
   Jorgensen J.H., MANUAL CLIN MICROBIO, P1152
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2881, DOI 10.1007/s10856-008-3417-2
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2889, DOI 10.1007/s10856-008-3437-y
   Miranzo P, 2011, CERAM INT, V37, P159, DOI 10.1016/j.ceramint.2010.08.019
   Siqueira JF, 2001, ORAL SURG ORAL MED O, V92, P451, DOI 10.1067/moe.2001.118620
   Tath Z., 2014, CERAM INT, V40, P1399
   Zhang BR, 1998, J AM CERAM SOC, V81, P1344
NR 12
TC 0
Z9 0
U1 0
U2 2
PU SERBAN SOLACOLU FOUNDATION
PI BUCUREST
PA STR GHEORGHE POLIZU NR 1, COD 011061 SECTOR 1, BUCUREST, 00000, ROMANIA
SN 1583-3186
J9 REV ROM MATER
JI Rev. Rom. Mat.
PY 2015
VL 45
IS 2
BP 160
EP 170
PG 11
WC Construction & Building Technology; Materials Science, Multidisciplinary
SC Construction & Building Technology; Materials Science
GA CL0MP
UT WOS:000356637100008
DA 2018-10-20
ER

PT J
AU Allenstein, U
   Mayr, SG
   Zink, M
AF Allenstein, U.
   Mayr, S. G.
   Zink, M.
TI Contractile cell forces deform macroscopic cantilevers and quantify
   biomaterial performance
SO SOFT MATTER
LA English
DT Article
ID SHAPE-MEMORY ALLOYS; SURFACE STRESS; LIVING CELLS; THIN-FILMS; FE-PD;
   ADHESION; FIBROBLASTS; BIOCOMPATIBILITY; SPECTROSCOPY; LOCOMOTION
AB Cells require adhesion to survive, proliferate and migrate, as well as for wound healing and many other functions. The strength of contractile cell forces on an underlying surface is a highly relevant quantity to measure the affinity of cells to a rigid surface with and without coating. Here we show with experimental and theoretical studies that these forces create surface stresses that are sufficient to induce measurable bending of macroscopic cantilevers. Since contractile forces are linked to the formation of focal contacts, results give information on adhesion promoting qualities and allow a comparison of very diverse materials. In exemplary studies, in vitro fibroblast adhesion on the magnetic shape memory alloy Fe-Pd and on the L-lysine derived plasma-functionalized polymer PPLL was determined. We show that cells on Fe-Pd are able to induce surface stresses three times as high as on pure titanium cantilevers. A further increase was observed for PPLL, where the contractile forces are four times higher than on the titanium reference. In addition, we performed finite element simulations on the beam bending to back up the calculation of contractile forces from cantilever bending under non-homogenous surface stress. Our findings consolidate the role of contractile forces as a meaningful measure of biomaterial performance.
C1 [Allenstein, U.; Mayr, S. G.] Leibniz Inst Surface Modificat IOM eV, D-04318 Leipzig, Germany.
   [Allenstein, U.; Mayr, S. G.; Zink, M.] Univ Leipzig, Fac Phys & Earth Sci, D-04103 Leipzig, Germany.
   [Mayr, S. G.] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04103 Leipzig, Germany.
RP Allenstein, U (reprint author), Leibniz Inst Surface Modificat IOM eV, Permoserstr 15, D-04318 Leipzig, Germany.
EM uta.allenstein@iom-leipzig.de; zink@physik.uni-leipzig.de
RI Zink, Mareike/D-8454-2016
OI Zink, Mareike/0000-0002-3603-3483
FU European Social Fund (ESF); German Science Foundation (DFG); Project
   "BIOSTRAIN''; Federal Ministry of Education and Research [BMBF 1315883]
FX We thank BSc N. John and Dr M. Ehrhard for help with cantilever
   preparation and laser cutting, respectively, Mr S. Daum at the workshop
   of the Leibniz Institute of Surface Modification for manufacturing the
   setups framework, as well as Prof. Dr J. Kas for general support. This
   work is funded in parts by the European Social Fund (ESF), the German
   Science Foundation (DFG), Project "BIOSTRAIN'' and Federal Ministry of
   Education and Research (BMBF 1315883) and was performed within the
   Leipzig Graduate School of Natural Sciences BuildMoNa, established
   within the German Excellence Initiative by the DFG.
CR Allenstein U, 2014, J MATER CHEM B, V2, P7739, DOI 10.1039/c4tb01061b
   Allenstein U, 2013, ACTA BIOMATER, V9, P5845, DOI 10.1016/j.actbio.2012.10.040
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Bertoncini P, 2012, J MOL RECOGNIT, V25, P262, DOI 10.1002/jmr.2193
   Dahmen K, 2000, SURF SCI, V446, P161, DOI 10.1016/S0039-6028(99)01174-7
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8
   HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736
   Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999
   Hu M, 1999, J BIOMED MATER RES, V47, P79, DOI 10.1002/(SICI)1097-4636(199910)47:1<79::AID-JBM11>3.0.CO;2-J
   Humphries MJ, 2001, MOL BIOTECHNOL, V18, P57, DOI 10.1385/MB:18:1:57
   Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7
   James RD, 1998, PHILOS MAG A, V77, P1273, DOI 10.1080/01418619808214252
   Kakeshita T., 2002, Materials Science Forum, V394-395, P531
   KOCH R, 1994, J PHYS-CONDENS MAT, V6, P9519, DOI 10.1088/0953-8984/6/45/005
   Koser J, 2011, EUR CELLS MATER, V21, P479
   Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999
   Mayr SG, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.036105
   Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472
   Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018
   Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181
   MURAKAMI M, 1979, THIN SOLID FILMS, V60, P1, DOI 10.1016/0040-6090(79)90339-0
   Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547
   Raiteri R, 2001, SENSOR ACTUAT B-CHEM, V79, P115, DOI 10.1016/S0925-4005(01)00856-5
   Rasband W., 1997, IMAGEJ VERSION 1 49
   Sander D, 2003, CURR OPIN SOLID ST M, V7, P51, DOI 10.1016/S1359-0286(02)00137-7
   Sander D, 2008, SENSORS-BASEL, V8, P4466, DOI 10.3390/s8074466
   Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X
   Selhuber-Unkel C, 2010, BIOPHYS J, V98, P543, DOI 10.1016/j.bpj.2009.11.001
   Shan CS, 2009, LANGMUIR, V25, P12030, DOI 10.1021/la903265p
   SINGER II, 1982, J CELL BIOL, V92, P398, DOI 10.1083/jcb.92.2.398
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stoney GG, 1909, P R SOC LOND A-CONTA, V82, P172, DOI 10.1098/rspa.1909.0021
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Turner N, 2004, CELL BIOL INT, V28, P541, DOI 10.1016/j.cellbi.2004.04.009
   Wyser Y, 2001, PACKAG TECHNOL SCI, V14, P97, DOI 10.1002/pts.540
   Zhang YJ, 2004, J PHYS CHEM B, V108, P15343, DOI 10.1021/jp0471094
   Zink M, 2014, MATER SCI TECH-LOND, V30, P1579, DOI 10.1179/1743284714Y.0000000592
   Zink M, 2013, ADV FUNCT MATER, V23, P1383, DOI 10.1002/adfm.201201789
NR 39
TC 3
Z9 3
U1 1
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2015
VL 11
IS 25
BP 5053
EP 5059
DI 10.1039/c5sm01212k
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA CK7EM
UT WOS:000356394400009
PM 26027952
OA Bronze
DA 2018-10-20
ER

PT J
AU Espinosa-Dzib, A
   Chen, J
   Zavgorodnya, O
   Kozlovskaya, V
   Liang, X
   Kharlampieva, E
AF Espinosa-Dzib, Alejandra
   Chen, Jun
   Zavgorodnya, Oleksandra
   Kozlovskaya, Veronika
   Liang, Xing
   Kharlampieva, Eugenia
TI Tuning assembly and enzymatic degradation of
   silk/poly(N-vinylcaprolactam) multilayers via molecular weight and
   hydrophobicity
SO SOFT MATTER
LA English
DT Article
ID HYDROGEN-BONDED MULTILAYERS; MORI SILK FIBROIN; BLEND FILMS; THIN-FILMS;
   BIOMATERIAL COATINGS; PHYSICAL-PROPERTIES; LENGTH SCALE; TANNIC-ACID;
   LAYER; MICROCAPSULES
AB We report on enzymatically degradable nanothin coatings obtained by layer-by-layer (LbL) assembly of silk fibroin with poly(N-vinylcaprolactam) (PVCL) via hydrogen bonding and hydrophobic interactions. We found that both silk beta-sheet content, controlled through dipping and spin-assisted LbL, and PVCL molecular weight regulate film thickness, microstructure, pH-stability, and biodegradability with a nanoscale precision. Thickness of (silk/PVCL) films increased with increase in PVCL molecular weight and decrease in deposition pH. The impact of assembly pH on film growth was more dramatic for dipped films. These systems show a significant rise in thickness with increase in PVCL molecular weight at pH < 5 but become independent on polymer chain length at pH >= 5. We also found that spin-assisted films exhibited a greater stability at elevated pH and against enzymatic degradation as compared to their dipped counterparts. For both film types, the pH and enzymatic stability was improved with increasing PVCL length and beta-sheet content, indicating enhanced hydrophobic and hydrogen-bonded interactions between PVCL and silk. Finally, we fabricated spherical and cubical (silk/PVCL) LbL capsules of regulated permeability and enzymatic degradation. Our approach gives a unique opportunity to tune thickness, morphology, structure, and biodegradability rate of silk films and capsules by varying silk secondary structure and PVCL length. Accounting for all-aqueous fabrication and the biocompatibility of both polymers these biodegradable materials provide novel platforms for delivery systems and medical devices.
C1 [Espinosa-Dzib, Alejandra; Chen, Jun; Zavgorodnya, Oleksandra; Kozlovskaya, Veronika; Liang, Xing; Kharlampieva, Eugenia] Univ Alabama Birmingham, Dept Chem, Ctr Nanoscale Mat & Biointegrat, Birmingham, AL 35294 USA.
RP Kharlampieva, E (reprint author), Univ Alabama Birmingham, Dept Chem, Ctr Nanoscale Mat & Biointegrat, Birmingham, AL 35294 USA.
EM ekharlam@uab.edu
OI Zavgorodnya, Oleksandra/0000-0001-8296-6340
FU NSF DMR Award [1306110]; Consejo Nacional de Ciencia y Tecnologia
   (CONACYT, Mexico) [203111]
FX This work was supported by NSF DMR Award 1306110 (EK). The Consejo
   Nacional de Ciencia y Tecnologia (CONACYT, Mexico) is acknowledged for
   postdoctoral scholarship 203111 (AED). Mr Will Higgins (UAB) is
   acknowledged for technical assistance. The UAB SEM Lab is also
   acknowledged.
CR Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746
   Basal G, 2011, J APPL POLYM SCI, V121, P1885, DOI 10.1002/app.33651
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Cheng C, 2014, MACROMOL BIOSCI, V14, P807, DOI 10.1002/mabi.201300497
   Chiarelli PA, 2001, ADV MATER, V13, P1167, DOI 10.1002/1521-4095(200108)13:15<1167::AID-ADMA1167>3.0.CO;2-A
   Cho J, 2001, ADV MATER, V13, P1076, DOI 10.1002/1521-4095(200107)13:14<1076::AID-ADMA1076>3.0.CO;2-M
   de Moraes MA, 2015, BIOMACROMOLECULES, V16, P97, DOI 10.1021/bm5012135
   de Moraes MA, 2014, MAT SCI ENG C-MATER, V40, P85, DOI 10.1016/j.msec.2014.03.047
   DeLongchamp DM, 2004, LANGMUIR, V20, P5403, DOI 10.1021/la049777m
   Dhyani V, 2014, ACS APPL MATER INTER, V6, P5005, DOI 10.1021/am4060595
   Du B, 2014, CHEM COMMUN, V50, P4423, DOI 10.1039/c3cc49489f
   Fleer GJ, 1999, MACROMOLECULES, V32, P845, DOI 10.1021/ma980794q
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   Guan Y, 2006, J PHYS CHEM B, V110, P13484, DOI 10.1021/jp061548g
   Jang Y, 2013, MACROMOLECULES, V46, P4580, DOI 10.1021/ma4007736
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jiang P, 2006, MATER LETT, V60, P919, DOI 10.1016/j.matlet.2005.10.056
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670
   Kharlampieva E, 2005, MACROMOLECULES, V38, P10523, DOI 10.1021/ma0516891
   Kharlampieva E, 2003, LANGMUIR, V19, P1235, DOI 10.1021/la026546b
   Kharlampieva E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.128303
   Kharlampieva E, 2010, ACS NANO, V4, P7053, DOI 10.1021/nn102456w
   Kharlampieva E, 2009, ADV MATER, V21, P3053, DOI 10.1002/adma.200803653
   Kozlovskaya V, 2015, ADV HEALTHC MATER, V4, P686, DOI 10.1002/adhm.201400657
   Kozlovskaya V, 2014, J MATER CHEM B, V2, P2494, DOI 10.1039/c4tb00165f
   Kozlovskaya V, 2013, ACS MACRO LETT, V2, P226, DOI 10.1021/mz300661f
   Kozlovskaya V, 2012, ACS MACRO LETT, V1, P384, DOI 10.1021/mz200118f
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lefaux CJ, 2004, J POLYM SCI POL PHYS, V42, P3654, DOI 10.1002/polb.20209
   Liang X, 2014, J POLYM SCI POL CHEM, V52, P2725, DOI 10.1002/pola.27291
   Liang X, 2012, CHEM MATER, V24, P3707, DOI 10.1021/cm301657q
   Liu F, 2014, SOFT MATTER, V10, P9237, DOI 10.1039/c4sm01813c
   Lutkenhaus JL, 2007, MACROMOLECULES, V40, P8367, DOI 10.1021/ma0713557CCC:$37.00
   Maeda Y, 2002, MACROMOLECULES, V35, P217, DOI 10.1021/ma011034+
   Mandal BB, 2009, EUR J PHARM SCI, V37, P160, DOI 10.1016/j.ejps.2009.02.005
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Nogueira GM, 2010, LANGMUIR, V26, P8953, DOI 10.1021/la904741h
   Padol A. R., 2012, INT J TOXICOL APPL P, V2, P31
   Quinn JF, 2007, CHEM SOC REV, V36, P707, DOI 10.1039/b610778h
   Rajkhowa R, 2012, BIOMACROMOLECULES, V13, P2503, DOI 10.1021/bm300736m
   Rao K.M., 2013, J APPL PHARM SCI, V3, P61
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sashina ES, 2006, RUSS J APPL CHEM+, V79, P869, DOI 10.1134/S1070427206060012
   Seo J, 2008, LANGMUIR, V24, P7995, DOI 10.1021/la800906x
   Shchepelina O, 2012, CHEM MATER, V24, P1245, DOI 10.1021/cm202820r
   Shchepelina O, 2011, ADV MATER, V23, P4655, DOI 10.1002/adma.201102234
   Shi PJ, 2013, BIOMACROMOLECULES, V14, P4465, DOI 10.1021/bm401381s
   Shu SJ, 2010, BIOMATERIALS, V31, P6039, DOI 10.1016/j.biomaterials.2010.04.016
   Shulha H, 2006, POLYMER, V47, P5821, DOI 10.1016/j.polymer.2006.06.002
   Stockton WB, 1997, MACROMOLECULES, V30, P2717, DOI 10.1021/ma9700486
   Sukhishvili SA, 2002, MACROMOLECULES, V35, P301, DOI 10.1021/ma011346c
   Sun YY, 1997, J POLYM SCI POL PHYS, V35, P1405
   Tanaka T, 1998, POLYM INT, V45, P175, DOI 10.1002/(SICI)1097-0126(199802)45:2<175::AID-PI883>3.0.CO;2-K
   Urinov E, 1989, POLYM SCI USSR, V31, P666
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wallet B, 2012, LANGMUIR, V28, P11481, DOI 10.1021/la300916e
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2007, MACROMOLECULES, V40, P7594, DOI 10.1021/ma071125s
   Wang Y, 2013, SOFT MATTER, V9, P9420, DOI 10.1039/c3sm51496j
   Xiang FM, 2015, SOFT MATTER, V11, P1001, DOI 10.1039/c4sm02363c
   Ye CH, 2011, BIOMACROMOLECULES, V12, P4319, DOI 10.1021/bm201246f
   Zelikin AN, 2007, ACS NANO, V1, P63, DOI 10.1021/nn700063w
   Zhang X, 2007, CHEM COMMUN, P1395, DOI 10.1039/b615590a
NR 69
TC 7
Z9 7
U1 1
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2015
VL 11
IS 25
BP 5133
EP 5145
DI 10.1039/c5sm00464k
PG 13
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA CK7EM
UT WOS:000356394400018
PM 26041120
DA 2018-10-20
ER

PT J
AU Assuncao-Silva, RC
   Gomes, ED
   Sousa, N
   Silva, NA
   Salgado, AJ
AF Assuncao-Silva, Rita C.
   Gomes, Eduardo D.
   Sousa, Nuno
   Silva, Nuno A.
   Salgado, Antonio J.
TI Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration
SO STEM CELLS INTERNATIONAL
LA English
DT Review
ID OLFACTORY ENSHEATHING CELLS; NEURAL STEM-CELLS; MARROW STROMAL CELLS;
   PROMOTES FUNCTIONAL RECOVERY; CENTRAL-NERVOUS-SYSTEM; COLONY-STIMULATING
   FACTOR; TEMPLATED AGAROSE SCAFFOLDS; ADULT-RAT BRAIN; BONE-MARROW;
   SCHWANN-CELL
AB Spinal cord injury (SCI) is a central nervous system- (CNS-) related disorder for which there is yet no successful treatment. Within the past several years, cell-based therapies have been explored for SCI repair, including the use of pluripotent human stem cells, and a number of adult-derived stem and mature cells such as mesenchymal stem cells, olfactory ensheathing cells, and Schwann cells. Although promising, cell transplantation is often overturned by the poor cell survival in the treatment of spinal cord injuries. Alternatively, the therapeutic role of different cells has been used in tissue engineering approaches by engrafting cells with biomaterials. The latter have the advantages of physically mimicking the CNS tissue, while promoting a more permissive environment for cell survival, growth, and differentiation. The roles of both cell- and biomaterial-based therapies as single therapeutic approaches for SCI repair will be discussed in this review. Moreover, as the multifactorial inhibitory environment of a SCI suggests that combinatorial approaches would be more effective, the importance of using biomaterials as cell carriers will be herein highlighted, as well as the recent advances and achievements of these promising tools for neural tissue regeneration.
C1 [Assuncao-Silva, Rita C.; Gomes, Eduardo D.; Sousa, Nuno; Silva, Nuno A.; Salgado, Antonio J.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal.
   [Assuncao-Silva, Rita C.; Gomes, Eduardo D.; Sousa, Nuno; Silva, Nuno A.; Salgado, Antonio J.] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal.
RP Salgado, AJ (reprint author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Campus Gualtar, P-4710057 Braga, Portugal.
EM asalgado@ecsaude.uminho.pt
RI Sousa, Nuno/N-9137-2017; Silva, Nuno/K-4077-2012
OI Sousa, Nuno/0000-0002-8755-5126; Silva, Nuno/0000-0002-1061-1716; Silva,
   Rita/0000-0002-8526-0279; Gomes, Eduardo/0000-0003-3179-1741
FU Portuguese Foundation for Science and Technology
   [PTDC/SAUBMA/114059/2009]; Programa Operacional Regional do Norte
   (ON.2-O Novo Norte), ao abrigo do Quadro de Referencia Estrategico
   Nacional (QREN), atraves do Fundo Europeu de Desenvolvimento Regional
   (FEDER)
FX The authors would like to acknowledge the Portuguese Foundation for
   Science and Technology (Grant no. PTDC/SAUBMA/114059/2009; IF
   Development Grant to Antonio J. Salgado); Premios Santa Casa
   Neurociencias for funds attributed to Antonio J. Salgado under the scope
   of the Prize Melo e Castro for Spinal Cord Injury Research; cofunded by
   Programa Operacional Regional do Norte (ON.2-O Novo Norte), ao abrigo do
   Quadro de Referencia Estrategico Nacional (QREN), atraves do Fundo
   Europeu de Desenvolvimento Regional (FEDER).
CR Abranches E, 2003, BIOTECHNOL LETT, V25, P725, DOI 10.1023/A:1023462832608
   ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   [Anonymous], 2013, MIAM PROJ CUR PAR DO
   Ansorena E, 2013, INT J PHARMACEUT, V455, P148, DOI 10.1016/j.ijpharm.2013.07.045
   Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807
   Arboleda D, 2011, CELL MOL NEUROBIOL, V31, P1113, DOI 10.1007/s10571-011-9712-3
   Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038
   Bachelin C, 2005, BRAIN, V128, P540, DOI 10.1093/brain/awh406
   BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x
   Barnett SC, 2004, TRENDS NEUROSCI, V27, P54, DOI 10.1016/j.tins.2003.10.011
   Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077
   Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2
   BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7
   Borgens RB, 2001, J NEUROSCI RES, V66, P1179
   Boruch AV, 2001, GLIA, V33, P225, DOI 10.1002/1098-1136(200103)33:3<225::AID-GLIA1021>3.0.CO;2-Y
   Boyd JG, 2005, FASEB J, V19, P694, DOI 10.1096/fj.04-2833rev
   Brack HP, 1997, POLYMER, V38, P2351, DOI 10.1016/S0032-3861(96)00780-X
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chan RTH, 2014, BIOMACROMOLECULES, V15, P339, DOI 10.1021/bm401572a
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002
   Cizkova D, 2011, J NEUROTRAUM, V28, P1951, DOI 10.1089/neu.2010.1413
   Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1
   Connolly P. J., 2003, SPINAL CORD MED PRIN
   Coviello T, 2006, EXPERT OPIN DRUG DEL, V3, P395, DOI 10.1517/17425247.3.3.395
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   DEVON R, 1992, BRAIN RES, V589, P175
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   DOUCETTE R, 1995, HISTOL HISTOPATHOL, V10, P503
   DOUCETTE R, 1993, MICROSC RES TECHNIQ, V24, P113, DOI 10.1002/jemt.1070240204
   Dubois Severine G., 2008, V449, P69, DOI 10.1007/978-1-60327-169-1_5
   Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P265, DOI 10.1097/00002826-200109000-00003
   Eftekharpour E, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E18
   Fan JA, 2011, J BIOMED MATER RES B, V97B, P271, DOI 10.1002/jbm.b.31810
   Fang DY, 2007, J APPL POLYM SCI, V103, P707, DOI 10.1002/app.24941
   Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657
   Ferrero-Gutierrez A, 2013, HISTOL HISTOPATHOL, V28, P89, DOI 10.14670/HH-28.89
   Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100
   Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005
   Fraga JS, 2013, BIOCHIMIE, V95, P2297, DOI 10.1016/j.biochi.2013.06.028
   FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F
   Franklin RJM, 1996, GLIA, V17, P217, DOI 10.1002/(SICI)1098-1136(199607)17:3<217::AID-GLIA4>3.0.CO;2-Y
   Franklin RJM, 1997, J NEUROSCI RES, V50, P665, DOI 10.1002/(SICI)1097-4547(19971201)50:5<665::AID-JNR4>3.3.CO;2-U
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   Fu-Jiang C, 2009, CHINESE MED J-PEKING, V122, P225, DOI 10.3760/cma.j.issn.0366-6999.2009.02.021
   Gao MY, 2013, BIOMATERIALS, V34, P1529, DOI 10.1016/j.biomaterials.2012.10.070
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Giannetti S, 2001, NEUROL RES, V23, P405, DOI 10.1179/016164101101198622
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   Gorgieva S., 2011, BIOMATERIALS APPL NA
   GRASDALEN H, 1987, CARBOHYD POLYM, V7, P371, DOI 10.1016/0144-8617(87)90004-X
   Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693
   Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471
   Haastert-Talini K, 2013, BIOMATERIALS, V34, P9886, DOI 10.1016/j.biomaterials.2013.08.074
   Hadley MN, 2002, NEUROSURGERY, V50, pS63, DOI 10.1097/00006123-200203001-00013
   Hagen Ellen Merete, 2012, Tidsskr Nor Laegeforen, V132, P831, DOI 10.4045/tidsskr.10.0859
   Hamann MCJ, 2005, EXP NEUROL, V194, P106, DOI 10.1016/j.expneurol.2005.01.030
   Hejcl A, 2008, PHYSIOL RES, V57, pS121
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Hejcl A, 2010, STEM CELLS DEV, V19, P1535, DOI 10.1089/scd.2009.0378
   Hoffman JA, 2007, FRONT BIOSCI-LANDMRK, V12, P3321, DOI 10.2741/2315
   Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   Imaizumi T, 1998, J NEUROSCI, V18, P6176
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436
   Iwaya K, 1999, NEUROSURGERY, V44, P589, DOI 10.1097/00006123-199903000-00085
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016135
   JANSSON PE, 1983, CARBOHYD RES, V124, P135, DOI 10.1016/0008-6215(83)88361-X
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72
   Ju YE, 2007, BIOMATERIALS, V28, P2097, DOI 10.1016/j.biomaterials.2007.01.008
   Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670
   Kamada T, 2005, J NEUROPATH EXP NEUR, V64, P37, DOI 10.1093/jnen/64.1.37
   Kamada T, 2011, NEUROPATHOLOGY, V31, P48, DOI 10.1111/j.1440-1789.2010.01130.x
   Kang KN, 2011, TISSUE ENG PT A, V17, P2143, DOI [10.1089/ten.tea.2011.0122, 10.1089/ten.TEA.2011.0122]
   Katayama Y, 2006, BIOMATERIALS, V27, P505, DOI 10.1016/j.biomaterials.2005.07.016
   Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0
   Kean T., 2009, DESK REFERENCE NATUR, P327
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Kim YT, 2009, BIOMATERIALS, V30, P2582, DOI 10.1016/j.biomaterials.2008.12.077
   King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018
   King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033
   Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787
   Koda M, 2007, BRAIN RES, V1149, P223, DOI 10.1016/j.brainres.2007.02.058
   Kubinova S., 2013, J TISSUE ENG REGENER
   Kubinova S, 2010, BIOMATERIALS, V31, P5966, DOI 10.1016/j.biomaterials.2010.04.040
   Kumar AA, 2009, EXP CLIN TRANSPLANT, V7, P241
   Laverty PH, 2004, J NEUROTRAUM, V21, P1767, DOI 10.1089/0897715042664867
   Lavik Erin, 2002, Methods Mol Biol, V198, P89
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106
   Lee KY, 2000, NATURE, V408, P998
   Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536
   Leonard M, 2004, J CONTROL RELEASE, V98, P395, DOI 10.1016/j.jconrel.2004.05.009
   Lima C, 2010, NEUROREHAB NEURAL RE, V24, P10, DOI 10.1177/1545968309347685
   Little L, 2008, CHEM REV, V108, P1787, DOI 10.1021/cr078228t
   Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126
   Liu Y, 2013, ACTA BIOMATER, V9, P8075, DOI 10.1016/j.actbio.2013.06.001
   Lopez-Vales R, 2006, NEUROBIOL DIS, V21, P57, DOI 10.1016/j.nbd.2005.06.011
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Lu S, 2011, TOXICOLOGY, V279, P189, DOI 10.1016/j.tox.2010.10.011
   Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   McCreedy DA, 2012, NEUROSCI LETT, V519, P115, DOI 10.1016/j.neulet.2012.02.025
   McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1
   Meilander NJ, 2003, J CONTROL RELEASE, V88, P321, DOI 10.1016/S0168-3659(03)00007-5
   Menei P, 1998, EUR J NEUROSCI, V10, P607, DOI 10.1046/j.1460-9568.1998.00071.x
   Meyerrose T, 2010, ADV DRUG DELIVER REV, V62, P1167, DOI 10.1016/j.addr.2010.09.013
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Mothe AJ, 2012, J CLIN INVEST, V122, P3824, DOI 10.1172/JCI64124
   Nakano N, 2010, NEUROSCI LETT, V483, P57, DOI 10.1016/j.neulet.2010.07.062
   Nehrt A, 2010, J NEUROTRAUM, V27, P151, DOI 10.1089/neu.2009.0993
   Nicaise C, 2011, NEUROPATH APPL NEURO, V37, P179, DOI 10.1111/j.1365-2990.2010.01124.x
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603
   Obermair FJ, 2008, PHYSIOLOGY, V23, P296, DOI 10.1152/physiol.00017.2008
   Ogawa E, 2006, FOOD HYDROCOLLOID, V20, P378, DOI 10.1016/j.foodhyd.2005.03.016
   Oliveira AL, 2012, J MATER SCI-MATER M, V23, P2821, DOI 10.1007/s10856-012-4741-0
   Oliveira JT, 2010, TISSUE ENG PT A, V16, P343, DOI [10.1089/ten.tea.2009.0117, 10.1089/ten.TEA.2009.0117]
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   Pal R, 2009, CYTOTHERAPY, V11, P897, DOI 10.3109/14653240903253857
   Patel V, 2010, J NEUROTRAUM, V27, P789, DOI 10.1089/neu.2008.0809
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Pego AP, 2012, J CELL MOL MED, V16, P2564, DOI 10.1111/j.1582-4934.2012.01603.x
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Pertici V, 2013, ASN NEURO, V5, P149, DOI 10.1042/AN20120082
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Plant GW, 2002, J NEUROSCI, V22, P6083
   Pollack A., 2011, US NEW YORK TIMES
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Puri MC, 2012, STEM CELLS, V30, P10, DOI 10.1002/stem.788
   Quinn F. X., 1993, Polymer Gels and Networks, V1, P93, DOI 10.1016/0966-7822(93)90014-9
   Rahimi-Movaghar V, 2013, NEUROEPIDEMIOLOGY, V41, P65, DOI 10.1159/000350710
   Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049
   RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099
   Rauch MF, 2009, EUR J NEUROSCI, V29, P132, DOI 10.1111/j.1460-9568.2008.06567.x
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Ribeiro CA, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt109
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rowe RC, 2009, HDB PHARM EXCIPIENTS
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x
   Saberi H, 2008, NEUROSCI LETT, V443, P46, DOI 10.1016/j.neulet.2008.07.041
   Saberi H, 2011, J NEUROSURG-SPINE, V15, P515, DOI 10.3171/2011.6.SPINE10917
   Saito F, 2008, J TRAUMA, V64, P53, DOI [10.1097/TA.0013e31815b847d, 10.1097/TA.0b013e31815b847d]
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   Salgado AJ, 2008, WOODHEAD PUBL MATER, P570, DOI 10.1533/9781845694814.4.570
   Salgado AJ, 2010, STEM CELLS DEV, V19, P1067, DOI 10.1089/scd.2009.0279
   Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103
   Samadikuchaksaraei A, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-15
   Samdani AF, 2009, SPINE, V34, P2605, DOI 10.1097/BRS.0b013e3181bdca87
   Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389
   Schachtrup C, 2007, P NATL ACAD SCI USA, V104, P11814, DOI 10.1073/pnas.0704045104
   Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Sharp KG, 2012, EXP NEUROL, V235, P345, DOI 10.1016/j.expneurol.2012.02.016
   Sheth RN, 2008, J NEUROSURG-SPINE, V8, P153, DOI 10.3171/SPI/2008/8/2/153
   Shi Q, 2014, SCI CHINA LIFE SCI, V57, P232, DOI 10.1007/s11427-014-4612-7
   Shi R, 1999, J NEUROPHYSIOL, V81, P2406
   Shi RY, 2013, NEUROSCI BULL, V29, P460, DOI 10.1007/s12264-013-1364-5
   Shields SA, 2000, J NEUROSCI RES, V60, P571, DOI 10.1002/(SICI)1097-4547(20000601)60:5<571::AID-JNR1>3.0.CO;2-Q
   Shu XZ, 2002, INT J PHARM, V233, P217, DOI 10.1016/S0378-5173(01)00943-7
   Sieminski AL, 2004, J BIOMAT SCI-POLYM E, V15, P237, DOI 10.1163/156856204322793610
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002
   Silva NA, 2013, BIOCHIMIE, V95, P2314, DOI 10.1016/j.biochi.2013.08.016
   Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]
   Silva NA, 2012, BIOMATERIALS, V33, P6345, DOI 10.1016/j.biomaterials.2012.05.050
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   StemCells, 2014, PROV UPD ITS PHAS 1
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Steward O, 2014, J NEUROSCI, V34, P14013, DOI 10.1523/JNEUROSCI.3066-14.2014
   Stocum DL, 2006, REGENERATIVE BIOL ME
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Sur S, 2013, BIOMATERIALS, V34, P4749, DOI 10.1016/j.biomaterials.2013.03.025
   Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381
   Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takami T, 2002, J NEUROSCI, V22, P6670
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Teixeira FG, 2013, CELL MOL LIFE SCI, V70, P3871, DOI 10.1007/s00018-013-1290-8
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107
   Tysseling VM, 2010, J NEUROSCI RES, V88, P3161, DOI 10.1002/jnr.22472
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379
   Vogel L. C., 2011, HDB PEDIAT NEUROPHYC
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Weidner N, 1999, J COMP NEUROL, V413, P495, DOI 10.1002/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z
   Weiss S, 1996, J NEUROSCI, V16, P7599
   Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Woerly S, 2001, INT J DEV NEUROSCI, V19, P63, DOI 10.1016/S0736-5748(00)00064-2
   WOODHALL E, 2001, MOL BRAIN RES, V88, P203
   Wu SF, 2001, NEUROSCI LETT, V312, P173, DOI 10.1016/S0304-3940(01)02219-4
   Xiong Y, 2009, BIOMATERIALS, V30, P3711, DOI 10.1016/j.biomaterials.2009.03.046
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yao L, 2013, GENE THER, V20, P1149, DOI 10.1038/gt.2013.42
   Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780
   Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807
   Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
   Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135
   Zhu Leyin, 2011, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V28, P774
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 250
TC 29
Z9 30
U1 5
U2 35
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-966X
EI 1687-9678
J9 STEM CELLS INT
JI Stem Cells Int.
PY 2015
AR 948040
DI 10.1155/2015/948040
PG 24
WC Cell & Tissue Engineering
SC Cell Biology
GA CK7CT
UT WOS:000356388900001
PM 26124844
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Dong, RJ
   Pang, Y
   Su, Y
   Zhu, XY
AF Dong, Ruijiao
   Pang, Yan
   Su, Yue
   Zhu, Xinyuan
TI Supramolecular hydrogels: synthesis, properties and their biomedical
   applications
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID HOST-GUEST INTERACTIONS; WALLED CARBON NANOTUBES; DRUG-DELIVERY; GENE
   DELIVERY; FLUORESCENT NANOPARTICLES; BIOLOGICAL SIGNIFICANCE;
   BLOCK-COPOLYMERS; AU NANOPARTICLES; SMALL MOLECULES; CROSS-LINKERS
AB As a novel class of three-dimensional (3D) hydrophilic cross-linked polymers, supramolecular hydrogels not only display unique physicochemical properties (e.g., water-retention ability, drug loading capacity, biodegradability and biocompatibility, biostability) as well as specific functionalities (e.g., optoelectronic properties, bioactivity, self-healing ability, shape memory ability), but also have the capability to undergo reversible gel-sol transition in response to various environmental stimuli inherent to the noncovalent cross-linkages, thereby showing great potential as promising biomaterial scaffolds for diagnosis and therapy. In this Review, we summarized the recent progress in the design and synthesis of supramolecular hydrogels through specific, directional noncovalent interactions, with particular emphasis on the structure-property relationship, as well as their wide-ranging applications in disease diagnosis and therapy including bioimaging, biodetection, therapeutic delivery, and tissue engineering. We believe that these current achievements in supramolecular hydrogels will greatly stimulate new ideas and inspire persistent efforts in this hot topic area in future.
C1 [Dong, Ruijiao; Pang, Yan; Su, Yue; Zhu, Xinyuan] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China.
RP Dong, RJ (reprint author), Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, State Key Lab Met Matrix Composites, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.
EM yuesu@sjtu.edu.cn; xyzhu@sjtu.edu.cn
RI Dong, Ruijiao/G-3185-2015
OI Dong, Ruijiao/0000-0002-3091-7712
FU National Basic Research Program [2015CB931801]; National Natural Science
   Foundation of China [21204048, 51473093]; China Postdoctoral Science
   Foundation [2013T60439]
FX This work was financially supported by the National Basic Research
   Program (2015CB931801), National Natural Science Foundation of China
   (21204048, 51473093), and Project funded by China Postdoctoral Science
   Foundation (2013T60439).
CR Adhikari B, 2012, LANGMUIR, V28, P1460, DOI 10.1021/la203498j
   Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962
   Altunbas A, 2012, TOP CURR CHEM, V310, P135, DOI 10.1007/128_2011_206
   Appel EA, 2014, ANGEW CHEM INT EDIT, V53, P10038, DOI 10.1002/anie.201403192
   Appel EA, 2012, CHEM SOC REV, V41, P6195, DOI 10.1039/c2cs35264h
   Appel EA, 2012, J AM CHEM SOC, V134, P11767, DOI 10.1021/ja3044568
   Appel EA, 2010, J AM CHEM SOC, V132, P14251, DOI 10.1021/ja106362w
   Babu SS, 2014, CHEM REV, V114, P1973, DOI 10.1021/cr400195e
   Bai W, 2013, J AM CHEM SOC, V135, P6977, DOI 10.1021/ja400576p
   Bairi P, 2013, ACS APPL MATER INTER, V5, P5478, DOI 10.1021/am4013566
   Bastings MMC, 2014, ADV HEALTHC MATER, V3, P70, DOI 10.1002/adhm.201300076
   Cafferty BJ, 2013, J AM CHEM SOC, V135, P2447, DOI 10.1021/ja312155v
   Cao W, 2013, ANGEW CHEM INT EDIT, V52, P6233, DOI 10.1002/anie.201300662
   Castellano RK, 2000, P NATL ACAD SCI USA, V97, P12418, DOI 10.1073/pnas.97.23.12418
   Chen KJ, 2011, BIOMATERIALS, V32, P2160, DOI 10.1016/j.biomaterials.2010.11.043
   Chen Y, 2010, LANGMUIR, V26, P9011, DOI 10.1021/la9048133
   Chen Y, 2010, ADV FUNCT MATER, V20, P579, DOI 10.1002/adfm.200901400
   Choi M, 2013, NAT PHOTONICS, V7, P987, DOI [10.1038/nphoton.2013.278, 10.1038/NPHOTON.2013.278]
   Cui HT, 2014, MACROMOL BIOSCI, V14, P440, DOI 10.1002/mabi.201300366
   Dankers PYW, 2006, BIOMATERIALS, V27, P5490, DOI 10.1016/j.biomaterials.2006.07.011
   Dankers PYW, 2012, ADV MATER, V24, P2703, DOI 10.1002/adma.201104072
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576
   Deng W, 2007, ANGEW CHEM INT EDIT, V46, P5144, DOI 10.1002/anie.200701272
   Dong RJ, 2015, ADV MATER, V27, P498, DOI 10.1002/adma.201402975
   Dong RJ, 2014, ACCOUNTS CHEM RES, V47, P2006, DOI 10.1021/ar500057e
   Dong RJ, 2014, NANOSCALE, V6, P4544, DOI 10.1039/c4nr00212a
   Dong RJ, 2013, CHEM COMMUN, V49, P9845, DOI 10.1039/c3cc46123h
   Dong RJ, 2012, ACS MACRO LETT, V1, P1208, DOI 10.1021/mz300375c
   Dong RJ, 2011, CHEM COMMUN, V47, P5473, DOI 10.1039/c1cc10934k
   Dong YX, 2014, ACTA BIOMATER, V10, P2076, DOI 10.1016/j.actbio.2013.12.045
   Du R, 2014, SMALL, V10, P1387, DOI 10.1002/smll.201302649
   Elmalem E, 2014, CHEM COMMUN, V50, P8930, DOI 10.1039/c4cc03167a
   Gao Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2040
   Gao Y, 2009, J AM CHEM SOC, V131, P13576, DOI 10.1021/ja904411z
   Griffith A, 2013, CHEM COMMUN, V49, P731, DOI 10.1039/c2cc37842f
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guo H, 2013, BIOMACROMOLECULES, V14, P2733, DOI 10.1021/bm4005645
   Guo MY, 2014, J AM CHEM SOC, V136, P6969, DOI 10.1021/ja500205v
   Guo WW, 2015, ADV MATER, V27, P73, DOI 10.1002/adma.201403702
   Ha W, 2014, ACS APPL MATER INTER, V6, P10623, DOI 10.1021/am5022864
   Han DL, 2014, ACS SUSTAIN CHEM ENG, V2, P296, DOI 10.1021/sc400352a
   He MT, 2013, J AM CHEM SOC, V135, P18718, DOI 10.1021/ja409000b
   Himmelein S, 2014, CHEM SCI, V5, P1054, DOI 10.1039/c3sc52964a
   HOGG R, 1962, J CHEM SOC, P341, DOI 10.1039/jr9620000341
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Huang P, 2014, J AM CHEM SOC, V136, P11748, DOI 10.1021/ja505212y
   Hwang I, 2007, ANGEW CHEM INT EDIT, V46, P210, DOI 10.1002/anie.200603149
   Ikeda M, 2014, NAT CHEM, V6, P511, DOI [10.1038/NCHEM.1937, 10.1038/nchem.1937]
   Ikeda M, 2011, ADV MATER, V23, P2819, DOI 10.1002/adma.201004658
   Ikeda M, 2011, J AM CHEM SOC, V133, P1670, DOI 10.1021/ja109692z
   Ikeda M, 2010, CHEM SCI, V1, P491, DOI 10.1039/c0sc00278j
   Ikeda M, 2008, CHEM-EUR J, V14, P10808, DOI 10.1002/chem.200801144
   Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30
   Jung H, 2014, BIOMACROMOLECULES, V15, P707, DOI 10.1021/bm401123m
   Jung SH, 2014, J AM CHEM SOC, V136, P6446, DOI 10.1021/ja5018199
   Kakuta T, 2013, ADV MATER, V25, P2849, DOI 10.1002/adma.201205321
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kim JH, 2007, PROG POLYM SCI, V32, P1031, DOI 10.1016/j.progpolymsci.2007.05.016
   Koenigs MME, 2014, MACROMOLECULES, V47, P2712, DOI 10.1021/ma500446g
   Komatsu H, 2009, J AM CHEM SOC, V131, P5580, DOI 10.1021/ja8098239
   Koshi Y, 2006, J AM CHEM SOC, V128, P10413, DOI 10.1021/ja0613963
   Kuang Y, 2014, ANGEW CHEM INT EDIT, V53, P8104, DOI 10.1002/anie.201402216
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   Lee J, 2012, NAT NANOTECHNOL, V7, P816, DOI [10.1038/NNANO.2012.211, 10.1038/nnano.2012.211]
   Li JY, 2013, ADV HEALTHC MATER, V2, P1586, DOI 10.1002/adhm.201300041
   Li JY, 2013, J AM CHEM SOC, V135, P9907, DOI 10.1021/ja404215g
   Li JY, 2013, J AM CHEM SOC, V135, P542, DOI 10.1021/ja310019x
   Li JB, 2014, CHEM COMMUN, V50, P3722, DOI 10.1039/c4cc00156g
   Li J, 2010, NPG ASIA MATER, V2, P112, DOI 10.1038/asiamat.2010.84
   Li XM, 2011, ANGEW CHEM INT EDIT, V50, P9365, DOI 10.1002/anie.201103641
   Li XM, 2010, J AM CHEM SOC, V132, P17707, DOI 10.1021/ja109269v
   Li ZB, 2012, BIOMACROMOLECULES, V13, P3162, DOI 10.1021/bm300936x
   Liao XJ, 2010, ANGEW CHEM INT EDIT, V49, P4409, DOI 10.1002/anie.201000141
   Lin N, 2013, BIOMACROMOLECULES, V14, P871, DOI 10.1021/bm301955k
   Liu JH, 2011, MACROMOLECULES, V44, P7682, DOI 10.1021/ma201620w
   Liu JH, 2010, MACROMOLECULES, V43, P8086, DOI 10.1021/ma101437k
   Liu KL, 2010, SOFT MATTER, V6, P2300, DOI 10.1039/b923472a
   Liu Y, 2011, ANGEW CHEM INT EDIT, V50, P3058, DOI 10.1002/anie.201005740
   Liu ZJ, 2014, POLYM CHEM-UK, V5, P1072, DOI 10.1039/c3py01083j
   Ma CX, 2014, ADV MATER, V26, P5665, DOI 10.1002/adma.201402026
   Ma D, 2011, BIOMACROMOLECULES, V12, P3124, DOI 10.1021/bm101566r
   Ma D, 2009, J POLYM SCI POL PHYS, V47, P740, DOI 10.1002/polb.21677
   Matsusaki M, 2011, ADV MATER, V23, P2957, DOI 10.1002/adma.201101284
   McKee JR, 2014, ADV FUNCT MATER, V24, P2706, DOI 10.1002/adfm.201303699
   Meng LL, 2012, MACROMOL BIOSCI, V12, P1524, DOI 10.1002/mabi.201200137
   Menyo MS, 2013, SOFT MATTER, V9, P10314, DOI [10.1039/c3sm51824h, 10.1039/C3SM51824H]
   Mukherjee S, 2014, CHEM-ASIAN J, V9, P2798, DOI 10.1002/asia.201402358
   Nakahata M, 2013, ANGEW CHEM INT EDIT, V52, P5731, DOI 10.1002/anie.201300862
   Nakahata M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1521
   Nandi S, 2012, ORG LETT, V14, P3826, DOI 10.1021/ol300555a
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]
   Ochi R, 2013, CHEM COMMUN, V49, P2115, DOI 10.1039/c2cc37908b
   Ogoshi T, 2007, J AM CHEM SOC, V129, P4878, DOI 10.1021/ja070457
   Oishi M, 2010, NANOMEDICINE-UK, V5, P451, DOI [10.2217/nnm.10.18, 10.2217/NNM.10.18]
   Park KM, 2012, ACS NANO, V6, P2960, DOI 10.1021/nn204123p
   Patil SP, 2012, CHEM COMMUN, V48, P8901, DOI 10.1039/c2cc34466a
   Pedron S, 2015, ADV MATER, V27, P1567, DOI 10.1002/adma.201404896
   Peng K, 2010, CHEM COMMUN, V46, P4094, DOI 10.1039/c002565h
   Ren CH, 2014, CHEM COMMUN, V50, P3473, DOI 10.1039/c3cc48807a
   Rybtchinski B, 2011, ACS NANO, V5, P6791, DOI 10.1021/nn2025397
   Saeed A, 2015, ADV MATER, V27, P662, DOI 10.1002/adma.201403626
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Shen YQ, 2010, J AM CHEM SOC, V132, P4259, DOI 10.1021/ja909475m
   Siegel RA, 2010, J CONTROL RELEASE, V141, P303, DOI 10.1016/j.jconrel.2009.12.012
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Singh A, 2013, ADV FUNCT MATER, V23, P575, DOI 10.1002/adfm.201201902
   Singh A, 2014, ADV MATER, V26, P6530, DOI 10.1002/adma.201402105
   Stuart MAC, 2005, CURR OPIN COLLOID IN, V10, P30, DOI 10.1016/j.cocis.2005.04.004
   Sun TL, 2013, NAT MATER, V12, P932, DOI [10.1038/nmat3713, 10.1038/NMAT3713]
   Sun ZF, 2013, J AM CHEM SOC, V135, P13379, DOI 10.1021/ja403345p
   Takashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2280
   Tamesue S, 2013, J AM CHEM SOC, V135, P15650, DOI 10.1021/ja408547g
   Tamesue S, 2010, ANGEW CHEM INT EDIT, V49, P7461, DOI 10.1002/anie.201003567
   Tan ZQ, 2011, ADV MATER, V23, P4053, DOI 10.1002/adma.201102160
   Tran NQ, 2010, BIOMACROMOLECULES, V11, P617, DOI 10.1021/bm100047y
   Wada A, 2009, J AM CHEM SOC, V131, P5321, DOI 10.1021/ja900500j
   Wang DL, 2014, CHEM COMMUN, V50, P11994, DOI 10.1039/c4cc03155e
   Wang H, 2010, ACS NANO, V4, P6235, DOI 10.1021/nn101908e
   Wang H, 2009, ANGEW CHEM INT EDIT, V48, P4344, DOI 10.1002/anie.200900063
   Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wu YL, 2013, ADV HEALTHC MATER, V2, P297, DOI 10.1002/adhm.201200183
   Wurm F, 2009, J AM CHEM SOC, V131, P7954, DOI 10.1021/ja9019148
   Yallapu MM, 2011, DRUG DISCOV TODAY, V16, P457, DOI 10.1016/j.drudis.2011.03.004
   Yan XZ, 2012, CHEM SOC REV, V41, P6042, DOI 10.1039/c2cs35091b
   Yang CB, 2014, BIOMATER SCI-UK, V2, P651, DOI 10.1039/c3bm60252d
   Yang JA, 2014, PROG POLYM SCI, V39, P1973, DOI 10.1016/j.progpolymsci.2014.07.006
   Yang ZM, 2007, CHEM COMMUN, P843, DOI 10.1039/b616563
   Yang ZM, 2012, CHEM COMMUN, V48, P9257, DOI 10.1039/c2cc34935c
   Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y
   Yin LC, 2013, ADV MATER, V25, P3063, DOI 10.1002/adma.201205088
   Yoshii T, 2014, ANGEW CHEM INT EDIT, V53, P7264, DOI 10.1002/anie.201404158
   Yu SR, 2012, POLYM CHEM-UK, V3, P3324, DOI 10.1039/c2py20487h
   Zhang H, 2014, J MATER CHEM B, V2, P4067, DOI 10.1039/c4tb00155a
   Zhang JX, 2013, ADV DRUG DELIVER REV, V65, P1215, DOI 10.1016/j.addr.2013.05.001
   Zhang JX, 2010, ACS NANO, V4, P1049, DOI 10.1021/nn901213a
   Zhang QW, 2013, CHEM COMMUN, V49, P9800, DOI 10.1039/c3cc46297h
   Zhang Y, 2013, J AM CHEM SOC, V135, P5008, DOI 10.1021/ja402490j
   Zhang ZX, 2013, ANGEW CHEM INT EDIT, V52, P6180, DOI 10.1002/anie.201301956
   Zhao F, 2009, CHEM SOC REV, V38, P883, DOI 10.1039/b806410p
   Zheng WT, 2013, J AM CHEM SOC, V135, P266, DOI 10.1021/ja308690y
   Zhou J, 2014, J AM CHEM SOC, V136, P2970, DOI 10.1021/ja4127399
   Zhu Q, 2013, RSC ADV, V3, P2071, DOI 10.1039/c2ra22210h
NR 145
TC 47
Z9 48
U1 20
U2 212
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 7
BP 937
EP 954
DI 10.1039/c4bm00448e
PG 18
WC Materials Science, Biomaterials
SC Materials Science
GA CK6AE
UT WOS:000356309200005
PM 26221932
DA 2018-10-20
ER

PT J
AU Yang, Z
   Gao, D
   Cao, Z
   Zhang, C
   Cheng, D
   Liu, J
   Shuai, XT
AF Yang, Zhe
   Gao, Di
   Cao, Zhong
   Zhang, Chao
   Cheng, Du
   Liu, Jie
   Shuai, Xintao
TI Drug and gene co-delivery systems for cancer treatment
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID MESOPOROUS SILICA NANOPARTICLES; OVERCOME MULTIDRUG-RESISTANCE;
   ANTICANCER DRUG; OVARIAN-CANCER; SHELL NANOPARTICLES; TUMOR-CELLS;
   ANTISENSE OLIGONUCLEOTIDES; POLYAMIDOAMINE DENDRIMER; BIODEGRADABLE
   COPOLYMER; TRANSFECTION EFFICIENCY
AB Cancer remains a major killer and a leading cause of death in the world; thus, a growing number of new treatments have been focused on cancer therapy over the past few decades. Chemotherapy, which is thought to be a powerful strategy for cancer treatment, has been widely used in clinical therapy in recent years. However, due to the complexity of cancer, a single therapeutic approach is insufficient for the suppression of cancer growth and migration. Therefore, increasing attention has been paid to the use of smart multifunctional carriers and combinatorially delivers chemotherapeutic drugs and functional genes in order to maximize therapeutic efficiency. Combination therapy using selected drugs and genes can not only overcome multidrug resistance and inhibit the cellular anti-apoptotic process but also achieve a synergistic therapeutic effect. Because multifunctional nanocarriers are important for achieving these goals, this review will illustrate and discuss some advanced biomaterial nanocarriers for co-delivering therapeutic genes and drugs, including multifunctional micelles, liposomes, polymeric conjugates and inorganic nanoparticles. In addition, the challenges and future perspectives for co-delivery systems, containing therapeutic drugs and genes to achieve better therapeutic effects for cancer treatment will be discussed.
C1 [Yang, Zhe; Gao, Di; Cao, Zhong; Zhang, Chao; Liu, Jie] Sun Yat Sen Univ, Sch Engn, Dept Biomed Engn, Guangzhou 510006, Guangdong, Peoples R China.
   [Cheng, Du; Shuai, Xintao] Sun Yat Sen Univ, Sch Chem & Chem Engn, PCFM Lab, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.
RP Yang, Z (reprint author), Sun Yat Sen Univ, Sch Engn, Dept Biomed Engn, Guangzhou 510006, Guangdong, Peoples R China.
EM bmeliu@gmail.com; Shuaixt@mail.sysu.edu
RI Zhang, Chao/G-9707-2014
OI Shuai, Xintao/0000-0003-4271-0310; Cheng, Du/0000-0001-5105-7777; Yang,
   Zhe/0000-0001-9525-035X
FU National Natural Science Foundation of China [51225305, 51103183,
   81101142, U1401242]; Doctoral Fund of Ministry of Education of China
   [20110171120004]; Project of Zhu Jiang Science and the Technology New
   Star [2012J2200053]; Science and Technology Planning Project of
   Guangdong Province [2012B091100452, 2013B010404014]; Fundamental
   Research Funds for the Central Universities [12lgpy04]
FX This study was supported by the National Natural Science Foundation of
   China (51225305, 51103183, 81101142 and U1401242), the Doctoral Fund of
   Ministry of Education of China (20110171120004), the Project of Zhu
   Jiang Science and the Technology New Star (2012J2200053), the Science
   and Technology Planning Project of Guangdong Province (2012B091100452
   and 2013B010404014) and the Fundamental Research Funds for the Central
   Universities (12lgpy04).
CR Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004
   Alani AWG, 2010, BIOMATERIALS, V31, P1765, DOI 10.1016/j.biomaterials.2009.11.038
   Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037
   Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]
   Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544
   Bagalkot V, 2009, MOL PHARMACEUT, V6, P1019, DOI 10.1021/mp800177f
   Beh CW, 2009, BIOMACROMOLECULES, V10, P41, DOI 10.1021/bm801109g
   Cai SS, 2007, PHARM RES, V24, P2099, DOI 10.1007/s11095-007-9335-z
   Cao N, 2011, BIOMATERIALS, V32, P2222, DOI 10.1016/j.biomaterials.2010.11.061
   Chan JM, 2009, BIOMATERIALS, V30, P1627, DOI 10.1016/j.biomaterials.2008.12.013
   Chen AM, 2009, SMALL, V5, P2673, DOI 10.1002/smll.200900621
   Chen WC, 2014, SMALL, V10, P2678, DOI 10.1002/smll.201303951
   Cheng D, 2012, BIOMATERIALS, V33, P1170, DOI 10.1016/j.biomaterials.2011.10.057
   Cheng J, 2007, BIOMATERIALS, V28, P869, DOI 10.1016/j.biomaterials.2006.09.047
   Cho H, 2013, J CONTROL RELEASE, V166, P1, DOI 10.1016/j.jconrel.2012.12.005
   Chung YC, 2010, BIOMATERIALS, V31, P4194, DOI 10.1016/j.biomaterials.2010.01.116
   Creixell M, 2012, NANO TODAY, V7, P367, DOI 10.1016/j.nantod.2012.06.013
   Deng C, 2012, NANO TODAY, V7, P467, DOI 10.1016/j.nantod.2012.08.005
   Dicheva BM, 2013, NANO LETT, V13, P2324, DOI 10.1021/nl3014154
   Ediriwickrema A, 2014, BIOMATERIALS, V35, P9343, DOI 10.1016/j.biomaterials.2014.07.043
   Endres TK, 2011, BIOMATERIALS, V32, P7721, DOI 10.1016/j.biomaterials.2011.06.064
   Feng Q, 2014, BIOMATERIALS, V35, P5028, DOI 10.1016/j.biomaterials.2014.03.012
   Fowers KD, 2012, MACROMOL BIOSCI, V12, P502, DOI 10.1002/mabi.201100350
   Ganta S, 2009, MOL PHARMACEUT, V6, P928, DOI 10.1021/mp800240j
   Ge ZS, 2014, BIOMATERIALS, V35, P3416, DOI 10.1016/j.biomaterials.2013.12.086
   Gullotti E, 2009, MOL PHARMACEUT, V6, P1041, DOI 10.1021/mp900090z
   Guo ST, 2011, J NANOMATER, DOI 10.1155/2011/742895
   Guo ST, 2010, J MATER CHEM, V20, P6935, DOI 10.1039/c0jm00506a
   Han LA, 2011, BIOMATERIALS, V32, P1242, DOI 10.1016/j.biomaterials.2010.09.070
   He CB, 2014, J AM CHEM SOC, V136, P5181, DOI 10.1021/ja4098862
   Hedayati R, 2012, J CHEM TECHNOL BIOT, V87, P1401, DOI 10.1002/jctb.3758
   Holoch PA, 2009, EUR J PHARMACOL, V625, P63, DOI 10.1016/j.ejphar.2009.06.066
   Hu QD, 2011, CHEM COMMUN, V47, P5572, DOI 10.1039/c1cc10721f
   Hu QL, 2012, BIOMATERIALS, V33, P6580, DOI 10.1016/j.biomaterials.2012.05.060
   Hu QY, 2013, BIOMATERIALS, V34, P9496, DOI 10.1016/j.biomaterials.2013.09.001
   Huang HY, 2011, J BIOMED MATER RES A, V97A, P330, DOI 10.1002/jbm.a.33055
   Huang RQ, 2007, FASEB J, V21, P1117, DOI 10.1096/fj.06-7380com
   Itaka K, 2010, BIOMATERIALS, V31, P3707, DOI 10.1016/j.biomaterials.2009.11.072
   Ito T, 2010, BIOMATERIALS, V31, P2912, DOI 10.1016/j.biomaterials.2009.12.032
   Iwamoto T, 2013, BIOL PHARM BULL, V36, P715, DOI 10.1248/bpb.b12-01102
   Jiang TY, 2012, BIOMATERIALS, V33, P9246, DOI 10.1016/j.biomaterials.2012.09.027
   Kaneshiro TL, 2009, BIOMATERIALS, V30, P5660, DOI 10.1016/j.biomaterials.2009.06.026
   Khan M, 2012, ADV HEALTHC MATER, V1, P373, DOI 10.1002/adhm.201200109
   Kibria G, 2014, ARCH PHARM RES, V37, P4, DOI 10.1007/s12272-013-0276-2
   Kim C, 2011, MOL PHARMACEUT, V8, P1955, DOI 10.1021/mp100460h
   Kim HJ, 2014, DRUG DELIV TRANSL RE, V4, P50, DOI 10.1007/s13346-013-0175-6
   Kim HJ, 2010, J CONTROL RELEASE, V145, P141, DOI 10.1016/j.jconrel.2010.03.019
   Kim YH, 2009, J CONTROL RELEASE, V134, P132, DOI 10.1016/j.jconrel.2008.10.020
   Konopleva M, 2000, BLOOD, V95, P3929
   Kurosaki T, 2010, J CONTROL RELEASE, V142, P404, DOI 10.1016/j.jconrel.2009.11.010
   Kusumoto K, 2013, ACS NANO, V7, P7534, DOI 10.1021/nn401317t
   Li P, 2012, INT J NANOMED, V7, P925, DOI 10.2147/IJN.S26955
   Lin S, 2008, BIOMACROMOLECULES, V9, P109, DOI 10.1021/bm7008747
   Liu SH, 2012, BIOMATERIALS, V33, P4907, DOI 10.1016/j.biomaterials.2012.03.031
   Liu T, 2013, CHINESE J POLYM SCI, V31, P924, DOI 10.1007/s10118-013-1281-0
   Liu XJ, 2012, BIOMACROMOLECULES, V13, P1307, DOI 10.1021/bm2018382
   Lo YL, 2014, RSC ADV, V4, P11089, DOI 10.1039/c3ra46914j
   Ma D, 2014, BIOMATERIALS, V35, P4357, DOI 10.1016/j.biomaterials.2014.01.070
   Ma M, 2012, ACTA BIOMATER, V8, P599, DOI 10.1016/j.actbio.2011.11.006
   Meng FH, 2012, MATER TODAY, V15, P436, DOI 10.1016/S1369-7021(12)70195-5
   Meng HA, 2010, ACS NANO, V4, P4539, DOI 10.1021/nn100690m
   Nie Y, 2011, BIOMATERIALS, V32, P858, DOI 10.1016/j.biomaterials.2010.09.032
   Nitta SK, 2013, INT J MOL SCI, V14, P1629, DOI 10.3390/ijms14011629
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Oh KT, 2009, INT J PHARMACEUT, V376, P134, DOI 10.1016/j.ijpharm.2009.04.021
   Pakunlu RI, 2004, CANCER RES, V64, P6214, DOI 10.1158/0008-5472.CAN-04-0001
   Pasut G, 2007, PROG POLYM SCI, V32, P933, DOI 10.1016/j.progpolymsci.2007.05.008
   Patil YB, 2010, BIOMATERIALS, V31, P358, DOI 10.1016/j.biomaterials.2009.09.048
   Qian XM, 2014, BIOMATERIALS, V35, P2322, DOI 10.1016/j.biomaterials.2013.11.039
   Qiu LY, 2007, BIOMATERIALS, V28, P4132, DOI 10.1016/j.biomaterials.2007-05.035
   Rebowski G, 2001, ACTA BIOCHIM POL, V48, P1061
   Saad M, 2008, NANOMEDICINE-UK, V3, P761, DOI 10.2217/17435889.3.6.761
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   Scholz C, 2014, BIOCONJUGATE CHEM, V25, P251, DOI 10.1021/bc400392y
   Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9
   Shim G, 2011, J CONTROL RELEASE, V155, P60, DOI 10.1016/j.jconrel.2010.10.017
   Shin HC, 2012, J CONTROL RELEASE, V163, P93, DOI 10.1016/j.jconrel.2012.04.024
   Sun XY, 2012, BIOMATERIALS, V33, P916, DOI 10.1016/j.biomaterials.2011.10.035
   Taratula O, 2013, J CONTROL RELEASE, V171, P349, DOI 10.1016/j.jconrel.2013.04.018
   Taratula O, 2011, J DRUG TARGET, V19, P900, DOI 10.3109/1061186X.2011.622404
   Torney F, 2007, NAT NANOTECHNOL, V2, P295, DOI 10.1038/nnano.2007.108
   van Veen HW, 1998, BBA-BIOENERGETICS, V1365, P31, DOI 10.1016/S0005-2728(98)00039-5
   Wang HJ, 2010, BIOMATERIALS, V31, P8741, DOI 10.1016/j.biomaterials.2010.07.082
   Wang Y, 2007, BIOMACROMOLECULES, V8, P1028, DOI 10.1021/bm061051c
   Wang Y, 2006, NAT MATER, V5, P791, DOI 10.1038/nmat1737
   Wiradharma N, 2009, BIOMATERIALS, V30, P3100, DOI 10.1016/j.biomaterials.2009.03.006
   Xiong XB, 2011, ACS NANO, V5, P5202, DOI 10.1021/nn2013707
   Xu XH, 2014, SMALL, V10, P1133, DOI 10.1002/smll.201301885
   Xue HY, 2011, BIOMATERIALS, V32, P2662, DOI 10.1016/j.biomaterials.2010.12.029
   Yadav S, 2009, CANCER CHEMOTH PHARM, V63, P711, DOI 10.1007/s00280-008-0790-y
   Yang JY, 2002, WORLD J GASTROENTERO, V8, P644, DOI 10.3748/wjg.v8.i4.644
   Yang Z, 2015, J BIOMED NANOTECHNOL, V11, P1401, DOI 10.1166/jbn.2015.2086
   Yang Z, 2014, NANOSCALE, V6, P10193, DOI 10.1039/c4nr02395a
   Yang Z, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025012
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
   Yuan YY, 2012, ADV MATER, V24, P5476, DOI 10.1002/adma.201202296
   Yue XY, 2010, BIOMACROMOLECULES, V11, P2306, DOI 10.1021/bm100410m
   Yue YN, 2013, BIOMATER SCI-UK, V1, P152, DOI 10.1039/c2bm00030j
   Zhang CY, 2014, J CONTROL RELEASE, V180, P42, DOI 10.1016/j.jconrel.2014.02.015
   Zhang JX, 2010, ACS NANO, V4, P1049, DOI 10.1021/nn901213a
   Zhang J, 2013, J AM CHEM SOC, V135, P5068, DOI 10.1021/ja312004m
   Zhao D, 2012, MOL PHARMACEUT, V9, P2887, DOI 10.1021/mp3002123
   Zheng CF, 2013, BIOMATERIALS, V34, P3431, DOI 10.1016/j.biomaterials.2013.01.053
   Zhou JB, 2012, NAT MATER, V11, P82, DOI [10.1038/NMAT3187, 10.1038/nmat3187]
   Zhu CH, 2010, BIOMATERIALS, V31, P2408, DOI 10.1016/j.biomaterials.2009.11.077
   Zou SY, 2012, INT J NANOMED, V7, P3823, DOI 10.2147/IJN.S29328
NR 106
TC 30
Z9 32
U1 9
U2 153
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 7
BP 1035
EP 1049
DI 10.1039/c4bm00369a
PG 15
WC Materials Science, Biomaterials
SC Materials Science
GA CK6AE
UT WOS:000356309200011
PM 26221938
DA 2018-10-20
ER

PT J
AU Lampot, JD
   Liu, B
   Yin, LJ
   Zhang, WW
   Wang, ZL
   Luther, G
   Wagner, E
   Li, RD
   Nan, GX
   Shui, W
   Yan, ZJ
   Rames, R
   Deng, F
   Zhang, HM
   Liao, Z
   Liu, W
   Zhang, JH
   Zhang, ZL
   Zhang, Q
   Ye, JX
   Deng, YL
   Qiao, M
   Haydon, RC
   Luu, HH
   Angeles, J
   Shi, LL
   He, TC
   Ho, SH
AF Lampot, Joseph D.
   Liu, Bo
   Yin, Liangjun
   Zhang, Wenwen
   Wang, Zhongliang
   Luther, Gaurav
   Wagner, Eric
   Li, Ruidong
   Nan, Guoxin
   Shui, Wei
   Yan, Zhengjian
   Rames, Richard
   Deng, Fang
   Zhang, Hongmei
   Liao, Zhan
   Liu, Wei
   Zhang, Junhui
   Zhang, Zhonglin
   Zhang, Qian
   Ye, Jixing
   Deng, Youlin
   Qiao, Min
   Haydon, Rex C.
   Luu, Hue H.
   Angeles, Jovito
   Shi, Lewis L.
   He, Tong-Chuan
   Ho, Sherwin H.
TI Reversibly Immortalized Mouse Articular Chondrocytes Acquire Long-Term
   Proliferative Capability While Retaining Chondrogenic Phenotype
SO CELL TRANSPLANTATION
LA English
DT Article
DE Articular cartilage; Chondrocytes; Chondrogenesis; Tissue engineering;
   Immortalization; Chondrogenic progenitors; Osteoarthritis
ID MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEINS; BMP-9-INDUCED
   OSTEOGENIC DIFFERENTIATION; HEPATIC PROGENITOR CELLS; LARGE T-ANTIGEN;
   HUMAN OSTEOSARCOMA; CARTILAGE TISSUE; OSTEOBLAST DIFFERENTIATION;
   RECOMBINANT ADENOVIRUSES; IN-VITRO
AB Cartilage tissue engineering holds great promise for treating cartilaginous pathologies including degenerative disorders and traumatic injuries. Effective cartilage regeneration requires an optimal combination of biomaterial scaffolds, chondrogenic seed cells, and biofactors. Obtaining sufficient chondrocytes remains a major challenge due to the limited proliferative capability of primary chondrocytes. Here we investigate if reversibly immortalized mouse articular chondrocytes (iMACs) acquire long-term proliferative capability while retaining the chondrogenic phenotype. Primary mouse articular chondrocytes (MACs) can be efficiently immortalized with a retroviral vector-expressing SV40 large T antigen flanked with Cre/loxP sites. iMACs exhibit long-term proliferation in culture, although the immortalization phenotype can be reversed by Cre recombinase. iMACs express the chondrocyte markers Col2a1 and aggrecan and produce chondroid matrix in micromass culture. iMACs form subcutaneous cartilaginous masses in athymic mice. Histologic analysis and chondroid matrix staining demonstrate that iMACs can survive, proliferate, and produce chondroid matrix. The chondrogenic growth factor BMP2 promotes iMACs to produce more mature chondroid matrix resembling mature articular cartilage. Taken together, our results demonstrate that iMACs acquire long-term proliferative capability without losing the intrinsic chondrogenic features of MACs. Thus, iMACs provide a valuable cellular platform to optimize biomaterial scaffolds for cartilage regeneration, to identify biofactors that promote the proliferation and differentiation of chondrogenic progenitors, and to elucidate the molecular mechanisms underlying chondrogenesis.
C1 [Lampot, Joseph D.; Liu, Bo; Yin, Liangjun; Zhang, Wenwen; Wang, Zhongliang; Luther, Gaurav; Wagner, Eric; Li, Ruidong; Nan, Guoxin; Shui, Wei; Yan, Zhengjian; Rames, Richard; Deng, Fang; Zhang, Hongmei; Liao, Zhan; Liu, Wei; Zhang, Junhui; Zhang, Zhonglin; Zhang, Qian; Ye, Jixing; Deng, Youlin; Qiao, Min; Haydon, Rex C.; Luu, Hue H.; Angeles, Jovito; Shi, Lewis L.; He, Tong-Chuan; Ho, Sherwin H.] Univ Chicago, Mol Oncol Lab, Med Ctr, Dept Orthopaed Surg & Rehabil Med, Chicago, IL 60637 USA.
   [Liu, Bo; Yin, Liangjun; Wang, Zhongliang; Li, Ruidong; Nan, Guoxin; Shui, Wei; Yan, Zhengjian; Zhang, Hongmei; Liu, Wei; Zhang, Junhui; Zhang, Qian; Deng, Youlin; Qiao, Min; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Chongqing, Peoples R China.
   [Liu, Bo; Yin, Liangjun; Wang, Zhongliang; Li, Ruidong; Nan, Guoxin; Shui, Wei; Yan, Zhengjian; Zhang, Hongmei; Liu, Wei; Zhang, Junhui; Zhang, Qian; Deng, Youlin; Qiao, Min; He, Tong-Chuan] Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China.
   [Liu, Bo; Yin, Liangjun; Wang, Zhongliang; Li, Ruidong; Nan, Guoxin; Shui, Wei; Yan, Zhengjian; Zhang, Hongmei; Liu, Wei; Zhang, Junhui; Zhang, Qian; Deng, Youlin; Qiao, Min; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China.
   [Zhang, Wenwen] Binzhou Med Univ, Affiliated Hosp, Dept Lab Med, Yantai, Shandong, Peoples R China.
   [Deng, Fang] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China.
   [Liao, Zhan] Cent S Univ, Xiang Ya Hosp, Dept Orthopaed Surg, Changsha, Hunan, Peoples R China.
   [Zhang, Zhonglin] Wuhan Univ, Zhongnan Hosp, Dept Surg, Wuhan 430072, Peoples R China.
   [Ye, Jixing] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China.
RP He, TC (reprint author), Univ Chicago, Mol Oncol Lab, Med Ctr, 5841 South Maryland Ave,MC 3079, Chicago, IL 60637 USA.
EM tche@uchicago.edu; sho@bsd.uchicago.edu
FU National Institutes of Health; North American Spine Society; SHOCK Fund;
   Pritzker Research Fellowship from The University of Chicago Pritzker
   School of Medicine; Alpha Omega Alpha Carolyn L. Kuckein Student
   Research Fellowship; University of Chicago Core Facility Subsidy grant
   from the National Center for Advancing Translational Sciences (NCATS) of
   the National Institutes of Health [UL1 TR000430]
FX The authors thank Dr. Philippe Leboulch of Harvard Medical School for
   providing the SSR #69 vector. The reported work was supported in part by
   research grants from the National Institutes of Health (R.C.H., H.H.L.,
   and T.C.H.), North American Spine Society (T.C.H.), and the SHOCK Fund
   (S.H.H.). J.D.L. was the recipient of the Pritzker Research Fellowship
   from The University of Chicago Pritzker School of Medicine and the Alpha
   Omega Alpha Carolyn L. Kuckein Student Research Fellowship. This work
   was also supported in part by The University of Chicago Core Facility
   Subsidy grant from the National Center for Advancing Translational
   Sciences (NCATS) of the National Institutes of Health through Grant
   Number UL1 TR000430. The authors declare no conflicts of interest.
CR AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P223, DOI 10.3109/03008208809016809
   Behery OA, 2013, J KNEE SURG, V26, P203, DOI 10.1055/s-0032-1329231
   Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254
   BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170
   BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3
   Cha BH, 2013, CELL TRANSPLANT, V22, P1519, DOI 10.3727/096368912X647261
   Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133
   Chen X., CELL PHYSL BIOCH, V32, P1083
   Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017
   Chiang H, 2013, OSTEOARTHR CARTILAGE, V21, P589, DOI 10.1016/j.joca.2013.01.004
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819
   Egli RJ, 2011, INT REV CEL MOL BIO, V289, P37, DOI 10.1016/B978-0-12-386039-2.00002-X
   Gardner O. F., HISTOL HISTOPATHOL, V28, P23
   GEE CJ, 1979, J CELL SCI, V36, P223
   Glowacki J, 2000, J REHABIL RES DEV, V37, P171
   Goldring MB, 1999, OSTEOARTHR CARTILAGE, V7, P386, DOI 10.1053/joca.1998.0219
   Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95
   Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719
   Haydon RC, 2002, CLIN CANCER RES, V8, P1288
   He B. C., MOL PHARM, V79, P211
   He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509
   HOWELL N, 1982, CYTOGENET CELL GENET, V34, P215, DOI 10.1159/000131809
   Hu N., 2012, J CELL SCI, V126, P532
   Huang E., 2011, J BONE MINER RES, V27, P1566
   Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428
   Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x
   Jeong C. G., J BIOMED MAT RES A, V100, P2088
   KAHN P, 1983, VIROLOGY, V126, P348, DOI 10.1016/0042-6822(83)90484-1
   Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298
   Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130
   Lee CR, 2000, J ORTHOPAED RES, V18, P790, DOI 10.1002/jor.1100180517
   Li RD, 2014, CURR CANCER DRUG TAR, V14, P274, DOI 10.2174/1568009614666140305105805
   Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135
   Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98
   Luther GA, 2013, CANCER LETT, V336, P222, DOI 10.1016/j.canlet.2013.05.002
   Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359
   Neumann AJ, 2013, TISSUE ENG PT A, V19, P1285, DOI [10.1089/ten.tea.2012.0411, 10.1089/ten.TEA.2012.0411]
   Nitta M, 2001, GYNECOL ONCOL, V81, P10, DOI 10.1006/gyno.2000.6084
   O'Sullivan J, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt49
   Oldershaw RA, 2012, INT J EXP PATHOL, V93, P389, DOI 10.1111/j.1365-2613.2012.00837.x
   Pelttari K, 2009, SWISS MED WKLY, V139, P602, DOI smw-12742
   Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200
   Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744
   PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I
   Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182
   Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200
   Shi SL, 2013, J CELL BIOCHEM, V114, P908, DOI 10.1002/jcb.24430
   Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006
   Srinivasan PP, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024109
   Su Y., ONCOGENE, V30, P3907
   Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x
   Tang QO, 2012, EXPERT OPIN BIOL TH, V12, P1361, DOI 10.1517/14712598.2012.707182
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Toh WS, 2011, STEM CELL REV REP, V7, P544, DOI 10.1007/s12015-010-9222-6
   Trinh TQ, 2013, ARTHROSCOPY, V29, P566, DOI 10.1016/j.arthro.2012.10.008
   Varghese S, 2010, STEM CELLS, V28, P765, DOI 10.1002/stem.325
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Wan Mei, 2005, Biochemical and Biophysical Research Communications, V328, P651, DOI 10.1016/j.bbrc.2004.11.067
   Westerman KA, 1996, P NATL ACAD SCI USA, V93, P8971, DOI 10.1073/pnas.93.17.8971
   Yang K, 2012, J INVEST DERMATOL, V132, P2479, DOI 10.1038/jid.2012.145
   Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211
   Zhang YJ, 2005, SPINE, V30, P2601, DOI 10.1097/01.brs.0000187880.39298.f0
   Zhou GD, 2006, TISSUE ENG, V12, P3209, DOI 10.1089/ten.2006.12.3209
   Zhou L, 2002, BIOTECHNIQUES, V33, P1126, DOI 10.2144/02335dd07
   Zhou L, 2002, BIOTECHNIQUES, V33, P1132
   Zhou L, 2002, BIOTECHNIQUES, V33, P1130
   Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001
   ZHU JY, 1991, J VIROL, V65, P6872
NR 71
TC 20
Z9 20
U1 3
U2 9
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2015
VL 24
IS 6
BP 1053
EP 1066
DI 10.3727/096368914X681054
PG 14
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA CK4PQ
UT WOS:000356206100008
PM 24800751
DA 2018-10-20
ER

PT J
AU Lee, F
   Lim, J
   Reithofer, MR
   Lee, SS
   Chung, JE
   Hauser, CAE
   Kurisawa, M
AF Lee, Fan
   Lim, Jaehong
   Reithofer, Michael R.
   Lee, Su Seong
   Chung, Joo Eun
   Hauser, Charlotte A. E.
   Kurisawa, Motoichi
TI Synthesis and bioactivity of a conjugate composed of green tea catechins
   and hyaluronic acid
SO POLYMER CHEMISTRY
LA English
DT Article
ID REACTIVE OXYGEN; EPIGALLOCATECHIN-3-GALLATE EGCG; (-)-EPIGALLOCATECHIN
   GALLATE; ANTIOXIDANT PROPERTIES; CONDENSATION PRODUCTS;
   RHEUMATOID-ARTHRITIS; GLYOXYLIC-ACID; IN-VITRO; PERSPECTIVES;
   POLYPHENOLS
AB (-)-Epigallocatechin-3-gallate (EGCG) is a green tea polyphenol that has several biological activities, including anti-cancer activity and anti-inflammation. Hyaluronic acid (HA) is a naturally-occurring polysaccharide that is widely used as a biomaterial for drug delivery and tissue engineering due to its visco-elastic, biocompatible and biodegradable properties. By conjugating HA with EGCG, the resulting HA-EGCG conjugate is expected to exhibit not only the inherent properties of HA but also the bioactivities of EGCG. Toward this end, we report the synthesis of an amine-functionalized EGCG as an intermediate compound for conjugation to HA. EGCG was reacted with 2,2-diethoxyethylamine (DA) under acidic conditions, forming ethylamine-bridged EGCG dimers. The EGCG dimers were composed of four isomers, which were characterized by HPLC, high-resolution mass spectrometry and NMR spectroscopy. The amine-functionalized EGCG dimers were conjugated to hyaluronic acid (HA) through the formation of amide bonds. HA-EGCG conjugates demonstrated several bioactivities which were not present in unmodified HA, including resistance to hyaluronidase-mediated degradation, inhibition of cell growth and scavenging of radicals. The potential applications of HA-EGCG conjugates are discussed.
C1 [Lee, Fan; Lim, Jaehong; Reithofer, Michael R.; Lee, Su Seong; Chung, Joo Eun; Hauser, Charlotte A. E.; Kurisawa, Motoichi] Inst Bioengn & Nanotechnol, Singapore 138669, Singapore.
RP Kurisawa, M (reprint author), Inst Bioengn & Nanotechnol, 31 Biopolis Way,04-01, Singapore 138669, Singapore.
EM mkurisawa@ibn.a-star.edu.sg
RI KURISAWA, MOTOICHI/C-1325-2014; Lee, Su Seong/B-8485-2014
OI KURISAWA, MOTOICHI/0000-0003-2413-6933; Lee, Su
   Seong/0000-0002-2968-5707; Hauser, Charlotte/0000-0001-8251-7246;
   Reithofer, Michael/0000-0002-6328-1896
FU Institute of Bioengineering and Nanotechnology (Biomedical Research
   Council, Agency for Science, Technology and Research, Singapore)
FX This research was funded by the Institute of Bioengineering and
   Nanotechnology (Biomedical Research Council, Agency for Science,
   Technology and Research, Singapore). The authors acknowledge JNC
   Corporation (Japan) for the gift of hyaluronic acid, and Yan Shan Ang
   for assistance in the purification of HA-EGCG conjugates and Yue Wang
   for assistance in the superoxide radical scavenging assay.
CR Ahmed S, 2004, J PHARMACOL EXP THER, V308, P767, DOI 10.1124/jpet.103.059220
   Ahmed S, 2009, ARTHRITIS RHEUM-US, V60, P1282, DOI 10.1002/art.24488
   Asari A, 2004, CHEMISTRY AND BIOLOGY OF HYALURONAN, P457
   Avila LZ, 2008, CARBOHYDRATE CHEMISTRY, BIOLOGY AND MEDICAL APPLICATIONS, P333, DOI 10.1016/B978-0-08-054816-6.00015-X
   Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x
   Chung JE, 2014, NAT NANOTECHNOL, V9, P907, DOI [10.1038/NNANO.2014.208, 10.1038/nnano.2014.208]
   Drinkine J, 2005, J AGR FOOD CHEM, V53, P7552, DOI 10.1021/jf0504723
   El-Safory NS, 2010, CARBOHYD POLYM, V81, P165, DOI 10.1016/j.carbpol.2010.02.047
   Es-Safi NE, 2000, J AGR FOOD CHEM, V48, P4233, DOI 10.1021/jf000283e
   Fernandes E, 2004, FREE RADICAL BIO MED, V37, P1895, DOI 10.1016/j.freeradbiomed.2004.09.001
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Gross G, 2007, J EUR ACAD DERMATOL, V21, P1404, DOI 10.1111/j.1468-3083.2007.02441.x
   HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3
   He Q, 2007, FOOD CHEM, V101, P1178, DOI 10.1016/j.foodchem.2006.03.020
   Henrotin Y, 2005, OSTEOARTHR CARTILAGE, V13, P643, DOI 10.1016/j.joca.2005.04.002
   Homma A, 2009, BIOORGAN MED CHEM, V17, P4647, DOI 10.1016/j.bmc.2009.04.063
   Kanwar Jyoti, 2012, Front Biosci (Elite Ed), V4, P111
   KUO JW, 1991, BIOCONJUGATE CHEM, V2, P232, DOI 10.1021/bc00010a007
   Lei F, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39732
   Li C, 2008, ADV DRUG DELIVER REV, V60, P886, DOI 10.1016/j.addr.2007.11.009
   Lin JK, 2000, J AGR FOOD CHEM, V48, P2736, DOI 10.1021/jf000066d
   Lo GH, 2003, JAMA-J AM MED ASSOC, V290, P3115, DOI 10.1001/jama.290.23.3115
   Loeser RF, 2002, ARTHRITIS RHEUM, V46, P2349, DOI 10.1002/art.10496
   Moseley R, 2002, BIOMATERIALS, V23, P2255, DOI 10.1016/S0142-9612(01)00360-X
   Nagle DG, 2006, PHYTOCHEMISTRY, V67, P1849, DOI 10.1016/j.phytochem.2006.06.020
   Nakagawa H, 2007, BIOCHEM PHARMACOL, V73, P34, DOI 10.1016/j.bcp.2006.09.002
   Nakagawa T, 2002, FOOD CHEM TOXICOL, V40, P1745, DOI 10.1016/S0278-6915(02)00169-2
   Nanjo F, 1996, FREE RADICAL BIO MED, V21, P895, DOI 10.1016/0891-5849(96)00237-7
   Nonier MF, 2006, ANAL CHIM ACTA, V563, P76, DOI 10.1016/j.aca.2005.09.036
   Oh EJ, 2010, J CONTROL RELEASE, V141, P2, DOI 10.1016/j.jconrel.2009.09.010
   Perron NR, 2010, DALTON T, V39, P9982, DOI 10.1039/c0dt00752h
   Picotti F, 2013, CARBOHYD POLYM, V93, P273, DOI 10.1016/j.carbpol.2012.04.009
   REISSIG JL, 1955, J BIOL CHEM, V217, P959
   Saucier C, 1997, PHYTOCHEMISTRY, V46, P229, DOI 10.1016/S0031-9422(97)00268-9
   Schante CE, 2011, CARBOHYD POLYM, V87, P2211
   Shaw CY, 2003, PHYTOTHER RES, V17, P823, DOI 10.1002/ptr.1170
   Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093
   Soltes L, 2006, BIOMACROMOLECULES, V7, P659, DOI 10.1021/bm050867v
   Sousa F, 2009, PROCESS BIOCHEM, V44, P749, DOI 10.1016/j.procbio.2009.03.009
   Sreejayan, 1997, J PHARM PHARMACOL, V49, P105, DOI 10.1111/j.2042-7158.1997.tb06761.x
   Sutherland BA, 2006, J NUTR BIOCHEM, V17, P291, DOI 10.1016/j.jnutbio.2005.10.005
   Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Wan SB, 2005, BIOORGAN MED CHEM, V13, P2177, DOI 10.1016/j.bmc.2004.12.056
   Wang XY, 2007, J AGR FOOD CHEM, V55, P4987, DOI 10.1021/jf070590l
   Wheeler DS, 2004, DRUG DEVELOP RES, V61, P45, DOI 10.1002/ddr.10341
   Yang CS, 2011, PHARMACOL RES, V64, P113, DOI 10.1016/j.phrs.2011.03.001
   Zhang YM, 2004, J BIOL CHEM, V279, P30994, DOI 10.1074/jbc.M403697200
NR 48
TC 9
Z9 10
U1 6
U2 45
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PY 2015
VL 6
IS 24
BP 4462
EP 4472
DI 10.1039/c5py00495k
PG 11
WC Polymer Science
SC Polymer Science
GA CK2EB
UT WOS:000356022300014
DA 2018-10-20
ER

PT J
AU Gieseler, D
   Jordan, R
AF Gieseler, Dan
   Jordan, Rainer
TI Poly(2-oxazoline) molecular brushes by grafting through of
   poly(2-oxazoline)methacrylates with aqueous ATRP
SO POLYMER CHEMISTRY
LA English
DT Article
ID CRITICAL SOLUTION TEMPERATURE; GROUP-TRANSFER POLYMERIZATION;
   RING-OPENING POLYMERIZATION; RADICAL POLYMERIZATION; DRUG-DELIVERY;
   CYLINDRICAL BRUSHES; LIGAND STRUCTURE; BUILDING-BLOCKS; SIDE-CHAINS;
   COPOLYMERS
AB Molecular brushes of poly(2-oxazoline)s (POx) are an intriguing class of polymers as they combine a unique architecture with the properties of POx as a biomaterial. Here, the synthesis of several POx macromonomers with methacrylate end groups and consecutive grafting through polymerization by aqueous atom transfer radical polymerization (ATRP) at room temperature is reported. H-1-NMR spectroscopy and size exclusion chromatography (SEC) confirmed the synthesis of POx molecular brushes with maximum side chain grafting densities, narrow molar mass distributions (D <= 1.16) and final molar masses corresponding to the initial macromonomer : initiator ratio. Chain extension experiments show high end group fidelity and formation of block copolymer molecular brushes, and kinetic studies revealed a polymerization behavior of oligo(2-methyl-2-oxazoline) methacrylate very similar to the frequently used oligo (ethylene glycol) methacrylate (OEGMA(475)). Aqueous solutions of POx molecular brushes with poly( 2-ethyl- and 2-isopropyl-2-oxazoline) side chains exhibit the typically defined thermoresponsive behavior with a tunable, very narrow and reversible phase transition.
C1 [Gieseler, Dan; Jordan, Rainer] Tech Univ Dresden, Dept Chem, Makromol Chem, D-01069 Dresden, Germany.
RP Jordan, R (reprint author), Tech Univ Dresden, Dept Chem, Makromol Chem, Mommsenstr 4, D-01069 Dresden, Germany.
EM Rainer.Jordan@tu-dresden.de
RI Jordan, Rainer/B-6542-2008
OI Jordan, Rainer/0000-0002-9414-1597
FU Excellence Initiative by the German Federal Government; Excellence
   Initiative by the German State Government
FX Financial support by the "Excellence Initiative by the German Federal
   and State Governments" (Institutional Strategy, measure "support the
   best") is gratefully acknowledged.
CR Aoi K, 1996, PROG POLYM SCI, V21, P151, DOI 10.1016/0079-6700(95)00020-8
   Averick S, 2012, ACS MACRO LETT, V1, P6, DOI 10.1021/mz200020c
   Barz M, 2011, POLYM CHEM-UK, V2, P1900, DOI 10.1039/c0py00406e
   Bauer M, 2013, J POLYM SCI POL CHEM, V51, P1816, DOI 10.1002/pola.26564
   Bergenudd H, 2009, MACROMOLECULES, V42, P3302, DOI 10.1021/ma8028425
   Bloksma MM, 2011, MACROMOLECULES, V44, P4057, DOI 10.1021/ma200514n
   Bonne TB, 2007, MACROMOL CHEM PHYSIC, V208, P1402, DOI 10.1002/macp.200700140
   Buhler J, 2014, CHEM-EUR J, V20, P12405, DOI 10.1002/chem.201403942
   Buhler J, 2013, MACROMOL RAPID COMM, V34, P588, DOI 10.1002/marc.201200784
   Cesana S, 2006, MACROMOL CHEM PHYSIC, V207, P183, DOI 10.1002/macp.200500495
   David G, 2003, EUR POLYM J, V39, P1209, DOI 10.1016/S0014-3057(02)00369-5
   Farrugia BL, 2013, BIOMACROMOLECULES, V14, P2724, DOI 10.1021/bm400518h
   Fijten MWM, 2008, MACROMOL CHEM PHYSIC, V209, P1887, DOI 10.1002/macp.200800226
   Gaertner FC, 2007, J CONTROL RELEASE, V119, P291, DOI 10.1016/j.jconrel.2007.02.015
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   Grasmuller M, 1998, MACROMOL SYMP, V127, P109, DOI 10.1002/masy.19981270115
   Gross A, 1996, MACROMOL CHEM PHYSIC, V197, P2811, DOI 10.1002/macp.1996.021970919
   Guillerm B, 2012, CHEM COMMUN, V48, P2879, DOI 10.1039/c2cc30191a
   Hoogenboom R, 2008, CHEM COMMUN, P5758, DOI 10.1039/b813140f
   Hoogenboom R, 2007, MACROMOLECULES, V40, P2837, DOI 10.1021/ma062725e
   Huber S, 2008, COLLOID POLYM SCI, V286, P395, DOI 10.1007/s00396-007-1781-y
   Jordan R, 2001, MACROMOLECULES, V34, P8858, DOI 10.1021/ma011573e
   KOBAYASHI S, 1991, POLYM J, V23, P1307, DOI 10.1295/polymj.23.1307
   Kobayashi S, 2002, J POLYM SCI POL CHEM, V40, P192, DOI 10.1002/pola.10090
   KOBAYASHI S, 1985, POLYM BULL, V13, P447, DOI 10.1007/BF01033343
   KOBAYASHI S, 1989, MACROMOLECULES, V22, P2878, DOI 10.1021/ma00197a002
   Konradi R, 2008, LANGMUIR, V24, P613, DOI 10.1021/la702917z
   Lava K, 2015, EUR POLYM J, V65, P98, DOI 10.1016/j.eurpolymj.2015.01.014
   Li CM, 2004, ANGEW CHEM INT EDIT, V43, P1101, DOI 10.1002/anie.200352845
   LIN PY, 1988, J POLYM SCI POL PHYS, V26, P603, DOI 10.1002/polb.1988.090260312
   Ludtke K, 2005, MACROMOL BIOSCI, V5, P384, DOI 10.1002/mabi.200500004
   Luxenhofer R, 2006, MACROMOLECULES, V39, P3509, DOI 10.1021/ma052515m
   Luxenhofer R, 2008, MACROMOL RAPID COMM, V29, P1509, DOI 10.1002/marc.200800293
   Luxenhofer R, 2011, J CONTROL RELEASE, V153, P73, DOI 10.1016/j.jconrel.2011.04.010
   Luxenhofer R, 2010, BIOMATERIALS, V31, P4972, DOI 10.1016/j.biomaterials.2010.02.057
   MIYAMOTO M, 1989, MACROMOLECULES, V22, P1604, DOI 10.1021/ma00194a016
   Mullner M, 2015, ACS NANO, V9, P1294, DOI 10.1021/nn505125f
   Nuyken O, 1997, POLYM BULL, V38, P657, DOI 10.1007/s002890050102
   Nuyken O, 1997, MACROMOL RAPID COMM, V18, P125, DOI 10.1002/marc.1997.030180209
   Park JS, 2006, MACROMOLECULES, V39, P6622, DOI 10.1021/ma0605548
   Rehfeldt F, 2002, LANGMUIR, V18, P4908, DOI 10.1021/la0112559
   Reif M, 2011, MACROMOL CHEM PHYS, V212, P1815, DOI 10.1002/macp.201100276
   Rosen BM, 2009, CHEM REV, V109, P5069, DOI 10.1021/cr900024j
   Rueda J, 2005, MACROMOLECULES, V38, P7330, DOI 10.1021/ma050570p
   Sheiko SS, 2008, PROG POLYM SCI, V33, P759, DOI 10.1016/j.progpolymsci.2008.05.001
   Shimano Y, 1999, POLYM J, V31, P296, DOI 10.1295/polymj.31.296
   Shimano Y, 1999, POLYM J, V31, P219, DOI 10.1295/polymj.31.219
   Shimano Y, 1999, POLYM J, V31, P458, DOI 10.1295/polymj.31.458
   SHODA S, 1992, J POLYM SCI POL CHEM, V30, P1489, DOI 10.1002/pola.1992.080300728
   Tang C, 2007, MACROMOLECULES, V40, P6199, DOI 10.1021/ma070892o
   Tang W, 2006, MACROMOLECULES, V39, P4953, DOI 10.1021/ma0609634
   Taubmann C, 2005, MACROMOL BIOSCI, V5, P603, DOI 10.1002/mabi.200500059
   TRIVEDI PD, 1980, POLYM BULL, V3, P37, DOI 10.1007/BF00263203
   Tsarevsky NV, 2004, MACROMOLECULES, V37, P9768, DOI 10.1021/ma048438x
   UYAMA H, 1993, J POLYM SCI POL CHEM, V31, P123, DOI 10.1002/pola.1993.080310114
   Viegas TX, 2011, BIOCONJUGATE CHEM, V22, P976, DOI 10.1021/bc200049d
   Wang WX, 2014, POLYM CHEM-UK, V5, P3533, DOI 10.1039/c3py01398g
   Wang XS, 2000, MACROMOLECULES, V33, P6640, DOI 10.1021/ma000671h
   Weber C, 2013, MACROMOLECULES, V46, P5107, DOI 10.1021/ma400947r
   Weber C, 2013, J POLYM SCI POL CHEM, V51, P139, DOI 10.1002/pola.26332
   Weber C, 2011, MACROMOL SYMP, V308, P17, DOI 10.1002/masy.201151004
   Weber C, 2012, PROG POLYM SCI, V37, P686, DOI 10.1016/j.progpolymsci.2011.10.002
   Weber C, 2009, DES MONOMERS POLYM, V12, P149, DOI 10.1163/156855509X412090
   Weber C, 2009, MACROMOLECULES, V42, P2965, DOI 10.1021/ma8028437
   Weberskirch R, 1999, MACROMOL CHEM PHYSIC, V200, P863, DOI 10.1002/(SICI)1521-3935(19990401)200:4<863::AID-MACP863>3.0.CO;2-N
   WOODLE MC, 1994, BIOCONJUGATE CHEM, V5, P493, DOI 10.1021/bc00030a001
   Zalipsky S, 1996, J PHARM SCI, V85, P133, DOI 10.1021/js9504043
   Zhang N, 2013, J AM CHEM SOC, V135, P8810, DOI 10.1021/ja4036175
   Zhang N, 2012, MACROMOL CHEM PHYS, V213, P1963, DOI 10.1002/macp.201200261
   Zhang N, 2012, MACROMOL BIOSCI, V12, P926, DOI 10.1002/mabi.201200026
   Zhang N, 2012, MACROMOL CHEM PHYS, V213, P973, DOI 10.1002/macp.201200015
   Zhang N, 2009, MACROMOLECULES, V42, P2215, DOI 10.1021/ma802627y
   Zhang T, 2015, POLYM CHEM-UK, V6, P2726, DOI 10.1039/c5py00093a
   Zhang YZ, 2012, MACROMOLECULES, V45, P78, DOI 10.1021/ma201963c
   Zhao P, 2012, MACROMOL RAPID COMM, V33, P1351, DOI 10.1002/marc.201200172
NR 75
TC 12
Z9 12
U1 2
U2 34
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PY 2015
VL 6
IS 25
BP 4678
EP 4689
DI 10.1039/c5py00561b
PG 12
WC Polymer Science
SC Polymer Science
GA CK5WW
UT WOS:000356298900015
OA Bronze
DA 2018-10-20
ER

PT J
AU Karthika, A
   Kavitha, L
   Surendiran, M
   Kannan, S
   Gopi, D
AF Karthika, A.
   Kavitha, L.
   Surendiran, M.
   Kannan, S.
   Gopi, D.
TI Fabrication of divalent ion substituted hydroxyapatite/gelatin
   nanocomposite coating on electron beam treated titanium: mechanical,
   anticorrosive, antibacterial and bioactive evaluations
SO RSC ADVANCES
LA English
DT Article
ID GRADE STAINLESS-STEEL; PULSED ELECTRODEPOSITION METHOD; IN-VITRO;
   ORTHOPEDIC APPLICATIONS; CORROSION-RESISTANCE; NANOPARTICLES SYNTHESIS;
   COMPOSITE MICROSPHERES; ANTIMICROBIAL ACTIVITY; NANO-HYDROXYAPATITE;
   CALCIUM-PHOSPHATE
AB The key property in the fabrication of a biomaterial is to facilitate the replacement and/or regeneration of damaged tissues and organs. To obtain such a biomaterial, we fabricated a triple mineral (strontium, magnesium and zinc) substituted hydroxyapatite/gelatin (M-HAP/Gel) nanocomposite coating on electron beam treated titanium (Ti) metal. The influence of gelatin concentration in M-HAP was studied to investigate its effect on morphological changes, crystallinity, mechanical and anticorrosion properties. The M-HAP/Gel nanocomposite coating (with 3 wt% gelatin) on treated Ti resulted in better mechanical and anticorrosion properties as a consequence of the electron beam treatment of Ti. A reduced number of bacterial colonies were observed for the M-HAP/Gel composite against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) microbes which evidences a lower chance of implant failure after implantation. Moreover, the cell proliferation assay, live/dead staining of MT3C3-E1 cells and cell viability of fibroblast stem cells on the resultant nanocomposite revealed that the M-HAP/Gel composite will definitely be an effective implant material for better cell growth in orthopedic applications.
C1 [Karthika, A.; Surendiran, M.; Gopi, D.] Periyar Univ, Dept Chem, Salem 636011, India.
   [Kavitha, L.] Cent Univ Tamilnadu, Sch Basic & Appl Sci, Dept Phys, Thiruvarur 610101, India.
   [Kannan, S.] Periyar Univ, Sch Life Sci, Dept Zool, Salem 636011, India.
   [Gopi, D.] Periyar Univ, Ctr Nanosci & Nanotechnol, Salem 636011, India.
RP Gopi, D (reprint author), Periyar Univ, Dept Chem, Salem 636011, India.
EM dhanaraj_gopi@yahoo.com
RI Gopi, Dhanaraj/A-9163-2012; Louis, Kavitha/B-9313-2017
OI Gopi, Dhanaraj/0000-0001-6662-1238; Louis, Kavitha/0000-0002-8893-2050
FU Department of Science and Technology, New Delhi, India (DST-TSD)
   [DST/TSG/NTS/2011/73]; DST-EMEQ [SB/EMEQ-185/2013]; Defence Research and
   Development Organisation, New Delhi, India, (DRDO)
   [ERIP/ER/1103949/M/01/1513]; UGC, New Delhi, India [F.
   30-1/2013(SA-II)/RA-2012-14-NEW-SC-TAM-3240]
FX One of the authors D. Gopi acknowledges major financial support from the
   Department of Science and Technology, New Delhi, India (DST-TSD, Ref.
   no.: DST/TSG/NTS/2011/73), DST-EMEQ, Ref. no.: SB/EMEQ-185/2013) and
   Defence Research and Development Organisation, New Delhi, India, (DRDO,
   no. ERIP/ER/1103949/M/01/1513). D. Gopi also acknowledges UGC, New
   Delhi, India for the Research Award (Ref. no. F.
   30-1/2013(SA-II)/RA-2012-14-NEW-SC-TAM-3240. The authors acknowledge
   Industrial and Medical Accelerator Section, Raja Ramanna Centre for
   Advanced Technology (RRCAT), Indore (MP), India for the support to carry
   out high energy electron beam surface treatment.
CR *ASTM INT, F104405 ASTM INT
   Bigi A, 2004, BIOMATERIALS, V25, P2893, DOI 10.1016/j.biomaterials.2003.09.059
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chen MF, 2008, APPL SURF SCI, V254, P2730, DOI 10.1016/j.apsusc.2007.10.011
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chiono V., 2008, J MATER SCI-MATER M, V19, P89
   DIGENIS GA, 1994, J PHARM SCI, V83, P915, DOI 10.1002/jps.2600830702
   Dong C, 2003, SURF COAT TECH, V163, P620, DOI 10.1016/S0257-8972(02)00657-6
   Favi PM, 2013, MAT SCI ENG C-MATER, V33, P1935, DOI 10.1016/j.msec.2012.12.100
   Gopi D, 2015, RSC ADV, V5, P27402, DOI 10.1039/c5ra03432a
   Gopi D, 2015, CERAM INT, V41, P5454, DOI 10.1016/j.ceramint.2014.12.114
   Gopi D, 2014, RSC ADV, V4, P34751, DOI 10.1039/c4ra04484c
   Gopi D, 2014, COLLOID SURFACE A, V451, P172, DOI 10.1016/j.colsurfa.2014.03.035
   Gopi D, 2013, APPL SURF SCI, V286, P83, DOI 10.1016/j.apsusc.2013.09.023
   Gopi D, 2013, MATER LETT, V105, P216, DOI 10.1016/j.matlet.2013.04.019
   Gopi D, 2012, SURF COAT TECH, V206, P2859, DOI 10.1016/j.surfcoat.2011.12.011
   Gopi D, 2014, MATER CHEM PHYS, V144, P75, DOI 10.1016/j.matchemphys.2013.12.017
   Haroun AA, 2010, INT J BIOL MACROMOL, V46, P310, DOI 10.1016/j.ijbiomac.2010.01.005
   Hong J., 2004, POLYMER, V45, P6699
   Huang Y, 2014, APPL SURF SCI, V290, P353, DOI 10.1016/j.apsusc.2013.11.082
   Huang Y, 2013, APPL SURF SCI, V282, P456, DOI 10.1016/j.apsusc.2013.05.152
   Huang Y, 2013, APPL SURF SCI, V282, P583, DOI 10.1016/j.apsusc.2013.06.015
   KIM HM, 1995, J AM CERAM SOC, V78, P2405, DOI 10.1111/j.1151-2916.1995.tb08677.x
   Kim HW, 2005, J BIOMED MATER RES A, V72A, P136, DOI 10.1002/jbm.a.30168
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kolanthai E, 2015, RSC ADV, V5, P18301, DOI 10.1039/c4ra14584d
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lee K, 2006, SURF COAT TECH, V201, P1620, DOI 10.1016/j.surfcoat.2006.02.032
   LeGeros RZ, 1991, CALCIUM PHOSPHATES O
   Li B., 2014, ACS APPL MATER INTER, V4, P18258
   Li XR, 2008, LANGMUIR, V24, P14145, DOI 10.1021/la802984a
   Liong M, 2009, ADV MATER, V21, P1684, DOI 10.1002/adma.200802646
   Liu HY, 2014, NANOSCALE, V6, P5315, DOI 10.1039/c4nr00355a
   Lu Y, 2010, APPL SURF SCI, V256, P7228, DOI 10.1016/j.apsusc.2010.05.056
   Milovac D., 2014, MAT SCI ENG C, V42, P262
   Proskurovsky DI, 1998, J VAC SCI TECHNOL A, V16, P2480, DOI 10.1116/1.581369
   Rajeswari D, 2014, RSC ADV, V4, P61525, DOI 10.1039/c4ra12207k
   Ravi ND, 2012, J AM CERAM SOC, V95, P2700, DOI 10.1111/j.1551-2916.2012.05262.x
   Rose P.I., 1987, ENCY POLYM SCI ENG, P488
   Sivakumar M, 2002, BIOMATERIALS, V23, P3175, DOI 10.1016/S0142-9612(02)00066-2
   Stanic V, 2010, APPL SURF SCI, V256, P6083, DOI 10.1016/j.apsusc.2010.03.124
   Suchanek WL, 2004, BIOMATERIALS, V25, P4647, DOI [10.1016/j.biomaterials.2003.12.008, 10.1016/biomaterials.2003.12.008]
   Sun GF, 2014, MAT SCI ENG C-MATER, V39, P67, DOI 10.1016/j.msec.2014.02.023
   Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P399, DOI 10.1016/S0753-3322(03)00081-7
   Teng SH, 2007, J INORG BIOCHEM, V101, P686, DOI 10.1016/j.jinorgbio.2006.11.018
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Xia W, 2010, ACTA BIOMATER, V6, P1591, DOI 10.1016/j.actbio.2009.10.030
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Zandi M, 2010, J BIOMED MATER RES A, V92A, P1244, DOI 10.1002/jbm.a.32452
NR 50
TC 12
Z9 13
U1 5
U2 41
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 59
BP 47341
EP 47352
DI 10.1039/c5ra05624a
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA CJ7TX
UT WOS:000355703700010
DA 2018-10-20
ER

PT J
AU Firempong, CK
   Cao, X
   Tong, SS
   Yu, JN
   Xu, XM
AF Firempong, Caleb Kesse
   Cao, Xia
   Tong, Shanshan
   Yu, Jiangnan
   Xu, Ximing
TI Prospects for multitarget lipid-raft-coated silica beads: a remarkable
   online biomaterial for discovering multitarget antitumor lead compounds
SO RSC ADVANCES
LA English
DT Review
ID GROWTH-FACTOR RECEPTOR; CELL-MEMBRANE CHROMATOGRAPHY; STATIONARY-PHASE
   CHROMATOGRAPHY; TYROSINE KINASE INHIBITOR; PROSTATE-CANCER CELLS;
   AFFINITY-CHROMATOGRAPHY; IN-VITRO; BREAST-CANCER; DRUG DISCOVERY;
   SIGNALING PATHWAYS
AB A recently discovered receptor-rich lipid raft, which is linked to numerous transmembrane signal transduction pathways, has emerged as a medically significant biomaterial for screening antitumor agents. Compounds that interact with the biomaterial might potentially inhibit cancer cell growth, and thus be valuable as antitumor agents. Two standard anticancer drugs, lestaurtinib and gefitinib, interacted with the tropomyosin-related tyrosine kinase A (TrkA) receptor-rich lipid raft. The fact that they are both well known inhibitors of TrkA receptor strengthened the observed linkage. There is now a considerable interest in developing other related biomaterials to serve a similar purpose, and more importantly, support the concept of multitarget drug discovery. It is expected that new anticancer drugs strategically act on multiple pathways to achieve optimal therapeutic efficacies and decreased stimulation of acquired resistance. However, the current conventional approaches such as chemical screening systems and in silico methods cannot fully satisfy the increasing demand for the therapeutic agents. It has therefore become imperative to explore other alternatives to increase the number of clinically important antitumor agents. Here, we report the prospect of establishing lipid raft biomaterial with well endowed multiple cancer-related receptors for screening antitumor leads that affect multiple pathways. This review also examines receptor-ligand interactions in the hunt for novel antitumor agents and the associated key receptors.
C1 [Firempong, Caleb Kesse; Cao, Xia; Tong, Shanshan; Yu, Jiangnan; Xu, Ximing] Jiangsu Univ, Ctr Nano Drug Gene Delivery & Tissue Engn, Sch Pharm, Dept Pharmaceut, Zhenjiang, Peoples R China.
   [Yu, Jiangnan] China Pharmaceut Univ, Sch Pharm, Nanjing, Jiangsu, Peoples R China.
RP Xu, XM (reprint author), Jiangsu Univ, Ctr Nano Drug Gene Delivery & Tissue Engn, Sch Pharm, Dept Pharmaceut, 301 Xuefu Rd, Zhenjiang, Peoples R China.
EM calebuse@yahoo.com; yjn@ujs.edu.cn; xmxu@ujs.edu.cn
FU National Natural Science Foundation of China [30973677, 81373371];
   Doctoral Fund of Ministry of Education of China [20113227110012];
   Special Funds in Zhenjiang [JHB2012-37, GY2012049, GY2013055,
   GY2011028]; Jiangsu Province
FX We appreciate the support by National Natural Science Foundation of
   China (30973677, 81373371), Doctoral Fund of Ministry of Education of
   China (20113227110012) and Special Funds (JHB2012-37, GY2012049,
   GY2013055, GY2011028) in Zhenjiang, Jiangsu Province for all projects
   related to lipid raft biomaterial.
CR Abulrob A, 2004, ONCOGENE, V23, P6967, DOI 10.1038/sj.onc.1207911
   Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025
   Arai MA, 2009, CHEM-ASIAN J, V4, P1802, DOI 10.1002/asia.200900357
   Araujo RP, 2007, NAT REV DRUG DISCOV, V6, P871, DOI 10.1038/nrd2381
   Aube J, 2012, ACS MED CHEM LETT, V3, P442, DOI 10.1021/ml300114c
   Bates David, 2003, Curr Opin Investig Drugs, V4, P1468
   Beigi F, 1999, J CHROMATOGR A, V852, P313, DOI 10.1016/S0021-9673(99)00025-4
   Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793
   Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815
   BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J
   Carroll FI, 2009, NEUROPSYCHOPHARMACOL, V34, P251, DOI 10.1038/npp.2008.160
   Chen XG, 2011, MOL THER, V19, P93, DOI 10.1038/mt.2010.214
   Chiu SJ, 2006, J CONTROL RELEASE, V112, P199, DOI 10.1016/j.jconrel.2006.02.011
   CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728
   Chung HY, 2008, INT J CANCER, V122, P816, DOI 10.1002/ijc.23182
   Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002
   Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4
   Edidin M, 2001, Sci STKE, V2001, ppe1, DOI 10.1126/stke.2001.67.pe1
   Escriba PV, 2006, TRENDS MOL MED, V12, P34, DOI 10.1016/j.molmed.2005.11.004
   Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027
   Franco-Molina M, 2003, PHYTOTHER RES, V17, P1076, DOI 10.1002/ptr.1313
   Gabizon A, 2010, CANCER CHEMOTH PHARM, V66, P43, DOI 10.1007/s00280-009-1132-4
   Gill AL, 2007, CURR TOP MED CHEM, V7, P1408
   Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016
   GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619
   Grewal IS, 2009, ADV EXP MED BIOL, V647, P1, DOI 10.1007/978-0-387-89520-8_1
   Habicht KL, 2013, J PHARMACEUT BIOMED, V72, P159, DOI 10.1016/j.jpba.2012.10.001
   Haggerty TJ, 2012, ASSAY DRUG DEV TECHN, V10, P187, DOI 10.1089/adt.2011.0379
   Han HD, 2010, CLIN CANCER RES, V16, P3910, DOI 10.1158/1078-0432.CCR-10-0005
   Han SL, 2014, J SEP SCI, V37, P1525, DOI 10.1002/jssc.201400236
   He LC, 1999, CHINESE SCI BULL, V44, P826, DOI 10.1007/BF02885029
   Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x
   Horrobin DF, 2003, NAT REV DRUG DISCOV, V2, P151, DOI 10.1038/nrd1012
   Hou XF, 2011, J SEP SCI, V34, P508, DOI 10.1002/jssc.201000643
   Hou XF, 2009, J CHROMATOGR A, V1216, P7081, DOI 10.1016/j.chroma.2009.08.062
   Houghten RA, 2006, AAPS J, V8, pE371, DOI 10.1208/aapsj080242
   Hryniewicz-Jankowska A, 2014, BBA-REV CANCER, V1845, P155, DOI 10.1016/j.bbcan.2014.01.006
   Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043
   Jacoby E, 2011, WIRES COMPUT MOL SCI, V1, P57, DOI 10.1002/wcms.11
   Alonso-Castro AJ, 2011, J ETHNOPHARMACOL, V133, P945, DOI 10.1016/j.jep.2010.11.055
   Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596
   Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8
   Kingsmore SF, 2008, NAT REV DRUG DISCOV, V7, P221, DOI 10.1038/nrd2519
   Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389
   Krug M, 2008, MINI-REV MED CHEM, V8, P1312, DOI 10.2174/138955708786369591
   Kubinyi H, 2003, NAT REV DRUG DISCOV, V2, P665, DOI 10.1038/nrd1156
   Kuo HP, 2011, J AGR FOOD CHEM, V59, P8216, DOI 10.1021/jf2012584
   LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804
   Lee CB, 2007, REV RECENT CLIN TRIA, V2, P117, DOI 10.2174/157488707780599401
   Lee LT, 2002, ANTICANCER RES, V22, P1615
   Li J, 2011, MOL CANCER THER, V10, P1346, DOI 10.1158/1535-7163.MCT-10-0985
   Li MA, 2010, J PHARMACEUT BIOMED, V53, P1063, DOI 10.1016/j.jpba.2010.07.011
   Liang MJ, 2005, LIFE SCI, V78, P128, DOI 10.1016/j.lfs.2005.04.038
   Lin CM, 2006, PLANTA MED, V72, P1305, DOI 10.1055/s-2006-951692
   Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193
   Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299
   Lu BA, 2010, TOXICOL IN VITRO, V24, P1482, DOI 10.1016/j.tiv.2010.07.017
   Medina-Franco JL, 2013, DRUG DISCOV TODAY, V18, P495, DOI 10.1016/j.drudis.2013.01.008
   Mena-Rejon G, 2009, J ETHNOPHARMACOL, V121, P462, DOI 10.1016/j.jep.2008.11.012
   Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636
   Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930
   Miodini P, 1999, BRIT J CANCER, V80, P1150, DOI 10.1038/sj.bjc.6690479
   Mitchell SH, 1999, CANCER RES, V59, P5892
   Mitri Zahi, 2012, Chemother Res Pract, V2012, P743193, DOI 10.1155/2012/743193
   Moaddel R, 2002, J CHROMATOGR B, V768, P41, DOI 10.1016/S0378-4347(01)00484-4
   Moaddel R, 2010, J PHARMACEUT BIOMED, V52, P416, DOI 10.1016/j.jpba.2009.06.035
   Mollinedo F, 2006, DRUG RESIST UPDATE, V9, P51, DOI 10.1016/j.durp.2006.04.002
   Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044
   Mou HB, 2011, TOXICOL IN VITRO, V25, P1027, DOI 10.1016/j.tiv.2011.03.023
   NOCTOR TAG, 1992, J CHROMATOGR-BIOMED, V577, P305, DOI 10.1016/0378-4347(92)80252-L
   Pan YJ, 2003, CHINESE SCI BULL, V48, P630, DOI 10.1360/03tb9134
   Pang MH, 2012, DRUG DISCOV TODAY, V17, P425, DOI 10.1016/j.drudis.2012.01.003
   Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228
   Partlow KC, 2008, BIOMATERIALS, V29, P3367, DOI 10.1016/j.biomaterials.2008.04.030
   Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002
   Patwardhan CA, 2015, J BIOMOL SCREEN, V20, P223, DOI 10.1177/1087057114549147
   Peng F, 2002, J CANCER RES CLIN, V128, P223, DOI 10.1007/S00432-002-0326-5
   Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200
   Pozo-Guisado E, 2004, INT J CANCER, V109, P167, DOI 10.1002/ijc.11720
   Raghu H, 2007, J VIROL, V81, P7941, DOI 10.1128/JVI.02848-06
   Roepstorff K, 2002, J BIOL CHEM, V277, P18954, DOI 10.1074/jbc.M201422200
   Sadagopan S, 2007, J VIROL, V81, P3949, DOI 10.1128/JVI.02333-06
   SAINSBURY JRC, 1987, LANCET, V1, P1398
   Sanchez I, 2001, PHYTOTHER RES, V15, P290, DOI 10.1002/ptr.954
   SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789
   Sarnataro D, 2006, MOL PHARMACOL, V70, P1298, DOI 10.1124/mol.106.025601
   Sathornsumetee S., 2009, TARGETING MULTILE KI
   Schwartz J, 2009, AM J HEALTH-SYST PH, V66, pS3, DOI 10.2146/ajhp090438
   Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474
   Shankar DB, 2007, BLOOD, V109, P3400, DOI 10.1182/blood-2006-06-029579
   Sharma R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043248
   Sherman SI, 2008, ENDOCRIN METAB CLIN, V37, P511, DOI 10.1016/j.ecl.2008.02.005
   Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4
   Silverman L, 1998, CURR OPIN CHEM BIOL, V2, P397, DOI 10.1016/S1367-5931(98)80015-X
   Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084
   Stockwell BR, 2004, NATURE, V432, P846, DOI 10.1038/nature03196
   Su XY, 2007, J CHROMATOGR A, V1154, P132, DOI 10.1016/j.chroma.2007.03.050
   Sun M, 2011, ACTA PHARM SIN B, V1, P115, DOI 10.1016/j.apsb.2011.06.008
   Sun M, 2012, RAPID COMMUN MASS SP, V26, P2027, DOI 10.1002/rcm.6318
   Sun M, 2010, J CHROMATOGR B, V878, P2712, DOI 10.1016/j.jchromb.2010.08.010
   Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209
   Takebayashi M, 2004, SYNAPSE, V53, P90, DOI 10.1002/syn.20041
   Tansey MG, 2009, DRUG DISCOV TODAY, V14, P1082, DOI 10.1016/j.drudis.2009.10.002
   Thomann-Harwood LJ, 2013, J CONTROL RELEASE, V166, P95, DOI 10.1016/j.jconrel.2012.11.015
   Tong SS, 2014, BIOMED CHROMATOGR, V28, P1615, DOI 10.1002/bmc.3189
   Tong SS, 2014, CHROMATOGRAPHIA, V77, P419, DOI 10.1007/s10337-014-2623-y
   Vadlapudi AD, 2012, INT J PHARMACEUT, V434, P315, DOI 10.1016/j.ijpharm.2012.05.033
   van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9
   Vuignier K, 2013, J PHARMACEUT BIOMED, V74, P205, DOI 10.1016/j.jpba.2012.10.030
   Wang L, 2010, J PHARMACEUT BIOMED, V51, P1032, DOI 10.1016/j.jpba.2009.11.007
   Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920
   Wang SC, 2010, J CHROMATOGR A, V1217, P5246, DOI 10.1016/j.chroma.2010.06.037
   Wong CI, 2009, J CLIN ONCOL, V27, P4718, DOI 10.1200/JCO.2008.21.7125
   Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529
   Yeh CH, 2012, CHIN J INTEGR MED, V18, P676, DOI 10.1007/s11655-012-1206-8
   Yi ZF, 2009, INT J CANCER, V124, P843, DOI 10.1002/ijc.24027
   Yu B, 2010, MOL MEMBR BIOL, V27, P286, DOI 10.3109/09687688.2010.521200
   Yuan BX, 2005, CHROMATOGRAPHIA, V61, P381, DOI 10.1365/s10337-005-0497-8
   Yuan BX, 2005, ACTA PHARMACOL SIN, V26, P113, DOI 10.1117/j.1745-7254.2005.00015.x
   Zhang C, 2012, J CHROMATOGR A, V1233, P78, DOI 10.1016/j.chroma.2012.02.013
   Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559
   Zhang L, 2013, CANCER SCI, V104, P604, DOI 10.1111/cas.12120
   Zhang X, 2008, TRENDS BIOTECHNOL, V26, P295, DOI 10.1016/j.tibtech.2008.02.008
   Zhang XL, 2011, INT J CANCER, V129, P2502, DOI 10.1002/ijc.25909
   Zhen Y, 2007, ONCOGENE, V26, P6372, DOI 10.1038/sj.onc.1210473
   Zheng XH, 2008, CHINESE SCI BULL, V53, P842, DOI 10.1007/s11434-007-0510-8
   Zhuang LY, 2005, J CLIN INVEST, V115, P959
NR 127
TC 2
Z9 2
U1 3
U2 26
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 61
BP 49330
EP 49342
DI 10.1039/c5ra08322b
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA CK1TE
UT WOS:000355989400041
DA 2018-10-20
ER

PT J
AU Zhuo, SM
   Ni, M
   Bi, L
   Xia, L
   Fan, JJ
   Chan, HHN
AF Zhuo, Shuangmu
   Ni, Ming
   Bi, Long
   Xia, Lei
   Fan, Junjun
   Chan, Hugh H. N.
TI Stem Cell-Biomaterial Interactions for Tissue Engineering
SO STEM CELLS INTERNATIONAL
LA English
DT Editorial Material
C1 [Zhuo, Shuangmu] Fujian Normal Univ, Minist Educ, Fujian Prov Key Lab Photon Technol, Fuzhou 350007, Peoples R China.
   [Zhuo, Shuangmu] Fujian Normal Univ, Minist Educ, Key Lab Optoelect Sci & Technol Med, Fuzhou 350007, Peoples R China.
   [Ni, Ming] Inst Bioengn & Nanotechnol, The Nanos 138669, Singapore.
   [Bi, Long; Fan, Junjun] Fourth Mil Med Univ, Xian 710032, Peoples R China.
   [Xia, Lei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.
   [Chan, Hugh H. N.] Lerner Res Inst, Cleveland, OH 44195 USA.
RP Zhuo, SM (reprint author), Fujian Normal Univ, Minist Educ, Fujian Prov Key Lab Photon Technol, Fuzhou 350007, Peoples R China.
EM shuangmuzhuo@gmail.com
RI Zhuo, Shuangmu/F-4826-2012
OI Zhuo, Shuangmu/0000-0001-5767-5197
NR 0
TC 0
Z9 0
U1 0
U2 9
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-966X
EI 1687-9678
J9 STEM CELLS INT
JI Stem Cells Int.
PY 2015
AR 126710
DI 10.1155/2015/126710
PG 2
WC Cell & Tissue Engineering
SC Cell Biology
GA CK7BO
UT WOS:000356385200001
PM 26124838
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Eom, T
   Shim, BS
AF Eom, Taesik
   Shim, Bong Sub
BE BarCohen, Y
TI Natural Melanin Composites by Layer-by-Layer Assembly
SO ELECTROACTIVE POLYMER ACTUATORS AND DEVICES (EAPAD) 2015
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Electroactive Polymer Actuators and Devices (EAPAD)
CY MAR 09-12, 2015
CL San Diego, CA
SP SPIE, American Soc Mech Engineers, Intelligent Mat Forum, Jet Propuls Lab, Natl Sci Fdn
DE melanin; polyvinyl alcohol (PVA); Layer-by-Layer (LBL) assembly;
   electrical conductive; biocompatible; neural interface; implantable
   device
ID X-RAY CHARACTERIZATION; FILMS; EUMELANINS
AB Melanin is an electrically conductive biomaterial from human skin, eyes, brain, and beyond, because their conjugated backbone structures provide conducting pathways. Thus, there is a potential of using as materials for the neural interfaces and the body implantable devices. Extracted from Sepia officinalis ink, our natural melanin was uniformly dispersed in polar solvents such as water and alcohols. Then, the dispersed melanin was further fabricated to nano-thin layered composites by the layer-by-layer (LBL) assembly technique. Combined with polyvinyl alcohol (PVA), the melanin nanoparticles behave as an LBL component to from finely tuned nanostructured films. The LBL process can adjust the smart performances of the composites by varying the layering conditions and sandwich thickness. We further demonstrated the melanin loading degree of stacked layers, combination nanostructures, and biocompatibility of the resulting composites by UV-vis spectrophotometer, scanning electron microscope (SEM), and in-vitro cell test of PC12, respectively.
C1 [Eom, Taesik; Shim, Bong Sub] Inha Univ, Dept Chem Engn, Inchon, South Korea.
RP Shim, BS (reprint author), Inha Univ, Dept Chem Engn, 100 Inha Ro, Inchon, South Korea.
EM bshim@inha.ac.kr
CR Bettinger CJ, 2009, BIOMATERIALS, V30, P3050, DOI 10.1016/j.biomaterials.2009.02.018
   CHENG J, 1994, PIGM CELL RES, V7, P255, DOI 10.1111/j.1600-0749.1994.tb00060.x
   CHENG J, 1994, PIGM CELL RES, V7, P263, DOI 10.1111/j.1600-0749.1994.tb00061.x
   d'Ischia M, 2013, PIGM CELL MELANOMA R, V26, P616, DOI 10.1111/pcmr.12121
   d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786
   Irimia-Vladu M, 2014, CHEM SOC REV, V43, P6470
   Irimia-Vladu M, 2012, MATER TODAY, V15, P340, DOI 10.1016/S1369-7021(12)70139-6
   Kim IG, 2011, ELECTROCHIM ACTA, V56, P2954, DOI 10.1016/j.electacta.2010.12.095
   Ligonzo T, 2009, J NON-CRYST SOLIDS, V355, P1221, DOI 10.1016/j.jnoncrysol.2009.05.014
   Liu Y, 2003, PIGM CELL RES, V16, P606, DOI 10.1046/j.1600-0749.2003.00098.x
   Liu YL, 2014, CHEM REV, V114, P5057, DOI 10.1021/cr400407a
   Mostert AB, 2012, P NATL ACAD SCI USA, V109, P8943, DOI 10.1073/pnas.1119948109
   Oh SH, 2013, TISSUE ENG PART C-ME, V19, P233, DOI [10.1089/ten.tec.2012.0221, 10.1089/ten.TEC.2012.0221]
   Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003
   Srivastava S, 2008, ACCOUNTS CHEM RES, V41, P1831, DOI 10.1021/ar8001377
   Subianto S, 2005, POLYMER, V46, P11505, DOI 10.1016/j.polymer.2005.10.068
NR 16
TC 0
Z9 0
U1 0
U2 11
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-1-62841-533-9
J9 PROC SPIE
PY 2015
VL 9430
AR 94302V
DI 10.1117/12.2085519
PG 7
WC Engineering, Electrical & Electronic; Optics; Physics, Applied; Polymer
   Science
SC Engineering; Optics; Physics; Polymer Science
GA BC8EW
UT WOS:000355580900074
DA 2018-10-20
ER

PT J
AU Asha, S
   Sangappa, Y
   Ganesh, S
AF Asha, S.
   Sangappa, Y.
   Ganesh, Sanjeev
TI Tuning the Refractive Index and Optical Band Gap of Silk Fibroin Films
   by Electron Irradiation
SO JOURNAL OF SPECTROSCOPY
LA English
DT Article
ID PHOTOCHEMICAL BEHAVIOR; BIOMATERIAL COATINGS; NATURAL SILK; DEPOSITION;
   POLYMERS; ROBUST
AB The Bombyx mori silk fibroin (SF) films were prepared by solution casting method and effects of electron beam on the optical properties and optical constants of the films have been studied by using UV-Visible spectrophotometer. Optical properties like optical band gap E-g, refractive index n, extinction coefficient k, optical conductivity sigma(opt), and dielectric constants epsilon* of virgin and electron irradiated films were determined by usingUV-Visible absorption and transmission spectra. It was found that the reduction in optical band gap and increase in refractive index with increasing radiation dosage was observed. It is also observed from results that there is increase in dielectric constants with increasing photon energy. The observed optical changes have been tried to be correlated with the structural changes, revealed through FT-IR spectroscopy. The present study is quite important for tailoring the optical responses of SF films as per specific requirements.
C1 [Asha, S.; Sangappa, Y.; Ganesh, Sanjeev] Mangalore Univ, Dept Studies Phys, Mangalore 574199, India.
   [Sangappa, Y.] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Asha, S (reprint author), Mangalore Univ, Dept Studies Phys, Mangalore 574199, India.
EM a_shinda@yahoo.co.in
FU UGC (New Delhi, India)
FX The first author (S. Asha) thanks UGC (New Delhi, India) for an RGNF
   fellowship.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Asha S., 2013, AIP C P, V1591, P219
   Awatif A. M., 2007, J ENG TECHNOL, V25, P558
   Bakr NA, 2011, PRAMANA-J PHYS, V76, P519, DOI 10.1007/s12043-011-0024-4
   Baltova S, 1998, POLYM DEGRAD STABIL, V60, P53, DOI 10.1016/S0141-3910(97)00016-5
   Baltova S, 1998, POLYM DEGRAD STABIL, V60, P61, DOI 10.1016/S0141-3910(98)80027-X
   CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537
   Demappa T., 2009, NUCL INSTRUMENTS M B, V267, P2385
   FOROUHI AR, 1988, PHYS REV B, V38, P1865, DOI 10.1103/PhysRevB.38.1865
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Giulivi C, 2003, AMINO ACIDS, V25, P227, DOI 10.1007/s00726-003-0013-0
   Guo HL, 2009, SENSOR ACTUAT B-CHEM, V139, P598, DOI 10.1016/j.snb.2009.03.046
   Holland C, 2012, ADV MATER, V24, P105, DOI 10.1002/adma.201103664
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim DH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238552
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kojthung A, 2008, INT BIODETER BIODEGR, V62, P487, DOI 10.1016/j.ibiod.2007.12.012
   Kumar SV, 2006, J APPL POLYM SCI, V101, P1591, DOI 10.1002/app.23552
   Kumar V, 2011, RADIAT EFF DEFECT S, V166, P109, DOI 10.1080/10420151003587385
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Metcalfe AD, 2007, BIOMATERIALS, V28, P5100, DOI 10.1016/j.biomaterials.2007.07.031
   Migahed MD, 2006, CURR APPL PHYS, V6, P91, DOI 10.1016/j.cap.2004.12.009
   Mott N., 1979, ELECT PROCESS NONCRY
   Omar MA, 1993, ELEMENTARY SOLID STA
   Parker ST, 2009, ADV MATER, V21, P2411, DOI 10.1002/adma.200801580
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Sargunamani D, 2006, POLYM DEGRAD STABIL, V91, P2644, DOI 10.1016/j.polymdegradstab.2006.05.001
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Singh S, 2004, NUCL INSTRUM METH B, V222, P518, DOI 10.1016/j.nimb.2004.03.004
   Sinha D, 2004, RADIAT EFF DEFECT S, V159, P587, DOI 10.1080/10420150412331330539
   Srisa-Ard M., 2008, J APPL SCI, V8, P3518
   Tao H, 2012, ADV MATER, V24, P1067, DOI 10.1002/adma.201103814
   Tauc J., 1972, Optical properties of solids, P277
   Tsuboi Y, 2002, JPN J APPL PHYS 1, V41, P4772, DOI 10.1143/JJAP.41.4772
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   URBACH F, 1953, PHYS REV, V92, P1324, DOI 10.1103/PhysRev.92.1324
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Yakuphanoglu F, 2005, OPT MATER, V27, P1363, DOI 10.1016/optmat.2004.09.021
   Zaki MF, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/17/175404
   Zidan HM, 2003, J APPL POLYM SCI, V88, P104, DOI 10.1002/app.11569
NR 43
TC 5
Z9 5
U1 3
U2 20
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-4920
EI 2314-4939
J9 J SPECTROSC
JI J. Spectrosc.
PY 2015
AR 879296
DI 10.1155/2015/879296
PG 7
WC Biochemical Research Methods; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA CJ4LC
UT WOS:000355455500001
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Khobragade, P
   Jain, A
   Nagesh, SVS
   Andreana, S
   Dziak, R
   Sunkara, SK
   Sunkara, S
   Bednarek, DR
   Rudin, S
   Ionita, CN
AF Khobragade, P.
   Jain, A.
   Nagesh, S. V. Setlur
   Andreana, S.
   Dziak, R.
   Sunkara, S. K.
   Sunkara, S.
   Bednarek, D. R.
   Rudin, S.
   Ionita, C. N.
BE Gimi, B
   Molthen, RC
TI Micro-Computed tomography (CT) based assessment of dental regenerative
   therapy in the canine mandible model
SO MEDICAL IMAGING 2015: BIOMEDICAL APPLICATIONS IN MOLECULAR, STRUCTURAL,
   AND FUNCTIONAL IMAGING
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Medical Imaging - Biomedical Applications in Molecular,
   Structural, and Functional Imaging
CY FEB 24-26, 2015
CL Orlando, FL
SP SPIE, ALIO Ind, Alpin Med Syst, Modus Med Devices Inc, Bruker
ID BONE-MINERAL DENSITY; TRABECULAR BONE; RAT MODEL; OSTEOPOROSIS;
   BIOMATERIAL; ALGORITHM; CARTILAGE; STRENGTH; SYSTEM
AB High-resolution 3D bone-tissue structure measurements may provide information critical to the understanding of the bone regeneration processes and to the bone strength assessment. Tissue engineering studies rely on such nondestructive measurements to monitor bone graft regeneration area. In this study, we measured bone yield, fractal dimension and trabecular thickness through micro-CT slices for different grafts and controls. Eight canines underwent surgery to remove a bone volume (defect) in the canine's jaw at a total of 44 different locations. We kept 11 defects empty for control and filled the remaining ones with three regenerative materials; NanoGen (NG), a FDA-approved material (n= 11), a novel NanoCalcium Sulfate (NCS) material (n= 11) and NCS alginate (NCS+ alg) material (n= 11). After a minimum of four and eight weeks, the canines were sacrificed and the jaw samples were extracted. We used a custom-built micro-CT system to acquire the data volume and developed software to measure the bone yield, fractal dimension and trabecular thickness. The software used a segmentation algorithm based on histograms derived from volumes of interest indicated by the operator. Using bone yield and fractal dimension as indices we are able to differentiate between the control and regenerative material (p< 0.005). Regenerative material NCS showed an average 63.15% bone yield improvement over the control sample, NCS+ alg showed 55.55% and NanoGen showed 37.5%. The bone regeneration process and quality of bone were dependent upon the position of defect and time period of healing. This study presents one of the first quantitative comparisons using non-destructive Micro-CT analysis for bone regenerative material in a large animal with a critical defect model. Our results indicate that Micro-CT measurement could be used to monitor in-vivo bone regeneration studies for greater regenerative process understanding.
C1 [Khobragade, P.; Rudin, S.; Ionita, C. N.] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA.
   [Khobragade, P.; Jain, A.; Nagesh, S. V. Setlur; Bednarek, D. R.; Rudin, S.; Ionita, C. N.] SUNY Buffalo, Toshiba Stroke & Vasc Res Ctr, Buffalo, NY 14260 USA.
   [Andreana, S.] SUNY Buffalo, Dept Restorat Dent, Buffalo, NY 14260 USA.
   [Dziak, R.; Sunkara, S. K.; Sunkara, S.] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA.
RP Khobragade, P (reprint author), SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA.
CR Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Boyd SK, 2006, BONE, V39, P854, DOI 10.1016/j.bone.2006.04.017
   Dziak R., 2014, RECENT PATENTS REGEN, V94-102
   Eckstein F, 2006, NMR BIOMED, V19, P822, DOI 10.1002/nbm.1063
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Genant HK, 2008, RHEUMATOLOGY, V47, P9, DOI 10.1093/rheumatology/ken180
   Geraets WGM, 2008, DENTOMAXILLOFAC RAD, V37, P375, DOI 10.1259/dmfr/29966973
   Guedon J., 2012, SPIE MED IMAGING
   Huh JY, 2005, ORAL SURG ORAL MED O, V100, P296, DOI 10.1016/j.tripleo.2004.12.015
   Ionita CN, 2008, J DIGIT IMAGING, V21, P296, DOI 10.1007/s10278-007-9024-9
   Kallai I, 2011, NAT PROTOC, V6, P105, DOI 10.1038/nprot.2010.180
   Kontogiorgos E, 2011, CALCIFIED TISSUE INT, V89, P43, DOI 10.1007/s00223-011-9492-2
   Laib A, 2000, MED BIOL ENG COMPUT, V38, P326, DOI 10.1007/BF02347054
   LIEBOVITCH LS, 1989, PHYS LETT A, V141, P386, DOI 10.1016/0375-9601(89)90854-2
   Luo GM, 1999, ULTRASOUND MED BIOL, V25, P823, DOI 10.1016/S0301-5629(99)00026-5
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   Park YB, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055007
   Patel V, 2009, MED PHYS, V36, P48, DOI 10.1118/1.3026615
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Plachokova AS, 2006, CLIN ORAL IMPLAN RES, V17, P305, DOI 10.1111/j.1600-0501.2005.01208.x
   Requicha JF, 2014, J ORTHOP RES, V32, P904, DOI 10.1002/jor.22609
   Rudin S., 2002, SPIE MED IMAGING
   Sanchez U.G., 2011, J DENT, V39, P273
   Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007
   Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077
   Seeman E, 2010, J BONE MINER RES, V25, P1886, DOI 10.1002/jbmr.81
   Sittinger M, 2004, CURR OPIN BIOTECH, V15, P411, DOI 10.1016/j.copbio.2004.08.010
   Swain MV, 2009, INT J ORAL SCI, V1, P177, DOI 10.4248/IJOS09031
   Ulrich D, 1999, BONE, V25, P55, DOI 10.1016/S8756-3282(99)00098-8
   Waarsing JH, 2004, BONE, V34, P163, DOI 10.1016/j.bone.2003.08.012
   Wachter NJ, 2002, BONE, V31, P90, DOI 10.1016/S8756-3282(02)00779-2
NR 32
TC 1
Z9 1
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-1-62841-507-0
J9 PROC SPIE
PY 2015
VL 9417
AR 94171D
DI 10.1117/12.2082173
PG 12
WC Optics; Radiology, Nuclear Medicine & Medical Imaging
SC Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BC8GL
UT WOS:000355665600045
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Anwar, S
   Mubarik, M
   Waheed, A
   Firdous, S
AF Anwar, S.
   Mubarik, M.
   Waheed, A.
   Firdous, S.
TI Polarization Imaging and Characterization of Chitosan for applications
   in tissue engineering
SO OPTIK
LA English
DT Article
DE Biomaterial; Chitosan; Polarization; SEM; XRD; FTIR; Mueller matrix;
   Tissue engineering
ID LIGHT
AB In this study we described the optical properties of Chitosan as a biomaterial using light polarization Mueller analytical model which are not well understood by conventional characterization techniques. Despite the physical, mechanical and chemical properties measured by Scanning Electron Microscope (SEM), X-ray Powder Diffraction (XRD) and FTIR (Fourier Transform Infrared) Spectroscopy, optical properties are very useful to investigate the biodegradable Chitosan based scaffolds in tissue engineering. It has been observed from the SEM, XRD, FTIR and polarimetric results (diattenuation, retardance, depolarization, and degree of polarization) that Chitosan has porosity, amorphous, compactable and anisotropic material. (C) 2015 Elsevier GmbH. All rights reserved.
C1 [Anwar, S.; Waheed, A.; Firdous, S.] Natl Inst Lasers & Optron NILOP, Nilore, Pakistan.
   [Mubarik, M.] FUUAST, Dept Phys, Islamabad, Pakistan.
RP Firdous, S (reprint author), Natl Inst Lasers & Optron NILOP, Nilore, Pakistan.
EM shamaraz@gmail.com
RI Firdous, Shamaraz/I-8028-2015
CR [Anonymous], 2001, P SPIE, V4532
   BICKEL WS, 1985, AM J PHYS, V53, P468, DOI 10.1119/1.14202
   Brosseau C., 1998, FUNDAMENTALS POLARIZ
   Collett E., 1993, POLARIZED LIGHT FUND
   Correlo VM, 2005, MAT SCI ENG A-STRUCT, V403, P57, DOI 10.1016/j.msea.2005.04.055
   Firdous S, 2005, APPL OPTICS, V44, P1171, DOI 10.1364/AO.44.001171
   Firdous S, 2013, OPTIK, V124, P1297, DOI 10.1016/j.ijleo.2012.03.069
   Firdous S, 2011, OPT SPECTROSC+, V110, P438, DOI 10.1134/S0030400X11030064
   Firdous S, 2011, OPTIK, V122, P99, DOI 10.1016/j.ijleo.2009.10.008
   Firdous S, 2010, LASER ENG, V19, P291
   FIRDOUS S, 2005, P SOC PHOTO-OPT INS, V5867, P25
   Firdous S., 2005, TURK J MED SCI, V35, P145
   Firdous S., 2007, P SPIE, V6632
   Kucklick T., 2005, MED DEVICE R D HDB
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kumar S., 2010, J ADV POLYM SCI, V1
   Kumirska J., 2010, MAR DRUGS
   Moore J., 2003, BIOMEDICAL TECHNOLOG
   NESALIN J.A.J., 2012, ASIAN J PHARM SCI, V7, P80
   Ogawa K, 2004, INT J BIOL MACROMOL, V34, P1, DOI 10.1016/j.ijbiomac.2003.11.002
   Ray M, 2010, DES MONOMERS POLYM, V13, P193, DOI 10.1163/138577210X12634696333479
   Rice W., 2008, BIOMATERIALS, V29, P2014
   Struszczyk H., 2005, ADV CHITIN SCI, VVIII
   Sun K, 2011, EXPRESS POLYM LETT, V5, P342, DOI 10.3144/expresspolymlett.2011.34
   Tuchin V.V., 2007, OPTICAL POLARIZATION
   Walters J., 2013, OPT ENG, V52, P27
   Zhang HL, 2010, J NANO MAT, V2010, P1, DOI DOI 10.1155/2010/898910
   Zivanovic S., 2007, BIOMACROMOLECULES, V8, P505
NR 28
TC 3
Z9 3
U1 0
U2 10
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0030-4026
J9 OPTIK
JI Optik
PY 2015
VL 126
IS 7-8
BP 871
EP 876
DI 10.1016/j.ijleo.2015.02.027
PG 6
WC Optics
SC Optics
GA CJ8UB
UT WOS:000355777900040
DA 2018-10-20
ER

PT J
AU Perez-Madrigal, MM
   Cianga, L
   del Valle, LJ
   Cianga, I
   Aleman, C
AF Perez-Madrigal, Maria M.
   Cianga, Luminita
   del Valle, Luis J.
   Cianga, Ioan
   Aleman, Carlos
TI Electroactive and bioactive films of random copolymers containing
   terthiophene, carboxyl and Schiff base functionalities in the main chain
SO POLYMER CHEMISTRY
LA English
DT Article
ID PHASE-TRANSFER CATALYSIS; POLYTHIOPHENE-G-POLY(ETHYLENE GLYCOL);
   ELECTROCHEMICAL PROPERTIES; ELECTROCHROMIC PROPERTIES; SURFACE
   CHARACTERIZATION; ANTITUBERCULAR ACTIVITY; POLYTHIOPHENE FILMS;
   CONJUGATED POLYMERS; POLYAZOMETHINES; NANOMEMBRANES
AB A new bis-thienyl type monomer with preformed azomethine linkages (AzbT) was chemically synthesized and, subsequently, electro-copolymerized with 2,2' : 5', 2 ''-terthiophene (Th-3). AzbT : Th-3 mixtures with different molar ratios (i.e. 50 : 50, 60 : 40 and 80 : 20) were considered, the resulting thin films being made of random insoluble copolymers, P(AzbT-co-Th-3)s. The content of AzbT in P(AzbT-co-Th-3) s was found to increase with the AzbT : Th-3 molar ratio in the electropolymerization medium. Furthermore, characterization of the different copolymers suggests the existence of several concomitant processes in the reaction medium. Thus, depending on the composition of the reaction medium, AzbT worked as a co-monomer and/or as a dopant for the growing polymer chains. The morphology of the films evolved from a porous multi-level surface to a more compact and flat globular structure with increasing AzbT content. On the other hand, the electrochemical and optical properties were also influenced by the AzbT : Th-3 ratio. Cytotoxicity and cell adhesion and proliferation tests, which were performed using human osteosarcoma and monkey kidney epithelial cell lines (MG-63 and Vero, respectively), revealed that P(AzbT-co-Th-3) matrices can be potentially applied as bioactive substrates. This behaviour was especially relevant for the 80 : 20 copolymer, which exhibits optical and electrochemical properties in the range of polythiophene derivatives, suggesting that it is a promising functional biomaterial.
C1 [Perez-Madrigal, Maria M.; del Valle, Luis J.; Aleman, Carlos] Univ Politecn Cataluna, ETSEIB, Dept Engn Quim, E-08028 Barcelona, Spain.
   [Perez-Madrigal, Maria M.; Aleman, Carlos] Univ Politecn Cataluna, Ctr Res Nanoengn, E-08028 Barcelona, Spain.
   [Cianga, Luminita; Cianga, Ioan] Petru Poni Inst Macromol Chem, Iasi 700487, Romania.
RP Aleman, C (reprint author), Univ Politecn Cataluna, ETSEIB, Dept Engn Quim, Avda Diagonal 647, E-08028 Barcelona, Spain.
EM ioanc@icmpp.ro; carlos.aleman@upc.edu
RI Perez-Madrigal, Maria M./I-1052-2015; del Valle, Luis J./I-1342-2015
OI Perez-Madrigal, Maria M./0000-0002-2498-8485; del Valle, Luis
   J./0000-0001-9916-1741; Aleman, Carlos/0000-0003-4462-6075
FU MINECO; FEDER [MAT2012-34498]; FPI-UPC grant
FX Authors are indebted to the support from MINECO and FEDER
   (MAT2012-34498). M.M.P.-M. acknowledges financial support through a
   FPI-UPC grant.
CR ABDOU MSA, 1993, MACROMOLECULES, V26, P2954, DOI 10.1021/ma00063a047
   Ahmad S, 2007, LANGMUIR, V23, P11430, DOI 10.1021/la702442c
   Alam MS, 2012, BIOORGAN MED CHEM, V20, P4103, DOI 10.1016/j.bmc.2012.04.058
   Ali MM, 2009, J SCI RES, V1, P641
   Aradilla D, 2012, POLYM CHEM-UK, V3, P436, DOI 10.1039/c1py00504a
   Aradilla D, 2011, POLYM CHEM-UK, V2, P2548, DOI 10.1039/c1py00291k
   Armelin E, 2012, J MATER CHEM, V22, P585, DOI 10.1039/c1jm14168f
   Avram M., 1966, SPECTROSCOPIA INFRAR
   Barik S, 2012, MACROMOLECULES, V45, P1165, DOI 10.1021/ma2024304
   Barik S, 2011, POLYM CHEM-UK, V2, P1091, DOI 10.1039/c0py00394h
   Bendrea AD, 2013, J MATER CHEM B, V1, P4135, DOI 10.1039/c3tb20679c
   Bendrea AD, 2013, POLYM CHEM-UK, V4, P2709, DOI 10.1039/c3py00029j
   Benoit R., LASURFACE XRAY PHOTO
   Berridge R, 2007, J MATER CHEM, V17, P225, DOI 10.1039/b613879a
   Bertran O, 2010, J PHYS CHEM B, V114, P6281, DOI 10.1021/jp1006796
   Bolduc A, 2014, POLYM CHEM-UK, V5, P1119, DOI 10.1039/c3py01370g
   Chastain J., 1995, HDB XRAY PHOTOELECTR
   Cianga I, 2006, EUR POLYM J, V42, P1922, DOI 10.1016/j.eurpolymj.2006.03.001
   Cianga L, 2005, HIGH PERFORM POLYM, V17, P117, DOI 10.1177/0954008305042758
   Colak D, 2006, J POLYM SCI POL CHEM, V44, P727, DOI 10.1002/pola.21165
   Delpeux S, 1998, EUR POLYM J, V34, P905, DOI 10.1016/S0014-3057(97)00225-5
   Destri S, 1998, MACROMOLECULES, V31, P1079, DOI 10.1021/ma970756r
   Dillingham TR, 1996, J VAC SCI TECHNOL A, V14, P1494, DOI 10.1116/1.579975
   Ezugwu C. I., 2013, CHEM SCI T, V2, P1118
   Fabregat G, 2014, ACS APPL MATER INTER, V6, P11940, DOI 10.1021/am503904h
   Ferreira MD, 2009, CARBOHYD RES, V344, P2042, DOI 10.1016/j.carres.2009.08.006
   Ganguli S, 2012, INT J PHARM PHARM SC, V4, P175
   Giuseppone N, 2006, CHEM-EUR J, V12, P1723, DOI 10.1002/chem.200501037
   Grande CD, 2011, MACROMOLECULES, V44, P966, DOI 10.1021/ma102065u
   Grigoras M, 2000, REV ROUM CHIM, V45, P703
   Hamciuc E, 2014, HIGH PERFORM POLYM, V26, P175, DOI 10.1177/0954008313505626
   Hendrickson DN, 1970, INORG CHEM, V9, P612, DOI 10.1021/ic50085a035
   Hu BL, 2012, J AM CHEM SOC, V134, P17408, DOI 10.1021/ja307933t
   Isik D, 2012, ORG ELECTRON, V13, P3022, DOI 10.1016/j.orgel.2012.08.018
   Iwan A, 2008, PROG POLYM SCI, V33, P289, DOI 10.1016/j.progpolymsci.2007.09.005
   Iwan A, 2013, SYNTHETIC MET, V185, P17, DOI 10.1016/j.synthmet.2013.10.008
   Janeliunas D, 2013, ANGEW CHEM INT EDIT, V52, P1998, DOI 10.1002/anie.201209004
   Jesmin M., 2010, THAI J PHARM SCI, V34, P20
   Kaya I, 2013, J FLUORESC, V23, P115, DOI 10.1007/s10895-012-1124-3
   Khan KM, 2009, BIOORGAN MED CHEM, V17, P7795, DOI 10.1016/j.bmc.2009.09.028
   Kiebooms R., 2001, HDB ADV ELECT PHOTON, V8, P15
   Kiss E, 2002, J COLLOID INTERF SCI, V245, P91, DOI 10.1006/jcis.2001.7954
   Krompiec M, 2011, ELECTROCHIM ACTA, V56, P8108, DOI 10.1016/j.electacta.2011.05.132
   Kumar KS, 2010, EUR J MED CHEM, V45, P5474, DOI 10.1016/j.ejmech.2010.07.058
   Kunz TK, 2011, POLYM CHEM-UK, V2, P640, DOI 10.1039/c0py00308e
   Lehn JM, 2005, PROG POLYM SCI, V30, P814, DOI 10.1016/j.progpolymsci.2005.06.002
   Li GT, 1998, MACROMOL CHEM PHYSIC, V199, P525, DOI 10.1002/macp.1998.021990404
   Li JQ, 1998, J ELECTROANAL CHEM, V458, P155, DOI 10.1016/S0022-0728(98)00355-6
   Li SL, 1999, CORROS SCI, V41, P1273, DOI 10.1016/S0010-938X(98)00183-8
   Li XG, 2009, J PHYS CHEM B, V113, P9718, DOI 10.1021/jp901395u
   Llorens E, 2014, RSC ADV, V4, P15245, DOI 10.1039/c3ra42829j
   Llorens E, 2013, POLYMERS-BASEL, V5, P1115, DOI 10.3390/polym5031115
   Lopez-Perez DE, 2013, J PHYS CHEM C, V117, P6607, DOI 10.1021/jp3123117
   Maeda T, 2009, PROG POLYM SCI, V34, P581, DOI 10.1016/j.progpolymsci.2009.03.001
   Maione S, 2015, J POLYM SCI POL PHYS, V53, P239, DOI 10.1002/polb.23617
   Mallet C, 2013, POLYM CHEM-UK, V4, P250, DOI 10.1039/c2py20703f
   Manceau M, 2009, POLYM DEGRAD STABIL, V94, P898, DOI 10.1016/j.polymdegradstab.2009.03.005
   Marin L, 2009, SOFT MATER, V7, P1, DOI 10.1080/15394450802656214
   Martins F, 2014, EUR J MED CHEM, V81, P119, DOI 10.1016/j.ejmech.2014.04.077
   Maruoka K, 2003, CHEM REV, V103, P3013, DOI 10.1021/cr020020e
   Mishra P, 2005, J GEN APPL MICROBIOL, V51, P133, DOI 10.2323/jgam.51.133
   Mohamed GG, 2005, SPECTROCHIM ACTA A, V62, P1140, DOI 10.1016/j.saa.2005.03.031
   Moulin E, 2012, CHEM SOC REV, V41, P1031, DOI 10.1039/c1cs15185a
   NEFEDOV VI, 1975, ZH NEORG KHIM+, V20, P2307
   Onciu M, 2007, J APPL POLYM SCI, V103, P2013, DOI 10.1002/app.25302
   Ooi T, 2007, ANGEW CHEM INT EDIT, V46, P4222, DOI 10.1002/anie.200601737
   Ozaytekin Y., 2014, POLYM COMPOSITE, V35, P372
   Peng H, 2007, POLYMER, V48, P3413, DOI 10.1016/j.polymer.2007.04.029
   Perez-Madrigal MM, 2014, POLYM CHEM-UK, V5, P1248, DOI 10.1039/c3py01313h
   Perez-Madrigal M. M., 2013, POLYM CHEM, V4, P568
   Perez-Madrigal MM, 2015, ACS APPL MATER INTER, V7, P1632, DOI 10.1021/am507142f
   Perez-Madrigal MM, 2014, ACS APPL MATER INTER, V6, P9719, DOI 10.1021/am502150q
   Perez-Madrigal MM, 2012, POLYM CHEM-UK, V3, P979, DOI 10.1039/c2py00584k
   Planellas M, 2015, POLYM CHEM-UK, V6, P925, DOI 10.1039/c4py01243g
   Purvis KL, 2000, J AM CHEM SOC, V122, P1808, DOI 10.1021/ja992910q
   Revanasiddappa B. C., 2013, UNIVERS J PHARM, V2, P145
   Sari N, 2004, Z NATURFORSCH B, V59, P692
   Sashidhara KV, 2009, EUR J MED CHEM, V44, P1813, DOI 10.1016/j.ejmech.2008.08.004
   Sharma S, 2003, APPL SURF SCI, V206, P218, DOI 10.1016/S0169-4332(02)01220-5
   Simionescu CI, 1999, EUR POLYM J, V35, P1895, DOI 10.1016/S0014-3057(98)00272-9
   Simionescu CI, 1998, EUR POLYM J, V34, P891, DOI 10.1016/S0014-3057(97)00226-7
   Simionescu CI, 1999, EUR POLYM J, V35, P587, DOI 10.1016/S0014-3057(98)00171-2
   Soto-Delgado J, 2015, RSC ADV, V5, P9189, DOI 10.1039/c4ra13812k
   Spanninga SA, 2010, J PHYS CHEM C, V114, P14992, DOI 10.1021/jp104591d
   Stevens JS, 2013, SURF INTERFACE ANAL, V45, P1238, DOI 10.1002/sia.5261
   Tarkuc S, 2006, POLYMER, V47, P2001, DOI 10.1016/j.polymer.2006.01.072
   Tumer M, 2008, J COORD CHEM, V61, P2935, DOI 10.1080/00958970801989902
   VANINI AS, 1994, CORROS SCI, V36, P1825
   Zhang Z, 2013, J INORG BIOCHEM, V123, P1, DOI 10.1016/j.jinorgbio.2013.02.004
   Zhou YJ, 2010, BIOORGAN MED CHEM, V18, P2165, DOI 10.1016/j.bmc.2010.01.075
NR 90
TC 6
Z9 6
U1 2
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PY 2015
VL 6
IS 23
BP 4319
EP 4335
DI 10.1039/c5py00480b
PG 17
WC Polymer Science
SC Polymer Science
GA CJ8FJ
UT WOS:000355735300015
DA 2018-10-20
ER

PT J
AU Kunert-Keil, C
   Botzenhart, U
   Gedrange, T
   Gredes, T
AF Kunert-Keil, Christiane
   Botzenhart, Ute
   Gedrange, Tomasz
   Gredes, Tomasz
TI Interrelationship between bone substitution materials and skeletal
   muscle tissue
SO ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER
LA English
DT Article
DE In vivo biocompatibility; MyHC expression; Muscle histology; Growth
   factor; Ectopic bone formation
ID MESSENGER-RNA EXPRESSION; IN-VIVO DEGRADATION; GENE-EXPRESSION;
   GROWTH-FACTOR; MYOGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX;
   LATISSIMUS-DORSI; FIBERS; CELLS; ADAPTATION
AB Bone density and quantity are primary conditions for the insertion and stability of dental implants. In cases of a lack of adequate maxillary or mandibulary bone, bone augmentation will be necessary. The use of synthetic bioactive bone substitution materials is of increasing importance as alternatives to autogenously bone grafts.
   It is well known that bone can influence muscle function and muscle function can influence bone structures. Muscles have a considerable potential of adaptation and muscle tissue surrounding an inserted implant or bone surrogate can integrate changes in mechanical load of the muscle and hereupon induce signaling cascades with protein synthesis and arrangement of the cytoskeleton.
   The Musculus latissimus dorsi is very often used for the analyses of the in vivo biocompatibility of newly designed biomaterials. Beside macroscopically and histologically examination, biocompatibility can be assessed by analyses of the biomaterial influence of gene expression.
   This review discusses changes in the fiber type distribution, myosin heavy chain isoform composition, histological appearance and vascularization of the skeletal muscle after implantation of bone substitution materials. Especially, the effects of bone surrogates should be described at the molecular-biological and cellular level. (C) 2014 Elsevier GmbH. All rights reserved.
C1 [Kunert-Keil, Christiane; Botzenhart, Ute; Gedrange, Tomasz; Gredes, Tomasz] Tech Univ Dresden, Dept Orthodont, D-01307 Dresden, Germany.
RP Kunert-Keil, C (reprint author), Tech Univ Dresden, Dept Orthodont, Carl Gustav Carus Campus,Fetscherstr 74,Haus 28, D-01307 Dresden, Germany.
EM christiane.kunert-keil@uniklinikum-dresden.de
CR ADAMS GR, 1993, J APPL PHYSIOL, V74, P911
   ALAMEDDINE HS, 1989, MUSCLE NERVE, V12, P544, DOI 10.1002/mus.880120705
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   BOOTH FW, 1983, MED SCI SPORT EXER, V15, P415
   Burugapalli K, 2007, BIOMACROMOLECULES, V8, P3439, DOI 10.1021/bm700560k
   Censi R, 2011, J BIOMED MATER RES A, V97A, P219, DOI 10.1002/jbm.a.33048
   Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001
   Deasy BM, 2009, MOL THER, V17, P1788, DOI 10.1038/mt.2009.136
   Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012
   FITTS RH, 1986, J APPL PHYSIOL, V60, P1946
   FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221
   FLORINI JR, 1991, J BIOL CHEM, V266, P15917
   FLORINI JR, 1991, MOL ENDOCRINOL, V5, P718, DOI 10.1210/mend-5-5-718
   Fluck M, 2003, Ther Umsch, V60, P371, DOI 10.1024/0040-5930.60.7.371
   Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004
   Gedrange T, 2008, J PHYSIOL PHARMACOL, V59, P3
   Giannoudis P.V., 2005, INJURY, V36
   Gotz W, 2010, FOLIA HISTOCHEM CYTO, V48, P589, DOI 10.2478/v10042-010-0096-x
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   GOLDSPINK G, 1992, AM J PHYSIOL, V262, pR356
   Gredes T, 2009, J PHYSIOL PHARMACOL, V60, P77
   Gredes T, 2012, ANN ANAT, V194, P179, DOI 10.1016/j.aanat.2011.10.003
   Gredes T, 2010, BIOMED TECH, V55, P323, DOI 10.1515/BMT.2010.048
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Hulsart-Billstrom G, 2011, ACTA BIOMATER, V7, P3042, DOI 10.1016/j.actbio.2011.04.021
   Jankala H, 1997, J APPL PHYSIOL, V82, P977
   Kaji Hiroshi, 2014, J Bone Metab, V21, P29, DOI 10.11005/jbm.2014.21.1.29
   Kerdoncuff V., 2002, Annales de Readaptation et de Medecine Physique, V45, P198, DOI 10.1016/S0168-6054(02)00203-9
   Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003
   Krutki P, 2008, J PHYSIOL PHARMACOL, V59, P85
   Kunert-Keil C., 2013, ANN ANAT
   LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9
   Lauer G, 2007, ANN ANAT, V189, P412, DOI 10.1016/j.aanat.2007.02.021
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mack HB, 2008, J PHYSIOL PHARMACOL, V59, P95
   Mai R, 2006, J CRANIO MAXILL SURG, V34, P101, DOI 10.1016/S1010-5182(06)60022-X
   McCroskery S, 2005, J CELL SCI, V118, P3531, DOI 10.1242/jcs.02482
   McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0
   Messina S, 2007, FASEB J, V21, P3737, DOI 10.1096/fj.07-8459com
   Pette D, 2002, CAN J APPL PHYSIOL, V27, P423, DOI 10.1139/h02-023
   Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1
   PUZAS JE, 1989, CLIN ORTHOP RELAT R, P269
   Ricotti L, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035010
   Ricotti L, 2011, IEEE ENG MED BIO, P3597, DOI 10.1109/IEMBS.2011.6090602
   SASSOUNI V, 1969, AMER J ORTHODONTICS, V55, P109, DOI 10.1016/0002-9416(69)90122-5
   SAWYER JR, 1991, CALCIFIED TISSUE INT, V49, P208, DOI 10.1007/BF02556120
   Schumacher G H, 1991, Phillip J, V8, P210
   Shishatskaya EI, 2007, B EXP BIOL MED+, V144, P786, DOI 10.1007/s10517-007-0432-0
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P719, DOI 10.1023/B:JMSM.0000030215.49991.0d
   Sondag GR, 2014, J CELL PHYSIOL, V229, P955, DOI 10.1002/jcp.24512
   STARON RS, 1993, COMP BIOCHEM PHYS B, V106, P463, DOI 10.1016/0305-0491(93)90120-T
   STARON RS, 1993, HISTOCHEMISTRY, V100, P149, DOI 10.1007/BF00572901
   Tanaka K, 2012, BONE, V51, P158, DOI 10.1016/j.bone.2012.04.017
   Warnke PH, 2006, BIOMATERIALS, V27, P1081, DOI 10.1016/j.biomaterials.2005.07.042
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Widrick JJ, 2002, AM J PHYSIOL-REG I, V283, pR408, DOI 10.1152/ajpregu.00120.2002
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   WOLF JH, 1995, ORTHOPADE, V24, P378
   Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200
NR 60
TC 1
Z9 1
U1 0
U2 7
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0940-9602
EI 1618-0402
J9 ANN ANAT
JI Ann. Anat.-Anat. Anz.
PY 2015
VL 199
SI SI
BP 73
EP 78
DI 10.1016/j.aanat.2014.07.008
PG 6
WC Anatomy & Morphology
SC Anatomy & Morphology
GA CJ5AB
UT WOS:000355498700012
PM 25159858
DA 2018-10-20
ER

PT J
AU Liu, XH
   Zhu, C
   Li, YJ
   Yan, YL
   Hou, CY
   Wang, H
   Yang, YL
   Guan, GP
   Feng, QL
AF Liu, Xinhui
   Zhu, Chao
   Li, Yijiong
   Yan, Yueling
   Hou, Chuanyong
   Wang, Hua
   Yang, Yelin
   Guan, Guoping
   Feng, Qingling
TI The Preparation and In Vitro Evaluations of a Nanoscaled Injectable Bone
   Repair Material
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID LASER-SCANNING MICROSCOPY; DRUG-DELIVERY; SUBSTITUTE; COMPOSITES;
   HYDROGELS; REGENERATION; SCAFFOLDS; MARROW; MATRIX; CELLS
AB There are usually two forms of bone repair materials, block and granular, for common clinical use. This paper describes a novel injectable material, nano-HA/collagen/alginate (nHAC/Alg) composite biomaterial, including its preparation and evaluations in vitro. Based on the idea of bionics and the study of collagen/calcium phosphate salt composite materials, the injectable bone repair material was developed. Then, human bone marrow stem cells (hBMSCs) were cultured on the nHAC/Alg material. The cell attachment, proliferation, and differentiation were evaluated with inverted microscope, scanning electron microscope, laser scanning confocal microscope, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) analysis, and alkaline phosphatase (ALP) test. The results showed that nHAC/Alg not only had no negative effect on cellular functions but also promotes cell proliferation and differentiation into osteogenic cells, which suggests that the nanoscaled injectable bone repair material has good clinical application prospects for bone repair.
C1 [Liu, Xinhui; Zhu, Chao; Hou, Chuanyong; Wang, Hua; Yang, Yelin; Guan, Guoping] Nanjing Med Univ, Jiangning Hosp, Orthopaed, Nanjing 211100, Jiangsu, Peoples R China.
   [Li, Yijiong; Yan, Yueling] Hebei Med Univ, Hosp 1, Orthopaed, Shijiazhuang 050031, Peoples R China.
   [Feng, Qingling] Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Liu, XH (reprint author), Nanjing Med Univ, Jiangning Hosp, Orthopaed, Nanjing 211100, Jiangsu, Peoples R China.
EM professorlxh2008@163.com
FU Natural Science Foundation of Jiangsu Province of China [BK20141436]
FX The authors acknowledge the financial support from the Natural Science
   Foundation of Jiangsu Province of China (no. BK20141436).
CR Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255
   Chen ZG, 2014, MAT SCI ENG C-MATER, V45, P94, DOI 10.1016/j.msec.2014.08.060
   D'Este M, 2013, ACTA BIOMATER, V9, P5421, DOI 10.1016/j.actbio.2012.11.022
   D'Este M, 2012, CARBOHYD POLYM, V90, P1378, DOI 10.1016/j.carbpol.2012.07.007
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Gan Shao-lei, 2006, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V28, P710
   Ghanaati S, 2011, ACTA BIOMATER, V7, P4018, DOI 10.1016/j.actbio.2011.07.003
   Ginebra MP, 2012, ADV DRUG DELIVER REV, V64, P1090, DOI 10.1016/j.addr.2012.01.008
   Han Y, 2013, ACTA BIOMATER, V9, P9107, DOI 10.1016/j.actbio.2013.06.022
   Hu NM, 2012, J MECH BEHAV BIOMED, V12, P119, DOI 10.1016/j.jmbbm.2011.12.007
   Huang Z, 2011, MAT SCI ENG C-MATER, V31, P683, DOI 10.1016/j.msec.2010.12.014
   Huang Z, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/5/055005
   KAZAMA JJ, 1993, BONE, V14, P885, DOI 10.1016/8756-3282(93)90319-6
   Khanarian NT, 2012, TISSUE ENG PT A, V18, P533, DOI [10.1089/ten.tea.2011.0279, 10.1089/ten.TEA.2011.0279]
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Li XM, 2014, J BIOMED MATER RES A, V102, P1580, DOI 10.1002/jbm.a.34801
   Li XM, 2014, J BIOMED MATER RES A, V102, P1092, DOI 10.1002/jbm.a.34774
   Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045
   Li XM, 2011, J BIOMED MATER RES B, V97B, P10, DOI 10.1002/jbm.b.31773
   Li XM, 2009, J BIOMED MATER RES B, V90B, P503, DOI 10.1002/jbm.b.31311
   Lian XJ, 2013, PROG NAT SCI-MATER, V23, P549, DOI 10.1016/j.pnsc.2013.11.003
   Liu H, 2006, ACTA BIOMATER, V2, P557, DOI 10.1016/j.actbio.2006.03.007
   Liu J, 2014, BONE, V67, P81, DOI 10.1016/j.bone.2014.06.040
   Liu XH, 2014, INT J POLYM SCI, DOI 10.1155/2014/238247
   Maggiano C, 2006, MOL CELL PROBE, V20, P154, DOI 10.1016/j.mcp.2005.11.009
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Navarro M, 2004, BIOMATERIALS, V25, P4233, DOI 10.1016/j.biomaterials.2003.11.012
   Pelin IM, 2009, MAT SCI ENG C-MATER, V29, P2188, DOI 10.1016/j.msec.2009.04.021
   Peng C, 2013, J BIOMATER TISS ENG, V3, P534, DOI 10.1166/jbt.2013.1117
   Scherliess R, 2011, INT J PHARMACEUT, V411, P98, DOI 10.1016/j.ijpharm.2011.03.053
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Xu HHK, 2006, BIOMATERIALS, V27, P4279, DOI 10.1016/j.biomaterials.2006.03.001
   Zheng L, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/6/065004
NR 33
TC 0
Z9 1
U1 1
U2 17
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-4110
EI 1687-4129
J9 J NANOMATER
JI J. Nanomater.
PY 2015
AR 858493
DI 10.1155/2015/858493
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CJ4GE
UT WOS:000355442000001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Hasan, J
   Raj, S
   Yadav, L
   Chatterjee, K
AF Hasan, Jafar
   Raj, Shammy
   Yadav, Lavendra
   Chatterjee, Kaushik
TI Engineering a nanostructured "super surface" with superhydrophobic and
   superkilling properties
SO RSC ADVANCES
LA English
DT Article
ID BLACK SILICON METHOD; BIOFILM FORMATION; CONTACT ANGLES; ARRAYS;
   BIOMATERIAL; RESISTANCE; ADHESION; ETCHER; WINGS
AB We present a nanostructured "super surface" fabricated using a simple recipe based on deep reactive ion etching of a silicon wafer. The topography of the surface is inspired by the surface topographical features of dragonfly wings. The super surface is comprised of nanopillars 4 mm in height and 220 nm in diameter with random inter-pillar spacing. The surface exhibited superhydrophobicity with a static water contact angle of 154.0 degrees and contact angle hysteresis of 8.3 degrees. Bacterial studies revealed the bactericidal property of the surface against both gram negative (Escherichia coli) and gram positive (Staphylococcus aureus) strains through mechanical rupture of the cells by the sharp nanopillars. The cell viability on these nanostructured surfaces was nearly six-fold lower than on the unmodified silicon wafer. The nanostructured surface also killed mammalian cells (mouse osteoblasts) through mechanical rupture of the cell membrane. Thus, such nanostructured super surfaces could find applications for designing selfcleaning and anti-bacterial surfaces in diverse applications such as microfluidics, surgical instruments, pipelines and food packaging.
C1 [Hasan, Jafar; Raj, Shammy; Chatterjee, Kaushik] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
   [Yadav, Lavendra] Indian Inst Sci, Ctr Nanosci & Engn, Bangalore 560012, Karnataka, India.
RP Chatterjee, K (reprint author), Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
EM kchatterjee@materials.iisc.ernet.in
OI Hasan, Jafar/0000-0002-0956-6145; Chatterjee,
   Kaushik/0000-0002-7204-2926
FU Wellcome Trust/DBT India Alliance for the Early Career Fellowship;
   Department of Science and Technology (DST), India; DST
FX Authors thank Mr Sumit Bahl for assistance with mammalian cell studies.
   Authors thank Ms Kriti Gupta and Prof. Sandhya Visweswariah for help
   with the fluorescence imaging of bacterial cells. J.H. acknowledges the
   financial support from the Wellcome Trust/DBT India Alliance for the
   Early Career Fellowship. K.C. acknowledges the Ramanujan fellowship from
   the Department of Science and Technology (DST), India. Financial support
   from DST is acknowledged.
CR Abdolvand R, 2008, SENSOR ACTUAT A-PHYS, V144, P109, DOI 10.1016/j.sna.2007.12.026
   Ayon AA, 1999, J ELECTROCHEM SOC, V146, P339, DOI 10.1149/1.1391611
   Bahl S, 2014, RSC ADV, V4, P38078, DOI 10.1039/c4ra05440g
   Bhushan B, 2011, PROG MATER SCI, V56, P1, DOI 10.1016/j.pmatsci.2010.04.003
   Bridier A, 2011, BIOFOULING, V27, P1017, DOI 10.1080/08927014.2011.626899
   Bucaro MA, 2012, ACS NANO, V6, P6222, DOI 10.1021/nn301654e
   Cavallaro A, 2014, BIOINTERPHASES, V9, DOI 10.1116/1.4866697
   Chatterjee K, 2011, BIOMATERIALS, V32, P1361, DOI 10.1016/j.biomaterials.2010.10.043
   Chu ZL, 2014, CHEM SOC REV, V43, P2784, DOI 10.1039/c3cs60415b
   DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012
   Diu T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07122
   Drelich J, 1996, J COLLOID INTERF SCI, V179, P37, DOI 10.1006/jcis.1996.0186
   Elnathan R, 2014, NANO TODAY, V9, P172, DOI 10.1016/j.nantod.2014.04.001
   Epstein AK, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494007
   Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020
   Gant RM, 2009, J BIOMED MATER RES A, V90A, P695, DOI 10.1002/jbm.a.32135
   Ghanbari A, 2014, SURF COAT TECH, V246, P26, DOI 10.1016/j.surfcoat.2014.02.057
   Hasan J, 2013, APPL MICROBIOL BIOT, V97, P9257, DOI 10.1007/s00253-012-4628-5
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hasan J, 2012, LANGMUIR, V28, P17404, DOI 10.1021/la303560w
   Ivanova EP, 2012, SMALL, V8, P2489, DOI 10.1002/smll.201200528
   Ivanova EP, 2011, APPL MICROBIOL BIOT, V91, P1149, DOI 10.1007/s00253-011-3195-5
   JANSEN H, 1995, J MICROMECH MICROENG, V5, P115, DOI 10.1088/0960-1317/5/2/015
   Jansen H, 1996, PROC IEEE MICR ELECT, P250, DOI 10.1109/MEMSYS.1996.493989
   Ji TJ, 2013, ADV MATER, V25, P3508, DOI 10.1002/adma.201300299
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Kumar S, 2015, ACS APPL MATER INTER, V7, P3237, DOI 10.1021/am5079732
   Li XM, 2007, CHEM SOC REV, V36, P1350, DOI 10.1039/b602486f
   Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098
   Liu KS, 2011, NANO TODAY, V6, P155, DOI 10.1016/j.nantod.2011.02.002
   Liu YF, 2013, IET NANOBIOTECHNOL, V7, P59, DOI 10.1049/iet-nbt.2012.0018
   Madkour AE, 2008, POLYM INT, V57, P6, DOI 10.1002/pi.2399
   Nejadnik MR, 2014, BIOMATERIALS, V35, P6918, DOI 10.1016/j.biomaterials.2014.05.003
   Nishimoto S, 2013, RSC ADV, V3, P671, DOI 10.1039/c2ra21260a
   Oh J, 2012, NAT NANOTECHNOL, V7, P743, DOI [10.1038/nnano.2012.166, 10.1038/NNANO.2012.166]
   Pignalosa P, 2012, OPT LETT, V37, P2808, DOI 10.1364/OL.37.002808
   Qi SJ, 2009, ACS APPL MATER INTER, V1, P30, DOI 10.1021/am800027d
   Shirtcliffe NJ, 2004, ADV MATER, V16, P1929, DOI 10.1002/adma.200400315
   Song Y, 2007, PROC I MECH ENG PART, V221, P41, DOI 10.1243/17403499JNN106
   Song YJ, 2011, ADV MATER, V23, P4215, DOI 10.1002/adma.201101853
   Takenaka S, 2007, APPL ENVIRON MICROB, V73, P1797, DOI 10.1128/AEM.02426-06
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   WAHLIG H, 1980, ACTA ORTHOP SCAND, V51, P49, DOI 10.3109/17453678008990768
   Walter H., 2010, NANOTECHNOLOGY, V21
   Wang ST, 2006, ADV MATER, V18, P767, DOI 10.1002/adma.200501794
   Warnes SL, 2011, APPL ENVIRON MICROB, V77, P6049, DOI 10.1128/AEM.00597-11
   Wisdom KM, 2013, P NATL ACAD SCI USA, V110, P7992, DOI 10.1073/pnas.1210770110
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
   Yan L, 2014, ADV MATER, V26, P5533, DOI 10.1002/adma.201305683
   Yu Q, 2015, ACTA BIOMATER, V16, P1, DOI 10.1016/j.actbio.2015.01.018
NR 52
TC 32
Z9 32
U1 4
U2 61
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 56
BP 44953
EP 44959
DI 10.1039/c5ra05206h
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA CI7SQ
UT WOS:000354965300028
PM 29075481
OA Bronze, Green Accepted
DA 2018-10-20
ER

PT J
AU Huang, CH
   Zhang, WM
   Yan, ZM
   Gao, J
   Liu, W
   Tong, P
   Zhang, L
AF Huang, Chuanhui
   Zhang, Wenmin
   Yan, Zhiming
   Gao, Jia
   Liu, Wei
   Tong, Ping
   Zhang, Lan
TI Protonated mesoporous graphitic carbon nitride for rapid and highly
   efficient removal of microcystins
SO RSC ADVANCES
LA English
DT Article
ID GRAPHENE OXIDE; HYDROGEN EVOLUTION; VISIBLE-LIGHT; LR; ADSORPTION;
   WATER; CYANOBACTERIA; EQUILIBRIUM; NANOSHEETS; NANOTUBES
AB Cyanotoxins have caused worldwide concern due to their diverse occurrence and toxic effects, which has led to an intensive search for cost-effective techniques for their removal from contaminated water. In this study, a novel biomaterial, protonated mesoporous graphitic carbon nitride (mpg-C3N4-H+) which is fabricated by treating mpg-C3N4 with concentrated hydrochloric acid, is applied as a promising bioadsorbent for the uptake of microcystins (MCs). The pH of the reaction media played a significant role in the removal of MCs; maximum adsorption occurred at pH 7. Kinetic studies showed that the adsorption of MC-LR and MC-RR onto the adsorbent was a rapid process. The mpgH(+) exhibited high adsorption capacities of 2360.96 and 2868.78 mu g g(-1) from the Langmuir model for MC-LR/RR, respectively. The high adsorption capacity, good solvent stability, and excellent reusability make mpg-C3N4-H+ promising as a novel adsorbent for the adsorption and removal of MCs from aqueous solution. This information may be useful for further research and practical applications of the novel two-dimensional layered, mesoporous graphitic carbon nitride.
C1 [Huang, Chuanhui; Zhang, Wenmin; Yan, Zhiming; Gao, Jia; Liu, Wei; Tong, Ping; Zhang, Lan] Fuzhou Univ, Coll Chem, Fujian Prov Key Lab Anal & Detect Technol Food Sa, Minist Educ,Key Lab Anal & Detect Food Safety, Fuzhou 350116, Fujian, Peoples R China.
   [Liu, Wei; Tong, Ping; Zhang, Lan] Fuzhou Univ, Testing Ctr, Sport Sci Res Ctr, Fuzhou 350002, Fujian, Peoples R China.
RP Zhang, L (reprint author), Fuzhou Univ, Coll Chem, Fujian Prov Key Lab Anal & Detect Technol Food Sa, Minist Educ,Key Lab Anal & Detect Food Safety, Fuzhou 350116, Fujian, Peoples R China.
EM tping@fzu.edu.cn; zlan@fzu.edu.cn
FU National Nature Sciences Foundation of China [21275029, 201405018];
   National Basic Research Program of China [2010CB732403]; 12th Five-Year
   National Science and Technology Support Program [2012BAD29B06]; Program
   for Changjiang Scholars and Innovative Research Team in University
   [IRT1116]
FX The authors are grateful for the National Nature Sciences Foundation of
   China (21275029 and 201405018), the National Basic Research Program of
   China (No. 2010CB732403), the "12th Five-Year National Science and
   Technology Support Program" (2012BAD29B06), and the Program for
   Changjiang Scholars and Innovative Research Team in University (no.
   IRT1116).
CR Bourne DG, 2006, WATER RES, V40, P1294, DOI 10.1016/j.watres.2006.01.022
   Cheng CM, 2013, ANAL CHEM, V85, P2601, DOI 10.1021/ac303263n
   Crini G, 2007, SEP PURIF TECHNOL, V53, P97, DOI 10.1016/j.seppur.2006.06.018
   De Maagd PGJ, 1999, WATER RES, V33, P677, DOI 10.1016/S0043-1354(98)00258-9
   Falconer IR, 1999, ENVIRON TOXICOL, V14, P5, DOI 10.1002/(SICI)1522-7278(199902)14:1<5::AID-TOX3>3.3.CO;2-S
   Feng LY, 2013, ADV MATER, V25, P168, DOI 10.1002/adma.201203229
   Groenewolt M, 2005, ADV MATER, V17, P1789, DOI 10.1002/adma.200401756
   Jurczak T, 2005, WATER RES, V39, P2394, DOI 10.1016/j.watres.2005.04.031
   Li XF, 2009, APPL PHYS A-MATER, V94, P387, DOI 10.1007/s00339-008-4816-4
   Lin LS, 2014, J MATER CHEM B, V2, P1031, DOI 10.1039/c3tb21479f
   Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907
   Merel S, 2009, CHEMOSPHERE, V74, P832, DOI 10.1016/j.chemosphere.2008.10.024
   Morris RJ, 2000, TOXICON, V38, P303, DOI 10.1016/S0041-0101(99)00149-X
   Pavagadhi S, 2013, WATER RES, V47, P4621, DOI 10.1016/j.watres.2013.04.033
   Ramesh S, 2004, J PHYS CHEM B, V108, P8794, DOI 10.1021/jp036971t
   Sathishkumar M, 2010, J HAZARD MATER, V184, P417, DOI 10.1016/j.jhazmat.2010.08.051
   Shen PP, 2003, ENVIRON INT, V29, P641, DOI 10.1016/S0160-4120(03)00047-3
   Su FZ, 2012, CATAL SCI TECHNOL, V2, P1005, DOI 10.1039/c2cy00012a
   Svrcek C, 2004, J ENVIRON ENG SCI, V3, P155, DOI 10.1139/S04-010
   Takanabe K, 2010, PHYS CHEM CHEM PHYS, V12, P13020, DOI 10.1039/c0cp00611d
   Teng W, 2013, ENERG ENVIRON SCI, V6, P2765, DOI 10.1039/c3ee41775a
   Teng W, 2013, ENVIRON SCI TECHNOL, V47, P8633, DOI 10.1021/es400659b
   Vadivelan V, 2005, J COLLOID INTERF SCI, V286, P90, DOI 10.1016/j.jcis.2005.01.007
   Wang L, 2010, DESALINATION, V254, P68, DOI 10.1016/j.desal.2009.12.012
   Wang X., 2008, NAT MATER, V8, P76
   Wang XC, 2009, ADV MATER, V21, P1609, DOI 10.1002/adma.200802627
   Wang XC, 2009, J AM CHEM SOC, V131, P1680, DOI 10.1021/ja809307s
   Wu XQ, 2011, ENVIRON SCI TECHNOL, V45, P2641, DOI 10.1021/es103729m
   Xia W, 2013, RSC ADV, V3, P11007, DOI 10.1039/c3ra40741a
   Yan H, 2006, CHEMOSPHERE, V62, P142, DOI 10.1016/j.chemosphere.2005.03.075
   Yang SB, 2013, ADV MATER, V25, P2452, DOI 10.1002/adma.201204453
   Zhang XD, 2014, ADV MATER, V26, P4438, DOI 10.1002/adma.201400111
   Zhang Y. J., 2008, J AM CHEM SOC, V131, P50
   Zhang YJ, 2010, CHEM-ASIAN J, V5, P1307, DOI 10.1002/asia.200900685
   Zhao YC, 2005, J MATER SCI, V40, P2645, DOI 10.1007/s10853-005-2096-3
NR 35
TC 6
Z9 6
U1 4
U2 40
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 56
BP 45368
EP 45375
DI 10.1039/c5ra01415h
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CI7SQ
UT WOS:000354965300073
DA 2018-10-20
ER

PT J
AU Shikha, D
   Jha, U
   Sinha, SK
   Nair, KGM
   Tyagi, AK
AF Shikha, Deep
   Jha, Usha
   Sinha, S. K.
   Nair, K. G. M.
   Tyagi, A. K.
TI Nitrogen Ion Beam Modification of Alumina for Hard Tissue Implants
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 3rd International Conference on Science and Engineering (ICSEM)
CY JAN 06-08, 2014
CL Sharda Univ, Noida, INDIA
SP Mat Res Lab
HO Sharda Univ
DE alumina; biomaterial; ion dose; ion implantation; nitrogen
ID FILMS
AB Alumina has wide applications in industry, automobiles, electrical appliances etc. However its application as biomaterial has started recently. We propose to improve the bio- physical, bio- chemical and bio-medical properties of alumina for its application as biomaterial by nitrogen ion implantation. Alumina is implanted with nitrogen ions at different energies (30 keV to 90 keV) and various ion doses (1 x 10(15) ions/cm(2) to 5 x 10(17) ions/cm(2)). The microstructural changes and surface roughness of the specimens are characterized using Optical Microscope, Scanning Electron Microscope (SEM) and Atomic Force Microscope (AFM). Nanolayered compound formation of nitrides & oxynitrides were observed using Glancing angle X- ray Diffraction (GXRD). Mechanical changes like hardness are studied using nanoindentation method. It is observed that corrosion resistance studied using Electrochemical analyzer (ECA) increases at lower energy and at intermediate ion dose. At higher energy and higher ion doses corrosion resistance deteriorates which is in co-ordinance with the micrstructural analysis. Bio-medical characterization of the specimens has been carried out by Wettability and Thrombogenicity tests. Wettability decreases in comparison with unimplanted samples. The thrombogenicity of unimplanted and implanted samples were evaluated using a whole blood kinetic clotting time method. From thrombogenicity test, it is concluded that at lower energy, thrombogenicity increases whereas for higher energy thrombogenicity decreases in comparison with the unimplanted samples. On the basis of all the above studies, best suitable energy and ion-dose is decided for the hard tissue replacement by alumina.
C1 [Shikha, Deep; Jha, Usha] BIT Mesra, Dept Appl Chem, Ranchi 835215, Jharkhand, India.
   [Sinha, S. K.] BIT Mesra, Dept Appl Phys, Ranchi 835215, Jharkhand, India.
   [Nair, K. G. M.; Tyagi, A. K.] Indira Gandhi Ctr Atom Res, Kalpakkam 603102, Tamil Nadu, India.
RP Shikha, D (reprint author), BIT Mesra, Dept Appl Chem, Ranchi 835215, Jharkhand, India.
EM deepshikha1011@gmail.com
CR Azevedo AF, 2005, SURF COAT TECH, V194, P271, DOI 10.1016/j.surfcoat.2004.10.007
   BIERSACK JP, 1980, NUCL INSTRUM METHODS, V174, P257, DOI 10.1016/0029-554X(80)90440-1
   Delgado-Alvarado P. A. Sundaram, 2006, ACTA BIOMATER, V2, P701
   Halitim F, 1997, J PHYS D APPL PHYS, V30, P330, DOI 10.1088/0022-3727/30/3/004
   HEIMKE G, 1989, ANGEW CHEM INT EDIT, V28, P111, DOI 10.1002/anie.198901111
   Heimke G., 1986, HDB BIOMATERIAL EVOL
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Hulbert S. F., 1993, INTRO BIOCERAMICS
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   Jagielski J, 2006, SURF COAT TECH, V200, P6355, DOI 10.1016/j.surfcoat.2005.11.005
   Liu ZS, 2006, MATER CHEM PHYS, V99, P75, DOI 10.1016/j.matchemphys.2005.09.088
   Motlagh D., 2006, BIOMATERIALS
   Shikha D, 2008, INT J APPL CERAM TEC, V5, P44, DOI 10.1111/j.1744-7402.2008.02184.x
   Shikha D, 2007, NUCL INSTRUM METH B, V264, P254, DOI 10.1016/j.nimb.2007.08.093
   Sinha SK, 2002, SURF COAT TECH, V158, P214, DOI 10.1016/S0257-8972(02)00210-4
   Vlcak P, 2013, J NANOMATER, DOI 10.1155/2013/475758
   Wang MC, 2001, J MATER SCI, V36, P3283, DOI 10.1023/A:1017907024197
   Zeigler J. F., 2003, SRIM COM
NR 19
TC 0
Z9 1
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JAN
PY 2015
VL 347
IS 1
SI SI
BP 39
EP 48
DI 10.1002/masy.201400037
PG 10
WC Polymer Science
SC Polymer Science
GA AZ9WM
UT WOS:000348564800006
DA 2018-10-20
ER

PT J
AU Lewis, KJR
   Tibbitt, MW
   Zhao, Y
   Branchfield, K
   Sun, X
   Balasubramaniam, V
   Anseth, KS
AF Lewis, Katherine J. R.
   Tibbitt, Mark W.
   Zhao, Yi
   Branchfield, Kelsey
   Sun, Xin
   Balasubramaniam, Vivek
   Anseth, Kristi S.
TI In vitro model alveoli from photodegradable microsphere templates
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID EPITHELIAL-CELLS; EXTRACELLULAR-MATRIX; 3-DIMENSIONAL CULTURE; II CELLS;
   MECHANICAL-PROPERTIES; SYNTHETIC MATRIX; LUNG DEVELOPMENT;
   GENE-EXPRESSION; STEM-CELLS; TISSUE
AB Recreating the 3D cyst-like architecture of the alveolar epithelium in vitro has been challenging to achieve in a controlled fashion with primary lung epithelial cells. Here, we demonstrate model alveoli formed within a tunable synthetic biomaterial platform using photodegradable microspheres as templates to create physiologically relevant, cyst structures. Poly(ethylene glycol) (PEG)-based hydrogels were polymerized in suspension to form microspheres on the order of 120 mu m in diameter. The gel chemistry was designed to allow erosion of the microspheres with cytocompatible light doses (<= 15 min exposure to 10 mW cm(-2) of 365 nm light) via cleavage of a photolabile nitrobenzyl ether crosslinker. Epithelial cells were incubated with intact microspheres, modified with adhesive peptide sequences to facilitate cellular attachment to and proliferation on the surface. A tumor-derived alveolar epithelial cell line, A549, completely covered the microspheres after only 24 hours, whereas primary mouse alveolar epithelial type II (ATII) cells took similar to 3 days. The cell-laden microsphere structures were embedded within a second hydrogel formulation at user defined densities; the microsphere templates were subsequently removed with light to render hollow epithelial cysts that were cultured for an additional 6 days. The resulting primary cysts stained positive for cell-cell junction proteins (beta-catenin and ZO-1), indicating the formation of a functional epithelial layer. Typically, primary ATII cells differentiated in culture to the alveolar epithelial type I (ATI) phenotype; however, each cyst contained similar to 1-5 cells that stained positive for an ATII marker (surfactant protein C), which is consistent with ATII cell numbers in native mouse alveoli. This biomaterial-templated alveoli culture system should be useful for future experiments to study lung development and disease progression, and is ideally suited for co-culture experiments where pulmonary fibroblasts or endothelial cells could be presented in the hydrogel surrounding the epithelial cysts.
C1 [Lewis, Katherine J. R.; Tibbitt, Mark W.; Zhao, Yi; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, BioFrontiers Inst, Boulder, CO 80303 USA.
   [Lewis, Katherine J. R.; Tibbitt, Mark W.; Zhao, Yi; Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA.
   [Branchfield, Kelsey; Sun, Xin] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.
   [Balasubramaniam, Vivek] Univ Colorado, Pediat Heart Lung Ctr Lab, Denver, CO 80202 USA.
RP Lewis, KJR (reprint author), Univ Colorado, Dept Chem & Biol Engn, BioFrontiers Inst, 3415 Colorado Ave,596 UCB, Boulder, CO 80303 USA.
EM kristi.anseth@colorado.edu
OI Tibbitt, Mark/0000-0002-4917-7187
FU National Science Foundation [CTS1236662]; Howard Hughes Medical
   Institute
FX The authors would like to thank Emi Kiyotake for histological
   sectioning, particle tracking, and image analysis and Sharon Ryan for
   mouse cell isolations. This work was supported in part by a grant from
   the National Science Foundation (CTS1236662) and the Howard Hughes
   Medical Institute.
CR Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782
   Bellusci S, 1997, DEVELOPMENT, V124, P4867
   Benton JA, 2009, BIOMATERIALS, V30, P6593, DOI 10.1016/j.biomaterials.2009.08.031
   Bhaskaran M, 2007, J BIOL CHEM, V282, P3968, DOI 10.1074/jbc.M609060200
   Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013
   Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016
   Burri PH, 2006, BIOL NEONATE, V89, P313, DOI 10.1159/000092868
   Carterson AJ, 2005, INFECT IMMUN, V73, P1129, DOI 10.1128/IAI.73.2.1129-1140.2005
   Cavalcante FSA, 2005, J APPL PHYSIOL, V98, P672, DOI 10.1152/japplphysiol.00619.2004
   Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009
   Ernst D, 2013, PHYS CHEM CHEM PHYS, V15, P845, DOI 10.1039/c2cp43433d
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172
   Gill BJ, 2012, CANCER RES, V72, P6013, DOI 10.1158/0008-5472.CAN-12-0895
   Gould ST, 2012, ACTA BIOMATER, V8, P3201, DOI 10.1016/j.actbio.2012.05.009
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Guillot L, 2013, INT J BIOCHEM CELL B, V45, P2568, DOI 10.1016/j.biocel.2013.08.009
   Herzog Erica L, 2008, Proc Am Thorac Soc, V5, P778, DOI 10.1513/pats.200803-028HR
   Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012
   Isakson BE, 2001, AM J PHYSIOL-CELL PH, V281, pC1291
   Isakson BE, 2002, IN VITRO CELL DEV-AN, V38, P443, DOI 10.1290/1071-2690(2002)038<0443:HCOPAE>2.0.CO;2
   Kitaoka H, 2007, J PHYSIOL SCI, V57, P175, DOI 10.2170/physiolsci.RP000807
   Kloxin AM, 2012, INTEGR BIOL-UK, V4, P1540, DOI 10.1039/c2ib20212c
   Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kyburz KA, 2013, ACTA BIOMATER, V9, P6381, DOI 10.1016/j.actbio.2013.01.026
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Lewis KJR, 2013, MRS BULL, V38, P260, DOI 10.1557/mrs.2013.54
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076
   Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x
   MATTER ML, 1994, J CELL BIOL, V124, P1083, DOI 10.1083/jcb.124.6.1083
   McKinnon DD, 2013, BIOMATER SCI-UK, V1, P460, DOI 10.1039/c3bm00166k
   Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914
   Mondrinos MJ, 2006, TISSUE ENG, V12, P717, DOI 10.1089/ten.2006.12.717
   Montesano R, 2002, J CELL SCI, V115, P4419, DOI 10.1242/jcs.00164
   O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859
   Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-11070C
   Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Perl AKT, 2009, AM J PHYSIOL-LUNG C, V297, pL299, DOI 10.1152/ajplung.00008.2009
   Prasad S, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-7
   Qiao R, 2008, AM J RESP CELL MOL, V38, P239, DOI 10.1165/rcmb.2007-0172OC
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Schumacher KM, 2008, KIDNEY INT, V73, P1187, DOI 10.1038/ki.2008.20
   Sharp JA, 2006, MATRIX BIOL, V25, P430, DOI 10.1016/j.matbio.2006.05.003
   Shenoy R, 2013, CHEM MATER, V25, P761, DOI 10.1021/cm303913f
   Soutiere SE, 2004, RESP PHYSIOL NEUROBI, V140, P283, DOI 10.1016/j.resp.2004.02.003
   Sugahara K, 2006, RESPIROLOGY, V11, pS28, DOI 10.1111/j.1440-1843.2006.00804.x
   SUGIHARA H, 1993, AM J PATHOL, V142, P783
   Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831
   Tibbitt MW, 2013, MACROMOLECULES, V46, P2785, DOI 10.1021/ma302522x
   Tibbitt MW, 2012, J BIOMED MATER RES A, V100A, P1647, DOI 10.1002/jbm.a.34107
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Uhal BD, 1997, AM J PHYSIOL-LUNG C, V272, pL1031
   Umino T, 2000, AM J RESP CELL MOL, V22, P702, DOI 10.1165/ajrcmb.22.6.3806
   Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC
   Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446
   Yano T, 2000, AM J PHYSIOL-LUNG C, V279, pL1146
   Yu W, 2007, MOL BIOL CELL, V18, P1693, DOI 10.1091/mbc.E06-11-1052
NR 61
TC 12
Z9 12
U1 4
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 6
BP 821
EP 832
DI 10.1039/c5bm00034c
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CI5IX
UT WOS:000354790100005
PM 26221842
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lee, Y
   Bae, JW
   Thi, TTH
   Park, KM
   Park, KD
AF Lee, Yunki
   Bae, Jin Woo
   Thi, Thai Thanh Hoang
   Park, Kyung Min
   Park, Ki Dong
TI Injectable and mechanically robust 4-arm PPO-PEO/graphene oxide
   composite hydrogels for biomedical applications
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID CROSS-LINKABLE GELATIN; GRAPHENE OXIDE; THERMOSENSITIVE HYDROGELS;
   POLY(VINYL ALCOHOL); POLYMER COMPOSITES; HYBRID HYDROGELS; TOUGH
   HYDROGELS; DRUG-DELIVERY; OXIDATION; BIOCOMPATIBILITY
AB Graphene-based nanomaterials with different oxidation degrees were incorporated into Tetronic-tyramine (Tet-TA) hydrogels via enzymatic cross-linking. The molecular oxidation of graphene in combination with amphiphilic Tet-TA significantly improved the water dispersibility of graphene oxide (GO), resulting in a significant reinforcement of Tet-TA/GO composite hydrogels that can be used as an injectable biomaterial platform.
C1 [Lee, Yunki; Bae, Jin Woo; Thi, Thai Thanh Hoang; Park, Ki Dong] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.
   [Park, Kyung Min] Incheon Natl Univ, Div Bioengn, Inchon 406772, South Korea.
RP Park, KD (reprint author), Ajou Univ, Dept Mol Sci & Technol, San 5, Suwon 443749, South Korea.
EM kdp@ajou.ac.kr
FU National Research Foundation of Korea (NRF) grant - Ministry of Science,
   ICT & Future Planning [NRF-2012R1A2A2A06046885]; Ministry of Education
   [NRF-2009-0093826]
FX This work was supported by Basic Science Research Program through the
   National Research Foundation of Korea (NRF) grant funded by the Ministry
   of Science, ICT & Future Planning (NRF-2012R1A2A2A06046885), and the
   Ministry of Education (NRF-2009-0093826).
CR Bae JW, 2015, J TISSUE ENG REGEN M, V9, P1225, DOI 10.1002/term.1917
   Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557
   Cha CY, 2014, SMALL, V10, P514, DOI 10.1002/smll.201302182
   Chen J, 2012, ADV MATER, V24, P4569, DOI 10.1002/adma.201201978
   Chiu CF, 2013, J AM CHEM SOC, V135, P13356, DOI 10.1021/ja400699y
   Choi I, 2013, LANGMUIR, V29, P9761, DOI 10.1021/la401597p
   Darnell MC, 2013, BIOMATERIALS, V34, P8042, DOI 10.1016/j.biomaterials.2013.06.061
   Fan HL, 2010, BIOMACROMOLECULES, V11, P2345, DOI 10.1021/bm100470q
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Hu KS, 2014, PROG POLYM SCI, V39, P1934, DOI 10.1016/j.progpolymsci.2014.03.001
   Jun I, 2012, ADV FUNCT MATER, V22, P4060, DOI 10.1002/adfm.201200667
   Kim DW, 2013, BIOMATERIALS, V34, P8258, DOI 10.1016/j.biomaterials.2013.07.071
   Kim J, 2010, J AM CHEM SOC, V132, P8180, DOI 10.1021/ja102777p
   Krishnamoorthy K, 2013, CARBON, V53, P38, DOI 10.1016/j.carbon.2012.10.013
   Kuilla T, 2010, PROG POLYM SCI, V35, P1350, DOI 10.1016/j.progpolymsci.2010.07.005
   Kurisawa M, 2005, CHEM COMMUN, P4312, DOI 10.1039/b506989k
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee SH, 2014, ADV FUNCT MATER, V24, P6771, DOI 10.1002/adfm.201401110
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Liang JJ, 2009, ADV FUNCT MATER, V19, P2297, DOI 10.1002/adfm.200801776
   Liu RQ, 2012, J MATER CHEM, V22, P14160, DOI [10.1039/c2jm32541, 10.1039/c2jm32541a]
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Park KM, 2011, SOFT MATTER, V7, P986, DOI 10.1039/c0sm00612b
   Park KM, 2012, BIOMACROMOLECULES, V13, P604, DOI 10.1021/bm201712z
   Qiu Y, 2014, NANOSCALE, V6, P11744, DOI 10.1039/c4nr03275f
   Rourke JP, 2011, ANGEW CHEM INT EDIT, V50, P3173, DOI 10.1002/anie.201007520
   Sahu A, 2012, CHEM COMMUN, V48, P5820, DOI 10.1039/c2cc31862h
   Seabra AB, 2014, CHEM RES TOXICOL, V27, P159, DOI 10.1021/tx400385x
   Sengupta R, 2011, PROG POLYM SCI, V36, P638, DOI 10.1016/j.progpolymsci.2010.11.003
   Seo JWT, 2011, J PHYS CHEM LETT, V2, P1004, DOI 10.1021/jz2003556
   Shin SR, 2013, ADV MATER, V25, P6385, DOI 10.1002/adma.201301082
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Zhang L, 2011, J MATER CHEM, V21, P10399, DOI 10.1039/c0jm04043f
   Zhao X, 2010, MACROMOLECULES, V43, P2357, DOI 10.1021/ma902862u
   Zhao XH, 2014, SOFT MATTER, V10, P672, DOI 10.1039/c3sm52272e
NR 35
TC 12
Z9 12
U1 2
U2 58
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2015
VL 51
IS 42
BP 8876
EP 8879
DI 10.1039/c5cc02511g
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA CI1CG
UT WOS:000354477600036
PM 25925723
DA 2018-10-20
ER

PT S
AU Yada, SH
   Terakaw, M
AF Yada, Shuhei
   Terakaw, Mitsuhiro
BE Heisterkamp, A
   Herman, PR
   Meunier, M
   Nolte, S
TI Optical and thermal properties in ultrafast laser surface
   nanostructuring on biodegradable polymer
SO FRONTIERS IN ULTRAFAST OPTICS: BIOMEDICAL, SCIENTIFIC, AND INDUSTRIAL
   APPLICATIONS XV
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Frontiers in Ultrafast Optics - Biomedical, Scientific,
   and Industrial Applications XV
CY FEB 08-10, 2015
CL San Francisco, CA
SP SPIE, Amplitude Syst, APE GmbH, TRUMPF Inc
DE Biodegradable; PLLA; LIPSS; Femtosecond Laser
ID FEMTOSECOND LASER; TOPOGRAPHICAL CONTROL; FILM; FABRICATION; MICRO
AB We investigate the effect of optical and thermal properties in laser-induced periodic surface structures (LIPSS) formation on a poly-L-lactic acid (PLLA), a biodegradable polymer. Surface properties of biomaterials are known to be one of the key factors in tissue engineering. Methods to process biomaterial surfaces have been studied widely to enhance cell adhesive and anisotropic properties. LIPSS formation has advantages in a dry processing which is able to process complex-shaped surfaces without using a toxic chemical component. LIPSS, however, was difficult to be formed on PLLA due to its thermal and optical properties compared to other polymers. To obtain new perspectives in effect of these properties above, LIPSS formation dependences on wavelength, pulse duration and repetition rate have been studied. At 800 nm of incident wavelength, high-spatial frequency LIPSS (HSFL) was formed after applying 10000 femtosecond pulses at 1.0 J/cm(2) in laser fluence. At 400 nm of the wavelength, HSFL was formed at fluences higher than 0.20 J/cm(2) with more than 3000 pulses. Since LIPSS was less formed with lower repetition rate, certain heat accumulation may be required for LIPSS formation. With the pulse duration of 2.0 ps, higher laser fluence as well as number of pulses compared to the case of 120 fs was necessary. This indicates that multiphoton absorption process is essential for LIPSS formation. Study on biodegradation modification was also performed.
C1 [Yada, Shuhei; Terakaw, Mitsuhiro] Keio Univ, Sch Integrated Design Engn, Yokohama, Kanagawa 2238522, Japan.
   [Terakaw, Mitsuhiro] Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan.
RP Yada, SH (reprint author), Keio Univ, Sch Integrated Design Engn, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.
CR Aguilar CA, 2005, BIOMATERIALS, V26, P7642, DOI 10.1016/j.biomaterials.2005.04.053
   Altomare L, 2010, ACTA BIOMATER, V6, P1948, DOI 10.1016/j.actbio.2009.12.040
   Baudach S, 1999, APPL PHYS A-MATER, V69, pS395, DOI 10.1007/s003390051424
   Beamson G, 1996, POLYMER, V37, P379, DOI 10.1016/0032-3861(96)82906-5
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   BOLLE M, 1993, APPL SURF SCI, V69, P31, DOI 10.1016/0169-4332(93)90478-T
   Bonse J, 2012, J LASER APPL, V24, DOI 10.2351/1.4712658
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Eaton SM, 2005, OPT EXPRESS, V13, P4708, DOI 10.1364/OPEX.13.004708
   Forster M, 2011, PHYS CHEM CHEM PHYS, V13, P4155, DOI 10.1039/c0cp01798a
   Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002
   Kaneko Y., 2011, P IEEE, P1918
   Kuetemeyer K, 2009, APPL PHYS B-LASERS O, V97, P695, DOI 10.1007/s00340-009-3746-y
   Lizundia E, 2012, POLYMER, V53, P2412, DOI 10.1016/j.polymer.2012.03.046
   Lu Y, 2004, ADV DRUG DELIVER REV, V56, P1621, DOI 10.1016/j.addr.2004.05.002
   NIKOGOSYAN DN, 1983, CHEM PHYS, V77, P131, DOI 10.1016/0301-0104(83)85070-8
   Oya K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.125203
   Perez S., 2012, APPL PHYS A, V110, P683
   Rebollar E, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3679103
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shinonaga T, 2014, APPL SURF SCI, V288, P649, DOI 10.1016/j.apsusc.2013.10.090
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
NR 24
TC 0
Z9 0
U1 1
U2 10
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-1-62841-445-5
J9 PROC SPIE
PY 2015
VL 9355
AR UNSP 935503
DI 10.1117/12.2080483
PG 7
WC Engineering, Biomedical; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BC6OP
UT WOS:000354259800002
DA 2018-10-20
ER

PT S
AU Widodo
AF Widodo
BE Sandhu, A
   Okada, H
   Boutchich, M
   Maenosono, S
   Wadhwa, R
TI Bioinformatics: Cheap and Robust Method to Explore Biomaterial from
   Indonesia Biodiversity
SO IRAGO CONFERENCE 2014
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT Irago Conference
CY NOV 06-07, 2014
CL Natl Inst Adv Ind Sci & Technol, Tsukuba, JAPAN
SP Tahara Low Carbon Greenhouse Hort Convent, Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst
HO Natl Inst Adv Ind Sci & Technol
DE bioinformatics; Virtual screening; Protein-protein interaction; pathway
   analysis; biomaterial
AB Indonesia has a huge amount of biodiversity, which may contain many biomaterials for pharmaceutical application. These resources potency should be explored to discover new drugs for human wealth. However, the bioactive screening using conventional methods is very expensive and time-consuming. Therefore, we developed a methodology for screening the potential of natural resources based on bioinformatics. The method is developed based on the fact that organisms in the same taxon will have similar genes, metabolism and secondary metabolites product. Then we employ bioinformatics to explore the potency of biomaterial from Indonesia biodiversity by comparing species with the well-known taxon containing the active compound through published paper or chemical database. Then we analyze drug-likeness, bioactivity and the target proteins of the active compound based on their molecular structure. The target protein was examined their interaction with other proteins in the cell to determine action mechanism of the active compounds in the cellular level, as well as to predict its side effects and toxicity. By using this method, we succeeded to screen anti-cancer, immunomodulators and anti-inflammation from Indonesia biodiversity. For example, we found anticancer from marine invertebrate by employing the method. The anti-cancer was explore based on the isolated compounds of marine invertebrate from published article and database, and then identified the protein target, followed by molecular pathway analysis. The data suggested that the active compound of the invertebrate able to kill cancer cell. Further, we collect and extract the active compound from the invertebrate, and then examined the activity on cancer cell (MCF7). The MTT result showed that the methanol extract of marine invertebrate was highly potent in killing MCF7 cells. Therefore, we concluded that bioinformatics is cheap and robust way to explore bioactive from Indonesia biodiversity for source of drug and another pharmaceutical material.
C1 Univ Brawijaya, Fac Math & Nat Sci, Dept Biol, Malang, Indonesia.
RP Widodo (reprint author), Univ Brawijaya, Fac Math & Nat Sci, Dept Biol, Malang, Indonesia.
EM widodo@ub.ac.id
CR Engel S, 2006, ENVIRON RESOUR ECON, V33, P73, DOI 10.1007/s10640-005-1706-5
   Franceschini A. L., 2013, NUCL ACIDS RES, V41
   Henley D, 2008, HUM ECOL, V36, P273, DOI 10.1007/s10745-007-9137-2
   Jensen L. J., 2009, NUCL ACIDS RES, V37
   Liu XP, 2013, BIOINFORMATICS, V29, P1910, DOI 10.1093/bioinformatics/btt303
   Mi H, 2007, NUCL ACIDS RES, V35
   Szklarczyk D, 2011, NUCL ACIDS RES, V39
   von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034
NR 8
TC 0
Z9 0
U1 0
U2 2
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1291-0
J9 AIP CONF PROC
PY 2015
VL 1649
BP 148
EP 151
DI 10.1063/1.4913560
PG 4
WC Physics, Applied
SC Physics
GA BC7HN
UT WOS:000354882800025
DA 2018-10-20
ER

PT J
AU Kim, YS
   Youe, WJ
   Kim, SJ
   Lee, OK
   Lee, SS
AF Kim, Yong Sik
   Youe, Won-Jae
   Kim, Seok Ju
   Lee, Oh-Kyu
   Lee, Sung-Suk
TI Preparation of a Thermoplastic Lignin-Based Biomaterial through Atom
   Transfer Radical Polymerization
SO JOURNAL OF WOOD CHEMISTRY AND TECHNOLOGY
LA English
DT Article
DE Lignin modification; ATRP; biomaterials; polystyrene; thermoplastic
   copolymers
ID GRAFT-COPOLYMERIZATION; N-ISOPROPYLACRYLAMIDE; METHYL-METHACRYLATE;
   CHEMICALS; CELLULOSE
AB Graft copolymerization of styrene onto kraft lignin (KL) was achieved by atom transfer radical polymerization (ATRP) using a fully substituted lignin-based macroinitiator (KLM). The number average of molecular mass (M-n) of polystyrene copolymer graft side-chains was achieved by varying the ratio of the DMF: water solvent system from 5:0 to 1:4. A M-n of up to approximate to 206,000 was obtained using a DMF/water ratio of 3:2 (v/v). However, as the M-n increased, the overall ATRP became less controlled. In addition, the thermal properties of the lignin-g-polystyrene copolymers improved significantly with increasing M-n of polystyrene copolymer side-chains.
C1 [Kim, Yong Sik; Youe, Won-Jae; Kim, Seok Ju; Lee, Oh-Kyu; Lee, Sung-Suk] Korea Forest Res Inst, Div Wood Chem & Microbiol, Seoul 130712, South Korea.
RP Kim, YS (reprint author), Korea Forest Res Inst, Div Wood Chem & Microbiol, 57 Hoegiro, Seoul 130712, South Korea.
EM yskim@forest.go.kr
FU Korea Forest Research Institute
FX The authors thank the Korea Forest Research Institute for financial
   support.
CR Alder E., 1977, WOOD SCI TECHNOL, V11, P169, DOI DOI 10.1007/BF00365615
   Bokias G, 2001, MACROMOLECULES, V34, P4958, DOI 10.1021/ma010154e
   Capanema EA, 2004, J AGR FOOD CHEM, V52, P1850, DOI 10.1021/jf035282b
   CHEN RL, 1986, J APPL POLYM SCI, V32, P4815, DOI 10.1002/app.1986.070320504
   Coessens V, 2001, PROG POLYM SCI, V26, P337, DOI 10.1016/S0079-6700(01)00003-X
   COOK PM, 1989, ACS SYM SER, V397, P324
   de Wild P, 2009, ENVIRON PROG SUSTAIN, V28, P461, DOI 10.1002/ep.10391
   Demirbas A, 2009, ENERG CONVERS MANAGE, V50, P2782, DOI 10.1016/j.enconman.2009.06.035
   FREUDENBERG K, 1965, SCIENCE, V148, P595, DOI 10.1126/science.148.3670.595
   Gao GZ, 2012, BIOMACROMOLECULES, V13, P3602, DOI 10.1021/bm301039f
   GLASSER WG, 1989, ACS SYM SER, V385, P43, DOI 10.1021/bk-1989-0385.ch004
   Gupta KC, 2003, BIOMACROMOLECULES, V4, P758, DOI 10.1021/bm020135s
   HUANG YF, 1992, J APPL POLYM SCI, V45, P71, DOI 10.1002/app.1992.070450108
   Ifuku S, 2008, BIOMACROMOLECULES, V9, P3308, DOI 10.1021/bm800911w
   Kennedy J. F., 1992, LIGNOCELLULOSIC SCI, P613
   Kim YS, 2010, BIOMACROMOLECULES, V11, P981, DOI 10.1021/bm901455p
   Lapierre C, 2000, J AGR FOOD CHEM, V48, P2326, DOI 10.1021/jf991398p
   Mai C, 2000, ENZYME MICROB TECH, V27, P167, DOI 10.1016/S0141-0229(00)00214-3
   Masci G, 2004, MACROMOL RAPID COMM, V25, P559, DOI 10.1002/marc.200300140
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   MEISTER JJ, 1984, J APPL POLYM SCI, V29, P3457, DOI 10.1002/app.1984.070291122
   Prade RA, 1996, BIOTECHNOL GENET ENG, V13, P101, DOI 10.1080/02648725.1996.10647925
   Qin DQ, 2000, POLYMER, V41, P7347, DOI 10.1016/S0032-3861(00)00105-1
   Sarkanen K. V., 1971, LIGNINS OCCURRENCE F, P11
   Shen D, 2006, CELLULOSE, V13, P235, DOI 10.1007/s10570-005-9044-x
   Shen DW, 2004, POLYMER, V45, P7091, DOI 10.1016/j.polymer.2004.08.042
   Tsarevsky NV, 2002, MACROMOLECULES, V35, P6142, DOI 10.1021/ma020560d
   Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u
NR 28
TC 12
Z9 12
U1 4
U2 24
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0277-3813
EI 1532-2319
J9 J WOOD CHEM TECHNOL
JI J. Wood Chem. Technol.
PY 2015
VL 35
IS 4
BP 251
EP 259
DI 10.1080/02773813.2014.937006
PG 9
WC Materials Science, Paper & Wood
SC Materials Science
GA CI7HB
UT WOS:000354932700002
DA 2018-10-20
ER

PT J
AU Pieroni, L
   Mortera, SL
   Greco, V
   Sirolli, V
   Ronci, M
   Felaco, P
   Fucci, G
   De Fulviis, S
   Massoud, R
   Condo, S
   Capria, A
   Di Daniele, N
   Bernardini, S
   Urbani, A
   Bonomini, M
AF Pieroni, Luisa
   Mortera, Stefano Levi
   Greco, Viviana
   Sirolli, Vittorio
   Ronci, Maurizio
   Felaco, Paolo
   Fucci, Giorgio
   De Fulviis, Silvia
   Massoud, Renato
   Condo, Stefano
   Capria, Ambrogio
   Di Daniele, Nicola
   Bernardini, Sergio
   Urbani, Andrea
   Bonomini, Mario
TI Biocompatibility assessment of haemodialysis membrane materials by
   proteomic investigations
SO MOLECULAR BIOSYSTEMS
LA English
DT Article
ID PROTEIN ADSORPTION; COMPLEMENT ACTIVATION; PLASMA-PROTEINS;
   ANTICOAGULATION; COAGULATION; HOMEOSTASIS; RELEVANCE; THERAPY; DISEASE;
   SYSTEM
AB The exposure of blood to an artificial surface such as the haemodialysis membrane results in the nearly instantaneous deposition of a layer of plasma proteins. The composition of the protein layer profoundly influences all subsequent events, and to a large extent determines the biocompatibility of the biomaterial. In the present study, we examine the protein adsorption capacity and coagulation profiles of the polysulfone-based helixone material in comparison to cellulose triacetate. A differential profiling investigation using shotgun proteomics data-independent analysis was applied to eluates obtained with each membrane after a dialysis session, in order to assess the function of desorbed proteins. Functional classification and network analysis performed using bioinformatics tools shed light on the involvement of adsorbed proteins into important molecular processes, such as lipid transport and metabolism, cell growth differentiation and communication, and the coagulation cascade. The collected evidence was further validated by targeted mass spectrometry using selected reaction monitoring on proteotypic transitions of key protein effectors, confirming the different panels of adsorbed protein on each membrane. The coagulation profile during haemodialysis of patients under polysulfone-based helixone filter cartridges was also assessed showing a slightly higher platelet activation profile after the dialysis session. The overall collected evidence highlights a modulation of the coagulation biological pathway during haemodialysis, which is largely influenced by the biomaterial used.
C1 [Pieroni, Luisa; Mortera, Stefano Levi; Greco, Viviana; Fucci, Giorgio; Massoud, Renato; Bernardini, Sergio; Urbani, Andrea] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy.
   [Pieroni, Luisa; Mortera, Stefano Levi; Greco, Viviana; Ronci, Maurizio; Urbani, Andrea] IRCCS, Santa Lucia Fdn, Rome, Italy.
   [Sirolli, Vittorio; Felaco, Paolo; De Fulviis, Silvia; Bonomini, Mario] Univ G DAnnunzio, Dept Med, Nephrol & Dialysis Inst, Pescara, Italy.
   [Ronci, Maurizio] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
   [Ronci, Maurizio] Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
   [Condo, Stefano; Capria, Ambrogio; Di Daniele, Nicola] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy.
RP Pieroni, L (reprint author), Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy.
OI Levi Mortera, Stefano/0000-0001-6184-0933; Ronci,
   Maurizio/0000-0002-0797-6087; Pieroni, Luisa/0000-0001-7141-1817
FU Nipro Corporation, Japan
FX The study was partially supported by unconditional grants from Nipro
   Corporation, Japan.
CR Alberio T, 2014, MOL BIOSYST, V10, P1332, DOI 10.1039/c3mb70611g
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1984, PURE APPL CHEM, V56, P1345, DOI 10.1351/pac198456101345
   Aoike I, 2007, NEPHROL DIAL TRANSPL, V22, P13, DOI 10.1093/ndt/gfm295
   Bomzin G. A., 1982, J COLLOID INTERF SCI, V86, P539
   Bonomini M, 2006, J PROTEOME RES, V5, P2666, DOI 10.1021/pr060150u
   Bonomini M, 2012, J NEPHROL, V25, P865, DOI 10.5301/jn.5000217
   Chanard J, 2003, NEPHROL DIAL TRANSPL, V18, P252, DOI 10.1093/ndt/18.2.252
   Ciavardelli D, 2013, MOL BIOSYST, V9, P1117, DOI 10.1039/c3mb25594h
   Domon B, 2012, PROTEOM CLIN APPL, V6, P609, DOI 10.1002/prca.201200111
   Frank RD, 2001, KIDNEY INT, V60, P1972, DOI 10.1046/j.1523-1755.2001.00009.x
   Holman SW, 2012, BIOANALYSIS, V4, P1763, DOI 10.4155/BIO.12.126
   Horl W. H., 2002, J AM SOC NEPHROL S2, V13, P562
   Horl WH, 2002, J AM SOC NEPHROL, V13, pS62
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   JONSSON U, 1982, J COLLOID INTERF SCI, V90, P148, DOI 10.1016/0021-9797(82)90408-8
   Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549
   Kuragano T, 2003, BLOOD PURIFICAT, V21, P176, DOI 10.1159/000069157
   Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1272, DOI 10.1093/ndt/gfg074
   Lucchi L, 2006, ARTIF ORGANS, V30, P106, DOI 10.1111/j.1525-1594.2006.00188.x
   Maiolica A, 2012, J PROTEOMICS, V75, P3495, DOI 10.1016/j.jprot.2012.04.048
   Mares J, 2009, KIDNEY INT, V76, P404, DOI 10.1038/ki.2009.138
   Marinelli S, 2014, PAIN, V155, P93, DOI 10.1016/j.pain.2013.09.013
   Marzano V, 2012, J PROTEOMICS, V75, P4632, DOI 10.1016/j.jprot.2012.05.029
   Mason R. G., 1983, THROMBOEMBOLIC DISOR, P533
   Mi H, 2012, NUCLEIC ACIDS RES, V41, P377, DOI DOI 10.1093/NAR/GKS1118
   Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092
   Mulvihill J, 1997, NEPHROL DIAL TRANSPL, V12, P1968, DOI 10.1093/ndt/12.9.1968
   Olafiranye F, 2011, CASE REP MED, V2011
   Ouseph R, 2000, SEMIN DIALYSIS, V13, P181, DOI 10.1046/j.1525-139X.2000.00052.x
   Pavone B, 2010, BLOOD TRANSFUS-ITALY, V8, pS113, DOI 10.2450/2010.018S
   Pesic I, 2013, BBA-PROTEINS PROTEOM, V1834, P754, DOI 10.1016/j.bbapap.2013.01.021
   Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]
   Pieroni L, 2011, MOL BIOSYST, V7, P630, DOI 10.1039/c0mb00135j
   Sagedal S, 2001, NEPHROL DIAL TRANSPL, V16, P987, DOI 10.1093/ndt/16.5.987
   SAGRIPANTI A, 1993, NEPHRON, V63, P273, DOI 10.1159/000187209
   Salame M, 1999, INT J CARDIOL, V69, P231, DOI 10.1016/S0167-5273(99)00046-7
   Sun SD, 2003, J MEMBRANE SCI, V222, P3, DOI 10.1016/S0376-7388(03)00313-2
   Thongboonkerd V, 2010, J PROTEOMICS, V73, P521, DOI 10.1016/j.jprot.2009.06.003
   Urbani A., 2012, J BLOOD TRANSFUS S2, V10, pS97
   Urbani A, 2012, MOL BIOSYST, V8, P1029, DOI 10.1039/c2mb05393d
   Wermer C., 1999, INT J ARTIF ORGANS, V22, P160
NR 42
TC 14
Z9 14
U1 0
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1742-206X
EI 1742-2051
J9 MOL BIOSYST
JI Mol. Biosyst.
PY 2015
VL 11
IS 6
BP 1633
EP 1643
DI 10.1039/c5mb00058k
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CI5JU
UT WOS:000354792500017
PM 25845767
OA Bronze
DA 2018-10-20
ER

PT J
AU Nishida, K
   Tamura, A
   Yui, N
AF Nishida, Kei
   Tamura, Atsushi
   Yui, Nobuhiko
TI Acid-labile polyrotaxane exerting endolysosomal pH-sensitive
   supramolecular dissociation for therapeutic applications
SO POLYMER CHEMISTRY
LA English
DT Article
ID HYDROLYZABLE POLYROTAXANE; BIOCLEAVABLE POLYROTAXANE;
   BETA-CYCLODEXTRINS; GENE DELIVERY; C-DISEASE; CHOLESTEROL; DRUG;
   ACIDIFICATION; MECHANISM; COPOLYMER
AB pH-sensitive polymeric materials are rational designs for therapeutics, because they can change their intrinsic properties selectively in response to pH changes in targeted tissues and organelles, such as tumor tissue, skin, inflammation sites, and intracellular endosomes and lysosomes. Herein, we describe a novel acid-labile Pluronic/beta-cyclodextrin (beta-CD)-based polyrotaxane (PRX) showing the dissociation of supramolecular interlocked structures in response to a pH change with a narrow acidic range for biomedical applications. Acid cleavable ketal linkages were introduced into both terminals of the axle polymer of the PRX (ket-PRX) to acquire acid sensitivity. The ket-PRX was sufficiently stable and maintained its supramolecular structure under physiological conditions (pH 7.4), whereas the dissociation of the ket-PRX was observed under weakly acidic pH conditions (pH 5.0) due to the cleavage of the ketal linkages. Concomitant with this supramolecular dissociation it was found that the ket-PRX released beta-CDs to form an inclusion complex with guest molecules specifically under weakly acidic pH conditions. As one of the possible intracellular therapeutic applications, it was confirmed that the ket-PRX showed superior reduction of lysosomal cholesterols in Niemann-Pick type C disease in comparison with beta-CD derivatives, presumably due to the local release of beta-CDs from the ket-PRX in response to the weakly acidic pH in endosomes and/or lysosomes. Altogether with these results, it is concluded that the ket-PRX exerting pH-sensitive dissociation is an attractive candidate as a potential therapeutic biomaterial.
C1 [Nishida, Kei; Tamura, Atsushi; Yui, Nobuhiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Chiyoda Ku, Tokyo 1010062, Japan.
RP Yui, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM yui.org@tmd.ac.jp
OI Tamura, Atsushi/0000-0003-0235-7364
FU Ministry of Education, Culture, Sports, Science, and Technology (MEXT)
   of Japan [23107004]; MEXT of Japan [26750155]; Mochida Memorial
   Foundation for Medical and Pharmaceutical Research; Sasakawa Scientific
   Research Grant from The Japan Science Society
FX This work was financially supported by the Grant-in-Aid for Scientific
   Research (no. 23107004) on Innovative Areas "Nanomedicine Molecular
   Science" (N. Y.) from the Ministry of Education, Culture, Sports,
   Science, and Technology (MEXT) of Japan: Grant-in-Aid for Young
   Scientists (B) (no. 26750155) (A. T.) from the MEXT of Japan: the
   Mochida Memorial Foundation for Medical and Pharmaceutical Research (A.
   T.): the Sasakawa Scientific Research Grant from The Japan Science
   Society (A. T.).
CR Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106
   Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   Bae Y, 2003, ANGEW CHEM INT EDIT, V42, P4640, DOI 10.1002/anie.200250653
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228
   Chang TY, 2005, J BIOL CHEM, V280, P20917, DOI 10.1074/jbc.R400040200
   CORDES EH, 1974, CHEM REV, V74, P581, DOI 10.1021/cr60291a004
   Dotsikas Y, 2000, J PHARMACEUT BIOMED, V23, P997, DOI 10.1016/S0731-7085(00)00392-7
   Fujita H, 1999, MACROMOLECULES, V32, P2534, DOI 10.1021/ma9814550
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Ichi T, 2001, BIOMACROMOLECULES, V2, P204, DOI 10.1021/bm005617n
   Katoono R, 2008, CHEM LETT, V37, P988, DOI 10.1246/cl.2008.988
   Kopecek J, 2000, EUR J PHARM BIOPHARM, V50, P61, DOI 10.1016/S0939-6411(00)00075-8
   Kwon YJ, 2005, MOL PHARMACEUT, V2, P83, DOI 10.1021/mp0498953
   Lee Y, 2007, J AM CHEM SOC, V129, P5362, DOI 10.1021/ja071090b
   Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106
   MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.bi.55.070186.003311
   Mondjinou YA, 2013, BIOMACROMOLECULES, V14, P4189, DOI 10.1021/bm400922a
   MURPHY RF, 1984, J CELL BIOL, V98, P1757, DOI 10.1083/jcb.98.5.1757
   Ooya T, 2006, J AM CHEM SOC, V128, P3852, DOI 10.1021/ja055868+
   Ooya T, 2005, MACROMOL BIOSCI, V5, P379, DOI 10.1002/mabi.200400216
   Ooya T, 1999, J CONTROL RELEASE, V58, P251, DOI 10.1016/S0168-3659(98)00163-1
   Ooya T, 2001, BIOMACROMOLECULES, V2, P200, DOI 10.1021/bm005618f
   STEEN KH, 1995, J NEUROSCI, V15, P3982
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tamura A, 2014, CHEM COMMUN, V50, P13433, DOI 10.1039/c4cc03709j
   Tamura A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04356
   Tamura A, 2013, J MATER CHEM B, V1, P3535, DOI 10.1039/c3tb20514b
   TANNOCK IF, 1989, CANCER RES, V49, P4373
   Yamashita A, 2006, NAT PROTOC, V1, P2861, DOI 10.1038/nprot.2006.438
   ZLOTOGORSKI A, 1987, ARCH DERMATOL RES, V279, P398, DOI 10.1007/BF00412626
NR 31
TC 5
Z9 5
U1 1
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PY 2015
VL 6
IS 21
BP 4040
EP 4047
DI 10.1039/c5py00445d
PG 8
WC Polymer Science
SC Polymer Science
GA CI5QA
UT WOS:000354812300016
DA 2018-10-20
ER

PT J
AU Chen, L
   Zhai, D
   Huan, ZG
   Ma, N
   Zhu, HB
   Wu, CT
   Chang, J
AF Chen, Lei
   Zhai, Dong
   Huan, Zhiguang
   Ma, Nan
   Zhu, Haibo
   Wu, Chengtie
   Chang, Jiang
TI Silicate bioceramic/PMMA composite bone cement with distinctive
   physicochemical and bioactive properties
SO RSC ADVANCES
LA English
DT Article
ID MECHANICAL-PROPERTIES; IN-VITRO; OSTEOGENIC DIFFERENTIATION;
   BIOLOGICAL-PROPERTIES; IONIC PRODUCTS; FILLER CONTENT; STEM-CELLS;
   AKERMANITE; PROLIFERATION; GLASS
AB Polymethyl methacrylate (PMMA) bone cement has been widely used for orthopedic application due to its high mechanical strength and proper setting time. However, the major shortcomings of PMMA bone cement are its relatively low osseointegration and strong exothermic reactions. Silicate-based bioceramics, like akermanite (Ca2MgSi2O7, AKT), have been demonstrated to possess excellent osteostimulation ability and controlled biodegradability. The purpose of this study is to harness the advantages of both PMMA and AKT in order to prepare a new kind of composite bone cement (AKT/PMMA) with superior mechanical strength, improved exothermic effect and osteogenic activity. AKT particles were uniformly incorporated into the matrix of PMMA cement. The effect of AKT on the in vitro setting behaviors, and mechanical and biological properties of resultant composite cements was systematically investigated. The results showed that the prepared AKT/PMMA composite bone cements revealed significantly decreased polymerization temperature as compared with pure PMMA, but maintained ideal setting times (12-14 min) and high mechanical strength (similar to 100 MPa for compressive strength). Most interestingly, the incorporation of AKT into PMMA improved its osteogenic activity, as indicated by the significantly enhanced apatite-mineralization ability and stimulatory effect on the proliferation and alkaline phosphate (ALP) activity of osteoblasts. The results suggest that AKT/PMMA composite bone cements possess distinctive physicochemical and bioactive properties, and are a promising injectable biomaterial for orthopedic applications.
C1 [Chen, Lei; Zhai, Dong; Huan, Zhiguang; Wu, Chengtie; Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Ma, Nan; Zhu, Haibo] Xuhui Dist Cent Hosp, Shanghai 200031, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.
EM chengtiewu@mail.sic.ac.cn; jchang@mail.sic.ac.cn
FU Natural Science Foundation of China [81190132]; Funds of the Clinical
   Research Center for Biomaterials, Shanghai Institute of Ceramics, CAS
   [BMCRC2010001]; Key Research Program of Chinese Academy of Sciences
   [KGZD-EW-T06]; Innovative Project of SIC, CAS; One Hundred Talent
   Project, SIC-CAS [Y36ZB1110G]
FX This work was supported by grants from the Natural Science Foundation of
   China (grants no. 81190132), the Funds of the Clinical Research Center
   for Biomaterials, Shanghai Institute of Ceramics, CAS (grants no.
   BMCRC2010001), Key Research Program of Chinese Academy of Sciences
   (Grant KGZD-EW-T06), Innovative Project of SIC, CAS, and One Hundred
   Talent Project, SIC-CAS (Y36ZB1110G).
CR Abd Samad H, 2011, BIO-MED MATER ENG, V21, P247, DOI 10.3233/BME-2011-0673
   [Anonymous], 1987, ISO58331
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Chang J., 2015, Invention Patent, CN, Patent No. 104307035A
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   Chou YF, 2005, BIOMATERIALS, V26, P285, DOI 10.1016/j.biomaterials.2004.02.030
   Cunningham Larry L, 2005, J Long Term Eff Med Implants, V15, P609
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   Endogan T, 2009, J APPL POLYM SCI, V113, P4077, DOI 10.1002/app.30488
   Jasso-Gastinel CF, 2009, MACROMOL SYMP, V283-84, P159, DOI 10.1002/masy.200950921
   FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489
   Fukuda C, 2011, ACTA BIOMATER, V7, P3595, DOI 10.1016/j.actbio.2011.06.006
   Fukuda C, 2010, J BIOMED MATER RES B, V95B, P407, DOI 10.1002/jbm.b.31731
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Gu HJ, 2011, BIOMATERIALS, V32, P7023, DOI 10.1016/j.biomaterials.2011.06.003
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077
   Kaysinger KK, 1998, J CELL BIOCHEM, V68, P83, DOI 10.1002/(SICI)1097-4644(19980101)68:1<83::AID-JCB8>3.0.CO;2-S
   Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kuhn K. D., 2000, BONE CEMENTS UP TO D
   Kwon SY, 1997, BIO-MED MATER ENG, V7, P129
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Lewis G, 2008, J BIOMED MATER RES B, V84B, P301, DOI 10.1002/jbm.b.30873
   Liu AX, 2008, ACTA BIOMATER, V4, P1005, DOI 10.1016/j.actbio.2008.02.013
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   Liu-Snyder P, 2008, CURR NANOSCI, V4, P111, DOI 10.2174/157341308783591799
   Miyazaki T, 2003, J BIOMED MATER RES A, V67A, P1417, DOI 10.1002/jbm.a.20042
   Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1
   Olmo N, 2003, BIOMATERIALS, V24, P3383, DOI 10.1016/S0142-9612(03)00200-X
   Razavi M, 2014, CERAM INT, V40, P3865, DOI 10.1016/j.ceramint.2013.08.027
   Serbetci K, 2004, POLYM TEST, V23, P145, DOI 10.1016/S0142-9418(03)00073-4
   Shinzato S, 2001, J BIOMED MATER RES, V54, P491, DOI 10.1002/1097-4636(20010315)54:4<491::AID-JBM40>3.3.CO;2-F
   Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3
   Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027
   Wu CT, 2013, J INORG MATER, V28, P29, DOI 10.3724/SP.J.1077.2013.12241
   Wu CT, 2006, J BIOMED MATER RES A, V76A, P73, DOI 10.1002/jbm.a.30496
   Wu CT, 2004, MATER LETT, V58, P2415, DOI 10.1016/j.matlet.2004.02.039
   Xia LG, 2011, EUR CELLS MATER, V22, P68, DOI 10.22203/eCM.v022a06
   Zhai WY, 2013, ACTA BIOMATER, V9, P8004, DOI 10.1016/j.actbio.2013.04.024
   Zhai WY, 2012, ACTA BIOMATER, V8, P341, DOI 10.1016/j.actbio.2011.09.008
   Zhou YH, 2014, J MATER CHEM B, V2, P3907, DOI 10.1039/c4tb00377b
NR 44
TC 8
Z9 8
U1 1
U2 43
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 47
BP 37314
EP 37322
DI 10.1039/c5ra04646g
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CG9QT
UT WOS:000353653200020
DA 2018-10-20
ER

PT J
AU John, AA
   Subramanian, AP
   Vellayappan, MV
   Balaji, A
   Jaganathan, SK
   Mohandas, H
   Paramalinggam, T
   Supriyanto, E
   Yusof, M
AF John, A. A.
   Subramanian, A. P.
   Vellayappan, M. V.
   Balaji, A.
   Jaganathan, S. K.
   Mohandas, H.
   Paramalinggam, T.
   Supriyanto, E.
   Yusof, M.
TI Review: physico-chemical modification as a versatile strategy for the
   biocompatibility enhancement of biomaterials
SO RSC ADVANCES
LA English
DT Review
ID CALCIUM-PHOSPHATE COATINGS; IN-VITRO BIOCOMPATIBILITY; VAPOR PLASMA
   TREATMENT; MUSCLE-CELL FUNCTION; SURFACE MODIFICATION; WATER-VAPOR;
   BLOOD COMPATIBILITY; STAINLESS-STEEL; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES
AB A biomaterial can be defined as a material intended to interface with biological systems to evaluate, treat, augment or replace any tissue, organ or function of the body. Major problems associated with biomaterials are their properties and biocompatibility, which need to be tackled and resolved before promoting a particular biomaterial to the market or implanting it into a biological system. To enhance the biocompatibility of the biomaterials, several surface modification strategies, such as physico-chemical, mechanical and biological modifications, have been explored. In this review, some recent applications of physico-chemical modification technologies, such as alteration in the structure of a molecule by chemical modification, surface grafting, abrasive blasting and acid etching, surface coatings, heat and steam treatment for medical materials such as polymers, metals, ceramics and nanocomposites are discussed. This article will promote physico-chemical modification as a versatile technology in surface engineering to improve the properties and biocompatibility of medical materials. Furthermore, it will instigate the growth of the biomaterial market with various high quality biomaterials.
C1 [John, A. A.; Subramanian, A. P.; Vellayappan, M. V.; Balaji, A.; Jaganathan, S. K.; Supriyanto, E.; Yusof, M.] Univ Teknol Malaysia, Fac Biosci & Med Engn, IJN UTM Cardiovasc Engn Ctr, Johor Baharu 81310, Malaysia.
   [Paramalinggam, T.] Univ Teknol Malaysia, Fac Sci, Dept Chem, Johor Baharu 81310, Malaysia.
   [Mohandas, H.] Univ Texas Arlington, Dept Biomed Engn, Texas, TX USA.
RP Jaganathan, SK (reprint author), Univ Teknol Malaysia, Fac Biosci & Med Engn, IJN UTM Cardiovasc Engn Ctr, Johor Baharu 81310, Malaysia.
EM jaganathaniitkgp@gmail.com
RI Jaganathan, Saravana Kumar/N-2385-2017
OI Balaji, Arunpandian/0000-0002-6745-9188
FU Ministry of Higher Education Malaysia [R.J130000.7809.4F444]; UPMU, UTM
FX This work was supported partly by the Ministry of Higher Education
   Malaysia with the Grant Vot no: R.J130000.7809.4F444 and also
   acknowledges the support of UPMU, UTM.
CR Abbasi F, 2002, POLYM INT, V51, P882, DOI 10.1002/pi.1069
   Adhikari A. R., 2014, J APPL PHYS, P115
   Akelah A., 2013, TECHNOLOGY ENG, P1, DOI [10.1007/978-1-4614-7061-8, DOI 10.1007/978-1-4614-7061-8]
   Aldenhoff Yvette B. J., 2003, European Cells & Materials, V5, P61
   Alekhin AP, 2010, NANOTECHNOL RUSS, V5, P696, DOI 10.1134/S1995078010090144
   Alves P., 2014, J MATER SCI-MATER M, P2017
   Babiuch K, 2011, MACROMOL BIOSCI, V11, P535, DOI 10.1002/mabi.201000374
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3495, DOI 10.1016/j.biomaterials.2004.09.032
   Barrere F, 2001, J MATER SCI-MATER M, V12, P529, DOI 10.1023/A:1011271713758
   Bertazzo S, 2009, CLIN ORAL IMPLAN RES, V20, P288, DOI 10.1111/j.1600-0501.2008.01642.x
   Bimbo LM, 2010, ACS NANO, V4, P3023, DOI 10.1021/nn901657w
   Bosco R, 2012, COATINGS, V2, P95, DOI 10.3390/coatings2030095
   Bowry SK, 2002, INT J ARTIF ORGANS, V25, P447
   Bronzino D., 2000, BIOMEDICAL ENG HDB, V1
   Butruk-Raszeja B., 2014, J BIOMATER APPL, P801
   Cao Y, 1996, BIOMATERIALS, V17, P419, DOI 10.1016/0142-9612(96)89658-X
   Cao YJ, 2012, BIORESOURCES, V7, P4109
   Chen CH, 2013, NANOMED-NANOTECHNOL, V9, P600, DOI 10.1016/j.nano.2012.12.004
   Cheng ZQ, 2012, ADV MATER RES-SWITZ, V535-537, P1095, DOI 10.4028/www.scientific.net/AMR.535-537.1095
   Citeau A, 2005, BIOMATERIALS, V26, P157, DOI 10.1016/j.biomaterials.2004.02.033
   Cui XY, 2008, J MATER SCI-MATER M, V19, P1767, DOI 10.1007/s10856-007-3314-0
   Danila M. Korotin, 2012, J BIOMATER NANOBIOTE, V3, P87
   de Groot K, 1989, J Biomed Mater Res, V23, P1367, DOI 10.1002/jbm.820231112
   DEGATICA NLH, 1993, APPL SURF SCI, V68, P107, DOI 10.1016/0169-4332(93)90220-6
   Deng C, 2011, INT J POLYM MATER, V60, P969, DOI 10.1080/00914037.2011.553847
   Dong SJ, 2009, CHEM J CHINESE U, V30, P1018
   Duan B, 2010, J R SOC INTERFACE, V7, pS615, DOI 10.1098/rsif.2010.0127.focus
   Ebara M, 2014, SMART BIOMATERIALS, P1, DOI 10.1007/978-4-431-54400-5
   Fedel M, 2009, J BIOMED MATER RES B, V90B, P338, DOI 10.1002/jbm.b.31291
   Feldbauer S. L., STEAM TREATING ENHAN
   Feng YK, 2013, J MATER SCI-MATER M, V24, P61, DOI 10.1007/s10856-012-4685-4
   Ferraris S, 2011, J MATER SCI-MATER M, V22, P1835, DOI 10.1007/s10856-011-4365-9
   Gabo L., 2013, CHEM-EUR J, V19, P10690
   Gentleman E., 2009, MED SCI, VII
   Gong XH, 2004, J MATER SCI-MATER M, V15, P1141, DOI 10.1023/B:JMSM.0000046397.09060.15
   Gottlander M, 1997, CLIN ORAL IMPLAN RES, V8, P345, DOI 10.1034/j.1600-0501.1997.080501.x
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Hoffman A. S., 1995, CHIN J POLYM SCI, V3, P13
   Hsua S., 2014, 41 INT C MET COAT TH, V572, P91
   Hung HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065738
   Jackson M. J., 2006, Journal of Medical Engineering & Technology, V30, P323, DOI 10.1080/03091900500441287
   Jaganathan S. K., 2014, J MATER SCI, P2007
   Jaganathan S. K., 2014, BIOMED RES INT, V2014, P1
   Jensen C, 2012, J BIOMED MATER RES A, V100A, P3400, DOI 10.1002/jbm.a.34284
   Jovanovic AV, 2006, BIOMACROMOLECULES, V7, P945, DOI 10.1021/bm050820+
   Kang CK, 2012, J IND ENG CHEM, V18, P1670, DOI 10.1016/j.jiec.2012.03.007
   Kashiwazaki H, 2009, BIO-MED MATER ENG, V19, P133, DOI 10.3233/BME-2009-0572
   Kawase T, 2015, J BIOMED MATER RES B, V103, P825, DOI 10.1002/jbm.b.33262
   KHANLOU HM, 2012, AUST J BASIC APPL SC, V6, P125
   Kim HW, 2004, BIOMATERIALS, V25, P4203, DOI 10.1016/j.biomaterials.2003.10.094
   Kim SM, 2014, J BIOMED MATER RES A, V102, P429, DOI 10.1002/jbm.a.34718
   Kim YD, 2010, LASER MED SCI, V25, P25, DOI 10.1007/s10103-008-0585-8
   Kostelijk EH, 2001, TRANSFUSION MED, V11, P199, DOI 10.1046/j.1365-3148.2001.00305.x
   Feng KC, 2007, MATER TRANS, V48, P2978, DOI 10.2320/matertrans.MER2007083
   Kyomoto M, 2009, J BIOMED MATER RES A, V91A, P730, DOI 10.1002/jbm.a.32280
   Lakstein D, 2009, ACTA BIOMATER, V5, P2258, DOI 10.1016/j.actbio.2009.01.033
   Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lee EJ, 2005, BIOMATERIALS, V26, P3843, DOI 10.1016/j.biomaterials.2004.10.019
   Lee HJ, 2007, EUR POLYM J, V43, P1602, DOI 10.1016/j.eurpolymj.2007.02.030
   LEE JH, 1991, BIOMATERIALS, V12, P443
   Lee MH, 2003, MET MATER-INT, V9, P35, DOI 10.1007/BF03027227
   Lee YH, 2010, APPL SURF SCI, V256, P5882, DOI 10.1016/j.apsusc.2010.03.069
   LEMONS J, 1986, DENT CLIN N AM, V30, P3
   Li SB, 2012, J BIOMED MATER RES B, V100B, P1587, DOI 10.1002/jbm.b.32727
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lim YW, 2011, CLIN ORTHOP RELAT R, V469, P330, DOI 10.1007/s11999-010-1613-0
   Liu PS, 2013, MAT SCI ENG C-MATER, V33, P3865, DOI 10.1016/j.msec.2013.05.025
   Liu YR, 2012, SURF COAT TECH, V208, P51, DOI 10.1016/j.surfcoat.2012.07.084
   Majumdar P, 2012, J MECH BEHAV BIOMED, V10, P1, DOI 10.1016/j.jmbbm.2012.02.014
   Manivasagam G., 2010, RECENT PAT CORROS SC, P40
   McCreery R. L., 2012, NANOFABRICATION, P163, DOI [10.1007/978-3-7091-0424-8_7, DOI 10.1007/978-3-7091-0424-8_7]
   Milinkovi I., 2012, MATER TECHNOL, V3, P251
   Milinkovi I., 2012, MATER TECHNOL, P251
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Minko S., 2008, POLYM SURFACES INTER, P215, DOI DOI 10.1007/978-3-540-73865-7_11
   Mohammadi A, 2013, J MATER SCI, V48, P7493, DOI 10.1007/s10853-013-7563-7
   Mondal D, 2013, J BIOMED MATER RES A, V101, P1489, DOI 10.1002/jbm.a.34455
   MORONI A, 1994, BIOMATERIALS, V15, P926, DOI 10.1016/0142-9612(94)90119-8
   Mu QX, 2010, BIOMATERIALS, V31, P5083, DOI 10.1016/j.biomaterials.2010.03.020
   Nader P., 2012, COMAT RECENT TRENDS, P1
   Nguyen HQ, 2004, BIOMATERIALS, V25, P865, DOI 10.1016/S0142-9612(03)00607-0
   Nie S., 2012, COLLOID SURFACE B, P116
   Niinomi M, 2014, INT J SURF SCI ENG, V8, P138, DOI 10.1504/IJSURFSE.2014.060487
   NISHIZAWA K, 1993, J FERMENT BIOENG, V75, P435, DOI 10.1016/0922-338X(93)90091-L
   Parida P., 2012, INT J ADV APPL SCI, P125
   Parl HD, 2003, J BIOMED MATER RES A, V66A, P596, DOI 10.1002/jbm.a.10505
   Parsapour A, 2012, J MATER SCI TECHNOL, V28, P125, DOI 10.1016/S1005-0302(12)60032-2
   Pascu M. C., 2008, J PHYS D, V41, P12
   Pattanaik Bikash, 2012, Indian J Dent Res, V23, P398, DOI 10.4103/0970-9290.102240
   Prabhakar PK, 2011, COLLOID SURFACE B, V86, P146, DOI 10.1016/j.colsurfb.2011.03.033
   Queffelec C, 2012, CHEM REV, V112, P3777, DOI 10.1021/cr2004212
   Rai R, 2013, MATER LETT, V105, P32, DOI 10.1016/j.matlet.2013.04.024
   Safonov V, 2010, J PHYS CONF SER, V253, DOI 10.1088/1742-6596/253/1/012068
   Schmalz G, 2002, J DENT RES, V81, P660, DOI 10.1177/154405910208101001
   Seivakumar M., 2015, J BIOMED NANOTECHNOL, V11, P291
   Shirzadian T., 2012, J INJ VIOLENCE RES, V4, P39
   Shuchman M, 2006, NEW ENGL J MED, V355, P1949, DOI 10.1056/NEJMp068234
   Singh B, 2012, J MECH BEHAV BIOMED, V9, P9, DOI 10.1016/j.jmbbm.2012.01.021
   Sirolli V, 2000, INT J ARTIF ORGANS, V23, P356
   Stevens K. N. J., 2011, THESIS MAASTRICHT U
   Strnad Z, 2000, INT J ORAL MAX IMPL, V15, P483
   Sultana R, 2006, DENT MATER J, V25, P470, DOI 10.4012/dmj.25.470
   Szabo G, 1999, J LONG-TERM EFF MED, V9, P247
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Wang HJ, 2009, COLLOID SURFACE B, V69, P109, DOI 10.1016/j.colsurfb.2008.11.015
   Wang J, 2004, BIOMATERIALS, V25, P583, DOI 10.1016/S0142-9612(03)00559-3
   Wang J, 2013, ACTA BIOMATER, V9, P8678, DOI 10.1016/j.actbio.2013.02.041
   Wang LS, 2011, ADVANCES IN NANOCOMPOSITES - SYNTHESIS, CHARACTERIZATION AND INDUSTRIAL APPLICATIONS, P289
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
   Williams David, 2003, Med Device Technol, V14, P10
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu CZ, 2011, J MECH BEHAV BIOMED, V4, P1548, DOI 10.1016/j.jmbbm.2011.02.007
   Xiang T, 2013, COLLOID SURFACE B, V110, P15, DOI 10.1016/j.colsurfb.2013.04.034
   Xu ZK, 2005, BIOMATERIALS, V26, P589, DOI 10.1016/j.biomaterials.2004.03.008
   Xue WC, 2005, BIOMATERIALS, V26, P3029, DOI 10.1016/j.biomaterials.2004.09.003
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Ye CH, 2012, APPL SURF SCI, V258, P3420, DOI 10.1016/j.apsusc.2011.11.087
   Ye HJ, 2013, COLLOID SURFACE A, V427, P19, DOI 10.1016/j.colsurfa.2013.02.068
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
   Yue Q, 2013, J MATER CHEM B, V1, P6085, DOI 10.1039/c3tb21028f
   Zhang WB, 2012, ADV MATER RES-SWITZ, V391-392, P195, DOI 10.4028/www.scientific.net/AMR.391-392.195
   Zhao Q, 1999, BIOMATERIALS, V20, P595, DOI 10.1016/S0142-9612(98)00218-X
   Zhao XB, 2006, SURF COAT TECH, V200, P5487, DOI 10.1016/j.surfcoat.2005.07.062
   Zhou Y, 2012, J MATER SCI-MATER M, V23, P2101, DOI 10.1007/s10856-012-4699-y
   Zhuang PY, 2012, INT J BIOL MACROMOL, V50, P658, DOI 10.1016/j.ijbiomac.2012.01.026
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
NR 128
TC 20
Z9 21
U1 5
U2 70
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 49
BP 39232
EP 39244
DI 10.1039/c5ra03018h
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA CH7FQ
UT WOS:000354201500051
DA 2018-10-20
ER

PT J
AU Zhao, CH
   Pan, CJ
   Sandstedt, J
   Fu, YF
   Lindahl, A
   Liu, JH
AF Zhao, Changhong
   Pan, Changjiang
   Sandstedt, Joakim
   Fu, Yifeng
   Lindahl, Anders
   Liu, Johan
TI Combination of positive charges and honeycomb pores to promote MC3T3-E1
   cell behaviour
SO RSC ADVANCES
LA English
DT Article
ID GLYCOL) DIBLOCK COPOLYMER; BREATH-FIGURE METHOD; POLY(ETHYLENE GLYCOL);
   EPSILON-CAPROLACTONE; OSTEOBLAST ADHESION; BANDED SPHERULITES;
   BLOCK-COPOLYMERS; DRUG-DELIVERY; IN-VITRO; POLY(L-LACTIDE)
AB A facile chemistry route to prepare symmetric poly(L-lactide) (PLLA)-based dendritic L-lysine copolymer (PLLA-d), with a PLLA block as the core and lysine dendrons in the two ends to provide certain density of positive charges, through a divergent method is reported. The polymers were characterized by H-1 NMR, GPC and MALDI-TOF to confirm the well-defined chemical architecture. The study on crystallization behaviour demonstrated that the introduction of the lysine dendron favoured the formation of banded spherulites when compared with the PLLA polymer. The differential scanning calorimetry (DSC) results showed that the lysine dendron disrupted PLLA crystalline region and lowered the melting point and crystallinity of PLLA. The PLLA-d was fabricated into honeycomb films (H-PLLA-d) through the breath-figure method for water contact angle test and in vitro study, with flat PLLA, honeycomb PLLA, and flat PLLA-d films (PLLA, H-PLLA, and F-PLLA-d, respectively) as the controls. The water contact angle test indicated that the hydrophilicity of the PLLA-d film was strongly improved after the incorporation of the lysine dendron into PLLA. The incorporation of the lysine dendron increased the surface zeta potential and decreased the mechanical properties of PLLA. Mouse osteoblastic cell (MC3T3-E1) functions including cell attachment, adhesion, proliferation, and differentiation were investigated on PLLA, H-PLLA, F-PLLA-d and H-PLLA-d films. The results indicated that MC3T3-E1 cell functions were significantly enhanced on F-PLLA-d or H-PLLA films and especially H-PLLA-d ones. This study not only demonstrates a facile approach to fabricate a novel copolymer film (H-PLLA-d), which combines positive charges with honeycomb pores, but also provides a potential biomaterial for bone repair by improving osteoblastic cell functions.
C1 [Zhao, Changhong; Liu, Johan] Shanghai Univ, SMIT Ctr, Sch Mechatron Engn & Automat, Shanghai 201800, Peoples R China.
   [Zhao, Changhong; Liu, Johan] Shanghai Univ, Key Lab Adv Display & Syst Applicat, Shanghai 201800, Peoples R China.
   [Pan, Changjiang] Huaiyin Inst Technol, Jiangsu Prov Key Lab Intervent Med Devices, Huaian 223003, Peoples R China.
   [Sandstedt, Joakim; Lindahl, Anders] Sahlgrens Acad, Inst Biomed, Dept Clin Chem & Transfus Med, S-41345 Gothenburg, Sweden.
   [Fu, Yifeng] SHT Smart High Tech AB, SE-41133 Gothenburg, Sweden.
   [Liu, Johan] Chalmers, Bionano Syst Lab, Dept Microtechnol & Nanosci MC2, S-41296 Gothenburg, Sweden.
RP Liu, JH (reprint author), Shanghai Univ, SMIT Ctr, Sch Mechatron Engn & Automat, 20 Chengzhong Rd, Shanghai 201800, Peoples R China.
EM johan.liu@chalmers.se
FU National Science Foundation, China [51272153]; Chongqing Science and
   Technology Key Projects Fund [CSTC2009AB5061]
FX This work was supported by National Science Foundation, China under the
   contract no. 51272153 and Chongqing Science and Technology Key Projects
   Fund under the contract no. CSTC2009AB5061. This work was also carried
   out within the Sustainable Production Initiative and the Production Area
   of Advance at Chalmers. The authors would like to thank Dr Michael
   Edwards, Chalmers University of Technology, for proof reading the
   manuscript.
CR Agrawal P, 2007, BIOMATERIALS, V28, P3349, DOI 10.1016/j.biomaterials.2007.04.004
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Breitenbach A, 2000, POLYMER, V41, P4781, DOI 10.1016/S0032-3861(99)00710-7
   Bunz UHF, 2006, ADV MATER, V18, P973, DOI 10.1002/adma.200501131
   Cai L, 2012, BIOMACROMOLECULES, V13, P342, DOI 10.1021/bm201763n
   Cai L, 2010, BIOMATERIALS, V31, P4457, DOI 10.1016/j.biomaterials.2010.02.020
   Cai Q, 2003, BIOMACROMOLECULES, V4, P828, DOI 10.1021/bm034051a
   Chen HT, 2004, J AM CHEM SOC, V126, P10044, DOI 10.1021/ja048548j
   Dahiya R, 2007, J CHIL CHEM SOC, V52, P1224, DOI 10.4067/S0717-97072007000300006
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Deng C, 2006, BIOMACROMOLECULES, V7, P590, DOI 10.1021/bm050678c
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Fukuhira Y, 2008, COLLOID SURFACE A, V313, P520, DOI 10.1016/j.colsurfa.2007.05.047
   Gong FR, 2009, POLYMER, V50, P2775, DOI 10.1016/j.polymer.2009.04.033
   Heath MD, 2010, LANGMUIR, V26, P5304, DOI 10.1021/la100678n
   Hernandez-Guerrero M, 2012, POLYM CHEM-UK, V3, P563, DOI 10.1039/c1py00219h
   Hynes SR, 2007, J BIOMAT SCI-POLYM E, V18, P1017, DOI 10.1163/156856207781494368
   Jin Y, 2011, APPL SPECTROSC, V65, P454, DOI 10.1366/10-06143
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Li SM, 2003, BIOMACROMOLECULES, V4, P372, DOI 10.1021/bm025748j
   Li SM, 2002, BIOMACROMOLECULES, V3, P525, DOI 10.1021/bm010168s
   Li Y, 2006, BIOMACROMOLECULES, V7, P224, DOI 10.1021/bm050602g
   Li Y, 2007, BIOMACROMOLECULES, V8, P1409, DOI 10.1021/bm0701806
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   McMillan JR, 2007, TISSUE ENG, V13, P789, DOI 10.1089/ten.2006.0321
   Nasongkla N, 2004, ANGEW CHEM INT EDIT, V43, P6323, DOI 10.1002/anie.200460800
   Nurkhamidah S, 2011, J APPL POLYM SCI, V122, P1976, DOI 10.1002/app.34021
   Okuda T, 2006, J CONTROL RELEASE, V114, P69, DOI 10.1016/j.jconrel.2006.05.009
   Ouchi T, 2002, BIOMACROMOLECULES, V3, P885, DOI 10.1021/bm0200231
   Rao SS, 2011, J BIOMAT SCI-POLYM E, V22, P611, DOI 10.1163/092050610X488241
   Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013
   Sun JR, 2004, POLYMER, V45, P5969, DOI 10.1016/j.polymer.2004.06.026
   Sunami H, 2006, COLLOID SURFACE A, V284, P548, DOI 10.1016/j.colsurfa.2005.11.041
   Tanaka M, 2011, BBA-GEN SUBJECTS, V1810, P251, DOI 10.1016/j.bbagen.2010.10.002
   Tsuruma A, 2008, COLLOID SURFACE A, V313, P536, DOI 10.1016/j.colsurfa.2007.05.079
   Wang B, 2010, COLLOID SURFACE B, V76, P38, DOI 10.1016/j.colsurfb.2009.10.006
   Wang JH, 2006, BIOMATERIALS, V27, P3441, DOI 10.1016/j.biomaterials.2006.02.002
   Wang K, 2012, LANGMUIR, V28, P4382, DOI 10.1021/la205162d
   Wei J, 2011, J NANOSCI NANOTECHNO, V11, P10746, DOI 10.1166/jnn.2011.3940
   Wei J, 2009, J AM CERAM SOC, V92, P1017, DOI 10.1111/j.1551-2916.2009.03002.x
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Wu X., 2014, J POSTDOC RES, V1, P17
   Wu XH, 2015, RSC ADV, V5, P6607, DOI 10.1039/c4ra13843k
   Wu XH, 2014, POLYMER, V55, P1756, DOI 10.1016/j.polymer.2014.02.029
   Wu XH, 2013, ADV HEALTHC MATER, V2, P326, DOI 10.1002/adhm.201200205
   Wu XH, 2012, ACS APPL MATER INTER, V4, P4966, DOI 10.1021/am301334s
   Wu XH, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035006
   Wu XH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045008
   Xu J, 2005, POLYMER, V46, P9176, DOI 10.1016/j.polymer.2005.07.010
   Yamamoto S, 2006, SURF SCI, V600, P3785, DOI 10.1016/j.susc.2006.01.085
   Yang Y, 2009, BIOMATERIALS, V30, P1947, DOI 10.1016/j.biomaterials.2008.12.044
   Ye R, 2014, FOOD HYDROCOLLOID, V35, P670, DOI 10.1016/j.foodhyd.2013.08.022
   Yu LMY, 2008, MATER TODAY, V11, P36, DOI 10.1016/S1369-7021(08)70088-9
   Zhao BH, 2006, J MATER CHEM, V16, P509, DOI 10.1039/b512398d
   Zhao YL, 2002, POLYMER, V43, P5819, DOI 10.1016/S0032-3861(02)00529-3
   Zhou HJ, 2011, J MATER SCI-MATER M, V22, P731, DOI 10.1007/s10856-011-4239-1
   Zhou HJ, 2010, J MATER SCI-MATER M, V21, P2175, DOI 10.1007/s10856-010-4083-8
NR 58
TC 3
Z9 3
U1 1
U2 25
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 53
BP 42276
EP 42286
DI 10.1039/c5ra00756a
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA CI0SI
UT WOS:000354447800009
DA 2018-10-20
ER

PT J
AU Pachuau, LS
AF Pachuau, Lalduh Sanga
TI A Mini Review on Plant-based Nanocellulose: Production, Sources,
   Modifications and Its Potential in Drug Delivery Applications
SO MINI-REVIEWS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Biomaterials; cellulose nanocrystals; cellulose nanofibrils; drug
   delivery; nanocellulose; nanocomposites
ID CELLULOSE MICROCRYSTAL SUSPENSION; NANOCRYSTALLINE CELLULOSE;
   NANOFIBRILLATED CELLULOSE; MICROFIBRILLATED CELLULOSE; NATIVE CELLULOSE;
   FIBERS; NANOWHISKERS; COMPOSITES; NANOFIBERS; HYDROGELS
AB Nanocellulose is an emerging sustainable biomaterial with exceptional physicochemical properties. It can be isolated from inexpensive renewable cellulosic biomass and a number of natural plant fibers have been extensively investigated as a source for such isolation. The geometrical dimensions of the prepared cellulose nanocrystals (CNCs) are however, found to vary widely, depending on the source of the cellulosic material and hydrolysis conditions. CNCs are biocompatible and biodegradable which exhibit very low cytotoxicity thus, offering a wide range of opportunities for biomedical applications. By surface modification of nanocellulose, various functional materials with tunable properties can also be developed. Over the past two decades, CNCs have garnered a significant interest as biobased reinforcing nanofiller material. This mini review will provide an overview into the production methods, sources of cellulosic fibers, surface modification strategies and drug delivery applications of the chemically or mechanically isolated nanocellulose.
C1 Assam Univ, Dept Pharmaceut Sci, Silchar 788011, Assam, India.
RP Pachuau, LS (reprint author), Assam Univ, Dept Pharmaceut Sci, Silchar 788011, Assam, India.
EM aduhapc@gmail.com
RI Pachuau, Lalduhsanga/S-7203-2018
OI Pachuau, Lalduhsanga/0000-0002-3827-9444
CR Abdulkhani A, 2014, POLYM TEST, V35, P73, DOI 10.1016/j.polymertesting.2014.03.002
   Abe K, 2009, CELLULOSE, V16, P1017, DOI 10.1007/s10570-009-9334-9
   Andresen M, 2006, CELLULOSE, V13, P665, DOI 10.1007/s10570-006-9072-1
   Araki J, 1998, COLLOID SURFACE A, V142, P75, DOI 10.1016/S0927-7757(98)00404-X
   Araki J, 1999, J WOOD SCI, V45, P258, DOI 10.1007/BF01177736
   Araki J, 2001, LANGMUIR, V17, P21, DOI 10.1021/la001070m
   Azzam F, 2010, BIOMACROMOLECULES, V11, P3652, DOI 10.1021/bm101106c
   Besbes I, 2011, CARBOHYD POLYM, V86, P1198, DOI 10.1016/j.carbpol.2011.06.015
   Bondeson D, 2006, CELLULOSE, V13, P171, DOI 10.1007/s10570-006-9061-4
   Brinchi L, 2013, CARBOHYD POLYM, V94, P154, DOI 10.1016/j.carbpol.2013.01.033
   Brito BSL, 2012, CELLULOSE, V19, P1527, DOI 10.1007/s10570-012-9738-9
   Cao XW, 2012, CARBOHYD POLYM, V90, P1075, DOI 10.1016/j.carbpol.2012.06.046
   Chen WS, 2011, CELLULOSE, V18, P433, DOI 10.1007/s10570-011-9497-z
   Cherian BM, 2011, CARBOHYD POLYM, V86, P1790, DOI 10.1016/j.carbpol.2011.07.009
   Domingues RMA, 2014, BIOMACROMOLECULES, V15, P2327, DOI 10.1021/bm500524s
   Dong H, 2012, CARBOHYD POLYM, V87, P2488, DOI 10.1016/j.carbpol.2011.11.015
   Dufresne A, 2013, MATER TODAY, V16, P220, DOI 10.1016/j.mattod.2013.06.004
   GARDNER KH, 1974, BIOPOLYMERS, V13, P1975, DOI 10.1002/bip.1974.360131005
   Gousse C, 2004, POLYMER, V45, P1569, DOI 10.1016/j.polymer.2003.12.028
   Gupta KC, 2003, BIOMACROMOLECULES, V4, P758, DOI 10.1021/bm020135s
   Haafiz MKM, 2014, CARBOHYD POLYM, V103, P119, DOI 10.1016/j.carbpol.2013.11.055
   Habibi Y, 2008, J MATER CHEM, V18, P5002, DOI 10.1039/b809212e
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Jackson JK, 2011, INT J NANOMED, V6, P321, DOI 10.2147/IJN.S16749
   Jiang F, 2010, LANGMUIR, V26, P17919, DOI 10.1021/la1028405
   Khalil HPSA, 2014, CARBOHYD POLYM, V99, P649, DOI 10.1016/j.carbpol.2013.08.069
   Khalil HPSA, 2012, CARBOHYD POLYM, V87, P963, DOI 10.1016/j.carbpol.2011.08.078
   Kloser E, 2010, LANGMUIR, V26, P13450, DOI 10.1021/la101795s
   Kolakovic R, 2012, EUR J PHARM BIOPHARM, V82, P308, DOI 10.1016/j.ejpb.2012.06.011
   Kolakovic R, 2012, INT J PHARMACEUT, V430, P47, DOI 10.1016/j.ijpharm.2012.03.031
   Kolakovic R, 2011, AAPS PHARMSCITECH, V12, P1366, DOI 10.1208/s12249-011-9705-z
   Lam E, 2012, TRENDS BIOTECHNOL, V30, P283, DOI 10.1016/j.tibtech.2012.02.001
   Lavoine N, 2012, CARBOHYD POLYM, V90, P735, DOI 10.1016/j.carbpol.2012.05.026
   Leung ACW, 2011, SMALL, V7, P302, DOI 10.1002/smll.201001715
   Liu HY, 2010, BIORESOURCE TECHNOL, V101, P5685, DOI 10.1016/j.biortech.2010.02.045
   Mandal A, 2011, CARBOHYD POLYM, V86, P1291, DOI 10.1016/j.carbpol.2011.06.030
   Nair SS, 2014, ACS SUSTAIN CHEM ENG, V2, P772, DOI 10.1021/sc400445t
   Nakagaito AN, 2004, APPL PHYS A-MATER, V78, P547, DOI 10.1007/s00339-003-2453-5
   OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579
   Peng BL, 2011, CAN J CHEM ENG, V89, P1191, DOI 10.1002/cjce.20554
   Plackett DV, 2014, NORD PULP PAP RES J, V29, P105
   Rachtanapun P, 2012, LWT-FOOD SCI TECHNOL, V48, P52, DOI 10.1016/j.lwt.2012.02.029
   Rosa MF, 2010, CARBOHYD POLYM, V81, P83, DOI 10.1016/j.carbpol.2010.01.059
   SAKURADA I, 1962, J POLYM SCI, V57, P651, DOI 10.1002/pol.1962.1205716551
   Sanna R, 2013, CELLULOSE, V20, P2393, DOI 10.1007/s10570-013-9988-1
   Morais JPS, 2013, CARBOHYD POLYM, V91, P229, DOI 10.1016/j.carbpol.2012.08.010
   Serge R, 2013, J BIOMATERIALS NANOB, V4, DOI DOI 10.4236/JBNB.2013.42022
   Sheltami RM, 2012, CARBOHYD POLYM, V88, P772, DOI 10.1016/j.carbpol.2012.01.062
   Sundari MT, 2012, CARBOHYD POLYM, V87, P1701, DOI 10.1016/j.carbpol.2011.09.076
   Tingaut P, 2012, J MATER CHEM, V22, P20105, DOI 10.1039/c2jm32956e
   Tonoli GHD, 2012, CARBOHYD POLYM, V89, P80, DOI 10.1016/j.carbpol.2012.02.052
   Wang HZ, 2011, BIOMACROMOLECULES, V12, P1585, DOI 10.1021/bm101584c
   Xiong R, 2012, CELLULOSE, V19, P1189, DOI 10.1007/s10570-012-9730-4
   Yang X, 2013, BIOMACROMOLECULES, V14, P4447, DOI 10.1021/bm401364z
   Zhu HL, 2014, ENERG ENVIRON SCI, V7, P269, DOI 10.1039/c3ee43024c
   Zimmermann T, 2004, ADV ENG MATER, V6, P754, DOI 10.1002/adem.200400097
   Zimmermann T, 2010, CARBOHYD POLYM, V79, P1086, DOI 10.1016/j.carbpol.2009.10.045
NR 57
TC 9
Z9 10
U1 2
U2 82
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-5575
EI 1875-5607
J9 MINI-REV MED CHEM
JI Mini-Rev. Med. Chem.
PY 2015
VL 15
IS 7
BP 543
EP 552
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA CH3FQ
UT WOS:000353914400003
PM 25877601
DA 2018-10-20
ER

PT J
AU Novotna, Z
   Reznickova, A
   Rimpelova, S
   Vesely, M
   Kolska, Z
   Svorcik, V
AF Novotna, Zdenka
   Reznickova, Alena
   Rimpelova, Silvie
   Vesely, Martin
   Kolska, Zdenka
   Svorcik, Vaclav
TI Tailoring of PEEK bioactivity for improved cell interaction: plasma
   treatment in action
SO RSC ADVANCES
LA English
DT Article
ID POLYMER SURFACE MODIFICATION; IN-VITRO; TITANIUM-ALLOYS;
   POLYETHERETHERKETONE; ADHESION; POLYETHYLENE; FIBROBLASTS; IMPLANTS;
   DIFFERENTIATION; BIOMATERIALS
AB Despite the extensive use of polyetheretherketone (PEEK) in biomedical applications, information about cell adhesion on this biomaterial is limited. This study focuses on PEEK tuned by argon plasma treatment with the aim to enhance its wettability and cytocompatibility. Changes in surface properties of the plasma treated surface were studied in relation to the adhesion, proliferation and metabolic activity of mouse fibroblasts (L929) and human osteoblast (U-2 OS) in vitro. Moreover, the expression profiles of two proteins (talin 1 and vinculin) responsible for cell adhesion, were determined at 2 time points in dependence on the PEEK treatment. Plasma treatment increased the surface wettability of PEEK and led to changes in its surface morphology and chemistry. The XPS method showed a decrease in carbon content and augmentation of oxygen concentration with increasing effect of the plasma. Plasma treatment of PEEK significantly enhanced cell adhesion, proliferation and metabolic activity of both cell lines when compared to pristine PEEK. Moreover, special attention was devoted to filopodia of L929 cell adhered on PEEK studied by means of scanning electron microscopy. The most abundant filopodia were present on PEEK plasma treated for "longer" times.
C1 [Novotna, Zdenka; Reznickova, Alena; Svorcik, Vaclav] Univ Chem & Technol, Dept Solid State Engn, Prague, Czech Republic.
   [Rimpelova, Silvie] Univ Chem & Technol, Dept Biochem & Microbiol, Prague, Czech Republic.
   [Vesely, Martin] Univ Chem & Technol, Dept Organ Technol, Prague, Czech Republic.
   [Kolska, Zdenka] JE Purkyne Univ Usti Nad Labem, Fac Sci, Usti Nad Labem, Czech Republic.
RP Novotna, Z (reprint author), Univ Chem & Technol, Dept Solid State Engn, Prague, Czech Republic.
EM zdenka1.novotna@vscht.cz
RI Vesely, Martin/V-2711-2017
OI Vesely, Martin/0000-0002-3147-4941; Rimpelova,
   Silvie/0000-0002-9731-8968
FU GACR [14-18149P, 108/12/G108]; specific university research MSMT
   [20/2015]
FX This work was supported by the GACR under projects 14-18149P (A.R.),
   108/12/G108 and by financial support from specific university research
   MSMT no. 20/2015 (Z.N.).
CR ALBIGESRIZO C, 1995, J CELL SCI, V108, P3317
   Althaus J, 2012, EUR J NANOMED, V4, P7, DOI 10.1515/ejnm-2011-0001
   Awaja F, 2012, PLASMA PROCESS POLYM, V9, P355, DOI 10.1002/ppap.201100034
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Briem D, 2005, J MATER SCI-MATER M, V16, P671, DOI 10.1007/s10856-005-2539-z
   Chan CM, 1996, SURF SCI REP, V24, P3
   Choi YH, 2005, SURF COAT TECH, V193, P319, DOI 10.1016/j.surfcoat.2004.08.145
   Hiebl B, 2010, J BIOTECHNOL, V148, P76, DOI 10.1016/j.jbiotec.2010.01.006
   HUSAIN S, 1993, CURR SCI INDIA, V64, P681
   Hwang ML, 2012, NUCL INSTRUM METH B, V281, P45, DOI 10.1016/j.nimb.2012.03.025
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Katzer A, 2002, BIOMATERIALS, V23, P1749, DOI 10.1016/S0142-9612(01)00300-3
   Kirby BJ, 2004, ELECTROPHORESIS, V25, P187, DOI 10.1002/elps.200305754
   Kitamura E, 2004, CLIN ORAL IMPLAN RES, V15, P401, DOI 10.1111/j.1600-0501.2004.01022.x
   Kobayashi T, 1998, SOLID STATE IONICS, V106, P219, DOI 10.1016/S0167-2738(97)00512-2
   Kolska Z, 2010, MATER LETT, V64, P1160, DOI 10.1016/j.matlet.2010.02.038
   Kolska Z., 2012, E-POLYMERS, V83, P1
   Kolska Z, 2014, POLYM DEGRAD STABIL, V101, P1, DOI 10.1016/j.polymdegradstab.2014.01.024
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Kuzuya M, 1998, MACROMOLECULES, V31, P3230, DOI 10.1021/ma970937t
   Lee JW, 2011, ANAL SCI, V27, P369, DOI 10.2116/analsci.27.369
   Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025
   Ma R, 2014, ACS APPL MATER INTER, V6, P12214, DOI 10.1021/am504409q
   Nieminen T, 2008, J BIOMED MATER RES A, V84A, P377, DOI 10.1002/jbm.a.31310
   Noiset O, 1999, J BIOMAT SCI-POLYM E, V10, P657, DOI 10.1163/156856299X00865
   Olivares-Navarrete R, 2013, SPINE J, V13, P1563, DOI 10.1016/j.spinee.2013.03.047
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Reznickova A, 2011, NUCL INSTRUM METH B, V269, P83, DOI 10.1016/j.nimb.2010.11.018
   Reznickova A., 2014, NANOSCALE RES LETT, V9, P1
   Rimpelova S, 2014, PLASMA PROCESS POLYM, V11, P1057, DOI 10.1002/ppap.201400021
   Rimpelova S, 2013, MAT SCI ENG C-MATER, V33, P1116, DOI 10.1016/j.msec.2012.12.003
   Rivard CH, 2002, J BIOMED MATER RES, V62, P488, DOI 10.1002/jbm.10159
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Slepicka P, 2013, EXPRESS POLYM LETT, V7, P535, DOI 10.3144/expresspolymlett.2013.50
   Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9
   Svorcik V, 2006, POLYM DEGRAD STABIL, V91, P1219, DOI 10.1016/j.polymdegradstab.2005.09.007
   Svorcik V, 2006, NUCL INSTRUM METH B, V244, P365, DOI 10.1016/j.nimb.2005.10.003
   Tsou HK, 2009, SURF COAT TECH, V204, P1121, DOI 10.1016/j.surfcoat.2009.06.018
   Wang YY, 2013, WEAR, V303, P255, DOI 10.1016/j.wear.2013.03.036
   Watanabe IS, 2013, MICROSC RES TECHNIQ, V76, P1226, DOI 10.1002/jemt.22289
   Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399
NR 41
TC 11
Z9 11
U1 3
U2 65
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 52
BP 41428
EP 41436
DI 10.1039/c5ra03861h
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CI0RP
UT WOS:000354445900015
OA Bronze
DA 2018-10-20
ER

PT J
AU Gajdziok, J
   Holesova, S
   Stembirek, J
   Pazdziora, E
   Landova, H
   Dolezel, P
   Vetchy, D
AF Gajdziok, Jan
   Holesova, Sylva
   Stembirek, Jan
   Pazdziora, Erich
   Landova, Hana
   Dolezel, Petr
   Vetchy, David
TI Carmellose Mucoadhesive Oral Films Containing Vermiculite/Chlorhexidine
   Nanocomposites as Innovative Biomaterials for Treatment of Oral
   Infections
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; NON-CLAY MINERALS; BUCCAL FILMS; IN-VITRO;
   EXCHANGED MONTMORILLONITE; ANTIBACTERIAL ACTIVITY; POLYMERIC PLATFORMS;
   CELLULOSE FIBERS; CARBOXYMETHYLCELLULOSE; CHLORHEXIDINE
AB Infectious stomatitis represents the most common oral cavity ailments. Current therapy is insufficiently effective because of the short residence time of topical liquid or semisolid medical formulations. An innovative application form based on bioadhesive polymers featuring prolonged residence time on the oral mucosa may be a solution to this challenge. This formulation consists of a mucoadhesive oral film with incorporated nanocomposite biomaterial that is able to release the drug directly at the target area. This study describes the unique approach of preparing mucoadhesive oral films from carmellose with incorporating a nanotechnologically modified clay mineral intercalated with chlorhexidine. The multivariate data analysis was employed to evaluate the influence of the formulation and process variables on the properties of the medical preparation. This evaluation was complemented by testing the antimicrobial and antimycotic activity of prepared films with the aim of finding the most suitable composition for clinical application. Generally, the best results were obtained with sample containing 20 mg of chlorhexidine diacetate carried by vermiculite, with carmellose in the form of nonwoven textile in its structure. In addition to its promising physicomechanical, chemical, and mucoadhesive properties, the formulation inhibited the growth of Staphylococcus and Candida; the effect was prolonged for tens of hours.
C1 [Gajdziok, Jan; Landova, Hana; Dolezel, Petr; Vetchy, David] Univ Vet & Pharmaceut Sci, Dept Pharmaceut, Brno 61242, Czech Republic.
   [Holesova, Sylva] Tech Univ Ostrava, Nanotechnol Ctr, Ostrava 70833, Czech Republic.
   [Holesova, Sylva] Tech Univ Ostrava, Ctr Excellence T4Innovat, Ostrava 70800, Czech Republic.
   [Stembirek, Jan] Univ Hosp Ostrava, Dept Maxillofacial Surg, Ostrava 70800, Czech Republic.
   [Pazdziora, Erich] Inst Publ Hlth Ostrava, Ctr Clin Labs, Ostrava 70200, Czech Republic.
RP Vetchy, D (reprint author), Univ Vet & Pharmaceut Sci, Dept Pharmaceut, Palackeho Trida 1-3, Brno 61242, Czech Republic.
EM vetchy@email.cz
RI Stembirek, Jan/G-7169-2014
OI Stembirek, Jan/0000-0002-1974-3096
FU Ministry of Health of the Czech Republic [1 RVO-FNOs/2012, NT14477]; IT4
   Innovations Centre of Excellence [CZ.1.05/1.1.00/02.0070]
FX This work was supported by Ministry of Health of the Czech Republic
   (Project no. 1 RVO-FNOs/2012 and Project no. NT14477) and the IT4
   Innovations Centre of Excellence (Project reg. no.
   CZ.1.05/1.1.00/02.0070). Authors also thank M. Heliova for SEM images
   and L. Pazourkova for particle size analysis.
CR Andrews GP, 2009, EUR J PHARM BIOPHARM, V71, P505, DOI 10.1016/j.ejpb.2008.09.028
   [Anonymous], 2000, AQUALON SODIUM CARBO
   Averineni RK, 2009, PHARM DEV TECHNOL, V14, P199, DOI 10.1080/10837450802498928
   Bali R, 2014, J MAXILLOFAC ORAL SU, V13, P128, DOI 10.1007/s12663-012-0458-3
   Barba C, 2002, CELLULOSE, V9, P319, DOI 10.1023/A:1021184509189
   Bergaya F, 2006, DEV CLAY SCI, V1, P1
   Bernkop-Schnurch A, 2005, ADV DRUG DELIVER REV, V57, P1569, DOI 10.1016/j.addr.2005.07.002
   Bertesteanu S, 2014, INT J PHARMACEUT, V463, P119, DOI [10.1016/j.ijpharm.2013.12.012, 10.1016/j.jpharm.2013.12.012]
   CAWSON RA, 2001, ORAL DIS CLIN PATHOL
   Cho HJ, 2010, INT J PHARMACEUT, V400, P59, DOI 10.1016/j.ijpharm.2010.08.030
   Coronado-Castellote Laura, 2013, J Clin Exp Dent, V5, pe279, DOI 10.4317/jced.51242
   DELACALLE C, 1988, REV MINERAL, V19, P455
   Ding J, 2012, ACTA BIOMATER, V8, P3643, DOI 10.1016/j.actbio.2012.06.027
   Dixit RP, 2009, J CONTROL RELEASE, V139, P94, DOI 10.1016/j.jconrel.2009.06.014
   Dorko E, 2001, FOLIA MICROBIOL, V46, P443, DOI 10.1007/BF02814436
   Dubolazov AV, 2006, BIOMACROMOLECULES, V7, P1637, DOI 10.1021/bm060090l
   Eisen D., 1998, MOUTH DIAGNOSIS TREA
   Esbensen K. H, 2004, MULTIVARIATE DATA AN
   European Directorate for the Quality of Medicines & Health Care, 2013, EUR PHARM 8 0
   Farmer V. C., 1974, INFRARED SPECTRA MIN
   Gajdziok J, 2012, CHEM LISTY, V106, P632
   Gurusamy K, 2013, COCHRANE DB SYST REV, V8
   Herrera P, 2000, VET MICROBIOL, V74, P259, DOI 10.1016/S0378-1135(00)00157-7
   Holesova S, 2014, MAT SCI ENG C-MATER, V42, P466, DOI 10.1016/j.msec.2014.05.054
   Holesova S, 2013, APPL CLAY SCI, V83-84, P17, DOI 10.1016/j.clay.2013.07.013
   Holesova S, 2010, J COLLOID INTERF SCI, V342, P593, DOI 10.1016/j.jcis.2009.10.051
   Hu CH, 2007, AQUACULTURE, V270, P200, DOI 10.1016/j.aquaculture.2007.01.027
   Hu CH, 2006, APPL CLAY SCI, V31, P180, DOI 10.1016/j.clay.2005.10.010
   Carretero MI, 2010, APPL CLAY SCI, V47, P171, DOI 10.1016/j.clay.2009.10.016
   Carretero MI, 2009, APPL CLAY SCI, V46, P73, DOI 10.1016/j.clay.2009.07.017
   Jain D, 2010, ACTA BIOMATER, V6, P1370, DOI 10.1016/j.actbio.2009.11.001
   Kneiflova J, 1988, Cesk Epidemiol Mikrobiol Imunol, V37, P97
   Kube T, 2006, GRAEF ARCH CLIN EXP, V244, P1385, DOI 10.1007/s00417-006-0326-2
   Kulicke WM, 1996, POLYMER, V37, P2723, DOI 10.1016/0032-3861(96)87634-8
   Kumar V., 2011, INT J PHARM BIOL SCI, V1, P89
   Lalla Rajesh V, 2013, J Calif Dent Assoc, V41, P263
   Lee JW, 2000, J PHARM SCI-US, V89, P850, DOI 10.1002/1520-6017(200007)89:7<850::AID-JPS2>3.3.CO;2-7
   Li HY, 2010, EUR J PHARM SCI, V40, P56, DOI 10.1016/j.ejps.2010.02.007
   Ma YL, 2010, APPL CLAY SCI, V50, P348, DOI 10.1016/j.clay.2010.08.025
   Macias JH, 2013, AM J INFECT CONTROL, V41, P634, DOI 10.1016/j.ajic.2012.10.002
   Madejova J, 2003, VIB SPECTROSC, V31, P1, DOI 10.1016/S0924-2031(02)00065-6
   Madhav NVS, 2012, EXPERT OPIN DRUG DEL, V9, P629, DOI 10.1517/17425247.2012.679260
   Magana SM, 2008, J MOL CATAL A-CHEM, V281, P192, DOI 10.1016/j.molcata.2007.10.024
   Malachova K, 2011, APPL CLAY SCI, V53, P642, DOI 10.1016/j.clay.2011.05.016
   Malachova K, 2009, APPL CLAY SCI, V43, P364, DOI 10.1016/j.clay.2008.11.003
   Mcginity J.W., 2002, Patent No. [US 6375963 BI, 6375963]
   Morales JO, 2011, EUR J PHARM BIOPHARM, V77, P187, DOI 10.1016/j.ejpb.2010.11.023
   Nafee NA, 2004, DRUG DEV IND PHARM, V30, P985, DOI 10.1081/DDC-200037245
   Nair AB, 2013, J CONTROL RELEASE, V166, P10, DOI 10.1016/j.jconrel.2012.11.019
   Ozdemir G, 2010, APPL CLAY SCI, V48, P319, DOI 10.1016/j.clay.2010.01.001
   Pasich Ewa, 2013, Medycyna Doswiadczalna i Mikrobiologia, V65, P187
   Perumal VA, 2008, INT J PHARM, V358, P184, DOI 10.1016/j.ijpharm.2008.03.005
   Pinto Andres, 2013, J Calif Dent Assoc, V41, P271
   Prajapati V., 2012, INT J PHARMTECH RES, V4, P582
   Prusov AN, 2007, FIBRE CHEM+, V39, P12, DOI 10.1007/s10692-007-0003-1
   Puratchikody A, 2011, ACTA PHARMACEUT, V61, P157, DOI 10.2478/v10007-011-0011-9
   Racz I, 1997, CELLULOSE, V4, P293, DOI 10.1023/A:1018400226052
   Rivera-Hidalgo F, 1999, PERIODONTOL 2000, V21, P106, DOI 10.1111/j.1600-0757.1999.tb00171.x
   Roy SK, 2010, TROP J PHARM RES, V9, P91
   Russell J. D., 1994, CLAY MINERALOGY SPEC, P11, DOI DOI 10.1007/978-94-011-0727-3_2
   Salamat-Miller N, 2005, ADV DRUG DELIVER REV, V57, P1666, DOI 10.1016/j.addr.2005.07.003
   Shidhaye SS, 2008, AAPS PHARMSCITECH, V9, P909, DOI 10.1208/s12249-008-9125-x
   Shizoru H., 1966, AM MINERAL, P1124
   SILVERSTEIN RM, 1991, SPECTROMETRIC IDENTI
   Slezak R., 2007, PREKLINICKA PARODONT
   SLsirak M., 2010, BOSNIAN J BASIC MED, V10, P32
   Socrates G., 2001, INFRARED RAMAN CHARA
   Sudhakar Y, 2006, J CONTROL RELEASE, V114, P15, DOI 10.1016/j.jconrel.2006.04.012
   Tan SZ, 2008, CHINESE J CHEM, V26, P865, DOI 10.1002/cjoc.200890160
   Tu YY, 2015, J FORMOS MED ASSOC, V114, P17, DOI 10.1016/j.jfma.2012.12.008
   Valaskova M, 2010, GEOCHIM COSMOCHIM AC, V74, P6287, DOI 10.1016/j.gca.2010.08.025
   Vetchy D, 2014, EUR J PHARM BIOPHARM, V86, P498, DOI 10.1016/j.ejpb.2013.12.002
   Walker G. F., 1961, XRAY IDENTIFICATION, P297
   Young H, 2014, J BONE JOINT SURG AM, V96A, P162, DOI 10.2106/JBJS.L.01379
NR 74
TC 3
Z9 3
U1 1
U2 30
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 580146
DI 10.1155/2015/580146
PG 15
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CH8RS
UT WOS:000354304400001
PM 26064926
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bahl, S
   Shreyas, P
   Trishul, MA
   Suwas, S
   Chatterjee, K
AF Bahl, Sumit
   Shreyas, P.
   Trishul, M. A.
   Suwas, Satyam
   Chatterjee, Kaushik
TI Enhancing the mechanical and biological performance of a metallic
   biomaterial for orthopedic applications through changes in the surface
   oxide layer by nanocrystalline surface modification
SO NANOSCALE
LA English
DT Article
ID FATIGUE LIFE IMPROVEMENT; MESENCHYMAL STEM-CELLS; ATTRITION TREATMENT;
   STAINLESS-STEEL; THIN-FILMS; CRYSTALLOGRAPHIC TEXTURE; CORROSION
   BEHAVIOR; OPTICAL-PROPERTIES; TITANIUM-ALLOYS; GRAIN-SIZE
AB Nanostructured metals are a promising class of biomaterials for application in orthopedics to improve the mechanical performance and biological response for increasing the life of biomedical implants. Surface mechanical attrition treatment (SMAT) is an efficient way of engineering nanocrystalline surfaces on metal substrates. In this work, 316L stainless steel (SS), a widely used orthopedic biomaterial, was subjected to SMAT to generate a nanocrystalline surface. Surface nanocrystallization modified the nature of the oxide layer present on the surface. It increased the corrosion-fatigue strength in saline by 50%. This increase in strength is attributed to a thicker oxide layer, residual compressive stresses, high strength of the surface layer, and lower propensity for intergranular corrosion in the nanocrystalline layer. Nanocrystallization also enhanced osteoblast attachment and proliferation. Intriguingly, wettability and surface roughness, the key parameters widely acknowledged for controlling the cellular response remained unchanged after nanocrystallization. The observed cellular behavior is explained in terms of the changes in electronic properties of the semiconducting passive oxide film present on the surface of 316L SS. Nanocrystallization increased the charge carrier density of the n-type oxide film likely preventing denaturation of the adsorbed cell-adhesive proteins such as fibronectin. In addition, a net positive charge developed on the otherwise neutral oxide layer, which is known to facilitate cellular adhesion. The role of changes in the electronic properties of the oxide films on metal substrates is thus highlighted in this work. This study demonstrates the advantages of nanocrystalline surface modification by SMAT for processing metallic biomaterials used in orthopedic implants.
C1 [Bahl, Sumit; Shreyas, P.; Trishul, M. A.; Suwas, Satyam; Chatterjee, Kaushik] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
RP Chatterjee, K (reprint author), Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
EM kchatterjee@materials.iisc.ernet.in
OI Bahl, Sumit/0000-0002-9471-5001; Chatterjee, Kaushik/0000-0002-7204-2926
FU Department of Science and Technology (DST), India; Department of Atomic
   Energy-Board of Research in Nuclear Sciences (DAE-BRNS), India; DST
FX This work was funded by the Department of Science and Technology (DST),
   India and Department of Atomic Energy-Board of Research in Nuclear
   Sciences (DAE-BRNS), India. K.C. acknowledges the Ramanujan fellowship
   from DST. The authors thank Prof. Praveen C. Ramamurthy for access to
   the electrochemical workstation. The help rendered by Prof. Chandan
   Srivastava and Dr Punith Kumar in impedance measurements is gratefully
   acknowledged.
CR Akl AA, 2004, APPL SURF SCI, V233, P307, DOI 10.1016/j.apsusc.2004.03.263
   Al-Kuhaili MF, 2012, J ALLOY COMPD, V521, P178, DOI 10.1016/j.jallcom.2012.01.115
   Arifvianto B, 2011, MATER CHEM PHYS, V125, P418, DOI 10.1016/j.matchemphys.2010.10.038
   Bahl S, 2014, RSC ADV, V4, P55677, DOI 10.1039/c4ra08484e
   Bahl S, 2014, RSC ADV, V4, P38078, DOI 10.1039/c4ra05440g
   Bain LE, 2013, ACS APPL MATER INTER, V5, P7236, DOI 10.1021/am4015555
   Bigi A, 2007, J BIOMED MATER RES A, V82A, P213, DOI 10.1002/jbm.a.31132
   Chen F, 2007, J BIOMED MATER RES B, V82B, P183, DOI 10.1002/jbm.b.30720
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Chimmalgi A, 2005, J APPL PHYS, V97, DOI 10.1063/1.1899245
   Cowin S., 1987, HDB BIOENGINEERING
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Di Schino A, 2002, J MATER SCI LETT, V21, P1631, DOI 10.1023/A:1020338103964
   Feng ZC, 2010, CORROS SCI, V52, P3646, DOI 10.1016/j.corsci.2010.07.013
   Gelderman K, 2007, J CHEM EDUC, V84, P685, DOI 10.1021/ed084p685
   Gittens RA, 2012, BIOMATERIALS, V33, P8986, DOI 10.1016/j.biomaterials.2012.08.059
   Guillemot F, 2004, APPL PHYS A-MATER, V79, P811, DOI 10.1007/s00339-004-2688-9
   HOEPPNER DW, 1994, WEAR, V173, P189, DOI 10.1016/0043-1648(94)90272-0
   Huiskes R, 1993, Acta Orthop Belg, V59 Suppl 1, P118
   Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005
   Kim TN, 2007, BIOMED MATER, V2, pS117, DOI 10.1088/1748-6041/2/3/S06
   Knoner G, 2003, P NATL ACAD SCI USA, V100, P3870, DOI 10.1073/pnas.0730783100
   Liu XD, 2006, CORROS SCI, V48, P3309, DOI 10.1016/j.corsci.2005.12.003
   Lu K, 2004, MAT SCI ENG A-STRUCT, V375, P38, DOI 10.1016/j.msea.2003.10.261
   Ma E, 2003, SCRIPTA MATER, V49, P663, DOI 10.1016/S1359-6462(03)00396-8
   Mathieu JP, 2006, J MATER PROCESS TECH, V173, P29, DOI 10.1016/j.jmatprotec.2005.11.007
   McCafferty E, 2003, CORROS SCI, V45, P1421, DOI 10.1016/S0010-938X(02)00231-7
   Mehranfar M, 2011, MAT SCI ENG A-STRUCT, V528, P3404, DOI 10.1016/j.msea.2011.01.016
   Miyamoto H, 2008, CORROS SCI, V50, P1215, DOI 10.1016/j.corsci.2008.01.024
   Mordyuk BN, 2006, MAT SCI ENG A-STRUCT, V437, P396, DOI 10.1016/j.msea.2006.07.119
   NAVAI F, 1995, J MATER SCI, V30, P1166, DOI 10.1007/BF00356115
   Petersson IU, 2009, BIOMATERIALS, V30, P4471, DOI 10.1016/j.biomaterials.2009.05.042
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   ROFAGHA R, 1991, SCRIPTA METALL MATER, V25, P2867, DOI 10.1016/0956-716X(91)90171-V
   Roland T, 2006, SCRIPTA MATER, V54, P1949, DOI 10.1016/j.scriptamat.2006.01.049
   Sato M, 2004, SCI TECHNOL ADV MAT, V5, P145, DOI 10.1016/j.stam.2003.10.015
   Shaarbaf M, 2008, MAT SCI ENG A-STRUCT, V473, P28, DOI 10.1016/j.msea.2007.03.065
   Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027
   Steinemann SG, 1986, BIOL BIOMECHANICAL P
   Takakuwa O, 2012, INT J HYDROGEN ENERG, V37, P5268, DOI 10.1016/j.ijhydene.2011.12.035
   Tao NR, 2002, ACTA MATER, V50, P4603, DOI 10.1016/S1359-6454(02)00310-5
   Tian YS, 2005, APPL SURF SCI, V242, P177, DOI 10.1016/j.apsusc.2004.08.011
   Tsay LW, 2008, CORROS SCI, V50, P2506, DOI 10.1016/j.corsci.2008.06.044
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Wang TS, 2006, SURF COAT TECH, V200, P4777, DOI 10.1016/j.surfcoat.2005.04.046
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Williams D. F., 1977, P INT S RETR AN ORTH
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   Xie JH, 2002, MATER CHARACT, V48, P271, DOI 10.1016/S1044-5803(02)00245-0
   Zhang HW, 2003, ACTA MATER, V51, P1871, DOI 10.1016/S1359-6454(02)00594-3
NR 50
TC 18
Z9 18
U1 0
U2 34
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PY 2015
VL 7
IS 17
BP 7704
EP 7716
DI 10.1039/c5nr00574d
PG 13
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CH4DI
UT WOS:000353981700026
PM 25833718
OA Bronze
DA 2018-10-20
ER

PT J
AU Johnson, NR
   Wang, YD
AF Johnson, Noah R.
   Wang, Yadong
TI Drug Delivery Systems for Wound Healing
SO CURRENT PHARMACEUTICAL BIOTECHNOLOGY
LA English
DT Article
DE Biomaterial; coacervate; controlled release; drug delivery; hydrogel;
   microparticle; scaffold; wound healing
ID FIBROBLAST-GROWTH-FACTOR; INCORPORATED COLLAGEN MATRICES; LOCAL
   ANTIBIOTIC DELIVERY; GENETICALLY DIABETIC MICE; INDUCED DECUBITUS ULCER;
   IMPAIRED DB/DB MICE; IN-VITRO EVALUATION; FULL-THICKNESS; FIBRIN
   SCAFFOLD; TISSUE REGENERATION
AB Protein, gene, and small molecule therapies hold great potential for facilitating comprehensive tissue repair and regeneration. However, their clinical value will rely on effective delivery systems which maximize their therapeutic benefit. Significant advances have been made in recent years towards biomaterial delivery systems to satisfy this clinical need. Here we summarize the most outstanding advances in drug delivery technology for cutaneous wound healing.
C1 [Johnson, Noah R.; Wang, Yadong] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Johnson, Noah R.; Wang, Yadong] McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Wang, Yadong] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15219 USA.
   [Wang, Yadong] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   [Wang, Yadong] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15219 USA.
RP Wang, YD (reprint author), 320 Benedum Hall,3700 OHara St, Pittsburgh, PA 15261 USA.
EM yaw20@pitt.edu
FU National Institutes of Health (NIH) [2T32HL076124]; National Science
   Foundation (NSF) [IIP-1444774]; American Heart Association
   [12EIA9020016]
FX The authors would like to thank Dr. Mantosh Sinha for providing the
   hydrogel image, Dr. Eric Jeffries for providing the electrospun scaffold
   image, and Mr. Andrew Glowacki for providing the microparticles image.
   This work was supported by grants from the National Institutes of Health
   (NIH 2T32HL076124), the National Science Foundation (NSF IIP-1444774),
   and the American Heart Association (12EIA9020016).
CR Adhirajan N, 2009, EUR J PHARM SCI, V36, P235, DOI 10.1016/j.ejps.2008.09.010
   Adhirajan N, 2009, J PHARM PHARMACOL, V61, P1617, DOI 10.1211/jpp/61.12.0005
   [Anonymous], 2012, REVIEW
   Anumolu SS, 2011, BIOMATERIALS, V32, P1204, DOI 10.1016/j.biomaterials.2010.08.117
   Arul V, 2005, J BIOMED MATER RES B, V73B, P383, DOI 10.1002/jbm.b.30246
   Arul V, 2012, J BIOMATER APPL, V26, P917, DOI 10.1177/0885328210390402
   Arul V, 2007, LIFE SCI, V80, P275, DOI 10.1016/j.lfs.2006.09.018
   Balakrishnan B, 2006, BIOMATERIALS, V27, P1355, DOI 10.1016/j.biomaterials.2005.08.021
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Behm B., 2011, J EUR ACAD DERMATOL
   Bertoncelj V., 2014, EUR J PHARM BIOPHARM
   Blecher K, 2012, NANOMED-NANOTECHNOL, V8, P1364, DOI 10.1016/j.nano.2012.02.014
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Branski LK, 2007, GENE THER, V14, P1, DOI 10.1038/sj.gt.3302837
   Breen A, 2009, TISSUE ENG PART B-RE, V15, P201, DOI [10.1089/ten.teb.2008.0527, 10.1089/ten.TEB.2008.0527]
   Breen A, 2009, J BIOMED MATER RES A, V89A, P876, DOI 10.1002/jbm.a.32039
   Breen AM, 2008, BIOMATERIALS, V29, P3143, DOI 10.1016/j.biomaterials.2008.04.020
   Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chereddy KK, 2013, J CONTROL RELEASE, V171, P208, DOI 10.1016/j.jconrel.2013.07.015
   Choi JS, 2008, BIOMATERIALS, V29, P587, DOI 10.1016/j.biomaterials.2007.10.012
   Choi JS, 2011, J MATER CHEM, V21, P5258, DOI 10.1039/c0jm03706k
   Choi JK, 2012, BIOMATERIALS, V33, P8579, DOI 10.1016/j.biomaterials.2012.07.061
   Chu HH, 2011, J CONTROL RELEASE, V150, P157, DOI 10.1016/j.jconrel.2010.11.025
   Chu YJ, 2010, WOUND REPAIR REGEN, V18, P499, DOI 10.1111/j.1524-475X.2010.00612.x
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   de Kruif CG, 2004, CURR OPIN COLLOID IN, V9, P340, DOI 10.1016/j.cocis.2004.09.006
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   *FDA, 2008, HLTH HUMAN SERVICES
   Fu SZ, 2014, J BIOMED MATER RES B, V102, P533, DOI 10.1002/jbm.b.33032
   Gainza G, 2014, J CONTROL RELEASE, V185, P51, DOI 10.1016/j.jconrel.2014.04.032
   Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Gomathi K, 2003, BIOMATERIALS, V24, P2767, DOI 10.1016/S0142-9612(03)00059-0
   Gong CY, 2013, BIOMATERIALS, V34, P6377, DOI 10.1016/j.biomaterials.2013.05.005
   Gopinath D, 2004, BIOMATERIALS, V25, P1911, DOI 10.1016/S0142-9612(03)00625-2
   Guo R, 2011, BIOMATERIALS, V32, P1019, DOI 10.1016/j.biomaterials.2010.08.087
   Guo R, 2010, BIOMATERIALS, V31, P7308, DOI 10.1016/j.biomaterials.2010.06.013
   Han G, 2012, AM J PATHOL, V180, P1465, DOI 10.1016/j.ajpath.2011.12.013
   Hardwicke J, 2008, J CONTROL RELEASE, V130, P275, DOI 10.1016/j.jconrel.2008.07.023
   Hardwicke J, 2010, MOL PHARMACEUT, V7, P699, DOI 10.1021/mp9002656
   Hardwicke JT, 2011, J CONTROL RELEASE, V152, P411, DOI 10.1016/j.jconrel.2011.03.016
   Henderson PW, 2011, WOUND REPAIR REGEN, V19, P420, DOI 10.1111/j.1524-475X.2011.00687.x
   Hirsch T, 2007, FRONT BIOSCI-LANDMRK, V12, P2507, DOI 10.2741/2251
   Hollier B, 2005, EXP CELL RES, V305, P221, DOI 10.1016/j.yexcr.2005.01.004
   Hong JP, 2008, ANN PLAS SURG, V61, P457, DOI 10.1097/SAP.0b013e31815b1feac
   Hong SR, 2001, BIOMATERIALS, V22, P2777, DOI 10.1016/S0142-9612(01)00021-7
   Huang S, 2006, J MICROENCAPSUL, V23, P277, DOI 10.1080/02652040500435170
   Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6
   Huang ZF, 2011, WOUND REPAIR REGEN, V19, P633, DOI 10.1111/j.1524-475X.2011.00722.x
   Hyde C, 2004, J INVEST DERMATOL, V122, P1198, DOI 10.1111/j.0022-202X.2004.022527.x
   Ishihara Masayuki, 2006, Current Drug Delivery, V3, P351, DOI 10.2174/156720106778559047
   Ito R, 2013, TISSUE ENG PT A, V19, P1398, DOI [10.1089/ten.tea.2012.0375, 10.1089/ten.TEA.2012.0375]
   Jackson SR, 2009, J ORTHOP RES, V27, P903, DOI 10.1002/jor.20828
   Jiang W, 2008, J ALLOY COMPD, V459, P508, DOI 10.1016/j.jallcom.2007.05.020
   Johnson N.R., 2014, EXPERT OPIN DRUG DEL, P1
   Johnson NR, 2014, ACTA BIOMATER, V10, P40, DOI 10.1016/j.actbio.2013.09.012
   Johnson NR, 2013, J CONTROL RELEASE, V166, P124, DOI 10.1016/j.jconrel.2012.11.004
   Kamel RA, 2013, J AM COLL SURGEONS, V217, P533, DOI 10.1016/j.jamcollsurg.2013.03.027
   Kanda N, 2014, J TISSUE ENG REGEN M, V8, P29, DOI 10.1002/term.1492
   Kanda N, 2012, ANN PLAS SURG, V69, P569, DOI 10.1097/SAP.0b013e318222832f
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Kawai K, 2005, BRIT J PLAST SURG, V58, P1115, DOI 10.1016/j.bjps.2005.04.010
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Kondo S, 2012, J BIOMAT SCI-POLYM E, V23, P629, DOI 10.1163/092050611X555687
   Koria P, 2012, BIODRUGS, V26, P163, DOI 10.2165/11631850-000000000-00000
   Koria P, 2011, P NATL ACAD SCI USA, V108, P1034, DOI 10.1073/pnas.1009881108
   Kulkarni M, 2014, BIOMATERIALS, V35, P2001, DOI 10.1016/j.biomaterials.2013.11.003
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Lai H.-J., 2014, ACTA BIOMATER
   Lee JH, 2013, J PHARM SCI-US, V102, P4109, DOI 10.1002/jps.23725
   Lee KW, 2013, BIOMATERIALS, V34, P9877, DOI 10.1016/j.biomaterials.2013.08.082
   Li B, 2009, BIOMATERIALS, V30, P3486, DOI 10.1016/j.biomaterials.2009.03.008
   Li Y, 2010, MOL PHARMACEUT, V7, P254, DOI [10.1021/mp900237f, 10.1021/mp900237t]
   Liu YC, 2007, WOUND REPAIR REGEN, V15, P245, DOI 10.1111/j.1524-475X.2007.00211.x
   Losi P, 2013, ACTA BIOMATER, V9, P7814, DOI 10.1016/j.actbio.2013.04.019
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MacEwan SR, 2010, BIOPOLYMERS, V94, P60, DOI 10.1002/bip.21327
   Martinez LR, 2009, J INVEST DERMATOL, V129, P2463, DOI 10.1038/jid.2009.95
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Matsumoto S, 2013, PRS-GLOB OPEN, V1, DOI 10.1097/GOX.0b013e3182a88787
   Matsumoto Y, 2010, J BIOMAT SCI-POLYM E, V21, P715, DOI 10.1163/156856209X435844
   Meng X, 2010, J MATER SCI-MATER M, V21, P1751, DOI 10.1007/s10856-010-3996-6
   Merrell JG, 2009, CLIN EXP PHARMACOL P, V36, P1149, DOI 10.1111/j.1440-1681.2009.05216.x
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   Mizuno K, 2003, J BIOMED MATER RES A, V64A, P177, DOI 10.1002/jbm.a.10396
   Moura LIF, 2014, ACTA BIOMATER, V10, P843, DOI 10.1016/j.actbio.2013.09.040
   Tran NQ, 2011, BIOMACROMOLECULES, V12, P2872, DOI 10.1021/bm200326g
   Noel SP, 2008, CLIN ORTHOP RELAT R, V466, P1377, DOI 10.1007/s11999-008-0228-1
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   OVERBEEK JAN THEODOOR GERARD, 1957, J CELL AND COMP PHYSIOL, V49, P7, DOI 10.1002/jcp.1030490404
   Pandit AS, 2000, J BIOMATER APPL, V14, P229, DOI 10.1177/088532820001400303
   Pandit AS, 1998, GROWTH FACTORS, V15, P113, DOI 10.3109/08977199809117187
   Park HJ, 2012, BIOMATERIALS, V33, P9148, DOI 10.1016/j.biomaterials.2012.09.005
   Porporato PE, 2012, ANGIOGENESIS, V15, P581, DOI 10.1007/s10456-012-9282-0
   Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782
   Ribeiro MP, 2013, MAT SCI ENG C-MATER, V33, P2958, DOI 10.1016/j.msec.2013.03.025
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Smith JK, 2013, CLIN ORTHOP RELAT R, V471, P3158, DOI 10.1007/s11999-013-2988-5
   Smith JK, 2010, J BIOMED MATER RES B, V94B, P203, DOI 10.1002/jbm.b.31642
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Stinner DJ, 2010, J ORTHOP TRAUMA, V24, P592, DOI 10.1097/BOT.0b013e3181ed296c
   Sun WJ, 2010, J BIOMED MATER RES A, V92A, P887, DOI 10.1002/jbm.a.32445
   Tan Q, 2014, J TISSUE ENG REGEN M, V8, P195, DOI 10.1002/term.1513
   Tortelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079610
   Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102
   Uebersax L, 2009, TISSUE ENG PART B-RE, V15, P263, DOI 10.1089/ten.TEB.2008.0668
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Upton Z, 2008, J INVEST DERMATOL, V128, P1535, DOI 10.1038/sj.jid.5701148
   Upton Z, 2011, INT WOUND J, V8, P522, DOI 10.1111/j.1742-481X.2011.00859.x
   Wang W, 2008, LIFE SCI, V82, P190, DOI 10.1016/j.lfs.2007.11.009
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Xie Y., 2011, J CONTROL RELEASE
   Xie ZW, 2013, ACTA BIOMATER, V9, P9351, DOI 10.1016/j.actbio.2013.07.030
   Yan X, 2010, DIABETES RES CLIN PR, V90, P66, DOI 10.1016/j.diabres.2010.07.001
   Yang HS, 2011, EXP MOL MED, V43, P622, DOI 10.3858/emm.2011.43.11.070
   Yang Y, 2012, MOL PHARMACEUT, V9, P48, DOI 10.1021/mp200246b
   Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042
NR 123
TC 5
Z9 5
U1 1
U2 25
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2010
EI 1873-4316
J9 CURR PHARM BIOTECHNO
JI Curr. Pharm. Biotechnol.
PY 2015
VL 16
IS 7
BP 621
EP 629
DI 10.2174/1389201016666150206113720
PG 9
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA CG9QZ
UT WOS:000353654100005
PM 25658378
DA 2018-10-20
ER

PT J
AU Dubey, P
   Nawale, L
   Sarkar, D
   Nisal, A
   Prabhune, A
AF Dubey, Parul
   Nawale, Laxman
   Sarkar, Dhiman
   Nisal, Anuya
   Prabhune, Asmita
TI Sophorolipid assisted tunable and rapid gelation of silk fibroin to form
   porous biomedical scaffolds
SO RSC ADVANCES
LA English
DT Article
ID HYDROGELS; BIOMATERIAL; GROWTH; ASSAY; SOL
AB Three dimensional polymer hydrogels, based on both natural and synthetic polymers, are increasingly being used as scaffolds and drug delivery vehicles for biomedical applications. Fibrous protein, silk fibroin (SF), obtained from the Bombyx mori silkworm is a promising candidate in this area. However, SF has a long gelation time of about a few weeks that can only be reduced by non-physiological treatments (e. g. high temperature, ultrasonication and low pH) or by addition of a chemical and non-biodegradable polymer and/or surfactant. We report here accelerated gelation of SF under physiological conditions using a biosurfactant, sophorolipid (SL) as a gelling agent. SL and SF are completely miscible and form a very clear solution upon mixing. Hence it is interesting to see that this clear solution gels in a time span of just a few hours. The hydrogels so formed have pore architecture, porosities and mechanical stability ideally suited for tissue culture applications. Here we also demonstrate that mouse fibroblast cells not only adhere to but also extensively proliferate on these SF-SL scaffolds.
C1 [Dubey, Parul; Prabhune, Asmita] Natl Chem Lab, Biochem Sci Div, Pune 411008, Maharashtra, India.
   [Nawale, Laxman; Sarkar, Dhiman] Natl Chem Lab, Combichem Bioresource Ctr, OCD, Pune 411008, Maharashtra, India.
   [Nisal, Anuya] Natl Chem Lab, Polymer Sci & Engn Dept, Pune 411008, Maharashtra, India.
RP Nisal, A (reprint author), Natl Chem Lab, Polymer Sci & Engn Dept, Pune 411008, Maharashtra, India.
EM aa.nisal@ncl.res.in; aa.prabhune@ncl.res.in
FU Council of Scientific and Industrial Research, New Delhi, India; 12th
   Five Year Plan project "Molecules to Materials to devices" [CSC00134]
FX This work is financially supported by the Council of Scientific and
   Industrial Research, New Delhi, India and the 12th Five Year Plan
   project CSC00134 titled "Molecules to Materials to devices". Authors
   would like to thank Ms Chaitali Deshpande for her help during
   rheological measurements.
CR Ashby RD, 2008, BIOTECHNOL LETT, V30, P1093, DOI 10.1007/s10529-008-9653-1
   Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h
   Borzeix F., 2000, US Patent, Patent No. [6.057.302, 6057302]
   Casas JA, 1999, J BIOSCI BIOENG, V88, P488, DOI 10.1016/S1389-1723(00)87664-1
   Chen J., 2006, ENZYME MICROB TECHNO, V39, P501, DOI DOI 10.1016/J.ENZMICTEC.2005.12.022
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   D'Britto V, 2011, NANOSCALE, V3, P2957, DOI 10.1039/c1nr10154d
   Dengle-Pulate V., 2013, J SURFACTANTS DETERG, V17, P543
   Gil ES, 2011, J BIOMED MATER RES A, V99A, P16, DOI 10.1002/jbm.a.33158
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Joshi-Navare K, 2013, BIOMED RES INT, DOI 10.1155/2013/512495
   Joshi-Navare K, 2011, BIOTECHNOL J, V6, P509, DOI 10.1002/biot.201000345
   Kang GD, 2000, MACROMOL RAPID COMM, V21, P788, DOI 10.1002/1521-3927(20000701)21:11<788::AID-MARC788>3.0.CO;2-X
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kjellin M., 2010, SURFACTANTS RENEWABL, P213
   Kundu B, 2012, BIOMATERIALS, V33, P7456, DOI 10.1016/j.biomaterials.2012.06.091
   Leisk GG, 2010, ADV MATER, V22, P711, DOI 10.1002/adma.200902643
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nagarkar S., 2014, US Pat., Patent No. [8779097 B2, 78779097]
   Nagarkar S, 2009, IND ENG CHEM RES, V48, P8014, DOI 10.1021/ie801723f
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Shah V, 2005, ANTIMICROB AGENTS CH, V49, P4093, DOI 10.1128/AAC.49.10.4093-4100.2005
   Van Bogaert INA, 2007, APPL MICROBIOL BIOT, V76, P23, DOI 10.1007/s00253-007-0988-7
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang L, 2013, J BIOMATER NANOBIOTE, V4, P213, DOI DOI 10.4236/JBNB.2013.43026
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wu XL, 2012, ACTA BIOMATER, V8, P2185, DOI 10.1016/j.actbio.2012.03.007
   Yamamoto M, 2000, J MATER SCI-MATER M, V11, P213, DOI 10.1023/A:1008960024262
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yucel T, 2010, J STRUCT BIOL, V170, P406, DOI 10.1016/j.jsb.2009.12.012
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
NR 32
TC 6
Z9 6
U1 1
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 43
BP 33955
EP 33962
DI 10.1039/c5ra04317d
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CG3GR
UT WOS:000353167500032
DA 2018-10-20
ER

PT J
AU Mei, FF
   Peng, Y
   Lu, ST
   Sun, F
   Zhang, Y
   Ge, C
   Zhang, Y
   Gu, HL
   Wang, YD
   Zhao, XW
   Wang, GY
AF Mei, Fangfang
   Peng, Ya
   Lu, Shoutao
   Sun, Fei
   Zhang, Ying
   Ge, Cui
   Zhang, Yong
   Gu, Hualin
   Wang, Yangdan
   Zhao, Xinwei
   Wang, Guoyao
TI Synthesis and Characterization of Biodegradable Poly(lactic-co-glycolic
   acid)
SO Journal of Macromolecular Science Part B-Physics
LA English
DT Article
DE biodegradable; biomaterial; hydrophilicity; poly(lactic-co-glycolic
   acid)
ID DEGRADATION; BLENDS
AB A series of poly(lactic-co-glycolic acid) (PLGA) was synthesized by bulk ring-opening copolymerization with different ratios of L-lactic acid (L-LA) to glycolic acid (GA); stannous octoate [Sn(Oct)2] was used as catalyst. The structures were characterized by FT-IR. The crystallinity and the glass-transition temperature (T-g) were studied by differential scanning calorimeter (DSC). T-g decreased with the increase of GA and the rate of degradation and degree of hydrophilicity increased with the increased content of GA.
C1 [Mei, Fangfang; Peng, Ya; Lu, Shoutao; Sun, Fei] XiHua Univ, Ctr Mat & Energy, Chengdu 610039, Peoples R China.
   [Peng, Ya; Zhang, Ying; Ge, Cui; Zhang, Yong; Gu, Hualin; Wang, Yangdan; Wang, Guoyao] XiHua Univ, Sch Mat Sci & Engn, Chengdu 610039, Peoples R China.
   [Zhao, Xinwei] Tokyo Univ Sci, Dept Phys, Tokyo 162, Japan.
RP Peng, Y (reprint author), XiHua Univ, Sch Mat Sci & Engn, Chengdu 610039, Peoples R China.
EM pengyar@mail.xhu.edu.cn
FU Chinese Ministry of Education [210193]; Science and Technology
   Department of Sichuan Province [2006J13-055]; Educational Commission of
   Sichuan Province of China [12ZA159]; Spring Sunshine Plan of the
   Ministry of Education of China [z20100193]
FX This work was carried out with financial support from the Key Project of
   Chinese Ministry of Education (210193), Applied Fundamental Program from
   Science and Technology Department of Sichuan Province (2006J13-055),
   Educational Commission of Sichuan Province of China (12ZA159), and the
   Spring Sunshine Plan of the Ministry of Education of China (z20100193).
CR Bhardwaj U, 2010, INT J PHARMACEUT, V384, P78, DOI 10.1016/j.ijpharm.2009.09.046
   Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0
   Claes LE, 1996, BIOMATERIALS, V17, P1621, DOI 10.1016/0142-9612(95)00327-4
   Hosseinabadi M.E., 2011, POLYM DEGRAD STABIL, V27, P1105
   Jahno VD, 2007, J BIOMED MATER RES A, V83A, P209, DOI 10.1002/jbm.a.31210
   Lao LH, 2011, J MATER SCI-MATER M, V22, P1873, DOI 10.1007/s10856-011-4374-8
   Liu LJ, 2001, CHINESE CHEM LETT, V12, P663
   Lu DD, 2008, J POLYM SCI POL CHEM, V46, P3802, DOI 10.1002/pola.22729
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   Nahar M, 2009, PHARM RES-DORD, V26, P2588, DOI 10.1007/s11095-009-9973-4
   Pandey A, 2008, J MECH BEHAV BIOMED, V1, P227, DOI 10.1016/j.jmbbm.2007.12.001
   Park JK, 2011, ADV FUNCT MATER, V21, P2906, DOI 10.1002/adfm.201100612
   Soares JS, 2010, BIOMATERIALS, V31, P3032, DOI 10.1016/j.biomaterials.2010.01.008
   Steele TWJ, 2011, ACTA BIOMATER, V7, P1973, DOI 10.1016/j.actbio.2011.02.002
   Wang XY, 2008, MACROMOLECULES, V41, P2791, DOI 10.1021/ma702705s
   Zamiri P, 2010, BIOMATERIALS, V31, P7847, DOI 10.1016/j.biomaterials.2010.06.057
NR 16
TC 2
Z9 2
U1 1
U2 23
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0022-2348
EI 1525-609X
J9 J MACROMOL SCI B
JI J. Macromol. Sci. Part B-Phys.
PY 2015
VL 54
IS 5
BP 562
EP 570
DI 10.1080/00222348.2014.1002325
PG 9
WC Polymer Science
SC Polymer Science
GA CG8ON
UT WOS:000353567700006
DA 2018-10-20
ER

PT J
AU Ding, XL
   Wei, X
   Huang, Y
   Guan, CD
   Zou, TQ
   Wang, S
   Liu, HF
   Fan, YB
AF Ding, Xili
   Wei, Xing
   Huang, Yan
   Guan, Changdong
   Zou, Tongqiang
   Wang, Shuo
   Liu, Haifeng
   Fan, Yubo
TI Delivery of demineralized bone matrix powder using a salt-leached silk
   fibroin carrier for bone regeneration
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; IN-VITRO; OSTEOGENIC
   DIFFERENTIATION; BIOMATERIAL SCAFFOLDS; EXTRACELLULAR-MATRIX; VASCULAR
   GRAFTS; COMPOSITE; REPAIR; HYDROXYAPATITE
AB Demineralized bone matrix (DBM) has been widely used for bone regeneration due to its osteoinductivity and osteoconductivity. However, the use of DBM powder is limited due to the difficulties in handling, the tendency to migrate from graft sites and the lack of stability after surgery. In this study, a mechanically stable, salt-leached porous silk fibroin carrier was used to improve the handling properties of DBM powder and to support the attachment, proliferation and osteogenic differentiation of rat bone marrow derived mesenchymal stem cells (rBMSCs). The DBM-silk fibroin (DBM/SF) scaffolds were fabricated with different contents of DBM powder (0%, 10%, 20%, 40% and 80% DBM/SF scaffolds). It was found that the DBM/SF scaffolds could form a stable composite preventing the migration of DBM powder. Moreover, the microarchitecture and mechanical properties of the scaffolds were influenced by the DBM powder. rBMSCs were seeded on the DBM/SF scaffolds and cultured for 14 days. Cell proliferation assays and cell morphology observations indicated that 20% DBM/SF scaffolds exhibited good cell attachment and proliferation. In addition, compared with the other groups, the cellular function was more actively exhibited on 20% DBM/SF scaffolds, as evident by the real-time reverse transcriptase-polymerase chain reaction (RT-PCR) analysis for osteoblast-related gene markers (e.g. COL1A1, ALP and cbfa1), the immunocytochemical evaluations of osteoblast-related extracellular matrix components (e.g. COL1A1, OCN and ONN) and the ALP activities. All the data suggested that DBM powder could be delivered using a silk fibroin carrier with improved handling characteristics and that 20% DBM/SF scaffolds had great potential as osteogenesis promoting scaffolds for successful applications in bone regeneration.
C1 [Ding, Xili; Huang, Yan; Guan, Changdong; Zou, Tongqiang; Liu, Haifeng; Fan, Yubo] Beihang Univ, Key Lab Biomechan & Mechnobiol, Int Res Ctr Implantable & Intervent Med Devices, Minist Educ,Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China.
   [Wei, Xing; Wang, Shuo] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Orthopaed, Beijing 100048, Peoples R China.
RP Liu, HF (reprint author), Beihang Univ, Key Lab Biomechan & Mechnobiol, Int Res Ctr Implantable & Intervent Med Devices, Minist Educ,Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China.
EM haifengliu@buaa.edu.cn; yubofan@buaa.edu.cn
FU National Key Technology RD Program [2012BAI18B06]; National Natural
   Science Foundation of China [31470938, 81171473, 61227902, 11421202,
   11120101001]; International Joint Research Center of Aerospace
   Biotechnology and Medical Engineering from Ministry of Science and
   Technology of China; 111 Project [B13003]; Research Fund for the
   Doctoral Program of Higher Education of China [20131102130004];
   Fundamental Research Funds for the Central Universities
FX This work was supported by the National Key Technology R&D Program
   (2012BAI18B06), the National Natural Science Foundation of China
   (31470938, 81171473, 61227902, 11421202 and 11120101001), the
   International Joint Research Center of Aerospace Biotechnology and
   Medical Engineering from Ministry of Science and Technology of China,
   the 111 Project (B13003), the Research Fund for the Doctoral Program of
   Higher Education of China (20131102130004) and the Fundamental Research
   Funds for the Central Universities.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0
   Behnam K, 2006, CONNECT TISSUE RES, V47, P271, DOI 10.1080/03008200600995908
   Dall'Agnol Rosiris, 2003, Acta Cir. Bras., V18, P0, DOI 10.1590/S0102-86502003000300003
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003
   Gertzman Arthur A., 2001, Cell and Tissue Banking, V2, P87, DOI 10.1023/A:1014398514168
   Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008
   Han B, 2003, CONNECT TISSUE RES, V44, P160, DOI 10.1080/03008200390215863
   Han B, 2003, J ORTHOPAED RES, V21, P648, DOI 10.1016/S0736-0266(03)00005-6
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   Holt DJ, 2012, ADV DRUG DELIVER REV, V64, P1123, DOI 10.1016/j.addr.2012.04.002
   Huang Y, 2012, NANOSCALE, V4, P2484, DOI 10.1039/c2nr12072k
   Huang Y, 2010, ARCH MED RES, V41, P497, DOI 10.1016/j.arcmed.2010.10.002
   Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Kaur G, 2010, BIOMATERIALS, V31, P1732, DOI 10.1016/j.biomaterials.2009.11.041
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lai GJ, 2014, CARBOHYD POLYM, V111, P288, DOI 10.1016/j.carbpol.2014.04.094
   Li XT, 2008, BIOMATERIALS, V29, P3720, DOI 10.1016/j.biomaterials.2008.06.004
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Lin YC, 2011, CURR NANOSCI, V7, P866, DOI 10.2174/157341311798220556
   Liu GP, 2008, CALCIFIED TISSUE INT, V83, P176, DOI 10.1007/s00223-008-9159-9
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Liu HF, 2013, MACROMOL BIOSCI, V13, P755, DOI 10.1002/mabi.201200470
   Liu HF, 2011, BIOMACROMOLECULES, V12, P2914, DOI 10.1021/bm200479f
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Liu SS, 2013, ACTA BIOMATER, V9, P8991, DOI 10.1016/j.actbio.2013.06.045
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Maddox E, 2000, TISSUE ENG, V6, P441, DOI 10.1089/107632700418146
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Moghadam HG, 2004, J ORAL MAXIL SURG, V62, P202, DOI 10.1016/j.joms.2003.10.002
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Park JS, 2007, FRONT BIOSCI-LANDMRK, V12, P5098, DOI 10.2741/2551
   Qi MC, 2008, INT J ORAL MAX SURG, V37, P453, DOI 10.1016/j.ijom.2007.12.008
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   Thomas CB, 2011, J BIOMAT SCI-POLYM E, V22, P589, DOI 10.1163/092050610X488232
   Tian M, 2012, ACTA BIOMATER, V8, P753, DOI 10.1016/j.actbio.2011.10.030
   Tu JW, 2009, BIOMATERIALS, V30, P4369, DOI 10.1016/j.biomaterials.2009.04.054
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vacanti JP, 1999, LANCET, V354, pSI32
   VANHAASTERT RM, 1994, J MATER SCI-MATER M, V5, P764, DOI 10.1007/BF00120373
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yan Z., 2012, J POROUS MAT, V19, P251
   Yoon SJ, 2008, TISSUE ENG PT A, V14, P539, DOI 10.1089/tea.2007.0129
   Zhang Q, 2012, ACTA BIOMATER, V8, P2628, DOI 10.1016/j.actbio.2012.03.033
NR 59
TC 12
Z9 13
U1 3
U2 41
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 16
BP 3177
EP 3188
DI 10.1039/c5tb00046g
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CF9FC
UT WOS:000352867800007
DA 2018-10-20
ER

PT J
AU Kim, SI
   Sahu, BB
   Kim, SE
   Ali, A
   Choi, EH
   Han, JG
AF Kim, Sung Il
   Sahu, Bibhuti Bhusan
   Kim, Si Eun
   Ali, Anser
   Choi, Eun Ha
   Han, Jeon Geon
TI Controlling conductivity of carbon film for L-929 cell biocompatibility
   using magnetron sputtering plasmas
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID DIAMOND-LIKE CARBON; AMORPHOUS-CARBON; IN-VITRO; BACTERIAL ADHESION;
   NEURONAL GROWTH; NANOTUBES; MEMBRANES; COATINGS; TITANIUM; LAYERS
AB As a material of current interest compatible with many living organisms, carbon has received considerable attention for applications in medicine. To improve and investigate the performance and applications of diamond-like carbon (DLC) films for implantable bio-organs, it is important to optimize the synthesis process from the original deposition conditions to control the characterization of DLC. Simultaneously, it is necessary to develop new techniques and processes that yield DLC films with stronger adhesion to the substrate and better biocompatibility. This work investigates the suitability of sputtering plasmas for application of carbon film biocompatibility in cell growth. This work also reports an approach to the study of the biomedical response of the well-characterized carbon films deposited by a DC unbalanced magnetron sputtering system (UBMS). Conductive carbon films are prepared at a working pressure of 3 mTorr, and their properties are studied under different operating conditions by varying the target power density. In the present work, we have used L-929 cells as the biomaterial. The influence of L-929 cells on the carbon films fabricated using closed field UBMS is studied. The data reveal that the change in L-929 cell growth with 1-5 day's proliferation is caused by the decreasing electrical resistivity with increasing sp(2) bonding structure.
C1 [Kim, Sung Il; Sahu, Bibhuti Bhusan; Han, Jeon Geon] Sungkyunkwan Univ, Inst Plasma Nano Mat, Ctr Adv Plasma Surface Technol, Suwon 440746, South Korea.
   [Kim, Si Eun; Ali, Anser; Choi, Eun Ha] Kwangwoon Univ, Plasma Biosci Res Ctr Dasanjae 101, Seoul 139701, South Korea.
RP Han, JG (reprint author), Sungkyunkwan Univ, Inst Plasma Nano Mat, Ctr Adv Plasma Surface Technol, 300 ChunChun Dong, Suwon 440746, South Korea.
EM ehchoi@kw.ac.kr; hanjg@skku.edu
FU Leading Foreign Research Institute Recruitment Program through the
   National Research Foundation of Korea (NRF) - Ministry of Science, ICT
   and Future Planning (MSIP) [2011-0031643]; Korea Institute for the
   Advancement of Technology (KIAT) - Ministry of Trade, Industry Energy
   (MOTIE) [N0000590]; National Research Foundation of Korea (NRF) grant -
   Korea government (MSIP) [2010-0027963]
FX The authors sincerely thank the anonymous referees for their valuable
   comments that helped significantly in improving the overall outlook of
   the paper. This work was supported by Leading Foreign Research Institute
   Recruitment Program through the National Research Foundation of Korea
   (NRF) funded by the Ministry of Science, ICT and Future Planning (MSIP)
   (2011-0031643) and Korea Institute for the Advancement of Technology
   (KIAT) funded by the Ministry of Trade, Industry & Energy (MOTIE)
   (N0000590). This work was also supported by the National Research
   Foundation of Korea (NRF) grant funded by the Korea government (MSIP)
   (No. 2010-0027963).
CR Acharya M, 1999, J MEMBRANE SCI, V161, P1, DOI 10.1016/S0376-7388(99)00173-8
   Ajayi OO, 2005, TRIBOL LUBR TECHNOL, V61, P40
   Akyol M, 2013, CUMHURIYET MED J, V35, P33
   Berlind T., 2011, ACTA BIOMATER, V3, P1369
   Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
   Bhat S, 2012, J BIOSCI BIOENG, V114, P663, DOI 10.1016/j.jbiosc.2012.07.005
   Bobzin K, 2009, SURF COAT TECH, V204, P1097, DOI 10.1016/j.surfcoat.2009.07.045
   Bougherara H, 2011, MED ENG PHYS, V33, P121, DOI 10.1016/j.medengphy.2010.09.011
   Broo J., 2012, WAR 21 CENTURY CELL
   Caminaga R. M. S., 2014, J APPL BIOL BIOTECHN, V2, P1
   Cao B, 2015, CHEM SCI, V6, P782, DOI 10.1039/c4sc02200a
   Carey JD, 2006, J MATER SCI-MATER EL, V17, P405, DOI 10.1007/s10854-006-8087-6
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chai F, 2008, ACTA BIOMATER, V4, P1369, DOI 10.1016/j.actbio.2008.04.011
   Chang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095590
   Che GL, 1998, NATURE, V393, P346, DOI 10.1038/30694
   Cherian R. S., 2014, J NANOMED NANOTECHNO, V5
   Ching HA, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/1/014402
   Clausen CA, 2013, INT BIODETER BIODEGR, V77, P68, DOI 10.1016/j.ibiod.2012.11.005
   Cui FZ, 2005, SURF COAT TECH, V200, P1009, DOI 10.1016/j.surfcoat.2005.02.157
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Das T, 2007, J MATER SCI-MATER M, V18, P493, DOI 10.1007/s10856-007-2009-x
   Endrino JL, 2008, APPL SURF SCI, V254, P5323, DOI 10.1016/j.apsusc.2008.02.065
   Flores AA, 2009, DIAM RELAT MATER, V18, P1179
   Guzman F., 2013, J PHYS D, V46
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hutchinson I, 1987, PRINCIPLES PLASMA DI
   International Organization for Standardization ISO, 2007, 1099312 ISO, P10993
   JOHANSSON L, 1966, ARK FYS, V31, P201
   Kamata T, 2014, DIAM RELAT MATER, V49, P25, DOI 10.1016/j.diamond.2014.07.007
   Karakecili AG, 2008, COLLOID SURFACE B, V61, P216, DOI 10.1016/j.colsurfb.2007.08.009
   Kim SE, 2010, SURF INTERFACE ANAL, V42, P524, DOI 10.1002/sia.3374
   Kim SI, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.010304
   KLEBER R, 1993, DIAM RELAT MATER, V2, P246, DOI 10.1016/0925-9635(93)90062-7
   Kwok SCH, 2007, DIAM RELAT MATER, V16, P1353, DOI 10.1016/j.diamond.2006.11.001
   Lackner J. M., 2010, BERG HUTTENMANNISCHE, V155, P528
   Li P, 2013, STEM CELLS DEV, V22, P340, DOI 10.1089/scd.2012.0357
   Liao Y, 2011, SCIENCE, V334, P1687, DOI 10.1126/science.1213902
   Lobo AO, 2008, MAT SCI ENG C-BIO S, V28, P532, DOI 10.1016/j.msec.2007.04.016
   Ma SL, 2007, ACTA MATER, V55, P6350, DOI 10.1016/j.actamat.2007.07.046
   Malarkey EB, 2009, NANO LETT, V9, P264, DOI 10.1021/nl802855c
   Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007
   Muller U, 2011, ACTA MATER, V59, P1150, DOI 10.1016/j.actamat.2010.10.048
   Murphy R, 2002, J PHYS CHEM B, V106, P3087, DOI 10.1021/jp0132836
   Musil J, 1998, MATER CHEM PHYS, V54, P116, DOI 10.1016/S0254-0584(98)00020-0
   Oksanen J, 2014, TRIBOL INT, V70, P94, DOI 10.1016/j.triboint.2013.09.005
   Popov AM, 2007, INT J NANOMED, V2, P361
   Rajzer I, 2010, J MATER SCI-MATER M, V21, P2611, DOI 10.1007/s10856-010-4108-3
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   ROBERTSON J, 1992, SURF COAT TECH, V50, P185, DOI 10.1016/0257-8972(92)90001-Q
   Roch T, 2010, DIAM RELAT MATER, V19, P1472, DOI 10.1016/j.diamond.2010.10.003
   Rodil SE, 2003, DIAM RELAT MATER, V12, P931, DOI 10.1016/S0925-9635(02)00217-0
   Sahu BB, 2015, J APPL PHYS, V117, DOI 10.1063/1.4905541
   Sahu BB, 2014, J APPL PHYS, V116, DOI 10.1063/1.4896833
   Schwan J, 1996, J APPL PHYS, V79, P1416, DOI 10.1063/1.360979
   SHERIDAN TE, 1990, J VAC SCI TECHNOL A, V8, P30, DOI 10.1116/1.577093
   Shiflett MB, 2000, J MEMBRANE SCI, V179, P275, DOI 10.1016/S0376-7388(00)00513-5
   Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Thorwarth K, 2014, INT J MOL SCI, V15, P10527, DOI 10.3390/ijms150610527
   TSUJI K, 1993, JPN J APPL PHYS 1, V32, P916, DOI 10.1143/JJAP.32.916
   Wachesk CC, 2013, APPL SURF SCI, V266, P176, DOI 10.1016/j.apsusc.2012.11.124
   Wang J, 2004, BIOMATERIALS, V25, P3163, DOI 10.1016/j.biomaterials.2003.10.010
   Wang JJ, 2013, ACS APPL MATER INTER, V5, P5015, DOI 10.1021/am400778p
   Wang MO, 2013, BIOMACROMOLECULES, V14, P1321, DOI 10.1021/bm301962f
   Willems B, 2014, DIAM RELAT MATER, V41, P25, DOI 10.1016/j.diamond.2013.09.010
   Wu ZR, 2007, SURF COAT TECH, V201, P5710, DOI 10.1016/j.surfcoat.2006.11.032
   Xu T, 1999, J MATER SCI-MATER M, V10, P83, DOI 10.1023/A:1008916903171
   YAMAMOTO S, 1991, ASTROPHYS J, V370, pL103, DOI 10.1086/185987
   Yap SS, 2011, DIAM RELAT MATER, V20, P294, DOI 10.1016/j.diamond.2011.01.013
   Zhao Q, 2007, APPL SURF SCI, V253, P7254, DOI 10.1016/j.apsusc.2007.03.011
   Zheng CL, 2005, SURF COAT TECH, V193, P361, DOI 10.1016/j.surfcoat.2004.08.152
   Zhou H, 2008, DIAM RELAT MATER, V17, P1416, DOI 10.1016/j.diamond.2008.01.047
NR 73
TC 15
Z9 15
U1 1
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 16
BP 3267
EP 3278
DI 10.1039/c4tb01397b
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CF9FC
UT WOS:000352867800017
DA 2018-10-20
ER

PT J
AU Liu, YG
   Chen, ZX
   Wang, SB
   Long, RM
   Fan, JQ
   Chen, AZ
   Wu, WG
AF Liu, Yuangang
   Chen, Zongxiang
   Wang, Shibin
   Long, Ruimin
   Fan, Jingqian
   Chen, Aizheng
   Wu, Wenguo
TI Preparation of ALG-g-Lys and its application as a novel drug carrier
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID ALGINATE; MICROCAPSULES; IMMOBILIZATION; MICROSPHERES; POLYCATION;
   STABILITY; BEHAVIOR; ARGININE; GENIPIN; ENZYME
AB In order to improve alginate microbead stability and further broaden the application of alginate in biomaterials, a new biomaterial, ALG-g-Lys, was prepared and its possibility as a novel drug carrier investigated. The carrier exhibited a sustained release property and preserved activity with no initial burst release, and interestingly, GP-crosslinked ALG-g-Lys microspheres showed obvious fluorescence properties, which showed promising potential for the future drug delivery systems.
C1 [Liu, Yuangang; Chen, Zongxiang; Wang, Shibin; Long, Ruimin; Fan, Jingqian; Chen, Aizheng; Wu, Wenguo] Huaqiao Univ, Coll Chem Engn, Xiamen, Peoples R China.
   [Liu, Yuangang; Wang, Shibin; Chen, Aizheng; Wu, Wenguo] Huaqiao Univ, Inst Pharmaceut Engn, Xiamen, Peoples R China.
RP Liu, YG (reprint author), Huaqiao Univ, Coll Chem Engn, Xiamen, Peoples R China.
EM ygliu@hqu.edu.cn; sbwang@hqu.edu.cn
FU NSFC [31000441, 31170939]; China Postdoctoral Science Foundation
   [2014M551833]; Natural Science Foundation of Fujian Province
   [2013J01189]; Program for New Century Excellent Talents in Fujian
   Province University [2014FJ-NCET-ZR01]; Science and Technology Project
   of Fujian Province, China [2013Y2002]; Scientific Research Foundation
   for Returned Overseas Chinese Scholars (State Education Ministry);
   Promotion Program for Young and Middle-aged Teachers in Science and
   Technology Research of Huaqiao University [ZQN-PY108]
FX We gratefully acknowledge financial support from the NSFC (31000441 and
   31170939), the China Postdoctoral Science Foundation (2014M551833), the
   Natural Science Foundation of Fujian Province (2013J01189), the Program
   for New Century Excellent Talents in Fujian Province University
   (2014FJ-NCET-ZR01), the Science and Technology Project of Fujian
   Province, China (2013Y2002), the Scientific Research Foundation for
   Returned Overseas Chinese Scholars (State Education Ministry) and the
   Promotion Program for Young and Middle-aged Teachers in Science and
   Technology Research of Huaqiao University (ZQN-PY108).
CR Agulhon P, 2014, CARBOHYD POLYM, V112, P525, DOI 10.1016/j.carbpol.2014.05.097
   Bekin S, 2014, SENSOR ACTUAT B-CHEM, V202, P878, DOI 10.1016/j.snb.2014.06.051
   Bhujbal SV, 2014, J MECH BEHAV BIOMED, V37, P196, DOI 10.1016/j.jmbbm.2014.05.020
   Chen HM, 2006, APPL BIOCHEM BIOTECH, V134, P207, DOI 10.1385/ABAB:134:3:207
   Commission C.P., 2010, PHARMACOPOEIA PEOPLE
   Gattas-Asfura KM, 2014, J MATER CHEM B, V2, P8208, DOI 10.1039/c4tb01241k
   Gryshkov O, 2014, MAT SCI ENG C-MATER, V36, P77, DOI 10.1016/j.msec.2013.11.048
   Hui PCL, 2013, COLLOID SURFACE A, V434, P95, DOI 10.1016/j.colsurfa.2013.05.043
   Lau TT, 2010, COMPOS SCI TECHNOL, V70, P1909, DOI 10.1016/j.compscitech.2010.05.015
   Liu YG, 2013, J SOL-GEL SCI TECHN, V67, P66, DOI 10.1007/s10971-013-3051-4
   Liu YG, 2013, J MATER SCI-MATER M, V24, P155, DOI 10.1007/s10856-012-4786-0
   Liu YG, 2012, MATER LETT, V75, P48, DOI 10.1016/j.matlet.2012.01.137
   Pannier A, 2014, J MATER CHEM B, V2, P7896, DOI 10.1039/c4tb00944d
   Rokstad A. M., 2012, IMMUNOBIOLOGY, V217, P1211
   Rokstad AM, 2013, BIOMATERIALS, V34, P621, DOI 10.1016/j.biomaterials.2012.10.012
   Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011
   Taqieddin E, 2004, BIOMATERIALS, V25, P1937, DOI 10.1016/j.biomaterials.2003.08.034
   THOMPSON PD, 1991, BIOCHEMISTRY-US, V30, P8124, DOI 10.1021/bi00247a005
   Wang JC, 2014, MATER LETT, V126, P263, DOI 10.1016/j.matlet.2014.03.178
   Wang SB, 2003, MACROMOL BIOSCI, V3, P347, DOI 10.1002/mabi.200350005
   Yang JS, 2012, CARBOHYD POLYM, V87, P1503, DOI 10.1016/j.carbpol.2011.09.046
NR 21
TC 0
Z9 0
U1 2
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 17
BP 3420
EP 3424
DI 10.1039/c5tb00410a
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA CG5QU
UT WOS:000353349300002
DA 2018-10-20
ER

PT J
AU Liu, C
   Liu, X
   Xue, Y
   Ding, TT
   Sun, J
AF Liu, Chao
   Liu, Xin
   Xue, Yang
   Ding, Tingting
   Sun, Jiao
TI Hydrolyzed tilapia fish collagen modulates the biological behavior of
   macrophages under inflammatory conditions
SO RSC ADVANCES
LA English
DT Article
ID GATED CHLORIDE CHANNEL; TNF-ALPHA PRODUCTION; NF-KAPPA-B; IN-VITRO;
   PROINFLAMMATORY CYTOKINES; CALCIUM INFLUX; CELLS CONTAIN; KUPFFER CELLS;
   GLYCINE; ACTIVATION
AB Implantation of a biomaterial causes an early and local inflammatory reaction, and regulation of the biological behavior of macrophages under inflammatory conditions caused by biomaterials is imperative for the full realization of their function after being implanted. In recent years, hydrolyzed fish collagen has attracted extensive attention resulting from its biological activity. However, to date, no studies have investigated the anti-inflammatory activity of hydrolyzed fish collagen. The aim of this study is to evaluate the effect of hydrolyzed tilapia fish collagen (HFC) on lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages at the gene and protein level and to elucidate its potential mechanism. The results show that glycine rich in HFC can activate the glycine receptor (GlyR) of macrophages, leading to decreased calcium concentration in macrophages, this decrease inhibits the activation of NF-kappa B, and then the inhibition of NF-kappa B further attenuates the inflammatory cytokine gene expression and protein secretion. The current study reveals for the first time that by regulating the biological behavior of the macrophages under an inflammatory state, HFC exhibits specific anti-inflammatory effects. More importantly, the presence of GlyR in RAW264.7 cells is verified for the first time. These findings provide a scientific basis for the future application of HFC in anti-inflammatory biomaterials.
C1 [Liu, Chao; Liu, Xin; Xue, Yang; Ding, Tingting; Sun, Jiao] Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Shanghai Biomat Res & Testing Ctr, Sch Med, Shanghai 200023, Peoples R China.
RP Sun, J (reprint author), Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Shanghai Biomat Res & Testing Ctr, Sch Med, Room 201,2 Bldg,427 Jumen Rd, Shanghai 200023, Peoples R China.
EM Jiaosun59@126.com
FU National Natural Science Foundation of China [31470917]
FX The authors are grateful to Qisheng Gu at the Institute of Shanghai
   Qisheng Biomaterial Technology for technical advice and Nanping Wang at
   the Shanghai Fisheries Research Institute for providing the hydrolyzed
   tilapia fish collagen. This work was supported by grants from the
   National Natural Science Foundation of China (31470917).
CR Amaravani M, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-58
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x
   Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287
   Broekema FI, 2013, CLIN ORAL INVEST, V17, P1273, DOI 10.1007/s00784-012-0809-y
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319
   Ding CH, 2003, CLIN EXP IMMUNOL, V132, P416, DOI 10.1046/j.1365-2249.2003.02167.x
   Froh M, 2002, AM J PHYSIOL-GASTR L, V283, pG856, DOI 10.1152/ajpgi.00503.2001
   Garcia-Macedo R, 2008, EUR J PHARMACOL, V587, P317, DOI 10.1016/j.ejphar.2008.03.051
   Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423
   Hasegawa S, 2011, INFLAMM RES, V60, P1013, DOI 10.1007/s00011-011-0362-1
   Ikejima K, 1997, AM J PHYSIOL-GASTR L, V272, pG1581
   Kajahn Jennifer, 2012, Biomatter, V2, P226, DOI 10.4161/biom.22855
   Lappas M, 2002, BIOL REPROD, V67, P668, DOI 10.1095/biolreprod67.2.668
   Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003
   Liu C, 2014, BIOMACROMOLECULES, V15, P436, DOI 10.1021/bm401780v
   Lo CJ, 2013, J SURG RES, V181, P287, DOI 10.1016/j.jss.2012.07.002
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7
   Meizel S, 2005, MOL REPROD DEV, V72, P250, DOI 10.1002/mrd.20336
   Miura R, 2010, BIOL PHARM BULL, V33, P1148, DOI 10.1248/bpb.33.1148
   Nagai N, 2007, J BIOMED MATER RES A, V82A, P395, DOI 10.1002/jbm.a.31110
   Ohara H, 2010, BIOSCI BIOTECH BIOCH, V74, P2096, DOI 10.1271/bbb.100193
   Perez-Torres I, 2011, CAN J PHYSIOL PHARM, V89, P899, DOI [10.1139/Y11-086, 10.1139/y11-086]
   Qu W, 2002, AM J PHYSIOL-GASTR L, V283, pG1249, DOI 10.1152/ajpgi.00197.2002
   Ryu B, 2010, PEPTIDES, V31, P79, DOI 10.1016/j.peptides.2009.10.019
   Saino E, 2011, BIOMACROMOLECULES, V12, P1900, DOI 10.1021/bm200248h
   Scherer EQ, 2006, CARDIOVASC RES, V70, P79, DOI 10.1016/j.cardiores.2006.01.011
   Sclavons C., 2013, INT J PEPT, V2013
   Seabra V, 1998, J LEUKOCYTE BIOL, V64, P615
   Spittler A, 1999, FASEB J, V13, P563
   Valdes JA, 2007, AM J PHYSIOL-CELL PH, V292, pC1960, DOI 10.1152/ajpcell.00320.2006
   Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421
   Wang HD, 2009, ACTA PHARMACOL SIN, V30, P1107, DOI 10.1038/aps.2009.106
   Wheeler M, 2000, FASEB J, V14, P476
   Wheeler MD, 1999, AM J PHYSIOL-LUNG C, V277, pL952, DOI 10.1152/ajplung.1999.277.5.L952
   Wheeler MD, 1999, CELL MOL LIFE SCI, V56, P843, DOI 10.1007/s000180050030
   Xu YJ, 2011, REGUL PEPTIDES, V172, P58, DOI 10.1016/j.regpep.2011.08.009
   YADID G, 1990, EUR J PHARMACOL, V175, P365, DOI 10.1016/0014-2999(90)90579-U
   Yamashina S, 2001, NUTR CANCER, V40, P197, DOI 10.1207/S15327914NC402_17
   Ye YX, 2012, INT IMMUNOPHARMACOL, V12, P384, DOI 10.1016/j.intimp.2011.12.011
   Zhang JY, 2015, FITOTERAPIA, V100, P35, DOI 10.1016/j.fitote.2014.11.002
   Zhu CF, 2010, APPL PHYSIOL NUTR ME, V35, P797, DOI 10.1139/H10-075
NR 45
TC 4
Z9 4
U1 1
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 39
BP 30727
EP 30736
DI 10.1039/c5ra02355f
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA CF8FK
UT WOS:000352791300044
DA 2018-10-20
ER

PT J
AU Jayakumar, GC
   Mehta, A
   Rao, JR
   Fathima, NN
AF Jayakumar, Gladstone Christopher
   Mehta, Ami
   Rao, Jonnalagadda Raghava
   Fathima, Nishter Nishad
TI Ionic liquids: new age materials for eco-friendly leather processing
SO RSC ADVANCES
LA English
DT Article
ID TECHNOLOGY; INDUSTRY
AB The manufacture of leather is a challenging and complicated process, which converts natural biomaterial to various high end applications. There are several stringent regulations in processing this natural biomaterial skin due to the discharge of effluent and impact on environment. In this study, an attempt has been made to use ionic liquids to remove inter-fibrillary materials from the skin. Cleaner leather processing is a new avenue to explore the existing pollution complications during leather manufacture. Herein, an ionic liquid, 1-butyl-3-methylimidazolium chloride, is used as a fiber opening agent. Conventional reliming process was avoided by the treatment of molten salt. Enzymatic unhairing methods have been adopted for the removal of hairs from the skin. After the complete removal of hair, the pelts are treated with various concentrations of molten salts by the drum method. The pelts treated with low concentrations of molten salts showed better appearance and there was no damage to the pelts. After the fiber opening process, the pelts were subjected to conventional chrome tanning and post tanning processes. The shrinkage temperature of the experimental leathers is around 108-116 degrees C. The physical strength characteristics like tensile strength, tear strength and grain crack index of crust leathers meet the standard norms. Morphological studies ascertain that there was no grain damage and coalescence of fibers. These results show a promising venture for the use of ionic liquid for leather manufacture. This study signifies the role of ionic liquid in the tanning industry and gives a new dimensional approach to existing cleaner processing systems.
C1 [Jayakumar, Gladstone Christopher; Mehta, Ami; Rao, Jonnalagadda Raghava; Fathima, Nishter Nishad] CSIR Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
RP Fathima, NN (reprint author), CSIR Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
EM nishad@clri.res.in
FU CSIR [RIWT-CSC0202]
FX The authors thank CSIR 12th five-year plan project-Research Initiatives
   for Waterless Tanning (RIWT-CSC0202) for financial support. CSIR-CLRI
   Communication Code-1117.
CR Andrea S., 2014, CHEM SOC REV, V43, P7358
   Avetta P, 2013, ACS SUSTAIN CHEM ENG, V1, P1545, DOI 10.1021/sc400294z
   Christopher JG, 2014, J CLEAN PROD, V83, P428, DOI 10.1016/j.jclepro.2014.07.039
   Chung J, 2013, RESOUR CONSERV RECY, V70, P32, DOI 10.1016/j.resconrec.2012.10.005
   CLESCERI LS, 1989, STANDARD METHODS EXA
   Griffini G, 2014, ADV ENG MATER, V5
   IUP 6, 2000, JSLTC, V84, P317
   IUP 8, 2000, JSLTC, V84, P327
   IUP2, 2000, J SOC LEATHER TECHNO, V84, P303
   Kase S, 2006, BRIT J OPHTHALMOL, V90, P96, DOI 10.1136/bjo.2005.078394
   Kyriakos A. E., 2012, COLLOID SURF A, V413, P65
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Madhan B., 2010, J AM LEATHER CHEM AS, V5, P105
   Mehta A, 2014, COLLOID SURFACE B, V117, P376, DOI 10.1016/j.colsurfb.2014.03.014
   Nancy G., 2014, J CLEAN PROD, V79, P249
   Orhan O., 2011, ADV COLLOID INTERFAC, V163, P1
   Saran S, 2013, J CLEAN PROD, V54, P315, DOI 10.1016/j.jclepro.2013.04.017
   Saravanan P, 2014, J CLEAN PROD, V79, P258, DOI 10.1016/j.jclepro.2014.05.022
   Shakilanishi S., 2011, J BIOSCI BIOENG, V111, P128
   Song J, 2012, J SOC LEATH TECH CH, V96, P250
   Souza F. R., 2012, BRAZ J CHEM ENG, V29, P473
   Swarna V. K., 2009, J CLEAN PROD, V17, P507
   Xia Z., 2014, RSC ADV, V4, P56831
   Yimei J., 2014, SEP PURIF TECHNOL, V132, P577
   Zelimir F. K., 2014, COMPUT AIDED CHEM EN, V33, P127
   Zhuojun M., 2012, INT J BIOL MACROMOL, V51, P440
NR 26
TC 10
Z9 10
U1 0
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 40
BP 31998
EP 32005
DI 10.1039/c5ra02167g
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CG3GD
UT WOS:000353165800096
DA 2018-10-20
ER

PT J
AU Wang, YF
   Wang, YM
   Guo, XC
   Xiong, YF
   Guo, MM
   Wang, X
AF Wang, Yifeng
   Wang, Yanmei
   Guo, Xuecheng
   Xiong, Yanfei
   Guo, Mengmeng
   Wang, Xia
TI Microbial Transglutaminase and Tyrosinase Modified Gelatin-Chitosan
   Material
SO SOFT MATERIALS
LA English
DT Article
DE Chitosan; Enzymatic modification; Gelatin; Microbial transglutaminase;
   Tyrosinase
ID CROSS-LINKING; BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES;
   SCAFFOLDS; HYDROGELS; FILMS; BACTERIA; GLUCOSE
AB A dual-enzymatically modified protein-polysaccharide, which is a potential biomaterial especially for biomedical film, is constructed, modified and reinforced entirely by biocompatible and environmentally-friendly biomacromolecules. We use gelatin/chitosan blend as protein-polysaccharide matrix, and then employ microbial transglutaminase and tyrosinase as biological modifiers. The subsequent tests indicated that the stability in aqueous medium, thermal stability, and tensile strength of the modified material have been improved due to the combined effects of two enzymes that microbial transglutaminase can cross-link gelatin and tyrosinase can catalyze gelatin-chitosan conjugation. Furthermore, the modified gelatin-chitosan shows better in vitro antibacterial activity in comparison with unmodified gelatin.
C1 [Wang, Yifeng; Wang, Yanmei; Guo, Xuecheng; Guo, Mengmeng; Wang, Xia] Wuhan Univ Technol, Sch Mat Sci & Engn, Wuhan 430070, Peoples R China.
   [Xiong, Yanfei] Wuhan Univ Technol, Dept Biol Sci & Technol, Wuhan 430070, Peoples R China.
RP Wang, YF (reprint author), Wuhan Univ Technol, Sch Mat Sci & Engn, 122 Luoshi Rd, Wuhan 430070, Peoples R China.
EM yifengwang@whut.edu.cn
FU Fundamental Research Funds for the Central Universities [WUT:
   2012-IV-001, 2013-IV-008]; National Natural Science Foundation of China
   [50703030]; Scientific Research Foundation for the Returned Overseas
   Chinese Scholars from State Education Ministry
FX The work was supported by the Fundamental Research Funds for the Central
   Universities (WUT: 2012-IV-001 and 2013-IV-008), the National Natural
   Science Foundation of China (Grant No. 50703030), and the Scientific
   Research Foundation for the Returned Overseas Chinese Scholars from
   State Education Ministry.
CR Bigi A, 1998, BIOMATERIALS, V19, P2335, DOI 10.1016/S0142-9612(98)00149-5
   Borges MR, 2009, MAT SCI ENG C-BIO S, V29, P519, DOI 10.1016/j.msec.2008.09.013
   Broderick EP, 2005, J BIOMED MATER RES B, V72B, P37, DOI 10.1002/jbm.b.30119
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Chen TH, 2002, BIOPOLYMERS, V64, P292, DOI 10.1002/bip.10196
   Chiono V, 2008, J MATER SCI-MATER M, V19, P889, DOI 10.1007/s10856-007-3212-5
   da Silva MA, 2014, MACROMOL BIOSCI, V14, P817, DOI 10.1002/mabi.201300472
   Dragusin DM, 2012, SOFT MATTER, V8, P9589, DOI 10.1039/c2sm25536g
   Giosafatto CVL, 2014, BIOPOLYMERS, V101, P931, DOI 10.1002/bip.22477
   Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2
   Holappa J, 2006, CARBOHYD POLYM, V65, P114, DOI 10.1016/j.carbpol.2005.11.041
   Huang X, 2013, MAT SCI ENG C-MATER, V33, P4816, DOI 10.1016/j.msec.2013.07.044
   Jatariu (Cadinoiu) A. N., 2013, SOFT MATER, V11, P7616
   Jatariu AN, 2011, J BIOMED MATER RES A, V98A, P342, DOI 10.1002/jbm.a.33122
   Jayasuriya AC, 2010, J MATER SCI-MATER M, V21, P393, DOI 10.1007/s10856-009-3874-2
   Koser SA, 1938, J BACTERIOL, V36, P57
   Li X, 2012, SOFT MATTER, V8, P3781, DOI 10.1039/c2sm06994f
   Liu Y, 2012, J AGR FOOD CHEM, V60, P8963, DOI 10.1021/jf301376b
   McDermott MK, 2004, BIOMACROMOLECULES, V5, P1270, DOI 10.1021/bm034529a
   Mishra D, 2011, MAT SCI ENG C-MATER, V31, P1295, DOI 10.1016/j.msec.2011.04.007
   Pal K, 2013, SOFT MATER, V11, P125, DOI 10.1080/1539445X.2011.586082
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Spanneberg R, 2012, SOFT MATTER, V8, P2222, DOI 10.1039/c2sm06659a
   Stancu IC, 2013, SOFT MATER, V11, P384, DOI 10.1080/1539445X.2011.642091
   Thakur G, 2011, J MATER SCI-MATER M, V22, P115, DOI 10.1007/s10856-010-4185-3
   Wang YF, 2012, COLLOID SURFACE B, V100, P77, DOI 10.1016/j.colsurfb.2012.05.030
   Wu HD, 2012, MAT SCI ENG C-MATER, V32, P207, DOI 10.1016/j.msec.2011.10.020
   Xiao B, 2011, CARBOHYD POLYM, V83, P144, DOI 10.1016/j.carbpol.2010.07.032
   Yang XH, 2009, J ADHESION, V85, P576, DOI 10.1080/00218460902996788
NR 29
TC 8
Z9 8
U1 8
U2 33
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1539-445X
EI 1539-4468
J9 SOFT MATER
JI Soft Mater.
PY 2015
VL 13
IS 1
BP 32
EP 38
DI 10.1080/1539445X.2014.1003270
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA CG8PR
UT WOS:000353572000006
DA 2018-10-20
ER

PT J
AU Gao, J
   Ti, CP
   Chen, N
AF Gao, Juan
   Ti, Chaopu
   Chen, Ning
TI Environmental Comparison of Straw Applications Based on a Life Cycle
   Assessment Model and Emergy Evaluation
SO BIORESOURCES
LA English
DT Review
DE Straw application; Life cycle assessment (LCA); Emergy evaluation;
   Bioethanol; Greenhouse gas emission
ID BIOETHANOL PRODUCTION; ETHANOL; RESIDUES; ACCOUNT; CROPS; LCA
AB Straw is considered to be a renewable resource for bioenergy and biomaterial. However, about 70% of straw is burned in fields, which causes serious air pollution in China. In this study, a life cycle assessment (LCA) model, together with emergy evaluation, was built to compare four straw applications after harvest vs. direct burning, including bioethanol (BE), combined heat and power plant (CHP), corrugated base paper (CP), and medium-density fiberboard (MDF). The results showed that BE and MDF would avoid greenhouse gas (GHG) emissions by 82% and 36%, respectively, while CHP and CP would emit 57% and 152% more GHG, respectively, compared with direct straw burning. Bioethanol had the highest renewability indicator (RI) of 47.7%, and MDF obtained the greatest profit of 657 Yuan.bale(-1). The applications CHP and CP had low RI (< 10.3%) and profit (< 180 Yuan.bale(-1)). Due to water recycling and electrical power as a coproduct, BE had the lowest value (3 x 10(11) sej.Yuan(-1)) of EmPM (emergy per unit money profit); the EmPM value of CP was 18.6 times higher than that of BE. The four straw applications would also greatly reduce particles emission (57 to 98%) to air. BE was judged to be the most environmentally friendly application among the four straw applications. Imposing a carbon tax would encourage investment in BE, but discourage the applications CHP and CP.
C1 [Gao, Juan; Chen, Ning] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing 210008, Jiangsu, Peoples R China.
   [Ti, Chaopu] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.
RP Gao, J (reprint author), Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing 210008, Jiangsu, Peoples R China.
EM juangao@issas.ac.cn
FU National Science Foundation of China (NSFC) [41201575]
FX This research was funded by the National Science Foundation of China
   (NSFC) No. 41201575. We thank Cun Liu for his help with the Monte Carlo
   analysis.
CR 21food, 2013, CORN ETH PRIC
   Baral A, 2012, ENVIRON SCI TECHNOL, V46, P2436, DOI 10.1021/es2025615
   Baral A, 2010, ENVIRON SCI TECHNOL, V44, P800, DOI 10.1021/es902571b
   Brown MT, 2004, ECOL MODEL, V178, P1, DOI 10.1016/j.ecolmodel.2003.12.001
   Cao GL, 2008, J ENVIRON SCI-CHINA, V20, P50, DOI 10.1016/S1001-0742(08)60007-8
   Cherubini F, 2010, APPL ENERG, V87, P47, DOI 10.1016/j.apenergy.2009.08.024
   del Campo I, 2006, IND CROP PROD, V24, P214, DOI 10.1016/j.indcrop.2006.06.014
   European Commission-Joint Research Centre-Institute for Environment and Sustainability, 2010, 24708 EUR EN EUR COM
   Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416
   Forster P, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129
   Frischknecht R., 2011, ECOINVENT VERSION 2
   Frischknocht R., 2007, OVERVIEW METHODOLOGY
   Fronning BE, 2008, AGRON J, V100, P1703, DOI 10.2134/agronj2008.0052
   Gao J, 2011, AGRON J, V103, P844, DOI 10.2134/agronj2010.0445
   Gao X., 2010, ACTA AGR JIANGXI, V22, P130
   Guinee J., 2001, LCA OPERATIONAL GUID
   Hau JL, 2004, ENVIRON SCI TECHNOL, V38, P3768, DOI 10.1021/es034513s
   Hossaini N., 2012, J SUSTAINABLE DEV, V5, P1
   Huang J., 2008, J SHENGYANG I ENG, V4, P7
   IETA, 2012, GREENH GAS MARK 2012
   ISO (International Organization for Standardization, 2006, 140402006 ISO
   ISO (International Organization for Standardization, 2006, 140442006 ISO
   Jiang MM, 2008, COMMUN NONLINEAR SCI, V13, P2337, DOI 10.1016/j.cnsns.2007.04.025
   Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002
   Lardon L, 2009, ENVIRON SCI TECHNOL, V43, P6475, DOI 10.1021/es900705j
   Lau MW, 2009, P NATL ACAD SCI USA, V106, P1368, DOI 10.1073/pnas.0812364106
   Li XJ, 2010, BIORESOURCE TECHNOL, V101, P4662, DOI 10.1016/j.biortech.2010.01.053
   Liu Li-hua, 2011, Huanjing Kexue, V32, P1242
   Maung T. A., 2008, EC BIOMASS FUELS ELE
   Naik S, 2010, RENEW ENERG, V35, P1624, DOI 10.1016/j.renene.2009.08.033
   Odum H. T, 1996, ENV ACCOUNTING EMERG
   Raugei M, 2014, ECOL MODEL, V271, P4, DOI 10.1016/j.ecolmodel.2012.11.025
   Rugani B, 2012, ENVIRON SCI TECHNOL, V46, P4701, DOI 10.1021/es203440n
   Steubing B, 2012, ENVIRON SCI TECHNOL, V46, P164, DOI 10.1021/es202154k
   Tabil L, 2011, BIOFUELS ENG PROCESS
   Volz T., 2013, GABI 6 0 SOFTWARE SY
   Wang M., 2001, ANLESDTM163 US DEP E
   Wang M., 2010, GREENHOUSE GASES REG
   Xi YG, 2009, ECOL ENG, V35, P1677, DOI 10.1016/j.ecoleng.2007.11.006
   Xiao C., 2005, BLACK LIQUOR CROP ST
   Yan X., 2010, AGR ECOLOGICAL SERIE
   Ye XP, 2007, BIORESOURCE TECHNOL, V98, P1077, DOI 10.1016/j.biortech.2006.04.022
   Yoon SH, 2001, ADV ENVIRON RES, V5, P91, DOI 10.1016/S1093-0191(00)00045-9
   Zhang HF, 2011, ENVIRON SCI TECHNOL, V45, P5477, DOI 10.1021/es1037904
   [张钦 Zhang Qin], 2010, [中国软科学, China Soft Science], P104
   Zhang W., 2010, STAT YB JIANGSU 2010
   Zhong C, 2009, APPL MICROBIOL BIOT, V84, P667, DOI 10.1007/s00253-009-2001-0
   Zhou D., 2003, Patents of Straw-based Panel Manufacture Technology, Patent No. [ZL 01137361.X, 01137361]
   ZZ91, 2011, WAST PAP
   ZZ91, 2011, CAST IR PRIC NOV 18
NR 50
TC 2
Z9 2
U1 2
U2 21
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2015
VL 10
IS 1
BP 548
EP 565
PG 18
WC Materials Science, Paper & Wood
SC Materials Science
GA CE6IV
UT WOS:000351941000046
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zhang, JP
   Wang, ZL
   Du, MH
   Yao, XH
   Hu, LS
AF Zhang, Jinping
   Wang, Zhoulian
   Du, Menghao
   Yao, Xiaohua
   Hu, Lisong
TI Physicochemical Properties of Camellia Nut Shell and its Thermal
   Degradation Characteristics
SO BIORESOURCES
LA English
DT Review
DE Camellia nut shell; Elemental analysis; Chemical composition;
   Crystallinity index; Thermal degradation
ID BAMBOO SHOOT SHELL; DIRECT LIQUEFACTION; PYROLYSIS; LIQUID;
   OPTIMIZATION; CELLULOSE; RESIDUES; BIOMASS; CARBON; GLYCOL
AB Camellia nut shell (CNS) is known as an important bio-resource that has great potential as a biomaterial. The elemental composition, chemical structure, crystallinity, and pyrolysis characteristics were analyzed in this paper for six species of CNS. The concentration of organic carbon, N, K, and Na in CNS ranges from 44.40 to 48.60%, 2.91 to 4.42 mg.g(-1), 7.67 to 13.80 mg.g(-1), and 0.02 to 0.26 mg.g(-1), respectively. The content of lignin, cellulose, hemicellulose, and ash varies between 30.07 and 36.23%, 13.87 and 20.95%, 35.15 and 49.34%, as well as 2.00 and 4.75%, respectively. Camellia nut shell cellulose crystalline structure belongs to typical cellulose type I, and the cellulose crystallinity index for the six species ranges from 37.4 to 62.3%. The CNS pyrolysis process can be divided into three phases, and the substantial degradation occurs within the temperature range of 200 to 430 degrees C, with nearly 60% loss of weight. The temperature could be reduced greatly during pyrolysis under acidic conditions with PEG 400/glycerol as a solvent. The degradation rate was impacted by K concentration. Increasing cellulose crystallinity negatively affected the degradation rate.
C1 [Zhang, Jinping; Wang, Zhoulian; Du, Menghao; Yao, Xiaohua; Hu, Lisong] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang 311400, Zhejiang, Peoples R China.
RP Zhang, JP (reprint author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang 311400, Zhejiang, Peoples R China.
EM jinpingzhang@126.com
FU Provincial Department of Science and Technology of Zhejiang, China
   [2013C32096]
FX The authors are grateful for the financial support from Provincial
   Department of Science and Technology of Zhejiang, China, Grant. No.
   2013C32096.
CR [Anonymous], 1994, 26776 GBT
   [Anonymous], 1993, 26773 GBT CHIN NAT S
   [Anonymous], 1999, 1270 LYT
   [Anonymous], 1994, 26778 GBT
   [Anonymous], 1999, 1269 LYT
   [Anonymous], 1999, 1237 LYT
   Baldinger T., 2000, LENZINGER BERICHTE, V79, P15
   Bensaid S, 2012, FUEL, V94, P324, DOI 10.1016/j.fuel.2011.11.053
   Cao XF, 2014, BIORESOURCE TECHNOL, V155, P21, DOI 10.1016/j.biortech.2013.12.006
   Chen FG, 2009, J APPL POLYM SCI, V111, P508, DOI 10.1002/app.29107
   Dawy M, 2003, POLYM-PLAST TECHNOL, V42, P643, DOI 10.1081/PPT-120023100
   GB/T, 1994, FIBR RAW MAT DET PEN, V9, P2677
   GB/T, 1995, FIBR RAW MAT DET HOL, V10, P2677
   Guo JX, 2012, BIORESOURCE TECHNOL, V120, P19, DOI 10.1016/j.biortech.2012.06.013
   Hassan EBM, 2008, IND CROP PROD, V27, P33, DOI 10.1016/j.indcrop.2007.07.004
   Hu JL, 2012, INT J FOOD SCI TECH, V47, P1676, DOI 10.1111/j.1365-2621.2012.03020.x
   Jiang JianXin, 2008, Journal of Beijing Forestry University, V30, P128
   Kim SS, 2010, BIORESOURCE TECHNOL, V101, P9797, DOI 10.1016/j.biortech.2010.07.094
   Kosikova B, 1995, CELL CHEM TECHNOL, V29, P683
   Kurimoto Y, 1999, HOLZFORSCHUNG, V53, P617, DOI 10.1515/HF.1999.102
   Lemus R, 2005, CRIT REV PLANT SCI, V24, P1, DOI 10.1080/07352680590910393
   Lin Tao, 2013, Journal of Northeast Forestry University, V41, P89
   Lu YD, 2011, WATER SCI TECHNOL, V64, P1566, DOI 10.2166/wst.2011.657
   Lu ZX, 2013, BIORESOURCE TECHNOL, V142, P579, DOI 10.1016/j.biortech.2013.05.091
   Mortazavi SM, 2010, FIBER POLYM, V11, P877, DOI 10.1007/s12221-010-0877-z
   [彭琳 Peng Lin], 2014, [水土保持通报, Bulletin of Soil and Water Conservation], V34, P129
   [邱贺媛 QIU He-yuan], 2009, [食品科学, Food Science], V30, P198
   Roder T., 2006, LENZINGER BERICHTE, V86, P85
   Su Wen-hui, 2013, Forest Research, V26, P252
   Tekin K, 2013, ENVIRON CHEM LETT, V11, P25, DOI 10.1007/s10311-012-0373-3
   Tong Q. Y., 2005, HEBEI CHEM IND, P74
   Ulloa CA, 2009, FUEL PROCESS TECHNOL, V90, P583, DOI 10.1016/j.fuproc.2008.12.015
   Xiao WH, 2011, IND CROP PROD, V34, P1602, DOI 10.1016/j.indcrop.2011.05.024
   Xu Man, 2009, Chemistry and Industry of Forest Products, V29, P187
   Xu Xiwei, 2012, Proceedings of the CSEE, V32, P118
   Xue K. P., 2012, CHEM RES APPL, V24, P1296
   Yang X. M., 2011, J CHINESE AGR MECH, V42, P151
   YAO Y, 1993, MOKUZAI GAKKAISHI, V39, P930
   Ye LY, 2014, BIORESOURCE TECHNOL, V153, P147, DOI 10.1016/j.biortech.2013.11.070
   Ye N. Y., 2005, FUJIAN CHEM IND, P69
   Yin CG, 2012, BIORESOURCE TECHNOL, V120, P273, DOI 10.1016/j.biortech.2012.06.016
   Zhang JT, 2012, J SOLID STATE ELECTR, V16, P2179, DOI 10.1007/s10008-012-1639-1
   Zhou CS, 2013, CHINESE J CHEM ENG, V21, P544, DOI 10.1016/S1004-9541(13)60509-1
   Zhou JianBin, 2008, Chemistry and Industry of Forest Products, V28, P105
   [周俊琴 Zhou Junqin], 2013, [植物遗传资源学报, Journal of Plant Genetic Resources], V14, P512
   Zou X. L., 2009, CHINA EC WEEKLY, V47, P45
NR 46
TC 2
Z9 3
U1 0
U2 7
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2015
VL 10
IS 1
BP 647
EP 659
PG 13
WC Materials Science, Paper & Wood
SC Materials Science
GA CE6IV
UT WOS:000351941000054
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Shalumon, KT
   Chen, JP
AF Shalumon, K. T.
   Chen, Jyh-Ping
TI Scaffold-based Drug Delivery for Cartilage Tissue Regeneration
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Regenerative engineering; cartilage tissue engineering; growth factors;
   proteins; nanofibers; gels; microspheres; scaffolds
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTOR DELIVERY; OSTEOGENIC
   DIFFERENTIATION; EXTRACELLULAR-MATRIX; PROGENITOR CELLS; ADIPOSE-TISSUE;
   IN-VITRO; ENGINEERING APPLICATIONS; ELECTROSPUN NANOFIBERS; CHITOSAN
   MICROSPHERES
AB Regenerative engineering is an advanced field comprising the collective benefit of biodegradable polymers with cells and tissue inducing factors. Current method of replacing the defective organ is through transplantation, but is limited due to immune rejection and availability. As a solution, new polymeric biomaterial-based three-dimensional (3D) scaffolds in combination with cells and inducing factors were aroused to fulfil the existing demands. These scaffolds apply material science, biomedical technology and translational medicine to develop functional tissue engineering constructs. Presence of small molecules and growth factors guides the cell phenotypes to specific organ development. The 3D scaffold thus could also be favorably used as carriers for various types of drugs and genes, with the release profile fine-tuned by modulation of the scaffold's morphology, porosity, and composition. An increasing trend was observed in recent years toward the combination of scaffolds and growth factors to fabricate a bioactive system, which not only provide a biomimetic biodegradable physical support for tissue growth but also explores biological signals to modulate tissue regeneration. In this review, along with general aspects of tissue engineering, we also discuss the importance of various scaffold architectures like nanofibers, hydrogels, beads, meshes, microspheres etc. in combination with specific drugs, growth factors and small molecules for cartilage regeneration. Growth factors may be incorporated into scaffolds by direct blending, physical adsorption, drop casting, surface grafting, covalent bonding, chemical immobilization, coaxial electrospinning, microparticle incorporation etc. This offers new possibilities for the development of biomimetic scaffolds that are endowed with a hierarchical architecture and sophisticated release kinetics of the growth factors. This review portrait the fundamentals of tissue engineering with emphasis on the role of inducing factors in scaffold based cartilage tissue regeneration.
C1 [Shalumon, K. T.; Chen, Jyh-Ping] Chang Gung Univ, Dept Chem & Mat Engn, Taoyuan 333, Taiwan.
   [Chen, Jyh-Ping] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan 333, Taiwan.
RP Chen, JP (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Taoyuan 333, Taiwan.
EM jpchen@mail.cgu.edu.tw
OI Chen, Jyh-Ping/0000-0001-6527-4801
FU Ministry of Science and Technology, Taiwan, ROC; Ministry of Health and
   Welfare, Taiwan, ROC; Chang Gung Memorial Hospital [CRRPD5C0201-3,
   CMRPD3D0201-2]
FX We are thankful for the financial supports from the Ministry of Science
   and Technology, Taiwan, ROC; Ministry of Health and Welfare, Taiwan,
   ROC; Chang Gung Memorial Hospital (CRRPD5C0201-3 and CMRPD3D0201-2).
CR BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223
   Bilousova G, 2011, STEM CELLS, V29, P206, DOI 10.1002/stem.566
   Bose S, 1999, SCRIPTA MATER, V41, P1009, DOI 10.1016/S1359-6462(99)00250-X
   Bose S, 2003, MAT SCI ENG C-BIO S, V23, P479, DOI 10.1016/S0928-4931(02)00129-7
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Chan PS, 2005, OSTEOARTHR CARTILAGE, V13, P387, DOI 10.1016/j.joca.2005.01.003
   Chang KH, 2013, ACTA BIOMATER, V9, P9012, DOI 10.1016/j.actbio.2013.06.046
   Chang KY, 2010, J BIOMED MATER RES A, V92A, P712, DOI 10.1002/jbm.a.32198
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Chen FM, 2007, J CONTROL RELEASE, V121, P81, DOI 10.1016/j.jconrel.2007.05.023
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170
   Chen JP, 2011, ACTA BIOMATER, V7, P234, DOI 10.1016/j.actbio.2010.08.015
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Cheng T, 2006, J ENVIRON MANAGE, V80, P222, DOI 10.1016/j.jenvman.2005.09.007
   Cheung HK, 2014, BIOMATERIALS, V35, P1914, DOI 10.1016/j.biomaterials.2013.11.067
   Dankers PYW, 2011, J CONTROL RELEASE, V152, P177, DOI 10.1016/j.jconrel.2011.01.034
   Dellamary L, 2004, J CONTROL RELEASE, V95, P489, DOI 10.1016/j.jconrel.2003.12.013
   Deng M, 2010, SOFT MATTER, V6, P3119, DOI 10.1039/b926402g
   Diogo GS, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/025001
   DOILLON CJ, 1994, MAT SCI ENG C-BIOMIM, V2, P43, DOI 10.1016/0928-4931(94)90028-0
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Egusa H, 2010, J ORAL BIOSCI, V52, P107, DOI 10.2330/joralbiosci.52.107
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003
   Garrigues NW, 2014, J BIOMED MATER RES A, V102, P3998, DOI 10.1002/jbm.a.35068
   Georgi N, 2017, J TISSUE ENG REGEN M, V11, P724, DOI 10.1002/term.1969
   Ghosh S, 2009, BIOMATERIALS, V30, P6530, DOI 10.1016/j.biomaterials.2009.08.019
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Granja PL, 2001, J MATER SCI, V36, P2163, DOI 10.1023/A:1017587815583
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guven S, 2011, BIOMATERIALS, V32, P5801, DOI 10.1016/j.biomaterials.2011.04.064
   Guler MO, 2006, BIOMACROMOLECULES, V7, P1855, DOI 10.1021/bm060161g
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Huang AH, 2010, J BIOMECH, V43, P128, DOI 10.1016/j.jbiomech.2009.09.018
   Hung KC, 2014, ADV HEALTHC MATER, V3, P1578, DOI 10.1002/adhm.201400018
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jaklenec A, 2008, BIOMATERIALS, V29, P185, DOI 10.1016/j.biomaterials.2007.09.017
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Kadzik RS, 2012, CELL STEM CELL, V10, P355, DOI 10.1016/j.stem.2012.03.013
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kanokpanont S, 2012, INT J PHARMACEUT, V436, P141, DOI 10.1016/j.ijpharm.2012.06.046
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Kellner K, 2001, J DRUG TARGET, V9, P439, DOI 10.3109/10611860108998778
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kim H, 2014, MAT SCI ENG C-MATER, V40, P324, DOI 10.1016/j.msec.2014.04.012
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Klock G, 1997, BIOMATERIALS, V18, P707, DOI 10.1016/S0142-9612(96)00204-9
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   Kwon DY, 2014, J MATER CHEM B, V2, P1689, DOI 10.1039/c3tb21563f
   Lai GJ, 2014, CARBOHYD POLYM, V111, P288, DOI 10.1016/j.carbpol.2014.04.094
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Lee JE, 2004, ARTIF ORGANS, V28, P829, DOI 10.1111/j.1525-1594.2004.00020.x
   Lee JW, 2013, J BIOMED MATER RES A, V101, P1865, DOI 10.1002/jbm.a.34485
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040
   Liao HT, 2011, TISSUE ENG PART C-ME, V17, P1139, DOI 10.1089/ten.tec.2011.0140
   Liao HT, 2011, J TRAUMA, V70, P228, DOI 10.1097/TA.0b013e3181e12b56
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Liu YY, 2012, MAT SCI ENG C-MATER, V32, P2361, DOI 10.1016/j.msec.2012.07.008
   Lu BS, 2014, DRUG DISCOV TODAY, V19, P801, DOI 10.1016/j.drudis.2013.11.011
   Lu S, 2014, BIOMATERIALS, V35, P8829, DOI 10.1016/j.biomaterials.2014.07.006
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Martinez EC, 2011, J MOL CELL CARDIOL, V50, P312, DOI 10.1016/j.yjmcc.2010.08.009
   Merrill JP, 1956, T AM CLIN CLIMAT ASS, V67, P166
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nanda HS, 2014, BIOMED RES INT, V2014, P10
   NEUMAN RE, 1950, J BIOL CHEM, V186, P549
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   Nuttelman CR, 2006, J BIOMED MATER RES A, V76A, P183, DOI 10.1002/jbm.a.30537
   Otani Y, 2015, TISSUE ENG PT A, V21, P627, DOI [10.1089/ten.TEA.2013.0655, 10.1089/ten.tea.2013.0655]
   Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x
   Pati F, 2015, BIOMATERIALS, V37, P230, DOI 10.1016/j.biomaterials.2014.10.012
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Pouton CW, 1996, ADV DRUG DELIVER REV, V18, P133, DOI 10.1016/0169-409X(95)00092-L
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Qiu QQ, 1999, BIOMATERIALS, V20, P989, DOI 10.1016/S0142-9612(98)00183-5
   Ratner BD, 2013, BIOMATERIALS SCI, pxxi
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Ronziere MC, 2003, BIOMATERIALS, V24, P851, DOI 10.1016/S0142-9612(02)00418-0
   Sahoo S, 2010, J BIOMED MATER RES A, V93A, P1539, DOI 10.1002/jbm.a.32645
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Schauss AG, 2007, FOOD CHEM TOXICOL, V45, P315, DOI 10.1016/j.fct.2006.08.011
   Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307
   Selimis A, 2015, MICROELECTRON ENG, V132, P83, DOI 10.1016/j.mee.2014.10.001
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shaikh FM, 2008, CELLS TISSUES ORGANS, V188, P333, DOI 10.1159/000139772
   Shalumon KT, 2011, J BIOMED NANOTECHNOL, V7, P609, DOI 10.1166/jbn.2011.1337
   Shalumon KT, 2011, INT J BIOL MACROMOL, V48, P571, DOI 10.1016/j.ijbiomac.2011.01.020
   Shalumon K.T., 2010, J MACROMOL SCI PURE, V48, P21
   Sharon N, 2007, HUMAN CELL CULTURE, P129
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Skardal A, 2012, BIOMATERIALS, V33, P4565, DOI 10.1016/j.biomaterials.2012.03.034
   Sridhar BV, 2014, J BIOMED MATER RES A, V102, P4464, DOI 10.1002/jbm.a.35115
   Suciati T, 2006, J MATER SCI-MATER M, V17, P1049, DOI 10.1007/s10856-006-0443-9
   Swarnalatha B, 2013, INT J BIOL MACROMOL, V58, P220, DOI 10.1016/j.ijbiomac.2013.03.060
   Tao SL, 2007, NANO LETT, V7, P1463, DOI 10.1021/nl0700346
   Timmons SF, 2002, USA, Patent No. [6,432,435 B, 6432435]
   Trachtenberg JE, 2014, J BIOMED MATER RES A, V102, P4326, DOI 10.1002/jbm.a.35108
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Verreck G, 2003, J CONTROL RELEASE, V92, P349, DOI 10.1016/S0168-3659(03)00342-0
   Vogelhuber W, 2003, EUR J PHARM BIOPHARM, V55, P133, DOI 10.1016/S0939-6411(02)00137-6
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Wang J, 2002, J CONTROL RELEASE, V82, P289, DOI 10.1016/S0168-3659(02)00137-2
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Xing XB, 2008, OPT EXPRESS, V16, P10815, DOI 10.1364/OE.16.010815
   Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160
   Ye KY, 2011, J VISUAL EXPT JOVE
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang Weijie, 2014, Biomed Res Int, V2014, P746138, DOI 10.1155/2014/746138
   Zhao L., 2010, TISSUE ENG PART A, V17, P969
NR 130
TC 8
Z9 8
U1 3
U2 60
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 15
BP 1979
EP 1990
DI 10.2174/1381612821666150302152836
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CF8YQ
UT WOS:000352848500007
PM 25732662
DA 2018-10-20
ER

PT J
AU Hansen, AW
   Fuhr, LT
   Antonini, LM
   Villarinho, DJ
   Marino, CEB
   Malfatti, CD
AF Hansen, Alana Witt
   Fuehr, Luciane Tais
   Antonini, Leonardo Marasca
   Villarinho, Denis Jardim
   Bruno Marino, Claudia Eliana
   Malfatti, Celia de Fraga
TI The Electrochemical Behavior of the NiTi Alloy in Different Simulated
   Body Fluids
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE metallic biomaterial; electrochemical behavior; NiTi; simulated body
   fluids
ID SHAPE-MEMORY ALLOY; IMMERSION ION-IMPLANTATION; NICKEL-TITANIUM ALLOY;
   CORROSION BEHAVIOR; SURFACE; RESISTANCE; OXIDATION; CYTOTOXICITY;
   BIOACTIVITY; TIO2
AB In order to improve the NiTi alloy biocompatibility, surface treatments become very important. Nevertheless, researchers use different solutions to simulate the body fluids in electrochemical assays, and the correlation between the obtained results is difficult and might not even be possible. The present paper evaluated the electrochemical behavior of polished NiTi surfaces exposed to different simulated body fluid solutions: Hanks solution, Hanks' balanced salt (HBSS) solution, saline body fluid (SBF) solution, and Ringer solution. The electrochemical behavior of NiTi was evaluated by open circuit potential (OCP) and cyclic voltammetry tests. The surfaces of the samples were also characterized by scanning electron microscopy, which was performed after the electrochemical tests. The results demonstrated that the NiTi alloy shows the same corrosion mechanism (pitting) in all simulated body fluids that were studied. However, the corrosion potential changes for each electrolyte, being HBSS, SBF and Ringer the most corrosive solutions. Furthermore, the Hanks and HBSS solutions demonstrated good reproducibility of the electochemical results. Considering that the HBSS represents an extreme environment, this solution seems to be the most indicated to study the corrosion behavior of NiTi treated surfaces.
C1 [Hansen, Alana Witt; Antonini, Leonardo Marasca; Malfatti, Celia de Fraga] Fed Univ Rio Grande Sul UFRGS, Corros Res Lab LAPEC, Porto Alegre, RS, Brazil.
   [Fuehr, Luciane Tais; Villarinho, Denis Jardim] Feevale Univ, Exact & Technol Sci Inst ICET, Novo Hamburgo, RS, Brazil.
   [Bruno Marino, Claudia Eliana] Fed Univ Parana UFPR, Mech Engn Dept, Curitiba, PR, Brazil.
RP Hansen, AW (reprint author), Fed Univ Rio Grande Sul UFRGS, Corros Res Lab LAPEC, 9500 Bento Goncalves Ave, Porto Alegre, RS, Brazil.
EM alanawitt@hotmail.com
RI MARINO, CLAUDIA/H-8169-2017; MALFATTI, CELIA/O-4102-2018
OI MARINO, CLAUDIA/0000-0003-2660-4577; MALFATTI, CELIA/0000-0002-0819-479X
CR [Anonymous], 2008, F212908 ASTM
   Bayat N, 2011, APPL SURF SCI, V257, P8493, DOI 10.1016/j.apsusc.2011.05.001
   Bernard SA, 2011, ACTA BIOMATER, V7, P1902, DOI 10.1016/j.actbio.2011.01.004
   Chrzanowski W, 2008, ACTA BIOMATER, V4, P1969, DOI 10.1016/j.actbio.2008.05.010
   Dhage SR, 2004, MATER LETT, V58, P2310, DOI 10.1016/j.matlet.2004.02.021
   Dinca VC, 2006, APPL SURF SCI, V252, P4619, DOI 10.1016/j.apsusc.2005.07.093
   Filip P, 2001, BIOMATERIALS, V22, P2131, DOI 10.1016/S0142-9612(00)00404-X
   Flamini DO, 2014, CORROS SCI, V81, P36, DOI 10.1016/j.corsci.2013.11.063
   Gupta R, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034005
   Han JB, 2011, INT J GREENH GAS CON, V5, P1680, DOI 10.1016/j.ijggc.2011.08.003
   Horiuchi Y, 2007, DENT MATER J, V26, P924, DOI 10.4012/dmj.26.924
   Hu T, 2010, J MATER RES, V25, P350, DOI 10.1557/JMR.2010.0051
   Huan Z, 2012, APPL SURF SCI, V258, P5244, DOI 10.1016/j.apsusc.2012.02.002
   Khalil-Allafi J, 2010, MAT SCI ENG C-MATER, V30, P1112, DOI 10.1016/j.msec.2010.06.007
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Li XJ, 2007, ACTA BIOMATER, V3, P807, DOI 10.1016/j.actbio.2007.02.002
   Liang CH, 2001, T NONFERR METAL SOC, V11, P579
   Lifeng Z, 2011, BIOMED MATER, V6, DOI [10.1088/1748-6041/6/2/025012, DOI 10.1088/1748-6041/6/2/025012]
   Liu XM, 2008, SURF COAT TECH, V202, P2463, DOI 10.1016/j.surfcoat.2007.08.017
   Liu XM, 2007, APPL SURF SCI, V253, P3154, DOI 10.1016/j.apsusc.2006.07.008
   Maho A, 2013, ELECTROCHIM ACTA, V89, P346, DOI 10.1016/j.electacta.2012.11.026
   McMahon RE, 2012, ACTA BIOMATER, V8, P2863, DOI 10.1016/j.actbio.2012.03.034
   MILOSEV I, 1995, SURF INTERFACE ANAL, V23, P529, DOI 10.1002/sia.740230713
   Oshida Y, 1990, MATER SCI FORUM, V56, P705
   Park HH, 2010, ELECTROCHIM ACTA, V55, P6109, DOI 10.1016/j.electacta.2010.05.082
   Qiu DL, 2010, APPL SURF SCI, V257, P1774, DOI 10.1016/j.apsusc.2010.09.014
   Rondelli G, 1996, BIOMATERIALS, V17, P2003, DOI 10.1016/0142-9612(95)00352-5
   Shabalovskaya SA, 2009, BIOMATERIALS, V30, P3662, DOI 10.1016/j.biomaterials.2009.03.034
   Shahrabi T, 2008, MATER LETT, V62, P2791, DOI 10.1016/j.matlet.2008.01.052
   Shen Y, 2009, ACTA BIOMATER, V5, P3593, DOI 10.1016/j.actbio.2009.05.021
   Shi P, 2007, MATER LETT, V61, P2385, DOI 10.1016/j.matlet.2006.09.020
   Siu HT, 2013, APPL SURF SCI, V274, P181, DOI 10.1016/j.apsusc.2013.03.008
   Tomashov ND, 1985, ZASCHYTA MYETALLOV, V5, P682
   Torres-Islas A, 2008, CORROS SCI, V50, P2831, DOI 10.1016/j.corsci.2008.07.007
   Trepanier C, 2005, Medical Device Materials II: Proceedings from the Materials & Processes for Medical Devices Conference 2004, P392
   Vojtech D, 2008, INTERMETALLICS, V16, P424, DOI 10.1016/j.intermet.2007.12.006
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   Zhao TT, 2011, SURF COAT TECH, V205, P4404, DOI 10.1016/j.surfcoat.2011.03.061
NR 38
TC 5
Z9 5
U1 1
U2 18
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD JAN-FEB
PY 2015
VL 18
IS 1
BP 184
EP 190
DI 10.1590/1516-1439.305614
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA CG1UU
UT WOS:000353061100024
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Mitchelson, AJ
   Wilson, CJ
   Mihalko, WM
   Grupp, TM
   Manning, BT
   Dennis, DA
   Goodman, SB
   Tzeng, TH
   Vasdev, S
   Saleh, KJ
AF Mitchelson, Andrew J.
   Wilson, Craig J.
   Mihalko, William M.
   Grupp, Thomas M.
   Manning, Blaine T.
   Dennis, Douglas A.
   Goodman, Stuart B.
   Tzeng, Tony H.
   Vasdev, Sonia
   Saleh, Khaled J.
TI Biomaterial Hypersensitivity: Is It Real? Supportive Evidence and
   Approach Considerations for Metal Allergic Patients following Total Knee
   Arthroplasty
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID TOTAL HIP-ARTHROPLASTY; CONTACT ALLERGY; ORTHOPEDIC IMPLANTS; JOINT
   REPLACEMENT; HUMAN OSTEOCLASTS; BENZOYL PEROXIDE; SENSITIVITY; NICKEL;
   OSTEOLYSIS; COBALT
AB The prospect of biomaterial hypersensitivity developing in response to joint implant materials was first presented more than 30 years ago. Many studies have established probable causation between first-generation metal-on-metal hip implants and hypersensitivity reactions. In a limited patient population, implant failure may ultimately be related to metal hypersensitivity. The examination of hypersensitivity reactions in current-generation metal-on-metal knee implants is comparatively limited. The purpose of this study is to summarize all available literature regarding biomaterial hypersensitivity after total knee arthroplasty, elucidate overall trends about this topic in the current literature, and provide a foundation for clinical approach considerations when biomaterial hypersensitivity is suspected.
C1 [Mitchelson, Andrew J.; Wilson, Craig J.; Manning, Blaine T.; Tzeng, Tony H.; Vasdev, Sonia; Saleh, Khaled J.] So Illinois Univ, Sch Med, Dept Surg, Div Orthopaed & Rehabil, Springfield, IL 62794 USA.
   [Mihalko, William M.] Univ Tennessee, Dept Orthopaed Surg & Biomed Engn, Memphis, TN 38017 USA.
   [Grupp, Thomas M.] Univ Munich, Clin Orthopaed Surg, D-80539 Munich, Germany.
   [Grupp, Thomas M.] Aesculap AG, Res & Dev, D-78532 Tuttlingen, Germany.
   [Dennis, Douglas A.] Colorado Joint Replacement, Denver, CO 80210 USA.
   [Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Redwood City, CA 94063 USA.
RP Saleh, KJ (reprint author), So Illinois Univ, Sch Med, Dept Surg, Div Orthopaed & Rehabil, POB 19679, Springfield, IL 62794 USA.
EM ksaleh@siumed.edu
CR Ashraf M. W., 2012, SCI WORLD J, V2012, DOI DOI 10.1100/2012/729430
   Basko-Plluska JL, 2011, DERMATITIS, V22, P65, DOI 10.2310/6620.2011.10055
   Beck RT, 2012, J ORTHOP RES, V30, P541, DOI 10.1002/jor.21554
   Beecker Jennifer, 2009, Dermatitis, V20, pE4
   Bergschmidt Philipp, 2011, Open Orthop J, V5, P354, DOI 10.2174/1874325001105010354
   Bergschmidt P, 2012, KNEE, V19, P144, DOI 10.1016/j.knee.2011.01.001
   Borchers A, 2010, CLIN REV ALLERG IMMU, V39, P95, DOI 10.1007/s12016-009-8176-4
   BROWN GC, 1977, J BONE JOINT SURG AM, V59, P164, DOI 10.2106/00004623-197759020-00004
   Burton L, 2013, J ORTHOP RES, V31, P73, DOI 10.1002/jor.22190
   Cadosch D, 2010, J BIOMED MATER RES A, V95A, P1004, DOI 10.1002/jbm.a.32914
   Cadosch D, 2010, J BIOMED MATER RES A, V92A, P475, DOI 10.1002/jbm.a.32390
   Cadosch D, 2009, J BIOMED MATER RES A, V91A, P1252, DOI 10.1002/jbm.a.32625
   Cadosch D, 2009, J ORTHOP RES, V27, P841, DOI 10.1002/jor.20831
   Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826
   Cancilleri F, 1992, Ital J Orthop Traumatol, V18, P407
   CARLSSON AS, 1980, ACTA ORTHOP SCAND, V51, P57, DOI 10.3109/17453678008990769
   Cousen PJ, 2012, CONTACT DERMATITIS, V66, P55, DOI 10.1111/j.1600-0536.2011.01970.x
   Davis Mark D P, 2004, Dermatitis, V15, P210, DOI 10.2310/6620.2004.04030
   DEUTMAN R, 1977, J BONE JOINT SURG AM, V59, P862, DOI 10.2106/00004623-197759070-00004
   Dietrich KA, 2009, J DTSCH DERMATOL GES, V7, P410, DOI 10.1111/j.1610-0387.2008.06987.x
   Eben R, 2010, DEUT MED WOCHENSCHR, V135, P1418, DOI 10.1055/s-0030-1262426
   Edwards SA, 2007, J ARTHROPLASTY, V22, P1226, DOI 10.1016/j.arth.2006.10.019
   ELVES MW, 1975, BRIT MED J, V4, P376, DOI 10.1136/bmj.4.5993.376
   EVANS EM, 1974, J BONE JOINT SURG BR, VB 56, P626
   Frigerio E, 2011, CONTACT DERMATITIS, V64, P273, DOI 10.1111/j.1600-0536.2011.01886.x
   Gao X, 2011, J ARTHROPLASTY, V26, P665, DOI DOI 10.1016/J.ARTH.2010.06.002
   Granchi D, 2006, J BIOMED MATER RES B, V77B, P257, DOI 10.1002/jbm.b.30445
   Granchi D, 2012, J BONE JOINT SURG BR, V94B, P1126, DOI 10.1302/0301-620X.94B8.28135
   Granchi D, 2008, BIOMATERIALS, V29, P1494, DOI 10.1016/j.biomaterials.2007.11.038
   Hallab N, 2001, JCR-J CLIN RHEUMATOL, V7, P215, DOI 10.1097/00124743-200108000-00004
   Hallab NJ, 2009, BULL HOSP JT DIS, V67, P182
   Hallab Nadim James, 2008, J Orthop Surg Res, V3, P6, DOI 10.1186/1749-799X-3-6
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Handa S, 2003, CONTACT DERMATITIS, V49, P259, DOI 10.1111/j.0105-1873.2003.0225b.x
   Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147
   KIEFFER M, 1979, CONTACT DERMATITIS, V5, P398, DOI 10.1111/j.1600-0536.1979.tb04913.x
   Krecisz Beata, 2006, International Journal of Occupational Medicine and Environmental Health, V19, P178, DOI 10.2478/v10001-006-0025-6
   Luetzner J, 2007, CLIN ORTHOP RELAT R, P136, DOI 10.1097/BLO.0b013e31806450ef
   Mesinkovska NA, 2012, ARCH DERMATOL, V148, P687, DOI 10.1001/archdermatol.2011.2561
   Nater J P, 1976, Contact Dermatitis, V2, P259, DOI 10.1111/j.1600-0536.1976.tb03044.x
   Ng VY, 2011, CLIN ORTHOP RELAT R, V469, P523, DOI 10.1007/s11999-010-1570-7
   Niki Y, 2005, BIOMATERIALS, V26, P1019, DOI 10.1016/j.biomaterials.2004.03.038
   Oiso N, 2004, CONTACT DERMATITIS, V51, P151, DOI 10.1111/j.0105-1873.2004.0426e.x
   Park YS, 2005, J BONE JOINT SURG AM, V87A, P1515, DOI 10.2106/JBJS.D.02641
   Reed KB, 2008, ARCH DERMATOL, V144, P999, DOI 10.1001/archderm.144.8.999
   ROOKER GD, 1980, J BONE JOINT SURG BR, V62, P502
   Rui F, 2010, CONTACT DERMATITIS, V62, P225, DOI 10.1111/j.1600-0536.2009.01650.x
   Schafer T, 2001, ALLERGY, V56, P1192, DOI 10.1034/j.1398-9995.2001.00086.x
   Schalock PC, 2012, CONTACT DERMATITIS, V66, P4, DOI 10.1111/j.1600-0536.2011.01971.x
   Summer B, 2010, CONTACT DERMATITIS, V63, P15, DOI 10.1111/j.1600-0536.2010.01744.x
   Swiontkowski MF, 2001, J ORTHOP TRAUMA, V15, P86, DOI 10.1097/00005131-200102000-00002
   Teow Y, 2011, CHEM COMMUN, V47, P7025, DOI 10.1039/c0cc05271j
   Thienpont E, 2013, KNEE SURG SPORT TR A, V21, P636, DOI 10.1007/s00167-012-2000-z
   Thomas P, 2000, ALLERGY, V55, P969, DOI 10.1034/j.1398-9995.2000.00619.x
   Thomsen Marc, 2011, Acta Orthop, V82, P386, DOI 10.3109/17453674.2011.579521
   Thyssen JP, 2011, BRIT J DERMATOL, V164, P473, DOI 10.1111/j.1365-2133.2010.10144.x
   Thyssen JP, 2010, CHEM RES TOXICOL, V23, P309, DOI 10.1021/tx9002726
   Thyssen JP, 2007, CONTACT DERMATITIS, V57, P287, DOI 10.1111/j.1600-0536.2007.01220.x
   Treudler R, 2007, CONTACT DERMATITIS, V57, P177, DOI 10.1111/j.1600-0536.2007.01195.x
   Uter W, 2009, CONTACT DERMATITIS, V61, P31, DOI 10.1111/j.1600-0536.2009.01572.x
   Valentine-Thon E, 2006, NEUROENDOCRINOL LETT, V27, P17
   Van Opstal N, 2011, ACTA ORTHOP BELG, V77, P691
   Verma SB, 2006, CONTACT DERMATITIS, V54, P228, DOI 10.1111/j.0105-1873.2006.0775o.x
   WATERMAN AH, 1985, CONTACT DERMATITIS, V13, P294, DOI 10.1111/j.1600-0536.1985.tb02581.x
   Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp
   Zug KA, 2009, DERMATITIS, V20, P149, DOI 10.2310/6620.2009.08097
NR 66
TC 11
Z9 11
U1 0
U2 10
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 137287
DI 10.1155/2015/137287
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CF2QA
UT WOS:000352391000001
PM 25883940
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Shao, RX
   Quan, RF
   Zhang, L
   Wei, XC
   Yang, DS
   Xie, SJ
AF Shao, Rongxue
   Quan, Renfu
   Zhang, Liang
   Wei, Xicheng
   Yang, Disheng
   Xie, Shangju
TI Porous hydroxyapatite bioceramics in bone tissue engineering: current
   uses and perspectives
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Review
DE Bone tissue engineering; Hydroxyapatite; Zirconia; Bone morphogenetic
   protein-2; Mesenchymal stem cells
ID PLURIPOTENT STEM-CELLS; BETA-TRICALCIUM PHOSPHATE; BIPHASIC
   CALCIUM-PHOSPHATE; HUMAN SOMATIC-CELLS; MORPHOGENETIC PROTEIN-2;
   IN-VIVO; MECHANICAL-PROPERTIES; GRAFT SUBSTITUTE; DEFINED FACTORS;
   SPINAL-FUSION
AB The goals of bone tissue engineering are to apply biomaterial scaffolds with adhered cells, such as osteoblasts, bone marrow stromal stem cells, or chondrocytes, to repair, regenerate, and restore the functions of damaged bone tissue or to replace those tissues with porous engineered biomaterials. Over recent decades, a diverse class of biomaterials has been applied in bone tissue engineering field. Porous hydroxyapatite bioceramic is currently receiving significant attention as a bone tissue engineering substitute because of its biological characteristics, including biocompatibility, bioactivity, osteoconduction, and vasculogenesis. This biomaterial has a three-dimensional structure with interconnected spherical pores of uniform size, which encourages bone ingrowth and achieves good integration of the material and the host bone over time. However, the compressive strength and elastic modulus of porous hydroxyapatite scaffolds generally weaken as the porosity increases, in both in vitro and in vivo testing. Zirconia can be used to toughen hydroxyapatite materials for bone repair and replacement because of its unique biomechanical properties, including compressive strength and fracture toughness. Additionally, a zirconia chitosan hybrid containing bone morphogenetic protein-2 and mesenchymal stem cells derived from induced pluripotent stem cells has been used as a coating material adhered to surface of scaffolds to promote bone regeneration and repair. Here, we provide a succinct review of zirconia toughened hydroxyapatite biomaterial scaffolds that incorporate bone morphogenetic protein-2 and mesenchymal stem cells for bone tissue engineering and describe the biomaterials that are currently being investigated based on the recent literature and our own data. (C) 2015 The Ceramic Society of Japan. All rights reserved.
C1 [Shao, Rongxue; Zhang, Liang; Xie, Shangju] Zhejiang Chinese Med Univ, Res Inst Orthoped, Hangzhou 310053, Zhengjiang Prov, Peoples R China.
   [Quan, Renfu] Xiaoshan Tradit Chinese Med Hosp, Dept Orthoped, Hangzhou 311200, Zhengjiang Prov, Peoples R China.
   [Wei, Xicheng] Shanghai Univ, Sch Mat Sci & Engn, Shanghai 200444, Peoples R China.
   [Yang, Disheng] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Orthoped, Hangzhou 310009, Zhengjiang Prov, Peoples R China.
RP Quan, RF (reprint author), Xiaoshan Tradit Chinese Med Hosp, Dept Orthoped, Hangzhou 311200, Zhengjiang Prov, Peoples R China.
EM spinequan@yahoo.com
FU Zhejiang Provincial Science and Technology Program [2012C33114];
   Hangzhou City Science and Technology Program [20122513A44]
FX This work was funded through the Zhejiang Provincial Science and
   Technology Program (NO:2012C33114) and Hangzhou City Science and
   Technology Program (NO:20122513A44).
CR Abarrategi A, 2009, ACTA BIOMATER, V5, P2633, DOI 10.1016/j.actbio.2009.02.031
   Alam I, 2001, J Biomed Mater Res, V54, P129
   Alt V, 2009, EUR SPINE J, V18, P800, DOI 10.1007/s00586-009-0935-7
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Ayers RA, 1998, J ORAL MAXIL SURG, V56, P1297, DOI 10.1016/S0278-2391(98)90613-9
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   BUCHOLZ RW, 1989, CLIN ORTHOP RELAT R, P53
   Burkus JK, 2009, J BONE JOINT SURG AM, V91A, P1181, DOI 10.2106/JBJS.G.01485
   Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   Chang E, 1997, J MATER SCI-MATER M, V8, P201, DOI 10.1023/A:1018535606393
   Chen L, 2014, J MATER SCI-MATER M, V25, P1709, DOI 10.1007/s10856-014-5194-4
   Ciacchi FT, 1996, SOLID STATE IONICS, V86-8, P1167, DOI 10.1016/0167-2738(96)00282-2
   Cornell C N, 1991, J Orthop Trauma, V5, P1
   Curran DJ, 2010, J MATER SCI-MATER M, V21, P1109, DOI 10.1007/s10856-009-3974-z
   de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110
   Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006
   Fujibayashi S, 2003, BIOMATERIALS, V24, P3445, DOI 10.1016/S0142-9612(03)00221-7
   Garcia-Gareta E, 2014, J MATER SCI-MATER M, V25, P1553, DOI 10.1007/s10856-014-5170-z
   Hannink G, 2013, J MATER SCI-MATER M, V24, P325, DOI 10.1007/s10856-012-4802-4
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HOLMES RE, 1988, J ORAL MAXIL SURG, V46, P661, DOI 10.1016/0278-2391(88)90109-7
   Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Jun SH, 2013, J MATER SCI-MATER M, V24, P773, DOI 10.1007/s10856-012-4822-0
   Jun SH, 2011, J MATER SCI-MATER M, V22, P2757, DOI 10.1007/s10856-011-4458-5
   Jun SH, 2010, ACTA BIOMATER, V6, P302, DOI 10.1016/j.actbio.2009.06.024
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436
   Lecomte A, 2008, J BIOMED MATER RES B, V84B, P1, DOI 10.1002/jbm.b.30569
   Lee EJ, 2009, BIOMATERIALS, V30, P743, DOI 10.1016/j.biomaterials.2008.10.025
   Lee JH, 2013, J MATER SCI-MATER M, V24, P2117, DOI 10.1007/s10856-013-4967-5
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Lim HP, 2013, J MATER SCI-MATER M, V24, P1895, DOI 10.1007/s10856-013-4939-9
   Linhart W, 2004, UNFALLCHIRURG, V107, P154, DOI 10.1007/s00113-003-0707-5
   Liu B, 2008, J MATER SCI-MATER M, V19, P1203, DOI 10.1007/s10856-007-3216-1
   Liu H, 2010, HEPATOLOGY, V51, P1810, DOI 10.1002/hep.23626
   Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033225
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Martinetti R, 2005, ANAL BIOANAL CHEM, V381, P634, DOI 10.1007/s00216-004-2957-7
   Matsumine A, 2004, J BONE JOINT SURG BR, V86B, P719, DOI 10.1302/0301-620X.86B5.14242
   Matsuno T, 2000, J MATER SCI LETT, V19, P573, DOI 10.1023/A:1006722110462
   Namikawa T, 2005, SPINE, V30, P1717, DOI 10.1097/01.brs.0000172155.17239.fa
   Nishio K, 2000, J BIOMED MATER RES, V52, P652, DOI 10.1002/1097-4636(20001215)52:4<652::AID-JBM9>3.3.CO;2-N
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107
   Omae H, 2006, J BIOMED MATER RES A, V79A, P329, DOI 10.1002/jbm.a.30797
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PROLO DJ, 1985, CLIN ORTHOP RELAT R, P322
   Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x
   Silva VV, 1997, J MATER SCI-MATER M, V8, P907, DOI 10.1023/A:1018566124507
   Strong M, 2009, BIOLOGICALS, V37, P103, DOI 10.1016/j.biologicals.2009.01.003
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sultana R., 2012, J AM CERAM SOC, V4, P1212
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tancred DC, 1998, BIOMATERIALS, V19, P2303, DOI 10.1016/S0142-9612(98)00141-0
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   Vaidhyanathan B, 1997, B MATER SCI, V20, P135, DOI 10.1007/BF02753220
   Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084
   Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314
   Yang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100285
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Yoshikawa H, 2009, J R SOC INTERFACE, V6, pS341, DOI 10.1098/rsif.2008.0425.focus
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
NR 70
TC 13
Z9 14
U1 2
U2 71
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JAN
PY 2015
VL 123
IS 1433
BP 17
EP 20
DI 10.2109/jcersj2.123.17
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA CE9DH
UT WOS:000352143300003
OA Bronze
DA 2018-10-20
ER

PT J
AU Chahal, S
   Hussain, FSJ
   Kumar, A
   Yusoff, MM
   Rasad, MSBA
AF Chahal, Sugandha
   Hussain, Fathima Shahitha Jahir
   Kumar, Anuj
   Yusoff, Mashitah M.
   Rasad, Mohammad Syaiful Bahari Abdull
TI Electrospun hydroxyethyl cellulose nanofibers functionalized with
   calcium phosphate coating for bone tissue engineering
SO RSC ADVANCES
LA English
DT Article
ID POLY(VINYL ALCOHOL) HYDROGELS; MECHANICAL-PROPERTIES; IN-VITRO;
   SCAFFOLDS; HYDROXYAPATITE; MINERALIZATION; FABRICATION; BEHAVIOR; DEVICE
AB The aim of this study is to develop a facile and efficient scaffold from electrospun hydroxyethyl cellulose (HEC) functionalized with bone-like calcium phosphate (CaP). The HEC/PVA nanofibers were fabricated by electrospinning and mineralized by incubating in 10x simulated body fluid (SBF) for different period of times. After 24 h of incubation, the nanofibers were uniformly coated by a thin layer of mineral deposit. SEM, FTIR, and FESEM-EDS analyses confirm the deposition of CaP on the nanofibers. The nanostructured biomaterial maintained its fibrous and porous structure after mineralization. The XRD results suggest that the deposited mineral phase is a mixture of calcium phosphate hydrate and apatite. The mechanical properties of CaP coated scaffolds show similar tensile strength and elastic modulus with that of trabecular and proximal femoral bones. The cytocompatibility of the CaP coated HEC/PVA scaffolds were evaluated using human osteosarcoma cells. The CaP coated HEC/PVA scaffolds support cellular attachment and proliferation of osteosarcoma cells and will be a promising candidate for bone tissue engineering.
C1 [Chahal, Sugandha; Hussain, Fathima Shahitha Jahir; Yusoff, Mashitah M.] Univ Malaysia Pahang, Fac Ind Sci & Technol, Kuantan 26070, Pahang, Malaysia.
   [Kumar, Anuj] Czech Tech Univ, Fac Civil Engn, Dept Bldg Struct, Prague 16629 6, Czech Republic.
   [Rasad, Mohammad Syaiful Bahari Abdull] IIUM, Kulliyyah Allied Hlth Sci, Dept Biomed Sci, Kuantan 25200, Pahang, Malaysia.
RP Chahal, S (reprint author), Univ Malaysia Pahang, Fac Ind Sci & Technol, Kuantan 26070, Pahang, Malaysia.
EM mlt.mony@gmail.com
RI Kumar, Anuj/I-2105-2014
OI Kumar, Anuj/0000-0001-6940-3850; Yusoff, Mashitah/0000-0003-4118-5307
FU Fundamental Research Grant Scheme (FRGS) [RDU100106]; Ministry of Higher
   Education, Malaysia
FX Authors wish to thanks Mr Tomas Vlach and Ms Lenka Laiblova for helping
   in conducting the tensile properties estimation at Czech Technical
   University in Prague, Czech Republic. This work was supported by
   Fundamental Research Grant Scheme (FRGS) RDU100106, by Ministry of
   Higher Education, Malaysia.
CR Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Beskardes IG, 2009, J BIOACT COMPAT POL, V24, P507, DOI 10.1177/0883911509349311
   Camargo N. H. A., 2007, REV MAT, V12, P574
   Chahal S, 2013, PROCEDIA ENGINEER, V53, P683, DOI 10.1016/j.proeng.2013.02.088
   Chalal S, 2014, BIO-MED MATER ENG, V24, P799, DOI 10.3233/BME-130871
   Domingues RMA, 2014, BIOMACROMOLECULES, V15, P2327, DOI 10.1021/bm500524s
   Fantner GE, 2004, BONE, V35, P1013, DOI 10.1016/j.bone.2004.05.027
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Gupta D, 2009, BIOMATERIALS, V30, P2085, DOI 10.1016/j.biomaterials.2008.12.079
   Hellmich C, 2003, BIOMECH MODEL MECHAN, V2, P21, DOI 10.1007/S10237-002-0025-9
   HYON SH, 1994, J BIOMAT SCI-POLYM E, V5, P397, DOI 10.1163/156856294X00103
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Juang JH, 1996, TRANSPLANTATION, V61, P1557, DOI 10.1097/00007890-199606150-00001
   Kobayashi M, 2004, ARTIF ORGANS, V28, P734, DOI 10.1111/j.1525-1594.2004.00079.x
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kovacs T, 2010, NANOTOXICOLOGY, V4, P255, DOI 10.3109/17435391003628713
   KROON G, 1993, PROG ORG COAT, V22, P245, DOI 10.1016/0033-0655(93)80027-8
   Krumova M, 2000, POLYMER, V41, P9265, DOI 10.1016/S0032-3861(00)00287-1
   Kummerer K, 2011, CHEMOSPHERE, V82, P1387, DOI 10.1016/j.chemosphere.2010.11.069
   Lee JS, 2004, J APPL POLYM SCI, V93, P1638, DOI 10.1002/app.20602
   LINDE F, 1989, J BIOMECH, V22, P485, DOI 10.1016/0021-9290(89)90209-1
   Madurantakam PA, 2009, BIOMATERIALS, V30, P5456, DOI 10.1016/j.biomaterials.2009.06.043
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Nho YC, 2005, J IND ENG CHEM, V11, P159
   Poinern GE, 2009, ULTRASON SONOCHEM, V16, P469, DOI 10.1016/j.ultsonch.2009.01.007
   Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007
   RADEBAUGH GW, 1988, INT J PHARM, V45, P39, DOI 10.1016/0378-5173(88)90032-4
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   ROHLMANN A, 1980, ARCH ORTHOP TRAUM SU, V97, P95, DOI 10.1007/BF00450930
   Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   Shah D, 2005, ADV MATER, V17, P525, DOI 10.1002/adma.200400984
   She FH, 2008, ROBOT CIM-INT MANUF, V24, P427, DOI 10.1016/j.rcim.2007.02.023
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Sun WB, 2007, J COLLOID INTERF SCI, V311, P228, DOI 10.1016/j.jcis.2007.02.082
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tas AC, 2004, J MATER RES, V19, P2742, DOI 10.1557/JMR.2004.0349
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Yang F, 2008, CHEM ENG J, V137, P154, DOI 10.1016/j.cej.2007.07.076
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
   Zhang W, 2003, J AM CERAM SOC, V86, P1052, DOI 10.1111/j.1151-2916.2003.tb03422.x
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
   Zheng CY, 2007, MAT SCI ENG C-BIO S, V27, P824, DOI 10.1016/j.msec.2006.09.021
   Zulkii F. H., 2014, J BIOMATER APPL
   Zulkii H., 2014, POLYM DEGRAD STABIL, V110, P473
NR 51
TC 13
Z9 13
U1 6
U2 44
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 37
BP 29497
EP 29504
DI 10.1039/c4ra17087c
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CE8KQ
UT WOS:000352091600086
DA 2018-10-20
ER

PT J
AU Brzeska, J
   Janeczek, H
   Janik, H
   Kowalczuk, M
   Rutkowska, M
AF Brzeska, J.
   Janeczek, H.
   Janik, H.
   Kowalczuk, M.
   Rutkowska, M.
TI Degradability in vitro of polyurethanes based on synthetic atactic
   poly[(R,S)-3-hydroxybutyrate]
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Polyurethane; atactic poly[(R,S)-3-hydroxybutyrate]; biomaterial;
   hydrolytic degradation; oxidative degradation
ID DEGRADATION
AB The aim of the present study was to determine the degradability of aliphatic polyurethanes, based on a different amount of synthetic, atactic poly[(R,S)-3-hydroxybutyrate] (a-PHB), in hydrolytic (phosphate buffer) and oxidative (H2O2/CoCl2) solutions. The soft segments were built with atactic poly[(R, S)-3-hydroxybutyrate] and polycaprolactone or polyoxytetramethylenediols, whereas hard segments were the reaction product of 4,4'-methylenedicyclohexyl diisocyanate and 1,4-butanediol.
   The selected properties - density and morphology of polymer surfaces - which could influence the sensitivity of polymers to degradation processes -were analyzed.
   The analysis of molecular mass (GPC), thermal properties (DSC) and the sample weight changes were undertaken to estimate the degree of degradability of polymer samples after incubation in environments studied.
   Investigated polyurethanes were amorphous with the very low amount of crystalline phases of hard segments.
   The polyurethane synthesized with a poly[(R, S)-3-hydroxybutyrate] and polyoxytetramethylenediol at a molar ratio of NCO : OH = 3.7 : 1 (prepolymer step) appeared as the most sensitive for both degradative solutions. Its weight and molecular mass losses were the highest in comparison to other investigated polyurethanes.
   It could be expected that playing with the amount of poly[(R, S)-3-hydroxybutyrate] in polyurethane synthesis the rate of polyurethane degradation after immersion in living body would be modeled.
C1 [Brzeska, J.; Rutkowska, M.] Gdynia Maritime Univ, Dept Chem & Commod Ind Sci, PL-81225 Gdynia, Poland.
   [Janeczek, H.; Kowalczuk, M.] Polish Acad Sci, Ctr Polymer & Carbon Mat, Zabrze, Poland.
   [Janik, H.] Gdansk Univ Technol, Fac Chem, Dept Polymer Technol, Gdansk, Poland.
RP Brzeska, J (reprint author), Gdynia Maritime Univ, Dept Chem & Commod Ind Sci, 83 Morska St, PL-81225 Gdynia, Poland.
EM j.brzeska@wpit.am.gdynia.pl
OI Brzeska, Joanna/0000-0001-7596-1381
CR [Anonymous], 2012, Pat PL, Patent No. [212 763, 212763, 212763 (B1)]
   Arslan H, 1999, RAPID COMMUN MASS SP, V13, P2433, DOI 10.1002/(SICI)1097-0231(19991230)13:24<2433::AID-RCM808>3.0.CO;2-X
   Brzeska J., 2011, ENG BIOMATER, V106-108, P73
   Brzeska J., 2012, OCHRONA PRZED KOROZJ, V1, P8
   Brzeska J., 2011, ENG BIOMATERIALS, V106-108, P65
   Brzeska J, 2012, J APPL POLYM SCI, V125, P4285, DOI 10.1002/app.36599
   Brzeska J, 2011, POLIMERY-W, V56, P27, DOI 10.14314/polimery.2011.027
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Christenson EM, 2006, BIOMATERIALS, V27, P3920, DOI 10.1016/j.biomaterials.2006.03.012
   Defoirdt T, 2009, BIOTECHNOL ADV, V27, P680, DOI 10.1016/j.biotechadv.2009.04.026
   Feng YK, 2006, POLYM DEGRAD STABIL, V91, P1711, DOI 10.1016/j.polymdegradstab.2005.12.002
   Glarner M, 2007, POLYM DEGRAD STABIL, V92, P310, DOI 10.1016/j.polymdegradstab.2006.10.009
   Gorna K, 2002, POLYM DEGRAD STABIL, V75, P113, DOI 10.1016/S0141-3910(01)00210-5
   Hong JH, 2007, POLYM DEGRAD STABIL, V92, P1186, DOI 10.1016/j.polymdegradstab.2007.04.007
   Mondal S, 2012, POLYM DEGRAD STABIL, V97, P1553, DOI 10.1016/j.polymdegradstab.2012.04.008
   Ryszkowska JL, 2010, COMPOS SCI TECHNOL, V70, P1894, DOI 10.1016/j.compscitech.2010.05.011
NR 16
TC 1
Z9 1
U1 0
U2 25
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2015
VL 25
IS 2
BP 117
EP 125
DI 10.3233/BME-151262
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE3PA
UT WOS:000351738200001
PM 25813950
DA 2018-10-20
ER

PT J
AU Benedetti, E
   Duchemin, N
   Bethge, L
   Vonhoff, S
   Klussmann, S
   Vasseur, JJ
   Cossy, J
   Smietana, M
   Arseniyadis, S
AF Benedetti, Erica
   Duchemin, Nicolas
   Bethge, Lucas
   Vonhoff, Stefan
   Klussmann, Sven
   Vasseur, Jean-Jacques
   Cossy, Janine
   Smietana, Michael
   Arseniyadis, Stellios
TI DNA-cellulose: an economical, fully recyclable and highly effective
   chiral biomaterial for asymmetric catalysis
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID ENANTIOSELECTIVE CATALYSIS; ORGANIC-SYNTHESIS; FLOW CHEMISTRY; WATER;
   TECHNOLOGY
AB The challenge in DNA-based asymmetric catalysis is to perform a reaction in the vicinity of the helix by incorporating a small-molecule catalyst anchored to the DNA in a covalent, dative, or non-covalent yet stable fashion in order to ensure high levels of enantio-discrimination. Here, we report the first generation of a DNA-based catalyst bound to a cellulose matrix. The chiral biomaterial is commercially available, trivial to use, fully recyclable and produces high levels of enantioselectivity in various Cu(II)-catalyzed asymmetric reactions including Friedel-Crafts alkylations and Michael additions. A single-pass, continuous-flow process is also reported affording fast conversions and high enantioselectivities at low catalyst loadings thus offering a new benchmark in the field of DNA-based asymmetric catalysis.
C1 [Benedetti, Erica; Duchemin, Nicolas; Cossy, Janine; Arseniyadis, Stellios] PSL Res Univ, CNRS, ESPCI ParisTech, Inst Chem Biol & Innovat CBI,Lab Chim Organ,UMR82, F-75231 Paris 05, France.
   [Bethge, Lucas; Vonhoff, Stefan; Klussmann, Sven] NOXXON Pharma AG, D-10589 Berlin, Germany.
   [Vasseur, Jean-Jacques; Smietana, Michael] Univ Montpellier I, CNRS, Inst Biomol Max Mousseron, UMR 5247, F-34095 Montpellier, France.
   [Vasseur, Jean-Jacques; Smietana, Michael] Univ Montpellier 2, F-34095 Montpellier, France.
RP Smietana, M (reprint author), Univ Montpellier I, CNRS, Inst Biomol Max Mousseron, UMR 5247, F-34095 Montpellier, France.
EM msmietana@um2.fr; stellios.arseniyadis@espci.fr
RI Smietana, Michael/F-7828-2016
OI Smietana, Michael/0000-0001-8132-7221; Cossy,
   Janine/0000-0001-8746-9239; Arseniyadis, Stellios/0000-0001-6831-2631;
   Vasseur, Jean-Jacques/0000-0002-4379-6139
FU Ministere de l'Enseignement Superieur et de la Recherche; Agence
   Nationale de la Recherche (NCiS) [ANR-2010-JCJC-715-1]
FX This research was supported by the Ministere de l'Enseignement Superieur
   et de la Recherche and the Agence Nationale de la Recherche (NCiS;
   ANR-2010-JCJC-715-1).
CR BIAGIONI S, 1978, ANAL BIOCHEM, V89, P616, DOI 10.1016/0003-2697(78)90390-1
   Boersma AJ, 2008, J AM CHEM SOC, V130, P11783, DOI 10.1021/ja803170m
   Boersma AJ, 2007, ORG LETT, V9, P3647, DOI 10.1021/ol7015274
   Boersma AJ, 2012, CHEM COMMUN, V48, P2394, DOI 10.1039/c2cc17350f
   Boersma AJ, 2010, NAT CHEM, V2, P991, DOI [10.1038/nchem.819, 10.1038/NCHEM.819]
   Boersma AJ, 2010, CHEM SOC REV, V39, P2083, DOI 10.1039/b811349c
   Boersma AJ, 2009, ANGEW CHEM INT EDIT, V48, P3346, DOI 10.1002/anie.200900371
   Bos J, 2014, CURR OPIN CHEM BIOL, V19, P135, DOI 10.1016/j.cbpa.2014.02.002
   Coquiere D, 2007, ANGEW CHEM INT EDIT, V46, P9308, DOI 10.1002/anie.200703459
   DEHASETH PL, 1977, BIOCHEMISTRY-US, V16, P4777, DOI 10.1021/bi00641a003
   Dijk EW, 2010, ORG BIOMOL CHEM, V8, P3868, DOI 10.1039/c005048b
   Dijk EW, 2008, TETRAHEDRON-ASYMMETR, V19, P2374, DOI 10.1016/j.tetasy.2008.10.004
   Frost CG, 2010, GREEN CHEM, V12, P1687, DOI 10.1039/c0gc00133c
   Garcia-Fernandez A, 2012, METAL IONS LIFE SCI, V10, P249, DOI 10.1007/978-94-007-2172-2_9
   Gjonaj L, 2013, CHEMCATCHEM, V5, P1718, DOI 10.1002/cctc.201300082
   Hartwig J, 2014, ORG BIOMOL CHEM, V12, P3611, DOI 10.1039/c4ob00662c
   KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889
   Li YH, 2013, TETRAHEDRON, V69, P6585, DOI 10.1016/j.tet.2013.05.133
   Mason BP, 2007, CHEM REV, V107, P2300, DOI 10.1021/cr050944c
   Megens RP, 2012, CHEM COMMUN, V48, P6366, DOI 10.1039/c2cc31854g
   Megens RP, 2010, ORG BIOMOL CHEM, V8, P1387, DOI 10.1039/b921385f
   Myers R. M., 2012, MODERN TOOLS SYNTHES, P359, DOI DOI 10.1002/9781118342886.CH11
   Nieuwland PJ, 2011, ORG PROCESS RES DEV, V15, P783, DOI 10.1021/op100338z
   Oelerich J, 2013, CHEM SCI, V4, P2013, DOI 10.1039/c3sc00100h
   PARK SJ, 2013, ASIAN WOMEN, V29, P1
   Park S, 2014, ACS CATAL, V4, P4070, DOI 10.1021/cs501086f
   Park S, 2012, CHEM COMMUN, V48, P10398, DOI 10.1039/c2cc35625b
   Pastre J. C., 2013, CHEM SOC REV, V42, P8801
   Petrova GP, 2014, CHEM PHYS LETT, V600, P87, DOI 10.1016/j.cplett.2014.03.060
   Roe S, 2010, CHEM COMMUN, V46, P4309, DOI 10.1039/c0cc00194e
   Roelfes G, 2005, ANGEW CHEM INT EDIT, V44, P3230, DOI 10.1002/anie.200500298
   Rosati F, 2010, CHEM COMMUN, V46, P7804, DOI 10.1039/c0cc02584d
   Rosati F, 2009, CHEM-EUR J, V15, P9596, DOI 10.1002/chem.200900456
   Shibata N, 2007, SYNLETT, P1153, DOI 10.1055/s-2007-977429
   Wang CH, 2012, ANGEW CHEM INT EDIT, V51, P9352, DOI 10.1002/anie.201204850
   Wang CH, 2012, CHEM COMMUN, V48, P6232, DOI 10.1039/c2cc31320k
   Wang J, 2013, ANGEW CHEM INT EDIT, V52, P11546, DOI 10.1002/anie.201306232
   Wegner J, 2012, ADV SYNTH CATAL, V354, P17, DOI 10.1002/adsc.201100584
   Wilking M, 2013, ORG BIOMOL CHEM, V11, P6940, DOI 10.1039/c3ob41366g
   Zhao H, 2014, RSC ADV, V4, P54051, DOI 10.1039/c4ra10749g
NR 40
TC 16
Z9 16
U1 7
U2 67
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2015
VL 51
IS 28
BP 6076
EP 6079
DI 10.1039/c4cc10190a
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA CE4YL
UT WOS:000351836300003
PM 25613918
DA 2018-10-20
ER

PT J
AU Ruangsomboon, S
AF Ruangsomboon, Suneerat
TI Enhanced Production of Polysaccharides and Protein Content in
   Cyanobacterium, Oscillatoria limnetica as a Defense Mechanism Against
   Low pH and Pb2+
SO CHIANG MAI JOURNAL OF SCIENCE
LA English
DT Article
DE adsorption capacity; chlorophyll fluorescence; detoxification; living
   biosorbent; Pb2+ precipitation
ID BIOSORPTION; WATER; REMOVAL; LEAD
AB Living biomass has better ability to remove Pb2+ from wastewaters as compare to dead biomass. But, living biomass also have some practical limitations, such as, they are not efficient at low pH, and at high concentrations of metal ions. In the present study living biomass of Oscillatoria limnetica was assessed for its metal sorption capacity. O. limnetica considerably sorbed a large amount of Pb2+ within pH range 3-7. The maximum Pb2+ sorption capacity of O. limnetica was 434.78 mg/g. As photochemical efficiency data depicted, Pb2+ exerted inhibitory effects on photosynthesis of the test cyanobacterium. However, the test cyanobacterium showed considerable tolerance to Pb2+ exposure as concentration increased from 0 to 5 mg/L. Defense mechanisms of O. limnetica under Pb2+ enriched condition is probably associated with greater accumulation of intracellular polysaccharides (IPS) and protein. Nonetheless, since Pb2+ binding capacity of O. limnetica is significantly high than that of several other biosorbents, it can be considered as a promising biomaterial for removal of Pb2+ from wastewaters.
C1 King Mongkuts Inst Technol Ladkrabang, Fac Agr Technol, Div Anim Prod Technol & Fisheries, Program Fisheries Sci, Bangkok 10520, Thailand.
RP Ruangsomboon, S (reprint author), King Mongkuts Inst Technol Ladkrabang, Fac Agr Technol, Div Anim Prod Technol & Fisheries, Program Fisheries Sci, Bangkok 10520, Thailand.
EM krsuneer@kmitl.ac.th
FU Thailand Research Fund (TRF)
FX The present work was financially supported by The Thailand Research Fund
   (TRF).
CR [Anonymous], 2010, MIN SCI TECHNOL, P566
   Ashraf MA, 2013, CHIANG MAI J SCI, V40, P198
   Becker E. W, 1994, MICROALGAE BIOTECHNO
   Chakraborty N, 2011, BIORESOURCE TECHNOL, V102, P4191, DOI 10.1016/j.biortech.2010.12.028
   DUBININ MM, 1960, CHEM REV, V60, P235, DOI 10.1021/cr60204a006
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Erten-Unal M, 1999, WATER AIR SOIL POLL, V116, P501, DOI 10.1023/A:1005176322247
   Gaur JP, 2001, ALGAL ADAPTATION TO ENVIRONMENTAL STRESSES, P363
   GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9
   Gupta VK, 2008, COLLOID SURFACE B, V64, P170, DOI 10.1016/j.colsurfb.2008.01.019
   Hirata K, 2001, J BIOSCI BIOENG, V92, P24, DOI 10.1263/jbb.92.24
   Kumar D, 2012, BIORESOURCE TECHNOL, V104, P202, DOI 10.1016/j.biortech.2011.11.002
   Malik A, 2004, ENVIRON INT, V30, P261, DOI 10.1016/j.envint.2003.08.001
   POST AF, 1985, FEMS MICROBIOL ECOL, V31, P97
   Pumpel T, 2001, HYDROMETALLURGY, V59, P383, DOI 10.1016/S0304-386X(00)00168-7
   Rai LC, 1996, ENVIRON EXP BOT, V36, P99, DOI 10.1016/0098-8472(95)00030-5
   Raungsomboon S, 2008, BIORESOURCE TECHNOL, V99, P5650, DOI 10.1016/j.biortech.2007.10.056
   Ruangsomboon S., 2006, Kasetsart Journal, Natural Sciences, V40, P784
   Sandford P A, 1979, Adv Carbohydr Chem Biochem, V36, P265
   SIMON RD, 1973, J BACTERIOL, V114, P1213
   Temkin M, 1940, ACTA PHYSICOCHIM URS, V12, P327
   Terry PA, 2002, CHEMOSPHERE, V47, P249, DOI 10.1016/S0045-6535(01)00303-4
   VINCENT P, 1994, APPL ENVIRON MICROB, V60, P4134
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Vymazal J., 1995, ALGAE ELEMENT CYCLIN
   Wilkins MR, 1996, BIO-TECHNOL, V14, P61, DOI 10.1038/nbt0196-61
NR 26
TC 0
Z9 0
U1 1
U2 3
PU CHIANG MAI UNIV, FAC SCIENCE
PI CHIANG MAI
PA 239 HUAY KAEW RD, T SUTHEP, CHIANG MAI, 50200, THAILAND
SN 0125-2526
J9 CHIANG MAI J SCI
JI Chiang Mai J. Sci.
PD JAN
PY 2015
VL 42
IS 1
BP 34
EP 43
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE6YR
UT WOS:000351984600003
DA 2018-10-20
ER

PT J
AU Park, C
   Vo, CLN
   Kang, T
   Oh, E
   Lee, BJ
AF Park, Chulhun
   Chau Le-Ngoc Vo
   Kang, Taehee
   Oh, Euichaul
   Lee, Beom-Jin
TI New method and characterization of self-assembled gelatin-oleic
   nanoparticles using a desolvation method via
   carbodiimide/N-hydroxysuccinimide (EDC/NHS) reaction
SO EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
LA English
DT Article
DE Gelatin-oleic conjugate; Irinotecan; Fattigation; Desolvation method;
   Self-assembled nanoparticles; Crosslinking agents
ID DRUG-DELIVERY; CARRIER SYSTEM; SERUM-ALBUMIN; ACID; NANOPRECIPITATION;
   PACLITAXEL; BINDING
AB In this study, we investigated a new method for the preparation of gelatin-oleic conjugate (GOC) as an amphiphilic biomaterial to load model anti-cancer drugs into self-assembled nanoparticles (NPs). Oleic acid (OA) was covalently bound to gelatin via carbodiimide/N-hydroxysuccinimide (EDC/NHS) reaction in water-ethanol cosolvent to form a GOC. Fourier transform infrared (FT-IR) spectroscopy and proton nuclear magnetic resonance (H-1 NMR) clearly indicated the successful synthesis of GOC. The percentage of gelatin amino groups reacted with OA was up to 50% as determined using the 2,4,6-trinitrobenzene sulfonic acid (TNBS) method. Subsequently, gelatin-oleic nanoparticles (GONs) were prepared using a desolvation method with glutaraldehyde or genipin used as a crosslinker for comparison. Irinotecan hydrochloride (IRT) was used as a model drug to load into GONs using incubation or an in-process adding method for comparison. Dynamic light scattering (DLS) and transmission electron microscopy (TEM) data showed that the sizes of GONs and IRT-loaded GONs (IRT-GONs) were below 250 nm. The zeta potentials of the GONs and irinotecan-loaded IRT-GONs were below -20 mV, which was found to be stable in suspension against the aggregation process. The incubation method was more suitable for drug loading because it did not affect the process of CON formation and thus did not increase their size much compared to the change in size with the in-process adding method. The lipophilic property of the oleic moiety in the GOC increased the affinity between GOC molecules, thus reducing the amount of crosslinking agents needed to stabilize GONs compared to gelatin nanoparticles (GNs). As novel approaches for the synthesis of protein-fatty acid complexes, chemical reaction has been suggested for the synthesis of GOC. The above results show that GOC synthesized via new method is a promising biomaterial based upon preparation of nanoparticles. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Park, Chulhun; Chau Le-Ngoc Vo; Kang, Taehee; Lee, Beom-Jin] Ajou Univ, Coll Pharm, Suwon 443749, South Korea.
   [Oh, Euichaul] Catholic Univ, Coll Pharm, Puchon, South Korea.
RP Lee, BJ (reprint author), Ajou Univ, Coll Pharm, Suwon 443749, South Korea.
EM beomjinlee@gmail.com
FU Bio & Medical Technology Development Program of the National Research
   Foundation - Ministry of Science, ICT & Future Planning, Korea
   [2013M3A9B5075840, 2013M3A9B5075841]
FX This research was supported by the Bio & Medical Technology Development
   Program of the National Research Foundation funded by the Ministry of
   Science, ICT & Future Planning (2013M3A9B5075840 & 2013M3A9B5075841),
   Korea. We would like to thank KBSI and Ajou University-Central
   Laboratory for the use of TEM, NMR and FTIR.
CR Bajpai AK, 2006, J MATER SCI-MATER M, V17, P345, DOI 10.1007/s10856-006-8235-9
   Balthasar S, 2005, BIOMATERIALS, V26, P2723, DOI 10.1016/j.biomaterials.2004.07.047
   Bernkop-Schnurch A, 1998, J CONTROL RELEASE, V50, P215, DOI 10.1016/S0168-3659(97)00136-3
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   Coester CJ, 2000, J MICROENCAPSUL, V17, P187
   DIGENIS GA, 1994, J PHARM SCI, V83, P915, DOI 10.1002/jps.2600830702
   Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036
   Gaihre B, 2009, INT J PHARM, V365, P180, DOI 10.1016/j.ijpharm.2008.08.020
   Gregoriadis G, 1995, TRENDS BIOTECHNOL, V13, P527, DOI 10.1016/S0167-7799(00)89017-4
   Gupta AK, 2004, J CONTROL RELEASE, V95, P197, DOI 10.1016/j.jconrel.2003.11.006
   Jahanshahi M., 2008, AFR J BIOTECHNOL, V7
   Kazunori K., 1993, J CONTROL RELEASE, V24, P119, DOI DOI 10.1016/0168-3659(93)90172-2
   Khan SA, 2013, MACROMOL BIOSCI, V13, P455, DOI 10.1002/mabi.201200382
   Landry V, 2008, PROG ORG COAT, V61, P76, DOI 10.1016/j.porgcoat.2007.09.013
   Lee EJ, 2012, BIOPROC BIOSYST ENG, V35, P297, DOI 10.1007/s00449-011-0591-2
   Lee KD, 2014, ARCH PHARM RES, V37, P1546, DOI 10.1007/s12272-014-0489-z
   Liu Z, 2008, CANCER RES, V68, P6652, DOI 10.1158/0008-5472.CAN-08-1468
   Park Eun Ji, 2014, Journal of Pharmaceutical Investigation, V44, P141, DOI 10.1007/s40005-013-0110-3
   Park JH, 2008, PROG POLYM SCI, V33, P113, DOI 10.1016/j.progpolymsci.2007.09.003
   Tran PHL, 2014, J BIOMED NANOTECHNOL, V10, P154, DOI 10.1166/jbn.2014.1660
   Tran PHL, 2013, J BIOMED NANOTECHNOL, V9, P1416, DOI 10.1166/jbn.2013.1621
   Tang YQ, 2008, J CONTROL RELEASE, V127, P70, DOI 10.1016/j.jconrel.2007.12.012
   Tian JN, 2004, BIOMACROMOLECULES, V5, P1956, DOI 10.1021/bm049668m
   Tseng CL, 2007, BIOMATERIALS, V28, P3996, DOI 10.1016/j.biomaterials.2007.05.006
   Ulbrich K, 2011, INT J PHARMACEUT, V406, P128, DOI 10.1016/j.ijpharm.2010.12.023
   Wang YX, 2011, J FLUORINE CHEM, V132, P489, DOI 10.1016/j.jfluchem.2011.05.003
   Won YW, 2008, J CONTROL RELEASE, V127, P154, DOI 10.1016/j.jconrel.2008.01.010
   Yeh TK, 2005, PHARM RES, V22, P867, DOI 10.1007/s11095-005-4581-4
   Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g
NR 29
TC 15
Z9 15
U1 4
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0939-6411
EI 1873-3441
J9 EUR J PHARM BIOPHARM
JI Eur. J. Pharm. Biopharm.
PD JAN
PY 2015
VL 89
BP 365
EP 373
DI 10.1016/j.ejpb.2014.12.002
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CE1FO
UT WOS:000351557700039
PM 25536111
DA 2018-10-20
ER

PT J
AU Sobrinho, JHOS
   Rodrigues, SF
   Silva, ES
   Reis, GS
   Sousa, RC
   Leal, VS
   Mercury, JMR
AF Oliveira Santos Sobrinho, Jose Helio
   Rodrigues, Samuel Filgueiras
   Silva, Eden Santos
   Reis, Gedeon Silva
   Sousa, Regina Celia
   Leal, Valdemar Silva
   Rivas Mercury, Jose Manuel
TI Plastic Instability in ISO 5832-9 High-nitrogen Austenitic Stainless
   Steel
SO ISIJ INTERNATIONAL
LA English
DT Article
DE stainless steel; workability; plastic instability; processing maps;
   corrosion
ID HOT-WORKING; RECRYSTALLIZATION; BIOMATERIAL; PREDICTION
AB ISO 5832-9 high-nitrogen austenitic stainless steel has shown promising results in the fabrication of temporary and permanent orthopedic prostheses, exhibiting better mechanical strength and corrosion resistance than the traditional ISO 5832-1 (ASTM F-138) steel. Recent studies have revealed that this alloy possesses unique properties, such as high mechanical strength and corrosion resistance and the presence of second phase particles (Z phase) in the matrix. However, it is not known how the microstructural and mechanical properties and the corrosion rate are correlated in regions of industrial processability of this alloy during hot forming. In this study, continuous and interrupted isothermal hot torsion tests were performed after solubilization heat treatment at 1 473 K for 300 s, with temperature intervals varying from 1 273 to 1 473 K and strain rates ranging from 0.05 to 5 s(-1). The purpose of these tests was to investigate the alloy's workability and stress corrosion rate by means of electrochemical impedance spectroscopy (EIS) and to characterize its microstructure by optical microscopy. The results indicate that the yield stress is sensitive to the strain parameters. The peak stress decreases with increasing temperature and decreasing strain rate, with a high rate of dynamic recovery, with elongated grains generating areas of stress build-up. These regions of plastic instability present a higher degree of corrosion than as-received samples. The regions of high temperature and low strain rate exhibit good workability with a refined final microstructure of dynamically recrystallized grains.
C1 [Oliveira Santos Sobrinho, Jose Helio; Rodrigues, Samuel Filgueiras; Silva, Eden Santos; Reis, Gedeon Silva; Leal, Valdemar Silva; Rivas Mercury, Jose Manuel] Fed Inst Educ Sci & Technol Maranhao, Dept Mat & Mech, BR-65030005 Sao Luis, MA, Brazil.
   [Sousa, Regina Celia] Univ Fed Maranhao, Dept Phys, BR-65080805 Sao Luis, MA, Brazil.
RP Rodrigues, SF (reprint author), Fed Inst Educ Sci & Technol Maranhao, Dept Mat & Mech, Ave Getulio Vargas 04, BR-65030005 Sao Luis, MA, Brazil.
EM samuel.filgueiras@ifma.edu.br
RI Rodrigues, Samuel/I-2873-2017
OI Rodrigues, Samuel/0000-0003-0002-4566
FU FAPEMA; CNPq; CAPES (Brazil)
FX The authors gratefully acknowledge FAPEMA, CNPq and CAPES (Brazil) for
   their financial support of this work.
CR El Wahabi M, 2003, MAT SCI ENG A-STRUCT, V343, P116, DOI 10.1016/S0921-5093(02)00357-X
   Fields D. S., 1957, P AM SOCIETY SOCIETY, V57, P1259
   Giordani E. J., 2006, SCRIPTA MATER, P743
   Giordani EJ, 2004, INT J FATIGUE, V26, P1129, DOI 10.1016/j.ijfatigue.2004.03.002
   Jocobs J. J., 1998, J BONE SURG A, V80A, P268
   Kocks UF, 2003, PROG MATER SCI, V48, P171, DOI 10.1016/S0079-6425(02)00003-8
   LAASRAOUI A, 1991, METALL TRANS A, V22, P1545, DOI 10.1007/BF02667368
   Mataya MC, 2003, METALL MATER TRANS A, V34A, P1683, DOI 10.1007/s11661-003-0313-8
   McQueen H. J., 2003, MAT SCI ENG A-STRUCT, V203, P387
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   Prasad Y. V. R. K., 1997, HOT WORKING GUIDE CO
   Prasad Y. V. R. K., 2003, J MATER ENG PERFORM, V12, P674
   Prasad Y. V. R. K., 2003, J MATER ENG PERFORM, V12, P656
   Rodrigues SF, 2014, MATER RES-IBERO-AM J, V17, P436, DOI [10.1590/S1516-14392014005000001, 10.1590/S1516-14392014000200023]
   SCHRAMM RE, 1975, METALL TRANS A, V6, P1345, DOI 10.1007/BF02641927
   Silva ES, 2012, MAT SCI ENG A-STRUCT, V543, P69, DOI 10.1016/j.msea.2012.02.048
   Souza RC, 2013, MAT SCI ENG A-STRUCT, V582, P96, DOI 10.1016/j.msea.2013.06.037
   Taylor AS, 2011, MAT SCI ENG A-STRUCT, V528, P3310, DOI 10.1016/j.msea.2010.12.093
   Venugopal S., 2003, J MATER ENG PERFORM, P675
   Ziegler H., 1963, PROGR SOLID MECHANIC, V4, P93
NR 21
TC 1
Z9 1
U1 0
U2 9
PU IRON STEEL INST JAPAN KEIDANREN KAIKAN
PI TOKYO
PA TEKKO KAIKAN-5F, 3-2-10, NIHONBASHI-KAYABACHO, TOKYO, CHUO-KU 103-0025,
   JAPAN
SN 0915-1559
EI 1347-5460
J9 ISIJ INT
JI ISIJ Int.
PY 2015
VL 55
IS 3
BP 670
EP 678
DI 10.2355/isijinternational.55.670
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA CE1IZ
UT WOS:000351566600027
OA Bronze
DA 2018-10-20
ER

PT J
AU Lu, SZ
   Li, JJ
   Zhang, SS
   Yin, ZP
   Xing, TL
   Kaplan, DL
AF Lu, Shenzhou
   Li, Jiaojiao
   Zhang, Shanshan
   Yin, Zhuping
   Xing, Tieling
   Kaplan, David L.
TI The influence of the hydrophilic-lipophilic environment on the structure
   of silk fibroin protein
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID PHYSICAL-PROPERTIES; BLEND FILMS; CONFORMATION; SPECTROSCOPY;
   BIOMATERIAL; MEMBRANES
AB The present study examines the influence of the hydrophilic-lipophilic environment, mediated by small molecules, on the structural changes in silk protein fibroin. Small molecules mediate the various hydrophilic-lipophilic balances (HLBs) that impact the organisation of silk protein chains. Changes in the silk fibroin structure due to additives are related to the HLB value. At HLB > 10, silk fibroin primarily forms Silk I crystalline structures. Small molecules with HLB < 8.9 primarily induce the formation of Silk II crystalline structures. When 8.9 < HLB < 10, the crystalline structure of silk is related to the content of small molecules. The Silk I structure is primarily formed when the content of small molecules is low, whereas the Silk II structure is formed when the small molecule content is high. The structure of silk fibroin is maintained by regulating the HLB in the fibroin environment. This type of control for the functional design of materials may play a role in fine-tuning the biomaterial properties of silk fibroin protein.
C1 [Lu, Shenzhou; Li, Jiaojiao; Zhang, Shanshan; Yin, Zhuping; Xing, Tieling] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Lu, SZ (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM lushenzhou@suda.edu.cn
RI Lu, Shenzhou/P-6519-2015; Xing, Tieling/C-9891-2018
OI Lu, Shenzhou/0000-0003-4188-2057; Xing, Tieling/0000-0002-4136-3137
FU National Natural Science Foundation of China [51203107, 51373114]; PAPD;
   Nature Science Foundation of Jiangsu, China [BK20131176]
FX The work is supported by the National Natural Science Foundation of
   China (Grant no. 51203107, 51373114), PAPD and the Nature Science
   Foundation of Jiangsu, China (Grant no. BK20131176).
CR Brown J, 2015, ACTA BIOMATER, V11, P212, DOI 10.1016/j.actbio.2014.09.013
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   Cebe P, 2013, SCI REP, V3, P1
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Davies J. T., 1957, P 2 INT C SURF ACT, V1, P426
   Gil ES, 2006, BIOMACROMOLECULES, V7, P728, DOI 10.1021/bm050622i
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   IIZUKA E, 1968, BIOCHEMISTRY-US, V7, P2218, DOI 10.1021/bi00846a026
   Jiang T, 2011, ON BIOMIMETICS, P357
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KRATKY O, 1950, NATURE, V165, P319, DOI 10.1038/165319a0
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   [卢神州 Lu Shenzhou], 2003, [高分子材料科学与工程, Polymer Materials Science & Engineering], V19, P104
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Prosa M, 2014, RSC ADV, V4, P44815, DOI 10.1039/c4ra08390c
   Sashina ES, 2006, RUSS J APPL CHEM+, V79, P869, DOI 10.1134/S1070427206060012
   Shulha H, 2006, POLYMER, V47, P5821, DOI 10.1016/j.polymer.2006.06.002
   Steven E, 2014, MATER HORIZONS, V1, P522, DOI 10.1039/c4mh00074a
   Tanaka T, 1998, POLYM INT, V45, P175, DOI 10.1002/(SICI)1097-0126(199802)45:2<175::AID-PI883>3.0.CO;2-K
   Trabbic KA, 1998, MACROMOLECULES, V31, P462, DOI 10.1021/ma9708860
   TSUKADA M, 1995, J POLYM SCI POL PHYS, V33, P1995, DOI 10.1002/polb.1995.090331402
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang HY, 2013, SOFT MATTER, V9, P138, DOI 10.1039/c2sm26945g
   Wu J, 2014, BIOMATERIALS, V35, P3744, DOI 10.1016/j.biomaterials.2013.12.078
   Wu XL, 2012, ACTA BIOMATER, V8, P2185, DOI 10.1016/j.actbio.2012.03.007
   Yang G, 2000, J MEMBRANE SCI, V177, P153, DOI 10.1016/S0376-7388(00)00467-1
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Zhou J, 2014, ACS APPL MATER INTER, V6, P21813, DOI 10.1021/am502278b
   Zhou W, 2006, PROG CHEM, V18, P1514
NR 36
TC 9
Z9 9
U1 3
U2 37
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 13
BP 2599
EP 2606
DI 10.1039/c4tb01873g
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CE1UZ
UT WOS:000351599400003
DA 2018-10-20
ER

PT J
AU Azeem, A
   English, A
   Kumar, P
   Satyam, A
   Biggs, M
   Jones, E
   Tripathi, B
   Basu, N
   Henkel, J
   Vaquette, C
   Rooney, N
   Riley, G
   O'Riordan, A
   Cross, G
   Ivanovski, S
   Hutmacher, D
   Pandit, A
   Zeugolis, D
AF Azeem, Ayesha
   English, Andrew
   Kumar, Pramod
   Satyam, Abhigyan
   Biggs, Manus
   Jones, Eleanor
   Tripathi, Bhawana
   Basu, Nandita
   Henkel, Jan
   Vaquette, Cedryck
   Rooney, Niall
   Riley, Graham
   O'Riordan, Alan
   Cross, Graham
   Ivanovski, Saso
   Hutmacher, Dietmar
   Pandit, Abhay
   Zeugolis, Dimitrios
TI The influence of anisotropic nano- to micro-topography on in vitro and
   in vivo osteogenesis
SO NANOMEDICINE
LA English
DT Article
DE anisotropic topography; cell/biomaterial interface; gene analysis;
   osteogenesis
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING APPLICATIONS;
   PERIPHERAL-NERVE REPAIR; FOCAL ADHESION KINASE; REGENERATIVE MEDICINE;
   DRUG-DELIVERY; OSTEOBLAST ALIGNMENT; CONTROLLED-RELEASE;
   SOFT-LITHOGRAPHY; CELLULAR MECHANOTRANSDUCTION
AB Aim: Topographically modified substrates are increasingly used in tissue engineering to enhance biomimicry. The overarching hypothesis is that topographical cues will control cellular response at the cell-substrate interface. Materials & methods: The influence of anisotropically ordered poly(lactic-co-glycolic acid) substrates (constant groove width of similar to 1860 nm; constant line width of similar to 2220 nm; variable groove depth of similar to 35, 306 and 2046 nm) on in vitro and in vivo osteogenesis were assessed. Results & discussion: We demonstrate that substrates with groove depths of approximately 306 and 2046 nm promote osteoblast alignment parallel to underlined topography in vitro. However, none of the topographies assessed promoted directional osteogenesis in vivo. Conclusion: 2D imprinting technologies are useful tools for in vitro cell phenotype maintenance.
C1 [Azeem, Ayesha; English, Andrew; Kumar, Pramod; Satyam, Abhigyan; Biggs, Manus; Pandit, Abhay; Zeugolis, Dimitrios] Natl Univ Ireland Galway NUI Galway, Network Excellence Funct Biomat NFB, Galway, Ireland.
   [Jones, Eleanor; Riley, Graham] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.
   [Tripathi, Bhawana; Basu, Nandita; Cross, Graham] Univ Dublin Trinity Coll, CRANN, Dublin 2, Ireland.
   [Henkel, Jan; Vaquette, Cedryck; Hutmacher, Dietmar] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.
   [Rooney, Niall] Proxy Biomed, Galway, Ireland.
   [O'Riordan, Alan] Tyndall Natl Inst, Cork, Ireland.
   [Ivanovski, Saso] Griffith Univ, Sch Dent & Oral Hlth, Southport, Qld 4215, Australia.
   [Ivanovski, Saso] Griffith Univ, Mol Basis Dis Program, Southport, Qld 4215, Australia.
RP Zeugolis, D (reprint author), Natl Univ Ireland Galway NUI Galway, Network Excellence Funct Biomat NFB, Biosci Bldg, Galway, Ireland.
EM dimitrios.zeugolis@nuigalway.ie
RI Pandit, Abhay/B-6187-2008; Ivanovski, Saso/I-1835-2016
OI Pandit, Abhay/0000-0002-6292-4933; Ivanovski, Saso/0000-0001-5339-0936;
   zeugolis, dimitrios/0000-0002-7599-5191; O'Riordan,
   Alan/0000-0002-7554-1536; SATYAM, ABHIGYAN/0000-0001-9838-4572; Cross,
   Graham/0000-0003-2299-6091; Hutmacher, Dietmar
   Werner/0000-0001-5678-2134; Vaquette, Cedryck/0000-0001-7937-4432;
   Biggs, Manus/0000-0003-4699-1025
FU Enterprise Ireland, Collaborative Centre for Applied Nanotechnology
   under Irish Government [CCIRP-2007-CCAN-0509]; Tyndall National
   Institute, SFI [NAP382]; Science Foundation Ireland, Research Frontiers
   Programme [SFI-09-RFP-ENM2483]; Health Research Board [HRA_POR/2011/84];
   College of Engineering & Informatics, NUI Galway
FX This work was supported by: Enterprise Ireland, Collaborative Centre for
   Applied Nanotechnology (project number CCIRP-2007-CCAN-0509), under the
   Irish Government's National Development Plan 2007-2013 to D Zeugolis;
   Tyndall National Institute, SFI-funded National Access Programme
   (project number NAP382) to D Zeugolis; Science Foundation Ireland,
   Research Frontiers Programme, (project number SFI-09-RFP-ENM2483) to D
   Zeugolis; Health Research Board (project number HRA_POR/2011/84) to D
   Zeugolis; and College of Engineering & Informatics, NUI Galway,
   Postgraduate Scholarship Scheme to P Kumar and D Zeugolis. The authors
   have no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Abu-Rub MT, 2011, SOFT MATTER, V7, P2770, DOI 10.1039/c0sm01062f
   Ankam S, 2013, ORGANOGENESIS, V9, P128, DOI 10.4161/org.25425
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056
   Baji A, 2010, COMPOS SCI TECHNOL, V70, P703, DOI 10.1016/j.compscitech.2010.01.010
   Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077
   Bhardwaj N, 2009, BIOTECHNOL ADV, V28, P325
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Biggs MJP, 2010, P I MECH ENG H, V224, P1441, DOI 10.1243/09544119JEIM775
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Binan L, 2014, BIOMATERIALS, V35, P664, DOI 10.1016/j.biomaterials.2013.09.097
   Blattler T, 2006, J NANOSCI NANOTECHNO, V6, P2237, DOI 10.1166/jnn.2006.501
   Braghirolli DI, 2014, DRUG DISCOV TODAY, V19, P743, DOI 10.1016/j.drudis.2014.03.024
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108
   Brydone AS, 2011, BIOMED MATER, V6, P1
   Cabezas MD, 2014, METHOD CELL BIOL, V119, P261, DOI 10.1016/B978-0-12-416742-1.00013-5
   Cassidy JW, 2014, ACTA BIOMATER, V10, P651, DOI 10.1016/j.actbio.2013.11.008
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Chen GC, 2005, MOL CELL BIOL, V25, P979, DOI 10.1128/MCB.25.3.979-987.2005
   Chen HL, 2011, INT J BIOL MACROMOL, V48, P13, DOI 10.1016/j.ijbiomac.2010.09.019
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Cheng XG, 2008, BIOMATERIALS, V29, P3278, DOI 10.1016/j.biomaterials.2008.04.028
   Choi ST, 2008, RHEUMATOLOGY, V47, P1775, DOI 10.1093/rheumatology/ken385
   Cigognini D, 2013, DRUG DISCOV TODAY, V18, P1099, DOI 10.1016/j.drudis.2013.06.007
   Cipitria A, 2012, J BONE MINER RES, V27, P1275, DOI 10.1002/jbmr.1589
   Cipriano AF, 2014, J BIOMED NANOTECHNOL, V10, P660, DOI 10.1166/jbn.2014.1760
   Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018
   Costa PF, 2014, J CLIN PERIODONTOL, V41, P283, DOI 10.1111/jcpe.12214
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2007, J CELL BIOCHEM, V100, P326, DOI 10.1002/jcb.21058
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Daly WT, 2012, BIOMATERIALS, V33, P6660, DOI 10.1016/j.biomaterials.2012.06.002
   Dang JM, 2007, ADV MATER, V19, P2775, DOI 10.1002/adma.200602159
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Edalat F, 2012, ANN BIOMED ENG, V40, P1301, DOI 10.1007/s10439-011-0452-9
   Eersels K, 2013, ACS APPL MATER INTER, V5, P7258, DOI 10.1021/am401605d
   Egerbacher M, 2008, CLIN ORTHOP RELAT R, V466, P1562, DOI 10.1007/s11999-008-0274-8
   Ekaputra AK, 2009, TISSUE ENG PT A, V15, P3779, DOI [10.1089/ten.tea.2009.0186, 10.1089/ten.TEA.2009.0186]
   Embrechts A, 2008, LANGMUIR, V24, P8841, DOI 10.1021/la800770y
   Enea D, 2013, KNEE SURG SPORT TR A, V21, P1783, DOI 10.1007/s00167-012-2102-7
   Engel E, 2009, ANN ANAT, V191, P136, DOI 10.1016/j.aanat.2008.07.013
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   English A, 2012, J MATER SCI-MATER M, V23, P137, DOI 10.1007/s10856-011-4471-8
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Flinn HM, 1996, J CELL SCI, V109, P1133
   Fontana G, 2014, ADV HEALTHC MATER, V3, P2012, DOI 10.1002/adhm.201400175
   Fowlkes JL, 2008, ENDOCRINOLOGY, V149, P1697, DOI 10.1210/en.2007-1408
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fuller K, 2014, PHARM NAN0TECHNOL, V2, P23
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Georgiou M, 2013, BIOMATERIALS, V34, P7335, DOI 10.1016/j.biomaterials.2013.06.025
   Guo J, 2012, NANOMEDICINE NERVOUS, P330
   Hu W, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/38/385301
   Hu XL, 2014, J CONTROL RELEASE, V185, P12, DOI 10.1016/j.jconrel.2014.04.018
   Huang Z, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1465
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Ingber DE, 2010, ANN BIOMED ENG, V38, P1148, DOI 10.1007/s10439-010-9946-0
   Ismail FSM, 2007, J MATER SCI-MATER M, V18, P705, DOI 10.1007/s10856-006-0012-2
   Jackson JK, 2004, INT J PHARM, V283, P97, DOI 10.1016/j.ijpharm.2004.06.025
   Kam KR, 2014, TISSUE ENG PT A, V20, P130, DOI [10.1089/ten.tea.2012.0772, 10.1089/ten.TEA.2012.0772]
   Kasko AM, 2010, FUTURE MED CHEM, V2, P1669, DOI 10.4155/FMC.10.253
   Kenar H, 2008, J BIOMED MATER RES A, V85A, P1001, DOI 10.1002/jbm.a.31638
   Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001
   Khan MR, 2012, BONE, V50, P1, DOI 10.1016/j.bone.2011.07.040
   Kim JK, 2014, ARCH PHARM RES, V37, P60, DOI 10.1007/s12272-013-0280-6
   Kim J, 2014, BIOMATERIALS, V35, P9058, DOI 10.1016/j.biomaterials.2014.07.036
   Kim JE, 2014, INT J NANOMED, V9, P141, DOI 10.2147/IJN.S54114
   Kim JY, 2009, J BIOMED MATER RES A, V88A, P419, DOI 10.1002/jbm.a.31799
   Kirmizidis G, 2009, TISSUE ENG PT A, V15, P1427, DOI 10.1089/ten.tea.2008.0137
   Kishore V, 2012, BIOMATERIALS, V33, P2137, DOI 10.1016/j.biomaterials.2011.11.066
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kolind K, 2014, ACTA BIOMATER, V10, P641, DOI 10.1016/j.actbio.2013.11.006
   Kosuge D, 2013, CURR STEM CELL RES T, V8, P185, DOI 10.2174/1574888X11308030002
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Kuo YJ, 2014, J ORTHOP SCI, V19, P313, DOI 10.1007/s00776-013-0510-2
   Kyle S, 2012, ADV HEALTHC MATER, V1, P640, DOI 10.1002/adhm.201200047
   Lamers E, 2012, EUR CELLS MATER, V23, P182, DOI 10.22203/eCM.v023a14
   Lamers E, 2010, EUR CELLS MATER, V20, P329
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lan HB, 2013, J NANOSCI NANOTECHNO, V13, P3145, DOI 10.1166/jnn.2013.7437
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Liu W, 2006, TISSUE ENG, V12, P775, DOI 10.1089/ten.2006.12.775
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lopez-Bosque MJ, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/25/255305
   Lu X, 2003, J BIOMED MATER RES A, V66A, P677, DOI 10.1002/jbm.a.10022
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Matsugaki A, 2013, ACTA BIOMATER, V9, P7227, DOI 10.1016/j.actbio.2013.03.015
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3
   McCall JD, 2012, DRUG DELIV TRANSL RE, V2, P305, DOI 10.1007/s13346-012-0090-2
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015
   Mujahid A, 2013, BIOTECHNOL ADV, V31, P1435, DOI 10.1016/j.biotechadv.2013.06.008
   Mullen CA, 2013, J MECH BEHAV BIOMED, V28, P183, DOI 10.1016/j.jmbbm.2013.06.013
   Murakami H, 1999, ONCOGENE, V18, P1975, DOI 10.1038/sj.onc.1202514
   Nebe B, 2004, MAT SCI ENG C-BIO S, V24, P619, DOI 10.1016/j.msec.2004.08.034
   Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Nguyen MK, 2014, BIOMATERIALS, V35, P6278, DOI 10.1016/j.biomaterials.2014.04.048
   Noble BS, 2003, AM J PHYSIOL-CELL PH, V284, pC934, DOI 10.1152/ajpcell.00234.2002
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Park H, 2007, TISSUE ENG, V13, P1867, DOI 10.1089/ten.2006.0198
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Pei M, 2012, SPINE, V37, P1538, DOI 10.1097/BRS.0b013e31825150bf
   Perez RA, 2013, ADV DRUG DELIVER REV, V65, P471, DOI 10.1016/j.addr.2012.03.009
   Phillips JB, 2011, METHODS MOL BIOL, V695, P183, DOI 10.1007/978-1-60761-984-0_12
   Pierres A., 2002, European Cells & Materials, V3, P31
   Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Rahmany MB, 2013, ACTA BIOMATER, V9, P5431, DOI 10.1016/j.actbio.2012.11.019
   Rebl H, 2012, ACTA BIOMATER, V8, P3840, DOI 10.1016/j.actbio.2012.06.015
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Rong JH, 2008, CHEM COMMUN, P5185, DOI 10.1039/b811039e
   Satyam A, 2014, ADV MATER, V26, P3024, DOI 10.1002/adma.201304428
   Scott A, 2005, BRIT J SPORT MED, V39, P1
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Singh AV, 2013, J BIOMED MATER RES A, V101, P3019, DOI 10.1002/jbm.a.34586
   Singh L, 2004, BIOMATERIALS, V25, P2611, DOI 10.1016/j.biomaterials.2003.09.040
   Soliman S, 2010, ACTA BIOMATER, V6, P1227, DOI 10.1016/j.actbio.2009.10.051
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Szentivanyi A, 2011, ADV DRUG DELIVER REV, V63, P209, DOI 10.1016/j.addr.2010.12.002
   Tawfick S, 2012, ADV MATER, V24, P1628, DOI 10.1002/adma.201103796
   Thomas D, 2014, BIOMATERIALS, V35, P8757, DOI 10.1016/j.biomaterials.2014.06.053
   Tong WY, 2012, BIOMATERIALS, V33, P7686, DOI 10.1016/j.biomaterials.2012.07.002
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Vatankhah E, 2014, J BIOMATER APPL, V28, P909, DOI 10.1177/0885328213486527
   Vozzi G, 2010, BIOTECHNOL BIOENG, V106, P804, DOI 10.1002/bit.22740
   Wang James Hc, 2010, Sports Med Arthrosc Rehabil Ther Technol, V2, P16, DOI 10.1186/1758-2555-2-16
   Wang PY, 2012, J MATER SCI-MATER M, V23, P3015, DOI 10.1007/s10856-012-4748-6
   Wang PY, 2011, ACTA BIOMATER, V7, P3285, DOI 10.1016/j.actbio.2011.05.021
   Wang YC, 2013, INT J NANOMED, V8, P159, DOI 10.2147/IJN.S36408
   Watari S, 2012, BIOMATERIALS, V33, P128, DOI 10.1016/j.biomaterials.2011.09.058
   Weightman A, 2014, NANOMED-NANOTECHNOL, V10, P291, DOI 10.1016/j.nano.2013.09.001
   Wolf M.T., 2014, ADV DRUG DELIV REV, DOI DOI 10.1016/J.ADDR.2014.08.011
   Wood MA, 2007, J R SOC INTERFACE, V4, P1, DOI 10.1098/rsif.2006.0149
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu XH, 2013, ADV HEALTHC MATER, V2, P326, DOI 10.1002/adhm.201200205
   Xu L, 2010, BIOMATERIALS, V31, P3894, DOI 10.1016/j.biomaterials.2010.01.106
   Yang HS, 2014, BIOMATERIALS, V35, P1478, DOI 10.1016/j.biomaterials.2013.10.067
   Yang JY, 2009, J BIOMED MATER RES A, V90A, P629, DOI 10.1002/jbm.a.32130
   Yang Y, 2011, MOL PHARM, V9, P48
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zhang DM, 2008, NANO LETT, V8, P3283, DOI 10.1021/nl801667s
   Zhang LJ, 2013, INT J NANOMED, V8, P1907, DOI 10.2147/IJN.S41570
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zheng WF, 2013, ADV HEALTHC MATER, V2, P95, DOI 10.1002/adhm.201200104
   Ziv V, 1996, BONE, V18, P417, DOI 10.1016/8756-3282(96)00049-X
NR 163
TC 23
Z9 24
U1 4
U2 30
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PY 2015
VL 10
IS 5
BP 693
EP 711
DI 10.2217/NNM.14.218
PG 19
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA CE6EY
UT WOS:000351930700005
PM 25816874
DA 2018-10-20
ER

PT J
AU Dhowre, HS
   Rajput, S
   Russell, NA
   Zelzer, M
AF Dhowre, Hala S.
   Rajput, Sunil
   Russell, Noah A.
   Zelzer, Mischa
TI Responsive cell-material interfaces
SO NANOMEDICINE
LA English
DT Review
DE biointerfaces; biomimetic surfaces; cell-material interactions; cell
   response; regenerative medicine; stimuli-responsive materials
ID SELF-ASSEMBLED MONOLAYERS; MESENCHYMAL STEM-CELLS; PHOTORESPONSIVE SMART
   TEMPLATE; REGENERATIVE MEDICINE; EXTRACELLULAR-MATRIX;
   SURFACE-CHEMISTRY; FUNCTIONAL-GROUPS; IN-VITRO; BIOMATERIAL
   INTERACTIONS; BIOMEDICAL APPLICATIONS
AB Major design aspects for novel biomaterials are driven by the desire to mimic more varied and complex properties of a natural cellular environment with man-made materials. The development of stimulus responsive materials makes considerable contributions to the effort to incorporate dynamic and reversible elements into a biomaterial. This is particularly challenging for cell-material interactions that occur at an interface (biointerfaces); however, the design of responsive biointerfaces also presents opportunities in a variety of applications in biomedical research and regenerative medicine. This review will identify the requirements imposed on a responsive biointerface and use recent examples to demonstrate how some of these requirements have been met. Finally, the next steps in the development of more complex biomaterial interfaces, including multiple stimuli-responsive surfaces, surfaces of 3D objects and interactive biointerfaces will be discussed.
C1 [Dhowre, Hala S.; Rajput, Sunil; Russell, Noah A.] Univ Nottingham, Neurophoton Lab, Fac Engn, Nottingham NG7 2RD, England.
   [Dhowre, Hala S.; Rajput, Sunil; Zelzer, Mischa] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
   [Zelzer, Mischa] Univ Nottingham, Interface & Surface Anal Ctr, Nottingham NG7 2RD, England.
   [Zelzer, Mischa] Natl Phys Lab, Teddington TW11 0LW, Middx, England.
RP Zelzer, M (reprint author), Univ Nottingham, Sch Pharm, Boots Sci Bldg,Univ Pk, Nottingham NG7 2RD, England.
EM mischa.zelzer@nottingham.ac.uk
OI Russell, N/0000-0002-0998-6094
FU EPSRC [EP/H022112/1]; University of Nottingham Strategic Fund;
   Engineering and Physical Sciences Research Council [EP/H022112/1]
FX This work was supported by the EPSRC (EP/H022112/1) and the University
   of Nottingham Strategic Fund. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.
CR Almquist BD, 2011, NANO LETT, V11, P2066, DOI 10.1021/nl200542m
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Auernheimer J, 2005, J AM CHEM SOC, V127, P16107, DOI 10.1021/ja053648q
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Barry JJA, 2006, ADV MATER, V18, P1406, DOI 10.1002/adma.200502719
   Barthes J., 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/921905
   Bebarova M, 2012, GEN PHYSIOL BIOPHYS, V31, P131, DOI 10.4149/gpb_2012_016
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Blau A, 2013, CURR OPIN COLLOID IN, V18, P481, DOI 10.1016/j.cocis.2013.07.005
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Cai L, 2014, ACTA BIOMATER, V10, P1751, DOI 10.1016/j.actbio.2013.12.028
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chan A, 2013, ADV DRUG DELIVER REV, V65, P497, DOI 10.1016/j.addr.2012.07.007
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   CURTIS ASG, 1984, J CELL SCI, V71, P17
   Custodio CA, 2014, ADV HEALTHC MATER, V3, P797, DOI 10.1002/adhm.201300603
   Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058
   Dalby MJ, 2008, J R SOC INTERFACE, V5, P1055, DOI 10.1098/rsif.2008.0016
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Davila J, 2012, J AM CHEM SOC, V134, P83, DOI 10.1021/ja208970b
   DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1
   ELUL R, 1967, J PHYSIOL-LONDON, V189, P351, DOI 10.1113/jphysiol.1967.sp008173
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Fuhrer R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081362
   Fukuda J, 2011, BIOMATERIALS, V32, P6663, DOI 10.1016/j.biomaterials.2011.05.068
   Garcia AJ, 2006, ADV POLYM SCI, P171, DOI 10.1007/12_071
   Garcia-Amoros J, 2012, ANGEW CHEM INT EDIT, V51, P12820, DOI 10.1002/anie.201207602
   Garcia-Parra P, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00010
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gensel J, 2012, ADV MATER, V24, P985, DOI 10.1002/adma.201103786
   Gilmore IS, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4816935
   Gong YH, 2013, J MATER CHEM B, V1, P2013, DOI 10.1039/c3tb20073f
   Gong YH, 2011, MACROMOLECULES, V44, P7499, DOI 10.1021/ma201676w
   Hayward AS, 2013, BIOMACROMOLECULES, V14, P4271, DOI 10.1021/bm401145x
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Higgins MJ, 2011, J PHYS CHEM B, V115, P3371, DOI 10.1021/jp112045k
   Higuchi A, 2014, PROG POLYM SCI, V39, P1585, DOI 10.1016/j.progpolymsci.2014.05.001
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Inaba R, 2009, BIOMATERIALS, V30, P3573, DOI 10.1016/j.biomaterials.2009.03.045
   Ivashenko O, 2013, LANGMUIR, V29, P4290, DOI 10.1021/la400192c
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Kim J, 2012, TRENDS BIOTECHNOL, V30, P426, DOI 10.1016/j.tibtech.2012.04.003
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kourouklis AP, 2014, BIOMATERIALS, V35, P4827, DOI 10.1016/j.biomaterials.2014.02.052
   Krupenkin TN, 2004, LANGMUIR, V20, P3824, DOI 10.1021/la036093q
   Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933
   Lam MT, 2008, BIOMATERIALS, V29, P1705, DOI 10.1016/j.biomaterials.2007.12.010
   Lamb BM, 2011, J AM CHEM SOC, V133, P8870, DOI 10.1021/ja203198y
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Le DM, 2011, ADV MATER, V23, P3278, DOI 10.1002/adma.201100821
   Leal-Egana A, 2013, ADV MATER, V25, P4049, DOI 10.1002/adma.201301227
   Liao XL, 2009, CHEM-EUR J, V15, P12303, DOI 10.1002/chem.200901345
   Liu B, 2010, J AM CHEM SOC, V132, P13630, DOI 10.1021/ja1054669
   Liu DB, 2009, ANGEW CHEM INT EDIT, V48, P4406, DOI 10.1002/anie.200901130
   Liu LY, 2005, J BIOMED MATER RES A, V74A, P23, DOI 10.1002/jbm.a.30221
   Liu XL, 2014, CHEM SOC REV, V43, P2385, DOI 10.1039/c3cs60419e
   Lowik DWPM, 2010, CHEM SOC REV, V39, P3394, DOI 10.1039/b914342b
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   MacEwan SR, 2010, BIOPOLYMERS, V94, P60, DOI 10.1002/bip.21327
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Maitre JL, 2013, CURR BIOL, V23, pR626, DOI 10.1016/j.cub.2013.06.019
   Mandal K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037548
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   Mendes PM, 2008, CHEM SOC REV, V37, P2512, DOI 10.1039/b714635n
   Mendes PM, 2013, CHEM SOC REV, V42, P9199
   Mertz D, 2009, NAT MATER, V8, P731, DOI [10.1038/NMAT2504, 10.1038/nmat2504]
   Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549
   Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002
   Nakayama M, 2012, MACROMOL BIOSCI, V12, P751, DOI 10.1002/mabi.201200018
   Ng CCA, 2012, ANGEW CHEM INT EDIT, V51, P7706, DOI 10.1002/anie.201202118
   Pan GQ, 2014, J AM CHEM SOC, V136, P6203, DOI 10.1021/ja501664f
   Paul N, 2013, SOFT MATTER, V9, P1364, DOI 10.1039/c2sm26896e
   Piantek M, 2009, J AM CHEM SOC, V131, P12729, DOI 10.1021/ja901238p
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Piggott M, 2014, CHEM OGGI, V32, P3
   Pranzetti A, 2013, ADV MATER, V25, P2181, DOI 10.1002/adma.201204880
   Qing GY, 2009, SOFT MATTER, V5, P2759, DOI 10.1039/b900504h
   Qing GY, 2009, J AM CHEM SOC, V131, P8370, DOI 10.1021/ja9028632
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Rahane SB, 2008, ADV FUNCT MATER, V18, P1232, DOI 10.1002/adfm.200701411
   Rashidi H, 2014, BIOMATER SCI-UK, V2, P1318, DOI 10.1039/c3bm60330j
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rawson FJ, 2013, NANO LETT, V13, P1, DOI 10.1021/nl203780d
   Rimmer S, 2009, POLYM INT, V58, P273, DOI 10.1002/pi.2537
   Roach P, 2006, J AM CHEM SOC, V17, P617
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Rodrigo-Navarro A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05849
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Saadeddin A, 2013, ADV HEALTHC MATER, V2, P1213, DOI 10.1002/adhm.201200473
   Santos E, CELL BIOMATERIAL INT
   Santos MI, 2009, J MATER CHEM, V19, P4091, DOI 10.1039/b819089e
   Schattling P, 2014, POLYM CHEM-UK, V5, P25, DOI [10.1039/c3py00880k, 10.1039/c3py00880]
   Seras-Franzoso J, 2013, J CONTROL RELEASE, V171, P63, DOI 10.1016/j.jconrel.2013.06.034
   Shaikh RP, 2010, AAPS PHARMSCITECH, V11, P441, DOI 10.1208/s12249-010-9403-2
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516
   Skorb EV, 2013, ADV FUNCT MATER, V23, P4483, DOI 10.1002/adfm.201203884
   Smith JT, 2004, LANGMUIR, V20, P8279, DOI 10.1021/la0489763
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sun TL, 2011, ADV MATER, V23, pH57, DOI 10.1002/adma.201004326
   Takahashi H, 2010, BIOMACROMOLECULES, V11, P1991, DOI 10.1021/bm100342e
   Tateno H, 2007, GLYCOBIOLOGY, V17, P1138, DOI 10.1093/glyco/cwm084
   Tekin H, 2011, AICHE J, V57, P3249, DOI 10.1002/aic.12801
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Todd SJ, 2009, LANGMUIR, V25, P7533, DOI 10.1021/la900376h
   Uchiyama S, 2004, J AM CHEM SOC, V126, P3032, DOI 10.1021/ja039697p
   Uto K, 2014, INT J MOL SCI, V15, P1511, DOI 10.3390/ijms15011511
   van Dongen SFM, 2013, ADV MATER, V25, P1687, DOI 10.1002/adma.201204474
   VanDersarl JJ, 2012, NANO LETT, V12, P3881, DOI 10.1021/nl204051v
   Ventre M, 2012, J R SOC INTERFACE, V9, P2017, DOI 10.1098/rsif.2012.0308
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Wandera D, 2010, J MEMBRANE SCI, V357, P6, DOI 10.1016/j.memsci.2010.03.046
   Wang GJ, 2012, J PHOTOCH PHOTOBIO C, V13, P299, DOI 10.1016/j.jphotochemrev.2012.06.002
   Wang XT, 2012, SOFT MATTER, V8, P2812, DOI 10.1039/c2sm06567c
   Ward MA, 2011, POLYMERS-BASEL, V3, P1215, DOI 10.3390/polym3031215
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Xia F, 2006, ADV MATER, V18, P432, DOI 10.1002/adma.200501772
   Yamato M, 2007, PROG POLYM SCI, V32, P1123, DOI 10.1016/j.progpolymsci.2007.06.002
   Yeo WS, 2006, LANGMUIR, V22, P10816, DOI 10.1021/la061212y
   Yeo WS, 2003, J AM CHEM SOC, V125, P14994, DOI 10.1021/ja038265b
   Yeung CL, 2010, ADV FUNCT MATER, V20, P2657, DOI 10.1002/adfm.201000411
   Yousaf M.N., 2001, ANGEW CHEM, V113, P1127
   Zarzar L.D., 2011, ANGEW CHEM, V123, P9528
   Zarzar LD, 2014, ACCOUNTS CHEM RES, V47, P530, DOI 10.1021/ar4001923
   Zarzar LD, 2011, ADV MATER, V23, P1442, DOI 10.1002/adma.201004231
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zelzer M, 2013, BIOMATER SCI-UK, V1, P11, DOI 10.1039/c2bm00041e
   Zelzer M, 2012, J MATER CHEM, V22, P12229, DOI 10.1039/c2jm31666h
   Zelzer M, 2012, PLASMA PROCESS POLYM, V9, P149, DOI 10.1002/ppap.201100054
   Zelzer M, 2009, J PHYS CHEM B, V113, P8487, DOI 10.1021/jp902137y
NR 148
TC 18
Z9 19
U1 2
U2 97
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PY 2015
VL 10
IS 5
BP 849
EP 871
DI 10.2217/NNM.14.222
PG 23
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA CE6EY
UT WOS:000351930700015
PM 25816884
OA Other Gold
DA 2018-10-20
ER

PT J
AU Hortensius, RA
   Becraft, JR
   Pack, DW
   Harley, BAC
AF Hortensius, Rebecca A.
   Becraft, Jacob R.
   Pack, Daniel W.
   Harley, Brendan A. C.
TI The effect of glycosaminoglycan content on polyethylenimine-based gene
   delivery within three-dimensional collagen-GAG scaffolds
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID GROWTH-FACTOR SUPPLEMENTATION; MESENCHYMAL STEM-CELLS; BONE
   REGENERATION; IN-VIVO; OSTEOGENIC DIFFERENTIATION; BIOPHYSICAL
   PROPERTIES; EXTRACELLULAR-MATRIX; TENOCYTE BIOACTIVITY;
   CONTROLLED-RELEASE; ACTIVATED MATRIX
AB The design of biomaterials for increasingly complex tissue engineering applications often requires exogenous presentation of biomolecular signals. Integration of gene delivery vectors with a biomaterial scaffold offers the potential to bypass the use of expensive and relatively inefficient growth factor supplementation strategies to augment cell behavior. However, integration of cationic polymer based gene delivery vectors within three-dimensional biomaterials, particularly matrices which can carry significant surface charge, remains poorly explored. We examined the potential of polyethylenimine (PEI) as a gene delivery vector for three-dimensional collagen-glycosaminoglycan (CG) scaffolds under development for tendon repair. While acetylated versions of PEI have demonstrated improved transfection efficiency in 2D culture assays, we investigated translation of this effect to a 3D biomaterial that contains significant electrostatic charge. A reporter gene was used to examine the impact of polymer modification, polymer : DNA ratio, and the degree of sulfation of the biomaterial microenvironment on gene delivery in vitro. We observed highest transgene expression in acetylated and unmodified PEI at distinct polymer : DNA ratios; notably, the enhancement often seen in two-dimensional culture for acetylated PEI did not fully translate to three-dimensional scaffolds. We also found highly sulfated heparin-based CG scaffolds showed enhanced initial luciferase expression but not prolonged activity. While PEI constructs significantly reduced tenocyte metabolic health during the period of transfection, heparin-based CG scaffolds showed the greatest recovery in tenocyte metabolic health over the full 2 week culture. These results suggest that the electrostatic environment of three-dimensional biomaterials may be an important design criterion for cationic polymer-based gene delivery.
C1 [Hortensius, Rebecca A.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
   [Becraft, Jacob R.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   [Pack, Daniel W.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY USA.
   [Pack, Daniel W.] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY USA.
   [Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biol Engn, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
RP Hortensius, RA (reprint author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
EM bharley@illinois.edu
OI Harley, Brendan/0000-0001-5458-154X
FU National Science Foundation [1105300]; National Institute of Arthritis
   and Musculoskeletal and Skin Diseases of the National Institutes of
   Health [R03 AR062811]; NSF Graduate Research Fellowship [DGE 11-44245
   FLLW]; Chemical and Biomolecular Engineering Dept.; Institute for
   Genomic Biology (BAH) at the University of Illinois at Urbana-Champaign
FX Author contributions: R.A.H., J.R.B., and B.A.C.H designed the research;
   J.R.B. and R.A.H. performed the research; D.W.P. contributed polyplexes
   and analytical facilities; R.A.H., J.R.B., and B.A.C.H. analyzed the
   data and interpreted the results; R.A.H. and B.A.H. wrote the paper. The
   authors would like to acknowledge Dr Allison Stewart (Veterinary
   Sciences, UIUC) for the equine tenocytes and Dr Sandra McMasters (SCS,
   UIUC) for culture media preparation. The authors would also like to
   acknowledge Dr Nathan Todd (UIUC) for assistance with statistical
   analysis of the data. This material is based upon work supported by the
   National Science Foundation under Grant No. 1105300. Research reported
   in this publication was supported by the National Institute of Arthritis
   and Musculoskeletal and Skin Diseases of the National Institutes of
   Health under Award Numbers R03 AR062811. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health. We are grateful for
   the funding for this study provided by the NSF Graduate Research
   Fellowship DGE 11-44245 FLLW (RAH). We are grateful for the funding for
   this study by the Chemical and Biomolecular Engineering Dept. (BAH) and
   the Institute for Genomic Biology (BAH) at the University of Illinois at
   Urbana-Champaign.
CR Abdallah B, 1996, HUM GENE THER, V7, P1947, DOI 10.1089/hum.1996.7.16-1947
   Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   Amaduzzi F, 2014, COLLOID SURFACE B, V114, P1, DOI 10.1016/j.colsurfb.2013.09.029
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Caliari SR, 2014, TISSUE ENG PT A, V20, P2463, DOI [10.1089/ten.tea.2013.0400, 10.1089/ten.TEA.2013.0400]
   Caliari SR, 2014, ADV HEALTHC MATER, V3, P1086, DOI 10.1002/adhm.201300646
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Capito RM, 2007, GENE THER, V14, P721, DOI 10.1038/sj.gt.3302918
   Carrillo C, 2014, BIOMED PHARMACOTHER, V68, P775, DOI 10.1016/j.biopha.2014.07.009
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Curtin CM, 2015, ADV HEALTHC MATER, V4, P223, DOI 10.1002/adhm.201400397
   Curtin CM, 2012, ADV MATER, V24, P749, DOI 10.1002/adma.201103828
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Davis ME, 2002, CURR OPIN BIOTECH, V13, P128, DOI 10.1016/S0958-1669(02)00294-X
   De la Riva B, 2010, J CONTROL RELEASE, V143, P45, DOI 10.1016/j.jconrel.2009.11.026
   Elangovan S, 2014, BIOMATERIALS, V35, P737, DOI 10.1016/j.biomaterials.2013.10.021
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478
   Forrest ML, 2004, PHARM RES, V21, P365, DOI 10.1023/B:PHAM.0000016251.42392.1e
   Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g
   Gabrielson NP, 2006, BIOMACROMOLECULES, V7, P2427, DOI 10.1021/bm060300u
   Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5
   Gulotta LV, 2009, CLIN SPORT MED, V28, P13, DOI 10.1016/j.csm.2008.09.002
   Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314
   Hanson JA, 2008, NATURE, V455, P85, DOI 10.1038/nature07197
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Hempel U, 2012, ACTA BIOMATER, V8, P659, DOI 10.1016/j.actbio.2011.10.026
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   Hosseinkhani H, 2008, J BIOMED MATER RES A, V85A, P47, DOI 10.1002/jbm.a.31327
   Hudalla GA, 2011, ADV MATER, V23, P5415, DOI 10.1002/adma.201103046
   Hudalla GA, 2011, INTEGR BIOL-UK, V3, P832, DOI 10.1039/c1ib00021g
   Kapoor A, 2010, ACTA BIOMATER, V6, P2580, DOI 10.1016/j.actbio.2009.12.047
   Lim JJ, 2013, BIOMATERIALS, V34, P5007, DOI 10.1016/j.biomaterials.2013.03.037
   Liu CF, 2012, TISSUE ENG PT A, V18, P598, DOI [10.1089/ten.tea.2011.0338, 10.1089/ten.TEA.2011.0338]
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498
   Shen WL, 2010, BIOMATERIALS, V31, P7239, DOI 10.1016/j.biomaterials.2010.05.040
   Sohier J, 2006, J CONTROL RELEASE, V111, P95, DOI 10.1016/j.conrel.2005.11.016
   Somia N, 2000, NAT REV GENET, V1, P91, DOI 10.1038/35038533
   Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35
   Tierney EG, 2013, J CONTROL RELEASE, V165, P173, DOI 10.1016/j.jconrel.2012.11.013
   Tierney EG, 2012, J CONTROL RELEASE, V158, P304, DOI 10.1016/j.jconrel.2011.11.026
   WAGNER E, 1990, P NATL ACAD SCI USA, V87, P3410, DOI 10.1073/pnas.87.9.3410
   Watson SS, 2009, DEV DYNAM, V238, P693, DOI 10.1002/dvdy.21866
   Weisgerber DW, 2013, J MECH BEHAV BIOMED, V28, P26, DOI 10.1016/j.jmbbm.2013.07.016
   WU GY, 1988, J BIOL CHEM, V263, P14621
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zhang L, 2006, J CONTROL RELEASE, V114, P130, DOI 10.1016/j.jconrel.2006.06.005
NR 63
TC 10
Z9 10
U1 2
U2 26
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 4
BP 645
EP 654
DI 10.1039/c5bm00033e
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CE0DN
UT WOS:000351474800010
PM 26097698
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Varshosaz, J
   Taymouri, S
   Hassanzadeh, F
   Javanmard, SH
   Rostami, M
AF Varshosaz, Jaleh
   Taymouri, Somayeh
   Hassanzadeh, Farshid
   Javanmard, Shaghayegh Haghjooy
   Rostami, Mahboobeh
TI Folated Synperonic-Cholesteryl Hemisuccinate Polymeric Micelles for the
   Targeted Delivery of Docetaxel in Melanoma
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID IN-VIVO EVALUATION; METHOXY POLY(ETHYLENE GLYCOL); BLOCK COPOLYMERIC
   MICELLE; DRUG-DELIVERY; METASTATIC MELANOMA; SUSTAINED-RELEASE; VITRO
   EVALUATION; MIXED MICELLES; BREAST-CANCER; TUMOR-CELLS
AB The objective of this study was the synthesis of folic acid-(FA-) targeted polymeric micelles of Synperonic PE/F 127-cholesteryl hemisuccinate (PF127-Chol) for specific delivery of docetaxel (DTX). Targeted or nontargeted micelles loaded with DTX were prepared via dialysis method. The effects of processing variables on the physicochemical properties of targeted micelles were evaluated using a full factorial design. After the optimization of the polymer/drug ratio, the organic solvent type used for the preparation of the micelles, and the temperature of dialyzing medium, the in vitro cytotoxicity and cellular uptake of the optimized micelles were studied on B16F10 melanoma cells by flow cytometry and fluorescent microscopy. The anticancer efficacy of DTX-loaded FA-PF127-Chol was evaluated in mice bearing melanoma tumor. Optimized targeted micelles had the particle size of 171.3 nm, zeta potential of -7.8mV, PDI of 0.325, and a high encapsulation efficiency that released the drug within 144 h. The MTT assay indicated that targeted micelles carrying DTX were significantly more cytotoxic, had higher cellular uptake, and reduced the tumor volume significantly more than the nontargeted micelles and the free drug. FA-PF127-Chol could be, therefore, a promising biomaterial for tumors overexpressing folate receptors.
C1 [Varshosaz, Jaleh; Taymouri, Somayeh] Isfahan Univ Med Sci, Sch Pharm, Dept Pharmaceut, Esfahan 8174673461, Iran.
   [Varshosaz, Jaleh; Taymouri, Somayeh] Isfahan Univ Med Sci, Novel Drug Delivery Syst Res Ctr, Esfahan 8174673461, Iran.
   [Hassanzadeh, Farshid; Rostami, Mahboobeh] Isfahan Univ Med Sci, Sch Pharm, Dept Med Chem, Esfahan 8174673461, Iran.
   [Javanmard, Shaghayegh Haghjooy] Isfahan Univ Med Sci, Appl Physiol Res Ctr, Esfahan 8174673461, Iran.
RP Varshosaz, J (reprint author), Isfahan Univ Med Sci, Sch Pharm, Dept Pharmaceut, Esfahan 8174673461, Iran.
EM varshosaz@pharm.mui.ac.ir
RI varshosaz, jaleh/V-6124-2017; Taymouri, Somayeh/W-3347-2017; Javanmard,
   Shaghayegh/W-5060-2017; Javanmard, Haghjoo, Shaghayeg/V-6376-2017;
   Varshosaz, Jaleh/W-2290-2017; hassanzadeh, Farshid/W-1961-2017
OI Javanmard, Shaghayegh/0000-0002-3853-5006; hassanzadeh,
   Farshid/0000-0003-1100-9820; , Jaleh/0000-0001-9333-5798
FU Isfahan University of Medical Sciences; Iran National Science Foundation
FX The authors wish to thank the Vice Chancellery of Isfahan University of
   Medical Sciences and Iran National Science Foundation for supporting
   this work.
CR Bae YH, 2011, J CONTROL RELEASE, V153, P198, DOI 10.1016/j.jconrel.2011.06.001
   Barreiro-Iglesias R, 2004, J CONTROL RELEASE, V97, P537, DOI 10.1016/j.jconrel.2004.04.007
   Bhatia S, 2009, ONCOLOGY-NY, V23, P488
   Chen MM, 2011, CARBOHYD POLYM, V84, P1244, DOI 10.1016/j.carbpol.2011.01.012
   Chen YZ, 2013, INT J PHARMACEUT, V452, P421, DOI 10.1016/j.ijpharm.2013.05.015
   Chiappetta DA, 2007, EUR J PHARM BIOPHARM, V66, P303, DOI 10.1016/j.ejpb.2007.03.022
   Choi H, 2004, ACAD RADIOL, V11, P996, DOI 10.1016/j.acra.2004.04.018
   Dahmani FZ, 2012, EUR J PHARM SCI, V47, P179, DOI 10.1016/j.ejps.2012.05.015
   Emami J, 2012, J NANOMATER, DOI 10.1155/2012/358782
   Erdei E, 2010, EXPERT REV ANTICANC, V10, P1811, DOI 10.1586/ERA.10.170
   Ernsting MJ, 2012, BIOMATERIALS, V33, P1445, DOI 10.1016/j.biomaterials.2011.10.061
   Fattahi A, 2012, CARBOHYD POLYM, V87, P1176, DOI 10.1016/j.carbpol.2011.08.093
   Gao QH, 2011, COLLOID SURFACE B, V88, P741, DOI 10.1016/j.colsurfb.2011.08.010
   Grossman J. H., 2012, PHYS TODAY, V65
   Guo DD, 2007, CANCER LETT, V254, P244, DOI 10.1016/j.canlet.2007.03.007
   Gupta Y, 2007, J DRUG TARGET, V15, P231, DOI 10.1080/10611860701289719
   He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065
   Ho KS, 2012, BIOMATERIALS, V33, P2223, DOI 10.1016/j.biomaterials.2011.11.072
   Ishimaru C, 2008, LIPIDS, V43, P373, DOI 10.1007/s11745-007-3149-y
   Jalalian SH, 2013, EUR J PHARM SCI, V50, P191, DOI 10.1016/j.ejps.2013.06.015
   Jones MC, 1999, EUR J PHARM BIOPHARM, V48, P101, DOI 10.1016/S0939-6411(99)00039-9
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Kim JH, 2006, J CONTROL RELEASE, V111, P228, DOI 10.1016/j.jconrel.2005.12.013
   Kim SY, 1998, J CONTROL RELEASE, V51, P13, DOI 10.1016/S0168-3659(97)00124-7
   Koopaei MN, 2011, INT J NANOMED, V6, P1903, DOI 10.2147/IJN.S23211
   Lee ALZ, 2012, BIOMATERIALS, V33, P1921, DOI 10.1016/j.biomaterials.2011.11.032
   Li L, 2008, J COLLOID INTERF SCI, V317, P326, DOI 10.1016/j.jcis.2007.09.053
   Lin GY, 2013, J MICROENCAPSUL, V30, P538, DOI 10.3109/02652048.2012.758182
   Lin WJ, 2003, PHARMACEUT RES, V20, P668, DOI 10.1023/A:1023215320026
   Liu DH, 2011, COLLOID SURFACE B, V85, P262, DOI 10.1016/j.colsurfb.2011.02.038
   Liu YH, 2011, INT J PHARMACEUT, V421, P160, DOI 10.1016/j.ijpharm.2011.09.006
   Lu Y, 2013, INT J PHARMACEUT, V453, P198, DOI 10.1016/j.ijpharm.2012.08.042
   Lu YJ, 2002, ADV DRUG DELIVER REV, V54, P675, DOI 10.1016/S0169-409X(02)00042-X
   Luk VN, 2008, LANGMUIR, V24, P6382, DOI 10.1021/la7039509
   Moazeni E, 2010, J MICROENCAPSUL, V27, P618, DOI 10.3109/02652048.2010.506579
   Nagavarma B.V.N., 2012, ASIAN J PHARM CLIN R, V5, P16
   Pan J, 2008, BIOMATERIALS, V29, P2663, DOI 10.1016/j.biomaterials.2008.02.020
   Park KM, 2008, COLLOID SURFACE B, V63, P1, DOI 10.1016/j.colsurfb.2007.10.024
   Pretto F, 2013, PHARMACOL THERAPEUT, V139, P405, DOI 10.1016/j.pharmthera.2013.05.006
   Pu X., 2012, ASIAN J PHARM SCI, V7, P1
   SHARMA A, 2013, BIOMED RES INT
   Shin ILG, 1998, J CONTROL RELEASE, V51, P1
   Shiraishi K., 2009, BIOL PHARM BULL, V36, P878
   Sun B, 2008, BIOMATERIALS, V29, P475, DOI 10.1016/j.biomaterials.2007.09.038
   Tran MA, 2009, PIGM CELL MELANOMA R, V22, P388, DOI 10.1111/j.1755-148X.2009.00581.x
   Varshosaz J., IET NANOBIO IN PRESS
   Varshosaz J., 2014, J LIPOSOME RES
   Varshosaz J, 2014, BIOMED RES INT, DOI 10.1155/2014/708593
   Velho Tiago Rodrigues, 2012, Drugs Context, V2012, P212242, DOI 10.7573/dic.212242
   WANG XZ, 2009, STUD FUZZINESS SOFT, V245, P1
   Yang Z, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025012
   Yinsong W., 2007, CARBOHYD POLYM, V69, P597
   Yu KF, 2013, INT J NANOMED, V8, P2473, DOI 10.2147/IJN.S46962
   Zhang L, 2002, J CONTROL RELEASE, V85, P73, DOI 10.1016/S0168-3659(02)00273-0
   Zhang L, 2012, INT J NANOMED, V7, P151, DOI 10.2147/IJN.S27639
   Zhang LH, 2012, NANOMED-NANOTECHNOL, V8, P925, DOI 10.1016/j.nano.2011.11.005
   Zhang W, 2011, BIOMATERIALS, V32, P5934, DOI 10.1016/j.biomaterials.2011.04.075
   Zhou JH, 2013, CHINESE J CANCER RES, V25, P527, DOI 10.3978/j.issn.1000-9604.2013.09.04
   Zhu XL, 2013, INT J MOL SCI, V14, P15755, DOI 10.3390/ijms140815755
NR 59
TC 3
Z9 3
U1 1
U2 12
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 746093
DI 10.1155/2015/746093
PG 17
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CE1TI
UT WOS:000351594500001
PM 25839040
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Jantova, S
   Bakos, D
   Birosova, L
   Matejov, P
AF Jantova, Sona
   Bakos, Dusan
   Birosova, Lucia
   Matejov, Patrik
TI Biological properties of a novel coladerm-beta glucan membrane. In vitro
   assessment using human fibroblasts
SO BIOMEDICAL PAPERS-OLOMOUC
LA English
DT Article
DE coladerm-beta glucan membrane; human fibroblasts; biocompatibility;
   cytotoxicity; genotoxicity; antimicrobial activity
ID PLEUROTUS-OSTREATUS; DNA-DAMAGE; RAT HEPATOCYTES; STEM-CELLS; CANCER;
   COLLAGEN; TISSUE; CYTOTOXICITY; FUNGAL; MICE
AB Aim. The purpose of this study was to prepare a coladerm-beta glucan membrane (CBGM) and to evaluate its biocompatibility, cytotoxicity, antimicrobial activity, genotoxicity and mutagenicity.
   Methods. The biocompatibility of the membrane was studied on the base of cell adhesion and colonization of human fibroblasts on the biomaterial surface by light microscopy. The MTT test and LDH level determination in the culture medium removed from the control and cells treated on the membrane, were used for viability and cytotoxic evaluations. Flow cytometry and gel electrophoresis were used for analysis of cell cycle and death. The antimicrobial activity of CBGM was tested using the qualitative dilution method. Ames bacteria gene mutation test and Comet assay were used for mutagenic and genotoxic studies.
   Results. MTT and LDH tests confirmed that CBGM is a non-toxic biomaterial. Flow cytometry and gel electrophoresis demonstrated that the membrane did not affect the cell cycle and did not induce either necrotic or apoptotic cell death. CBGM exhibited antibacterial activity against G-bacteria E. sakazakii, S. marcescens, E. coli and agains G(+) sporogenic bacteria B. cereus. No antifungal activity was detected. The membrane did not induce mutagenicity in the bacterial reverse mutation test in Salmonella Typhimurium strains. Similarly, the comet assay showed that the tested fibroblast cells growing with/without the membrane did not show any statistically significant DNA damage.
   Conclusions. The CBGM has good biocompatibility, no cytotoxicity/genotoxicity/mutagenicity and it can be included as a potential scaffold for tissue engineering.
C1 [Jantova, Sona; Birosova, Lucia; Matejov, Patrik] Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Inst Biochem Nutr & Hlth Protect, Bratislava 81237, Slovakia.
   [Bakos, Dusan] Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Inst Polymer Mat, Bratislava 81237, Slovakia.
RP Birosova, L (reprint author), Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Inst Biochem Nutr & Hlth Protect, Radlinskeho 9, Bratislava 81237, Slovakia.
EM lucia.birosova@stuba.sk
CR Akramiene D, 2007, MED LITH, V43, P597
   Akramiene D, 2010, TOHOKU J EXP MED, V220, P299, DOI 10.1620/tjem.220.299
   Akturk O, 2011, J BIOSCI BIOENG, V112, P279, DOI 10.1016/j.jbiosc.2011.05.014
   Ardizzoni A, 2011, J MATER SCI-MATER M, V22, P2329, DOI 10.1007/s10856-011-4408-2
   Behring J, 2008, ODONTOLOGY, V96, P1, DOI 10.1007/s10266-008-0087-y
   Berahim Z, 2011, J PERIODONTOL, V82, P790, DOI 10.1902/jop.2010.100533
   Bergendiova K, 2011, EUR J APPL PHYSIOL, V111, P2033, DOI 10.1007/s00421-011-1837-z
   Bergmeier H. U., 1970, METHODEN ENZYMATISCH
   Bobek P, 2001, BRIT J BIOMED SCI, V58, P164
   BODAJLA M, 1994, CHEM PAP, V48, P432
   Chen J, 2007, VASC HLTH RISK MANAG, V4, P1265
   Chen JZ, 2007, MYCOL RES, V111, P635, DOI 10.1016/j.mycres.2007.02.011
   Esposito A, 2006, J MATER SCI-MATER M, V17, P1365, DOI 10.1007/s10856-006-0612-x
   Gabelova A, 1997, NEOPLASMA, V44, P380
   Harvanova D, 2009, BIOLOGIA, V64, P1032, DOI 10.2478/s11756-009-0171-y
   Horvathova E, 2008, NEUROENDOCRINOL LETT, V29, P644
   Jantova S, 2008, INT TOXICOL, V4, pA36
   KANEKO Y, 1989, INT J IMMUNOTHER, V5, P203
   Kurashige S, 1997, IMMUNOPHARM IMMUNOT, V19, P175, DOI 10.3109/08923979709007657
   Lazarova M, 2006, NUTR CANCER, V56, P113, DOI 10.1207/s15327914nc5601_15
   Lazova M, 2004, NEOPLASMA, V51, P431
   Lim CK, 2010, TOXICOL IN VITRO, V24, P721, DOI 10.1016/j.tiv.2010.01.006
   Magnani M, 2011, GENET MOL BIOL, V34, P131, DOI 10.1590/S1415-47572010005000103
   Majtan J, 2009, Z NATURFORSCH C, V64, P597
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mantovani MS, 2008, MUTAT RES-REV MUTAT, V658, P154, DOI 10.1016/j.mrrev.2007.07.002
   MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9
   Marone PA, 2010, TOXICOL MECH METHOD, V20, P175, DOI 10.3109/15376511003646440
   Miadokova Eva, 2005, Biomedical Papers (Olomouc), V149, P493
   Mossman T., 1989, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4
   Muramatsu K, 2004, J BIOMED MATER RES A, V71A, P635, DOI 10.1002/jbm.a.30197
   Nosal'ova V, 2001, PHYSIOL RES, V50, P575
   Poruban D, 2005, CASE REP CLIN PR REV, V6, P62
   Rahar S, 2011, J ADV PHARM TECHNOL, V2, P94, DOI 10.4103/2231-4040.82953
   Ren L., 2012, FOOD FUNCT IN PRESS
   Rop O, 2009, NUTR REV, V67, P624, DOI 10.1111/j.1753-4887.2009.00230.x
   Rovensky J, 2011, RHEUMATOL INT, V31, P507, DOI 10.1007/s00296-009-1258-z
   Ruozi B, 2009, INT J PHARMACEUT, V378, P108, DOI 10.1016/j.ijpharm.2009.05.049
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Slamenova D, 2003, CANCER LETT, V198, P153, DOI 10.1016/S0304-3835(03)00336-7
   SLAMENOVA D, 1992, MUTAT RES, V279, P109, DOI 10.1016/0165-1218(92)90252-U
   Theiszova M, 2008, NEOPLASMA, V55, P312
   VIZAROVA K, 1995, BIOMATERIALS, V16, P1217, DOI 10.1016/0142-9612(95)98127-Z
   Vojtassak J, 2006, NEUROENDOCRINOL LETT, V27, P134
   Vojtassak Jan, 2001, Cell and Tissue Banking, V2, P225, DOI 10.1023/A:1021146217176
   Vojtassak J, 2006, BIOLOGIA, V61, P713, DOI 10.2478/s11756-006-0146-1
   Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7
   Woo YI, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/044109
   Yang ZY, 2010, SCI CHINA LIFE SCI, V53, P215, DOI 10.1007/s11427-010-0036-1
   Yoon HJ, 2005, ARCH PHARM RES, V28, P1079, DOI 10.1007/BF02977405
NR 51
TC 2
Z9 2
U1 1
U2 10
PU PALACKY UNIV, MEDICAL FAC
PI OLOMOUC
PA CENTRAL LIBRARY, HNEVOTINSKA 3, OLOMOUC, 00000, CZECH REPUBLIC
SN 1213-8118
EI 1804-7521
J9 BIOMED PAP
JI Biomed. Pap-Olomouc
PY 2015
VL 159
IS 1
BP 67
EP 76
DI 10.5507/bp.2012.115
PG 10
WC Engineering, Biomedical; Medicine, Research & Experimental
SC Engineering; Research & Experimental Medicine
GA CE3HE
UT WOS:000351716500011
PM 23446210
OA Bronze
DA 2018-10-20
ER

PT J
AU Dalmonico, GML
   Silva, DF
   Franczak, PF
   Camargo, NHA
   Rodriguez, MA
AF Dalmonico, G. M. L.
   Silva, D. F.
   Franczak, P. F.
   Camargo, N. H. A.
   Rodriguez, M. A.
TI Elaboration biphasic calcium phosphate nanostructured powders
SO BOLETIN DE LA SOCIEDAD ESPANOLA DE CERAMICA Y VIDRIO
LA English
DT Article
DE Synthesis; Calcium Phosphate; Hydroxyapatite; Biphasic; Biomaterial
AB Nanostructured calcium phosphate and biphasic calcium phosphates have been studied and stand out as biomaterials for bone regeneration. This is due to the fact that thesebiomaterials present bioactivity and morphological, chemical and crystallographic similarities to the bone apatite. The aim of the present work has been the synthesis and characterization of two calcium phosphates with Ca/P=1.5 e 1.67 as molar ratio. These were synthesized through the chemical wet process. After synthesis, the hydrated calcium phosphate powders were subsequently calcined at temperatures of 900 degrees C/2 h providing beta-calcium phosphate (beta-TCP) and hydroxyapatite (HA) powders. These powders were used to elaborate the biphasic powders in the wt.% ratios HA/beta-TCP as follows: 80/20, 20/80, 70/30 and 30/70. The method used for the elaboration of the p-tricalcium phosphate nanostructured powder, hydroxyapatite and biphasic compositions was the attrition milling. The nanostructured powders obtained were characterized by the scanning electron microscopy technique, X-ray diffractometry. Infrared spectroscopy and Specific surface using BET model. (C) 2015 Sociedad Espanola de Ceramica y Vidrio. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license
C1 [Dalmonico, G. M. L.; Silva, D. F.; Franczak, P. F.; Camargo, N. H. A.] Santa Catarina State Univ SC, Program Postgrad Sci & Mat Engn, Joinville, Brazil.
   [Rodriguez, M. A.] CSIC, Inst Ceram & Vidrio, Madrid, Spain.
RP Dalmonico, GML (reprint author), Santa Catarina State Univ SC, Program Postgrad Sci & Mat Engn, Joinville, Brazil.
EM gidalmonico@gmail.com
OI Leite Dalmonico, Gisele Maria/0000-0001-6570-6264; Rodriguez, Miguel
   A./0000-0001-5725-9679
FU Higher Education Personnel Training Coordination (CAPES-BRASIL);
   Institute Ceramic and Glass [MAT2013-48426-C2-1R]
FX The financial support of the Higher Education Personnel Training
   Coordination (CAPES-BRASIL) and Institute Ceramic and Glass
   (MAT2013-48426-C2-1R).
CR Berzina-Cimdina L, 2012, MAT SCI ENG TECHNOL, P524
   Borba E.E.G., 2014, 58 C BRAS CER, P1
   Camargo N.H.A., 2014, J BIOSCI MED, V2, P36
   Camargo N.H.A., 2014, ADV MAT RES, V936, P687
   Camargo N. H. A, 2012, AM J BIOMED ENG, V2, P41, DOI DOI 10.1016/J.BSECV.2015.02.006
   Correa Pricyla, 2013, THESIS CCT UDESC JOI, P108
   Dalmonico G.M.L., 2011, THESIS CCT UDESC JOI
   De Delima S. A., 2009, 7 INT LAT AM C POWD, P913
   Dorozhkin SV, 2012, ACTA BIOMATER, V8, P963, DOI 10.1016/j.actbio.2011.09.003
   Franczak Priscila Ferraz, 2014, THESIS CCT UDESC JOI, P120
   Gbureck U, 2003, BIOMATERIALS, V24, P4123, DOI 10.1016/S0142-9612(03)00283-7
   Godinho J.M, 2008, THESIS U SAO CARLOS, P84
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Levandowski-Jr N., 2014, THESIS CCT UDESC JOI, P153
   Mitri L.F.F, 2013, THESIS U FLUMINENSE, P182
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Rigo E. C. S., 2007, REV DENT PRESS PERIO, V1, P39
   Silva R, 2012, THESIS CURITIBA, P104
   Vieira EFS, 2014, QUIM NOVA, V37, P398, DOI 10.5935/0100-4042.20140074
   Villani Angelina, 2012, Rev. Fac. Ing. UCV, V27, P7
NR 20
TC 2
Z9 2
U1 1
U2 6
PU SOC ESPANOLA CERAMICA VIDRIO
PI MADRID
PA DESPACHO 176, INST CERAMICA VIDRIO, CSIC, C-KELSEN 5, 28049 MADRID,
   SPAIN
SN 0366-3175
EI 2173-0431
J9 BOL SOC ESP CERAM V
JI Bol. Soc. Esp. Ceram. Vidr.
PD JAN-FEB
PY 2015
VL 54
IS 1
BP 37
EP 43
DI 10.1016/j.bsecv.2015.02.006
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA CD4AA
UT WOS:000351023800005
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Kim, KJ
   Joe, YA
   Kim, MK
   Lee, SJ
   Ryu, YH
   Cho, DW
   Rhie, JW
AF Kim, Ki Joo
   Joe, Young Ae
   Kim, Min Kyoung
   Lee, Su Jin
   Ryu, Yeon Hee
   Cho, Dong-Woo
   Rhie, Jong Won
TI Silica nanoparticles increase human adipose tissue-derived stem cell
   proliferation through ERK1/2 activation
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE particle; ceramic; biomaterial; mesenchymal stem cells; ERK
ID IN-VITRO; OSTEOGENIC DIFFERENTIATION; SCAFFOLDS; CERAMICS; CALCIUM; P38;
   RESPONSES; IMPLANTS; TITANIUM; ADHESION
AB Background: Silicon dioxide composites have been found to enhance the mechanical properties of scaffolds and to support growth of human adipose tissue-derived stem cells (hADSCs) both in vitro and in vivo. Silica (silicon dioxide alone) exists as differently sized particles when suspended in culture medium, but it is not clear whether particle size influences the beneficial effect of silicon dioxide on hADSCs. In this study, we examined the effect of different sized particles on growth and mitogen-activated protein kinase signaling in hADSCs.
   Methods: Silica gel was prepared by a chemical reaction using hydrochloric acid and sodium silicate, washed, sterilized, and suspended in serum-free culture medium for 48 hours, and then sequentially filtered through a 0.22 mu m filter (filtrate containing nanoparticles smaller than 220 nm; silica NPs). hADSCs were incubated with silica NPs or 3 mu m silica microparticles (MPs), examined by transmission electron microscopy, and assayed for cell proliferation, apoptosis, and mitogen-activated protein kinase signaling.
   Results: Eighty-nine percent of the silica NPs were around 50-120 nm in size. When hADSCs were treated with the study particles, silica NPs were observed in endocytosed vacuoles in the cytosol of hADSCs, but silica MPs showed no cell entry. Silica NPs increased the proliferation of hADSCs, but silica MPs had no significant effect in this regard. Instead, silica MPs induced slight apoptosis. Silica NPs increased phosphorylation of extracellular signal-related kinase (ERK) 1/2, while silica MPs increased phosphorylation of p38. Silica NPs had no effect on phosphorylation of Janus kinase or p38. Pretreatment with PD98059, a MEK inhibitor, prevented the ERK1/2 phosphorylation and proliferation induced by silica NPs.
   Conclusion: Scaffolds containing silicon dioxide for tissue engineering may enhance cell growth through ERK1/2 activation only when NPs around 50-120 nm in size are included, and single component silica-derived NPs could be useful for bioscaffolds in stem cell therapy.
C1 [Kim, Ki Joo; Kim, Min Kyoung; Lee, Su Jin; Ryu, Yeon Hee; Rhie, Jong Won] Catholic Univ Korea, Coll Med, Dept Plast Surg, Seoul 137701, South Korea.
   [Kim, Ki Joo; Kim, Min Kyoung; Ryu, Yeon Hee; Rhie, Jong Won] Catholic Univ Korea, Coll Med, Dept Mol Biomed, Seoul 137701, South Korea.
   [Joe, Young Ae] Catholic Univ Korea, Coll Med, Inst Canc Res, Seoul 137701, South Korea.
   [Joe, Young Ae] Catholic Univ Korea, Coll Med, Dept Med Lifesci, Seoul 137701, South Korea.
   [Cho, Dong-Woo] Pohang Univ Sci & Technol, Dept Mech Engn, Gyeongbuk, South Korea.
   [Cho, Dong-Woo] Pohang Univ Sci & Technol, Dept Integrat Biosci & Bioengn, Gyeongbuk, South Korea.
RP Rhie, JW (reprint author), Catholic Univ Korea, Coll Med, Dept Plast Surg, 222 Banpo Dearo, Seoul 137701, South Korea.
EM rhie@catholic.ac.kr
RI Rhie, Jong Won/C-4652-2012
OI Rhie, Jong Won/0000-0002-9398-8059
FU Seoul R&BD Program of the Seoul Government of Korea [SS110011C0211601];
   National Research Foundation of Korea grant - Government of Korea
FX This work was supported financially by the Seoul R&BD Program of the
   Seoul Government of Korea (SS110011C0211601) and by a National Research
   Foundation of Korea grant funded by the Government of Korea.
CR Brandao SM, 2012, ORBIT, V31, P143, DOI 10.3109/01676830.2011.648798
   Chan S, 2014, ACTA HAEMATOL-BASEL, V132, P200, DOI 10.1159/000356808
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244
   Domanski M, 2012, J MATER SCI-MATER M, V23, P1637, DOI 10.1007/s10856-012-4635-1
   FARMER VC, 1986, CIBA F SYMP, V121, P4
   Ho PJ, 2012, LIFE SCI, V91, P1358, DOI 10.1016/j.lfs.2012.10.007
   Jin Z, 2008, TISSUE ENG REGEN MED, V5, P869
   Kang KS, 2014, TISSUE ENG PT A, V20, P1767, DOI [10.1089/ten.tea.2013.0157, 10.1089/ten.TEA.2013.0157]
   Kim BS, 2011, AGING CELL, V10, P277, DOI 10.1111/j.1474-9726.2011.00670.x
   Kim KJ, 2010, TISSUE ENG REGEN MED, V7, P171
   Lee JH, 2012, ARCH PLAST SURG-APS, V39, P593, DOI 10.5999/aps.2012.39.6.593
   Lee JH, 2008, BIOCHEM BIOPH RES CO, V370, P456, DOI 10.1016/j.bbrc.2008.03.123
   Lu HX, 2010, J BIOMATER APPL, V25, P39, DOI 10.1177/0885328209342469
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Murphy S, 2010, J MATER SCI-MATER M, V21, P2827, DOI 10.1007/s10856-010-4139-9
   Oh N, 2014, INT J NANOMED, V9, P51, DOI 10.2147/IJN.S26592
   Payne KA, 2010, TISSUE ENG PT A, V16, P3647, DOI [10.1089/ten.tea.2009.0738, 10.1089/ten.TEA.2009.0738]
   Puckett S, 2008, INT J NANOMED, V3, P229
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Sarina, 2013, BRAIN RES, V1490, P61, DOI 10.1016/j.brainres.2012.10.059
   Schubert R, 2009, J IMMUNOL METHODS, V350, P200, DOI 10.1016/j.jim.2009.08.015
   Shi XT, 2009, BIOMATERIALS, V30, P3996, DOI 10.1016/j.biomaterials.2009.04.021
   Shie MY, 2012, INT ENDOD J, V45, P337, DOI 10.1111/j.1365-2591.2011.01981.x
   Sommerfeld J, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0055-5
   Sun JY, 2009, BIOMED PHARMACOTHER, V63, P650, DOI 10.1016/j.biopha.2009.01.007
   Tan F, 2011, BIOTECHNOL BIOENG, V108, P454, DOI 10.1002/bit.22955
   Thanyaphoo S, 2012, J PHARM SCI-US, V101, P2870, DOI 10.1002/jps.23230
   Wang C, 2013, BIOMATERIALS, V34, P64, DOI 10.1016/j.biomaterials.2012.09.021
   Webster TJ, 2012, ACTA BIOMATER, V8, P4447, DOI 10.1016/j.actbio.2012.07.038
   Widenmaier SB, 2009, J BIOL CHEM, V284, P30372, DOI 10.1074/jbc.M109.060178
   Wiens M, 2010, CALCIFIED TISSUE INT, V87, P513, DOI 10.1007/s00223-010-9408-6
   Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019
   Xia LG, 2014, BIOMATERIALS, V35, P8514, DOI 10.1016/j.biomaterials.2014.06.028
   Xu CX, 2011, BIOMATERIALS, V32, P1051, DOI 10.1016/j.biomaterials.2010.09.068
   Yang JJ, 2012, CELL BIOCHEM FUNCT, V30, P505, DOI 10.1002/cbf.2829
   Yun HS, 2011, INT J NANOMED, V6, P2521, DOI 10.2147/IJN.S25647
   Zhang ML, 2012, J BIOMED MATER RES A, V100A, P2979, DOI 10.1002/jbm.a.34246
   Zhou HJ, 2010, J MATER SCI-MATER M, V21, P2175, DOI 10.1007/s10856-010-4083-8
   Zou S, 2009, J BIOMED MATER RES B, V90B, P123, DOI 10.1002/jbm.b.31262
NR 40
TC 23
Z9 23
U1 1
U2 22
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2015
VL 10
BP 2261
EP 2272
DI 10.2147/IJN.S71925
PG 12
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA CD9RX
UT WOS:000351437000001
PM 25848249
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Sun, BB
   Li, J
   Liu, W
   Aqeel, BM
   El-Hamshary, H
   Al-Deyab, SS
   Mo, XM
AF Sun, Binbin
   Li, Jun
   Liu, Wei
   Aqeel, Bhutto M.
   El-Hamshary, Hany
   Al-Deyab, Salem S.
   Mo, Xiumei
TI Fabrication and characterization of mineralized P(LLA-CL)/SF
   three-dimensional nanoyarn scaffolds
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE Nanoyarns; P(LLA-CL)/SF; Dynamic liquid support electrospinning;
   Biomineralization
ID MESENCHYMAL STEM-CELLS; REGENERATED SILK FIBROIN; SIMULATED BODY-FLUID;
   BIOMIMETIC MINERALIZATION; NANOFIBROUS SCAFFOLDS; APATITE FORMATION;
   IN-VITRO; TISSUE; SURFACE; BIOMATERIAL
AB Particular attention has been given to three-dimensional scaffolds for bone tissue regeneration. In this study, poly(L-lactic acid-co-epsilon-caprolactone) (P(LLA-CL) nanoyarn scaffold and poly(L-lactic acid-co-caprolactone)/silk fibroin (P(LLA-CL)/SF) nanoyarn scaffold were fabricated by a dynamic liquid support electrospinning system; and then the three-dimensional (3D) nanoyarn scaffolds were prepared by freeze-drying processes. The results indicated the average diameter of P(LLA-CL) and P(LLA-CL)/SF nanoyarns were 29.44 +/- 3.47 mu m and 11.59 +/- 0.46 mu m, respectively. The yarn in the nanoyarn scaffold was twisted by many nanofibers as evidenced by scanning electron microscope (SEM) result. These nanoyarn scaffolds were biomineralized by alternatively immersing the nanoyarn scaffolds into phosphoric acid and calcium ion solutions. After biomineralization, the existence of hydroxyapatite (HA) particles on the scaffolds was confirmed using fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD) analysis. In vitro study of cell proliferation was found to be higher on P(LLA-CL)/SF scaffold as compared to P(LLA-CL) scaffold after culturing for 14 days. H&E staining results showed that cells not only attached to the surface of 3D scaffold but also infiltrated into the scaffold. This study indicated that the electrospun P(LLA-CL)/SF scaffold with nanostructure morphology could improve cell adhesion and proliferation and electrospun P(LLA-CL)/SF scaffold with biomineralization has a potential application for bone tissue engineering.
C1 [Sun, Binbin; Li, Jun; Liu, Wei; Aqeel, Bhutto M.; Mo, Xiumei] Donghua Univ, Coll Chem Chem Engn & Bioengn, Biomat & Tissue Engn Lab, Shanghai 201620, Peoples R China.
   [El-Hamshary, Hany; Al-Deyab, Salem S.; Mo, Xiumei] King Saud Univ, Coll Sci, Dept Chem, Riyadh 11451, Saudi Arabia.
   [El-Hamshary, Hany] Tanta Univ, Dept Chem, Fac Sci, Tanta 31527, Egypt.
RP Mo, XM (reprint author), Donghua Univ, Coll Chem Chem Engn & Bioengn, Biomat & Tissue Engn Lab, Rm 4088 4 Coll Bldg, Shanghai 201620, Peoples R China.
EM med@dhu.edu.cn
RI mo, xiumei/C-9340-2013; EL-HAMSHARY, HANY/C-1473-2010
OI EL-HAMSHARY, HANY/0000-0001-6805-7255
FU State Key Laboratory of Bioreactor Engineering, Science and Technology
   Commission of Shanghai Municipality Program [11nm0506200]; National
   Nature Science Foundation of China [31470941, 31271035]; Deanship of
   Scientific Research at King Saud University [RGP-201]
FX This research was supported by Open Funding Project of the State Key
   Laboratory of Bioreactor Engineering, Science and Technology Commission
   of Shanghai Municipality Program (11nm0506200), National Nature Science
   Foundation of China (Project No. 31470941, 31271035), Deanship of
   Scientific Research at King Saud University research group project no.
   RGP-201.
CR Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Calvert P, 1996, CHEM MATER, V8, P1715, DOI 10.1021/cm960126o
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048
   Fang ZD, 2011, APPL SURF SCI, V257, P4133, DOI 10.1016/j.apsusc.2010.12.011
   Helsen J.A., 1998, METALS BIOMATERIALS
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Kim SI, 2013, APPL SURF SCI, V276, P586, DOI 10.1016/j.apsusc.2013.03.137
   Kuo Catherine K, 2010, Sports Med Arthrosc Rehabil Ther Technol, V2, P20, DOI 10.1186/1758-2555-2-20
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Mavis B, 2009, ACTA BIOMATER, V5, P3098, DOI 10.1016/j.actbio.2009.04.037
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Muthumanickkam A, 2013, IRAN POLYM J, V22, P143, DOI 10.1007/s13726-012-0113-3
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Sato K, 2000, J BIOMED MATER RES, V50, P16, DOI 10.1002/(SICI)1097-4636(200004)50:1<16::AID-JBM3>3.0.CO;2-G
   Takeuchi A, 2003, J BIOMED MATER RES A, V65A, P283, DOI 10.1002/jbm.a.10456
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Teo WE, 2011, ACTA BIOMATER, V7, P193, DOI 10.1016/j.actbio.2010.07.041
   Teo WE, 2007, POLYMER, V48, P3400, DOI 10.1016/j.polymer.2007.04.044
   Thorvaldsson A, 2008, BIOMACROMOLECULES, V9, P1044, DOI 10.1021/bm701225a
   Tzezana R, 2008, TISSUE ENG PART C-ME, V14, P281, DOI 10.1089/ten.tec.2008.0201
   Vaquette C, 2010, J BIOMED MATER RES A, V94A, P1270, DOI 10.1002/jbm.a.32801
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wu JL, 2012, MATER LETT, V89, P146, DOI 10.1016/j.matlet.2012.08.141
   Xu AW, 2007, J MATER CHEM, V17, P415, DOI 10.1039/b611918m
   Xu Y, 2013, TISSUE ENG PART C-ME, V19, P925, DOI [10.1089/ten.tec.2012.0328, 10.1089/ten.TEC.2012.0328]
   Yin AL, 2013, J BIOMED MATER RES A, V101, P1292, DOI 10.1002/jbm.a.34434
   Zhang KH, 2010, J BIOMED MATER RES A, V95A, P870, DOI 10.1002/jbm.a.32895
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P984, DOI 10.1002/jbm.a.32504
   Zheng L, 2013, IRAN POLYM J, V22, P833, DOI 10.1007/s13726-013-0182-y
   Zhou P, 2001, J PHYS CHEM B, V105, P12469, DOI 10.1021/jp0125395
NR 41
TC 4
Z9 4
U1 2
U2 72
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1026-1265
EI 1735-5265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD JAN
PY 2015
VL 24
IS 1
BP 29
EP 40
DI 10.1007/s13726-014-0297-9
PG 12
WC Polymer Science
SC Polymer Science
GA CE1IK
UT WOS:000351565100004
DA 2018-10-20
ER

PT J
AU Pawar, AP
   Munde, PL
   Bothiraja, C
   Kuchekar, AB
AF Pawar, A. P.
   Munde, P. L.
   Bothiraja, C.
   Kuchekar, A. B.
TI Development of ranolazine loaded floating biomaterial gellan beads using
   Box-Behnken factorial design
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Ranolazine; Floating gellan beads; Ionotropic gelation; Box-Behnken
   factorial design; Controlled release; Non-everted rat stomach sac model
ID IN-VITRO EVALUATION; DRUG-DELIVERY SYSTEM; CONTROLLED-RELEASE; GELATION
   METHOD; FORMULATION; AMOXICILLIN; OPTIMIZATION; EFFICIENCY; ACID
AB The present work aimed at development of ranolazine loaded floating biomaterial gellan beads to enhance its site specific absorption. The beads obtained by ionotropic gelation method using sodium bicarbonate as gas-forming agent, calcium chloride and chitosan as a crosslinker were evaluated for physicochemical properties and in vitro performance. Yield and entrapment efficiency varied from 90 to 97% and 58 to 81% respectively. Surface topography revealed spherical microparticles with evenly distributed pores. Differential scanning calorimetry and powder X-ray diffraction pointed out amorphous nature of the drug. Effect of formulation variables on floating lag time and time required for 50% drug release was studied using Box-Behnken factorial design. The beads displayed good in vitro floatability in 0.1 N HCl with initial burst release followed by a controlled release up to 10 h whereas slow drug release was observed in phosphate buffer pH 6.8; probably due to decreased drug solubility and accelerated internal gelation through ionic crosslinking of gellan monomers. The beads, when studied in non-everted rat stomach and intestinal sac models, demonstrated twofold decrease in flux and apparent permeability coefficient as compared to pure ranolazine. Floating gellan beads proved advantageous for controlling the release and enhancing therapeutic activity of ranolazine.
C1 [Pawar, A. P.; Munde, P. L.; Bothiraja, C.; Kuchekar, A. B.] Bharati Vidyapeeth Univ, Poona Coll Pharm, Dept Pharmaceut, Pune 411038, Maharashtra, India.
RP Pawar, AP (reprint author), Bharati Vidyapeeth Univ, Poona Coll Pharm, Dept Pharmaceut, Pune 411038, Maharashtra, India.
EM p_atmaram@rediffmail.com
RI Deemed University, Bharati Vidyapeeth/A-6025-2016
CR Agnihotri SA, 2006, EUR J PHARM BIOPHARM, V63, P249, DOI 10.1016/j.ejpb.12.008
   Angadi SC, 2012, INT J BIOL MACROMOL, V51, P45, DOI 10.1016/j.ijbiomac.2012.04.018
   Arora A., 2005, AAPS PHARMSCITECH, V6, P372
   Babu R. Jayachandra, 2010, Current Drug Delivery, V7, P36
   Bhardwaj T, 2000, DRUG DEV IND PHARM, V26, P1025, DOI 10.1081/DDC-100100266
   Bothiraja C, 2012, NANOSCI NANOTECH LET, V4, P445, DOI 10.1166/nnl.2012.1337
   Bothiraja C, 2012, J PHARMACOL TOX MET, V66, P35, DOI 10.1016/j.vascn.2012.05.007
   Choi BY, 2002, INT J PHARM, V239, P81, DOI 10.1016/S0378-5173(02)00054-6
   Depan D, 2011, MAT SCI ENG C-MATER, V31, P1305, DOI 10.1016/j.msec.2011.04.010
   Depan D, 2011, ACTA BIOMATER, V7, P2163, DOI 10.1016/j.actbio.2011.01.029
   Jerling M, 2006, CLIN PHARMACOKINET, V45, P469, DOI 10.2165/00003088-200645050-00003
   Maiti S, 2011, CARBOHYD POLYM, V85, P164, DOI 10.1016/j.carbpol.2011.02.010
   Malakar J, 2012, INT J BIOL MACROMOL, V50, P138, DOI 10.1016/j.ijbiomac.2011.10.001
   Mao R, 2000, CARBOHYD POLYM, V41, P331, DOI 10.1016/S0144-8617(99)00108-3
   Miyazaki S, 2001, INT J PHARM, V220, P161, DOI 10.1016/S0378-5173(01)00669-X
   Munish A., 2010, CARBOHYD POLYM, V80, P161
   Murthy TEGK, 2011, ASIAN J PHARM, V5, P162, DOI 10.4103/0973-8398.91992
   Narkar M, 2010, AAPS PHARMSCITECH, V11, P267, DOI 10.1208/s12249-010-9384-1
   Nayak AK, 2013, INT J BIOL MACROMOL, V54, P144, DOI 10.1016/j.ijbiomac.2012.12.008
   Nayak AK, 2011, INT J BIOL MACROMOL, V49, P784, DOI 10.1016/j.ijbiomac.2011.07.013
   Patil S, 2006, DRUG DEV IND PHARM, V32, P315, DOI 10.1080/03639040500518930
   Pawar AP, 2012, J MICROENCAPSUL, V29, P409, DOI 10.3109/02652048.2012.655330
   Rajinikanth Parauvathanahalli Siddalingam, 2007, Acta Pharmaceutica (Zagreb), V57, P413, DOI 10.2478/v10007-007-0033-5
   Sanju Dhawan, 2004, AAPS PHARMSCITECH, V5, P1
   Sato Y, 2004, EUR J PHARM BIOPHARM, V57, P235, DOI 10.1016/s0939-6411(03)00185-1
   Sharma S, 2006, INT J PHARM, V313, P150, DOI 10.1016/j.ijpharm.2006.02.001
   Shradha S. B., 2007, EUR J PHARM BIOPHARM, V65, P85
   Singh BN, 2000, J CONTROL RELEASE, V63, P235, DOI 10.1016/S0168-3659(99)00204-7
   Sossalla S, 2012, PHARMACOL THERAPEUT, V133, P311, DOI 10.1016/j.pharmthera.2011.11.003
   Tripathi G, 2010, DARU, V18, P247
   Wang Q, 2010, INT J BIOL MACROMOL, V46, P356, DOI 10.1016/j.ijbiomac.2010.01.009
   Whitehead L, 2000, INT J PHARM, V210, P45, DOI 10.1016/S0378-5173(00)00567-6
NR 32
TC 1
Z9 1
U1 0
U2 3
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD JAN
PY 2015
VL 30
IS 1
BP 33
EP 42
DI 10.1179/1753555714Y.0000000199
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA CD5JJ
UT WOS:000351123600007
DA 2018-10-20
ER

PT J
AU Hou, XF
   Chen, Y
   Liu, Y
AF Hou, Xiao-Fang
   Chen, Yong
   Liu, Yu
TI Enzyme-responsive protein/polysaccharide supramolecular nanoparticles
SO SOFT MATTER
LA English
DT Article
ID DRUG-DELIVERY; ORGANIC FRAMEWORK; BUILDING-BLOCKS; WATER; VESICLES;
   POLYMERIZATION; COMPLEXATION; POLYMERS; SYSTEMS; HYDROGELS
AB Biocompatible and enzyme-responsive supramolecular assemblies have attracted more and more interest in biomaterial fields, and find many feasible applications especially in the controlled drug release at specific sites where the target enzyme is located. In this work, novel supramolecular nanoparticles were successfully constructed from two biocompatible materials, i.e. a cyclic polysaccharide named sulfato-beta-cyclodextrin (SCD) and a protein named protamine, through non-covalent association, and fully characterized by means of atomic force microscopy (AFM) and high-resolution transmission electron microscopy (TEM). Significantly, the disassembly of the resulting nanoparticles can respond especially to trypsin over other enzymes. Owing to their trypsin-triggered disassembly behaviors, these nanoparticles can efficiently release the encapsulated model substrate in a controlled manner. That is, the model substrate can be encapsulated inside the nanoparticles with a high stability and released when treated with trypsin.
C1 [Hou, Xiao-Fang; Chen, Yong; Liu, Yu] Nankai Univ, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Dept Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China.
RP Liu, Y (reprint author), Nankai Univ, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Dept Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China.
EM yuliu@nankai.edu.cn
RI LIU, Yu/C-3197-2012
FU 973 Program [2011CB932502]; NSFC [91227107, 21432004, 21272125]
FX We thank the 973 Program (2011CB932502) and NSFC (91227107, 21432004,
   and 21272125) for financial support.
CR Almutairi A, 2008, J AM CHEM SOC, V130, P444, DOI 10.1021/ja078147e
   Appel EA, 2012, J AM CHEM SOC, V134, P11767, DOI 10.1021/ja3044568
   Assaf KI, 2015, CHEM SOC REV, V44, P394, DOI 10.1039/c4cs00273c
   Cao Y, 2014, J AM CHEM SOC, V136, P10762, DOI 10.1021/ja505344t
   Chen Y, 2010, CHEM SOC REV, V39, P495, DOI 10.1039/b816354p
   Chen Y, 2010, CHEM COMMUN, V46, P5622, DOI 10.1039/c0cc00690d
   Du JZ, 2005, J AM CHEM SOC, V127, P17982, DOI 10.1021/ja056514l
   Duan QP, 2013, J AM CHEM SOC, V135, P10542, DOI 10.1021/ja405014r
   Guo DS, 2012, CHEM SOC REV, V41, P5907, DOI 10.1039/c2cs35075k
   Guo DS, 2012, J AM CHEM SOC, V134, P10244, DOI 10.1021/ja303280r
   Harada A, 2009, CHEM SOC REV, V38, P875, DOI 10.1039/b705458k
   Hu JM, 2012, CHEM SOC REV, V41, P5933, DOI 10.1039/c2cs35103j
   Huang ZH, 2014, ANGEW CHEM INT EDIT, V53, P5351, DOI 10.1002/anie.201402817
   Jiao DZ, 2010, J AM CHEM SOC, V132, P15734, DOI 10.1021/ja106716j
   Kamaly N, 2012, CHEM SOC REV, V41, P2971, DOI 10.1039/c2cs15344k
   Kim K, 2007, CHEM SOC REV, V36, P267, DOI 10.1039/b603088m
   Kiser PF, 1998, NATURE, V394, P459
   Kumpfer JR, 2011, J AM CHEM SOC, V133, P12866, DOI 10.1021/ja205332w
   Lee TC, 2013, NAT CHEM, V5, P376, DOI 10.1038/nchem.1618
   Liu YL, 2011, CHEM-EUR J, V17, P9930, DOI 10.1002/chem.201101611
   Peng S, 2015, SOFT MATTER, V11, P290, DOI 10.1039/c4sm02170c
   Qin ZB, 2014, SOFT MATTER, V10, P2253, DOI 10.1039/c3sm52866a
   Randolph LM, 2012, CHEM SCI, V3, P1363, DOI [10.1039/c2sc00857b, 10.1039/C2SC00857B]
   Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o
   Reynolds F, 2005, BIOCONJUGATE CHEM, V16, P1240, DOI 10.1021/bc0501451
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Tan LL, 2014, ADV MATER, V26, P7027, DOI 10.1002/adma.201401672
   Tan XX, 2015, POLYM CHEM-UK, V6, P681, DOI 10.1039/c4py01440e
   Tian J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6574
   Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p
   van Hest JCM, 2009, NATURE, V461, P45, DOI 10.1038/461045a
   Vriezema DM, 2005, CHEM REV, V105, P1445, DOI 10.1021/cr0300688
   Wang C, 2012, ACCOUNTS CHEM RES, V45, P608, DOI 10.1021/ar200226d
   Wang K, 2016, CHEM-EUR J, V22, P1475, DOI 10.1002/chem.201303963
   Wang Y, 2009, ADV MATER, V21, P2849, DOI 10.1002/adma.200803276
   Yang YW, 2014, ACCOUNTS CHEM RES, V47, P1950, DOI 10.1021/ar500022f
   Yu GC, 2012, J AM CHEM SOC, V134, P19489, DOI 10.1021/ja3099905
   Zhang KD, 2013, J AM CHEM SOC, V135, P17913, DOI 10.1021/ja4086935
   Zhang X, 2011, CHEM SOC REV, V40, P94, DOI 10.1039/b919678c
   Zhang X, 2009, NAT CHEM, V1, P623, DOI [10.1038/nchem.368, 10.1038/NCHEM.368]
   Zhou CC, 2014, LANGMUIR, V30, P3381, DOI 10.1021/la500010p
   Zhou CC, 2013, LANGMUIR, V29, P13175, DOI 10.1021/la403257v
NR 42
TC 21
Z9 22
U1 5
U2 40
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2015
VL 11
IS 12
BP 2488
EP 2493
DI 10.1039/c4sm02896a
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA CD9DC
UT WOS:000351396500018
PM 25679755
DA 2018-10-20
ER

PT J
AU Munro, NH
   McGrath, KM
AF Munro, Natasha H.
   McGrath, Kathryn M.
TI Advances in techniques and technologies for bone implants
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE biomaterial; bone; tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; CALCIUM-PHOSPHATE COATINGS;
   MECHANICAL-PROPERTIES; MAGNESIUM ALLOYS; HYDROXYAPATITE; COLLAGEN;
   CHITOSAN; BIOMATERIALS; FABRICATION; DEFECTS
AB Materials which can augment and repair the function of damaged bone are required. Metals, ceramics and plastics have been widely used as artificial bone implants, although their material properties are not optimally matched to those of the native bone tissue. New materials, and methods of production, are being extensively investigated to overcome the limitations of the current implants. In this review, we give an oversight into the current materials used and their limitations followed by an analysis of the new types of materials and techniques which are under development. The groups of materials covered specifically include new metals and metal alloys which are potentially more biocompatible, porous metal foams which mimic the structure of spongy bone and advanced composites which incorporate the properties of multiple materials within one implant. The use of additive manufacturing techniques is also discussed as these techniques allow for the tailoring of the physical properties of the implant and the production of customisable implants.
C1 [Munro, Natasha H.; McGrath, Kathryn M.] Victoria Univ Wellington, Sch Chem & Phys Sci, Wellington, New Zealand.
   [Munro, Natasha H.; McGrath, Kathryn M.] MacDiarmid Inst Adv Mat & Nanotechnol, Wellington, New Zealand.
RP McGrath, KM (reprint author), Victoria Univ Wellington, Sch Chem & Phys Sci, Wellington, New Zealand.
EM kathryn.mcgrath@vuw.ac.nz
OI McGrath, Kathryn/0000-0003-3531-0562
CR Aboudzadeh N, 2010, J BIOMED MATER RES A, V94A, P137, DOI 10.1002/jbm.a.32673
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Billiet T, 2012, BIOMATERIALS, V33, P6020, DOI 10.1016/j.biomaterials.2012.04.050
   Bobbio A, 1972, Bull Hist Dent, V20, P1
   Bohner M, 2005, BIOMATERIALS, V26, P6099, DOI 10.1016/j.biomaterials.2005.03.026
   Bugbee WD, 1997, J BONE JOINT SURG AM, V79A, P1007, DOI 10.2106/00004623-199707000-00006
   Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   Cai X, 2009, ACTA BIOMATER, V5, P2693, DOI 10.1016/j.actbio.2009.03.005
   Chua CK, 2004, J MATER SCI-MATER M, V15, P1113, DOI 10.1023/B:JMSM.0000046393.81449.a5
   Clarke SA, 2011, BIOTECHNOL ADV, V29, P610, DOI 10.1016/j.biotechadv.2011.04.003
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   DAMIEN CJ, 1994, CALCIFIED TISSUE INT, V55, P151, DOI 10.1007/BF00297191
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Fielding GA, 2012, DENT MATER, V28, P113, DOI 10.1016/j.dental.2011.09.010
   Fu Q, 2011, MAT SCI ENG C-MATER, V31, P1245, DOI 10.1016/j.msec.2011.04.022
   Gagg G, 2013, MAT SCI ENG C-MATER, V33, P3858, DOI 10.1016/j.msec.2013.05.021
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Goyenvalle E, 2006, BIOMATERIALS, V27, P1119, DOI 10.1016/j.biomaterials.2005.07.039
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang Z, 2011, CARBOHYD POLYM, V85, P261, DOI 10.1016/j.carbpol.2011.02.029
   Huang Z, 2011, MAT SCI ENG C-MATER, V31, P683, DOI 10.1016/j.msec.2010.12.014
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Klammert U, 2010, J CRANIO MAXILL SURG, V38, P565, DOI 10.1016/j.jcms.2010.01.009
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   Lam CXF, 2002, MAT SCI ENG C-BIO S, V20, P49, DOI 10.1016/S0928-4931(02)00012-7
   Li JP, 2006, BIOMATERIALS, V27, P1223, DOI 10.1016/j.biomaterials.2005.08.033
   Li JJ, 2011, CARBOHYD POLYM, V85, P885, DOI 10.1016/j.carbpol.2011.04.015
   Li XM, 2013, J BIOMED MATER RES A, V101, P2424, DOI 10.1002/jbm.a.34539
   Li XM, 2006, BIOMATERIALS, V27, P1917, DOI 10.1016/j.biomaterials.2005.11.013
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   LUCAS LC, 1993, COLLOID SURFACE A, V77, P141, DOI 10.1016/0927-7757(93)80110-Z
   Ma J, 2012, CERAM INT, V38, P6677, DOI 10.1016/j.ceramint.2012.05.056
   Maleksaeedi S, 2013, PROC CIRP, V5, P158, DOI 10.1016/j.procir.2013.01.032
   Mangano F, 2013, IMPLANT DENT, V22, P388, DOI 10.1097/ID.0b013e31829afa9d
   National Cancer Institute, 2013, SEER TRAIN MOD AN PH
   Ni M, 2003, BIOMATERIALS, V24, P4323, DOI 10.1016/S0142-9612(03)00236-9
   Nijhuis AWG, 2010, MACROMOL BIOSCI, V10, P1316, DOI 10.1002/mabi.201000142
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Poukens J., 2010, DIGITAL DENT NEWS, V4, P30
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Rojaee R., 2013, ADV BIOMECHANICAL SY, V40, P25, DOI [10.1007/978-3-319-00479-2_3, DOI 10.1007/978-3-319-00479-2_3]
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Schoof H, 2001, J BIOMED MATER RES, V58, P352, DOI 10.1002/jbm.1028
   Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Seyedraoufi ZS, 2013, J MECH BEHAV BIOMED, V21, P1, DOI 10.1016/j.jmbbm.2013.01.023
   Shadanbaz S, 2012, ACTA BIOMATER, V8, P20, DOI 10.1016/j.actbio.2011.10.016
   Song SJ, 2011, ARTIF ORGANS, V35, P1132, DOI 10.1111/j.1525-1594.2011.01377.x
   Staiger MP, 2010, MATER LETT, V64, P2572, DOI 10.1016/j.matlet.2010.08.049
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Stoodley MA, 1996, J CLIN NEUROSCI, V3, P149, DOI 10.1016/S0967-5868(96)90009-0
   Tan KH, 2003, BIOMATERIALS, V24, P3115, DOI 10.1016/S0142-9612(03)00131-5
   Tarafder S, 2013, J TISSUE ENG REGEN M, V7, P631, DOI 10.1002/term.555
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   WANG RZ, 1995, J MATER SCI LETT, V14, P490, DOI 10.1007/BF00665911
   Waterman J, 2011, MATER SCI ENG B-ADV, V176, P1756, DOI 10.1016/j.mseb.2011.06.021
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wong KV, 2012, ISRN MECH ENG, V2012, DOI DOI 10.5402/2012/208760
   Yu CC, 2013, MATER LETT, V93, P133, DOI 10.1016/j.matlet.2012.11.040
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhou WY, 2008, J MATER SCI-MATER M, V19, P2535, DOI 10.1007/s10856-007-3089-3
NR 72
TC 0
Z9 0
U1 3
U2 59
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2015
VL 4
IS 1
BP 26
EP 36
DI 10.1680/bbn.14.00015
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD1XI
UT WOS:000350867400004
DA 2018-10-20
ER

PT J
AU Cox, SC
   Walton, RI
   Mallick, KK
AF Cox, Sophie C.
   Walton, Richard I.
   Mallick, Kajal K.
TI Comparison of techniques for the synthesis of hydroxyapatite
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE bioinorganic; biomaterial; bone; material chemistry; material properties
ID BIOCERAMIC CALCIUM PHOSPHATES; HYDROTHERMAL SYNTHESIS; COMBUSTION
   SYNTHESIS; PRECIPITATION; EMULSION; MICROEMULSION; TEMPERATURE;
   MORPHOLOGY; SCAFFOLDS; CHEMISTRY
AB Hydroxyapatite (HA) is a widely researched calcium phosphate biomaterial that is used primarily in bone replacement due to its chemical similarity to bone mineral. Many synthesis methods have been reported for the production of stoichiometric HA; however, processing parameters vary widely for each technique. Herein, the authors present a comparison of nanosized HA produced by aqueous precipitation, solvothermal synthesis and two self-propagating combustion synthesis (SPCS) methods using urea or citric acid combined with nitric acid. Powders were characterised via scanning electron microscopy, transmission electron microscopy and thermogravimetric analysis, which enabled subtle compositional differences identified via powder X-ray diffraction to be clearly distinguished. Phase transformation of ` HA' prepared by aqueous precipitation to beta-tricalcium phosphate and HA above 600 degrees C revealed as-synthesised samples were in fact calcium-deficient HA. Mixed-phase particles formed spontaneously from solution via SPCS were shown to exhibit a larger average particle size (5.8-11.4 mu m) and degree of agglomeration compared with aqueous precipitation (0.6 mu m) and solvothermal (2 mu m) samples. Ultimately, such physicochemical variations could significantly influence key properties such as solubility, bioactivity and potentially also biocompatibility. This paper provides evidence that the selection of a synthesis method and conditions to produce HA cannot be deemed as a trivial process.
C1 [Cox, Sophie C.; Mallick, Kajal K.] Univ Warwick, Warwick Mfg Grp, Coventry CV4 7AL, W Midlands, England.
   [Walton, Richard I.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.
RP Walton, RI (reprint author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.
EM R.I.Walton@warwick.ac.uk
RI Walton, Richard/C-2058-2009
OI Walton, Richard/0000-0001-9706-2774
FU Warwick Chancellor's Scholarship; Institute of Advanced Study at the
   University of Warwick
FX The authors would like to acknowledge Reza J. Kashtiban for his
   assistance with TEM imaging. The Warwick Chancellor's Scholarship and
   the Institute of Advanced Study at the University of Warwick are
   gratefully acknowledged for financially supporting this work.
CR [Anonymous], REL 2000 POWD DIFFR
   [Anonymous], EV DIFFRACPLUS BASIC
   Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Bohner M, 2000, INJURY, V31, pS37
   Bouyer E, 2000, J MATER SCI-MATER M, V11, P523, DOI 10.1023/A:1008918110156
   Cazalbou S, 2004, J MATER CHEM, V14, P2148, DOI 10.1039/b401318b
   Chaudhry AA, 2006, CHEM COMMUN, P2286, DOI 10.1039/b518102j
   Cox S. C., 2013, J MATER SCI-MATER M, V1, P1
   Cox SC, 2014, MAT SCI ENG C-MATER, V35, P106, DOI 10.1016/j.msec.2013.10.015
   Cunniffe GM, 2010, J BIOMED MATER RES A, V95A, P1142, DOI 10.1002/jbm.a.32931
   Drouet C, 2013, BIO MED RES INT, V2013, DOI [10.1155/2013/490946, DOI 10.1155/2013/490946]
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Guo XY, 2007, J BIOMED MATER RES A, V82A, P1022, DOI 10.1002/jbm.a.31200
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Kothapalli C, 2004, ACTA MATER, V52, P5655, DOI 10.1016/j.actamat.2004.08.027
   Koumoulidis GC, 2003, J COLLOID INTERF SCI, V259, P254, DOI 10.1016/S0021-9797(02)00233-3
   Lester E, 2013, CRYSTENGCOMM, V15, P3256, DOI 10.1039/c3ce26798a
   Leukers B, 2005, J MATER SCI-MATER M, V16, P1121, DOI 10.1007/s10856-005-4716-5
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Lim GK, 1997, BIOMATERIALS, V18, P1433, DOI 10.1016/S0142-9612(97)00081-1
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   Ma MG, 2009, EUR J INORG CHEM, P5522, DOI 10.1002/ejic.200900839
   Niu JL, 2007, KEY ENG MAT, V330-332, P247, DOI 10.4028/www.scientific.net/KEM.330-332.247
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   OSAKA A, 1991, J MATER SCI-MATER M, V2, P51, DOI 10.1007/BF00701687
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Pramanik S, 2007, CERAM INT, V33, P419, DOI 10.1016/j.ceramint.2005.10.025
   Rao RR, 2002, MAT SCI ENG C-BIO S, V20, P187
   Sasikumar S, 2008, CERAM INT, V34, P1373, DOI 10.1016/j.ceramint.2007.03.009
   Sasikumar S, 2010, J MATER SCI TECHNOL, V26, P1114, DOI 10.1016/S1005-0302(11)60010-8
   Tas AC, 2000, J EUR CERAM SOC, V20, P2389, DOI 10.1016/S0955-2219(00)00129-1
   Wang PP, 2010, POWDER TECHNOL, V203, P315, DOI 10.1016/j.powtec.2010.05.023
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Weng WJ, 2002, MATER CHEM PHYS, V74, P92, DOI 10.1016/S0254-0584(01)00399-6
   Yang C, 2008, J COLLOID INTERF SCI, V328, P203, DOI 10.1016/j.jcis.2008.09.010
   Yang JH, 2011, J BIOMED MATER RES B, V99B, P150, DOI 10.1002/jbm.b.31882
   Yoshimura M, 2008, J MATER SCI, V43, P2085, DOI 10.1007/s10853-007-1853-x
   Zhang HF, 2005, SOFT MATTER, V1, P107, DOI 10.1039/b502551f
   Zhang SY, 2007, AUST J CHEM, V60, P99, DOI 10.1071/CH06117
   Zhao Y, 2007, J BIOMED MATER RES B, V83B, P121, DOI 10.1002/jbm.b.30774
NR 42
TC 3
Z9 3
U1 1
U2 32
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2015
VL 4
IS 1
BP 37
EP 47
DI 10.1680/bbn.14.00010
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD1XI
UT WOS:000350867400005
DA 2018-10-20
ER

PT J
AU Naseri, S
   Hum, J
   Lepry, WC
   Miri, AK
   Nazhat, SN
   Boccaccini, AR
AF Naseri, Shiva
   Hum, Jasmin
   Lepry, William Cole
   Miri, Amir Kamal
   Nazhat, Showan Najdat
   Boccaccini, Aldo Roberto
TI Fabrication and characterization of zein-bioactive glass scaffolds
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE bioactive glass; bioactivity; composite materials; scaffolds; zein
ID X-RAY-DIFFRACTION; MECHANICAL-PROPERTIES; COMPOSITE SCAFFOLDS;
   DELIVERY-SYSTEM; FILMS; BIOCOMPATIBILITY; BIOGLASS; PROTEIN;
   MINERALIZATION; MICROSPHERES
AB Plant proteins show advantages over animal-based proteins for biomaterial applications attributable to their ease of availability and suitable biodegradability. In this study, composite foams based on zein and 45S5 bioactive glass (BG) particles were produced through salt leaching for potential applications in bone tissue engineering (BTE) applications. Different characterization techniques were used including scanning electron microscopy for morphological and microstructural analysis, ATR-FTIR spectroscopy and X-ray diffraction for composition characterization and mechanical tests. Zein-BG composite scaffolds demonstrate enhanced bioactivity with a compressive modulus and strength around 5.7 MPa and 1.9 MPa, respectively. Zein-BG composite scaffolds constitute a new bioactive material with potential applications in BTE.
C1 [Naseri, Shiva; Hum, Jasmin; Boccaccini, Aldo Roberto] Univ Erlangen Nurnberg, Inst Biomat, Erlangen, Germany.
   [Lepry, William Cole; Miri, Amir Kamal; Nazhat, Showan Najdat] McGill Univ, Dept Min & Mat Engn, Montreal, PQ, Canada.
RP Boccaccini, AR (reprint author), Univ Erlangen Nurnberg, Inst Biomat, Erlangen, Germany.
EM aldo.boccaccini@ww.uni-erlangen.de
RI Lepry, William/F-7824-2017; Boccaccini, Aldo/C-7905-2013
OI Lepry, William/0000-0002-3980-209X; 
CR Bai J, 2003, POSTHARVEST BIOL TEC, V28, P259, DOI 10.1016/S0925-5214(02)00182-5
   Birch RG, 1997, ANNU REV PLANT PHYS, V48, P297, DOI 10.1146/annurev.arplant.48.1.297
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Forato LA, 2003, BIOPOLYMERS, V72, P421, DOI 10.1002/bip.10481
   Gao ZB, 2007, INT J PHARM, V328, P57, DOI 10.1016/j.ijpharm.2006.07.048
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lai HM, 1997, CEREAL CHEM, V74, P771, DOI 10.1094/CCHEM.1997.74.6.771
   Lai HM, 1999, J APPL POLYM SCI, V71, P1267, DOI 10.1002/(SICI)1097-4628(19990222)71:8<1267::AID-APP7>3.0.CO;2-O
   LARKINS BA, 1984, TRENDS BIOCHEM SCI, V9, P306, DOI 10.1016/0968-0004(84)90297-4
   Li YL, 2012, POLYM COMPOSITE, V33, P961, DOI 10.1002/pc.22202
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   Marelli B, 2010, BIOMACROMOLECULES, V11, P1470, DOI 10.1021/bm1001087
   Mecitoglu C, 2006, FOOD RES INT, V39, P12, DOI 10.1016/j.foodres.2005.05.007
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   Qu ZH, 2008, ACTA BIOMATER, V4, P1360, DOI 10.1016/j.actbio.2008.03.006
   Reddy N, 2011, TRENDS BIOTECHNOL, V29, P490, DOI 10.1016/j.tibtech.2011.05.003
   Rehman I, 1998, J BIOMED MATER RES, V41, P162, DOI 10.1002/(SICI)1097-4636(199807)41:1<162::AID-JBM19>3.0.CO;2-P
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Tu JW, 2009, BIOMATERIALS, V30, P4369, DOI 10.1016/j.biomaterials.2009.04.054
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017
   Wang YJ, 2006, MACROMOL MATER ENG, V291, P254, DOI 10.1002/mame.200500381
   Wu YR, 2010, PLANT PHYSIOL, V153, P337, DOI 10.1104/pp.110.154690
   Zhou PY, 2013, J MATER CHEM B, V1, P685, DOI 10.1039/c2tb00102k
NR 27
TC 3
Z9 3
U1 2
U2 23
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2015
VL 4
IS 1
BP 73
EP 78
DI 10.1680/bbn.14.00025
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD1XI
UT WOS:000350867400009
DA 2018-10-20
ER

PT J
AU Pokrywczynska, M
   Gubanska, I
   Drewa, G
   Drewa, T
AF Pokrywczynska, Marta
   Gubanska, Iga
   Drewa, Gerard
   Drewa, Tomasz
TI Application of Bladder Acellular Matrix in Urinary Bladder Regeneration:
   The State of the Art and Future Directions
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; SMALL-INTESTINAL
   SUBMUCOSA; UMBILICAL-CORD BLOOD; EXTRACELLULAR-MATRIX; BONE-MARROW;
   SMOOTH-MUSCLE; URETHRAL RECONSTRUCTION; BIOMECHANICAL PROPERTIES;
   BASEMENT-MEMBRANES
AB Construction of the urinary bladder de novo using tissue engineering technologies is the "holy grail" of reconstructive urology. The search for the ideal biomaterial for urinary bladder reconstruction has been ongoing for decades. One of the most promising biomaterials for this purpose seems to be bladder acellular matrix (BAM). In this review we determine the most important factors, which may affect biological and physical properties of BAM and its regeneration potential in tissue engineered urinary bladder. We also point out the directions in modification of BAM, which include incorporation of exogenous growth factors into the BAM structure. Finally, we discuss the results of the urinary bladder regeneration with cell seeded BAM.
C1 [Pokrywczynska, Marta; Drewa, Tomasz] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Med Coll Bydgoszcz, Chair Regenerat Med, PL-85092 Bydgoszcz, Poland.
   [Gubanska, Iga] Gdansk Univ Technol, Dept Polymer Technol, PL-80233 Gdansk, Poland.
   [Drewa, Gerard] Univ Bydgoszcz, PL-85059 Bydgoszcz, Poland.
   [Drewa, Tomasz] Nicolaus Copernicus Hosp, Dept Urol, PL-87100 Torun, Poland.
RP Pokrywczynska, M (reprint author), Nicolaus Copernicus Univ Torun, Ludwik Rydygier Med Coll Bydgoszcz, Chair Regenerat Med, Karlowicza 24 St, PL-85092 Bydgoszcz, Poland.
EM marta.pokrywczynska@interia.pl
RI Pokrywczynska, Marta/E-9323-2014
OI Pokrywczynska, Marta/0000-0003-3259-087X
CR Adamowicz J, 2012, TRANSPL P, V44, P1439, DOI 10.1016/j.transproceed.2012.01.128
   Adamowicz J, 2013, CENT EUR J UROL, V66, P202, DOI 10.5173/ceju.2013.02.art23
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Baka-Ostrowska M, 2011, CENT EUR J UROL, V64, P237, DOI 10.5173/ceju.2011.04.art11
   Barnes CA, 2011, BIOMATERIALS, V32, P137, DOI 10.1016/j.biomaterials.2010.09.007
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Brown AL, 2006, BIOMATERIALS, V27, P3825, DOI 10.1016/j.biomaterials.2006.02.040
   Brown AL, 2005, BIOMATERIALS, V26, P529, DOI 10.1016/j.biomaterials.2004.02.055
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Calle EA, 2014, IEEE T BIO-MED ENG, V61, P1482, DOI 10.1109/TBME.2014.2314261
   Cartwright LM, 2006, J BIOMED MATER RES A, V77A, P180, DOI 10.1002/jbm.a.30652
   Cayan S, 2002, J UROLOGY, V168, P798, DOI 10.1016/S0022-5347(05)64746-5
   Chen BS, 2011, INT J ARTIF ORGANS, V34, P1137, DOI 10.5301/ijao.5000069
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Consolo F., 2013, J TISSUE ENG REGENER
   Leite MTC, 2014, PEDIATR SURG INT, V30, P361, DOI 10.1007/s00383-014-3465-2
   Dahms SE, 1998, BRIT J UROL, V82, P411
   Davis NF, 2013, INT J ARTIF ORGANS, V36, P251, DOI 10.5301/ijao.5000194
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Drewa T, 2009, TRANSPL P, V41, P4345, DOI 10.1016/j.transproceed.2009.08.059
   Eberli D, 2007, INT J IMPOT RES, V19, P602, DOI 10.1038/sj.ijir.3901587
   Eberli D, 2011, J MATER SCI-MATER M, V22, P741, DOI 10.1007/s10856-011-4242-6
   Eberli D, 2009, METHODS, V47, P109, DOI 10.1016/j.ymeth.2008.10.014
   Farhat W, 2003, J BIOMED MATER RES A, V67A, P970, DOI 10.1002/jbm.a.10171
   Farhat W. A., 2008, BIOMEDICAL MAT, V3
   Feng C, 2010, J BIOMED MATER RES A, V94A, P317, DOI 10.1002/jbm.a.32729
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Freytes DO, 2006, J BIOMED MATER RES B, V78B, P327, DOI 10.1002/jbm.b.30491
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   Fu Q, 2008, ASIAN J ANDROL, V10, P719, DOI 10.1111/j.1745-7262.2008.00419.x
   Fu Q, 2007, BJU INT, V99, P1162, DOI 10.1111/j.1464-410X.2006.06691.x
   Gilbert TW, 2008, BIOMATERIALS, V29, P4775, DOI 10.1016/j.biomaterials.2008.08.022
   Hodde J, 2002, BIOMATERIALS, V23, P1841, DOI 10.1016/S0142-9612(01)00310-6
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Jiang WC, 2014, BIOMATERIALS, V35, P3607, DOI 10.1016/j.biomaterials.2014.01.024
   Joo KJ, 2006, ASIAN J ANDROL, V8, P543, DOI 10.1111/j.1745-7262.2006.00192.x
   Kanematsu A, 2003, J UROLOGY, V170, P1633, DOI 10.1097/01.ju.0000084021.51099.8a
   Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kikuno N, 2009, BJU INT, V103, P1424, DOI 10.1111/j.1464-410X.2008.08129.x
   Kurzrock EA, 2005, J UROLOGY, V173, P281, DOI 10.1097/01.ju.0000141585.17953.fa
   Li C, 2008, UROL INT, V81, P290, DOI 10.1159/000151406
   Li QC, 2013, AESTHET PLAST SURG, V37, P822, DOI 10.1007/s00266-013-0173-6
   Liao W, 2013, TRANSPL P, V45, P730, DOI 10.1016/j.transproceed.2012.08.023
   Loai Y, 2010, J BIOMED MATER RES A, V94A, P1205, DOI 10.1002/jbm.a.32777
   Mahara A., 2014, BIOMED RES INT, V2014
   Malinda KM, 1999, FASEB J, V13, P53
   Mareschi K, 2001, HAEMATOLOGICA, V86, P1099
   MEEZAN E, 1975, LIFE SCI, V17, P1721, DOI 10.1016/0024-3205(75)90119-8
   Merguerian PA, 2000, BJU INT, V85, P894, DOI 10.1046/j.1464-410x.2000.00513.x
   Moriya K, 2005, BJU INT, V96, P152, DOI 10.1111/j.1464-410X.2005.05586.x
   Mueller SM, 2001, J CELL BIOCHEM, V82, P583, DOI 10.1002/jcb.1174
   Nishida S, 1999, J BONE MINER METAB, V17, P171, DOI 10.1007/s007740050081
   Nuininga JE, 2010, TISSUE ENG PT A, V16, P3319, DOI 10.1089/ten.tea.2010.0053
   Ozeki M, 2001, J DRUG TARGET, V9, P461, DOI 10.3109/10611860108998780
   Palmer EM, 2003, TISSUE ENG, V9, P307, DOI 10.1089/107632703764664774
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Piechota HJ, 1999, UROL RES, V27, P206, DOI 10.1007/s002400050111
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pokrywczynska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105295
   Pokrywczynska M, 2014, EXP BIOL MED, V239, P264, DOI 10.1177/1535370213517615
   Pokrywczynska M, 2013, ARCH IMMUNOL THER EX, V61, P483, DOI 10.1007/s00005-013-0249-7
   Pokrywczynska M, 2013, POSTEP HIG MED DOSW, V67, P790
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   Ram-Liebig G, 2004, BJU INT, V94, P922, DOI 10.1111/j.1464-410X.2004.05061.x
   Robertson MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090406
   Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145
   Ross EA, 2012, ORGANOGENESIS, V8, P49, DOI 10.4161/org.20209
   RUBINSTEIN P, 1993, BLOOD, V81, P1679
   Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659
   SKRABANJA ATP, 1994, J PHARM SCI TECHNOL, V48, P311
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0
   Suzuki K, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/951512
   Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127
   Urakami S, 2007, WORLD J UROL, V25, P207, DOI 10.1007/s00345-006-0142-7
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x
   Yang SX, 2005, CHINESE MED J-PEKING, V118, P957
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Youssif M, 2005, UROLOGY, V66, P201, DOI 10.1016/j.urology.2005.01.054
   Yuan HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080959
   Zhou LH, 2013, TISSUE ENG PT A, V19, P264, DOI [10.1089/ten.tea.2011.0609, 10.1089/ten.TEA.2011.0609]
   Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 90
TC 5
Z9 5
U1 0
U2 11
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 613439
DI 10.1155/2015/613439
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CD5CL
UT WOS:000351105400001
PM 25793199
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Campanha-Rodrigues, AL
   Grazioli, G
   Oliveira, TC
   Campos-Lisboa, ACV
   Mares-Guia, TR
   Sogayar, MC
AF Campanha-Rodrigues, Ana Lucia
   Grazioli, Gisella
   Oliveira, Talita C.
   Campos-Lisboa, Ana Carolina V.
   Mares-Guia, Thiago R.
   Sogayar, Mari C.
TI Therapeutic Potential of Laminin-Biodritin Microcapsules for Type 1
   Diabetes Mellitus
SO CELL TRANSPLANTATION
LA English
DT Article
DE Laminin (LN); Alginate; Type 1 diabetes mellitus; Islet transplantation;
   Microencapsulation; Biomaterials
ID ALGINATE-BASED MICROCAPSULES; BETA-CELL FUNCTION; PANCREATIC-ISLET
   TRANSPLANTATION; MATRIX INTERACTIONS; INSULIN-SECRETION;
   EXTRACELLULAR-MATRIX; IN-VITRO; CHEMOATTRACTANT PROTEIN-1; DIFFERENTIAL
   EXPRESSION; RAT ISLETS
AB Pancreatic islet microencapsulation constitutes an attractive therapy for type 1 diabetes mellitus; however, long-term beta-cell function remains a major problem. Loss of extracellular matrix interactions during islet isolation dramatically affects beta-cell viability. We have previously shown beneficial effects of laminin (LN) in human islet cultures. Herein, we investigated whether LN could improve the outcome of transplantation after islet microencapsulation in Biodritin, an alginate-based material. To test LN-Biodritin stability, microcapsules were subjected to different types of in vitro stress. Focusing on biocompatibility, empty microcapsules were coincubated with the RAW 264.7 macrophage cell line for up to 24 h, and empty beads were implanted IP in mice and retrieved for analyses after 7 and 30 days. Upon culturing for 48 h, mRNA, protein levels, and caspase 3 activity were evaluated in islets microencapsulated with LN-Biodritin. Mice rendered diabetic by streptozotocin injection were transplanted with microencapsulated islets, followed by assessment of body weight, glycemia, and graft function (evaluated by OGTT). Graft efficiency was observed upon microencapsulated islet explantation. The results obtained showed that LN-Biodritin microcapsules were as stable and biocompatible as Biodritin. Modulation of mRNA and protein levels suggested protection against apoptosis and islet stress. Mice transplanted with LN-Biodritin microencapsulated islets presented a better outcome at 198 days postsurgery. Graft explantation led animals to hyperglycemia. In conclusion, LN-Biodritin constitutes a very promising biomaterial for islet transplantation.
C1 [Campanha-Rodrigues, Ana Lucia; Grazioli, Gisella; Oliveira, Talita C.; Campos-Lisboa, Ana Carolina V.; Mares-Guia, Thiago R.; Sogayar, Mari C.] Univ Sao Paulo, Sch Med, Cell & Mol Therapy Ctr NUCEL NETCEM, Inst Chem,Biochem Dept, BR-05508000 Sao Paulo, SP, Brazil.
   [Grazioli, Gisella; Campos-Lisboa, Ana Carolina V.; Mares-Guia, Thiago R.] Cell Protect Biotechnol Ltda, Sao Paulo, SP, Brazil.
RP Sogayar, MC (reprint author), Univ Sao Paulo, Inst Chem, Av Prof Lineu Prestes 748,Bloco 9S, BR-05508000 Sao Paulo, SP, Brazil.
EM mcsoga@iq.usp.br
FU Fundaccio de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FINEP
   (Financiadora de Estudos e Projetos); BNDES (Banco Nacional de
   Desenvolvimento EconOmico e Social); Brazilian Ministries of Science,
   Technology and Innovation (MCTI) and Health (MS-DECIT)
FX The authors acknowledge the excellent technical support of Zizi de
   Mendonca, Marluce da Cunha Mantovani, Debora Cristina da Costa, Ricardo
   Krett de Oliveira, and Sandra Regina de Souza (Chemistry Institute,
   University of Silo Paulo). This work was supported by Fundaccio de Apoio
   a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), FINEP (Financiadora de
   Estudos e Projetos), BNDES (Banco Nacional de Desenvolvimento EconOmico
   e Social), and the Brazilian Ministries of Science, Technology and
   Innovation (MCTI) and Health (MS-DECIT). This work has been published in
   abstract form in the Annals of the International Pancreas and Islet
   Transplant Association (IPITA) and of the Brazilian Society of
   Biochemistry and Molecular Biology (SBBq), in 2011. Ana Lucia
   Campanha-Rodrigues performed most of the experiments, researched data,
   and wrote the manuscript. Gisella Grazioli performed some of the
   experiments, researched data, and contributed to discussion. Talita C.
   Oliveira performed some of the experiments and researched data. Ana
   Carolina V. Campos-Lisboa researched data and contributed to discussion.
   Thiago R. dos Mares-Guia researched data and contributed to discussion.
   Mari Cleide Sogayar reviewed/edited the manuscript and contributed to
   discussion. Mari C. Sogayar is the guarantor of this work and, as such,
   had full access to all the data in the study and takes responsibility
   for the integrity of the data and the accuracy of the data analysis.
   This work was carried out in collaboration with CellProtect
   Biotechnology Ltda. The authors declare no conflict of interest.
CR Armanet M, 2009, FASEB J, V23, P4046, DOI 10.1096/fj.08-127142
   Banerjee M, 2012, MOL CELL ENDOCRINOL, V355, P78, DOI 10.1016/j.mce.2012.01.020
   Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649
   Basta G, 2011, DIABETES CARE, V34, P2406, DOI 10.2337/dc11-0731
   Basta G, 2011, CURR DIABETES REP, V11, P384, DOI 10.1007/s11892-011-0219-6
   Berney T, 2006, DIABETES METAB, V32, P503, DOI 10.1016/S1262-3636(06)72803-8
   Bertuzzi F, 2004, J CLIN ENDOCR METAB, V89, P5724, DOI 10.1210/jc.2004-0659
   Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233
   Campos-Lisboa ACV, 2008, TRANSPL P, V40, P433, DOI 10.1016/j.transproceed.2008.01.057
   Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395
   Chen MC, 2001, DIABETOLOGIA, V44, P325, DOI 10.1007/s001250051622
   Contreras JL, 2001, TRANSPLANTATION, V71, P1015, DOI 10.1097/00007890-200104270-00001
   Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057
   de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018
   De Vos P, 1999, DIABETES, V48, P1381, DOI 10.2337/diabetes.48.7.1381
   de Vos P, 2003, BIOMATERIALS, V24, P305, DOI 10.1016/S0142-9612(02)00319-8
   de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010
   deVos P, 1997, TRANSPLANT P, V29, P756, DOI 10.1016/S0041-1345(96)00456-3
   Dufrane D, 2006, BIOMATERIALS, V27, P3201, DOI 10.1016/j.biomaterials.2006.01.028
   Duvivier-Kali VF, 2001, DIABETES, V50, P1698, DOI 10.2337/diabetes.50.8.1698
   Emamaullee J, 2005, AM J TRANSPLANT, V5, P1297, DOI 10.1111/j.1600-6143.2005.00891.x
   Emamaullee JA, 2006, DIABETES, V55, P1907, DOI 10.2337/db05-1254
   Jang HJ, 2008, TRANSPL P, V40, P2581, DOI 10.1016/j.transproceed.2008.08.075
   JANSSON L, 1995, J CLIN INVEST, V96, P721, DOI 10.1172/JCI118115
   Jiang FX, 1999, DIABETES, V48, P722, DOI 10.2337/diabetes.48.4.722
   Johansson A, 2009, DIABETOLOGIA, V52, P2385, DOI 10.1007/s00125-009-1485-6
   Juste S, 2005, J BIOMED MATER RES A, V72A, P389, DOI 10.1002/jbm.a.30254
   KAKITA K, 1982, P NATL ACAD SCI-BIOL, V79, P2803, DOI 10.1073/pnas.79.9.2803
   King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L
   Klein D, 2004, BIOCHEM BIOPH RES CO, V323, P473, DOI 10.1016/j.bbrc.2004.08.116
   Kobayashi T, 2008, CELL TRANSPLANT, V17, P1243, DOI 10.3727/096368908787236602
   Labriola L, 2007, MOL CELL ENDOCRINOL, V263, P120, DOI 10.1016/j.mce.2006.09.011
   Lai Y, 2009, CLIN EXP IMMUNOL, V157, P1, DOI 10.1111/j.1365-2249.2009.03899.x
   Lee I, 2003, J IMMUNOL, V171, P6929, DOI 10.4049/jimmunol.171.12.6929
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Ling ZD, 1998, ENDOCRINOLOGY, V139, P491, DOI 10.1210/en.139.2.491
   MARGULIS BA, 1991, DIABETES, V40, P1418, DOI 10.2337/diabetes.40.11.1418
   Melzi R, 2010, CELL TRANSPLANT, V19, P1031, DOI 10.3727/096368910X514639
   Mokhtari D, 2009, BIOCHEM BIOPH RES CO, V387, P553, DOI 10.1016/j.bbrc.2009.07.051
   MORGAN CR, 1963, DIABETES, V12, P115, DOI 10.2337/diab.12.2.115
   Nanji SA, 2006, DIABETES OBES METAB, V8, P15, DOI 10.1111/j.1463-1326.2005.00476.x
   Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048
   Orive G, 2005, BIOMACROMOLECULES, V6, P927, DOI 10.1021/bm049380x
   Papas KK, 1999, BIOTECHNOL BIOENG, V66, P231, DOI 10.1002/(SICI)1097-0290(1999)66:4<231::AID-BIT4>3.3.CO;2-L
   Paraskevas S, 1999, FEBS LETT, V455, P203, DOI 10.1016/S0014-5793(99)00882-0
   Perfetti R, 1996, PANCREAS, V13, P47, DOI 10.1097/00006676-199607000-00006
   Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55
   Ris F, 2002, DIABETOLOGIA, V45, P841, DOI 10.1007/s00125-002-0840-7
   Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1016/S0039-6060(99)70183-2
   Safley Susan A, 2008, J Diabetes Sci Technol, V2, P760
   Saldeen J, 2000, ENDOCRINOLOGY, V141, P2003, DOI 10.1210/en.141.6.2003
   Saluja A, 2008, J GASTROEN HEPATOL, V23, pS42, DOI 10.1111/j.1440-1746.2007.05272.x
   Schneider S, 2005, DIABETES, V54, P687, DOI 10.2337/diabetes.54.3.687
   Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195
   Thomas F, 2001, SURGERY, V130, P333, DOI 10.1067/msy.2001.116413
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   Venter S., 2010, TISSUE ENG PART A, V16, P1503
   Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   Weber LM, 2008, MATRIX BIOL, V27, P667, DOI 10.1016/j.matbio.2008.08.001
   Weber LM, 2008, TISSUE ENG PT A, V14, P1959, DOI 10.1089/ten.tea.2007.0238
   Wilson JT, 2008, ADV DRUG DELIVER REV, V60, P124, DOI 10.1016/j.addr.2007.08.034
   Zhang N, 2006, DIABETES, V55, P2429, DOI 10.2337/db06-0173
   Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340
   Zimmermann H, 2007, BIOMATERIALS, V28, P1327, DOI 10.1016/j.biomaterials.2006.11.032
   Zimmermann U, 2000, BIOTECHNIQUES, V29, P564, DOI 10.2144/00293rv01
NR 68
TC 3
Z9 3
U1 0
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2015
VL 24
IS 2
BP 247
EP 261
DI 10.3727/096368913X675160
PG 15
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA CD7DQ
UT WOS:000351251400010
PM 24256689
OA Bronze
DA 2018-10-20
ER

PT J
AU Zhang, SZ
   Peng, Y
   Wang, B
   Chen, GM
AF Zhang, Shaozhi
   Peng, Yu
   Wang, Bo
   Chen, Guangming
TI VAPOR PRESSURES ABOVE THE VITRIFIED SUCROSE SOLUTION AT LOW TEMPERATURES
SO CRYOLETTERS
LA English
DT Article
DE freeze drying; sucrose solution; vitrification; water vapor pressure
ID AMORPHOUS PHARMACEUTICAL SOLIDS; GLASS-TRANSITION TEMPERATURE;
   AQUEOUS-SOLUTIONS; WATER ACTIVITY; CRYOPROTECTANTS; PARAMETERS;
   DEPENDENCE; ABSORPTION; MODELS; SUGARS
AB BACKGROUND: Vitrified solutions are encountered in food and biomaterial preservation. Data of the equilibrium water vapor pressure above the vitrified solution are scarce at temperatures below 0 degrees C. OBJECTIVE: The study measures the water vapor pressures above vitrified sucrose solutions. MATERIALS AND METHODS: Sucrose solutions with concentration ranging from 75% to 79% (wt) were vitrified by cooling in liquid nitrogen, and placed in a thermostat bath. Vapor pressure was measured with a high precision pressure gauge using static method. The vitrification of sucrose solution was verified with DSC. RESULTS: Experimental data were compared with two models. The empirical Zobrist model fits the experimental data well. The free volume model was improved by fitting the interaction parameter to experimental data. The average discrepancy could be reduced from 5.57% to 2.86%. CONCLUSION: The data have significant implications in the driving force of water removal in secondary drying process.
C1 [Zhang, Shaozhi; Peng, Yu; Chen, Guangming] Zhejiang Univ, Inst Refrigerat & Cryogen, Hangzhou 310003, Zhejiang, Peoples R China.
   [Wang, Bo] 117 Hosp, Hangzhou, Zhejiang, Peoples R China.
RP Chen, GM (reprint author), Zhejiang Univ, Inst Refrigerat & Cryogen, Hangzhou 310003, Zhejiang, Peoples R China.
EM gmchen@zju.edu.cn
FU archaeological artifact protection technology project of Zhejiang
   Province; National Natural Science Foundation of China [51106074];
   Medical Science and Technology Program of Zhejiang Province
FX This work was supported by archaeological artifact protection technology
   project of Zhejiang Province, National Natural Science Foundation of
   China (No. 51106074) and Medical Science and Technology Program of
   Zhejiang Province.
CR Angell CA, 2002, CHEM REV, V102, P2627, DOI 10.1021/cr000689q
   Fernicola V, 2012, INT J THERMOPHYS, V33, P1363, DOI 10.1007/s10765-011-1128-2
   Frank GA, 2007, J PHYS CHEM REF DATA, V36, P1279, DOI 10.1063/1.2779330
   Fuller BJ, 2004, CRYOLETTERS, V25, P375
   GORDON M, 1952, J APPL CHEM, V2, P493
   HANCOCK BC, 1994, PHARMACEUT RES, V11, P471, DOI 10.1023/A:1018941810744
   HANCOCK BC, 1993, PHARMACEUT RES, V10, P1262, DOI 10.1023/A:1018901325842
   He X, 2006, J APPL PHYS, V100
   He Xiaoming, 2011, Open Biomed Eng J, V5, P47, DOI 10.2174/1874120701105010047
   Hyland RW, 1983, ASHRAE T, V89, P500
   Karel M, 1975, PRINCIPLES FOOD SC 2, P237
   Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1
   LABUZA TP, 1976, J FOOD SCI, V41, P910, DOI 10.1111/j.1365-2621.1976.tb00751.x
   LABUZA TP, 1980, FOOD TECHNOL-CHICAGO, V34, P36
   MAXIMOV N. A., 1929, PROTOPLASMA, V7, P259, DOI 10.1007/BF01612809
   Miyawaki O, 1997, BIOSCI BIOTECH BIOCH, V61, P466, DOI 10.1271/bbb.61.466
   Morillon V, 1999, FLUID PHASE EQUILIBR, V155, P297, DOI 10.1016/S0378-3812(99)00009-6
   Murphy DM, 2005, Q J ROY METEOR SOC, V131, P1539, DOI 10.1256/qj.04.94
   Norrish R.S, 1966, J FOOD TECHNOL, V1, P25
   Sadikoglu H, 2005, DRY TECHNOL, V23, P33, DOI 10.1081/DRT-200047915
   Shamblin SL, 1999, PHARMACEUT RES, V16, P1119, DOI 10.1023/A:1018960405504
   Sikora A, 2007, J MACROMOL SCI B, V46, P71, DOI 10.1080/00222340601036819
   SLADE L, 1995, J FOOD ENG, V24, P431, DOI 10.1016/0260-8774(95)90766-5
   SPIELES G, 1995, CHEM ENG PROCESS, V34, P351, DOI 10.1016/0255-2701(94)00503-6
   Starzak M, 2006, FOOD CHEM, V96, P346, DOI 10.1016/j.foodchem.2005.02.052
   SUTTON RL, 1992, CRYOBIOLOGY, V29, P585, DOI 10.1016/0011-2240(92)90063-8
   TAKAISHI T, 1963, T FARADAY SOC, V59, P2503, DOI 10.1039/tf9635902503
   Velezmoro CE, 2000, J CHEM ENG JPN, V33, P645, DOI 10.1252/jcej.33.645
   VRENTAS JS, 1991, MACROMOLECULES, V24, P2404, DOI 10.1021/ma00009a043
   Wright DL, 2004, REPROD BIOMED ONLINE, V9, P179, DOI 10.1016/S1472-6483(10)62127-X
   YASUMOTO I, 1980, J PHYS CHEM-US, V84, P589, DOI 10.1021/j100443a006
   Yue YZ, 2004, NATURE, V427, P717, DOI 10.1038/nature02295
   Zhang J, 2000, J PHARM SCI, V89, P1063
   Zobrist B, 2008, ATMOS CHEM PHYS, V8, P5221, DOI 10.5194/acp-8-5221-2008
NR 34
TC 0
Z9 0
U1 0
U2 4
PU CRYO LETTERS
PI LONDON
PA C/O ROYAL VETERINARY COLLEGE, ROYAL COLLEGE ST, LONDON NW1 0TU, ENGLAND
SN 0143-2044
EI 1742-0644
J9 CRYOLETTERS
JI CryoLetters
PD JAN-FEB
PY 2015
VL 36
IS 1
BP 60
EP 67
PG 8
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA CC8KN
UT WOS:000350617400009
PM 26017174
DA 2018-10-20
ER

PT J
AU Kupkova, M
   Hrubovcakova, M
   Kupka, M
   Orinakova, R
   Turonova, AM
AF Kupkova, Miriam
   Hrubovcakova, Monika
   Kupka, Martin
   Orinakova, Renyta
   Turonova, Andrea Morovska
TI Corrosion Behaviour of Powder Metallurgy Biomaterials from Phosphated
   Carbonyl-Iron Powders
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE biodegradable PM materials; phosphated iron powder; corrosion potential;
   fractal dimension; Fe-P biomaterial
ID FE-MN ALLOYS; MORPHOLOGY; STENTS
AB Phosphate coated carbonyl-iron powders were compacted and sintered to investigate the effect of 0.5 and 1.0wt.% of phosphorus supplied through a phosphate coating on the microstructure and corrosion of sintered samples. The resultant materials consisted of spheroidized iron or iron oxide particles surrounded by a solidified liquid phase composed of various ferric phosphate compounds. The addition of phosphorus to carbonyl iron i) raised the fractal dimension of time series generated by the open -circuit potential fluctuations from 1.14 to about 1.5, ii) more than tripled the corrosion rate and iii) made the steady-state corrosion potential more noble (lower phosphorus content) or less noble (higher phosphorus content) than the corrosion potential of carbonyl-iron sample.
C1 [Kupkova, Miriam; Hrubovcakova, Monika] Slovak Acad Sci, Inst Mat Res, SK-04001 Kosice, Slovakia.
   [Kupka, Martin] Slovak Acad Sci, Inst Expt Phys, SK-04001 Kosice, Slovakia.
   [Orinakova, Renyta; Turonova, Andrea Morovska] Safarik Univ, Fac Sci, Inst Chem, Dept Phys Chem, SK-04154 Kosice, Slovakia.
RP Kupkova, M (reprint author), Slovak Acad Sci, Inst Mat Res, Watsonova 47, SK-04001 Kosice, Slovakia.
EM mkupkova@imr.saske.sk
RI Morovska Turonova, Andrea/B-8754-2017
OI Morovska Turonova, Andrea/0000-0002-7775-2679; Orinakova,
   Renata/0000-0001-8103-2634
FU Slovak Research and Development Agency under contract APVV [0677-11];
   Slovak Research and Development Agency under contract VEGA [2/0168/12]
FX The authors thank for financial support of the research by the Slovak
   Research and Development Agency under contract APVV No. 0677-11 and VEGA
   grant 2/0168/12.
CR Addison P., 1997, FRACTALS CHAOS ILLUS
   [Anonymous], 2010, G10289 ASTM INT
   Brunckova H, 2010, SURF INTERFACE ANAL, V42, P13, DOI 10.1002/sia.3132
   DAWSON JL, 1996, ELECTROCHEMICAL NOIS, P3
   DeBruyn H. J., 1996, ELECTROCHEMICAL NOIS, V1277, P214
   Hermawan H., 2009, ACTA MAT, V6, P1693
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Hermawan H, 2010, J BIOMED MATER RES A, V93A, P1, DOI 10.1002/jbm.a.32224
   HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4
   Kabatova M, 2013, SURF INTERFACE ANAL, V45, P1166, DOI 10.1002/sia.5244
   Landolf D., 2007, CORROSION SURFACE CH
   McCafferty E., 2010, INTRO CORROSION SCI
   Quadbeck P., 2010, P POWD MET WORLD C E, V2, P239
   Simard P, 2000, MECH SYST SIGNAL PR, V14, P459, DOI 10.1006/mssp.1999.1245
   Turcotte D.L., 1997, FRACTALS CHAOS GEOLO
   Wegener B, 2011, MATER SCI ENG B-ADV, V176, P1789, DOI 10.1016/j.mseb.2011.04.017
   Yun YH, 2009, MATER TODAY, V12, P22, DOI 10.1016/S1369-7021(09)70273-1
NR 17
TC 2
Z9 2
U1 0
U2 10
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD JAN
PY 2015
VL 10
IS 1
BP 671
EP 681
PG 11
WC Electrochemistry
SC Electrochemistry
GA CD4UM
UT WOS:000351080000037
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Wu, S
   Chen, QR
   Zhou, XH
   Wei, ZL
AF Zhang, Ya
   Wu, Sen
   Chen, Qiurong
   Zhou, Xuehua
   Wei, Zhongling
TI The Research on Corrosion Properties of Some Magnesium Alloys for
   Biomaterials
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE degradable planting alloy; magnesium alloys; corrosion properties;
   mechanical properties
ID IN-VIVO CORROSION; BONE IMPLANT APPLICATION; PURE MAGNESIUM;
   BIO-CORROSION; VITRO; SCAFFOLDS; DEGRADATION; BEHAVIOR; SURFACE; FLUID
AB Metals which consist of elements existing in the human body are promising candidates for planting materials. Many magnesium alloys are developed as degradable implanting alloys with improved mechanical properties and enhanced corrosion properties. In this paper, the corrosion properties of these tested alloys are studied for biomaterial through the immersion test and electrochemical potentiodynamic polarization test. The microstructure before and after immersion tests was observed by optical Microscopy and fieldemission scanning electron Microscope. The mechanical properties of these alloys were studied by Universal Testing Machine. The influence of different elements in magnesium alloys on the corrosion properties was analyzed in this paper.
C1 [Zhang, Ya; Wu, Sen; Chen, Qiurong; Zhou, Xuehua; Wei, Zhongling] Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, Shanghai 200050, Peoples R China.
   [Zhang, Ya; Chen, Qiurong; Zhou, Xuehua] Chinese Acad Sci, Jiaxing Light Alloy Engn Technol Ctr, Jiaxing 314022, Peoples R China.
RP Zhang, Y (reprint author), Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, 865 Changning Rd, Shanghai 200050, Peoples R China.
EM yzhang@mail.sim.ac.cn
FU Shanghai Scientific Research Projects [11DJ1400302]
FX At the point of finishing this paper, I'd like to express my sincere
   thanks to all those who have lent me hands in the course of my writing
   this paper. This paper is funded by Shanghai Scientific Research
   Projects (11DJ1400302).
CR Henderson SE, 2014, ACTA BIOMATER, V10, P2323, DOI 10.1016/j.actbio.2013.12.040
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   MEL, 2005, MAGN EL DAT 467 EL W
   Muller W. D., 2007, J MATER RES, V10, P5
   Ren YB, 2005, ACTA METALL SIN, V41, P1228
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Rousselle AV, 2002, HISTOL HISTOPATHOL, V17, P1025, DOI 10.14670/HH-17.1025
   Shi ZM, 2011, CORROS SCI, V53, P226, DOI 10.1016/j.corsci.2010.09.016
   Shingde M, 2005, MED J AUSTRALIA, V183, P145
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Von der Hoeh N, 2006, DEUT TIERARZTL WOCH, V113, P439
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Wang H., 2010, CORROS SCI, V52, P255
   Wang QD, 2001, J MATER SCI, V36, P3035
   Winston R., 2008, CORROSION CORROSION, P43
   Wintermantel E, 2002, MEDIZINTECHNIK BIOKO
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2006, MATERIALWISS WERKST, V37, P504, DOI 10.1002/mawe.200600027
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Zhang GD, 2007, ACTA METALL SIN, V43, P1186
NR 31
TC 2
Z9 2
U1 3
U2 22
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD JAN
PY 2015
VL 10
IS 1
BP 1015
EP 1026
PG 12
WC Electrochemistry
SC Electrochemistry
GA CD4UM
UT WOS:000351080000067
DA 2018-10-20
ER

PT J
AU Gagnon, J
   Clift, MJD
   Vanhecke, D
   Kuhn, DA
   Weber, P
   Petri-Fink, A
   Rothen-Rutishauser, B
   Fromm, KM
AF Gagnon, J.
   Clift, M. J. D.
   Vanhecke, D.
   Kuhn, D. A.
   Weber, P.
   Petri-Fink, A.
   Rothen-Rutishauser, B.
   Fromm, K. M.
TI Integrating silver compounds and nanoparticles into ceria nanocontainers
   for antimicrobial applications
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID OXIDE NANOPARTICLES; AQUEOUS SUSPENSIONS; IMPLANT; ENCAPSULATION;
   INFECTIONS; COATINGS; AGAR; SUSCEPTIBILITY; CYTOTOXICITY; NANOCERIA
AB Silver compounds and nanoparticles (NPs) are gaining increasing interest in medical applications, specifically in the treatment and prevention of biomaterial-related infections. However, the silver release from these materials, resulting in a limited antimicrobial activity, is often difficult to control. In this paper, ceria nanocontainers were synthesized by a template-assisted method and were then used to encapsulate silver nitrate (AgNO3/CeO2 nanocontainers). Over the first 30 days, a significant level of silver was released, as determined using inductively coupled plasma optical emission spectroscopy (ICP-OES). A novel type of ceria container containing silver NPs (AgNP/CeO2 containers) was also developed using two different template removal methods. The presence of AgNPs was confirmed both on the surface and in the interior of the ceria containers by X-ray diffraction (XRD), transmission electron microscopy (TEM) and scanning electron microscopy (SEM). Upon removal of the template by calcination, the silver was released over a period exceeding three months (>90 days). However, when the template was removed by dissolution, the silver release was shortened to <= 14 days. The antimicrobial activity of the silver-containing CeO2 containers was observed and the minimum bactericidal concentration (MBC) was determined using the broth dilution method. Investigation on human cells, using a model epithelial barrier cell type (A549 cells), highlighted that all three samples induced a heightened cytotoxicity leading to cell death when exposed to all containers in their raw form. This was attributed to the surface roughness of the CeO2 nanocontainers and the kinetics of the silver release from the AgNO3/CeO2 and AgNP/CeO2 nanocontainers. In conclusion, despite the need for further emphasis on their biocompatibility, the concept of the AgNP/CeO2 nanocontainers offers a potentially alternative long-term antibactericidal strategy for implant materials.
C1 [Gagnon, J.; Weber, P.; Fromm, K. M.] Univ Fribourg, Dept Chem, CH-1700 Fribourg, Switzerland.
   [Gagnon, J.; Weber, P.; Fromm, K. M.] Univ Fribourg, Fribourg Ctr Nanomat, CH-1700 Fribourg, Switzerland.
   [Clift, M. J. D.; Vanhecke, D.; Kuhn, D. A.; Petri-Fink, A.; Rothen-Rutishauser, B.] Univ Fribourg, Adolphe Merkle Inst, CH-1723 Marly, Switzerland.
   [Clift, M. J. D.; Vanhecke, D.; Kuhn, D. A.; Petri-Fink, A.; Rothen-Rutishauser, B.] Univ Fribourg, Fribourg Ctr Nanomat, CH-1723 Marly, Switzerland.
RP Fromm, KM (reprint author), Univ Fribourg, Dept Chem, Chemin Musee 9, CH-1700 Fribourg, Switzerland.
EM Jacinthe.Gagnon@iaf.inrs.ca; Katharina.Fromm@unifr.ch
OI Fink, Alke/0000-0003-3952-7849; CLIFT, MARTIN/0000-0001-6133-3368;
   Merkle Institute, Adolphe/0000-0002-6220-424X; Rothen-Rutishauser,
   Barbara/0000-0002-7805-9366
FU Swiss National Science Foundation; University of Fribourg; Adolphe
   Merkle Foundation; FriMat; NCCR "Bioinspired Materials"
FX We are grateful to the Swiss National Science Foundation, the University
   of Fribourg, the Adolphe Merkle Foundation, FriMat and the NCCR
   "Bioinspired Materials" for generously supporting this project. We also
   thank Dr N. H. Kwon and Dr P. S. Brunetto for the SEM images and Y.
   Umehara for her help with the eukaryotic cell culture.
CR Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]
   Bonev B, 2008, J ANTIMICROB CHEMOTH, V61, P1295, DOI 10.1093/jac/dkn090
   Brunetto PS, 2008, CHIMIA, V62, P249, DOI 10.2533/chimia.2008.249
   Cassee FR, 2011, CRIT REV TOXICOL, V41, P213, DOI 10.3109/10408444.2010.529105
   Chaudhary YS, 2010, J MATER CHEM, V20, P2381, DOI 10.1039/b922914k
   Chen FJ, 2011, APPL SURF SCI, V257, P9226, DOI 10.1016/j.apsusc.2011.06.009
   Cheng XL, 2013, RSC ADV, V3, P2296, DOI 10.1039/c2ra23131j
   COOPER KE, 1955, NATURE, V176, P510, DOI 10.1038/176510b0
   Damm C, 2007, J MATER SCI, V42, P6067, DOI 10.1007/s10853-006-1158-5
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Eckhardt S, 2013, CHEM REV, V113, P4708, DOI 10.1021/cr300288v
   Emmerson M, 1998, NEW HORIZ-SCI PRACT, V6, pS3
   Evanoff DD, 2004, J PHYS CHEM B, V108, P13948, DOI 10.1021/jp047565s
   GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865
   Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hackenberg S, 2011, TOXICOL LETT, V201, P27, DOI 10.1016/j.toxlet.2010.12.001
   Hardas SS, 2010, TOXICOL SCI, V116, P562, DOI 10.1093/toxsci/kfq137
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Kalimuthu K, 2008, COLLOID SURFACE B, V65, P150, DOI 10.1016/j.colsurfb.2008.02.018
   Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8
   Kartsonakis I, 2008, J SOL-GEL SCI TECHN, V48, P24, DOI 10.1007/s10971-008-1810-4
   Kartsonakis IA, 2008, J AM CERAM SOC, V91, P372, DOI 10.1111/j.1551-2916.2007.02088.x
   Kassaee MZ, 2008, J APPL POLYM SCI, V110, P1699, DOI 10.1002/app.28762
   Kumbhar AS, 2009, CHEM MATER, V21, P2835, DOI 10.1021/cm900436n
   Lehmann A, 2010, ARTECH HSE METH BIOE, P239
   Madadlou A, 2010, BBA-GEN SUBJECTS, V1800, P459, DOI 10.1016/j.bbagen.2010.01.004
   McFarland J, 1907, J AMER MED ASSOC, V49, P1176
   Mittal S., 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/891934
   Montali Andrea, 2006, Injury, V37 Suppl 2, pS81, DOI 10.1016/j.injury.2006.04.013
   Mukherjee S, 2014, THERANOSTICS, V4, P316, DOI 10.7150/thno.7819
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Pei AH, 2007, MATER LETT, V61, P2757, DOI 10.1016/j.matlet.2006.04.123
   Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069
   Rothen-Rutishauser BM, 2005, AM J RESP CELL MOL, V32, P281, DOI 10.1165/rcmb.2004-0187OC
   Santillan MJ, 2010, SURF COAT TECH, V205, P2562, DOI 10.1016/j.surfcoat.2010.10.001
   Schubert D, 2006, BIOCHEM BIOPH RES CO, V342, P86, DOI 10.1016/j.bbrc.2006.01.129
   Slenters TV, 2008, J MATER CHEM, V18, P5359, DOI 10.1039/b813026d
   Urabe Y, 2007, CHEMBIOCHEM, V8, P668, DOI 10.1002/cbic.200600486
   Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521
   Wong LL, 2014, ADV EXP MED BIOL, V801, P821, DOI 10.1007/978-1-4614-3209-8_103
   Wu J, 2009, BIOMACROMOLECULES, V10, P2686, DOI 10.1021/bm900620w
   Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   Zampino D, 2011, J MATER SCI, V46, P6734, DOI 10.1007/s10853-011-5629-y
NR 47
TC 14
Z9 14
U1 1
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 9
BP 1760
EP 1768
DI 10.1039/c4tb02079k
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CC4SM
UT WOS:000350343700003
OA Bronze
DA 2018-10-20
ER

PT S
AU Arciola, CR
   Campoccia, D
   Ehrlich, GD
   Montanaro, L
AF Arciola, Carla Renata
   Campoccia, Davide
   Ehrlich, Garth D.
   Montanaro, Lucio
BE Donelli, G
TI Biofilm-Based Implant Infections in Orthopaedics
SO BIOFILM-BASED HEALTHCARE-ASSOCIATED INFECTIONS, VOL I
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
ID PROSTHETIC JOINT INFECTION; FIBRONECTIN-BINDING PROTEINS; TOTAL
   HIP-ARTHROPLASTY; HIGH-WATER-CONTENT; STAPHYLOCOCCUS-AUREUS; IN-VITRO;
   DNA RELEASE; ANTIMICROBIAL PEPTIDES; INTERCELLULAR-ADHESION;
   ENTEROCOCCUS-FAECALIS
AB The demand for joint replacement surgery is continuously increasing with rising costs for hospitals and healthcare systems. Staphylococci are the most prevalent etiological agents of orthopedic infections. After an initial adhesin-mediated implant colonization, Staphylococcus aureus and Staphylococcus epidermidis produce biofilm. Biofilm formation proceeds as a four-step process: (1) initial attachment of bacterial cells; (2) cell aggregation and accumulation in multiple cell layers; (3) biofilm maturation and (4) detachment of cells from the biofilm into a planktonic state to initiate a new cycle of biofilm formation elsewhere. The encasing of bacteria in biofilms gives rise to insuperable difficulties not only in the treatment of the infection, but also in assessing the state and the nature of the infection using traditional cultural methods. Therefore, DNA-based molecular methods have been developed to provide rapid identification of all microbial pathogens. To combat biofilm-centered implant infections, new strategies are being developed, among which anti-infective or infective-resistant materials are at the forefront. Infection-resistant materials can be based on different approaches: (i) modifying the biomaterial surface to give anti-adhesive properties, (ii) doping the material with antimicrobial substances, (iii) combining anti-adhesive and antimicrobial effects in the same coating, (iv) designing materials able to oppose biofilm formation and support bone repair.
C1 [Arciola, Carla Renata; Campoccia, Davide; Montanaro, Lucio] Rizzoli Orthopaed Inst, Res Unit Implant Infect, Bologna, Italy.
   [Arciola, Carla Renata; Montanaro, Lucio] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.
   [Ehrlich, Garth D.] Drexel Univ, Coll Med, Ctr Genom Sci, Inst Mol Med & Infect Dis, Philadelphia, PA 19104 USA.
   [Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.
   [Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Otolaryngol, Philadelphia, PA 19104 USA.
RP Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Res Unit Implant Infect, Bologna, Italy.
EM carlarenata.arciola@ior.it; lucio.montanaro@unibo.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219; Ehrlich,
   Garth/0000-0003-1140-6594
CR Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x
   Arciola CR, 2008, BIOMATERIALS, V29, P580, DOI 10.1016/j.biomaterials.2007.10.008
   Arciola CR, 2012, INT J ARTIF ORGANS, V35, P713, DOI 10.5301/ijao.5000158
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arciola CR, 2011, INT J ARTIF ORGANS, V34, P727, DOI 10.5301/IJAO.2011.8784
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   ARCIOLA CR, 1995, BIOMATERIALS, V16, P685, DOI 10.1016/0142-9612(95)99695-I
   Arciola CR, 2001, J CLIN MICROBIOL, V39, P2151, DOI 10.1128/JCM.39.6.2151-2156.2001
   Arciola CR, 1998, J BIOMED MATER RES, V42, P1
   Arciola CR, 1999, BIOMATERIALS, V20, P323, DOI 10.1016/S0142-9612(98)00168-9
   ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100
   Campoccia D, 2003, BIOMATERIALS, V24, P587, DOI 10.1016/S0142-9612(02)00373-3
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Campoccia D, 2009, BIOMATERIALS, V30, P6621, DOI 10.1016/j.biomaterials.2009.08.032
   Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306
   Corvec S, 2012, INT J ARTIF ORGANS, V35, P923, DOI 10.5301/ijao.5000168
   Costerton JW, 2011, PLAST RECONSTR SURG, V127, p36S, DOI 10.1097/PRS.0b013e3182001845
   Costerton JW, 2011, FEMS IMMUNOL MED MIC, V61, P133, DOI 10.1111/j.1574-695X.2010.00766.x
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Costerton JW, 2003, J CLIN INVEST, V112, P1466
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001
   Della Valle C, 2012, INT J ARTIF ORGANS, V35, P864, DOI 10.5301/ijao.5000161
   Ehrlich GD, 2013, JAMA INTERN MED, V173, P1405, DOI 10.1001/jamainternmed.2013.7042
   Ehrlich GD, 2012, INT J ARTIF ORGANS, V35, P695, DOI 10.5301/ijao.5000169
   Ehrlich GD, 2010, FEMS IMMUNOL MED MIC, V59, P269, DOI 10.1111/j.1574-695X.2010.00704.x
   Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000175124.52590.c0
   Ehrlich GD, 2014, J APPL BIOMATER FUNC, V12, pe13
   Ehrlich GD, 2012, CULTURE NEGATIVE ORT
   Esteban J, 2014, EXPERT REV MOL DIAGN, V14, P83, DOI 10.1586/14737159.2014.861327
   Fitzgerald RH, 1995, J AM ACAD ORTHOP SUR, V3, P249
   FOSTER SJ, 1995, J BACTERIOL, V177, P5723, DOI 10.1128/jb.177.19.5723-5725.1995
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Geoghegan JA, 2010, J BACTERIOL, V192, P5663, DOI 10.1128/JB.00628-10
   Grandi S, 2011, INT J ARTIF ORGANS, V34, P920, DOI 10.5301/ijao.5000059
   GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hansen EN, 2012, INT J ARTIF ORGANS, V35, P935, DOI 10.5301/ijao.5000145
   Harris LG, 2010, INT J ARTIF ORGANS, V33, P568
   Hauck CR, 2006, CURR OPIN MICROBIOL, V9, P5, DOI 10.1016/j.mib.2005.12.002
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312
   Hirschhausen N, 2010, CELL MICROBIOL, V12, P1746, DOI 10.1111/j.1462-5822.2010.01506.x
   Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10
   Hunt LP, 2013, LANCET, V382, P1097, DOI 10.1016/S0140-6736(13)61749-3
   Jacovides CL, 2012, J BONE JOINT SURG AM, V94A, P2247, DOI 10.2106/JBJS.L.00210
   Kang SJ, 2012, ARCH PHARM RES, V35, P409, DOI 10.1007/s12272-012-0302-9
   Kapadia BH, 2014, J ARTHROPLASTY, V29, P929, DOI 10.1016/j.arth.2013.09.017
   Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017
   Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022
   Legeay G, 2006, INT J ARTIF ORGANS, V29, P453
   Leone James M, 2006, Instr Course Lect, V55, P449
   Lindeque B, 2014, ORTHOPEDICS, V37, P257, DOI 10.3928/01477447-20140401-08
   Mack D, 2004, INT J MED MICROBIOL, V294, P203, DOI 10.1016/j.ijmm.2004.06.015
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P781, DOI 10.5301/ijao.5000052
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Montanaro L, 2010, J BIOMED MATER RES A, V94A, P825, DOI 10.1002/jbm.a.32764
   Nemes S, 2014, ACTA ORTHOP
   Neoh KG, 2011, ACS APPL MATER INTER, V3, P2808, DOI 10.1021/am200646t
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   Osmon DR, 2013, CLIN INFECT DIS, V56, P1, DOI 10.1093/cid/cis966
   Parvizi J, 2014, J BONE JOINT SURG AM, V96A, P430, DOI 10.2106/JBJS.L.01793
   Parvizi J, 2011, INT J ARTIF ORGANS, V34, P847, DOI 10.5301/ijao.5000054
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PATTI JM, 1994, INFECT IMMUN, V62, P152
   Potter A, 2009, J MICROBIOL, V47, P319, DOI 10.1007/s12275-009-0008-y
   Puig-Verdie L, 2013, BONE JOINT J, V95B, P244, DOI 10.1302/0301-620X.95B2.30486
   Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0
   Rak M, 2013, FEMS MICROBIOL LETT, V343, P42, DOI 10.1111/1574-6968.12125
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Ryden C, 1997, BIOCHEM J, V327, P825, DOI 10.1042/bj3270825
   Schinsky MF, 2008, J BONE JOINT SURG AM, V90A, P1869, DOI 10.2106/JBJS.G.01255
   Sculco T P, 1993, Instr Course Lect, V42, P349
   Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x
   Sittka A, 2008, CELL HOST MICROBE, V4, P310, DOI 10.1016/j.chom.2008.09.006
   Speziale P, 2009, FUTURE MICROBIOL, V4, P1337, DOI [10.2217/fmb.09.102, 10.2217/FMB.09.102]
   Speziale P, 2008, CURR MED CHEM, V15, P3185, DOI 10.2174/092986708786848442
   Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084
   Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13
   Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08
   Thomas VC, 2009, INT J ARTIF ORGANS, V32, P537
   Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794
   Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0
   Trampuz A, 2006, J CLIN MICROBIOL, V44, P628, DOI 10.1128/JCM.44.2.628-631.2006
   Tsaras G, 2012, INFECT CONT HOSP EP, V33, P1207, DOI 10.1086/668421
   Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09
   Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033
   Wolcott R, 2011, PLAST RECONSTR SURG, V127, p28S, DOI 10.1097/PRS.0b013e3181fca244
   Zhao L, 2014, COLLOIDS SURF B BIOI
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 99
TC 33
Z9 33
U1 1
U2 49
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
BN 978-3-319-11038-7; 978-3-319-11037-0
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2015
VL 830
BP 29
EP 46
DI 10.1007/978-3-319-11038-7_2
D2 10.1007/978-3-319-11038-7
PG 18
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA BC1SD
UT WOS:000350409600003
PM 25366219
DA 2018-10-20
ER

PT J
AU Feller, L
   Jadwat, Y
   Khammissa, RAG
   Meyerov, R
   Schechter, I
   Lemmer, J
AF Feller, Liviu
   Jadwat, Yusuf
   Khammissa, Razia A. G.
   Meyerov, Robin
   Schechter, Israel
   Lemmer, Johan
TI Cellular Responses Evoked by Different Surface Characteristics of
   Intraosseous Titanium Implants
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID DENTAL IMPLANTS; UNDERLYING MECHANISMS; PLATELET INTERACTIONS;
   BIOMATERIAL SURFACES; RELATIVE INFLUENCE; IN-VITRO; PART 1; BONE;
   TOPOGRAPHY; OSSEOINTEGRATION
AB The properties of biomaterials, including their surface microstructural topography and their surface chemistry or surface energy/wettability, affect cellular responses such as cell adhesion, proliferation, and migration. The nanotopography of moderately rough implant surfaces enhances the production of biological mediators in the peri-implant microenvironment with consequent recruitment of differentiating osteogenic cells to the implant surface and stimulates osteogenic maturation. Implant surfaces with moderately rough topography and with high surface energy promote osteogenesis, increase the ratio of bone-to-implant contact, and increase the bonding strength of the bone to the implant at the interface. Certain features of implant surface chemistry are also important in enhancing peri-implant bone wound healing. It is the purpose of this paper to review some of the more important features of titanium implant surfaces which have an impact on osseointegration.
C1 [Feller, Liviu; Jadwat, Yusuf; Khammissa, Razia A. G.; Meyerov, Robin; Lemmer, Johan] Sefako Makgatho Hlth Sci Univ, Dept Periodontol & Oral Med, ZA-0204 Pretoria, South Africa.
   [Schechter, Israel] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel.
RP Feller, L (reprint author), Sefako Makgatho Hlth Sci Univ, Dept Periodontol & Oral Med, ZA-0204 Pretoria, South Africa.
EM liviu.feller@smu.ac.za
CR Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Bico J, 2002, COLLOID SURFACE A, V206, P41, DOI 10.1016/S0927-7757(02)00061-4
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   BOURDON MA, 1989, J CELL BIOL, V108, P1149, DOI 10.1083/jcb.108.3.1149
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   Bren L., 2004, P 7 WORLD BIOM C SYD, P1121
   Bucci-Sabattini V, 2010, ORAL SURG ORAL MED O, V109, P217, DOI 10.1016/j.tripleo.2009.09.007
   Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Davies John E, 2003, J Dent Educ, V67, P932
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   de Gennes P.-G., 2002, CAPILLARITY WETTING
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   Decuzzi P, 2010, BIOMATERIALS, V31, P173, DOI 10.1016/j.biomaterials.2009.09.018
   Ehrenfest DMD, 2010, TRENDS BIOTECHNOL, V28, P198, DOI 10.1016/j.tibtech.2009.12.003
   Elias CN, 2010, EXPERT REV MED DEVIC, V7, P241, DOI [10.1586/erd.09.74, 10.1586/ERD.09.74]
   Feller L, 2014, SADJ, V69, P114
   Feller L, 2014, IMPLANT DENT, V23, P745, DOI 10.1097/ID.0000000000000140
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Ivanovski S, 2011, CLIN ORAL IMPLAN RES, V22, P373, DOI 10.1111/j.1600-0501.2010.02112.x
   Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Lang NP, 2009, CLIN ORAL IMPLAN RES, V20, P228, DOI 10.1111/j.1600-0501.2009.01771.x
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Marmur A., 1992, MODERN APPROACHES WE
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   Nanci A, 2008, 10 CATES ORAL HISTOL, P57
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Park JY, 2000, CLIN ORAL IMPLAN RES, V11, P530, DOI 10.1034/j.1600-0501.2000.011006530.x
   Ponche A, 2010, P I MECH ENG H, V224, P1471, DOI 10.1243/09544119JEIM900
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Qu Z, 2007, J BIOMED MATER RES A, V82A, P658, DOI 10.1002/bjm.a.31023
   Raines AL, 2010, BIOMATERIALS, V31, P4909, DOI 10.1016/j.biomaterials.2010.02.071
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Schrader M. E. L., 1992, MODERN APPROACHES WE
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Schwarz F, 2007, CLIN ORAL IMPLAN RES, V18, P481, DOI 10.1111/j.1600-0501.2007.01341.x
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   Tambasco De Oliveira P., 2004, BIOMATERIALS, V25, P403
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wall I, 2009, BONE, V45, P17, DOI 10.1016/j.bone.2009.03.662
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Woodruff D. P., 2002, SURFACE ALLOYS ALLOY, V10
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
NR 53
TC 18
Z9 20
U1 0
U2 10
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 171945
DI 10.1155/2015/171945
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CC3GG
UT WOS:000350234000001
PM 25767803
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wettstein, P
   Priest, C
   Al-Bataineh, SA
   Short, RD
   Bryant, PM
   Bradley, JW
   Low, SP
   Parkinson, L
   Szili, EJ
AF Wettstein, Pascal
   Priest, Craig
   Al-Bataineh, Sameer A.
   Short, Robert D.
   Bryant, Paul M.
   Bradley, James W.
   Low, Suet P.
   Parkinson, Luke
   Szili, Endre J.
TI Surface protein gradients generated in sealed microchannels using
   spatially varying helium microplasma
SO BIOMICROFLUIDICS
LA English
DT Article
ID MICROFLUIDIC SYSTEMS; MORPHOGEN GRADIENT; CHEMICAL GRADIENTS; DENSITY
   GRADIENTS; DESIGN; TECHNOLOGY; DEPOSITION; PRESSURE; ADHESION; DEVICES
AB Spatially varied surface treatment of a fluorescently labeled Bovine Serum Albumin (BSA) protein, on the walls of a closed (sealed) microchannel is achieved via a well-defined gradient in plasma intensity. The microchips comprised a microchannel positioned in-between two microelectrodes (embedded in the chip) with a variable electrode separation along the length of the channel. The channel and electrodes were 50 mu m and 100 mu m wide, respectively, 50 mu m deep, and adjacent to the channel for a length of 18 mm. The electrode separation distance was varied linearly from 50 mu m at one end of the channel to a maximum distance of 150, 300, 500, or 1000 mu m to generate a gradient in helium plasma intensity. Plasma ignition was achieved at a helium flow rate of 2.5 ml/min, 8.5 kV(pk-pk), and 10 kHz. It is shown that the plasma intensity decreases with increasing electrode separation and is directly related to the residual amount of BSA left after the treatment. The plasma intensity and surface protein gradient, for the different electrode gradients studied, collapse onto master curves when plotted against electrode separation. This precise spatial control is expected to enable the surface protein gradient to be tuned for a range of applications, including high-throughput screening and cell-biomolecule-biomaterial interactions. (c) 2015 AIP Publishing LLC.
C1 [Wettstein, Pascal; Al-Bataineh, Sameer A.; Short, Robert D.; Low, Suet P.; Szili, Endre J.] Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
   [Priest, Craig; Parkinson, Luke] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
   [Bryant, Paul M.; Bradley, James W.] Univ Liverpool, Dept Elect Engn & Elect, Liverpool L69 3GJ, Merseyside, England.
RP Wettstein, P (reprint author), Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
EM endre.szili@unisa.edu.au
RI Priest, Craig/F-4212-2013; Al-Bataineh, Sameer/D-4604-2009; Bradley,
   James/M-7577-2018
OI Priest, Craig/0000-0002-8861-2161; Al-Bataineh,
   Sameer/0000-0003-1711-8032; Bradley, James/0000-0002-8833-0180
FU ANFF-SA start-up award
FX The microfluidic devices were fabricated at the South Australian node of
   the Australian National Fabrication Facility (ANFF-SA). We would like to
   thank the ANFF-SA staff for the use of state-of-the-art facilities and
   their technical assistance. Part of this work was supported by the
   ANFF-SA start-up award. We thank Doug Veale (Cantech) for the design and
   construction of the power supply and the microchip holder.
CR Al-Bataineh SA, 2011, PLASMA PROCESS POLYM, V8, P695, DOI 10.1002/ppap.201000176
   Beebe DJ, 2000, P NATL ACAD SCI USA, V97, P13488, DOI 10.1073/pnas.250273097
   Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523
   Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061
   deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062
   Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Eccles SA, 2005, CURR OPIN GENET DEV, V15, P77, DOI 10.1016/j.gde.2004.12.001
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   Evju JK, 2004, APPL PHYS LETT, V84, P1668, DOI 10.1063/1.1668327
   Friedrich D, 2012, CHEM ENG J, V193, P296, DOI 10.1016/j.cej.2012.04.041
   Genzer J, 2008, LANGMUIR, V24, P2294, DOI 10.1021/la7033164
   Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500
   Handique K, 2001, ANAL CHEM, V73, P1831, DOI 10.1021/ac000711f
   Jin T, 2008, CYTOKINE, V44, P1, DOI 10.1016/j.cyto.2008.06.017
   Kaji H, 2006, ANAL CHEM, V78, P5469, DOI 10.1021/ac060304p
   Kang CE, 2004, J BIOMED MATER RES A, V71A, P403, DOI 10.1002/jbm.a.30137
   Klages CP, 2007, CONTRIB PLASM PHYS, V47, P49, DOI 10.1002/ctpp.200710008
   Klages CP, 2007, PLASMA PROCESS POLYM, V4, P208, DOI 10.1002/ppap.200600116
   Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MANZ A, 1991, TRAC-TREND ANAL CHEM, V10, P144, DOI 10.1016/0165-9936(91)85116-9
   Menzies DJ, 2010, LANGMUIR, V26, P13987, DOI 10.1021/la102033d
   Michelmore A., 2012, J NANOMATER, V2012
   Morgenthaler S, 2008, SOFT MATTER, V4, P419, DOI 10.1039/b715466f
   Noor MO, 2011, ANAL CHIM ACTA, V708, P1, DOI 10.1016/j.aca.2011.10.004
   Plummer ST, 2003, LANGMUIR, V19, P7528, DOI 10.1021/la030075r
   Priest C, 2011, LAB CHIP, V11, P541, DOI 10.1039/c0lc00339e
   Qin D, 1996, ADV MATER, V8, P917, DOI 10.1002/adma.19960081110
   Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030
   Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9
   Salim M, 2007, LAB CHIP, V7, P523, DOI 10.1039/b615328c
   Salim M, 2009, ELECTROPHORESIS, V30, P1877, DOI 10.1002/elps.200800619
   Sudarsan AP, 2006, LAB CHIP, V6, P74, DOI 10.1039/b511524h
   Szili EJ, 2012, RSC ADV, V2, P12007, DOI 10.1039/c2ra21504g
   Szili EJ, 2011, PROC SPIE, V8204, DOI 10.1117/12.903293
   Thorslund S, 2007, J MICROMECH MICROENG, V17, pN16, DOI 10.1088/0960-1317/17/4/N02
   Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151
   Verma MKS, 2006, LANGMUIR, V22, P10291, DOI 10.1021/la062516n
   Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148
   Wells N, 2009, BIOMATERIALS, V30, P1066, DOI 10.1016/j.biomaterials.2008.10.027
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Xiao YH, 2012, J IMMUNOL METHODS, V384, P148, DOI 10.1016/j.jim.2012.06.009
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zhao B, 2001, SCIENCE, V291, P1023, DOI 10.1126/science.291.5506.1023
   Zhou JW, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3523055
   Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104
NR 48
TC 7
Z9 7
U1 3
U2 16
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1932-1058
J9 BIOMICROFLUIDICS
JI Biomicrofluidics
PD JAN
PY 2015
VL 9
IS 1
AR 014124
DI 10.1063/1.4913367
PG 10
WC Biochemical Research Methods; Biophysics; Nanoscience & Nanotechnology;
   Physics, Fluids & Plasmas
SC Biochemistry & Molecular Biology; Biophysics; Science & Technology -
   Other Topics; Physics
GA CC7KS
UT WOS:000350546900024
PM 25759757
OA Green Published
DA 2018-10-20
ER

PT J
AU Kumar, P
   Choonara, YE
   Modi, G
   Naidoo, D
   Pillay, V
AF Kumar, Pradeep
   Choonara, Yahya E.
   Modi, Girish
   Naidoo, Dinesh
   Pillay, Viness
TI Multifunctional Therapeutic Delivery Strategies for Effective
   Neuro-Regeneration Following Traumatic Spinal Cord Injury
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Spinal cord injury; hydrogels; scaffolds; multiple channel bridges;
   nerve conduits; fibrous architectures; neurotrophic factors; sustained
   release
ID NERVE GROWTH-FACTOR; PROMOTES FUNCTIONAL RECOVERY; SUSTAINED
   LOCAL-DELIVERY; DRUG-DELIVERY; CHONDROITINASE ABC; CONTROLLED-RELEASE;
   INTRATHECAL DELIVERY; NEUROTROPHIC FACTOR; AXONAL REGENERATION;
   BRAIN-INJURY
AB Traumatic Spinal Cord Injuries (TSCI), due to their devastating nature, present several interventional challenges (extensive inflammation, axonal tethering, scar formation, neuronal degeneration and functional loss) that need to be addressed before even a slight neuronal recovery can be achieved. Recent post-TSCI investigational approaches include a combination of "support and therapeutic" strategies capable of providing localized delivery of therapeutic molecules along with specialized architecture to allow axonal growth and conformal repair. This review provides a brief overview of multifunctional therapeutic delivery strategies for effective neuroregeneration post-TSCI with special emphasis on intrathecal hydrogel-based injectable systems, chondroitinase ABC releasing matrices, micro/nano-sized particulate strategies, 3D-scaffold architectures, biopolymeric channeled bridges for directed neuronal growth, functionalized nerve conduits, nano- and micro-fibrous scaffolds and multicomponent combinatorial paradigms for localized delivery to spinal cord. In addition; a comprehensive account of most widely employed macromolecules and the related neuro-pharmacological, -anatomical, and -functionaloutcomes conferred by the abovementioned neural tissue engineering approaches is provided. Furthermore, the performance of individual delivery systems towards the enhancement of effectiveness, efficiency, and stability of therapeutic molecules and neurotrophic factors is discussed. In conclusion, it is suggested that a multifunctional combinatorial device assimilating the biomaterial, cellular, molecular, structural and functional aspects altogether is the best way forward for effective neuroregeneration post-TSCI.
C1 [Kumar, Pradeep; Choonara, Yahya E.; Modi, Girish; Naidoo, Dinesh; Pillay, Viness] Univ Witwatersrand, Wits Adv Drug Delivery Platform Res Unit, Fac Hlth Sci, Sch Therapeut Sci,Dept Pharm & Pharmacol, ZA-2193 Johannesburg, Parktown, South Africa.
RP Pillay, V (reprint author), Univ Witwatersrand, Wits Adv Drug Delivery Platform Res Unit, Fac Hlth Sci, Sch Therapeut Sci,Dept Pharm & Pharmacol, 7 York Rd, ZA-2193 Johannesburg, Park Town, South Africa.
EM viness.pillay@wits.ac.za
RI Pillay, Viness/C-1569-2010; Choonara, Yahya/B-2955-2013; Kumar,
   Pradeep/C-9424-2013
OI Pillay, Viness/0000-0002-8119-3347; Choonara, Yahya/0000-0002-3889-1529;
   Kumar, Pradeep/0000-0002-8640-4350
FU National Research Foundation (NRF) of South Africa
FX This work was funded by the National Research Foundation (NRF) of South
   Africa.
CR Ansorena E, 2013, INT J PHARMACEUT, V455, P148, DOI 10.1016/j.ijpharm.2013.07.045
   Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004
   Baumann MD, 2009, J CONTROL RELEASE, V138, P205, DOI 10.1016/j.jconrel.2009.05.009
   Bawa P, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/022001
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   de Boer R, 2011, MICROSURG, V31, P293, DOI 10.1002/micr.20869
   De Laporte L, 2011, J BIOMED MATER RES A, V98A, P372, DOI 10.1002/jbm.a.33112
   De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   Ding YM, 2005, CURR PHARM DESIGN, V11, P1441, DOI 10.2174/1381612053507855
   Downing TL, 2012, J CONTROL RELEASE, V161, P910, DOI 10.1016/j.jconrel.2012.05.034
   Fan JA, 2011, J BIOMED MATER RES B, V97B, P271, DOI 10.1002/jbm.b.31810
   Fan JA, 2010, J NEUROTRAUM, V27, P1671, DOI 10.1089/neu.2010.1281
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hamann MCJ, 2005, EXP NEUROL, V194, P106, DOI 10.1016/j.expneurol.2005.01.030
   Hamann MCJ, 2003, EXP NEUROL, V182, P300, DOI 10.1016/S0014-4886(03)00040-2
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Huang YC, 2011, CARBOHYD POLYM, V84, P788, DOI 10.1016/j.carbpol.2010.03.034
   Hulsebosch CE, 2005, CURR PHARM DESIGN, V11, P1411, DOI 10.2174/1381612053507864
   Hyatt AJT, 2010, J CONTROL RELEASE, V147, P24, DOI 10.1016/j.jconrel.2010.06.026
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468
   Kang CE, 2010, J CONTROL RELEASE, V144, P25, DOI 10.1016/j.jconrel.2010.01.029
   Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349
   Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284
   Kern H, 2005, CURR PHARM DESIGN, V11, P1429, DOI 10.2174/1381612053507882
   Kim YT, 2009, BIOMATERIALS, V30, P2582, DOI 10.1016/j.biomaterials.2008.12.077
   Kokai LE, 2010, BIOMATERIALS, V31, P2313, DOI 10.1016/j.biomaterials.2009.11.075
   Kumar P, 2014, MED HYPOTHESES, V82, P437, DOI 10.1016/j.mehy.2014.01.019
   Kumar P, 2014, NANOMEDICINE-UK, V9, P331, DOI 10.2217/nnm.13.203
   Kumar Pradeep, 2011, Recent Pat Drug Deliv Formul, V5, P24, DOI 10.2174/187221111794109510
   Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106
   Liu T, 2012, J BIOMED MATER RES A, V100A, P236, DOI 10.1002/jbm.a.33271
   Madduri S, 2010, BIOMATERIALS, V31, P8402, DOI 10.1016/j.biomaterials.2010.07.052
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Maquet V, 2001, BIOMATERIALS, V22, P1137, DOI 10.1016/S0142-9612(00)00357-4
   Merelli A, 2013, CURR PHARM DESIGN, V19, P6791
   Nakaji-Hirabayashi T, 2009, BIOMATERIALS, V30, P4581, DOI 10.1016/j.biomaterials.2009.05.009
   Pakulska MM, 2013, J CONTROL RELEASE, V171, P11, DOI 10.1016/j.jconrel.2013.06.029
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   Perale G, 2012, J CONTROL RELEASE, V159, P271, DOI 10.1016/j.jconrel.2011.12.025
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Pillay V, 2012, RECENT ADVANCES IN NOVEL DRUG CARRIER SYSTEMS, P355, DOI 10.5772/51256
   Pritchard CD, 2011, BIOMATERIALS, V32, P587, DOI 10.1016/j.biomaterials.2010.08.106
   Rossi Filippo, 2012, J Funct Biomater, V3, P199, DOI 10.3390/jfb3010199
   Sakiyama-Elbert S, 2012, Handb Clin Neurol, V109, P575, DOI 10.1016/B978-0-444-52137-8.00036-X
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sanchez-Covarrubias L, 2014, CURR PHARM DESIGN, V20, P1422, DOI 10.2174/13816128113199990463
   Sharma HS, 2007, CURR PHARM DESIGN, V13, P1841
   Shoichet MS, 2007, PROG BRAIN RES, V161, P385, DOI 10.1016/S0079-6123(06)61027-3
   Skop NB, 2013, ACTA BIOMATER, V9, P6834, DOI 10.1016/j.actbio.2013.02.043
   Song BB, 2012, BIOMATERIALS, V33, P9105, DOI 10.1016/j.biomaterials.2012.08.060
   Stanwick JC, 2012, J CONTROL RELEASE, V160, P666, DOI 10.1016/j.jconrel.2012.03.024
   Stanwick JC, 2012, INT J PHARMACEUT, V426, P284, DOI 10.1016/j.ijpharm.2012.01.035
   Steuer I, 2013, CURR PHARM DESIGN, V19, P4423, DOI 10.2174/1381612811319240009
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138
   Tsai EC, 2005, CURR PHARM DESIGN, V11, P1211, DOI 10.2174/1381612053507404
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Vijay N, 2014, CURR PHARM DESIGN, V20, P1487, DOI 10.2174/13816128113199990462
   Walmsey AR, 2007, CURR PHARM DESIGN, V13, P2470
   Wang HJ, 2010, BIOMATERIALS, V31, P6589, DOI 10.1016/j.biomaterials.2010.04.057
   Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050
   Weaver SM, 2014, CURR PHARM DESIGN, V20, P4275
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Xia TL, 2013, BRAIN RES, V1538, P41, DOI 10.1016/j.brainres.2013.09.027
   Xiang SL, 2005, CURR PHARM DESIGN, V11, P1267, DOI 10.2174/1381612053507431
   Xie J, 2014, ACS NANO, V8, P1878
   Xie JW, 2014, ACS APPL MATER INTER, V6, P9472, DOI 10.1021/am5018557
   Xu XY, 2002, BIOMATERIALS, V23, P3765, DOI 10.1016/S0142-9612(02)00116-3
   Yang Y, 2005, J CONTROL RELEASE, V104, P433, DOI 10.1016/j.jconrel.2005.02.022
   Yao L, 2013, GENE THER, V20, P1149, DOI 10.1038/gt.2013.42
NR 80
TC 6
Z9 7
U1 7
U2 39
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 12
BP 1517
EP 1528
DI 10.2174/1381612821666150115152323
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CC3WN
UT WOS:000350281800003
PM 25594407
DA 2018-10-20
ER

PT J
AU Liu, LB
   Zhou, XW
   Xu, YF
   Zhang, WM
   Liu, CH
   Wang, XH
AF Liu, Libiao
   Zhou, Xinwei
   Xu, Yufan
   Zhang, Weiming
   Liu, Cheng-Hsien
   Wang, Xiaohong
TI Controlled Release of Growth Factors for Regenerative Medicine
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Controlled release; growth factors (GFs); regenerative medicine;
   microencapsulation techniques; stem cells
ID EMBRYONIC STEM-CELLS; PLATELET-RICH PLASMA; FACTOR DELIVERY;
   MYOCARDIAL-INFARCTION; BONE REGENERATION; TRANSFORMING
   GROWTH-FACTOR-BETA-1; THERAPEUTIC ANGIOGENESIS; CARDIAC-MUSCLE;
   IN-VITRO; TISSUE
AB How to release growth factors (GFs) scientifically to promote stem cell proliferation and differentiation is one of the most significant research focuses in the field of regenerative medicine. In a controlled release system, growth factors, extracellular matrices or biomaterial carriers, and sometimes stem cells together form a geometric entirety. Biomaterial carriers provide GFs with a support structure to be adhered, immobilized, encapsulated or/and protected. As a unity, the release rate and rhythm of GFs on cells are normally very delicate and precise. Up to now, the best strategy for clinical applications is the combination systems that encapsulate GFs in microspheres, particularly the nano- or micro-encapsulation techniques integrated GFs with biomaterial carriers. In this mini review, we summarize the current progress in GF delivery systems for regenerative medicine and provide an outlook on two main aspects: one is the classes of stem cells and GFs that have been used frequently in regenerative medicine, including their respective application conditions and functions; the other is the controlled GF release systems, in which various GFs are released orderly and continuously without diffusing simply and rapidly, including their respective opportunities and challenges.
C1 [Liu, Libiao; Zhou, Xinwei; Xu, Yufan; Zhang, Weiming; Wang, Xiaohong] Tsinghua Univ, Key Lab Adv Mat Proc Technol, Minist Educ, Beijing 100084, Peoples R China.
   [Liu, Libiao; Zhou, Xinwei; Xu, Yufan; Zhang, Weiming; Wang, Xiaohong] Tsinghua Univ, Ctr Organ Mfg, Dept Mech Engn, Beijing 100084, Peoples R China.
   [Liu, Cheng-Hsien] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu 30013, Taiwan.
   [Wang, Xiaohong] Huazhong Univ Sci & Technol, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
RP Wang, XH (reprint author), Tsinghua Univ, Key Lab Adv Mat Proc Technol, Minist Educ, Beijing 100084, Peoples R China.
EM wangxiaohong@tsinghua.edu.cn
OI Liu, Cheng-Hsien/0000-0003-1882-3892
FU Cross-Strait Tsinghua Cooperation Basic Research [2012THZ02-3]; Beijing
   Municipal Natural Science Foundation [3152015]; National Natural Science
   Foundation of China (NSFC) [81271665, 30970748]; International
   Cooperation and Exchanges NSFC; Japanese Society for the Promotion of
   Science (JSPS) [81411140040]; State Key Laboratory of Materials
   Processing and Die & Mold Technology, Huazhong University of Science and
   Technology [2012-P03]; National High Tech 863 Grant [2009AA043801]
FX The work was supported by grants from the Cross-Strait Tsinghua
   Cooperation Basic Research (No. 2012THZ02-3), Beijing Municipal Natural
   Science Foundation (No. 3152015), National Natural Science Foundation of
   China (NSFC) (No. 81271665 & 30970748), International Cooperation and
   Exchanges NSFC and Japanese Society for the Promotion of Science (JSPS)
   (No. 81411140040), State Key Laboratory of Materials Processing and Die
   & Mold Technology, Huazhong University of Science and Technology (No.
   2012-P03), and the National High Tech 863 Grant (No. 2009AA043801).
CR Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549
   Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147
   Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890
   Attanasio S, 2009, CARDIOL REV, V17, P115, DOI 10.1097/CRD.0b013e318199e9b7
   Bai J, 2006, CN SCI B, V51, P506
   Barthes J, 2014, BIOMED RES INT, V10, P905
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Bi L, 2010, BIOMATERIALS, V31, P3201, DOI 10.1016/j.biomaterials.2010.01.038
   Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099
   Bohm F, 2010, EMBO MOL MED, V2, P294, DOI 10.1002/emmm.201000085
   Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chen PF, 2012, CN J TISSUE ENG RES, V49, P422
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   Fabio RF, 2010, J CONTROLL RELEASE, V147, P30
   Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1
   Formiga FR, 2014, J CONTROL RELEASE, V173, P132, DOI 10.1016/j.jconrel.2013.10.034
   Franz WM, 2003, LANCET, V362, P675, DOI 10.1016/S0140-6736(03)14240-7
   Gaffney MM, 2007, BRIT J PHARMACOL, V152, P175, DOI 10.1038/sj.bjp.0707315
   Gallego L, 2010, TISSUE ENG PT A, V16, P1179, DOI [10.1089/ten.tea.2009.0517, 10.1089/ten.TEA.2009.0517]
   Ginty PJ, 2008, EUR J PHARM BIOPHARM, V68, P82, DOI 10.1016/j.ejpb.2007.05.023
   Golub JS, 2010, AM J PHYSIOL-HEART C, V298, P1959
   He XS, 2014, THEORY PRACTICE SURG, V19, P281
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Holland TA, 2003, J CONTROL RELEASE, V86, P1, DOI 10.1016/S0168-3659(02)00373-5
   Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150
   Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Kimura Y, 2010, TISSUE ENG PT A, V16, P1263, DOI 10.1089/ten.TEA.2009.0322
   Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361
   Lebkowski JS, 2001, CANCER J, V7, pS83
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee KY, 2000, NATURE, V408, P998
   Liao C, 2013, INCORPORRATION CHITO
   Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05
   Lu HH, 2008, J BIOMED MATER RES A, V86A, P1128, DOI 10.1002/jbm.a.31740
   Meier P, 2009, CIRCULATION, V120, P1355, DOI 10.1161/CIRCULATIONAHA.109.866269
   Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Mooney DJ, 2003, BIOTECHNOL BIOENG, V50, P9214
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Nguyen LH, 2009, TISSUE ENG PART B-RE, V15, P363
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Park YJ, 2000, J CONTROL RELEASE, V67, P385, DOI 10.1016/S0168-3659(00)00232-7
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Phillips Frank M, 2006, Spine J, V6, P500, DOI 10.1016/j.spinee.2006.01.014
   Prabhakaran MP, 2011, MAT SCI ENG C-MATER, V31, P503, DOI 10.1016/j.msec.2010.12.017
   Rich MH, 2014, J CONTROL RELEASE, V196, P363, DOI 10.1016/j.jconrel.2014.10.020
   Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726
   Richardson T. P., 2001, NAT BIOTECHNOL, V19, P2001, DOI DOI 10.1038/NBT1101-1029
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Sha H, 2008, DEV CONTROLLED RELEA
   Shah NJ, 2011, BIOMATERIALS, V32, P61
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Spiller KL, 2012, J CONTROL RELEASE, V157, P39, DOI 10.1016/j.jconrel.2011.09.057
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101
   Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052
   Tang YD, 2009, AM HEART J, V158, P941, DOI 10.1016/j.ahj.2009.06.032
   Vo TN, 2012, ADV DRUG DELIVER REV, V64, P1292, DOI 10.1016/j.addr.2012.01.016
   Wang SG, 2011, CN J REPA RECONSTRUC, V15, P280
   Wang W, 2010, BIOMATERIALS, V31, P8964, DOI 10.1016/j.biomaterials.2010.08.018
   Wang X, 2014, J STEM CELLS RES REV, V1, P5
   Wang X, 2013, ADV BIOMATERIALS SCI, P437, DOI DOI 10.5772/53114
   Wang XH, 2007, TRENDS BIOTECHNOL, V25, P505, DOI 10.1016/j.tibtech.2007.08.010
   Wang XH, 2010, TISSUE ENG PART B-RE, V16, P189, DOI [10.1089/ten.teb.2009.0576, 10.1089/ten.TEB.2009.0576]
   Wang XH, 2012, ARTIF ORGANS, V36, P951, DOI 10.1111/j.1525-1594.2012.01499.x
   Wang XH, 2011, ARTIF ORGANS, V35, pE191, DOI 10.1111/j.1525-1594.2011.01341.x
   Wang XH, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P269, DOI 10.1007/978-1-4419-5919-5_14
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wu B, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044111
   Xu MG, 2009, J BIOACT COMPAT POL, V24, P31, DOI 10.1177/0883911509102794
   Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042
   Yang H., 2011, TISSUE ENG, V17, P1
   Zhao X, 2014, J TISSUE ENG REGEN M, DOI [10.1002/term.1863, DOI 10.1002/TERM.1863]
   Zhao XR, 2013, J BIOACT COMPAT POL, V28, P191, DOI 10.1177/0883911513481892
   Zhao XR, 2014, RES CONSTRUCTION 3D
NR 78
TC 14
Z9 15
U1 4
U2 37
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 12
BP 1627
EP 1632
DI 10.2174/1381612821666150115154602
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CC3WN
UT WOS:000350281800012
PM 25594403
DA 2018-10-20
ER

PT J
AU Tovstonog, GB
   Sych, OE
   Skorokhod, VV
AF Tovstonog, G. B.
   Sych, O. E.
   Skorokhod, V. V.
TI THE STRUCTURE AND PROPERTIES OF BIOGENIC HYDROXYAPATITE CERAMICS:
   MICROWAVE AND CONVENTIONAL SINTERING
SO POWDER METALLURGY AND METAL CERAMICS
LA English
DT Article
DE hydroxyapatite; biomaterial; microwave sintering; porosity; compressive
   strength; solubility
ID MECHANICAL-PROPERTIES; BONE
AB The structure and properties of biogenic hydroxyapatite ceramics for medical applications produced by microwave and conventional sintering at 800, 900, 1000, and 1100 degrees C are studied. It is established that microwave sintering allows a 33 to 50% decrease in the minimum grain size, which can be attributed to the influence of microwaves on the material structure compared to conventional sintering. The bioceramic samples produced by microwave sintering have stable porosity (similar to 40%) and 30-59 MPa compressive strength, being close to that of native bone and 1.6 to 2 times higher than the compressive strength of samples prepared by conventional sintering. In vitro studies have shown that the solubility of bioceramics sintered in a microwave oven in saline is 1.7 to 5.5 times higher than the solubility of samples produced by conventional sintering. Thus, microwave sintering allows obtaining biogenic hydroxyapatite ceramics with improved mechanical and biological properties for filling bone defects in orthopedics and traumatology.
C1 [Tovstonog, G. B.] Natl Tech Univ Ukraine, Kiev Polytech Inst, Kiev, Ukraine.
   [Sych, O. E.; Skorokhod, V. V.] Natl Acad Sci Ukraine, Frantsevich Inst Problems Mat Sci, Kiev, Ukraine.
RP Sych, OE (reprint author), Natl Acad Sci Ukraine, Frantsevich Inst Problems Mat Sci, Kiev, Ukraine.
EM lena_sych@ukr.net
RI Sych, Olena/T-3111-2017
OI Sych, Olena/0000-0001-9902-7833
CR Dasgupta S, 2013, MAT SCI ENG C-MATER, V33, P2846, DOI 10.1016/j.msec.2013.03.004
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Fang Y., 1994, J MATER RES, V9, P147
   Gao Y, 2006, J MATER SCI-MATER M, V17, P815, DOI 10.1007/s10856-006-9840-3
   Gergely G, 2010, CERAM INT, V36, P803, DOI 10.1016/j.ceramint.2009.09.020
   GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6
   HEISE U, 1990, INT ORTHOP, V14, P329
   Ivashutenko A. S., 2010, THESIS TOMSK, P22
   Kalita SJ, 2010, MAT SCI ENG C-MATER, V30, P295, DOI 10.1016/j.msec.2009.11.007
   Libenson G. A., 2002, POWDER METALLURGY PR, V2, P320
   Nakahira A, 2005, J AM CERAM SOC, V88, P1334, DOI 10.1111/j.1551-2916.2005.00238.x
   Nazir R, 2012, CERAM INT, V38, P457, DOI 10.1016/j.ceramint.2011.07.027
   Oktar FN, 2007, CERAM INT, V33, P1309, DOI 10.1016/j.ceramint.2006.05.022
   Putlyaev V. I., 2004, SOROS OBRAZOVAT ZH, V8, P44
   Raksujarit A, 2010, MATER DESIGN, V31, P1658, DOI 10.1016/j.matdes.2009.06.050
   Seo DS, 2008, ANN BIOMED ENG, V36, P132, DOI 10.1007/s10439-007-9394-7
   Sych O., 2007, PROCESS APPL CERAM, V1, P1
   Vanetsov A. S., MICROWAVE SINTERING
   Yanga Z., 2004, MATER LETT, V58, P3686
   Zhang Y, 2009, CERAM INT, V35, P2151, DOI 10.1016/j.ceramint.2008.11.022
NR 20
TC 1
Z9 1
U1 1
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1068-1302
EI 1573-9066
J9 POWDER METALL MET C+
JI Powder Metall. Met. Ceram.
PD JAN
PY 2015
VL 53
IS 9-10
BP 566
EP 573
DI 10.1007/s11106-015-9651-5
PG 8
WC Materials Science, Ceramics; Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CC6NT
UT WOS:000350482800009
DA 2018-10-20
ER

PT J
AU Fu, N
   Xie, J
   Li, G
   Shao, XR
   Shi, SR
   Lin, SY
   Deng, SW
   Sun, K
   Lin, YF
AF Fu, Na
   Xie, Jing
   Li, Guo
   Shao, Xiaoru
   Shi, Sirong
   Lin, Shiyu
   Deng, Shuwen
   Sun, Ke
   Lin, Yunfeng
TI P34HB film promotes cell adhesion, in vitro proliferation, and in vivo
   cartilage repair
SO RSC ADVANCES
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION;
   ARTICULAR-CARTILAGE; CULTURED CHONDROCYTES; CLINICAL-APPLICATION; FUSION
   PROTEIN; DEFECTS; TISSUE; SCAFFOLDS; RABBIT
AB The management of chondral defects is a challenging topic of current interest for scientists and surgeons, which has a crucial impact on human cost. Even after several centuries after its first observation, this problem has still not found a satisfactory and definitive answer. Cartilage tissue engineering, which involves novel natural scaffolds, has emerged as a promising strategy for cartilage regeneration and repair. In this study, bio-plasticpoly-3-hydroxybutyrate-4-hydroxybutyrate (P34HB) film was first fabricated. The characteristics of P34HB film were tested using SEM and AFM. Cell morphologies on P34HB film were obtained using SEM and fluorescence microscopy after cell seeding. The tests of cell adhesion and proliferation on P34HB film were conducted using MTT and CCK-8 assays, respectively. Furthermore, full cartilage defects in rats were created and P34HB films were implanted to evaluate their healing effects within 8 weeks. It was found that P34HB film, as a biomaterial implant, possessed good in vitro properties for cell adhesion, migration, and proliferation. Importantly, in the in vivo experiment, P34HB film exhibited desirable healing outcomes. These results demonstrated that P34HB film was a good scaffold for cartilage tissue engineering for improving cell proliferation and adhesion.
C1 [Fu, Na; Xie, Jing; Li, Guo; Shao, Xiaoru; Shi, Sirong; Lin, Shiyu; Deng, Shuwen; Sun, Ke; Lin, Yunfeng] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
RP Lin, YF (reprint author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
EM yunfenglin@scu.edu.cn
RI Lin, Yunfeng/M-5438-2013; Lin, Yunfeng/H-3393-2011
OI Lin, Yunfeng/0000-0003-1224-6561; Lin, Yunfeng/0000-0003-1224-6561
FU National Natural Science Foundation of China [81470721, 31170929];
   Sichuan Science and Technology Innovation Team [2014TD0001]; State Key
   Laboratory of Oral Diseases [SKLOD201405]
FX This work was funded by the National Natural Science Foundation of China
   (81470721, 31170929), Sichuan Science and Technology Innovation Team
   (2014TD0001), and Funding of State Key Laboratory of Oral Diseases
   (SKLOD201405).
CR AMIEL D, 1985, J BONE JOINT SURG AM, V67A, P911, DOI 10.2106/00004623-198567060-00013
   Amsaveni G, 2013, ADV SCI ENG MED, V5, P1340
   BERT JM, 1993, RHEUM DIS CLIN N AM, V19, P725
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Cheng ST, 2008, BIOMATERIALS, V29, P4187, DOI 10.1016/j.biomaterials.2008.07.022
   Dong CL, 2012, BIOMATERIALS, V33, P2593, DOI 10.1016/j.biomaterials.2011.12.020
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Filardo G, 2013, KNEE SURG SPORT TR A, V21, P1717, DOI 10.1007/s00167-012-2329-3
   Fu N, 2014, CELL PROLIFERAT, V47, P465, DOI 10.1111/cpr.12122
   Gomez-Camarillo MA, 2009, CELL PROLIFERAT, V42, P207, DOI 10.1111/j.1365-2184.2008.00580.x
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Grottkau BE, 2010, INT J ORAL SCI, V2, P21, DOI 10.4248/IJOS10015
   HOIKKA VEJ, 1990, ACTA ORTHOP SCAND, V61, P36, DOI 10.3109/17453679008993062
   Huang R, 2014, J BIOMED NANOTECHNOL, V10, P1346, DOI 10.1166/jbn.2014.1802
   Jackson DW, 1996, ARTHROSCOPY, V12, P732, DOI 10.1016/S0749-8063(96)90179-6
   JOHNSON L L, 1986, Arthroscopy, V2, P54, DOI 10.1016/S0749-8063(86)80012-3
   Katsube K, 2000, ARCH ORTHOP TRAUM SU, V120, P121, DOI 10.1007/PL00021232
   Kuroda R, 2006, ARTHRITIS RHEUM, V54, P433, DOI 10.1002/art.21632
   Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118
   Levi B, 2011, STEM CELLS, V29, P576, DOI 10.1002/stem.612
   Li G, 2015, J BIOMED NANOTECHNOL, V11, P105, DOI 10.1166/jbn.2015.2053
   Li XT, 2008, BIOMATERIALS, V29, P3720, DOI 10.1016/j.biomaterials.2008.06.004
   Luo L, 2009, J BIOMAT SCI-POLYM E, V20, P1537, DOI 10.1163/092050609X12464345023041
   Luo RC, 2007, J APPL POLYM SCI, V105, P3402, DOI 10.1002/app.26369
   Ma NN, 2013, J NANOSCI NANOTECHNO, V13, P6485, DOI 10.1166/jnn.2013.7525
   MATSUSUE Y, 1993, ARTHROSCOPY, V9, P318, DOI 10.1016/S0749-8063(05)80428-1
   Minas T, 1997, ORTHOPEDICS, V20, P525
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Mkhabela VJ, 2014, J NANOSCI NANOTECHNO, V14, P535, DOI 10.1166/jnn.2014.9055
   Newman AP, 1998, AM J SPORT MED, V26, P309, DOI 10.1177/03635465980260022701
   Opitz F, 2004, CARDIOVASC RES, V63, P719, DOI 10.1016/j.cardiores.2004.05.002
   Shen J, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.2
   Shortkroff S, 1996, BIOMATERIALS, V17, P147, DOI 10.1016/0142-9612(96)85759-0
   Sodian R, 2000, ANN THORAC SURG, V70, P140, DOI 10.1016/S0003-4975(00)01255-8
   Stock UA, 2000, J THORAC CARDIOV SUR, V120, P1158, DOI 10.1067/mtc.2000.109539
   SUMEN Y, 1995, ARTHROSCOPY, V11, P185, DOI 10.1016/0749-8063(95)90065-9
   Sun J, 2007, BIOMATERIALS, V28, P3896, DOI 10.1016/j.biomaterials.2007.05.011
   Turksen K, 2004, DEV CELL, V6, P454, DOI 10.1016/S1534-5807(04)00105-4
   Vats A, 2002, CLIN OTOLARYNGOL, V27, P227, DOI 10.1046/j.1365-2273.2002.00579.x
   Wu L, 2012, TISSUE ENG PT A, V18, P1542, DOI [10.1089/ten.tea.2011.0715, 10.1089/ten.TEA.2011.0715]
   Xu JB, 2014, J NANOSCI NANOTECHNO, V14, P4007, DOI 10.1166/jnn.2014.8231
   Xu XY, 2010, BIOMATERIALS, V31, P3967, DOI 10.1016/j.biomaterials.2010.01.132
   Yang XD, 2009, J BIOMAT SCI-POLYM E, V20, P1729, DOI 10.1163/156856208X386291
   Ye K, 2013, REGEN MED, V8, P333, DOI [10.2217/RME.13.28, 10.2217/rme.13.28]
   Zhang FJ, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.12
   Zhao W, 2013, J CHEM TECHNOL BIOT, V88, P327, DOI 10.1002/jctb.3970
   Zhu Y, 2013, OSTEOARTHR CARTILAGE, V21, P1627, DOI 10.1016/j.joca.2013.07.017
NR 47
TC 7
Z9 7
U1 1
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 28
BP 21572
EP 21579
DI 10.1039/c5ra02016f
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CC3CO
UT WOS:000350222400018
DA 2018-10-20
ER

PT J
AU Dul, K
   Kolezynski, A
   Sitarz, M
   Madej, D
AF Dul, K.
   Kolezynski, A.
   Sitarz, M.
   Madej, D.
TI Vibrational spectra of a baghdadite synthetic analogue
SO VIBRATIONAL SPECTROSCOPY
LA English
DT Article
DE Baghdadite; Vibrational spectra; Ab initio; MIR spectroscopy; FIR
   spectroscopy; Raman spectroscopy; Biomaterial
ID AB-INITIO; CRYSTAL CODE; FREQUENCIES; CA3ZRSI2O9; REFINEMENT
AB Single Ca3ZrSi2O9 phase, baghdadite, was synthesized by the standard ceramic route at a high temperature. Calcium zirconosilicate, Ca3ZrSi2O9, was characterized by FT-IR and Raman spectroscopy. The ab initio calculations of IR and Raman spectra for the baghdadite crystal structure were carried out by means of the Crystal09 program. The obtained results were used in the analysis of experimental vibrational spectra of baghdadite samples. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Dul, K.; Kolezynski, A.; Sitarz, M.; Madej, D.] AGH Univ Sci & Technol, PL-30059 Krakow, Poland.
RP Dul, K (reprint author), AGH Univ Sci & Technol, Al Mickiewicza 30, PL-30059 Krakow, Poland.
EM kdul@agh.edu.pl
RI Kolezynski, Andrzej/L-8218-2016; Sitarz, Maciej/Q-7487-2016
OI Kolezynski, Andrzej/0000-0002-4682-8300; Sitarz,
   Maciej/0000-0002-8339-2710
FU PL-Grid Infrastructure
FX This research was supported in part by PL-Grid Infrastructure.
CR ALHERMEZI HM, 1986, MINERAL MAG, V50, P119, DOI 10.1180/minmag.1986.050.355.15
   Biagioni C, 2010, PERIOD MINERAL, V79, P1, DOI 10.2451/2010PM0013
   BLASSE G, 1995, J ALLOY COMPD, V217, P29, DOI 10.1016/0925-8388(94)01285-P
   Casillas R, 2008, LITHOS, V105, P25, DOI 10.1016/j.lithos.2008.02.003
   Corno M, 2006, PHYS CHEM CHEM PHYS, V8, P2464, DOI 10.1039/b602419j
   Dovesi R., 2009, CRYSTAL09 USERS MANU, V220, P571
   Galuskin E. V., 2007, MINERAL POL, V38, P15
   Handke M., 1984, CERAMIKA 48
   Jamveit B., 1997, AM MINERAL, V82, P1241
   Kordyuk R.A., 1964, DOKL CHEM TECHNOL, V154, P28
   Liebau F., 1985, STRUCTURAL CHEM SILI
   Matsubara S., 1999, B NAT SCI MUS C, V25, P65
   McCusker LB, 1999, J APPL CRYSTALLOGR, V32, P36, DOI 10.1107/S0021889898009856
   Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970
   Nadachowski F., 1993, P UNITECR C SAO PAUL, P324
   Noel Y, 2006, PHYS CHEM MINER, V33, P383, DOI 10.1007/s00269-006-0085-y
   Pascale F, 2005, J PHYS CHEM B, V109, P18522, DOI 10.1021/jp052991e
   Pascale F, 2004, J COMPUT CHEM, V25, P888, DOI 10.1002/jcc.20019
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   PLAISIER JR, 1995, J SOLID STATE CHEM, V115, P464, DOI 10.1006/jssc.1995.1160
   QURESHI MH, 1968, BRIT CERAM TRANS J, V67, P569
   Ramaswamy Y, 2008, BIOMATERIALS, V29, P4392, DOI 10.1016/j.biomaterials.2008.08.006
   Shiraga K., 2001, J MINER PETROL SCI, V96, P43
   Valenzano L, 2006, Z PHYS CHEM, V220, P893, DOI 10.1524/zpch.2006.220.7.893
   Zicovich-Wilson CM, 2004, J COMPUT CHEM, V25, P1873, DOI 10.1002/jcc.20120
NR 25
TC 2
Z9 2
U1 2
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-2031
EI 1873-3697
J9 VIB SPECTROSC
JI Vib. Spectrosc.
PD JAN
PY 2015
VL 76
BP 1
EP 5
DI 10.1016/j.vibspec.2014.11.001
PG 5
WC Chemistry, Analytical; Chemistry, Physical; Spectroscopy
SC Chemistry; Spectroscopy
GA CC2OU
UT WOS:000350185300001
DA 2018-10-20
ER

PT J
AU Rostam, HM
   Singh, S
   Vrana, NE
   Alexander, MR
   Ghaemmaghami, AM
AF Rostam, H. M.
   Singh, S.
   Vrana, N. E.
   Alexander, M. R.
   Ghaemmaghami, A. M.
TI Impact of surface chemistry and topography on the function of antigen
   presenting cells
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID DENDRITIC CELLS; MACROPHAGE ACTIVATION; IN-VITRO; INFLAMMATORY RESPONSE;
   GIANT-CELLS; FOAM CELLS; BIOMATERIALS; DIFFERENTIATION; BEHAVIOR;
   WETTABILITY
AB Antigen presenting cells (APCs) such as macrophages and dendritic cells (DCs) play a crucial role in orchestrating immune responses against foreign materials. The activation status of APCs can determine the outcome of an immune response following implantation of synthetic materials, towards either healing or inflammation. A large range of biomaterials are used in the fabrication of implantable devices and drug delivery systems. These materials will be in close contact with APCs and characteristics such as surface chemistry and topography may have a critical role in initiating pro- or anti-inflammatory immune responses. Controlling biomaterial surface attributes provides a powerful tool for modulating the phenotype and function of immune cells with the aim of reducing detrimental pro-inflammatory responses and promoting beneficial healing responses. In this article, we review recent literature on how biomaterial surface topography and chemistry can modulate APC populations towards distinct pro- or anti-inflammatory phenotypes with specific examples of how these properties can be used to control host response in vivo. Topographical and/or chemical design of biomaterial surfaces with respect to the APC responses can pave the way for a new generation of 'cell instructive' materials with immunomodulatory properties with a wide range of clinical applications.
C1 [Rostam, H. M.; Singh, S.; Ghaemmaghami, A. M.] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Immunol & Tissue Modelling Grp, Nottingham NG7 2UH, England.
   [Vrana, N. E.] Univ Strasbourg, Fac Chirurg Dentaire, Strasbourg, France.
   [Vrana, N. E.] Protip SAS, F-67000 Strasbourg, France.
   [Alexander, M. R.] Univ Nottingham, Sch Pharm, Interface & Surface Anal Ctr, Nottingham NG7 2RD, England.
RP Ghaemmaghami, AM (reprint author), Univ Nottingham, Queens Med Ctr, Sch Life Sci, Immunol & Tissue Modelling Grp, Nottingham NG7 2UH, England.
EM amg@nottingham.ac.uk
RI Alexander, Morgan/C-2506-2009
OI Alexander, Morgan/0000-0001-5182-493X; Ghaemmaghami,
   Amir/0000-0003-3160-8759; Singh, Sonali/0000-0003-0600-9084
FU European Union [602694]; Kurdistan Regional Government
FX Authors (SS, NEV and AMG) would like to acknowledge funding from the
   European Union's Seventh Framework Programme for research, technological
   development and demonstration under grant agreement no. 602694
   (IMMODGEL). HMR is recipient of a PhD scholarship from Kurdistan
   Regional Government under Human Capacity Development Program in Higher
   Education (HCDP).
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Alfarsi MA, 2014, J BIOMED MATER RES A, V102, P60, DOI 10.1002/jbm.a.34666
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Antonio B. S., 2013, BIOMATER ASS INFECT, P151
   Bain LE, 2014, ACTA BIOMATER, V10, P2455, DOI 10.1016/j.actbio.2014.02.038
   Baker M, 2011, NAT METHODS, V8, P900, DOI 10.1038/nmeth.1760
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Barth KA, 2013, J BIOMED MATER RES A, V101, P2679, DOI 10.1002/jbm.a.34562
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Bartneck M, 2010, ACTA BIOMATER, V6, P3864, DOI 10.1016/j.actbio.2010.04.025
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   BRADDING P, 1992, J EXP MED, V176, P1381, DOI 10.1084/jem.176.5.1381
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Cantini M, 2013, BIOMATER SCI-UK, V1, P202, DOI 10.1039/c2bm00063f
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Cejudo-Guillen M, 2012, ACTA BIOMATER, V8, P4295, DOI 10.1016/j.actbio.2012.07.026
   Chau DYS, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045011
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Collart-Dutilleul PY, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-564
   Collie AMB, 2011, J BIOMED MATER RES A, V96A, P162, DOI 10.1002/jbm.a.32963
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Evans MDM, 1998, J BIOMED MATER RES, V40, P621, DOI 10.1002/(SICI)1097-4636(19980615)40:4<621::AID-JBM14>3.0.CO;2-I
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515
   Ghrebi S, 2013, J BIOMED MATER RES A, V101, P2118, DOI 10.1002/jbm.a.34509
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828
   Harding FJ, 2012, ACTA BIOMATER, V8, P1739, DOI 10.1016/j.actbio.2012.01.034
   Hofstetter W, 2013, J BIOMED MATER RES A, V101, P2355, DOI 10.1002/jbm.a.34541
   Hume PS, 2012, BIOMATERIALS, V33, P3615, DOI 10.1016/j.biomaterials.2012.02.009
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Karagkiozaki V, 2012, INT J NANOMED, V7, P6063, DOI 10.2147/IJN.S34320
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Kilic C, 2014, BIOMATER SCI-UK, V2, P318, DOI 10.1039/c3bm60194c
   Kim JY, 2009, J BIOMED MATER RES A, V88A, P419, DOI 10.1002/jbm.a.31799
   Kingham E, 2013, SMALL, V9, P2140, DOI 10.1002/smll.201202340
   Komasa S, 2014, J NANOMATER, DOI 10.1155/2014/642527
   Kou P. M., 2011, THESIS GEORGIA I TEC
   Kou PM, 2012, BIOMATERIALS, V33, P1699, DOI 10.1016/j.biomaterials.2011.10.066
   Kou PM, 2011, ACTA BIOMATER, V7, P1354, DOI 10.1016/j.actbio.2010.10.020
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Kratky W, 2011, P NATL ACAD SCI USA, V108, P17414, DOI 10.1073/pnas.1108945108
   Le Saux G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021869
   Li XW, 2014, STEM CELL TRANSL MED, V3, P662, DOI 10.5966/sctm.2013-0015
   Liu K, 2010, EUR J IMMUNOL, V40, P2099, DOI 10.1002/eji.201040501
   Liu X, 2013, J TISSUE ENG REGEN M, V7, P112, DOI 10.1002/term.498
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mak KY, 2013, MICROELECTRON ENG, V111, P396, DOI 10.1016/j.mee.2013.04.009
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   Mccoy CP, 2012, BIOMATERIALS, V33, P7952, DOI 10.1016/j.biomaterials.2012.07.052
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   McNally AK, 2015, J BIOMED MATER RES A, V103, P1380, DOI 10.1002/jbm.a.35280
   McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110
   Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883
   Mitchell SA, 2004, BIOMATERIALS, V25, P4079, DOI 10.1016/j.biomaterials.2003.11.010
   Mohan G, 2015, J BIOMED MATER RES A, V103, P2066, DOI 10.1002/jbm.a.35349
   Mohiuddin M, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-394
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Myrna KE, 2012, INVEST OPHTH VIS SCI, V53, P811, DOI 10.1167/iovs.11-7982
   Ohteki T., 2007, ALLERGOL INT, V56, P214
   Owen GR, 2005, BIOMATERIALS, V26, P7447, DOI 10.1016/j.biomaterials.2005.05.055
   Park J, 2012, ACTA BIOMATER, V8, P3606, DOI 10.1016/j.actbio.2012.06.006
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Qi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059022
   Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010
   Ranella A, 2010, ACTA BIOMATER, V6, P2711, DOI 10.1016/j.actbio.2010.01.016
   Roach P, 2010, SURF SCI REP, V65, P145, DOI 10.1016/j.surfrep.2010.07.001
   Roach P, 2013, BIOMATER SCI-UK, V1, P83, DOI 10.1039/c2bm00060a
   Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5
   Saino E, 2011, BIOMACROMOLECULES, V12, P1900, DOI 10.1021/bm200248h
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   Schmid H, 2002, BIOL CHEM, V383, P1277, DOI 10.1515/BC.2002.143
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064
   Shen Y, 2012, J R SOC INTERFACE, V9, P313, DOI 10.1098/rsif.2011.0278
   Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070
   Smith RS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004120
   Solheim E, 2000, J BIOMED MATER RES, V49, P257, DOI 10.1002/(SICI)1097-4636(200002)49:2<257::AID-JBM15>3.0.CO;2-5
   STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142
   Stover Timo, 2009, GMS Curr Top Otorhinolaryngol Head Neck Surg, V8, pDoc10, DOI 10.3205/cto000062
   Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977
   Taguchi T, 2014, J ARTIF ORGANS, V17, P285, DOI 10.1007/s10047-014-0775-z
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415
   Waldeck H, 2012, BIOMATERIALS, V33, P29, DOI 10.1016/j.biomaterials.2011.09.044
   Walkey CD, 2012, J AM CHEM SOC, V134, P2139, DOI 10.1021/ja2084338
   Waterfield JD, 2010, J BIOMED MATER RES A, V95A, P837, DOI 10.1002/jbm.a.32857
   Wilke CM, 2011, INT REV IMMUNOL, V30, P120, DOI 10.3109/08830185.2011.567362
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xia ZD, 2006, J BIOMED MATER RES A, V79A, P582, DOI 10.1002/jbm.a.30853
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yang J, 2009, ADV MATER, V21, P300, DOI 10.1002/adma.200801942
   Yoshida M., 2002, 2 JOINT EMBS BMES C, V1-3, P619
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
   Zelzer M, 2011, ACTA BIOMATER, V7, P4120, DOI 10.1016/j.actbio.2011.07.021
   Zheng WF, 2013, ADV HEALTHC MATER, V2, P95, DOI 10.1002/adhm.201200104
   Zhi ZL, 2010, BIOMACROMOLECULES, V11, P610, DOI 10.1021/bm901152k
   Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138
   Zhu MT, 2012, SMALL, V8, P2841, DOI 10.1002/smll.201200381
NR 114
TC 29
Z9 29
U1 7
U2 38
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 3
BP 424
EP 441
DI 10.1039/c4bm00375f
PG 18
WC Materials Science, Biomaterials
SC Materials Science
GA CB7TV
UT WOS:000349831700001
PM 26222286
DA 2018-10-20
ER

PT J
AU Romanazzo, S
   Forte, G
   Morishima, K
   Taniguchi, A
AF Romanazzo, Sara
   Forte, Giancarlo
   Morishima, Keisuke
   Taniguchi, Akiyoshi
TI IL-12 involvement in myogenic differentiation of C2C12 in vitro
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID STEM-CELL NICHE; EXTRACELLULAR-MATRIX; T-CELLS; INTERLEUKIN-12;
   EXPRESSION; MICROENVIRONMENTS; MYOBLASTS; THERAPY; CULTURE; GROWTH
AB Recently, the extracellular microenvironment has been shown to be critical for the correct differentiation of stem cells to specific tissues. Many factors, including physical (e.g. biomaterial stiffness and topography) and biological (as growth factors, cytokines and chemokines) components, cooperate to create an ideal microenvironment for muscle stem cells, with many of these factors having been widely investigated. We previously demonstrated that the use of non-proliferating muscle-specific and unrelated cells as feeder layers for skeletal muscle progenitor cell differentiation resulted in significant differences in the ability to form myotubes, suggesting the importance of biological factors in myogenic differentiation. In this study, we investigated the biological factors involved in this process, analyzing the expression profile of 84 genes coding for cytokines and chemokines. We successfully identified a novel role for the cytokine IL-12 in the myogenic differentiation of C2C12 mouse skeletal muscle cells. Experiments involving the overexpression or silencing of the IL-12 gene in C2C12 showed that IL-12 enhanced the myogenic differentiation process. Moreover, when IL-12 was overexpressed in non-biologically related feeder cells, the new co-culture system was able to improve myogenic differentiation of C2C12 seeded on top. Although IL-12 is known to be a cytokine involved in inflammatory responses, it also appears to be involved in the myogenic differentiation process, acting as a positive regulator of this mechanism. This fact is expected to prove to be important for the development of functional biomaterials.
C1 [Romanazzo, Sara; Taniguchi, Akiyoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan.
   [Romanazzo, Sara; Taniguchi, Akiyoshi] NIMS, Int Ctr Mat Nanoarchitecton MANA, Biomat Unit, Cell Mat Interact Grp, Tsukuba, Ibaraki, Japan.
   [Romanazzo, Sara; Morishima, Keisuke] Osaka Univ, Dept Mech Engn, Grad Sch Mech Engn, Suita, Osaka, Japan.
   [Forte, Giancarlo] St Annes Univ Hosp, ICRC, Integrated Ctr Cell Therapy & Regenerat Med ICCT, Brno, Czech Republic.
   [Morishima, Keisuke] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka, Japan.
RP Romanazzo, S (reprint author), Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan.
EM Taniguchi.Akiyoshi@nims.go.jp
RI Forte, Giancarlo/M-1447-2017
OI Forte, Giancarlo/0000-0002-1341-1023
FU MEXT/JSPS KAKENHI [20034017, 21676002, 21225007, 21111503, 23111705,
   26249027, 26560210]; New Energy and Industrial Technology Development
   Organization (NEDO) of Japan; Center for Advanced Medical Engineering
   and Informatics, Osaka University; European Regional Development Fund
   Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]
FX This work was partly supported by MEXT/JSPS KAKENHI grant numbers
   20034017, 21676002, 21225007, 21111503, 23111705, 26249027, 26560210,
   the Industrial Technology Research Grant Program (2006) from the New
   Energy and Industrial Technology Development Organization (NEDO) of
   Japan, and the Center for Advanced Medical Engineering and Informatics,
   Osaka University. Giancarlo Forte was supported by the European Regional
   Development Fund Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123).
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Ariel A, 2002, J LEUKOCYTE BIOL, V72, P192
   Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007
   Bentzinger C.F., 2012, COLD SPRING HARB PER, V4
   Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006
   Borg C, 2004, BLOOD, V104, P3267, DOI 10.1182/blood-2004-01-0380
   BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223
   Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Cantini M, 2002, NEUROL SCI, V23, P189, DOI 10.1007/s100720200060
   Chang JT, 1999, J EXP MED, V189, P969, DOI 10.1084/jem.189.6.969
   Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
   Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006
   Cooper ST, 2004, CELL MOTIL CYTOSKEL, V58, P200, DOI 10.1002/cm.20010
   Damm TB, 2014, CELL PHYSIOL BIOCHEM, V33, P249, DOI 10.1159/000356667
   De Paepe B, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/540370
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fisher MB, 2013, TISSUE ENG PART B-RE, V19, P1, DOI [10.1089/ten.teb.2012.0723, 10.1089/ten.TEB.2012.0723]
   Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085
   Forte G, 2012, TISSUE ENG PT A, V18, P1837, DOI [10.1089/ten.tea.2011.0707, 10.1089/ten.TEA.2011.0707]
   Ge YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068068
   Griffin CA, 2010, J CELL SCI, V123, P3052, DOI 10.1242/jcs.066241
   Havasi P, 2013, MOL BIOL REP, V40, P3023, DOI 10.1007/s11033-012-2376-3
   Hinds S, 2011, BIOMATERIALS, V32, P3575, DOI 10.1016/j.biomaterials.2011.01.062
   Hodgetts SI, 2003, J CELL SCI, V116, P4131, DOI 10.1242/jcs.00721
   Hoene M, 2013, AM J PHYSIOL-CELL PH, V304, pC128, DOI 10.1152/ajpcell.00025.2012
   Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2
   Hosoda T, 2011, J THROMB HAEMOST, V9, P151, DOI 10.1111/j.1538-7836.2011.04363.x
   HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338
   Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101
   Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319
   Kato K, 1996, P NATL ACAD SCI USA, V93, P9085, DOI 10.1073/pnas.93.17.9085
   Kato Kazunori, 1997, Leukemia (Basingstoke), V11, P572
   Kim DH, 2012, INTEGR BIOL-UK, V4, P1019, DOI 10.1039/c2ib20067h
   Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127
   Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463
   Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012
   Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525
   Londhe P, 2011, MOL CELL BIOL, V31, P2854, DOI 10.1128/MCB.05397-11
   Meng XL, 2012, GENE, V499, P124, DOI 10.1016/j.gene.2011.12.012
   Moran JL, 2002, PHYSIOL GENOMICS, V10, P103, DOI 10.1152/physiolgenomics.00011.2002
   Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038
   MULTHAUF C, 1986, J CELL PHYSIOL, V126, P211, DOI 10.1002/jcp.1041260209
   Myers KJ, 1998, AM J PATHOL, V152, P457
   Nedachi T, 2009, AM J PHYSIOL-ENDOC M, V297, pE866, DOI 10.1152/ajpendo.00104.2009
   Odemis V, 2007, J CELL SCI, V120, P4050, DOI 10.1242/jcs.010009
   Pagliari S, 2011, ADV MATER, V23, P514, DOI 10.1002/adma.201003479
   Parker MH, 2012, SKELET MUSCLE, V2, DOI [10.1186/2044-5040-2-4, 10.1186/2044-5040-2-6]
   Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007
   Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202
   Pedersen L, 2012, ADIPOCYTE, V1, P164, DOI 10.4161/adip.20344
   Pekkanen-Mattila M., 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/875059
   Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002
   Romanazzo S, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064211
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406
   Siddiqui F, 2006, INT J HYPERTHER, V22, P587, DOI 10.1080/02656730600983063
   Sordi Valeria, 2010, Rev Diabet Stud, V7, P132, DOI 10.1900/RDS.2010.7.132
   Sunadome K, 2011, DEV CELL, V20, P192, DOI 10.1016/j.devcel.2010.12.005
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Terayama H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096120
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001
   Vitello L, 2004, BASIC APPL MYOL, V14, P45
   Votteler M, 2010, MACROMOL BIOSCI, V10, P1302, DOI 10.1002/mabi.201000102
   Warren GL, 2004, AM J PHYSIOL-CELL PH, V286, pC1031, DOI 10.1152/ajpcell.00467.2003
   Wicik Z, 2010, POL J VET SCI, V13, P629, DOI 10.2478/v10181-010-0008-1
   Wieteska-Skrzeczynska W, 2011, POL J VET SCI, V14, P425, DOI 10.2478/v10181-011-0063-2
   Yamashita Y, 2004, MOL CANCER THER, V3, P1177
   Yue FM, 2010, ANN ANAT, V192, P314, DOI 10.1016/j.aanat.2010.07.001
   Yue XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032707
   Yusuf B, 2013, DEV GROWTH DIFFER, V55, P330, DOI 10.1111/dgd.12043
NR 73
TC 5
Z9 5
U1 1
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 3
BP 469
EP 479
DI 10.1039/c4bm00315b
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA CB7TV
UT WOS:000349831700005
PM 26222290
DA 2018-10-20
ER

PT J
AU Elsner, MB
   Herold, HM
   Muller-Herrmann, S
   Bargel, H
   Scheibel, T
AF Elsner, Martina B.
   Herold, Heike M.
   Mueller-Herrmann, Susanne
   Bargel, Hendrik
   Scheibel, Thomas
TI Enhanced cellular uptake of engineered spider silk particles
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID ARGININE-RICH PEPTIDES; CONTROLLED DRUG-DELIVERY; PENETRATING PEPTIDES;
   POLYMERIC NANOPARTICLES; INTEGRIN TRAFFICKING; PLASMA-MEMBRANE; DOMAIN
   PEPTIDES; GENE-EXPRESSION; PROTEIN; FIBROIN
AB Drug delivery systems allow tissue/cell specific targeting of drugs in order to reduce total drug amounts administered to an organism and potential side effects upon systemic drug delivery. Most drug delivery systems are polymer-based, but the number of possible materials is limited since many commercially available polymers induce allergic or inflammatory responses or lack either biodegradability or the necessary stability in vivo. Spider silk proteins represent a new class of (bio) polymers that can be used as drug depots or drug delivery systems. The recombinant spider silk protein eADF4(C16), which can be processed into different morphologies such as particles, films, or hydrogels, has been shown to fulfil most criteria necessary for its use as biomaterial. Further, eADF4(C16) particles have been shown to be well-suited for drug delivery. Here, a new method was established for particle production to reduce particle size and size distribution. Importantly, cellular uptake of these particles was shown to be poor in HeLa cells. Therefore, variants of eADF4(C16) with inversed net charge or incorporated cell penetrating peptides and receptor interacting motifs were tested, showing much better cellular uptake. Interestingly, uptake of all silk variant particles was mainly achieved by clathrin-mediated endocytosis.
C1 [Elsner, Martina B.; Herold, Heike M.; Mueller-Herrmann, Susanne; Bargel, Hendrik; Scheibel, Thomas] Univ Bayreuth, Lehrstuhl Biomaterialien, D-95447 Bayreuth, Germany.
   [Scheibel, Thomas] Univ Bayreuth, BZKG, D-95447 Bayreuth, Germany.
   [Scheibel, Thomas] Univ Bayreuth, Bayreuther Zentrum Biomakromol Biomac, D-95447 Bayreuth, Germany.
   [Scheibel, Thomas] Univ Bayreuth, BZMB, D-95447 Bayreuth, Germany.
   [Scheibel, Thomas] Univ Bayreuth, Bayreuther Mat Zentrum BayMAT, D-95447 Bayreuth, Germany.
RP Elsner, MB (reprint author), Univ Bayreuth, Lehrstuhl Biomaterialien, Univ Str 30, D-95447 Bayreuth, Germany.
EM Thomas.scheibel@bm.uni-bayreuth.de
RI Scheibel, Thomas/I-1170-2014
OI Scheibel, Thomas/0000-0002-0457-2423
CR Berkland C, 2001, J CONTROL RELEASE, V73, P59, DOI 10.1016/S0168-3659(01)00289-9
   Bin Choy Y, 2008, MACROMOL BIOSCI, V8, P758, DOI 10.1002/mabi.200700316
   Blum C, 2014, ADV FUNCT MATER, V24, P763, DOI 10.1002/adfm.201302100
   Blum C, 2012, BIONANOSCIENCE, V2, P67, DOI 10.1007/s12668-012-0036-7
   Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799
   Copolovici DM, 2014, ACS NANO, V8, P1972, DOI 10.1021/nn4057269
   DAVIS RJ, 1985, J BIOL CHEM, V260, P2543
   Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005
   Doblhofer E, 2015, J PHARM SCI-US, V104, P988, DOI 10.1002/jps.24300
   Faraji AH, 2009, BIOORGAN MED CHEM, V17, P2950, DOI 10.1016/j.bmc.2009.02.043
   Firdessa R, 2014, EUR J CELL BIOL, V93, P323, DOI 10.1016/j.ejcb.2014.08.001
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200
   Galvez BG, 2004, MOL BIOL CELL, V15, P678, DOI 10.1091/mbc.E03-07-0516
   Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Gobin AS, 2006, INT J NANOMED, V1, P81, DOI 10.2147/nano.2006.1.1.81
   GREEN M, 1989, CELL, V58, P215, DOI 10.1016/0092-8674(89)90417-0
   Gros E, 2006, BBA-BIOMEMBRANES, V1758, P384, DOI 10.1016/j.bbamem.2006.02.006
   Grund S, 2011, ADV ENG MATER, V13, pB61, DOI 10.1002/adem.201080088
   Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007
   Guterstam P, 2009, BBA-BIOMEMBRANES, V1788, P2509, DOI 10.1016/j.bbamem.2009.09.014
   He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065
   Helfricht N, 2013, BIOMATER SCI-UK, V1, P1166, DOI 10.1039/c3bm60109a
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   HERRMANN J, 1995, J CONTROL RELEASE, V36, P63, DOI 10.1016/0168-3659(95)00051-9
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Humenik M, 2014, J STRUCT BIOL, V186, P431, DOI 10.1016/j.jsb.2014.03.010
   Humenik M, 2014, ACS NANO, V8, P1342, DOI 10.1021/nn404916f
   Hunter R. J, 1981, ZETA POTENTIAL COLLO
   Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2
   Jarvert P, 2007, BIOCHEM SOC T, V35, P770
   Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354
   Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309
   Kawamura KS, 2006, BIOCHEMISTRY-US, V45, P1116, DOI 10.1021/bi051338e
   Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086
   Kulkarni SA, 2013, PHARM RES-DORDR, V30, P2512, DOI 10.1007/s11095-012-0958-3
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Leal-Egana A, 2012, J MATER CHEM, V22, P14330, DOI 10.1039/c2jm31174g
   Leal-Egana A, 2012, ADV ENG MATER, V14, pB67, DOI 10.1002/adem.201180072
   Lehto T, 2012, EXPERT OPIN DRUG DEL, V9, P823, DOI 10.1517/17425247.2012.689285
   Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200
   Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729
   Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004
   Mathur AB, 2010, NANOMEDICINE-UK, V5, P807, DOI 10.2217/NNM.10.51
   Meade BR, 2008, ADV DRUG DELIVER REV, V60, P530, DOI 10.1016/j.addr.2007.10.004
   Meinel L, 2012, ADV DRUG DELIVER REV, V64, P1111, DOI 10.1016/j.addr.2012.03.016
   Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x
   Muller R.H., 1996, ZETAPOTENTIAL PARTIK
   Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010
   Nakase I, 2012, J CONTROL RELEASE, V159, P181, DOI 10.1016/j.jconrel.2012.01.016
   Nasrollahi SA, 2012, INT J DERMATOL, V51, P923, DOI 10.1111/j.1365-4632.2011.05214.x
   Neubauer MP, 2013, BIOMATER SCI-UK, V1, P1160, DOI 10.1039/c3bm60108k
   Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003
   Nitta SK, 2013, INT J MOL SCI, V14, P1629, DOI 10.3390/ijms14011629
   Numata K, 2009, BIOMATERIALS, V30, P5775, DOI 10.1016/j.biomaterials.2009.06.028
   Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001
   Schacht K, 2011, BIOMACROMOLECULES, V12, P2488, DOI 10.1021/bm200154k
   Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046
   Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203
   Seib FP, 2013, ADV HEALTHC MATER, V2, P1606, DOI 10.1002/adhm.201300034
   Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977
   Slotta U, 2006, SUPRAMOL CHEM, V18, P465, DOI 10.1080/10610270600832042
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Spiess K, 2010, SOFT MATTER, V6, P4168, DOI 10.1039/b927267d
   Subia B, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/3/035103
   Subia B, 2014, INTEGR BIOL-UK, V6, P203, DOI 10.1039/c3ib40184g
   Szabo I, 1999, EMBO J, V18, P5517, DOI 10.1093/emboj/18.20.5517
   Ter-Avetisyan G, 2009, J BIOL CHEM, V284, P3370, DOI 10.1074/jbc.M805550200
   Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
   Yigit S, 2014, MACROMOL BIOSCI, V14, P1291, DOI 10.1002/mabi.201400113
   Zhu J, 2013, TALANTA, V107, P408, DOI 10.1016/j.talanta.2013.01.037
NR 80
TC 11
Z9 11
U1 1
U2 28
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 3
BP 543
EP 551
DI 10.1039/c4bm00401a
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CB7TV
UT WOS:000349831700012
PM 26222296
OA Bronze
DA 2018-10-20
ER

PT J
AU Wang, ZW
   Su, YL
   Li, Q
   Liu, Y
   She, ZX
   Chen, FN
   Li, LQ
   Zhang, XX
   Zhang, P
AF Wang, Zhongwei
   Su, Yongliang
   Li, Qing
   Liu, Yan
   She, Zuxin
   Chen, Funan
   Li, Longqin
   Zhang, Xiaoxu
   Zhang, Peng
TI Researching a highly anti-corrosion superhydrophobic film fabricated on
   AZ91D magnesium alloy and its anti-bacteria adhesion effect
SO MATERIALS CHARACTERIZATION
LA English
DT Article
DE Magnesium; Superhydrophobic; In vitro test; Corrosion; Bacterial
   adhesion
ID IN-VITRO; CORROSION-RESISTANCE; SURFACE; ANTIBACTERIAL; COATINGS;
   ENERGY; PERFORMANCE; DURABILITY; ATTACHMENT; BEHAVIOR
AB In this paper, an anti-corrosion superhydrophobic film with anti-bacteria adhesion effect was successfully fabricated on AZ91D Mg alloy by hydrothermal method. The as-prepared superhydrophobic film has a contact angle of 155 and a low sliding angle of similar to 2 degrees. Electrochemical measurements and long-term immersion test showed that the superhydrophobic film can greatly enhance the corrosion resistance of Mg alloy in the Hank's solution. Cytotoxicity test showed that the superhydrophobic film could effectively lower the toxicity of Mg alloy. Furthermore, the superhydrophobic film can obviously resist the adhesion of the bacteria on Mg alloy, showing a good anti-bacteria adhesion effect and then reducing the risk of infection in/after the implanting operation. The superhydrophobic film can significantly improve the performance of Mg alloy as an implant material. It's believed that the superhydrophobic materials have huge potential application value in the biomaterial area. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wang, Zhongwei; Li, Qing; She, Zuxin; Chen, Funan; Li, Longqin; Zhang, Xiaoxu; Zhang, Peng] Southwest Univ, Sch Chem & Chem Engn, Chongqing 400715, Peoples R China.
   [Su, Yongliang; Liu, Yan] Southwest Univ, Sch Life Sci, Chongqing 400715, Peoples R China.
RP Li, Q (reprint author), Southwest Univ, Sch Chem & Chem Engn, Chongqing 400715, Peoples R China.
EM liqingswu@163.com
FU National Natural Science Foundation of China [2107116]; Fundamental
   Research Funds for the Central Universities [XDIK2011C069]
FX This work is supported by the National Natural Science Foundation of
   China (2107116) and the Fundamental Research Funds for the Central
   Universities (XDIK2011C069).
CR Altun H, 2004, MATER DESIGN, V25, P637, DOI 10.1016/j.matdes.2004.02.002
   [Anonymous], 2009, 109935 ISO
   Bayoudh S, 2006, MAT SCI ENG C-BIO S, V26, P300, DOI 10.1016/j.msec.2005.10.045
   Cao LL, 2009, LANGMUIR, V25, P12444, DOI 10.1021/la902882b
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Cengiz U, 2014, APPL SURF SCI, V292, P591, DOI 10.1016/j.apsusc.2013.12.013
   Cengiz U, 2012, APPL SURF SCI, V258, P5815, DOI 10.1016/j.apsusc.2012.02.107
   Cho B.G., 2012, J PHYS CHEM C, V116, P3207
   Chung JS, 2012, J COLLOID INTERF SCI, V366, P64, DOI 10.1016/j.jcis.2011.09.080
   Crawford RJ, 2012, ADV COLLOID INTERFAC, V179, P142, DOI 10.1016/j.cis.2012.06.015
   Crick CR, 2011, THIN SOLID FILMS, V519, P3722, DOI 10.1016/j.tsf.2011.01.282
   Efremov AN, 2013, BIOMATERIALS, V34, P1757, DOI 10.1016/j.biomaterials.2012.11.034
   Epaillard F.P., 2013, MAT SCI ENG C, V33, P1152
   Erbil HY, 2011, J ADHES SCI TECHNOL, V25, P2137, DOI 10.1163/016942411X574871
   Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Gu XN, 2011, MATER SCI ENG B-ADV, V176, P1802, DOI 10.1016/j.mseb.2011.04.003
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Guo ZG, 2011, J COLLOID INTERF SCI, V353, P335, DOI 10.1016/j.jcis.2010.08.047
   Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Huang QL, 2012, BIOMATERIALS, V33, P8213, DOI 10.1016/j.biomaterials.2012.08.017
   Ishizaki T, 2011, LANGMUIR, V27, P4780, DOI 10.1021/la2002783
   Ishizaki T, 2011, LANGMUIR, V27, P2375, DOI 10.1021/la1051029
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lopez M., 2010, ACTA BIOMATER, V6, P1763
   Luong-Van E., 2012, J MATER RES, V28, P165
   Marcon L, 2013, ACTA BIOMATER, V9, P4585, DOI 10.1016/j.actbio.2012.08.026
   Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010
   Parhi P, 2010, J ADHES SCI TECHNOL, V24, P853, DOI 10.1163/016942409X12598231567907
   Park Y.B., 2001, J MATER CHEM, V21, P633
   Pernites RB, 2012, CHEM MATER, V24, P870, DOI 10.1021/cm2007044
   Ren L, 2011, MATER LETT, V65, P3509, DOI 10.1016/j.matlet.2011.07.109
   She ZX, 2013, CHEM ENG J, V228, P415, DOI 10.1016/j.cej.2013.05.017
   She ZX, 2012, ACS APPL MATER INTER, V4, P4348, DOI 10.1021/am3009949
   Shen LY, 2012, ACS APPL MATER INTER, V4, P4476, DOI 10.1021/am301118f
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Song YW, 2008, ELECTROCHIM ACTA, V53, P2135, DOI 10.1016/j.electacta.2007.09.026
   Taleghani MAJ, 2013, MATER LETT, V98, P182, DOI 10.1016/j.matlet.2013.02.052
   Wang P, 2011, CORROS SCI, V53, P2080, DOI 10.1016/j.corsci.2011.02.025
   Wang ZW, 2012, J MATER CHEM, V22, P4097, DOI 10.1039/c2jm14475a
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Xu LP, 2012, COLLOID SURFACE B, V93, P67, DOI 10.1016/j.colsurfb.2011.12.009
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Yagi S, 2012, CORROS SCI, V57, P74, DOI 10.1016/j.corsci.2011.12.032
   Zhang QN, 2000, INT J PHARM, V200, P153, DOI 10.1016/S0378-5173(00)00361-6
   Zhang XX, 2013, RSC ADV, V3, P12003, DOI 10.1039/c3ra40497h
   Zhu YY, 2011, APPL SURF SCI, V257, P6129, DOI 10.1016/j.apsusc.2011.02.017
NR 49
TC 30
Z9 33
U1 8
U2 96
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1044-5803
EI 1873-4189
J9 MATER CHARACT
JI Mater. Charact.
PD JAN
PY 2015
VL 99
BP 200
EP 209
DI 10.1016/j.matchar.2014.12.004
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CC1FF
UT WOS:000350085900025
DA 2018-10-20
ER

PT S
AU Boudot, C
   Recht, S
   Eblenkamp, M
   Haerst, M
   Wintermantel, E
AF Boudot, Cecile
   Recht, Stefanie
   Eblenkamp, Markus
   Haerst, Miriam
   Wintermantel, Erich
BE Lackovic, I
   Vasic, D
TI Protein Adsorption and Adhesion of Blood Platelets on Silicone Rubber
   under Static and Dynamic Flow Conditions
SO 6TH EUROPEAN CONFERENCE OF THE INTERNATIONAL FEDERATION FOR MEDICAL AND
   BIOLOGICAL ENGINEERING
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 6th European Conference of the
   International-Federation-for-Medical-and-Biological-Engineering (MBEC)
CY SEP 07-11, 2014
CL Dubrovnik, CROATIA
SP Croatian Med & Biolog Engn Soc, Int Federat Med & Biolog Engn, Minist Sci Educ & Sports Republic Croatia, Minist Health Republic Croatia, Univ Zagreb, Facu Elect Engn & Comp, European Alliance Med & Biolog Engn & Sci, European Cooperat Sci & Technol
DE Silicone rubber; platelet adhesion; thrombocyte; protein adsorption;
   static and dynamic flow conditions
ID IN-VITRO HEMOCOMPATIBILITY; SURFACE SCIENCE; BIOMATERIALS
AB Understanding the spontaneous protein adsorption on biomaterial surfaces is a key element to evaluate their thrombogenicity and especially their propensity to trigger the adhesion of blood platelets (thrombocytes). In this work, the adhesion of two proteins (bovine fibrinogen and bovine serum albumin) on silicone rubber and the thrombocyte adhesion on different preadsorbed protein layers has been investigated under static and dynamic flow conditions. It has been shown that proteins do not adhere equally to silicone rubber and that both the composition of protein layer and the flow conditions influence the thrombocyte adhesion.
C1 [Boudot, Cecile; Recht, Stefanie; Eblenkamp, Markus; Haerst, Miriam; Wintermantel, Erich] Tech Univ Munich, Inst Med & Polymer Engn, D-85748 Garching, Germany.
RP Boudot, C (reprint author), Tech Univ Munich, Inst Med & Polymer Engn, Boltzmannstr 15, D-85748 Garching, Germany.
EM cecile.boudot@tum.de
CR ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   [Anonymous], 2009, 1099342009 DIN EN IS
   Backovic A, 2007, J PROTEOME RES, V6, P376, DOI 10.1021/pr0603755
   BELLAVITE P, 1994, ANAL BIOCHEM, V216, P444, DOI 10.1006/abio.1994.1066
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Jansen P, 2012, EUR J CARDIO-THORAC, V41, pe166, DOI 10.1093/ejcts/ezs187
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Michanetzis GPA, 2003, BIOMATERIALS, V24, P677, DOI 10.1016/S0142-9612(02)00382-4
   Otto M, 2004, J MATER SCI-MATER M, V15, P35, DOI 10.1023/B:JMSM.0000010095.19693.67
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Seyfert UT, 2002, BIOMOL ENG, V19, P91, DOI 10.1016/S1389-0344(02)00015-1
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   van Oeveren W, 2002, ARTIF ORGANS, V26, P506, DOI 10.1046/j.1525-1594.2002.06872.x
   Vladkova TG, 2010, INT J POLYM SCI, DOI 10.1155/2010/296094
   Wilson C J, 2005, TISSUE ENG, V11
   Wintermantel E, 2008, MEDIZINTECHNIK LIFE
   Zhou J, 2005, COLLOID SURFACE B, V41, P55, DOI 10.1016/j.colsurfb.2004.11.006
NR 21
TC 1
Z9 1
U1 0
U2 10
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 1680-0737
BN 978-3-319-11127-8
J9 IFMBE PROC
PY 2015
VL 45
BP 541
EP 544
DI 10.1007/978-3-319-11128-5_135
PG 4
WC Engineering, Biomedical; Medical Informatics; Neurosciences
SC Engineering; Medical Informatics; Neurosciences & Neurology
GA BC0RY
UT WOS:000349454200135
DA 2018-10-20
ER

PT J
AU Raja, STK
   Thiruselvi, T
   Aravindhan, R
   Mandal, AB
   Gnanamani, A
AF Raja, S. Thirupathi Kumara
   Thiruselvi, T.
   Aravindhan, R.
   Mandal, Asit Baran
   Gnanamani, A.
TI In vitro and in vivo assessments of a
   3-(3,4-dihydroxyphenyl)-2-propenoic acid bioconjugated gelatin-based
   injectable hydrogel for biomedical applications
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID CAFFEIC ACID; DRUG-DELIVERY; REGENERATIVE MEDICINE; TISSUE; COLLAGEN;
   ANTIOXIDANT; BIOMATERIALS; DESIGN; IMMOBILIZATION; STABILITY
AB Imparting functional properties on a biomaterial for high end applications is always a challenging task. In the present study, an attempt was made to construct an injectable hydrogel through bioconjugation of dihydroxy phenolic acids to a gelatin backbone. Bioconjugating caffeic acid with gelatin followed by oxidation with mild oxidation agents provided a hydrogel with all the requisite properties (biocompatibility, controlled biodegradability, and antioxidant, antimicrobial and wound healing ability). Bioconjugation was performed using EDC/NHS and the resultant gel named as caffeic acid bioconjugated gel (CBG gel). The physicochemical, rheological, swelling, in vitro (biocompatibility, biodegradability, antimicrobial properties, antioxidant properties and drug release properties) and in vivo (biocompatibility, biodegradability and wound healing properties) studies on the CBG gel were carried out using standard protocols. The bioconjugation was confirmed by H-1 NMR and UV-Vis analysis. Rheological analysis of the CBG gel revealed that the storage modulus was greater than the loss modulus at all the frequencies and suggested the elastic nature of the gel. About 50% weight gain within 12 hours during swelling studies and 50% weight loss within 12 hours during evaporation suggested the suitability of the CBG gel as a drug carrier. The drug release studies implied that there was an initial burst and later the release was sustained. The CBG gel promotes cell migration and demonstrates radical scavenging behavior. When subcutaneously injected into the animal, as in situ CBG gel, the gel was highly biocompatible and did not cause any necrosis. The crosstalk with adjacent tissue cells was smooth and the gel completely degraded within 24 days. The wound healing efficacy on full-thickness wounds suggested that the CBG gel accelerated healing and imparted high strength on the healed skin at an appreciable level. With all these additional functional properties, the CBG gel could be useful for biomedical applications.
C1 [Raja, S. Thirupathi Kumara; Thiruselvi, T.; Aravindhan, R.; Mandal, Asit Baran; Gnanamani, A.] CSIR CLRI, Div Microbiol, Madras, Tamil Nadu, India.
RP Gnanamani, A (reprint author), CSIR CLRI, Div Microbiol, Madras, Tamil Nadu, India.
EM gnanamani3@gmail.com
RI Mandal, Asit Baran/B-9977-2009
FU DBT, New Delhi; Council of Scientific and Industrial Research (CSIR, New
   Delhi)
FX The authors thank DBT, New Delhi for funding this project in the form of
   a TATA innovation Fellowship. The first author thanks the Council of
   Scientific and Industrial Research (CSIR, New Delhi) for the Senior
   Research Fellowship. The first author also thanks Prof. Dr M. A.
   Akbarsha, Director, Mahatma Gandhi-Doerenkamp Centre (MGDC),
   Tiruchirappalli, India, for giving effective training on in vitro animal
   cell culture. Thanks are also given to Dr T. S. Sampathkumar, Professor,
   IIT Madras for his help with contact angle measurements.
CR Albu MG, 2009, REV CHIM-BUCHAREST, V60, P666
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI 10.1089/ten.TEB.2009.0639
   Bae KH, 2013, J MATER CHEM B, V1, P5371, DOI 10.1039/c3tb20940g
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Bodmeier R. A., 1998, ENCY PHARM TECHNOLOG
   Burdick JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003997
   Chen JH, 1997, J AGR FOOD CHEM, V45, P2374, DOI 10.1021/jf970055t
   Choi YC, 2014, J MATER CHEM B, V2, P201, DOI 10.1039/c3tb20696c
   CIVERCHIAPEREZ L, 1980, P NATL ACAD SCI-BIOL, V77, P2064, DOI 10.1073/pnas.77.4.2064
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   Dongargaonkar AA, 2013, BIOMACROMOLECULES, V14, P4038, DOI 10.1021/bm401143p
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dumitriu S., 2001, POLYM BIOMATERIALS
   Elson LA, 1933, BIOCHEM J, V27, P1824, DOI 10.1042/bj0271824
   Fan ZJ, 2014, ADV FUNCT MATER, V24, P3933, DOI 10.1002/adfm.201304202
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Ganji F, 2010, IRAN POLYM J, V19, P375
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008
   Guan S, 2009, TOXICOL IN VITRO, V23, P201, DOI 10.1016/j.tiv.2008.11.008
   Horbett T. A., 1995, PROTEINS INTERFACES, V602, P1
   Huang YF, 2014, J MATER CHEM A, V2, P10508, DOI 10.1039/c4ta01464b
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Koganov MM, 1999, J NAT PROD, V62, P481, DOI 10.1021/np9801559
   Kommareddy S, 2005, BIOCONJUGATE CHEM, V16, P1423, DOI 10.1021/bc050146t
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mandal BB, 2009, BIOMATERIALS, V30, P2826, DOI 10.1016/j.biomaterials.2009.01.040
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Mateen R, 2014, J MATER CHEM B, V2, P5157, DOI 10.1039/c4tb00631c
   Mitra T, 2013, J POROUS MAT, V20, P647, DOI 10.1007/s10934-012-9638-2
   Mitra T, 2011, INT J BIOL MACROMOL, V48, P276, DOI 10.1016/j.ijbiomac.2010.11.011
   Oommen OP, 2013, ADV FUNCT MATER, V23, P1273, DOI 10.1002/adfm.201201698
   Parameshwaraiah S., 1998, INDIAN J EXP BIOL, V36, P569
   Park KM, 2011, J MATER CHEM, V21, P13180, DOI 10.1039/c1jm12527c
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Raja STK, 2013, BBA-GEN SUBJECTS, V1830, P4030, DOI 10.1016/j.bbagen.2013.04.009
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ricotti L, 2010, BIOMED MICRODEVICES, V12, P809, DOI 10.1007/s10544-010-9435-0
   Rieger KA, 2013, J MATER CHEM B, V1, P4531, DOI 10.1039/c3tb20795a
   Sailakshmi G, 2011, J MATER SCI-MATER M, V22, P1419, DOI 10.1007/s10856-011-4337-0
   Sajedi M, 2014, FOOD HYDROCOLLOID, V36, P93, DOI 10.1016/j.foodhyd.2013.09.007
   Sakai S, 2013, J MATER CHEM B, V1, P5067, DOI 10.1039/c3tb20780c
   Schrieber R, 2007, GELATINE HDB THEORY
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Song HS, 2008, KOREAN J PHYSIOL PHA, V12, P343, DOI 10.4196/kjpp.2008.12.6.343
   Stevens KR, 2002, J BIOMAT SCI-POLYM E, V13, P1353, DOI 10.1163/15685620260449741
   Stojkovic D, 2013, J SCI FOOD AGR, V93, P3205, DOI 10.1002/jsfa.6156
   Sumitra M, 2009, WOUND REPAIR REGEN, V17, P99, DOI 10.1111/j.1524-475X.2008.00446.x
   Trombino S, 2009, CARBOHYD POLYM, V75, P184, DOI 10.1016/j.carbpol.2008.05.018
   Van Vlierberghe S, 2011, POLYMERS-BASEL, V3, P114, DOI 10.3390/polym3010114
   WAITE JH, 1987, INT J ADHES ADHES, V7, P9, DOI 10.1016/0143-7496(87)90048-0
   Wang H, 2008, EUR J PHARMACOL, V599, P24, DOI 10.1016/j.ejphar.2008.09.030
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   WICHTERLE O, 1961, Cesk Oftalmol, V17, P70
   Williams D., 1990, CONCISE ENCY MED DEN
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Wu WM, 2007, FOOD CHEM, V105, P107, DOI 10.1016/j.foodchem.2007.03.049
   Yang X, 2014, INT J NANOMED, V9, P2753, DOI 10.2147/IJN.S60624
NR 70
TC 11
Z9 11
U1 3
U2 38
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 7
BP 1230
EP 1244
DI 10.1039/c4tb01196a
PG 15
WC Materials Science, Biomaterials
SC Materials Science
GA CB4SG
UT WOS:000349617600008
DA 2018-10-20
ER

PT J
AU Miao, QQ
   Wu, ZY
   Hai, ZJ
   Tao, CL
   Yuan, QP
   Gong, YD
   Guan, YF
   Jiang, J
   Liang, GL
AF Miao, Qingqing
   Wu, Ziye
   Hai, Zijuan
   Tao, Changlu
   Yuan, Qingpan
   Gong, Yadi
   Guan, Yafeng
   Jiang, Jun
   Liang, Gaolin
TI Bipyridine hydrogel for selective and visible detection and absorption
   of Cd2+
SO NANOSCALE
LA English
DT Article
ID ATOMIC FLUORESCENCE SPECTROMETRY; ONLINE PRECONCENTRATION;
   SUPRAMOLECULAR HYDROGELS; GOLD NANOPARTICLES; AQUEOUS-SOLUTION; CADMIUM
   IONS; METAL-IONS; IN-VITRO; SENSOR; CELLS
AB Herein, we report for the first time the use of bipyridine-based hydrogel for selective and visible detection and absorption of Cd2+. At low concentrations, hydrogelator 1 was applied for selective detection of Cd2+ in vitro and in living cells with high sensitivity. In the absence of metal ions, 1 is nonfluorescent at 470 nm. Upon addition of metal ions, 1 selectively coordinates to Cd2+, causing an 86-fold increase of fluorescence intensity at 470 nm via the chelation enhanced fluorescence (CHEF) effect, as revealed by first-principles simulations. At 1.5 wt% and pH 5.5, 1 self-assembles into nanofibers to form hydrogel Gel I. Since Cd2+ could actively participate in the hydrogelation and promote the self-assembly, we also successfully applied Gel I for visible detection and absorption of Cd2+. With these excellent properties, Gel I is expected to be explored as one type of versatile biomaterial for not only environmental monitoring but also for pollution treatment in the near future.
C1 [Miao, Qingqing; Hai, Zijuan; Yuan, Qingpan; Gong, Yadi; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.
   [Wu, Ziye; Jiang, Jun] Univ Sci & Technol China, Dept Chem Phys, Hefei 230026, Anhui, Peoples R China.
   [Tao, Changlu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Ctr Integrat Imaging, Hefei 230026, Anhui, Peoples R China.
   [Tao, Changlu] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.
   [Guan, Yafeng] Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, Dalian 116023, Peoples R China.
RP Jiang, J (reprint author), Univ Sci & Technol China, Dept Chem Phys, 96 Jinzhai Rd, Hefei 230026, Anhui, Peoples R China.
EM jiangj1@ustc.edu.cn; gliang@ustc.edu.cn
RI jiang, jun/P-5378-2014; Liang, Gaolin/F-1786-2010
OI jiang, jun/0000-0002-6116-5605; Liang, Gaolin/0000-0002-6159-9999
FU Collaborative Innovation Center of Suzhou Nano Science and Technology;
   Major Program of Development Foundation of Hefei Center for Physical
   Science and Technology; National Natural Science Foundation of China
   [21175122, 91127036, 21375121]
FX This work was supported by the Collaborative Innovation Center of Suzhou
   Nano Science and Technology, the Major Program of Development Foundation
   of Hefei Center for Physical Science and Technology, and the National
   Natural Science Foundation of China (grants 21175122, 91127036, and
   21375121).
CR AHLGREN L, 1981, PHYS MED BIOL, V26, P19, DOI 10.1088/0031-9155/26/1/004
   Anthemidis AN, 2008, MICROCHIM ACTA, V160, P455, DOI 10.1007/s00604-007-0775-2
   Aragoni MC, 2002, INORG CHEM, V41, P6623, DOI 10.1021/ic020270d
   Balaji T, 2006, ANAL BIOANAL CHEM, V384, P488, DOI 10.1007/s00216-005-0187-2
   Banerjee S, 2008, CHEM COMMUN, P3037, DOI 10.1039/b803166e
   BOND AM, 1984, ANAL CHEM, V56, P2085, DOI 10.1021/ac00276a025
   Cai YB, 2014, ANAL CHEM, V86, P2193, DOI 10.1021/ac4038653
   Caricato M, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2183309
   Charles S, 2001, ANAL CHIM ACTA, V440, P37, DOI 10.1016/S0003-2670(01)00857-1
   Cheng TY, 2008, J AM CHEM SOC, V130, P16160, DOI 10.1021/ja806928n
   Cockrell GM, 2008, J AM CHEM SOC, V130, P1420, DOI 10.1021/ja077141m
   Colbert D, 1998, ANAL CHIM ACTA, V377, P255, DOI 10.1016/S0003-2670(98)00428-0
   Davis AC, 2007, TALANTA, V71, P1144, DOI 10.1016/j.talanta.2006.06.005
   Grimm F, 2009, CHEM COMMUN, P1331, DOI 10.1039/b822043c
   GUO XW, 1995, ANAL CHIM ACTA, V310, P377, DOI 10.1016/0003-2670(95)00114-F
   Huang R, 2013, ANAL CHEM, V85, P6203, DOI 10.1021/ac4014012
   Ikeda M, 2014, NAT CHEM, V6, P511, DOI [10.1038/NCHEM.1937, 10.1038/nchem.1937]
   Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522
   Jiang X, 2008, CHEM COMMUN, P6028, DOI 10.1039/b812261j
   Kaya G, 2008, TALANTA, V75, P1127, DOI 10.1016/j.talanta.2008.01.008
   Kuang Y, 2014, CHEM COMMUN, V50, P2772, DOI 10.1039/c3cc48832b
   Lam KF, 2007, ENVIRON SCI TECHNOL, V41, P3329, DOI 10.1021/es062370e
   Liu XH, 2014, ADV MATER, V26, P4370, DOI 10.1002/adma.201400240
   McFarland CN, 2002, J ENVIRON MONITOR, V4, P791, DOI 10.1039/b206045k
   MONTASER A, 1976, ANAL CHEM, V48, P1490, DOI 10.1021/ac50005a021
   Park SY, 2008, J ORG CHEM, V73, P8212, DOI 10.1021/jo8012918
   Peng XJ, 2007, J AM CHEM SOC, V129, P1500, DOI 10.1021/ja0643319
   Su T, 2014, CHEM SCI, V5, P4204, DOI 10.1039/c4sc01603c
   Tang AM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01848
   Tang AM, 2013, NANOSCALE, V5, P8963, DOI 10.1039/c3nr03339b
   Tang XL, 2008, ORG LETT, V10, P3653, DOI 10.1021/ol801382f
   Tian GJ, 2013, ANGEW CHEM INT EDIT, V52, P4814, DOI 10.1002/anie.201301209
   Varriale A, 2007, ANAL CHEM, V79, P5760, DOI 10.1021/ac0705667
   Wang WJ, 2014, ANAL CHEM, V86, P5955, DOI 10.1021/ac500967x
   Wang Z, 2008, ANAL CHEM, V80, P7451, DOI 10.1021/ac801165v
   Wei J, 2013, NANOSCALE, V5, P9902, DOI 10.1039/c3nr02937a
   Willie SN, 1998, ATOM SPECTROSC, V19, P67
   Xianyu YL, 2013, NANOSCALE, V5, P6303, DOI 10.1039/c3nr01697h
   Xu KM, 2008, INT J RADIAT BIOL, V84, P353, DOI 10.1080/09553000802029902
   Xue L, 2009, ORG LETT, V11, P1655, DOI 10.1021/ol900315r
   Xue Y, 2011, ANALYST, V136, P3725, DOI 10.1039/c1an15238f
   Yan XZ, 2013, J AM CHEM SOC, V135, P14036, DOI 10.1021/ja406877b
   Yang YM, 2013, NANOSCALE, V5, P231, DOI 10.1039/c2nr32835f
   Yang ZM, 2005, CHEM COMMUN, P4414, DOI 10.1039/b507314f
   Yin J, 2011, CHEM MATER, V23, P4756, DOI 10.1021/cm201791r
   Zhang Y, 2013, J AM CHEM SOC, V135, P5008, DOI 10.1021/ja402490j
   Zhao YY, 2013, NANOSCALE, V5, P8340, DOI 10.1039/c3nr01990j
NR 47
TC 26
Z9 26
U1 7
U2 122
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PY 2015
VL 7
IS 6
BP 2797
EP 2804
DI 10.1039/c4nr06467d
PG 8
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CB2QH
UT WOS:000349472300075
PM 25584838
DA 2018-10-20
ER

PT J
AU Peralta, MDR
   Karsai, A
   Ngo, A
   Sierra, C
   Fong, KT
   Hayre, NR
   Mirzaee, N
   Ravikumar, KM
   Kluber, AJ
   Chen, X
   Liu, GY
   Toney, MD
   Singh, RR
   Cox, DL
AF Peralta, Maria D. R.
   Karsai, Arpad
   Ngo, Alice
   Sierra, Catherine
   Fong, Kai T.
   Hayre, Natha Robert
   Mirzaee, Nima
   Ravikumar, Krishnakumar Mayuram
   Kluber, Alexander J.
   Chen, Xi
   Liu, Gang-yu
   Toney, Michael D.
   Singh, Rajiv. R.
   Cox, Daniel Lee
TI Engineering Amyloid Fibrils from beta-Solenoid Proteins for Biomaterials
   Applications
SO ACS NANO
LA English
DT Article
DE amyloid; antifreeze protein; beta-solenoid; atomic force microscopy;
   thioflavin-T fluorescence
ID POLYGLUTAMINE AGGREGATION NUCLEATION; PENTAPEPTIDE REPEAT PROTEIN;
   CIRCULAR-DICHROISM SPECTRA; THIOFLAVIN-T-BINDING; ANTIFREEZE PROTEIN;
   SECONDARY STRUCTURE; MOLECULAR-MECHANISM; CRYSTAL-STRUCTURE; SPIDER
   SILK; DNA ORIGAMI
AB Nature provides numerous examples of self-assembly that can potentially be implemented for materials applications. Considerable attention has been given to one-dimensional cross-beta or amyloid structures that can serve as templates for wire growth or strengthen materials such as glue or cement. Here, we demonstrate controlled amyloid self-assembly based on modifications of beta-solenoid proteins. They occur naturally in several contexts (e.g., antifreeze proteins, drug resistance proteins) but do not aggregate in vivo due to capping structures or distortions at their ends. Removal of these capping structures and regularization of the ends of the spruce budworm and rye grass antifreeze proteins yield micron length amyloid fibrils with predictable heights, which can be a platform for biomaterial-based self-assembly. The design process, including all-atom molecular dynamics simulations, purification, and self-assembly procedures are described. Fibril formation with the predicted characteristics is supported by evidence from thioflavin-T fluorescence, circular dichroism, dynamic light scattering, and atomic force microscopy. Additionally, we find evidence for lateral assembly of the modified spruce budworm antifreeze fibrils with sufficient incubation time. The kinetics of polymerization are consistent with those for other amyloid formation reactions and are relatively fast due to the preformed nature of the polymerization nucleus.
C1 [Peralta, Maria D. R.; Karsai, Arpad; Ngo, Alice; Sierra, Catherine; Fong, Kai T.; Chen, Xi; Liu, Gang-yu; Toney, Michael D.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.
   [Hayre, Natha Robert; Mirzaee, Nima; Ravikumar, Krishnakumar Mayuram; Singh, Rajiv. R.; Cox, Daniel Lee] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA.
   [Hayre, Natha Robert; Mirzaee, Nima; Ravikumar, Krishnakumar Mayuram; Kluber, Alexander J.; Singh, Rajiv. R.; Cox, Daniel Lee] Univ Calif Davis, Inst Complex Adapt Matter, Davis, CA 95616 USA.
   [Kluber, Alexander J.] Rice Univ, Dept Chem, Houston, TX 77251 USA.
RP Toney, MD (reprint author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.
EM mdtoney@ucdavis.edu; dlcox@ucdavis.edu
RI Mayuram Ravikumar, Krishnakumar/K-5648-2015
OI Kluber, Alex/0000-0003-4880-8271
FU UC Davis Office of Research; US National Science Foundation
   [DMR-1207624, DMR-0844115]
FX This work was supported by the RISE program from the UC Davis Office of
   Research (to M.D.R.P., A.K., A.N., C.S., N.R.H., N.H., A.J.K., K.M.R.,
   M.D.T., G.Y.L., X.C., R.R.P.S, and D.L.C.). The GPU computing cluster
   used here was sponsored by the US National Science Foundation grants
   .DMR-1207624 and DMR-0844115 (to A.J.K., N.M., N.R.H., K.M.R., D.L.C.,
   and R.R.P.S.). Some AFM images were acquired using the instrument at
   Keck Spectral Imaging Facility initiated by NSF-MRI and subsequently
   upgraded under the support of W. M. Keck Foundation. Protein expression,
   purification, folding, and spectral analysis of SBAFP-m1 was done by
   MDRP and CS. SBAFP-m1 was designed by MDT. The RGAFP-m1 work was done by
   A.N. and K.F., with protein design by M.D.R.P. and M.D.T. Computer
   simulations were designed by N.R.H., and performed by N.R.H., N.M., and
   A.J.K. MD based height analysis was performed by K.M.R. and N.M. MD
   based beta-sheet content analysis was performed by K.M.R. AFM sample
   preparations, imaging, and data analysis were done by A.K. and G.Y.L.
   D.L.C. is the lead principal investigator on the project, supervising
   the theoretical design and simulation work with R.R.P.S., motivating the
   selection of proteins, and writing of the paper along with M.D.T.
CR Arora A, 2004, PROTEIN SCI, V13, P2429, DOI 10.1110/ps.04823504
   Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106
   Baxa U, 2004, J MOL BIOL, V339, P259, DOI 10.1016/j.jmb.2004.03.033
   Benach J., NE STRUCTURAL GENOMI
   BENBASSAT A, 1987, J BACTERIOL, V169, P751, DOI 10.1128/jb.169.2.751-757.1987
   BERNE B J, 1974, Journal of Molecular Biology, V89, P755, DOI 10.1016/0022-2836(74)90049-7
   Bhattacharyya AM, 2005, P NATL ACAD SCI USA, V102, P15400, DOI 10.1073/pnas.0501651102
   Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001
   Buchko GW, 2006, PROTEIN SCI, V15, P2579, DOI 10.1110/ps.062407506
   Buell AK, 2011, J AM CHEM SOC, V133, P7737, DOI 10.1021/ja109620d
   Case D. A., 2012, AMBER 12
   Castro CE, 2011, NAT METHODS, V8, P221, DOI [10.1038/nmeth.1570, 10.1038/NMETH.1570]
   Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304
   Cox DL, 2006, BIOPHYS J, V90, pL77, DOI 10.1529/biophysj.106.081703
   Ferrone F, 1999, METHOD ENZYMOL, V309, P256
   Gauthier SY, 1998, EUR J BIOCHEM, V258, P445, DOI 10.1046/j.1432-1327.1998.2580445.x
   Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101
   Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   Hammer ND, 2008, J ALZHEIMERS DIS, V13, P407
   Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701
   Humenik M, 2014, J STRUCT BIOL, V186, P431, DOI 10.1016/j.jsb.2014.03.010
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Ionescu-Zanetti C, 1999, P NATL ACAD SCI USA, V96, P13175, DOI 10.1073/pnas.96.23.13175
   Ivnitski D, 2014, CHEM COMMUN, V50, P6733, DOI 10.1039/c4cc00717d
   Janes R. W., 2009, MODERN TECHNIQUES CI
   Kardos J, 2011, BIOCHEMISTRY-US, V50, P3211, DOI 10.1021/bi2000017
   Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006
   Knowles T. P. J., 2006, PHYS REV LETT, V96
   Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]
   Knowles TPJ, 2010, NAT NANOTECHNOL, V5, P204, DOI [10.1038/nnano.2010.26, 10.1038/NNANO.2010.26]
   Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250
   Kunes KC, 2008, PRION, V2, P81, DOI 10.4161/pri.2.2.7059
   Kusumoto Y, 1998, P NATL ACAD SCI USA, V95, P12277, DOI 10.1073/pnas.95.21.12277
   Lauersen KJ, 2011, CRYOBIOLOGY, V62, P194, DOI 10.1016/j.cryobiol.2011.03.003
   Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+
   Lee YJ, 2011, J MATER CHEM, V21, P1033, DOI 10.1039/c0jm02544e
   Leinala EK, 2002, J BIOL CHEM, V277, P33349, DOI 10.1074/jbc.M205575200
   LeVine H, 1999, METHOD ENZYMOL, V309, P274
   LEVINE H, 1993, PROTEIN SCI, V2, P404
   Liu JF, 2013, LANGMUIR, V29, P11176, DOI 10.1021/la402678j
   Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155
   Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740
   Middleton AJ, 2012, J MOL BIOL, V416, P713, DOI 10.1016/j.jmb.2012.01.032
   Ni SS, 2009, J STRUCT BIOL, V165, P47, DOI 10.1016/j.jsb.2008.09.010
   Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c
   NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338
   OLMSTED JB, 1973, ANNU REV BIOCHEM, V42, P507, DOI 10.1146/annurev.bi.42.070173.002451
   Pentelute BL, 2008, J AM CHEM SOC, V130, P9695, DOI 10.1021/ja8013538
   Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399
   PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Rufo CM, 2014, NAT CHEM, V6, P303, DOI [10.1038/NCHEM.1894, 10.1038/nchem.1894]
   Ryu J, 2010, BIOTECHNOL BIOENG, V105, P221, DOI 10.1002/bit.22544
   Sacca B, 2010, ANGEW CHEM INT EDIT, V49, P9378, DOI 10.1002/anie.201005931
   Sakai H, 2013, ADV FUNCT MATER, V23, P4881, DOI 10.1002/adfm.201300577
   Sara M, 1996, PROG BIOPHYS MOL BIO, V65, P83, DOI 10.1016/S0079-6107(96)00007-7
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244
   Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008
   Slotta U, 2007, MACROMOL BIOSCI, V7, P183, DOI 10.1002/mabi.200600201
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325
   Stork M, 2005, BIOPHYS J, V88, P2442, DOI 10.1529/biophysj.104.052415
   Sullan RMA, 2009, BIOFOULING, V25, P263, DOI 10.1080/08927010802688095
   Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4
   VASSAR PS, 1959, ARCH PATHOL, V68, P487
   Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839
   Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853
   Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 73
TC 27
Z9 28
U1 5
U2 78
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD JAN
PY 2015
VL 9
IS 1
BP 449
EP 463
DI 10.1021/nn5056089
PG 15
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA CA0PJ
UT WOS:000348619000047
PM 25562726
DA 2018-10-20
ER

PT J
AU Henstock, JR
   Canham, LT
   Anderson, SI
AF Henstock, J. R.
   Canham, L. T.
   Anderson, S. I.
TI Silicon: The evolution of its use in biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Silicon; Biomaterials; Biomaterial; Silicic acid; Orthosilicic acid
ID SUBSTITUTED HYDROXYAPATITE; BIOACTIVE GLASS; POROUS SILICON; IN-VITRO;
   CONNECTIVE-TISSUE; DIETARY SILICON; OSTEOBLAST RESPONSE; PROTEIN
   ADSORPTION; BIOMIMETIC PROCESS; ENDOTHELIAL-CELLS
AB In the 1970s, several studies revealed the requirement for silicon in bone development, while bioactive silicate glasses simultaneously pioneered the current era of bioactive materials. Considerable research has subsequently focused on the chemistry and biological function of silicon in bone, demonstrating that the element has at least two separate effects in the extracellular matrix: (i) interacting with glycosaminoglycans and proteoglycans during their synthesis, and (ii) forming ionic substitutions in the crystal lattice structure of hydroxyapatite. In addition, the dissolution products of bioactive glass (predominantly silicic acids) have significant effects on the molecular biology of osteoblasts in vitro, regulating the expression of several genes including key osteoblastic markers, cell cycle regulators and extracellular matrix proteins. Researchers have sought to capitalize on these effects and have generated a diverse array of biomaterials, which include bioactive glasses, silicon-substituted hydroxyapatites and pure, porosified silicon, but all these materials share similarities in the mechanisms that result in their bioactivity. This review discusses the current data obtained from original research in biochemistry and biomaterials science supporting the role of silicon in bone, comparing both the biological function of the element and analysing the evolution of silicon-containing biomaterials. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Henstock, J. R.] Keels Univ, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England.
   [Canham, L. T.] pSiMed Ltd, Malvern WR14 3SZ, Worcs, England.
   [Anderson, S. I.] Univ Nottingham, Royal Derby Hosp Ctr, Sch Med, Div Med Sci & Grad Entry Med, Derby DE22 3DT, England.
RP Henstock, JR (reprint author), Keels Univ, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England.
EM j.r.henstock@keele.ac.uk
CR Al-Mutaz IS, 2002, 6 SAUD ENG C, V2, P3
   Alvarez SD, 2009, BIOMATERIALS, V30, P26, DOI 10.1016/j.biomaterials.2008.09.005
   Anderson MC, 2010, J BIOMED MATER RES A, V92A, P1598, DOI 10.1002/jbm.a.32498
   Anderson SI, 1998, J MATER SCI-MATER M, V9, P731, DOI 10.1023/A:1008955002955
   Arias JL, 2000, APPL SURF SCI, V154, P434, DOI 10.1016/S0169-4332(99)00457-2
   Arumugam MQ, 2006, KEY ENG MATER, V254, P869
   BIRCHALL JD, 1995, CHEM SOC REV, V24, P351, DOI 10.1039/cs9952400351
   BIRCHALL JD, 1986, CIBA F SYMP, V121, P140
   Bisse E, 2005, ANAL BIOCHEM, V337, P130, DOI 10.1016/j.ab.2004.10.034
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Boivin G, 2007, MEDICOGRAPHIA, V29, P126
   Botelho CM, 2006, J BIOMED MATER RES A, V79A, P723, DOI 10.1002/jbm.a.30806
   Bouletreau PJ, 2002, PLAST RECONSTR SURG, V109, P2384, DOI 10.1097/00006534-200206000-00033
   Buchman AL, 2009, GASTROENTEROLOGY, V137, pS1, DOI 10.1053/j.gastro.2009.09.001
   Canham L, 2001, PHYS WORLD, V14, P27
   Canham L, 2013, NANOMEDICINE, V8, P1
   Canham L., 1997, PROPERTIES POROUS SI
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Canham LT, 1997, PROPERTIES POROUS SI
   CARLISLE EM, 1976, J NUTR, V106, P478
   CARLISLE EM, 1983, FED PROC, V42, P398
   CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619
   CARLISLE EM, 1975, NUTR REV, V33, P257
   CARLISLE EM, 1974, FED PROC, V33, P1758
   CARLISLE EM, 1988, SCI TOTAL ENVIRON, V73, P95, DOI 10.1016/0048-9697(88)90190-8
   Castano O, 2014, ACS APPL MATER INTER, V6, P7512, DOI 10.1021/am500885v
   Castanova V, 1996, SILICA SILICA INDUCE
   Comb LF, 1996, ULTRAPURE WATER, V13, P41
   ELLIOT MA, 1991, J NUTR, V121, P201
   Feng Z. C., 1994, POROUS SILICON
   Fenoglio I, 2000, CHEM RES TOXICOL, V13, P971, DOI 10.1021/tx000125h
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   Fubini B, 1998, SURFACE PROPERTIES S
   Giammarioli S, 2005, J FOOD SCI, V70, pS509, DOI 10.1111/j.1365-2621.2005.tb11526.x
   Gibson IR, 2002, J AM CERAM SOC, V85, P2771
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Giovine Marco, 2013, Prog Mol Subcell Biol, V54, P143, DOI 10.1007/978-3-642-41004-8_6
   Goosen JHM, 2009, ARCH ORTHOP TRAUM SU, V129, P1165, DOI 10.1007/s00402-008-0749-9
   Gough JE, 2001, J BIOMED MATER RES, V57, P497, DOI 10.1002/1097-4636(20011215)57:4<497::AID-JBM1195>3.0.CO;2-U
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Henstock JR, 2014, J MATER SCI-MATER M, V25, P1087, DOI 10.1007/s10856-014-5140-5
   Heublein B, 1998, J ENDOVASC SURG, V5, P32, DOI 10.1583/1074-6218(1998)005<0032:SCCSCE>2.0.CO;2
   Hildebrand M, 1998, MOL GEN GENET, V260, P480, DOI 10.1007/s004380050920
   Hwong, 2012, SCIENCE, P1640
   IARC. International Agency for Research on Cancer, 1979, IARC MON EV CARC RIS, V68, P210
   Iler R. K., 1979, CHEM SILICA
   Jaganathan H, 2012, ADV DRUG DELIVER REV, V64, P1800, DOI 10.1016/j.addr.2012.05.008
   Janowsky EC, 2000, NEW ENGL J MED, V342, P781, DOI 10.1056/NEJM200003163421105
   Johansson F, 2008, IEEE T BIO-MED ENG, V55, P1447, DOI 10.1109/TBME.2007.912423
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225
   Jugdaohsingh R, 2000, AM J CLIN NUTR, V71, P944
   Jugdaohsingh R, 2002, AM J CLIN NUTR, V75, P887
   Kashutina IA, 2008, P 33 WORKSH GEOTH RE
   Kaufmann EABE, 2000, J BIOMED MATER RES, V52, P825, DOI 10.1002/1097-4636(20001215)52:4<825::AID-JBM28>3.0.CO;2-M
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   Kwon S, 2013, J TISSUE ENG, V4
   LANDIS WJ, 1978, J ULTRA MOL STRUCT R, V63, P188, DOI 10.1016/S0022-5320(78)80074-4
   LANDIS WJ, 1986, CALCIFIED TISSUE INT, V38, P52, DOI 10.1007/BF02556595
   Leventouri T, 2003, BIOMATERIALS, V24, P4205, DOI 10.1016/S0142-9612(03)00333-8
   Li H, 2013, ACTA BIOMATER, V9, P6981, DOI 10.1016/j.actbio.2013.02.014
   LI PJ, 1993, BIOMATERIALS, V14, P963, DOI 10.1016/0142-9612(93)90186-6
   Lobel KD, 1998, J BIOMED MATER RES, V39, P575, DOI 10.1002/(SICI)1097-4636(19980315)39:4<575::AID-JBM11>3.0.CO;2-6
   Lopez PJ, 2003, CHEMBIOCHEM, V3, P1
   Lopez-Esteban S, 2003, J EUR CERAM SOC, V23, P2921, DOI 10.1016/S0955-2219(03)00303-0
   Loty C, 2000, J BIOMED MATER RES, V49, P423, DOI 10.1002/(SICI)1097-4636(20000315)49:4<423::AID-JBM1>3.3.CO;2-Z
   Low SP, 2009, BIOMATERIALS, V30, P2873, DOI 10.1016/j.biomaterials.2009.02.008
   Lugowski SJ, 2000, J TRACE ELEM MED BIO, V14, P31, DOI 10.1016/S0946-672X(00)80021-8
   Lutgens F. K., 2000, ESSENTIALS GEOLOGY
   Mahony O, 2008, NANOMEDICINE-UK, V3, P233, DOI 10.2217/17435889.3.2.233
   Mahony O, 2010, ADV FUNCT MATER, V20, P3835, DOI 10.1002/adfm.201000838
   Manzano M, 2011, ACTA BIOMATER, V7, P3555, DOI 10.1016/j.actbio.2011.06.004
   Marchat D, 2013, ACTA BIOMATER, V9, P6992, DOI 10.1016/j.actbio.2013.03.011
   Marron AO, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2543
   Martin KR, 2007, J NUTR HEALTH AGING, V11, P94
   Misra SK, 2008, BIOMATERIALS, V29, P1750, DOI 10.1016/j.biomaterials.2007.12.040
   Mladenovic Z, 2014, ACTA BIOMATER, V10, P406, DOI 10.1016/j.actbio.2013.08.039
   Nakasaki M, 2008, BONE, V43, P869, DOI 10.1016/j.bone.2008.07.241
   NASH KJ, 1994, J LUMIN, V60-1, P297, DOI 10.1016/0022-2313(94)90150-3
   Oliveira GM, 2008, J MATER SCI-MATER M, V19, P1775, DOI 10.1007/s10856-007-3331-z
   Olofsson I, 2012, BIOMATTER, V2, P1
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Parkhutik V, 2000, J POROUS MAT, V7, P363, DOI 10.1023/A:1009643206266
   Perry Carole C., 2009, V47, P295, DOI 10.1007/978-3-540-88552-8_13
   POLICARD A, 1961, J BIOPHYS BIOCHEM CY, V9, P236, DOI 10.1083/jcb.9.1.236
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   Pruksa S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-4
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Rau JV, 2010, MATER RES BULL, V45, P1304, DOI 10.1016/j.materresbull.2010.04.028
   Rau JV, 2013, THIN SOLID FILMS, V543, P167, DOI 10.1016/j.tsf.2012.12.113
   Rau JV, 2009, ACS APPL MATER INTER, V1, P1813, DOI 10.1021/am900356e
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Reid JW, 2005, BIOMATERIALS, V26, P2887, DOI 10.1016/j.biomaterials.2004.09.005
   Rosengren A, 2003, BIOMATERIALS, V24, P147, DOI 10.1016/S0142-9612(02)00272-7
   Rosenholm JM, 2012, NANOMEDICINE-UK, V7, P111, DOI [10.2217/NNM.11.166, 10.2217/nnm.11.166]
   Sachot N, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0684
   Santos H, 2014, POROUS SILICON BIOME, P526
   Scarfi S, 2007, FEBS J, V274, P60, DOI 10.1111/j.1742-4658.2006.05564.x
   Schroder HC, 2008, NAT PROD REP, V25, P455, DOI 10.1039/b612515h
   SCHWARZ K, 1973, P NATL ACAD SCI USA, V70, P1608, DOI 10.1073/pnas.70.5.1608
   SEO YH, 1994, JPN J APPL PHYS 1, V33, P6425, DOI 10.1143/JJAP.33.6425
   Serda RE, 2009, BIOMATERIALS, V30, P2440, DOI 10.1016/j.biomaterials.2009.01.019
   Shabir Q, 2011, SILICON
   Shabir Q, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-407
   Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2
   Soderling E, 1996, J BIOMED MATER RES, V31, P525, DOI 10.1002/(SICI)1097-4636(199608)31:4<525::AID-JBM13>3.0.CO;2-F
   Sripanyakorn S, 2004, BRIT J NUTR, V91, P403, DOI 10.1079/BJN20031082
   Sripanyakorn S, 2005, NUTR BULL, V30, P222, DOI 10.1111/j.1467-3010.2005.00507.x
   SUESS HE, 1956, REV MOD PHYS, V28, P53, DOI 10.1103/RevModPhys.28.53
   Thian ES, 2007, MAT SCI ENG C-BIO S, V27, P251, DOI 10.1016/j.msec.2006.05.016
   Thomas Mark V, 2005, J Long Term Eff Med Implants, V15, P585
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Vivero-Escoto JL, 2012, CHEM SOC REV, V41, P2673, DOI 10.1039/c2cs15229k
   Webster TJ, 2012, ACTA BIOMATER, V8, P4447, DOI 10.1016/j.actbio.2012.07.038
   Whitehead MA, 2008, TISSUE ENG PT A, V14, P195, DOI 10.1089/ten.a.2006.0370
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yamaji N, 2012, PLANT PHYSIOL, V160, P1491, DOI 10.1104/pp.112.204578
   Zhang EL, 2009, ACTA BIOMATER, V5, P1732, DOI 10.1016/j.actbio.2009.01.014
   Zhang K, 2005, CLIN CANCER RES, V11, P7532, DOI 10.1158/1078-0432.CCR-05-0400
NR 120
TC 57
Z9 58
U1 9
U2 119
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 1
PY 2015
VL 11
BP 17
EP 26
DI 10.1016/j.actbio.2014.09.025
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AY7NZ
UT WOS:000347747900002
PM 25246311
DA 2018-10-20
ER

PT J
AU Yodmuang, S
   McNamara, SL
   Nover, AB
   Mandal, BB
   Aganwal, M
   Kelly, TAN
   Chao, PHG
   Hung, C
   Kaplan, DL
   Vunjak-Novakovic, G
AF Yodmuang, Supansa
   McNamara, Stephanie L.
   Nover, Adam B.
   Mandal, Biman B.
   Aganwal, Monica
   Kelly, Terri-Ann N.
   Chao, Pen-hsiu Grace
   Hung, Clark
   Kaplan, David L.
   Vunjak-Novakovic, Gordana
TI Silk microfiber-reinforced silk hydrogel composites for functional
   cartilage tissue repair
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cartilage; Hydrogel; Tissue engineering; Chondrocyte; Silk
ID HIGH MECHANICAL STRENGTH; MESENCHYMAL STEM-CELLS; IN-VITRO; ENGINEERED
   CARTILAGE; ARTICULAR-CARTILAGE; EXTRACELLULAR-MATRIX; CONFINED
   COMPRESSION; FIBROIN SCAFFOLDS; DRUG-DELIVERY; VIVO
AB Cartilage tissue lacks an intrinsic capacity for self-regeneration due to slow matrix turnover, a limited supply of mature chondrocytes and insufficient vasculature. Although cartilage tissue engineering has achieved some success using agarose as a scaffolding material, major challenges of agarose-based cartilage repair, including non-degradability, poor tissue-scaffold integration and limited processing capability, have prompted the search for an alternative biomaterial. In this study, silk fiber-hydrogel composites (SF-silk hydrogels) made from silk microfibers and silk hydrogels were investigated for their potential use as a support material for engineered cartilage. We demonstrated the use of 100% silk-based fiber-hydrogel composite scaffolds for the development of cartilage constructs with properties comparable to those made with agarose. Cartilage constructs with an equilibrium modulus in the native tissue range were fabricated by mimicking the collagen fiber and proteoglycan composite architecture of native cartilage using biocompatible, biodegradable silk fibroin from Bombyx mari. Excellent chondrocyte response was observed on SF-silk hydrogels, and fiber reinforcement resulted in the development of more mechanically robust constructs after 42 days in culture compared to silk hydrogels alone. Thus, we demonstrate the versatility of silk fibroin as a composite scaffolding material for use in cartilage tissue repair to create functional cartilage constructs that overcome the limitations of agarose biomaterials, and provide a much-needed alternative to the agarose standard. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Yodmuang, Supansa; Nover, Adam B.; Aganwal, Monica; Hung, Clark; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY USA.
   [McNamara, Stephanie L.; Kelly, Terri-Ann N.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Mandal, Biman B.] Indian Inst Technol, Dept Biotechnol, Gauhati 781039, India.
   [Chao, Pen-hsiu Grace] Natl Taiwan Univ, Sch Engn, Inst Biomed Engn, Taipei 10764, Taiwan.
   [Chao, Pen-hsiu Grace] Natl Taiwan Univ, Sch Med, Taipei 10764, Taiwan.
RP Vunjak-Novakovic, G (reprint author), Vanderbilt Clin, 622 West 168th St,12th Floor,Room VC12-234, New York, NY 10032 USA.
EM gv2131@columbia.edu
RI Chao, Pen-hsiu Grace/F-4845-2012
OI Chao, Pen-hsiu Grace/0000-0001-8520-4800; Nover,
   Adam/0000-0003-1008-2233; Vunjak-Novakovic, Gordana/0000-0002-9382-1574
FU NIH [DE016525, EB002520, AR061988]; Royal Thai Graduate Fellowship
FX We gratefully acknowledge research funding received from the NIH (grants
   DE016525 to G.V.N., EB002520 to D.K. and G.V.N., AR061988 to D.K., C.H.
   and G.V.N.), and the Royal Thai Graduate Fellowship (to S.Y.).
CR Agrawal A, 2013, ACTA BIOMATER, V9, P5313, DOI 10.1016/j.actbio.2012.10.011
   Ahmed M, 2013, ADV MAT SCI, P80
   Albro MB, 2009, CELL MOL BIOENG, V2, P295, DOI 10.1007/s12195-009-0076-4
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Asanbaeva A, 2007, ARTHRITIS RHEUM, V56, P188, DOI 10.1002/art.22298
   Becerra J, 2010, TISSUE ENG PART B-RE, V16, P617, DOI [10.1089/ten.teb.2010.0191, 10.1089/ten.TEB.2010.0191]
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167
   Boschetti F, 2004, BIORHEOLOGY, V41, P159
   Byers BA, 2008, TISSUE ENG PT A, V14, P1821, DOI 10.1089/ten.tea.2007.0222
   Can X, 2002, J BIOMAT SCI-POLYM E, V13, P623
   Cao Z, 2009, BIOMACROMOLECULES, V10, P2954, DOI 10.1021/bm900670n
   Cha C, 2014, BIOMATER SCI, V2, P141
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Coburn J, 2011, SMART STRUCT SYST, V7, P213, DOI 10.12989/sss.2011.7.3.213
   De Paepe I, 2002, POLYM INT, V51, P867, DOI 10.1002/pi.945
   Detterline AJ, 2005, ORTHOP NURS, V24, P361
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Fang Jia-You, 2006, Chem Pharm Bull (Tokyo), V54, P156, DOI 10.1248/cpb.54.156
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Hannouche D, 2007, TISSUE ENG, V13, P87, DOI 10.1089/ten.2006.0067
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435
   Hsieh A, 2010, SOFT MATTER, V6, P2227, DOI 10.1039/b924349f
   Huang T, 2007, ADV MATER, V19, P1622, DOI 10.1002/adma.200602533
   Hunter CJ, 2004, TISSUE ENG, V10, P736, DOI 10.1089/1076327041348310
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Klein TJ, 2010, SOFT MATTER, V6, P5175, DOI 10.1039/c0sm00229a
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   Lee SM, 1992, HDB COMPOSITE REINFO, P91
   Lima EG, 2007, OSTEOARTHR CARTILAGE, V15, P1025, DOI 10.1016/j.joca.2007.03.008
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mansour JM, 2003, KINESIOLOGY MECH PAT, P1992
   MARSHALL DB, 1985, ACTA METALL MATER, V33, P2013, DOI 10.1016/0001-6160(85)90124-5
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2012, ADV DRUG DELIVER REV, V64, P1111, DOI 10.1016/j.addr.2012.03.016
   Mouw JK, 2005, OSTEOARTHR CARTILAGE, V13, P828, DOI 10.1016/j.joca.2005.04.020
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Murphy L, 2012, AM J NURS, V112, pS13, DOI 10.1097/01.NAJ.0000412646.80054.21
   Nakayama A, 2004, ADV FUNCT MATER, V14, P1124, DOI 10.1002/adfm.200305197
   Nuernberger S, 2011, BIOMATERIALS, V32, P1032, DOI 10.1016/j.biomaterials.2010.08.100
   Park SY, 2010, TISSUE ENG PT A, V16, P1271, DOI [10.1089/ten.tea.2009.0328, 10.1089/ten.TEA.2009.0328]
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Ronken S, 2013, BIOMECH MODEL MECHAN, V12, P243, DOI 10.1007/s10237-012-0395-6
   Salinas CN, 2009, J BIOMED MATER RES A, V90A, P456, DOI 10.1002/jbm.a.32112
   Soltz MA, 1998, J BIOMECH, V31, P927, DOI 10.1016/S0021-9290(98)00105-5
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Vunjak-Novakovic G, 2004, BASIC ORTHOPAEDIC BI, P363
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   Yu F, 2013, CARBOHYD POLYM, V97, P188, DOI 10.1016/j.carbpol.2013.04.046
   Zheng L, 2013, IRAN POLYM J, V22, P833, DOI 10.1007/s13726-013-0182-y
   Zhou CJ, 2011, COLLOID SURFACE B, V84, P155, DOI 10.1016/j.colsurfb.2010.12.030
NR 64
TC 67
Z9 72
U1 12
U2 231
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 1
PY 2015
VL 11
BP 27
EP 36
DI 10.1016/j.actbio.2014.09.032
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AY7NZ
UT WOS:000347747900003
PM 25281788
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Akintewe, OO
   DuPont, SJ
   Elineni, KK
   Cross, MC
   Toomey, RG
   Gallant, ND
AF Akintewe, Olukemi O.
   DuPont, Samuel J.
   Elineni, Kranthi Kumar
   Cross, Michael C.
   Toomey, Ryan G.
   Gallant, Nathan D.
TI Shape-changing hydrogel surfaces trigger rapid release of patterned
   tissue modules
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Stimulus responsive materials; Hydrogel; Poly-N-isopropylacrylamide;
   Cell release; Tissue building block
ID CELL SHEET DETACHMENT; NANOCOMPOSITE HYDROGELS; EXTRACELLULAR-MATRIX;
   CULTURE MEMBRANES; POLYMER; TRANSPLANTATION; RECONSTRUCTION; RECOVERY;
   DESIGN; MODEL
AB The formation and assembly of diverse tissue building blocks is considered a promising bottom-up approach for the construction of complex three-dimensional tissues. Patterned shape-changing materials were investigated as an innovative method to form and harvest free-standing tissue modules with preserved spatial organization and cell-cell connections. Arrays of micro-scale surface-attached hydrogels made of a thermoresponsive polymer were used as cell culture supports to fabricate tissue modules of defined geometric shape. Upon stimulation, these hydrogels swelled anisotropically, resulting in significant expansion of the culture surface and subsequent expulsion of the intact tissue modules. By varying the network crosslink density, the surface strain was modulated and a strain threshold for tissue module release was identified. This mechanical mechanism for rapid tissue module harvest was found to require inter- and intra-cellular tension. These results suggest that the cell-matrix adhesions are disrupted by the incompatibility of surface expansion with tissue module cohesion and stiffness, thus providing a novel method of forming and harvesting tissue building blocks by a mechanism independent of the thermal stimulus that induces the biomaterial shape change. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Akintewe, Olukemi O.; DuPont, Samuel J.; Toomey, Ryan G.] Univ S Florida, Dept Chem & Biomed Engn, Tampa, FL 33620 USA.
   [Elineni, Kranthi Kumar; Gallant, Nathan D.] Univ S Florida, Dept Mech Engn, Tampa, FL 33620 USA.
   [Cross, Michael C.] Univ S Florida, Dept Phys, Tampa, FL 33620 USA.
RP Toomey, RG (reprint author), Univ S Florida, Dept Chem & Biomed Engn, Tampa, FL 33620 USA.
EM toomey@usf.edu; ngallant@usf.edu
OI Gallant, Nathan/0000-0001-6454-7660
FU NSF [DMR-0645574, DMR-1056475]; USF-STARS fellowship (NSF-GK-12) [DGE
   0638709]; UNCF-Merck fellowship
FX The authors thank Spencer Reed, Matthew Vega and Safia Khawaja for
   sample preparation, and Mark Lloyd and Joseph O. Johnson for assistance
   in the acquisition of images via confocal microscopy. This research was
   supported in part by NSF Grants DMR-0645574, DMR-1056475, USF-STARS
   fellowship (NSF-GK-12 award DGE 0638709) and a UNCF-Merck fellowship.
CR Al-Fageeh MB, 2006, BIOTECHNOL BIOENG, V93, P829, DOI 10.1002/bit.20789
   Canavan HE, 2005, J BIOMED MATER RES A, V75A, P1, DOI 10.1002/jbm.a.30297
   Canavan HE, 2005, LANGMUIR, V21, P1949, DOI 10.1021/la048546c
   Da Silva RMP, 2007, TRENDS BIOTECHNOL, V25, P577, DOI 10.1016/j.tibtech.2007.08.014
   Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084
   DuPont SJ, 2010, SOFT MATTER, V6, P3876, DOI 10.1039/c0sm00021c
   Dupont SJ, 2012, THESIS
   Elbert DL, 2011, CURR OPIN BIOTECH, V22, P674, DOI 10.1016/j.copbio.2011.04.001
   Elloumi-Hannachi I, 2010, J INTERN MED, V267, P54, DOI 10.1111/j.1365-2796.2009.02185.x
   Fujita Jun, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P243
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Gallant Nathan D, 2007, Methods Mol Biol, V370, P83
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Haraguchi K, 2006, BIOMACROMOLECULES, V7, P3267, DOI 10.1021/bm060549b
   Hasegawa M, 2005, TISSUE ENG, V11, P469, DOI 10.1089/ten.2005.11.469
   Hayashida Y, 2006, INVEST OPHTH VIS SCI, V47, P552, DOI 10.1167/iovs.05-0995
   Hou Y, 2008, BIOMATERIALS, V29, P3175, DOI 10.1016/j.biomaterials.2008.04.024
   Ishizaki T, 2000, MOL PHARMACOL, V57, P976
   Kim SJ, 2013, BIOMACROMOLECULES, V14, P4309, DOI 10.1021/bm4011744
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Kolettis TM, 2011, MINI-REV MED CHEM, V11, P8
   Kumar A, 2007, PROG POLYM SCI, V32, P1205, DOI 10.1016/j.progpolymsci.2007.05.003
   Kwon OH, 2000, J BIOMED MATER RES, V50, P82, DOI 10.1002/(SICI)1097-4636(200004)50:1<82::AID-JBM12>3.3.CO;2-Z
   Kwon OH, 2003, BIOMATERIALS, V24, P1223, DOI 10.1016/S0142-9612(02)00469-6
   Lee EL, 2010, J BIOMED MATER RES A, V93A, P411, DOI 10.1002/jbm.a.32754
   Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031
   Mcguigan AP, 2007, TISSUE ENG, V13, P1069, DOI 10.1089/ten.2006.0253
   Muraoka M, 2013, BIOMATERIALS, V34, P696, DOI 10.1016/j.biomaterials.2012.10.009
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   PALMIERI F, 1967, EUR J BIOCHEM, V1, P439, DOI 10.1111/j.1432-1033.1967.tb00093.x
   Reed JA, 2008, J APPL BIOMATER BIOM, V6, P81
   Roy I, 2003, CHEM BIOL, V10, P1161, DOI 10.1016/j.chembiol.2003.12.004
   Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286
   SHIBAYAMA M, 1993, ADV POLYM SCI, V109, P1
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732
   Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001
   Sutton MS, 2003, CIRCULATION, V107, P2577, DOI 10.1161/01.CIR.0000070420.51787.A8
   Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z
   Yamato M, 1999, J BIOMED MATER RES, V44, P44, DOI 10.1002/(SICI)1097-4636(199901)44:1<44::AID-JBM5>3.3.CO;2-O
   Yamato M, 2004, MATER TODAY, V7, P6
   Yang GP, 2007, GUT, V56, P313, DOI 10.1136/gut.2006.100073
   Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052
NR 46
TC 10
Z9 10
U1 4
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 1
PY 2015
VL 11
BP 96
EP 103
DI 10.1016/j.actbio.2014.09.040
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AY7NZ
UT WOS:000347747900010
PM 25266505
DA 2018-10-20
ER

PT J
AU Hadidi, P
   Yeh, TC
   Hu, JC
   Athanasiou, KA
AF Hadidi, Pasha
   Yeh, Timothy C.
   Hu, Jerry C.
   Athanasiou, Kyriacos A.
TI Critical seeding density improves the properties and translatability of
   self-assembling anatomically shaped knee menisci
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomaterials; Biomechanics; Tissue engineering; Knee meniscus;
   Self-assembling process
ID ENGINEERED ARTICULAR-CARTILAGE; MATRICES IN-VITRO; CHONDROITINASE-ABC;
   TENSILE PROPERTIES; TISSUE; CONSTRUCTS; REPAIR; REGENERATION;
   TGF-BETA-1; PRESSURE
AB A recent development in the field of tissue engineering is the rise of all-biologic, scaffold-free engineered tissues. Since these biomaterials rely primarily upon cells, investigation of initial seeding densities constitutes a particularly relevant aim for tissue engineers. In this study, a scaffold-free method was used to create fibrocartilage in the shape of the rabbit knee meniscus. The objectives of this study were to: (i) determine the minimum seeding density, normalized by an area of 44 mm(2), necessary for the self-assembling process of fibrocartilage to occur; (ii) examine relevant biomechanical properties of engineered fibrocartilage, such as tensile and compressive stiffness and strength, and their relationship to seeding density; and (iii) identify a reduced, or optimal, number of cells needed to produce this biomaterial. It was found that a decreased initial seeding density, normalized by the area of the construct, produced superior mechanical and biochemical properties. Collagen per wet weight, glycosaminoglycans per wet weight, tensile properties and compressive properties were all significantly greater in the 5 million cells per construct group as compared to the historical 20 million cells per construct group. Scanning electron microscopy demonstrated that a lower seeding density results in a denser tissue. Additionally, the translational potential of the self-assembling process for tissue engineering was improved though this investigation, as fewer cells may be used in the future. The results of this study underscore the potential for critical seeding densities to be investigated when researching scaffold-free engineered tissues. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Hadidi, Pasha; Yeh, Timothy C.; Hu, Jerry C.; Athanasiou, Kyriacos A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
   [Athanasiou, Kyriacos A.] Univ Calif Davis, Dept Orthoped Surg, Davis, CA 95616 USA.
RP Athanasiou, KA (reprint author), Univ Calif Davis, Dept Biomed Engn, One Shields Ave, Davis, CA 95616 USA.
EM athanasiou@ucdavis.edu
FU HHMI Med into Grad Initiative [56006769]; NIH [R01 AR047839, R01
   DE019666]
FX We acknowledge funding from HHMI Med into Grad Initiative 56006769
   (fellowship for P.H.), NIH R01 AR047839 and NIH R01 DE019666. P.H. and
   K.A.A. conceived and designed the experiments in this study; P.H. and
   T.Y. acquired the data; P.H., T.Y., J.C.H. and K.A.A. reviewed and
   interpreted the data; and P.H., J.C.H. and K.A.A. wrote and edited the
   paper.
CR Allen MD, 2006, J BIOMECH, V39, P312
   Andrews JW, 2013, SOFT MATTER, V9, P5581, DOI 10.1039/c3sm50706h
   [Anonymous], 2010, E11104 ASTM
   Athanasiou MA, 2013, ANN REV BIOMED ENG
   Athens AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060719
   Aufderheide AC, 2007, TISSUE ENG, V13, P2195, DOI 10.1089/ten.2006.0291
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Conti Paulo Cesar R., 1996, Journal of Orofacial Pain, V10, P254
   Detamore MS, 2003, J BIOMECH ENG-T ASME, V125, P558, DOI 10.1115/1.1589778
   Donahue TLH, 2004, J ORTHOPAED RES, V22, P807, DOI 10.1016/j.orthres.2003.12.010
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Elder BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002341
   FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664
   FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19
   Fukuda J, 2006, BIOMATERIALS, V27, P1061, DOI 10.1016/j.biomaterials.2005.07.031
   Grayson WL, 2008, TISSUE ENG PT A, V14, P1809, DOI 10.1089/ten.tea.2007.0255
   Gunja NJ, 2009, J TISSUE ENG REGEN M, V3, P521, DOI 10.1002/term.191
   Gunja NJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2293
   Hadidi P, 2013, BIOCH BIOPHYS RES CO
   HARRIS RI, 1954, J BONE JOINT SURG BR, V36, P304
   Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   Huey DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027857
   Huey DJ, 2011, BIOMATERIALS, V32, P2052, DOI 10.1016/j.biomaterials.2010.11.041
   Kalpakci KN, 2011, ACTA BIOMATER, V7, P1710, DOI 10.1016/j.actbio.2010.12.015
   KEMPSON GE, 1970, BIOCHIM BIOPHYS ACTA, V215, P70, DOI 10.1016/0304-4165(70)90388-0
   Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1
   Leslie BW, 2000, P I MECH ENG H, V214, P631, DOI 10.1243/0954411001535651
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   MacBarb RF, 2013, ACTA BIOMATER, V9, P4626, DOI 10.1016/j.actbio.2012.09.037
   Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Mueller SM, 1999, BIOMATERIALS, V20, P701, DOI 10.1016/S0142-9612(98)00189-6
   Natoli RM, 2009, TISSUE ENG PT A, V15, P3119, DOI [10.1089/ten.tea.2008.0478, 10.1089/ten.TEA.2008.0478]
   Natoli RM, 2010, ARTHRITIS RHEUM-US, V62, P1097, DOI 10.1002/art.27313
   Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795
   PROCTOR CS, 1989, J ORTHOP RES, V7, P771, DOI 10.1002/jor.1100070602
   Puetzer JL, 2013, ACTA BIOMATER, V9, P7787, DOI 10.1016/j.actbio.2013.05.002
   Rattner JB, 2011, SCAND J MED SCI SPOR, V21, P543, DOI 10.1111/j.1600-0838.2009.01073.x
   Responte DJ, 2012, BIOMATERIALS, V33, P3187, DOI 10.1016/j.biomaterials.2012.01.028
   Revell CM, 2008, ANN BIOMED ENG, V36, P1441, DOI 10.1007/s10439-008-9524-x
   Salata MJ, 2010, AM J SPORT MED, V38, P1907, DOI 10.1177/0363546510370196
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Sweigart MA, 2004, ANN BIOMED ENG, V32, P1569, DOI 10.1114/B:ABME.0000049040.70767.5c
   Taglieber A, 2007, ANGEW CHEM INT EDIT, V46, P8597, DOI 10.1002/anie.200702751
   TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   WALKER PS, 1975, CLIN ORTHOP RELAT R, P184
   Zaleskas JM, 2004, BIOMATERIALS, V25, P1299, DOI 10.1016/j.biomaterials.2003.08.005
NR 50
TC 3
Z9 4
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 1
PY 2015
VL 11
BP 173
EP 182
DI 10.1016/j.actbio.2014.09.011
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AY7NZ
UT WOS:000347747900017
PM 25234157
OA Green Accepted, Green Published
DA 2018-10-20
ER

PT J
AU Rauck, BM
   Novosat, TL
   Oudega, M
   Wang, YD
AF Rauck, Britta M.
   Novosat, Tabitha L.
   Oudega, Martin
   Wang, Yadong
TI Biocompatibility of a coacervate-based controlled release system for
   protein delivery to the injured spinal cord
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Spinal cord injury; Growth factor delivery; Biocompatibility; Nervous
   tissue loss; Sonic hedgehog
ID FIBROBLAST GROWTH FACTOR-2; SONIC HEDGEHOG; ADULT-RAT; FUNCTIONAL
   RECOVERY; IN-VITRO; NEUROTROPHIC FACTORS; PROLIFERATION; REGENERATION;
   MACROPHAGE; REPAIR
AB The efficacy of protein-based therapies for treating injured nervous tissue is limited by the short half-life of free proteins in the body. Affinity-based biomaterial delivery systems provide sustained release of proteins, thereby extending the efficacy of such therapies. Here, we investigated the biocompatibility of a novel coacervate delivery system based on poly(ethylene argininylaspartate diglyceride) (PEAD) and heparin in the damaged spinal cord. We found that the presence of the [PEAD:heparin] coacervate did not affect the macrophage response, glial scarring or nervous tissue loss, which are hallmarks of spinal cord injury. Moreover, the density of axons, including serotonergic axons, at the injury site and the recovery of motor and sensorimotor function were comparable in rats with and without the coacervate. These results revealed the biocompatibility of our delivery system and supported its potential to deliver therapeutic proteins to the injured nervous system. (C) 2014 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Rauck, Britta M.; Oudega, Martin; Wang, Yadong] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Rauck, Britta M.; Wang, Yadong] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Novosat, Tabitha L.; Oudega, Martin] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15261 USA.
   [Oudega, Martin] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15219 USA.
   [Wang, Yadong] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   [Wang, Yadong] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15219 USA.
RP Oudega, M (reprint author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
EM moudega@pitt.edu; yaw20@pitt.edu
FU NIH [2T32EB003392-07]; NSF [DMR-1206589]
FX The authors are deeply thankful to Callen Wallace in the Center for
   Biological Imaging at the University of Pittsburgh for assistance in
   automated image analysis, and Mr. Lou Johnson for statistical
   consultation. Funding for this work was generously provided by NIH
   2T32EB003392-07 and NSF DMR-1206589.
CR Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936
   Bambakidis NC, 2003, J NEUROSURG, V99, P70, DOI 10.3171/spi.2003.99.1.0070
   Bambakidis NC, 2012, J NEUROSURG, V116, P1114, DOI 10.3171/2012.1.JNS111285
   Bambakidis NC, 2009, J NEUROSURG-SPINE, V10, P171, DOI 10.3171/2008.10.SPI08231
   Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Basso DM, 2000, PHYS THER, V80, P808
   Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705
   CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296
   Chu HH, 2013, BIOMATERIALS, V34, P1747, DOI 10.1016/j.biomaterials.2012.11.019
   Chu HH, 2012, BIOTECHNOL PROGR, V28, P257, DOI 10.1002/btpr.728
   Chu HH, 2011, P NATL ACAD SCI USA, V108, P13444, DOI 10.1073/pnas.1110121108
   Chu HH, 2011, J CONTROL RELEASE, V150, P157, DOI 10.1016/j.jconrel.2010.11.025
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Fitch MT, 1999, J NEUROSCI, V19, P8182
   Gumera C, 2011, J MATER CHEM, V21, P7033, DOI 10.1039/c0jm04335d
   Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263
   Hashimoto M, 2008, J NEUROCHEM, V107, P918, DOI 10.1111/j.1471-4159.2008.05666.x
   Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483
   Johnson NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063075
   Johnson NR, 2013, J CONTROL RELEASE, V166, P124, DOI 10.1016/j.jconrel.2012.11.004
   Kigerl KA, 2012, EXP NEUROL, V233, P333, DOI 10.1016/j.expneurol.2011.10.025
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983
   Leskovar A, 2000, J EXP BIOL, V203, P1783
   Li HS, 2013, STEM CELL TRANSL MED, V2, P667, DOI 10.5966/sctm.2013-0027
   Lowry N, 2012, BIOMATERIALS, V33, P2892, DOI 10.1016/j.biomaterials.2011.12.048
   Mantilla CB, 2013, EXP NEUROL, V247, P101, DOI 10.1016/j.expneurol.2013.04.002
   Marti E, 2002, TRENDS NEUROSCI, V25, P89, DOI 10.1016/S0166-2236(02)02062-3
   McTigue DM, 1998, J NEUROSCI, V18, P5354
   MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853
   Nishimaru H, 2000, NEUROSCI LETT, V280, P187, DOI 10.1016/S0304-3940(00)00805-3
   Parr AM, 2007, NEUROSURGERY, V60, P926, DOI 10.1227/01.NEU.0000255441.59612.98
   Rabchevsky AG, 1999, J NEUROTRAUM, V16, P817, DOI 10.1089/neu.1999.16.817
   Ritfeld GJ, 2014, BIOMATERIALS, V35, P1924, DOI 10.1016/j.biomaterials.2013.11.062
   Ritfeld GJ, 2012, CELL TRANSPLANT, V21, P1561, DOI 10.3727/096368912X640484
   Sayer FT, 2002, EXP NEUROL, V175, P282, DOI 10.1006/exnr.2002.7901
   Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019
   Straface G, 2009, J CELL MOL MED, V13, P2424, DOI 10.1111/j.1582-4934.2008.00440.x
   Takeoka A, 2009, J COMP NEUROL, V515, P664, DOI 10.1002/cne.22080
   XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056
   Zern BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011017
NR 43
TC 7
Z9 7
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 1
PY 2015
VL 11
BP 204
EP 211
DI 10.1016/j.actbio.2014.09.037
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AY7NZ
UT WOS:000347747900020
PM 25266504
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Brown, J
   Lu, CL
   Coburn, J
   Kaplan, DL
AF Brown, Joseph
   Lu, Chia-Li
   Coburn, Jeannine
   Kaplan, David L.
TI Impact of silk biomaterial structure on proteolysis
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk; Protease; Digestion; Hydrogels; Films
ID PROTEIN SECONDARY STRUCTURES; ENZYMATIC DEGRADATION; BOMBYX-MORI; MATRIX
   METALLOPROTEINASES; FIBROIN; FILMS; HYDROGELS; WATER; GENE;
   PROLIFERATION
AB The goal of this study was to determine the impact of silk biomaterial structure (e.g. solution, hydrogel, film) on proteolytic susceptibility. In vitro enzymatic degradation of silk fibroin hydrogels and films was studied using a variety of proteases, including proteinase K, protease XIV, alpha-chymotrypsin, collagenase, matrix metalloproteinase-1 (MMP-1) and MMP-2. Hydrogels were used to assess bulk degradation while films were used to assess surface degradation. Weight loss, secondary structure determined by Fourier transform infrared spectroscopy and degradation products analyzed via sodium dodecyl sulfate-polyacrylamide gel electrophoresis were used to evaluate degradation over 5 days. Silk films were significantly degraded by proteinase K, while silk hydrogels were degraded more extensively by protease XIV and proteinase K. Collagenase preferentially degraded the beta-sheet content in hydrogels while protease XIV and alpha-chymotrypsin degraded the amorphous structures. MMP-1 and MMP-2 degraded silk fibroin in solution, resulting in a decrease in peptide fragment sizes over time. The link between primary sequence mapping with protease susceptibility provides insight into the role of secondary structure in impacting proteolytic access by comparing solution vs. solid state proteolytic susceptibility. (C) 2014 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Brown, Joseph; Lu, Chia-Li; Coburn, Jeannine; Kaplan, David L.] Tufts Univ, Sch Engn, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Sch Engn, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Coburn, Jeannine M./0000-0001-6354-5436
FU NIH [P41 EB002520, U01 EB014976, R01 DE017207]
FX We thank the NIH for support of this research (P41 EB002520, U01
   EB014976, R01 DE017207).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   APPEL W, 1986, CLIN BIOCHEM, V19, P317, DOI 10.1016/S0009-9120(86)80002-9
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Bello L, 2001, CANCER RES, V61, P8730
   BOON ME, 1995, BIOMATERIALS, V16, P1089, DOI 10.1016/0142-9612(95)98905-T
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   C-A Bauer, 1978, AM CHEM SOC, V17, P375
   Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C
   deJongh HHJ, 1996, ANAL BIOCHEM, V242, P95, DOI 10.1006/abio.1996.0434
   DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022
   EBELING W, 1974, EUR J BIOCHEM, V47, P91, DOI 10.1111/j.1432-1033.1974.tb03671.x
   Eppley BL, 2006, PLAST RECONSTR SURG, V118, p98E, DOI 10.1097/01.prs.0000232436.91409.30
   Fernandez-Patron C, 2000, CIRC RES, V87, P670, DOI 10.1161/01.RES.87.8.670
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Jackson JK, 2010, J MATER SCI-MATER M, V21, P1435, DOI 10.1007/s10856-010-4019-3
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jones D, 2010, DERMATOL SURG, V36, P804, DOI 10.1111/j.1524-4725.2010.01550.x
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lee JE, 2001, YONSEI MED J, V42, P172, DOI 10.3349/ymj.2001.42.2.172
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491
   Numata K, 2010, BIOMACROMOLECULES, V11, P3189, DOI 10.1021/bm101055m
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017
   Petibois C, 2006, ANALYST, V131, P640, DOI 10.1039/b518076g
   Petibois C, 2001, CLIN CHEM, V47, P730
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Saarinen J, 1999, EUR J BIOCHEM, V259, P829, DOI 10.1046/j.1432-1327.1999.00105.x
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sweeney P J, 1993, Methods Mol Biol, V16, P305, DOI 10.1385/0-89603-234-5:305
   Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Turpeenniemi-Hujanen T, 2005, BIOCHIMIE, V87, P287, DOI 10.1016/j.biochi.2005.01.014
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Yamada H, 2004, BIOMATERIALS, V25, P467, DOI 10.1016/S0142-9612(03)00540-4
   Yu AE, 1998, BIOL EXTRAC, P85
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 50
TC 29
Z9 29
U1 4
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 1
PY 2015
VL 11
BP 212
EP 221
DI 10.1016/j.actbio.2014.09.013
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AY7NZ
UT WOS:000347747900021
PM 25240984
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ndiaye, M
   Terranova, L
   Mallet, R
   Mabilleau, G
   Chappard, D
AF Ndiaye, Mambaye
   Terranova, Lisa
   Mallet, Romain
   Mabilleau, Guillaume
   Chappard, Daniel
TI Three-dimensional arrangement of beta-tricalcium phosphate granules
   evaluated by microcomputed tomography and fractal analysis
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Granular material; Fractal geometry; Lacunarity; Succolarity; beta-TCP
ID CANCELLOUS BONE; TRABECULAR BONE; POROUS HYDROXYAPATITE;
   COMPUTED-TOMOGRAPHY; IMAGE-ANALYSIS; ILIAC CREST; LACUNARITY; SCAFFOLDS;
   DIMENSION; MODELS
AB The macrophysical properties of granular biomaterials used to fill bone defects have rarely been considered. Granules of a given biomaterial occupy three-dimensional (3-D) space when packed together and create a macroporosity suitable for the invasion of vascular and bone cells. Granules of beta-tricalcium phosphate were prepared using polyurethane foam technology and increasing the amount of material powder in the slurry (10, 11, 15, 18, 21 and 25 g). After sintering, granules of 1000-2000 gm were prepared by sieving. They were analyzed morphologically by scanning electron microscopy and placed in polyethylene test tubes to produce 3-D scaffolds. Microcomputed tomography (microCT) was used to image the scaffolds and to determine porosity and fractal dimension in three dimensions. Two-dimensional sections of the microCT models were binarized and used to compute classical morphometric parameters describing porosity (interconnectivity index, strut analysis and star volumes) and fractal dimensions. In addition, two newly important fractal parameters (lacunarity and succolarity) were measured. Compression analysis of the stacks of granules was done. Porosity decreased as the amount of material in the slurry increased but non-linear relationships were observed between microarchitectural parameters describing the pores and porosity. Lacunarity increased in the series of granules but succolarity (reflecting the penetration of a fluid) was maximal in the 15-18 g groups and decreased noticeably in the 25 g group. The 3-D arrangement of biomaterial granules studied by these new fractal techniques allows the optimal formulation to be derived based on the lowest amount of material, suitable mechanical resistance during crushing and the creation of large interconnected pores. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ndiaye, Mambaye; Terranova, Lisa; Mallet, Romain; Mabilleau, Guillaume; Chappard, Daniel] LUNAM Univ, CHU Angers, IRIS IBS Inst Biol Sante, GEROM LHEA, F-49933 Angers, France.
   [Mallet, Romain; Mabilleau, Guillaume; Chappard, Daniel] LUNAM Univ, CHU Angers, IRIS IBS Inst Biol Sante, SCIAM, F-49933 Angers, France.
RP Chappard, D (reprint author), LUNAM Univ, CHU Angers, IRIS IBS Inst Biol Sante, GEROM LHEA, F-49933 Angers, France.
EM daniel.chappard@univ-angers.fr
RI Mabilleau, Guillaume/M-8261-2018
OI Mabilleau, Guillaume/0000-0003-1445-329X
FU Bioregos2 regional contract
FX This work was funded by a Grant from the Bioregos2 regional contract.
   The authors thank Kasios, 18 chemin de la Violette, 31240 L'Union,
   France for help in preparing the different formulations of granules.
CR Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039
   Alexander JM, 2001, J BONE MINER RES, V16, P1665, DOI 10.1359/jbmr.2001.16.9.1665
   ALLAIN C, 1991, PHYS REV A, V44, P3552, DOI 10.1103/PhysRevA.44.3552
   Chappard D, 1996, J BONE MINER RES, V11, P676
   Chappard D, 2005, J BONE MINER RES, V20, P1177, DOI 10.1359/JBMR.050205
   Chappard D, 2001, J PATHOL, V195, P515, DOI 10.1002/path.970
   Chappard D, 1999, MICROSC RES TECHNIQ, V45, P303, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<303::AID-JEMT14>3.0.CO;2-8
   Chappard D, 2010, MICRON, V41, P321, DOI 10.1016/j.micron.2009.12.005
   Chazono M, 2008, J ORTHOP SCI, V13, P550, DOI 10.1007/s00776-008-1271-1
   Chun HC, 2008, GEODERMA, V146, P83, DOI 10.1016/j.geoderma.2008.05.018
   COMPSTON JE, 1987, BONE, V8, P289, DOI 10.1016/8756-3282(87)90004-4
   COMPSTON JE, 1994, BONE, V15, P463, DOI 10.1016/8756-3282(94)90267-4
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   de Melo RHC, 2013, TELECOMMUN SYST, V52, P1643, DOI 10.1007/s11235-011-9657-3
   de Melo RHC, 2007, USING FRACTAL CHARAC
   de Melo RHC, 2006, 13 INT C SYST SIGN I, P299
   Fazzalari NL, 1997, J BONE MINER RES, V12, P632, DOI 10.1359/jbmr.1997.12.4.632
   Filmon R, 2002, J BIOMAT SCI-POLYM E, V13, P1105, DOI 10.1163/156856202320813828
   Filmon R, 2009, IMAGE ANAL STEREOL, V28, P1
   Ghosh SK, 2008, J BIOMED MATER RES B, V86B, P217, DOI 10.1002/jbm.b.31009
   Guldberg RE, 2008, BIOMATERIALS, V29, P3757, DOI 10.1016/j.biomaterials.2008.06.018
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Haire TJ, 1998, MED ENG PHYS, V20, P588, DOI 10.1016/S1350-4533(98)00063-0
   HECKEL RW, 1961, T METALL SOC AIME, V221, P1001
   Hordon LD, 2006, BONE, V38, P444, DOI 10.1016/j.bone.2005.09.020
   Hu BX, 2009, J CONTAM HYDROL, V108, P77, DOI 10.1016/j.jconhyd.2009.06.001
   Ikeda N, 1999, BIOMATERIALS, V20, P1087, DOI 10.1016/S0142-9612(99)00005-8
   Jones JR, 2007, BIOMATERIALS, V28, P1404, DOI 10.1016/j.biomaterials.2006.11.014
   Kadiri MS, 2004, COMPRESSION POUDRES
   Klein M, 2009, CLIN ORAL IMPLAN RES, V20, P67, DOI 10.1111/j.1600-0501.2008.01605.x
   Laib A, 1999, BONE, V24, P35, DOI 10.1016/S8756-3282(98)00159-8
   Latief FDE, 2012, INT J ROCK MECH MIN, V50, P117, DOI 10.1016/j.ijrmms.2011.12.005
   LE HM, 1992, ACTA STEREOL, V11, P267
   LEVITZ P, 1992, J PHYS I, V2, P771
   MANDELBROT BB, 1977, FRACTAL GEOMETRY NAT
   MELLISH RWE, 1991, J BONE MINER RES, V6, P689
   N'Diaye M, 2013, MAT SCI ENG C-MATER, V33, P2025, DOI 10.1016/j.msec.2013.01.020
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Roy TD, 2003, J BIOMED MATER RES A, V67A, P1228, DOI 10.1002/jbm.a.20034
   Sasov A, 1998, J MICROSC-OXFORD, V191, P151
   Schwartzwalder K., 1963, Patent US, Patent No. [3090094 A, 3090094, 3,090,094]
   Shahzad F, 2010, NONLINEAR PROC GEOPH, V17, P137, DOI 10.5194/npg-17-137-2010
   Witkowska-Zimny M, 2013, CELL BIOL INT, V37, P608, DOI 10.1002/cbin.10078
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Zeng Y, 1996, SOIL SCI SOC AM J, V60, P1718, DOI 10.2136/sssaj1996.03615995006000060016x
NR 45
TC 10
Z9 11
U1 2
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 1
PY 2015
VL 11
BP 404
EP 411
DI 10.1016/j.actbio.2014.09.015
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AY7NZ
UT WOS:000347747900039
PM 25242650
DA 2018-10-20
ER

PT J
AU Samodurova, A
   Kocjan, A
   Swain, MV
   Kosmac, T
AF Samodurova, Anastasia
   Kocjan, Andraz
   Swain, Michael V.
   Kosmac, Tomaz
TI The combined effect of alumina and silica co-doping on the ageing
   resistance of 3Y-TZP bioceramics
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Zirconia; Bioceramics; Low-temperature degradation; Microcracking;
   FIB-SEM
ID LOW-TEMPERATURE DEGRADATION; TETRAGONAL ZIRCONIA POLYCRYSTALS;
   MONOCLINIC PHASE-TRANSFORMATION; Y-TZP CERAMICS; HYDROTHERMAL
   DEGRADATION; MECHANICAL-PROPERTIES; BIOMEDICAL IMPLANTS; DOPED ZIRCONIA;
   YTTRIA; SYSTEM
AB The combined effect of alumina and silica co-doping on the ageing resistance of 3Y-TZP bioceramics was investigated. In order to differentiate between the distinct contributions of two dopants to the overall resistance to low-temperature degradation (LTD), specimens were prepared by infiltration of silica sol into pre-sintered 3Y-TZP pellets, produced from commercially available powders, which were alumina-free or contained 0.05 and 0.25 wt.%. After sintering, specimens were exposed to accelerated ageing in distilled water at 134 degrees C for 6-48 h. X-ray diffraction was applied to quantify the tetragonal-to-monoclinic (t-m) phase transformation associated with the LTD, while a focused ion beam-scanning electron microscopy technique was employed to study the microstructural features in the transformed layer. The results showed that the minor alumina and/or silica additions did not drastically change the densities, grain sizes or mechanical properties of 3Y-TZP, but they did significantly reduce LTD. The addition of either alumina or silica has the potential to influence both the nucleation and the propagation of moisture-induced transformation, but in different ways and to different extents. The co-doped ceramics exhibited predominantly transgranular fracture, reflecting strong grain boundaries (limiting microcracking of the transformed layer), for alumina doping, and rounded grains with a glassy phase at multiple grain junctions (reducing internal stresses) for silica-doped material. These two additives evidently have different dominant mechanisms associated with the deceleration of LTD of 3Y-TZP, but their combination increases resistance to ageing, importantly, without reducing the fracture toughness of this popular biomaterial. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Samodurova, Anastasia; Kocjan, Andraz; Kosmac, Tomaz] Jozef Stefan Inst, Dept Ceram Engn, SI-1000 Ljubljana, Slovenia.
   [Swain, Michael V.] Univ Sydney, Fac Dent, Biomat Lab, Sydney, NSW 2010, Australia.
RP Samodurova, A (reprint author), Jozef Stefan Inst, Dept Ceram Engn, Jamova 39, SI-1000 Ljubljana, Slovenia.
EM samodurova.a@gmail.com
RI Swain, Michael/J-7266-2017
OI Kocjan, Andraz/0000-0002-4726-2775
FU Slovenian Research Agency (ARRS)
FX The financial support from the Slovenian Research Agency (ARRS) is
   acknowledged. The authors also gratefully acknowledge Dr. Sreco D.
   Skapin and Dr. Irena Pribosic for performing the XRD and TEM analyses,
   respectively.
CR Cattani-Lorente M, 2011, ACTA BIOMATER, V7, P858, DOI 10.1016/j.actbio.2010.09.020
   Chen C-C, 2008, J GEOPHYS RES, V9, P1
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   CURTIS CE, 1953, J AM CERAM SOC, V36, P190, DOI 10.1111/j.1151-2916.1953.tb12865.x
   Deville S, 2003, J AM CERAM SOC, V86, P2225, DOI 10.1111/j.1151-2916.2003.tb03639.x
   Deville S, 2003, J EUR CERAM SOC, V23, P2975, DOI 10.1016/S0955-2219(03)00313-3
   Franks GV, 2007, J AM CERAM SOC, V90, P3373, DOI 10.1111/j.1551-2916.2007.02013.x
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Glass SJ, 1996, J AM CERAM SOC, V79, P2227, DOI 10.1111/j.1151-2916.1996.tb08967.x
   Gremillard L, 2002, J AM CERAM SOC, V85, P401
   Gremillard L, 2000, ACTA MATER, V48, P4647, DOI 10.1016/S1359-6454(00)00252-4
   Guo X, 2003, J AM CERAM SOC, V86, P1867, DOI 10.1111/j.1151-2916.2003.tb03574.x
   Jimenez-Pique E, 2012, J EUR CERAM SOC, V32, P2129, DOI 10.1016/j.jeurceramsoc.2012.02.011
   KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7
   Kosmac T, 2012, J EUR CERAM SOC, V32, P2613, DOI 10.1016/j.jeurceramsoc.2012.02.024
   Lakiza SM, 1997, J AM CERAM SOC, V80, P893
   Marro FG, 2009, INT J MATER RES, V100, P92, DOI 10.3139/146.101791
   Matsui K, 2006, J MATER RES, V21, P2278, DOI 10.1557/JMR.2006.0274
   Munoz-Tabares JA, 2011, ACTA MATER, V59, P473, DOI 10.1016/j.actamat.2010.09.047
   MURASE Y, 1983, J AM CERAM SOC, V66, P196, DOI 10.1111/j.1151-2916.1983.tb10016.x
   Nakamura T, 2012, DENT MATER J, V31, P106, DOI 10.4012/dmj.2011-048
   Nakamura T, 2011, DENT MATER J, V30, P330, DOI 10.4012/dmj.2010-142
   NIIHARA K, 1982, J MATER SCI LETT, V1, P13, DOI 10.1007/BF00724706
   Nogiwa-Valdez AA, 2013, ACTA BIOMATER, V9, P6226, DOI 10.1016/j.actbio.2012.11.027
   Papanagiotou HP, 2006, J PROSTHET DENT, V96, P154, DOI 10.1016/j.prosdent.2006.08.004
   Ramesh S, 2008, CERAM INT, V34, P1603, DOI 10.1016/j.ceramint.2007.04.012
   Ross IM, 2001, SCRIPTA MATER, V45, P653, DOI 10.1016/S1359-6462(01)01076-4
   SCHMAUDER S, 1986, J AM CERAM SOC, V69, P534, DOI 10.1111/j.1151-2916.1986.tb04789.x
   SCOTT HG, 1975, J MATER SCI, V10, P1527, DOI 10.1007/BF01031853
   Soldera F, 2007, MICROSC MICROANAL, V13, P1510
   Swain MV, 2009, ACTA BIOMATER, V5, P1668, DOI 10.1016/j.actbio.2008.12.016
   TSUBAKINO H, 1991, J AM CERAM SOC, V74, P440, DOI 10.1111/j.1151-2916.1991.tb06905.x
NR 36
TC 25
Z9 25
U1 0
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 1
PY 2015
VL 11
BP 477
EP 487
DI 10.1016/j.actbio.2014.09.009
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AY7NZ
UT WOS:000347747900045
PM 25234155
DA 2018-10-20
ER

PT J
AU Luo, ZW
   Zhang, Q
   Shi, MJ
   Zhang, Y
   Tao, W
   Li, MZ
AF Luo, Zuwei
   Zhang, Qin
   Shi, Meijing
   Zhang, Yang
   Tao, Wei
   Li, Mingzhong
TI Effect of Pore Size on the Biodegradation Rate of Silk Fibroin Scaffolds
SO ADVANCES IN MATERIALS SCIENCE AND ENGINEERING
LA English
DT Article
ID IN-VIVO DEGRADATION; ENZYMATIC DEGRADATION; NANOFIBROUS SCAFFOLDS;
   FILMS; BIOMATERIALS; MECHANISM; DELIVERY; BEHAVIOR; FIBERS; VITRO
AB Controlling the degradation rate of silk fibroin-based biomaterial is an important capability for the fabrication of silk-based tissue engineering scaffolds. In this study, scaffolds with different pore sizes were prepared by controlling the freezing temperature and the silk fibroin concentration. In vitro degradation results showed that the internal pore walls of the scaffolds with a larger pore size collapsed upon exposure to collagenase IA for times ranging from 6 to 12 days, and the silk scaffolds exhibited a faster rate of weight loss. The morphological and structural features of the silk scaffolds with a smaller pore size maintained structural integrity after incubation in the protease solution for 18 days, and the rate of weight loss was relatively slow. Scaffolds with a smaller pore size or a higher pore density degraded more slowly than scaffolds with a larger pore size or lower pore density. These results demonstrate that the pore size of silk biomaterials is crucial in controlling the degradation rate of tissue engineering scaffolds.
C1 [Luo, Zuwei; Zhang, Qin; Shi, Meijing; Zhang, Yang; Li, Mingzhong] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Tao, Wei] Suzhou SOHO Biomat Technol Co Ltd, Suzhou 215128, Peoples R China.
RP Li, MZ (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, 199 Renai Rd,Ind Pk, Suzhou 215123, Peoples R China.
EM mzli@suda.edu.cn
FU National Nature Science Foundation of China [31370968]; Natural Science
   Foundation of Jiangsu Province [BK20131177]; College of Natural Science
   Research Project of Jiangsu Province [12KJA430003]; Jiangsu Province
   Science and Technology Support Program [BE2013734]
FX This work was supported by the National Nature Science Foundation of
   China (31370968), Natural Science Foundation of Jiangsu Province
   (BK20131177), College of Natural Science Research Project of Jiangsu
   Province (12KJA430003), and Jiangsu Province Science and Technology
   Support Program (BE2013734).
CR Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Cheung HY, 2010, COMPOS PART B-ENG, V41, P223, DOI 10.1016/j.compositesb.2009.09.004
   Du YZ, 2014, MATER LETT, V122, P62, DOI 10.1016/j.matlet.2014.02.031
   Gil ES, 2014, MACROMOL BIOSCI, V14, P257, DOI 10.1002/mabi.201300321
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu YP, 2012, ADV MATER SCI ENG, DOI 10.1155/2012/185905
   Kim JH, 2012, J BIOMED MATER RES A, V100A, P3287, DOI 10.1002/jbm.a.34274
   Koperska MA, 2014, POLYM DEGRAD STABIL, V105, P185, DOI 10.1016/j.polymdegradstab.2014.04.008
   Lee OJ, 2012, J BIOMED MATER RES A, V100A, P2018, DOI 10.1002/jbm.a.33308
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Li XF, 2013, J CHEM-NY, DOI 10.1155/2013/640913
   Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Pritchard EM, 2013, MACROMOL BIOSCI, V13, P311, DOI 10.1002/mabi.201200323
   Pritchard EM, 2011, BIOMATERIALS, V32, P909, DOI 10.1016/j.biomaterials.2010.09.055
   Rajkhowa R, 2012, BIOMACROMOLECULES, V13, P2503, DOI 10.1021/bm300736m
   Sasithorn N., 2014, J NANOMATER, V2014
   SRISUWAN Y, 2013, ADV MATER SCI ENG
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wongnarat C., 2013, ENGINEERING, V5, P61
   Wongpanit P, 2007, MACROMOL BIOSCI, V7, P1258, DOI 10.1002/mabi.200700074
   Xu Y., 2011, J FIBER BIOENGINEERI, V4, P35
   Yang YM, 2009, POLYM DEGRAD STABIL, V94, P2213, DOI 10.1016/j.polymdegradstab.2009.09.002
   Zhang KH, 2011, POLYM DEGRAD STABIL, V96, P2266, DOI 10.1016/j.polymdegradstab.2011.08.011
   Zhang Q, 2013, MATER LETT, V105, P8, DOI 10.1016/j.matlet.2013.04.049
   Zhao CX, 2011, INT J BIOL MACROMOL, V48, P249, DOI 10.1016/j.ijbiomac.2010.11.004
   Zhou JA, 2010, POLYM DEGRAD STABIL, V95, P1679, DOI 10.1016/j.polymdegradstab.2010.05.025
   Zuo B, 2006, J MATER SCI, V41, P3357, DOI 10.1007/s10853-005-5384-z
NR 30
TC 0
Z9 0
U1 2
U2 29
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-8434
EI 1687-8442
J9 ADV MATER SCI ENG
JI Adv. Mater. Sci. Eng.
PY 2015
AR 315397
DI 10.1155/2015/315397
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA CB6SF
UT WOS:000349756200001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Mekhail, M
   Almazan, G
   Tabrizian, M
AF Mekhail, Mina
   Almazan, Guillermina
   Tabrizian, Maryam
TI Purine-crosslinked injectable chitosan sponges promote oligodendrocyte
   progenitor cells' attachment and differentiation
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID SPINAL-CORD-INJURY; MYELINATION IN-VITRO; NEURAL STEM-CELLS;
   OXYGEN/GLUCOSE DEPRIVATION; EXTRACELLULAR GUANOSINE; FUNCTIONAL
   RECOVERY; PATHWAY ACTIVATION; HIPPOCAMPAL SLICES; GLUTAMATE UPTAKE;
   REMYELINATION
AB Oligodendrocyte Progenitor Cells (OPCs) reside in the central nervous system (CNS) and are responsible for remyelinating axons after a spinal cord injury (SCI). However, the remyelination process is incomplete and abnormal due to the inability of OPCs to fully differentiate at the site of injury. In this study a newly developed injectable chitosan sponge crosslinked using guanosine 5'-diphosphate (GDP) was used to enhance OPC survival, attachment and differentiation. This purine-based biomaterial is the first of its kind and its inception was based on the growing body of literature concerning the role of purinergic signalling in the CNS. GDP-crosslinked chitosan sponges are rapidly-gelling and can be easily administered in situ using an injection system based on a double-lumen design. The chitosan sponges prompted OPC differentiation even in the presence of mitogens. Moreover, neurotrophin-3 (NT-3) was successfully entrapped in the sponges and a sustained release for up to 30 days was achieved. OPCs were shown to differentiate into mature oligodendrocytes that express myelin basic protein (MBP) when cultured on sponges containing NT-3. These findings, along with the suitable physicochemical and biological properties, make these sponges conducive to use as viable therapeutic agents for enhancing remyelination post-SCI.
EM mina.mekhail@mail.mcgill.ca; Guillermina.almazan@mcgill.ca;
   maryam.tabrizian@mcgill.ca
CR ALMAZAN G, 1993, J NEUROSCI RES, V36, P163, DOI 10.1002/jnr.490360206
   Biernaskie J, 2007, J NEUROSCI, V27, P9545, DOI 10.1523/JNEUROSCI.1930-07.2007
   BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1
   Ciccarelli R, 2000, GLIA, V29, P202, DOI 10.1002/(SICI)1098-1136(20000201)29:3<202::AID-GLIA2>3.0.CO;2-C
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Dal-Cim T, 2011, NEUROSCIENCE, V183, P212, DOI 10.1016/j.neuroscience.2011.03.022
   Dal-Cim TA, 2010, PURINERG SIGNAL, V6, P109
   De Paula ML, 2014, GLIA, V62, P64, DOI 10.1002/glia.22584
   Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928
   Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480
   Jagielska A, 2012, STEM CELLS DEV, V21, P2905, DOI 10.1089/scd.2012.0189
   Jiang SC, 2003, NEUROREPORT, V14, P2463, DOI 10.1097/01.wnr.0000095494.09138.ff
   Jiang SC, 2007, PURINERG SIGNAL, V3, P411, DOI 10.1007/s11302-007-9079-6
   Jiang SC, 2008, PURINERG SIGNAL, V4, P61, DOI 10.1007/s11302-007-9093-8
   Kakulas B A, 1999, J Spinal Cord Med, V22, P119
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Li XW, 2013, FASEB J, V27, P1127, DOI 10.1096/fj.12-211151
   Li Y, 2013, STEM CELLS DEV, V22, P1497, DOI 10.1089/scd.2012.0508
   McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345
   McTigue DM, 1998, J NEUROSCI, V18, P5354
   Mekhail M, 2013, ADV HEALTHC MATER, V2, P1126, DOI 10.1002/adhm.201200371
   Mekhail M, 2012, PROG NEUROBIOL, V96, P322, DOI 10.1016/j.pneurobio.2012.01.008
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   Nastasijevic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039595
   Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575
   Rathbone M, 2008, NUCLEOS NUCLEOT NUCL, V27, P666, DOI 10.1080/15257770802143913
   Rathbone MP, 1999, PROG NEUROBIOL, V59, P663, DOI 10.1016/S0301-0082(99)00017-9
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Schmidt AP, 2007, PHARMACOL THERAPEUT, V116, P401, DOI 10.1016/j.pharmthera.2007.07.004
   Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Wu B., 2009, J NEUROTRAUM, V26, P1847
   Yan HL, 2000, J NEUROSCI RES, V62, P329, DOI 10.1002/1097-4547(20001101)62:3<329::AID-JNR2>3.0.CO;2-C
   Yao L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt320
NR 36
TC 8
Z9 8
U1 2
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 2
BP 279
EP 287
DI 10.1039/c4bm00215f
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA AZ4OQ
UT WOS:000348202600007
PM 26218118
DA 2018-10-20
ER

PT J
AU Helary, C
   Abed, A
   Mosser, G
   Louedec, L
   Letourneur, D
   Coradin, T
   Giraud-Guille, MM
   Meddahi-Pelle, A
AF Helary, Christophe
   Abed, Aicha
   Mosser, Gervaise
   Louedec, Liliane
   Letourneur, Didier
   Coradin, Thibaud
   Giraud-Guille, Marie Madeleine
   Meddahi-Pelle, Anne
TI Evaluation of dense collagen matrices as medicated wound dressing for
   the treatment of cutaneous chronic wounds
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID MECHANICAL-PROPERTIES; DIABETIC FOOT; HUMAN-FIBROBLASTS; DRUG-DELIVERY;
   HYDROGELS; SKIN; FIBRILLOGENESIS; BIOMATERIALS; SCAFFOLDS; CULTURE
AB Cutaneous chronic wounds are characterized by an impaired wound healing which may lead to infection and amputation. When current treatments are not effective enough, the application of wound dressings is required. To date, no ideal biomaterial is available. In this study, highly dense collagen matrices have been evaluated as novel medicated wound dressings for the treatment of chronic wounds. For this purpose, the structure, mechanical properties, swelling ability and in vivo stability of matrices concentrated from 5 to 40 mg mL(-1) were tested. The matrix stiffness increased with the collagen concentration and was associated with the fibril density and thickness. Increased collagen concentration also enhanced the material resistance against accelerated digestion by collagenase. After subcutaneous implantation in rats, dense collagen matrices exhibited high stability without any degradation after 15 days. The absence of macrophages and neutrophils evidenced their biocompatibility. Subsequently, dense matrices at 40 mg mL(-1) were evaluated as drug delivery system for ampicillin release. More concentrated matrices exhibited the best swelling abilities and could absorb 20 times their dry weight in water, allowing for an efficient antibiotic loading from their dried form. They released efficient doses of antibiotics that inhibited the bacterial growth of Staphylococcus Aureus over 3 days. In parallel, they show no cytotoxicity towards human fibroblasts. These results show that dense collagen matrices are promising materials to develop medicated wound dressings for the treatment of chronic wounds.
C1 [Helary, Christophe; Mosser, Gervaise; Coradin, Thibaud; Giraud-Guille, Marie Madeleine] Univ Paris 06, CNRS, Ecole Prat Hautes Etud, UMR 7574,Condensed Matter Chem Lab, F-75005 Paris, France.
   [Abed, Aicha; Louedec, Liliane; Letourneur, Didier; Meddahi-Pelle, Anne] CHU Xavier Bichat, LVTS, INSERM, U1148, F-75018 Paris, France.
   [Abed, Aicha; Letourneur, Didier; Meddahi-Pelle, Anne] Univ Paris 13, Sorbonne Paris Cite, F-93430 Villetaneuse, France.
   [Meddahi-Pelle, Anne] Univ Paris 13, PRES Sorbonne Paris Cite, IUT St Denis, F-93206 St Denis, France.
RP Helary, C (reprint author), Univ Paris 06, CNRS, Ecole Prat Hautes Etud, UMR 7574,Condensed Matter Chem Lab, 4 Pl Jussieu,Batiment F, F-75005 Paris, France.
EM christophe.helary@upmc.fr
RI Mosser, Gervaise/M-4943-2018; Didier, letourneur/H-5268-2012
OI Mosser, Gervaise/0000-0002-9812-5340; Didier,
   letourneur/0000-0003-2197-9468
CR Abou Neel EA, 2006, SOFT MATTER, V2, P986, DOI 10.1039/b609784g
   Badylak SE, 2010, J BONE JOINT SURG AM, V92A, P1317
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Besseau L, 2002, BIOMATERIALS, V23, P27, DOI 10.1016/S0142-9612(01)00075-8
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Chen WYJ, 2007, WOUND REPAIR REGEN, V15, P434, DOI 10.1111/j.1524-475X.2007.00250.x
   Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5
   Coulomb B, 1998, PLAST RECONSTR SURG, V101, P1891, DOI 10.1097/00006534-199806000-00018
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dong YX, 2014, ACTA BIOMATER, V10, P2076, DOI 10.1016/j.actbio.2013.12.045
   Dumville J. C., 2012, COCHRANE DB SYST REV, V15
   Ehrenreich M, 2006, TISSUE ENG, V12, P2407, DOI 10.1089/ten.2006.12.2407
   Eming S, 2008, BIOMATERIALS, V29, P2932, DOI 10.1016/j.biomaterials.2008.03.029
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8
   Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gobeaux F, 2008, J MOL BIOL, V376, P1509, DOI 10.1016/j.jmb.2007.12.047
   Greer N, 2013, ANN INTERN MED, V159, P532, DOI 10.7326/0003-4819-159-8-201310150-00006
   Helary C, 2006, BIOMATERIALS, V27, P4443, DOI 10.1016/j.biomaterials.2006.04.005
   Helary C, 2005, BIOMATERIALS, V26, P1533, DOI 10.1016/j.biomaterials.2004.05.016
   Helary C, 2012, J TISSUE ENG REGEN M, V6, P225, DOI 10.1002/term.420
   Helary C, 2011, J TISSUE ENG REGEN M, V5, P248, DOI 10.1002/term.326
   Helary C, 2010, BIOMATERIALS, V31, P481, DOI 10.1016/j.biomaterials.2009.09.073
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Matyash M, 2014, TISSUE ENG PART C-ME, V20, P401, DOI [10.1089/ten.tec.2013.0252, 10.1089/ten.TEC.2013.0252]
   Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005
   Moura LIF, 2013, ACTA BIOMATER, V9, P7093, DOI 10.1016/j.actbio.2013.03.033
   Nam K, 2012, SOFT MATTER, V8, P472, DOI 10.1039/c1sm06543b
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Powers JG, 2013, DERMATOL THER, V26, P197, DOI 10.1111/dth.12055
   QUTEISH D, 1990, J BIOMED MATER RES, V24, P749, DOI 10.1002/jbm.820240609
   Ramasastry SS, 2005, CLIN PLAST SURG, V32, P195, DOI 10.1016/j.cps.2004.12.001
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   TRELSTAD RL, 1976, P NATL ACAD SCI USA, V73, P4027, DOI 10.1073/pnas.73.11.4027
   Vaissiere G, 2000, MED BIOL ENG COMPUT, V38, P205, DOI 10.1007/BF02344778
   Vasconcelos A, 2011, APPL MICROBIOL BIOT, V90, P445, DOI 10.1007/s00253-011-3135-4
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wong VW, 2011, TISSUE ENG PT A, V17, P631, DOI [10.1089/ten.tea.2010.0298, 10.1089/ten.TEA.2010.0298]
   Zaulyanov L, 2007, CLIN INTERV AGING, V2, P93, DOI 10.2147/ciia.2007.2.1.93
NR 43
TC 25
Z9 26
U1 3
U2 37
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 2
BP 373
EP 382
DI 10.1039/c4bm00370e
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AZ4OQ
UT WOS:000348202600017
PM 26218128
DA 2018-10-20
ER

PT J
AU Montgomery, A
   Wong, A
   Gabers, N
   Willerth, SM
AF Montgomery, Amy
   Wong, Alix
   Gabers, Nicole
   Willerth, Stephanie M.
TI Engineering personalized neural tissue by combining induced pluripotent
   stem cells with fibrin scaffolds
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID SPINAL MOTOR-NEURONS; DIRECTED DIFFERENTIATION; GROWTH-FACTOR;
   CONTROLLED-RELEASE; NERVOUS-SYSTEM; RETINOIC ACID; SOMATIC-CELLS;
   LINEAGE CELLS; MOUSE EMBRYOS; HEDGEHOG
AB Induced pluripotent stem cells (iPSCs) are generated from adult somatic cells through the induction of key transcription factors that restore the ability to become any cell type found in the body. These cells are of interest for tissue engineering due to their potential for developing patient-specific therapies. As the technology for generating iPSCs advances, it is important to concurrently investigate protocols for the efficient differentiation of these cells to desired downstream phenotypes in combination with biomaterial scaffolds as a way of engineering neural tissue. For such applications, the generation of neurons within three dimensional fibrin scaffolds has been well characterized as a cell-delivery platform for murine embryonic stem cells (ESCs) but has not yet been applied to murine iPSCs. Given that iPSCs have been reported to differentiate less effectively than ESCs, a key objective of this investigation is to maximize the proportion of iPSC-derived neurons in fibrin through the choice of differentiation protocol. To this end, this study compares two EB-mediated protocols for generating neurons from murine iPSCs and ESCs: an 8 day 4-/4+ protocol using soluble retinoic acid in the last 4 days and a 6 day 2-/4+ protocol using soluble retinoic acid and the small molecule sonic hedgehog agonist purmorphamine in the last 4 days. EBs were then seeded in fibrin scaffolds for 14 days to allow further differentiation into neurons. EBs generated by the 2-/4+ protocol yielded a higher percentage of neurons compared to those from the 4-/4+ protocol for both iPSCs and ESCs. The results demonstrate the successful translation of the fibrin-based cell-delivery platform for use with murine iPSCs and furthermore that the proportion of neurons generated from murine iPSC-derived EBs seeded in fibrin can be maximized using the 2-/4+ differentiation protocol. Together, these findings validate the further exploration of 3D fibrin-based scaffolds as a method of delivering neuronal cells derived from iPSCs - an important step toward the development of iPSC-based tissue engineering strategies for spinal cord injury repair.
C1 [Montgomery, Amy; Willerth, Stephanie M.] Univ Victoria, Dept Mech Engn, Victoria, BC V8W 2Y2, Canada.
   [Wong, Alix] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 2Y2, Canada.
   [Gabers, Nicole] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada.
   [Willerth, Stephanie M.] Univ Victoria, Div Med Sci, Victoria, BC V8W 2Y2, Canada.
RP Montgomery, A (reprint author), Univ Victoria, Dept Mech Engn, Victoria, BC V8W 2Y2, Canada.
EM willerth@uvic.ca
OI Willerth, Stephanie/0000-0002-1665-7723
FU National Sciences and Engineering Council (NSERC)
FX The authors would like to acknowledge the National Sciences and
   Engineering Council (NSERC) funding from their Discovery, Engage and
   Research Tools and Instrument grant programs for supporting this work.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   Briscoe J, 2006, NAT CHEM BIOL, V2, P10, DOI 10.1038/nchembio0106-10
   Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295
   Brown CR, 2014, STEM CELLS DEV, V23, P1765, DOI 10.1089/scd.2013.0628
   DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S
   Doolittle R.F., 2001, ELS
   El-Akabawy G, 2011, STEM CELLS DEV, V20, P1873, DOI 10.1089/scd.2010.0282
   Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107
   Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31
   Kolehmainen K, 2012, JOVE-J VIS EXP, V2012, pe3641
   Kothapalli CR, 2013, BIOMATERIALS, V34, P5995, DOI 10.1016/j.biomaterials.2013.04.042
   Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063
   Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620
   Lohle M, 2012, STEM CELLS, V30, P570, DOI 10.1002/stem.1016
   Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441
   McCreedy DA, 2012, STEM CELL RES, V8, P368, DOI 10.1016/j.scr.2011.12.003
   Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004
   Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554
   Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001
   Mooney R, 2010, TISSUE ENG PT A, V16, P1607, DOI [10.1089/ten.tea.2009.0372, 10.1089/ten.TEA.2009.0372]
   Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270
   Pellett S, 2011, BIOCHEM BIOPH RES CO, V404, P388, DOI 10.1016/j.bbrc.2010.11.128
   Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587
   Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Schwartz PH, 2008, METHODS, V45, P142, DOI 10.1016/j.ymeth.2008.03.007
   Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio.753
   Stacpoole SRL, 2011, NAT PROTOC, V6, P1229, DOI 10.1038/nprot.2011.380
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tokumoto Y, 2010, J BIOSCI BIOENG, V109, P622, DOI 10.1016/j.jbiosc.2009.11.013
   Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107
   Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008
   Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2007, J BIOMED MATER RES A, V80A, P13, DOI 10.1002/jbm.a.30844
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Willerth SM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt58
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Wosnick J.H., 2008, PRINCIPLES REGENERAT, P1248
   Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
NR 52
TC 18
Z9 19
U1 2
U2 28
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 2
BP 401
EP 413
DI 10.1039/c4bm00299g
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA AZ4OQ
UT WOS:000348202600020
PM 26218131
DA 2018-10-20
ER

PT J
AU Sunija, AJ
   Ilango, SS
   Kumar, KPV
AF Sunija, A. J.
   Ilango, S. Siva
   Kumar, K. P. Vinod
TI Electrical studies on biopolyurethane from cashew nut husk tannin
SO CIRCUIT WORLD
LA English
DT Article
DE Printed circuit board; Bio-based polyurethane; Dielectric property
ID DIELECTRIC-PROPERTIES; TEMPERATURE
AB Purpose - This paper aims to focus on the evaluation of the electrical properties of bio-based polyurethane material derived from cashew nut husk tannin and also the effect of temperature and frequency on the dielectric values and alternate current (AC) conductivity.
   Design/methodology/approach - Bio-based polyurethane is prepared from cashew nut husk tannin as polyol, their dielectric constant and dielectric loss factor are measured using an inductance capacitance resistance (LCR) metre, and the AC conductivity is determined using dielectric constant and loss values.
   Findings - The dielectric constant values are high, and the values decrease with an increase in frequency but increase with an increase in temperature. The AC conductivity values are low; hence, the material can be categorized as insulators or semi-conductors. Because the polyurethanes have a good dielectric value and are cost-effective, as they are derived from renewable biomaterial waste, they have promising applications for the future.
   Research limitations/implications - The experiment is carried out up to the frequency of 200 KHz because of the limitation in the instrument. But for the institute of printed circuits (IPC) and other specifications, the values of dielectric loss and dielectric constant will be generally coated for 1 MHz.
   Practical implications - The high dielectric constant and loss values show that the polyurethane can be opted for use as capacitors in electronic devices, and the values are comparable to the requirements of IPC4101A/24IPC; hence, they are suitable for the application as printed circuit board (PCB) laminate.
   Social implications - The use of biomaterial waste in the production of polyurethane will bring down the dependence of polyurethane industry on fossil fuel reserve, reduce carbon dioxide foot print and reduce the cost of production.
   Originality/value - The motivation of the work was its ecological aspect and also aims on the use of an alternative bio-based material in the PCB industry.
C1 [Sunija, A. J.; Kumar, K. P. Vinod] Anna Univ, Dept Chem, Univ Coll Engn Nagercoil, Nagercoil, India.
   [Ilango, S. Siva] Thiagarajar Coll Engn, Dept Chem, Madurai, Tamil Nadu, India.
RP Sunija, AJ (reprint author), Anna Univ, Dept Chem, Univ Coll Engn Nagercoil, Nagercoil, India.
EM sunija_aj@yahoo.com
CR Abdullah OG, 2011, INT J APPL PHYS MATH, V1, P101
   Akram M., 2005, J PHYS, V29, P355
   Baillie C., 2004, GREEN COMPOSITES POL, P1
   Ehrler S, 2002, CIRCUIT WORLD, V28, P38, DOI 10.1108/03056120210431534
   JOHNSON RT, 1983, IND ENG CHEM PROD RD, V22, P599, DOI 10.1021/i300012a016
   Kumar KPV, 2004, PROG ORG COAT, V49, P244, DOI 10.1016/j.porgcoat.2003.10.004
   Lilli S., 2007, PLAST TECHNOL, V105, P1
   Lligadas G, 2010, BIOMACROMOLECULES, V11, P2825, DOI 10.1021/bm100839x
   Nelson SO, 1999, T ASAE, V42, P523
   Pathania D, 2009, INT J THEOR APPL SCI, V1, P34
   RITCHEY LW, 1999, CIRCUITREE MAGAZINE
   Scott Hinaga S., 2014, THERMAL EFFECTS PCB
   Shah V., 1954, HDB POLYM TECHNOLOGY
   Trox J, 2011, FOOD CHEM, V128, P1094, DOI 10.1016/j.foodchem.2011.04.018
   Yadav VS, 2010, LECT NOTES ENG COMP, P1593
NR 15
TC 0
Z9 1
U1 0
U2 7
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0305-6120
EI 1758-602X
J9 CIRCUIT WORLD
JI Circuit World
PY 2015
VL 41
IS 1
BP 41
EP 46
DI 10.1108/CW-07-2014-0030
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA CB5BF
UT WOS:000349641800007
DA 2018-10-20
ER

PT J
AU Barney, LE
   Dandley, EC
   Jansen, LE
   Reich, NG
   Mercurio, AM
   Peyton, SR
AF Barney, L. E.
   Dandley, E. C.
   Jansen, L. E.
   Reich, N. G.
   Mercurio, A. M.
   Peyton, S. R.
TI A cell-ECM screening method to predict breast cancer metastasis
SO INTEGRATIVE BIOLOGY
LA English
DT Article
ID BRAIN EXTRACELLULAR-MATRIX; BONE METASTASIS; IN-VIVO; MAMMARY-CARCINOMA;
   NICHE COMPONENT; TUMOR-CELLS; INTEGRIN; LINES; PROTEINS; GROWTH
AB Breast cancer preferentially spreads to the bone, brain, liver, and lung. The clinical patterns of this tissue-specific spread (tropism) cannot be explained by blood flow alone, yet our understanding of what mediates tropism to these physically and chemically diverse tissues is limited. While the microenvironment has been recognized as a critical factor in governing metastatic colonization, the role of the extracellular matrix (ECM) in mediating tropism has not been thoroughly explored. We created a simple biomaterial platform with systematic control over the ECM protein density and composition to determine if integrin binding governs how metastatic cells differentiate between secondary tissue sites. Instead of examining individual behaviors, we compiled large patterns of phenotypes associated with adhesion to and migration on these controlled ECMs. In combining this novel analysis with a simple biomaterial platform, we created an in vitro fingerprint that is predictive of in vivo metastasis. This rapid biomaterial screen also provided information on how beta(1), alpha(2), and alpha(6) integrins might mediate metastasis in patients, providing insights beyond a purely genetic analysis. We propose that this approach of screening many cell-ECM interactions, across many different heterogeneous cell lines, is predictive of in vivo behavior, and is much simpler, faster, and more economical than complex 3D environments or mouse models. We also propose that when specifically applied toward the question of tissue tropism in breast cancer, it can be used to provide insight into certain integrin subunits as therapeutic targets.
C1 [Barney, L. E.; Jansen, L. E.; Peyton, S. R.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
   [Dandley, E. C.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.
   [Reich, N. G.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Div Biostat & Epidemiol, Amherst, MA 01003 USA.
   [Mercurio, A. M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA.
RP Peyton, SR (reprint author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
EM speyton@ecs.umass.edu
OI Peyton, Shelly/0000-0002-7364-8727
FU NSF-NCI award [DMR-1234852]; University of Massachusetts, Amherst; NIH
   [1DP2CA186573-01, CA168464]; Pew Charitable Trusts; National Research
   Service Award from the National Institutes of Health [T32 GM008515];
   HHMI undergraduate research fellowship
FX We are grateful to Shannon Hughes, Doug Lauffenburger, Jeffrey
   Blanchard, and Aaron Meyer for helpful intellectual discussions, Wei
   Chen for guidance with silane chemistry, Thomas McCarthy and the UMass
   MRSEC for use of equipment, and Isaac Han, Matthew Crotty, Elyse
   Hartnett, and Patrick Colleton for technical assistance. We thank Joan
   Massague, Shannon Hughes, and Mario Niepel for generously providing cell
   lines. This work was funded by an NSF-NCI award DMR-1234852 to SRP and
   NGR, the University of Massachusetts, Amherst, and by a grant from the
   NIH (1DP2CA186573-01). SRP is a Pew Biomedical Scholar supported by the
   Pew Charitable Trusts. LEB was partially supported by National Research
   Service Award T32 GM008515 from the National Institutes of Health. ECD
   was partially supported by an HHMI undergraduate research fellowship.
   AMM was supported by NIH Grant CA168464.
CR Abdel-Ghany M, 2002, J BIOL CHEM, V277, P34391, DOI 10.1074/jbc.M205307200
   BADE EG, 1985, IN VITRO CELL DEV B, V21, P245
   Banerjee A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3054
   Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849
   BIGNAMI A, 1993, ANAT EMBRYOL, V188, P419
   Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021
   Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005
   Clinchy B, 2000, BREAST CANCER RES TR, V61, P217, DOI 10.1023/A:1006494001861
   Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748
   dos Santos PB, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-104
   Dumont B, 2012, J PROTEOME RES, V11, P2247, DOI 10.1021/pr201022n
   Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081
   Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853
   Gauchet C, 2006, J AM CHEM SOC, V128, P9274, DOI 10.1021/ja061131o
   Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767
   Goel HL, 2014, CELL REP, V7, P747, DOI 10.1016/j.celrep.2014.03.059
   Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026
   Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312
   Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037
   Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618
   Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6
   Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186
   Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307
   Kato H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046576
   Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820
   Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361
   Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8
   Kruger TE, 2014, CRIT REV ONCOL HEMAT, V89, P330, DOI 10.1016/j.critrevonc.2013.08.013
   Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408
   Lee YC, 2013, MOL CANCER RES, V11, P405, DOI 10.1158/1541-7786.MCR-12-0551
   Malara A, 2014, STEM CELLS, V32, P926, DOI 10.1002/stem.1626
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Meyer AS, 2012, J CELL BIOL, V197, P721, DOI 10.1083/jcb.201201003
   Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799
   Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.3.CO;2-V
   Morpurgo M, 1999, J BIOCHEM BIOPH METH, V38, P17, DOI 10.1016/S0165-022X(98)00027-X
   Mukhopadhyay R, 1999, CLIN EXP METASTAS, V17, P325
   Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647
   Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008
   Niepel M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004379
   Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379
   Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0
   Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390
   Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071
   Parvani JG, 2013, MOL BIOL CELL, V24, P3449, DOI 10.1091/mbc.E12-10-0776
   Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328
   Reticker-Flynn NE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2128
   Rucci N, 2004, BONE, V34, P697, DOI 10.1016/j.bone.2003.07.012
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953
   SHAFIE SM, 1980, CANCER LETT, V11, P81, DOI 10.1016/0304-3835(80)90097-X
   Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610
   Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106
   Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992
   Takayama S, 2005, ANTICANCER RES, V25, P79
   Tarragona M, 2012, J BIOL CHEM, V287, P21346, DOI 10.1074/jbc.M112.355834
   Taubenberger AV, 2013, J BONE MINER RES, V28, P1399, DOI 10.1002/jbmr.1875
   Truong HH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004751
   Wang H, 2004, J CELL BIOL, V164, P935, DOI 10.1083/jcb.200309112
   Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486
   Zaman MH, 2013, NAT REV CANCER, V13, P596, DOI 10.1038/nrc3564
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
   ZHANG RD, 1991, INVAS METAST, V11, P204
   Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017
   Zhou B, 2014, MOL CANCER RES, V12, P143, DOI 10.1158/1541-7786.MCR-13-0184
   Zhu MJ, 2012, LANGMUIR, V28, P416, DOI 10.1021/la203638g
NR 68
TC 22
Z9 22
U1 5
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1757-9694
EI 1757-9708
J9 INTEGR BIOL-UK
JI Integr. Biol.
PY 2015
VL 7
IS 2
BP 198
EP 212
DI 10.1039/c4ib00218k
PG 15
WC Cell Biology
SC Cell Biology
GA CB5LM
UT WOS:000349668600006
PM 25537447
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Nandi, SK
   Kundu, B
   Mahato, A
   Thakur, NL
   Joardar, SN
   Mandal, BB
AF Nandi, Samit K.
   Kundu, Biswanath
   Mahato, Arnab
   Thakur, Narsinh L.
   Joardar, Siddhartha N.
   Mandal, Biman B.
TI In vitro and in vivo evaluation of the marine sponge skeleton as a bone
   mimicking biomaterial
SO INTEGRATIVE BIOLOGY
LA English
DT Article
ID TISSUE ENGINEERING SCAFFOLDS; GROWTH-FACTOR-I; MORPHOGENETIC PROTEIN-2;
   STEM-CELLS; OSTEOBLASTIC DIFFERENTIATION; CLINICAL-APPLICATIONS;
   SEGMENTAL DEFECT; STROMAL CELLS; DELIVERY; COLLAGEN
AB This investigation was carried out to identify and characterize marine sponges as potential bioscaffolds in bone tissue engineering. The marine sponge (Biemna fortis) samples were collected from the rocky intertidal region of Anjuna, Goa, India, freeze-dried and converted to pure cristobalite at low temperature. After thorough evaluation of sponge samples by DTA-TGA thermography, XRD, FTIR, SEM and cell cytotoxicity by MTT assay, bare sponge scaffolds were fabricated by firing at 1190 degrees C. These scaffolds were loaded with growth factors (IGF-1 and BMP-2), checked for quasi-dynamic in vitro release kinetics and finally implanted into femoral bone defects in rabbits for up to 90 days, by keeping an empty defect as a control. The in vivo bone healing process was evaluated and compared using chronological radiology, histology, SEM and fluorochrome labeling studies. SEM revealed that the sponge skeleton possesses a collagenous fibrous network consisting of highly internetworked porosity in the size range of 10-220 mu m. XRD and FTIR analysis showed a cristobalite phase with acicular crystals of high aspect ratio, and crystallinity was found to increase from 725 to 1190 degrees C. MTT assay demonstrated the non-cytotoxicity of the samples. A combination of burst and sustained release profile was noticed for both the growth factors and about 74.3% and 83% total release at day 28. In the radiological, histological, scanning electron microscopy and fluorochrome labeling analysis, the IGF-1 impregnated converted sponge scaffold promoted excellent osseous tissue formation followed by the BMP-2 loaded and bare one. These observations suggest that the marine sponge alone and in combination with growth factors is a promising biomaterial for bone repair and bone augmentation.
C1 [Nandi, Samit K.] West Bengal Univ Anim & Fishery Sci, Dept Vet Surg & Radiol, Kolkata, India.
   [Kundu, Biswanath; Mahato, Arnab] CSIR, Cent Glass & Ceram Res Inst, Bioceram & Coating Div, Kolkata, India.
   [Thakur, Narsinh L.] CSIR, Natl Inst Oceanog, Panaji, Goa, India.
   [Joardar, Siddhartha N.] West Bengal Univ Anim & Fishery Sci, Dept Vet Microbiol, Kolkata, India.
   [Mandal, Biman B.] Indian Inst Technol, Dept Biotechnol, Gauhati, India.
RP Nandi, SK (reprint author), West Bengal Univ Anim & Fishery Sci, Dept Vet Surg & Radiol, Kolkata, India.
EM samitnandi1967@gmail.com; biswa_kundu@rediffmail.com
FU Department of Biotechnology, Ministry of Science and Technology,
   Government of India, National Bioscience Award for career Development
   [BT/HRd/34/15/2008]; CSIR TFYP BIOCERAM [ESC0103]
FX The authors wish to express their sincere thanks for the financial
   support from the Department of Biotechnology, Ministry of Science and
   Technology, Government of India as a part of National Bioscience
   Award-2008 for career Development [BT/HRd/34/15/2008]. Thanks are also
   due to the Director, CSIR-Central Glass and Ceramic Research Institute,
   Kolkata, India (through partial funding from CSIR TFYP BIOCERAM
   ESC0103), the Director, CSIR-NIO, Goa, India, and Vice Chancellor, West
   Bengal University of Animal and Fishery Sciences, Kolkata, India, for
   their generous and kind support to this work. All the personnel involved
   in the characterization of the materials are sincerely acknowledged.
CR Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   BILEZIKIAN JP, 2002, PRINCIPLES BONE BIOL, V2
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Bostrom MPG, 1999, ORTHOP CLIN N AM, V30, P647, DOI 10.1016/S0030-5898(05)70117-6
   Brown KV, 2011, TISSUE ENG PT A, V17, P1735, DOI 10.1089/ten.tea.2010.0446
   Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68
   Burg KJL, 2000, CRIT REV BIOMED ENG, V28, P383, DOI 10.1615/CritRevBiomedEng.v28.i34.60
   Cunningham E, 2010, J MATER SCI-MATER M, V21, P2255, DOI 10.1007/s10856-009-3961-4
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   DEMASTER DJ, 1991, GEOPH MONOG SERIES, V63, P363
   Ehnert S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014073
   Ehrlich H, 2010, INT J BIOL MACROMOL, V47, P141, DOI 10.1016/j.ijbiomac.2010.05.009
   Ehrlich H., 2007, PORIFERA RES BIODIVE, P217
   Ehrlich H., 2013, BIOMIMETIC BIOMATERI, P47
   Ehrlich H., 2010, BIOL MAT MARINE ORIG
   Fubini B, 1999, CHEM RES TOXICOL, V12, P737, DOI 10.1021/tx980261a
   GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2
   GIBSON CJ, 1978, CALC TISS RES, V26, P29, DOI 10.1007/BF02013230
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   Gittens SA, 2001, J DRUG TARGET, V9, P407, DOI 10.3109/10611860108998776
   Green D, 2003, TISSUE ENG, V9, P1159, DOI 10.1089/10763270360728062
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Green DW, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034010
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   Hou R, 2007, J BIOMED MATER RES A, V80A, P85, DOI 10.1002/jbm.a.30840
   Jeon O, 2008, BIOCHEM BIOPH RES CO, V369, P774, DOI 10.1016/j.bbrc.2008.02.099
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kempen D. H. R., 2008, TISSUE ENG PART A, V15, P587
   Kim SS, 2008, J BIOMED MATER RES A, V87A, P245, DOI 10.1002/jbm.a.31782
   Kim S, 2012, ACTA BIOMATER, V8, P1768, DOI 10.1016/j.actbio.2012.01.009
   Kundu B, 2011, J MATER SCI-MATER M, V22, P705, DOI 10.1007/s10856-010-4221-3
   Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lin Z, 2011, INT J BIOL SCI, V7, P968, DOI 10.7150/ijbs.7.968
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   Meinel L, 2003, BONE, V33, P660, DOI 10.1016/S8756-3282(03)00207-2
   Nandi SK, 2008, SMALL RUMINANT RES, V75, P144, DOI 10.1016/j.smallrumres.2007.09.006
   Nandi SK, 2009, RES VET SCI, V86, P162, DOI 10.1016/j.rvsc.2008.04.008
   Nicklas M, 2009, DRUG DEV IND PHARM, V35, P1035, DOI 10.1080/03639040902755213
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Pallela R, 2011, INT J BIOL MACROMOL, V49, P85, DOI 10.1016/j.ijbiomac.2011.03.019
   Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813
   Pineda LM, 1996, J BIOMED MATER RES, V31, P385
   PLUMB JA, 1989, CANCER RES, V49, P4435
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   REDDI AH, 1994, J CELL BIOCHEM, V56, P192, DOI 10.1002/jcb.240560213
   Reddi AH, 1997, NAT MED, V3, P837, DOI 10.1038/nm0897-837
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Ripamonti U, 2006, BIOMATERIALS, V27, P807, DOI 10.1016/j.biomaterials.2005.09.021
   Ripamonti U, 2004, J CELL MOL MED, V8, P169, DOI 10.1111/j.1582-4934.2004.tb00272.x
   Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217
   Schofer MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025462
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Steck E, 2010, XENOTRANSPLANTATION, V17, P153, DOI 10.1111/j.1399-3089.2010.00577.x
   Tatsuyama K, 2000, EUR J HISTOCHEM, V44, P269
   Thakur NL, 2004, CURR SCI INDIA, V86, P1506
   THALLER SR, 1993, ANN PLAS SURG, V31, P429, DOI 10.1097/00000637-199311000-00007
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
   Vogel V, 2003, ANNU REV BIOMED ENG, V5, P441, DOI 10.1146/annurev.bioeng.5.040202.121615
   Wang XH, 2014, MAR DRUGS, V12, P1131, DOI 10.3390/md12021131
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Xiao CW, 2010, INT J MOL MED, V26, P517, DOI 10.3892/ijmm_00000494
   Zhukauskas R, 2010, J BIOMATER APPL, V24, P639, DOI 10.1177/0885328209335101
NR 66
TC 11
Z9 11
U1 2
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1757-9694
EI 1757-9708
J9 INTEGR BIOL-UK
JI Integr. Biol.
PY 2015
VL 7
IS 2
BP 250
EP 262
DI 10.1039/c4ib00289j
PG 13
WC Cell Biology
SC Cell Biology
GA CB5LM
UT WOS:000349668600010
PM 25578396
DA 2018-10-20
ER

PT J
AU Grigolato, R
   Pizzi, N
   Brotto, MC
   Corrocher, G
   Desando, G
   Grigolo, B
AF Grigolato, Roberto
   Pizzi, Natalia
   Brotto, Maria C.
   Corrocher, Giovanni
   Desando, Giovanna
   Grigolo, Brunella
TI Magnesium-enriched hydroxyapatite as bone filler in an ameloblastoma
   mandibular defect
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Bone substitute; bone tissue regeneration; magnesium-enriched
   hydroxyapatite
ID ODONTOGENIC-TUMORS; REGENERATION; SUBSTITUTES; GRANULES; SOCKETS; CYSTS;
   JAWS
AB The aim of this study was to evaluate the clinical performance of a magnesium-enriched hydroxyapatite biomaterial used as bone substitute in a case of mandibular ameloblastoma treated with conservative surgery. A 63 year old male patient was treated for an ameloblastoma in the anterior mandibular profile. After tissue excision, the bone defect was filled with a synthetic hydroxyapatite biomaterial enriched with magnesium ions, in order to promote bone tissue regeneration and obtain a good aesthetic result. Twenty-five months after surgery, due to ameloblastoma recurrence in an area adjacent to the previously treated one, the patient underwent to a further surgery. In that occasion the surgeon performed a biopsy in the initially treated area, in order to investigate the nature of the newly-formed tissue and to evaluate the bone regenerative potential of this biomaterial by clinical, radiographic and histological analyses. The clinical, radiographic and histological evaluations showed various characteristics of bone remodeling stage with an ongoing osteogenic formation and a good osteo-integration. In conclusion, magnesium-enriched hydroxyapatite used as bone substitute in a mandibular defect due to ameloblastoma excision showed an effective bone regeneration at 25 months follow-up, demonstrating an excellent biocompatibility and a high osteo-integration property.
C1 [Pizzi, Natalia] IRCCS Ist Nazl Tumori, Milan, Italy.
   [Brotto, Maria C.] Studio Odontoiatr Ortognatodont, I-20123 Milan, Italy.
   [Desando, Giovanna; Grigolo, Brunella] Ist Ortoped, Lab RAMSES, Lab Immunoreumatol & Rigeneraz Tissutale, Bologna, Italy.
RP Grigolo, B (reprint author), Ist Ortoped, Lab RAMSES, Lab Immunoreumatol & Rigeneraz Tissutale, Bologna, Italy.
EM roberto.grigo@tiscali.it
RI Grigolo, Brunella/J-5417-2016
OI Grigolo, Brunella/0000-0002-3990-6745
CR Camargo PM, 2000, ORAL SURG ORAL MED O, V90, P581, DOI 10.1067/moe.2000.110035
   Checchi V, 2011, INT J ORAL MAX SURG, V40, P526, DOI 10.1016/j.ijom.2010.12.005
   Crespi R, 2012, INT J ORAL MAX IMPL, V27, P95
   Crespi R, 2009, J PERIODONTOL, V80, P1616, DOI 10.1902/jop.2009.090156
   Crespi R, 2009, J PERIODONTOL, V80, P210, DOI [10.1902/jop.2009.080400, 10.1902/jop.2009.080400 ]
   Dallari D, 2012, BIOMATERIALS, V33, P72, DOI 10.1016/j.biomaterials.2011.09.029
   Dandriyal R, 2011, NATL J MAXILLOFAC SU, V2, P22, DOI DOI 10.4103/0975-5950.85849
   Dash H, 2008, BRAZ J OTORHINOLAR, V74, P155
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Ettl T, 2012, J CRANIO MAXILL SURG, V40, P485, DOI 10.1016/j.jcms.2011.07.023
   Feinberg SE, 1996, ORAL SURG ORAL MED O, V81, P383, DOI 10.1016/S1079-2104(96)80012-6
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   Hren NI, 2008, INT J ORAL MAX SURG, V37, P1111, DOI 10.1016/j.ijom.2008.07.008
   Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y
   Manfrini M, 2013, J CELL PHYSIOL, V228, P1229, DOI 10.1002/jcp.24276
   Mangano C, 2008, J PERIODONTOL, V79, P929, DOI [10.1902/jop.2008.070245, 10.1902/jop.2008.070245 ]
   Mangano Carlo, 2006, J Oral Implantol, V32, P122, DOI 10.1563/796.1
   Martini L, 2012, PLAST RECONSTR SURG, V129, p625E, DOI 10.1097/PRS.0b013e318244220d
   Morgan PR, 2011, PERIODONTOL 2000, V57, P160, DOI 10.1111/j.1600-0757.2011.00393.x
   Pettinicchio M, 2012, CLIN ORAL INVEST, V16, P45, DOI 10.1007/s00784-010-0484-9
   Pryor LS, 2009, CRANIOMAX TRAUM REC, V2, P151, DOI [10.1055/s-0029-1224777, 10.1055/s-0029-1224777.ISSN1943-3875]
   Ramesh RS, 2010, HEAD NECK ONCOL, V14, P1
   Rebaudi A, 2010, INT J PERIODONT REST, V30, P53
   Regezi JA, 2002, MODERN PATHOL, V15, P331, DOI 10.1038/modpathol.3880527
   Tampieri A, 2011, TRENDS BIOTECHNOL, V29, P526, DOI 10.1016/j.tibtech.2011.04.011
   Velich N, 2004, J CRANIOFAC SURG, V15, P11, DOI 10.1097/00001665-200401000-00006
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
NR 27
TC 6
Z9 6
U1 0
U2 0
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2015
VL 8
IS 1
BP 281
EP 288
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CB8RA
UT WOS:000349897200031
PM 25784998
DA 2018-10-20
ER

PT J
AU Zhao, GF
   Zhong, HM
   Zhang, M
   Hong, YC
AF Zhao, Guangfeng
   Zhong, Huiming
   Zhang, Mao
   Hong, Yucai
TI Effects of antimicrobial peptides on Staphylococcus aureus growth and
   biofilm formation in vitro following isolation from implant-associated
   infections
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Implant-associated infection; antimicrobial peptide; titanium; biofilm
ID RESISTANCE; DEFENSINS; BACTERIA; TITANIUM; SYSTEMS; BLOOD
AB To prevent biomaterial-associated infections, antibiotic agents are recommended for various medical conditions requiring biomaterial implants, but resistance often appears after the introduction of antibiotics into clinical use. Therefore, new strategies for the prevention or treatment for biomaterial-associated infections are required. The purpose of this study was to evaluate the effects of antimicrobial peptides on growth and biofilm formation of Staphylococcus aureus isolated from implant-associated infections. A total of 20 patients with culture-proven staphylococcal infection associated with stable orthopedic implants were selected as the experimental group. S. aureus were isolated from tissue biopsies for identification, the isolated strains were mixed with Tet213 incubated at 37 degrees C and viable bactrial number of S. aureus was counted. For the biofilm formation, the broad spectrum AMP Tet213 was selected and loaded onto the Ti coating first. At the same time Ti coated with Tet213 were mixed with S. aureus in vitro to form biofilm. After 30 min, 2 h, 4 h, 6 h, 8 h, the population of S. aureus in the biofilm was counted. Tet213 showed significant antibacterial effect on 16 strains (P < 0.05, Table 1). The inhibition rate reached above 80% among 12 strains of the clinically isolated strain. In biofilm experiments, counts of the NO. 1, 2, 3, 4 strains in biofilms decreased significantly after 2 h (P < 0.05), while there was no obvious difference in counts of NO. 5 strain (P > 0.05). The broad spectrum AMP Tet213 could strongly reduce the growth and biofilm formation of S. aureus in vitro, and the use of this might be an important new approach to target implant-associated infections.
C1 [Zhao, Guangfeng; Zhong, Huiming; Zhang, Mao; Hong, Yucai] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Emergency Med, Hangzhou 310009, Zhejiang, Peoples R China.
RP Hong, YC (reprint author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Emergency Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.
EM yucaihong66@126.com
CR Basu A, 2013, J MATER CHEM B, V1, P4746, DOI 10.1039/c3tb20805b
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Carson CC, 2004, J UROLOGY, V171, P1611, DOI 10.1097/01.ju.0000118245.66976.e1
   Chennupati SK, 2009, AMJ RHINOL ALLERGY, V23, P46, DOI 10.2500/ajra.2009.23.3261
   Biancalana FSC, 2011, MYCOPATHOLOGIA, V172, P279, DOI 10.1007/s11046-011-9433-7
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Deck MK, 2012, J CLIN MICROBIOL, V50, P1994, DOI 10.1128/JCM.00225-12
   Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P3208, DOI 10.1128/AAC.49.8.3208-3216.2005
   Ellermeier CD, 2006, GENE DEV, V20, P1911, DOI 10.1101/gad.1440606
   Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Gruenheid S, 2012, FEMS MICROBIOL LETT, V330, P81, DOI 10.1111/j.1574-6968.2012.02528.x
   Gupta S, 2012, INDIAN J OTOLOGY, P18
   Kazemzadeh-Narbat M, 2012, J BIOMED MATER RES B, V100B, P1344, DOI 10.1002/jbm.b.32701
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7
   Lu S, 2009, IMMOBILIZATION ANTIM
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Mombelli A, 1992, Clin Oral Implants Res, V3, P162, DOI 10.1034/j.1600-0501.1992.030402.x
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   Park SC, 2011, INT J MOL SCI, V12, P5971, DOI 10.3390/ijms12095971
   Park Y, 2005, J BIOCHEM MOL BIOL, V38, P507
   Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405
   Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007
   Sobczak M, 2013, MOLECULES, V18, P14122, DOI 10.3390/molecules181114122
   Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Zasloff M, 2002, NEW ENGL J MED, V347, P1199, DOI 10.1056/NEJMe020106
   Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537
NR 31
TC 6
Z9 6
U1 0
U2 12
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2015
VL 8
IS 1
BP 1546
EP 1551
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CB8RA
UT WOS:000349897200204
PM 25785171
DA 2018-10-20
ER

PT J
AU Umoren, S
   Obot, IB
   Gasem, Z
   Odewunmi, NA
AF Umoren, Saviour
   Obot, Ime Bassey
   Gasem, Zuhair
   Odewunmi, Nurudeen Adewale
TI Experimental and Theoretical Studies of Red Apple Fruit Extract as Green
   Corrosion Inhibitor for Mild Steel in HCl Solution
SO JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Acid corrosion; biomaterial; computational chemistry; corrosion
   inhibition; mild steel
ID HYDROCHLORIC-ACID SOLUTION; LOW-CARBON STEEL; BENZIMIDAZOLE DERIVATIVES;
   H2SO4 SOLUTIONS; LEAVES EXTRACT; LEAF EXTRACT; MEDIA; AL; ADSORPTION;
   MECHANISM
AB The corrosion inhibition effect of red apple (Malus domestica) fruit extract for mild steel in hydrochloric acid was investigated by gravimetric and electrochemical methods at 30-60 degrees C. Inhibition efficiency increased with the increase in concentration and temperature. Polarization curves indicate that the extract functions as mixed-type inhibitor. The adsorption of the extract onto mild steel surface followed Langmuir adsorption isotherm model. Chemisorption mechanism is proposed based on the trend of inhibition efficiency with temperature. Quantum chemical calculations and molecular dynamics simulations have been used to provide insights into the mechanism of interaction of the major extract components with mild steel.
C1 [Umoren, Saviour; Obot, Ime Bassey; Gasem, Zuhair; Odewunmi, Nurudeen Adewale] King Fahd Univ Petr & Minerals, Res Inst, Ctr Res Excellence Corros, Dhahran 31261, Saudi Arabia.
RP Umoren, S (reprint author), King Fahd Univ Petr & Minerals, Res Inst, Ctr Res Excellence Corros, Dhahran 31261, Saudi Arabia.
EM umoren@kfupm.edu.sa
RI Gasem, Zuhair/E-6030-2017; Umoren, Saviour/J-9720-2013; OBOT,
   IME/I-5379-2013
OI Gasem, Zuhair/0000-0001-7419-0888; Umoren, Saviour/0000-0002-8564-4897;
   OBOT, IME/0000-0002-2700-9529
CR Akalezi CO, 2012, INT J IND CHEM, V3, DOI 10.1186/2228-5547-3-13
   [Anonymous], 2011, MAT STUD REV 6 0
   Avci G, 2011, SURF INTERFACE ANAL, V43, P1311, DOI 10.1002/sia.3714
   Avdeev YG, 2013, CORROS SCI, V69, P50, DOI 10.1016/j.corsci.2012.11.016
   Cao C, 1996, CORROS SCI, V38, P2073, DOI 10.1016/S0010-938X(96)00034-0
   Chidiebere MA, 2012, IND ENG CHEM RES, V51, P668
   Pereira SSDA, 2012, CORROS SCI, V65, P360, DOI 10.1016/j.corsci.2012.08.038
   Deng SD, 2012, CORROS SCI, V55, P407, DOI 10.1016/j.corsci.2011.11.005
   Ebenso EE, 2012, INT J ELECTROCHEM SC, V7, P5643
   Ekanem UF, 2010, J MATER SCI, V45, P5558, DOI 10.1007/s10853-010-4617-y
   Elbakri M, 2013, RES CHEM INTERMEDIAT, V39, P2417, DOI 10.1007/s11164-012-0768-6
   Ferreira ES, 2004, MATER CHEM PHYS, V83, P129, DOI 10.1016/j.matchemphys.2003.09.020
   Frenkel D., 2001, UNDERSTANDING MOL SI
   Frisch M.J., 2004, GAUSSIAN 03 W
   Garai S, 2012, CORROS SCI, V60, P193, DOI 10.1016/j.corsci.2012.03.036
   Gece G, 2009, CORROS SCI, V51, P1876, DOI 10.1016/j.corsci.2009.04.003
   Gece G, 2012, IND ENG CHEM RES, V51, P14115, DOI 10.1021/ie302324b
   Gerengi H, 2012, IND ENG CHEM RES, V51, P780, DOI 10.1021/ie201776q
   Hegazy MA, 2013, CORROS SCI, V69, P110, DOI 10.1016/j.corsci.2012.11.031
   Ji G, 2011, IND ENG CHEM RES, V50, P11954, DOI 10.1021/ie201450d
   Kabanda MM, 2013, INT J ELECTROCHEM SC, V8, P10839
   Kabanda MM, 2012, INT J ELECTROCHEM SC, V7, P5035
   Kamal C, 2012, IND ENG CHEM RES, V51, P10399, DOI 10.1021/ie3010379
   Kesavan D., 2012, CHEM SCI REV LETT, V1, P1
   Khadom AA, 2009, PORT ELECTROCHIM ACT, V27, P699, DOI 10.4152/pea.200906699
   Khaled KF, 2006, CORROS SCI, V48, P3014, DOI 10.1016/j.corsci.2005.11.011
   Khaled KF, 2011, J SOLID STATE ELECTR, V15, P663, DOI 10.1007/s10008-010-1110-0
   Khaled KF, 2014, ARAB J CHEM, V7, P319, DOI 10.1016/j.arabjc.2010.11.005
   Khaled KF, 2009, MATER CHEM PHYS, V113, P150, DOI 10.1016/j.matchemphys.2008.07.060
   Krishnegowda PM, 2013, IND ENG CHEM RES, V52, P722, DOI 10.1021/ie3018862
   Lebrini M, 2011, CORROS SCI, V53, P687, DOI 10.1016/j.corsci.2010.10.006
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Lee KW, 2003, J AGR FOOD CHEM, V51, P6516, DOI 10.1021/jf034475w
   Li LJ, 2012, CORROS SCI, V63, P82, DOI 10.1016/j.corsci.2012.05.026
   Li WH, 2008, J APPL ELECTROCHEM, V38, P289, DOI 10.1007/s10800-007-9437-7
   Li XH, 2012, CORROS SCI, V62, P163, DOI 10.1016/j.corsci.2012.05.008
   Li XH, 2009, CORROS SCI, V51, P620, DOI 10.1016/j.corsci.2008.12.021
   MACDONALD JR, 1987, J ELECTROANAL CHEM, V223, P25, DOI 10.1016/0022-0728(87)85249-X
   Machnikova E, 2008, ELECTROCHIM ACTA, V53, P6024, DOI 10.1016/j.electacta.2008.03.021
   Martinez S, 2001, J APPL ELECTROCHEM, V31, P973, DOI 10.1023/A:1017989510605
   Noor EA, 2009, MATER CHEM PHYS, V114, P533, DOI 10.1016/j.matchemphys.2008.09.065
   Obi-Egbedi NO, 2012, ARAB J CHEM, V5, P361, DOI 10.1016/j.arabjc.2010.09.002
   Obi-Egbedi NO, 2011, CORROS SCI, V53, P263, DOI 10.1016/j.corsci.2010.09.020
   Obot IB, 2011, CURR APPL PHYS, V11, P382, DOI 10.1016/j.cap.2010.08.007
   Obot IB, 2010, CORROS SCI, V52, P657, DOI 10.1016/j.corsci.2009.10.017
   Obot IB, 2010, CORROS SCI, V52, P198, DOI 10.1016/j.corsci.2009.09.002
   Obot IB, 2009, CORROS SCI, V51, P1868, DOI 10.1016/j.corsci.2009.05.017
   Obot IB, 2009, CORROS SCI, V51, P276, DOI 10.1016/j.corsci.2008.11.013
   Obot IB, 2013, J ENVIRON CHEM ENG, V1, P431, DOI 10.1016/j.jece.2013.06.007
   Oguzie EE, 2012, J MATER SCI, V47, P3592, DOI 10.1007/s10853-011-6205-1
   Oguzie EE, 2010, J COLLOID INTERF SCI, V349, P283, DOI 10.1016/j.jcis.2010.05.027
   Oguzie E.E., 2007, J SOLID STATE ELECTR, V12, P721
   Oguzie EE, 2012, J PHYS CHEM C, V116, P13603, DOI 10.1021/jp300791s
   Outirite M, 2010, ELECTROCHIM ACTA, V55, P1670, DOI 10.1016/j.electacta.2009.10.048
   Popova A, 2003, CORROS SCI, V45, P33, DOI 10.1016/S0010-938X(02)00072-0
   Raja PB, 2013, CORROS SCI, V69, P292, DOI 10.1016/j.corsci.2012.11.042
   Rani BEA, 2012, INT J CORROS, DOI 10.1155/2012/380217
   Sethuraman M.G., 2008, MATER LETT, V60, P113
   Singh A, 2012, INT J CORROS, DOI 10.1155/2012/897430
   Soltani N, 2012, CORROS SCI, V62, P122, DOI 10.1016/j.corsci.2012.05.003
   Umoren SA, 2012, GREEN CHEM LETT REV, V5, P303, DOI 10.1080/17518253.2011.625980
   Villamil RFV, 1999, J ELECTROANAL CHEM, V472, P112, DOI 10.1016/S0022-0728(99)00267-3
   Zarrouk A., 2012, INT J ELECTROCHEM SC, V7, P5643
NR 63
TC 4
Z9 4
U1 2
U2 19
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0193-2691
EI 1532-2351
J9 J DISPER SCI TECHNOL
JI J. Dispersion Sci. Technol.
PY 2015
VL 36
IS 6
BP 789
EP 802
DI 10.1080/01932691.2014.922887
PG 14
WC Chemistry, Physical
SC Chemistry
GA CB3JH
UT WOS:000349523600005
DA 2018-10-20
ER

PT J
AU Shibata, Y
   Tanimoto, Y
AF Shibata, Yo
   Tanimoto, Yasuhiro
TI A review of improved fixation methods for dental implants. Part I:
   Surface optimization for rapid osseointegration
SO JOURNAL OF PROSTHODONTIC RESEARCH
LA English
DT Review
DE Titanium implant; Surface chemistry; Surface topography;
   Osseointegration; Antibacterial
ID DISCHARGE PLASMA TREATMENT; BONE-TITANIUM INTERFACE; HYDROTHERMALLY
   TREATED TITANIUM; EPIDERMAL-GROWTH-FACTOR; OSTEOBLAST-LIKE CELLS;
   STREPTOCOCCUS-GORDONII; OSTEOGENIC PROPERTIES; EXTRACELLULAR-MATRIX;
   PROTEIN ADSORPTION; HYDROGEN-PEROXIDE
AB Purpose: Titanium is a primary metallic biomaterial used in load-bearing orthopedic or dental implants because of its favorable mechanical properties and osseointegration capability. This article reviews the current status of surface optimization techniques for titanium implants, whether such concepts are in the form of sufficiently evidence-based, and highlights the related experimental tools.
   Study selection: A strong emphasis was placed on the enhanced biological responses to titanium implants by modifying the surface finishing process. On this basis, a clear partition of surface chemistry and topography was critical.
   Results: The intrinsic host tissue response to titanium implants is facilitated by the chemistry or topography of a passive oxide film, although the extent to which the surface characteristics enable rapid osseointegration is still uncertain.
   Conclusion: Besides the fundamental requirements, such as the promotion of osteogenic differentiation, the titanium implant surface should accelerate wound-healing phenomena prior to bone ingrowth toward the surface. Moreover, because initial bacterial attachment to the implant surface is unavoidable, infection control by surface modification is also an important determinant in reducing surgical failure. A desirable surface-biological relationship often needs to be characterized at the nanoscale by means of advanced technologies. (C) 2014 Japan Prosthodontic Society. Published by Elsevier Ireland. All rights reserved.
C1 [Shibata, Yo] Showa Univ, Sch Dent, Dept Conservat Dent, Div Biomat & Engn, Tokyo 142, Japan.
   [Tanimoto, Yasuhiro] Nihon Univ, Sch Dent Matsudo, Dept Dent Biomat, Chiba, Japan.
RP Shibata, Y (reprint author), 1-5-8 Hatanodai,Shinagawa Ku, Tokyo 1428555, Japan.
EM yookun@dent.showa-u.ac.jp
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   Aita H, 2009, ACTA BIOMATER, V5, P3247, DOI 10.1016/j.actbio.2009.04.022
   Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1986, BIOMATERIALS, V7, P201, DOI 10.1016/0142-9612(86)90103-1
   Ao CH, 2005, CHEM ENG SCI, V60, P103, DOI 10.1016/j.ces.2004.01.073
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   Att W, 2009, BIOMATERIALS, V30, P4268, DOI 10.1016/j.biomaterials.2009.04.048
   Atta W, 2009, BIOMATERIALS, V30, P5352, DOI 10.1016/j.biomaterials.2009.06.040
   Ayukawa Y, 1998, J BIOMED MATER RES, V41, P111
   Barbour ME, 2009, J BIOMED MATER RES A, V90A, P993, DOI 10.1002/jbm.a.32170
   Becker W, 2000, Clin Implant Dent Relat Res, V2, P159, DOI 10.1111/j.1708-8208.2000.tb00007.x
   Beutner R, 2009, BIOMATERIALS, V30, P2774, DOI 10.1016/j.biomaterials.2009.01.047
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brett PM, 2004, BONE, V35, P124, DOI 10.1016/j.bone.2004.03.009
   BROWN GL, 1986, J EXP MED, V163, P1319
   BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203
   Brunski J B, 1999, Adv Dent Res, V13, P99
   BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Cabrini M, 1997, BIOMATERIALS, V18, P783, DOI 10.1016/S0142-9612(96)00205-0
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   Czerwiec T, 1998, SURF COAT TECH, V108, P182, DOI 10.1016/S0257-8972(98)00555-6
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Deng JY, 2010, J BIOMATER APPL, V25, P179, DOI 10.1177/0885328209349316
   Ellingsen JE, 2004, INT J ORAL MAX IMPL, V19, P659
   Gittens RA, 2014, ACTA BIOMATER, V10, P3363, DOI 10.1016/j.actbio.2014.03.037
   Gittens RA, 2014, ACTA BIOMATER, V10, P2907, DOI 10.1016/j.actbio.2014.03.032
   Glass-Brudzinski JT, 2002, J BIOMED MATER RES, V61, P608, DOI 10.1002/jbm.10243
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Hanawa T, 1998, J MATER SCI-MATER M, V9, P89, DOI 10.1023/A:1008847014938
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103
   Hori N, 2009, J DENT RES, V88, P663, DOI 10.1177/0022034509339567
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   Iwai-Yoshida M, 2012, J MECH BEHAV BIOMED, V13, P230, DOI 10.1016/j.jmbbm.2012.01.016
   Iwasa F, 2010, BIOMATERIALS, V31, P2717, DOI 10.1016/j.biomaterials.2009.12.024
   Kataoka Y, 2011, BIO-MED MATER ENG, V21, P113, DOI 10.3233/BME-2011-0661
   Kawai H, 2004, BIOMATERIALS, V25, P1805, DOI 10.1016/j.biomaterials.2003.08.032
   Kim H, 2006, INT J ORAL MAX IMPL, V21, P354
   Kohal RJ, 2013, DENT MATER, V29, P763, DOI 10.1016/j.dental.2013.04.003
   Kohavi D, 2013, CLIN ORAL IMPLAN RES, V24, P1002, DOI 10.1111/j.1600-0501.2012.02508.x
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lee K, 2011, BIOMATERIALS, V32, P2556, DOI 10.1016/j.biomaterials.2010.11.072
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Lin HY, 2004, APPL SURF SCI, V225, P21, DOI 10.1016/j.apsusc.2003.09.027
   LINDER L, 1985, ACTA ORTHOP SCAND, V56, P269, DOI 10.3109/17453678508993011
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McCafferty E, 1999, APPL SURF SCI, V143, P92, DOI 10.1016/S0169-4332(98)00927-1
   McCarron EM, 1990, PHYS REV B, V41, P7238
   MEDAGLINI D, 1995, P NATL ACAD SCI USA, V92, P6868, DOI 10.1073/pnas.92.15.6868
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Mitchell SA, 2004, BIOMATERIALS, V25, P4079, DOI 10.1016/j.biomaterials.2003.11.010
   Miura S, 2012, J PROSTHODONT RES, V56, P178, DOI 10.1016/j.jpor.2011.11.004
   Miyata K, 2013, J PROSTHODONT RES, V57, P99, DOI 10.1016/j.jpor.2012.12.002
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Murakami A, 2012, NANOMED-NANOTECHNOL, V8, P374, DOI 10.1016/j.nano.2011.07.001
   NANCI A, 1994, CELL MATER, V4, P1
   Ogawa T, 2008, J DENT RES, V87, P751, DOI 10.1177/154405910808700809
   Ohtsuki C, 1997, J BIOMED MATER RES, V35, P39, DOI 10.1002/(SICI)1097-4636(199704)35:1<39::AID-JBM5>3.0.CO;2-N
   Okawa S, 2009, DENT MATER J, V28, P68, DOI 10.4012/dmj.28.68
   Omori S, 2009, J DENT RES, V88, P957, DOI 10.1177/0022034509343426
   Otsuka F, 2012, DENT MATER J, V31, P309, DOI 10.4012/dmj.2011-039
   Park JW, 2009, ACTA BIOMATER, V5, P3272, DOI 10.1016/j.actbio.2009.04.038
   Park YJ, 2007, J MATER SCI-MATER M, V18, P565, DOI 10.1007/s10856-007-2303-7
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Radin S, 1997, BIOMATERIALS, V18, P777, DOI 10.1016/S0142-9612(96)00190-1
   Rajagopal G, 2006, COLLOID SURFACE B, V51, P107, DOI 10.1016/j.colsurfb.2006.06.003
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Robert D, 2002, SCI TOTAL ENVIRON, V291, P85, DOI 10.1016/S0048-9697(01)01094-4
   Rupp F, 2014, ACTA BIOMATER, V10, P2894, DOI 10.1016/j.actbio.2014.02.040
   Sato N, 2009, DENT MATER, V25, P1532, DOI 10.1016/j.dental.2009.07.006
   SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Shibata Y, 2004, J DENT RES, V83, P115, DOI 10.1177/154405910408300206
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   Shibata Y, 2010, BIOMATERIALS, V31, P8546, DOI 10.1016/j.biomaterials.2010.07.098
   Shibata Y, 2002, J DENT RES, V81, P841, DOI 10.1177/154405910208101209
   Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x
   Sugita Y, 2011, BIOMATERIALS, V32, P8374, DOI 10.1016/j.biomaterials.2011.07.077
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K
   Tizazu G, 2009, LANGMUIR, V25, P10746, DOI 10.1021/la901271c
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Tsaryk R, 2007, BIOMATERIALS, V28, P806, DOI 10.1016/j.biomaterials.2006.09.033
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   Wilson AD, 1999, SURF COAT TECH, V114, P70, DOI 10.1016/S0257-8972(99)00024-9
   Yamaki K, 2012, DENT MATER J, V31, P427, DOI 10.4012/dmj.2011-051
   Yamamoto H, 2005, J DENT RES, V84, P668, DOI 10.1177/154405910508400717
   YAMAMURA K, 1992, J BIOMED MATER RES, V26, P1053, DOI 10.1002/jbm.820260807
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 111
TC 51
Z9 54
U1 1
U2 67
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1883-1958
EI 2212-4632
J9 J PROSTHODONT RES
JI J. Prosthodont. Res.
PD JAN
PY 2015
VL 59
IS 1
BP 20
EP 33
DI 10.1016/j.jpor.2014.11.007
PG 14
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CB4HO
UT WOS:000349589000004
PM 25530606
DA 2018-10-20
ER

PT J
AU Singh, KM
   Jisha, TK
   Reddy, B
   Parmar, N
   Patel, A
   Patel, AK
   Joshi, CG
AF Singh, K. M.
   Jisha, T. K.
   Reddy, Bhaskar
   Parmar, Nidhi
   Patel, Anand
   Patel, A. K.
   Joshi, C. G.
TI Microbial profiles of liquid and solid fraction associated biomaterial
   in buffalo rumen fed green and dry roughage diets by tagged 16S rRNA
   gene pyrosequencing
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE Buffalo; Microbiota; Pyrosequencing; 16S r RNA
ID REAL-TIME PCR; BACTERIAL DIVERSITY; BUBALUS-BUBALIS; COW RUMEN;
   PREVOTELLA; COMMUNITIES; CATTLE
AB The microbiome of buffalo rumen plays an important role in animal health and productivity. The rumen bacterial composition of both liquid and solid fraction was surveyed using pyrosequencing of the 16S rRNA gene. Sequences were analyzed using taxonomy-dependent clustering methods and revealed that the dominant ruminal bacteria shared by samples belonged to phyla Bacteroidetes, Firmicutes, Fibrobacteres and Proteobacteria. The core rumen microbiome of the rumen consisted of 10 phyla, 19 classes, 22 orders and 25 families. However, the relative abundance of these bacterial groups was markedly affected by diet composition as well as in type of biomaterial. In animals fed with a green and dry roughage diet, the cellulolytic bacteria, Ruminococcaceae, and Fibrobacteraceae was found in highest abundance in all biomaterials which reflected the need for enhanced fiber-digesting capacity in buffalo. The polysaccharide-degrading Prevotellaceae bacteria were most abundant in buffalo rumen. In taxonomic comparison of rumen bacteria, about 26 genera were differentially abundant among liquid and solid fraction of ruminal fluid. These results highlight the buffalo ruminal microbiome's ability to adapt to feed with different composition.
C1 [Singh, K. M.; Jisha, T. K.; Reddy, Bhaskar; Parmar, Nidhi; Patel, Anand; Patel, A. K.; Joshi, C. G.] Anand Agr Univ, Dept Anim Biotechnol, Anand, Gujarat, India.
RP Singh, KM (reprint author), Xcelris Labs Ltd, Xcelris Genom, Old Premchandnagar Rd, Ahmadabad 380054, Gujarat, India.
EM kmsingh18@gmail.com; cgjoshi@aau.in
RI Joshi, Chaitanya/A-2591-2013
OI Joshi, Chaitanya/0000-0003-4680-2861
FU Niche area of excellence project - Indian Council of Agricultural
   Research, New Delhi, India
FX This research work was supported by Niche area of excellence project
   funded by Indian Council of Agricultural Research, New Delhi, India.
CR Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836
   Avgustin G, 2001, FOLIA MICROBIOL, V46, P40, DOI 10.1007/BF02825882
   Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x
   Chandler DP, 1997, MOL ECOL, V6, P475, DOI 10.1046/j.1365-294X.1997.00205.x
   Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-125
   Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24
   Evans NJ, 2011, APPL ENVIRON MICROB, V77, P138, DOI 10.1128/AEM.00993-10
   GREGG K, 1995, TRENDS BIOTECHNOL, V13, P418, DOI 10.1016/S0167-7799(00)88995-7
   Hespell Robert B., 1997, P59
   Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387
   Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09
   Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306
   Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127
   Kamra DN, 2005, CURR SCI INDIA, V89, P124
   Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x
   KLIEVE AV, 1988, APPL ENVIRON MICROB, V54, P1637
   Lee HJ, 2012, APPL ENVIRON MICROB, V78, P5983, DOI 10.1128/AEM.00104-12
   Li RW, 2011, DYNAMICS RUMEN MICRO, P135
   Matsui H, 2000, CURR MICROBIOL, V41, P45, DOI 10.1007/s002840010089
   Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520
   Nathani NM, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-55
   Pandya PR, 2010, J APPL GENET, V51, P395, DOI 10.1007/BF03208869
   Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041
   Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6
   PRINS RA, 1975, A VAN LEEUW J MICROB, V41, P1, DOI 10.1007/BF02565031
   Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8
   Ramsak A, 2000, FEMS MICROBIOL ECOL, V33, P69, DOI 10.1016/S0168-6496(00)00049-0
   Sanapareddy N, 2009, APPL ENVIRON MICROB, V75, P1688, DOI 10.1128/AEM.01210-08
   Singh KM, 2012, MOL BIOL REP, V39, P10595, DOI 10.1007/s11033-012-1947-7
   Singh KM, 2012, MOL BIOL REP, V39, P4841, DOI 10.1007/s11033-011-1278-0
   Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y
   Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001
   Thoetkiattikul H, 2013, CURR MICROBIOL, V67, P130, DOI 10.1007/s00284-013-0336-3
   Wallace RJ, 2008, ANIMAL, V2, P661, DOI 10.1017/S1751731108001687
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Wu S, 2012, METAGENOMICS, V1, P1, DOI DOI 10.4303/MG/235571
NR 36
TC 11
Z9 12
U1 2
U2 25
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD JAN
PY 2015
VL 42
IS 1
BP 95
EP 103
DI 10.1007/s11033-014-3746-9
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CA6FU
UT WOS:000349006400012
PM 25249226
DA 2018-10-20
ER

PT J
AU Liao, L
   Dong, JT
   Shi, L
   Fan, ZY
   Li, SM
   Lu, ZQ
AF Liao, Lan
   Dong, Jianting
   Shi, Li
   Fan, Zhongyong
   Li, Suming
   Lu, Zhiqian
TI In vitro degradation behavior of L-lactide/trimethylene
   carbonate/glycolide terpolymers and a composite with
   poly(L-lactide-co-glycolide) fibers
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE In vitro degradation; (L-lactide-trimethylene carbonate-glycolide)
   terpolymers; Biomaterial; Cardiovascular stent
ID CARDIOVASCULAR STENT MATERIAL; L-LACTIC ACID; HYDROLYTIC DEGRADATION;
   TRIMETHYLENE CARBONATE; BIODEGRADABLE POLYMERS; EPSILON-CAPROLACTONE;
   POLY(1,3-TRIMETHYLENE CARBONATE); 1,3-TRIMETHYLENE CARBONATE;
   COPOLYMERS; GLYCOLIDE
AB A series of high molar mass terpolymers are synthesized by ring-opening polymerization of L-lactide (LLA), 1,3-trimethylene carbonate (TMC) and glycolide (GA). In vitro degradation of the obtained terpolymers was realized in phosphate buffered saline (PBS) at 37 degrees C for one year, in comparison with PLLA-TMC copolymer and a composite made up of a PLLA-TMC-GA terpolymer matrix reinforced by poly(L-lactide-co-glycolide) (PLGA) fibers. Degradation was characterized as a function of incubation time by using GPC, DSC and H-1 NMR.
   PLLA-TMC-GA terpolymers degrade faster than PLLA and PLLA-TMC because of lower chain regularity and lower crystallinity. In the case of the composite, the fast degradation of PLGA fibers speeds up the degradation of the PLLA-TMC-GA matrix due to internal autocatalysis. Morphological changes with increase of melting enthalpy were observed in all cases with crystallization of degradation by-products and selective degradation of amorphous domains. On the other hand, compositional changes appeared more complex since different phenomena are involved, including crystallization of LLA component, selective degradation in amorphous domains, and release of soluble oligomers. Among the various polymers, PLTG90/10/5 and PLTG95/5/5 present appropriate degradation rates, and are promising for the fabrication of totally bioresorbable stents. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Liao, Lan; Dong, Jianting; Shi, Li; Fan, Zhongyong] Fudan Univ, Dept Mat Sci, Shanghai 200433, Peoples R China.
   [Li, Suming] Univ Montpellier 2, UMR CNRS 5635, European Inst Membranes, Dept Interface Physicochem & Polymers, F-34095 Montpellier, France.
   [Lu, Zhiqian] Shanghai Jiao Tong Univ, Peoples Hosp 6, Shanghai 200233, Peoples R China.
RP Fan, ZY (reprint author), Fudan Univ, Dept Mat Sci, Handan Rd 220, Shanghai 200433, Peoples R China.
EM zyfan@fudan.edu.cn; sli@univ-montp2.fr; 18930177678@163.com
FU National Natural Science Foundation of China [51073041, 51373041];
   Science and Technology Commission of Shanghai Municipality [12441903103]
FX The authors acknowledge the financial support from the National Natural
   Science Foundation of China (51073041 and 51373041) and the Science and
   Technology Commission of Shanghai Municipality (12441903103).
CR Andronova N, 2006, BIOMACROMOLECULES, V7, P1489, DOI 10.1021/bm060081c
   Asplund B, 2006, J BIOMAT SCI-POLYM E, V17, P615, DOI 10.1163/156856206777346331
   Aunoble S, 2006, J BIOMED MATER RES A, V78A, P416, DOI 10.1002/jbm.a.30749
   Cai Q, 2000, J BIOMAT SCI-POLYM E, V11, P273, DOI 10.1163/156856200743698
   Dong JT, 2014, POLYM ENG SCI, V54, P1418, DOI 10.1002/pen.23662
   Dong JT, 2014, POLYM DEGRAD STABIL, V103, P26, DOI 10.1016/j.polymdegradstab.2014.03.004
   Dong JT, 2014, POLYM B
   Espartero JL, 1996, MACROMOLECULES, V29, P3535, DOI 10.1021/ma950529u
   Felfel RM, 2011, J MECH BEHAV BIOMED, V4, P1462, DOI 10.1016/j.jmbbm.2011.05.016
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Han YR, 2012, POLYM ENG SCI, V52, P741, DOI 10.1002/pen.22137
   Han YR, 2012, MACROMOL MATER ENG, V297, P128, DOI 10.1002/mame.201100113
   Hua JJ, 2009, J POLYM SCI POL CHEM, V47, P3869, DOI 10.1002/pola.23453
   KATZ AR, 1985, SURG GYNECOL OBSTET, V161, P213
   Kawai T, 2007, MACROMOLECULES, V40, P9463, DOI 10.1021/ma070082c
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   LI SM, 1990, J MATER SCI-MATER M, V1, P198, DOI 10.1007/BF00701077
   MainilVarlet P, 1997, BIOMATERIALS, V18, P257, DOI 10.1016/S0142-9612(96)00126-3
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mohanty AK, 2000, MACROMOL MATER ENG, V276, P1, DOI 10.1002/(SICI)1439-2054(20000301)276:1<1::AID-MAME1>3.0.CO;2-W
   Onuma Y, 2011, CIRC J, V75, P509, DOI 10.1253/circj.CJ-10-1135
   Pamula E, 2005, J MOL STRUCT, V744, P557, DOI 10.1016/j.molstruc.2004.11.016
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Pego AP, 2002, MACROMOL BIOSCI, V2, P411, DOI 10.1002/mabi.200290000
   Prokop A, 2005, BIOMATERIALS, V26, P4129, DOI 10.1016/j.biomaterials.2004.10.031
   Rong WR, 2005, J POLYM SCI POL PHYS, V43, P2243, DOI 10.1002/polb.20513
   Srisa-ard M, 2001, POLYM INT, V50, P891, DOI 10.1002/pi.713
   Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496
   Sullivan TM, 2002, J VASC SURG, V36, P143, DOI 10.1067/mva.2002.122878
   Tamai H, 2000, CIRCULATION, V102, P399
   Yang J, 2010, EUR POLYM J, V46, P783, DOI 10.1016/j.eurpolymj.2009.12.017
   Zhang Z, 2006, BIOMATERIALS, V27, P1741, DOI 10.1016/j.biomaterials.2005.09.017
   Zhou XG, 2010, J BIOMED MATER RES A, V95A, P755, DOI 10.1002/jbm.a.32896
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
   Zurita R, 2007, POLYM DEGRAD STABIL, V92, P975, DOI 10.1016/j.polymdegradstab.2007.03.002
NR 37
TC 10
Z9 10
U1 4
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
EI 1873-2321
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD JAN
PY 2015
VL 111
BP 203
EP 210
DI 10.1016/j.polymdegradstab.2014.11.013
PG 8
WC Polymer Science
SC Polymer Science
GA CA5LD
UT WOS:000348949000024
DA 2018-10-20
ER

PT J
AU Teeter, MG
   Kopacz, AJ
   Nikolov, HN
   Holdsworth, DW
AF Teeter, Matthew G.
   Kopacz, Alexander J.
   Nikolov, Hristo N.
   Holdsworth, David W.
TI Metrology test object for dimensional verification in additive
   manufacturing of metals for biomedical applications
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE Additive manufacturing; rapid prototyping; selective laser melting;
   metrology; test object
ID MECHANICAL-BEHAVIOR; TITANIUM; IMPLANTS
AB Additive manufacturing continues to increase in popularity and is being used in applications such as biomaterial ingrowth that requires sub-millimeter dimensional accuracy. The purpose of this study was to design a metrology test object for determining the capabilities of additive manufacturing systems to produce common objects, with a focus on those relevant to medical applications. The test object was designed with a variety of features of varying dimensions, including holes, cylinders, rectangles, gaps, and lattices. The object was built using selective laser melting, and the produced dimensions were compared to the target dimensions. Location of the test objects on the build plate did not affect dimensions. Features with dimensions less than 0.300mm did not build or were overbuilt to a minimum of 0.300mm. The mean difference between target and measured dimensions was less than 0.100mm in all cases. The test object is applicable to multiple systems and materials, tests the effect of location on the build, uses a minimum of material, and can be measured with a variety of efficient metrology tools (including measuring microscopes and micro-CT). Investigators can use this test object to determine the limits of systems and adjust build parameters to achieve maximum accuracy.
C1 [Teeter, Matthew G.] Lawson Hlth Res Inst, London, ON N6A 5A5, Canada.
   [Teeter, Matthew G.; Holdsworth, David W.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada.
   [Teeter, Matthew G.; Holdsworth, David W.] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada.
   [Kopacz, Alexander J.; Nikolov, Hristo N.; Holdsworth, David W.] Univ Western Ontario, Imaging Res Labs, Robarts Res Inst, London, ON, Canada.
RP Teeter, MG (reprint author), Lawson Hlth Res Inst, 339 Windermere Rd, London, ON N6A 5A5, Canada.
EM matthew.teeter@lhsc.on.ca
RI Teeter, Matthew/C-1102-2014; Holdsworth, David/F-6315-2012
OI Teeter, Matthew/0000-0002-3911-3171; Holdsworth,
   David/0000-0002-0603-5322
FU Canadian Institutes of Health Research; National Sciences and
   Engineering Research Council of Canada
FX This study was supported by a grant from the Canadian Institutes of
   Health Research and the National Sciences and Engineering Research
   Council of Canada.
CR Basalah A, 2012, J BIOMED MATER RES B, V100B, P1970, DOI 10.1002/jbm.b.32764
   Brajlih T, 2011, RAPID PROTOTYPING J, V17, P64, DOI 10.1108/13552541111098644
   Fukuda A, 2011, ACTA BIOMATER, V7, P2327, DOI 10.1016/j.actbio.2011.01.037
   Ghany KA, 2006, RAPID PROTOTYPING J, V12, P86, DOI 10.1108/13552540610652429
   Moylan S, 2012, 23 ANN INT SOL FREEF, P902
   Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219
   Murr LE, 2009, J MECH BEHAV BIOMED, V2, P20, DOI 10.1016/j.jmbbm.2008.05.004
   Ning Y, 2006, IEEE T AUTOM SCI ENG, V3, P73, DOI 10.1109/TASE.2005.857656
   Pattanayak DK, 2011, ACTA BIOMATER, V7, P1398, DOI 10.1016/j.actbio.2010.09.034
   Ryan G, 2009, J BIOMED MATER RES B, V90B, P894, DOI 10.1002/jbm.b.31361
   Singh S, 2012, INT J APPL SCI ENG, V10, P59
   Strano G, 2013, J MATER PROCESS TECH, V213, P589, DOI 10.1016/j.jmatprotec.2012.11.011
   Stubinger S, 2013, J BIOMED MATER RES B, V101, P1154, DOI 10.1002/jbm.b.32925
   Van Bael S, 2011, MAT SCI ENG A-STRUCT, V528, P7423, DOI 10.1016/j.msea.2011.06.045
   van Elsen M, 2008, RAPID PROTOTYPING J, V14, P15, DOI 10.1108/13552540810841526
   Warnke PH, 2009, TISSUE ENG PART C-ME, V15, P115, DOI 10.1089/ten.tec.2008.0288
NR 16
TC 7
Z9 7
U1 0
U2 24
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-4119
EI 2041-3033
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PD JAN
PY 2015
VL 229
IS 1
BP 20
EP 27
DI 10.1177/0954411914565222
PG 8
WC Engineering, Biomedical
SC Engineering
GA CB2CZ
UT WOS:000349435600003
PM 25542613
DA 2018-10-20
ER

PT J
AU Thormann, U
   Alt, V
   Heimann, L
   Gasquere, C
   Heiss, C
   Szalay, G
   Franke, J
   Schnettler, R
   Lips, KS
AF Thormann, Ulrich
   Alt, Volker
   Heimann, Lydia
   Gasquere, Cyrille
   Heiss, Christian
   Szalay, Gabor
   Franke, Joerg
   Schnettler, Reinhard
   Lips, Katrin Susanne
TI The Biocompatibility of Degradable Magnesium Interference Screws: An
   Experimental Study with Sheep
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID IN-VIVO DEGRADATION; PLASMA ELECTROLYTIC OXIDATION; OXIDE COATINGS; BONE
   RESPONSE; ALLOYS; ALUMINUM; PERFORMANCE; IMPLANTS; BEHAVIOR; MODEL
AB Screws for ligament reconstruction are nowadays mostly made of poly-L-lactide (PLLA). However, magnesium-based biomaterials are gathering increased interest in this research field because of their good mechanical property and osteoanabolic influence on bone metabolism. The aim of this pilot study was to evaluate the biocompatibility of an interference screw for ligament reconstruction made of magnesium alloy W4 by diecasting and milling and using different PEO-coatings with calcium phosphates. PLLA and titanium screws were used as control samples. The screws were implanted in the femur condyle of the hind leg of a merino sheep. The observation period was six and twelve weeks and one year. Histomorphometric, immunohistochemical, immunofluorescence, and molecular biological evaluation were conducted. Further TEM analysis was done. In all magnesium screws a clinically relevant gas formation in the vicinity of the biomaterial was observed. Except for the PLLA and titanium control samples, no screw was fully integrated in the surrounding bone tissue. Regarding the fabrication process, milling seems to produce less gas liberation and has a better influence on bone metabolism than diecasting. Coating by PEO with calcium phosphates could not reduce the initial gas liberation but rather reduced the bone metabolism in the vicinity of the biomaterial.
C1 [Thormann, Ulrich; Alt, Volker; Heiss, Christian; Schnettler, Reinhard; Lips, Katrin Susanne] Univ Giessen, Lab Expt Trauma Surg, D-35394 Giessen, Germany.
   [Thormann, Ulrich; Alt, Volker; Heiss, Christian; Szalay, Gabor; Schnettler, Reinhard] Univ Giessen, Univ Hosp Giessen Marburg, Dept Trauma Surg Giessen, D-35392 Giessen, Germany.
   [Heimann, Lydia; Gasquere, Cyrille] Aap Biomat GmbH, D-64807 Dieburg, Germany.
   [Franke, Joerg] Elbe Kliniken Stade, Dept Trauma & Orthoped Surg, D-21682 Stade, Germany.
RP Thormann, U (reprint author), Univ Giessen, Lab Expt Trauma Surg, Kerkrader Str 9, D-35394 Giessen, Germany.
EM ulrich.thormann@chiru.med.uni-giessen.de
OI Franke, Joerg/0000-0002-0724-1785
FU aap Biomaterials GmbH, Dieburg
FX The authors wish to thank Ivonne Bergen, Olga Dakischew, Rainer Braun,
   Martina Fink, Ida Oberst, and Iris Schutz for their excellent technical
   assistance. This study was supported by aap Biomaterials GmbH, Dieburg.
CR Bobe K, 2013, ACTA BIOMATER, V9, P8611, DOI [10.1016/j.actbio.2013.03.035, 10.1016/j.actbio2013.03.035]
   Bondarenko A, 2014, J BIOMED MATER RES A, V102, P1449, DOI 10.1002/jbm.a.34828
   Butyagin PI, 2003, MATER LETT, V57, P1748, DOI 10.1016/S0167-577X(02)01062-5
   Castellani C, 2011, ACTA BIOMATER, V7, P432, DOI 10.1016/j.actbio.2010.08.020
   Curran JA, 2006, ACTA MATER, V54, P1985, DOI [10.1016/j.actamat.2005.12.029, 10.1016/j.acatamat.2005.12.029]
   Curran JA, 2005, SURF COAT TECH, V199, P177, DOI 10.1016/j.surfcoat.2004.11.045
   Dorozhkin SV, 2014, ACTA BIOMATER, V10, P2919, DOI 10.1016/j.actbio.2014.02.026
   Eliezer A, 2010, ADV MATER RES-SWITZ, V95, P17, DOI 10.4028/www.scientific.net/AMR.95.17
   Fischerauer SF, 2013, ACTA BIOMATER, V9, P5411, DOI 10.1016/j.actbio.2012.09.017
   Gasqueres C, 2012, SURF COAT TECH, V206, P3410, DOI 10.1016/j.surfcoat.2012.02.015
   Gnedenkov SV, 2000, SURF COAT TECH, V123, P24, DOI 10.1016/S0257-8972(99)00421-1
   Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Huehnerschulte TA, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-14
   Kim SM, 2014, J BIOMED MATER RES A, V102, P429, DOI 10.1002/jbm.a.34718
   Krishna LR, 2003, SURF COAT TECH, V163, P484, DOI 10.1016/S0257-8972(02)00646-1
   Leem Y. H., 2014, J TISSUE ENG REGENER
   Lin X, 2013, MAT SCI ENG C-MATER, V33, P3881, DOI 10.1016/j.msec.2013.05.023
   Nie X, 2002, SURF COAT TECH, V149, P245, DOI 10.1016/S0257-8972(01)01453-0
   Parfenov EV, 2007, SURF COAT TECH, V201, P8661, DOI 10.1016/j.surfcoat.2007.04.044
   Pietak A, 2008, J MATER SCI-MATER M, V19, P407, DOI 10.1007/s10856-007-3172-9
   Qi ZR, 2014, J BIOMED MATER RES A, V102, P1255, DOI 10.1002/jbm.a.34795
   Shadanbaz S, 2013, J BIOMED MATER RES B, V101B, P162, DOI 10.1002/jbm.b.32830
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tian J, 2002, SURF COAT TECH, V154, P1, DOI 10.1016/S0257-8972(01)01671-1
   Voevodin AA, 1996, SURF COAT TECH, V86-7, P516, DOI 10.1016/S0257-8972(96)03069-1
   Waizy H, 2014, J BIOMATER APPL, V28, P667, DOI 10.1177/0885328212472215
   Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707
   Willbold E, 2013, ACTA BIOMATER, V9, P8509, DOI 10.1016/j.actbio.2013.02.015
   Wirtz G.P., 1991, MAT MANUFACTURING PR, V6, P87
   Witte F, 2008, ORTHOPADE, V37, P125, DOI 10.1007/s00132-008-1193-9
   Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wu LL, 2014, ACTA BIOMATER, V10, P2843, DOI 10.1016/j.actbio.2014.02.010
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   Yerokhin AL, 2000, SURF COAT TECH, V130, P195, DOI 10.1016/S0257-8972(00)00719-2
   Yoshizawa S, 2014, ACTA BIOMATER, V10, P2834, DOI 10.1016/j.actbio.2014.02.002
NR 37
TC 11
Z9 11
U1 1
U2 37
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 943603
DI 10.1155/2015/943603
PG 15
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CA9YQ
UT WOS:000349282000001
PM 25717474
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Tong, JB
   Wu, XY
   Jia, GL
   Zhao, KJ
   Wang, SL
   Ma, ZJ
AF Tong, Jia-Bei
   Wu, Xiao-Yun
   Jia, Ge-Liuchang
   Zhao, Kui-Jun
   Wang, Shi-Li
   Ma, Zhi-Jie
TI Hematopoietic Stem and Progenitor Cells Can Be Enriched by Implanting
   Biomaterial into Spatium Intermusculare
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID BONE-MARROW-TRANSPLANTATION; HUMAN ADIPOSE-TISSUE; NICHE; BLOOD;
   PROLIFERATION; SCLEROSIS; DISEASE; MUSCLE
AB Hematopoietic stem and progenitor cells (HSPCs) have been used successfully to treat patients with cancer and disorders of the blood and immune systems. In this study, we tried to enrich HSPCs by implanting biomaterials into the spatium intermusculare of mice hind limbs. Gelatine sponges were implanted into the spatium intermusculare of mice and then retrieved after 12 days. The presence of HSPCs in the migrating cells (MCs) was detected by phenotypically probing with CD34(+) Sca-1(+) and functionally confirming the presence of using colony-forming cell assay and assessing the long-term reconstitution ability. The frequency of CD34+, Sca-1(+), andCD34(+) Sca-1(+) cells and colony formation unit in the MCs wasmuch higher than that in the bone marrow (BM). Moreover, transplanted MCs were able to home to BM, muscle, and spleen, which induced an efficient long-term hematopoietic reconstitution in vivo. In addition, HSPCs within the MCs originated from the BM. Furthermore, the administration of G-CSF greatly reduced the time of implantation, and increased the number of MCs and frequency of HSPCs in the MCs. These data provide compelling evidence that HSPCs can be enriched by implanting biomaterial into spatium intermusculare. Implantation of biomaterial may be seen as the first step to a proof of their applicability to clinical practice in enriching HSPCs.
C1 [Tong, Jia-Bei; Jia, Ge-Liuchang; Zhao, Kui-Jun; Ma, Zhi-Jie] Capital Med Univ, Beijing Friendship Hosp, Dept Pharm, Beijing 100050, Peoples R China.
   [Tong, Jia-Bei; Wu, Xiao-Yun; Wang, Shi-Li] Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Key Lab Biotech Drugs,Minist Hlth,Key Lab Modern, Key Lab Virol Shandong Prov,Key Lab Rare & Uncomm, Jinan 250000, Peoples R China.
   [Wu, Xiao-Yun] Beijing Jingmeng Stem Cell Technol Co Ltd, Dept Technol, Beijing 100085, Peoples R China.
RP Ma, ZJ (reprint author), Capital Med Univ, Beijing Friendship Hosp, Dept Pharm, 95 Yongan Rd, Beijing 100050, Peoples R China.
EM 13811647091@163.com
FU National Natural Science Foundation of China [30940065, 30571766];
   Shandong Province Natural Science Foundation [Y2008C06]
FX The authors thank Dr. Yu Shi-guang, University of Maryland, for critical
   reading of the paper. This work was supported by grants from the
   National Natural Science Foundation of China (Grant nos. 30940065 and
   30571766) and the Shandong Province Natural Science Foundation (Grant
   no. Y2008C06).
CR Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331
   BOGGS DR, 1984, AM J HEMATOL, V16, P277, DOI 10.1002/ajh.2830160309
   Burt RK, 2010, BLOOD, V116, P6123, DOI 10.1182/blood-2010-06-292391
   Chapel A, 2003, J GENE MED, V5, P1028, DOI 10.1002/jgm.452
   Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908
   Fassas A, 1997, BONE MARROW TRANSPL, V20, P631, DOI 10.1038/sj.bmt.1700944
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   Han J, 2010, BLOOD, V115, P957, DOI 10.1182/blood-2009-05-219923
   HARRIS RBS, 1991, J NUTR, V121, P1075
   Kawada H, 2001, BLOOD, V98, P2008, DOI 10.1182/blood.V98.7.2008
   Knudsen E, 2011, EUR J HAEMATOL, V87, P302, DOI 10.1111/j.1600-0609.2011.01658.x
   Kotton DN, 2005, BLOOD, V106, P1574, DOI 10.1182/blood-2005-03-1017
   Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086
   Li JL, 2008, HISTOCHEM CELL BIOL, V130, P741, DOI 10.1007/s00418-008-0446-3
   Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434
   Marmont AM, 1997, LUPUS, V6, P545, DOI 10.1177/096120339700600613
   Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047
   MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X
   O'Neill H. C., 2011, STEM CELLS INT, V2011
   Oyama Y, 2005, GASTROENTEROLOGY, V128, P552, DOI 10.1053/j.gastrop.2004.11.051
   Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147
   Robinson S, 2000, J HEMATOTH STEM CELL, V9, P711, DOI 10.1089/15258160050196759
   Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007
   Tyndall A, 1997, BRIT J RHEUMATOL, V36, P1
   Tyndall A, 1997, LANCET, V349, P254, DOI 10.1016/S0140-6736(05)64864-7
   van Laar J M, 2001, J Rheumatol Suppl, V64, P25
   Wagner-Souza K, 2008, INT J MOL MED, V22, P237, DOI 10.3892/ijmm_00000014
   Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779
   Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081
   Wu XY, 2011, EXP BIOL MED, V236, P1477, DOI 10.1258/ebm.2011.011061
   Wu XY, 2010, CELL TISSUE RES, V340, P549, DOI 10.1007/s00441-010-0978-4
   Zhong JF, 2002, BLOOD, V100, P3521, DOI 10.1182/blood-2002-04-1256
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 33
TC 0
Z9 0
U1 0
U2 2
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 398642
DI 10.1155/2015/398642
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CA9AP
UT WOS:000349213000001
PM 25695072
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Schlee, M
   van der Schoor, WP
   van der Schoor, ARM
AF Schlee, Marcus
   van der Schoor, W. Peter
   van der Schoor, Alexandra R. M.
TI Immediate Loading of Trabecular Metal-Enhanced Titanium Dental Implants:
   Interim Results from an International Proof-of-Principle Study
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE bone ingrowth; osseoincorporation; porous tantalum; trabecular metal
ID RESONANCE FREQUENCY-ANALYSIS; MONOBLOCK ACETABULAR COMPONENT; POROUS
   TANTALUM BIOMATERIAL; TOTAL HIP-ARTHROPLASTY; MECHANICAL-PROPERTIES;
   CLINICAL-EXPERIENCE; TISSUE INGROWTH; BONE; TRIAL; OSTEOGENESIS
AB ObjectivesA 3-year proof-of-principle study was initiated to evaluate the clinical efficacy of immediately loading titanium dental implants with surfaces enhanced with porous tantalum trabecular metal (PTTM). First-year interim results are presented.
   Materials and MethodsHealthy, partially edentulous patients (n=30) were enrolled and treated per protocol (minimum insertion torque: 35Ncm) with 37 implants placed in one or two premolar or molar locations in either jaw (study group). Implants were immediately provisionalized out of occlusion with single acrylic crowns. After 7 to 14 days of soft tissue healing, implants were definitively restored in occlusion with ceramometal crowns. Because most study group implants (54.1%, n=20) had less than 1 year of clinical follow-up, this interim analysis was limited to the first 22 consecutively placed implants in 17 subjects (10 women and 7 men) who completed 1 year of clinical follow-up to date (focus group).
   ResultsTo date, one implant failed to integrate in the study group (survival=97.3%, n=36/37). Focus group implants achieved 100% (n=22/22) survival with 0.430.41mm of mean marginal bone loss. There were no serious complications.
   ConclusionEarly clinical findings indicated that immediate loading of PTTM implants was safe and effective under the controlled study conditions.
C1 [Schlee, Marcus] Goethe Univ, Dept Oral Surg, Frankfurt, Germany.
RP Schlee, M (reprint author), Bayreuther Str 39, D-91301 Forchheim, Germany.
EM markus.schlee@32schoenezaehne.de
FU Zimmer Dental Inc., Carlsbad, CA, USA
FX The authors would like to thank Pirkka Nummikoski, DDS, MS, for his
   contributions as the independent radiologist for this study; Na Ren, MS,
   for statistical analysis; Shilpa Kottalgi, BDS, for data management; and
   Michael M. Warner, MA, for manuscript support. Sponsorship of the study
   was provided by Zimmer Dental Inc., Carlsbad, CA, USA. The authors were
   compensated for patient treatment costs but had no financial interest in
   any of the products used in this study.
CR Alvim-Pereira F, 2008, INT J ORAL MAX IMPL, V23, P409
   Annibali S, 2012, INT J ORAL MAXILLOF, V26, P1108
   Avila G, 2007, IMPLANT DENT, V16, P235, DOI 10.1097/ID.0b013e3180de4ec5
   Bateli M, 2012, INT J ORAL MAXILLOF, V26, P290
   Bencharit S, 2014, CLIN IMPLANT DENT R, V16, P817, DOI 10.1111/cid.12059
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Brentel Aline Scalone, 2006, J. Appl. Oral Sci., V14, P213, DOI 10.1590/S1678-77572006000300013
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   den Hartog L, 2011, CLIN ORAL IMPLAN RES, V22, P1289, DOI 10.1111/j.1600-0501.2010.02109.x
   dos Santos MV, 2011, CLIN IMPLANT DENT R, V13, P215, DOI 10.1111/j.1708-8208.2009.00202.x
   Esposito M, 2007, INT J ORAL MAX IMPL, V22, P893
   Gapski R, 2003, CLIN ORAL IMPLAN RES, V14, P515, DOI 10.1034/j.1600-0501.2003.00950.x
   Gfeller F, 2011, Schweiz Monatsschr Zahnmed, V121, P235
   Grenoble D E, 1977, Oral Implantol, V6, P509
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   Grundschober F, 1982, BIOMATERIALS 1980, P365
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   HULBERT SF, 1973, J BIOMED MATER RES, V7, P1, DOI 10.1002/jbm.820070303
   Huwiler MA, 2007, CLIN ORAL IMPLAN RES, V18, P275, DOI 10.1111/j.1600-0501.2007.01336.x
   Javed F, 2010, J DENT, V38, P612, DOI 10.1016/j.jdent.2010.05.013
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Lai HC, 2008, CLIN ORAL IMPLAN RES, V19, P469, DOI 10.1111/j.1600-0501.2007.01501.x
   Lang LA, 2014, CLIN IMPLANT DENT R, V16, P248, DOI 10.1111/j.1708-8208.2012.00475.x
   Ledermann P, 1979, SSO Schweiz Monatsschr Zahnheilkd, V89, P1137
   Lekholm U, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Linkow L I, 1988, Int J Oral Maxillofac Implants, V3, P109
   Linkow Leonard I, 2004, J Oral Implantol, V30, P314, DOI 10.1563/0683.1
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   Masse J F, 1993, Int Dent J, V43, P121
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Nasser S, 2004, J ARTHROPLASTY, V19, P562, DOI 10.1016/j.arth.2004.02.025
   Norton Michael R, 2011, Int J Oral Maxillofac Implants, V26, P1333
   Ormianer Z, 2012, INT J ORAL MAX IMPL, V27, P442
   Ostman PO, 2007, CLIN ORAL IMPLAN RES, V18, P409, DOI 10.1111/j.1600-0501.2007.01346.x
   Ottoni JMP, 2005, INT J ORAL MAX IMPL, V20, P769
   Pilliar R M, 1988, Univ Tor Dent J, V1, P10
   Romanos GE, 2002, INT J ORAL MAX IMPL, V17, P44
   ROMANOS GE, 2005, IMMEDIATE LOADING PO, P145
   Romanos GE, 2009, IMPLANT DENT, V18, P203, DOI 10.1097/ID.0b013e3181991248
   SCHROEDER A, 1981, J MAXILLOFAC SURG, V9, P15, DOI 10.1016/S0301-0503(81)80007-0
   Sennerby L, 2008, PERIODONTOL 2000, V47, P51, DOI 10.1111/j.1600-0757.2008.00267.x
   Sforza NM, 2008, INT J PERIODONT REST, V28, P291
   Shiigai Tatsuo, 2007, J Oral Implantol, V33, P13, DOI 10.1563/0-832.1
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Siddiqui Azfar A, 2008, J Oral Implantol, V34, P208, DOI 10.1563/0.926.1
   SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968
   Spector M, 1987, J Arthroplasty, V2, P163, DOI 10.1016/S0883-5403(87)80024-4
   Strock A., 1939, AM J ORTHOD ORAL SUR, V25, P467
   Szmukler-Moncler S, 2000, CLIN ORAL IMPLAN RES, V11, P12, DOI 10.1034/j.1600-0501.2000.011001012.x
   Tan WC, 2011, CLIN ORAL IMPLAN RES, V22, P14, DOI 10.1111/j.1600-0501.2010.01982.x
   Thierer Todd, 2008, J Oral Implantol, V34, P39, DOI 10.1563/1548-1336(2008)34[39:FPCEOH]2.0.CO;2
   Trisi P, 2009, CLIN ORAL IMPLAN RES, V20, P467, DOI 10.1111/j.1600-0501.2008.01679.x
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023
   Vandamme K, 2008, J PERIODONTOL, V79, P150, DOI [10.1902/jop.2008.060413, 10.1902/jop.2008.060413 ]
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
   World Medical Association, 2013, WMA DECL HELS ETH PR
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
NR 69
TC 9
Z9 11
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD JAN
PY 2015
VL 17
SU 1
BP E308
EP E320
DI 10.1111/cid.12127
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CA7EP
UT WOS:000349080800030
PM 23899206
OA Other Gold
DA 2018-10-20
ER

PT J
AU Huang, QL
   Yang, Y
   Hu, RG
   Lin, CJ
   Sun, L
   Vogler, EA
AF Huang, Qiaoling
   Yang, Yun
   Hu, Ronggang
   Lin, Changjian
   Sun, Lan
   Vogler, Erwin A.
TI Reduced platelet adhesion and improved corrosion resistance of
   superhydrophobic TiO2-nanotube-coated 316L stainless steel
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE 316L stainless steel; Superhydrophobic; Superhydrophilic; Platelet
   adhesion; Corrosion resistance
ID BLOOD COMPATIBILITY; TIO2 NANOTUBES; IN-VITRO; BIOMEDICAL APPLICATIONS;
   CORONARY STENTS; SURFACE; TITANIUM; FILMS; HEMOCOMPATIBILITY;
   BIOMATERIALS
AB Superhydrophilic and superhydrophobic TiO2 nanotube (TNT) arrays were fabricated on 316L stainless steel (SS) to improve corrosion resistance and hemocompatibility of SS. Vertically-aligned superhydrophilic amorphous TNTs were fabricated on SS by electrochemical anodization of Ti films deposited on SS. Calcination was carried out to induce anatase phase (superhydrophilic), and fluorosilanization was used to convert superhydrophilicity to superhydrophobicity. The morphology, structure and surface wettability of the samples were characterized by scanning electron microscopy (SEM), X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), and contact angle goniometry. The effects of surface wettability on corrosion resistance and platelet adhesion were investigated. The results showed that crystalline phase (anatase vs. amorphous) and wettability strongly affected corrosion resistance and platelet adhesion. The superhydrophilic amorphous TNTs failed to protect SS from corrosion whereas superhydrophobic amorphous TNTs slightly improved corrosion resistance of SS. Both superhydrophilic and superhydrophobic anatase TNTs significantly improved corrosion resistance of SS. The superhydrophilic amorphous TNTs minimized platelet adhesion and activation whereas superhydrophilic anatase TNTs activated the formation of fibrin network. On the contrary, both superhydrophobic TNTs (superhydrophobic amorphous TNTs and superhydrophobic anatase TNTs) reduced platelet adhesion significantly and improved corrosion resistance regardless of crystalline phase. Superhydrophobic anatase TNTs coating on SS surface offers the opportunity for the application of SS as a promising permanent biomaterial in blood contacting biomedical devices, where both reducing platelets adhesion/activation and improving corrosion resistance can be effectively combined. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Huang, Qiaoling; Yang, Yun; Lin, Changjian; Sun, Lan] Xiamen Univ, State Key Lab Phys Chem Solid Surfaces, Xiamen 361005, Peoples R China.
   [Huang, Qiaoling; Yang, Yun; Lin, Changjian; Sun, Lan] Xiamen Univ, Coll Chem & Chem Engn, Dept Chem, Xiamen 361005, Peoples R China.
   [Hu, Ronggang] Guiyang Univ, Coll Chem & Mat Engn, Guiyang 550005, Peoples R China.
   [Vogler, Erwin A.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
   [Vogler, Erwin A.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA.
RP Sun, L (reprint author), Xiamen Univ, State Key Lab Phys Chem Solid Surfaces, Xiamen 361005, Peoples R China.
EM sunlan@xmu.edu.cn
FU National Natural Science Foundation of China [21321062]; National
   Scientific Support Program of China [2012BAI07B09]
FX Authors gratefully acknowledge financial supports from the National
   Natural Science Foundation of China (21321062) and the National
   Scientific Support Program of China (2012BAI07B09). Authors thanks Dr.
   Avantika Golas for a careful check of English language style and
   accuracy of the manuscript.
CR Amin MS, 2009, DIAM RELAT MATER, V18, P1139, DOI 10.1016/j.diamond.2009.02.034
   Bakir M, 2012, J BIOMATER APPL, V27, P3, DOI 10.1177/0885328212439615
   Balamurugan A, 2008, MATER CORROS, V59, P855, DOI 10.1002/maco.200804173
   Bayram C, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/055007
   Berger S, 2008, ELECTROCHEM SOLID ST, V11, pC37, DOI 10.1149/1.2908199
   Bjursten L.M., 2009, J BIOMED MATER RES A, V92A, P1218
   Brammer K.S., 2010, ENHANCED CELL GROWTH, P1
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Chen L, 2009, J AM CHEM SOC, V131, P10467, DOI 10.1021/ja9019935
   Chen LJ, 2008, APPL SURF SCI, V255, P3459, DOI 10.1016/j.apsusc.2008.07.122
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Deng X, 2012, SCIENCE, V335, P67, DOI 10.1126/science.1207115
   Efremov AN, 2013, BIOMATERIALS, V34, P1757, DOI 10.1016/j.biomaterials.2012.11.034
   Feng LB, 2013, APPL SURF SCI, V283, P367, DOI 10.1016/j.apsusc.2013.06.117
   Furstner R, 2005, LANGMUIR, V21, P956, DOI 10.1021/la0401011
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   Huang QL, 2012, BIOMATERIALS, V33, P8213, DOI 10.1016/j.biomaterials.2012.08.017
   Karpagavalli R, 2007, J BIOMED MATER RES A, V83A, P1087, DOI 10.1002/jbm.a.31447
   Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036
   Kim SH, 2014, J TISSUE ENG REGEN M, V8, P257
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Kummer KM, 2012, NANOSCI NANOTECH LET, V4, P483, DOI 10.1166/nnl.2012.1352
   Lai YK, 2013, SMALL, V9, P2945, DOI 10.1002/smll.201300187
   Lai YK, 2013, ADV MATER, V25, P1682, DOI 10.1002/adma.201203797
   Lai YK, 2009, ADV MATER, V21, P3799, DOI 10.1002/adma.200900686
   Lin YH, 2008, EUR POLYM J, V44, P2927, DOI 10.1016/j.eurpolymj.2008.06.030
   Liu HQ, 2012, J MATER ENG PERFORM, V21, P424, DOI 10.1007/s11665-011-9935-y
   Liu HQ, 2011, SURF COAT TECH, V206, P893, DOI 10.1016/j.surfcoat.2011.04.048
   Liu XL, 2014, J MATER CHEM B, V2, P5718, DOI 10.1039/c4tb00881b
   Maitz MF, 2003, J BIOMATER APPL, V17, P303, DOI 10.1177/088532803033178
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Marcon L, 2013, ACTA BIOMATER, V9, P4585, DOI 10.1016/j.actbio.2012.08.026
   McCafferty E, 1998, SURF INTERFACE ANAL, V26, P549, DOI 10.1002/(SICI)1096-9918(199807)26:8<549::AID-SIA396>3.3.CO;2-H
   Minagar S, 2012, ACTA BIOMATER, V8, P2875, DOI 10.1016/j.actbio.2012.04.005
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Ong SE, 2007, BIOMATERIALS, V28, P4033, DOI 10.1016/j.biomaterials.2007.05.031
   Park HH, 2010, ELECTROCHIM ACTA, V55, P6109, DOI 10.1016/j.electacta.2010.05.082
   Pretorius E, 2007, MICROSC RES TECHNIQ, V70, P823, DOI 10.1002/jemt.20482
   Pretorius E, 2010, ONDERSTEPOORT J VET, V77, P20, DOI 10.4102/ojvr.v77i1.4
   Roy RK, 2009, ACTA BIOMATER, V5, P249, DOI 10.1016/j.actbio.2008.07.031
   Roy SC, 2007, BIOMATERIALS, V28, P4667, DOI 10.1016/j.biomaterials.2007.07.045
   Shen GX, 2005, THIN SOLID FILMS, V489, P130, DOI 10.1016/j.tsf.2005.05.016
   Shin DH, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/31/315704
   Smith BS, 2012, J BIOMED NANOTECHNOL, V8, P642, DOI 10.1166/jbn.2012.1421
   Song WL, 2009, ADV MATER, V21, P1830, DOI 10.1002/adma.200803680
   Sun TL, 2011, CHEM SOC REV, V40, P2909, DOI 10.1039/c0cs00124d
   Sun TL, 2005, SMALL, V1, P959, DOI 10.1002/smll.200500095
   Takemoto S, 2004, BIOMATERIALS, V25, P3485, DOI 10.1016/j.biomaterials.2003.10.070
   Tan AW, 2012, CERAM INT, V38, P4421, DOI 10.1016/j.ceramint.2012.03.002
   Ueda E., 2013, ADV MATER, V25, P1368
   Wang P, 2011, CORROS SCI, V53, P2080, DOI 10.1016/j.corsci.2011.02.025
   Wei L, 2011, MAT SCI ENG C-MATER, V31, P1861, DOI 10.1016/j.msec.2011.09.001
   Weng YJ, 2011, BIOMATERIALS, V32, P1253, DOI 10.1016/j.biomaterials.2010.10.039
   Xie XY, 2009, J BIOMED MATER RES B, V89B, P223, DOI 10.1002/jbm.b.31212
   Yahia SAA, 2012, J ELECTROCHEM SOC, V159, pK83, DOI 10.1149/2.077204jes
   Yanagisawa K, 1999, J PHYS CHEM B, V103, P7781, DOI 10.1021/jp990521c
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   Yang Y, 2010, COLLOID SURFACE B, V79, P309, DOI 10.1016/j.colsurfb.2010.04.013
   Yang ZL, 2010, BIOMATERIALS, V31, P2072, DOI 10.1016/j.biomaterials.2009.11.091
   Yu WQ, 2011, COLLOID SURFACE B, V84, P400, DOI 10.1016/j.colsurfb.2011.01.033
   Yu WQ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065012
   Yuan SJ, 2011, CORROS SCI, V53, P2738, DOI 10.1016/j.corsci.2011.05.008
   Zhang F, 2011, APPL SURF SCI, V257, P2587, DOI 10.1016/j.apsusc.2010.10.027
   Zhou M, 2008, J NANO RES-SW, V2, P129, DOI 10.4028/www.scientific.net/JNanoR.2.129
   Zhu SF, 2009, APPL SURF SCI, V256, P99, DOI 10.1016/j.apsusc.2009.07.082
NR 66
TC 42
Z9 43
U1 12
U2 97
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JAN 1
PY 2015
VL 125
BP 134
EP 141
DI 10.1016/j.colsurfb.2014.11.028
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CA5MB
UT WOS:000348951400018
PM 25481855
DA 2018-10-20
ER

PT J
AU Yang, MH
   Chung, TW
   Lu, YS
   Chen, YL
   Tsai, WC
   Jong, SB
   Yuan, SS
   Liao, PC
   Lin, PC
   Tyan, YC
AF Yang, Ming-Hui
   Chung, Tze-Wen
   Lu, Yi-Shan
   Chen, Yi-Ling
   Tsai, Wan-Chi
   Jong, Shiang-Bin
   Yuan, Shyng-Shiou
   Liao, Pao-Chi
   Lin, Po-Chiao
   Tyan, Yu-Chang
TI Activation of the Ubiquitin Proteasome Pathway by Silk Fibroin Modified
   Chitosan Nanoparticles in Hepatic Cancer Cells
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE silk fibroin; chitosan nanoparticle; biomaterial; proteomics; ubiquitin
   proteasome pathway
ID SCAFFOLDS; METABOLISM; BIOMATERIALS; METASTASIS; DELIVERY; REPAIR;
   SPIDER
AB Silk fibroin (SF) is a protein with bulky hydrophobic domains and can be easily purified as sericin-free silk-based biomaterial. Silk fibroin modified chitosan nanoparticle (SF-CSNP), a biocompatible material, has been widely used as a potential drug delivery system. Our current investigation studied the bio-effects of the SF-CSNP uptake by liver cells. In this experiment, the characterizations of SF-CSNPs were measured by particle size analysis and protein assay. The average size of the SF-CSNP was 311.9 +/- 10.7 nm, and the average zeta potential was +13.33 +/- 0.3 mV. The SF coating on the SF-CSNP was 6.27 +/- 0.17 mu g/mL. Moreover, using proteomic approaches, several proteins involved in the ubiquitin proteasome pathway were identified by analysis of differential protein expressions of HepG2 cell uptake the SF-CSNP. Our experimental results have demonstrated that the SF-CSNP may be involved in liver cancer cell survival and proliferation.
C1 [Yang, Ming-Hui; Yuan, Shyng-Shiou] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung 807, Taiwan.
   [Yang, Ming-Hui; Yuan, Shyng-Shiou; Tyan, Yu-Chang] Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung 807, Taiwan.
   [Chung, Tze-Wen] Natl Yang Ming Univ, Dept Biomed Engn, Taipei 112, Taiwan.
   [Lu, Yi-Shan; Jong, Shiang-Bin; Tyan, Yu-Chang] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung 807, Taiwan.
   [Chen, Yi-Ling] Kaohsiung Med Univ Hosp, Dept Nucl Med, Kaohsiung 807, Taiwan.
   [Tsai, Wan-Chi] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung 807, Taiwan.
   [Tsai, Wan-Chi] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung 807, Taiwan.
   [Yuan, Shyng-Shiou] Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung 807, Taiwan.
   [Yuan, Shyng-Shiou] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung 807, Taiwan.
   [Liao, Pao-Chi] Natl Cheng Kung Univ, Dept Environm & Occupat Hlth, Tainan 701, Taiwan.
   [Lin, Po-Chiao] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 804, Taiwan.
   [Tyan, Yu-Chang] Natl Sun Yat Sen Univ Kaohsiung Med Univ Joint Re, Kaohsiung 804, Taiwan.
   [Tyan, Yu-Chang] Natl Sun Yat Sen Univ, Inst Med Sci & Techmol, Kaohsiung 804, Taiwan.
RP Tyan, YC (reprint author), Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung 807, Taiwan.
EM myang@mail.kmuh.org.tw; twchung@ms.ym.edu.tw; eshan5413@gmail.com;
   1010.yiling@gmail.com; wanchi@cc.kmu.edu.tw; jongsb@kmu.edu.tw;
   yuanssf@kmu.edu.tw; liaopc@mail.ncku.edu.tw; pclin@mail.nsysu.edu.tw;
   yctyan@kmu.edu.tw
FU Ministry of Science and Technology [MOST 103-2320-B-037-025]; Ministry
   of Health and Welfare [MOHW103-TD-B-111-05]; Kaohsiung Medical
   University [KMU-DT103010, KMU-O104003]; NSYSU-KMU Joint Research
   Project, Taiwan [NSYSUKMU103-P006]
FX The authors thank S. Sheldon (Medical Technologist, American Society of
   Clinical Pathology, retired, MT, ASCP) of Oklahoma University Medical
   Center Edmond for fruitful discussions and editorial assistance. The
   authors thank the Center of Excellence for Environmental Medicine,
   Kaohsiung Medical University for the assistance in protein
   identification. This work was supported by research grants MOST
   103-2320-B-037-025 from the Ministry of Science and Technology,
   MOHW103-TD-B-111-05 from Ministry of Health and Welfare, KMU-DT103010
   and KMU-O104003 from Kaohsiung Medical University (Aim for the Top
   Journal Grant and Aim for the Top 500 Universities Grant), and
   NSYSUKMU103-P006 from NSYSU-KMU Joint Research Project, Taiwan.
CR Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004
   Calvo P, 1997, PHARMACEUT RES, V14, P1431, DOI 10.1023/A:1012128907225
   Cheema SK, 2007, INT J PHARMACEUT, V341, P221, DOI 10.1016/j.ijpharm.2007.03.043
   Chi NH, 2013, CARBOHYD POLYM, V92, P591, DOI 10.1016/j.carbpol.2012.09.012
   Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027
   Dyakonov T, 2012, J DRUG DELIV, DOI 10.1155/2012/490514
   Finley LWS, 2013, CELL METAB, V17, P466, DOI 10.1016/j.cmet.2013.02.016
   Geske FJ, 2000, CELL DEATH DIFFER, V7, P393, DOI 10.1038/sj.cdd.4400663
   Gupta V, 2009, INT J NANOMED, V4, P115
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012
   Hirsch E, 2014, ONCOGENE, V33, P3083, DOI 10.1038/onc.2013.265
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lopez-Leon T, 2005, J COLLOID INTERF SCI, V283, P344, DOI 10.1016/j.jcis.2004.08.186
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743
   Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081
   Munoz-Pinedo C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.123
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019
   Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   van der Lubben IM, 2001, ADV DRUG DELIVER REV, V52, P139, DOI 10.1016/S0169-409X(01)00197-1
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wilkins MR, 1996, ELECTROPHORESIS, V17, P830, DOI 10.1002/elps.1150170504
   Yang MH, 2014, BIOMED RES INT, DOI 10.1155/2014/209469
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
NR 33
TC 5
Z9 5
U1 3
U2 34
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN
PY 2015
VL 16
IS 1
BP 1657
EP 1676
DI 10.3390/ijms16011657
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA AZ7MN
UT WOS:000348403100094
PM 25588218
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Deng, Y
   Liu, XC
   Xu, AX
   Wang, LX
   Luo, ZY
   Zheng, YF
   Deng, F
   Wei, J
   Tang, ZH
   Wei, SC
AF Deng, Yi
   Liu, Xiaochen
   Xu, Anxiu
   Wang, Lixin
   Luo, Zuyuan
   Zheng, Yunfei
   Deng, Feng
   Wei, Jie
   Tang, Zhihui
   Wei, Shicheng
TI Effect of surface roughness on osteogenesis in vitro and
   osseointegration in vivo of carbon fiber-reinforced
   polyetheretherketone-nanohydroxyapatite composite
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE polyetheretherketone; tenary; biocomposite; bioactivity; bone formation
ID MESENCHYMAL STEM-CELLS; OSTEOBLAST RESPONSE; BIOACTIVE COMPOSITE;
   PROTEIN ADSORPTION; TENSILE PROPERTIES; BONE REGENERATION; TITANIUM
   IMPLANT; WEAR PROPERTIES; DIFFERENTIATION; BEHAVIOR
AB As United States Food and Drug Administration-approved implantable material, carbon fiber-reinforced polyetheretherketone (CFRPEEK) possesses an adjustable elastic modulus similar to cortical bone and is a prime candidate to replace surgical metallic implants. The bioinertness and inferior osteogenic properties of CFRPEEK, however, limit its clinical application as orthopedic/dental implants. In this study, CFRPEEK-nanohydroxyapatite ternary composites (PEEK/n-HA/CF) with variable surface roughness have been successfully fabricated. The effect of surface roughness on their in vitro cellular responses of osteoblast-like MG-63 cells (attachment, proliferation, apoptosis, and differentiation) and in vivo osseointegration is evaluated. The results show that the hydrophilicity and the amount of Ca ions on the surface are significantly improved as the surface roughness of composite increases. In cell culture tests, the results reveal that the cell proliferation rate and the extent of osteogenic differentiation of cells are a function of the size of surface roughness. The composite with moderate surface roughness significantly increases cell attachment/proliferation and promotes the production of alkaline phosphatase (ALP) activity and calcium nodule formation compared with the other groups. More importantly, the PEEK/n-HA/CF implant with appropriate surface roughness exhibits remarkably enhanced bioactivity and osseointegration in vivo in the animal experiment. These findings will provide critical guidance for the design of CFRPEEK-based implants with optimal roughness to regulate cellular behaviors, and to enhance biocompability and osseointegration. Meanwhile, the PEEK/n-HA/CF ternary composite with optimal surface roughness might hold great potential as bioactive biomaterial for bone grafting and tissue engineering applications.
C1 [Deng, Yi; Zheng, Yunfei; Tang, Zhihui; Wei, Shicheng] Peking Univ, Sch Hosp Stomatol, Dent Ctr 2, Lab Interdisciplinary Studies, Beijing 100081, Peoples R China.
   [Deng, Yi; Liu, Xiaochen; Luo, Zuyuan; Wei, Shicheng] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Biomed Mat & Tissue Engn, Beijing 100081, Peoples R China.
   [Xu, Anxiu; Deng, Feng; Wei, Shicheng] Chongqing Med Univ, Chongqing Key Lab Oral Dis & Biomed Sci, Beijing, Peoples R China.
   [Wang, Lixin] Capital Med Univ, Beijing Shijitan Hosp, Dept Stomatol, Beijing, Peoples R China.
   [Wei, Jie] E China Univ Sci & Technol, Key Lab Ultrafine Mat, Minist Educ, Shanghai 200237, Peoples R China.
   [Wei, Jie] E China Univ Sci & Technol, Engn Res Ctr Biomed Mat, Minist Educ, Shanghai 200237, Peoples R China.
RP Wei, SC (reprint author), Peking Univ, Dent Ctr 2, Lab Interdisciplinary, 22 Zhong Guan Chun South Rd, Beijing 100081, Peoples R China.
EM tang_zhihui@live.cn; sc-wei@pku.edu.cn
FU Beijing Natural Science Foundation [7132124]; State Key Development
   Program for Basic Research of China [2007CB936103]; Peking University's
   985 Grant
FX This work was supported by the Beijing Natural Science Foundation
   (7132124), State Key Development Program for Basic Research of China
   (grant 2007CB936103), and Peking University's 985 Grant.
CR Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   Cao LY, 2014, BIOMATERIALS, V35, P684, DOI 10.1016/j.biomaterials.2013.10.005
   Collaert B, 2011, CLIN ORAL IMPLAN RES, V22, P1111, DOI 10.1111/j.1600-0501.2010.02077.x
   Converse GL, 2007, BIOMATERIALS, V28, P927, DOI 10.1016/j.biomaterials.2006.10.031
   Converse GL, 2010, ACTA BIOMATER, V6, P856, DOI 10.1016/j.actbio.2009.08.004
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Devine DM, 2013, J BIOMED MATER RES B, V101B, P591, DOI 10.1002/jbm.b.32861
   Ding SJ, 2011, ACS APPL MATER INTER, V3, P4142, DOI 10.1021/am201017v
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Gittens RA, 2014, ACTA BIOMATER, V10, P3363, DOI 10.1016/j.actbio.2014.03.037
   Gittens RA, 2012, BIOMATERIALS, V33, P8986, DOI 10.1016/j.biomaterials.2012.08.059
   Guldberg RE, 2008, BIOMATERIALS, V29, P3757, DOI 10.1016/j.biomaterials.2008.06.018
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Khonsari RH, 2014, J ORAL MAX SURG MED, V26, P477, DOI 10.1016/j.ajoms.2013.04.006
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Li DW, 2014, ACS APPL MATER INTER, V6, P9402, DOI 10.1021/am5017792
   Li HF, 2012, J BIOMED MATER RES B, V100B, P1721, DOI 10.1002/jbm.b.32738
   Lin KL, 2013, ACS APPL MATER INTER, V5, P8008, DOI 10.1021/am402089w
   Lu LX, 2013, ACS APPL MATER INTER, V5, P319, DOI 10.1021/am302146w
   Lu T, 2014, BIOMATERIALS, V35, P5731, DOI 10.1016/j.biomaterials.2014.04.003
   Ma R, 2014, INT J NANOMED, V9, P3949, DOI 10.2147/IJN.S67358
   Ma R, 2014, ACS APPL MATER INTER, V6, P12214, DOI 10.1021/am504409q
   Ma R, 2014, INT J MOL SCI, V15, P5426, DOI 10.3390/ijms15045426
   Olivares-Navarrete R, 2008, P NATL ACAD SCI USA, V105, P15767, DOI 10.1073/pnas.0805420105
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Pei XQ, 2012, TRIBOL INT, V55, P135, DOI 10.1016/j.triboint.2012.05.020
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pittrof A, 2012, ACTA BIOMATER, V8, P2639, DOI 10.1016/j.actbio.2012.03.040
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Raines AL, 2010, BIOMATERIALS, V31, P4909, DOI 10.1016/j.biomaterials.2010.02.071
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   Sarmento C, 2004, J BIOMED MATER RES A, V69A, P351, DOI 10.1002/jbm.a.30012
   Simmons CA, 1999, J BIOMED MATER RES, V47, P127, DOI 10.1002/(SICI)1097-4636(199911)47:2<127::AID-JBM3>3.0.CO;2-C
   Smith LJ, 2007, INT J NANOMED, V2, P493
   Stallard CP, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0031-0
   Stein GS, 1996, PHYSIOL REV, V76, P593
   Taxt-Lamolle SF, 2010, ACTA BIOMATER, V6, P1025, DOI 10.1016/j.actbio.2009.09.014
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   Wang HY, 2012, ADV MATER, V24, P3315, DOI 10.1002/adma.201104967
   Wang LX, 2014, BIOMATERIALS, V35, P6758, DOI 10.1016/j.biomaterials.2014.04.085
   Wang QH, 1998, J APPL POLYM SCI, V69, P135, DOI 10.1002/(SICI)1097-4628(19980705)69:1<135::AID-APP16>3.0.CO;2-Z
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Wu XM, 2012, INT J NANOMED, V7, P1215, DOI 10.2147/IJN.S28101
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Zhang WJ, 2013, INT J NANOMED, V8, P257, DOI 10.2147/IJN.S39357
   Zhao Y, 2013, BIOMATERIALS, V34, P9264, DOI 10.1016/j.biomaterials.2013.08.071
   Zhao Y, 2013, ACS APPL MATER INTER, V5, P1510, DOI 10.1021/am302961h
NR 50
TC 37
Z9 39
U1 6
U2 80
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2015
VL 10
BP 1425
EP 1447
DI 10.2147/IJN.S75557
PG 23
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA CB3OE
UT WOS:000349537000001
PM 25733834
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zheng, L
   Wang, L
   Qin, J
   Sun, XL
   Yang, TT
   Ni, YX
   Zhou, YM
AF Zheng, Ling
   Wang, Lin
   Qin, Jie
   Sun, Xiaolin
   Yang, Tingting
   Ni, Yuxin
   Zhou, Yanmin
TI New Biodegradable Implant Material Containing Hydrogel with Growth
   Factors of Lyophilized PRF in Combination with an nHA/PLGA Scaffold
SO JOURNAL OF HARD TISSUE BIOLOGY
LA English
DT Article
DE Biomaterial; Composite Scaffold; Growth factors; Hydrogel; Osteogenesis
ID PLATELET; COPOLYMERS; RELEASE
AB The temperature-sensitive triblock copolymer poly-(D, L-lactic acid-co-glycolic acid) (PLGA)polyethylene glycol (PEG)-PLGA (PLGA-PEG-PLGA) is an FDA-approved material that has the ability to provide a sustained release of drugs and/or proteins. Platelet-rich fibrin(PRF)is second generation platelet concentration that contains growth factors such as transforming growth factor-beta l (TGF-beta 1), platelet derived growth factor-AB (PDGF-AB), and insulin-like growth factor-I (IGF-I). These growth factors affect the migration and proliferation of diverse cell types, including endothelial cells, smooth muscle cells, and osteoblast-like cells. This study sought to combine the hydrogel into scaffolds in order to serve as a sustained release system for PRF-derived growth factors. Poly (lactic-co-glycolic) acid (PLGA) and nano-hydroxyapatite (nHA) were used to prepare the hydrogel-containing scaffolds with the PRF-derived growth factors. We then investigated the effects of the hydrogel on modulating the activity of osteoblasts in vitro. We indicated that the hydrogel (Gel) was well-distributed in the inner surface of scaffolds, which themselves exhibited relatively interconnected pores with uniform sizes. The addition of the hydrogel didn't affect their inherently high porosity. In vitro release tests indicated that the system containing nHA/PLGA/Gel/PRF provided for a slow and sustained release of PRF-derived growth factors. The results from our in vitro studies indicated that the MG63 cells cultured with both scaffold media extracts did not appear to have cytotoxic responses, and the nHA/PLGA/Gel/PRF system could improve the adhesion and proliferation of MG63 cells when compared to controls (p < 0.05). This in vitro evaluation suggests that the hydrogel-scaffold system is suitable as a model for bone tissue engineering, and that it allows for the sustained release of growth factors to improve bone reconstruction.
C1 [Zheng, Ling; Qin, Jie; Sun, Xiaolin; Yang, Tingting; Ni, Yuxin; Zhou, Yanmin] Jilin Univ, Stomatol Hosp, Implant Ctr, Changchun 130021, Jilin Province, Peoples R China.
   [Wang, Lin] Jilin Univ, Stomatol Hosp, VIP Integrated Dept, Changchun 130021, Jilin Province, Peoples R China.
RP Zhou, YM (reprint author), Jilin Univ, Stomatol Hosp, Implant Ctr, Changchun 130021, Jilin Province, Peoples R China.
EM zhouyanmin2014@126.com
FU Science and Technology Agency of Jilin Province [20125053]
FX The authors sincerely appreciate the financial support from the Science
   and Technology Agency of Jilin Province (Grant no. 20125053). They also
   thank L.G.Cui and C.L.He for technical assistance.
CR Dohan DM, 2006, ORAL SURG ORAL MED O, V101, P45, DOI DOI 10.1016/J.TRIPLE0.2005.07.009
   Ehrenfest DMD, 2009, GROWTH FACTORS, V27, P63, DOI 10.1080/08977190802636713
   Kazemi D, 2014, BIOMED RES INT, V486436, P1
   Kulkarni Mihir Raghavendra, 2014, J Indian Soc Periodontol, V18, P399, DOI 10.4103/0972-124X.134591
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lee JW, 2012, OR SURG OR MED OR PA, V113, P459, DOI 10.1016/j.tripleo.2011.03.043
   Matsunaga D, 2013, KNEE, V20, P545, DOI 10.1016/j.knee.2013.04.018
   Muraglia A, 2014, PLATELETS, V25, P211, DOI 10.3109/09537104.2013.803529
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   Panda S, 2014, J PHARM BIOALLIED SC, V6, P127, DOI 10.4103/0975-7406.129178
   Pietramaggiori G, 2006, WOUND REPAIR REGEN, V14, P573, DOI 10.1111/j.1743-6109.2006.00164.x
   Qiao MX, 2005, INT J PHARM, V294, P103, DOI 10.1016/j.ijpharm.2005.01.017
   Seiler J G 3rd, 2000, J South Orthop Assoc, V9, P91
   Wolkers WF, 2001, CRYOBIOLOGY, V42, P79, DOI 10.1006/cryo.2001.2306
   Yang KC, 2012, J TISSUE ENG REGEN M, V6, P777, DOI 10.1002/term.483
   Yoshioka T, 2008, BIOMATERIALS, V29, P3438, DOI 10.1016/j.biomaterials.2008.04.011
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang PB, 2009, BIOMATERIALS, V30, P58, DOI 10.1016/j.biomaterials.2008.08.041
NR 20
TC 3
Z9 3
U1 1
U2 26
PU JOURNAL HARD TISSUE BIOLOGY
PI MINATO KU
PA NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO
   106-0031, JAPAN
SN 1341-7649
J9 J HARD TISSUE BIOL
JI J. Hard Tissue Biol.
PD JAN
PY 2015
VL 24
IS 1
BP 54
EP 60
DI 10.2485/jhtb.24.54
PG 7
WC Engineering, Biomedical
SC Engineering
GA CA1SF
UT WOS:000348691100009
OA Bronze
DA 2018-10-20
ER

PT J
AU Chakar, C
   Soffer, E
   Cohen, N
   Petite, H
   Naaman, N
   Anagnostou, F
AF Chakar, C.
   Soffer, E.
   Cohen, N.
   Petite, H.
   Naaman, N.
   Anagnostou, F.
TI Vertical bone regeneration with deproteinised bovine bone mineral or
   biphasic calcium phosphate in the rabbit calvarium: effect of autologous
   platelet lysate
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID OCCLUSIVE TITANIUM BARRIER; SINUS FLOOR ELEVATION; RICH PLASMA;
   CLINICAL-TRIAL; AUGMENTATION; BIO-OSS(R); SUBSTITUTES; SCAFFOLDS;
   DEFECTS; IMPLANT
AB Although bone substitutes associated with platelet concentrates are widely used to vertically reconstruct alveolar ridges, their respective and specific contribution remain controversial. The aim of this study was to evaluate the benefit of using either biphasic calcium phosphate (BCP) or demineralised bovine bone mineral (DBBM) alone or with autologous platelet lysate (APL) in vertical bone regeneration. The study involved fourteen New Zealand rabbits. Autologous APL was prepared by freeze-thawing from a platelet suspension (10(9) platelets/ml). Four CP titanium (cpTi) cylinders were fixed to each calvarium; one cylinder was empty, one was filled with APL alone and the others were filled either with BCP or BCP + APL or DBBM or DBBM + APL. New bone formation and biomaterial resorption were evaluated using non-demineralised histology and histomorphometry. After 6 weeks, new bone formation was observed in all cylinders. The newly formed bone in the cylinders filled with APL alone, DBBM and BCP was significantly increased by (0.6-, 2.5- and 3.3-fold, respectively) (P < 0.0001) compared to results obtained with the empty cylinders. Vertical bone height in the cylinders filled with BCP was greater to that observed with DBBM. The residual material in the cylinders filled with BCP was significantly (P < 0.0001) lower (0.35-fold) than that with DBBM. Both newly formed bone and residual material in the cylinders filled with BCP + APL or DBBM + APL were similar to those filled with either BCP or DBBM, respectively. This study provided evidence that APL alone, as well as DBBM and BCP, have a beneficial effect on vertical bone formation and remodelling. APL associated with either DBBM or BCP did not provide additional benefits.
C1 [Chakar, C.; Naaman, N.] St Joseph Univ, Sch Dent, Dept Periodontol, Beirut, Lebanon.
   [Chakar, C.; Soffer, E.; Cohen, N.; Petite, H.; Anagnostou, F.] CNRS, UMR 7052, Lab Bioingn & Bioimagerie Osteoarticulaires, F-75010 Paris, France.
   [Soffer, E.] Diderot Univ, UFR Odontol Paris 7, Pitie Salpetriere Hosp, AP HP,Serv Odontol,Dept Prosthet Dent, Paris, France.
   [Cohen, N.; Anagnostou, F.] Denis Diderot Univ, UFR Odontol Paris 7, Pitie Salpetriere Hosp, AP HP,Serv Odontol,Dept Periodontol, Paris, France.
RP Anagnostou, F (reprint author), CNRS, UMR 7052, Lab Bioingn & Bioimagerie Osteoarticulaires, 10 Ave Verdun, F-75010 Paris, France.
EM fani.anagnostou@univ-paris-diderot.fr
RI Petite, Herve/E-3478-2016
OI Petite, Herve/0000-0003-1694-5060; Naaman, Nada/0000-0002-1860-8300
FU Faculte de Chirurgie Dentaire, Universite Denis Diderot Paris 7; School
   of Dentistry, Saint-Joseph University, Beirut, Lebanon [FMD 69]
FX We gratefully acknowledge the help of Prof. Rena Bizios for the paper
   critical review. We also thank Dr. Nada El Osta for her help with the
   statistical analyse. This study was partly funded by the Faculte de
   Chirurgie Dentaire, Universite Denis Diderot Paris 7 and School of
   Dentistry, Saint-Joseph University, Beirut, Lebanon (FMD 69).
CR Baldini N, 2011, DENT MATER, V27, P61, DOI 10.1016/j.dental.2010.10.017
   Busenlechner D, 2008, BIOMATERIALS, V29, P3195, DOI 10.1016/j.biomaterials.2008.04.021
   Cabbar F, 2011, J ORAL MAXIL SURG, V69, P2537, DOI 10.1016/j.joms.2011.03.040
   Caramella CM, 2013, CURR DRUG DELIV, V10, P18
   Chevallier N, 2010, BIOMATERIALS, V31, P270, DOI 10.1016/j.biomaterials.2009.09.043
   Chiara Barsotti M, 2013, PLOS ONE, V27
   Clementini M, 2012, INT J ORAL MAX SURG, V41, P847, DOI 10.1016/j.ijom.2012.03.016
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Del Fabbro M, 2013, CLIN IMPLANT DENT R, V15, P205, DOI 10.1111/j.1708-8208.2011.00343.x
   Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391
   Ezirganli S, 2011, CLIN ORAL IMPLAN RES, V24, P312
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Froum SJ, 2008, INT J PERIODONT REST, V28, P273
   Hallman M, 2008, PERIODONTOL 2000, V47, P172, DOI 10.1111/j.1600-0757.2008.00251.x
   Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218
   Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014
   Lambert F, 2011, CLIN ORAL IMPLAN RES, V22, P538, DOI 10.1111/j.1600-0501.2010.02069.x
   Leotot J, 2013, ACTA BIOMATER, V9, P6630, DOI 10.1016/j.actbio.2013.02.003
   Marechal M, 2008, J PERIODONTOL, V79, P896, DOI [10.1902/jop.2008.070043, 10.1902/jop.2008.070043 ]
   Min S, 2007, J PERIODONTOL, V78, P1978, DOI 10.1902/jop.2007.070086
   Mooren RECM, 2010, TISSUE ENG PT A, V16, P3159, DOI 10.1089/ten.tea.2009.0832
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P567, DOI 10.1111/j.1600-0501.2010.01922.x
   Schmitt CM, 2013, CLIN ORAL IMPLAN RES, V24, P576, DOI 10.1111/j.1600-0501.2012.02431.x
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   Soffer E, 2006, J BIOMED MATER RES B, V79B, P86, DOI 10.1002/jbm.30516
   Soffer E, 2004, CLIN ORAL IMPLAN RES, V15, P581, DOI 10.1111/j.1600-0501.2004.01063.x
   Tapety FI, 2004, CLIN ORAL IMPLAN RES, V15, P315, DOI 10.1111/j.1600-0501.2004.01012.x
   Torres J, 2008, CLIN IMPLANT DENT R, V10, P106, DOI 10.1111/j.1708-8208.2007.00068.x
   Torres J, 2009, J CLIN PERIODONTOL, V36, P677, DOI 10.1111/j.1600-051X.2009.01437.x
   van Steenberghe D, 2003, CLIN ORAL IMPLAN RES, V14, P63, DOI 10.1034/j.1600-0501.2003.140109.x
   Waasdorp J, 2010, INT J ORAL MAX IMPL, V25, P525
   Wagner W, 2012, CLIN ORAL IMPLAN RES, V23, P1112, DOI 10.1111/j.1600-0501.2011.02275.x
   Wang J, 2013, J BIOMED MATER RES B, V101B, P1069, DOI 10.1002/jbm.b.32917
   Yilmaz S, 2013, PLATELETS, V24, P308, DOI 10.3109/09537104.2012.695033
   Zigdon H, 2014, CLIN IMPLANT DENT R, V16, P138, DOI 10.1111/j.1708-8208.2012.00452.x
NR 35
TC 0
Z9 0
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2015
VL 26
IS 1
AR UNSP 23
DI 10.1007/s10856-014-5339-5
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA6IZ
UT WOS:000349016900023
PM 25578693
DA 2018-10-20
ER

PT J
AU Wu, ZZ
   Tang, Y
   Fang, HD
   Su, ZC
   Xu, B
   Lin, YL
   Zhang, P
   Wei, X
AF Wu, Zhengzheng
   Tang, Yan
   Fang, Hongdou
   Su, Zhongchun
   Xu, Bin
   Lin, Yongliang
   Zhang, Peng
   Wei, Xing
TI Decellularized scaffolds containing hyaluronic acid and EGF for
   promoting the recovery of skin wounds
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID EPIDERMAL-GROWTH-FACTOR; TISSUE-ENGINEERED SKIN; DEXTRIN-RHEGF;
   DIABETIC-RATS; STEM-CELLS; REGENERATION; COLLAGEN; REPAIR;
   RECONSTRUCTION; BIOMATERIALS
AB There is no effective therapy for the treatment of deep and large area skin wounds. Decellularized scaffolds can be prepared from animal tissues and represent a promising biomaterial for investigation in tissue regeneration studies. In this study, MTT assay showed that epidermal growth factor (EGF) increased NIH3T3 cell proliferation in a bell-shaped dose response, and the maximum cell proliferation was achieved at a concentration of 25 ng/ml. Decellularized scaffolds were prepared from pig peritoneum by a series of physical and chemical treatments. Hyaluronic acid (HA) increased EGF adsorption to the scaffolds. Decellularized scaffolds containing HA sustained the release of EGF compared to no HA. Rabbits contain relatively large skin surface and are less expensive and easy to be taken care, so that a rabbit wound healing model was use in this study. Four full-thickness skin wounds were created in each rabbit for evaluation of the effects of the scaffolds on the skin regeneration. Wounds covered with scaffolds containing either 1 or 3 mu g/ml EGF were significantly smaller than with vaseline oil gauzes or with scaffolds alone, and the wounds covered with scaffolds containing 1 mu g/ml EGF recovered best among all four wounds. Hematoxylin-Eosin staining confirmed these results by demonstrating that significantly thicker dermis layers were also observed in the wounds covered by the decellularized scaffolds containing HA and either 1 or 3 mu g/ml EGF than with vaseline oil gauzes or with scaffolds alone. In addition, the scaffolds containing HA and 1 mu g/ml EGF gave thicker dermis layers than HA and 3 mu g/ml EGF and showed the regeneration of skin appendages on day 28 post-transplantation. These results demonstrated that decellularized scaffolds containing HA and EGF could provide a promising way for the treatment of human skin injuries.
C1 [Wu, Zhengzheng; Fang, Hongdou; Su, Zhongchun; Wei, Xing] Jinan Univ, Key Lab Genet Med Guangdong Prov, Natl Engn Res Ctr Genet Med, Inst Biomed, Guangzhou 510632, Guangdong, Peoples R China.
   [Tang, Yan] Shantou Univ, Multidisciplinary Res Ctr, Coll Sci, Shantou 515063, Guangdong, Peoples R China.
   [Xu, Bin; Lin, Yongliang; Zhang, Peng] Grandhope Biotech Co Ltd, Guangzhou 510663, Guangdong, Peoples R China.
RP Wei, X (reprint author), Jinan Univ, Key Lab Genet Med Guangdong Prov, Natl Engn Res Ctr Genet Med, Inst Biomed, Guangzhou 510632, Guangdong, Peoples R China.
EM wei70@hotmail.com
FU National Natural Science Foundation of China [30870650, 31171304];
   Research Foundation for Doctoral Discipline of Higher Education
   [20114401110007]; Fundamental Research Funds for the Central
   Universities [21612107]
FX This work was supported by National Natural Science Foundation of China
   (Grant No. 30870650 and Grant No. 31171304 to Xing Wei), Research
   Foundation for Doctoral Discipline of Higher Education (Grant No.
   20114401110007 to Xing Wei), and the Fundamental Research Funds for the
   Central Universities (Grant No. 21612107 to Xing Wei).
CR Atiyeh BS, 2007, BURNS, V33, P405, DOI 10.1016/j.burns.2006.11.002
   Banerjee I, 2012, J BIOMAT SCI-POLYM E, V23, P111, DOI 10.1163/092050610X545049
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Brohem CA, 2011, PIGM CELL MELANOMA R, V24, P35, DOI 10.1111/j.1755-148X.2010.00786.x
   Chin MS, 2013, PLAST RECONSTR SURG, V131, P707, DOI 10.1097/PRS.0b013e3182818b94
   Choi JK, 2012, BIOMATERIALS, V33, P8579, DOI 10.1016/j.biomaterials.2012.07.061
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Cowman MK, 2005, CARBOHYD RES, V340, P791, DOI 10.1016/j.carres.2005.01.022
   Degim Z, 2011, INT WOUND J, V8, P343, DOI 10.1111/j.1742-481X.2011.00795.x
   Espinosa L, 2010, TISSUE ENG PT A, V16, P1667, DOI [10.1089/ten.tea.2008.0571, 10.1089/ten.TEA.2008.0571]
   Ferguson EL, 2011, INT J PHARMACEUT, V420, P84, DOI 10.1016/j.ijpharm.2011.08.031
   Ferguson EL, 2010, INT J PHARMACEUT, V402, P95, DOI 10.1016/j.ijpharm.2010.09.029
   Hardwicke J, 2008, J CONTROL RELEASE, V130, P275, DOI 10.1016/j.jconrel.2008.07.023
   Hardwicke J, 2010, MOL PHARMACEUT, V7, P699, DOI 10.1021/mp9002656
   Hardwicke JT, 2011, J CONTROL RELEASE, V152, P411, DOI 10.1016/j.jconrel.2011.03.016
   Hong Joon Pio, 2006, Int Wound J, V3, P123, DOI 10.1111/j.1742-4801.2006.00187.x
   Huang L, 2009, J BIOMED MATER RES A, V90A, P1177, DOI 10.1002/jbm.a.32173
   Kimura A, 2012, EXP DERMATOL, V21, P515, DOI 10.1111/j.1600-0625.2012.01515.x
   Ko J, 2011, DIABETES METAB J, V35, P226
   Kondo S, 2012, J BIOMAT SCI-POLYM E, V23, P629, DOI 10.1163/092050611X555687
   Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004
   Lee KB, 2011, J ORTHOP RES, V29, P1554, DOI 10.1002/jor.21385
   Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   Mineo A, 2013, J BIOMAT SCI-POLYM E, V24, P726, DOI 10.1080/09205063.2012.708190
   Nauta AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059167
   Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098
   Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184
   Patel M, 2008, PEDIATR RES, V63, P497, DOI 10.1203/01.PDR.0b013e318165eb3e
   Pereira RF, 2013, NANOMEDICINE-UK, V8, P603, DOI [10.2217/NNM.13.50, 10.2217/nnm.13.50]
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Ramakrishnan KM, 2013, ANN BURNS FIRE DISAS, V26, P98
   Rose MT, 2012, VET J, V193, P539, DOI 10.1016/j.tvjl.2012.01.010
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   Shi HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059966
   Singh Onkar, 2011, J Cutan Aesthet Surg, V4, P12, DOI 10.4103/0974-2077.79180
   Singh R, 2011, J TISSUE VIABILITY, V20, P49, DOI 10.1016/j.jtv.2010.06.001
   Steinstraesser L, 2010, LASER SURG MED, V42, P141, DOI 10.1002/lsm.20901
   Torikai K, 2008, J THORAC CARDIOV SUR, V136, P37, DOI 10.1016/j.jtcvs.2007.06.039
   Yang X, 2011, INT J BIOL SCI, V7, P685, DOI 10.7150/ijbs.7.685
   Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042
   Yannas IV, 2007, TISSUE ENG, V13, P1789, DOI 10.1089/ten.2006.0054
NR 43
TC 7
Z9 8
U1 3
U2 32
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2015
VL 26
IS 1
AR 59
DI 10.1007/s10856-014-5322-1
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA6IZ
UT WOS:000349016900059
PM 25604697
DA 2018-10-20
ER

PT J
AU Yano, S
   Mori, M
   Teramoto, N
   Iisaka, M
   Suzuki, N
   Noto, M
   Kaimoto, Y
   Kakimoto, M
   Yamada, M
   Shiratsuchi, E
   Shimasaki, T
   Shibata, M
AF Yano, Shinya
   Mori, Megumi
   Teramoto, Naozumi
   Iisaka, Makoto
   Suzuki, Natsumi
   Noto, Masanari
   Kaimoto, Yasuko
   Kakimoto, Masashi
   Yamada, Michio
   Shiratsuchi, Eri
   Shimasaki, Toshiaki
   Shibata, Mitsuhiro
TI Preparation of Photocrosslinked Fish Elastin
   Polypeptide/Microfibrillated Cellulose Composite Gels with Elastic
   Properties for Biomaterial Applications
SO MARINE DRUGS
LA English
DT Article
DE elastin; fish peptide; microfibrillated cellulose; hydrogel;
   photocrosslinking; composite gel
ID MECHANICAL-PROPERTIES; MICROFIBRILLATED CELLULOSE; NANOFIBRILLATED
   CELLULOSE; BACTERIAL CELLULOSE; ARTICULAR-CARTILAGE; CROSS-LINKING;
   HYDROGELS; NANOCRYSTALS; FIBROBLASTS; NETWORK
AB Photocrosslinked hydrogels reinforced by microfibrillated cellulose (MFC) were prepared from a methacrylate-functionalized fish elastin polypeptide and MFC dispersed in dimethylsulfoxide (DMSO). First, a water-soluble elastin peptide with a molecular weight of ca. 500 g/mol from the fish bulbus arteriosus was polymerized by N,N'-dicyclohexylcarbodiimide (DCC), a condensation reagent, and then modified with 2-isocyanatoethyl methacrylate (MOI) to yield a photocrosslinkable fish elastin polypeptide. The product was dissolved in DMSO and irradiated with UV light in the presence of a radical photoinitiator. We obtained hydrogels successfully by substitution of DMSO with water. The composite gel with MFC was prepared by UV irradiation of the photocrosslinkable elastin polypeptide mixed with dispersed MFC in DMSO, followed by substitution of DMSO with water. The tensile test of the composite gels revealed that the addition of MFC improved the tensile properties, and the shape of the stress-strain curve of the composite gel became more similar to the typical shape of an elastic material with an increase of MFC content. The rheology measurement showed that the elastic modulus of the composite gel increased with an increase of MFC content. The cell proliferation test on the composite gel showed no toxicity.
C1 [Yano, Shinya; Mori, Megumi; Teramoto, Naozumi; Iisaka, Makoto; Suzuki, Natsumi; Noto, Masanari; Kaimoto, Yasuko; Kakimoto, Masashi; Shimasaki, Toshiaki; Shibata, Mitsuhiro] Chiba Inst Technol, Dept Life & Environm Sci, Fac Engn, Narashino, Chiba 2750016, Japan.
   [Yamada, Michio; Shiratsuchi, Eri] Hayashikane Sangyo Co Ltd, Div Res & Dev, Yamaguchi 7508608, Japan.
RP Teramoto, N (reprint author), Chiba Inst Technol, Dept Life & Environm Sci, Fac Engn, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.
EM shinya.y08232@gmail.com; megumi.m07232@gmail.com;
   teramoto.naozumi@it-chiba.ac.jp; makoto.i10230@gmail.com;
   natsumi.s09231@gmail.com; masanari.n11231@gmail.com;
   yasuko.k05230@gmail.com; masashi.k06230@gmail.com;
   myamada@hayashikane.co.jp; esiratsuti@hayashikane.co.jp;
   shimasaki.toshiaki@it-chiba.ac.jp; mitsuhiro.shibata@p.chibakoudai.jp
RI Shimasaki, Toshiaki/G-1565-2017
OI Shimasaki, Toshiaki/0000-0002-3447-7435
CR Abitbol T, 2011, SOFT MATTER, V7, P2373, DOI 10.1039/c0sm01172j
   Annabi N, 2011, BIOMATERIALS, V32, P1517, DOI 10.1016/j.biomaterials.2010.10.024
   Annabi N, 2009, BIOMATERIALS, V30, P4550, DOI 10.1016/j.biomaterials.2009.05.014
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Borges AC, 2011, ACTA BIOMATER, V7, P3412, DOI 10.1016/j.actbio.2011.05.029
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Ehrlich H., 2015, BIOL MAT MARINE ORIG, P415
   GRINNELL F, 1979, CELL, V17, P117, DOI 10.1016/0092-8674(79)90300-3
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Henriksson M, 2007, EUR POLYM J, V43, P3434, DOI 10.1016/j.eurpolymj.2007.05.038
   Kaiitani M, 2001, ASAIO J, V47, P342, DOI 10.1097/00002480-200107000-00009
   Karaaslan MA, 2011, CARBOHYD POLYM, V86, P192, DOI 10.1016/j.carbpol.2011.04.030
   Khalil HPSA, 2012, CARBOHYD POLYM, V87, P963, DOI 10.1016/j.carbpol.2011.08.078
   Konig G, 2009, BIOMATERIALS, V30, P1542, DOI 10.1016/j.biomaterials.2008.11.011
   Lavoine N, 2012, CARBOHYD POLYM, V90, P735, DOI 10.1016/j.carbpol.2012.05.026
   Leach JB, 2005, ACTA BIOMATER, V1, P155, DOI 10.1016/j.actbio.2004.12.001
   Lee SJ, 2000, CARBOHYD POLYM, V41, P197, DOI 10.1016/S0144-8617(99)00088-0
   LELOUP VM, 1991, J CEREAL SCI, V13, P1, DOI 10.1016/S0733-5210(09)80023-4
   Lopergolo LC, 2003, POLYMER, V44, P6217, DOI 10.1016/S0032-3861(03)00686-4
   Martino M, 2002, BIOMACROMOLECULES, V3, P297, DOI 10.1021/bm010129g
   McMillan RA, 2000, MACROMOLECULES, V33, P4809, DOI 10.1021/ma9921091
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Nair SS, 2014, ACS SUSTAIN CHEM ENG, V2, P772, DOI 10.1021/sc400445t
   Nakaba M, 2006, FISHERIES SCI, V72, P1322, DOI 10.1111/j.1444-2906.2006.01293.x
   Nakagaito AN, 2005, APPL PHYS A-MATER, V80, P155, DOI 10.1007/s00339-003-2225-2
   Nakagaito AN, 2005, APPL PHYS A-MATER, V80, P93, DOI 10.1007/s00339-004-2932-3
   NEUMANN P, 1992, J BIOMECH, V25, P1185, DOI 10.1016/0021-9290(92)90074-B
   Ninan N, 2013, CARBOHYD POLYM, V98, P877, DOI 10.1016/j.carbpol.2013.06.067
   Nogi M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2146056
   Ouchi T, 2006, POLYMER, V47, P429, DOI 10.1016/j.polymer.2005.11.039
   Pan JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112885
   Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s
   Shiratsuchi E, 2010, J PEPT SCI, V16, P652, DOI 10.1002/psc.1277
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Spagnol C, 2012, CELLULOSE, V19, P1225, DOI 10.1007/s10570-012-9711-7
   Spagnol C, 2012, EUR POLYM J, V48, P454, DOI 10.1016/j.eurpolymj.2011.12.005
   Temple MM, 2007, OSTEOARTHR CARTILAGE, V15, P1042, DOI 10.1016/j.joca.2007.03.005
   Teramoto N, 2007, J APPL POLYM SCI, V106, P4024, DOI 10.1002/app.27043
   Teramoto N, 2012, MATERIALS, V5, P2573, DOI 10.3390/ma5122573
   Turbak A.F., 1983, J APPL POLYM SCI, P815
   Urry DW, 2002, J MUSCLE RES CELL M, V23, P543, DOI 10.1023/A:1023422925910
   Urry DW, 1998, J BIOMAT SCI-POLYM E, V9, P1015, DOI 10.1163/156856298X00316
   Viet D, 2007, CELLULOSE, V14, P109, DOI 10.1007/s10570-006-9093-9
   Watanabe K, 1998, CELLULOSE, V5, P187, DOI 10.1023/A:1009272904582
   Wren TAL, 2001, CLIN BIOMECH, V16, P245, DOI 10.1016/S0268-0033(00)00089-9
   Wu KS, 2006, BIOMATERIALS, V27, P785, DOI 10.1016/j.biomaterials.2005.06.019
   Yang J, 2012, J MATER CHEM, V22, P22467, DOI 10.1039/c2jm35498e
   Yu J, 2010, J ANAT, V216, P533, DOI 10.1111/j.1469-7580.2009.01207.x
   Zhou CJ, 2011, J COLLOID INTERF SCI, V353, P116, DOI 10.1016/j.jcis.2010.09.035
NR 50
TC 3
Z9 3
U1 2
U2 43
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD JAN
PY 2015
VL 13
IS 1
BP 338
EP 353
DI 10.3390/md13010338
PG 16
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AZ7MO
UT WOS:000348403200019
PM 25584682
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yon, J
   Lee, JS
   Lim, HC
   Kim, MS
   Hong, JY
   Choi, SH
   Jung, UW
AF Yon, Jeyoung
   Lee, Jung-Seok
   Lim, Hyun-Chang
   Kim, Min-Soo
   Hong, Ji-Youn
   Choi, Seong-Ho
   Jung, Ui-Won
TI Pre-clinical evaluation of the osteogenic potential of bone
   morphogenetic protein-2 loaded onto a particulate porcine bone
   biomaterial
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE animal model; bone morphogenetic protein-2; bone regeneration;
   Schneiderian membrane; xenograft
ID SINUS FLOOR AUGMENTATION; AUTOGENOUS BONE; COLLAGEN SPONGE; RHBMP-2;
   MODEL; REGENERATION; IMPLANTS; RABBITS; DELIVERY; DEFECTS
AB AimThe objective of study was to determine the osteogenic potential of bone morphogenetic protein-2 (BMP-2) loaded onto a particulate porcine bone mineral (PBM) biomaterial using a sinus augmentation model.
   MethodsRelease kinetics of BMP-2/PBM was determined in vitro. Eight rabbits received BMP-2/PBM or PBM alone into contra-lateral sinus sites. The animals were killed following a 2-week healing interval for micro-CT and histometrical analysis.
   ResultsApproximately 40% of the BMP-2 was released from PBM over the first 3days in vitro; release maintained at a reduced level through day 21. In vivo, total augmented implant volume did not differ significantly between treatments. However, local bone formation was enhanced in the BMP-2/PBM group compared with PBM control (10.5% versus 6.6%; p=0.03), specifically in the central aspect of the PBM implant (14.2% versus 5.5%; p<0.01) and adjoining the Schneiderian membrane (11.9% versus 5.0%; p<0.05). There were no significant overall differences in residual biomaterial and fibrovascular tissue.
   ConclusionBone morphogenetic protein-2 enhanced local bone formation in the rabbit maxillary sinus model following implantation using a PBM carrier.
C1 [Yon, Jeyoung; Lee, Jung-Seok; Lim, Hyun-Chang; Kim, Min-Soo; Choi, Seong-Ho; Jung, Ui-Won] Yonsei Univ, Coll Dent, Dept Periodontol, Res Inst Periodontal Regenerat, Seoul 120752, South Korea.
   [Hong, Ji-Youn] Kyung Hee Univ, Dept Periodontol, Sch Dent, Seoul, South Korea.
RP Jung, UW (reprint author), Yonsei Univ, Coll Dent, Dept Periodontol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM drjew@yuhs.ac
OI Hong, Ji-Youn/0000-0003-1040-7077; Jung, Ui-Won/0000-0001-6371-4172;
   Lim, Hyun-Chang/0000-0001-7695-1708
FU Korea Health Technology R&D Project, Ministry of Health & Welfare,
   Republic of Korea [A120822]
FX This study was supported by a grant of the Korea Health Technology R&D
   Project, Ministry of Health & Welfare, Republic of Korea (no. A120822).
CR Asai S, 2002, CLIN ORAL IMPLAN RES, V13, P405, DOI 10.1034/j.1600-0501.2002.130409.x
   Barboza EP, 2000, J PERIODONTOL, V71, P488, DOI 10.1902/jop.2000.71.3.488
   Barboza JA, 2004, MOL BIOL REP, V31, P13, DOI 10.1023/B:MOLE.0000013503.16301.82
   Barone A, 2012, CLIN IMPLANT DENT R, V14, P373, DOI 10.1111/j.1708-8208.2010.00274.x
   Boyne PJ, 2005, J ORAL MAXIL SURG, V63, P1693, DOI 10.1016/j.joms.2005.08.018
   Choi Y, 2013, TISSUE ENG PT A, V19, P1994, DOI [10.1089/ten.tea.2012.0724, 10.1089/ten.TEA.2012.0724]
   Choi Y, 2012, CLIN ORAL IMPLAN RES, V23, P682, DOI 10.1111/j.1600-0501.2011.02222.x
   De Santis E, 2012, CLIN ORAL IMPLAN RES, V23, P340, DOI 10.1111/j.1600-0501.2011.02326.x
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   FORSGREN K, 1993, ANN OTO RHINOL LARYN, V102, P459, DOI 10.1177/000348949310200610
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Hanseler P, 2012, ACTA BIOMATER, V8, P116, DOI 10.1016/j.actbio.2011.08.002
   Hall J, 2007, J CLIN PERIODONTOL, V34, P444, DOI 10.1111/j.1600-051X.2007.01064.x
   Hanisch O, 1997, INT J ORAL MAX IMPL, V12, P785
   Hong SJ, 2006, BIOMATERIALS, V27, P3810, DOI 10.1016/j.biomaterials.2006.02.045
   Jung RE, 2003, CLIN ORAL IMPLAN RES, V14, P556, DOI 10.1034/j.1600-0501.2003.00921.x
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   Kim SH, 2004, J BIOMED MATER RES B, V68B, P69, DOI 10.1002/jbm.b.10084
   Lee J, 2013, CLIN ORAL IMPLAN RES, V24, P497, DOI 10.1111/j.1600-0501.2011.02419.x
   Lee JH, 2010, BIOMATERIALS, V31, P3512, DOI 10.1016/j.biomaterials.2010.01.075
   Lindgren C, 2012, INT J ORAL MAX IMPL, V27, P1151
   Mordenfeld A, 2010, CLIN ORAL IMPLAN RES, V21, P961, DOI 10.1111/j.1600-0501.2010.01939.x
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Triplett RG, 2009, J ORAL MAXIL SURG, V67, P1947, DOI 10.1016/j.joms.2009.04.085
   Wang XD, 1998, BIO-MED MATER ENG, V8, P1
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   Willette RN, 1999, J VASC RES, V36, P120, DOI 10.1159/000025634
NR 29
TC 10
Z9 10
U1 2
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
EI 1600-051X
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD JAN
PY 2015
VL 42
IS 1
BP 81
EP 88
DI 10.1111/jcpe.12329
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AZ7DS
UT WOS:000348379300010
PM 25370371
DA 2018-10-20
ER

PT J
AU Doguzhaeva, LA
   Mapes, RH
AF Doguzhaeva, Larisa A.
   Mapes, Royal H.
TI Arm hooks and structural features in the Early Permian Glochinomorpha
   Gordon 1971, indicative of its coleoid affiliation
SO LETHAIA
LA English
DT Article
DE Cephalopoda; Coleoidea; Early Permian; gladius ultrastructure; gladius;
   arm hooks association
ID CEPHALOPOD; BELEMNITE; EVOLUTION; MODE; ALPS
AB Data on the re-examined-type specimens of the Early Permian Glochinomorpha stifeli Gordon (Coleoidea, Cephalopoda) gives new insight into the evolutionary origination of gladius-bearing coleoids in the Late Palaeozoic and suggests their parallel evolution with the belemnoids and phragmoteuthids. The iron-oxidized arm hooks are found in front of a gladius on an un-illustrated paratype (USNM 170614). They are dispersed in a maximum distance equal to 2.5 the gladius length from the incomplete anterior end of the rachis of the gladius. The hook height ranges from less than 1mm to as much as 4mm. They have a massive curved base, and a strongly curved shaft with a long thin distal part. The hooks confirm the cephalopod and the coleoid affiliation of G. stifeli that is widely rejected. The iron-oxidized gladii (preserved length is less than 20mm) show micro-laminations and a fibrous ultrastructure; the fibre bundles are approximately 0.5m thick. Lack of calcium and the high content of nitrogen (up to 12% of total weight) confirm the originally non-biomineralized (apparently chitin) composition of the gladii suggested by their fibrous ultrastructure. These data lead to the conclusion that in the evolutionary history of gladius-bearing coleoids, the biomaterial (biochemical) development of the skeleton preceded its morphological transformation. This phenomenon resulted in a recombination of an advanced composition (being non-biomineralized) with archaic features (sensu morphological structure of the posterior part) in the gladius of G. stifeli. The data cast doubt on the hypothesized origination of a gladius from a phragmoteuthid pro-ostracum as well as the evolutionary origination of the gladius-bearing coleoids from pro-ostracum-bearing phragmoteuthids or belemnitids.
C1 [Doguzhaeva, Larisa A.] Swedish Museum Nat Hist, Dept Palaeobiol, SE-10405 Stockholm, Sweden.
   [Mapes, Royal H.] North Carolina Museum Nat Sci, Raleigh, NC 27601 USA.
RP Doguzhaeva, LA (reprint author), Swedish Museum Nat Hist, Dept Palaeobiol, POB 50007, SE-10405 Stockholm, Sweden.
EM larisa.doguzhaeva@nrm.se; mapes@ohio.edu
OI Doguzhaeva, Larisa/0000-0002-1231-2488
FU Royal Swedish Academy of Sciences
FX This study was carried out thanks to support by the Royal Swedish
   Academy of Sciences and personally by Professors Stefan Bengtson and
   Else Marie Friis, Department of Palaebiology of the Swedish Museum of
   Natural History. Daniel Levin, Smithsonian Institute, USA, helped to
   loan the specimens from the collection of the United States Natural
   Museum for our study. Jonas Hagstrom, Department of Palaebiology of the
   Swedish Museum of Natural History, helped with literature. Christian
   Klug (Zurich University, Switzerland) and Dirk Fuchs (Free University,
   Berlin, Germany) reviewed the paper. We are indebted to all these
   persons for their valuable support and kind help.
CR Bandel K., 1986, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1986, P129
   Bandel K, 1988, CEPHALOPODS PRESENT, P229
   Berry S.Stillman, 1913, Proceedings of the Academy of Natural Sciences of Philadelphia, V65
   BERTHOLD T, 1987, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, V29, P187
   Boletzky S. v., 2003, Berliner Palaeobiologische Abhandlungen, V3, P19
   Bronn H.G., 1859, NEUES JB MINERALOGIE, V1859, P39
   Chen T.-e., 1982, Acta Palaeontologica Sinica, V21, P181
   Doguzhaeva L.A., 2003, Berliner Palaeobiologische Abhandlungen, V3, P61
   Doguzhaeva L. A., 2010, CEPHALOPODS PRESENT, P171
   Doguzhaeva Larisa A., 2003, Revue de Paleobiologie, V22, P877
   Doguzhaeva LA, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P121
   Doguzhaeva Larisa A., 2004, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V88, P37
   Doguzhaeva Larisa A., 2005, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V89, P41
   Doguzhaeva LA, 2014, LETHAIA, V47, P49, DOI 10.1111/let.12037
   Doguzhaeva LA, 2014, ACTA PALAEONTOL POL, V59, P147, DOI 10.4202/app.2011.0208
   Doguzhaeva LA, 2012, NEUES JAHRB GEOL P-A, V266, P31, DOI 10.1127/0077-7749/2012/0266
   Doguzhaeva LA, 2012, PALAEONTOLOGY, V55, P249, DOI 10.1111/j.1475-4983.2012.01136.x
   Doguzhaeva Larisa A., 2010, Ferrantia, V59, P37
   Doguzhaeva Larisa A., 2007, Acta Universitatis Carolinae Geologica, V49, P83
   Doguzhaeva Larisa A., 2007, Acta Universitatis Carolinae Geologica, V49, P95
   Doguzhaeva Larisa A., 2002, Berliner Palaeobiologische Abhandlungen, V1, P34
   Doguzhaeva Larisa A., 2007, Palaeoworld, V16, P272, DOI 10.1016/j.palwor.2007.08.002
   Donovan DT, 2010, J NAT HIST, V44, P1475, DOI 10.1080/00222931003624838
   Donovan D. T., 1988, MOLLUSCA, V12, P89
   Donovan DT, 2006, PALAEONTOLOGY, V49, P673, DOI 10.1111/j.1475-4983.2006.00552.x
   DONOVAN DT, 1977, S ZOOL SOC LOND, V38, P15
   Doyle P., 1994, University of Kansas Paleontological Contributions New Series, V5, P1
   Engeser T., 1990, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V124, P123
   Engeser T., 1986, GEOLOGY, V40, P249
   Engeser T., 1988, CEPHALOPODS PRESENT, P763
   Engeser T.S., 1988, MOLLUSCA, V12, P133
   Fischer A G., 1947, Meddelelser om Gronland, V133, P1
   Fuchs D., 2003, Berliner Palaeobiologische Abhandlungen, V3, P101
   Fuchs D., 2006, BERLINER PALAOBIOLOG, V8, P1
   Fuchs D., 2005, 2 INT S COL CEPH TIM, P68
   Fuchs D, 2006, ACTA U CAROLINAE GEO, V49, P119
   Fuchs D, 2010, PALAEONTOL Z, V84, P523, DOI 10.1007/s12542-010-0066-9
   Gordon M, 1971, US GEOLOGICAL SURV C, pC34
   Gordon M, 1966, US GEOLOGICAL SURV B, pB28
   Haas W., 2003, Berliner Palaeobiologische Abhandlungen, V3, P113
   Haas W., 2002, CEPHALOPODS PRESENT, V57, P341
   Haas Winfried, 1997, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V245, P63
   Haug J. T., 2012, PALAEONTOL ELECTRON, V15, P8
   JELETZKY J A, 1967, Annalen des Naturhistorischen Museums in Wien, V71, P69
   Jeletzky J.A., 1966, U KANSAS PALEONTOLOG
   Kroger B, 2011, BIOESSAYS, V33, P602, DOI 10.1002/bies.201100001
   Mapes R.H., 2010, CEPHALOPODS PRESENT, P155
   McCarthy P. T., 2002, MISCELLANEOUS PUBLIC, V02-2
   Mojsisovics E. V., 1882, ABHANDLUNGEN KAISERL, V10, P295
   Nesis K. N., 1992, RUTHENICA, V2, P91103
   Nesis KN., 1982, ABRIDGED KEY CEPHALO
   Pavlow A. P, 1914, ZAPISKI IMPERATORSKO, V21, P1
   Quenstedt F., 1849, CEPHALOPODEN, VI, P1
   REITNER J, 1978, Palaeontologische Zeitschrift, V52, P205
   Riccardi A. C., 2005, Geologica Acta, V3, P179
   Rieber H., 1970, NEUES JB GEOLOGIE PA, V1974, P415
   ROSENKRANTZ A., 1946, MEDDELEL DANSK GEOL FORENING, V11, P160
   Saunders W.B., 1979, P333
   Schweigert G, 2012, NEUES JAHRB GEOL P-A, V266, P19, DOI 10.1127/0077-7749/2012/0258
   Strugnell J, 2006, CLADISTICS, V22, P89, DOI 10.1111/j.1096-0031.2006.00086.x
   Warnke K., 2003, Berliner Palaeobiologische Abhandlungen, V3, P253
   Warnke KM, 2011, MOL PHYLOGENET EVOL, V58, P390, DOI 10.1016/j.ympev.2010.11.024
   Young RE, 1998, S AFR J MARINE SCI, V20, P393
   Zieten C. H. v., 1832, VERSTEINERUNGEN WURT, P33
NR 64
TC 5
Z9 5
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0024-1164
EI 1502-3931
J9 LETHAIA
JI Lethaia
PD JAN
PY 2015
VL 48
IS 1
BP 100
EP 114
DI 10.1111/let.12091
PG 15
WC Paleontology
SC Paleontology
GA CA2HI
UT WOS:000348729000010
DA 2018-10-20
ER

PT J
AU Hryniewicz, T
   Rokosz, K
   Rokicki, R
   Prima, F
AF Hryniewicz, Tadeusz
   Rokosz, Krzysztof
   Rokicki, Ryszard
   Prima, Frederic
TI Nanoindentation and XPS Studies of Titanium TNZ Alloy after
   Electrochemical Polishing in a Magnetic Field
SO MATERIALS
LA English
DT Article
DE nanoindentation; XPS studies; magnetoelectropolishing (MEP); TNZ surface
ID BIOMATERIAL; INDENTATION; MODULUS; FILMS
AB This work presents the nanoindentation and XPS results of a newly-developed biomaterial of titanium TNZ alloy after different surface treatments. The investigations were performed on the samples AR (as received), EP (after a standard electropolishing) and MEP (after magnetoelectropolishing). The electropolishing processes, both EP and MEP, were conducted in the same proprietary electrolyte based on concentrated sulfuric acid. The mechanical properties of the titanium TNZ alloy biomaterial demonstrated an evident dependence on the surface treatment method, with MEP samples revealing extremely different behavior and mechanical properties. The reason for that different behavior appeared to be influenced by the surface film composition, as revealed by XPS study results displayed in this work. The increase of niobium and zirconium in the surface film of the same titanium TNZ alloy after magnetoelectropolishing MEP treatment is meaningful and especially advantageous considering the application of this alloy as a biomaterial.
C1 [Hryniewicz, Tadeusz; Rokosz, Krzysztof] Koszalin Univ Technol, Div Surface Electrochem, PL-75620 Koszalin, Poland.
   [Rokicki, Ryszard] Electrobright, Macungie, PA 18062 USA.
   [Prima, Frederic] CNRS Chim ParisTech, Inst Rech Chim Paris, F-75005 Paris, France.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Div Surface Electrochem, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM Tadeusz.Hryniewicz@tu.koszalin.pl; rokosz@tu.koszalin.pl;
   ryszardr@ptd.net; frederic.prima@chimie-paristech.fr
CR Cheng YT, 2004, MAT SCI ENG R, V44, P91, DOI 10.1016/j.mser.2004.05.001
   Chuang LC, 2011, APPL SURF SCI, V258, P297, DOI 10.1016/j.apsusc.2011.08.055
   Crist B.V., 2000, HDB MONOCHROMATIC XP
   Hryniewicz T, 2007, Metal Finishing, V104, P26, DOI 10.1016/S0026-0576(06)80361-2
   Hryniewicz T, 2007, T I MET FINISH, V85, P325, DOI 10.1179/174591907X246537
   Hryniewicz Tadeusz, 2009, Pomiary Automatyka Kontrola, V55, P247
   Hryniewicz T, 2009, SURF COAT TECH, V203, P1508, DOI 10.1016/j.surfcoat.2008.11.028
   Hryniewicz T., 2011, MAGNETOELECTROPOLISH, P227
   Hryniewicz T., 2009, P MRS P BIOM 18 INT, V9, P21
   Hryniewicz T., 2014, INT LETT CHEM PHYS A, V4, P98, DOI DOI 10.18052/WWW.SCIPRESS.COM/ILCPA.23.98
   Hryniewicz T, 2014, FRONT MATER, DOI 10.3389/fmats.2014.00003
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Hryniewicz T, 2012, SURF COAT TECH, V206, P4027, DOI 10.1016/j.surfcoat.2012.03.083
   Kuhn A., 2004, MET FINISH, V102, P80
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Marteleur M, 2012, SCRIPTA MATER, V66, P749, DOI 10.1016/j.scriptamat.2012.01.049
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Pluta Z., 2011, J QUANTUM INFORM SCI, V1, P127, DOI DOI 10.4236/JQIS.2011.13018
   Pulletikurthi C, 2015, J BIOMED MATER RES B, V103, P1366, DOI 10.1002/jbm.b.33317
   Reddy Police Anil Kumar, 2010, Journal of Water Resource and Protection, V2, P235, DOI 10.4236/jwarp.2010.23027
   Rokicki R., 2008, MED DEVICE DIAGN IND, V30, P102
   Rokicki R., 1990, MET FINISH, V88, P65
   Rokicki R., 2009, US Patent, Patent No. 7632390
   Rokicki R, 2012, J MATER SCI-MATER M, V23, P2127, DOI 10.1007/s10856-012-4696-1
   Rokosz Krzysztof, 2012, Pomiary Automatyka Kontrola, V58, P460
   Shuman D, 2005, NANOINDENTATION, P21
   Simka W, 2012, SURF COAT TECH, V213, P239, DOI 10.1016/j.surfcoat.2012.10.055
   Simka W, 2010, ELECTROCHIM ACTA, V55, P2437, DOI 10.1016/j.electacta.2009.11.097
   STATSOFT INC, 2011, STATISTICA DAT AN SO
   Wang SJ, 2002, APPL PHYS LETT, V80, P2541, DOI 10.1063/1.1467970
NR 30
TC 19
Z9 19
U1 2
U2 23
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JAN
PY 2015
VL 8
IS 1
BP 205
EP 215
DI 10.3390/ma8010205
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA AZ7MQ
UT WOS:000348403400013
PM 28787933
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Markaki, AE
   Ohman, C
   Porter, AE
AF Markaki, A. E.
   Ohman, C.
   Porter, A. E.
TI Biomaterial characterisation
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Editorial Material
C1 [Markaki, A. E.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.
   [Ohman, C.] Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Angstrom Lab, Uppsala, Sweden.
   [Porter, A. E.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
RP Markaki, AE (reprint author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.
EM am253@cam.ac.uk; caroline.ohman@angstrom.uu.se; a.porter@imperial.ac.uk
RI Markaki, Athina/H-9676-2012
OI Ohman Magi, Caroline/0000-0003-2709-9541
CR Arkudas A, 2015, MATER SCI TECH-LOND, V31, P180, DOI 10.1179/1743284714Y.0000000611
   Davis GR, 2015, MATER SCI TECH-LOND, V31, P162, DOI 10.1179/1743284714Y.0000000618
   Denbigh JL, 2015, MATER SCI TECH-LOND, V31, P137, DOI 10.1179/1743284714Y.0000000648
   Fearn S, 2015, MATER SCI TECH-LOND, V31, P148, DOI 10.1179/1743284714Y.0000000668
   Gatzioufas Z, 2015, MATER SCI TECH-LOND, V31, P188, DOI 10.1179/1743284714Y.0000000612
   Tang HM, 2015, MATER SCI TECH-LOND, V31, P197, DOI 10.1179/1743284714Y.0000000601
   Thorfve A, 2015, MATER SCI TECH-LOND, V31, P174, DOI 10.1179/1743284714Y.0000000687
   Yang J, 2015, MATER SCI TECH-LOND, V31, P131, DOI 10.1179/1743284714Y.0000000613
   Zehbe R, 2015, MATER SCI TECH-LOND, V31, P167, DOI 10.1179/1743284714Y.0000000667
NR 9
TC 0
Z9 0
U1 2
U2 15
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
EI 1743-2847
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD JAN
PY 2015
VL 31
IS 2
BP 129
EP 130
DI 10.1179/0267083614Z.000000000877
PG 2
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA AZ6FN
UT WOS:000348314600001
OA Bronze
DA 2018-10-20
ER

PT J
AU Yang, J
   Gilmore, I
AF Yang, J.
   Gilmore, I.
TI Application of secondary ion mass spectrometry to biomaterials, proteins
   and cells: a concise review
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Review
DE SIMS; Biomaterials; Protein; Cell; Tissue engineering; Biomedical
   devices; Regenerative medicine; Reviews
ID PRINCIPAL COMPONENT ANALYSIS; TOF-SIMS IMAGES; MULTIVARIATE-ANALYSIS;
   SURFACE CHARACTERIZATION; ANALYSIS STRATEGIES; ADSORBED PROTEINS;
   CHEMICAL-ANALYSIS; BEAMS; SPECTROSCOPY; BOMBARDMENT
AB Secondary ion mass spectrometry (SIMS) is a powerful tool to probe the chemical and structural information of the top a few monolayers of a surface. The surface of a biomaterial that is in contact with a biological environment plays a critical role in interacting with its surroundings. Much research has been focusing on modifying the surface chemistry of a biomaterial to exert desirable cellular response such as adhesion, proliferation, migration and differentiation. Surface characterisation is essential to assess the properties of the modified surfaces. The properties of a surface also influence the protein adsorbed onto it. The adsorbed proteins play a vital role in mediating cellular response. Secondary ion mass spectrometry can be used to probe the identity, orientation, conformation and spatial distribution of this adsorbed layer. With the introduction of large cluster ions such as C-60(+) and Ar-n(+), the yield of high mass molecular ions has been greatly enhanced. In addition, large cluster ion beams cause minimum damage to subsurface, which makes molecular depth profiling possible. The ability of eroding materials away without causing chemical damage to the subsurface has realised the three-dimensional molecular imaging of multilayered polymer structures, drug loaded polymers and cells. The subject of this review is the applications of SIMS to biomaterials, surface adsorbed proteins and biological materials.
C1 [Yang, J.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
   [Gilmore, I.] Natl Phys Lab, Teddington TW11 0LW, Middx, England.
RP Yang, J (reprint author), Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
EM Jing.Yang@nottingham.ac.uk
RI yang, jing/L-6313-2015
OI yang, jing/0000-0002-8822-7124; Gilmore, Ian/0000-0002-0981-2318
FU National Physical Laboratory [117362]
CR APPELHANS AD, 1989, ANAL CHEM, V61, P1087, DOI 10.1021/ac00185a009
   Baio JE, 2012, LANGMUIR, V28, P2107, DOI 10.1021/la203907t
   BARBER M, 1977, SURF SCI, V68, P130, DOI 10.1016/0039-6028(77)90197-2
   BENNINGHOVEN A, 1969, PHYS STATUS SOLIDI, V34, pK169, DOI 10.1002/pssb.19690340267
   Breitenstein D, 2007, ANGEW CHEM INT EDIT, V46, P5332, DOI 10.1002/anie.200604468
   BRIGGS D, 1982, SURF INTERFACE ANAL, V4, P109, DOI 10.1002/sia.740040306
   Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061
   Cheng J, 2006, J PHYS CHEM B, V110, P8329, DOI 10.1021/jp0573341
   Colliver TL, 1997, ANAL CHEM, V69, P2225, DOI 10.1021/ac9701748
   DAVIES MC, 1988, SURF INTERFACE ANAL, V11, P591, DOI 10.1002/sia.740111202
   Davies N, 2003, APPL SURF SCI, V203, P223, DOI 10.1016/S0169-4332(02)00631-1
   Fisher GL, 2009, ANAL CHEM, V81, P9930, DOI 10.1021/ac901587k
   Fletcher JS, 2007, ANAL CHEM, V79, P2199, DOI 10.1021/ac061370u
   Fletcher JS, 2011, RAPID COMMUN MASS SP, V25, P925, DOI 10.1002/rcm.4944
   Fletcher JS, 2008, ANAL CHEM, V80, P9058, DOI 10.1021/ac8015278
   Garrison BJ, 2008, MASS SPECTROM REV, V27, P289, DOI 10.1002/mas.20165
   GILLEN G, 1990, ANAL CHEM, V62, P2122, DOI 10.1021/ac00218a014
   Gillen G, 2001, J VAC SCI TECHNOL A, V19, P568, DOI 10.1116/1.1340651
   Gillen G, 1998, RAPID COMMUN MASS SP, V12, P1303, DOI 10.1002/(SICI)1097-0231(19981015)12:19<1303::AID-RCM330>3.0.CO;2-7
   Gillen G, 2006, APPL SURF SCI, V252, P6537, DOI 10.1016/j.apsusc.2006.02.235
   Gilmore I. S., 2013, J VAC SCI TECHNOL A, V31A
   Gnaser H, 2013, RAPID COMMUN MASS SP, V27, P1490, DOI 10.1002/rcm.6599
   Hanley L, 2009, ANAL CHEM, V81, P4174, DOI 10.1021/ac8013675
   JABS H, 1986, J LIPID RES, V27, P613
   Kollmer F, 2004, APPL SURF SCI, V231, P153, DOI 10.1016/j.apsusc.2004.03.101
   Kucher A, 2013, SURF INTERFACE ANAL, V45, P510, DOI 10.1002/sia.5118
   Lee JLS, 2008, SURF INTERFACE ANAL, V40, P1, DOI 10.1002/sia.2713
   Lee JLS, 2009, SURF INTERFACE ANAL, V41, P653, DOI 10.1002/sia.3070
   Lee JLS, 2009, SURF INTERFACE ANAL, V41, P76, DOI 10.1002/sia.2935
   Lee TG, 2008, APPL SURF SCI, V255, P1241, DOI 10.1016/j.apsusc.2008.05.156
   Li GT, 2011, SURF INTERFACE ANAL, V43, P498, DOI 10.1002/sia.3161
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Mochiji K, 2009, RAPID COMMUN MASS SP, V23, P648, DOI 10.1002/rcm.3922
   Muramoto S, 2011, J PHYS CHEM C, V115, P24247, DOI 10.1021/jp208035x
   Ninomiya S, 2009, RAPID COMMUN MASS SP, V23, P1601, DOI 10.1002/rcm.4046
   Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791
   Rafati A, 2012, J CONTROL RELEASE, V162, P321, DOI 10.1016/j.jconrel.2012.05.008
   Robinson MA, 2012, ANAL CHEM, V84, P4880, DOI 10.1021/ac300480g
   Scurr DJ, 2010, LANGMUIR, V26, P17143, DOI 10.1021/la1029933
   SHORT RD, 1988, ABSTR PAP AM CHEM S, V196, P56
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   Tyler BJ, 2007, BIOMATERIALS, V28, P2412, DOI 10.1016/j.biomaterials.2007.02.002
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
   Wang H, 2004, LANGMUIR, V20, P1877, DOI 10.1021/la035376f
   Weibel D, 2003, ANAL CHEM, V75, P1754, DOI 10.1021/ac026338o
   WINOGRAD N, 1993, ANAL CHEM, V65, pA622, DOI 10.1021/ac00062a001
   WITTMAACK K, 1979, SURF SCI, V90, P557, DOI 10.1016/0039-6028(79)90360-1
NR 48
TC 10
Z9 10
U1 2
U2 116
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
EI 1743-2847
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD JAN
PY 2015
VL 31
IS 2
BP 131
EP 136
DI 10.1179/1743284714Y.0000000613
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA AZ6FN
UT WOS:000348314600002
DA 2018-10-20
ER

PT J
AU Zehbe, R
   Schmitt, VH
   Kirkpatrick, CJ
   Brochhausen, C
AF Zehbe, R.
   Schmitt, V. H.
   Kirkpatrick, C. J.
   Brochhausen, C.
TI High resolution X-ray tomography - three-dimensional characterisation of
   cell-scaffold constructs for cartilage tissue engineering
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Tissue engineering; Cartilage; Synchrotron-mu CT; Biomaterial; High
   resolution X-ray tomography
ID MICRO-COMPUTED TOMOGRAPHY; SYNCHROTRON MU-CT; ARTICULAR-CARTILAGE;
   GELATIN SCAFFOLDS; MICROTOMOGRAPHY; COMPRESSION; NETWORK
AB Synchrotron radiation based microcomputed tomography (SR-mu CT) has become a valuable tool for the structural analysis of different types of biomaterials. This methodology allows the non-destructive investigation of specimens in their three-dimensional context. In the present paper, articular cartilage is taken as an exemplary tissue to demonstrate the suitability of the SR-mu CT method for the investigation of biomaterials for different tissue engineering approaches. Thus, a biodegradable scaffold for cartilage tissue engineering in different modifications was analysed. Using enhanced phase contrast imaging, it was possible to demonstrate single cells without further metal staining. The three-dimensional data acquired for each investigated sample allowed qualitative and quantitative analyses without irreversibly damaging the samples. The use of the phase contrast mode enables the analysis of single cells within a scaffold material even under mechanical stimulation. This opens up innovative perspectives for the future study of the behaviour of cells in their three-dimensional environment and the non-destructive study of morphogenesis in cell-scaffold constructs.
C1 [Zehbe, R.] Tech Univ Berlin, Inst Mat Sci & Technol, Berlin, Germany.
   [Schmitt, V. H.; Kirkpatrick, C. J.; Brochhausen, C.] Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, Mainz, Germany.
RP Brochhausen, C (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, Mainz, Germany.
EM brochhausen@pathologie.klinik.uni-mainz.de
FU Deutsche Forschungsgemeinschaft (DFG) [SCHU 679/27-1, SCHU 679/27-2]
FX This study was partly supported by Deutsche Forschungsgemeinschaft (DFG)
   under grants SCHU 679/27-1 and SCHU 679/27-2. The authors would like to
   thank U. Gross, A. Thiem, B. Watzer, R. Grupp and M. Dilger for
   discussion and technical assistance.
CR Bernhardt R, 2004, Eur Cell Mater, V7, P42
   Bonse U, 1996, PROG BIOPHYS MOL BIO, V65, P133, DOI 10.1016/S0079-6107(96)00011-9
   BRAVERMAN MS, 1986, J INVEST DERMATOL, V86, P290, DOI 10.1111/1523-1747.ep12285445
   Cloetens P, 2006, P NATL ACAD SCI USA, V103, P14626, DOI 10.1073/pnas.0603490103
   Dilmanian F. A., 1992, American Journal of Physiologic Imaging, V7, P175
   Ginty PJ, 2006, P NATL ACAD SCI USA, V103, P7426, DOI 10.1073/pnas.0508895103
   Giuliani A, 2014, TISSUE ENG PART C-ME, V20, P308, DOI [10.1089/ten.tec.2013.0213, 10.1089/ten.TEC.2013.0213]
   Giuliani A, 2011, J TISSUE ENG REGEN M, V5, pE168, DOI 10.1002/term.409
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Olubamiji A. D., 2014, TISSUE ENG B
   Riesemeier H., 2007, ID022
   Schafers F., 1996, 20196 BESSY TB
   Thiem A, 2010, ADV MATER RES-SWITZ, V89-91, P551, DOI 10.4028/www.scientific.net/AMR.89-91.551
   van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Zehbe R, 2010, ACTA BIOMATER, V6, P2097, DOI 10.1016/j.actbio.2009.11.020
   Zehbe R., 2010, TISSUE ENG, P337
   Zehbe R, 2007, INT J MATER RES, V98, P562, DOI 10.3139/146.101509
   Zehbe R, 2012, MICRON, V43, P1060, DOI 10.1016/j.micron.2012.05.001
   Zehbe R, 2010, J R SOC INTERFACE, V7, P49, DOI 10.1098/rsif.2008.0539
NR 21
TC 8
Z9 8
U1 2
U2 12
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
EI 1743-2847
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD JAN
PY 2015
VL 31
IS 2
BP 167
EP 173
DI 10.1179/1743284714Y.0000000667
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA AZ6FN
UT WOS:000348314600006
DA 2018-10-20
ER

PT J
AU Aoyagi, H
   Iwasaki, S
   Nakamura, K
AF Aoyagi, Hidekazu
   Iwasaki, Shin-ichi
   Nakamura, Kenzirou
TI Three-dimensional observation of mouse tongue muscles using
   micro-computed tomography
SO Odontology
LA English
DT Article
DE Tongue muscles; Three-dimensional observation; Micro-CT
ID MORPHOLOGY; ANATOMY; RAT; CT; ORGANIZATION; ARCHITECTURE; PROTRUSION;
   APPARATUS; MRI
AB The aim of this study is to obtain information about the mouse tongue muscle rendered using micro-computed tomography (mu CT) at low, middle, and high magnifications. Three-dimensional (3D) mu CT is used in various fields. Most mu CT observations are restricted to hard tissue in biomaterial samples. Recently, with the use of osmium tetroxide, mu CT has been effectively employed to observe soft tissue; it is now believed that mu CT observation of soft tissue is feasible. On the other hand, the structure of the tongue muscle has been well studied, but cross-sectional imaging enhanced by 3D rendering is lacking. We chose the mouse tongue as a soft tissue case study for mu CT and generated cross-sectional images of the tongue enhanced by 3-D image rendering with histological resolution. During this observation, we developed new methods of low-magnification observation to show the relation between the tongue muscles and surrounding tissues. We also applied high-resolution mu CT in high-magnification observation of muscle fiber fascicles. Our methodological techniques give the following results: (1) For low-magnification observation (field of view: 12,000 mu m), pretreatment with decalcification and freeze drying is suitable for observing the area between the muscle of the tongue and the bone around the tongue using mu CT. (2) For middle-magnification observation (Field of view: 3,500 mu m), the use of osmium tetroxide to observe the muscle arrangement of the tongue by mu CT is suitable. (3) For high-magnification observation (Field of view: 450 mu m), high-resolution mu CT is suitable for observation of the transversus muscle fiber fascicles.
C1 [Aoyagi, Hidekazu; Nakamura, Kenzirou] Nippon Dent Univ, Adv Res Ctr, Sch Life Dent Niigata, Chuo Ku, Niigata 9518580, Japan.
   [Iwasaki, Shin-ichi] Nippon Dent Univ, Sch Life Dent Niigata, Dept Physiol, Chuo Ku, Niigata 9518580, Japan.
RP Aoyagi, H (reprint author), Nippon Dent Univ, Adv Res Ctr, Sch Life Dent Niigata, Chuo Ku, 1-8 Hamaura Chou, Niigata 9518580, Japan.
EM aoy@ngt.ndu.ac.jp
FU Nippon Dental University [NDUF-12-07]
FX We are grateful to Prof. M. Tsuchimochi of the Department of Oral and
   Maxillofacial Radiology of the Nippon Dental University School of Life
   Dentistry at Niigata for his encouragement and constant support. We also
   wish to thank Prof. A. Ezura of General Dentistry at the Nippon Dental
   University School of Life Dentistry at Niigata for his help and
   suggestions. This research was supported by Research Promotion Grants
   (No. NDUF-12-07) from the Nippon Dental University.
CR Aoyagi H, 2012, TONGUE ANATOMY KINEM, P53
   Aoyagi H, 2012, ODONTOLOGY, V100, P134
   Aoyagi H, 2010, ODONTOLOGY, V98, P26, DOI 10.1007/s10266-009-0112-9
   Barnwell EM, 1976, INT J ORAL MYOL, V2, P31
   Boom HPW, 2008, ARCH ORAL BIOL, V53, P273, DOI 10.1016/j.archoralbio.2007.08.013
   Cooper D, 2007, CALCIFIED TISSUE INT, V80, P211, DOI 10.1007/s00223-005-0274-6
   Diogo R, 2009, J MORPHOL, V270, P14, DOI 10.1002/jmor.10666
   Faraj KA, 2009, TISSUE ENG PART C-ME, V15, P493, DOI 10.1089/ten.tec.2008.0436
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Fiebig T, 2012, PLOS ONE, V7
   GANS C, 1982, AM J ANAT, V163, P195, DOI 10.1002/aja.1001630302
   Herrel A, 2001, J MORPHOL, V249, P154, DOI 10.1002/jmor.1047
   Im K, 2013, PLOS ONE, V8
   Iwaka Y, 2006, J ORAL BIOSCI, V48, P94, DOI 10.2330/joralbiosci.48.94
   Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027
   Kayalioglu M, 2007, ARCH ORAL BIOL, V52, P786, DOI 10.1016/j.archoralbio.2007.01.004
   Laine FJ, 1995, SEMIN ULTRASOUND CT, V16, P527, DOI 10.1016/S0887-2171(06)80024-7
   LOMBARD RE, 1977, J MORPHOL, V153, P39
   McClung JR, 2000, ANAT REC, V260, P378, DOI 10.1002/1097-0185(20001201)260:4<378::AID-AR70>3.0.CO;2-A
   McClung JR, 2002, BRAIN RES, V950, P321, DOI 10.1016/S0006-8993(02)03240-7
   Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11
   Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857
   Mu LC, 1999, ANAT REC, V256, P412
   Mu L, 2008, ANAT REC, V291, P927, DOI 10.1002/ar.20727
   Napadow VJ, 1999, J BIOMECH, V32, P1, DOI 10.1016/S0021-9290(98)00109-2
   Nowinski WL, 2012, J NEUROSCI METH, V206, P205, DOI 10.1016/j.jneumeth.2012.02.026
   Ogata S, 2002, ANN ANAT, V184, P493, DOI 10.1016/S0940-9602(02)80087-5
   OREILLY PMR, 1990, J ANAT, V172, P227
   Parkinson CR, 2008, DENT MATER, V24, P773, DOI 10.1016/j.denta1.2007.09.003
   Peters OA, 2003, INT ENDOD J, V36, P86, DOI 10.1046/j.1365-2591.2003.00626.x
   Saito H, 2007, ANN ANAT, V189, P261, DOI 10.1016/j.aanat.2006.10.002
   Saito S, 2012, PLOS ONE, V7
   Schaffer J., 1951, COLLECTIVE REV OS OM, P1287
   SCHWENK K, 1994, SCIENCE, V263, P1573, DOI 10.1126/science.263.5153.1573
   Shibata Yasuaki, 2000, Histochemistry and Cell Biology, V113, P153, DOI 10.1007/s004180050434
   Smith JC, 2006, ARCH ORAL BIOL, V51, P520, DOI 10.1016/j.archoralbio.2005.10.006
   SMITH KK, 1988, J MORPHOL, V196, P157, DOI 10.1002/jmor.1051960205
   SMITH KK, 1986, J MORPHOL, V187, P261, DOI 10.1002/jmor.1051870302
   Sosnovik DE, 2009, CIRC-CARDIOVASC IMAG, V2, P206, DOI 10.1161/CIRCIMAGING.108.815050
   STUTLEY J, 1989, CLIN RADIOL, V40, P248, DOI 10.1016/S0009-9260(89)80184-9
   Takemoto H., 2001, J SPEECH LANG HEAT R, V44, P1
   Volk J, 2010, AM J ORTHOD DENTOFAC, V138, P608, DOI 10.1016/j.ajodo.2008.12.028
NR 42
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1618-1247
EI 1618-1255
J9 ODONTOLOGY
JI Odontology
PD JAN
PY 2015
VL 103
IS 1
BP 1
EP 8
DI 10.1007/s10266-013-0131-4
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AZ9WS
UT WOS:000348565600001
PM 23975065
DA 2018-10-20
ER

PT J
AU Naqvi, SM
   Buckley, CT
AF Naqvi, Syeda Masooma
   Buckley, Conor Timothy
TI Differential Response of Encapsulated Nucleus Pulposus and Bone Marrow
   Stem Cells in Isolation and Coculture in Alginate and Chitosan Hydrogels
SO Tissue Engineering Part A
LA English
DT Article
ID INTERVERTEBRAL DISC DEGENERATION; IN-VITRO; CHONDROGENIC
   DIFFERENTIATION; MECHANICAL-PROPERTIES; DYNAMIC COMPRESSION; STROMAL
   CELLS; SAND RAT; TISSUE; CARTILAGE; REGENERATION
AB Cell-based therapies may hold significant promise for the treatment of early stage degeneration of the intervertebral disc (IVD). Given their propensity to proliferate and ability to form multiple tissue types, mesenchymal stem cells (MSCs) have been proposed as a potential cell source to promote repair of the nucleus pulposus (NP). However, for any successful cell-based therapy, a carrier biomaterial may be essential for targeted delivery providing key biophysical and biochemical cues to facilitate differentiation of MSCs. Two widely used biomaterials for NP regeneration are chitosan and alginate. The primary objective of this study was to assess the influence of alginate and chitosan hydrogels on bone marrow stem cells (BM) and NP cells in isolation or in coculture. A secondary objective of this study was to investigate coculture seeding density effects of BM and NP cells and simultaneously explore which cell type is responsible for matrix formation in a cocultured environment. Porcine NP and BM cells were encapsulated in alginate and chitosan hydrogels separately at two seeding densities (4x10(6) and 8x10(6) cells/mL) or in coculture (1:1, 8x10(6) cells/mL). Constructs (diameter=5 mm, height=3 mm) were maintained under IVD-like conditions [low-glucose, low (5%) oxygen] with or without transforming growth factor-beta 3 (TGF-beta 3) supplementation for 21 days. Results demonstrated differential viability depending on hydrogel type. NP cells remained viable in both biomaterial types whereas BM viability was diminished in chitosan. Further, hydrogel type was found to regulate sulfated glycosaminoglycan (sGAG) and collagen accumulation. Specifically, alginate better supports sGAG accumulation and collagen type II deposition for both NP and BM cell types compared with chitosan. Having identified that alginate more readily supports cell viability and matrix accumulation, we further explored additional effects of seeding density ratios (NP:BM-1:1, 1:2) for coculture studies. Interestingly, in coculture conditions, the BM cell population declined in number while NP cells increased, indicating that MSCs may in fact be signaling NP cells to proliferate rather than contributing to matrix formation. These findings provide exciting new insights on the potential of MSCs for NP tissue regeneration strategies.
C1 [Naqvi, Syeda Masooma; Buckley, Conor Timothy] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin 2, Ireland.
   [Naqvi, Syeda Masooma; Buckley, Conor Timothy] Univ Dublin Trinity Coll, Sch Engn, Dept Mech Engn, Dublin 2, Ireland.
RP Buckley, CT (reprint author), Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin 2, Ireland.
EM conor.buckley@tcd.ie
OI Buckley, Conor/0000-0001-7452-4534
FU Graduate Research Education Programme in Engineering (GREP-Eng); PRTLI
   Cycle 5; European Regional Development Fund
FX This work was supported by the Graduate Research Education Programme in
   Engineering (GREP-Eng) and PRTLI Cycle 5 funded programme. PRTLI is 50%
   cofunded under the European Regional Development Fund.
CR Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Buckley CT, 2012, J MECH BEHAV BIOMED, V11, P102, DOI 10.1016/j.jmbbm.2011.09.004
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011
   Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805
   Chou AI, 2009, OSTEOARTHR CARTILAGE, V17, P1377, DOI 10.1016/j.joca.2009.04.012
   Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c
   Dadsetan M, 2011, ACTA BIOMATER, V7, P2080, DOI 10.1016/j.actbio.2011.01.012
   Dudhia J, 2007, AGING CELL, V6, P547, DOI 10.1111/j.1474-9726.2007.00307.x
   Gaetani P, 2008, TISSUE ENG PT A, V14, P1415, DOI 10.1089/ten.tea.2007.0330
   Gantenbein-Ritter Benjamin, 2012, Eur Spine J, V21 Suppl 6, pS819, DOI 10.1007/s00586-011-2026-9
   Ge ZG, 2004, BIOMATERIALS, V25, P1049, DOI 10.1016/S0142-9612(03)00612-4
   GOTZ W, 1995, CELL TISSUE RES, V280, P455
   Gruber HE, 2002, SPINE, V27, P1626, DOI 10.1097/01.BRS.0000018788.88555.21
   Gruber HE, 2007, SPINE, V32, P321, DOI 10.1097/01.brs.0000253960.57051.de
   Guaccio A, 2008, BIOMATERIALS, V29, P1484, DOI 10.1016/j.biomaterials.2007.12.020
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Hoemann CD, 2002, ANAL BIOCHEM, V300, P1, DOI 10.1006/abio.2001.5436
   Ignat'eva NY, 2007, J ANAL CHEM+, V62, P51, DOI 10.1134/S106193480701011X
   Kafienah Wa'el, 2004, Methods Mol Biol, V238, P217
   Kandel RA, 2007, EUR SPINE J, V16, P2166, DOI 10.1007/s00586-007-0467-y
   Korecki CL, 2009, J ORTHOP RES, V27, P800, DOI 10.1002/jor.20814
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Kwon HJ, 2010, ACTA BIOMATER, V6, P494, DOI 10.1016/j.actbio.2009.07.033
   Le Maitre CL, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2611
   Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198
   Le Visage C, 2006, SPINE, V31, P2036, DOI 10.1097/01.brs.0000231442.05245.87
   Leone G, 2008, J BIOMED MATER RES A, V84A, P391, DOI 10.1002/jbm.a.31334
   Liu JF, 2011, TISSUE ENG PT A, V17, P2343, DOI [10.1089/ten.tea.2011.0034, 10.1089/ten.TEA.2011.0034]
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   Martin JA, 2002, BIOGERONTOLOGY, V3, P257, DOI 10.1023/A:1020185404126
   Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]
   McCanless JD, 2011, SPINE, V36, P2275, DOI 10.1097/BRS.0b013e31820cd1b1
   Meisel HJ, 2006, EUR SPINE J, V15, pS397, DOI 10.1007/s00586-006-0169-x
   Mwale F, 2004, Eur Cell Mater, V8, P58
   Nomura T, 2001, CLIN ORTHOP RELAT R, P94
   Okuma M, 2000, J ORTHOPAED RES, V18, P988, DOI 10.1002/jor.1100180620
   Perrien DS, 2007, AM J PHYSIOL-REG I, V292, pR988, DOI 10.1152/ajpregu.00302.2006
   Pittenger MF, 2000, CURR TOP MICROBIOL, V251, P3
   Renani Hamid Bahramian, 2012, Adv Biomed Res, V1, P81, DOI 10.4103/2277-9175.102996
   Richardson SM, 2008, CURR PAIN HEADACHE R, V12, P83, DOI 10.1007/s11916-008-0016-3
   Richardson SM, 2006, STEM CELLS, V24, P707, DOI 10.1634/stemcells.2005-0205
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Risbud MV, 2004, SPINE, V29, P2627, DOI 10.1097/01.brs.0000146462.92171.7f
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Scuteri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084309
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Spillekom S, 2014, TISSUE ENG PART C-ME, V20, P8
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Strassburg S, 2010, REGEN MED, V5, P701, DOI 10.2217/RME.10.59
   Taylor TKF, 2000, SPINE, V25, P3014, DOI 10.1097/00007632-200012010-00008
   Thorpe SD, 2010, ANN BIOMED ENG, V38, P2896, DOI 10.1007/s10439-010-0059-6
   Vadala G, 2008, SPINE, V33, P870, DOI 10.1097/BRS.0b013e31816b4619
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4
   Wu JH, 2014, J ORTHOP RES, V32, P159, DOI 10.1002/jor.22474
   Xu JP, 2008, TISSUE ENG PT A, V14, P667, DOI 10.1089/tea.2007.0272
   Yamamoto Y, 2004, SPINE, V29, P1508, DOI 10.1097/01.BRS.0000131416.90906.20
NR 60
TC 17
Z9 16
U1 1
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN 1
PY 2015
VL 21
IS 1-2
BP 288
EP 299
DI 10.1089/ten.tea.2013.0719
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CA1YQ
UT WOS:000348706100010
PM 25060596
DA 2018-10-20
ER

PT J
AU Hruschka, V
   Saeed, A
   Slezak, P
   Al Ghanami, RC
   Feichtinger, GA
   Alexander, C
   Redl, H
   Shakesheff, K
   Wolbank, S
AF Hruschka, Veronika
   Saeed, Aram
   Slezak, Paul
   Al Ghanami, Racha Cheikh
   Feichtinger, Georg Alexander
   Alexander, Cameron
   Redl, Heinz
   Shakesheff, Kevin
   Wolbank, Susanne
TI Evaluation of a Thermoresponsive Polycaprolactone Scaffold for In Vitro
   Three-Dimensional Stem Cell Differentiation
SO Tissue Engineering Part A
LA English
DT Article
ID PORE-SIZE; OSTEOGENIC DIFFERENTIATION; BONE REGENERATION; HYDROGELS;
   RAT; POLYMER; MATRIX; PROLIFERATION; DISPERSIONS; MYOTUBES
AB Tissue engineering (TE) strategies aim at imitating the natural process of regeneration by using bioresorbable scaffolds that support cellular attachment, migration, proliferation, and differentiation. Based on the idea of combining a fully degradable polymer [poly(e-caprolactone)] with a thermoresponsive polymer (polyethylene glycol methacrylate), a scaffold was developed, which liquefies below 20 degrees C and solidifies at 37 degrees C. In this study, this scaffold was evaluated for its ability to support C2C12 cells and human adipose-derived stem cells (ASCs) to generate an expandable three-dimensional (3D) construct for soft or bone TE. As a first step, biomaterial seeding was optimized and cellular attachment, survival, distribution, and persistence within the 3D material were characterized. C2C12 cells were differentiated toward the osteogenic as well as myogenic lineage, while ASCs were cultured in control, adipogenic, or osteogenic differentiation media. Differentiation was examined using quantitative real-time PCR for the expression of osteogenic, myogenic, and adipogenic markers and by enzyme activity and immunoassays. Both cell types attached and were found evenly distributed within the material. C2C12 cells and ASCs demonstrated the potential to differentiate in all tested lineages under 2D conditions. Under 3D osteogenic conditions for C2C12 cells, only osteocalcin expression (fold induction: 16.3 +/- 0.2) and alkaline phosphatase (ALP) activity (p<0.001) were increased compared with the control C2C12 cells. Three-dimensional osteogenic differentiation of ASC was limited and donor dependent. Only one donor showed an increase in the osteogenic markers osteocalcin (p=0.027) and osteopontin (p=0.038). In contrast, differentiation toward the myogenic or adipogenic lineage showed expression of specific markers in 3D, at least at the level of the 2D culture. In 3D culture, strong induction of myogenin (p<0.001) as well as myoD (p<0.001) was found in C2C12 cells. The adipogenic differentiation of one donor showed greater expression of peroxisome proliferative-activated receptor gamma (PPAR gamma) (p=0.004), fatty acid binding protein 4 (FABP4) (p=0.008), and adiponectin (p=0.045) in 3D compared with 2D culture. Leptin levels in the supernatant of the ASC cultures were elevated in the 3D cultures in both donors at day 14 and 21. In conclusion, the thermoresponsive scaffold was found suitable for 3D in vitro differentiation toward soft tissue.
C1 [Hruschka, Veronika; Slezak, Paul; Feichtinger, Georg Alexander; Redl, Heinz; Wolbank, Susanne] Austrian Cluster Tissue Regenerat, AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria.
   [Saeed, Aram] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England.
   [Al Ghanami, Racha Cheikh; Alexander, Cameron; Shakesheff, Kevin] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England.
RP Hruschka, V (reprint author), Austrian Cluster Tissue Regenerat, AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria.
EM veronika.hruschka@trauma.lbg.ac.at
RI Alexander, Cameron/N-7729-2014; Shakesheff, Kevin/O-6371-2018; Saeed,
   Aram/N-2639-2015
OI Alexander, Cameron/0000-0001-8337-1875; Shakesheff,
   Kevin/0000-0003-3236-2439; Saeed, Aram/0000-0003-2903-5875
FU European Research Council under the European Community [FP7-2007-227845,
   NMP-LA-2008-214402]; EPSRC Center for Innovative Manufacturing in
   Regenerative Medicine; Engineering and Physical Sciences Research
   Council [EP/E021042/1]
FX The authors would like to thank Johannes Zipperle for the graphic design
   and Johanna Gaul as well as Renata Gizella Szoeloesi for technical
   assistance and for helpful discussion. The research leading to these
   results has received funding from the European Research Council under
   the European Community's Seventh Framework Programs (FP7-2007-227845)
   and Angioscaff (NMP-LA-2008-214402). The Nottingham authors acknowledge
   the support of the EPSRC Center for Innovative Manufacturing in
   Regenerative Medicine.
CR Al Ghanami RC, 2010, SOFT MATTER, V6, P5037, DOI 10.1039/c0sm00059k
   Amini AA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024105
   Capkin M, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045013
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Dhanaraju MD, 2006, J BIOMED MATER RES A, V76A, P63, DOI 10.1002/jbm.a.30458
   Dosier CR, 2012, J MECH BEHAV BIOMED, V11, P112, DOI 10.1016/j.jmbbm.2011.08.014
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Ferreira MSV, 2012, BIOMATERIALS, V33, P6987, DOI 10.1016/j.biomaterials.2012.06.029
   Fu SZ, 2012, BIOMATERIALS, V33, P4801, DOI 10.1016/j.biomaterials.2012.03.040
   Howard D, 2008, J ANAT, V213, P66, DOI 10.1111/j.1469-7580.2008.00878.x
   Hruschka V, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/041001
   Huang X, 2007, TISSUE ENG, V13, P2645, DOI 10.1089/ten.2007.0084
   Im GI, 2012, CELL TRANSPLANT, V21, P2397, DOI 10.3727/096368912X638865
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Kaur Gurvinder, 2012, Spermatogenesis, V2, P1
   Kim MH, 2010, BIOMATERIALS, V31, P1213, DOI 10.1016/j.biomaterials.2009.10.057
   Kim MS, 2006, J POLYM SCI POL CHEM, V44, P5413, DOI 10.1002/pola.21659
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   La Gatta A, 2005, MACROMOL BIOSCI, V5, P1108, DOI 10.1002/mabi.200500114
   Larsson S, 2011, INJURY, V42, pS30, DOI 10.1016/j.injury.2011.06.013
   Lee TJ, 2013, ANN PLAS SURG, V70, P98, DOI 10.1097/SAP.0b013e31822f9a81
   Lei N, 2012, NANOSCALE, V4, P5686, DOI [10.1039/c2nr30731f, 10.1039/c2nr30731]
   Leong David Tai, 2008, Curr Drug Discov Technol, V5, P319, DOI 10.2174/157016308786733537
   Liu RX, 2010, J COLLOID INTERF SCI, V349, P527, DOI 10.1016/j.jcis.2010.05.080
   Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417
   Marino G, 2012, J BIOMED MATER RES A, V100A, P543, DOI 10.1002/jbm.a.33296
   Moon HJ, 2012, CHEM SOC REV, V41, P4860, DOI 10.1039/c2cs35078e
   Moutos FT, 2010, MACROMOL BIOSCI, V10, P1355, DOI 10.1002/mabi.201000124
   Nii M, 2013, ACTA BIOMATER, V9, P5475, DOI 10.1016/j.actbio.2012.11.002
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Peterbauer-Scherb A, 2012, J TISSUE ENG REGEN M, V6, P434, DOI 10.1002/term.446
   Reid AJ, 2011, NEUROSCIENCE, V199, P515, DOI 10.1016/j.neuroscience.2011.09.064
   Rnjak-Kovacina J, 2011, TISSUE ENG PART B-RE, V17, P365, DOI 10.1089/ten.teb.2011.0235
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Seo HW, 2013, BIOMATERIALS, V34, P2748, DOI 10.1016/j.biomaterials.2013.01.006
   Shahidan NN, 2013, J COLLOID INTERF SCI, V396, P187, DOI 10.1016/j.jcis.2013.01.025
   Shim JH, 2013, J MATER SCI-MATER M, V24, P1053, DOI 10.1007/s10856-013-4867-8
   Stoddart M J, 2012, Eur Cell Mater, V24, pi
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Tian L, 2011, J CARDIOVASC TRANSL, V4, P685, DOI 10.1007/s12265-011-9301-3
   Tse KH, 2010, J BIOMED MATER RES A, V95A, P701, DOI 10.1002/jbm.a.32889
   Wiggenhauser P. S., 2011, CELL TISSUE RES, V347, P747
   Wolbank S, 2009, TISSUE ENG PT A, V15, P1843, DOI 10.1089/ten.tea.2008.0205
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Wu DQ, 2009, ACS APPL MATER INTER, V1, P319, DOI 10.1021/am8000456
   Xia K, 2006, PLOS COMPUT BIOL, V2, P1482, DOI 10.1371/journal.pcbi.0020145
   Yang B, 2012, INT J NANOMED, V7, P547, DOI 10.2147/IJN.S26141
   Yang J, 2003, POLYM INT, V52, P1892, DOI 10.1002/pi.1272
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 51
TC 7
Z9 7
U1 3
U2 20
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN 1
PY 2015
VL 21
IS 1-2
BP 310
EP 319
DI 10.1089/ten.tea.2013.0710
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CA1YQ
UT WOS:000348706100012
PM 25167885
DA 2018-10-20
ER

PT J
AU Sankaran, KK
   Subramanian, A
   Krishnan, UM
   Sethuraman, S
AF Sankaran, Krishna Kumar
   Subramanian, Anuradha
   Krishnan, Uma Maheswari
   Sethuraman, Swaminathan
TI Nanoarchitecture of scaffolds and endothelial cells in engineering small
   diameter vascular grafts
SO BIOTECHNOLOGY JOURNAL
LA English
DT Review
DE Endothelial cells; Extracellular matrix; Gene expression; Nanofibers;
   Vascular graft
ID CAPILLARY-LIKE STRUCTURES; FLUID SHEAR-STRESS; EXTRACELLULAR-MATRIX;
   IN-VITRO; BASEMENT-MEMBRANE; BLOOD-VESSELS; REGENERATIVE MEDICINE;
   NANOFIBROUS SCAFFOLDS; GENE-EXPRESSION; FOCAL ADHESION
AB Regeneration of functional small diameter blood vessels still remains a challenge, as the synthetic vascular grafts fail to mimic the complex structural architecture and dynamic functions of blood vessels and also lack with the lack of non-thrombogenicity. Although, the existence of nanofibrous extracellular matrix components in the native tissue promotes many physical and molecular signals to the endothelial cells for the regulation of morphogenesis, homeostasis, and cellular functions in vascular tissue, poor understanding of the structural architecture on the functional activation of appropriate genes limits the development of successful vascular graft design. Hence, the present review outlines the functional contributions of various nanofibrous extracellular matrix components in native blood vessels. Further, the review focuses on the role of nanofiber topography of biomaterial scaffolds in endothelial cell fate processes such as adhesion, proliferation, migration, and infiltration with the expression of vasculature specific genes; thereby allowing the reader to envisage the communication between the nano-architecture of scaffolds and endothelial cells in engineering small diameter vascular grafts.
C1 [Sankaran, Krishna Kumar; Subramanian, Anuradha; Krishnan, Uma Maheswari; Sethuraman, Swaminathan] SASTRA Univ, Ctr Nanotechnol & Adv Biomat, Sch Chem & Biotechnol, Thanjavur 613401, Tamil Nadu, India.
RP Sethuraman, S (reprint author), SASTRA Univ, Ctr Nanotechnol & Adv Biomat, Sch Chem & Biotechnol, Thanjavur 613401, Tamil Nadu, India.
EM swami@sastra.edu
FU FIST [SR/FST/LSI-327/2007]; SASTRA
FX Authors were hereby expressing their gratitude for the generous funding
   from FIST (SR/FST/LSI-327/2007) and SASTRA for the infrastructure
   facilities.
CR Abrahamson DR, 2007, J AM SOC NEPHROL, V18, P2465, DOI 10.1681/ASN.2007030328
   Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a
   Albig AR, 2008, MICROVASC RES, V76, P7, DOI 10.1016/j.mvr.2008.01.001
   Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583
   Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033
   Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7
   Berillis P., 2013, TOCV J, V6, P1
   Berthiaume F, 1996, FASEB J, V10, P1471
   Bluyssen HAR, 2004, FEBS LETT, V556, P137, DOI 10.1016/S0014-5793(03)01392-9
   Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002
   Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749
   Carlier A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002724
   Chlupac J, 2009, PHYSIOL RES, V58, pS119
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P269, DOI 10.1111/1523-1747.ep12500076
   Cleary MA, 2012, TRENDS MOL MED, V18, P394, DOI 10.1016/j.molmed.2012.04.013
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   DeHahn KC, 2004, EXP CELL RES, V294, P281, DOI 10.1016/j.yexcr.2003.11.006
   Du FY, 2012, BIOMATERIALS, V33, P762, DOI 10.1016/j.biomaterials.2011.10.037
   Ekaputra AK, 2011, BIOMATERIALS, V32, P8108, DOI 10.1016/j.biomaterials.2011.07.022
   Estrach S, 2011, CIRC RES, V109, P172, DOI 10.1161/CIRCRESAHA.111.240622
   Fisher MB, 2013, TISSUE ENG PART B-RE, V19, P1, DOI [10.1089/ten.teb.2012.0723, 10.1089/ten.TEB.2012.0723]
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Galley HF, 2004, BRIT J ANAESTH, V93, P105, DOI 10.1093/bja/aeh163
   Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064
   Goonoo N, 2014, RSC ADV, V4, P31618, DOI 10.1039/c4ra05218h
   GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8
   Grasl C, 2010, J BIOMED MATER RES A, V93A, P716, DOI 10.1002/jbm.a.32584
   Gu JW, 2002, MAT SCI ENG C-BIO S, V20, P199, DOI 10.1016/S0928-4931(02)00033-4
   Han FX, 2013, BIOMATERIALS, V34, P7302, DOI 10.1016/j.biomaterials.2013.06.006
   He SH, 2012, ACTA BIOMATER, V8, P2659, DOI 10.1016/j.actbio.2012.03.044
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Hoshi RA, 2013, BIOMATERIALS, V34, P30, DOI 10.1016/j.biomaterials.2012.09.046
   Hung HS, 2009, BIOMATERIALS, V30, P1502, DOI 10.1016/j.biomaterials.2008.12.003
   INGBER DE, 1990, J CELL BIOL, V110, P1803, DOI 10.1083/jcb.110.5.1803
   Jakobsson L, 2008, FASEB J, V22, P1530, DOI 10.1096/fj.07-9617com
   Jensen SA, 2012, STRUCTURE, V20, P215, DOI 10.1016/j.str.2011.12.008
   Jeong SI, 2007, BIOMATERIALS, V28, P1115, DOI 10.1016/j.biomaterials.2006.10.025
   Jia XL, 2011, J BIOMAT SCI-POLYM E, V22, P1811, DOI 10.1163/092050610X528534
   Kikkawa Y., IN VITRO CELL DEV BI, V119, P46
   Kim HW, 2008, J BIOMED MATER RES A, V87A, P25, DOI 10.1002/jbm.a.31677
   Klein S, 2002, MOL CELL BIOL, V22, P5912, DOI 10.1128/MCB.22.16.5912-5922.2002
   Kovala T, 2012, FASEB J, V26
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Kumbar Sangamesh Q., 2008, Recent Patents on Biomedical Engineering, V1, P68
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e
   Lee J, 2012, BIOMATERIALS, V33, P6709, DOI 10.1016/j.biomaterials.2012.06.017
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Li S., 2013, SYS BIOMED, V6, P61
   Limaye V., 2007, TXB VASCULAR SURG, P1
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Malinda KM, 1999, FASEB J, V13, P53
   Mammadov R, 2012, BIOMACROMOLECULES, V13, P3311, DOI 10.1021/bm3010897
   Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   McLean AE, 2005, ADV DEV BIOL, V15, P81, DOI DOI 10.1016/S1574-3349(05)15003-0
   Mokkapati S, 2011, J BIOL CHEM, V286, P1911, DOI 10.1074/jbc.M110.149864
   Montero RB, 2012, ACTA BIOMATER, V8, P1778, DOI 10.1016/j.actbio.2011.12.008
   Nayak R, 2012, TEXT RES J, V82, P129, DOI 10.1177/0040517511424524
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Nugent HM, 2003, CIRC RES, V92, P1068, DOI 10.1161/01.RES.0000073844.41372.38
   Owatverot TB, 2005, J BIOMECH ENG-T ASME, V127, P374, DOI 10.1115/1.1894180
   Paik JY, 2009, J NUCL MED, V50, P618, DOI 10.2967/jnumed.108.059386
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   PAULSSON M, 1992, CYTOTECHNOLOGY, V9, P99, DOI 10.1007/BF02521736
   Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001
   Peran M, 2012, INT J MOL SCI, V13, P3847, DOI 10.3390/ijms13033847
   Preis M, 2006, BIOCHEM BIOPH RES CO, V348, P1024, DOI 10.1016/j.bbrc.2006.07.156
   Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307
   Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009
   Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77
   Rayan GM, 2000, J HAND SURG-AM, V25A, P150
   Rodriguez C, 2002, ARTERIOSCL THROM VAS, V22, P1409, DOI 10.1161/01.ATV.0000033818.21748.99
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Sankaran KK, 2014, J BIOMAT SCI-POLYM E, V25, P1791, DOI 10.1080/09205063.2014.950505
   Sankaran KK, 2014, J TISSUE ENG REGEN M, V8, P640, DOI 10.1002/term.1566
   Sarkar S, 2007, MED BIOL ENG COMPUT, V45, P327, DOI 10.1007/s11517-007-0176-z
   SCHNAPER HW, 1993, KIDNEY INT, V43, P20, DOI 10.1038/ki.1993.5
   Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x
   Sell S, 2007, POLYM INT, V56, P1349, DOI 10.1002/pi.2344
   Shen ZY, 1996, J HEART LUNG TRANSPL, V15, P1034
   Shoajei S, 2014, CELL BIOL INT, V38, P577, DOI 10.1002/cbin.10237
   Singha K., 2012, INT J BIOL ENG, V2, P1
   Theisen C, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-9
   Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002
   Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Verstraete M, 1990, Recenti Prog Med, V81, P221
   Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008
   Wang P, 2013, J NANOMATER, DOI 10.1155/2013/452854
   Wang ZX, 2013, J BIOACT COMPAT POL, V28, P154, DOI 10.1177/0883911512469707
   Wang ZH, 2011, CHEM COMMUN, V47, P8901, DOI 10.1039/c1cc11564b
   Wilgus T. A., 2012, ADV WOUND CARE, V1, P249
   Williamson MR, 2006, BIOMATERIALS, V27, P3608, DOI 10.1016/j.biomaterials.2006.02.025
   Wu HJ, 2010, J MATER SCI-MATER M, V21, P3207, DOI 10.1007/s10856-010-4164-8
   Yang C, 2006, ANN THORAC SURG, V81, P57, DOI 10.1016/j.athoracsur.2005.07.013
   Yao Y, 2014, ACTA BIOMATER, V10, P2739, DOI 10.1016/j.actbio.2014.02.042
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649
   Zhang YZ, 2007, INT J NANOMED, V2, P623
NR 107
TC 13
Z9 15
U1 3
U2 57
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1860-6768
EI 1860-7314
J9 BIOTECHNOL J
JI Biotechnol. J.
PD JAN
PY 2015
VL 10
IS 1
SI SI
BP 96
EP 108
DI 10.1002/biot.201400415
PG 13
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA AZ2IT
UT WOS:000348058200012
PM 25641941
DA 2018-10-20
ER

PT J
AU Moreira, JMR
   Simes, M
   Melo, LF
   Mergulhao, FJ
AF Moreira, Joana M. R.
   Simes, Manuel
   Melo, Luis F.
   Mergulhao, Filipe J.
TI Escherichia coli adhesion to surfaces-a thermodynamic assessment
SO COLLOID AND POLYMER SCIENCE
LA English
DT Article
DE Adhesion; Escherichia coli; Surface properties; Thermodynamics; Contact
   angle
ID INFECTION-RESISTANT SURFACES; BACTERIAL ADHESION; BIOFILM FORMATION;
   ENERGY COMPONENTS; STAPHYLOCOCCUS-EPIDERMIDIS; BIOMATERIAL SURFACES;
   CONTACT ANGLES; GIBBS ENERGY; ATTACHMENT; GLASS
AB Several studies have tried to correlate bacterial adhesion with the physicochemical properties of the surface with limited success. Most often, the obtained correlations seem to be only applicable to a particular set of experimental conditions making it difficult to obtain guidelines for the design of antibiofouling surfaces. The ratio between Lifshitz van der Waals apolar component and the electron donor component (gamma(LW)/gamma(-)) was recently shown to correlate with bacterial adhesion to the surfaces of ship hulls and heat exchangers. In this work, four materials with biomedical application (polystyrene, poly-l-lactide, cellulose acetate, and polydimethylsiloxane) and glass were characterized and Escherichia coli adhesion to those materials was assayed with a parallel-plate flow chamber operating in physiological shear stress conditions. Adhesion was correlated with the gamma(LW)/gamma(-) ratio, further extending the application range tested on the original study. Additionally, results from other studies were also evaluated to confirm the applicability of this correlation to other surfaces, microorganisms, and experimental conditions. Results show that bacterial adhesion is reduced in surfaces with lower gamma(LW)/gamma(-)and enhanced otherwise. This finding may be helpful in the design of new coatings by controlling gamma(LW)/gamma(-) or in the selection of existing materials according to the desired application.
C1 [Moreira, Joana M. R.; Simes, Manuel; Melo, Luis F.; Mergulhao, Filipe J.] Univ Porto, LEPABE Dept Chem Engn, Fac Engn, P-4200465 Oporto, Portugal.
RP Mergulhao, FJ (reprint author), Univ Porto, LEPABE Dept Chem Engn, Fac Engn, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.
EM filipem@fe.up.pt
OI Mergulhao, Filipe/0000-0001-5233-1037; Melo, Luis/0000-0002-8469-4462;
   Simoes, Manuel/0000-0002-3355-4398
FU Operational Programme for Competitiveness Factors-COMPETE; European Fund
   for Regional Development-FEDER; Portuguese Foundation for Science and
   Technology-FCT [PTDC/EBB-BIO/104940/2008, PTDC/EQU-FTT/105535/2008]
FX The authors acknowledge the financial support provided by the
   Operational Programme for Competitiveness Factors-COMPETE, European Fund
   for Regional Development-FEDER and by the Portuguese Foundation for
   Science and Technology-FCT through Projects PTDC/EBB-BIO/104940/2008 and
   PTDC/EQU-FTT/105535/2008. J. Ponmozhi (CEFT, Faculty of Engineering,
   University of Porto) is acknowledged for the preparation of the polymer
   surfaces.
CR Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Aubert D, 2010, PROG UROL, V20, P251, DOI 10.1016/j.purol.2009.10.017
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Buergers R, 2007, J PROSTHET DENT, V98, P461, DOI 10.1016/S0022-3913(07)60146-2
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   Chen G, 2005, COLLOID SURFACE B, V44, P41, DOI 10.1016/j.colsurfb.2005.05.012
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   Desrousseaux C, 2013, J HOSP INFECT, V85, P87, DOI 10.1016/j.jhin.2013.06.015
   Gallardo-Moreno AM, 2011, COLLOID SURFACE B, V88, P373, DOI 10.1016/j.colsurfb.2011.07.016
   Georgiadis MC, 1998, COMPUT CHEM ENG, V22, pS331, DOI 10.1016/S0098-1354(98)00072-6
   Goulter RM, 2009, LETT APPL MICROBIOL, V49, P1, DOI 10.1111/j.1472-765X.2009.02591.x
   Grewe D., 2011, MANUFACTURING METHOD
   Hong Z, 2012, EUR J SOIL SCI, V63, P457, DOI 10.1111/j.1365-2389.2012.01460.x
   Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07
   JANCZUK B, 1993, J COLLOID INTERF SCI, V159, P421, DOI 10.1006/jcis.1993.1342
   Kaali P, 2011, BIOMEDICAL ENG TREND, P514
   Katsikogianni M, 2008, COLLOID SURFACE B, V65, P257, DOI 10.1016/j.colsurfb.2008.04.017
   Kochkodan V, 2008, DESALINATION, V220, P380, DOI 10.1016/j.desal.2007.01.042
   Koseoglu H, 2006, UROLOGY, V68, P942, DOI 10.1016/j.urology.2006.06.008
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Liu C, 2011, LANGMUIR, V27, P9512, DOI 10.1021/la200910f
   Liu C, 2011, BIOFOULING, V27, P275, DOI 10.1080/08927014.2011.563842
   McClaine JW, 2002, APPL ENVIRON MICROB, V68, P1280, DOI 10.1128/AEM.68.3.1280-1289.2002
   Missirlis YF, 2004, CELLS MAT, V8, P37
   Multanen M, 2000, BJU INT, V86, P966, DOI 10.1046/j.1464-410x.2000.00964.x
   Nauman EA, 2007, APPL ENVIRON MICROB, V73, P699, DOI 10.1128/AEM.02428-06
   Nikolaev YA, 2007, MICROBIOLOGY+, V76, P125, DOI 10.1134/S0026261707020014
   Oliveira K, 2006, J FOOD PROTECT, V69, P2352, DOI 10.4315/0362-028X-69.10.2352
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12
   Poortinga A. T., 2002, SURF SCI REP, P1, DOI [10.1016/S0167-5729(02)00032-8, DOI 10.1016/S0167-5729(02)00032-8]
   Qureshi N, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-24
   Ronald LS, 2011, ANAL PATHOADAPTIVE M
   Shi XM, 2009, TRENDS FOOD SCI TECH, V20, P407, DOI 10.1016/j.tifs.2009.01.054
   Shunmugaperumal T, 2010, BIOFILM ERADICTION P
   Simes M, 2008, INT J FOOD MICROBIOL, V121, P335, DOI 10.1016/j.ijfoodmicro.2007.11.041
   Simoes LC, 2010, ANTON LEEUW INT J G, V98, P317, DOI 10.1007/s10482-010-9444-2
   Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008
   Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001
   Soon CF, 2013, PROC TECH, V11, P487, DOI 10.1016/j.protcy.2013.12.219
   Stoodley P., 2013, BIOMATERIALS SCI INT, P565
   Teodosio JS, 2013, BIOFOULING, V29, P953, DOI 10.1080/08927014.2013.821467
   Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x
   Van Oss C. J., 1994, INTERFACIAL FORCES A
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
NR 52
TC 3
Z9 3
U1 0
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0303-402X
EI 1435-1536
J9 COLLOID POLYM SCI
JI Colloid Polym. Sci.
PD JAN
PY 2015
VL 293
IS 1
BP 177
EP 185
DI 10.1007/s00396-014-3390-x
PG 9
WC Chemistry, Physical; Polymer Science
SC Chemistry; Polymer Science
GA AY6SO
UT WOS:000347696100015
DA 2018-10-20
ER

PT J
AU Munarin, F
   Petrini, P
   Gentilini, R
   Pillai, RS
   Dire, S
   Tanzi, MC
   Sglavo, VM
AF Munarin, F.
   Petrini, P.
   Gentilini, R.
   Pillai, R. S.
   Dire, S.
   Tanzi, M. C.
   Sglavo, V. M.
TI Micro- and nano-hydroxyapatite as active reinforcement for soft
   biocomposites
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Biocomposites; Pectin; Hydroxyapatite; Hydrogels
ID BIOMEDICAL APPLICATIONS; COMPOSITE SCAFFOLDS; BONE REGENERATION;
   DEGRADATION; HYDROGEL; PECTIN; BIOMATERIAL; ALGINATE; DELIVERY; TENSION
AB Pectin-based biocomposite hydrogels were produced by internal gelation, using different hydroxyapatite (HA) powders from commercial source or synthesized by the wet chemical method. HA possesses the double functionality of cross-linking agent and inorganic reinforcement. The mineralogical composition, grain size, specific surface area and microstructure of the hydroxyapatite powders are shown to strongly influence the properties of the biocomposites. Specifically, the grain size and specific surface area of the HA powders are strictly correlated to the gelling time and rheological properties of the hydrogels at room temperature. Pectin pH is also significant for the formation of ionic cross-links and therefore for the hydrogels stability at higher temperatures.
   The obtained results point out that micrometric-size hydroxyapatite can be proposed for applications which require rapid gelling kinetics and improved mechanical properties; conversely the nanometric hydroxyapatite synthesized in the present work seems the best choice to obtain homogeneous hydrogels with more easily controlled gelling kinetics. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Munarin, F.; Petrini, P.; Gentilini, R.; Tanzi, M. C.] Politecn Milan, Lab Biomat, Dipartimento Chim Mat & Ingn Chim G Natta, I-20133 Milan, Italy.
   [Munarin, F.; Petrini, P.; Gentilini, R.; Tanzi, M. C.] Politecn Milan, Unita Ric Consorzio INSTM, I-20133 Milan, Italy.
   [Pillai, R. S.; Dire, S.; Sglavo, V. M.] Univ Trento, Dipartimento Ingn Ind, Unita Ric INSTM, I-38123 Trento, Italy.
RP Petrini, P (reprint author), Politecn Milan, Lab Biomat, Dipartimento Chim Mat & Ingn Chim G Natta, Piazza L da Vinci 32, I-20133 Milan, Italy.
EM paola.petrini@polimi.it
RI Tanzi, Maria Cristina/I-4620-2013; Dire', Sandra/G-2455-2016
OI Tanzi, Maria Cristina/0000-0002-4913-6633; Dire',
   Sandra/0000-0002-6000-6231; sglavo, vincenzo m./0000-0001-9133-7204;
   Petrini, Paola/0000-0002-5081-5254
FU Fondazione Cassa di Risparmio di Trento e Rovereto
   [SG2329/2011-2011/0206]; MIUR [prot. 2010FPTBSH 009]
FX This work was supported by grants from Fondazione Cassa di Risparmio di
   Trento e Rovereto, SG2329/2011-2011/0206 to M.C. Tanzi and from MIUR,
   PRIN 2010-11 project (prot. 2010FPTBSH 009) to P. Petrini. Dr. E.
   Callone ("Klaus Muller" NMR Laboratory, DII, University of Trento) is
   gratefully acknowledged for the NMR analyses.
CR Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   Averous L., 2010, MATER TODAY, V13, P57
   Barber FA, 2011, ARTHROSCOPY, V27, P637, DOI 10.1016/j.arthro.2010.11.056
   Bonfield W, 1988, Ann N Y Acad Sci, V523, P173, DOI 10.1111/j.1749-6632.1988.tb38510.x
   Borum-Nicholas L, 2003, BIOMATERIALS, V24, P3671, DOI 10.1016/S0142-9612(03)00239-4
   Brun F, 2011, J MATER SCI-MATER M, V22, P2617, DOI 10.1007/s10856-011-4447-8
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Chen JP, 2013, COLLOID SURFACE B, V110, P120, DOI 10.1016/j.colsurfb.2013.04.028
   Cheng ZH, 1998, LANGMUIR, V14, P6681, DOI 10.1021/la980339n
   Coradin T, 2003, APPL MICROBIOL BIOT, V61, P429, DOI 10.1007/s00253-003-1308-5
   De Paula F. L., 2009, Frontiers of Materials Science in China, V3, P145, DOI 10.1007/s11706-009-0029-9
   Gomes S, 2010, ACTA BIOMATER, V6, P3264, DOI 10.1016/j.actbio.2010.02.034
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Ignjatovic N, 2004, APPL SURF SCI, V238, P314, DOI 10.1016/j.apsusc.2004.05.227
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Jager C, 2006, MAGN RESON CHEM, V44, P573, DOI 10.1002/mrc.1774
   Khan F, 2013, MACROMOL BIOSCI, V13, P395, DOI 10.1002/mabi.201200409
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Korach C., 2011, CONF PROC SOC EXP ME, V2, P125
   Legrand AP, 2009, J BIOMED MATER RES B, V91B, P46, DOI 10.1002/jbm.b.31372
   Liang JZ, 2013, COMPOS PART B-ENG, V51, P224, DOI 10.1016/j.compositesb.2013.03.019
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   Lu L, 2008, IFMBE PROC, V19, P22, DOI 10.1007/978-3-540-79039-6_6
   MIQUEL JL, 1990, COLLOID SURFACE, V45, P427, DOI 10.1016/0166-6622(90)80041-2
   Moreira HR, 2014, CARBOHYD POLYM, V103, P339, DOI 10.1016/j.carbpol.2013.12.057
   Munarin F, 2012, INT J BIOL MACROMOL, V51, P681, DOI 10.1016/j.ijbiomac.2012.07.002
   Munarin F, 2011, BIOMACROMOLECULES, V12, P568, DOI 10.1021/bm101110x
   Munarin F, 2010, J MATER SCI-MATER M, V21, P365, DOI 10.1007/s10856-009-3860-8
   Munarin F, 2012, SOFT MATTER, V8, P4731, DOI 10.1039/c2sm07260b
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Pedley DG, 1980, BRIT POLYM J, V12, P99
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Petrini P., 2012, International patent, Patent No. [WO/2012/007917, 2012007917]
   Piccinini M, 2013, IMPLANT DENT, V22, P83, DOI 10.1097/ID.0b013e31827afc19
   Pielichowska K, 2010, ADV POLYM SCI, V232, P97, DOI 10.1007/12_2010_50
   Pourpoint F, 2007, APPL MAGN RESON, V32, P435, DOI 10.1007/s00723-007-0040-1
   Raucci MG, 2010, COMPOS SCI TECHNOL, V70, P1861, DOI 10.1016/j.compscitech.2010.05.030
   Renard CMGC, 1996, CARBOHYD RES, V286, P139, DOI 10.1016/0008-6215(96)00056-0
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Rouquerol F, 1999, ADSORPTION POWDERS P
   Scherrer P., 1918, NACHR GES WISS GOTT, V2, P98, DOI [DOI 10.1007/978-3-662-33915-2, 10.1007/978-3-662-33915-2_7]
   Slosarczyk A, 1997, CERAM INT, V23, P297, DOI 10.1016/S0272-8842(96)00016-8
   Sotome S, 2004, MAT SCI ENG C-BIO S, V24, P341, DOI 10.1016/j.msec.2003.12.003
   Struillou X, 2011, J MATER SCI-MATER M, V22, P1707, DOI 10.1007/s10856-011-4344-1
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Turco G, 2009, BIOMACROMOLECULES, V10, P1575, DOI 10.1021/bm900154b
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wang F, 2010, ACTA BIOMATER, V6, P1978, DOI 10.1016/j.actbio.2009.12.011
   Watanabe J, 2007, J BIOMED MATER RES A, V83A, P845, DOI 10.1002/jbm.a.31435
NR 49
TC 13
Z9 14
U1 2
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JAN
PY 2015
VL 72
BP 199
EP 209
DI 10.1016/j.ijbiomac.2014.07.050
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AY4XH
UT WOS:000347577900029
PM 25109458
DA 2018-10-20
ER

PT J
AU Raja, IS
   Fathima, NN
AF Raja, I. Selestin
   Fathima, Nishter Nishad
TI Thermoporometry and impedance analysis to study dynamics of water and
   polymer present in hydrogel
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Thermoporometry; Impedance analysis; Gelatin; Polyvinyl alcohol; Drug
   delivery
ID DRUG-DELIVERY; DIELECTRIC-SPECTROSCOPY; BIOMEDICAL APPLICATIONS;
   IN-VITRO; GELATIN; RELEASE; FILMS; SKIN; DERIVATIVES; HYDRATION
AB Though various conventional methods are available to explore hydrogels, they have drawbacks such as analysis in solid state and failure to give insights into individual components of hydrogel viz. water (dispersion medium) and hydrophilic polymers (dispersed phase). The combined study of porosity and dielectric nature of hydrogel succeeds, in this context, as it investigates both the components individually. In this study, we have taken well-known hydrogel system gelatin-polyvinyl alcohol (PVA) cross linked with genipin. Thermoporometry has been used to investigate the state of water and porosity whereas Alternative Current (AC) impedance analysis has been used to study about nature of polymers through dielectric properties in hydrogel. The influence of physic-chemical properties was examined with SEM and in vitro drug release using catechin. The study revealed that increasing concentration of PVA to gelatin has retained excessive bound water molecules exhibiting high polarity in each polymeric component. Further, it is shown that reduction in pore size and high reactivity with drug molecules have led to lower initial release and increase total amount of release. We conclude that non-conventional methods such as thermoporometry and AC impedance analysis yield more valuable information about hydrogel, which can aid in designing appropriate biomaterial for intended drug release. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Raja, I. Selestin; Fathima, Nishter Nishad] CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Fathima, NN (reprint author), CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
EM nishad.naveed@gmail.com
FU Department of Science and Technology (DST), Govt. of India Fast Track
   Project
FX The authors thank Department of Science and Technology (DST), Govt. of
   India Fast Track Project for the financial support.
CR Abd El-Kader FH, 1999, J APPL POLYM SCI, V72, P1395, DOI 10.1002/(SICI)1097-4628(19990613)72:11<1395::AID-APP3>3.0.CO;2-8
   Alexe-Ionescu AL, 2010, PHYSIOL MEAS, V31, pS169, DOI 10.1088/0967-3334/31/10/S02
   Ashley GW, 2013, P NATL ACAD SCI USA, V110, P2318, DOI 10.1073/pnas.1215498110
   Baba S, 2001, J NUTR, V131, P2885
   Chae E, 2013, RSC ADV, V3, P26328, DOI 10.1039/c3ra42897d
   Chaubaroux C, 2012, BIOMACROMOLECULES, V13, P2128, DOI 10.1021/bm300529a
   CRAIG DQM, 1994, J CONTROL RELEASE, V30, P213, DOI 10.1016/0168-3659(94)90027-2
   Dash S, 2010, ACTA POL PHARM, V67, P217
   Ding FY, 2013, J MATER CHEM B, V1, P1729, DOI 10.1039/c3tb00517h
   Fathima NN, 2010, THERMOCHIM ACTA, V501, P98, DOI 10.1016/j.tca.2010.01.016
   Fathima NN, 2002, BIOMACROMOLECULES, V3, P899, DOI 10.1021/bm025541q
   Fejerskov B., 2012, LANGMUIR, V29, P344
   HOUGHAM G, 1994, MACROMOLECULES, V27, P5964, DOI 10.1021/ma00099a006
   Ino JM, 2013, J BIOMED MATER RES B, V101, P1549, DOI 10.1002/jbm.b.32977
   Jaiswal M, 2013, J BIOMED NANOTECHNOL, V9, P1495, DOI 10.1166/jbn.2013.1643
   Kanungo I, 2013, MATER CHEM PHYS, V140, P357, DOI 10.1016/j.matchemphys.2013.03.049
   Kanungo I, 2013, MAT SCI ENG C-MATER, V33, P2455, DOI 10.1016/j.msec.2013.01.057
   Kanungo I, 2011, INT J BIOL MACROMOL, V49, P289, DOI 10.1016/j.ijbiomac.2011.05.003
   Karadag E, 2013, ADV POLYM TECH, V32, pE531, DOI 10.1002/adv.21299
   Khodaverdi E, 2012, AAPS PHARMSCITECH, V13, P460, DOI 10.1208/s12249-012-9764-9
   Kucerik J, 2011, THERMOCHIM ACTA, V523, P245, DOI 10.1016/j.tca.2011.04.034
   KYRITSIS A, 1995, J POLYM SCI POL PHYS, V33, P1737, DOI 10.1002/polb.1995.090331205
   Li WB, 2005, POLYMER, V46, P12026, DOI 10.1016/j.polymer.2005.09.016
   Lowman A., 2000, INT J CHEM ENG APPL, V88, P933
   Merkle VM, 2014, BIOPOLYMERS, V101, P336, DOI 10.1002/bip.22367
   MIYAHARA T, 1978, J GERONTOL, V33, P498, DOI 10.1093/geronj/33.4.498
   Passauer L, 2012, ACS APPL MATER INTER, V4, P5852, DOI 10.1021/am3015179
   Peng C., 2011, LANGMUIR, V28, P1478
   Pulieri E, 2008, J BIOMED MATER RES A, V86A, P311, DOI 10.1002/jbm.a.31492
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Tae G, 2005, BIOMATERIALS, V26, P5259, DOI 10.1016/j.biomaterials.2005.01.042
   Thankam FG, 2013, RSC ADV, V3, P24509, DOI 10.1039/c3ra43710h
   Veluri R, 2004, J AGR FOOD CHEM, V52, P1077, DOI 10.1021/jf040453d
   Wang QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034122
   WHALLEY WR, 1992, J AGR ENG RES, V52, P147, DOI 10.1016/0021-8634(92)80056-X
   Wolf M, 2011, BBA-GEN SUBJECTS, V1810, P727, DOI 10.1016/j.bbagen.2011.05.012
   Wolfe J, 2002, CRYOLETTERS, V23, P157
   Wu TY, 2013, J MATER CHEM B, V1, P3304, DOI [10.1039/C3TB20261E, 10.1039/c3tb20261e]
   Zeugolis DI, 2010, POLYM INT, V59, P1403, DOI 10.1002/pi.2882
   Zhang Z, 2013, ACS APPL MATER INTER, V5, P10760, DOI 10.1021/am402840f
   Zhou SZ, 2013, J MATER CHEM B, V1, P4736, DOI 10.1039/c3tb20888e
   Zhou Y, 2011, SOFT MATER, V9, P393, DOI 10.1080/1539445X.2010.525446
NR 42
TC 3
Z9 3
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JAN
PY 2015
VL 72
BP 437
EP 444
DI 10.1016/j.ijbiomac.2014.08.049
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AY4XH
UT WOS:000347577900057
PM 25199869
DA 2018-10-20
ER

PT J
AU Martins, AF
   Facchi, SP
   Monteiro, JP
   Nocchi, SR
   Silva, CTP
   Nakamura, CV
   Girotto, EM
   Rubira, AF
   Muniz, EC
AF Martins, Alessandro F.
   Facchi, Suelen P.
   Monteiro, Johny P.
   Nocchi, Samara R.
   Silva, Cleiser T. P.
   Nakamura, Celso V.
   Girotto, Emerson M.
   Rubira, Adley F.
   Muniz, Edvani C.
TI Preparation and cytotoxicity of N,N,N-trimethyl chitosan/alginate beads
   containing gold nanoparticles
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE N,N,N-trimethyl chitosan; Alginate; Beads; Polyelectrolyte complex; Gold
   nanoparticles
ID TRIMETHYL CHITOSAN CHLORIDE; SILVER NANOPARTICLES; CONTROLLED-RELEASE;
   DRUG-DELIVERY; COMPLEXES; COPOLYMERS; CURCUMIN; THERAPY; HEPARIN
AB Polyelectrolyte complex beads based on N,N,N-trimethyl chitosan (TMC) and sodium alginate (ALG) were obtained. This biomaterial was characterised by FTIR, TGA/DTG, DSC and SEM analysis. The good properties of polyelectrolyte complex hydrogel beads were associated, for the first time, with gold nanoparticles (AuNPs). Through a straightforward methodology, AuNPs were encapsulated into the beads. The in vitro cytotoxicity assays on the Caco-2 colon cancer cells and healthy VERO cells showed that the beads presented good biocompatibility on both cell lines, whereas the beads loaded with gold nanoparticles (beads/AuNPs) was slightly cytotoxic on the Caco-2 and VERO cells. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Martins, Alessandro F.; Monteiro, Johny P.; Silva, Cleiser T. P.; Girotto, Emerson M.; Rubira, Adley F.; Muniz, Edvani C.] Univ Estadual Maringa, Dept Quim, Grp Mat Polimer & Compositos, BR-87020900 Maringa, Parana, Brazil.
   [Nocchi, Samara R.; Nakamura, Celso V.] Univ Estadual Maringa, Dept Ciencias Basicas Saude, Lab Inovacao Tecnol Desenvolvimento Farmacos & Co, BR-87020900 Maringa, Parana, Brazil.
   [Martins, Alessandro F.; Facchi, Suelen P.] Univ Tecnol Fed Parana UTFPR, BR-85660000 Dois Vizinhos, Parana, Brazil.
RP Martins, AF (reprint author), Univ Tecnol Fed Parana, Estr Boa Esperanca,Km 04, Dois Vizinhos, Brazil.
EM afmartins50@yahoo.com.br
RI Pereira da Silva, Cleiser Thiago/B-1087-2013; martins,
   alessandro/J-6143-2014
OI Pereira da Silva, Cleiser Thiago/0000-0003-4983-4703; martins,
   alessandro/0000-0003-1002-3436; Muniz, Edvani/0000-0001-6685-1519
FU CNPq/CAPES, Brazil [Proc. 481424/2010-5, Proc. 308337/2013-1]
FX The authors thank CNPq/CAPES, Brazil, for the doctorate fellowship (AFM)
   and for the financial support (Proc. 481424/2010-5 and Proc.
   308337/2013-1).
CR Boca SC, 2011, CANCER LETT, V311, P131, DOI 10.1016/j.canlet.2011.06.022
   Rodriguez-Arguelles MC, 2011, J COLLOID INTERF SCI, V364, P80, DOI 10.1016/j.jcis.2011.08.006
   Chen HL, 2012, J LIPOSOME RES, V22, P100, DOI 10.3109/08982104.2011.621127
   de Britto D, 2012, FOOD HYDROCOLLOID, V27, P487, DOI 10.1016/j.foodhyd.2011.09.002
   Ding Y, 2006, NANOTECHNOLOGY, V17, P4156, DOI 10.1088/0957-4484/17/16/027
   Guan M, 2012, NANOMED-NANOTECHNOL, V8, P1172, DOI 10.1016/j.nano.2012.01.009
   Guo CX, 2011, MICROCHIM ACTA, V173, P375, DOI 10.1007/s00604-011-0570-y
   Ho YC, 2009, INT J PHARMACEUT, V376, P69, DOI 10.1016/j.ijpharm.2009.04.048
   Huang HZ, 2004, BIOMACROMOLECULES, V5, P2340, DOI 10.1021/bm0497116
   Jena P, 2012, INT J NANOMED, V7, P1805, DOI 10.2147/IJN.S28077
   Laudenslager MJ, 2008, BIOMACROMOLECULES, V9, P2682, DOI 10.1021/bm800835e
   Mao SR, 2005, BIOMATERIALS, V26, P6343, DOI 10.1016/j.biomaterials.2005.03.036
   Martins AF, 2013, CARBOHYD RES, V381, P153, DOI 10.1016/j.carres.2012.11.014
   Martins AF, 2013, INT J BIOL MACROMOL, V57, P174, DOI 10.1016/j.ijbiomac.2013.03.029
   Martins AF, 2012, INT J BIOL MACROMOL, V51, P1127, DOI 10.1016/j.ijbiomac.2012.08.032
   Martins AF, 2011, CARBOHYD POLYM, V86, P1266, DOI 10.1016/j.carbpol.2011.06.024
   Martins AF, 2011, COLLOID POLYM SCI, V289, P1133, DOI 10.1007/s00396-011-2437-5
   Mourya VK, 2009, J MATER SCI-MATER M, V20, P1057, DOI 10.1007/s10856-008-3659-z
   Nazar H, 2011, EUR J PHARM BIOPHARM, V77, P225, DOI 10.1016/j.ejpb.2010.11.022
   Park HH, 2011, J NANOPART RES, V13, P2909, DOI 10.1007/s11051-010-0180-3
   SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107
   Thi B. Cham, 2010, COLLOID SURF A, V360, P32
   Tiwari AD, 2011, INT J BIOL MACROMOL, V48, P682, DOI 10.1016/j.ijbiomac.2011.02.008
   TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055
NR 24
TC 19
Z9 19
U1 4
U2 70
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JAN
PY 2015
VL 72
BP 466
EP 471
DI 10.1016/j.ijbiomac.2014.08.020
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AY4XH
UT WOS:000347577900060
PM 25159881
OA Bronze
DA 2018-10-20
ER

PT J
AU Yin, HY
   Lu, T
   Liu, L
   Lu, CH
AF Yin, Huayue
   Lu, Tao
   Liu, Li
   Lu, Chuanhua
TI Preparation, characterization and application of a novel biodegradable
   macromolecule: Carboxymethyl zein
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Carboxymethyl zein; 5-Fluorouracil; Biomaterial
ID SEQUENCE-ANALYSIS; ALPHA-ZEIN; MESSENGER-RNAS; MAIZE; GENES
AB Zein, a naturally biocompatible and biodegradable macromolecule, is widely used as plastic film material; however, the poor water solubility limits its other applications. In this study, we aimed to obtain carboxymethyl zein (CM-zein) by modifying it with sodium monochloroacetate in weakly basic environment. CM-zein showed a new FTIR peak of C-O-C bond at 1080 cm(-1), with a new signal region appearing at 4.0-4.05 ppm that assigned to the protons of the CH2 group from a carboxymethyl on H-1 NMR and a T-g of 168.0 degrees C by thermal analysis. Compared with the -123 mV of zeta potential of unmodified zein, CM-zein increased it significantly to -23.9 mV as a consequence of carboxymethylation. 5-Fluorouracil (5-FU), a model drug used in CM-zein-based tablet, was rarely detected in 0.1 mol/L HCl (pH 1.0) but it was released massively and quickly in phosphates buffer (pH 6.8) in vitro assays. The unmodified zein-based tablet illustrated much lower release level in these two fluids. Furthermore, the pharmacokinetic study of rats showed that CM-zein released 5-FU in intestine but not in stomach after dissolving. These findings indicated that CM-zein has the potential to be used for enteric preparation as a novel pH-selective biomaterial. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Yin, Huayue; Liu, Li; Lu, Chuanhua] Anhui Univ Chinese Med, Dept Pharmaceut, Hefei 230038, Anhui, Peoples R China.
   [Lu, Tao] Anhui Univ Chinese Med, Minist Educ, Key Lab Xinan Med, Hefei 230038, Anhui, Peoples R China.
RP Lu, CH (reprint author), Anhui Univ Chinese Med, Dept Pharmaceut, Hefei 230038, Anhui, Peoples R China.
EM lchchem@126.com
CR [Anonymous], 2010, CHIN PHARM, VII
   Bugs MR, 2004, EUR BIOPHYS J BIOPHY, V33, P335, DOI 10.1007/s00249-003-0354-3
   [蔡乐 CAI Le], 2007, [中国药学杂志, Chinese Pharmaceutical Journal], V42, P1441
   Chen XG, 2003, CARBOHYD POLYM, V53, P355, DOI 10.1016/S0144-8617(03)00051-1
   Li Y., 2009, CHIN CANC PREV TREAT, V16, P1192
   Lin T, 2011, AAPS PHARMSCITECH, V12, P172, DOI 10.1208/s12249-010-9565-y
   MARKS MD, 1985, J BIOL CHEM, V260, P6451
   MARKS MD, 1982, J BIOL CHEM, V257, P9976
   Matsushima N, 1997, BBA-PROTEIN STRUCT M, V1339, P14, DOI 10.1016/S0167-4838(96)00212-9
   Momany FA, 2006, J AGR FOOD CHEM, V54, P543, DOI 10.1021/jf058135h
   Panchapakesan C, 2012, J CEREAL SCI, V55, P174, DOI 10.1016/j.jcs.2011.11.004
   PEDERSEN K, 1982, CELL, V29, P1015, DOI 10.1016/0092-8674(82)90465-2
   Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252
   Sessa DJ, 2013, IND CROP PROD, V43, P106, DOI 10.1016/j.indcrop.2012.06.034
   Shozo M., 1979, PHARMACOBIODYNAMICS, V2, P286
   SMITH P, 1988, PHARMACEUT RES, V5, P598, DOI 10.1023/A:1015950215230
   Sousa FFO, 2012, INT J PHARMACEUT, V439, P41, DOI 10.1016/j.ijpharm.2012.09.046
   THOMPSON GA, 1992, PLANT MOL BIOL, V18, P827, DOI 10.1007/BF00020030
   Wang Y, 2012, LANGMUIR, V28, P2429, DOI 10.1021/la204204j
   Wheelwright W. V. K., 2012, APPL POLYM SCI, V127, P1
   Wu QX, 2003, POLYMER, V44, P3909, DOI 10.1016/S0032-3861(03)00314-8
   Yin H. Y., 2013, CHEM MATER, V41, P178
   Zhang H., 2004, SE U, V23, P68
NR 23
TC 13
Z9 13
U1 1
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JAN
PY 2015
VL 72
BP 480
EP 486
DI 10.1016/j.ijbiomac.2014.08.025
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AY4XH
UT WOS:000347577900062
PM 25173708
DA 2018-10-20
ER

PT J
AU Ahamed, MIN
   Sankar, S
   Kashif, PM
   Basha, SKH
   Sastry, TP
AF Ahamed, M. I. Niyas
   Sankar, S.
   Kashif, P. Mohammed
   Basha, S. K. Hayath
   Sastry, T. P.
TI Evaluation of biomaterial containing regenerated cellulose and chitosan
   incorporated with silver nanoparticles
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Regenerated cellulose; Chitosan; Silver nanoparticles
ID SKIN SUBSTITUTES; ACID; GELATIN; COMPOSITES; DRESSINGS; HYDROGELS;
   EFFICACY; WOUNDS; CHITIN; TISSUE
AB Biomaterials are used in regenerative medicine, implantable materials, controlled release carriers or scaffolds for tissue engineering. In the present study, the composites containing regenerated cellulose (RC) and chitosan (Ch) impregnated with silver nanoparticles (AgNP) with and without antibiotic gentamicin (G) were prepared. The composites prepared were characterized for their physico-chemical and mechanical properties and the results have shown the composite nature. RC-Ch-Ag and RC-Ch-Ag-G composites were used as wound dressing materials in experimental wounds of rats. The healing pattern of the wounds was evaluated by planimetric studies, macroscopic observations, biochemical studies and mechanical properties. The results have shown faster healing pattern in the wounds treated with RC-Ch-Ag and RC-Ch-Ag-G composites compared to untreated control. This study revealed that RC-Ch-Ag composite might be a potential, economical wound dressing material and may be tried on the clinical wounds of animals before being applied on humans. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Ahamed, M. I. Niyas; Sankar, S.; Sastry, T. P.] Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
   [Kashif, P. Mohammed; Basha, S. K. Hayath] Islamiah Coll Autonomous, Dept Biochem, Vaniyambadi 635751, India.
RP Ahamed, MIN (reprint author), Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
EM iniyasahamed@gmail.com
CR Ahmed R., 2004, J BIOMED MATER RES B, V69 B, P241
   Bernabei R, 1999, LANCET, V354, P307, DOI 10.1016/S0140-6736(99)02784-1
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071
   Cohen I.K., 1995, WOUND HEALING SKIN P, P27
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Daniela E., 2008, CHEM ENG COMMUN, V195, P1269
   Deng CM, 2007, CARBOHYD POLYM, V69, P583, DOI 10.1016/j.carbpol.2007.01.014
   DUNPHY JE, 1956, ANN SURG, V144, P304, DOI 10.1097/00000658-195609000-00002
   Eldin MSM, 2008, TRENDS BIOMATER ARTI, V22, P154
   Elson LA, 1933, BIOCHEM J, V27, P1824, DOI 10.1042/bj0271824
   Emir B.D., 2006, J BIOACT COMPAT POLY, V21, P351
   Enoch S., 2005, SURGERY OXFORD, V26, P31
   Horch RE, 2005, J CELL MOL MED, V9, P592, DOI 10.1111/j.1582-4934.2005.tb00491.x
   In-Yong K, 2008, BIOTECHNOLOGY ADV, V26, P1
   Ivan S, 2004, J COLLOID INTERF SCI, V275, P177
   Kamal SSK, 2010, ACTA CHIM SLOV, V57, P808
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8
   Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030
   Kumar MS, 2008, J SURG RES, V144, P94, DOI 10.1016/j.jss.2007.02.049
   Lin SY, 2001, BIOMATERIALS, V22, P2999, DOI 10.1016/S0142-9612(01)00046-1
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MORGAN PW, 1994, VET SURG, V23, P494, DOI 10.1111/j.1532-950X.1994.tb00511.x
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   Niyas Ahamed M., 2011, INT J RES AYURVEDA P, V2, P1203
   Noorjahan SE, 2004, J BIOMED MATER RES B, V71B, P305, DOI 10.1002/jbm.b.30094
   Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014
   Pilcher B.K., 1998, ARCH DERMATOL RES, V290, P37
   Ruan D, 2008, POLYMER, V49, P1027, DOI 10.1016/j.polymer.2007.12.044
   Saraswathy G, 2001, B MATER SCI, V24, P415, DOI 10.1007/BF02708641
   SCHILLER S, 1961, J BIOL CHEM, V236, P983
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Shelma R., 2008, TRENDS BIOMATER ARTI, V22, P107
   Su CH, 1997, BIOMATERIALS, V18, P1169, DOI 10.1016/S0142-9612(97)00048-3
   Sumitra M, 2005, INT J BIOCHEM CELL B, V37, P566, DOI 10.1016/j.biocel.2004.08.003
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   VARSHNEY AC, 1988, INDIAN VET J, V65, P436
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Wright JB, 1999, AM J INFECT CONTROL, V27, P344, DOI 10.1016/S0196-6553(99)70055-6
   Wu J, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035005
   Wu J, 2014, CARBOHYD POLYM, V102, P762, DOI 10.1016/j.carbpol.2013.10.093
NR 43
TC 29
Z9 30
U1 2
U2 61
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JAN
PY 2015
VL 72
BP 680
EP 686
DI 10.1016/j.ijbiomac.2014.08.055
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AY4XH
UT WOS:000347577900088
PM 25224288
DA 2018-10-20
ER

PT J
AU Chen, XH
   Zhao, YB
   Geng, SN
   Miron, RJ
   Zhang, Q
   Wu, CT
   Zhang, YF
AF Chen, Xiaohui
   Zhao, Yanbing
   Geng, Shinan
   Miron, Richard J.
   Zhang, Qiao
   Wu, Chengtie
   Zhang, Yufeng
TI In vivo experimental study on bone regeneration in critical bone defects
   using PIB nanogels/boron-containing mesoporous bioactive glass composite
   scaffold
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE bone graft; boron; osteoporosis; osteoporotic defect; mesoporous
   bioactive graft; tissue engineering
ID MESENCHYMAL STEM-CELLS; METHYLACRYLATE) NANOGEL; MORPHOGENIC PROTEIN-2;
   TISSUE REGENERATION; OSTEOPOROSIS; HYDROXYAPATITE; HYDROGEL; REPAIR;
   DIFFERENTIATION; MINERALIZATION
AB Purpose: In the present study, the fabrication of novel p(N-isopropylacrylamide-co-butyl methylacrylate) (PIB) nanogels was combined with boron-containing mesoporous bioactive glass (B-MBG) scaffolds in order to improve the mechanical properties of PIB nanogels alone. Scaffolds were tested for mechanical strength and the ability to promote new bone formation in vivo.
   Patients and methods: To evaluate the potential of each scaffold in bone regeneration, ovariectomized rats were chosen as a study model to determine the ability of PIB nanogels to stimulate bone formation in a complicated anatomical bone defect. PIB nanogels and PIB nanogels/B-MBG composites were respectively implanted into ovariectomized rats with critical-sized femur defects following treatment periods of 2, 4, and 8 weeks post-implantation.
   Results: Results from the present study demonstrate that PIB nanogels/B-MBG composites showed greater improvement in mechanical strength when compared to PIB nanogels alone. In vivo, hematoxylin and eosin staining revealed significantly more newly formed bone in defects containing PIB nanogels/B-MBG composite scaffolds when compared to PIB nanogels alone. Tartrate-resistant acid phosphatase-positive staining demonstrated that both scaffolds were degraded over time and bone remodeling occurred in the surrounding bone defect as early as 4 weeks post-implantation.
   Conclusion: The results from the present study indicate that PIB nanogels are a potential bone tissue engineering biomaterial able to treat defects of irregular shapes and deformities as an injectable, thermoresponsive, biocompatible hydrogel which undergoes rapid thermal gelation once body temperature is reached. Furthermore, its combination with B-MBG scaffolds improves the mechanical properties and ability to promote new bone formation when compared to PIB nanogels alone.
C1 [Chen, Xiaohui; Miron, Richard J.; Zhang, Qiao; Zhang, Yufeng] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China.
   [Chen, Xiaohui; Miron, Richard J.; Zhang, Qiao; Zhang, Yufeng] Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Wuhan, Peoples R China.
   [Chen, Xiaohui; Miron, Richard J.; Zhang, Qiao; Zhang, Yufeng] Wuhan Univ, Sch & Hosp Stomatol, Wuhan, Peoples R China.
   [Chen, Xiaohui; Zhang, Yufeng] Wuhan Univ, Sch & Hosp Stomatol, Dept Dent Implantol, Wuhan, Peoples R China.
   [Zhao, Yanbing; Geng, Shinan] Huazhong Univ Sci & Technol, Coll Life Sci, Natl Engn Res Ctr Nanomed, Wuhan, Peoples R China.
   [Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Wu, CT (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM chengtiewu@mail.sic.ac.cn; zyf@whu.edu.cn
FU Program for New Century Excellent Talents in University [NCET-11-0414];
   Wuhan Planning Project of Science and Technology; National Natural
   Science Foundation of China [81271108]
FX This work was supported by Program for New Century Excellent Talents in
   University (NCET-11-0414), Wuhan Planning Project of Science and
   Technology (to XH Chen), and the funds of the National Natural Science
   Foundation of China (81271108 to YF Zhang).
CR Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P1633, DOI 10.1007/s00198-009-0920-3
   Becker David J, 2010, Curr Rheumatol Rep, V12, P186, DOI 10.1007/s11926-010-0097-y
   Cheng N, 2013, J MATER SCI-MATER M, V24, P1963, DOI 10.1007/s10856-013-4945-y
   Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004
   Dong Y, MACROMOL RAPID COMMU
   Fernandes JC, 2008, MOL THER, V16, P1243, DOI 10.1038/mt.2008.99
   Genant HK, 1999, OSTEOPOROSIS INT, V10, P259, DOI 10.1007/s001980050224
   Gorustovich AA, 2006, BIOMED MATER, V1, P100, DOI 10.1088/1748-6041/1/3/002
   Hayashi C, 2009, J CELL PHYSIOL, V220, P1, DOI 10.1002/jcp.21760
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kong SW, 2011, BONE, V48, P298, DOI 10.1016/j.bone.2010.09.029
   Li SH, 2002, J BIOMED MATER RES, V61, P109, DOI 10.1002/jbm.10163
   Li X, 2008, J BIOMED MATER RES A, V84A, P84, DOI 10.1002/jbm.a.31371
   Lopez-Noriega A, 2006, CHEM MATER, V18, P3137, DOI 10.1021/cm060488o
   Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260
   Miron RJ, 2014, CLIN ORAL INVEST, V18, P471, DOI 10.1007/s00784-013-0992-5
   Mondrinos MJ, 2006, BIOMATERIALS, V27, P4399, DOI 10.1016/j.biomaterials.2006.03.049
   Park KH, 2009, J BIOSCI BIOENG, V108, P530, DOI 10.1016/j.jbiosc.2009.05.021
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Roush K, 2011, AM J NURS, V111, P26, DOI 10.1097/01.NAJ.0000403358.44058.f7
   Saulacic N, CLIN ORAL IMPLANTS R
   Seeman E, 2004, MED J AUSTRALIA, V180, P298
   Silva BC, 2011, ANNU REV MED, V62, P307, DOI 10.1146/annurev-med-061709-145401
   Tsigkou O, 2007, J BIOMED MATER RES A, V80A, P837, DOI 10.1002/jbm.a.30910
   Wang L, 2010, BIOMATERIALS, V31, P9452, DOI 10.1016/j.biomaterials.2010.08.036
   Wei L, 2014, OSTEOPOROSIS INT, V25, P2089, DOI 10.1007/s00198-014-2735-0
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu CT, 2011, ACTA BIOMATER, V7, P2644, DOI 10.1016/j.actbio.2011.03.009
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Yang S, CLIN IMPLANT DENT RE
   Yun HS, 2008, J BIOMED MATER RES B, V87B, P374, DOI 10.1002/jbm.b.31114
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang YF, 2012, BONE, V51, P704, DOI 10.1016/j.bone.2012.06.029
   Zhang YF, 2012, BIOMATERIALS, V33, P6698, DOI 10.1016/j.biomaterials.2012.06.021
   Zhao H, 2013, AM J NEURORADIOL, V34, P169, DOI 10.3174/ajnr.A3177
   Zhao YB, 2011, ADV FUNCT MATER, V21, P2035, DOI 10.1002/adfm.201002510
   Zhou ZY, 2009, J BIOACT COMPAT POL, V24, P405, DOI 10.1177/0883911509341774
NR 37
TC 12
Z9 12
U1 2
U2 64
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2015
VL 10
BP 839
EP 846
DI 10.2147/IJN.S69001
PG 8
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AZ4LX
UT WOS:000348193800002
PM 25653525
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Merli, M
   Mariotti, G
   Moscatelli, M
   Motroni, A
   Mazzoni, A
   Mazzoni, S
   Nieri, M
AF Merli, Mauro
   Mariotti, Giorgia
   Moscatelli, Marco
   Motroni, Alessandro
   Mazzoni, Annalisa
   Mazzoni, Simona
   Nieri, Michele
TI Fence Technique for Localized Three-Dimensional Bone Augmentation: A
   Technical Description and Case Reports
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID VERTICAL RIDGE AUGMENTATION; CONTROLLED CLINICAL-TRIAL; ALVEOLAR
   DISTRACTION OSTEOGENESIS; ATROPHIC EDENTULOUS MAXILLA; RANDOMIZED
   CONTROLLED-TRIAL; AUTOGENOUS BONE; IMPLANT PLACEMENT; RESORBABLE
   BARRIERS; ILIAC CREST; BOVINE BONE
AB This study presents a novel bone reconstructive technique based on guided bone regeneration for localized three-dimensional hard tissue augmentation. This two-stage technique utilized a titanium osteosynthesis plate and a collagen membrane to form a physical barrier resembling a fence that contains bone graft biomaterial composed of a combination of deproteinized bovine bone matrix and autologous bone grafted from intraoral sites. Six patients were treated. At 6 months postsurgery, an increase in bone volume of 953 mm(3) was shown. Mean maximum linear augmentation in the vertical direction was 6.75 mm. Histologic analysis of the regenerated area revealed the presence of compact newly formed bone with no sign of inflammation. A total of 13 implants were placed. Peri-implant marginal bone level was 0.94 mm at implant placement and 1.30 mm after 6 months. The patients were satisfied with the procedure and no complications were observed.
C1 [Merli, Mauro] Int Dent Res & Educ InDent, Rimini, Italy.
   [Mariotti, Giorgia; Moscatelli, Marco; Nieri, Michele] InDent, Rimini, Italy.
   [Motroni, Alessandro] Appl Med Imaging Res Grp, Milan, Italy.
   [Mazzoni, Annalisa] Univ Trieste, Dept Med Sci, Trieste, Italy.
RP Merli, M (reprint author), Viale Settembrini 17, I-47923 Rimini, Italy.
EM mauromerli@gmail.com
CR Bianchi A, 2008, ORAL SURG ORAL MED O, V105, P282, DOI 10.1016/j.tripleo.2007.07.009
   Cannizzaro G, 2007, INT J ORAL MAX IMPL, V22, P280
   Chiapasco M, 2004, CLIN ORAL IMPLAN RES, V15, P82, DOI 10.1111/j.1600-0501.2004.00999.x
   Chiapasco M, 2007, CLIN ORAL IMPLAN RES, V18, P432, DOI 10.1111/j.1600-0501.2007.01351.x
   Clementini M, 2012, INT J ORAL MAX SURG, V41, P847, DOI 10.1016/j.ijom.2012.03.016
   Cordaro L, 2002, CLIN ORAL IMPLAN RES, V13, P103, DOI 10.1034/j.1600-0501.2002.130113.x
   Cordaro L, 2011, CLIN ORAL IMPLAN RES, V22, P1320, DOI 10.1111/j.1600-0501.2010.02115.x
   Cordaro L, 2011, CLIN ORAL IMPLAN RES, V22, P1145, DOI 10.1111/j.1600-0501.2010.02093.x
   Cricchio Giovanni, 2003, Clin Implant Dent Relat Res, V5, P161, DOI 10.1111/j.1708-8208.2003.tb00198.x
   Esposito M, 2009, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD003607.PUB4
   Felice P, 2011, EUR J ORAL IMPLANTOL, V4, P191
   Felice P, 2009, CLIN ORAL IMPLAN RES, V20, P1386, DOI 10.1111/j.1600-0501.2009.01765.x
   Felice P, 2008, EUR J ORAL IMPLANTOL, V1, P183
   Fontana F, 2008, INT J ORAL MAX IMPL, V23, P1003
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P66, DOI 10.1034/j.1600-0501.1994.050202.x
   Kourkouta S, 2009, INT J ORAL MAX IMPL, V24, P353
   Merli M., 2013, INTEGRATED TREATMENT, V1, P369
   Merli M, 2007, INT J ORAL MAX IMPL, V22, P373
   Merli M, 2006, INT J PERIODONT REST, V26, P581
   Merli M, 2013, EUR J ORAL IMPLANTOL, V6, P27
   Merli M, 2010, INT J ORAL MAX IMPL, V25, P801
   Nystrom E, 2009, INT J ORAL MAX SURG, V38, P111, DOI 10.1016/j.ijom.2008.10.008
   Renouard F, 2006, CLIN ORAL IMPLAN RES, V17, P35, DOI 10.1111/j.1600-0501.2006.01349.x
   Ridell A, 2009, CLIN ORAL IMPLAN RES, V20, P94, DOI 10.1111/j.1600-0501.2007.01491.x
   Rocchietta I, 2008, J CLIN PERIODONTOL, V35, P203, DOI 10.1111/j.1600-051X.2008.01271.x
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P496
   Simion M, 2001, CLIN ORAL IMPLAN RES, V12, P35, DOI 10.1034/j.1600-0501.2001.012001035.x
   Szabo G, 2005, INT J ORAL MAX IMPL, V20, P371
   Triaca A, 2001, INT J ORAL MAX IMPL, V16, P851
   Urban IA, 2009, INT J ORAL MAX IMPL, V24, P502
   Zitzmann NU, 1997, INT J ORAL MAX IMPL, V12, P844
NR 31
TC 3
Z9 3
U1 1
U2 4
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
EI 1945-3388
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD JAN-FEB
PY 2015
VL 35
IS 1
BP 57
EP 64
DI 10.11607/prd.2029
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AZ1NJ
UT WOS:000348005300008
PM 25734707
OA Bronze
DA 2018-10-20
ER

PT J
AU Liu, J
   Liu, XL
   Xi, TF
   Chu, CC
AF Liu, J.
   Liu, X. L.
   Xi, T. F.
   Chu, C. C.
TI A novel pseudo-protein-based biodegradable coating for magnesium
   substrates: in vitro corrosion phenomena and cytocompatibility
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID POLY(ESTER AMIDE) COPOLYMERS; IMMERSION ION-IMPLANTATION; POLY(ETHER
   ESTER AMIDE)S; POLYMER-COATED MAGNESIUM; SIMULATED BODY-FLUID;
   DRUG-RELEASE; BIOMEDICAL APPLICATIONS; BIOCORROSION BEHAVIOR; SURFACE
   MODIFICATION; CONVERSION COATINGS
AB The goal of this study is to examine whether a member of the newly developed biodegradable pseudo-protein biomaterial family could provide a far better protection and performance than the popular hydrolytically degradable poly(glycolide-co-lactide) (PLGA) biomaterial on an experimental magnesium substrate as a model. A member of the phenylalanine-based poly(ester amide)s, (8-Phe-4), was chosen as a model pseudo-protein polymer to coat onto as-cast magnesium (Mg) metal as the experimental model. The microstructures of the coatings were characterized by SEM, FTIR and water contact angle measurements. Nano-scratch test data indicated that the scratch resistance and elastic resilience of the 8-Phe-4 coating were superior to the PLGA coating. Standard electrochemical measurements along with the long-term immersion results indicated that the 8-Phe-4-coated Mg had preferable in vitro degradation and corrosion behavior than the PLGA-coated Mg. The cytocompatibility test was conducted via vascular smooth muscle cells (VSMCs) and human umbilical vein endothelial cells (ECV304), and the 8-Phe-4-coated Mg showed significantly better cell viability than the pure Mg and PLGA-coated Mg substrates over a 3 day incubation period. The favorable anti-corrosion behavior and cytocompatibility of the 8-Phe-4 coating suggest that the newly developed biodegradable pseudo-protein biomaterials may have great potential as biodegradable coating materials to enhance the protection and performance of Mg-based biomaterials and their application compared to the popular PLGA, and may bring the application of Mg-based biomaterials closer to clinical reality.
C1 [Liu, J.; Xi, T. F.] Peking Univ, Ctr Biomed Mat & Tissue Engn, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.
   [Liu, X. L.] Univ Sci & Technol Beijing, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
   [Xi, T. F.] Peking Univ, Shenzhen Res Inst, Shenzhen 518055, Peoples R China.
   [Chu, C. C.] Cornell Univ, Biomed Engn Program, Ithaca, NY 14853 USA.
RP Xi, TF (reprint author), Peking Univ, Ctr Biomed Mat & Tissue Engn, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.
EM xitingfeipku@163.com
FU 973 Project [2012CB619102]; National Science and Technology Support
   Program [2012BAI18B01]; National Natural Science Foundation of China
   [31370956]; Rebecca Q. Morgan Foundation Grant; Cornell University
   Jeffrey S. Lehman Fund for Scholarly Exchange with China
FX Tingfei Xi at Peking University was supported by the 973 Project (no.
   2012CB619102), the National Science and Technology Support Program (no.
   2012BAI18B01) and the National Natural Science Foundation of China (no.
   31370956), and Chih-Chang Chu at Cornell University was supported by the
   Rebecca Q. Morgan Foundation Grant and the Cornell University Jeffrey S.
   Lehman Fund for Scholarly Exchange with China.
CR Abdal-Hay A, 2012, APPL SURF SCI, V261, P536, DOI 10.1016/j.apsusc.2012.08.051
   Abulsain M, 2004, ELECTROCHIM ACTA, V49, P899, DOI 10.1016/j.electacta.2003.09.042
   Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   Ardelean H, 2008, CORROS SCI, V50, P1907, DOI 10.1016/j.corsci.2008.03.015
   Arrabal R, 2008, CORROS SCI, V50, P1744, DOI 10.1016/j.corsci.2008.03.002
   Baril G, 2001, CORROS SCI, V43, P471, DOI 10.1016/S0010-938X(00)00095-0
   Blawert C, 2006, ADV ENG MATER, V8, P511, DOI 10.1002/adem.200500257
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Cao C. N., 2008, PRINCIPLES ELECTROCH, P139
   Chan WY, 2013, MAT SCI ENG C-MATER, V33, P5019, DOI 10.1016/j.msec.2013.08.025
   Chen W, 2014, J MATER CHEM B, V2, P1653, DOI 10.1039/c3tb21769h
   Chen Y, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025005
   Chen YQ, 2013, CORROS SCI, V75, P280, DOI 10.1016/j.corsci.2013.06.011
   Cheng YL, 2009, T NONFERR METAL SOC, V19, P517, DOI 10.1016/S1003-6326(08)60305-2
   Chkhaidze E, 2011, J MACROMOL SCI A, V48, P544, DOI 10.1080/10601325.2011.579817
   Chu C. C., 2003, US Patent, Patent No. [6,503,538, 6503538]
   Chu C C, 2012, J FIBER BIOENG INFOR, V5, P1
   Chu C. C., 2012, 9 WORLD BIOM C
   CORNWELL TL, 1994, AM J PHYSIOL-CELL PH, V267, pC1405
   Cui HT, 2012, BIOMACROMOLECULES, V13, P2881, DOI 10.1021/bm300897j
   da Conceicao TF, 2010, THIN SOLID FILMS, V518, P5209, DOI 10.1016/j.tsf.2010.04.114
   De W. M., 2008, J POLYM SCI A, V46, P6376
   DeFife K., 2005, 30 ANN M SOC BIOM
   DeFife KM, 2009, J BIOMAT SCI-POLYM E, V20, P1495, DOI 10.1163/092050609X12464344572881
   Deng M. X., 2009, BIOMACROMOLECULES, V10, P14
   Deng MX, 2011, ACTA BIOMATER, V7, P1504, DOI 10.1016/j.actbio.2010.12.026
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Gu XN, 2011, MATER SCI ENG B-ADV, V176, P1778, DOI 10.1016/j.mseb.2011.05.032
   Gu XN, 2011, ACTA BIOMATER, V7, P1880, DOI 10.1016/j.actbio.2010.11.034
   Guo K, 2008, J APPL POLYM SCI, V110, P1858, DOI 10.1002/app.28826
   Guo K, 2007, J BIOMAT SCI-POLYM E, V18, P489, DOI 10.1163/156856207780852569
   Guo K, 2007, J POLYM SCI POL CHEM, V45, P1595, DOI 10.1002/pola.21926
   Hadzima B, 2014, J MATER SCI-MATER M, V25, P1227, DOI 10.1007/s10856-014-5161-0
   Hanzi AC, 2009, ACTA BIOMATER, V5, P162, DOI 10.1016/j.actbio.2008.07.034
   He MY, 2014, ACTA BIOMATER, V10, P2482, DOI 10.1016/j.actbio.2014.02.011
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Horwitz JA, 2010, J BIOMED MATER RES A, V95A, P371, DOI 10.1002/jbm.a.32858
   Huang J. J., 2007, T NONFERR METAL SOC, V17, P1465
   Jain GK, 2010, POLYM DEGRAD STABIL, V95, P2360, DOI 10.1016/j.polymdegradstab.2010.08.015
   Janoria KG, 2007, INT J PHARM, V338, P133, DOI 10.1016/j.ijpharm.2007.01.038
   Jokhadze G, 2007, J BIOMAT SCI-POLYM E, V18, P411, DOI 10.1163/156856207780425031
   Kaesel V., 2004, MAGNESIUM, P534
   Killian MS, 2010, LANGMUIR, V26, P12044, DOI 10.1021/la101880r
   Kong N, 2014, J MATER CHEM B, V2, P1100, DOI 10.1039/c3tb21529f
   Kum CH, 2013, J MATER CHEM B, V1, P2764, DOI [10.1039/C3TB00490B, 10.1039/c3tb00490b]
   Lee SH, 2002, CORONARY ARTERY DIS, V13, P237, DOI 10.1097/00019501-200206000-00006
   Li JN, 2010, J MATER SCI, V45, P6038, DOI 10.1007/s10853-010-4688-9
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Li L, 2009, J BIOMAT SCI-POLYM E, V20, P341, DOI 10.1163/156856209X412209
   Lin X, 2014, APPL SURF SCI, V288, P718, DOI 10.1016/j.apsusc.2013.10.113
   Liu CL, 2007, THIN SOLID FILMS, V516, P422, DOI 10.1016/j.tsf.2007.05.048
   Liu X, 2013, ACTA BIOMATER, V9, P8671, DOI 10.1016/j.actbio.2012.12.025
   Lu P, 2011, MAT SCI ENG C-MATER, V31, P1285, DOI 10.1016/j.msec.2011.04.005
   Lyu S, 2005, J POLYM SCI POL PHYS, V43, P383, DOI 10.1002/polb.20340
   Mandelli A, 2011, SURF COAT TECH, V205, P4459, DOI 10.1016/j.surfcoat.2011.03.066
   Mi FL, 2002, BIOMATERIALS, V23, P3257, DOI 10.1016/S0142-9612(02)00084-4
   NAKAKI T, 1990, EUR J PHARM-MOLEC PH, V189, P347, DOI 10.1016/0922-4106(90)90031-R
   Narayanan TSNS, 2014, J MATER CHEM B, V2, P3365, DOI 10.1039/c3tb21565b
   Ostrowski N, 2013, ACTA BIOMATER, V9, P8704, DOI 10.1016/j.actbio.2013.05.010
   Ostrowski NJ, 2013, J MATER SCI-MATER M, V24, P85, DOI 10.1007/s10856-012-4773-5
   Pang XA, 2010, J POLYM SCI POL CHEM, V48, P3758, DOI 10.1002/pola.24160
   Pang X, 2010, BIOMATERIALS, V31, P3745, DOI 10.1016/j.biomaterials.2010.01.027
   PEBERE N, 1990, ELECTROCHIM ACTA, V35, P555, DOI 10.1016/0013-4686(90)87043-2
   Pereda MD, 2010, ACTA BIOMATER, V6, P1772, DOI 10.1016/j.actbio.2009.11.004
   Pinto R, 2010, PROG ORG COAT, V69, P143, DOI 10.1016/j.porgcoat.2010.04.014
   Qian ZY, 2004, BIOMATERIALS, V25, P1975, DOI 10.1016/S0142-9612(03)00604-5
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   Rodriguez-Galan A, 2000, POLYMER, V41, P5967, DOI 10.1016/S0032-3861(99)00756-9
   Roy ME, 2010, ACTA BIOMATER, V6, P1619, DOI 10.1016/j.actbio.2009.10.037
   Schwartz S., 2008, 3 WORLD UN WOUND HEA
   Sherif ESM, 2011, INT J ELECTROCHEM SC, V6, P2131
   Song GL, 1998, CORROS SCI, V40, P1769, DOI 10.1016/S0010-938X(98)00078-X
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tang W, 2007, SURF COAT TECH, V201, P5664, DOI 10.1016/j.surfcoat.2006.07.054
   Tanner FC, 2000, CIRCULATION, V101, P1982, DOI 10.1161/01.CIR.101.16.1982
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Wan GJ, 2007, SURF COAT TECH, V201, P8267, DOI 10.1016/j.surfcoat.2006.02.088
   Wang N, 2000, J BIOMAT SCI-POLYM E, V11, P301, DOI 10.1163/156856200743715
   Wang XB, 2013, J MATER CHEM B, V1, P5036, DOI 10.1039/c3tb20855a
   Wang XL, 1995, J ALLOY COMPD, V231, P397, DOI 10.1016/0925-8388(95)01854-9
   Wang XM, 2007, J ALLOY COMPD, V437, P87, DOI 10.1016/j.jallcom.2006.07.074
   Webster S. H. M., 2013, EUROINTERVENTION, V9, P46
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019
   Wu D. Q., 2012, 9 WORLD BIOM C
   Wu DQ, 2013, SOFT MATTER, V9, P3965, DOI 10.1039/c3sm27820d
   Wu GS, 2009, SCRIPTA MATER, V61, P269, DOI 10.1016/j.scriptamat.2009.03.061
   Wu J, 2013, J MATER CHEM B, V1, P353, DOI 10.1039/c2tb00070a
   Wu J, 2012, ADV FUNCT MATER, V22, P3815, DOI 10.1002/adfm.201103147
   Wu J, 2012, J MATER CHEM, V22, P18983, DOI 10.1039/c2jm33753c
   Wu J, 2011, J MATER SCI-MATER M, V22, P469, DOI 10.1007/s10856-011-4243-5
   Xu LP, 2012, APPL SURF SCI, V258, P6353, DOI 10.1016/j.apsusc.2012.03.036
   Xu LP, 2012, COLLOID SURFACE B, V93, P67, DOI 10.1016/j.colsurfb.2011.12.009
   Xu XH, 2010, APPL SURF SCI, V256, P2367, DOI 10.1016/j.apsusc.2009.10.069
   Yamanouchi D, 2008, BIOMATERIALS, V29, P3269, DOI 10.1016/j.biomaterials.2008.04.026
   Yamauchi N, 2007, SURF COAT TECH, V201, P4913, DOI 10.1016/j.surfcoat.2006.07.080
   Yan TT, 2010, MAT SCI ENG C-MATER, V30, P740, DOI 10.1016/j.msec.2010.03.007
   YANG J, 2011, J BIOMATER APPL, V27, P153
   Yang L, 2009, MAT SCI ENG C-BIO S, V29, P1691, DOI 10.1016/j.msec.2009.01.014
   Ye CH, 2012, APPL SURF SCI, V258, P3420, DOI 10.1016/j.apsusc.2011.11.087
   [赵常利 ZHAO Changli], 2008, [功能材料, Journal of Functional Materials], V39, P987
   Zhao MC, 2008, CORROS SCI, V50, P3168, DOI 10.1016/j.corsci.2008.08.023
   Zhou JC, 2013, J MATER CHEM B, V1, P6213, DOI 10.1039/c3tb20960a
   Zhou WR, 2013, ACTA BIOMATER, V9, P8488, DOI 10.1016/j.actbio.2013.01.032
NR 107
TC 17
Z9 17
U1 5
U2 57
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 5
BP 878
EP 893
DI 10.1039/c4tb01527d
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA AZ4NK
UT WOS:000348198700021
DA 2018-10-20
ER

PT J
AU Temelli, F
   Ciftci, ON
AF Temelli, Feral
   Ciftci, Ozan N.
TI Developing an integrated supercritical fluid biorefinery for the
   processing of grains
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article; Proceedings Paper
CT Workshop on Supercritical Fluids and Energy
CY 2013
CL Campinas, BRAZIL
DE Biorefinery; Extraction; Refining; Lipids; Process development;
   Reactions
ID CARBON-DIOXIDE EXTRACTION; DISTILLERS DRIED GRAINS; CANOLA OIL;
   SOLUBILITY BEHAVIOR; CHEMICAL-COMPOSITION; IMMOBILIZED LIPASE;
   PROCESS-SCALE; PILOT-SCALE; CO2; LIPIDS
AB With the rapid growth of the bioeconomy, there are major developments in the biorefinery concept to maximize utilization of renewable resources, including grains of cereals and oilseeds, targeting applications not only in food, nutraceutical, pharmaceutical and cosmetic products but also in biofuel, biochemical and biomaterial sectors. Supercritical carbon dioxide (SC-CO2) technology could have a major role to play in modern biorefineries. Know-how has been building on individual unit operations based on SC-CO2, especially extraction, fractionation and reactions involving lipids and particle formation for delivery of bioactives as summarized in this study mostly based on the previous work of the authors. Based on a solid understanding of fundamentals, the focus is now on optimal integration of these unit operations to build supercritical biorefineries. Such approaches should also consider integration of supercritical operations with conventional technologies for efficient and optimal process design. Even though the future of supercritical biorefineries seems to be bright, offering numerous advantages, there are also some substantial technical and economic challenges requiring further research. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Temelli, Feral; Ciftci, Ozan N.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada.
RP Temelli, F (reprint author), Univ Alberta, Dept Agr Food & Nutr Sci, 4-10 Agr For Bldg, Edmonton, AB T6G 2P5, Canada.
EM feral.temelli@ualberta.ca
OI Temelli, Feral/0000-0002-0379-8535
FU Natural Sciences and Engineering Research Council of Canada
FX We are grateful to the Natural Sciences and Engineering Research Council
   of Canada for their financial support through their Discovery Grants
   program and to Dr. Jerry King for his assistance in compiling the
   information presented in Table 1.
CR Bruni R, 2002, PHYTOCHEM ANALYSIS, V13, P257, DOI 10.1002/pca.651
   Brunner G, 2009, J SUPERCRIT FLUID, V47, P574, DOI 10.1016/j.supflu.2008.09.022
   Catchpole Owen, 2012, American Journal of Biochemistry and Biotechnology, V8, P263, DOI 10.3844/ajbbsp.2012.263.287
   Catchpole OJ, 2009, J SUPERCRIT FLUID, V47, P591, DOI 10.1016/j.supflu.2008.10.008
   CHRISTIANSON DD, 1984, J FOOD SCI, V49, P229, DOI 10.1111/j.1365-2621.1984.tb13714.x
   Ciftci ON, 2014, BIOENERG RES, V7, P702, DOI 10.1007/s12155-013-9394-4
   Ciftci ON, 2013, BIOMASS BIOENERG, V54, P140, DOI 10.1016/j.biombioe.2013.03.031
   Ciftci ON, 2012, J AGR FOOD CHEM, V60, P12482, DOI 10.1021/jf302932w
   Ciftci ON, 2011, J SUPERCRIT FLUID, V58, P79, DOI 10.1016/j.supflu.2011.05.011
   Da Porto C, 2015, J FOOD SCI TECH MYS, V52, P1748, DOI 10.1007/s13197-013-1143-3
   del Valle JM, 2004, J SUPERCRIT FLUID, V31, P159, DOI 10.1016/j.sulflu.2003.11.005
   Dunford NT, 1998, J SUPERCRIT FLUID, V13, P303, DOI 10.1016/S0896-8446(98)00064-3
   Dunford NT, 1997, J FOOD SCI, V62, P155, DOI 10.1111/j.1365-2621.1997.tb04389.x
   Eisenmenger M, 2006, J AM OIL CHEM SOC, V83, P863, DOI 10.1007/s11746-006-5038-6
   Eltringham W., 2008, SUPERCRITICAL FLUID, P141
   Fang T., 2008, SUPERCRITICAL FLUID, P103
   Fiori L, 2009, J SUPERCRIT FLUID, V50, P218, DOI 10.1016/j.supflu.2009.06.011
   Gast K, 2005, J SUPERCRIT FLUID, V34, P17, DOI 10.1016/j.supflu.2004.09.003
   Guclu-Ustundag O, 2004, J SUPERCRIT FLUID, V31, P235, DOI 10.1016/j.supflu.2003.12.007
   Guclu-Ustundag O, 2000, IND ENG CHEM RES, V39, P4756, DOI 10.1021/ie0001523
   Guclu-Ustundag O, 2006, J SUPERCRIT FLUID, V38, P275, DOI 10.1016/j.supflu.2005.12.009
   Hu AJ, 2007, ULTRASON SONOCHEM, V14, P219, DOI 10.1016/j.ultsonch.2006.03.005
   Ixtaina VY, 2010, J SUPERCRIT FLUID, V55, P192, DOI 10.1016/j.supflu.2010.06.003
   Jenab E, 2012, J SUPERCRIT FLUID, V70, P57, DOI 10.1016/j.supflu.2012.03.018
   Jenab E, 2011, J SUPERCRIT FLUID, V58, P7, DOI 10.1016/j.supflu.2011.05.001
   Jung J, 2001, J SUPERCRIT FLUID, V20, P179, DOI 10.1016/S0896-8446(01)00064-X
   King J.W., 2010, ALTERNATIVES CONVENT
   King J.W., 2000, P 7 M SUP FLUIDS, P537
   King JW, 2014, ANNU REV FOOD SCI T, V5, P215, DOI 10.1146/annurev-food-030713-092447
   King JW, 1997, J SUPERCRIT FLUID, V10, P127, DOI 10.1016/S0896-8446(97)00007-7
   Knez Z, 2003, CURR OPIN SOLID ST M, V7, P353, DOI 10.1016/j.cossms.2003.11.002
   Kondo M, 2002, IND ENG CHEM RES, V41, P5770, DOI 10.1021/ie010816o
   Lisboa P, 2014, J SUPERCRIT FLUID, V85, P31, DOI 10.1016/j.supflu.2013.10.018
   Martin A, 2008, ADV DRUG DELIVER REV, V60, P339, DOI 10.1016/j.addr.2007.06.019
   Martinez ML, 2008, J FOOD ENG, V88, P399, DOI 10.1016/j.jfoodeng.2008.02.026
   McHugh M.A., 1994, SUPERCRITICAL FLUID
   Meireles M.A.A., 2008, SUPERCRITICAL FLUID, P243
   Perrut M, 2000, IND ENG CHEM RES, V39, P4531, DOI 10.1021/ie000211c
   Prado IM, 2013, FOOD BIOPROD PROCESS, V91, P656, DOI 10.1016/j.fbp.2013.05.007
   Prado JM, 2012, J FOOD ENG, V109, P249, DOI 10.1016/j.jfoodeng.2011.10.007
   Prado JM, 2011, J SUPERCRIT FLUID, V56, P231, DOI 10.1016/j.supflu.2010.10.036
   Rathore V, 2007, FUEL, V86, P2650, DOI 10.1016/j.fuel.2007.03.014
   Reverchon E, 2006, J SUPERCRIT FLUID, V37, P298, DOI 10.1016/j.supflu.2006.01.017
   Rezaei K, 2001, J SUPERCRIT FLUID, V19, P263, DOI 10.1016/S0896-8446(00)00099-1
   Rosa PTV, 2005, J FOOD ENG, V67, P235, DOI 10.1016/j.jfoodeng.2004.05.064
   Saldana MDA, 2006, J SUPERCRIT FLUID, V37, P342, DOI 10.1016/j.supflu.2006.01.010
   Santos DT, 2010, J FOOD ENG, V101, P23, DOI 10.1016/j.jfoodeng.2010.06.005
   Seifried B, 2010, J SUPERCRIT FLUID, V52, P203, DOI 10.1016/j.supflu.2009.12.009
   Seifried B, 2009, J SUPERCRIT FLUID, V50, P97, DOI 10.1016/j.supflu.2009.05.011
   Shen ZP, 1997, J AGR FOOD CHEM, V45, P4540, DOI 10.1021/jf970292w
   Snyder JM, 1999, J AM OIL CHEM SOC, V76, P717, DOI 10.1007/s11746-999-0165-5
   Steinhagen V., 2010, P 2 IB C SUP FLUIDS, P9
   Sun M, 2008, J AM OIL CHEM SOC, V85, P667, DOI 10.1007/s11746-008-1239-5
   Temelli F, 1996, J AM OIL CHEM SOC, V73, P699, DOI 10.1007/BF02517943
   Temelli F, 2009, J SUPERCRIT FLUID, V47, P583, DOI 10.1016/j.supflu.2008.10.014
   Vazquez L, 2007, J SUPERCRIT FLUID, V40, P59, DOI 10.1016/j.supflu.2006.04.012
   Willems P, 2008, J SUPERCRIT FLUID, V45, P298, DOI 10.1016/j.supflu.2008.01.010
   Zacchi P, 2006, BRAZ J CHEM ENG, V23, P105, DOI 10.1590/S0104-66322006000100011
NR 58
TC 13
Z9 13
U1 2
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0896-8446
EI 1872-8162
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD JAN
PY 2015
VL 96
SI SI
BP 77
EP 85
DI 10.1016/j.supflu.2014.09.028
PG 9
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA AZ1SE
UT WOS:000348017300009
DA 2018-10-20
ER

PT J
AU Katti, DR
   Sharma, A
   Ambre, AH
   Katti, KS
AF Katti, Dinesh R.
   Sharma, Anurag
   Ambre, Avinash H.
   Katti, Kalpana S.
TI Molecular interactions in biomineralized hydroxyapatite amino acid
   modified nanoclay: In silico design of bone biomaterials
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterials; Molecular dynamics; Interaction energies; Nanoclays
ID SODIUM MONTMORILLONITE INTERLAYER; NANOSCALE MECHANICAL-BEHAVIOR;
   DENSITY-FUNCTIONAL THEORY; SWELLING CLAY-MINERALS;
   MONTE-CARLO-SIMULATION; COMPOSITE SCAFFOLDS; BARRIER PROPERTIES; CRYSTAL
   SHAPE; DYNAMICS; NANOCOMPOSITES
AB A simulations driven approach to design of a novel biomaterial nanocomposite system is described in this study. Nanoclays modified with amino acids (OMMT) were used to mineralize hydroxyapatite (HAP), mimicking biomineralization. Representative models of organically modified montmorillonite clay (OMMT) and OMMT-hydroxyapatite (OMMT-HAP) were constructed using molecular dynamics and validated using X-ray Diffraction (XRD), Fourier Transforms Infrared (FIR) spectroscopy and Transmission Electron Microscopy (TEM). Attractive interactions exist between Ca atoms of HAP and C=O group of aminovaleric acid, indicating chelate formation in OMMT-HAP. Interaction energy maps describe molecular interactions among different constituents and their quantitative contributions in the OMMT and OMMT-HAP systems at both parallel and perpendicular orientations. High attractive and high repulsive interactions were found between PO43- and MMT clay as well as aminovaleric molecules in OMMT-HAP perpendicular and parallel models. Large non-bonded interactions in OMMT-HAP indicate influence of neighboring environment on PO43- in in situ HAPclay. Extensive hydrogen bonds were observed between functional hydrogen atoms of modifier and MMT clay in OMMT-HAP as compared to OMMT. Thus, HAP interacts with clay through the aminovaleric acid. This computational study provides a framework for materials design and selection for biomaterials used in tissue engineering and other areas of regenerative medicine. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Katti, Dinesh R.; Sharma, Anurag; Ambre, Avinash H.; Katti, Kalpana S.] N Dakota State Univ, Dept Civil Engn, Fargo, ND 58105 USA.
RP Katti, DR (reprint author), N Dakota State Univ, Dept Civil Engn, Fargo, ND 58105 USA.
EM Dinesh.Katti@ndsu.edu
RI Sharma, Anurag/A-7160-2017
OI Sharma, Anurag/0000-0002-2108-7200
FU National Science Foundation [1229316, 0320657, 0821655]
FX The authors acknowledge MRI instrumentation grant from the National
   Science Foundation (#1229316, #0320657 and #0821655) for acquisition of
   field emission TEM, used in this work. We are thankful to Mr. Scott
   Payne from NDSU EM Center for his assistance in transmission electron
   microscopy laboratory experiments. We also would like to acknowledge
   CCAST (Center for Computationally assisted Science and Engineering) NDSU
   for providing computational resources.
CR Almora-Barrios N., 2011, CRYST GROWTH DES, V12, P756
   Almora-Barrios N, 2010, LANGMUIR, V26, P14535, DOI 10.1021/la101151e
   Almora-Barrios N, 2009, LANGMUIR, V25, P5018, DOI 10.1021/la803842g
   Ambre Avinash H, 2010, Journal of Nanotechnology in Engineering and Medicine, V1, DOI 10.1115/1.4002149
   Ambre A, 2011, MAT SCI ENG C-MATER, V31, P1017, DOI 10.1016/j.msec.2011.03.001
   Ambre AH, 2013, J BIOMED MATER RES A, V101, P2644, DOI 10.1002/jbm.a.34561
   Bharadwaj RK, 2001, MACROMOLECULES, V34, P9189, DOI 10.1021/ma010780b
   Bhowmik R, 2007, J MATER SCI, V42, P8795, DOI 10.1007/s10853-007-1914-1
   Bhowmik R, 2007, MAT SCI ENG C-BIO S, V27, P352, DOI 10.1016/j.msec.2006.05.048
   Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   Bhowmik R, 2009, J ENG MECH, V135, P413, DOI 10.1061/(ASCE)0733-9399(2009)135:5(413)
   Botelho CM, 2006, J BIOMED MATER RES A, V79A, P723, DOI 10.1002/jbm.a.30806
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Corno M, 2010, PHYS CHEM CHEM PHYS, V12, P6309, DOI 10.1039/c002146f
   de Leeuw NH, 2010, GEOCHIM COSMOCHIM AC, V74, pA220
   Dubey DK, 2010, J COMPUT THEOR NANOS, V7, P1306, DOI 10.1166/jctn.2010.1485
   Dubey DK, 2010, J MATER SCI-MATER M, V21, P161, DOI 10.1007/s10856-009-3837-7
   Dubey DK, 2009, MAT SCI ENG C-MATER, V29, P2133, DOI 10.1016/j.msec.2009.04.015
   Fritsch A, 2010, PHILOS T R SOC A, V368, P1913, DOI 10.1098/rsta.2010.0005
   Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u
   Giannelis EP, 1996, ADV MATER, V8, P29, DOI 10.1002/adma.19960080104
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hauptmann S, 2003, PHYS CHEM CHEM PHYS, V5, P635, DOI 10.1039/b208209h
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hum J, 2013, STRAIN, V49, P431, DOI 10.1111/str.12049
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Iwatsubo T, 2006, BIOMACROMOLECULES, V7, P95, DOI 10.1021/bm0504476
   Jabbarzadeh E, 2007, TISSUE ENG, V13, P2073, DOI 10.1089/ten.2006.0057
   Jeffrey GA, 1994, HYDROGEN BONDING BIO
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Katti DR, 2010, J BIOMECH, V43, P1723, DOI 10.1016/j.jbiomech.2010.02.027
   Katti DR, 2005, BIOMACROMOLECULES, V6, P3276, DOI 10.1021/bm0503219
   Katti DR, 2005, CLAY CLAY MINER, V53, P171, DOI 10.1346/CCMN.2005.0530207
   Katti KS, 2010, PHILOS T R SOC A, V368, P1963, DOI 10.1098/rsta.2010.0008
   Katti KS, 2008, BIOMED MATER, V3, P12
   Lacroix D, 2009, PHILOS T R SOC A, V367, P1993, DOI 10.1098/rsta.2009.0024
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Latour RA, 1999, CURR OPIN SOLID ST M, V4, P413, DOI 10.1016/S1359-0286(99)00022-4
   Leszczynska A, 2007, THERMOCHIM ACTA, V453, P75, DOI 10.1016/j.tca.2006.11.002
   Li Y, 2008, J PHYS CHEM B, V112, P16647, DOI 10.1021/jp8051906
   Maiti P, 2007, BIOMACROMOLECULES, V8, P3393, DOI 10.1021/bm700500t
   Mieszawska AJ, 2011, ACTA BIOMATER, V7, P3036, DOI 10.1016/j.actbio.2011.04.016
   Nukavarapu SP, 2008, BIOMACROMOLECULES, V9, P1818, DOI 10.1021/bm800031t
   OKADA A, 1990, MATER RES SOC SYMP P, V171, P45
   Olmo N, 2003, BIOMATERIALS, V24, P3383, DOI 10.1016/S0142-9612(03)00200-X
   Paul MA, 2003, POLYMER, V44, P443, DOI 10.1016/S0032-3861(02)00778-4
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Picard E, 2007, J MEMBRANE SCI, V292, P133, DOI 10.1016/j.memsci.2007.01.030
   Pradhan S.M., 2012, BIOMACROMOLECULES, V13, P8
   Pramanik M, 2003, J APPL POLYM SCI, V87, P2216, DOI 10.1002/app.11475
   Raabe D, 2007, ACTA MATER, V55, P4475, DOI 10.1016/j.actamat.2007.04.024
   Redondo A, 2004, ANNU REV MATER RES, V34, P279, DOI 10.1146/annurev.matsci.34.070503.123908
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rimola A, 2008, J AM CHEM SOC, V130, P16181, DOI 10.1021/ja806520d
   Schmidt SR, 2005, LANGMUIR, V21, P8069, DOI 10.1021/la050615f
   Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001
   Shenhar R, 2003, ACCOUNTS CHEM RES, V36, P549, DOI 10.1021/ar020083j
   Sikdar D., 2006, LANGMUIR, V22, P7738
   Sikdar D, 2008, LANGMUIR, V24, P5599, DOI 10.1021/la800583h
   SKIPPER NT, 1995, CLAY CLAY MINER, V43, P285, DOI 10.1346/CCMN.1995.0430303
   SKIPPER NT, 1995, CLAY CLAY MINER, V43, P294, DOI 10.1346/CCMN.1995.0430304
   Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591
   Teppen BJ, 1997, J PHYS CHEM B, V101, P1579, DOI 10.1021/jp961577z
   Verma D, 2008, MAT SCI ENG C-BIO S, V28, P399, DOI 10.1016/j.msec.2007.04.026
   Verma D, 2006, J BIOMED MATER RES A, V78A, P772, DOI 10.1002/jbm.a.30774
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
NR 68
TC 15
Z9 17
U1 2
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2015
VL 46
BP 207
EP 217
DI 10.1016/j.msec.2014.07.057
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AY7RQ
UT WOS:000347757100027
PM 25491979
DA 2018-10-20
ER

PT J
AU Gomes, SR
   Rodrigues, G
   Martins, GG
   Roberto, MA
   Mafra, M
   Henriques, CMR
   Silva, JC
AF Gomes, S. R.
   Rodrigues, G.
   Martins, G. G.
   Roberto, M. A.
   Mafra, M.
   Henriques, C. M. R.
   Silva, J. C.
TI In vitro and in vivo evaluation of electrospun nanofibers of PCL,
   chitosan and gelatin: A comparative study
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Electrospinning; Polycaprolactone; Chitosan; Fish gelatin; Fibroblasts;
   Skin substitute; Wound healing
ID FIBROUS SCAFFOLDS; CELL-ADHESION; HUMAN SKIN; TISSUE; PROTEIN;
   REGENERATION; SURFACE; IMMOBILIZATION; BIOMATERIAL; DERIVATIVES
AB Many polymers have been investigated with respect to their use in skin tissue engineering. However, directly comparable data on the role played by different polymers in assisting skin wound healing requires their in vitro and in vivo evaluation under the same conditions. Therefore, we performed a study in order to compare the performance of electrospun nanofiber mats from three different polymers concerning cell-scaffold interaction and wound healing promotion. A polyester (polycaprolactone, PCL), a protein (gelatin from cold water fish skin, GEL) and a polysaccharide (chitosan, CS) were the polymers chosen. Gelatin nanofibers were crosslinked with glutaraldehyde vapor. The scaffolds were characterized physico-chemically, in vitro by seeding with human fetal fibroblasts, HFFF2, and used in vivo as skin substitutes in a rat wound model with total skin removal ln vitro tests revealed that cells adhered and proliferated in all scaffolds. However, cells deep into the scaffold were only observed in the PCL and CS scaffolds. In in vivo tests CS scaffolds had the highest impact on the healing process by decreasing the extent of wound contraction and enhancing the production of a neodermis and re-epithelialization of the wound. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Gomes, S. R.; Henriques, C. M. R.; Silva, J. C.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Fis, Ctr Fis & Invest Tecnol, P-2829516 Caparica, Portugal.
   [Rodrigues, G.; Martins, G. G.] Univ Nova Lisboa, Fac Ciencias, Dept Biol Anim, Ctr Biol Ambiental, P-1749016 Lisbon, Portugal.
   [Martins, G. G.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal.
   [Roberto, M. A.] Hosp Sao Jose, Dept Cirurgia Plast & Reconstrut, P-1150199 Lisbon, Portugal.
   [Roberto, M. A.] Hosp Sao Jose, Unidade Queimados, P-1150199 Lisbon, Portugal.
   [Mafra, M.] Hosp Sao Jose, Serv Anat Patol, P-1150199 Lisbon, Portugal.
RP Gomes, SR (reprint author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Fis, Ctr Fis & Invest Tecnol, P-2829516 Caparica, Portugal.
EM srrg@campus.fct.unl.pt; jcs@fct.unl.pt
RI Silva, Jorge/A-3979-2012; Rodrigues, Gabriela/A-1909-2013; Martins,
   Gabriel/A-1538-2012; Henriques, Celia/J-7841-2013
OI Silva, Jorge/0000-0001-9959-4272; Rodrigues,
   Gabriela/0000-0002-0598-4040; Martins, Gabriel/0000-0002-6506-9776;
   Henriques, Celia/0000-0003-2711-1184
FU Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/37854/2007,
   PTDC/SAU-BMA/109886/2009]
FX The authors are thankful to Telmo Nunes from the Microscopy Unit of FCUL
   for the assistance with SEM, to Prof. Joao Paulo Borges from
   Cenimat/Materials Department, FCT/UNL, for the access to uniaxial
   tensile testing machine, to Prof. Maria Joao Melo from Department of
   Conservation and Restoration, FCT/UNL, for the access to FTIR and to
   Prof. Joao Sotomayor from the Chemistry Department, FCT/UNL, for the
   access to the surface tensiometer. This work was supported by Fundacao
   para a Ciencia e a Tecnologia, Portugal, through the fellowship
   SFRH/BD/37854/2007 and the project PTDC/SAU-BMA/109886/2009.
CR Alain D., 2001, POLYM BIOMATERIALS
   Azad AK, 2004, J BIOMED MATER RES B, V69B, P216, DOI 10.1002/jbm.b.30000
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Cuy JL, 2003, J BIOMED MATER RES A, V67A, P538, DOI 10.1002/jbm.a.10095
   De Wael K, 2011, INT J ELECTROCHEM SC, V6, P1810
   Dubsky M, 2012, J MATER SCI-MATER M, V23, P931, DOI 10.1007/s10856-012-4577-7
   Fang N, 2005, MACROMOL BIOSCI, V5, P1022, DOI 10.1002/mabi.200500123
   Gautam S, 2013, MAT SCI ENG C-MATER, V33, P1228, DOI 10.1016/j.msec.2012.12.015
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Gomes SR, 2013, MAT SCI ENG C-MATER, V33, P1219, DOI 10.1016/j.msec.2012.12.014
   Henriques C, 2009, J NANOSCI NANOTECHNO, V9, P3535, DOI 10.1166/jnn.2009.NS27
   Hosseinkhani H, 2003, J CONTROL RELEASE, V86, P169, DOI 10.1016/S0168-3659(02)00412-1
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Huss FRM, 2010, J PLAST RECONSTR AES, V63, P848, DOI 10.1016/j.bjps.2009.01.068
   King WWK, 1997, BURNS, V23, pS30
   Ko JH, 2010, MACROMOL RES, V18, P137, DOI 10.1007/s13233-009-0103-2
   Kriegel C, 2009, POLYMER, V50, P189, DOI 10.1016/j.polymer.2008.09.041
   Luna SM, 2011, J BIOMATER APPL, V26, P101, DOI 10.1177/0885328210362924
   Ma ZW, 2002, EUR POLYM J, V38, P2279, DOI 10.1016/S0014-3057(02)00119-2
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Mingyu Cheng, 2004, J Biomater Appl, V19, P59, DOI 10.1177/0885328204043450
   Mori T, 2005, J VET MED SCI, V67, P51, DOI 10.1292/jvms.67.51
   NANDAN D, 1988, EXP CELL RES, V179, P289, DOI 10.1016/0014-4827(88)90368-0
   Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073
   Ng KW, 2007, J BIOMAT SCI-POLYM E, V18, P925, DOI 10.1163/156856207781367693
   Pailler-Mattei C, 2006, TRIBOL INT, V39, P12, DOI 10.1016/j.triboint.2004.11.003
   Powell HM, 2008, J BIOMED MATER RES A, V84A, P1078, DOI 10.1002/jbm.a.31498
   Prabhakaran MP, 2008, TISSUE ENG PT A, V14, P1787, DOI 10.1089/ten.tea.2007.0393
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   Ragetly GR, 2010, J MATER SCI-MATER M, V21, P2479, DOI 10.1007/s10856-010-4096-3
   Shores J.T., 2007, ADV SKIN WOUND CARE, P20
   Silva JM, 2014, ADV HEALTHC MATER, V3, P433, DOI 10.1002/adhm.201300265
   Silver FH, 2001, SKIN RES TECHNOL, V7, P18, DOI 10.1034/j.1600-0846.2001.007001018.x
   Sisson K., 2009, BIOMACROMOLECULES, P10
   Songchotikunpan P, 2008, INT J BIOL MACROMOL, V42, P247, DOI 10.1016/j.ijbiomac.2007.11.005
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Van Vlierberghe S, 2011, POLYMERS-BASEL, V3, P114, DOI 10.3390/polym3010114
   Wang XH, 2006, J BIOACT COMPAT POL, V21, P39, DOI 10.1177/0883911506060201
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   Wu YG, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/24/245101
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yildirimer L, 2012, TRENDS BIOTECHNOL, V30, P638, DOI 10.1016/j.tibtech.2012.08.004
   Zha ZB, 2012, BIOPOLYMERS, V97, P1026, DOI 10.1002/bip.22120
   Zhan J., 2012, J RES UPDATES POLYM, V1, P59, DOI DOI 10.6000/1929-5995.2012.01.02.1
   Zhang JZ, 2014, J BIOMAT SCI-POLYM E, V25, P61, DOI 10.1080/09205063.2013.836950
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   Zhang YZ, 2006, POLYMER, V47, P2911, DOI 10.1016/j.polymer.2006.02.046
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhu XL, 2008, BIOMACROMOLECULES, V9, P1795, DOI 10.1021/bm800476u
   Zhu YB, 2004, BIOMATERIALS, V25, P423, DOI 10.1016/S0142-9612(03)00549-0
   Zvezdova D., 2010, ANN P 49 ANG KANCH U, V49, P65
NR 51
TC 47
Z9 49
U1 9
U2 124
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2015
VL 46
BP 348
EP 358
DI 10.1016/j.msec.2014.10.051
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AY7RQ
UT WOS:000347757100045
PM 25491997
DA 2018-10-20
ER

PT J
AU Kariem, H
   Pastrama, MI
   Roohani-Esfahani, SI
   Pivonka, P
   Zreiqat, H
   Hellmich, C
AF Kariem, Hawraa
   Pastrama, Maria-Ioana
   Roohani-Esfahani, Seyed Iman
   Pivonka, Peter
   Zreiqat, Hala
   Hellmich, Christian
TI Micro-poro-elasticity of baghdadite-based bone tissue engineering
   scaffolds: A unifying approach based on ultrasonics, nanoindentation,
   and homogenization theory
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Scaffold; Baghdadite; Nanoindentation; Ultrasound; Micromechanics
ID MECHANICAL-PROPERTIES; GRAFT SUBSTITUTES; MICROMECHANICAL MODEL;
   INDENTATION; MODULUS; BIOMATERIALS; COMPOSITES; CERAMICS; STRENGTH;
   BEHAVIOR
AB Microstructure-elasticity relations for bone tissue engineering scaffolds are key to rational biomaterial design. As a contribution thereto, we here report comprehensive length measuring, weighing, and ultrasonic tests at 0.1 MHz frequency, on porous baghdadite (Ca3ZrSi2O9) scaffolds. The resulting porosity-stiffness relations further confirm a formerly detected, micromechanically explained, general relationship for a great variety of different polycrystals, which also allows for estimating the zero-porosity case, i.e. Young modulus and Poisson ratio of pure (dense) baghdadite. These estimates were impressively confirmed by a physically and statistically independent nanoindentation campaign. comprising some 1750 indents. Consequently, we can present a remarkably complete picture of porous baghdadite elasticity across a wide range of porosities, and, thanks to the micromechanical understanding, reaching out beyond classical elasticity, towards poroelastic properties, quantifying the effect of pore pressure on the material system behavior. (C) 2014 The Authors. Published by Elsevier B.V.
C1 [Kariem, Hawraa; Pastrama, Maria-Ioana; Hellmich, Christian] Vienna Univ Technol, TU Wien, Inst Mech Mat & Struct, A-1040 Vienna, Austria.
   [Roohani-Esfahani, Seyed Iman; Zreiqat, Hala] Univ Sydney, Sch AMME, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.
   [Pivonka, Peter] Univ Melbourne, NorthWest Acad Ctr, Australian Inst Musculoskeletal Sci, Dept Med, Melbourne, Vic 3021, Australia.
RP Hellmich, C (reprint author), Vienna Univ Technol, TU Wien, Inst Mech Mat & Struct, Karlspl 13-6202, A-1040 Vienna, Austria.
EM christian.hellmich@tuwien.ac.at
OI Pivonka, Peter/0000-0001-9183-530X; Roohani, Iman/0000-0001-6618-8577;
   Pastrama, Maria-Ioana/0000-0001-9813-7512
FU European Research Council (ERC) [ERC-2010-StG-257032-MICROBONE];
   Australian Research Council (ARC) [LP0991099]
FX Maria Pastrama and Christian Hellmich were financially supported by the
   European Research Council (ERC), through project
   ERC-2010-StG-257032-MICROBONE. The work of Hata Zreiqat and Peter
   Pivonka was supported by the Australian Research Council (ARC) for
   linkage project funding (LP0991099).
CR ALHERMEZI HM, 1986, MINERAL MAG, V50, P119, DOI 10.1180/minmag.1986.050.355.15
   ALI MA, 1975, J MATER SCI, V10, P1920, DOI 10.1007/BF00754481
   [Anonymous], 2008, IND SOFTW US MAN
   Auriault J. L., 2009, HOMOGENIZATION COUPL
   Bala Y, 2011, J MECH BEHAV BIOMED, V4, P1473, DOI 10.1016/j.jmbbm.2011.05.017
   Bobko C, 2008, MECH MATER, V40, P318, DOI 10.1016/j.mechmat.2007.09.006
   Calori GM, 2011, INJURY, V42, pS56, DOI 10.1016/j.injury.2011.06.011
   Carcione J. M., 2001, WAVE FIELDS REAL MED
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   COBLE RL, 1956, J AM CERAM SOC, V39, P377, DOI 10.1111/j.1151-2916.1956.tb15608.x
   Colak A, 2006, MATER LETT, V60, P1977, DOI 10.1016/j.matlet.2005.12.062
   Constantinides G, 2006, MAT SCI ENG A-STRUCT, V430, P189, DOI 10.1016/j.msea.2006.05.125
   Constantinides G, 2007, J MECH PHYS SOLIDS, V55, P64, DOI 10.1016/j.jmps.2006.06.003
   Craciun F, 1998, FERROELECTRICS, V205, P49, DOI 10.1080/00150199808228387
   DEWITH G, 1981, J MATER SCI, V16, P1592
   Diaz A, 2004, J EUR CERAM SOC, V24, P413, DOI 10.1016/S0955-2219(03)00212-7
   Dormieux L, 2006, MICROPOROMECHANICS
   Drugan WJ, 1996, J MECH PHYS SOLIDS, V44, P497, DOI 10.1016/0022-5096(96)00007-5
   Fritsch A, 2006, CR MECANIQUE, V334, P151, DOI 10.1016/j.crme.2006.01.008
   Fritsch A, 2013, J APPL MECH-T ASME, V80, DOI 10.1115/1.4007922
   Fritsch A, 2009, J BIOMED MATER RES A, V88A, P149, DOI 10.1002/jbm.a.31727
   GILMORE RS, 1982, J MATER SCI, V17, P1131, DOI 10.1007/BF00543533
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   HAGLUND JA, 1973, J AM CERAM SOC, V56, P327, DOI 10.1111/j.1151-2916.1973.tb12506.x
   HASHIN Z, 1983, J APPL MECH-T ASME, V50, P481, DOI 10.1115/1.3167081
   HERSHEY AV, 1954, J APPL MECH-T ASME, V21, P236
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hum J, 2013, STRAIN, V49, P431, DOI 10.1111/str.12049
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jaindl M., 2009, ELECT ENERGETICS, V22, P159
   Khanna R., 2012, J NANOTECHNOL ENG ME, V2
   Khanna R, 2009, J ENG MECH, V135, P468, DOI 10.1061/(ASCE)EM.1943-7889.0000002
   Kiefer B, 2001, AM MINERAL, V86, P1387
   Kohlhauser C, 2013, ENG STRUCT, V47, P115, DOI 10.1016/j.engstruct.2012.10.027
   Kohlhauser C, 2009, STRAIN, V45, P34, DOI 10.1111/j.1475-1305.2008.00417.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P757, DOI 10.1016/S0142-9612(99)00179-9
   Liu DM, 1998, CERAM INT, V24, P441, DOI 10.1016/S0272-8842(97)00033-3
   Luczynski KW, 2013, J BIOMED MATER RES A, V101, P138, DOI 10.1002/jbm.a.34316
   Malandrino A, 2012, MATER LETT, V78, P154, DOI 10.1016/j.matlet.2012.03.052
   Malasoma A, 2008, ADV APPL CERAM, V107, P277, DOI 10.1179/174367508X306488
   MEILLE S, 2001, THESIS INSA LYON
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Mullner HW, 2008, STRAIN, V44, P153, DOI 10.1111/j.1475-1305.2007.00360.x
   Nix WD, 1998, J MECH PHYS SOLIDS, V46, P411, DOI 10.1016/S0022-5096(97)00086-0
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Pabst W, 2006, J EUR CERAM SOC, V26, P1085, DOI 10.1016/j.jeurceramsoc.2005.01.041
   Pabst W, 2004, CERAM-SILIKATY, V48, P165
   PHANI KK, 1986, AM CERAM SOC BULL, V65, P1584
   Pichler B, 2009, ACTA MECH, V203, P137, DOI 10.1007/s00707-008-0007-9
   Ramaswamy Y, 2008, BIOMATERIALS, V29, P4392, DOI 10.1016/j.biomaterials.2008.08.006
   Reynaud C, 2005, J EUR CERAM SOC, V25, P589, DOI 10.1016/j.jeurceramsoc.2004.02.009
   Roohani-Esfahani SI, 2012, ACTA BIOMATER, V8, P4162, DOI 10.1016/j.actbio.2012.07.036
   Sanahuja J, 2010, J ENG MECH, V136, P239, DOI 10.1061/(ASCE)EM.1943-7889.0000072
   SAWAMOTO H, 1984, SCIENCE, V224, P749, DOI 10.1126/science.224.4650.749
   Scheiner S, 2009, BIOMATERIALS, V30, P2411, DOI 10.1016/j.biomaterials.2008.12.048
   Schumacher TC, 2014, J MECH BEHAV BIOMED, V34, P294, DOI 10.1016/j.jmbbm.2014.02.021
   Tazawa E, 1998, ADV CEM BASED MATER, V7, P1, DOI 10.1016/S1065-7355(97)00010-2
   Ulm FJ, 2007, J AM CERAM SOC, V90, P2677, DOI [10.1111/j.1551-2916.2007.02012.x, 10.1111/j.1551-2916.2007.02012.Xx]
   Weicker K., 2007, EVOLUTIONDRE ALGORIT
   Zaoui A., 2002, J ENG MECH, V128
NR 62
TC 15
Z9 15
U1 1
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2015
VL 46
BP 553
EP 564
DI 10.1016/j.msec.2014.10.072
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA AY7RQ
UT WOS:000347757100069
PM 25492021
OA Other Gold
DA 2018-10-20
ER

PT J
AU Han, HS
   Lee, SH
   Kim, WJ
   Jeon, H
   Seok, HK
   Ahn, JP
   Kim, YC
AF Han, Hyung-Seop
   Lee, Sun Hee
   Kim, Won-Joo
   Jeon, Hojeong
   Seok, Hyun-Kwang
   Ahn, Jae-Pyung
   Kim, Yu-Chan
TI Reduction of Initial Corrosion Rate and Improvement of Cell Adhesion
   Through Surface Modification of Biodegradable Mg Alloy
SO METALS AND MATERIALS INTERNATIONAL
LA English
DT Article
DE biomaterials; metals; alloys; surface modification; corrosion; focused
   ion beam
ID PURE MAGNESIUM; ORTHOPEDIC IMPLANTS; AMINO-ACIDS; IN-VITRO; DEGRADATION;
   TITANIUM; SUSCEPTIBILITY; BIOMATERIAL; BEHAVIOR; BONE
AB In this study, the surface modification of biodegradable pure Magnesium and Mg-5wt%Ca-1 wt%Zn alloy was performed through immersion in HBSS, inorganic salt solution and cell media to reduce initial hydrogen evolution and improve cell adhesion. The formation of different CaP-like coatings from immersion of pure Mg and Mg alloy were observed using Cryo FM analysis and their performances were measured through cell adhesion, quantification of released Mg ions, and cell cytotoxicity assays. The coating layers displayed significant reduction of initial corrosion rate, and cell adhesion for both pure Mg and Mg alloy appeared to be influenced by the amino acids and proteins in the cell media. In general, Mg alloy showed a denser coating layer with higher Ca contents, resulting in greater reduction of initial corrosion rate and improved cell adhesion, when compared to pure Mg. This is due to saturation of Ca around the corrosion site that provided much favorable environmental condition to produce denser calcium phosphate coating mixture. The result from this study suggests that the surface modification of biodegradable Mg alloy by immersion in alkaline solutions can be utilized to obtain ideal biodegradable orthopedic implant material with reduced initial hydrogen evolution rate and improved cell adhesion.
C1 [Han, Hyung-Seop; Lee, Sun Hee; Kim, Won-Joo; Jeon, Hojeong; Seok, Hyun-Kwang; Kim, Yu-Chan] Korea Inst Sci & Technol, Ctr Biomat, Seoul 136650, South Korea.
   [Ahn, Jae-Pyung] Korea Inst Sci & Technol, Nano Anal Ctr, Seoul 136650, South Korea.
   [Jeon, Hojeong; Seok, Hyun-Kwang; Kim, Yu-Chan] Univ Sci & Technol, Seoul 136650, South Korea.
RP Kim, YC (reprint author), Korea Inst Sci & Technol, Ctr Biomat, Seoul 136650, South Korea.
EM chany@kist.re.kr
OI Han, Hyung-Seop/0000-0001-6870-1485
FU KIST TRC Project [2E25501]; Seoul R&BD program, Seoul Development
   Institute, Republic of Korea [SS100008]
FX This study was supported by the KIST TRC Project (2E25501) and Seoul
   R&BD program, Seoul Development Institute, Republic of Korea (SS100008).
   The authors would like to express our sincere gratitude to J. H. Noh at
   Advanced Analysis Center, KIST, for the microstructure characterization
   using cryo-FIB. The author(s) declare no competing financial interests.
CR Ashassi-Sorkhabi H, 2004, APPL SURF SCI, V225, P176, DOI 10.1016/j.apsusc.2003.10.007
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Cha PR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02367
   Claes L, 2002, CHIRURG, V73, P990, DOI 10.1007/s00104-002-0543-0
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Emstberger T., 2007, SPINE J, V7, P360
   Giordani EJ, 2004, INT J FATIGUE, V26, P1129, DOI 10.1016/j.ijfatigue.2004.03.002
   Gu XN, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065011
   HOFMANN GO, 1995, ARCH ORTHOP TRAUM SU, V114, P123, DOI 10.1007/BF00443385
   Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001
   Kim Y, 2013, MET MATER INT, V19, P19, DOI 10.1007/s12540-013-1004-7
   Lee JY, 2009, MET MATER INT, V15, P955, DOI 10.1007/s12540-009-0955-1
   Lee MH, 2007, MET MATER INT, V13, P109, DOI 10.1007/BF03027560
   Levesque J., 2004, ADV MATER, V9, P45
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   Nordlien JH, 1997, CORROS SCI, V39, P1397, DOI 10.1016/S0010-938X(97)00037-1
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Williams David, 2006, Med Device Technol, V17, P9
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014
   Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015
   Yen SK, 2001, BIOMATERIALS, V22, P125, DOI 10.1016/S0142-9612(00)00133-2
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 28
TC 2
Z9 2
U1 0
U2 31
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881,
   SOUTH KOREA
SN 1598-9623
EI 2005-4149
J9 MET MATER INT
JI Met. Mater.-Int.
PD JAN
PY 2015
VL 21
IS 1
BP 194
EP 201
DI 10.1007/s12540-015-1024-6
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA AZ5FH
UT WOS:000348245300024
DA 2018-10-20
ER

PT J
AU Qu, FN
   Pintauro, MP
   Haughan, JE
   Henning, EA
   Esterhai, JL
   Schaer, TP
   Mauck, RL
   Fisher, MB
AF Qu, Feini
   Pintauro, Michael P.
   Haughan, Joanne E.
   Henning, Elizabeth A.
   Esterhai, John L.
   Schaer, Thomas P.
   Mauck, Robert L.
   Fisher, Matthew B.
TI Repair of dense connective tissues via biomaterial-mediated matrix
   reprogramming of the wound interface
SO BIOMATERIALS
LA English
DT Article
DE Connective tissue; Drug delivery; ECM (extracellular matrix); In vivo
   test; Scaffold; Wound healing
ID CELL-MIGRATION; KNEE-JOINT; POLYURETHANE SCAFFOLD; MENISCUS INTEGRATION;
   TENDON REPAIR; FETAL SHEEP; IN-VITRO; REGENERATION; DEFECT; MODEL
AB Repair of dense connective tissues in adults is limited by their intrinsic hypocellularity and is exacerbated by a dense extracellular matrix (ECM) that impedes cellular migration to and local proliferation at the wound site. Conversely, healing in fetal tissues occurs due in part to an environment conducive to cell mobility and division. Here, we investigated whether the application of a degradative enzyme, collagenase, could reprogram the adult wound margin to a more fetal-like state, and thus abrogate the biophysical impediments that hinder migration and proliferation. We tested this concept using the knee meniscus, a commonly injured structure for which few regenerative approaches exist. To focus delivery and degradation to the wound interface, we developed a system in which collagenase was stored inside poly(ethylene oxide) (PEO) electrospun nanofibers and released upon hydration. Through a series of in vitro and in vivo studies, our findings show that partial digestion of the wound interface improves repair by creating a more compliant and porous microenvironment that expedites cell migration to and/or proliferation at the wound margin. This innovative approach of targeted manipulation of the wound interface, focused on removing the naturally occurring barriers to adult tissue repair, may find widespread application in the treatment of injuries to a variety of dense connective tissues. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Qu, Feini; Pintauro, Michael P.; Henning, Elizabeth A.; Esterhai, John L.; Mauck, Robert L.; Fisher, Matthew B.] Univ Penn, Perelman Sch Med, McKay Orthopaed Res Lab, Dept Orthopaed Surg, Philadelphia, PA 19104 USA.
   [Qu, Feini; Pintauro, Michael P.; Mauck, Robert L.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Qu, Feini; Pintauro, Michael P.; Henning, Elizabeth A.; Esterhai, John L.; Mauck, Robert L.; Fisher, Matthew B.] Philadelphia Vet Adm Med Ctr, Translat Musculoskeletal Res Ctr, Philadelphia, PA 19104 USA.
   [Qu, Feini; Haughan, Joanne E.; Schaer, Thomas P.] Univ Penn, Sch Vet Med, New Bolton Ctr, Comparat Orthopaed Res Lab, Kennett Sq, PA 19348 USA.
RP Mauck, RL (reprint author), Univ Penn, Perelman Sch Med, McKay Orthopaed Res Lab, 36th St & Hamilton Walk, Philadelphia, PA 19104 USA.
EM lemauck@mail.med.upenn.edu; mbfisher@ncsu.edu
RI Fisher, Matthew/M-5809-2016
OI Fisher, Matthew/0000-0002-3212-0870; Mauck, Robert/0000-0002-9537-603X
FU National Institutes of Health [R01 AR056624, T32 GM007170, T32
   AR007132]; Department of Veterans Affairs [101 RX000174];
   Musculoskeletal Transplant Foundation; Armour-Lewis Foundation; School
   of Veterinary Medicine
FX We thank the staff at the Philadelphia VA Medical Center and the New
   Bolton Center for veterinary and administrative support. We also thank
   Claire McLeod and Brian Cosgrove for assistance with AFM. This work was
   supported by the National Institutes of Health (R01 AR056624, T32
   GM007170, T32 AR007132), the Department of Veterans Affairs (101
   RX000174), the Musculoskeletal Transplant Foundation, the Armour-Lewis
   Foundation, and the School of Veterinary Medicine. The content is solely
   the responsibility of the authors and does not represent the official
   views of the National Institutes of Health or the Department of Veterans
   Affairs. No funding source had a role in the study design, collection,
   analysis and interpretation of data, writing of the manuscript, or the
   decision to submit the manuscript for publication.
CR Ansorge HL, 2011, ANN BIOMED ENG, V39, P1904, DOI 10.1007/s10439-011-0299-0
   Arnoczky SP, 2010, TISSUE ENG PART B-RE, V16, P31, DOI [10.1089/ten.teb.2009.0428, 10.1089/ten.TEB.2009.0428]
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Baker BM, 2011, TISSUE ENG PT A, V17, P1445, DOI [10.1089/ten.TEA.2010.0535, 10.1089/ten.tea.2010.0535]
   Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109
   Baker BM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3192140
   Bendon CL, 2012, J BONE JOINT SURG BR, V94B, P1390, DOI 10.1302/0301-620X.94B10.29331
   Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931
   Bhargava MM, 1999, AM J SPORT MED, V27, P636, DOI 10.1177/03635465990270051601
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Bravenboer JV, 2004, ARTHRITIS RES THER, V6, pR469, DOI 10.1186/ar1216
   CLARK CR, 1983, J BONE JOINT SURG AM, V65, P538, DOI 10.2106/00004623-198365040-00018
   Cook JL, 2006, AM J SPORT MED, V34, P32, DOI 10.1177/0363546505278702
   EGGLI S, 1995, AM J SPORT MED, V23, P715, DOI 10.1177/036354659502300614
   Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082
   Farrell MJ, 2014, J BIOMECH, V47, P2173, DOI 10.1016/j.jbiomech.2013.10.030
   Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271
   Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648
   Guterl CC, 2013, EUR CELLS MATER, V25, P1
   Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029
   Henriksson HB, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt315
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Ionescu LC, 2011, TISSUE ENG PT A, V17, P193, DOI [10.1089/ten.tea.2010.0272, 10.1089/ten.TEA.2010.0272]
   Ionescu LC, 2012, ACTA BIOMATER, V8, P3687, DOI 10.1016/j.actbio.2012.06.005
   Kambic HE, 2000, WOUND REPAIR REGEN, V8, P554, DOI 10.1046/j.1524-475x.2000.00554.x
   Kobayashi Y, 2010, AM J SPORT MED, V38, P740, DOI 10.1177/0363546509350749
   Kon E, 2014, KNEE SURG SPORT TR A, V22, P128, DOI 10.1007/s00167-012-2328-4
   Koohestani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075844
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Maher SA, 2010, ARTHROSCOPY, V26, P1510, DOI 10.1016/j.arthro.2010.02.033
   Makris EA, 2014, BIOMATERIALS, V35, P6787, DOI 10.1016/j.biomaterials.2014.04.083
   Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037
   Manning CN, 2013, ACTA BIOMATER, V9, P6905, DOI 10.1016/j.actbio.2013.02.008
   McNulty AL, 2009, CLIN ORTHOP RELAT R, V467, P1557, DOI 10.1007/s11999-008-0596-6
   Mesiha M, 2007, AM J SPORT MED, V35, P103, DOI 10.1177/0363546506293700
   Ng KW, 2012, TISSUE ENG PT A, V18, P1273, DOI [10.1089/ten.TEA.2011.0276, 10.1089/ten.tea.2011.0276]
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   Puetzer JL, 2012, TISSUE ENG PT A, V18, P1365, DOI [10.1089/ten.tea.2011.0589, 10.1089/ten.TEA.2011.0589]
   Qu FN, 2013, ACTA BIOMATER, V9, P6393, DOI 10.1016/j.actbio.2013.01.016
   Sanchez-Adams J, 2013, J ORTHOP RES, V31, P1218, DOI 10.1002/jor.22362
   Shi L, 2010, INT WOUND J, V7, P87, DOI 10.1111/j.1742-481X.2010.00659.x
   Shrive N G, 1978, Clin Orthop Relat Res, P279
   Stalling SS, 2008, CLIN ORTHOP RELAT R, V466, P3130, DOI 10.1007/s11999-008-0391-4
   Tatti O, 2008, EXP CELL RES, V314, P2501, DOI 10.1016/j.yexcr.2008.05.018
   Vanderhave KL, 2011, J PEDIATR ORTHOPED, V31, P496, DOI 10.1097/BPO.0b013e31821ffb8d
   Verdonk R, 2011, AM J SPORT MED, V39, P774, DOI 10.1177/0363546511398040
   WALKER PS, 1975, CLIN ORTHOP RELAT R, P184
   Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152
   Yang G, 2013, BIRTH DEFECTS RES C, V99, P203, DOI 10.1002/bdrc.21041
   Zhang XZ, 2012, J SHOULDER ELB SURG, V21, P266, DOI 10.1016/j.jse.2011.11.016
NR 51
TC 23
Z9 23
U1 1
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2015
VL 39
BP 85
EP 94
DI 10.1016/j.biomaterials.2014.10.067
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AY7TB
UT WOS:000347760600010
PM 25477175
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Blackburn, NJR
   Sofrenovic, T
   Kuraitis, D
   Ahmadi, A
   McNeill, B
   Deng, C
   Rayner, KJ
   Zhong, ZY
   Ruel, M
   Suuronen, EJ
AF Blackburn, Nick J. R.
   Sofrenovic, Tanja
   Kuraitis, Drew
   Ahmadi, Ali
   McNeill, Brian
   Deng, Chao
   Rayner, Katey J.
   Zhong, Zhiyuan
   Ruel, Marc
   Suuronen, Erik J.
TI Timing underpins the benefits associated with injectable collagen
   biomaterial therapy for the treatment of myocardial infarction
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Extracellular matrix; Fibrosis; Heart; Hydrogel
ID LEFT-VENTRICULAR FUNCTION; HEART-FAILURE; EXTRACELLULAR-MATRIX; CELL
   THERAPY; REGENERATION; DELIVERY; DISEASE; PROLIFERATION; MACROPHAGES;
   INJECTION
AB Injectable hydrogel biomaterials are promising therapies to promote repair and regeneration post-myocardial infarction (MI). However, the timing of delivery and the mechanisms through which biomaterial treatments confer their benefits are translational issues that remain to be addressed. We assessed the efficacy of an injectable collagen matrix at 3 different delivery time points post-MI. Infarcted mice received the matrix or control (saline) treatment at 3 h, 1 week or 2 weeks after MI. The earlier treatment delivery better prevented negative ventricular remodeling and long-term deterioration of cardiac function (up to 3 months), whereas waiting longer to administer the matrix (1 and 2 weeks post-MI) reduced the therapeutic effects. Collagen matrix delivery did not stimulate an inflammatory response acutely and favorably modulated inflammation in the myocardium long-term. We found that the matrix interacts with the host tissue to alter the myocardial cytokine profile, promote angiogenesis, and reduce fibrosis and cell death. This work highlights that the timing of delivery can significantly affect the ability of an injectable hydrogel to protect the post-MI environment, which will be an important consideration in the clinical translation of cardiac biomaterial therapy. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Blackburn, Nick J. R.; Sofrenovic, Tanja; Kuraitis, Drew; Ahmadi, Ali; McNeill, Brian; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Blackburn, Nick J. R.; Sofrenovic, Tanja; Kuraitis, Drew; Ahmadi, Ali; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.
   [Deng, Chao; Zhong, Zhiyuan] Soochow Univ, Biomed Polymers Lab, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
   [Deng, Chao; Zhong, Zhiyuan] Soochow Univ, Jiangsu Key Lab Adv Funct Polymer Design & Applic, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
   [Rayner, Katey J.] Univ Ottawa, Inst Heart, Atherosclerosis Genom & Cell Biol Grp, Ottawa, ON K1Y 4W7, Canada.
RP Suuronen, EJ (reprint author), Univ Ottawa, Inst Heart, Div Cardiac Surg, 40 Ruskin St,Room H5227, Ottawa, ON K1Y 4W7, Canada.
EM esuuronen@ottawaheart.ca
RI Zhong, Zhiyuan/D-8508-2011
OI Zhong, Zhiyuan/0000-0003-4175-4741; RUEL, MARC/0000-0002-0487-1319;
   Rayner, Katey/0000-0001-6230-426X
FU Heart and Stroke Foundation of Canada (HSFC) [T6793]; Canadian
   Institutes of Health Research (CIHR) [FRN 125678, MOP-77536]; National
   Natural Science Foundation of China [NSFC 81261120557]; University of
   Ottawa's Faculty of Medicine Endowed Funds for Cardiac Research; UOHI
   Foundation; HSFC; CIHR
FX The authors thank Rick Seymour, Kimberly McEwan, Dr. Donna Padavan and
   Suzanne Crowe for technical assistance, and the animal care staff at the
   University of Ottawa for their help in animal surgery and maintenance.
   This work was supported by the Heart and Stroke Foundation of Canada
   (HSFC; grant-in-aid T6793 to E.J.S.), by the Canadian Institutes of
   Health Research (CIHR; grant FRN 125678 to E.J.S., and grant MOP-77536
   to M.R. and E.J.S.), and by the National Natural Science Foundation of
   China (grant NSFC 81261120557 to Z.Z., C.D.). N.J.R.B. and B.M. were
   supported by awards from the University of Ottawa's Faculty of Medicine
   Endowed Funds for Cardiac Research and the UOHI Foundation, T.S. by
   Master's studentship award from the HSFC, T.S. and D.K. by Canadian
   Graduate Scholarships from the CIHR, and B.M. by a Research Fellowship
   from the HSFC.
CR Ahmadi A, 2014, BIOMATERIALS, V35, P4749, DOI 10.1016/j.biomaterials.2014.02.028
   Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181
   Bayomy AF, 2012, LIFE SCI, V91, P823, DOI 10.1016/j.lfs.2012.08.034
   Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878
   Burdick JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003997
   CECCHINI MG, 1987, J BONE MINER RES, V2, P135
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015
   Eckhouse SR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007244
   Eyman D, 2009, J CELL PHYSIOL, V220, P376, DOI 10.1002/jcp.21776
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Haberstroh U, 2002, KIDNEY INT, V62, P1264, DOI 10.1111/j.1523-1755.2002.kid572.x
   Hedayat M, 2010, HEART FAIL REV, V15, P543, DOI 10.1007/s10741-010-9168-4
   Hwang MW, 2001, J AM COLL CARDIOL, V38, P1546, DOI 10.1016/S0735-1097(01)01591-1
   Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kadner K, 2012, BIOMATERIALS, V33, P2060, DOI 10.1016/j.biomaterials.2011.11.031
   Kemp CD, 2012, CARDIOVASC PATHOL, V21, P365, DOI 10.1016/j.carpath.2011.11.007
   KLONER RA, 1978, CIRCULATION, V57, P56, DOI 10.1161/01.CIR.57.1.56
   Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986
   Kuraitis D, 2012, EUR CELLS MATER, V24, P175, DOI 10.22203/eCM.v024a13
   Kuraitis D, 2013, DIS MODEL MECH, V6, P793, DOI 10.1242/dmm.011072
   Kuraitis D, 2012, BIOMATERIALS, V33, P428, DOI 10.1016/j.biomaterials.2011.09.078
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Li AH, 2014, CIRC RES, V114, P916, DOI 10.1161/CIRCRESAHA.114.302819
   Lin YD, 2012, SCI TRANSL MED, V4
   Malliaras K, 2011, CLIN PHARMACOL THER, V90, P532, DOI 10.1038/clpt.2011.175
   McGarvey JR, 2014, J PHARMACOL EXP THER, V350, P701, DOI 10.1124/jpet.114.215798
   McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4
   Monden Y, 2007, CARDIOVASC RES, V73, P794, DOI 10.1016/j.cardiores.2006.12.016
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Radhakrishnan J, 2014, BIOTECHNOL ADV, V32, P449, DOI 10.1016/j.biotechadv.2013.12.010
   Ramani R, 2011, CTS-CLIN TRANSL SCI, V4, P24, DOI 10.1111/j.1752-8062.2010.00252.x
   Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219
   Santini MP, 2012, J CARDIOVASC TRANSL, V5, P700, DOI 10.1007/s12265-012-9383-6
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5
   Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007
   Surder D, 2013, CIRCULATION, V127, P1968, DOI 10.1161/CIRCULATIONAHA.112.001035
   Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007
   Traverse JH, 2014, JAMA-J AM MED ASSOC, V311, P301, DOI 10.1001/jama.2013.282674
   Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906
   Virag JAI, 2007, AM J PATHOL, V171, P1431, DOI 10.2353/ajpat.2007.070003
NR 47
TC 18
Z9 21
U1 5
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2015
VL 39
BP 182
EP 192
DI 10.1016/j.biomaterials.2014.11.004
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AY7TB
UT WOS:000347760600020
PM 25468370
DA 2018-10-20
ER

PT J
AU Bhardwaj, N
   Sow, WT
   Devi, D
   Ng, KW
   Mandal, BB
   Cho, NJ
AF Bhardwaj, Nandana
   Sow, Wan Ting
   Devi, Dipali
   Ng, Kee Woei
   Mandal, Biman B.
   Cho, Nam-Joon
TI Silk fibroin-keratin based 3D scaffolds as a dermal substitute for skin
   tissue engineering
SO INTEGRATIVE BIOLOGY
LA English
DT Article
ID IN-VITRO; ARTIFICIAL SKIN; CHONDROGENIC DIFFERENTIATION; PROTEIN
   SCAFFOLDS; POROUS SCAFFOLDS; DRUG-DELIVERY; GROWTH-FACTOR; CELL SHEETS;
   STEM-CELLS; PORE-SIZE
AB Development of highly vascular dermal tissue-engineered skin substitutes with appropriate mechanical properties and cellular cues is in need for significant advancement in the field of dermal reconstruction. Limitations have been imposed on natural biomaterials despite their superb biocompatibility hence, studies in biomaterial blending have been ongoing. Herein, we investigated blends of silk fibroin and human hair-derived keratin as wound-healing substrates that promote enhanced fibroblast cell adhesion and proliferation. Three-dimensional (3D) blended scaffolds were fabricated by freeze-drying, and their physico-chemical, mechanical and degradable properties were extensively characterized. Cytocompatibility tests observing cell adhesion and cell proliferation have shown significant enhancements in blended scaffolds. Also, its structural composition with high porosity (485%) and interconnected pores in the range of 100-120 microns further confirms the superiority of the complex compared to its counterparts. FTIR studies identified the enhanced stability within its structure and were followed-up with sequential experiments to demonstrate improved thermal, degradation, and mechanical properties. Furthermore, immunohistochemical staining revealed greater expression of collagen type I in the cultured cells, indicating functional fibroblast proliferation and, hence, the exciting potential of this construct for dermal applications. Taken together, this study demonstrates the promising attributes from blended biomaterials and specifically present silk fibroin and human hair keratin blended scaffolds as a promising dermal substitute for skin tissue engineering.
C1 [Bhardwaj, Nandana; Sow, Wan Ting; Ng, Kee Woei; Cho, Nam-Joon] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   [Bhardwaj, Nandana; Cho, Nam-Joon] Nanyang Technol Univ, Ctr Biomimet Sensor Sci, Singapore 639553, Singapore.
   [Bhardwaj, Nandana; Devi, Dipali] Inst Adv Study Sci & Technol, Div Life Sci, Seri Biotechnol Unit, Gauhati 781035, India.
   [Mandal, Biman B.] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati 781039, India.
   [Cho, Nam-Joon] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.
RP Cho, NJ (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
EM nandana.bhardwaj@gmail.com; biman.mandal@iitg.ernet.in; njcho@ntu.edu.sg
RI Cho, Nam-Joon/J-7816-2012; Ng, Kee Woei/B-7242-2008
OI Cho, Nam-Joon/0000-0002-8692-8955; Ng, Kee Woei/0000-0002-7276-3563;
   Bhardwaj, Dr. Nandana/0000-0002-7747-3661
FU National Research Foundation [NRF-NRFF2011-01, NRF-CRP10-2012-07];
   National Medical Research Council [NMRC/CBRG/0005/2012]
FX This work was supported by the National Research Foundation
   (NRF-NRFF2011-01) and (NRF-CRP10-2012-07), the National Medical Research
   Council (NMRC/CBRG/0005/2012).
CR Bellas E, 2012, MACROMOL BIOSCI, V12, P1627, DOI 10.1002/mabi.201200262
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Bhardwaj N, 2011, INT J BIOL MACROMOL, V49, P260, DOI 10.1016/j.ijbiomac.2011.04.013
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Bottcher-Haberzeth S, 2010, BURNS, V36, P450, DOI 10.1016/j.burns.2009.08.016
   Brohem CA, 2011, PIGM CELL MELANOMA R, V24, P35, DOI 10.1111/j.1755-148X.2010.00786.x
   Carlson M., 2010, TISSUE ENG PART A, V17, P487
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054055
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Choi W, 2010, J CELL SCI, V123, P3102, DOI 10.1242/jcs.064774
   Gauglitz GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029942
   Gosain A, 2004, WORLD J SURG, V28, P321, DOI 10.1007/s00268-003-7397-6
   Groeber F, 2011, ADV DRUG DELIVER REV, V63, P352, DOI 10.1016/j.addr.2011.01.005
   Guan GP, 2010, BIO-MED MATER ENG, V20, P295, DOI 10.3233/BME-2010-0643
   Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125
   Ishibuchi H, 2010, EXP DERMATOL, V19, pE111, DOI 10.1111/j.1600-0625.2009.00999.x
   Kremer M, 2000, BRIT J PLAST SURG, V53, P459, DOI 10.1054/bjps.2000.3368
   Lawrence BJ, 2008, CELL ADHES MIGR, V2, P9, DOI 10.4161/cam.2.1.5884
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Liu YY, 2012, MAT SCI ENG C-MATER, V32, P2361, DOI 10.1016/j.msec.2012.07.008
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2013, MACROMOL BIOSCI, V13, P48, DOI 10.1002/mabi.201200230
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Metcalfe AD, 2007, BIOMATERIALS, V28, P5100, DOI 10.1016/j.biomaterials.2007.07.031
   Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6
   Murphy CM, 2010, CELL ADHES MIGR, V4, P377, DOI 10.4161/cam.4.3.11747
   Navone SE, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt396
   Navsaria HA, 2004, PLAST RECONSTR SURG, V113, P978, DOI 10.1097/01.PRS.0000105632.86651.EF
   Ng KW, 2006, BIOMATERIALS, V27, P4591, DOI 10.1016/j.biomaterials.2006.04.020
   Ng Kee Woei, 2001, Tissue Engineering, V7, P441, DOI 10.1089/10763270152436490
   Ng KW, 2005, J BIOMED MATER RES A, V75A, P425, DOI 10.1002/jbm.a.30454
   Nguyen DQA, 2010, BURNS, V36, P23, DOI 10.1016/j.burns.2009.07.011
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Schulz JT, 2000, ANNU REV MED, V51, P231, DOI 10.1146/annurev.med.51.1.231
   Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161
   Seet WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040978
   Shevchenko RV, 2014, ACTA BIOMATER, V10, P3156, DOI 10.1016/j.actbio.2014.03.027
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Souto Luís Ricardo Martinhão, 2006, Sao Paulo Med. J., V124, P71, DOI 10.1590/S1516-31802006000200005
   Sow WT, 2013, NANOMEDICINE-UK, V8, P531, DOI [10.2217/NNM.13.38, 10.2217/nnm.13.38]
   Srinivasan B, 2010, J BIOMED MATER RES B, V92B, P5, DOI 10.1002/jbm.b.31483
   Stiefel D, 2010, BURNS, V36, P114, DOI 10.1016/j.burns.2009.02.023
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Taraballi F, 2012, ADV HEALTHC MATER, V1, P513, DOI 10.1002/adhm.201200043
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   van der Veen VC, 2010, BURNS, V36, P305, DOI 10.1016/j.burns.2009.07.012
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Vasconcelos A, 2010, BIOMACROMOLECULES, V11, P2213, DOI 10.1021/bm100537b
   Vasconcelos A, 2009, BIOMACROMOLECULES, V10, P1019, DOI 10.1021/bm9002927
   Wang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056330
   Wang S, 2012, CELL TISSUE RES, V347, P795, DOI 10.1007/s00441-011-1295-2
   Wang W., 2009, TISSUE ENG PART C-ME, V16, P269
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yan SQ, 2013, ACTA BIOMATER, V9, P6771, DOI 10.1016/j.actbio.2013.02.016
   YANNAS I V, 1992, Clinical Materials, V9, P179, DOI 10.1016/0267-6605(92)90098-E
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang Q, 2009, MATERIALS, V2, P2276, DOI 10.3390/ma2042276
   Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100
   Zoccola M, 2008, BIOMACROMOLECULES, V9, P2819, DOI 10.1021/bm800579a
NR 73
TC 57
Z9 58
U1 11
U2 85
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1757-9694
EI 1757-9708
J9 INTEGR BIOL-UK
JI Integr. Biol.
PY 2015
VL 7
IS 1
BP 53
EP 63
DI 10.1039/c4ib00208c
PG 11
WC Cell Biology
SC Cell Biology
GA AY7ET
UT WOS:000347724900005
PM 25372050
DA 2018-10-20
ER

PT J
AU Li, T
   Zhang, H
   He, Y
   Wang, X
AF Li, T.
   Zhang, H.
   He, Y.
   Wang, X.
TI Comparison of corrosion behavior of Mg-1.5Zn-0.6Zr and AZ91D alloys in a
   NaCl solution
SO MATERIALS AND CORROSION-WERKSTOFFE UND KORROSION
LA English
DT Article
ID IN-VITRO CORROSION; MG-AG ALLOYS; MAGNESIUM ALLOYS; PHYSIOLOGICAL
   ENVIRONMENT; HEAT-TREATMENT; ZR ALLOY; MICROSTRUCTURE; IMPLANTS; VIVO
AB The microstructure and corrosion behavior of as-cast Mg-1.5Zn-0.6Zr alloy and a comparative AZ91D alloy were investigated through metallographic observations, X-ray diffraction, electron probe micro-analysis, immersion tests, and cyclic polarization measurements. The Mg-1.5Zn-0.6Zr exhibited a single-phase solid solution characteristic and had fine equiaxed grains, while the AZ91D consisted of alpha-Mg matrix and beta-Mg17Al12 second phases. It was found that Zr is enriched in the center of most grains in Mg-1.5Zn-0.6Zr. Immersion tests showed that the corrosion rate of Mg-1.5Zn-0.6Zr was only about half of that of AZ91D in 5% NaCl solution. The better corrosion properties of Mg-1.5Zn-0.6Zr we owe to the elimination of intensive galvanic corrosion reactions, the formation of much more compact and uniform corrosion films, and the stabilization of magnesium solid solution by Zr. The Mg-1.5Zn-0.6Zr showed a desired uniform corrosion behavior during degradation, which can be reasonably explained by cyclic polarization measurements. The Mg-1.5Zn-0.6Zr alloy displays good corrosion resistance and could be a promising degradable biomaterial.
C1 [Li, T.; Zhang, H.; He, Y.; Wang, X.] Univ Sci & Technol Beijing, State Key Lab Adv Met & Mat, Beijing 100083, Peoples R China.
RP Wang, X (reprint author), Univ Sci & Technol Beijing, State Key Lab Adv Met & Mat, 30 Xueyuan Rd, Beijing 100083, Peoples R China.
EM xtwang@ustb.edu.cn
OI Li, Tao/0000-0002-0396-4775; Wang, Xitao/0000-0002-1138-3372
FU National Natural Science Foundation of China [51174025]; Specialized
   Research Fund for the Doctoral Program of Higher Education of China
   [20110006130004]
FX This project was supported by the National Natural Science Foundation of
   China (No. 51174025) and Specialized Research Fund for the Doctoral
   Program of Higher Education of China (No. 20110006130004).
CR Abidin NIZ, 2013, CORROS SCI, V75, P354, DOI 10.1016/j.corsci.2013.06.019
   Alvarez-Lopez M, 2010, ACTA BIOMATER, V6, P1763, DOI 10.1016/j.actbio.2009.04.041
   [Anonymous], 2004, G3172 ASTM
   [Anonymous], 1999, G190 ASTM
   Atrens A, 2013, J MAGNES ALLOY, V1, P177, DOI 10.1016/j.jma.2013.09.003
   Atrens A, 2011, MATER SCI ENG B-ADV, V176, P1609, DOI 10.1016/j.mseb.2010.12.017
   Cao FY, 2013, CORROS SCI, V75, P78, DOI 10.1016/j.corsci.2013.05.018
   Chang JW, 2008, J APPL ELECTROCHEM, V38, P207, DOI 10.1007/s10800-007-9426-x
   Chang JW, 2007, CORROS SCI, V49, P2612, DOI 10.1016/j.corsci.2006.12.011
   Choudhary L, 2013, ENG FRACT MECH, V103, P94, DOI 10.1016/j.engfracmech.2012.09.016
   Choudhary L, 2012, ACTA BIOMATER, V8, P916, DOI 10.1016/j.actbio.2011.10.031
   Ferreira PC, 2008, REV LAT-AM ENFERM, V16, P151, DOI 10.1590/S0104-11692008000100023
   Geng L, 2009, MATER LETT, V63, P557, DOI 10.1016/j.matlet.2008.11.044
   Gu XN, 2011, MATER SCI ENG B-ADV, V176, P1778, DOI 10.1016/j.mseb.2011.05.032
   Gu XN, 2010, ACTA BIOMATER, V6, P4605, DOI 10.1016/j.actbio.2010.07.026
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Gunde P, 2011, MAT SCI ENG A-STRUCT, V528, P1047, DOI 10.1016/j.msea.2010.09.068
   Huan ZG, 2010, J MATER SCI-MATER M, V21, P2623, DOI 10.1007/s10856-010-4111-8
   King J. F., 2006, MAGNESIUM TECHNOLOGY, P128
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Liu M, 2009, CORROS SCI, V51, P1115, DOI 10.1016/j.corsci.2009.02.017
   Lu LW, 2012, MATER DESIGN, V36, P687, DOI 10.1016/j.matdes.2011.12.023
   Rosemann P, 2013, MATER CORROS, V64, P714, DOI 10.1002/maco.201206590
   Schmigalla S, 2013, MATER CORROS, V64, P578, DOI 10.1002/maco.201106433
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   SONG G, 2002, J LIGHT MET, V2, P1, DOI DOI 10.1016/S1471-5317(02)00008-1
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 1998, CORROS SCI, V40, P1769, DOI 10.1016/S0010-938X(98)00078-X
   Song YW, 2010, CORROS SCI, V52, P1830, DOI 10.1016/j.corsci.2010.02.017
   Sun Y, 2012, MATER DESIGN, V34, P58, DOI 10.1016/j.matdes.2011.07.058
   Tie D, 2014, MATER CORROS, V65, P569, DOI 10.1002/maco.201206903
   Tie D, 2013, EUR CELLS MATER, V25, P284, DOI 10.22203/eCM.v025a20
   Wang L, 2010, MATER DESIGN, V31, P857, DOI 10.1016/j.matdes.2009.07.049
   Wen ZH, 2009, J ALLOY COMPD, V488, P392, DOI 10.1016/j.jallcom.2009.08.147
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Xu ZG, 2011, MATER SCI ENG B-ADV, V176, P1660, DOI 10.1016/j.mseb.2011.06.008
   Ye XY, 2010, J MATER SCI-MATER M, V21, P1321, DOI 10.1007/s10856-009-3954-3
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhang XB, 2012, MATER LETT, V86, P42, DOI 10.1016/j.matlet.2012.07.030
   Zhou W, 2010, CORROS SCI, V52, P1035, DOI 10.1016/j.corsci.2009.11.030
NR 44
TC 11
Z9 11
U1 2
U2 20
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0947-5117
EI 1521-4176
J9 MATER CORROS
JI Mater. Corros.
PD JAN
PY 2015
VL 66
IS 1
BP 7
EP 15
DI 10.1002/maco.201307528
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA AY6ZO
UT WOS:000347711300001
DA 2018-10-20
ER

PT J
AU Rigat-Brugarolas, LG
   Homs-Corbera, A
   Samitier, J
AF Rigat-Brugarolas, L. G.
   Homs-Corbera, A.
   Samitier, J.
TI Highly hydrophilic microfluidic device prototyping using a novel
   poly(dimethylsiloxane)-based polymeric mix
SO RSC ADVANCES
LA English
DT Article
ID SURFACE MODIFICATION; HYDROPHOBICITY RECOVERY; PDMS;
   POLYDIMETHYLSILOXANE; SYSTEMS; PLASMA
AB We present a novel methodology to create in a simple, fast and cheap way an interpenetrating polymer network biomaterial, mixing 2-hydroxyethilmethacrylate and poly(dimethylsiloxane), for long-lasting highly hydrophilic microfluidic device prototyping. The presented polymer could be potentially useful to develop point-of-care microfluidic diagnostic devices allowing blood displacement without exertion in microchannels while proving to have low biological analytes adhesion.
C1 [Rigat-Brugarolas, L. G.; Homs-Corbera, A.; Samitier, J.] Inst Bioengn Catalonia IBEC, Nanobioengn Grp, Barcelona, Spain.
   [Rigat-Brugarolas, L. G.; Homs-Corbera, A.; Samitier, J.] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Zaragoza, Spain.
   [Samitier, J.] Univ Barcelona, Dept Elect, E-08028 Barcelona, Spain.
RP Rigat-Brugarolas, LG (reprint author), Inst Bioengn Catalonia IBEC, Nanobioengn Grp, Barcelona, Spain.
EM lrigat@ibecbarcelona.eu
RI Homs Corbera, Antoni/J-1972-2014; Homs Corbera, Antoni/A-5848-2012
OI Homs Corbera, Antoni/0000-0001-7889-273X; Homs Corbera,
   Antoni/0000-0001-7889-273X
FU technology transfer program of the Fundacion Botin
FX This project was funded by the technology transfer program of the
   Fundacion Botin. We thank David Izquierdo, Miriam Funes and IBEC
   Nanotechnology platform staff for technical help and Elena Martinez and
   Anna Lagunas for helpful discussions. We would like to specially thank
   David Caballero and Albert Garcia for their generous help. We thank
   Barcelona Centre for International Health Research (CRESIB) for
   providing the human blood samples.
CR Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Bodas D, 2006, MICROELECTRON ENG, V83, P1277, DOI 10.1016/j.mee.2006.01.195
   Boxshall K, 2006, SURF INTERFACE ANAL, V38, P198, DOI 10.1002/sia.2274
   Dimov IK, 2011, LAB CHIP, V11, P845, DOI [10.1039/c0lc00403k, 10.1039/c01c00403k]
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Hillborg H, 1998, POLYMER, V39, P1991, DOI 10.1016/S0032-3861(97)00484-9
   Hong SM, 2006, J PHYS CONF SER, V34, P656, DOI 10.1088/1742-6596/34/1/108
   Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w
   Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+
   Liu L, 2005, BIOMATERIALS, V26, P233, DOI 10.1016/j.biomaterials.2004.02.025
   Lotters JC, 1997, J MICROMECH MICROENG, V7, P145, DOI 10.1088/0960-1317/7/3/017
   Mata A, 2005, BIOMED MICRODEVICES, V7, P281, DOI 10.1007/s10544-005-6070-2
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   Meincken M, 2005, POLYMER, V46, P203, DOI 10.1016/j.polymer.2004.11.012
   Paguirigan AL, 2009, INTEGR BIOL, V1, P182, DOI 10.1039/b814565b
   Ratner B. D., 1989, BIOMEDICAL APPL SYNT, P201
   STOL M, 1993, CLIN MATER, V13, P19
   Sui GD, 2006, ANAL CHEM, V78, P5543, DOI 10.1021/ac060605z
   Tranoudis Ioannis, 2004, Cont Lens Anterior Eye, V27, P193, DOI 10.1016/j.clae.2004.08.003
   Turner JS, 2003, MACROMOLECULES, V36, P1962, DOI 10.1021/ma012253y
   van Poll L. M., 2009, SOFT MATTER, V5, P2286
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Zang H., 2014, ACS APPL MATER INTER, V6, P9126
   Zimmermann M, 2007, LAB CHIP, V7, P119, DOI 10.1039/b609813d
NR 24
TC 2
Z9 2
U1 3
U2 32
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 10
BP 7423
EP 7425
DI 10.1039/c4ra14750b
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA AY5JX
UT WOS:000347609400051
DA 2018-10-20
ER

PT J
AU Hossain, A
   Bhattacharyya, SR
   Aditya, G
AF Hossain, Asif
   Bhattacharyya, Satya Ranjan
   Aditya, Gautam
TI Biosorption of Cadmium by Waste Shell Dust of Fresh Water Mussel
   Lamellidens marginalis: Implications for Metal Bioremediation
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Biosorption; Cadmium; Mussel shell dust (MSD); Isotherm; Kinetics
ID AQUEOUS-SOLUTIONS; MOLLUSK SHELLS; REMOVAL; LEAD; EQUILIBRIUM;
   ADSORPTION; ARAGONITE; SORPTION; CALCITE; IONS
AB The ability of the shell dust of freshwater mussel Lamellidens marginalis (MSD) to remove cadmium from the aquatic system was evaluated. The results indicate that MSD, a waste biomaterial, bears the potential to remove cadmium from contaminated water with a biosorption capacity of 18.18 mg g(-1) at pH 6. At equilibrium, the adsorption data fitted to Langmuir (r(2) = 0.992) significantly more than the Freundlich equation (r(2) = 0.66). Regression analysis suggests that the biosorption kinetics followed the pseudo-second-order model (r(2) = 0.999) better than the Lagergren model (r(2) = 0.879). The possible mechanism of biosorption appeared to be ion exchanges with Fe, Al, Si, In, Co, and Ca ions together with binding of different functional groups such as -OH, -C=O, -C=C, and -C-C, as revealed through FTIR and EDX analyses. Although low in comparison to cadmium, the MSD-adsorbed zinc (q(max) = 10.64 mg g(-1)) and lead (q(max) = 8.06 mg g(-1)) varied in amounts, depending upon the initial metal ion concentration and biomass of the adsorbent. These observations substantiate MSD as a low cost and environment friendly biosorbent for heavy metal ion bioremediation.
C1 [Hossain, Asif; Aditya, Gautam] Univ Burdwan, Dept Zool, Ecol Lab, Burdwan 713104, W Bengal, India.
   [Bhattacharyya, Satya Ranjan] Saha Inst Nucl Phys, Kolkata 700064, India.
   [Hossain, Asif; Aditya, Gautam] Univ Calcutta, Dept Zool, Kolkata 700019, India.
RP Aditya, G (reprint author), Univ Burdwan, Dept Zool, Ecol Lab, Burdwan 713104, W Bengal, India.
EM gautamaditya2001@gmail.com
OI ADITYA, GAUTAM/0000-0001-9445-879X
FU Council of Scientific and Industrial Research (CSIR), New Delhi, India
FX We are grateful to the anonymous reviewers for their critical evaluation
   and suggestions that enhanced the manuscript to its present form. We
   express our gratitude and regards to Prof. David Allen for his kind
   cooperation and encouragement in revising the earlier version of the
   manuscript. We are thankful to the respective heads of the Department of
   Zoology, Department of Chemistry, and Department of Environmental
   Science, The University of Burdwan, Burdwan, India, for the facilities
   provided including DST-FIST. We acknowledge the instrumental facilities
   provided by SINP, Kolkata, India, and Department of Zoology, University
   of Calcutta, Kolkata, India. A.H. thankfully acknowledges the financial
   assistance provided by the Council of Scientific and Industrial Research
   (CSIR), New Delhi, India (Sanction 20-12/2009(ii)EU-IV, dated May 31,
   2010).
CR Azouaou N., 2008, Journal of Applied Sciences, V8, P4638
   Bernard A, 2008, INDIAN J MED RES, V128, P557
   Blazquez G, 2011, CHEM ENG J, V168, P170, DOI 10.1016/j.cej.2010.12.059
   Burger J, 2008, SCI TOTAL ENVIRON, V389, P37, DOI 10.1016/j.scitotenv.2007.08.037
   Cui LZ, 2010, CAN J CHEM ENG, V88, P109, DOI 10.1002/cjce.20241
   Dahiya S, 2008, BIORESOURCE TECHNOL, V99, P179, DOI 10.1016/j.biortech.2006.11.011
   de Paula SM, 2009, MICRON, V40, P669, DOI 10.1016/j.micron.2009.05.006
   Ding Y, 2012, BIORESOURCE TECHNOL, V114, P20, DOI 10.1016/j.biortech.2012.01.110
   Du Y, 2012, J COLLOID INTERF SCI, V367, P378, DOI 10.1016/j.jcis.2011.10.023
   Du Y, 2011, ENVIRON POLLUT, V159, P1763, DOI 10.1016/j.envpol.2011.04.017
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Gifford S, 2005, MAR POLLUT BULL, V50, P417, DOI 10.1016/j.marpolbul.2004.11.024
   Gupta VK, 2008, J HAZARD MATER, V152, P407, DOI 10.1016/j.jhazmat.2007.07.028
   Gupta Vinod K, 2010, J Colloid Interface Sci, V342, P533, DOI 10.1016/j.jcis.2009.10.074
   Gupta VK, 2007, J HAZARD MATER, V142, P443, DOI 10.1016/j.jhazmat.2006.08.048
   Hetzer A, 2006, APPL ENVIRON MICROB, V72, P4020, DOI 10.1128/AEM.00295-06
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Ho YS, 2006, BIOCHEM ENG J, V30, P117, DOI 10.1016/j.bej.2006.02.012
   Jana BB, 1997, ECOL ENG, V8, P179, DOI 10.1016/S0925-8574(97)00259-0
   John N., 2010, BIOMETALS, V23, P783, DOI DOI 10.1007/S10534-010-9328-Y
   Kamari A, 2009, COLLOID SURFACE B, V73, P257, DOI 10.1016/j.colsurfb.2009.05.024
   Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156
   Lagergren S., 1898, VETENSKAPSAKAD HANDL, V24, P1
   Langmuir I., 1918, J AM CHEM SOC, V40, P1361
   Liu Y, 2009, J HAZARD MATER, V168, P156, DOI 10.1016/j.jhazmat.2009.02.009
   MacFarlane G. R., 2006, TRENDS BIOTECHNOL, V25, P60
   Nouri L, 2007, J HAZARD MATER, V149, P115, DOI 10.1016/j.jhazmat.2007.03.055
   Pakseresht M. A., 2012, J CHEM TECHNOL BIOT, V88, P572
   Pena-Rodriguez S, 2010, J HAZARD MATER, V180, P622, DOI 10.1016/j.jhazmat.2010.04.079
   Perez-Garrido C, 2007, SURF SCI, V601, P5499, DOI 10.1016/j.susc.2007.09.021
   Prieto M, 2003, GEOCHIM COSMOCHIM AC, V67, P3859, DOI 10.1016/S0016-7037(00)00309-0
   Ramos R. L., 2005, SEP PURIF TECHNOL, V45, P41
   Reddy H. K. D., 2010, HAZARD MAT, V174, P831
   Saleh T, 2012, ENVIRON SCI POLLUT R, V19, P1224, DOI 10.1007/s11356-011-0670-6
   Sen TK, 2010, CLEAN-SOIL AIR WATER, V38, P850, DOI 10.1002/clen.200900246
   Sharma M., 2011, ECOL ENG, V37, P1589
   Sinha R. K., 2007, ENV BIOREMEDIATION T, P315
   Vijayaraghavan K, 2006, BIORESOURCE TECHNOL, V97, P1411, DOI 10.1016/j.biortech.2005.07.001
   Vimala R, 2009, J HAZARD MATER, V168, P376, DOI 10.1016/j.jhazmat.2009.02.062
   Wang FY, 2010, J HAZARD MATER, V177, P300, DOI 10.1016/j.jhazmat.2009.12.032
   Witek-Krowiak A, 2011, DESALINATION, V265, P126, DOI 10.1016/j.desal.2010.07.042
   Yasemin B., 2007, Journal of Environmental Sciences, V19, P160
NR 42
TC 11
Z9 12
U1 1
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD JAN
PY 2015
VL 3
IS 1
BP 1
EP 8
DI 10.1021/sc500635e
PG 8
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA AY3XY
UT WOS:000347513900001
DA 2018-10-20
ER

PT J
AU Tokarski, AT
   Novack, TA
   Parvizi, J
AF Tokarski, A. T.
   Novack, T. A.
   Parvizi, J.
TI Is tantalum protective against infection in revision total hip
   arthroplasty?
SO BONE & JOINT JOURNAL
LA English
DT Article
ID PERIPROSTHETIC JOINT INFECTION; CONCISE FOLLOW-UP; ACETABULAR CUPS;
   POROUS TANTALUM; UNITED-STATES; COMPONENTS; CEMENT; BIOMATERIAL;
   VALIDATION; FIXATION
AB We hypothesised that the use of tantalum (Ta) acetabular components in revision total hip arthroplasty (THA) was protective against subsequent failure due to infection. We identified 966 patients (421 men, 545 women and 990 hips) who had undergone revision THA between 2000 and 2013. The mean follow up was 40.2 months (3 months to 13.1 years). The mean age of the men and women was 62.3 years (31 to 90) and 65.1 years (25 to 92), respectively.
   Titanium (Ti) acetabular components were used in 536 hips while Ta components were used in 454 hips. In total, 73 (7.3%) hips experienced subsequent acetabular failure. The incidence of failure was lower in the Ta group at 4.4% (20/454) compared with 9.9% (53/536) in the Ti group (p < 0.001, odds ratio 2.38; 95% CI 1.37 to 4.27). Among the 144 hips (64 Ta, 80 Ti) for which revision had been performed because of infection, failure due to a subsequent infection was lower in the Ta group at 3.1% (2/64) compared with 17.5% (14/80) for the Ti group (p = 0.006).
   Thus, the use of Ta acetabular components during revision THA was associated with a lower incidence of failure from all causes and Ta components were associated with a lower incidence of subsequent infection when used in patients with periprosthetic joint infection.
C1 [Tokarski, A. T.; Novack, T. A.; Parvizi, J.] Rothman Inst, Philadelphia, PA 19107 USA.
RP Parvizi, J (reprint author), Rothman Inst, 925 Chestnut St, Philadelphia, PA 19107 USA.
EM research@rothmaninstitute.com
FU Zimmer Orthopedics
FX We are grateful to Zimmer Orthopedics whose funding enabled us to
   complete this study.
CR Abolghasemian M, 2013, BONE JOINT J, V95B, P166, DOI 10.1302/0301-620X.95B2.30608
   [Anonymous], 2014, CTR DIS CONTR PREV S
   Berend Keith R, 2013, Instr Course Lect, V62, P251
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Chatrath Vikram, 2013, Instr Course Lect, V62, P215
   Colman M, 2013, INJURY, V44, P249, DOI 10.1016/j.injury.2012.10.032
   Della Valle CJ, 2005, J BONE JOINT SURG AM, V87A, P1795, DOI 10.2106/00004623-200508000-00019
   Fernandez-Fairen Mariano, 2008, Acta Ortop Mex, V22, P215
   Garbuz DS, 2008, J BONE JOINT SURG AM, V90A, P1090, DOI 10.2106/JBJS.G.00415
   Garcia-Cimbrelo E, 1999, J ARTHROPLASTY, V14, P397, DOI 10.1016/S0883-5403(99)90094-3
   Gehrke T, 2013, BONE JOINT J, V95B, P77, DOI 10.1302/0301-620X.95B11.32646
   Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P459, DOI 10.1007/s11999-009-1090-5
   Karam JA, 2012, PHYSICIAN SPORTSMED, V40, P96, DOI 10.3810/psm.2012.11.1992
   Klika Alison K, 2007, J Long Term Eff Med Implants, V17, P187
   Kosashvili Y, 2011, J ARTHROPLASTY, V26, P1170, DOI 10.1016/j.arth.2011.04.022
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022
   Lachiewicz PF, 2010, CLIN ORTHOP RELAT R, V468, P454, DOI 10.1007/s11999-009-0940-5
   Lazarinis S, 2012, ACTA ORTHOP, V83, P427, DOI 10.3109/17453674.2012.720117
   Mahomed NN, 2003, J BONE JOINT SURG AM, V85A, P27, DOI 10.2106/00004623-200301000-00005
   Manley MT, 1998, J BONE JOINT SURG AM, V80A, P1175, DOI 10.2106/00004623-199808000-00011
   Meneghini RM, 2010, J ARTHROPLASTY, V25, P337, DOI 10.1016/j.arth.2009.03.003
   Vicente JRN, 2010, CLINICS, V65, P1111, DOI 10.1590/S1807-59322010001100009
   PADGETT DE, 1993, J BONE JOINT SURG AM, V75A, P663, DOI 10.2106/00004623-199305000-00005
   Parvizi J, 2013, BONE JOINT J, V95B, P1450, DOI 10.1302/0301-620X.95B11.33135
   Parvizi Javad, 2011, Am J Orthop (Belle Mead NJ), V40, P614
   Pierannunzii L, 2011, INT J IMMUNOPATH PH, V24, P133, DOI 10.1177/03946320110241S225
   Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4
   Pulido L, 2011, INT ORTHOP, V35, P289, DOI 10.1007/s00264-010-1198-y
   RAPPERPORT DJ, 1987, J ORTHOP RES, V5, P548, DOI 10.1002/jor.1100050410
   Small SR, 2013, J ARTHROPLASTY, V28, P510, DOI 10.1016/j.arth.2012.07.035
   Trumm BN, 2012, J BONE JOINT SURG AM, V94A, P2001, DOI [10.2106/JBJS.L.00058, 10.2106/JBJS.L00058]
NR 34
TC 18
Z9 20
U1 1
U2 7
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 2049-4394
J9 BONE JOINT J
JI Bone Joint J.
PD JAN
PY 2015
VL 97B
IS 1
BP 45
EP 49
DI 10.1302/0301-620X.97B1.34236
PG 5
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA AY3CX
UT WOS:000347463200008
PM 25568412
DA 2018-10-20
ER

PT J
AU Long, DP
   Lu, WJ
   Zhang, Y
   Guo, Q
   Xiang, ZH
   Zhao, AC
AF Long, Dingpei
   Lu, Weijian
   Zhang, Yang
   Guo, Qing
   Xiang, Zhonghuai
   Zhao, Aichun
TI New insight into the mechanism underlying fibroin secretion in silkworm,
   Bombyx mori
SO FEBS JOURNAL
LA English
DT Article
DE EGFP; H-chain fusion protein; fibroin secretion mechanism; piggyBac;
   silk; transgenic silkworm
ID LINKED OLIGOSACCHARIDE CHAINS; AMINO-ACID-SEQUENCE; TRANSGENIC
   SILKWORMS; GERMLINE TRANSFORMATION; SUBUNIT COMBINATION; ELEMENTARY
   UNIT; H-CHAIN; HEAVY; PROTEIN; VECTOR
AB In order to investigate the role of different parts of the fibroin heavy chain (H-chain) in the secretion of fibroin in the silk gland of the silkworm (Bombyxmori) invivo, two enhanced green fluorescent protein (EGFP)/H-chain fusion genes with deduced protein sequences containing an identical N-terminal region and different C-terminal regions of the H-chain were introduced into the B.mori genome using a piggyBac-mediated germline transformation. EGFP fluorescence and molecular analysis showed the products of two different EGFP/H-chain fusion proteins were secreted into the posterior silk gland lumen and aggregated in the middle silk gland and spun into cocoons. The results revealed that only the non-repetitive N terminus of the H-chain is essential for secretion of the H-chain into the posterior silk gland lumen. In addition, our results also indicated that the most likely post-translational modification of the H-chain is at the C-terminal domain. Here, our results not only provide a theoretical basis for the genetic modification of silk fiber as a functional biomaterial but also are of great significance to establishing a new silk gland bioreactor to mass-produce exogenous proteins in an active form.
C1 [Long, Dingpei; Lu, Weijian; Zhang, Yang; Guo, Qing; Xiang, Zhonghuai; Zhao, Aichun] Southwest Univ, Minist Agr, Key Lab Sericulture Funct Genom & Biotechnol, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.
RP Zhao, AC (reprint author), Southwest Univ, Minist Agr, Key Lab Sericulture Funct Genom & Biotechnol, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.
EM zhaoaichun@hotmail.com
RI Zhao, Aichun/T-4308-2018
OI Zhao, Aichun/0000-0001-6140-0102
FU Hi-Tech Research and Development (863) Program of China [2013AA102507];
   China Agriculture Research System [CARS-22-ZJ0102]
FX This work was supported by grants from the Hi-Tech Research and
   Development (863) Program of China (No. 2013AA102507) and the China
   Agriculture Research System (No. CARS-22-ZJ0102).
CR Fedic R, 2003, J BIOL CHEM, V278, P35255, DOI 10.1074/jbc.M305304200
   GRZELAK K, 1995, COMP BIOCHEM PHYS B, V110, P671, DOI 10.1016/0305-0491(94)00215-G
   Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110
   Iizuka T, 2013, ADV FUNCT MATER, V23, P5232, DOI 10.1002/adfm.201300365
   Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.jibm.2004.10.002
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Inoue S, 2004, EUR J BIOCHEM, V271, P356, DOI 10.1046/j.1432-1033.2003.03934.x
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kojima K, 2007, BIOSCI BIOTECH BIOCH, V71, P2943, DOI 10.1271/bbb.70353
   Kurihara H, 2007, BIOCHEM BIOPH RES CO, V355, P976, DOI 10.1016/j.bbrc.2007.02.055
   Long DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040150
   Long DP, 2013, INSECT BIOCHEM MOLEC, V43, P997, DOI 10.1016/j.ibmb.2013.08.001
   Michal CA, 1996, BIOPHYS J, V70, P489, DOI 10.1016/S0006-3495(96)79594-2
   MITA K, 1994, J MOL EVOL, V38, P583
   MORI K, 1995, J MOL BIOL, V251, P217, DOI 10.1006/jmbi.1995.0429
   Nagano A, 2011, ACTA BIOMATER, V7, P1192, DOI 10.1016/j.actbio.2010.10.032
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Shimizu K, 2007, INSECT BIOCHEM MOLEC, V37, P713, DOI 10.1016/j.ibmb.2007.03.016
   SHIMURA K, 1983, EXPERIENTIA, V39, P455, DOI 10.1007/BF01965160
   TAKANO E, 1988, BIOCHEMISTRY-US, V27, P1964, DOI 10.1021/bi00406a024
   TAKEI F, 1984, J CELL BIOL, V99, P2005, DOI 10.1083/jcb.99.6.2005
   TAKEI F, 1987, J CELL BIOL, V105, P175, DOI 10.1083/jcb.105.1.175
   Tamura T, 2000, NAT BIOTECHNOL, V18, P81
   Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   Tatemastu K, 2012, J BIOTECHNOL BIOMA S, VS9, P1
   Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023
   Wang SP, 2006, BIOCHEM BIOPH RES CO, V341, P1203, DOI 10.1016/j.bbrc.2006.01.081
   Zhang PB, 2006, PROTEOMICS, V6, P2586, DOI 10.1002/pmic.200500348
   Zhao AC, 2012, INSECT SCI, V19, P172, DOI 10.1111/j.1744-7917.2011.01422.x
   Zhao AC, 2010, TRANSGENIC RES, V19, P29, DOI 10.1007/s11248-009-9295-7
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zhu ZH, 2010, J BIOMAT SCI-POLYM E, V21, P395, DOI 10.1163/156856209X423126
NR 36
TC 8
Z9 8
U1 1
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD JAN
PY 2015
VL 282
IS 1
BP 89
EP 101
DI 10.1111/febs.13105
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AY1SF
UT WOS:000347371500008
PM 25302556
OA Bronze
DA 2018-10-20
ER

PT J
AU Liang, KN
   Yuan, H
   Li, JS
   Yang, JJ
   Zhou, X
   He, LB
   Cheng, L
   Gao, Y
   Xu, X
   Zhou, XD
   Li, JY
AF Liang, Kunneng
   Yuan, He
   Li, Jianshu
   Yang, Jiaojiao
   Zhou, Xin
   He, Libang
   Cheng, Lei
   Gao, Yuan
   Xu, Xin
   Zhou, Xuedong
   Li, Jiyao
TI Remineralization of Demineralized Dentin Induced by Amine-Terminated
   PAMAM Dendrimer
SO MACROMOLECULAR MATERIALS AND ENGINEERING
LA English
DT Article
DE amine-terminated PAMAM dendrimer; dentin; dental restorative
   biomaterial; hydroxyapatite; remineralization
ID ENAMEL
AB The remineralization of demineralized dentin with biomimetic templates is of great interest in the fields of material science and stomatology. Amine-terminated PAMAM dendrimer (PAMAM-NH2), which possesses a highly ordered architecture and many calcium coordination sites, may be a desirable template for inducing dentin remineralization. In this study, the remineralization effect of the third generation PAMAM-NH2 (G3-PAMAM-NH2) on demineralized dentin is investigated. Demineralized dentin samples are treated with G3-PAMAM-NH2 solution (1mgmL(-1)), and then immersed in artificial saliva for different periods. The results confirm that G3-PAMAM-NH2 has a good binding capacity to demineralized dentin and can induce needle-like crystals to precipitate both on the dentin surface and in the dentinal tubules. A good ability of the regenerated minerals to resist acid challenge and good biocompatibility of G3-PAMAM-NH2 are also proved. Overall, the results suggest that G3-PAMAM-NH2 is a promising biomaterial for inducing dentin remineralization.
C1 [Liang, Kunneng; Yuan, He; Zhou, Xin; He, Libang; Cheng, Lei; Gao, Yuan; Xu, Xin; Zhou, Xuedong; Li, Jiyao] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
   [Liang, Kunneng; Yuan, He; Zhou, Xin; He, Libang; Cheng, Lei; Gao, Yuan; Xu, Xin; Zhou, Xuedong; Li, Jiyao] Sichuan Univ, West China Hosp Stomatol, Dept Operat Dent & Endodont, Chengdu 610041, Peoples R China.
   [Li, Jianshu; Yang, Jiaojiao] Sichuan Univ, Dept Biomed Polymers & Artificial Organs, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
RP Li, JY (reprint author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
EM jiyaoliscu@163.com
OI Li, Jianshu/0000-0002-1522-7326
FU National Natural Science Foundation of China [81170958, 51073102];
   Specialized Research Fund for the Doctoral Program of Higher Education
   [20100181110056]; Sichuan Province Science and Technology support
   program [2011SZ0130]
FX This project was supported by the National Natural Science Foundation of
   China (Grant Nos. 81170958 and 51073102), the Specialized Research Fund
   for the Doctoral Program of Higher Education (Grant No. 20100181110056)
   and Sichuan Province Science and Technology support program (Grant No.
   2011SZ0130).
CR Bertassoni LE, 2009, CARIES RES, V43, P70, DOI 10.1159/000201593
   Donners JJJM, 2003, ADV MATER, V15, P313, DOI 10.1002/adma.200390076
   Fan Y, 2009, BIOMATERIALS, V30, P478, DOI 10.1016/j.biomaterials.2008.10.019
   Featherstone J D B, 2009, Adv Dent Res, V21, P4, DOI 10.1177/0895937409335590
   Filoche S, 2010, J DENT RES, V89, P8, DOI 10.1177/0022034509351812
   GATE J, 1995, EUR J ORAL SCI, V103, P362
   George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729
   Gu LS, 2011, ACTA BIOMATER, V7, P268, DOI 10.1016/j.actbio.2010.07.036
   Kinney JH, 1996, ARCH ORAL BIOL, V41, P9, DOI 10.1016/0003-9969(95)00109-3
   Lungu A, 2009, DIG J NANOMATER BIOS, V4, P97
   Omelon SJ, 2008, CHEM REV, V108, P4694, DOI 10.1021/cr0782527
   Pitts N B, 2009, Adv Dent Res, V21, P83, DOI 10.1177/0895937409335644
   Reis C, 2008, DENT MATER, V24, P1608, DOI 10.1016/j.dental.2008.03.027
   Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018
   Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001
   TENCATE JM, 1982, CARIES RES, V16, P201, DOI 10.1159/000260599
   Toroian D, 2007, J BIOL CHEM, V282, P22437, DOI 10.1074/jbc.M700591200
   Tsiourvas D, 2011, J AM CERAM SOC, V94, P2023, DOI 10.1111/j.1551-2916.2010.04342.x
   Venuganti VV, 2011, PHARM RES-DORDR, V28, P2246, DOI 10.1007/s11095-011-0455-0
   Wang ZJ, 2011, J DENT, V39, P746, DOI 10.1016/j.jdent.2011.08.006
   Wang ZJ, 2010, J DENT, V38, P400, DOI 10.1016/j.jdent.2010.01.007
   Weir MD, 2012, J DENT RES, V91, P979, DOI 10.1177/0022034512458288
   Xie L., 2010, POLYM B, V66, P119
   XU Z, 2010, MAT SCI ENG C, V3, P822
   Yan SJ, 2006, MATER CHEM PHYS, V99, P164, DOI 10.1016/j.matchemphys.2005.10.009
   Zhang F, 2005, MATER LETT, V59, P1422, DOI 10.1016/j.matlet.2004.11.058
   Zhou YZ, 2012, ACS APPL MATER INTER, V4, P6900, DOI 10.1021/am302041b
   Zhou ZH, 2007, MATER RES BULL, V42, P1611, DOI 10.1016/j.materresbull.2006.11.041
NR 28
TC 16
Z9 17
U1 3
U2 25
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1438-7492
EI 1439-2054
J9 MACROMOL MATER ENG
JI Macromol. Mater. Eng.
PD JAN
PY 2015
VL 300
IS 1
BP 107
EP 117
DI 10.1002/mame.201400207
PG 11
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA AY1TC
UT WOS:000347373800012
DA 2018-10-20
ER

PT J
AU Srinivasa, P
   Kulachenko, A
AF Srinivasa, Prashanth
   Kulachenko, Artem
TI Analysis of the compressive response of Nano Fibrillar Cellulose foams
SO MECHANICS OF MATERIALS
LA English
DT Article
DE NFC foams; Internal contact; Voronoi structures; Foam densification;
   Effect of foam porosity
ID OPEN-CELL FOAMS; ELASTIC PROPERTIES; IRREGULARITY; STRAIN;
   MICROSTRUCTURES; SIMULATIONS; PERFORMANCE; PROJECTORS; HONEYCOMB;
   MECHANICS
AB Nano Fibrillar Cellulose (NFC) is fast emerging as a biomaterial with promising applications, one of which is cellular foam. The inner structure of the foam can take various shapes and hierarchical micro-structures depending on the manufacturing parameters. The compressive response of foams developed from these materials is currently a primary criterion for the material development. In this work, we focus on the connection between the non-linear part of the response and the inner structure of the material. We study the effect of internal contact and its contribution to gradual stiffening in the energy absorbing region and accelerated stiffening in the densification region of the large strain compressive response. We use the finite element method in this study and discuss the applicability and efficiency of different modelling techniques by considering well defined geometries and available experimental data. The relative contribution of internal contact is singled out and mapped onto the overall compressive response of the material. The effect of initial non-straightness of the cell walls is studied through superposing differing percentages of the buckling modes on the initial geometry. The initial non-straightness is seen to have a significant effect for only strains up to 1%. The secant modulus measured at slightly higher strains of 4%, demonstrates lesser effect from the non-straightness of cell walls. The simulations capture the compressive response well into the densification regime and there is an order of magnitude agreement in between simulations and experiments. We observed that internal contact is crucial for capturing the trend of compressive response. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Srinivasa, Prashanth; Kulachenko, Artem] KTH Royal Inst Technol, Sch Engn Sci, Dept Solid Mech, SE-10044 Stockholm, Sweden.
RP Kulachenko, A (reprint author), KTH Royal Inst Technol, Sch Engn Sci, Dept Solid Mech, SE-10044 Stockholm, Sweden.
EM pns@kth.se; artem@kth.se
OI /0000-0003-3611-2250
FU Swedish Research Council
FX Financial support from The Swedish Research Council is gratefully
   acknowledged by the authors. P. Srinivasa wishes to acknowledge Dr.
   Houssine Sehaqui for providing the data from experiments on compression
   of foams.
CR Ali ZM, 2013, SOFT MATTER, V9, P1580, DOI 10.1039/c2sm27197d
   Alsayednoor J, 2013, MECH MATER, V66, P7, DOI 10.1016/j.mechmat.2013.06.006
   Aulin C, 2010, SOFT MATTER, V6, P3298, DOI 10.1039/c001939a
   Chen C, 1999, J MECH PHYS SOLIDS, V47, P2235, DOI 10.1016/S0022-5096(99)00030-7
   Gibson L. J., 1988, CELLULAR SOLIDS
   GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P43, DOI 10.1098/rspa.1982.0088
   Gong L, 2005, INT J SOLIDS STRUCT, V42, P1355, DOI 10.1016/j.ijsolstr.2004.07.023
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Kulachenko A, 2012, CELLULOSE, V19, P793, DOI 10.1007/s10570-012-9685-5
   Kulachenko A, 2012, MECH MATER, V51, P1, DOI 10.1016/j.mechmat.2012.03.010
   Li QM, 2006, J CELL PLAST, V42, P371, DOI 10.1177/0021955X06063519
   Lindstrom SB, 2013, SOFT MATTER, V9, P7302, DOI 10.1039/c3sm50451d
   Mesarovic SD, 2005, PHILOS MAG, V85, P65, DOI 10.1080/14786430412331313321
   NOUROMID B, 1991, COMPUT METHOD APPL M, V93, P353, DOI 10.1016/0045-7825(91)90248-5
   OKABE A, 1995, SPATIAL TESSELLATION
   Papka SD, 1998, ACTA MATER, V46, P2765, DOI 10.1016/S1359-6454(97)00453-9
   PAPKA SD, 1994, J MECH PHYS SOLIDS, V42, P1499, DOI 10.1016/0022-5096(94)90085-X
   Przemieniecki J. S., 1968, THEORY MATRIX STRUCT
   RANKIN CC, 1988, COMPUT STRUCT, V30, P257, DOI 10.1016/0045-7949(88)90231-3
   Roberts AP, 2002, J MECH PHYS SOLIDS, V50, P33, DOI 10.1016/S0022-5096(01)00056-4
   Sehaqui H., 2011, THESIS KTH
   Sehaqui H, 2010, SOFT MATTER, V6, P1824, DOI 10.1039/b927505c
   SILVA MJ, 1995, INT J MECH SCI, V37, P1161, DOI 10.1016/0020-7403(94)00018-F
   Svagan AJ, 2008, ADV MATER, V20, P1263, DOI 10.1002/adma.200701215
   Svagan AJ, 2010, J MATER CHEM, V20, P6646, DOI 10.1039/c0jm00779j
   VanderBurg MWD, 1997, J CELL PLAST, V33, P31, DOI 10.1177/0021955X9703300103
   Zhu HX, 2000, ACTA MATER, V48, P4893, DOI 10.1016/S1359-6454(00)00282-2
   Zhu HX, 2002, ACTA MATER, V50, P1041, DOI 10.1016/S1359-6454(01)00402-5
   Zhu HX, 2001, PHILOS MAG A, V81, P2765, DOI 10.1080/01418610010032364
   Zhu HX, 2001, J MECH PHYS SOLIDS, V49, P857, DOI 10.1016/S0022-5096(00)00046-6
NR 30
TC 1
Z9 1
U1 1
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-6636
EI 1872-7743
J9 MECH MATER
JI Mech. Mater.
PD JAN
PY 2015
VL 80
BP 13
EP 26
DI 10.1016/j.mechmat.2014.09.006
PN A
PG 14
WC Materials Science, Multidisciplinary; Mechanics
SC Materials Science; Mechanics
GA AY3OP
UT WOS:000347493100002
DA 2018-10-20
ER

PT J
AU Lange, D
   Bidnur, S
   Hoag, N
   Chew, BH
AF Lange, Dirk
   Bidnur, Samir
   Hoag, Nathan
   Chew, Ben H.
TI Ureteral stent-associated complications-where we are and where we are
   going
SO NATURE REVIEWS UROLOGY
LA English
DT Review
ID URINARY-TRACT-INFECTION; QUALITY-OF-LIFE; PORCINE MODEL; IN-VITRO;
   BIOMATERIAL ENCRUSTATION; METALLIC STENTS; ELUTING STENTS; DRAINAGE
   STENT; URETHRAL STENT; CLINICAL-TRIAL
AB Ureteral stents are one of the most commonly used devices in the treatment of benign and malignant urological diseases. However, they are associated with common complications including encrustation, infection, pain and discomfort caused by ureteral tissue irritation and possibly irregular peristalsis. In addition, stent migration and failure due to external compression by malignancies or restenosis occur, albeit less frequently. As these complications restrict optimal stent function, including maintenance of adequate urine drainage and alleviation of hydronephrosis, novel stent materials and designs are required. In recent years, progress has been made in the development of drug-eluting expandable metal stents and biodegradable stents. New engineering technologies are being investigated to provide stents with increased biocompatibility, decreased susceptibility to encrustation and improved drug-elution characteristics. These novel stent characteristics might help eliminate some of the common complications associated with ureteral stenting and will be an important step towards understanding the behaviour of stents within the urinary tract.
C1 [Lange, Dirk; Bidnur, Samir; Hoag, Nathan; Chew, Ben H.] Univ British Columbia, Dept Urol Sci, Vancouver Gen Hosp, Stone Ctr,Jack Bell Res Ctr, Vancouver, BC V6H 3Z6, Canada.
RP Lange, D (reprint author), Univ British Columbia, Dept Urol Sci, Vancouver Gen Hosp, Stone Ctr,Jack Bell Res Ctr, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.
EM dirk.lange@ubc.ca
CR Acosta-Miranda AM, 2009, J ENDOUROL, V23, P409, DOI 10.1089/end.2008.0214
   Agrawal S, 2009, BJU INT, V103, P372, DOI 10.1111/j.1464-410X.2008.08018.x
   Al-Aown A, 2010, THER ADV UROL, V2, P85, DOI 10.1177/1756287210370699
   Al-Kandari AM, 2007, J ENDOUROL, V21, P698, DOI 10.1089/end.2007.9949
   Amiel GE, 2001, J UROLOGY, V165, P2091, DOI 10.1016/S0022-5347(05)66300-8
   Ather M H, 2000, Tech Urol, V6, P189
   Barbalias GA, 1997, J UROLOGY, V158, P54, DOI 10.1097/00005392-199707000-00015
   Beddingfield R, 2009, J UROLOGY, V181, P170, DOI 10.1016/j.juro.2008.09.026
   Borboroglu PG, 2000, J UROLOGY, V164, P648, DOI 10.1016/S0022-5347(05)67272-2
   Borin JF, 2006, J ENDOUROL, V20, P300, DOI 10.1089/end.2006.20.300
   Canales BK, 2009, J ENDOUROL, V23, P1437, DOI 10.1089/end.2009.0389
   Chew BH, 2007, J ENDOUROL, V21, P1069, DOI 10.1089/end.2006.0252
   Chew BH, 2010, J UROLOGY, V183, P765, DOI 10.1016/j.juro.2009.09.073
   Damiano R, 2005, EUR UROL, V48, P673, DOI 10.1016/j.eururo.2005.06.006
   Damiano R, 2008, J ENDOUROL, V22, P651, DOI 10.1089/end.2007.0257
   Davenport K, 2006, BJU INT, V98, P651, DOI 10.1111/j.1464-410X.2006.06346.x
   Deliveliotis C, 2006, UROLOGY, V67, P35, DOI 10.1016/j.urology.2005.07.038
   Dunn CJ, 2002, DRUG AGING, V19, P135, DOI 10.2165/00002512-200219020-00004
   ELFAQIH SR, 1991, J UROLOGY, V146, P1487, DOI 10.1016/S0022-5347(17)38146-6
   Elwood CN, 2013, BIOFOULING, V29, P1115, DOI 10.1080/08927014.2013.829049
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Erturk E, 2003, J ENDOUROL, V17, P59, DOI 10.1089/08927790360587342
   Farsi HMA, 1995, J ENDOUROL, V9, P469, DOI 10.1089/end.1995.9.469
   FINNEY RP, 1978, J UROLOGY, V120, P678, DOI 10.1016/S0022-5347(17)57326-7
   Giannarini G, 2011, BJU INT, V107, P648, DOI 10.1111/j.1464-410X.2010.09482.x
   Gorman SP, 1997, J BIOMATER APPL, V12, P136, DOI 10.1177/088532829701200204
   Hadaschik BA, 2008, J UROLOGY, V180, P1161, DOI 10.1016/j.juro.2008.05.003
   Hendlin K, 2012, J ENDOUROL, V26, P271, DOI 10.1089/end.2011.0332
   Jeon SS, 2007, J ENDOUROL, V21, P906, DOI 10.1089/end.2006.0476
   Joshi HB, 2003, J UROLOGY, V169, P1060, DOI 10.1097/01.ju.0000049198.53425.1d
   Kadlec AO, 2013, J UROLOGY, V190, P937, DOI 10.1016/j.juro.2013.02.070
   Kallidonis P, 2011, J ENDOUROL, V25, P1661, DOI 10.1089/end.2011.0308
   Kallidonis PS, 2014, INDIAN J UROL, V30, P8, DOI 10.4103/0970-1591.124198
   Kehinde EO, 2004, J ENDOUROL, V18, P891, DOI 10.1089/end.2004.18.891
   Kehinde EO, 2002, J UROLOGY, V167, P1334, DOI 10.1016/S0022-5347(05)65294-9
   Kinn AC, 2002, UROL RES, V30, P213, DOI 10.1007/s00240-002-0258-1
   Klis R, 2009, J ENDOUROL, V23, P1015, DOI 10.1089/end.2008.0518
   Kotsar A, 2012, J ENDOUROL, V26, P387, DOI 10.1089/end.2011.0327
   Kotsar A, 2009, BJU INT, V103, P626, DOI 10.1111/j.1464-410X.2008.08111.x
   Krambeck AE, 2010, J UROLOGY, V183, P1037, DOI 10.1016/j.juro.2009.11.035
   Kukreja N, 2008, PHARMACOL RES, V57, P171, DOI 10.1016/.i.phrs.2008.01.012
   Lam JS, 2002, J ENDOUROL, V16, P733, DOI 10.1089/08927790260472881
   LEROY AJ, 1986, RADIOLOGY, V158, P219, DOI 10.1148/radiology.158.1.3510020
   Li G, 2011, BJU INT, V108, P901, DOI 10.1111/j.1464-410X.2010.09992.x
   Liatsikos E, 2010, EUR UROL, V57, P480, DOI 10.1016/j.eururo.2009.02.004
   Liatsikos EN, 2007, EUR UROL, V51, P217, DOI 10.1016/j.eururo.2006.05.054
   Liatsikos EN, 2009, J UROLOGY, V182, P2613, DOI 10.1016/j.juro.2009.08.040
   Lingeman JE, 2003, J ENDOUROL, V17, P169, DOI 10.1089/089277903321618734
   Lingeman JE, 2003, J UROLOGY, V169, P1682, DOI 10.1097/01.ju.0000055600.18515.a1
   Livadas KE, 2007, J UROLOGY, V178, P1998, DOI 10.1016/j.juro.2007.07.027
   Lumiaho J, 2000, J UROLOGY, V164, P1360, DOI 10.1016/S0022-5347(05)67199-6
   Lumiaho J, 1999, J ENDOUROL, V13, P107, DOI 10.1089/end.1999.13.107
   Lumiaho J, 2007, J ENDOUROL, V21, P1559, DOI 10.1089/end.2005.0085
   Lumiaho J, 2011, SCAND J UROL NEPHROL, V45, P129, DOI 10.3109/00365599.2010.544673
   Mendez-Probst CE, 2012, BJU INT, V110, P749, DOI 10.1111/j.1464-410X.2011.10903.x
   Nagele U, 2006, J ENDOUROL, V20, P418, DOI 10.1089/end.2006.20.418
   Nakayama Y, 2007, J ARTIF ORGANS, V10, P171, DOI 10.1007/s10047-007-0376-1
   Olweny EO, 2002, J UROLOGY, V167, P2198, DOI 10.1016/S0022-5347(05)65128-2
   Pryor J., 1988, J ENDOUROL, V2, P283
   Rajpathy J, 2008, BJU INT, V102, P1743, DOI 10.1111/j.1464-410X.2008.08022.x
   RAMSAY JWA, 1985, BRIT J UROL, V57, P630, DOI 10.1111/j.1464-410X.1985.tb07021.x
   REID G, 1992, J UROLOGY, V148, P1592, DOI 10.1016/S0022-5347(17)36976-8
   Roupret M, 2005, UROLOGY, V66, P246, DOI 10.1016/j.urology.2005.03.054
   Schierholz JM, 1999, AM J MED, V107, P101
   Schlick RW, 1998, J ENDOUROL, V12, P451, DOI 10.1089/end.1998.12.451
   Schlick RW, 1997, BRIT J UROL, V80, P908, DOI 10.1046/j.1464-410X.1997.00484.x
   Shaw GL, 2005, UROL RES, V33, P17, DOI 10.1007/s00240-004-0423-9
   Singh I, 2001, UROLOGY, V58, P526, DOI 10.1016/S0090-4295(01)01317-6
   Sountoulides P, 2010, BJU INT, V105, P1066, DOI 10.1111/j.1464-410X.2009.09140.x
   Talja M, 2002, J ENDOUROL, V16, P299, DOI 10.1089/089277902760102785
   Tieszer C, 1998, J UROLOGY, V160, P876, DOI 10.1016/S0022-5347(01)62825-8
   Tsuji Takafumi, 2003, Int J Cardiovasc Intervent, V5, P13
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 1997, J BIOMED MATER RES, V38, P87, DOI 10.1002/(SICI)1097-4636(199722)38:2<87::AID-JBM2>3.0.CO;2-C
   Venkatesan N, 2010, J ENDOUROL, V24, P191, DOI 10.1089/end.2009.0516
   Venkatesh R, 2005, J ENDOUROL, V19, P170, DOI 10.1089/end.2005.19.170
   Wakui M, 2000, BJU INT, V85, P227, DOI 10.1046/j.1464-410x.2000.00401.x
   Wang C. J., UROL RES, V37, P147
NR 78
TC 32
Z9 34
U1 0
U2 34
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-4812
EI 1759-4820
J9 NAT REV UROL
JI Nat. Rev. Urol.
PD JAN
PY 2015
VL 12
IS 1
BP 17
EP 25
DI 10.1038/nrurol.2014.340
PG 9
WC Urology & Nephrology
SC Urology & Nephrology
GA AY3AJ
UT WOS:000347456700006
PM 25534997
DA 2018-10-20
ER

PT J
AU Guerra, F
   La Torre, M
   Giuliani, G
   Coletta, D
   Amore Bonapasta, S
   Velluti, F
   La Torre, F
AF Guerra, F.
   La Torre, M.
   Giuliani, G.
   Coletta, D.
   Amore Bonapasta, S.
   Velluti, F.
   La Torre, F.
TI Long-term evaluation of bulking agents for the treatment of fecal
   incontinence: clinical outcomes and ultrasound evidence
SO TECHNIQUES IN COLOPROCTOLOGY
LA English
DT Article
DE Fecal incontinence; Bulking agents; Anorectal manometry; Endoanal
   ultrasound
ID INJECTABLE SILICONE BIOMATERIAL; STABILIZED HYALURONIC-ACID; FOLLOW-UP;
   INJECTION; EFFICACY; DEXTRANOMER; IMPLANTS; PTQ(TM); TRIAL; BEADS
AB The injection of bulking agents into the anal canal has been reported to help patients with fecal incontinence. Although it has been advocated as a safe and effective option, substantial data concerning long-term efficacy are still lacking, and the resorption process of the implants has not yet been carefully studied. The aim of our study was to investigate the long-term outcomes of bulking agents for the treatment of fecal incontinence and the behavior of implanted materials in the anorectum.
   At a median follow-up of 7 years, 19 patients with idiopathic fecal incontinence who had received bulking agent implants were evaluated. Clinical, manometric and ultrasound assessments were carried out.
   The clinical improvements that were achieved in the short term were not maintained over time. For each patient, the number of implants that could no longer be identified on ultrasound was significantly correlated with poorer clinical long-term outcomes. On average, only 14 % of the originally injected volume was still detectable.
   In the long term, perianally injected bulking agents seem to lose effectiveness. The ultrasound assessment suggests that the process of resorption is almost complete, and the implants are no longer effective in treating incontinence.
C1 [Guerra, F.; Giuliani, G.; Coletta, D.; Amore Bonapasta, S.; Velluti, F.; La Torre, F.] Umberto I Hosp, Dept Surg, I-00161 Rome, Italy.
   [La Torre, M.] St Andrea Hosp, Dept Surg, I-00189 Rome, Italy.
RP Guerra, F (reprint author), Via Sabelli 211, I-00185 Rome, Italy.
EM fra.guerra.mail@gmail.com
OI La Torre, Marco/0000-0002-7051-6120; Guerra,
   Francesco/0000-0003-2891-4659
CR Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   Bartlett L, 2009, BRIT J SURG, V96, P1468, DOI 10.1002/bjs.6745
   Chrouser KL, 2004, J UROLOGY, V171, P1152, DOI 10.1097/01.ju.0000103688.83606.06
   Dodi G, 2010, GASTROENT RES PRACT, DOI 10.1155/2010/467136
   Gorton E, 1999, BJU INT, V84, P966
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Guerra F, 2010, PELVIPERINEOLOGY, V29, P27
   Hussain ZI, 2011, BRIT J SURG, V98, P1526, DOI 10.1002/bjs.7645
   La Torre F, 2013, COLORECTAL DIS, V15, P569, DOI 10.1111/codi.12155
   Luo C, 2010, COLORECTAL DIS, V12, P296, DOI 10.1111/j.1463-1318.2009.01828.x
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   Maeda Y, 2010, COCHRANE DB SYST REV, V12
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Ratto C, 2011, BRIT J SURG, V98, P1644, DOI 10.1002/bjs.7699
   SHAFIK A, 1993, INT SURG, V78, P159
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Watson NFS, 2012, COLORECTAL DIS, V14, P29, DOI 10.1111/codi.12047
NR 18
TC 8
Z9 8
U1 0
U2 6
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1123-6337
EI 1128-045X
J9 TECH COLOPROCTOL
JI Tech. Coloproctology
PD JAN
PY 2015
VL 19
IS 1
BP 23
EP 27
DI 10.1007/s10151-014-1236-7
PG 5
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA AY0NX
UT WOS:000347294100004
PM 25381455
DA 2018-10-20
ER

PT J
AU Thingale, AD
   Shaikh, KS
   Channekar, PR
   Galgatte, UC
   Chaudhari, PD
   Bothiraja, C
AF Thingale, Amol D.
   Shaikh, Karimunnisa S.
   Channekar, Prajakta R.
   Galgatte, Upendra C.
   Chaudhari, Praveen D.
   Bothiraja, Chellampillai
TI Enhanced hepatoprotective activity of andrographolide complexed with a
   biomaterial
SO DRUG DELIVERY
LA English
DT Article
DE Andrographolide; biomaterial; hepatoprotective; humic acid; solubility
ID HUMIC-ACID; IN-VIVO; SURFACTANTS
AB Context: Humic acid (HA), a natural organic matter is recently being investigated for pharmaceutical purposes. Andrographolide (AGP), a potent hepatoprotective, possesses low aqueous solubility which results in a low bioavailability after oral administration, inappropriate tissue localization and consequently poor therapeutic application.
   Objective: The present study investigates the complexation of AGP with HA to increase its solubility and hepatoprotective efficacy.
   Materials and methods: Complexes prepared by solvent evaporation in various weight ratios were characterized using differential scanning calorimetry, Fourier Transform InfraRed spectroscopy, X-ray diffraction, and scanning electron microscopy.
   Results and discussion: The complexed AGP demonstrated improved solubility, dissolution, and permeation across rat intestine. It also displayed better hepatoprotection against carbontetrachloride- induced liver toxicity than the free drug in rats.
   Conclusion: Complexation with HA is a valuable technique to improve solubility and bioavailability of pharmaceuticals.
C1 [Thingale, Amol D.; Shaikh, Karimunnisa S.; Channekar, Prajakta R.; Galgatte, Upendra C.; Chaudhari, Praveen D.] Modern Coll Pharm, Dept Pharmaceut, Pune 411044, Maharashtra, India.
   [Bothiraja, Chellampillai] Sharadchandra Pawar Coll Pharm, Dept Phytopharmaceut, Pune, Maharashtra, India.
RP Shaikh, KS (reprint author), Modern Coll Pharm, Dept Pharmaceut, Sector 21, Pune 411044, Maharashtra, India.
EM karima78@rediffmail.com
RI Shaikh, Karimunnisa/F-1422-2015; Galgatte, Upendra/P-6646-2015;
   Chaudhari, Pravin/P-8622-2015
OI Shaikh, Karimunnisa/0000-0001-8315-6200; Galgatte,
   Upendra/0000-0001-8427-0945; Chaudhari, Pravin/0000-0002-0813-5554
CR Aamir M, 2011, DRUG DEV IND PHARM, V37, P310
   Aamir M, 2010, J CURR PHARM RES, V1, P2
   Agarwal SP, 2007, ASIAN J CHEM, V19, P4711
   Arshia S., 2007, PAK J PHARM SCI, V20, P1
   Bothiraja C, 2009, NANOSCI NANOTECH LET, V1, P156, DOI 10.1166/nnl.2009.1029
   Bothiraja C, 2009, J PHARM PHARMACOL, V61, P1465, DOI 10.1211/jpp/61.11.0005
   Chandana M, 2011, INT J PHARM TECH RES, V3, P1586
   Eladia M, 2005, J APPL BIOMED, V3, P13
   Enzo M, 2008, BIO RESOUR, V3, P123
   Gamboa C, 2006, COLLOID SURFACE A, V278, P241, DOI 10.1016/j.colsurfa.2005.12.026
   Klocking R, 2005, BIOPOLYMERS MED PHAR, P4
   Laplante M, 1999, ADV ENVIRON RES, V2, P467
   Martini S, 2010, J PHOTOCH PHOTOBIO B, V101, P355, DOI 10.1016/j.jphotobiol.2010.08.008
   Mirza Mohd Aamir, 2011, Results Pharma Sci, V1, P16, DOI 10.1016/j.rinphs.2011.06.001
   Ren K, 2009, PHARMAZIE, V64, P515, DOI 10.1691/ph.2009.9062
   Salati S, 2011, BIOTECHNOL ADV, V29, P913, DOI 10.1016/j.biotechadv.2011.07.012
   Samios S, 2007, DESALINATION, V210, P125, DOI 10.1016/j.desal.2006.05.038
   Sinha J, 2000, DRUG DELIV, V7, P209
NR 18
TC 5
Z9 7
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1071-7544
EI 1521-0464
J9 DRUG DELIV
JI Drug Deliv.
PD JAN
PY 2015
VL 22
IS 1
BP 117
EP 124
DI 10.3109/10717544.2013.871602
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AX5OC
UT WOS:000346975000013
PM 24400590
OA Bronze
DA 2018-10-20
ER

PT J
AU Choi, BH
   Cheong, H
   Ahn, JS
   Zhou, C
   Kwon, JJ
   Cha, HJ
   Jun, SH
AF Choi, Bong-Hyuk
   Cheong, Hogyun
   Ahn, Jin-Soo
   Zhou, Cong
   Kwon, Jong Jin
   Cha, Hyung Joon
   Jun, Sang Ho
TI Engineered mussel bioglue as a functional osteoinductive binder for
   grafting of bone substitute particles to accelerate in vivo bone
   regeneration
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID CELL-ADHESION; COMPUTED-TOMOGRAPHY; GENE-EXPRESSION; L-DOPA; MEMBRANES;
   PROTEIN; DIFFERENTIATION; HYDROXYAPATITE; GENERATION; GROWTH
AB Xenograft bone substitutes, such as deproteinized bovine bone mineral (DBBM), have been widely employed as osteoconductive structural materials for bone tissue engineering. However, the loss of xenograft bone substitute particles in defects has been a major limitation, along with a lack of osteoinductive function. Mussel adhesive protein (MAP), a remarkable and powerful adhesive biomaterial in nature, can attach to various substrates, even in wet environments. Its adhesive and water-resistant abilities are considered to be mainly derived from the reduced catechol form, 3,4-dihydroxyphenylalanine (DOPA), of its tyrosine residues. Here, we evaluated the use of DOPA-containing MAP as a functional binder biomaterial to effectively retain DBBM particles at the defect site during in vivo bone regeneration. We observed that DOPA-containing MAP was able to bind DBBM particles easily to make an aggregate, and grafted DBBM particles were not lost in a defect in the rat calvaria during the healing period. Importantly, grafting of a DOPA-containing MAP-bound DBBM aggregate resulted in remarkably accelerated in vivo bone regeneration and even bone remodeling. Interestingly, we found that the DOPA residues in the modified MAP had an osteoinductive ability based on clear observation of the in vivo maturation of new bones with a similar bone density to the normal bone and of the in vitro osteogenic differentiation of osteoblast cells. Collectively, DOPA-containing MAP is a promising functional binder biomaterial for xenograft bone substitute-assisted bone regeneration with enhanced osteoconductivity and acquired osteoinductivity. This mussel glue could also be successfully utilized as a potential biomaterial for general bone tissue engineering.
C1 [Choi, Bong-Hyuk; Cheong, Hogyun; Cha, Hyung Joon] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea.
   [Ahn, Jin-Soo] Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea.
   [Ahn, Jin-Soo] Seoul Natl Univ, Dept Dent Biomat Sci, Seoul 110749, South Korea.
   [Zhou, Cong] Korea Univ, Grad Sch, Dept Med, Seoul 136705, South Korea.
   [Kwon, Jong Jin; Jun, Sang Ho] Korea Univ, Anam Hosp, Med Ctr, Dept Dent,Div Oral & Maxillofacial Surg, Seoul 136705, South Korea.
RP Cha, HJ (reprint author), Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea.
EM hjcha@postech.ac.kr; junsang@korea.ac.kr
FU Marine Biotechnology Program (Marine BioMaterials Research Center);
   Basic Science Research Program through the National Research Foundation
   - Ministry of Science, ICT & Future Planning of Korea
   [NRF-2013R1A1A1065373]; Rising Star Program - POSTECH
FX This work was supported by the Marine Biotechnology Program (Marine
   BioMaterials Research Center) funded by the Ministry of Oceans and
   Fisheries of Korea (to HJ Cha & SH Jun), Basic Science Research Program
   (NRF-2013R1A1A1065373) through the National Research Foundation funded
   by the Ministry of Science, ICT & Future Planning of Korea (to SH Jun),
   and the Rising Star Program funded by POSTECH (to HJ Cha).
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Alves RDAM, 2011, J PROTEOME RES, V10, P4725, DOI 10.1021/pr200522n
   Ambrosio AMA, 2001, J BIOMED MATER RES, V58, P295, DOI 10.1002/1097-4636(2001)58:3<295::AID-JBM1020>3.3.CO;2-#
   BALDINI A, 2010, ANN STOMATOL, V1, P2
   Bigi A, 2005, BIOMATERIALS, V26, P2381, DOI 10.1016/j.biomaterials.2004.07.057
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cho Hyung Joon, 2008, Biotechnology Journal, V3, P631, DOI 10.1002/biot.200700258
   Choi BH, 2010, BIOMATERIALS, V31, P8980, DOI 10.1016/j.biomaterials.2010.08.027
   Drevelle O, 2010, BIOMATERIALS, V31, P6468, DOI 10.1016/j.biomaterials.2010.05.010
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Hwang DS, 2007, BIOMATERIALS, V28, P3560, DOI 10.1016/j.biomaterials.2007.04.039
   Hwang DS, 2012, SOFT MATTER, V8, P5640, DOI 10.1039/c2sm25173f
   Jones GT, 1996, J ORAL MAXIL SURG, V54, P470, DOI 10.1016/S0278-2391(96)90124-X
   Kim BJ, 2012, ANGEW CHEM INT EDIT, V51, P675, DOI 10.1002/anie.201105789
   Kim SH, 2012, J BIOMATER APPL, V27, P143, DOI 10.1177/0885328210397679
   La WG, 2013, TISSUE ENG PT A, V19, P1255, DOI [10.1089/ten.tea.2012.0165, 10.1089/ten.TEA.2012.0165]
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Lim S, 2010, BIOMATERIALS, V31, P3715, DOI 10.1016/j.biomaterials.2010.01.063
   Liu YT, 2013, COLLOID SURFACE B, V106, P37, DOI 10.1016/j.colsurfb.2013.01.023
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu QY, 2013, ANGEW CHEM INT EDIT, V52, P3944, DOI 10.1002/anie.201210365
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260
   Monteiro ASF, 2010, MED ORAL PATOL ORAL, V15, pE401, DOI 10.4317/medoral.15.e401
   O'Neill CA, 2000, CALCIFIED TISSUE INT, V67, P53, DOI 10.1007/s00223001097
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Rakhmatia YD, 2013, J PROSTHODONT RES, V57, P3, DOI 10.1016/j.jpor.2012.12.001
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schieker M, 2006, EUR J TRAUMA, V32, P114, DOI DOI 10.1007/S00068-006-6047-8
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   SCHMID J, 1994, CLIN ORAL IMPLAN RES, V5, P125, DOI 10.1034/j.1600-0501.1994.050302.x
   Schwartz Z, 2007, CLIN ORAL IMPLAN RES, V18, P204, DOI 10.1111/j.1600-0501.2006.01303.x
   Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759
   Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x
   Song JM, 2014, INT J ORAL SCI, V6, P87, DOI 10.1038/ijos.2014.16
   STEIN GS, 1990, FASEB J, V4, P3111
   Stubbs JT, 1997, J BONE MINER RES, V12, P1210, DOI 10.1359/jbmr.1997.12.8.1210
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   Yang B, 2013, BIOFOULING, V29, P483, DOI 10.1080/08927014.2013.782541
NR 42
TC 4
Z9 4
U1 6
U2 26
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 4
BP 546
EP 555
DI 10.1039/c4tb01197j
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AX4ML
UT WOS:000346906500003
OA Green Published
DA 2018-10-20
ER

PT J
AU De, S
   Mohanty, S
   Nayak, SK
AF De, Sriparna
   Mohanty, Smita
   Nayak, Sanjay Kumar
TI Structure-Property Relationship of Layered Metal Oxide
   Phosphonate/Chitosan Nanohybrids for Transducer in Biosensing Device
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE biosensing device; chitosan; nanocomposites; transducer; zirconium
   sulfophenylphosphonate
ID NANOCOMPOSITE FILMS; ZIRCONIUM-PHOSPHATE; FUEL-CELL; COMPOSITE
   MEMBRANES; PHYSICAL-PROPERTIES; DRUG-DELIVERY; CHITOSAN; BEHAVIOR;
   ELECTROLYTES; CONDUCTIVITY
AB A candid approach to analyze the performance characteristics of phenyl phosphonate-functionalized zirconium oxide and pure zirconium oxide (ZrO2) fillers reinforced chitosan nanocomposites and their suitability as a potential biomaterial for the development of transducer surface in biosensing device has been investigated in this communication. Functionalization of ZrO2 has been carried out using sulfophenylphosphonate which was confirmed using Fourier transform infrared spectrographs. The electrostatic intercalation of chitosan with filler particles was monitored using electrochemical impedance analyzer which exhibits lowest bulk resistance which is highly effective for ionic switching. Incorporation of zirconium sulfophenylphosphonate (ZrSP) the ionic conductivity of the chitosan film attained a value of 1.2 x 10(-6) S/cm as compared to the unmodified one which is a prefeasibility work for the fabrication of biosensing platform. Variation in performance characteristics has been evaluated through morphological and thermal characterization. TGA and DSC analysis reveal that the thermal stability and decomposition temperature of the nanocomposites were improved by the addition of reinforcing filler particles. XRD and SEM and TEM results support the above assumption. The continuous alignment of the proton transfer channels of the nanocomposites was thoroughly investigated by AFM analysis which revealed phase morphology for improved enzyme entrapment. Further, surface functionalized nanofillers result considerable increment of mechanical properties in terms of elastic modulus and tensile stress.
C1 [De, Sriparna; Mohanty, Smita; Nayak, Sanjay Kumar] Cent Inst Plast Engn & Technol CIPET, Madras, Tamil Nadu, India.
   [Mohanty, Smita; Nayak, Sanjay Kumar] CIPET, Lab Adv Res Polymer Mat LARPM, Bhubaneswar 751024, Odisha, India.
RP De, S (reprint author), Cent Inst Plast Engn & Technol CIPET, Madras, Tamil Nadu, India.
EM papers.journal@gmail.com
CR Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7
   Arlete B. R., 2011, J POLYM INT, V60, P963
   Avella M, 2005, FOOD CHEM, V93, P467, DOI 10.1016/j.foodchem.2004.10.024
   Barbara K., 2004, ENZYME MICROB TECHNO, V35, P126
   Beattie PD, 2001, J ELECTROANAL CHEM, V503, P45, DOI 10.1016/S0022-0728(01)00355-2
   Bhatnagar A, 2009, ADV COLLOID INTERFAC, V152, P26, DOI 10.1016/j.cis.2009.09.003
   CLEARFIELD A, 1995, J SOLID STATE CHEM, V117, P275, DOI 10.1006/jssc.1995.1274
   CLEARFIELD A, 1964, J INORG NUCL CHEM, V26, P117, DOI 10.1016/0022-1902(64)80238-4
   Costamagna P, 2002, ELECTROCHIM ACTA, V47, P1023, DOI 10.1016/S0013-4686(01)00829-5
   Cuq B, 1998, CEREAL CHEM, V75, P1, DOI 10.1094/CCHEM.1998.75.1.1
   de Grotthuss CJT, 1806, ANN CHIM, V58, P54
   Deluca NW, 2006, J POLYM SCI POL PHYS, V44, P2201, DOI 10.1002/polb.20861
   Devendra V., 2008, J MAT SCI ENG C, V28, P399
   Giannakas A, 2014, CARBOHYD POLYM, V108, P103, DOI 10.1016/j.carbpol.2014.03.019
   Han JH, 2005, INNOVATIONS IN FOOD PACKAGING, P239, DOI 10.1016/B978-012311632-1/50047-4
   He LH, 2014, APPL SURF SCI, V314, P510, DOI 10.1016/j.apsusc.2014.07.033
   Kreuer KD, 2004, CHEM REV, V104, P4637, DOI 10.1021/cr020715f
   Lai SM, 2006, POLYM-PLAST TECHNOL, V45, P997, DOI 10.1080/03602550600726269
   Liu C., 2010, J APPL POLYM SCI, V120, P1106
   Liu CH, 2009, POLYM TEST, V28, P801, DOI 10.1016/j.polymertesting.2009.07.002
   Marroquin JB, 2013, CARBOHYD POLYM, V92, P1783, DOI 10.1016/j.carbpol.2012.11.042
   Muzzarelli R. A. A., 2012, J POLYM SCI A, V10, P153
   Nunthanid J, 2001, DRUG DEV IND PHARM, V27, P143, DOI 10.1081/DDC-100000481
   OGAWA K, 1984, MACROMOLECULES, V17, P973, DOI 10.1021/ma00134a076
   PEARSON FG, 1960, J POLYM SCI, V43, P101, DOI 10.1002/pol.1960.1204314109
   Peniche H, 2011, POLYM INT, V60, P883, DOI 10.1002/pi.3056
   Pica M, 2014, INORG CHEM, V53, P2222, DOI 10.1021/ic402884g
   Pradhan DK, 2007, INT J ELECTROCHEM SC, V2, P861
   Puttipipatkhachorn S, 2001, J CONTROL RELEASE, V75, P143, DOI 10.1016/S0168-3659(01)00389-3
   Qin HL, 2004, J POLYM SCI POL PHYS, V42, P3006, DOI 10.1002/polb.20068
   Raafat D, 2009, MICROB BIOTECHNOL, V2, P186, DOI 10.1111/j.1751-7915.2008.00080.x
   Riva A, 2002, POLYM DEGRAD STABIL, V77, P299, DOI 10.1016/S0141-3910(02)00065-4
   Shukla SK, 2013, INT J BIOL MACROMOL, V59, P46, DOI 10.1016/j.ijbiomac.2013.04.043
   Sun LY, 2007, CHEM MATER, V19, P1749, DOI 10.1021/cm062993r
   Svoboda J, 2013, J SOLID STATE CHEM, V208, P58, DOI 10.1016/j.jssc.2013.09.042
   Tang CY, 2008, J PHYS CHEM B, V112, P3876, DOI 10.1021/jp709977m
   Upadhyaya L, 2014, J CONTROL RELEASE, V186, P54, DOI 10.1016/j.jconrel.2014.04.043
   Vaivars G, 2003, J SOLID STATE ELECTR, V7, P724, DOI 10.1007/s10008-003-0391-y
   Varhadi P, 2013, APPL CATAL A-GEN, V462, P129, DOI 10.1016/j.apcata.2013.04.043
   Wang SF, 2005, POLYM DEGRAD STABIL, V90, P123, DOI 10.1016/j.polymdegradstab.2005.03.001
   Wang XY, 2007, CARBOHYD POLYM, V69, P41, DOI 10.1016/j.carbpol.2006.08.025
   Weber AZ, 1971, IND ENG CHEM FUND, V10, P554
   Wei'an Z., 2004, J RAD PHYS CHEM, V69, P467
   Wu HX, 2010, POLYM INT, V59, P923, DOI 10.1002/pi.2807
   Wu HX, 2009, CARBOHYD POLYM, V77, P358, DOI 10.1016/j.carbpol.2009.01.002
   Yang C, 2004, J MEMBRANE SCI, V237, P145, DOI 10.1016/j.memsci.2004.03.009
   YANG CY, 1987, REACT POLYM, V5, P13, DOI 10.1016/0167-6989(87)90161-9
   Yang YJ, 2010, CARBOHYD RES, V345, P148, DOI 10.1016/j.carres.2009.10.012
   Yang YJ, 2009, POLYM TEST, V28, P371, DOI 10.1016/j.polymertesting.2008.12.008
   Youssef AM, 2014, INT J BIOL MACROMOL, V69, P185, DOI 10.1016/j.ijbiomac.2014.05.047
   Zang Y., 2008, J BIOMATER, V29, P4314
   Zeng RQ, 2008, J ORGANOMET CHEM, V693, P2666, DOI 10.1016/j.jorganchem.2008.04.009
   Zima V, 2010, SOLID STATE IONICS, V181, P705, DOI 10.1016/j.ssi.2010.03.034
   Zohuriaan MJ, 2004, POLYM TEST, V23, P575, DOI 10.1016/j.polymertesting.2003.11.001
NR 54
TC 3
Z9 3
U1 2
U2 22
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD JAN
PY 2015
VL 24
IS 1
BP 114
EP 127
DI 10.1007/s11665-014-1293-0
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA AX6KG
UT WOS:000347030600013
DA 2018-10-20
ER

PT J
AU Barboza, ALL
   Kang, KW
   Bonetto, RD
   Llorente, CL
   Bilmes, PD
   Gervasi, CA
AF Lemos Barboza, Adriana L.
   Kang, Kyung Won
   Bonetto, Rita D.
   Llorente, Carlos L.
   Bilmes, Pablo D.
   Gervasi, Claudio A.
TI Blasting and Passivation Treatments for ASTM F139 Stainless Steel for
   Biomedical Applications: Effects on Surface Roughness, Hardening, and
   Localized Corrosion
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE 316 LVM stainless steel; corrosion; glass bead blasting; hardness;
   nitric acid passivation; roughness parameters
ID SCANNING-ELECTRON-MICROSCOPY; DENTAL IMPLANT APPLICATIONS; FRACTAL
   ANALYSIS; MECHANICAL-PROPERTIES; BEHAVIOR; TOPOGRAPHY; PARAMETERS;
   RESISTANCE; TITANIUM; 3D
AB Due to the combination of good biofunctionality and biocompatibility at low cost, AISI 316 low carbon vacuum melting (LVM) stainless steel, as considered in ASTM F139 standard, is often the first choice for medical implants, particularly for use in orthopedic surgery. Proper surface finish must be provided to ensure adequate interactions of the alloy with human body tissues that in turn allows the material to deliver the desired performance. Preliminary studies performed in our laboratory on AISI 316LVM stainless steel surfaces modified by glass bead blasting (from industrial supplier) followed by different nitric acid passivation conditions disclosed the necessity to extend parameters of the surface treatments and to further consider roughness, pitting corrosion resistance, and surface and subsurface hardening measurements, all in one, as the most effective characterization strategy. This was the approach adopted in the present work. Roughness assessment was performed by means of amplitude parameters, functional parameters, and an estimator of the fractal dimension that characterizes surface topography. We clearly demonstrate that the blasting treatment should be carried out under controlled conditions in order to obtain similar surface and subsurface properties. Otherwise, a variation in one of the parameters could modify the surface properties, exerting a profound impact on its application as biomaterial. A passivation step is necessary to offset the detrimental effect of blasting on pitting corrosion resistance.
C1 [Lemos Barboza, Adriana L.; Kang, Kyung Won; Llorente, Carlos L.; Bilmes, Pablo D.; Gervasi, Claudio A.] Fac Ingn UNLP, Lab Invest Met Fis LIMF, RA-1900 La Plata, Buenos Aires, Argentina.
   [Bonetto, Rita D.] Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Exactas UNLP, Ctr Invest & Desarrollo Ciencias Aplicadas Dr Jor, RA-1900 La Plata, Buenos Aires, Argentina.
   [Llorente, Carlos L.; Gervasi, Claudio A.] Comis Invest Cient Prov Buenos Aires CICPBA, La Plata, Buenos Aires, Argentina.
   [Gervasi, Claudio A.] Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Exactas UNLP, Inst Invest Fis Quim Teor & Aplicadas INIFTA, RA-1900 La Plata, Buenos Aires, Argentina.
RP Barboza, ALL (reprint author), Fac Ingn UNLP, Lab Invest Met Fis LIMF, Calle 1 & 47, RA-1900 La Plata, Buenos Aires, Argentina.
EM adriana.barboza@ing.unlp.edu.ar; adriana.kang@ing.unlp.edu.ar;
   bonetto@quimica.unlp.edu.ar; cllorent@ing.unlp.edu.ar;
   pabilmes@ing.unlp.edu.ar; gervasi@inifta.unlp.edu.ar
CR Amada S, 1998, SURF COAT TECH, V102, P132, DOI 10.1016/S0257-8972(97)00628-2
   Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   Arifvianto B, 2012, SURF COAT TECH, V210, P176, DOI 10.1016/j.surfcoat.2012.09.014
   Arvidsson A, 2006, CLIN IMPLANT DENT R, V8, P70, DOI 10.1111/j.1708-8208.2006.00001.x
   ASM, E38499 ASTM
   Azar V, 2010, SURF COAT TECH, V204, P3546, DOI 10.1016/j.surfcoat.2010.04.015
   Bariani P, 2005, PRECIS ENG, V29, P219, DOI 10.1016/j.precisioneng.2004.08.002
   Barranco V, 2007, ELECTROCHIM ACTA, V52, P4374, DOI 10.1016/j.electacta.2006.12.031
   Barranco V, 2010, SURF COAT TECH, V204, P3783, DOI 10.1016/j.surfcoat.2010.04.051
   Ben Rhouma A, 2001, J MATER ENG PERFORM, V10, P507
   Bigerelle M, 2013, TRIBOL INT, V59, P190, DOI 10.1016/j.triboint.2012.04.027
   Bonetto RD, 2006, MICROSC MICROANAL, V12, P178, DOI 10.1017/S143192760606003X
   Brown LT, 2006, THESIS U HUDDERSFIEL
   Chander KP, 2009, MATER DESIGN, V30, P2895, DOI 10.1016/j.matdes.2009.01.014
   Cionea C., 2010, THESIS U TEXAS ARLIN
   DONG WP, 1994, WEAR, V178, P29, DOI 10.1016/0043-1648(94)90127-9
   Faller M, 2005, MATER CORROS, V56, P373, DOI 10.1002/maco.200403846
   Galvan JC, 2012, J MATER SCI-MATER M, V23, P657, DOI 10.1007/s10856-012-4549-y
   Gil FJ, 2007, DENT MATER, V23, P486, DOI 10.1016/j.dental.2006.03.003
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Kang KW, 2012, MICRON, V43, P387, DOI 10.1016/j.micron.2011.10.005
   Korb L. J., 1987, ASME METALS HDB, V13
   Liang XH, 2012, APPL SURF SCI, V258, P6406, DOI 10.1016/j.apsusc.2012.03.050
   Loberg J., 2011, THESIS U GOTHENBURG
   MAN HC, 1981, CORROS SCI, V21, P323, DOI 10.1016/0010-938X(81)90007-X
   Momber AW, 2005, JCT RES, V2, P453, DOI 10.1007/BF02733888
   Multigner M, 2010, SURF COAT TECH, V205, P1830, DOI 10.1016/j.surfcoat.2010.07.126
   Multigner M, 2009, MAT SCI ENG C-BIO S, V29, P1357, DOI 10.1016/j.msec.2008.11.002
   Niemczewska-Wojcik M, 2011, WEAR, V271, P596, DOI 10.1016/j.wear.2010.06.013
   O'Hare P, 2010, BIOMATERIALS, V31, P515, DOI 10.1016/j.biomaterials.2009.09.067
   Ostadi H, 2010, PRECIS ENG, V34, P798, DOI 10.1016/j.precisioneng.2010.03.011
   Otsubo F, 2003, J THERM SPRAY TECHN, V12, P555, DOI 10.1361/105996303772082305
   Pereda MD, 2012, PROC MAT SCI, V1, P446, DOI 10.1016/j.mspro.2012.06.060
   Pereda MD, 2011, CORROS SCI, V53, P3934, DOI 10.1016/j.corsci.2011.07.040
   Ponz E, 2006, MICROSC MICROANAL, V12, P170, DOI 10.1017/S1431927606060028
   Provder T, 1996, PROG ORG COAT, V27, P219, DOI 10.1016/0300-9440(94)00538-9
   Rasband WS, 2012, IMAGEJ
   Ratner B. D., 1996, THIN FILMS GRAFTS CO, P105
   Reidenbach F., 1994, ASME METALS HDB, V5
   Risovic D, 2009, APPL SURF SCI, V255, P4283, DOI 10.1016/j.apsusc.2008.11.028
   Singh R, 2007, J MATER SCI-MATER M, V18, P725, DOI 10.1007/s10856-006-0016-y
   Stout K. J., 1993, DEV METHODS CHARACTE
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
NR 43
TC 1
Z9 1
U1 1
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD JAN
PY 2015
VL 24
IS 1
BP 175
EP 184
DI 10.1007/s11665-014-1300-5
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA AX6KG
UT WOS:000347030600020
DA 2018-10-20
ER

PT J
AU Rokicki, R
   Haider, W
   Maffi, SK
AF Rokicki, Ryszard
   Haider, Waseem
   Maffi, Shivani Kaushal
TI Hemocompatibility Improvement of Chromium-Bearing Bare-Metal Stent
   Platform After Magnetoelectropolishing
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE biomaterial; magnetic; magnets; oxidation; stainless; steel
ID SELF-ASSEMBLED MONOLAYERS; NON-INFERIORITY TRIAL; BIODEGRADABLE POLYMER;
   PROTEIN ADSORPTION; STAINLESS-STEEL; ELUTING STENT; SURFACE; FIBRINOGEN
AB Research was undertaken to determine the influence of the increased content of chromium in the outermost passive layer of magneto-electrochemically refined Co-Cr alloy L-605 surface on its hemocompatibility. The chemistry, roughness, surface energy, and wettability of conventionally electropolished (EP) and magnetoelectropolished (MEP) samples were studied with x-ray photoelectron spectroscopy (XPS), open circuit potential, atomic force microscopy, and contact angle meter. In vitro hemocompatibility of tested material surfaces was assessed using two important indicators of vascular responses to biomaterial, namely endothelialization and platelets adhesion. The endothelialization was assessed by seeding and incubating samples with human umbilical vein endothelial cells (HUVEC) for 3 days before counting and observing them under a fluorescent microscope. The platelet (rich plasma blood) adhesion and activation test on EP and MEP L-605 alloy surfaces was assessed using a laser scanning confocal microscope. The XPS analysis of MEP samples showed significant enrichment of the passive layer with Cr and O when compared with the EP one. The amount of other elements in the passive layer did not show a significant difference between EP and MEP treatments. The adhesion of HUVEC cells shows remarkable affinity to surfaces enriched in Cr (MEP) with almost 100% confluency. In addition, the number of platelets that adhered to standard EP surfaces was higher compared to the MEP surface. The present study shows that the chromium-enriched surface of cobalt-chromium alloy L-605 by the magnetoelectropolishing process tremendously improves surface hemocompatibility with regard to stent functionality by enhanced endothelialization and lower platelet adhesion and should be taken under consideration as an alternative surface of biodegradable polymer drug-eluting stents, polymer-free drug-eluting stents as well as bare-metal stents.
C1 [Rokicki, Ryszard] Elect, Macungie, PA USA.
   [Haider, Waseem] Univ Texas Pan Amer, Dept Mech Engn, Edinburg, TX USA.
   [Maffi, Shivani Kaushal] San Antonio & Edinburg Reg Acad Hlth Ctr, Univ Texas Hlth Sci Ctr, Dept Mol Med, Edinburg, TX USA.
RP Rokicki, R (reprint author), Elect, Macungie, PA USA.
EM info@electrobright.com
FU US Army Research Office [W911NF-14-1-0100]
FX Fort Wayne Metals Research Products Corporation is gratefully
   acknowledged for providing Co-Cr alloy L-605 sample for the studies. We
   also are thankful to Mrs. Chandan Pulletikurthi from Florida
   International University, Miami, FL, USA for growing HUVEC cell
   cultures. Dr. Waseem Haider would also like to thank the US Army
   Research Office (W911NF-14-1-0100) for their support.
CR Bae IH, 2012, J MATER SCI-MATER M, V23, P1259, DOI 10.1007/s10856-012-4587-5
   Barnabeu P., 1990, BIOMATERIALS, V11, P258
   Boilar J., 1966, CHEM COORDINATION CO, P448
   Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X
   De Scheerder I, 2001, MATERIALWISS WERKST, V32, P142, DOI 10.1002/1521-4052(200102)32:2<142::AID-MAWE142>3.0.CO;2-N
   De Scheerder I, 2000, J INTERV CARDIOL, V13, P179
   Hryniewicz T, 2008, CORROS SCI, V50, P2676, DOI 10.1016/j.corsci.2008.06.048
   LAMBRECHT LK, 1986, THROMB RES, V41, P99, DOI 10.1016/0049-3848(86)90283-5
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   Lin JC, 2000, J BIOMED MATER RES, V51, P413, DOI 10.1002/1097-4636(20000905)51:3<413::AID-JBM16>3.0.CO;2-L
   Martins MCL, 2003, BIOMATERIALS, V24, P3697, DOI 10.1016/S0142-9612(03)00244-8
   NORDE W, 1989, COLLOID SURFACE, V38, P1, DOI 10.1016/0166-6622(89)80138-6
   O'Brien B, 2009, ACTA BIOMATER, V5, P945, DOI 10.1016/j.actbio.2008.11.012
   POPERENKO LV, 2003, FUNCT MAT, V10, P447
   Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065
   Rokicki R., US Patent, Patent No. 7632390
   Siravaman B., 2010, BIOMATERIALS, V31, P1036
   Slack S. M., ACS S SERIES, V602, P112
   Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2
   Tada T, 2013, CARDIOVASC REVASCULA, V14, P84, DOI 10.1016/j.carrev.2012.12.003
   Toscano A, 2006, LANGMUIR, V22, P2588, DOI 10.1021/la051641g
   Trigwell S., 2005, MAT PROCESSES MED DI
   VANBEUSEKOM HMM, 1994, CORONARY ARTERY DIS, V5, P590, DOI 10.1097/00019501-199407000-00006
   Waksman R., WILL BIODEGRADABLE P
   Waksman R, 2013, CARDIOVASC REVASCULA, V14, P69, DOI 10.1016/j.carrev.2013.02.001
   Weng YJ, 2012, INTERFACE FOCUS, V2, P356, DOI 10.1098/rsfs.2011.0126
   Wood S., 2011, CORDIS QUITS CORONAR
   Wood S., 2009, SPJ PALMAZ URGES DES
   Yoshioka T, 2003, BIOMATERIALS, V24, P2889, DOI 10.1016/S0142-9612(03)00127-3
   Zuckerman B., DUAL ANTIPLATELE THE
NR 30
TC 0
Z9 0
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD JAN
PY 2015
VL 24
IS 1
BP 345
EP 352
DI 10.1007/s11665-014-1277-0
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA AX6KG
UT WOS:000347030600037
DA 2018-10-20
ER

PT J
AU Fernandez-Garcia, E
   Guillem-Marti, J
   Gutierrez-Gonzalez, CF
   Fernandez, A
   Ginebra, MP
   Lopez-Esteban, S
AF Fernandez-Garcia, Elisa
   Guillem-Marti, Jordi
   Gutierrez-Gonzalez, Carlos F.
   Fernandez, Adolfo
   Ginebra, Maria-Pau
   Lopez-Esteban, Sonia
TI Osteoblastic cell response to spark plasma-sintered zirconia/titanium
   cermets
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Zirconia; titanium; nanostructured; spark plasma sintering;
   biocompatibility
ID ZIRCONIA CERAMICS; 3Y-TZP/NB COMPOSITES; JOINT REPLACEMENT; DENTAL
   IMPLANTS; ADHESION; TITANIUM; DIFFERENTIATION; TOPOGRAPHY; SURFACES;
   OSSEOINTEGRATION
AB Ceramic/metal composites, cermets, arise from the idea to combine the dissimilar properties in the pure materials. This work aims to study the biocompatibility of new micro-nanostructured 3Y-TZP/Ti materials with 25, 50 and 75vol.% Ti, which have been successfully obtained by spark slasma sintering technology, as well as to correlate their surface properties (roughness, wettability and chemical composition) with the osteoblastic cell response. All samples had isotropic and slightly waved microstructure, with sub-micrometric average roughness. Composites with 75vol.% Ti had the highest surface hydrophilicity. Surface chemical composition of the cermets correlated well with the relative amounts used for their fabrication. A cell viability rate over 80% dismissed any cytotoxicity risk due to manufacturing. Cell adhesion and early differentiation were significantly enhanced on materials containing the nanostructured 3Y-TZP phase. Proliferation and differentiation of SaOS-2 were significantly improved in their late-stage on the composite with 75vol.% Ti that, from the osseointegration standpoint, is presented as an excellent biomaterial for bone replacement. Thus, spark plasma sintering is consolidated as a suitable technology for manufacturing nanostructured biomaterials with enhanced bioactivity.
C1 [Fernandez-Garcia, Elisa; Gutierrez-Gonzalez, Carlos F.; Fernandez, Adolfo] UO, Nanomat & Nanotechnol Res Ctr CINN, CSIC, Principado Asturias PA 33940, El Entrego, Spain.
   [Guillem-Marti, Jordi; Ginebra, Maria-Pau] Tech Univ Catalonia UPC, Dept Met Engn & Mat Sci, Biomech & Tissue Engn Grp, Barcelona, Spain.
   [Guillem-Marti, Jordi; Ginebra, Maria-Pau] CIBER BBN, Zaragoza, Spain.
   [Lopez-Esteban, Sonia] CSIC, ICMM, Madrid, Spain.
RP Fernandez-Garcia, E (reprint author), UO, Nanomat & Nanotechnol Res Ctr CINN, CSIC, Ave Vega 4-6, Principado Asturias PA 33940, El Entrego, Spain.
EM e.fernandez@cinn.es
RI Ginebra, Maria-Pau/J-8149-2017; Fernandez, Adolfo/H-7978-2017;
   Guillem-Marti, Jordi/G-8411-2015; Gutierrez-Gonzalez, Carlos/H-7312-2017
OI Ginebra, Maria-Pau/0000-0002-4700-5621; Fernandez,
   Adolfo/0000-0002-8742-4572; Guillem-Marti, Jordi/0000-0003-0307-2221;
   Gutierrez-Gonzalez, Carlos/0000-0002-4328-4635; Fernandez-Garcia,
   Elisa/0000-0003-0612-8825
FU Spanish Ministry of Science and Innovation (MICINN) [MAT2009-14542-C02];
   Spanish Ministry of Economy and Competitiveness (MINECO)
   [MATBIO-INTERFACES-MAT2012-38645]; ICREA Academia - Generalitat de
   Catalunya; CSIC
FX This work was supported by the Spanish Ministry of Science and
   Innovation (MICINN) under the project MAT2009-14542-C02 and by the
   Spanish Ministry of Economy and Competitiveness (MINECO) under the
   MATBIO-INTERFACES-MAT2012-38645. Support for the research by M. P.
   Ginebra was received through the prize "ICREA Academia" for excellence
   in research, funded by the Generalitat de Catalunya. E. Fernandez-Garcia
   received grant from CSIC through the concession of a JAE-PreDoc 2010.
   C.F. Gutierrez-Gonzalez received grant from CSIC through the concession
   of a JAE-Doc 2009.
CR [Anonymous], 1099352009 ISO
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Bahraminasab M, 2013, MATER DESIGN, V44, P155, DOI 10.1016/j.matdes.2012.07.066
   Ball M, 2008, J BIOMED MATER RES A, V86A, P637, DOI 10.1002/jbm.a.31652
   Bartolome JF, 2007, ACTA MATER, V55, P5924, DOI 10.1016/j.actamat.2007.07.004
   Bartolome JF, 2004, J AM CERAM SOC, V87, P2282, DOI 10.1111/j.1151-2916.2004.tb07505.x
   Biggs MJP, 2010, P I MECH ENG H, V224, P1441, DOI 10.1243/09544119JEIM775
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   De Oliveira R., 2012, MEASUREMENT NANOSCAL
   Depprich Rita, 2008, Head Face Med, V4, P29, DOI 10.1186/1746-160X-4-29
   DOMAGALA RF, 1973, J AM CERAM SOC, V56, P584, DOI 10.1111/j.1151-2916.1973.tb12421.x
   Fenoglio I, 2011, ADV DRUG DELIVER REV, V63, P1186, DOI 10.1016/j.addr.2011.08.001
   Fernandez-Garcia E, 2013, CERAM INT, V39, P6931, DOI 10.1016/j.ceramint.2013.02.029
   Gittens RA, 2014, ACTA BIOMATER, V10, P2907, DOI 10.1016/j.actbio.2014.03.032
   Gutierrez-Gonzalez CF, 2012, J AM CERAM SOC, V95, P851, DOI 10.1111/j.1551-2916.2011.05036.x
   Gutierrez-Gonzalez CF, 2010, J AM CERAM SOC, V93, P1842, DOI 10.1111/j.1551-2916.2010.03628.x
   Hempel U, 2013, CLIN ORAL IMPLAN RES, V24, P174, DOI 10.1111/j.1600-0501.2011.02328.x
   Hempel U, 2010, CLIN ORAL IMPLAN RES, V21, P174, DOI 10.1111/j.1600-0501.2009.01797.x
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Gil FJ, 2014, CLIN ORAL INVEST, V18, P59, DOI 10.1007/s00784-013-0953-z
   Jianhua W., 2009, BIOMED MATER, V4
   Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Keller John C, 2003, Implant Dent, V12, P175
   Kohorst P, 2012, ACTA BIOMATER, V8, P1213, DOI 10.1016/j.actbio.2011.11.016
   Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Li ZX, 2011, J ARTIF ORGANS, V14, P163, DOI 10.1007/s10047-011-0585-5
   Lim JY, 2004, J BIOMED MATER RES A, V68A, P504, DOI 10.1002/jbm.a.20087
   Lin KL, 2007, J AM CERAM SOC, V90, P2220, DOI 10.1111/j.1551-2916.2007.01708.x
   Mai R, 2012, ANN ANAT, V194, P561, DOI 10.1016/j.aanat.2012.09.004
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Mendonca G, 2011, MAT SCI ENG C-MATER, V31, P1809, DOI 10.1016/j.msec.2011.08.021
   Miranda M, 2012, J MATER SCI-MATER M, V23, P1655, DOI 10.1007/s10856-012-4642-2
   Mitov G, 2011, DENT MATER, V27, P684, DOI 10.1016/j.dental.2011.03.010
   Moya JS, 2007, PROG MATER SCI, V52, P1017, DOI 10.1016/j.pmatsci.2006.09.003
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Pegueroles M, 2010, ACTA BIOMATER, V6, P291, DOI 10.1016/j.actbio.2009.07.030
   Pinto AM, 2013, COLLOID SURFACE B, V104, P229, DOI 10.1016/j.colsurfb.2012.12.006
   Ponche A, 2010, P I MECH ENG H, V224, P1471, DOI 10.1243/09544119JEIM900
   Rosa Adalberto Luiz, 2003, Braz. Dent. J., V14, P16, DOI 10.1590/S0103-64402003000100003
   Salem NA, 2013, J PROSTHODONT, V22, P261, DOI 10.1111/j.1532-849X.2012.00940.x
   Skorb EV, 2013, ADV FUNCT MATER, V23, P4483, DOI 10.1002/adfm.201203884
   Stumm W., 2012, AQUATIC CHEM CHEM EQ
   Torrecillas R, 2009, WIRES NANOMED NANOBI, V1, P540, DOI 10.1002/wnan.47
   Wang GC, 2011, COLLOID SURFACE B, V86, P267, DOI 10.1016/j.colsurfb.2011.04.006
   Wen LP, 1997, J BIOL CHEM, V272, P26056, DOI 10.1074/jbc.272.41.26056
   Zhang SL, 2013, BIO-MED MATER ENG, V23, P373, DOI 10.3233/BME-130761
NR 54
TC 6
Z9 6
U1 1
U2 20
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2015
VL 29
IS 6
BP 813
EP 823
DI 10.1177/0885328214547400
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AX2II
UT WOS:000346766400003
PM 25145987
DA 2018-10-20
ER

PT J
AU Li, WC
   Lan, Y
   Guo, R
   Zhang, Y
   Xue, W
   Zhang, YM
AF Li, Weichang
   Lan, Yong
   Guo, Rui
   Zhang, Yi
   Xue, Wei
   Zhang, Yuanming
TI In vitro and in vivo evaluation of a novel collagen/cellulose
   nanocrystals scaffold for achieving the sustained release of basic
   fibroblast growth factor
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Collagen; cellulose nanocrystals; gelatin microspheres; basic fibroblast
   growth factor; angiogenesis; wound healing
ID GELATIN MICROSPHERES; ARTIFICIAL DERMIS; CELLULOSE NANOCRYSTALS; FACTOR
   BFGF; TISSUE; COLLAGEN; ANGIOGENESIS; SKIN; VEGF; DELIVERY
AB Tissue-engineered dermis is thought to be the best treatment for skin defects; however, slow vascularization of these biomaterial scaffolds limits their clinical application. Exogenous administration of angiogenic growth factors is highly desirable for tissue regeneration. In this study, biodegradable gelatin microspheres (GMs) containing basic fibroblast growth factor (bFGF) were fabricated and incorporated into a porous collagen/cellulose nanocrystals (CNCs) scaffold, as a platform for long-term release and consequent angiogenic boosting. The physicochemical properties of these scaffolds were examined and the invitro release pattern of bFGF from scaffolds was measured by ELISA. Collagen/CNCs scaffolds with and without bFGF-GMs were incubated with human umbilical vein endothelial cells for 1 week, results showed that the scaffolds with bFGF-GMs significantly augmented cell proliferation. Then, four different groups of scaffolds were implanted subcutaneously into Sprague-Dawley rats to study angiogenesis invivo via macroscopic observation, and hematoxylin and eosin and immunohistochemical staining. The results suggested that the collagen/CNCs/bFGF-GMs scaffolds had a significantly higher number of newly formed and mature blood vessels, and the fastest degradation rate. This study demonstrated that collagen/CNCs/bFGF-GMs scaffolds have great potential in skin tissue engineering.
C1 [Li, Weichang; Lan, Yong; Guo, Rui; Zhang, Yi; Xue, Wei; Zhang, Yuanming] Jinan Univ, Key Lab Biomat Guangdong Higher Educ Inst, Guangzhou 510632, Guangdong, Peoples R China.
   [Li, Weichang; Zhang, Yuanming] Jinan Univ, Dept Chem, Guangzhou 510632, Guangdong, Peoples R China.
   [Lan, Yong; Guo, Rui; Zhang, Yi; Xue, Wei] Jinan Univ, Dept Biomed Engn, Guangzhou 510632, Guangdong, Peoples R China.
RP Guo, R (reprint author), Jinan Univ, Key Lab Biomat Guangdong Higher Educ Inst, Guangzhou 510632, Guangdong, Peoples R China.
EM guorui@jnu.edu.cn
RI Yuanming, Zhang/B-9285-2008
FU Natural Science Foundation of China [51303064]; Natural Science
   Foundation of Guangdong [S2012040008003]; Key Project of DEGP
   [cxzd1109]; Ph.D. Programs Foundation of the Ministry of Education of
   China; Fundamental Research Funds of the Central Universities
   [21612327]; Key Disciplines of Biomedical Engineering of Guangdong
   Province
FX This study was supported financially by the Natural Science Foundation
   of China (51303064), Natural Science Foundation of Guangdong
   (S2012040008003), the Key Project of DEGP (cxzd1109), the Ph.D. Programs
   Foundation of the Ministry of Education of China, the Fundamental
   Research Funds of the Central Universities (21612327) and as well as the
   fund from Key Disciplines of Biomedical Engineering of Guangdong
   Province.
CR Abitbol T, 2011, SOFT MATTER, V7, P2373, DOI 10.1039/c0sm01172j
   Akita S, 2008, J TRAUMA, V64, P809, DOI 10.1097/TA.0b013e31802c8247
   Baiguera S, 2013, ANGIOGENESIS, V16, P1, DOI 10.1007/s10456-012-9307-8
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Borselli C, 2010, J BIOMED MATER RES A, V92A, P94, DOI 10.1002/jbm.a.32332
   Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   d'Angelo I, 2013, ACTA BIOMATER, V9, P7389, DOI 10.1016/j.actbio.2013.03.013
   Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022
   Del Gaudio C, 2013, BIOMATERIALS, V34, P7754, DOI 10.1016/j.biomaterials.2013.06.040
   Dong XM, 1998, CELLULOSE, V5, P19, DOI 10.1023/A:1009260511939
   Ehrbar M, 2008, BIOMATERIALS, V29, P1720, DOI 10.1016/j.biomaterials.2007.12.002
   Hiraoka Y, 2003, TISSUE ENG, V9, P1101, DOI 10.1089/10763270360728017
   Ito K, 2005, PLAST RECONSTR SURG, V115, P567, DOI 10.1097/01.PRS.0000149485.60638.30
   Jungebluth P, 2011, CLIN PHARMACOL THER, V91, P81
   Jungebluth P, 2012, BIOMATERIALS, V33, P4319, DOI 10.1016/j.biomaterials.2012.03.016
   Kanda N, 2014, J TISSUE ENG REGEN M, V8, P29, DOI 10.1002/term.1492
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Kim S, 2012, ACTA BIOMATER, V8, P1768, DOI 10.1016/j.actbio.2012.01.009
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Li WC, 2014, J BIOMED MATER RES A, V102, P1131, DOI 10.1002/jbm.a.34792
   Liu HF, 2007, BIOMACROMOLECULES, V8, P1446, DOI 10.1021/bm061025e
   Liu YY, 2012, MAT SCI ENG C-MATER, V32, P2361, DOI 10.1016/j.msec.2012.07.008
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   Muneuchi G, 2005, BURNS, V31, P514, DOI 10.1016/j.burns.2004.11.016
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267
   Pooyan P, 2012, J MECH BEHAV BIOMED, V7, P50, DOI 10.1016/j.jmbbm.2011.09.009
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Ruiz MM, 2000, COMPOS INTERFACE, V7, P117
   Spizzirri UG, 2012, J MATER SCI, V47, P3648, DOI 10.1007/s10853-011-6211-3
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Uchi H, 2009, EUR J DERMATOL, V19, P461, DOI 10.1684/ejd.2009.0750
   Zhou CJ, 2011, J COLLOID INTERF SCI, V353, P116, DOI 10.1016/j.jcis.2010.09.035
   Zhu XH, 2008, TISSUE ENG PT A, V14, P1939, DOI 10.1089/ten.tea.2007.0346
NR 39
TC 22
Z9 22
U1 4
U2 52
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2015
VL 29
IS 6
BP 882
EP 893
DI 10.1177/0885328214547091
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AX2II
UT WOS:000346766400008
PM 25114196
DA 2018-10-20
ER

PT J
AU Mohebbifar, M
   Ghazanfari, MH
   Vossoughi, M
AF Mohebbifar, Mahdi
   Ghazanfari, Mohammadi Hossein
   Vossoughi, Manouchehr
TI Experimental Investigation of Nano-Biomaterial Applications for Heavy
   Oil Recovery in Shaly Porous Models: A Pore-Level Study
SO JOURNAL OF ENERGY RESOURCES TECHNOLOGY-TRANSACTIONS OF THE ASME
LA English
DT Article
DE nano-biomaterial; displacement mechanism; shaly porous media;
   wettability alteration; five spot micromodel
ID POTENTIAL APPLICATIONS; STRAIN; MEDIA
AB Application of nano or biomaterials for enhanced oil recovery (EOR) has been recently much attended by petroleum engineering researchers. However, how would be the displacement mechanisms and how would change the recovery efficiency while nano and biomaterials are used simultaneously is still an open question. To this end, a series of injection tests performed on micromodel containing shale strikes. Three types of biomaterials including biosurfactant, bioemulsifier, and biopolymer beside two types of nanoparticles including SiO2 and TiO2 at different concentrations were used as injection fluids. The microscopic as well as macroscopic efficiency of displacements were observed from analysis of images recorded during the tests. Microscopic observations revealed different mechanisms responsible for oil recovery including: wettability alteration, thinning oil film, interfacial tension (IFT) reduction, and water in oil emulsion formation. Contact angle experiments showed changes in the surface wetness from an oil-wet to neutral-wet/water-wet conditions when a layer of nano-biomaterial covered thin sections of a shaly sandstone. Also the results showed that the presence of shales causes early breakthrough and ultimate oil recovery reduction. Shales act as flow barriers and enhance injection fluid viscous fingering. Displacement efficiency in shaly systems is sharply related to the shale distribution. Oil recovery after breakthrough in shaly systems is progressive and considerable volume of oil in place is recovered after breakthrough. The highest efficiency, 78%, observed while injecting one pore volume of biopolymer and SiO2 nanoparticles. This work illustrates for the first time the mechanisms involved in nano-biomaterial-crude oil displacements.
C1 [Mohebbifar, Mahdi; Ghazanfari, Mohammadi Hossein; Vossoughi, Manouchehr] Sharif Univ Technol, Dept Chem & Petr Engn, Tehran 1136511155, Iran.
RP Mohebbifar, M (reprint author), Sharif Univ Technol, Dept Chem & Petr Engn, Tehran 1136511155, Iran.
EM mehdi.mohebbifar@gmail.com
CR Amani H, 2010, J PETROL SCI ENG, V75, P209, DOI 10.1016/j.petrol.2010.11.008
   Ayatollahi S., 2012, SPE INT OILF NAN C N
   Bach H, 2004, STUD SURF SCI CATAL, V151, P233
   Banat IM, 2010, APPL MICROBIOL BIOT, V87, P427, DOI 10.1007/s00253-010-2589-0
   Dastgheib SMM, 2008, BIOTECHNOL LETT, V30, P263, DOI 10.1007/s10529-007-9530-3
   Hoffman BT, 2014, J ENERG RESOUR-ASME, V136, DOI 10.1115/1.4025843
   HOMMERT PJ, 1981, J ENERG RESOUR-ASME, V103, P138, DOI 10.1115/1.3230826
   Leontaritis KJ, 2005, J ENERG RESOUR-ASME, V127, P191, DOI 10.1115/1.1937416
   Li S., 2013, IPTC 2013 INT PETR T
   Martinez-Checa F, 2007, BIORESOURCE TECHNOL, V98, P3130, DOI 10.1016/j.biortech.2006.10.026
   Mohammadi S, 2012, TRANSPORT POROUS MED, V91, P973, DOI 10.1007/s11242-011-9886-7
   Nasr Shaghayegh, 2007, Pak J Biol Sci, V10, P3010
   Panwar A., 2012, ASME J ENER IN PRESS
   Rosalam S, 2006, ENZYME MICROB TECH, V39, P197, DOI 10.1016/j.enzmictec.2005.10.019
   Sedaghat MH, 2013, J ENERG RESOUR-ASME, V135, DOI 10.1115/1.4023171
   Shabani Afrapoli M., 2011, SPE AM E P HLTH SAF
   Soudmand-Asli A, 2007, J PETROL SCI ENG, V58, P161, DOI 10.1016/j.petrol.2006.12.004
NR 17
TC 6
Z9 6
U1 2
U2 33
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0195-0738
J9 J ENERG RESOUR-ASME
JI J. Energy Resour. Technol.-Trans. ASME
PD JAN
PY 2015
VL 137
IS 1
AR 014501
DI 10.1115/1.4028270
PG 8
WC Energy & Fuels
SC Energy & Fuels
GA AX4FQ
UT WOS:000346889500015
DA 2018-10-20
ER

PT J
AU Shao, W
   Liu, H
   Liu, XF
   Wang, SX
   Zhang, R
AF Shao, Wei
   Liu, Hui
   Liu, Xiufeng
   Wang, Shuxia
   Zhang, Rui
TI Anti-bacterial performances and biocompatibility of bacterial
   cellulose/graphene oxide composites
SO RSC ADVANCES
LA English
DT Article
ID GRAPHENE OXIDE; BIOMEDICAL APPLICATIONS; SILVER NANOPARTICLES; FILMS;
   NANOCOMPOSITES; CYTOTOXICITY; COATINGS; SCAFFOLD; CARTILAGE; ADHESION
AB In the present work, a novel composite material formed by bacterial cellulose (BC) networks and graphene oxide (GO) nanosheets was synthesized by a sonochemical method. The BC and as-prepared BC/GO composites were characterized by several techniques including Scanning Electron Microscopy (SEM), Fourier-transform infrared (FTIR) spectra, ultraviolet-visible (UV-vis) absorption spectra, thermogravimetric analyses (TG) and X-ray diffraction (XRD). SEM images showed that the morphologies of composites became more compact than BC. FTIR, UV, TG and XRD confirmed the existence of GO in the composites. Moreover, HEK 293 cells were cultivated, and both the biocompatibility of the materials and the cell viability were demonstrated. Meanwhile, the anti-bacterial performances of BC/GO composites were evaluated with Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), which frequently cause medically associated infections. The experimental results showed that the BC/GO composites have excellent anti-bacterial activities, thus confirming its utility as a potential biomaterial in biomedical applications. Furthermore, the anti-bacterial behavior had been well explained by the extended DLVO theory.
C1 [Shao, Wei; Liu, Hui; Wang, Shuxia; Zhang, Rui] Nanjing Forestry Univ, Coll Chem Engn, Nanjing 210037, Jiangsu, Peoples R China.
   [Liu, Xiufeng] Nanjing Univ, Coll Life Sci, Nanjing 210093, Jiangsu, Peoples R China.
RP Shao, W (reprint author), Nanjing Forestry Univ, Coll Chem Engn, Nanjing 210037, Jiangsu, Peoples R China.
EM w.shao@njfu.edu.cn; zhangrui@njfu.edu.cn
FU National Natural Science Foundation of China [51401109]; High-level
   Talent Project of Nanjing Forestry University [GXL201301]; Major Program
   of the Natural Science Foundation of Jiangsu Higher Education of China
   [14KJB430018]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD)
FX The work was financially supported by the National Natural Science
   Foundation of China (51401109), the High-level Talent Project of Nanjing
   Forestry University (GXL201301), the Major Program of the Natural
   Science Foundation of Jiangsu Higher Education of China (14KJB430018)
   and the Project Funded by the Priority Academic Program Development of
   Jiangsu Higher Education Institutions (PAPD).
CR Achaby M. E., 2014, J APPL POLYM SCI, V131, P41042
   Cheng YM, 2014, CARBOHYD POLYM, V107, P57, DOI 10.1016/j.carbpol.2014.02.034
   CHIBOWSKI E, 1994, COLLOID SURFACE A, V92, P79, DOI 10.1016/0927-7757(94)02949-0
   Deutschle T, 2006, TOXICOL IN VITRO, V20, P1472, DOI 10.1016/j.tiv.2006.07.006
   Feng YY, 2012, CARBOHYD POLYM, V87, P644, DOI 10.1016/j.carbpol.2011.08.039
   Ge HJ, 2011, APPL BIOCHEM BIOTECH, V165, P1519, DOI 10.1007/s12010-011-9372-2
   Gilje S, 2007, NANO LETT, V7, P3394, DOI 10.1021/nl0717715
   Gkikas M, 2014, EUR POLYM J, V60, P106, DOI 10.1016/j.eurpolymj.2014.08.022
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Jiang GP, 2012, INT J HYDROGEN ENERG, V37, P9182, DOI 10.1016/j.ijhydene.2012.02.195
   Jipa IM, 2012, LWT-FOOD SCI TECHNOL, V47, P400, DOI 10.1016/j.lwt.2012.01.039
   Katsikogianni MG, 2010, ACTA BIOMATER, V6, P1107, DOI 10.1016/j.actbio.2009.08.006
   Katsnelson MI, 2007, SOLID STATE COMMUN, V143, P3, DOI 10.1016/j.ssc.2007.02.043
   Kim J., 2010, J NANOTECHNOL ENG ME, V1
   Lerdkanchanaporn S, 1998, THERMOCHIM ACTA, V324, P25, DOI 10.1016/S0040-6031(98)00520-6
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Li L, 2012, BIOMATERIALS, V33, P1714, DOI 10.1016/j.biomaterials.2011.11.030
   Li YQ, 2013, CARBON, V55, P321, DOI 10.1016/j.carbon.2012.12.071
   Lin WC, 2013, CARBOHYD POLYM, V94, P603, DOI 10.1016/j.carbpol.2013.01.076
   Liu JQ, 2013, ACTA BIOMATER, V9, P9243, DOI 10.1016/j.actbio.2013.08.016
   Liu Y, 2014, J IND ENG CHEM, V20, P4415, DOI 10.1016/j.jiec.2014.02.009
   LLOYD A, 2004, MATER TODAY, V7, P28
   Loh JW, 2012, TOXICOL APPL PHARM, V262, P273, DOI 10.1016/j.taap.2012.04.037
   Luo DC, 2011, J PHYS CHEM C, V115, P11327, DOI 10.1021/jp110001y
   Martins NCT, 2013, COLLOID SURFACE A, V417, P111, DOI 10.1016/j.colsurfa.2012.10.042
   McArdle P., 2005, AM J INFECT CONTROL, V33, pe130
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Nam JA, 2013, ACTA BIOMATER, V9, P7996, DOI 10.1016/j.actbio.2013.04.022
   Ouyang WZ, 2013, CARBON, V62, P501, DOI 10.1016/j.carbon.2013.06.049
   Park M, 2013, COLLOID SURFACE B, V102, P238, DOI 10.1016/j.colsurfb.2012.07.046
   Pavlidou S, 2008, PROG POLYM SCI, V33, P1119, DOI 10.1016/j.progpolymsci.2008.07.008
   Pinto AM, 2013, COLLOID SURFACE B, V111, P188, DOI 10.1016/j.colsurfb.2013.05.022
   Qin Z, 2014, CARBOHYD POLYM, V101, P947, DOI 10.1016/j.carbpol.2013.09.068
   Satheesh K, 2013, MATER LETT, V113, P5, DOI 10.1016/j.matlet.2013.09.044
   Shah N, 2013, CARBOHYD POLYM, V98, P1585, DOI 10.1016/j.carbpol.2013.08.018
   Shao W, 2010, COLLOID SURFACE B, V76, P98, DOI 10.1016/j.colsurfb.2009.10.018
   Sharma PK, 2002, ADV COLLOID INTERFAC, V98, P341, DOI 10.1016/S0001-8686(02)00004-0
   Shezad O, 2010, CARBOHYD POLYM, V82, P173, DOI 10.1016/j.carbpol.2010.04.052
   Shi Q, 2012, BIOMATERIALS, V33, P6644, DOI 10.1016/j.biomaterials.2012.05.071
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Ul-Islam M, 2012, CARBOHYD POLYM, V89, P1189, DOI 10.1016/j.carbpol.2012.03.093
   Valentini L, 2013, MATER LETT, V105, P4, DOI 10.1016/j.matlet.2013.04.034
   Van Oss C. J., 1994, INTERFACIAL FORCES A
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wang JJ, 2014, OPT LASER TECHNOL, V57, P84, DOI 10.1016/j.optlastec.2013.09.040
   Wang JH, 2010, MAT SCI ENG C-MATER, V30, P214, DOI 10.1016/j.msec.2009.10.006
   Wei B, 2011, CARBOHYD POLYM, V84, P533, DOI 10.1016/j.carbpol.2010.12.017
   Wu J, 2014, CARBOHYD POLYM, V102, P762, DOI 10.1016/j.carbpol.2013.10.093
   Yan ZY, 2008, CARBOHYD POLYM, V74, P659, DOI 10.1016/j.carbpol.2008.04.028
   Yang G, 2012, CARBOHYD POLYM, V87, P839, DOI 10.1016/j.carbpol.2011.08.079
   Yang JZ, 2013, CHINESE J CHEM ENG, V21, P1419, DOI 10.1016/S1004-9541(13)60636-9
   Zhang H, 2010, ACS NANO, V4, P380, DOI 10.1021/nn901221k
   Zhao Q, 2005, APPL SURF SCI, V252, P1620, DOI 10.1016/j.apsusc.2005.02.098
   Zhao Q, 2007, INT J ADHES ADHES, V27, P85, DOI 10.1016/j.ijadhadh.2006.01.001
NR 54
TC 42
Z9 44
U1 7
U2 128
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 7
BP 4795
EP 4803
DI 10.1039/c4ra13057j
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA AX1WH
UT WOS:000346733500011
DA 2018-10-20
ER

PT J
AU Las, AG
   Pitakjakpipop, H
   Rahn, MS
   Siedlecki, CA
   Vogler, EA
AF Las, Avantika Go
   Pitakjakpipop, Harit
   Rahn, Matthew S.
   Siedlecki, Christopher A.
   Vogler, Erwin A.
TI Enzymes produced by autoactivation of blood factor XII in buffer A
   contribution from the Hematology at Biomaterial Interfaces Research
   Group
SO BIOMATERIALS
LA English
DT Article
DE Autoactivation; Autoamplification; Autohydrolysis; FXII; Plasma
   coagulation; Conformers
ID HUMAN HAGEMAN-FACTOR; COAGULATION-FACTOR-XII; MOLECULAR-WEIGHT
   KININOGEN; CONTACT ACTIVATION; SURFACE ACTIVATION; PLASMA COAGULATION;
   CIRCULAR-DICHROISM; PROTEIN-ADSORPTION; FACTOR FRAGMENTS; ELLAGIC ACID
AB High-resolution electrophoresis of FXII-derived proteins produced by contact activation of FXII in buffer solutions (i.e. in absence of plasma proteins) with hydrophilic and silanized-glass activators spanning the observable range of water wettability (hydrophilic to hydrophobic), shows no evidence of proteolytic cleavage of FXII into alpha FXIIa or beta FXIIa. The autoactivation mixture contains only a single-chain protein with a molecular weight of similar to 80 kDa, confirming Oscar Ratnoff's previous finding of a single-chain activated form of FXII that he called 'HFea'. Functional assays have shown that these autoactivation products exhibit procoagulant potential (protease activity inducing clotting of blood) or amidolytic potential (cleaves amino bonds in s-2302 chromogen but do not cause coagulation of plasma) or both amidolytic potential and procoagulant potential. Some of these proteins also have the remarkable potential to 'suppress autoactivation' (i.e. suppress creation of enzymes with procoagulant potential). It is thus hypothesized that autoactivation of FXII in the absence of plasma proteins generates not just a single type of activated conformer, as suggested by previous researchers, but rather an ensemble of conformer products with collective activity that varies with activator surface energy used in contact activation of FXII. Furthermore, reaction of alpha FXIIa with FXII in buffer solution does not produce additional alpha FXIIa by the putative autoamplification reaction FXIIa + FXII --> 2FXIIa as has been proposed in past literature to account for the discrepancy between chromogenic and plasma-coagulation assays for alpha FXIIa in buffer solution. Instead, net procoagulant activity measured directly by plasma-coagulation assays, decreases systematically with increasing FXII solution concentration. Under the same reaction conditions, chromogenic assay reveals that net amidolytic activity increases with increasing FXII solution concentration. Thus, although autoamplification does not occur it appears that there is some form of "FXII self reaction" that influences products of alpha FXIIa reaction with FXII. Electrophoretic measurements indicate that no proteolytic cleavage takes in this reaction leading us to conclude that change in activity is most likely due to change(s) in FXII conformation (with related change in enzyme activity). (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Las, Avantika Go; Pitakjakpipop, Harit; Rahn, Matthew S.; Vogler, Erwin A.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
   [Siedlecki, Christopher A.; Vogler, Erwin A.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA.
   [Siedlecki, Christopher A.] Penn State Univ, Coll Med, Inst Biomed Engn, Dept Surg, Hershey, PA 17033 USA.
RP Vogler, EA (reprint author), Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
EM EAV3@PSU.EDU
FU National Institute of Health [PHS 5R01HL069965]; Departments of
   Bioengineering and Materials Science and Engineering, The Pennsylvania
   State University
FX This work was supported by National Institute of Health grant PHS
   5R01HL069965. Authors appreciate support from the Departments of
   Bioengineering and Materials Science and Engineering, The Pennsylvania
   State University.
CR Chatterjee K, 2006, BIOMATERIALS, V27, P5643, DOI 10.1016/j.biomaterials.2006.07.025
   Chatterjee K, 2009, BIOMATERIALS, V30, P4915, DOI 10.1016/j.biomaterials.2009.05.076
   Chatterjee K, 2009, J BIOMED MATER RES A, V90A, P27, DOI 10.1002/jbm.a.32076
   Citarella F, 1997, BRIT J HAEMATOL, V99, P197, DOI 10.1046/j.1365-2141.1997.3513165.x
   COLMAN RW, 1985, BLOOD, V65, P311
   DUNN JT, 1982, J CLIN INVEST, V70, P627, DOI 10.1172/JCI110656
   DUNN JT, 1982, J BIOL CHEM, V257, P1779
   DUNN JT, 1982, CLIN RES, V30, pA315
   ESPANA F, 1983, J LAB CLIN MED, V102, P31
   Fastrez J, 2009, CHEMBIOCHEM, V10, P2824, DOI 10.1002/cbic.200900590
   FRIBERGER P, 1983, SEMIN THROMB HEMOST, V9, P281
   Golas A, 2013, BIOMATERIALS, V34, P607, DOI 10.1016/j.biomaterials.2012.09.034
   Golas A, 2011, BIOMATERIALS, V32, P9747, DOI 10.1016/j.biomaterials.2011.09.020
   Golas A, 2010, BIOMATERIALS, V31, P1068, DOI 10.1016/j.biomaterials.2009.10.039
   GRIEP MA, 1986, BIOCHEMISTRY-US, V25, P6688, DOI 10.1021/bi00369a054
   Guo Z, 2006, BIOMATERIALS, V27, P796, DOI 10.1016/j.biomaterials.2005.06.021
   HEIMARK RL, 1980, NATURE, V286, P456, DOI 10.1038/286456a0
   Henriques ES, 2001, J COMPUT AID MOL DES, V15, P309, DOI 10.1023/A:1011128521816
   Krishnan A, 2005, COLLOID SURFACE B, V43, P95, DOI 10.1016/j.colsurfb.2005.04.003
   LANDER LM, 1993, LANGMUIR, V9, P2237, DOI 10.1021/la00032a055
   Maas C, 2011, SEMIN THROMB HEMOST, V37, P375, DOI 10.1055/s-0031-1276586
   MCMILLIN CR, 1974, J CLIN INVEST, V54, P1312, DOI 10.1172/JCI107877
   MCMILLIN CR, 1974, J COLLOID INTERF SCI, V48, P345, DOI 10.1016/0021-9797(74)90170-2
   MILLER G, 1980, BIOCHEM BIOPH RES CO, V92, P803, DOI 10.1016/0006-291X(80)90774-3
   Nguyen MSW, APPL EXPERION AUTOMA
   Parhi P, 2009, BIOMATERIALS, V30, P6814, DOI 10.1016/j.biomaterials.2009.09.005
   PIXLEY RA, 1993, METHOD ENZYMOL, V222, P51
   RATNOFF OD, 1980, J LAB CLIN MED, V96, P267
   RATNOFF OD, 1981, BLOOD, V57, P55
   RATNOFF OD, 1979, P NATL ACAD SCI USA, V76, P1461, DOI 10.1073/pnas.76.3.1461
   RATNOFF OD, 1982, J LAB CLIN MED, V100, P248
   REVAK SD, 1974, J CLIN INVEST, V54, P619, DOI 10.1172/JCI107799
   REVAK SD, 1978, J EXP MED, V147, P719, DOI 10.1084/jem.147.3.719
   REVAK SD, 1976, THROMB HAEMOSTASIS, V35, P570, DOI 10.1055/s-0038-1647999
   REVAK SD, 1976, FED PROC, V35, P692
   REVAK SD, 1977, J CLIN INVEST, V59, P1167, DOI 10.1172/JCI108741
   REVAK SD, 1977, FED PROC, V36, P329
   SAMUEL M, 1994, THROMB RES, V75, P259, DOI 10.1016/0049-3848(94)90237-2
   SAMUEL M, 1992, J BIOL CHEM, V267, P19691
   SILVERBERG M, 1980, J BIOL CHEM, V255, P7281
   SILVERBERG M, 1982, BLOOD, V60, P64
   VANDERKAMP KWHJ, 1994, J BIOMED MATER RES, V28, P349, DOI 10.1002/jbm.820280309
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   WUEPPER KD, 1972, P SOC EXP BIOL MED, V141, P271
   Yeh C-HJ, 2011, BIOMATERIALS, V33, P9
   Zhuo R, 2006, BIOMATERIALS, V27, P4840, DOI 10.1016/j.biomaterials.2006.05.008
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
NR 48
TC 3
Z9 3
U1 1
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2015
VL 37
BP 1
EP 12
DI 10.1016/j.biomaterials.2014.09.015
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AW8WW
UT WOS:000346541100001
PM 25443791
DA 2018-10-20
ER

PT J
AU Georgiou, M
   Golding, JP
   Loughlin, AJ
   Kingham, PJ
   Phillips, JB
AF Georgiou, Melanie
   Golding, Jon P.
   Loughlin, Alison J.
   Kingham, Paul J.
   Phillips, James B.
TI Engineered neural tissue with aligned, differentiated adipose-derived
   stem cells promotes peripheral nerve regeneration across a critical
   sized defect in rat sciatic nerve
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Stem cell; Nerve guide; Nerve regeneration; Nerve tissue
   engineering; Adipose-derived stem cell
ID IN-VITRO; NEURITE OUTGROWTH; FUNCTIONAL RECOVERY; SCHWANN-CELLS; REPAIR;
   MODEL; TRANSPLANTATION; INJURY; ALLOGRAFTS; SCAFFOLDS
AB Adipose-derived stem cells were isolated from rats and differentiated to a Schwann cell-like phenotype in vitro. The differentiated cells (dADSCs) underwent self-alignment in a tethered type-1 collagen gel, followed by stabilisation to generate engineered neural tissue (EngNT-dADSC). The pro-regenerative phenotype of dADSCs was enhanced by this process, and the columns of aligned dADSCs in the aligned collagen matrix supported and guided neurite extension in vitro. EngNT-dADSC sheets were rolled to form peripheral nerve repair constructs that were implanted within NeuraWrap conduits to bridge a 15 mm gap in rat sciatic nerve. After 8 weeks regeneration was assessed using immunofluorescence imaging and transmission electron microscopy and compared to empty conduit and nerve graft controls. The proportion of axons detected in the distal stump was 3.5 fold greater in constructs containing EngNT-dADSC than empty tube controls. Our novel combination of technologies that can organise autologous therapeutic cells-within an artificial tissue construct provides a promising new cellular biomaterial for peripheral nerve repair. (C) 2014 The Authors. Published by Elsevier Ltd.
C1 [Georgiou, Melanie] UCL, Adv Ctr Biochem Engn, London WC1H 0AH, England.
   [Georgiou, Melanie; Golding, Jon P.; Loughlin, Alison J.; Phillips, James B.] Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes MK7 6AA, Bucks, England.
   [Kingham, Paul J.] Umea Univ, Dept Integrat Med Biol, S-90187 Umea, Sweden.
   [Phillips, James B.] UCL, Eastman Dent Inst, London WC1X 8LD, England.
RP Phillips, JB (reprint author), UCL, Eastman Dent Inst, Dept Biomat & Tissue Engn, 256 Grays Inn Rd, London WC1X 8LD, England.
EM jb.phillips@ucl.ac.uk
RI Golding, Jon/L-2700-2017
OI Golding, Jon/0000-0002-7910-7382; Phillips, James/0000-0001-8117-3074;
   Kingham, Paul/0000-0003-2596-5936
FU Open University Studentship; Swedish Research Council; European Union;
   Umea University; County of Vasterbotten; Ake Wibergs Stiftelse; Clas
   Groschinskys Minnesfond; Medical Research Council [G113/31]
FX This work was funded by an Open University Studentship (MG). PJK is
   supported by the Swedish Research Council, European Union, Umea
   University, County of Vasterbotten, Ake Wibergs Stiftelse, and the Clas
   Groschinskys Minnesfond. The authors are grateful to the Open University
   Biomedical Research Unit staff for post-surgical animal care, and to
   Heather Davies and Francis Colyer for TEM.
CR Angius D, 2012, BIOMATERIALS, V33, P8034, DOI 10.1016/j.biomaterials.2012.07.056
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   di Summa PG, 2011, NEUROSCIENCE, V181, P278, DOI 10.1016/j.neuroscience.2011.02.052
   di Summa PG, 2010, J PLAST RECONSTR AES, V63, P1544, DOI 10.1016/j.bjps.2009.09.012
   di Summa PG, 2013, TISSUE ENG PT A, V19, P368, DOI [10.1089/ten.tea.2012.0124, 10.1089/ten.TEA.2012.0124]
   East E, 2009, J TISSUE ENG REGEN M, V3, P634, DOI 10.1002/term.209
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   Georgiou M, 2013, BIOMATERIALS, V34, P7335, DOI 10.1016/j.biomaterials.2013.06.025
   Gu JH, 2012, CURR STEM CELL RES T, V7, P347
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693
   Gupta D, 2009, ACTA BIOMATER, V5, P2560, DOI 10.1016/j.actbio.2009.01.039
   Hsueh YY, 2014, BIOMATERIALS, V35, P2234, DOI 10.1016/j.biomaterials.2013.11.081
   Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029
   Jiang L, 2008, NEUROREPORT, V19, P1015, DOI 10.1097/WNR.0b013e3283040efc
   Kaewkhaw R, 2011, GLIA, V59, P734, DOI 10.1002/glia.21145
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029
   Kingham PJ, 2014, STEM CELLS DEV, V23, P741, DOI 10.1089/scd.2013.0396
   Kolar MK, 2014, BIOCHEM SOC T, V42, P697, DOI 10.1042/BST20140004
   Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899
   Marconi S, 2012, TISSUE ENG PT A, V18, P1264, DOI [10.1089/ten.tea.2011.0491, 10.1089/ten.TEA.2011.0491]
   Martens W, 2014, FASEB J, V28, P1634, DOI 10.1096/fj.13-243980
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Phillips JB, 2014, ORGANOGENESIS, V10, P6, DOI 10.4161/org.27487
   Radtke C, 2009, INT J DEV NEUROSCI, V27, P817, DOI 10.1016/j.ijdevneu.2009.08.006
   Reid AJ, 2011, NEUROSCIENCE, V199, P515, DOI 10.1016/j.neuroscience.2011.09.064
   Ribeiro-Resende VT, 2009, BIOMATERIALS, V30, P5251, DOI 10.1016/j.biomaterials.2009.07.007
   Richardson JA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046015
   Rodrigues MCO, 2012, SCI WORLD J, DOI 10.1100/2012/413091
   Ruijs AC, 2005, PLAST RECONSTR SURG, V116, P95
   Ruijs ACJ, 2005, PLAST RECONSTR SURG, V116, P484, DOI 10.1097/01.prs.0000172896.86594.07
   Scholz T, 2011, ARCH SURG-CHICAGO, V146, P666, DOI 10.1001/archsurg.2011.148
   Seggio AM, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046001
   Sun F, 2011, NEUROSCI LETT, V499, P104, DOI 10.1016/j.neulet.2011.05.043
   Thompson DM, 2006, ANN BIOMED ENG, V34, P161, DOI 10.1007/s10439-005-9013-4
   Tomita K, 2013, NEUROSCIENCE, V236, P55, DOI 10.1016/j.neuroscience.2012.12.066
   Tomita K, 2012, J NEUROSCI RES, V90, P1392, DOI 10.1002/jnr.23002
   Tremp M., 2013, CELL TRANSPLANT
   Walsh S, 2009, NEUROSURGERY, V65, pA80, DOI 10.1227/01.NEU.0000335651.93926.2F
   Wang XM, 2011, BRAIN RES, V1383, P71, DOI 10.1016/j.brainres.2011.01.098
   Wang Y, 2012, NEUROSCI LETT, V514, P96, DOI 10.1016/j.neulet.2012.02.066
   Wei Y, 2010, CELL PROLIFERAT, V43, P606, DOI 10.1111/j.1365-2184.2010.00710.x
   Widgerow AD, 2013, J NEUROSCI RES, V91, P1517, DOI 10.1002/jnr.23284
   Wright KE, 2009, BRIT J CANCER, V101, P658, DOI 10.1038/sj.bjc.6605197
   Zhang YJ, 2010, BIOMATERIALS, V31, P5312, DOI 10.1016/j.biomaterials.2010.03.029
NR 49
TC 68
Z9 71
U1 5
U2 99
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2015
VL 37
BP 242
EP 251
DI 10.1016/j.biomaterials.2014.10.009
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AW8WW
UT WOS:000346541100023
PM 25453954
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Zhang, HJ
   Hou, L
   Jiao, XJ
   Ji, YD
   Zhu, XL
   Zhang, ZZ
AF Zhang, Huijuan
   Hou, Lin
   Jiao, Xiaojing
   Ji, Yandan
   Zhu, Xiali
   Zhang, Zhenzhong
TI Transferrin-mediated fullerenes nanoparticles as Fe2+-dependent drug
   vehicles for synergistic anti-tumor efficacy
SO BIOMATERIALS
LA English
DT Article
DE Iron-dependent artesunate; Transferrin; Hyaluronic acid-derivatized
   fullerenes vehicles; Photodynamic therapy
ID BREAST-CANCER CELLS; PHOTODYNAMIC THERAPY; DELIVERY; ARTEMISININ; C-60;
   IRON; WATER; PHOTOSENSITIZERS; CYTOTOXICITY; INHIBITION
AB Artesunate (AS) is an iron-dependent drug, which has been used extensively as anti-malarial drugs worldwide with no obvious side effects. Recently, studies have shown that AS also possess profound cytotoxicity against tumor cells. However, simultaneous delivery of hydrophobic AS and Fe2+ into tumor cells remains a major challenge. Herein, we report a new kind of active-targeting preparations which could not only specially target to tumor cells but also synchronously transfer AS and irons into tumor tissue. In this study, hyaluronic acid (HA) was grafted onto fullerene to get a water-soluble biomaterial (HA-C60) with excellent biocompatibility, and then combined with transferrin (Tf) to obtain a multifunctional drug delivery system (HA-C60-Tf) with significant tumor-targeting efficacy and powerful photodynamic therapy capacity. Finally, AS was adsorbed on HA-C60-Tf with a high loading efficacy of 162.4% (weight ratio of AS: HA-C60-Tf). Compared with free AS, remarkably enhanced antitumor efficacy of AS-loaded HA-C60-Tf nanoparticles was realized both in a cultured MCF-7 cells in vitro and in a tumor bearing murine model in vivo, due to increased intracellular accumulation of AS in tumor and activated mechanism by co-delivery of Tf and AS analogs. Furthermore, with laser irradiation in vivo, the relative tumor volume (V/V-0) of HA-C60-Tf/AS declined by half, from 1.72 +/- 0.12 to 0.84 +/- 0.07, suggesting a new way with multi-mechanism for tumor treatment was developed. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zhang, Huijuan; Hou, Lin; Jiao, Xiaojing; Ji, Yandan; Zhu, Xiali; Zhang, Zhenzhong] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China.
   [Zhu, Xiali] Henan Univ Trat Chinese Med, Sch Pharmaceut Sci, Zhengzhou, Peoples R China.
RP Zhang, ZZ (reprint author), Zhengzhou Univ, Sch Pharmaceut Sci, 100 Kexue Rd, Zhengzhou 450001, Peoples R China.
EM zhangzz08@126.com
FU National Natural Science Foundation of China [81273451, 81101684]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 81273451 and 81101684).
CR Bae BC, 2010, BIOMATERIALS, V31, P6325, DOI 10.1016/j.biomaterials.2010.04.030
   Blazkova I, 2014, ELECTROPHORESIS, V35, P1040, DOI 10.1002/elps.201300393
   Bogdanovic G, 2004, TOXICOL IN VITRO, V18, P629, DOI 10.1016/j.tiv.2004.02.010
   Brant JA, 2006, LANGMUIR, V22, P3878, DOI 10.1021/la053293o
   Celli JP, 2010, CHEM REV, V110, P2795, DOI 10.1021/cr900300p
   Chen J, 2014, BIOMATERIALS, V35, P6498, DOI 10.1016/j.biomaterials.2014.04.028
   Chen YW, 2004, AM J PHYSIOL-REG I, V287, pR21, DOI 10.1152/ajpregu.00310.2003
   Choi KY, 2010, BIOMATERIALS, V31, P106, DOI 10.1016/j.biomaterials.2009.09.030
   Crespo-Ortiz MP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/247597
   Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010
   Daniels TR, 2012, BBA-GEN SUBJECTS, V1820, P291, DOI 10.1016/j.bbagen.2011.07.016
   Doherty JF, 1999, T ROY SOC TROP MED H, V93, P543, DOI 10.1016/S0035-9203(99)90376-0
   Efferth T, 2004, FREE RADICAL BIO MED, V37, P998, DOI 10.1016/j.freeradbiomed.2004.06.023
   FRASER JRE, 1989, CIBA F SYMP, V143, P41
   Gandra N, 2013, SMALL, V9, P215, DOI 10.1002/smll.201202090
   Gomme PT, 2005, DRUG DISCOV TODAY, V10, P267, DOI 10.1016/S1359-6446(04)03333-1
   Graham RM, 2008, J HEPATOL, V48, P327, DOI 10.1016/j.jhep.2007.10.009
   Hamilton DH, 2004, J BIOL INORG CHEM, V9, P936, DOI 10.1007/s00775-004-0592-6
   Hu Z, 2012, CHEM-BIOL INTERACT, V195, P86, DOI 10.1016/j.cbi.2011.11.003
   Hu Z, 2010, BIOMATERIALS, V31, P8872, DOI 10.1016/j.biomaterials.2010.08.025
   Huang P, 2011, THERANOSTICS, V1, P240, DOI 10.7150/thno/v01p0240
   Ikeda A, 2007, J AM CHEM SOC, V129, P4140, DOI 10.1021/ja070243s
   Isakovic A, 2006, TOXICOL SCI, V91, P173, DOI 10.1093/toxsci/kfj127
   Isakovic A, 2006, BIOMATERIALS, V27, P5049, DOI 10.1016/j.biomaterials.2006.05.047
   Islam SDM, 2000, CHEM LETT, P78, DOI 10.1246/cl.2000.78
   Kato S, 2009, BIOORG MED CHEM LETT, V19, P5293, DOI 10.1016/j.bmcl.2009.07.149
   Li JL, 2009, CANCER LETT, V274, P319, DOI 10.1016/j.canlet.2008.09.024
   Li PCH, 2008, CANCER RES, V68, P4347, DOI 10.1158/0008-5472.CAN-07-2970
   Liu YH, 2011, INT J PHARMACEUT, V421, P160, DOI 10.1016/j.ijpharm.2011.09.006
   Lyon DY, 2008, ENVIRON SCI TECHNOL, V42, P8127, DOI 10.1021/es801869m
   Markovic Z, 2008, BIOMATERIALS, V29, P3561, DOI 10.1016/j.biomaterials.2008.05.005
   Meijer MD, 2001, ORGANOMETALLICS, V20, P4198, DOI 10.1021/om010328g
   Mikata Y, 2003, BIOORG MED CHEM LETT, V13, P3289, DOI 10.1016/S0960-894X(03)00595-X
   Mirakyan AL, 2002, J CHEM SOC PERK T 2, P1173, DOI 10.1039/b200145d
   Montellano A, 2011, NANOSCALE, V3, P4035, DOI 10.1039/c1nr10783f
   Nakamura E, 2003, ACCOUNTS CHEM RES, V36, P807, DOI 10.1021/ar030027y
   Nakase I, 2009, CANCER LETT, V274, P290, DOI 10.1016/j.canlet.2008.09.023
   Nam W, 2007, HEAD NECK-J SCI SPEC, V29, P335, DOI 10.1002/hed.20524
   Oh EJ, 2010, J CONTROL RELEASE, V141, P2, DOI 10.1016/j.jconrel.2009.09.010
   Oh S, 2009, CANCER LETT, V274, P33, DOI [10.1016/j.canlet.2008.08.031, 10.1016/j.canlet.2008.08.03l]
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561
   Raoof M, 2012, BIOMATERIALS, V33, P2952, DOI 10.1016/j.biomaterials.2011.12.043
   REIZENSTEIN P, 1991, MED ONCOL TUMOR PHAR, V8, P229
   Sadava D, 2002, CANCER LETT, V179, P151, DOI 10.1016/S0304-3835(02)00005-8
   Shi JJ, 2013, BIOMATERIALS, V34, P9666, DOI 10.1016/j.biomaterials.2013.08.049
   Shi JJ, 2013, INT J NANOMED, V8, P2361, DOI 10.2147/IJN.S45407
   Shi JJ, 2013, BIOMATERIALS, V34, P251, DOI 10.1016/j.biomaterials.2012.09.039
   Ungurenasu C, 2000, J MED CHEM, V43, P3186, DOI 10.1021/jm991175q
   Weerasinghe K. L., 2002, Ceylon Medical Journal, V47, P83
   Wharton T, 2002, BIOORGAN MED CHEM, V10, P3545, DOI 10.1016/S0968-0896(02)00252-3
   Xie WL, 2010, CHINESE SCI BULL, V55, P2390, DOI 10.1007/s11434-010-3284-3
   Xu QA, 2011, J ZHEJIANG UNIV-SC B, V12, P247, DOI 10.1631/jzus.B1000373
   Yan L, 2013, CARBON, V57, P120, DOI 10.1016/j.carbon.2013.01.042
   Yang Y, 2014, INT J PHARMACEUT, V467, P113, DOI 10.1016/j.ijpharm.2014.03.044
   Yitong Z, 2013, PLOS ONE, V8, P1
   Zakharian TY, 2005, J AM CHEM SOC, V127, P12508, DOI 10.1021/ja0546525
   Zeng XH, 2014, BIOMATERIALS, V35, P1227, DOI 10.1016/j.biomaterials.2013.10.042
   ZHANG F, 1992, BIOCHEM PHARMACOL, V43, P1805, DOI 10.1016/0006-2952(92)90713-S
   Zhao TT, 2012, NANOSCALE, V4, P7712, DOI 10.1039/c2nr32196c
   Zhou ZG, 2010, BIOCONJUGATE CHEM, V21, P1656, DOI 10.1021/bc1001664
NR 62
TC 28
Z9 29
U1 8
U2 106
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2015
VL 37
BP 353
EP 366
DI 10.1016/j.biomaterials.2014.10.031
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AW8WW
UT WOS:000346541100034
PM 25453964
DA 2018-10-20
ER

PT J
AU Alshemary, AZ
   Goh, YF
   Shakir, I
   Hussain, R
AF Alshemary, Ammar Z.
   Goh, Yi-Fan
   Shakir, Imran
   Hussain, Rafaqat
TI Synthesis, characterization and optical properties of chromium doped
   beta-Tricalcium phosphate
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE beta-Tricalcium phosphate (beta TCP); Chromium; Optical properties;
   Photoluminescence; Biomaterial
ID TCP CERAMICS; CALCIUM-HYDROXYAPATITE; POWDER DIFFRACTION; REFINEMENT;
   IONS; DEGRADATION; MECHANISMS; BEHAVIOR
AB The increasing demand to monitor the resorption of bone grafting materials in a biological environment has led the scientists to focus their attention towards the synthesis of photoluminescent biomaterials. Chromium (1111) exhibits a strong photoluminescence signal, which can be used to monitor the flow of body fluids or resorption of Cr3+ doped biomaterials. In this study we have successfully doped Cr3+ ions into beta-Tricalcium phosphate [Ca3-(3/2)xCrx(1/2)x square(PO4)(2)] structure by a two steps process: microwave assisted wet precipitation of calcium deficient apatite [Ca9-xCrx(HPO4)(PO4)(5)(OH)] followed by its calcination at 1200 degrees C for 2 h. Physicochemical properties of the samples analyzed by X-ray diffraction (XRD), X-ray fluorescence spectrometry (XRF) and Fourier transform infrared (FUR), Field emission scanning electron microscopy (FESEM). XRD and FTIR data confirmed the formation of crystalline Cr3+ doped beta-Tricalcium phosphate. XRD data revealed a gradual decrease in the lattice parameters along the a and c-axis with increasing concentration of Cr3+ ions. The FESEM analysis showed a change in morphology from stacked nanoflakes to micron sized spherical particles upon Cr3+ doping into the crystal structure. Optical spectra and photoluminescence spectra of Cr3+ doped beta-Tricalcium phosphate confirmed their possible biomedical use as fluorescent probes. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Alshemary, Ammar Z.; Goh, Yi-Fan] Univ Teknol Malaysia, Fac Sci, Dept Chem, Utm Skudai 81310, Johor Darul Taz, Malaysia.
   [Shakir, Imran] King Saud Univ, Coll Engn, Sustainable Energy Technol SET Ctr, Riyadh 11451, Saudi Arabia.
   [Hussain, Rafaqat] Univ Teknol Malaysia, Ibnu Sina Inst Fundamental Sci Studies, Utm Skudai 81310, Johor Darul Taz, Malaysia.
RP Hussain, R (reprint author), Univ Teknol Malaysia, Ibnu Sina Inst Fundamental Sci Studies, Utm Skudai 81310, Johor Darul Taz, Malaysia.
EM rafaqat@kimia.fs.utm.my
OI Hussain, Rafaqat/0000-0003-4810-4776
FU Universiti Teknologi Malaysia [Vot. Q.J.130000.2509.06H20]
FX Authors would like to acknowledge the financial assistance via Geran
   Universiti Penyelidikan scheme, Vot. Q.J.130000.2509.06H20 from
   Universiti Teknologi Malaysia.
CR Araujo JC, 2009, MATER CHEM PHYS, V118, P337, DOI 10.1016/j.matchemphys.2009.07.064
   Araujo T.S., 2007, J MATER SCI, V42, P2236
   Asmae Massit A.E.Y., 2014, IOSR J APPL CHEM, V7, P57
   Aswani T, 2014, SPECTROCHIM ACTA A, V121, P544, DOI 10.1016/j.saa.2013.11.018
   Balamurugan K, 1999, BBA-GEN SUBJECTS, V1427, P357, DOI 10.1016/S0304-4165(99)00047-1
   Bandyopadhyay A, 2012, J BIOMED MATER RES B, V100B, P2203, DOI 10.1002/jbm.b.32789
   Banerjee SS, 2010, ACTA BIOMATER, V6, P4167, DOI 10.1016/j.actbio.2010.05.012
   Boucetta C, 2009, APPL CATAL A-GEN, V356, P201, DOI 10.1016/j.apcata.2009.01.005
   Cacciotti I, 2011, CERAM INT, V37, P127, DOI 10.1016/j.ceramint.2010.08.023
   DeVoe K., 2011, CERAM T, V228, P27
   Dhal J, 2013, MAT SCI ENG C-MATER, V33, P3061, DOI 10.1016/j.msec.2013.03.043
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Enderle R, 2005, BIOMATERIALS, V26, P3379, DOI 10.1016/j.biomaterials.2004.09.017
   HENCH LL, 1998, INTRO BIOCERAMICS
   Holland TJB, 1997, MINERAL MAG, V61, P65, DOI 10.1180/minmag.1997.061.404.07
   ISHIKAWA K, 1993, J MATER SCI-MATER M, V4, P165, DOI 10.1007/BF00120386
   Kannan S, 2011, J AM CERAM SOC, V94, P231, DOI 10.1111/j.1551-2916.2010.04070.x
   Kawabata K, 2008, J CERAM SOC JPN, V116, P108, DOI 10.2109/jcersj2.116.108
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P157, DOI 10.1016/0142-9612(84)90051-6
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   Kumar R, 2001, J MATER PROCESS TECH, V113, P456, DOI 10.1016/S0924-0136(01)00611-2
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   Matsumoto N, 2010, J CERAM SOC JPN, V118, P451, DOI 10.2109/jcersj2.118.451
   Mellier C., 2012, Key Engineering Materials, V493-494, P195, DOI 10.4028/www.scientific.net/KEM.493-494.195
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   Music S, 1999, CROAT CHEM ACTA, V72, P789
   Ramasami T, 2001, J AM LEATHER CHEM AS, V96, P290
   Sallam S.M., 2012, J BIOPHYS CHEM, V03, P278
   Sangeetha S, 2012, COLLOID SURFACE B, V100, P36, DOI 10.1016/j.colsurfb.2012.05.015
   Sayer M, 2003, BIOMATERIALS, V24, P369, DOI 10.1016/S0142-9612(02)00327-7
   SCHROEDER LW, 1977, J SOLID STATE CHEM, V22, P253, DOI 10.1016/0022-4596(77)90002-0
   Singh RS, 2004, SOL ENERG MAT SOL C, V82, P315, DOI 10.1016/j.solmat.2004.02.006
   Sreeram KJ, 2003, RESOUR CONSERV RECY, V38, P185, DOI 10.1016/S0921-3449(02)00151-9
   Tarafder S, 2013, J TISSUE ENG REGEN M, V7, P631, DOI 10.1002/term.555
   Wakamura M, 1997, POLYHEDRON, V16, P2047, DOI 10.1016/S0277-5387(96)00513-X
   Wakamura M, 2011, ADV POWDER TECHNOL, V22, P498, DOI 10.1016/j.apt.2010.10.012
   Wang X.L. Y.M.X., 2012, INT P CHEM BIOL ENV, V38, P115
   Xia ZG, 2012, J PHYS CHEM C, V116, P15604, DOI 10.1021/jp304722z
   Xu HT, 2004, INORG CHEM COMMUN, V7, P666, DOI 10.1016/j.inoche.2004.03.012
   Yashima M, 2003, J SOLID STATE CHEM, V175, P272, DOI 10.1016/S0022-4596(03)00279-2
   Yokozeki H, 1998, J MATER SCI-MATER M, V9, P381, DOI 10.1023/A:1013279412600
   Zhang ML, 2012, J MATER CHEM, V22, P21686, DOI 10.1039/c2jm34395a
   Zhang X, 2008, J MATER SCI-MATER M, V19, P3063, DOI 10.1007/s10856-008-3442-1
NR 44
TC 9
Z9 9
U1 0
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD JAN
PY 2015
VL 41
IS 1
BP 1663
EP 1669
DI 10.1016/j.ceramint.2014.09.107
PN B
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA AW3XM
UT WOS:000346216500095
DA 2018-10-20
ER

PT J
AU Maia, LP
   Reino, DM
   Muglia, VA
   de Souza, SLS
   Palioto, DB
   Novaes, AB
AF Maia, Luciana P.
   Reino, Danilo M.
   Muglia, Valdir A.
   de Souza, Sergio L. S.
   Palioto, Daniela B.
   Novaes, Arthur B., Jr.
TI The influence of the periodontal biotype on peri-implant tissues around
   immediate implants with and without xenografts. Clinical and
   micro-computerized tomographic study in small Beagle dogs
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; dogs; extraction socket; grafting; immediate implant
ID FRESH EXTRACTION SOCKETS; GUIDED BONE REGENERATION; FLAPLESS SURGERY;
   BIO-OSS(R) COLLAGEN; TOOTH EXTRACTION; PLACEMENT; PRESERVATION;
   STABILITY; THICKNESS; DIMENSION
AB Objective: Soft tissues and buccal bone plate remodeling after immediate implantation in sockets with thin buccal bone, using the flapless approach with or without bone graft into the buccal gap, was compared between sites with thin and normal gingiva.
   Material and methods: Eight dogs had the gingiva of one side of the mandible thinned, the mandibular premolars were extracted without flaps, and 4 implants were installed in each side, positioned 1.5 mm from the buccal bone. The sites were randomly assigned into: TG (test group) = thin gingiva; TG + GM (TG with grafting material); CG (control group) = normal gingiva; and CG + GM (CG with grafting material). Buccal bone thickness (BBT), thickness of keratinized tissue (TKT), alveolar thickness (AT), gingival recession (GR), and probing depth (PD) were clinically evaluated. Within 12 weeks the dogs were sacrificed and the samples were analyzed by micro-computerized tomography.
   Results: A thin BBT was observed in all the dogs. The presurgical procedures reduced TKT in the test group, with minimal changes of the AT. There were no statistically significant differences among the groups for the clinical parameters and the tomographic analysis showed similar linear and tri-dimensional bone reduction in all the groups.
   Conclusion: The thickness of the buccal bone was a fundamental factor in buccal bone plate resorption, even with flapless implantation. The decrease in gingival thickness or the addition of a biomaterial in the gap did not influence the results.
C1 [Maia, Luciana P.; Reino, Danilo M.; de Souza, Sergio L. S.; Palioto, Daniela B.; Novaes, Arthur B., Jr.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Buccomaxilofacial Surg & Traumatol & Periodo, BR-14040904 Ribeirao Preto, SP, Brazil.
   [Muglia, Valdir A.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Dent Mat Prosthet, BR-14040904 Ribeirao Preto, SP, Brazil.
RP Novaes, AB (reprint author), Univ Sao Paulo, Fac Odontol Ribeirao Preto, Ave Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
EM novaesjr@forp.usp.br
RI Palioto, Daniela/H-3054-2016; novaes, arthur/O-2945-2013
OI Maia, Luciana/0000-0001-5697-2587
FU State of Sao Paulo Research Foundation [11/00674- 6]
FX The authors thank the Coordination for the Improvement of Graduated
   Personnel (CAPES) for the scholarship that supported Ms. Maia, the State
   of Sao Paulo Research Foundation for the financial support of this study
   ( process number 11/00674- 6), Geistlich Pharma AG for the donation of
   the BOC used in this study. We also thank Adriana L. G. Almeida,
   Microscopic and Image Analysis Laboratory Technician at the School of
   Dentistry of Ribeirno Preto, University of Sao Paulo, SP, Brazil, for
   the assistance with Micro-CT analysis, and Pierre Rompre, Research
   Assistant at the University of Montreal, Montreal, Canada, for the
   statistical analysis.
CR Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P615, DOI 10.1111/j.1600-0501.2006.01317.x
   Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P1, DOI 10.1111/j.1600-0501.2010.01920.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Becker W, 2005, CLIN IMPLANT DENT R, V7, pS21, DOI 10.1111/j.1708-8208.2005.tb00071.x
   Becker W, 1994, Int J Oral Maxillofac Implants, V9, P31
   Berglundh T, 1996, J CLIN PERIODONTOL, V23, P971, DOI 10.1111/j.1600-051X.1996.tb00520.x
   Berglundh T, 2012, J CLIN PERIODONTOL, V39, P1, DOI 10.1111/j.1600-051X.2011.01827.x
   Blanco J, 2010, CLIN ORAL IMPLAN RES, V21, P624, DOI 10.1111/j.1600-0501.2009.01885.x
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P309, DOI 10.1111/j.1600-051X.2004.00502.x
   Bragger U, 1996, CLIN ORAL IMPLAN RES, V7, P268, DOI 10.1034/j.1600-0501.1996.070309.x
   BRAGGER U, 1988, J CLIN PERIODONTOL, V15, P558, DOI 10.1111/j.1600-051X.1988.tb02129.x
   Campelo LD, 2002, INT J ORAL MAX IMPL, V17, P271
   Caneva M, 2010, CLIN ORAL IMPLAN RES, V21, P891, DOI 10.1111/j.1600-0501.2010.01946.x
   Degidi M, 2013, CLIN ORAL IMPLAN RES, V24, P1201, DOI 10.1111/j.1600-0501.2012.02561.x
   Denissen H W, 1993, Int J Oral Maxillofac Implants, V8, P191
   Ferrus J, 2010, CLIN ORAL IMPLAN RES, V21, P22, DOI 10.1111/j.1600-0501.2009.01825.x
   Fickl S, 2008, J CLIN PERIODONTOL, V35, P356, DOI 10.1111/j.1600-051X.2008.01209.x
   Fickl S, 2009, J CLIN PERIODONTOL, V36, P898, DOI 10.1111/j.1600-051X.2009.01463.x
   Fickl S, 2009, J CLIN PERIODONTOL, V36, P442, DOI 10.1111/j.1600-051X.2009.01381.x
   Gelb D A, 1993, Int J Oral Maxillofac Implants, V8, P388
   GHER ME, 1994, J PERIODONTOL, V65, P881, DOI 10.1902/jop.1994.65.9.881
   Heberer S, 2008, CLIN ORAL IMPLAN RES, V19, P1219, DOI 10.1111/j.1600-0501.2008.01617.x
   Jeong SM, 2011, ORAL SURG ORAL MED O, V111, P170, DOI 10.1016/j.tripleo.2010.04.024
   Kan JYK, 2003, INT J ORAL MAX IMPL, V18, P31
   Kim BS, 2009, ORAL SURG ORAL MED O, V107, pE24, DOI 10.1016/j.tripleo.2008.12.010
   Kim JI, 2009, ORAL SURG ORAL MED O, V107, P508, DOI 10.1016/j.tripleo.2008.08.003
   Kohal RJ, 1998, J PERIODONTOL, V69, P927, DOI 10.1902/jop.1998.69.8.927
   Linkevicius T, 2010, J ORAL MAXIL SURG, V68, P2272, DOI 10.1016/j.joms.2009.08.018
   Linkevicius T, 2009, INT J ORAL MAX IMPL, V24, P712
   Misch CE, 2008, IMPLANT DENT, V17, P5, DOI 10.1097/ID.0b013e3181676059
   Muller R, 1996, J BONE MINER RES, V11, P1745
   Novaes AB, 2012, J ORAL IMPLANTOL, V38, P687, DOI 10.1563/AAID-JOI-D-10-00176
   Novaes AB, 2011, J OSSEOINTEGRATION, V3, P45
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   Sclar AG, 2007, J ORAL MAXIL SURG, V65, P20, DOI 10.1016/j.joms.2007.03.017
   SEIBERT J, 1997, TXB CLIN PERIODONTOL, P647
   Spinato S, 2014, CLIN ORAL IMPLAN RES, V25, pE120, DOI 10.1111/clr.12073
   Spray J R, 2000, Ann Periodontol, V5, P119, DOI 10.1902/annals.2000.5.1.119
   Suaid F. A., 2012, CLIN ORAL IMPLANTS R
   Tomasi C, 2010, CLIN ORAL IMPLAN RES, V21, P30, DOI 10.1111/j.1600-0501.2009.01848.x
   Watzek G, 1995, Int J Oral Maxillofac Implants, V10, P561
   WOOD DL, 1972, J PERIODONTOL, V43, P141, DOI 10.1902/jop.1972.43.3.141
NR 47
TC 1
Z9 2
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JAN
PY 2015
VL 26
IS 1
BP 35
EP 43
DI 10.1111/clr.12298
PG 9
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA AW5XL
UT WOS:000346344200009
PM 24303896
DA 2018-10-20
ER

PT J
AU Correa, D
   Almirall, A
   Carrodeguas, RG
   dos Santos, LA
   De Aza, AH
   Parra, J
   Morejon, L
   Delgado, JA
AF Correa, Daniel
   Almirall, Amisel
   Garcia Carrodeguas, Raul
   dos Santos, Luis Alberto
   De Aza, Antonio H.
   Parra, Juan
   Morejon, Lizette
   Angel Delgado, Jose
TI alpha-Tricalcium phosphate cements modified with beta-dicalcium silicate
   and tricalcium aluminate: Physicochemical characterization, in vitro
   bioactivity and cytotoxicity
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE calcium phosphate cement; alpha-tricalcium phosphate; beta-dicalcium
   silicate; tricalcium aluminate; cytocompatibility
ID COMPOSITE BONE-CEMENT; PORTLAND-CEMENT; MECHANICAL-PROPERTIES;
   RESTORATIVE MATERIAL; CALCIUM ALUMINATE; BIOCERAMICS; BIOCOMPATIBILITY;
   DIFFERENTIATION; STRENGTH; GLASS
AB Biocompatibility, injectability and in situ self-setting are characteristics of calcium phosphate cements which make them promising materials for a wide range of clinical applications in traumatology and maxillo-facial surgery. One of the main disadvantages is their relatively low strength which restricts their use to nonload-bearing applications. -Tricalcium phosphate (-C3P) cement sets into calcium-deficient hydroxyapatite (CDHA), which is biocompatible and plays an essential role in the formation, growth and maintenance of tissue-biomaterial interface. -Dicalcium silicate (-C2S) and tricalcium aluminate (C(3)A) are Portland cement components, these compounds react with water to form hydrated phases that enhance mechanical strength of the end products. In this study, setting time, compressive strength (CS) and in vitro bioactivity and biocompatibility were evaluated to determine the influence of addition of -C2S and C(3)A to -C3P-based cement. X-ray diffraction and scanning electron microscopy were used to investigate phase composition and morphological changes in cement samples. Addition of C(3)A resulted in cements having suitable setting times, but low CS, only partial conversion into CDHA and cytotoxicity. However, addition of -C2S delayed the setting times but promoted total conversion into CDHA by soaking in simulated body fluid and strengthened the set cement over the limit strength of cancellous bone. The best properties were obtained for cement added with 10 wt % of -C2S, which showed in vitro bioactivity and cytocompatibility, making it a suitable candidate as bone substitute. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 72-83, 2015.
C1 [Correa, Daniel; Almirall, Amisel; Angel Delgado, Jose] Univ La Habana, Ctr Biomat, Dept Ceram & Composites, Havana 10400, Cuba.
   [Garcia Carrodeguas, Raul; De Aza, Antonio H.] CSIC, Inst Ceram & Vidrio, Dept Ceram, Madrid, Spain.
   [dos Santos, Luis Alberto] Univ Fed Rio Grande del Sur, Labiomat Dept Mat, Escuela Ingn, BR-91509900 Porto Alegre, RS, Brazil.
   [Parra, Juan] Hosp Prov Avila, Ctr Invest Red Bioingn Biomat & Nanomed CIBER BBN, Unidad Invest Clin & Biopatol Expt, Avila, Spain.
   [Morejon, Lizette] Univ La Habana, Ctr Biomat, Dept Quim Macromol, Havana 10400, Cuba.
RP Delgado, JA (reprint author), Ave Univ & Ronda & G, Havana 10400, Cuba.
EM jadelgado@biomat.uh.cu
RI de Aza, Antonio/G-4626-2015; Garcia Carrodeguas, Raul/E-5087-2012
OI de Aza, Antonio/0000-0002-1655-3932; Garcia Carrodeguas,
   Raul/0000-0002-4379-4598; Almirall La Serna, Amisel/0000-0002-9260-2206
FU Ministry of Foreign Affairs and Cooperation of Spain for the MAEC-AECID
   Scholarships Program; Ministry of Economy and Competitiveness of Spain
   [CICYT MAT2010-17753]; Program JAE-CSIC from Spain [JAEDOC087-2009];
   INNPACTO from Spain [IPT-2012-0560-010000]; CAPES Program of Brazil
   [032/07]
FX Contract grant sponsor: Ministry of Foreign Affairs and Cooperation of
   Spain for the MAEC-AECID Scholarships Program granted to members of the
   Cuban team; Contract grant sponsor: Ministry of Economy and
   Competitiveness of Spain; contract grant number: Project CICYT
   MAT2010-17753; Contract grant sponsor: Program JAE-CSIC from Spain for
   supporting R. G. Carrodeguas; contract grant number: JAEDOC087-2009;
   Contract grant sponsor: INNPACTO from Spain for supporting R. G.
   Carrodeguas; contract grant number: IPT-2012-0560-010000; Contract grant
   sponsor: CAPES Program of Brazil; contract grant number: Project No.
   032/07
CR Abdullah D, 2002, BIOMATERIALS, V23, P4001, DOI 10.1016/S0142-9612(02)00147-3
   [Anonymous], 1099352009 ISO
   Barralet JE, 2004, BIOMATERIALS, V25, P2197, DOI 10.1016/j.biomaterials.2003.09.085
   Black L, 2006, J MATER CHEM, V16, P1263, DOI 10.1039/b509904h
   Boanini E, 2010, ACTA BIOMATER, V6, P936, DOI 10.1016/j.actbio.2009.10.014
   Booncharoen W, 2011, J BIOMED MATER RES B, V99B, P230, DOI 10.1002/jbm.b.31890
   Cai L, 2011, ACTA BIOMATER, V7, P2185, DOI 10.1016/j.actbio.2011.01.034
   Carrodeguas RG, 2011, ACTA BIOMATER, V7, P3536, DOI 10.1016/j.actbio.2011.06.019
   Carrodeguas RG, 2008, J AM CERAM SOC, V91, P1281, DOI 10.1111/j.1551-2916.2008.02294.x
   Chrysafi R, 2007, J EUR CERAM SOC, V27, P1707, DOI 10.1016/j.jeurceramsoc.2006.05.004
   Coleman NJ, 2009, J BIOMED MATER RES A, V90A, P166, DOI 10.1002/jbm.a.32070
   Dorozhkin SV, 2009, MATERIALS, V2, P221, DOI 10.3390/ma2010221
   dos Santos LA, 2002, BIOMATERIALS, V23, P2035, DOI 10.1016/S0142-9612(01)00333-7
   Durucan C, 2002, J AM CERAM SOC, V85, P2013, DOI 10.1111/j.1151-2916.2002.tb00397.x
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   Engqvist H, 2008, TRENDS BIOMATER ARTI, V21, P98
   Fei LS, 2012, J BIOMED MATER RES B, V100B, P1237, DOI 10.1002/jbm.b.32688
   Ginebra MP, 2010, ACTA BIOMATER, V6, P2863, DOI 10.1016/j.actbio.2010.01.036
   Ginebra MP, 1996, THESIS TU CATALONIA
   Gou ZG, 2004, J EUR CERAM SOC, V24, P93, DOI 10.1016/S0955-2219(03)00320-0
   Gu T, 2012, J BIOMED MATER RES B, V100B, P350, DOI 10.1002/jbm.b.31956
   Gustavsson J, 2011, ACTA BIOMATER, V7, P4242, DOI 10.1016/j.actbio.2011.07.016
   Heinemann S, 2013, ACTA BIOMATER, V9, P4878, DOI 10.1016/j.actbio.2012.10.010
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Higuita-Castro N, 2012, J BIOMED MATER RES B, V100B, P501, DOI 10.1002/jbm.b.31976
   Huan ZG, 2008, J BIOMED MATER RES B, V87B, P387, DOI 10.1002/jbm.b.31116
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kim BS, 2012, J BIOMED MATER RES A, V100A, P1673, DOI 10.1002/jbm.a.34113
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 1997, AN QUIM, V93, pS49
   Lazau I, 2011, J THERM ANAL CALORIM, V105, P427, DOI 10.1007/s10973-010-1246-2
   Li HY, 2013, ACTA BIOMATER, V9, P5379, DOI 10.1016/j.actbio.2012.10.019
   Lim KT, 2011, J BIOMED MATER RES B, V99B, P399, DOI 10.1002/jbm.b.31912
   Liou C, 2002, BIOMATERIALS, V23, P4541
   Liu CS, 2003, BIOMATERIALS, V24, P2995, DOI 10.1016/S0142-9612(03)00125-X
   Liu WN, 2012, J BIOMED MATER RES B, V100B, P1257, DOI 10.1002/jbm.b.32690
   Loof J, 2003, J MATER SCI-MATER M, V14, P1033, DOI 10.1023/B:JMSM.0000003999.52349.0d
   Loof J, 2008, DENT MATER, V24, P653, DOI 10.1016/j.dental.2007.06.028
   Magallanes-Perdomo M, 2010, ACTA BIOMATER, V6, P2254, DOI 10.1016/j.actbio.2009.12.027
   Moreau JL, 2012, J BIOMED MATER RES B, V100B, P1264, DOI 10.1002/jbm.b.32691
   Morejon-Alonso L, 2012, J BIOMED MATER RES B, V100B, P94, DOI 10.1002/jbm.b.31926
   O'Hara RM, 2012, ACTA BIOMATER, V8, P4043, DOI 10.1016/j.actbio.2012.07.003
   Oh SH, 2002, J BIOMED MATER RES, V62, P593, DOI 10.1002/jbm.10347
   Pan HB, 2010, ACTA BIOMATER, V6, P4181, DOI 10.1016/j.actbio.2010.05.013
   Pascual B, 1996, BIOMATERIALS, V17, P509, DOI 10.1016/0142-9612(96)82725-6
   Perez-Escamilla R., 2012, J APPL RES CHILDREN, V3, P1
   Pina S, 2010, ACTA BIOMATER, V6, P928, DOI 10.1016/j.actbio.2009.09.001
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rigo ECS, 2007, LAT AM APPL RES, V37, P267
   Shiwaku Y, 2012, ACTA BIOMATER, V8, P4417, DOI 10.1016/j.actbio.2012.07.041
   Sun F, 2011, ACTA BIOMATER, V7, P3813, DOI 10.1016/j.actbio.2011.07.002
   Taylor HF, 1997, CEMENT CHEM
   Van den Vreken NMF, 2010, ACTA BIOMATER, V6, P617, DOI 10.1016/j.actbio.2009.07.038
   Viola NV, 2012, J BIOMED MATER RES B, V100B, P1773, DOI 10.1002/jbm.b.32744
   Wang XP, 2006, J BIOMED MATER RES B, V78B, P259, DOI 10.1002/jbm.b.30481
   Wynn-Jones G, 2012, J BIOMED MATER RES B, V100B, P2213, DOI 10.1002/jbm.b.32790
   Yuan X, 2007, MAT SCI ENG A-STRUCT, V447, P142, DOI 10.1016/j.msea.2006.10.011
   Zhai WY, 2012, ACTA BIOMATER, V8, P341, DOI 10.1016/j.actbio.2011.09.008
NR 60
TC 10
Z9 10
U1 3
U2 50
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2015
VL 103
IS 1
BP 72
EP 83
DI 10.1002/jbm.b.33176
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AW3MT
UT WOS:000346191600009
PM 24764271
DA 2018-10-20
ER

PT J
AU Yazawa, M
   Mori, T
   Nakayama, Y
   Kishi, K
AF Yazawa, Masaki
   Mori, Taisuke
   Nakayama, Yasuhide
   Kishi, Kazuo
TI Basic study of soft tissue augmentation by adipose-inductive biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE adipose; biomaterial; augmentation; soft tissue
ID ACTIVATED RECEPTOR-GAMMA; SALMON COLLAGEN; GROWTH-FACTOR; PPAR-GAMMA;
   ADIPOGENESIS; ADIPOCYTES; DIFFERENTIATION; GEL
AB Reconstructive surgery for tumor resection, trauma, and congenital anomaly involves volume augmentation with autologous tissue transfer. However, a healthy region is damaged as a donor site, and the autologous tissue is transferred like a patchwork to the recipient site. We have attempted to induce adipogenesis activity in artificial biomaterial that is injectable with an injection needle for soft tissue augmentation. First of all, the optimal dose of pioglitazone hydrochloride was examined with adipo-precursor cells in terms of the proliferator-activated receptor- mRNA expression levels affected by reagent in vitro. Then, salmon collagen with pioglitazone was adjusted in terms of the dose and the salmon collagen was injected into mouse back using an injection needle in vivo. At 4 weeks after implantation, the pioglitazone collagen gel was substituted by mature adipocytes in comparison with the case for control collagen gel without pioglitazone. These results are indicative of the possibility of promoting adipogenesis using collagen with pioglitazone as an adipose-inductive substance. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 92-96, 2015.
C1 [Yazawa, Masaki; Kishi, Kazuo] Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan.
   [Mori, Taisuke] Natl Canc Ctr Lab, Dept Pathol, Tokyo, Japan.
   [Nakayama, Yasuhide] Natl Cerebral & Cardiovasc Ctr Res Inst, Div Med Engn & Mat, Osaka, Japan.
RP Yazawa, M (reprint author), Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan.
EM prsyazawa@gmail.com
FU Japan Society for the Promotion of Science [KAKENHI 23792059]
FX Contract grant sponsor: Japan Society for the Promotion of Science;
   contract grant number: KAKENHI 23792059
CR Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614
   Bodles AM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1100, DOI 10.1152/ajpendo.00187.2006
   Findlay MW, 2009, PLAST RECONSTR SURG, V124, P1077, DOI 10.1097/PRS.0b013e3181b59ff6
   Gurnell M, 2005, BEST PRACT RES CL EN, V19, P501, DOI 10.1016/j.beem.2005.10.001
   Higashi Y, 2010, J BIOL CHEM, V285, P36361, DOI 10.1074/jbc.M110.137661
   Kawaguchi Y, 2011, J MATER SCI-MATER M, V22, P397, DOI 10.1007/s10856-010-4215-1
   Kelly JL, 2006, TISSUE ENG, V12, P2041, DOI 10.1089/ten.2006.12.2041
   KERN PA, 1985, J CLIN INVEST, V75, P199, DOI 10.1172/JCI111675
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   Kleiman A, 2013, EXP MOL PATHOL, V94, P126, DOI 10.1016/j.yexmp.2012.09.023
   Nagai N, 2008, J BIOMED MATER RES B, V87B, P432, DOI 10.1002/jbm.b.31121
   Nagai N, 2009, J ARTIF ORGANS, V12, P61, DOI 10.1007/s10047-008-0446-z
   Nagai N, 2008, J BIOSCI BIOENG, V106, P412, DOI 10.1263/jbb.106.412
   Phulpin B, 2009, PLAST RECONSTR SURG, V123, P1187, DOI 10.1097/PRS.0b013e31819f2928
   Rosen ED, 2000, GENE DEV, V14, P1293
   Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, P1195
   Yamanouchi K, 2007, J REPROD DEVELOP, V53, P563, DOI 10.1262/jrd.18169
   Youm YH, 2010, AGING CELL, V9, P478, DOI 10.1111/j.1474-9726.2010.00574.x
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
NR 19
TC 2
Z9 2
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2015
VL 103
IS 1
BP 92
EP 96
DI 10.1002/jbm.b.33180
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AW3MT
UT WOS:000346191600011
PM 24764287
DA 2018-10-20
ER

PT J
AU Togami, W
   Sei, A
   Okada, T
   Taniwaki, T
   Fujimoto, T
   Tahata, S
   Nagamura, K
   Nakanishi, Y
   Mizuta, H
AF Togami, Wakana
   Sei, Akira
   Okada, Tatsuya
   Taniwaki, Takuya
   Fujimoto, Toru
   Tahata, Shogo
   Nagamura, Kazuma
   Nakanishi, Yoshitaka
   Mizuta, Hiroshi
TI Effects of the water-holding capability of polyvinyl formal sponges on
   osteogenic ability in in vivo experiments
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE coated polyvinyl formal sponge; high water-holding capability;
   osteogenic ability; bone tissue engineering; microcomputed tomography
ID CREST BONE-GRAFT; COMPOSITE SCAFFOLD; TISSUE FABRICATION; CELL-ADHESION;
   CARTILAGE; BIOCOMPATIBILITY; POLYSACCHARIDE; BIOMATERIALS; HYDROGELS;
   REPAIR
AB In this study, dextran-coated polyvinyl formal (PVF) sponges with high water-holding capability were developed to increase the osteogenic response in the PVF sponge. The study aimed to estimate the effect of the increased water-holding capability of the sponges on osteogenic capacity at a bone defect site in the rabbit femur epiphysis. Bone formation was evaluated using radiography, microcomputed tomography (CT), and histological analysis at 2, 4, and 6 weeks after implantation. As shown by radiography and micro-CT findings, the dextran-coated PVF sponge without water-holding capability showed little bone formation at all evaluated time points. However, the dextran-coated PVF sponge with high water-holding capability showed increasing bone formation around the implant at 4 and 6 weeks after implantation. Furthermore, as shown by micro-CT quantitative analysis, the grafted PVF sponge with high water-holding capability showed significantly greater values for percentage of bone volume per total volume and mean bone mineral density compared with the grafted PVF sponge without water-holding capability at 4 and 6 weeks after implantation. These results suggest that the dextran-coated PVF sponge with high water-holding capability promoted osteogenesis in vivo. The PVF sponge might be a new biomaterial to be used as a fill material for bone defects. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 188-194, 2015.
C1 [Togami, Wakana; Sei, Akira; Okada, Tatsuya; Taniwaki, Takuya; Fujimoto, Toru; Tahata, Shogo; Mizuta, Hiroshi] Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Chuo Ku, Kumamoto, Japan.
   [Nagamura, Kazuma; Nakanishi, Yoshitaka] Kumamoto Univ, Grad Sch Sci & Technol, Dept Adv Mech Syst, Chuo Ku, Kumamoto, Japan.
RP Togami, W (reprint author), Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Chuo Ku, Kumamoto, Japan.
EM wakana@fc.kuh.kumamoto-u.ac.jp
CR Albert Adrien, 2006, Acta Orthop Belg, V72, P734
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Beirne JC, 1996, INT J ORAL MAX SURG, V25, P268, DOI 10.1016/S0901-5027(06)80053-6
   Cadee JA, 2000, J BIOMED MATER RES, V50, P397
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Chang YS, 1996, BIOMATERIALS, V17, P1141, DOI 10.1016/0142-9612(96)85917-5
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   CHENU C, 1993, GEODERMA, V56, P143, DOI 10.1016/0016-7061(93)90106-U
   Flory PJ, 1939, J AM CHEM SOC, V61, P1518, DOI 10.1021/ja01875a053
   FLORY PJ, 1950, J AM CHEM SOC, V72, P5052, DOI 10.1021/ja01167a064
   Gallo JAQ, 2005, ACTA HORTIC, P1709
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   Le Guehennec L, 2005, J BIOMED MATER RES B, V72B, P69, DOI 10.1002/jbm.b.30118
   Li B, 2009, BIOMATERIALS, V30, P6768, DOI 10.1016/j.biomaterials.2009.08.038
   Liu JM, 2000, ANTICANCER RES, V20, P3265
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Merkx MAW, 1999, BIOMATERIALS, V20, P639, DOI 10.1016/S0142-9612(98)00219-1
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Nakanishi Y, 2009, J BIOMECH SCI ENG, V4, P249, DOI DOI 10.1299/JBSE.4.249
   Nodarian T, 2010, ORTHOP TRAUMATOL-SUR, V96, P593, DOI 10.1016/j.otsr.2010.03.016
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   Panagiotis M, 2005, INJURY, V36, pS30, DOI 10.1016/j.injury.2005.10.008
   ROBINSON BP, 1995, OTOLARYNG HEAD NECK, V112, P707
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   Stubbs D, 2004, BIOMATERIALS, V25, P5037, DOI 10.1016/j.biomaterials.2004.02.014
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Togami W, 2014, J BIOMED MATER RES A, V102, P247, DOI 10.1002/jbma.34695
   YAMAGUCHI M, 2004, J ARTIF ORGANS, V7, P187
   Yoshikawa Masataka, 2010, Journal of Biomedical Science & Engineering, V3, P751, DOI 10.4236/jbise.2010.38100
   Yoshikawa M, 2009, WORLD ACAD SCI ENG T, V54, P580
NR 38
TC 5
Z9 5
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2015
VL 103
IS 1
BP 188
EP 194
DI 10.1002/jbm.b.33200
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AW3MT
UT WOS:000346191600022
PM 24819983
DA 2018-10-20
ER

PT J
AU Wang, LQ
   Ma, RJ
   Du, GP
   Guo, HL
   Huang, YF
AF Wang, Liqiang
   Ma, Ruijue
   Du, Gaiping
   Guo, Huiling
   Huang, Yifei
TI Biocompatibility of helicoidal multilamellar arginine-glycine-aspartic
   acid-functionalized silk biomaterials in a rabbit corneal model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE silk fibroin; keratoprosthesis; corneal transplantation; tissue
   engineering; collagen; fibronectin; immune response; neovascularization
ID KERATOCONUS CORNEAS; FIBROIN MEMBRANES; COLLAGEN TYPES; IN-VIVO;
   SURFACE; FILMS; SCAFFOLDS; RGD; IMMOBILIZATION; FIBRONECTIN
AB Silk proteins represent a unique choice in the selection of biomaterials that can be used for corneal tissue engineering and regenerative medical applications. We implanted helicoidal multilamellar arginine-glycine-aspartic acid-functionalized silk biomaterials into the corneal stroma of rabbits, and evaluated its biocompatibility. The corneal tissue was examined after routine hematoxylin-eosin staining, immunofluorescence for collagen I and III, and fibronectin, and scanning electron microscopy. The silk films maintained their integrity and transparency over the 180-day experimental period without causing immunogenic and neovascular responses or degradation of the rabbit corneal stroma. Collagen I increased, whereas Collagen III and fibronectin initially increased and then gradually decreased. The extracellular matrix deposited on the surface of the silk films, tightly adhered to the biomaterial. We have shown this kind of silk film graft has suitable biocompatibility with the corneal stroma and is an initial step for clinical trials to evaluate this material as a transplant biomaterial for keratoplasty tissue constructs. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 204-211, 2015.
C1 [Wang, Liqiang; Du, Gaiping; Guo, Huiling; Huang, Yifei] Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing 100853, Peoples R China.
   [Ma, Ruijue] Tianjin Med Univ, Tianjin Eye Hosp, Tianjin Key Lab Ophthalmol & Visual Sci, Clin Coll Ophthalmol, Tianjin 300020, Peoples R China.
RP Huang, YF (reprint author), Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing 100853, Peoples R China.
EM 301yk@sina.com
FU Returnee Foundation at the PLA Hospital, Beijing, China [301]
FX Contract grant sponsor: The Returnee Foundation at the PLA 301 Hospital,
   Beijing, China
CR Amsden JJ, 2010, ADV MATER, V22, P1746, DOI 10.1002/adma.200903166
   [Anonymous], 2005, 2005 ANNUAL REPORT
   Boateng SY, 2005, AM J PHYSIOL-CELL PH, V288, pC30, DOI 10.1152/ajpcell.00199.2004
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI 10.1089/tea.2007.0224
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   Deng C, 2010, ACTA BIOMATER, V6, P187, DOI 10.1016/j.actbio.2009.07.027
   Ethier CR, 2004, ANNU REV BIOMED ENG, V6, P249, DOI 10.1146/annurev.bioeng.6.040803.140055
   Fagerholm P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001022
   George AJT, 2004, AM J TRANSPLANT, V4, P678, DOI 10.1111/j.1600-6143.2004.00417.x
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Higa K, 2011, J BIOMAT SCI-POLYM E, V22, P2261, DOI 10.1163/092050610X538218
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hu XJ, 2005, TISSUE ENG, V11, P1710, DOI 10.1089/ten.2005.11.1710
   Ilhan-Sarac Ozge, 2005, Curr Opin Ophthalmol, V16, P246, DOI 10.1097/01.icu.0000172829.33770.d3
   Jun HW, 2004, J BIOMAT SCI-POLYM E, V15, P73, DOI 10.1163/156856204322752246
   Jung HJ, 2005, MACROMOL RES, V13, P446, DOI 10.1007/BF03218479
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   MAUMENEE IH, 1978, OPHTHALMOLOGY, V85, P1014
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Myung D, 2007, BIOMED MICRODEVICES, V9, P911, DOI 10.1007/s10544-006-9040-4
   NEWSOME DA, 1981, INVEST OPHTH VIS SCI, V20, P738
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Sandeman SR, 2003, BIOMATERIALS, V24, P4729, DOI 10.1016/S0142-9612(03)00370-3
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3
   TSUCHIYA S, 1986, JPN J OPHTHALMOL, V30, P14
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vieira A FK YA, 2010, ANNUAL MEETING OF TH
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Xiong Jie DY-P, 2011, OPHTHALMOL CHINA, V20, P6
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yoon JJ, 2004, BIOMATERIALS, V25, P5613, DOI 10.1016/j.biomaterials.2004.01.014
NR 39
TC 7
Z9 8
U1 0
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2015
VL 103
IS 1
BP 204
EP 211
DI 10.1002/jbm.b.33192
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AW3MT
UT WOS:000346191600024
PM 24825733
DA 2018-10-20
ER

PT J
AU Hoyt, AJ
   Yalzacki, CM
   Fertig, RS
   Carpenter, RD
   Frick, CP
AF Hoyt, Anthony J.
   Yalzacki, Christopher M.
   Fertig, Ray S., III
   Carpenter, R. Dana
   Frick, Carl P.
TI Monotonic and cyclic loading behavior of porous scaffolds made from
   poly(para-phenylene) for orthopedic applications
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Aromatic polymers; Porous; Fatigue; Orthopedics; Poly(para-phenylene);
   Mechanical properties
ID BOVINE TRABECULAR BONE; TOTAL HIP-ARTHROPLASTY; FATIGUE BEHAVIOR;
   OPEN-CELL; METHACRYLATE COPOLYMERS; HYDROXYALKYL ACRYLATE; SYNTHETIC
   HYDROGELS; FRACTURE-BEHAVIOR; TISSUE; FOAMS
AB Porous poly(para-phenylene) (PPP) scaffolds have tremendous potential as an orthopedic biomaterial; however, the underlying mechanisms controlling the monotonic and cyclic behavior are poorly understood. The purpose of this study was to develop a method to integrate micro-computed tomography (mu CT), finite-element analysis (PEA), and experimental results to uncover the relationships between the porous structure and mechanical behavior. The mu CT images were taken from porous PPP scaffolds with a porosity of 75 vol% and pore size distribution between 420 and 500 mu m. Representative sections of the image were segmented and converted into finite-element meshes. It was shown through PEA that localized stresses within the microstructure were approximately 100 times higher than the applied global stress during the linear loading regime. Experimental analysis revealed the S-N fatigue curves for fully dense and porous PPP samples were parallel on log-log plots, with the endurance limit for porous samples in tension being approximately 100 times lower than their solid PPP counterparts (0.3-35 MPa) due to the extreme stress concentrations caused by the porous microarchitecture. The endurance limit for porous samples in compression was much higher than in tension (1.60 MPa). Through optical, laser-scanning, and scanning-electron microscopy it was found that porous tensile samples failed under Mode I fracture in both monotonic and cyclic loading. By comparison, porous compressive samples failed via strut buckling/pore collapse monotonically and by shearing fracture during cyclic loading. Monotonic loading showed that deformation behavior was strongly correlated with pore volume fraction, matching foam theory well; however, fatigue behavior was much more sensitive to local stresses believed to cause crack nucleation. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Hoyt, Anthony J.; Fertig, Ray S., III; Frick, Carl P.] Univ Wyoming, Dept Mech Engn, Laramie, WY 82071 USA.
   [Yalzacki, Christopher M.; Carpenter, R. Dana] Univ Colorado, Dept Mech Engn, Denver, CO 80202 USA.
RP Frick, CP (reprint author), Univ Wyoming, Dept Mech Engn, Laramie, WY 82071 USA.
EM cfrick@uwyo.edu
RI Fertig III, Ray/F-9481-2010; Fertig, Ray/T-5019-2017
OI Fertig III, Ray/0000-0001-8983-2337; Fertig, Ray/0000-0001-8983-2337;
   Frick, Carl/0000-0002-8202-924X
FU Solvay Specialty Polymers, LLC
FX The authors would like to thank Solvay Specialty Polymers, LLC for their
   support with this research. We would also like to express gratitude to
   Dustin Bales and Eric J. Losty for their contributions towards the
   initial results of this work. In addition, we would like to thank Kendra
   Huber for her assistance with mu CT imaging and Chris Laursen, Susan
   Swapp, and Norbert Swoboda-Colberg for their assistance with SEM
   imaging.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   BARNES A, 1988, POLYMER, V29, P2191, DOI 10.1016/0032-3861(88)90111-5
   Basquin O.H., 1910, P AM SOC TEST MAT
   BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   Boerckel JD, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3148472
   BRILLHART M, 1991, POLYMER, V32, P1605, DOI 10.1016/0032-3861(91)90395-Y
   BRILLHART M, 1994, INT J FATIGUE, V16, P134, DOI 10.1016/0142-1123(94)90103-1
   Bugbee WD, 1997, J BONE JOINT SURG AM, V79A, P1007, DOI 10.2106/00004623-199707000-00006
   Callister W. D., 2010, MAT SCI ENG INTRO
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Chawla N, 2005, MAT SCI ENG A-STRUCT, V390, P98, DOI 10.1016/j.msea.2004.08.046
   CHOI K, 1992, J BIOMECH, V25, P1371, DOI 10.1016/0021-9290(92)90051-2
   Cianga I, 2002, MACROMOL SYMP, V183, P145, DOI 10.1002/1521-3900(200207)183:1<145::AID-MASY145>3.0.CO;2-R
   Converse GL, 2010, ACTA BIOMATER, V6, P856, DOI 10.1016/j.actbio.2009.08.004
   Converse GL, 2009, J MECH BEHAV BIOMED, V2, P627, DOI 10.1016/j.jmbbm.2009.07.002
   CORKHILL PH, 1987, POLYMER, V28, P1758, DOI 10.1016/0032-3861(87)90021-8
   DiRienzo AL, 2014, J MECH BEHAV BIOMED, V30, P347, DOI 10.1016/j.jmbbm.2013.10.012
   Elliott JA, 2002, J MATER SCI, V37, P1547, DOI 10.1023/A:1014920902712
   Frick CP, 2014, J BIOMED MATER RES A, V102, P3122, DOI 10.1002/jbm.a.34982
   FRICKE J, 1988, J NON-CRYST SOLIDS, V100, P169, DOI 10.1016/0022-3093(88)90014-2
   Ganguly P, 2004, J BIOMECH ENG-T ASME, V126, P330, DOI 10.1115/1.1762893
   Harte AM, 1999, ACTA MATER, V47, P2511, DOI 10.1016/S1359-6454(99)00097-X
   HARTWIG G, 1991, CRYOGENICS, V31, P231, DOI 10.1016/0011-2275(91)90081-7
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Kabir ME, 2006, MAT SCI ENG A-STRUCT, V429, P225, DOI 10.1016/j.msea.2006.05.133
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kashef S, 2013, MAT SCI ENG A-STRUCT, V578, P115, DOI 10.1016/j.msea.2013.03.062
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   Landy BC, 2013, J APPL BIOMATER FUNC, V11, P35, DOI 10.5301/JABFM.2012.9771
   Lewis G, 2013, J MATER SCI-MATER M, V24, P2293, DOI 10.1007/s10856-013-4998-y
   Lipinski P, 2013, J MECH BEHAV BIOMED, V28, P274, DOI 10.1016/j.jmbbm.2013.08.011
   MICHEL MC, 1993, J BIOMECH, V26, P453, DOI 10.1016/0021-9290(93)90009-4
   Morgan SE, 2006, POLYMER, V47, P2865, DOI 10.1016/j.polymer.2006.02.025
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Palissery V, 2004, J MATER SCI-MATER M, V15, P61, DOI 10.1023/B:JMSM.0000010098.65572.3b
   Pei XQ, 2012, WEAR, V274, P452, DOI 10.1016/j.wear.2011.09.009
   Percec V, 1999, MACROMOLECULES, V32, P2597, DOI 10.1021/ma9900129
   Pruitt LA, 2005, BIOMATERIALS, V26, P905, DOI 10.1016/j.biomaterials.2004.03.022
   Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Roberts AP, 2002, P ROY SOC A-MATH PHY, V458, P1033, DOI 10.1098/rspa.2001.0900
   RODEO SA, 1993, J BONE JOINT SURG AM, V75A, P1795, DOI 10.2106/00004623-199312000-00009
   Simske SJ, 1997, MATER SCI FORUM, V250, P151, DOI 10.4028/www.scientific.net/MSF.250.151
   SIMULIA Abaqus, 2011, SIMULIA AB
   Sobieraj MC, 2010, BIOMATERIALS, V31, P9156, DOI 10.1016/j.biomaterials.2010.08.032
   Taylor DK, 2000, MACROMOLECULES, V33, P2355, DOI 10.1021/ma9911896
   Vuotinen AM, 2008, DENT MATER, V24, P708, DOI 10.1016/j.dental.2007.07.003
   Yakacki C.M., 2013, P ANTEC 2013
   Yavari SA, 2013, MAT SCI ENG C-MATER, V33, P4849, DOI 10.1016/j.msec.2013.08.006
   Youssef S, 2005, ACTA MATER, V53, P719, DOI 10.1016/j.actamat.2004.10.024
   Zhou J, 2005, J ENG MATER-T ASME, V127, P40, DOI 10.1115/1.1836770
   Zhou J, 2004, MECH MATER, V36, P781, DOI 10.1016/j.mechmat.2003.05.004
NR 54
TC 7
Z9 7
U1 1
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JAN
PY 2015
VL 41
BP 136
EP 148
DI 10.1016/j.jmbbm.2014.10.004
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AW3XW
UT WOS:000346217400013
PM 25460410
DA 2018-10-20
ER

PT J
AU Dougherty, PSM
   Srivastava, G
   Onler, R
   Ozdoganlar, OB
   Higgs, CF
AF Dougherty, Patrick S. M.
   Srivastava, Gagan
   Onler, Recep
   Ozdoganlar, O. Burak
   Higgs, C. Fred, III
TI Lubrication Enhancement for UHMWPE Sliding Contacts through Surface
   Texturing
SO TRIBOLOGY TRANSACTIONS
LA English
DT Article
DE Surface Texturing; Boundary Lubrication; Mixed Lubrication; Friction
   Mechanisms; Human Joints; Replacements
ID MOLECULAR-WEIGHT POLYETHYLENE; RECIPROCATING AUTOMOTIVE COMPONENTS;
   ARTIFICIAL HIP JOINTS; TRIBOLOGICAL CHARACTERIZATION; CONCAVE DIMPLES;
   WEAR MECHANISMS; FRICTION; ROUGHNESS; COATINGS; REPLACEMENT
AB Considered a self-lubricating, abrasion-resistant biomaterial, ultra-high-molecular-weight polyethylene (UHMWPE) has become the most common acetabular cup material used in artificial hip joints. Artificial hip joints exist primarily in the boundary and mixed regimes, which can lead to premature failure due to surface wear, debris generation, and subsequent osteolysis. The tendency of failure due to the generation of wear debris has turned the hip problem into a complex tribological challenge with a focus on abrasion-resistant surfaces. Surface texturing in the form of microdimples has been shown in other applications to provide enhanced wear resistance through the trapping of wear debris and through the enhancement of fluid pressures to levels that promote mixed-to full-film lubrication even at low speeds. The objective of this investigation is to explore the potential for surface texturing of UHMWPE sliding contacts in enhancing the lubrication regimes present in total hip replacements. Surface textures were created using a mechanical micromachining process, and experiments were conducted on a pin-on-disk tribometer under lubricated conditions present in the hip for textured and untextured samples. Results show that the surface textures were able to reduce friction by up to 50% over that observed with untextured UHMWPE samples, with evidence that suggests a regime shift from boundary lubrication to mixed and full-film lubrication as the primary mechanism for friction reduction.
C1 [Dougherty, Patrick S. M.; Srivastava, Gagan; Onler, Recep; Ozdoganlar, O. Burak; Higgs, C. Fred, III] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15243 USA.
RP Dougherty, PSM (reprint author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15243 USA.
RI Srivastava, Gagan/N-1995-2018
OI Srivastava, Gagan/0000-0003-3407-4481; Ozdoganlar,
   Burak/0000-0001-5098-5184; Onler, Recep/0000-0002-8123-0400
FU National Science Graduate Research Fellowship; Carnegie Mellon Philip
   and Marsha Dowd Fellowship
FX The authors acknowledge funding for this process through the National
   Science Graduate Research Fellowship and the Carnegie Mellon Philip and
   Marsha Dowd Fellowship.
CR Affatato S, 2008, MED ENG PHYS, V30, P1305, DOI 10.1016/j.medengphy.2008.07.006
   Arghir M, 2003, J TRIBOL-T ASME, V125, P309, DOI 10.1115/1.1506328
   BARRETT TS, 1992, WEAR, V153, P331, DOI 10.1016/0043-1648(92)90174-7
   Borghi A, 2008, WEAR, V265, P1046, DOI 10.1016/j.wear.2008.02.011
   Buford A, 2004, MATER DESIGN, V25, P385, DOI 10.1016/j.matdes.2003.11.010
   de Kraker A, 2007, J TRIBOL-T ASME, V129, P221, DOI 10.1115/1.2540156
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Dowson D, 2006, P I MECH ENG H, V220, P107, DOI 10.1243/095441105X69114
   Etsion I, 1999, TRIBOL T, V42, P511, DOI 10.1080/10402009908982248
   Etsion I., 2005, J TRIBOLOGY, V127
   Filiz S, 2008, INT J MACH TOOL MANU, V48, P459, DOI 10.1016/j.ijmachtools.2007.08.020
   FISHER J, 1994, WEAR, V175, P219, DOI 10.1016/0043-1648(94)90185-6
   Fisher J., 1991, J ENG MED H, V205, P73
   Gispert MP, 2006, WEAR, V260, P149, DOI 10.1016/j.wear.2004.12.040
   HAMILTON DB, 1966, J BASIC ENG-T ASME, V88, P177
   HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46
   HODGE WA, 1986, P NATL ACAD SCI USA, V83, P2879, DOI 10.1073/pnas.83.9.2879
   Ito H, 2000, J ARTHROPLASTY, V15, P332, DOI 10.1016/S0883-5403(00)90670-3
   Kovalchenko A, 2005, TRIBOL INT, V38, P219, DOI 10.1016/j.triboint.2004.08.004
   Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7
   Li X., 2007, AUT LOG 2007 IEEE IN
   LLOYD AIG, 1988, TRIBOL INT, V21, P83, DOI 10.1016/0301-679X(88)90079-5
   Masuzawa T, 2000, CIRP ANN-MANUF TECHN, V49, P473, DOI DOI 10.1016/S0007-8506(07)63451-9
   Mattei L, 2011, TRIBOL INT, V44, P532, DOI 10.1016/j.triboint.2010.06.010
   Myant C, 2013, TRIBOL INT, V63, P97, DOI 10.1016/j.triboint.2012.64.029
   Okularczyk W, 2007, ARCH CIV MECH ENG, V7, P167
   Ronen A, 2001, TRIBOL T, V44, P359, DOI 10.1080/10402000108982468
   Ryk G, 2002, TRIBOL T, V45, P444, DOI 10.1080/10402000208982572
   Sahlin F, 2005, J TRIBOL-T ASME, V127, P96, DOI 10.1115/1.1828067
   SALAMA ME, 1950, P I MECH ENG, V163, P149
   Sawano H, 2009, PRECIS ENG, V33, P492, DOI 10.1016/j.precisioneng.2009.01.005
   Sheeja D, 2005, SURF COAT TECH, V190, P231, DOI 10.1016/j.surfcoat.2004.02.051
   Sheeja D, 2001, DIAM RELAT MATER, V10, P1043, DOI 10.1016/S0925-9635(00)00413-1
   Stokes C., 2006, MEMS SENS ACT I ENG
   Terrell E. J., 2008, J TRIBOLOGY, V131
   Voevodin AA, 2006, WEAR, V261, P1285, DOI 10.1016/j.wear.2006.03.013
   Voevodin AA, 2002, J VAC SCI TECHNOL A, V20, P1434, DOI 10.1116/1.1487875
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95
   Wilson ME, 2011, LAB CHIP, V11, P1550, DOI 10.1039/c0lc00561d
   Yan Y., 2006, CORROSION TRIBO CORR
   Zhou XC, 2012, P I MECH ENG J-J ENG, V226, P455, DOI 10.1177/1350650111425439
   Zoo YS, 2004, TRIBOL LETT, V16, P305, DOI 10.1023/B:TRIL.0000015206.21688.87
NR 42
TC 7
Z9 8
U1 2
U2 39
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-2004
EI 1547-397X
J9 TRIBOL T
JI Tribol. Trans.
PD JAN-FEB
PY 2015
VL 58
IS 1
BP 79
EP 86
DI 10.1080/10402004.2014.933935
PG 8
WC Engineering, Mechanical
SC Engineering
GA AW4IH
UT WOS:000346244000009
DA 2018-10-20
ER

PT J
AU Cao, B
   Tang, Q
   Li, LL
   Lee, CJ
   Wang, H
   Zhang, YQ
   Castaneda, H
   Cheng, G
AF Cao, Bin
   Tang, Qiong
   Li, Linlin
   Lee, Chen-Jung
   Wang, Hua
   Zhang, Yanqiao
   Castaneda, Homero
   Cheng, Gang
TI Integrated zwitterionic conjugated poly(carboxybetaine thiophene) as a
   new biomaterial platform
SO CHEMICAL SCIENCE
LA English
DT Article
ID CONDUCTING POLYMER HYDROGEL; FOREIGN-BODY REACTION; NEURAL INTERFACES;
   NEURITE OUTGROWTH; BIOFILM FORMATION; ADHESION; CELLS; POLYPYRROLE;
   SURFACES; GROWTH
AB An integrated zwitterionic conjugated polymer-based biomaterial platform was designed and studied to address some of the key challenges of conjugated polymers in biomedical applications. This biomaterial platform consists of conjugated polymer backbones and multifunctional zwitterionic side chains. Zwitterionic materials gain electrical conductivity and interesting optical properties through conjugated polymer backbones, and non-biocompatible conjugated polymers obtain excellent antifouling properties, enhanced electrical conductivity, functional groups of bioconjugation and response to environmental stimuli via multifunctional zwitterionic side chains. This platform can potentially be adapted to a wide range of applications (e.g. bioelectronics, tissue engineering and biofuel cell), which require high performance conducting materials with excellent antifouling/biocompatibility at biointerfaces.
C1 [Cao, Bin; Tang, Qiong; Lee, Chen-Jung; Wang, Hua; Castaneda, Homero; Cheng, Gang] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
   [Li, Linlin] Univ Akron, Dept Chem, Akron, OH 44325 USA.
   [Zhang, Yanqiao] Northeastern Ohio Univ Coll Med & Pharm, Dept Integrat Med Sci, Rootstown, OH 44272 USA.
RP Cheng, G (reprint author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
EM homeroc@uakron.edu; gc@uakron.edu
FU US National Science Foundation NSF [ECCS-1200032]
FX This work is supported by the US National Science Foundation NSF
   ECCS-1200032. We would like to thank Dr Roberto Hernandez Maya for the
   conductivity measurements.
CR Abidian M. R., 2007, 2007 3 INT IEEE EMBS, V1 and 2, P61
   Abidian MR, 2008, BIOMATERIALS, V29, P1273, DOI 10.1016/j.biomaterials.2007.11.022
   Abidian MR, 2009, ADV FUNCT MATER, V19, P573, DOI 10.1002/adfm.200801473
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bihong Cao, 2014, J BIOMAT SCI-POLYM E, P1
   Cao B, 2014, CHEM COMMUN, V50, P3234, DOI 10.1039/c3cc48878k
   Cao ZQ, 2010, ANGEW CHEM INT EDIT, V49, P3771, DOI 10.1002/anie.200907079
   Cheng G, 2008, ANGEW CHEM INT EDIT, V47, P8831, DOI 10.1002/anie.200803570
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Cheng G, 2010, LANGMUIR, V26, P10425, DOI 10.1021/la101542m
   Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui XY, 2003, SENSOR ACTUAT A-PHYS, V103, P384, DOI 10.1016/S0924-4247(02)00427-2
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   Fichou D., 1999, HDB OLIGO POLYTHIOPH
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   Gerritsen M, 2000, BIOMATERIALS, V21, P71, DOI 10.1016/S0142-9612(99)00136-2
   Ghosh S, 1998, ADV MATER, V10, P1097, DOI 10.1002/(SICI)1521-4095(199810)10:14<1097::AID-ADMA1097>3.0.CO;2-M
   Gifford R, 2006, BIOMATERIALS, V27, P2587, DOI 10.1016/j.biomaterials.2005.11.033
   Green R. A., 2010, SCI TECHNOL ADV MAT, V11
   Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047
   Green RA, 2009, BIOMATERIALS, V30, P3637, DOI 10.1016/j.biomaterials.2009.03.043
   Guarino V, 2013, ADV HEALTHC MATER, V2, P218, DOI 10.1002/adhm.201200152
   Johansen JB, 2011, EUR HEART J, V32, P991, DOI 10.1093/eurheartj/ehq497
   Keefe AJ, 2012, NAT CHEM, V4, P60, DOI 10.1038/nchem.1213
   Kim J, 2006, BIOTECHNOL ADV, V24, P296, DOI 10.1016/j.biotechadv.2005.11.006
   LAUGHLIN RG, 1991, LANGMUIR, V7, P842, DOI 10.1021/la00053a006
   Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007
   Mano N, 2007, J AM CHEM SOC, V129, P7006, DOI 10.1021/ja071946c
   Martina V, 2007, ANAL BIOANAL CHEM, V387, P2101, DOI 10.1007/s00216-006-1102-1
   Mawad D, 2012, ADV FUNCT MATER, V22, P2692, DOI 10.1002/adfm.201102373
   MAZIA D, 1975, J CELL BIOL, V66, P198, DOI 10.1083/jcb.66.1.198
   McQuade DT, 2000, CHEM REV, V100, P2537, DOI 10.1021/cr9801014
   Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006
   Page SM, 2014, J MATER CHEM B, V2, P620, DOI 10.1039/c3tb21493a
   Pan LJ, 2012, P NATL ACAD SCI USA, V109, P9287, DOI 10.1073/pnas.1202636109
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631
   WIELEMA TA, 1990, EUR POLYM J, V26, P415, DOI 10.1016/0014-3057(90)90043-4
   Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556
   Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E
   WRIGHT MR, 1968, J CHEM SOC B, P548, DOI 10.1039/j29680000548
   Yang W, 2011, BIOSENS BIOELECTRON, V26, P2454, DOI 10.1016/j.bios.2010.10.031
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
NR 48
TC 15
Z9 15
U1 3
U2 82
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2041-6520
EI 2041-6539
J9 CHEM SCI
JI Chem. Sci.
PY 2015
VL 6
IS 1
BP 782
EP 788
DI 10.1039/c4sc02200a
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU9HD
UT WOS:000345901600095
PM 28936320
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Prestwich, GD
   Healy, KE
AF Prestwich, Glenn D.
   Healy, Kevin E.
TI Why regenerative medicine needs an extracellular matrix
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Editorial Material
DE cell delivery; cell differentiation; cell retention; cell therapy;
   clinical biomaterial; extracellular matrix; regulatory barriers;
   stem-cell transplantation; tissue engineering; translational medicine
ID GROWTH-FACTORS; BIOMATERIALS; HYDROGELS; CELLS
AB Regenerative medicine is now coming of age. Many attempts at cell therapy have failed to show significant efficacy, and the umbrella term 'stem cell therapy' is perceived in some quarters as hype or just expensive and unnecessary medical tourism. Here we present a short editorial in three parts. First, we examine the importance of using a semisynthetic extracellular matrix (ECM) mimetic, or sECM, to deliver and retain therapeutic cells at the site of administration. Second, we describe one approach in which biophysical and biochemical properties are tailored to each tissue type, which we call "design for optimal functionality." Third, we describe an alternative approach to sECM design and implementation, called "design for simplicity," in which a deconstructed, minimalist sECM is employed and biology is allowed to perform the customization in situ. We opine that an sECM, whether minimal or instructive, is an essential contributor to improve the outcomes of cell-based therapies.
C1 [Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA.
   [Healy, Kevin E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Healy, Kevin E.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
RP Prestwich, GD (reprint author), Univ Utah, Dept Med Chem, 419 Wakara Way,Suite 205, Salt Lake City, UT 84108 USA.
EM gprestwich@pharm.utah.edu
CR Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Chung EH, 2006, J BIOMED MATER RES A, V79A, P815, DOI 10.1002/jbm.a.30809
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Harbers GM, 2005, LANGMUIR, V21, P8374, DOI 10.1021/la050396y
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732
   Little LE, 2011, BIOMATERIALS, V32, P1484, DOI 10.1016/j.biomaterials.2010.10.032
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Pollock JF, 2009, STRATEGIES REGENERAT
   Prestwich GD, 2008, ACCOUNTS CHEM RES, V41, P139, DOI 10.1021/ar7000827
   Prestwich GD, 2007, J CELL BIOCHEM, V101, P1370, DOI 10.1002/jeb.21386
   Prestwich GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004915
   Prestwich GD, 2012, ACTA BIOMATER, V8, P4200, DOI 10.1016/j.actbio.2012.06.043
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Prestwich GD, 2010, ADV WOUND CARE, V1, P394, DOI 10.1089/awc.2009.0124
   Prestwich Glenn D, 2008, Organogenesis, V4, P42
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Williams DF, 2014, TISSUE ENG PT A, V20, P1129, DOI 10.1089/ten.tea.2013.0769
NR 24
TC 6
Z9 6
U1 0
U2 23
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1471-2598
EI 1744-7682
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PD JAN
PY 2015
VL 15
IS 1
BP 3
EP 7
DI 10.1517/14712598.2015.975200
PG 5
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AW1XC
UT WOS:000346080900002
PM 25482878
DA 2018-10-20
ER

PT B
AU Gupta, R
   Singh, VP
AF Gupta, Ruchi
   Singh, Vinay Pratap
GP IEEE
TI RECENT TRENDS IN COATING OF BIOMATERIALS WITH EMPHASIS ON MICROWAVE
   TECHNOLOGY: REVIEW
SO 2015 NATIONAL CONFERENCE ON RECENT ADVANCES IN ELECTRONICS & COMPUTER
   ENGINEERING (RAECE)
LA English
DT Proceedings Paper
CT National Conference on Recent Advances in Electronics & Computer
   Engineering (RAECE)
CY FEB 13-15, 2015
CL Roorkee, INDIA
SP Indian Inst Technol Roorkee, Dept Elect & Commun Engn, Indian Inst Technol Roorkee, Dept Comp Sci & Engn, IEEE UP Sect, HP Invent, CISCO, KEYSIGHT TECHNOLOGIES, ROHDE & SCHWARZ
DE Microwave; bio-implant; biomaterial
ID FUEL HVOF SPRAY; HYDROXYAPATITE; TEMPERATURE; COMPOSITE; NANORODS; ALLOY
AB Research in medical science is always seeking new technologies which meet the growing demands of better, more stable and durable implant in body environment. An ideal implant should excel in both the basic requirements i.e. in mechanical properties and in biocompatibility. Till now, very few materials can fulfill both the needs. To cope up with the emerging demands, new inventions are always required. Mechanical properties of implant like strength besides adhesion and integration of implant with human tissue is of paramount importance. Recent development in this field led to development of various biocoatings which exhibit enhanced integration of implant with the human tissue. Various recent technologies used in coating of metallic implants are reviewed in this paper. These alternative coating techniques have shown better adhesion to varieties of substrates. Microwave processing is emerging as an innovative technology in efficient, economic, effective manner with many attractive advantages.
C1 [Gupta, Ruchi] PSIT, Dept Mech Engn, Kanpur, Uttar Pradesh, India.
   [Singh, Vinay Pratap] HBTI, Dept Mech Engn, Kanpur, Uttar Pradesh, India.
RP Gupta, R (reprint author), PSIT, Dept Mech Engn, Kanpur, Uttar Pradesh, India.
EM vinayforus@gmail.com
CR Agrawal D., 2006, T INDIAN CERAMIC SOC, V65
   Aydin HM, 2013, BIOMATER SCI-UK, V1, P503, DOI 10.1039/c3bm00157a
   Cao JM, 2005, J MATER SCI, V40, P6311, DOI 10.1007/s10853-005-4221-8
   Choudhuri A., 2009, INT THERM SPRAY C IT, P391
   Dinelli M, 2011, J SOL-GEL SCI TECHN, V58, P463, DOI 10.1007/s10971-011-2413-z
   FANG Y, 1992, J MATER RES, V7, P490, DOI 10.1557/JMR.1992.0490
   Farzadi A, 2011, CERAM INT, V37, P65, DOI 10.1016/j.ceramint.2010.08.021
   Feng C., 2013, BIOMATER SCI, V1, P1074
   Gupta M, 2003, ENERGY EFFICIENT MIC, V24
   Katakam S, 2003, MATER LETT, V57, P2716, DOI 10.1016/S0167-577X(02)01364-2
   Kutty MG, 2014, ACS APPL MATER INTER, V6, P13587, DOI 10.1021/am502967n
   Kweh SWK, 2000, BIOMATERIALS, V21, P1223, DOI 10.1016/S0142-9612(99)00275-6
   Li H, 2002, BIOMATERIALS, V23, P2105, DOI 10.1016/S0142-9612(01)00326-X
   Li H, 2002, BIOMATERIALS, V23, P85, DOI 10.1016/S0142-9612(01)00082-5
   Mahabole MP, 2005, B MATER SCI, V28, P535, DOI 10.1007/BF02706339
   Man HC, 2006, SURF COAT TECH, V200, P4612, DOI 10.1016/j.surfcoat.2005.04.034
   Metaxas A. A., 1983, IND MICROWAVE HEATIN
   Mukherjee S., 2014, 1 INT EL C MAT MONTR
   Pandey A., 2009, BIOMATER SCI, V20, P33
   Pushpakanth S, 2008, MATER CHEM PHYS, V107, P492, DOI 10.1016/j.matchemphys.2007.08.029
   Rameshbabu N, 2006, B MATER SCI, V29, P611, DOI 10.1007/s12034-006-0012-3
   Rameshbabu N, 2005, J MATER SCI, V40, P6319, DOI 10.1007/s10853-005-2957-9
   Ramli R, 2012, AIP CONF PROC, V1455, P45, DOI 10.1063/1.4732470
   Ren YF, 2015, MAT SCI ENG C-MATER, V49, P364, DOI 10.1016/j.msec.2015.01.046
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Roy R, 1999, NATURE, V399, P668, DOI 10.1038/21390
   Sharma AK, 2002, J EUR CERAM SOC, V22, P2849, DOI 10.1016/S0955-2219(02)00051-1
   Sridhar TM, 2003, CORROS SCI, V45, P2337, DOI 10.1016/S0010-938X(03)00063-5
   Yang YZ, 2002, J MATER SCI LETT, V21, P67, DOI 10.1023/A:1014250813564
   Zhou H, 2013, MAT SCI ENG C-MATER, V33, P4435, DOI 10.1016/j.msec.2013.06.043
NR 30
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5090-2146-8
PY 2015
BP 290
EP 295
PG 6
WC Computer Science, Theory & Methods; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BI4CJ
UT WOS:000411621600060
DA 2018-10-20
ER

PT J
AU Ballester-Beltran, J
   Biggs, MJP
   Dalby, MJ
   Salmeron-Sanchez, M
   Leal-Egana, A
AF Ballester-Beltran, Jose
   Biggs, Manus J. P.
   Dalby, Matthew J.
   Salmeron-Sanchez, Manuel
   Leal-Egana, Aldo
TI Sensing the difference: the influence of anisotropic cues on cell
   behavior
SO FRONTIERS IN MATERIALS
LA English
DT Review
DE surface topography; anisotropic materials; cell-biomaterial interface;
   cell-matrix anchorage; topographical cues
AB From tissue morphogenesis to homeostasis, cells continuously experience and respond to physical, chemical, and biological cues commonly presented in gradients. In this article, we focus our discussion on the importance of nano/micro topographic cues on cell activity, and the role of anisotropic milieus play on cell behavior, mostly adhesion and migration. We present the need to study physiological gradients in vitro. To do this, we review different cell migration mechanisms and how adherent cells react to the presence of complex tissue-like environments and cell-surface stimulation in 2D and 3D (e.g., ventral/dorsal anisotropy).
C1 [Ballester-Beltran, Jose; Salmeron-Sanchez, Manuel] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow, Lanark, Scotland.
   [Biggs, Manus J. P.; Leal-Egana, Aldo] Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
   [Dalby, Matthew J.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland.
RP Leal-Egana, A (reprint author), Univ Glasgow, CMVLS, Ctr Cell Engn, Inst Mol Cell & Syst Biol, Joseph Black Bldg, Glasgow G12 8QQ, Lanark, Scotland.
EM aldo.leal-egana@glasgow.ac.uk
OI BALLESTER-BELTRAN, JOSE/0000-0002-3287-2925
FU MRC [MR/L022710/1]
FX This work was supported by MRC grant MR/L022710/1 "synergistic
   microenvironments for non-union bone defects:'
CR Andreas K, 2014, TRENDS BIOTECHNOL, V32, P483, DOI 10.1016/j.tibtech.2014.06.008
   Ankam S, 2015, BIOMATERIALS, V47, P20, DOI 10.1016/j.biomaterials.2015.01.003
   Anselme K, 2004, BIO-MED MATER ENG, V14, P545
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Ashraf S, 2015, METHODS MOL BIOL, V1221, P63, DOI 10.1007/978-1-4939-1571-2_6
   Att W, 2009, INT J ORAL MAX IMPL, V24, P419
   Azeem A, 2015, NANOMEDICINE-UK, V10, P693, DOI [10.2217/NNM.14.218, 10.2217/nnm.14.218]
   Ballester-Beltran J, 2014, BIOMATER SCI-UK, V2, P381, DOI 10.1039/c3bm60248f
   Ballester-Beltran J, 2015, NANOMEDICINE-UK, V10, P815, DOI [10.2217/NNM.14.217, 10.2217/nnm.14.217]
   Ballester-Beltran J, 2013, BIOTECHNOL BIOENG, V110, P3048, DOI 10.1002/bit.24972
   Ballester-Beltran J, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0039-5
   Ballester-Beltran J, 2012, J MATER SCI-MATER M, V23, P195, DOI 10.1007/s10856-011-4532-z
   Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441
   Bartneck M, 2010, ACTA BIOMATER, V6, P3864, DOI 10.1016/j.actbio.2010.04.025
   Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102
   Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109
   Bhattacharyya SP, 1999, IMMUNOLOGY, V98, P357, DOI 10.1046/j.1365-2567.1999.00883.x
   Bi YA, 2006, DRUG METAB DISPOS, V34, P1658, DOI 10.1124/dmd.105.009118
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Cassidy JW, 2014, ACTA BIOMATER, V10, P651, DOI 10.1016/j.actbio.2013.11.008
   Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453
   Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897
   Chaudhuri O, 2009, NAT METHODS, V6, P383, DOI [10.1038/NMETH.1320, 10.1038/nmeth.1320]
   Chua JS, 2014, BIOMATERIALS, V35, P7750, DOI 10.1016/j.biomaterials.2014.06.008
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Cohen-Hillel E, 2009, CELL MOL LIFE SCI, V66, P884, DOI 10.1007/s00018-009-8447-5
   Cowin SC, 1998, AM J MED SCI, V316, P184, DOI 10.1097/00000441-199809000-00006
   Crouch AS, 2009, BIOMATERIALS, V30, P1560, DOI 10.1016/j.biomaterials.2008.11.041
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Callejas FD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100537
   De Luca AC, 2015, J BIOMED MATER RES A, V103, P2689, DOI 10.1002/jbm.a.35407
   DeSimone DW, 2014, SCIENCE, V345, P1002, DOI 10.1126/science.1259176
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043
   Ebara M, 2014, INT J NANOMED, V9, P117, DOI 10.2147/IJN.S50677
   Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081
   Farahani E, 2014, CARCINOGENESIS, V35, P747, DOI 10.1093/carcin/bgu045
   Fernandez-Yague MA, 2015, ADV DRUG DELIVER REV, V84, P1, DOI 10.1016/j.addr.2014.09.005
   Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015
   Fuentes DE, 2011, CELL MOL BIOENG, V4, P616, DOI 10.1007/s12195-011-0214-7
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Gaharwar AK, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015001
   Gamboa JR, 2013, COLLOID SURFACE B, V104, P318, DOI 10.1016/j.colsurfb.2012.11.035
   Garland SP, 2014, LANGMUIR, V30, P2101, DOI 10.1021/la403590v
   Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010
   Germanier Y, 2006, CLIN ORAL IMPLAN RES, V17, P251, DOI 10.1111/j.1600-0501.2005.01222.x
   Gong T, 2014, ADV HEALTHC MATER, V3, P1608, DOI 10.1002/adhm.201300692
   Hanein D, 2012, CURR OPIN CELL BIOL, V24, P134, DOI 10.1016/j.ceb.2011.12.001
   Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   Herrero-Climent M, 2013, J MATER SCI-MATER M, V24, P2047, DOI 10.1007/s10856-013-4935-0
   Hocde SA, 2009, BIOPHYS J, V97, P379, DOI 10.1016/j.bpj.2009.04.035
   Huang Haiying, 2005, J Artif Organs, V8, P110, DOI 10.1007/s10047-005-0291-2
   Ishibazawa A, 2011, INVEST OPHTH VIS SCI, V52, P8496, DOI 10.1167/iovs.11-7686
   Itala A, 2003, J BIOMED MATER RES A, V67A, P496, DOI 10.1002/jbm.a.10501
   Janson IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090719
   Jeon KJ, 2014, J BIOSCI BIOENG, V117, P242, DOI 10.1016/j.jbiosc.2013.08.002
   Jia YY, 2014, INT J MOL MED, V33, P1282, DOI 10.3892/ijmm.2014.1694
   Kasorn A, 2009, J IMMUNOL, V183, P1032, DOI 10.4049/jimmunol.0802984
   Kim J, 2014, BIOMATERIALS, V35, P9058, DOI 10.1016/j.biomaterials.2014.07.036
   Kim J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03552
   Kim JS, 2014, TOXICOLOGY, V317, P31, DOI 10.1016/j.tox.2014.01.005
   Kim SS, 2015, J CELL MOL MED, V19, P1183, DOI 10.1111/jcmm.12451
   Kim Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015456
   Kooter IM, 2013, TOXICOL IN VITRO, V27, P2342, DOI 10.1016/j.tiv.2013.10.007
   Kwon KW, 2012, J IMMUNOL, V189, P2266, DOI 10.4049/jimmunol.1102273
   Leal-Egana A, 2013, ADV MATER, V25, P4049, DOI 10.1002/adma.201301227
   Lee VK, 2014, CELL MOL BIOENG, V7, P460, DOI 10.1007/s12195-014-0340-0
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Lim KT, 2013, TISSUE ENG PART C-ME, V19, P128, DOI 10.1089/ten.tec.2012.0017
   LINDNER V, 1991, CIRC RES, V68, P106, DOI 10.1161/01.RES.68.1.106
   Londono C, 2014, P NATL ACAD SCI USA, V111, P1807, DOI 10.1073/pnas.1321852111
   Losert W, 2013, BIOPHYS J, V104, p148A, DOI 10.1016/j.bpj.2012.11.840
   Marino A, 2013, ACS APPL MATER INTER, V5, P13012, DOI 10.1021/am403895k
   McKee CT, 2011, BIOPHYS J, V101, P2139, DOI 10.1016/j.bpj.2011.09.042
   McMurray RJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03545
   McNamara LE, 2011, BIOMATERIALS, V32, P7403, DOI 10.1016/j.biomaterials.2011.06.063
   Metallo CM, 2008, BIOTECHNOL BIOENG, V100, P830, DOI 10.1002/bit.21809
   Nadeem D, 2013, J BIOMED MATER RES A, V101, P3247, DOI 10.1002/jbm.a.34622
   Olivares-Navarrete R, 2015, BONE, V73, P208, DOI 10.1016/j.bone.2014.12.057
   Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005
   Papadaki M, 1998, AM J PHYSIOL-HEART C, V274, pH616, DOI 10.1152/ajpheart.1998.274.2.H616
   Papadopoulos MC, 2015, BBA-BIOMEMBRANES, V1848, P2576, DOI 10.1016/j.bbamem.2014.09.001
   Pedron S, 2015, ADV MATER, V27, P1567, DOI 10.1002/adma.201404896
   Peng P, 2010, J NANOSCI NANOTECHNO, V10, P7287, DOI 10.1166/jnn.2010.2858
   Perez-Garnes M, 2011, INT J ARTIF ORGANS, V34, P54, DOI 10.5301/IJAO.2011.6316
   Petrie RJ, 2014, SCIENCE, V345, P1062, DOI 10.1126/science.1256965
   Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732
   PIEKARSKI K, 1977, NATURE, V269, P80, DOI 10.1038/269080a0
   Potter CMF, 2014, ARTERIOSCL THROM VAS, V34, P2184, DOI 10.1161/ATVBAHA.114.303423
   Ranganathan SI, 2011, J APPL MECH-T ASME, V78, DOI 10.1115/1.4004553
   Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053
   Sant S, 2010, CAN J CHEM ENG, V88, P899, DOI 10.1002/cjce.20411
   Sjostrom T, 2013, ADV HEALTHC MATER, V2, P1285, DOI 10.1002/adhm.201200353
   Sjostrom T, 2012, ACS APPL MATER INTER, V4, P6354, DOI 10.1021/am301987e
   Smalt R, 1997, AM J PHYSIOL-ENDOC M, V273, pE751, DOI 10.1152/ajpendo.1997.273.4.E751
   Smith CLC, 2014, NANO LETT, V14, P1659, DOI 10.1021/nl5002058
   Song KH, 2014, INTEGR BIOL-UK, V6, P450, DOI 10.1039/c4ib00021h
   Song KH, 2012, BIOMATERIALS, V33, P2007, DOI 10.1016/j.biomaterials.2011.12.002
   Stroka KM, 2014, CURR OPIN CELL BIOL, V30, P41, DOI 10.1016/j.ceb.2014.06.001
   Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052
   Svensson S, 2013, NANOMED-NANOTECHNOL, V9, P1048, DOI 10.1016/j.nano.2013.04.009
   Swift B, 2010, DRUG METAB REV, V42, P446, DOI 10.3109/03602530903491881
   Takahashi H, 2013, BIOMATERIALS, V34, P7372, DOI 10.1016/j.biomaterials.2013.06.033
   Tan KKB, 2015, BIOMATERIALS, V43, P32, DOI 10.1016/j.biomaterials.2014.11.036
   Tate MLK, 2000, J EXP BIOL, V203, P2737
   Tate MLK, 1998, AM J MED SCI, V316, P189, DOI 10.1097/00000441-199809000-00007
   Tavangar A, 2013, J BIOMED NANOTECHNOL, V9, P1837, DOI 10.1166/jbn.2013.1679
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Tonazzini I, 2014, ADV HEALTHC MATER, V3, P581, DOI 10.1002/adhm.201300216
   Tonazzini I, 2013, BIOMATERIALS, V34, P6027, DOI 10.1016/j.biomaterials.2013.04.039
   Tsai HY, 2014, ACS NANO, V8, P5227, DOI 10.1021/nn501300b
   Vicente-Manzanares M, 2011, J CELL SCI, V124, P3923, DOI 10.1242/jcs.095653
   VOISIN C, 1977, B EUR PHYSIOPATH RES, V13, P69
   Vozzi F, 2014, BIOTECHNOL J, V9, P146, DOI 10.1002/biot.201300016
   Wang PY, 2012, J MATER SCI-MATER M, V23, P3015, DOI 10.1007/s10856-012-4748-6
   Wang YM, 2013, CHEM COMMUN, V49, P10421, DOI 10.1039/c3cc46359a
   Wang ZY, 2013, TISSUE ENG PART C-ME, V19, P538, DOI [10.1089/ten.TEC.2012.0472, 10.1089/ten.tec.2012.0472]
   Watari S, 2012, BIOMATERIALS, V33, P128, DOI 10.1016/j.biomaterials.2011.09.058
   WEISS P, 1952, P NATL ACAD SCI USA, V38, P264, DOI 10.1073/pnas.38.3.264
   Wilson K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3896
   WOJCIAK B, 1995, J MATER SCI-MATER M, V6, P266, DOI 10.1007/BF00120269
   Wu XH, 2013, ADV HEALTHC MATER, V2, P326, DOI 10.1002/adhm.201200205
   Wu YN, 2014, NANOMED-NANOTECHNOL, V10, P1507, DOI 10.1016/j.nano.2014.04.002
   Xia L, 2012, BIOMATERIALS, V33, P7925, DOI 10.1016/j.biomaterials.2012.06.078
   Xia L, 2009, BIOMATERIALS, V30, P5927, DOI 10.1016/j.biomaterials.2009.07.022
   Xia L, 2012, INT J NANOMED, V7, P4873, DOI 10.2147/IJN.S29496
   Xie L, 2011, J BIOMED MATER RES A, V98A, P312, DOI 10.1002/jbm.a.33120
   Yang K, 2014, ACS NANO, V8, P7809, DOI 10.1021/nn501182f
   Yang Y, 2010, J BIOMED MATER RES A, V95A, P294, DOI 10.1002/jbm.a.32838
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   ZAMORA PO, 1986, J ENVIRON PATHOL TOX, V7, P159
   ZAMORA PO, 1983, ENVIRON MUTAGEN, V5, P795, DOI 10.1002/em.2860050604
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
   Zhu J, 2010, BIOMATERIALS, V31, P6952, DOI 10.1016/j.biomaterials.2010.05.058
NR 142
TC 5
Z9 5
U1 8
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-8016
J9 FRONT MATER
JI Front. Mater.
PY 2015
DI 10.3389/fmats.2015.00039
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA V3Q6O
UT WOS:000218498500066
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Li, LL
   Shi, Y
   Pan, LJ
   Shi, Y
   Yu, GH
AF Li, Lanlan
   Shi, Ye
   Pan, Lijia
   Shi, Yi
   Yu, Guihua
TI Rational design and applications of conducting polymer hydrogels as
   electrochemical biosensors
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Review
ID ENZYME IMMOBILIZATION MATRIX; GLUCOSE-OXIDASE; AMPEROMETRIC BIOSENSOR;
   GOLD NANOPARTICLES; CARBON NANOTUBES; BIOMEDICAL APPLICATIONS;
   CHOLESTEROL BIOSENSOR; MULTILAYER FILMS; URIC-ACID; TRIGLYCERIDE
   DETERMINATION
AB Conducting polymer hydrogels (CPHs) are conducting polymer-based materials that contain high water content and have physical properties, resembling the extracellular environment. Synergizing the advantages of both the organic conductors and hydrogels, CPHs emerged to be candidates for high performance biosensors by providing advantageous interfaces for electrochemical bio-electrodes. Examples include the following: (1) the interface between a biomaterial and an artificial inorganic electrode material; (2) the hybrid electronic interface between an ionic carrier and an electron charge carrier; and (3) the extension of the planar electrode surface to a three-dimensional (3D) porous surface. CPHs with rationally designed 3D nanostructures and molecular structures are advantageous for enhancing the biocompatibility of the electrode, improving enzyme immobilization, creating protective layers to control diffusion, and wiring the electron transference. This review presents a brief overview of the current state-of-the-art research in electrochemical biosensors based on CPHs and describes future directions.
C1 [Li, Lanlan; Pan, Lijia; Shi, Yi] Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Sch Elect Sci & Engn, Nanjing 210093, Jiangsu, Peoples R China.
   [Shi, Ye; Yu, Guihua] Univ Texas Austin, Mat Sci & Engn Program, Austin, TX 78712 USA.
   [Shi, Ye; Yu, Guihua] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.
RP Pan, LJ (reprint author), Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Sch Elect Sci & Engn, Nanjing 210093, Jiangsu, Peoples R China.
EM ljpan@nju.edu.cn; ghyu@austin.utexas.edu
RI Pan, Lijia/C-5768-2011
OI Pan, Lijia/0000-0002-8917-7843; Shi, Ye/0000-0002-5228-1604
FU University of Texas at Austin; Welch Foundation Grant [F-1861]; Chinese
   National Key Fundamental Research Project [2013CB932900, 2011CB92210];
   National Natural Science Foundation of China [61229401, 61076017,
   41401257, 60990314]; NCET Program; PAPD Program
FX G.Y. acknowledges the financial support of a faculty start-up grant from
   the University of Texas at Austin and the Welch Foundation Grant F-1861.
   L.P. and Y.S. are grateful for funding support from the Chinese National
   Key Fundamental Research Project (2013CB932900, 2011CB92210), the
   National Natural Science Foundation of China (61229401, 61076017,
   41401257, and 60990314), and the NCET and the PAPD Programs.
CR Annabi N, 2014, ADV MATER, V26, P85, DOI 10.1002/adma.201303233
   Arya SK, 2007, ANALYST, V132, P1005, DOI 10.1039/b707000d
   Asberg DP, 2003, SYNTHETIC MET, V137, P1403, DOI 10.1016/S0379-6779(02)01060-3
   Asberg P, 2003, BIOSENS BIOELECTRON, V19, P199, DOI 10.1016/S0956-5663(03)00220-3
   Behera S, 2007, BIOSENS BIOELECTRON, V23, P556, DOI 10.1016/j.bios.2007.06.012
   Brahim S, 2002, BIOSENS BIOELECTRON, V17, P53, DOI 10.1016/S0956-5663(01)00262-7
   Brahim S, 2003, MICROCHIM ACTA, V143, P123, DOI 10.1007/s00604-003-0065-6
   Brahim S, 2002, BIOSENS BIOELECTRON, V17, P973, DOI 10.1016/S0956-5663(02)00089-1
   Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0
   Caldorera-Moore M, 2009, ADV DRUG DELIVER REV, V61, P1391, DOI 10.1016/j.addr.2009.09.002
   Charles PT, 2004, BIOSENS BIOELECTRON, V20, P753, DOI 10.1016/j.bios.2004.04.007
   Chen L, 2000, MACROMOLECULES, V33, P1232, DOI 10.1021/ma990923i
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   Cosnier S, 1999, BIOSENS BIOELECTRON, V14, P443, DOI 10.1016/S0956-5663(99)00024-X
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   Dai TY, 2008, CHEM COMMUN, P4279, DOI 10.1039/b807116k
   Dey RS, 2010, J PHYS CHEM C, V114, P21427, DOI 10.1021/jp105895a
   Dhand C, 2011, BIOSENS BIOELECTRON, V26, P2811, DOI 10.1016/j.bios.2010.10.017
   Dhand C, 2010, ELECTROANAL, V22, P2683, DOI 10.1002/elan.201000269
   Ding HJ, 2014, ACS NANO, V8, P4348, DOI 10.1021/nn406019m
   Ekanayake EMIM, 2007, BIOSENS BIOELECTRON, V23, P107, DOI 10.1016/j.bios.2007.03.022
   Elliott JE, 2004, POLYMER, V45, P1503, DOI 10.1016/j.polymer.2003.12.040
   Fang AP, 2003, BIOSENS BIOELECTRON, V19, P43, DOI 10.1016/S0956-5663(03)00133-7
   Farahi RH, 2012, ACS NANO, V6, P4548, DOI 10.1021/nn204999j
   Farmer TG, 2008, IND ENG CHEM RES, V47, P10053, DOI 10.1021/ie070957b
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Forzani ES, 2004, NANO LETT, V4, P2519, DOI 10.1021/nl048314y
   Forzani ES, 2004, NANO LETT, V4, P1785, DOI [10.1021/nl049080l, 10.1021/nl049080I]
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gerard M, 2002, BIOSENS BIOELECTRON, V17, P345, DOI 10.1016/S0956-5663(01)00312-8
   Ghosh S, 2000, J ELECTROCHEM SOC, V147, P1872, DOI 10.1149/1.1393450
   Ghosh S, 1999, ADV MATER, V11, P1214, DOI 10.1002/(SICI)1521-4095(199910)11:14<1214::AID-ADMA1214>3.0.CO;2-3
   Gong JP, 2014, SCIENCE, V344, P161, DOI 10.1126/science.1252389
   Gouda MD, 2002, BIOSENS BIOELECTRON, V17, P503, DOI 10.1016/S0956-5663(02)00021-0
   Green RA, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014107
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Guiseppi-Elie A, 2010, BIOMATERIALS, V31, P2701, DOI 10.1016/j.biomaterials.2009.12.052
   Guo BL, 2011, CHEM MATER, V23, P1254, DOI 10.1021/cm103498s
   Guo SJ, 2009, TRAC-TREND ANAL CHEM, V28, P96, DOI 10.1016/j.trac.2008.10.014
   Heller A, 2006, CURR OPIN CHEM BIOL, V10, P664, DOI 10.1016/j.cbpa.2006.09.018
   HORANYI G, 1988, ELECTROCHIM ACTA, V33, P947, DOI 10.1016/0013-4686(88)80093-8
   Horng YY, 2009, ELECTROCHEM COMMUN, V11, P850, DOI 10.1016/j.elecom.2009.02.010
   Huang JX, 2003, J AM CHEM SOC, V125, P314, DOI 10.1021/ja028371y
   Ivekovic D, 2004, BIOSENS BIOELECTRON, V20, P872, DOI 10.1016/j.bios.2004.04.001
   Karam P, 2008, ANAL CHEM, V80, P5441, DOI 10.1021/ac702358d
   Kergoat L, 2014, ADV MATER, V26, P5658, DOI 10.1002/adma.201401608
   Kim BC, 2000, REACT FUNCT POLYM, V44, P31, DOI 10.1016/S1381-5148(99)00074-7
   Kim DH, 2007, ADV FUNCT MATER, V17, P79, DOI 10.1002/adfm.200500594
   Kim SJ, 2006, NAT MATER, V5, P48, DOI 10.1038/nmat1553
   Kirchmeyer S, 2005, J MATER CHEM, V15, P2077, DOI 10.1039/b417803n
   Kowalczyk A, 2014, BIOSENS BIOELECTRON, V54, P222, DOI 10.1016/j.bios.2013.11.017
   Krepker MA, 2013, ANAL CHEM, V85, P7353, DOI 10.1021/ac4011815
   Lange U, 2008, ANAL CHIM ACTA, V614, P1, DOI 10.1016/j.aca.2008.02.068
   Lee K, 2006, NATURE, V441, P65, DOI 10.1038/nature04705
   Li LL, 2015, NANO LETT, V15, P1146, DOI 10.1021/nl504217p
   Lin P, 2012, ADV MATER, V24, P34, DOI 10.1002/adma.201103334
   Liu YG, 2008, J PHYS CHEM B, V112, P9237, DOI 10.1021/jp801938w
   Lu XF, 2011, PROG POLYM SCI, V36, P671, DOI 10.1016/j.progpolymsci.2010.07.010
   Luo XL, 2005, BIOSENS BIOELECTRON, V21, P190, DOI 10.1016/j.bios.2004.07.029
   Luo YC, 2006, BIOSENS BIOELECTRON, V22, P482, DOI 10.1016/j.bios.2006.07.013
   Mano N, 2007, J AM CHEM SOC, V129, P7006, DOI 10.1021/ja071946c
   Mao F, 2003, J AM CHEM SOC, V125, P4951, DOI 10.1021/ja029510e
   Minakshi CSP, 2008, SENSOR ACTUAT B-CHEM, V133, P251, DOI 10.1016/j.snb.2008.02.036
   Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1
   Muskovich M, 2012, ADV HEALTHC MATER, V1, P248, DOI 10.1002/adhm.201200071
   Nambiar S, 2011, BIOSENS BIOELECTRON, V26, P1825, DOI 10.1016/j.bios.2010.09.046
   Nyberg T, 2002, BIOMED MICRODEVICES, V4, P43, DOI 10.1023/A:1014219828983
   Pan LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4002
   Pan LJ, 2012, P NATL ACAD SCI USA, V109, P9287, DOI 10.1073/pnas.1202636109
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Phongphut A, 2013, SENSOR ACTUAT B-CHEM, V178, P501, DOI 10.1016/j.snb.2013.01.012
   Podual K, 2000, J CONTROL RELEASE, V67, P9, DOI 10.1016/S0168-3659(00)00195-4
   Qu FL, 2014, ANAL CHEM, V86, P973, DOI 10.1021/ac403478z
   Ruzgas T, 1996, ANAL CHIM ACTA, V330, P123, DOI 10.1016/0003-2670(96)00169-9
   Saei AA, 2013, TRAC-TREND ANAL CHEM, V42, P216, DOI 10.1016/j.trac.2012.09.011
   Shan D, 2007, BIOSENS BIOELECTRON, V22, P1612, DOI 10.1016/j.bios.2006.07.019
   Shi Y, 2014, J MATER CHEM A, V2, P6086, DOI 10.1039/c4ta00484a
   Singh A, 2014, ADV MATER, V26, P6530, DOI 10.1002/adma.201402105
   Singh S, 2006, ANAL CHIM ACTA, V568, P126, DOI 10.1016/j.aca.2005.10.008
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Stenger-Smith JD, 1998, PROG POLYM SCI, V23, P57, DOI 10.1016/S0079-6700(97)00024-5
   Thevenot DR, 2001, BIOSENS BIOELECTRON, V16, P121, DOI 10.1016/S0956-5663(01)00115-4
   Tian ZRR, 2003, NANO LETT, V3, P89, DOI 10.1021/nl025828t
   Toma M, 2013, J PHYS CHEM C, V117, P11705, DOI 10.1021/jp400255u
   Vargas E, 2013, TALANTA, V105, P93, DOI 10.1016/j.talanta.2012.11.058
   Wallace GG, 2009, SCIENCE, V324, P185, DOI 10.1126/science.1168346
   Wang HC, 2009, BIOSENS BIOELECTRON, V25, P142, DOI 10.1016/j.bios.2009.06.022
   Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a
   Wang RH, 2013, BIOSENS BIOELECTRON, V42, P148, DOI 10.1016/j.bios.2012.10.038
   Wang ZY, 2009, ANAL CHEM, V81, P1638, DOI 10.1021/ac802421h
   Wu BY, 2007, BIOSENS BIOELECTRON, V22, P2854, DOI 10.1016/j.bios.2006.11.028
   Wu BY, 2007, BIOSENS BIOELECTRON, V22, P838, DOI 10.1016/j.bios.2006.03.009
   Xia YY, 2011, SOFT MATTER, V7, P9388, DOI 10.1039/c1sm05890h
   Xian YZ, 2006, BIOSENS BIOELECTRON, V21, P1996, DOI 10.1016/j.bios.2005.09.014
   Xiao YH, 2004, SENSOR ACTUAT B-CHEM, V99, P437, DOI 10.1016/j.snb.2003.12.067
   Xie JN, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/6/065503
   Xu LH, 2009, MAT SCI ENG C-BIO S, V29, P1306, DOI 10.1016/j.msec.2008.10.031
   Xue HG, 2005, BIOSENS BIOELECTRON, V20, P2330, DOI 10.1016/j.bios.2004.07.018
   Yang J, 2012, SENSOR ACTUAT B-CHEM, V171, P374, DOI 10.1016/j.snb.2012.04.070
   Yang MH, 2006, BIOMATERIALS, V27, P246, DOI 10.1016/j.biomaterials.2005.05.077
   Yang W, 2011, BIOSENS BIOELECTRON, V26, P2454, DOI 10.1016/j.bios.2010.10.031
   Zhai DY, 2013, ACS NANO, V7, P3540, DOI [10.1021/nn400482d, 10.1021/nn4004132d]
   Zhang Y, 2007, BIOSENS BIOELECTRON, V22, P1791, DOI 10.1016/j.bios.2006.08.038
   Zhao Y, 2013, ENERG ENVIRON SCI, V6, P2856, DOI 10.1039/c3ee40997j
   Zhong HA, 2011, TALANTA, V85, P104, DOI 10.1016/j.talanta.2011.03.040
   Zhou J, 2014, ANAL CHEM, V86, P4395, DOI 10.1021/ac500231e
NR 107
TC 45
Z9 45
U1 22
U2 49
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2015
VL 3
IS 25
BP 2920
EP 2930
DI 10.1039/c5tb00090d
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA CK6YS
UT WOS:000356375800023
DA 2018-10-20
ER

PT S
AU Lemons, JE
AF Lemons, Jack E.
BE Greenwald, AS
   Kurtz, SM
   Lemons, JE
   Mihalko, WM
TI Studies of Modular Connections for Surgical Implant Devices
SO MODULARITY AND TAPERS IN TOTAL JOINT REPLACEMENT DEVICES
SE American Society for Testing and Materials Selected Technical Papers
LA English
DT Proceedings Paper
CT ASTM Symposium on Modularity and Tapers in Total Joint Replacement
   Devices
CY NOV 10, 2014
CL New Orleans, LA
SP ASTM International Comm F04
DE corrosion; modularity; orthopaedic; dental; retrievals
ID IN-VIVO CORROSION; COBALT-BASE ALLOY; INVITRO CORROSION; TITANIUM
   IMPLANTS; STAINLESS-STEEL; HIP PROSTHESES; STENTS; BIOMATERIALS; CARBON;
   COMPONENTS
AB In vivo damage to modular connections for medical and dental multipart construct implant devices, such as hip and tooth root replacements, that transfer forces from host function to bone, has been shown to be complex and multifactorial. Many investigators have recommended that if we are to better understand the most critical factors that influence in vivo modular connection damage, studies should include interrelated data from the patient health and function, the details of surgery and rehabilitation, and the biomaterial and biomechanical properties of the device. Once again, focusing on the device construct design, biomaterial bulk and surface properties, and the established mechanisms of general, pitting, crevice, fretting, fatigue, stress, intergranular, and galvanic corrosion, evaluations have shown that a multifactorial series of considerations exist. These various properties and mechanisms may or may not influence modular interface region damage, and these also should be considered. The intent of this summary is to review and provide relative information based on past (1970-1990s) and more recent (2000-2014) experiences with a focus on the mental-on-metal, ceramic-on-ceramic, and metal- or ceramic-on-polymer assemblies, including articulations for orthopaedic and dental implant systems. This paper also focuses on modifications and new consensus standards that may be needed for future (after 2015) device evaluations related to treatments that include device modularity.
C1 [Lemons, Jack E.] Univ Alabama Birmingham, Box 61 SDB UAB, Birmingham, AL 25294 USA.
RP Lemons, JE (reprint author), Univ Alabama Birmingham, Box 61 SDB UAB, Birmingham, AL 25294 USA.
CR [Anonymous], 2013, FDA ADV PAN OP SESS
   [Anonymous], 2014, F04 ASTM INT, V13
   Anusavice K., 2014, PHILLIPS SCI DENT MA
   Bhambri S., 1994, STP1173 ASTM INT, P111
   BIDEZ MW, 1987, SPINE, V12, P605, DOI 10.1097/00007632-198707000-00021
   Blaha D., 2013, F04 WORKSH NOV 2013
   Branemark P-I, 1977, OSSEOINTEGRATED IMPL
   Brown S., 1996, STP1272 ASTM INT, P231
   Brown S. A., 1996, STP1272 ASTM INT
   BUCHANAN RA, 1981, J BIOMED MATER RES, V15, P611, DOI 10.1002/jbm.820150415
   COLLIER JP, 1992, J BONE JOINT SURG BR, V74, P511
   Esquivel J., 2014, PHILLIPS SCI DENT MA, P499
   Fontana M., 1985, CORROSION ENG
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   GILBERT JL, 1993, J BIOMED MATER RES, V27, P1533, DOI 10.1002/jbm.820271210
   Greenwald A., 2013, ASTM INT F04 WORKSH
   GRIFFIN CD, 1983, J BIOMED MATER RES, V17, P489, DOI 10.1002/jbm.820170308
   Halab N., 2013, BIOMATERIALS SCI, P841
   Halwani DO, 2012, J BIOMED MATER RES B, V100B, P292, DOI 10.1002/jbm.b.31911
   Halwani DO, 2010, J INVASIVE CARDIOL, V22, P528
   Halwani DO, 2010, J BIOMED MATER RES B, V95B, P225, DOI 10.1002/jbm.b.31698
   Horowitz E., 1994, STP1196 ASTM INT
   Imam M., 1996, ASTM STP, P3
   Jacobs J. J., 1998, STAND TABL REF SOL S, P159
   JOHANSSON BI, 1989, J BIOMED MATER RES-A, V23, P349, DOI 10.1002/jbm.820231409
   JOHANSSON BI, 1989, J DENT MAT, V5, P324
   John K. R., 2013, ASTM INT S CEL 50 YE
   Kapnisis KK, 2013, J MECH BEHAV BIOMED, V20, P227, DOI 10.1016/j.jmbbm.2012.11.006
   Kilpadi DV, 1998, J BIOMED MATER RES, V40, P646, DOI 10.1002/(SICI)1097-4636(19980615)40:4<646::AID-JBM17>3.3.CO;2-L
   Kirkpatrick JS, 2005, J SPINAL DISORD TECH, V18, P247
   Kovaks P., 1994, COMPATIBILITY BIOMED
   Lemons J, 2013, AM SOC TEST MATER, V1560, P115, DOI 10.1520/STP156020120034
   Lemons J, 2010, J Long Term Eff Med Implants, V20, P81
   LEMONS J, 1992, DENT MATER, V8, P375, DOI 10.1016/0109-5641(92)90023-6
   Lemons J., 2011, JOINT REPLACEMENT AR, VII
   Lemons J., 2010, AAOS SCI EXH 46 AAOS
   Lemons J., 2012, J LONG TERM EFF MED
   Lemons J., 2008, AAOS SCI EXH 41 AAOS
   Lemons J., 2011, JOINT REPLACEMENT AR, VI
   Lemons J., 2011, DOCTOR DENT ORAL HLT, V5, P54
   Lemons J E, 1977, J Oral Implantol, V7, P362
   Lemons J E, 1986, Instr Course Lect, V35, P258
   Lemons J E, 1992, Implant Dent, V1, P107, DOI 10.1097/00008505-199205000-00002
   Lemons J E, 1975, Oral Implantol, V5, P503
   Lemons J E, 1988, J Dent Educ, V52, P748
   Lemons J. E., 1992, MUSCULOSKELETAL INFE, P155
   Lemons J. E., 1991, CONT IMPLANT DENT, P271
   Lemons J. E., 1983, STP796 ASTM INT, P220
   Lemons J. E., 1998, CONT DENT IMPLANTS, P271
   Lemons J. E., 1998, IMPL DENT, V7, P48
   Lemons J. E., 1996, METALLIC ALLOYS RECO, P19
   Lemons J. E., 1996, AAOS B, V44, P9
   Lemons J. E., 1992, DENT IMPL PERSP, V1, P7
   Lemons J. E., 2000, P ACAD DENT MAT, V14, P15
   Lemons J. E., 1983, BIOMATERIALS RECONST, P662
   Lemons J. E., 1987, TECHNICAL PRINCIPALS
   Lemons J. E., 2002, BONEZONE, P5
   Lemons J. E., 1991, CONTROVERSIES TOTAL, P81
   Lemons J. E., 1991, TOTAL JOINT REPLACEM, P21
   Lemons J. E., 1996, BIOMATERIALS SCI INT, P308
   Lemons J. E., 1994, P S COMPATABILITY BI, P27
   Lemons J. E., 1991, JOINT REPLACEMENT AR, P13
   Lemons J. E., 1994, STP1196 ASTM INT, P199
   Lemons J. E., 1994, BONE IMPLANT INTERFA, P307
   Lemons J. E., 1994, TECHNICAL PRINCIPLES, P19
   Lemons J. E., 1986, PERSEPECTIVES BIOMAT, P245
   Lemons J. E., 1985, THE DENTAL IMPLANT, P143
   LEMONS JE, 1993, BRIS MYER Z, P13
   LEMONS JE, 1990, J AM DENT ASSOC, V121, P716, DOI 10.14219/jada.archive.1990.0268
   LEMONS JE, 1976, J BIOMED MATER RES, V10, P549, DOI 10.1002/jbm.820100411
   LEMONS JE, 1975, J DENT RES, V54, pB166, DOI 10.1177/00220345750540021201
   Lemons JE, 1998, SURF COAT TECH, V104, P135
   LEMONS JE, 1993, BRIS MYER Z, P447
   LEMONS JE, 1975, J BIOMED MATER RES, V9, P9, DOI 10.1002/jbm.820090404
   Lucas L., 1985, BIOMEDICAL ENG, P103
   Lucas L C, 1992, Adv Dent Res, V6, P32
   Lucas L C, 1991, J Invest Surg, V4, P13, DOI 10.3109/08941939109140757
   Lucas L. C., 1985, STP859 ASTM INT, P208
   LUCAS LC, 1982, J BIOMED MATER RES, V16, P799, DOI 10.1002/jbm.820160606
   LUCAS LC, 1981, J BIOMED MATER RES, V15, P731, DOI 10.1002/jbm.820150509
   Macon N. D., 1985, BIOMEDICAL ENG, P11
   Mayor M. B., 1986, ASTM STD NEWS, P40
   Misch C., 2005, DENT IMPLANT PROSTHE
   Misch C, 2008, CONT IMPLANT DENT
   Morrey B., 2003, JOINT REPLACEMENT AR
   Moseley J., 2013, F04 WORKSH NOV 2013
   MOW VC, 1997, BASIC ORTHOPAEDIC BI
   Pallero MA, 2010, J VASC RES, V47, P309, DOI 10.1159/000265565
   Ratner B., 2012, BIOMATERIALS SCI INT, V3
   Ratner B. D., 2013, BIOMATERIALS SCI
   THOMPSON NG, 1979, J BIOMED MATER RES, V13, P35, DOI 10.1002/jbm.820130106
   Venugopalan K., 2000, BIOMAT, P1669
   vonRecum AF, 1999, HDB BIOMATERIALS EVA
   Walsh CP, 2015, J ARTHROPLASTY, V30, P822, DOI 10.1016/j.arth.2014.12.002
   Weinstein A., 1981, 601 NBS DOC
   Williams D., 1973, IMPLANTS IN SURG
   Wright T., 2001, IMPLANT WEAR TOTAL J
   WRIGHT TM, 1996, IMPLANT WEAR FUTURE
NR 98
TC 0
Z9 0
U1 0
U2 0
PU ASTM INTERNATIONAL
PI WEST CONSHOHOCKEN
PA 100 BARR HARBOR DRIVE, PO BOX C700, WEST CONSHOHOCKEN, PA 19428-2959 USA
SN 0066-0558
BN 978-0-8031-7627-0
J9 AM SOC TEST MATER
PY 2015
VL 1591
BP 379
EP 395
DI 10.1520/STP159120140119
PG 17
WC Engineering, Biomedical; Materials Science, Characterization & Testing;
   Orthopedics
SC Engineering; Materials Science; Orthopedics
GA BK9SJ
UT WOS:000444925200025
DA 2018-10-20
ER

PT B
AU Acet, RC
   Khosroshahi, FS
AF Acet, Rusen Can
   Khosroshahi, Ferina Saati
BE Crocker, MJ
   Pawelczyk, M
   Pedrielli, F
   Carletti, E
   Luzzi, S
TI SOUND PERFORMANCE INVESTIGATION OF COMPOSITE MATERIALS FOR THE SOUNDBOX
   OF A MEMBRANE MUSICAL INSTRUMENT
SO PROCEEDINGS OF THE 22ND INTERNATIONAL CONGRESS ON SOUND AND VIBRATION:
   MAJOR CHALLENGES IN ACOUSTICS, NOISE AND VIBRATION RESEARCH, 2015
LA English
DT Proceedings Paper
CT 22nd International Congress on Sound and Vibration (ICSV)
CY JUL 12-16, 2015
CL Florence, ITALY
AB The materials used in the manufacture of musical instruments with wooden sound box is obtained from trees in general. This fact creates difficulties due to problems with limited environmental resources. In addition, such materials vary widely in quality as they are biomaterial, and so it is necessary for musical instrument makers to invest a great deal of effort in quality control and in the wood drying process. To resolve these issues, we have begun the development of synthetic structure using glass fiber and carbon fiber composites with polyester resin for Turkish folk violin (Kemane) traditionally made from gourd was used in the construction. Three instruments were manufactured exactly the same using the traditional measures; two kinds of composite materials and the gourd. Computer modeling was created for composite and sound analysis was performed according to sound recordings of instruments. The analyzes were compared with the traditional gourd Kemane.
C1 [Acet, Rusen Can; Khosroshahi, Ferina Saati] Ozyegin Univ, Fac Mech Engn, Nisantepe Mah, TR-34794 Cekmekoy Istanbul, Turkey.
RP Khosroshahi, FS (reprint author), Ozyegin Univ, Fac Mech Engn, Nisantepe Mah, TR-34794 Cekmekoy Istanbul, Turkey.
EM rusen.acet@ozu.edu.tr
CR Celik O., 2010, 3 BOW INSTRUMENTS TU
   Saati Khosroshahi F., 2014, MODAL ANAL PERSIAN M
   Sun Ruting, 2011, ROCK GUITAR OPTIMISI
   Wegst UG, 2008, MAT RES, V38, P323
NR 4
TC 0
Z9 0
U1 1
U2 1
PU INT INST ACOUSTICS & VIBRATION
PI AUBURN
PA AUBURN UNIV, MECHANICAL ENGINEERING DEPT, 270 ROSS HALL, AUBURN, AL
   36849 USA
BN 978-88-88942-48-3
PY 2015
PG 8
WC Acoustics; Engineering, Mechanical
SC Acoustics; Engineering
GA BH2JX
UT WOS:000398997000040
DA 2018-10-20
ER

PT J
AU Chen, SS
   Lu, XM
   Hu, Y
   Lu, QH
AF Chen, Shuangshuang
   Lu, Xuemin
   Hu, Ying
   Lu, Qinghua
TI Biomimetic honeycomb-patterned surface as the tunable cell adhesion
   scaffold
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID PROTEIN ADSORPTION; BLOOD COMPATIBILITY; SMART BIOMATERIALS; IN-VITRO;
   FILMS; INTERFACES; DESIGN; POLYMERS; RESISTANCE; AVENUE
AB Inspired by the typically adhesive behaviors of fish skin and Parthenocissus tricuspidata, two different decorations of polystyrene honeycomb membrane (PSHCM) prepared by the breath figure approach were carried out with poly(N-(3-Sulfopropyl)-N-(methacryloxyethyl)-N,N-dimethylammonium betaine)(polySBMA) to explore controllable bioadhesive surfaces. Casting and dip-coating were employed to graft polySBMA onto the plasma treated PSHCM. The polySBMA casted PSHCM showed a uniform covering layer on the PSHCM similar to the mucus layer of fish skin, presenting excellent antifouling properties. On the contrary, a dip-coated one showed the polySBMA aggregating on the honeycomb pore walls forming a large number of sucking disks such as the adhesive disks of the tendrils of P. tricuspidata, which remarkably boosts cell adhesion on substrates. Thus, bioadhesion could be regulated as desired by tuning the distribution of zwitterionic polymer on the honeycomb surface. The results may provide a new approach for the design of biomaterial surfaces.
C1 [Chen, Shuangshuang; Lu, Xuemin; Hu, Ying; Lu, Qinghua] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, State Key Lab Met Matrix Composite, Shanghai 200240, Peoples R China.
RP Chen, SS (reprint author), Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, State Key Lab Met Matrix Composite, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.
EM xueminlu@sjtu.edu.cn; qhlu@sjtu.edu.cn
RI shuangshuang, chen/R-4029-2017
OI shuangshuang, chen/0000-0002-8478-5030
FU Major Program of Chinese National Programs for Fundamental Research and
   Development (973 project) [2012CB933803, 2014CB643605]; National Science
   Fund for distinguished Young Scholars [50925310]; National Science
   Foundation of China [51173103, 21374060]; Excellent Academic Leaders of
   Shanghai [11XD1403000]
FX This work was supported by Major Program of Chinese National Programs
   for Fundamental Research and Development (973 project: 2012CB933803,
   2014CB643605); National Science Fund for distinguished Young Scholars
   (50925310), The National Science Foundation of China (51173103,
   21374060), and the Excellent Academic Leaders of Shanghai (11XD1403000).
CR Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Bechert DW, 2000, EXP FLUIDS, V28, P403, DOI 10.1007/s003480050400
   Birch MA, 2013, TISSUE ENG PT A, V19, P2087, DOI [10.1089/ten.TEA.2012.0729, 10.1089/ten.tea.2012.0729]
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Carman ML, 2006, BIOFOULING, V22, P11, DOI 10.1080/08927010500484854
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Chen SF, 2008, ADV MATER, V20, P335, DOI 10.1002/adma.200701164
   Choy DKS, 2013, TISSUE ENG PT A, V19, P2382, DOI [10.1089/ten.tea.2012.0733, 10.1089/ten.TEA.2012.0733]
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Duan CX, 2011, BIOMACROMOLECULES, V12, P4335, DOI 10.1021/bm201270m
   Escale P, 2012, EUR POLYM J, V48, P1001, DOI 10.1016/j.eurpolymj.2012.03.001
   Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592
   Fairman C, 2013, CHEMPHYSCHEM, V14, P2183, DOI 10.1002/cphc.201300040
   Fan HL, 2009, SMALL, V5, P2144, DOI 10.1002/smll.200900345
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fukuhira Y, 2006, BIOMATERIALS, V27, P1797, DOI 10.1016/j.biomaterials.2005.10.019
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Hancock MJ, 2012, ADV FUNCT MATER, V22, P2223, DOI 10.1002/adfm.201103017
   He TX, 2011, MATER CHEM PHYS, V131, P23, DOI 10.1016/j.matchemphys.2011.09.064
   Heng LP, 2013, LANGMUIR, V29, P14947, DOI 10.1021/la403720s
   Heng LP, 2013, LANGMUIR, V29, P9491, DOI 10.1021/la401991n
   Hernandez-Guerrero M, 2012, POLYM CHEM-UK, V3, P563, DOI 10.1039/c1py00219h
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kawano T, 2014, BIOMATER SCI-UK, V2, P52, DOI 10.1039/c3bm60195a
   Kawano T, 2013, BIOMACROMOLECULES, V14, P1208, DOI 10.1021/bm400202d
   Kim DJ, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/39/395102
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma HM, 2011, CHEM SOC REV, V40, P5457, DOI 10.1039/c1cs15059f
   McMillan JR, 2007, TISSUE ENG, V13, P789, DOI 10.1089/ten.2006.0321
   Menzies DJ, 2013, BIOMACROMOLECULES, V14, P413, DOI 10.1021/bm301652q
   Min E, 2008, ADV MATER, V20, P3550, DOI 10.1002/adma.200800569
   Muir BW, 2006, ADV MATER, V18, P3079, DOI 10.1002/adma.200600343
   Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109
   Niklason LE, 1997, TRANSPL IMMUNOL, V5, P303
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   Petrone L, 2013, ADV COLLOID INTERFAC, V195, P1, DOI 10.1016/j.cis.2013.03.006
   Prestwich GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004915
   Preuss CM, 2014, J MATER CHEM B, V2, P36, DOI 10.1039/c3tb21317j
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   de Leon AS, 2013, BIOMATERIALS, V34, P1453, DOI 10.1016/j.biomaterials.2012.10.074
   Sarvestani AS, 2013, SOFT MATTER, V9, P5927, DOI 10.1039/c3sm00036b
   Schlie-Wolter S, 2013, EXP CELL RES, V319, P1553, DOI 10.1016/j.yexcr.2013.03.016
   Shi XJ, 2012, LANGMUIR, V28, P17011, DOI 10.1021/la303042d
   Sun TL, 2006, ACCOUNTS CHEM RES, V39, P487, DOI 10.1021/ar068150n
   Wenli D., 2008, NATURE PRECEDINGS
   Xia F, 2008, ADV MATER, V20, P2842, DOI 10.1002/adma.200800836
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Ye W, 2013, MACROMOL BIOSCI, V13, P676, DOI 10.1002/mabi.201200463
   Zhang Y, 2007, ADV MATER, V19, P913, DOI 10.1002/adma.200601169
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   Zhang Z, 2006, LANGMUIR, V22, P10072, DOI 10.1021/la062175d
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
NR 56
TC 17
Z9 17
U1 5
U2 84
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2015
VL 3
IS 1
BP 85
EP 93
DI 10.1039/c4bm00233d
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA AU9JL
UT WOS:000345908400009
PM 26214192
DA 2018-10-20
ER

PT J
AU Jain, S
   Sharma, A
   Basu, B
AF Jain, Shilpee
   Sharma, Ashutosh
   Basu, Bikramjit
TI Vertical electric field induced bacterial growth inactivation on
   amorphous carbon electrodes
SO CARBON
LA English
DT Article
ID BIOMATERIAL SURFACES; CELL-PROLIFERATION; IN-VITRO; POLYACRYLONITRILE;
   FUNCTIONALITY; STIMULATION; MODULATION; ROUGHNESS; SUBSTRATE; RESPONSES
AB The objective of the present work is to understand the vertical electric field stimulation of the bacterial cells, when grown on amorphous carbon substrates in vitro. In particular, the antibacterial activity against Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli are studied using MTTassay, live/dead assay and inner membrane permeabilization assays. In our experiments, the carbon substrate acts as one electrode and the counter electrode is positioned outside the culture medium, thus suppressing the current, electrokinetic motions and chemical reactions. Guided by similar experiments conducted in our group on neuroblastoma cells, the present experimental results further establish the interdependence of field strength and exposure duration towards bacterial growth inactivation in vitro. Importantly, significant reduction in bacterial viability was recorded at the 2.5 V/cm electric field stimulation conditions, which does not reduce the neural cell viability to any significant extent on an identical substrate. Following electrical stimulation, the bacterial growth is significantly inhibited for S. aureus bacterial strain in an exposure time dependent manner. In summary, our experiments establish the effectiveness of the vertical electric field towards bacterial growth inactivation on amorphous carbon substrates, which is a cell type dependent phenomenon (Gram-positive vs. Gram-negative). (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Jain, Shilpee; Basu, Bikramjit] Indian Inst Technol, Dept Mat Sci & Engn, Kanpur 208016, Uttar Pradesh, India.
   [Sharma, Ashutosh] Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India.
   [Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
   [Jain, Shilpee; Basu, Bikramjit] Indian Inst Sci, Interdisciplinary Bioengn Program, Bangalore 560012, Karnataka, India.
RP Basu, B (reprint author), Indian Inst Sci, Mat Res Ctr, Bangalore 560012, Karnataka, India.
EM ashutos@iitk.ac.in; bikram@mrc.iisc.ernet.in
RI Sharma, Ashutosh/D-1034-2011
OI Sharma, Ashutosh/0000-0002-2653-0806; Jain, Shilpee/0000-0002-2909-9476
FU Department of Science and Technology; Unit of Excellence on Soft
   Nanofabrication at IIT Kanpur; Department of Biotechnology (DBT)
FX The authors acknowledge the support provided by Department of Science
   and Technology and its Unit of Excellence on Soft Nanofabrication at IIT
   Kanpur for providing various research facilities. The financial support
   from Department of Biotechnology (DBT) is also gratefully acknowledged.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Cao HB, 2003, PROCESS BIOCHEM, V38, P1139, DOI 10.1016/S0032-9592(02)00250-9
   Colon G, 2006, J BIOMED MATER RES A, V78, P2006
   COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803
   Drees KP, 2003, WATER RES, V37, P2291, DOI 10.1016/S0043-1354(03)00009-5
   Dubey AK, 2014, J AM CERAM SOC, V97, P481, DOI 10.1111/jace.12647
   Dubey AK, 2013, J MATER SCI-MATER M, V24, P1789, DOI 10.1007/s10856-013-4921-6
   Dubey AK, 2011, J BIOMED MATER RES B, V98B, P18, DOI 10.1002/jbm.b.31827
   El-Hag AH, 2011, IEEE T NANOBIOSCI, V10, P133, DOI 10.1109/TNB.2011.2163078
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Fortunati E, 2013, BIOMACROMOLECULES, V14, P626, DOI 10.1021/bm301524e
   HOFMANN GA, 1986, IEEE ENG MED BIOL, V5, P6, DOI 10.1109/MEMB.1986.5006335
   Huffer S, 2011, APPL ENVIRON MICROB, V77, P6400, DOI 10.1128/AEM.00694-11
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   Jain S, 2013, BIOMATERIALS, V34, P9252, DOI 10.1016/j.biomaterials.2013.08.057
   Khoury A E, 1992, ASAIO J, V38, pM174, DOI 10.1097/00002480-199207000-00013
   Ko TH, 1999, J APPL POLYM SCI, V71, P2219, DOI 10.1002/(SICI)1097-4628(19990328)71:13<2219::AID-APP12>3.0.CO;2-W
   Litzler PY, 2007, J THORAC CARDIOV SUR, V134, P1025, DOI 10.1016/j.jtcvs.2007.06.013
   Liu W-K, 1997, J ANTIMICROB CHEMOTH, P39
   Lui H, 2004, INT J FOOD MICROBIOL, V95, P147
   Luo QS, 2005, APPL ENVIRON MICROB, V71, P423, DOI 10.1128/AEM.71.1.423-427.2005
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113
   Mondal K, 2013, COLLOID SURFACE A, V427, P83, DOI 10.1016/j.colsurfa.2013.03.024
   Ploux L, 2009, LANGMUIR, V25, P8161, DOI 10.1021/la900457f
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Qin B.-L., 1994, DIELECTRICS ELECT IN, V1, P1047, DOI DOI 10.1109/94.368658
   Rahaman MSA, 2007, POLYM DEGRAD STABIL, V92, P1421, DOI 10.1016/j.polymdegradstab.2007.03.023
   ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Thrivikraman G, 2014, BIOMATERIALS, V35, P6219, DOI 10.1016/j.biomaterials.2014.04.018
   Thrivikraman G, 2013, BIOMATERIALS, V34, P7073, DOI 10.1016/j.biomaterials.2013.05.076
   TSONG TY, 1990, ANNU REV BIOPHYS BIO, V19, P83, DOI 10.1146/annurev.bb.19.060190.000503
   Valic B, 2003, EUR BIOPHYS J BIOPHY, V32, P519, DOI 10.1007/s00249-003-0296-9
   Yu Q, 2013, ACS APPL MATER INTER, V5, P9295, DOI 10.1021/am4022279
NR 35
TC 7
Z9 7
U1 1
U2 26
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0008-6223
EI 1873-3891
J9 CARBON
JI Carbon
PD JAN
PY 2015
VL 81
BP 193
EP 202
DI 10.1016/j.carbon.2014.09.048
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA AU5ZX
UT WOS:000345682900022
DA 2018-10-20
ER

PT J
AU Ball, JP
   Mound, BA
   Monsalve, AG
   Nino, JC
   Allen, JB
AF Ball, Jordan P.
   Mound, Brittnee A.
   Monsalve, Adam G.
   Nino, Juan C.
   Allen, Josephine B.
TI Biocompatibility evaluation of porous ceria foams for orthopedic tissue
   engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; ceramic foams; orthopedic; porous scaffold; ceria
ID CELLS IN-VITRO; OXIDE NANOPARTICLES; FREE-RADICALS; BONE; BIOMATERIALS;
   SCAFFOLDS; NANOCERIA; ANTIOXIDANTS; MODULATION; INDUCTION
AB Ceria ceramics have the unique ability to protect cells from free radical-induced damage, making them materials of interest for biomedical applications. To expand upon the understanding of the potential of ceria as a biomaterial, porous ceria, fabricated via direct foaming, was investigated to assess its biocompatibility and its ability to scavenge free radicals. A mouse osteoblast (7F2) cell line was cultured with the ceria foams to determine the extent of the foams' toxicity. Toxicity assessments indicate that mouse osteoblasts cultured directly on the ceria scaffold for 72 h did not show a significant (p>0.05) increase in toxicity, but rather show comparable toxicity to cells cultured on porous 45S5 Bioglass (R). The in vitro inflammatory response elicited from porous ceria foams was measured as a function of tumor necrosis factor alpha (TNF-) secreted from a human monocytic leukemia cell line. Results indicate that the ceria foams do not cause a significant inflammatory response, eliciting a response of 27.1 +/- 7.1 pg mL(-1) of TNF- compared to 36.3 +/- 5.8 pg mL(-1) from cells on Bioglass, and 20.1 +/- 2.9 pg mL(-1) from untreated cells. Finally, we report cellular toxicity in response to free radicals from tert-butyl hydroperoxide with and without foamed ceria. Our preliminary results show that the foamed ceria is able to decrease the toxic effect of induced oxidative stress. Collectively, this study demonstrates that foamed ceria scaffolds do not activate an inflammatory response, and show potential free radical scavenging ability, thus they have promise as an orthopedic biomaterial. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 8-15, 2015.
C1 [Ball, Jordan P.; Mound, Brittnee A.; Monsalve, Adam G.; Nino, Juan C.; Allen, Josephine B.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.
RP Allen, JB (reprint author), Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.
EM jallen@mse.ufl.edu
RI Nino, Juan/A-6496-2008
OI Nino, Juan/0000-0001-8256-0535; Ball, Jordan/0000-0003-2145-061X
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Ball JP, 2014, J BIOMED MATER RES A, V102, P2089, DOI 10.1002/jbm.a.34879
   Benzaid R, 2008, BIOMATERIALS, V29, P3636, DOI 10.1016/j.biomaterials.2008.05.021
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   Chen J, 2008, ADV EXP MED BIOL, V613, P53, DOI 10.1007/978-0-387-74904-4_5
   Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91
   Cutando A, 2006, J PERIODONTOL, V77, P1533, DOI 10.1902/jop.2006.050287
   Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036
   Das S, 2012, BIOMATERIALS, V33, P7746, DOI 10.1016/j.biomaterials.2012.07.019
   DEKKER A, 1994, CELL MATER, V4, P101
   Droge W, 2002, PHYSIOL REV, V82, P47
   Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Hajdara K, 2008, TOXICOL APPL PHARM, V229, P65, DOI 10.1016/j.taap.2008.01.010
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   Heil TL, 2002, J ORAL REHABIL, V29, P401, DOI 10.1046/j.1365-2842.2002.00893.x
   Hirst SM, 2009, SMALL, V5, P2848, DOI 10.1002/smll.200901048
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Janney MA, 1998, J AM CERAM SOC, V81, P581, DOI 10.1111/j.1151-2916.1998.tb02377.x
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8
   Karakoti AS, 2010, J MATER CHEM, V20, P8912, DOI 10.1039/c0jm01072c
   Karakoti AS, 2009, J AM CHEM SOC, V131, P14144, DOI 10.1021/ja9051087
   Kim CK, 2012, ANGEW CHEM INT EDIT, V51, P11039, DOI 10.1002/anie.201203780
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Korsvik C, 2007, CHEM COMMUN, P1056, DOI 10.1039/b615134e
   Mandoli C, 2010, ADV FUNCT MATER, V20, P1617, DOI 10.1002/adfm.200902363
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Motlagh D, 2007, J BIOMED MATER RES A, V82A, P907, DOI 10.1002/jbm.a.31211
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nakade O, 1999, J PINEAL RES, V27, P106, DOI 10.1111/j.1600-079X.1999.tb00603.x
   Niu JL, 2007, CARDIOVASC RES, V73, P549, DOI 10.1016/j.cardiores.2006.11.031
   Perez JM, 2008, SMALL, V4, P552, DOI 10.1002/smll.200700824
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Silva GA, 2006, NAT NANOTECHNOL, V1, P92, DOI 10.1038/nnano.2006.111
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Tanner KE, 2010, P I MECH ENG H, V224, P1359, DOI 10.1243/09544119JEIM823
   Tarnuzzer RW, 2005, NANO LETT, V5, P2573, DOI 10.1021/nl052024f
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Washburn EW, 1921, P NATL ACAD SCI USA, V7, P115, DOI 10.1073/pnas.7.4.115
   White B, 2000, BRIT J HAEMATOL, V110, P130, DOI 10.1046/j.1365-2141.2000.02128.x
   Wucherer L, 2009, INT J APPL CERAM TEC, V6, P651, DOI 10.1111/j.1744-7402.2008.02303.x
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
NR 53
TC 6
Z9 6
U1 4
U2 38
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2015
VL 103
IS 1
BP 8
EP 15
DI 10.1002/jbm.a.35137
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU4HT
UT WOS:000345572100002
PM 24677427
DA 2018-10-20
ER

PT J
AU Ramalingam, N
   Natarajan, TS
   Rajiv, S
AF Ramalingam, Nithya
   Natarajan, T. S.
   Rajiv, Sheeja
TI Preparation and characterization of electrospun curcumin loaded
   poly(2-hydroxyethyl methacrylate) nanofiber-A biomaterial for multidrug
   resistant organisms
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE electrospinning; nanofibers; curcumin; multidrug resistant organism
ID PORE STRUCTURE-ANALYSIS
AB Curcumin loaded poly(2-hydroxy ethyl methacrylate) p(HEMA) nanofiber were produced using electrospinning method and characterized. The nanofibrous scaffold supports good cell growth, attachment and retains its original morphology. Sustained and controlled release pattern of curcumin seen to be efficient against infectious disease caused by multidrug resistant organisms. Antibacterial activity of curcumin against Methicillin resistant staphylococcus aureus (MRSA) and extended spectrum lactamase (ESBL) proved to be a good alternate herbal compound for antibiotics. Hence the results indicate p(HEMA) nanofiber loaded with curcumin have potential to use as patch in wound healing of infectious disease caused by multidrug resistant organisms and excellent drug delivery vessel. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 16-24, 2015.
C1 [Ramalingam, Nithya; Rajiv, Sheeja] Anna Univ, Dept Chem, Madras 600025, Tamil Nadu, India.
   [Natarajan, T. S.] Indian Inst Technol, Dept Phys, Conducting Polymer Lab, Madras 600036, Tamil Nadu, India.
RP Rajiv, S (reprint author), Anna Univ, Dept Chem, Madras 600025, Tamil Nadu, India.
EM tsniit@gmail.com; sheeja@annauniv.edu
FU Council of Scientific and Industrial Reasearch (CSIR), Government of
   India [09/468(432)/2011]
FX Nithya Ramalingam acknowledges Council of Scientific and Industrial
   Reasearch (CSIR), Government of India, for the financial assistance in
   the form of senior research fellowships (09/468(432)/2011). The
   instrumentation facility provided under FIST-DST and DRS-UGC to
   Department of Chemistry, Anna University, Chennai are gratefully
   acknowledged.
CR Alex JC, 2005, J NEURAL ENG, V2, P114
   Bagherzadeh R, 2014, J BIOMED MATER RES A, V102, P903, DOI 10.1002/jbm.a.34736
   Bagherzadeh R, 2013, J BIOMED MATER RES A, V101, P2107, DOI 10.1002/jbm.a.34487
   Bagherzadeh R, 2013, J BIOMED MATER RES A, V101, P765, DOI 10.1002/jbm.a.34379
   Bhaarathi D, 2013, FRONT MATER SCI, V7, P350
   Bhawana, 2011, J AGR FOOD CHEM, V59, P2056, DOI 10.1021/jf104402t
   Chen Y, 2012, FIBER POLYM, V13, P1254, DOI 10.1007/s12221-012-1254-x
   Chen Y, 2010, FIBER POLYM, V11, P1128, DOI 10.1007/s12221-010-1128-z
   Elakkiya T, 2012, FIBER POLYM, V13, P823
   Francesco D, 2010, J AGR FOOD CHEM, V58, P2848
   Frank A, 2004, J CONTROL RELEASE, V98, P67
   Gloria A, 2011, J BIOMATER APPL, V25, P795, DOI 10.1177/0885328209360933
   Han D, 2011, POLYMERS-BASEL, V3, P1684, DOI 10.3390/polym3041684
   Jonathan GM, 2009, CLIN EXP PHARM PHYSL, V36, P1149
   Mahmood K, 2010, ANNALS, V16, P91
   Manuela C, 2011, J FUNCT BIOMATER, V2, P1
   Naveen N, 2010, ADV ENG MATER, V12, pB380, DOI 10.1002/adem.200980067
   Phelan T, 2010, J UNDERGRAD RES BIOE, V8, pn1
   Robert S, 2012, INT J ANTIMICROB AG, V39, P193
   Shanmugam H, 2008, PHYTOMEDICINE, V15, P639
   Strohal R, 2005, J HOSP INFECT, V60, P226, DOI 10.1016/j.jhin.2005.04.001
   Sujatha MB, 2006, DIAGN MICROBIOL INFE, V54, P231
   Sun XZ, 2013, CARBOHYD POLYM, V94, P147, DOI 10.1016/j.carbpol.2012.12.064
   Sundarananthavalli S., 2011, International Journal of ChemTech Research, V3, P2040
   Sundaray B, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2193462
   Venugopal J, 2005, APPL BIOCHEM BIOTECH, V125, P147, DOI 10.1385/ABAB:125:3:147
   Yoshiaki I, 2012, NAGOYA J MED SCI, V74, P105
NR 27
TC 18
Z9 18
U1 1
U2 58
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2015
VL 103
IS 1
BP 16
EP 24
DI 10.1002/jbm.a.35138
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU4HT
UT WOS:000345572100003
PM 24578218
DA 2018-10-20
ER

PT J
AU Sebaa, M
   Nguyen, TY
   Dhillon, S
   Garcia, S
   Liu, HN
AF Sebaa, Meriam
   Thanh Yen Nguyen
   Dhillon, Shan
   Garcia, Salvador
   Liu, Huinan
TI The effects of poly(3,4-ethylenedioxythiophene) coating on magnesium
   degradation and cytocompatibility with human embryonic stem cells for
   potential neural applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE magnesium degradation; biomaterials; poly(3; 4-ethylenedioxythiophene);
   conductive polymer; electrochemical deposition; coatings; human
   embryonic stem cells; cell viability and proliferation;
   cytocompatibility
ID IN-VITRO; ELECTROCHEMICAL DEPOSITION; ATRIAL-FIBRILLATION;
   CEREBRAL-ISCHEMIA; ACUTE STROKE; PEDOT; VIVO; PERFORMANCE; IMPLANTS;
   THERAPY
AB Magnesium (Mg) is a promising conductive metallic biomaterial due to its desirable mechanical properties for load bearing and biodegradability in human body. Controlling the rapid degradation of Mg in physiological environment continues to be the key challenge toward clinical translation. In this study, we investigated the effects of conductive poly(3,4-ethylenedioxythiophene) (PEDOT) coating on the degradation behavior of Mg substrates and their cytocompatibility. Human embryonic stem cells (hESCs) were used as the in vitro model system to study cellular responses to Mg degradation because they are sensitive and can potentially differentiate into many cell types of interest (e.g., neurons) for regenerative medicine. The PEDOT was deposited on Mg substrates using electrochemical deposition. The greater number of cyclic voltammetry (CV) cycles yielded thicker PEDOT coatings on Mg substrates. Specifically, the coatings produced by 2, 5, and 10 CV cycles (denoted as 2x-PEDOT-Mg, 5x-PEDOT-Mg, and 10x-PEDOT-Mg) had an average thickness of 31, 63, and 78 mu m, respectively. Compared with non-coated Mg samples, all PEDOT coated Mg samples showed slower degradation rates, as indicated by Tafel test results and Mg ion concentrations in the post-culture media. The 5x-PEDOT-Mg showed the best coating adhesion and slowest Mg degradation among the tested samples. Moreover, hESCs survived for the longest period when cultured with the 5x-PEDOT-Mg samples compared with the non-coated Mg and 2x-PEDOT-Mg. Overall, the results of this study showed promise in using PEDOT coating on biodegradable Mg-based implants for potential neural recording, stimulation and tissue engineering applications, thus encouraging further research. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 25-37, 2015.
C1 [Sebaa, Meriam; Thanh Yen Nguyen; Dhillon, Shan; Liu, Huinan] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.
   [Garcia, Salvador] Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA.
   [Garcia, Salvador; Liu, Huinan] Univ Calif Riverside, Stem Cell Ctr, Riverside, CA 92521 USA.
   [Liu, Huinan] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA.
RP Liu, HN (reprint author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.
EM huinan.liu@ucr.edu
OI Liu, Huinan/0000-0001-9366-6204
FU U.S. National Science Foundation (NSF) NSF BRIGE award [CBET 1125801];
   Burroughs Wellcome Fund; Hellman Faculty Fellowship; University of
   California (UC) Regents Faculty Fellowship
FX Contract grant sponsor: U.S. National Science Foundation (NSF Graduate
   Research Fellowship for supporting Thanh Yen Nguyen); contract grant
   number: NSF BRIGE award CBET 1125801; Contract grant sponsors: The
   Burroughs Wellcome Fund, the Hellman Faculty Fellowship, and the
   University of California (UC) Regents Faculty Fellowship
CR Alok Nayer M-H, 1997, METALS DATABOOK
   [Anonymous], 1994, G102 ASTM INT, V03
   Baek S, 2013, J BIOMED MAT RES A
   Campbell K, 2008, BRAIN RES BULL, V77, P320, DOI 10.1016/j.brainresbull.2008.08.017
   Chatterjee P, 2011, JOVE-J VIS EXP, DOI 10.3791/3110
   Cheng L, 2012, ACS NANO, V6, P5605, DOI 10.1021/nn301539m
   Cipriano AF, 2012, C P IEEE ENG MED BIO, V5
   Clarkson AN, 2007, LIFE SCI, V80, P1157, DOI 10.1016/j.lfs.2006.12.022
   Cui XY, 2003, SENSOR ACTUAT B-CHEM, V89, P92, DOI 10.1016/S0925-4005(02)00448-3
   Davila JC, 2004, TOXICOL SCI, V79, P214, DOI 10.1093/toxsci/kfh100
   di Summa PG, 2010, J PLAST RECONSTR AES, V63, P1544, DOI 10.1016/j.bjps.2009.09.012
   Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020
   Grillo CA, 2011, COLLOID SURFACE B, V88, P471, DOI 10.1016/j.colsurfb.2011.07.035
   Guan RG, 2013, MAT SCI ENG C-MATER, V33, P3661, DOI 10.1016/j.msec.2013.04.054
   Gupta VK, 2004, STROKE, V35, P2758, DOI 10.1161/01.STR.0000147971.14988.50
   Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008
   Johnson I, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/37/375103
   Johnson I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065603
   Kainer KU, 2007, MAGNESIUM
   Kim G, 2011, METHODOLOGICAL ADV C
   Kohno H, 2005, ANN THORAC SURG, V79, P117, DOI 10.1016/j.athoracsur.2004.06.062
   LASCHINSKI G, 1991, REPROD TOXICOL, V5, P57, DOI 10.1016/0890-6238(91)90111-R
   Ludwig KA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/1/014001
   Luo SC, 2008, LANGMUIR, V24, P8071, DOI 10.1021/la800333g
   Luo XL, 2011, ACTA BIOMATER, V7, P441, DOI 10.1016/j.actbio.2010.09.006
   Malarkey EB, 2009, NANO LETT, V9, P264, DOI 10.1021/nl802855c
   Melanie Urbanchek M R A, 2009, PLAST RECONSTR SURG, V124, P67
   Miriani RM, 2008, IEEE ENG MED BIO, P1841, DOI 10.1109/IEMBS.2008.4649538
   Muir KW, 1998, MAGNESIUM RES, V11, P43
   Nasybulin E, 2011, J PHYS CHEM C, V115, P17623, DOI 10.1021/jp207343w
   Nelson G, 1995, GARDNER SWARD HDB
   Ostrakhovitch EA, 2012, ARCH BIOCHEM BIOPHYS, V528, P21, DOI 10.1016/j.abb.2012.08.006
   Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026
   Saver JL, 2004, STROKE, V35, pE106, DOI 10.1161/01.STR.0000124458.98123.52
   Sebaa MA, 2013, J MATER SCI-MATER M, V24, P307, DOI 10.1007/s10856-012-4796-y
   Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348
   Takadoum J, 1997, SURF COAT TECH, V96, P272, DOI 10.1016/S0257-8972(97)00182-5
   Talbot P, 2011, CURR TOP MED CHEM, V11, P1638
   Nguyen TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076547
   Nguyen TY, 2012, IEEE ENG MED BIO, P723, DOI 10.1109/EMBC.2012.6346033
   Waligorski S, 2010, KARDIOCHIR TORAKOCHI, V7, P141
   Wei YJ, 2011, J MATER SCI-MATER M, V22, P1947, DOI 10.1007/s10856-011-4370-z
   West PR, 2010, TOXICOL APPL PHARM, V247, P18, DOI 10.1016/j.taap.2010.05.007
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Wu WL, 2011, NEUROSCI LETT, V491, P73, DOI 10.1016/j.neulet.2011.01.009
   Xiao YM, 2012, ELECTROCHIM ACTA, V85, P432, DOI 10.1016/j.electacta.2012.08.077
   Xue DC, 2012, J MATER SCI TECHNOL, V28, P261, DOI 10.1016/S1005-0302(12)60051-6
   Yang YM, 2011, TISSUE ENG PT A, V17, P2231, DOI [10.1089/ten.tea.2010.0633, 10.1089/ten.TEA.2010.0633]
   Zhou DD, 2010, BIOL MED PHYS BIOMED, P217, DOI 10.1007/978-0-387-98120-8_8
NR 50
TC 7
Z9 7
U1 2
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2015
VL 103
IS 1
BP 25
EP 37
DI 10.1002/jbm.a.35142
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU4HT
UT WOS:000345572100004
PM 24677580
DA 2018-10-20
ER

PT J
AU Suri, S
   Lehman, SM
   Selvam, S
   Reddie, K
   Maity, S
   Murthy, N
   Garcia, AJ
AF Suri, Shalu
   Lehman, Susan M.
   Selvam, Shivaram
   Reddie, Khalilah
   Maity, Santanu
   Murthy, Niren
   Garcia, Andres J.
TI In vivo fluorescence imaging of biomaterial-associated inflammation and
   infection in a minimally invasive manner
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE implant; bacteria; macrophage; reactive oxygen species; nitric oxide;
   fibrosis; near-infrared fluorescence
ID STAPHYLOCOCCUS-AUREUS; OXIDATIVE STRESS; BACTERIAL-INFECTION;
   NITRIC-OXIDE; MICE; MACROPHAGES; RESPONSES; IMPLANTS; PROBES
AB Implant-associated inflammation and bacterial infection severely limit the functional performance of medical devices and are a major cause of implant failure. Therefore, it is crucial to develop methodologies to monitor/image implant-associated aseptic inflammation and bacterial infection in a minimally invasive manner. Here, we exploited near-infrared fluorescence (NIRF) molecular probes injected locally at the implant site to perform minimally invasive, simultaneous imaging of inflammation, and infection associated with implanted polymer disks. The hydro-sulfo-Cy5 (H-s-Cy5) probe detected reactive oxygen species associated with inflammatory responses to both aseptic and biofilm-containing implants, whereas diaminocyanine sulfonate selectively detected nitric oxide associated with a biofilm on the biomaterial at acute time points (<4 days). This imaging modality also allows longitudinal monitoring because of high specificity and fast clearance rate of the fluorescent probes. Taken together, these NIRF molecular probes represent a useful tool to directly image inflammatory responses and infections associated with implanted devices for the diagnosis of device-associated inflammation and infection as well as the development of effective therapies. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 76-83, 2015.
C1 [Suri, Shalu; Lehman, Susan M.; Selvam, Shivaram; Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Suri, Shalu; Lehman, Susan M.; Selvam, Shivaram; Reddie, Khalilah; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Maity, Santanu; Murthy, Niren] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
OI Selvam, Shivaram/0000-0002-0005-7707
FU National Institutes of Health [R21 AI094624]; Georgia Tech/Emory Center
   for the Engineering of Living Tissues; Atlanta Clinical and
   Translational Science Institute under PHS Grant (from the Clinical and
   Translational Science Award Program) [UL RR025008]
FX Contract grant sponsor: National Institutes of Health; contract grant
   number: R21 AI094624 (A.J.G.); Contract grant sponsor: The Georgia
   Tech/Emory Center for the Engineering of Living Tissues; Contract grant
   sponsor: The Atlanta Clinical and Translational Science Institute under
   PHS Grant (from the Clinical and Translational Science Award Program);
   contract grant number: UL RR025008
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bettegowda C, 2005, P NATL ACAD SCI USA, V102, P1145, DOI 10.1073/pnas.0408861102
   Curtin JJ, 2006, ANTIMICROB AGENTS CH, V50, P1268, DOI 10.1128/AAC.50.4.1268-1275.2006
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09
   HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665
   HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9
   Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029
   Hooper KA, 2000, J BIOMED MATER RES, V50, P365, DOI 10.1002/(SICI)1097-4636(20000605)50:3<365::AID-JBM10>3.0.CO;2-X
   Jiang LL, 2007, TETRAHEDRON LETT, V48, P5825, DOI 10.1016/j.tetlet.2007.06.060
   Karlsson M, 2006, J MATER SCI-MATER M, V17, P1101, DOI 10.1007/s10856-006-0537-4
   Kong Y, 2010, P NATL ACAD SCI USA, V107, P12239, DOI 10.1073/pnas.1000643107
   Kundu K, 2009, ANGEW CHEM INT EDIT, V48, P299, DOI 10.1002/anie.200804851
   Leevy WM, 2008, BIOCONJUGATE CHEM, V19, P686, DOI 10.1021/bc700376v
   Leevy WM, 2006, J AM CHEM SOC, V128, P16476, DOI 10.1021/ja0665592
   Lennertz RC, 2010, J NEUROSCI, V30, P4353, DOI 10.1523/JNEUROSCI.4666-09.2010
   Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011
   MIWA M, 1987, CARCINOGENESIS, V8, P955, DOI 10.1093/carcin/8.7.955
   Ning XH, 2011, NAT MATER, V10, P602, DOI [10.1038/NMAT3074, 10.1038/nmat3074]
   Niska JA, 2013, ANTIMICROB AGENTS CH, V57, P5080, DOI 10.1128/AAC.00702-13
   Piatkevich KD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3153
   Sasaki E, 2005, J AM CHEM SOC, V127, P3684, DOI 10.1021/ja042967z
   Selvam S, 2011, BIOMATERIALS, V32, P7785, DOI 10.1016/j.biomaterials.2011.07.020
   Serrano MC, 2005, BIOMATERIALS, V26, P5827, DOI 10.1016/j.biomaterials.2005.02.039
   STUEHR DJ, 1985, P NATL ACAD SCI USA, V82, P7738, DOI 10.1073/pnas.82.22.7738
   Tsaryk R, 2007, BIOMATERIALS, V28, P806, DOI 10.1016/j.biomaterials.2006.09.033
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   White AG, 2012, BIOORG MED CHEM LETT, V22, P2833, DOI 10.1016/j.bmcl.2012.02.078
NR 30
TC 11
Z9 11
U1 3
U2 40
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2015
VL 103
IS 1
BP 76
EP 83
DI 10.1002/jbm.a.35162
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU4HT
UT WOS:000345572100010
PM 24616254
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Park, J
   Gerber, MH
   Babensee, JE
AF Park, Jaehyung
   Gerber, Michael H.
   Babensee, Julia E.
TI Phenotype and polarization of autologous T cells by biomaterial-treated
   dendritic cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; dendritic cells; T cells; polarization; immunotherapy
ID ARTICULAR-CARTILAGE REPAIR; HUMAN PERIPHERAL-BLOOD;
   NECROSIS-FACTOR-ALPHA; IN-VITRO; POLY(LACTIC-CO-GLYCOLIC ACID);
   REGULATORY PROPERTIES; CANCER-PATIENTS; BREAST-CANCER; MATURATION; TUMOR
AB Given the central role of dendritic cells (DCs) in directing T-cell phenotypes, the ability of biomaterial-treated DCs to dictate autologous T-cell phenotype was investigated. In this study, we demonstrate that differentially biomaterial-treated DCs differentially directed autologous T-cell phenotype and polarization, depending on the biomaterial used to pretreat the DCs. Immature DCs (iDCs) were derived from human peripheral blood monocytes and treated with biomaterial films of alginate, agarose, chitosan, hyaluronic acid, or 75:25 poly(lactic-co-glycolic acid) (PLGA), followed by co-culture of these biomaterial-treated DCs and autologous T cells. When autologous T cells were co-cultured with DCs treated with biomaterial film/antigen (ovalbumin, OVA) combinations, different biomaterial films induced differential levels of T-cell marker (CD4, CD8, CD25, CD69) expression, as well as differential cytokine profiles [interferon (IFN)-, interleukin (IL)-12p70, IL-10, IL-4] in the polarization of T helper (Th) types. Dendritic cells treated with agarose films/OVA induced CD4+CD25+FoxP3+ (T regulatory cells) expression, comparable to untreated iDCs, on autologous T cells in the DC-T co-culture system. Furthermore, in this co-culture, agarose treatment induced release of IL-12p70 and IL-10 at higher levels as compared with DC treatment with other biomaterial films/OVA, suggesting Th1 and Th2 polarization, respectively. Dendritic cells treated with PLGA film/OVA treatment induced release of IFN- at higher levels compared with that observed for co-cultures with iDCs or DCs treated with all other biomaterial films. These results indicate that DC treatment with different biomaterial films has potential as a tool for immunomodulation by directing autologous T-cell responses. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 170-184, 2015.
C1 [Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
FU National Institutes of Health [1RO1EB004633-01A1]; National Science
   Foundation [BES-0239152]; Arthritis Foundation (through an Arthritis
   Investigator Grant)
FX Contract grant sponsor: National Institutes of Health; contract grant
   number: 1RO1EB004633-01A1; Contract grant sponsor: National Science
   Foundation; contract grant number: BES-0239152; Contract grant sponsor:
   Arthritis Foundation (through an Arthritis Investigator Grant)
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Ajdary S, 2007, VACCINE, V25, P4595, DOI 10.1016/j.vaccine.2007.03.039
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   BAXEVANIS CN, 1988, IMMUNOPHARMACOLOGY, V15, P73, DOI 10.1016/0162-3109(88)90054-9
   Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   BLUE ML, 1985, J IMMUNOL, V134, P2281
   BROMBERG JS, 1995, CURR OPIN IMMUNOL, V7, P639, DOI 10.1016/0952-7915(95)80070-0
   CUNNINGHAM AJ, 1977, SCAND J IMMUNOL, V6, P1, DOI 10.1111/j.1365-3083.1977.tb00317.x
   Delluc S, 2011, FASEB J, V25, P2040, DOI 10.1096/fj.10-173872
   Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303
   Emans PJ, 2010, P NATL ACAD SCI USA, V107, P3418, DOI 10.1073/pnas.0907774107
   Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0
   Fukumoto T, 2003, OSTEOARTHR CARTILAGE, V11, P55, DOI 10.1053/joca.2002.0869
   Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1081/jem.20011961
   Gazda LS, 2007, CELL TRANSPLANT, V16, P609, DOI 10.3727/000000007783465028
   Ghosh TK, 2006, CELL IMMUNOL, V243, P48, DOI 10.1016/j.cellimm.2006.12.002
   Goto S, 1999, CANCER IMMUNOL IMMUN, V48, P435, DOI 10.1007/s002620050620
   Hippen KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001809
   Huang CYC, 2004, ANAT REC PART A, V278A, P428, DOI 10.1002/ar.a.20010
   Hueman MT, 2006, BREAST CANCER RES TR, V98, P17, DOI 10.1007/s10549-005-9108-5
   Hunter TB, 2007, SCAND J IMMUNOL, V65, P479, DOI 10.1111/j.1365-3083.2007.01927.x
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285
   Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9
   Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246
   Kleinbeck KR, 2010, WOUND REPAIR REGEN, V18, P486, DOI 10.1111/j.1524-475X.2010.00609.x
   Kou PM, 2011, ACTA BIOMATER, V7, P1354, DOI 10.1016/j.actbio.2010.10.020
   Kulhankova K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043609
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X
   Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233
   Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295
   Li WJ, 2005, MACROMOL SYMP, V227, P65, DOI 10.1002/masy.200550906
   Liman M, 2007, VACCINE, V25, P7914, DOI 10.1016/j.vaccine.2007.09.001
   Lisby S, 1999, CLIN EXP IMMUNOL, V117, P217
   Machy P, 2000, EUR J IMMUNOL, V30, P848, DOI 10.1002/1521-4141(200003)30:3<848::AID-IMMU848>3.3.CO;2-H
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433
   Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734
   Musabak U, 2004, CLIN EXP IMMUNOL, V138, P526, DOI 10.1111/j.1365-2249.2004.02632.x
   Nakahara T, 2004, INT IMMUNOL, V16, P1701, DOI 10.1093/intimm/dxh171
   Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223
   Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395
   Ng KW, 2010, TISSUE ENG PT A, V16, P1041, DOI [10.1089/ten.tea.2009.0581, 10.1089/ten.TEA.2009.0581]
   Ng WF, 2001, BLOOD, V98, P2736, DOI 10.1182/blood.V98.9.2736
   Norton LW, 2010, J CONTROL RELEASE, V146, P341, DOI 10.1016/j.jconrel.2010.05.032
   ORTOLANI C, 1993, BIOCHEM BIOPH RES CO, V191, P601, DOI 10.1006/bbrc.1993.1260
   Papas KK, 1999, BIOTECHNOL BIOENG, V66, P231, DOI 10.1002/(SICI)1097-0290(1999)66:4<231::AID-BIT4>3.3.CO;2-L
   Park J, 2012, ACTA BIOMATER, V8, P3606, DOI 10.1016/j.actbio.2012.06.006
   Piemonti L, 1999, INT IMMUNOL, V11, P1519, DOI 10.1093/intimm/11.9.1519
   Pockaj BA, 2004, ANN SURG ONCOL, V11, P328, DOI 10.1245/ASO.2004.05.027
   Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869
   Rogers TH, 2011, BIOMATERIALS, V32, P1270, DOI 10.1016/j.biomaterials.2010.10.014
   ROMAGNANI S, 1983, SCAND J HAEMATOL, V31, P305
   Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6
   Rothoeft T, 2006, EUR J IMMUNOL, V36, P3105, DOI 10.1002/eji.200636145
   Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020
   Schnurr M, 2001, CANCER RES, V61, P6445
   Seferian PG, 2000, VACCINE, V19, P661, DOI 10.1016/S0264-410X(00)00248-6
   SETUM CM, 1991, DIABETES, V40, P1719, DOI 10.2337/diabetes.40.12.1719
   Shankar SP, 2010, J BIOMED MATER RES A, V92A, P1329, DOI 10.1002/jbm.a.32457
   Shilyansky J, 2007, J PEDIATR SURG, V42, P54, DOI 10.1016/j.jpedsurg.2006.09.008
   SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876
   Sokolovska A, 2007, VACCINE, V25, P4575, DOI 10.1016/j.vaccine.2007.03.045
   Stax AM, 2008, MOL IMMUNOL, V45, P2641, DOI 10.1016/j.molimm.2007.12.014
   Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001
   Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P
   Termeer C, 2003, IMMUNOLOGY, V109, P32, DOI 10.1046/j.1365-2567.2003.01617.x
   Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6
   Todorovic M, 2012, J IMMUNOTHER, V35, P579, DOI 10.1097/CJI.0b013e31826b1fd9
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   TONUTTI E, 1994, CLIN IMMUNOL IMMUNOP, V73, P312, DOI 10.1006/clin.1994.1204
   Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656
   Triozzi PL, 1997, J LEUKOCYTE BIOL, V61, P600
   Tun T, 1996, CELL TRANSPLANT, V5, pS59, DOI 10.1016/0963-6897(96)00042-5
   Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753
   Weiss L, 1998, J INFECT DIS, V178, P1158, DOI 10.1086/515674
   West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153
   Whiteside TL, 2004, CANCER IMMUNOL IMMUN, V53, P240, DOI 10.1007/s00262-003-0468-6
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Zou GM, 2002, EUR CYTOKINE NETW, V13, P186
   Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806
NR 91
TC 9
Z9 9
U1 2
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2015
VL 103
IS 1
BP 170
EP 184
DI 10.1002/jbm.a.35150
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU4HT
UT WOS:000345572100020
PM 24616366
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Akilbekova, D
   Philiph, R
   Graham, A
   Bratlie, KM
AF Akilbekova, Dana
   Philiph, Rachel
   Graham, Austin
   Bratlie, Kaitlin M.
TI Macrophage reprogramming: Influence of latex beads with various
   functional groups on macrophage phenotype and phagocytic uptake in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cytokines; in vitro; latex beads; macrophage reprogramming; phenotypes
ID TUMOR-ASSOCIATED MACROPHAGES; ALTERNATIVE ACTIVATION; MICROSPHERES;
   LIPOPOLYSACCHARIDE; POLARIZATION; EXPRESSION; GENERATION; DELIVERY;
   CELLS; SIZE
AB Macrophages play a crucial role in initiating immune responses with various functions ranging from wound healing to antimicrobial actions. The type of biomaterial is suggested to influence macrophage phenotype. Here, we show that exposing M1- and M2-activated macrophages to polystyrene latex beads bearing different functional groups can alter secretion profiles, providing a possible method for altering the course of the host response. Macrophages were stimulated with either lipopolysaccharide or interleukin (IL) 4 and cultured for 24 h with 10 different latex beads. Proinflammatory cytokines (tumor necrosis factor , monocyte chemotactic protein 1) and nitrite served as markers for the M1 phenotype and proangiogenic cytokine (IL-10) and arginase activity for M2 cells. The ability of the macrophages to phagocytize Escherichia coli particles and water contact angles of the polymers were also assessed. Different patterns of cytokine expression and phagocytosis activity were induced by the various particles. Particles did not polarize the cells toward one specific phenotype versus another, but rather induced changes in both pro- and anti-inflammatory markers. Our results suggest a dependence of pro- and anti-inflammatory cytokines and phagocytic activities on material type and cytokine stimuli. These data also illustrate how biomaterials can be exploited to alter host responses for drug delivery and tissue engineering applications. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 262-268, 2015.
C1 [Akilbekova, Dana; Philiph, Rachel; Graham, Austin; Bratlie, Kaitlin M.] Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
   [Bratlie, Kaitlin M.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.
RP Bratlie, KM (reprint author), Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
EM kbratlie@iastate.edu
RI Akilbekova, Dana/L-3319-2016
OI Akilbekova, Dana/0000-0003-3694-0355
FU National Science Foundation [CBET-1227867]; Roy J. Carver Charitable
   Trust [13-4265]; NSF ARI-R2 (the renovation of the research laboratories
   used for these studies) [CMMI-0963224]
FX Contract grant sponsor: National Science Foundation; contract grant
   number: CBET-1227867; Contract grant sponsor: Roy J. Carver Charitable
   Trust; contract grant number: 13-4265; Contract grant sponsor: NSF
   ARI-R2 (the renovation of the research laboratories used for these
   studies); contract grant number: CMMI-0963224
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bansal V, 2003, CURR OPIN CLIN NUTR, V6, P223, DOI [10.1097/00075197-200303000-00012, 10.1097/01.mco.0000058594.27240.12]
   Barth KA, 2013, J BIOMED MATER RES A, V101, P2679, DOI 10.1002/jbm.a.34562
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689
   DesPalma M, 2008, CANCER CELL, V14, P299
   Frick VC, 2006, J LONG TERM MED IMPL, V16, P423
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992
   Hanes J, 1995, Pharm Biotechnol, V6, P389
   Hao NB, 2012, CLIN DEV IMMUNOL, V2012
   Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1
   Henneke P, 2004, J EXP MED, V199, P1, DOI 10.1084/jem.20031256
   Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216
   HOROWITZ SM, 1991, J ORTHOPAED RES, V9, P406, DOI 10.1002/jor.1100090313
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Katakura T, 2004, J IMMUNOL, V172, P1407, DOI 10.4049/jimmunol.172.3.1407
   LaVan DA, 2002, NAT REV DRUG DISCOV, V1, P77, DOI 10.1038/nrd707
   Lynn AD, 2011, ACTA BIOMATER, V7, P123, DOI 10.1016/j.actbio.2010.07.033
   Makino K, 2003, COLLOID SURFACE B, V27, P33, DOI 10.1016/S0927-7765(02)00042-5
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Naim JO, 1998, COLLOID SURFACE B, V11, P79, DOI 10.1016/S0927-7765(98)00023-X
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   SUNG YJ, 1991, J LEUKOCYTE BIOL, V50, P49
   Tomioka H, 2012, CLIN DEV IMMUNOL, V2012, P1
   van Schilfgaarde R, 1999, J MOL MED-JMM, V77, P199, DOI 10.1007/s001090050336
   vansOss CJ, 1978, ANNU REV MICROBIOL, V32, P19
   Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711
NR 32
TC 17
Z9 17
U1 2
U2 43
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2015
VL 103
IS 1
BP 262
EP 268
DI 10.1002/jbm.a.35169
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU4HT
UT WOS:000345572100029
PM 24639060
DA 2018-10-20
ER

PT J
AU Shirosaki, Y
   Hirai, M
   Hayakawa, S
   Fujii, E
   Lopes, MA
   Santos, JD
   Osaka, A
AF Shirosaki, Yuki
   Hirai, Masashi
   Hayakawa, Satoshi
   Fujii, Eiji
   Lopes, Maria A.
   Santos, Jose D.
   Osaka, Akiyoshi
TI Preparation and in vitro cytocompatibility of chitosan-siloxane hybrid
   hydrogels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE chitosan-siloxane hybrid; hydrogel; biodegradability; cytocompatibility;
   silicon species
ID SUBCHONDRAL BONE; SILICATE HYBRIDS; DEFECTS; SITU; BIOMATERIAL;
   SCAFFOLD; GELATION; VEHICLE; CELLS; GLASS
AB Injectable systems can be used in minimally invasive surgical applications. Although chitosan-glycerophosphate hydrogel systems are biodegradable and biocompatible, the long periods of time required for their effective gelation have severely limited their clinical application. The challenges currently facing researchers in this field are therefore focused on shortening the gelation time and biocompatibility of these materials to develop hydrogels suitable for clinical application. Chitosan and -glycidoxypropyltrimethoxysilane (GPTMS) hybrids have recently demonstrated good cytocompatibility with respect to human osteoblastic cells (MG63) and human bone marrow cells. Although these precursor sols could form gels under physiological conditions, they required neutralization with a sodium hydroxide solution. In this study, the chitosan-GPTMS hybrid systems were neutralized with glycerophosphate to prepare injectable hydrogels. The results revealed that the gelation time of the hydrogels could be controlled by the amount of GPTMS in the precursor sols. The in vitro cytocompatibility of the hydrogels were evaluated in terms of the proliferation of MG63 cells cultured either directly onto the hydrogels or indirectly onto the cell culture plate under a hydrogel insert. In the former case, the cells showed good attachment and proliferated for up to 7 days. Similar results were observed in the in direct culture. These results suggest that this new chitosan-GPTMS hydrogel could potentially be used as an injectable biomaterial in clinical applications. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 289-299, 2015.
C1 [Shirosaki, Yuki] Kyushu Inst Technol, Frontier Res Acad Young Researchers, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan.
   [Hirai, Masashi; Hayakawa, Satoshi; Osaka, Akiyoshi] Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Tsushima, Okayama 7008530, Japan.
   [Fujii, Eiji] Ind Technol Ctr, Kita Ku, Haga, Okayama 7011296, Japan.
   [Lopes, Maria A.; Santos, Jose D.] Univ Porto, Fac Engn, CEMUC, Dept Met & Mat Engn, P-4200465 Oporto, Portugal.
RP Shirosaki, Y (reprint author), Kyushu Inst Technol, Frontier Res Acad Young Researchers, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan.
EM yukis@lsse.kyutech.ac.jp
RI HAYAKAWA, Satoshi/B-2104-2011; Lopes, Maria A./P-4442-2014
OI HAYAKAWA, Satoshi/0000-0002-1097-8614; Lopes, Maria
   A./0000-0003-4105-8148; Santos, Jose Domingos/0000-0002-6871-9850
FU Kinki Chiho-Hatsumei Center Foundation; Ministry of Education, Culture,
   Sports, Science and Technology for Atomic Energy Facilities; Kazuchika
   Okura Memorial Foundation
FX Contract grant sponsor: Kinki Chiho-Hatsumei Center Foundation, a Grant
   for the Promotion of Science and Technology in Okayama Prefecture, which
   was provided by the Ministry of Education, Culture, Sports, Science and
   Technology for Atomic Energy Facilities, and the Kazuchika Okura
   Memorial Foundation
CR Ahmadi R, 2008, J BIOMED MATER RES A, V86A, P824, DOI 10.1002/jbm.a.31676
   BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311
   Bielby RC, 2005, TISSUE ENG, V11, P479, DOI 10.1089/ten.2005.11.479
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chevrier A, 2007, OSTEOARTHR CARTILAGE, V15, P316, DOI 10.1016/j.joca.2006.08.007
   Cho JY, 2005, BIOMACROMOLECULES, V6, P3267, DOI 10.1021/bm050313s
   Davis RS, 2003, J NONCRYST SOLIDS, V315, P197
   DOMARD A, 1983, INT J BIOL MACROMOL, V5, P49, DOI 10.1016/0141-8130(83)90078-8
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gabrielli L, 2013, CHEM-EUR J, V19, P7856, DOI 10.1002/chem.201204326
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   Hench LL, 2002, J INORG MATER, V17, P897
   Hoemann CD, 2007, J BIOMED MATER RES A, V83A, P521, DOI 10.1002/jbm.a.31365
   Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.08.014, 10.1016/j.biomaterials.2003.10.092]
   Prochazkova S, 1999, CARBOHYD POLYM, V38, P115, DOI 10.1016/S0144-8617(98)00108-8
   Shirosaki Y, 2005, BIOMATERIALS, V26, P485, DOI 10.1016/j.biomaterials.2004.02.056
   Shirosaki Y., 2013, INT J MAT CHEM, V3, P1
   Shirosaki Y, 2008, CHEM ENG J, V137, P122, DOI 10.1016/j.cej.2007.10.012
   Shirosaki Y, 2010, J CERAM SOC JPN, V118, P989, DOI 10.2109/jcersj2.118.989
   Shirosaki Y, 2009, J NANOSCI NANOTECHNO, V9, P3714, DOI 10.1166/jnn.2009.NS56
   Shirosaki Y, 2009, ACTA BIOMATER, V5, P346, DOI 10.1016/j.actbio.2008.07.022
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Xynos JD, 2000, CALCIFIED TISSUE INT, V67, P321
   Xynos JD, 2001, J BIOMED MATER RES, V55, P151
   ZHANG M, 1994, BIOSCI BIOTECH BIOCH, V58, P1906, DOI 10.1271/bbb.58.1906
   Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3
NR 31
TC 9
Z9 9
U1 5
U2 56
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2015
VL 103
IS 1
BP 289
EP 299
DI 10.1002/jbm.a.35171
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU4HT
UT WOS:000345572100033
PM 24677593
DA 2018-10-20
ER

PT J
AU Zhang, K
   Yang, SY
   Yang, SY
   Bai, L
   Li, P
   Liu, D
   Schurman, JR
   Wooley, PH
AF Zhang, Kai
   Yang, Shang-You
   Yang, Shuye
   Bai, Ling
   Li, Peng
   Liu, Dong
   Schurman, John R., II
   Wooley, Paul H.
TI Different influence of Ti, PMMA, UHMWPE, and Co-Cr particles on
   peripheral blood monocytes during periprosthetic inflammation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE aseptic loosening; wear debris; cell trafficking; monocytes;
   inflammation
ID PARTICULATE WEAR DEBRIS; MURINE AIR POUCH; BONE-CEMENT PARTICLES;
   REVISION TOTAL HIP; IN-VITRO; JOINT REPLACEMENT; UNITED-STATES;
   GENE-TRANSFER; OSTEOBLASTS; SURGERY
AB This study investigated cellular trafficking and inflammatory markers in orthopedic biomaterial particle-challenged human peripheral blood monocytes (PBMCs) using a murine immunodeficiency (SCID) model. Periprosthetic tissues from aseptic loosening patients were transplanted into muscles of SCID mice. PBMCs from the same patients were stimulated in vitro with Ti-6Al-4V, PMMA, UHMWPE, or Co-Cr particles for 3 days before administered intraperitoneally to the periprosthetic tissue-implanted mice. The xenografts were harvested 2 weeks later for histological and molecular analyses. Significant cell infiltration was obvious in the transplanted tissues from mice transfused with Ti-alloy, PMMA and UHMWPE-provoked PBMCs compared to controls, and UHMWPE-provoked PBMCs group accumulated significantly more cells among all groups. There were ubiquitous TRAP+ stained cells in all xenografts from particle-stimulated PBMCs mice. Immunohistochemical staining indicated that significantly more IL-1 and TNF positive cells occurred in Ti and PMMA groups; while the UHMWPE group resulted in stronger positive MCP-1 and IL-6 stains. Polymerase chain reaction (PCR) confirmed overexpression of both IL-1 and TNF in Ti and PMMA-stimulated groups; and more MIP-1 gene expression developed in the UHMWPE group. Overall, different type of orthopedic materials influenced the trafficking ability of particle-activated PBMCs which may depend on upregulation of various proinflammatory cytokines and chemokines. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 358-364, 2015.
C1 [Zhang, Kai; Yang, Shuye; Li, Peng; Liu, Dong] Affiliated Hosp, Binzhou Med Coll, Dept Orthopaed, Binzhou, Peoples R China.
   [Yang, Shang-You; Yang, Shuye; Wooley, Paul H.] Wichita State Univ, Dept Biol Sci, Wichita, KS 67214 USA.
   [Yang, Shang-You; Bai, Ling; Wooley, Paul H.] Orthopaed Res Inst, Wichita, KS 67214 USA.
   [Schurman, John R., II] Adv Orthopaed Associates PA, Wichita, KS USA.
RP Yang, SY (reprint author), Wichita State Univ, Dept Biol Sci, Wichita, KS 67214 USA.
EM shang-you.yang@viachristi.org
OI Yang, Shang-You/0000-0002-8835-5302
FU Orthopaedic Research & Education Foundation, USA; National Natural
   Science Foundation of China [81241061]
FX Contract grant sponsor: Orthopaedic Research & Education Foundation,
   USA; Contract grant sponsor: National Natural Science Foundation of
   China; contract grant number: No. 81241061
CR Bergeson AG, 2013, J ARTHROPLASTY, V28, P172, DOI 10.1016/j.arth.2013.01.005
   Biffl WL, 1996, ARCH SURG-CHICAGO, V131, P24
   BOBYN JD, 1995, CLIN ORTHOP RELAT R, P21
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155
   Dasa V, 2012, CLIN ORTHOP RELAT R, V470, P1879, DOI 10.1007/s11999-011-2191-5
   Fritz EA, 2006, J BIOMED MATER RES A, V77A, P192, DOI 10.1002/jbm.a.30609
   Fritz EA, 2002, J ORTHOPAED RES, V20, P490, DOI 10.1016/S0736-0266(01)00154-1
   Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108
   Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I
   Goodman Stuart B, 2013, Instr Course Lect, V62, P201
   Hallab NJ, 2005, J BIOMED MATER RES A, V74A, P124, DOI 10.1002/jbm.a.30345
   Henegouwen MIV, 1998, AM J SURG, V175, P311
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Jiang YP, 2013, J BIOMED MATER RES A, V101, P2817, DOI 10.1002/jbm.a.34595
   Jiang YP, 2013, ACTA ORTHOP BELG, V79, P1
   Koreny T, 2006, ARTHRITIS RHEUM, V54, P3221, DOI 10.1002/art.22134
   Kotake S, 1996, J BONE MINER RES, V11, P88
   KRAEMER WJ, 1995, J APPL BIOMATER, V6, P225, DOI 10.1002/jab.770060402
   Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441
   LEE JM, 1992, J BONE JOINT SURG BR, V74, P380
   Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200
   Lin E, 2000, SURGERY, V127, P117, DOI 10.1067/msy.2000.101584
   Matthews JB, 2000, J BIOMED MATER RES, V52, P296, DOI 10.1002/1097-4636(200011)52:2<296::AID-JBM8>3.0.CO;2-9
   Musib Mrinal K, 2011, J Long Term Eff Med Implants, V21, P281
   Nakashima Y, 1999, J BONE JOINT SURG BR, V81B, P155, DOI 10.1302/0301-620X.81B1.8884
   Nesbit M, 2001, J IMMUNOL, V166, P6483, DOI 10.4049/jimmunol.166.11.6483
   Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599
   Rao AJ, 2012, ACTA BIOMATER, V8, P2815, DOI 10.1016/j.actbio.2012.03.042
   Ren PG, 2008, BIOMATERIALS, V29, P4760, DOI 10.1016/j.biomaterials.2008.09.004
   Sethi RK, 2003, BIOMATERIALS, V24, P2561, DOI 10.1016/S0142-9612(03)00056-5
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712
   Sud S, 2001, INFLAMMATION, V25, P361, DOI 10.1023/A:1012898513512
   Taichman RS, 2000, BRIT J HAEMATOL, V108, P275
   Vermes C, 2001, J BONE JOINT SURG AM, V83A, P201, DOI 10.2106/00004623-200102000-00007
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
   Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368
   Yang S, 2002, INFLAMM RES, V51, P342, DOI 10.1007/PL00000313
   Yang SY, 2011, J ORTHOP RES, V29, P781, DOI 10.1002/jor.21287
   Yang SY, 2005, J BONE JOINT SURG AM, V87A, P1088, DOI 10.2106/JBJS.D.02052
   Zhang K, 2009, INFLAMM RES, V58, P837, DOI 10.1007/s00011-009-0051-5
   Zhang L, 2010, GENE THER, V17, P1262, DOI 10.1038/gt.2010.64
NR 42
TC 9
Z9 10
U1 1
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2015
VL 103
IS 1
BP 358
EP 364
DI 10.1002/jbm.a.35176
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU4HT
UT WOS:000345572100040
PM 24659563
DA 2018-10-20
ER

PT J
AU Veres, SP
   Brennan-Pierce, EP
   Lee, JM
AF Veres, Samuel P.
   Brennan-Pierce, Ellen P.
   Lee, J. Michael
TI Macrophage-like U937 cells recognize collagen fibrils with
   strain-induced discrete plasticity damage
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen fibril; discrete plasticity; macrophage; U937; mechanical
   overload; ultrastructure
ID HUMAN ALVEOLAR MACROPHAGES; DECELLULARIZED PERICARDIAL BIOMATERIAL;
   FIBRONECTIN GENE-EXPRESSION; ACHILLES-TENDON RUPTURE;
   SURFACE-MORPHOLOGY; I COLLAGEN; EXTRACELLULAR-MATRIX; PULMONARY
   MACROPHAGES; ANKLE SPRAIN; LIGAMENT
AB At its essence, biomechanical injury to soft tissues or tissue products means damage to collagen fibrils. To restore function, damaged collagen must be identified, then repaired or replaced. It is unclear at present what the kernel features of fibrillar damage are, how phagocytic or synthetic cells identify that damage, and how they respond. We recently identified a nanostructural motif characteristic of overloaded collagen fibrils that we have termed discrete plasticity. In this study, we have demonstrated that U937 macrophage-like cells respond specifically to overload-damaged collagen fibrils. Tendons from steer tails were bisected, one half undergoing 15 cycles of subrupture mechanical overload and the other serving as an unloaded control. Both halves were decellularized, producing sterile collagen scaffolds that contained either undamaged collagen fibrils, or fibrils with discrete plasticity damage. Matched-pairs were cultured with U937 cells differentiated to a macrophage-like form directly on the substrate. Morphological responses of the U937 cells to the two substratesand evidence of collagenolysis by the cellswere assessed using scanning electron microscopy. Enzyme release into medium was quantified for prototypic matrix metalloproteinase-1 (MMP-1) collagenase, and MMP-9 gelatinase. When adherent to damaged collagen fibrils, the cells clustered less, showed ruffled membranes, and frequently spread: increasing their contact area with the damaged substrate. There was clear structural evidence of pericellular enzymolysis of damaged collagenbut not of control collagen. Cells on damaged collagen also released significantly less MMP-9. These results show that U937 macrophage-like cells recognize strain-induced discrete plasticity damage in collagen fibrils: an ability that may be important to their removal or repair. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 397-408, 2015.
C1 [Veres, Samuel P.] St Marys Univ, Div Engn, Halifax, NS B3H 3C3, Canada.
   [Veres, Samuel P.; Lee, J. Michael] Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada.
   [Brennan-Pierce, Ellen P.] Colorado State Univ, Coll Engn, Ft Collins, CO 80523 USA.
   [Lee, J. Michael] Dalhousie Univ, Dept Appl Oral Sci, Halifax, NS, Canada.
RP Veres, SP (reprint author), St Marys Univ, Div Engn, Halifax, NS B3H 3C3, Canada.
EM sam.veres@smu.ca
OI Veres, Samuel/0000-0001-6308-4836
FU Killam Trust; Natural Sciences and Engineering Research Council of
   Canada (NSERC)
FX Contract grant sponsor: Killam Trust (Postdoctoral Funding to S.P.V.);
   Contract grant sponsor: Natural Sciences and Engineering Research
   Council of Canada (NSERC) (to J.M.L.)
CR ADACHI K, 1988, AM J PATHOL, V133, P193
   AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872
   AMIEL D, 1991, MATRIX, V11, P184, DOI 10.1016/S0934-8832(11)80157-5
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Ariganello MB, 2010, J BIOMED MATER RES A, V93A, P280, DOI 10.1002/jbm.a.32554
   Ariganello MB, 2009, J HEART VALVE DIS, V18, P187
   Bramono DS, 2005, CONNECT TISSUE RES, V46, P53, DOI 10.1080/03008200590935556
   Bruns J, 2000, KNEE SURG SPORT TR A, V8, P364, DOI 10.1007/s001670000149
   Chamberlain CS, 2011, CONNECT TISSUE RES, V52, P203, DOI 10.3109/03008207.2010.511355
   Chamberlain CS, 2009, WOUND REPAIR REGEN, V17, P206, DOI 10.1111/j.1524-475X.2009.00465.x
   CHANDRASEKHAR S, 1983, P NATL ACAD SCI-BIOL, V80, P4747, DOI 10.1073/pnas.80.15.4747
   Chen Y, 1997, SCANNING, V19, P349, DOI 10.1002/sca.4950190505
   DAVIS GS, 1980, EXP LUNG RES, V1, P281, DOI 10.3109/01902148009069649
   Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001
   DEPORTER DA, 1979, J PERIODONTAL RES, V14, P323, DOI 10.1111/j.1600-0765.1979.tb00796.x
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   ENGVALL E, 1978, J EXP MED, V147, P1584, DOI 10.1084/jem.147.6.1584
   FINCH GL, 1982, J RETICULOENDOTH SOC, V32, P1
   FRANK C, 1983, AM J SPORT MED, V11, P379, DOI 10.1177/036354658301100602
   FRANK C, 1983, Journal of Orthopaedic Research, V1, P179, DOI 10.1002/jor.1100010209
   Godbout C, 2010, J ORTHOP RES, V28, P1084, DOI 10.1002/jor.21092
   Gowen BB, 2000, MATRIX BIOL, V19, P61, DOI 10.1016/S0945-053X(99)00052-9
   GRINNELL F, 1981, J INVEST DERMATOL, V76, P181, DOI 10.1111/1523-1747.ep12525694
   HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407
   HOPPER KE, 1976, IMMUNOLOGY, V30, P249
   Hubbard TJ, 2008, J ATHL TRAINING, V43, P523, DOI 10.4085/1062-6050-43.5.523
   Hubbard TJ, 2009, ARCH PHYS MED REHAB, V90, P1142, DOI 10.1016/j.apmr.2009.01.020
   Iwuagwu FC, 1998, PLAST RECONSTR SURG, V102, P2064, DOI 10.1097/00006534-199811000-00038
   Jensen KT, 2008, AM J SPORT MED, V36, P1347, DOI 10.1177/0363546508314431
   JOHANSSON S, 1980, BIOCHEM J, V187, P521, DOI 10.1042/bj1870521
   Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672
   JOZSA L, 1989, ACTA ORTHOP SCAND, V60, P469, DOI 10.3109/17453678909149322
   Karousou E, 2008, CLIN ORTHOP RELAT R, V466, P1577, DOI 10.1007/s11999-008-0255-y
   Kastelic J., 1980, Symposia of the Society for Experimental Biology, P397
   Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544
   KNORZER E, 1986, ARCH ORTHOP TRAUM SU, V105, P113, DOI 10.1007/BF00455845
   Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943
   Koyama Y, 2000, ARCH HISTOL CYTOL, V63, P71, DOI 10.1679/aohc.63.71
   LAWS G, 1988, J BONE JOINT SURG BR, V70, P390
   Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007
   Lo IKY, 2004, AM J SPORT MED, V32, P1223, DOI 10.1177/0363546503262200
   Marsolais D, 2003, LAB INVEST, V83, P991, DOI 10.1097/01.LAB.0000078688.07696.AC
   Matheson LA, 2002, J BIOMED MATER RES, V61, P505, DOI 10.1002/jbm.10286
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   Matheson LA, 2006, BIOCHEM CELL BIOL, V84, P763, DOI 10.1139/O06-093
   Matthews JB, 2001, J MATER SCI-MATER M, V12, P249, DOI 10.1023/A:1008967200706
   McDade JK, 2013, ACTA BIOMATER, V9, P7191, DOI 10.1016/j.actbio.2013.02.021
   MCDONALD JA, 1988, ANNU REV CELL BIOL, V4, P183, DOI 10.1146/annurev.cellbio.4.1.183
   McKee MD, 1996, ANAT RECORD, V245, P394, DOI 10.1002/(SICI)1097-0185(199606)245:2<394::AID-AR19>3.0.CO;2-K
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   Neurath M, 1992, EUR SURG RES S2, V24, P72
   NEURATH MF, 1994, ACTA ORTHOP SCAND, V65, P71, DOI 10.3109/17453679408993722
   OKADA Y, 1992, J BIOL CHEM, V267, P21712
   Oshiro W, 2003, J HAND SURG-AM, V28A, P814, DOI 10.1053/S0363-5023(03)00366-6
   POSTLETHWAITE AE, 1981, J EXP MED, V153, P494, DOI 10.1084/jem.153.2.494
   QUAN SG, 1977, EXP CELL RES, V109, P71, DOI 10.1016/0014-4827(77)90045-3
   RENNARD SI, 1981, P NATL ACAD SCI-BIOL, V78, P7147, DOI 10.1073/pnas.78.11.7147
   Riley GP, 2002, MATRIX BIOL, V21, P185, DOI 10.1016/S0945-053X(01)00196-2
   RUCKLIDGE GJ, 1986, COLLAGEN REL RES, V6, P41
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707
   Screen HRC, 2005, ANN BIOMED ENG, V33, P1090, DOI 10.1007/s10439-005-5777-9
   STEVEN FS, 1975, INJURY, V6, P317, DOI 10.1016/0020-1383(75)90181-3
   SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504
   Svensson RB, 2011, CONNECT TISSUE RES, V52, P415, DOI 10.3109/03008207.2010.551569
   SVOBODA ELA, 1980, J ULTRA MOL STRUCT R, V72, P169, DOI 10.1016/S0022-5320(80)90054-4
   Torp S., 1975, COLSTON PAP, V26, P223
   VANDERREST M, 1991, FASEB J, V5, P2814
   Veres SP, 2014, MATRIX BIOL, V33, P54, DOI 10.1016/j.matbio.2013.07.003
   Veres SP, 2013, J ORTHOP RES, V31, P731, DOI 10.1002/jor.22292
   Veres SP, 2012, BIOPHYS J, V102, P2876, DOI 10.1016/j.bpj.2012.05.022
   Verollet C, 2011, EUR J IMMUNOL, V41, P2805, DOI 10.1002/eji.201141538
   WARHEIT DB, 1988, J APPL PHYSIOL, V64, P1953
   WARHEIT DB, 1984, EXP LUNG RES, V6, P71, DOI 10.3109/01902148409087896
   Weitkamp B, 1999, FASEB J, V13, P1445
   Willett TL, 2008, J ORTHOP RES, V26, P1605, DOI 10.1002/jor.20672
   Willett TL, 2007, ANN BIOMED ENG, V35, P1961, DOI 10.1007/s10439-007-9375-x
   Willett TL, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000933
   Yagil-Kelmer E, 2004, J ORTHOPAED RES, V22, P832, DOI 10.1016/j.orthres.2003.10.022
   YAMAUCHI K, 1987, J CLIN INVEST, V80, P1720, DOI 10.1172/JCI113263
NR 80
TC 6
Z9 6
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2015
VL 103
IS 1
BP 397
EP 408
DI 10.1002/jbm.a.35156
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU4HT
UT WOS:000345572100044
PM 24616426
DA 2018-10-20
ER

PT J
AU Alemon, B
   Flores, M
   Ramirez, W
   Huegel, JC
   Broitman, E
AF Alemon, B.
   Flores, M.
   Ramirez, W.
   Huegel, J. C.
   Broitman, E.
TI Tribocorrosion behavior and ions release of CoCrMo alloy coated with a
   TiAlVCN/CNx multilayer in simulated body fluid plus bovine serum albumin
SO TRIBOLOGY INTERNATIONAL
LA English
DT Article
DE Tribocorrosion; CoCrMo; TiAlVCN/CNx multilayer; Bovine serum albumin
ID AMORPHOUS-CARBON NITRIDE; CORROSION PROPERTIES; IMPLANT ALLOY; CNX
   FILMS; COATINGS; TIN; DISSOLUTION; RESISTANCE; BINDING; WATER
AB While the CoCrMo biomaterial is currently employed in artificial joints, there are medical concerns regarding its metal ion release and material loss caused by tribocorrosion. In this work, a TiAlVCN/CNx multilayer coating has been employed to improve the tribocorrosion-resistance of the CoCrMo substrate. During the tribocorrosion test, with the sample immersed in a simulated body fluid containing bovine serum albumin, open-circuit potential measurements showed more noble potential as well as a reduction of both the friction coefficient and wear-rate during the sliding phase. Inductive coupled plasma results demonstrate that the multilayer coating effectively blocked the emigration of metallic ions. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Alemon, B.; Flores, M.; Ramirez, W.] Univ Guadalajara, CUCEI, Dept Ingn Proyectos, Los Belenes 45101, Zapopan Jal, Mexico.
   [Alemon, B.; Huegel, J. C.] Tecnol Monterrey, Zapopan 45201, Jalisco, Mexico.
   [Broitman, E.] Linkoping Univ, IFM, Thin Films Phys Div, SE-58183 Linkoping, Sweden.
RP Alemon, B (reprint author), Univ Guadalajara, CUCEI, Dept Ingn Proyectos, J Guadalupe Zuno 48, Los Belenes 45101, Zapopan Jal, Mexico.
EM balemon@itesm.mx
RI Huegel, Joel/G-7891-2012
OI Huegel, Joel/0000-0002-5661-5026; Broitman, Esteban/0000-0003-3277-1945;
   Flores, M./0000-0002-2917-8561
FU CONACYT [FOMIX Jal-2010-10-149472]; Swedish Government Strategic
   Research Area in Materials Science on Functional Materials at Linkoping
   University (Faculty Grant SFO-Mat-LiU) [2009-00971]; Tecnologico de
   Monterrey research seed fund
FX The authors acknowledge the financial support received from CONACYT,
   FOMIX Jal-2010-10-149472. EB acknowledges the Swedish Government
   Strategic Research Area in Materials Science on Functional Materials at
   Linkoping University (Faculty Grant SFO-Mat-LiU # 2009-00971). JH and BA
   acknowledges support from the Tecnologico de Monterrey research seed
   fund. The authors acknowledge Dr. Susann Schmidt and Dr. Lars-Ake
   Naaslund from Linkoping University (Sweden) for the XPS characterization
   and further discussions and to Lizette Reyes, Luis Manuel Aparicio from
   Tecnologico de Monterrey and Luis Alberto Lopez from Universidad de
   Guadalajara for the ions release test and ICP measurements.
CR Alemon B, 2014, NUCL INSTRUM METH B, V331, P134, DOI 10.1016/j.nimb.2013.12.040
   ASTURIZAGA O, 1993, SURF COAT TECH, V61, P30, DOI 10.1016/0257-8972(93)90198-W
   Bal W, 2013, BBA-GEN SUBJECTS, V1830, P5444, DOI 10.1016/j.bbagen.2013.06.018
   Balagna C, 2012, MAT SCI ENG C-MATER, V32, P887, DOI 10.1016/j.msec.2012.02.007
   Bayon R, 2010, ANAL BIOANAL CHEM, V396, P2855, DOI 10.1007/s00216-010-3538-6
   Larbi AB, 2006, SURF COAT TECH, V201, P1511, DOI 10.1016/j.surfcoat.2006.02.025
   Bettini E, 2013, INT J ELECTROCHEM SC, V8, P11791
   Booth L, 2011, MATERIALS, V4, P857, DOI 10.3390/ma4050857
   Braic M, 2005, SURF COAT TECH, V200, P1014, DOI 10.1016/j.surfcoat.2005.02.140
   Broitman E, 2012, J PHYS CONF SER, V370, DOI 10.1088/1742-6596/370/1/012009
   Broitman E, 2010, SURF COAT TECH, V204, P3349, DOI 10.1016/j.surfcoat.2010.03.038
   Broitman E, 2001, WEAR, V248, P55, DOI 10.1016/S0043-1648(00)00519-6
   Broitman E, 2000, DIAM RELAT MATER, V9, P1984, DOI 10.1016/S0925-9635(00)00352-6
   Bull SJ, 1996, SURF COAT TECH, V78, P173, DOI 10.1016/0257-8972(94)02407-3
   Casaban J L, 2011, TRIBOL INT, V44, P318
   Charitidis CA, 2010, INT J REFRACT MET H, V28, P51, DOI 10.1016/j.ijrmhm.2009.08.003
   Chastain J, 1992, HDB XRAY PHOTOELECTR
   Christenson RH, 2001, CLIN CHEM, V47, P464
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Flores M, 2003, THIN SOLID FILMS, V433, P217, DOI 10.1016/S0040-6090(03)00340-7
   Goldberg JR, 2004, BIOMATERIALS, V25, P851, DOI 10.1016/S0142-9612(03)00606-9
   Grips VKW, 2006, THIN SOLID FILMS, V514, P204, DOI 10.1016/j.tsf.2006.03.008
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   Hart AJ, 2010, ACTA BIOMATER, V6, P4439, DOI 10.1016/j.actbio.2010.06.006
   Helsen Jozef A, BIOMEDICAL ENG
   Hesketh J, 2013, TRIBOL INT, V65, P128, DOI 10.1016/j.triboint.2013.02.025
   Hodgson AWE, 2004, ELECTROCHIM ACTA, V49, P2167, DOI 10.1016/j.electacta.2003.12.043
   Hovsepian P.E., 2012, IOP C SERIES MAT SCI, V39
   Karimi S, 2014, MAT SCI ENG C-MATER, V40, P435, DOI 10.1016/j.msec.2014.04.007
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lewis AC, 2005, J BIOMED MATER RES A, V73A, P456, DOI 10.1002/jbm.a.30368
   Liang H, 2001, J INORG BIOCHEM, V85, P167, DOI 10.1016/S0162-0134(01)00195-7
   Liu DG, 2011, SURF COAT TECH, V206, P165, DOI 10.1016/j.surfcoat.2011.07.007
   Lou HQ, 1996, DIAM RELAT MATER, V5, P1303, DOI 10.1016/0925-9635(96)00557-2
   Luo QS, 2011, J MATER CHEM, V21, P9746, DOI 10.1039/c1jm10707k
   Mathew MT, 2014, J MECH BEHAV BIOMED, V29, P199, DOI 10.1016/j.jmbbm.2013.08.018
   Mathew MT, 2011, WEAR, V271, P1210, DOI 10.1016/j.wear.2011.01.086
   Mathew MT, 2009, ADV TRIBOL, DOI 10.1155/2009/250986
   Metikos-Hukovic M, 2006, ACTA BIOMATER, V2, P693, DOI 10.1016/j.actbio.2006.06.002
   MISCHLER S, 1993, TRIBOLOGY S, V25, P245, DOI 10.1016/S0167-8922(08)70380-8
   Mischler S, 2013, WEAR, V297, P1081, DOI 10.1016/j.wear.2012.11.061
   NIST, 2003, NIST XRAY PHOT SPECT
   Oliver WC, 1992, J MATER RES, V7, P564
   Panigrahi P, 2014, J BIOMED MATER RES B, V102, P850, DOI 10.1002/jbm.b.33067
   Ratner Buddy D., 2012, BIOMATERIALS SCI INT
   Rodil SE, 2004, DIAM RELAT MATER, V13, P1521, DOI 10.1016/j.diamond.2003.11.008
   Sargeant A, 2007, MATER DESIGN, V28, P155, DOI 10.1016/j.matdes.2005.05.018
   Services U.S.D.o.H.H., 2010, REC SPEC MET MET HIP
   Silva-Bermudez P, 2013, SURF COAT TECH, V233, P147, DOI 10.1016/j.surfcoat.2013.04.028
   Szivek JA, 1996, J ARTHROPLASTY, V11, P952, DOI 10.1016/S0883-5403(96)80137-9
   Thowarth G, 2010, ACTA BIOMATER, V6, P2335
   Turkan U, 2006, SURF COAT TECH, V200, P5020, DOI 10.1016/j.surfcoat.2005.05.005
   Vidal CV, 2010, COLLOID SURFACE B, V80, P1, DOI 10.1016/j.colsurfb.2010.05.005
   Vidal CV, 2008, CORROS SCI, V50, P1954, DOI 10.1016/j.corsci.2008.04.002
   Virtanen S, 2008, ACTA BIOMATER, V4, P468, DOI 10.1016/j.actbio.2007.12.003
   Was GS, 1996, THIN SOLID FILMS, V286, P1, DOI 10.1016/S0040-6090(96)08905-5
   Wood J K, 2007, J PHYS D, V40, P5502
   Yan Y, 2007, WEAR, V263, P1105, DOI 10.1016/j.wear.2007.01.114
   Zhang K, 2012, SURF COAT TECH, V206, P4040, DOI 10.1016/j.surfcoat.2012.03.085
NR 59
TC 18
Z9 19
U1 5
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-679X
EI 1879-2464
J9 TRIBOL INT
JI Tribol. Int.
PD JAN
PY 2015
VL 81
BP 159
EP 168
DI 10.1016/j.triboint.2014.08.011
PG 10
WC Engineering, Mechanical
SC Engineering
GA AU2TA
UT WOS:000345469200017
DA 2018-10-20
ER

PT J
AU Carvalho, M
   Costa, LM
   Pereira, JE
   Shirosaki, Y
   Hayakawa, S
   Santos, JD
   Geuna, S
   Fregnan, F
   Cabrita, AM
   Mauricio, AC
   Varejao, AS
AF Carvalho, Miguel
   Costa, Luis M.
   Pereira, Jose E.
   Shirosaki, Yuki
   Hayakawa, Satoshi
   Santos, Jose D.
   Geuna, Stefano
   Fregnan, Federica
   Cabrita, Antonio M.
   Mauricio, Ana C.
   Varejao, Artur S.
TI The role of hybrid chitosan membranes on scarring process following
   lumbar surgery: post-laminectomy experimental model
SO NEUROLOGICAL RESEARCH
LA English
DT Article
DE Chitosan-silane; Epidural fibrosis; Hybrid chitosan; Laminectomy; Lumbar
   surgery
ID RAT MODEL; DISC HERNIATION; REGENERATION; REPAIR
AB Objectives: Post-operative scarring process on lumbar surgery is object of several studies mainly because of the epidural fibrosis formation. Hybrid chitosan have shown promising effect on fibrosis prevention. The aim of this study was to determine the influence of chitosan-silane membrane on the lumbar surgery scarring process. These membranes have improved mechanical strength which makes them suitable to maintain a predefined shape.
   Methods: A two level lumbar laminectomy was performed in 14 New Zealand male rabbits. Laminectomy sites were randomly selected for biomaterial or control. Chitosan membranes were prepared and care was taken in order to make it adapted to the bone defect dimensions covering the totality of the defect including the bone margins. Histological analysis was performed by haematoxylin/eosin and by Masson's trichrome staining four weeks after laminectomy.
   Results: Microscope observations revealed the presence of a well-organized regenerating tissue, integrated in the surrounding vertebral bone tissue with a regular and all-site interface on the chitosan sites, in clear contrast with the presence of a disorganized regenerating tissue with aspects consistent with the persistence of a chronic inflammatory condition, on control sites.
   Discussion: The results of this study clearly demonstrated that hybrid chitosan had an organizing effect on post-operative scarring process. The presence of the hybrid chitosan membrane resulted on a well-organized tissue integrated in the surrounding vertebral bone tissue with signs of regenerative bone tissue in continuity with native bone. This can be a major feature on the dynamics of epidural fibrosis formation.
C1 [Carvalho, Miguel] CHUC, Dept Neurosurg, Coimbra, Portugal.
   [Costa, Luis M.; Pereira, Jose E.; Varejao, Artur S.] UTAD, Dept Vet Sci, P-5000801 Vila Real, Portugal.
   [Shirosaki, Yuki] Kyushu Inst Technol, Frontier Res Acad Young Researchers, Kitakyushu, Fukuoka 804, Japan.
   [Hayakawa, Satoshi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan.
   [Santos, Jose D.] Univ Porto, CEMUC, Fac Engn, Dept Met & Mat Engn, P-4100 Oporto, Portugal.
   [Geuna, Stefano; Fregnan, Federica] Univ Turin, Dept Clin & Biol Sci, I-10124 Turin, Italy.
   [Cabrita, Antonio M.] Univ Coimbra, Fac Med, Dept Expt Pathol, Coimbra, Portugal.
   [Mauricio, Ana C.] Univ Porto, ICBAS, Dept Clin Vet, Oporto, Portugal.
   [Mauricio, Ana C.; Varejao, Artur S.] Inst Ciencias Tecnol Agr & Agro Alimentares ICETA, CECA, Oporto, Portugal.
RP Varejao, AS (reprint author), UTAD, Dept Vet Sci, P-5000801 Vila Real, Portugal.
EM avarejao@utad.pt
RI HAYAKAWA, Satoshi/B-2104-2011
OI HAYAKAWA, Satoshi/0000-0002-1097-8614; Varejao,
   Artur/0000-0002-0736-3635; Mauricio, Ana Colette/0000-0002-0018-9363;
   Pereira, Jose/0000-0003-1963-441X; Santos, Jose
   Domingos/0000-0002-6871-9850; Cabrita, Antonio/0000-0001-5165-5849
FU Project TRIBONE [11458]; European Community FEDER fund
   [OE/AGR/UI0211/2011, QREN 2008/1372]
FX Project TRIBONE, No. 11458, co-financed by the European Community FEDER
   fund through ON2 - O Novo Norte - North Portugal Regional Operational
   Program 2007-2013 and from the program COMPETE - Programa Operacional
   Factores de Competitividade, project Pest-OE/AGR/UI0211/2011, and from
   project QREN I&DT Cluster in Development of Products for Regenerative
   Medicine and Cell Therapies - Biomat & Cell QREN 2008/1372.
CR Alkalay RN, 2003, SPINE, V28, P1659, DOI 10.1097/00007632-200308010-00006
   Amado S, 2008, BIOMATERIALS, V29, P4409, DOI 10.1016/j.biomaterials.2008.07.043
   Chang JJ, 2012, CARBOHYD POLYM, V88, P1304, DOI 10.1016/j.carbpol.2012.02.011
   Cho Y, 2012, EXP NEUROL, V233, P126, DOI 10.1016/j.expneurol.2011.09.028
   Cho Y, 2010, J EXP BIOL, V213, P1513, DOI 10.1242/jeb.035162
   Chuang JP, 2010, KAOHSIUNG J MED SCI, V26, P357, DOI 10.1016/S1607-551X(10)70059-0
   Cortez PP, 2008, KEY ENG MATER, V361-363, P1265, DOI 10.4028/www.scientific.net/KEM.361-363.1265
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Ehni BL, 2005, SPINE SURG TECHNIQUE, P601
   Frederickson RC, 1996, NEUROSURGERY, V38, P861
   Sandoval-Sanchez JH, 2012, WORLD NEUROSURG, V77, P577, DOI [10.1016/j.wneu.2011.07.007, 10.1016/J.WNEU.2011.07.007]
   Javedan S, 2003, NEUROSURGERY, V52, P160, DOI 10.1227/01.NEU.0000039180.36338.6f
   Javedan S, 2003, NEUROSURGERY, V52, P162
   Klopp Lisa S, 2004, Neurosurg Focus, V16, pE2
   Koebbe Christopher J, 2002, Neurosurg Focus, V13, pE3
   Liu J, 2010, SPINE J, V10, P441, DOI 10.1016/j.spinee.2010.02.017
   NORTH RB, 1991, NEUROSURGERY, V28, P685, DOI 10.1227/00006123-199105000-00008
   Ozer AF1, 2006, NEUROSURGERY S1, V59
   Rodgers KE, 2003, SPINE J, V3, P284
   Rosner MK, 2011, YOUMANS NEUROLOGICAL, P2919
   Ross JS, 1996, NEUROSURGERY, V38, P855, DOI 10.1227/00006123-199604000-00053
   Sangsanoh P, 2010, EUR POLYM J, V46, P428, DOI 10.1016/j.eurpolymj.2009.10.029
   Schofferman Jerome, 2003, Spine J, V3, P400, DOI 10.1016/S1529-9430(03)00122-0
   Shirosaki Y, 2008, CHEM ENG J, V137, P122, DOI 10.1016/j.cej.2007.10.012
   Shirosaki Y, 2009, ACTA BIOMATER, V5, P346, DOI 10.1016/j.actbio.2008.07.022
   Simoes Maria J., 2010, Italian Journal of Anatomy and Embryology, V115, P190
   Su CH, 2012, EUR J PHARMACOL, V674, P7, DOI 10.1016/j.ejphar.2011.10.028
   Waguespack A, 2002, PAIN MED, V3, P18, DOI 10.1046/j.1526-4637.2002.02007.x
   Weinstein JN, 2008, SPINE, V33, P2789, DOI 10.1097/BRS.0b013e31818ed8f4
   Wenger M, 2001, NEUROSURGERY, V49, P329, DOI 10.1097/00006123-200108000-00013
   Wenger M, 2001, NEUROSURGERY, V49, P334
   Yucesoy K, 2000, SPINAL CORD, V38, P442, DOI 10.1038/sj.sc.3101029
   Zhou JA, 2010, J THORAC CARDIOV SUR, V140, P801, DOI 10.1016/j.jtcvs.2009.11.030
NR 33
TC 2
Z9 2
U1 2
U2 25
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0161-6412
EI 1743-1328
J9 NEUROL RES
JI Neurol. Res.
PD JAN
PY 2015
VL 37
IS 1
BP 23
EP 29
DI 10.1179/1743132814Y.0000000414
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AT9DQ
UT WOS:000345228600004
PM 24965895
DA 2018-10-20
ER

PT J
AU Lopez-Lopez, E
   Moreno, R
   Baudin, C
AF Lopez-Lopez, Emilio
   Moreno, Rodrigo
   Baudin, Carmen
TI Fracture strength and fracture toughness of zirconium titanate-zirconia
   bulk composite materials
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE Reaction sintering; Fracture strength; Fracture toughness; ZrTiO4-ZrO2
   composites; Structural applications
ID THERMAL-SHOCK APPLICATIONS; HIGH-TEMPERATURE; MECHANICAL-PROPERTIES;
   MULLITE COMPOSITE; ELASTIC BEHAVIOR; EXPANSION; RESISTANCE; CERAMICS;
   BIOMATERIAL; ZRTIO4
AB Zirconium titanate zirconia based materials could be suggested for applications involving temperature variations. The determination of mechanical properties such as fracture strength and fracture toughness is necessary to evaluate the response of materials during their use in these kinds of applications. In this work, fracture strength (sigma(f)) and fracture toughness (K-IC) of two zirconium titanate zirconia bulk composites (Z(Y)T70 and Z(Y)T50) have been determined at room temperature by 4 point bending tests and by stable fracture tests using a crack mouth opening displacement (CMOD) as control variable. Furthermore, fracture strength has been determined at high temperature for both composites. Critical defects are responsible for fracture initiation at room and high temperature of Z(Y)T70. Coalescence of microcracks is responsible for fracture initiation at room and high temperature of Z(Y)T50. K-IC values for Z(Y)T70 and Z(Y)T50 are 2.1 +/- 0.3 and 0.6 +/- 0.1 MPa.m(1/2), respectively. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Lopez-Lopez, Emilio; Moreno, Rodrigo; Baudin, Carmen] CSIC, Inst Ceram & Vidrio, E-28049 Madrid, Spain.
RP Lopez-Lopez, E (reprint author), Global Innovat Ctr, Element Six Fermi Ave,Harwell Campus, Chilton OX11 0QR, Oxon, England.
EM emilioll@icv.csic.es
RI Moreno, Rodrigo/L-3750-2017
OI Moreno, Rodrigo/0000-0002-4826-5193; Baudin, Carmen/0000-0002-9037-0931
FU Spanish Ministry of Science and Innovation [MAT2009-14369-C02-01];
   Community of Madrid (Spain); European Social Fund [CPI/0552/2007]
FX The work in Madrid was supported by Spanish Ministry of Science and
   Innovation under contract MAT2009-14369-C02-01. E. Lopez-Lopez
   acknowledges to Community of Madrid (Spain) and European Social Fund for
   economical support by CPI/0552/2007 contract.
CR BANSAL GK, 1976, J AM CERAM SOC, V59, P87, DOI 10.1111/j.1151-2916.1976.tb09406.x
   Borrell A, 2014, COMPOS PART B-ENG, V56, P330, DOI 10.1016/j.compositesb.2013.08.046
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Garcia-Prieto A, 2010, J EUR CERAM SOC, V30, P3297, DOI 10.1016/j.jeurceramsoc.2010.08.007
   IKAWA H, 1988, J AM CERAM SOC, V71, P120, DOI 10.1111/j.1151-2916.1988.tb05827.x
   Liu ZG, 2009, J ALLOY COMPD, V473, pL17, DOI 10.1016/j.jallcom.2008.05.053
   Lopez-Lopez E, 2013, J EUR CERAM SOC, V33, P3195, DOI 10.1016/j.jeurceramsoc.2013.06.026
   Lopez-Lopez E, 2012, J EUR CERAM SOC, V32, P4083, DOI 10.1016/j.jeurceramsoc.2012.07.027
   Lopez-Lopez E, 2012, J EUR CERAM SOC, V32, P1205, DOI 10.1016/j.jeurceramsoc.2011.11.024
   Lopez-Lopez E, 2012, J EUR CERAM SOC, V32, P299, DOI 10.1016/j.jeurceramsoc.2011.08.004
   Lopez-Lopez E, 2011, BOL SOC ESP CERAM V, V50, P169, DOI 10.3989/cyv.222011
   Lopez-Lopez E, 2010, J EUR CERAM SOC, V30, P981, DOI 10.1016/j.jeurceramsoc.2009.10.012
   Lopez-Lopez E, 2009, J EUR CERAM SOC, V29, P3219, DOI 10.1016/j.jeurceramsoc.2009.06.003
   MORISHIMA H, 1987, J MATER SCI LETT, V6, P389, DOI 10.1007/BF01756772
   MORISHIMA H, 1986, J AM CERAM SOC, V69, pC226
   ORANGE G, 1985, J MATER SCI, V20, P2533, DOI 10.1007/BF00556085
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   ROY R, 1989, ANNU REV MATER SCI, V19, P59, DOI 10.1146/annurev.ms.19.080189.000423
   Shen ZJ, 2001, ADV MATER, V13, P214, DOI 10.1002/1521-4095(200102)13:3<214::AID-ADMA214>3.0.CO;2-5
   Szutkowska M, 2004, J MATER PROCESS TECH, V153, P868, DOI 10.1016/j.jmatprotec.2004.04.406
   Tuan WH, 2002, J EUR CERAM SOC, V22, P2827, DOI 10.1016/S0955-2219(02)00043-2
NR 21
TC 4
Z9 4
U1 1
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
EI 1873-619X
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD JAN
PY 2015
VL 35
IS 1
BP 277
EP 283
DI 10.1016/j.jeurceramsoc.2014.08.005
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA AS2QE
UT WOS:000344123700030
DA 2018-10-20
ER

PT J
AU Jindarat, W
   Sungsoontorn, S
   Rattanadecho, P
AF Jindarat, W.
   Sungsoontorn, S.
   Rattanadecho, P.
TI ANALYSIS OF ENERGY CONSUMPTION IN A COMBINED MICROWAVE-HOT AIR SPOUTED
   BED DRYING OF BIOMATERIAL: COFFEE BEANS
SO EXPERIMENTAL HEAT TRANSFER
LA English
DT Article
DE specific energy consumption; energy efficiency; microwave energy
ID COMBUSTION; EFFICIENCY; VACUUM
AB In this study, an energy model based on the first law of thermodynamics is developed to evaluated energy efficiency and specific energy consumption. The influences of hot air temperature and initial weight of coffee beans on energy consumption are considered. Furthermore, a comparison between combined microwave-hot air spouted bed drying and hot air spouted bed drying methods on energy consumption is also investigated in detail. The results show that energy efficiency as well as energy consumption depends on hot air temperature, initial weight of coffee bean, and typical drying methods (combined microwave-hot air spouted bed and hot air spouted bed). The optimum drying condition is also achieved in this study.
C1 [Jindarat, W.; Sungsoontorn, S.; Rattanadecho, P.] Thammasat Univ, Fac Engn, Dept Mech Engn, Ctr Excellence Electromagnet Energy Utilizat Engn, Pathum Thani 12120, Thailand.
RP Rattanadecho, P (reprint author), Thammasat Univ, Fac Engn, Dept Mech Engn, Rangsit Campus, Pathum Thani 12120, Thailand.
EM ratphadu@engr.tu.ac.th
FU Thailand Research Fund; National Research University Project of
   Thailand, Office of the Higher Education Commission
FX This work was supported by the Thailand Research Fund and National
   Research University Project of Thailand, Office of the Higher Education
   Commission.
CR Alibas I, 2007, BIOSYST ENG, V96, P495, DOI 10.1016/j.biosystemseng.2006.12.011
   Boyaci IH, 2009, FOOD BIOPROCESS TECH, V2, P353, DOI 10.1007/s11947-008-0064-z
   Cheng J, 2008, ENERG FUEL, V22, P2422, DOI 10.1021/ef7005244
   Cunniff P., 1995, OFFICIAL METHODS ANA, P2
   Datta A. K., 2001, HDB MICROWAVE TECHNO, P69
   Dincer I, 2004, INT J HEAT MASS TRAN, V47, P645, DOI 10.1016/j.ijheatmasstransfer.2003.08.013
   Feng H., 1998, J FOOD SCI, V47, P1499
   Feng YF, 2012, DRY TECHNOL, V30, P1482, DOI 10.1080/07373937.2012.691929
   Gazis A, 2008, EXP HEAT TRANSFER, V21, P257, DOI 10.1080/08916150802291087
   Goksu EI, 2005, J FOOD ENG, V66, P463, DOI 10.1016/j.foodeng.2004.04.017
   Holtz E, 2009, DRY TECHNOL, V27, P173, DOI 10.1080/07373930802603334
   Jindarat W, 2011, DRY TECHNOL, V29, P926, DOI 10.1080/07373937.2011.560318
   Lakshmi S., 2005, J FOOD ENG, V78, P715
   Leiker M, 2004, HOLZ ROH WERKST, V62, P203, DOI 10.1007/s00107-004-0479-9
   Lipinski W, 2008, EXP HEAT TRANSFER, V21, P73, DOI 10.1080/08916150701647843
   Metaxas A C., 1983, IND MICROWAVE HEATIN, p[5, 28, 43, 211, 217, 278, 284]
   Poli G, 2006, MAT SCI ENG A-STRUCT, V441, P149, DOI 10.1016/j.msea.2006.08.114
   Prommas R, 2010, INT COMMUN HEAT MASS, V37, P372, DOI 10.1016/j.icheatmasstransfer.2009.12.006
   Rattanadecho P., 2001, INT COMMUNICATIONS H, V28, P605
   Schiffmann R. F., 1995, HDB IND DRYING
   Sharma G. P., 2005, J FOOD ENG, V31, P1921
   Soysal Y, 2006, BIOSYST ENG, V93, P403, DOI 10.1016/j.biosystemseng.2006.01.017
   Vadivambal R., 2009, FOOD BIOPROCESS TECH, V3, P161
   Varith J, 2007, J FOOD ENG, V81, P459, DOI 10.1016/j.jfoodeng.2006.11.023
   Vongpradubchai S., 2009, CHEM ENG PROCESS, V33, P472
NR 25
TC 6
Z9 6
U1 1
U2 35
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0891-6152
EI 1521-0480
J9 EXP HEAT TRANSFER
JI Exp. Heat Transf.
PY 2015
VL 28
IS 2
BP 107
EP 124
DI 10.1080/08916152.2013.821544
PG 18
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA AN1VI
UT WOS:000340371500001
DA 2018-10-20
ER

EF